PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ma, SJ; Dong, ZZ; Huang, YF; Liu, JY; Zhang, JT				Ma, Shijie; Dong, Zizheng; Huang, Yanfei; Liu, Jing-Yuan; Zhang, Jian-Ting			Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE AMPK; CANCER; PHOSPHORYLATION; LKB1; GROWTH; TRANSFORMATION; MECHANISMS; SUPPRESSOR; EXPRESSION; UPSTREAM	Eukaryotic translation initiation factor 3 subunit A (eIF3a), the largest subunit of the eIF3 complex, has been shown to be overexpressed in malignant cancer cells, potentially making it a proto-oncogene. eIF3a overexpression can drive cancer cell proliferation but contributes to better prognosis. While its contribution to prognosis was previously shown to be due to its function in suppressing synthesis of DNA damage repair proteins, it remains unclear how eIF3a regulates cancer cell proliferation. In this study, we show using genetic approaches that eIF3a controls cell proliferation by regulating glucose metabolism via the phosphorylation and activation of AMP activated protein kinase alpha (AMPK alpha) at Thr(172) in its kinase activation loop. We demonstrate that eIF3a regulates AMPK activation mainly by controlling synthesis of the small GTPase Rheb, largely independent of the well-known AMPK upstream liver kinase B1 and Ca2+/calmodulin-dependent protein kinase kinase 2, and also independent of mammalian target of rapamycin signaling and glucose levels. Our findings suggest that glucose metabolism in and proliferation of cancer cells may be translationally regulated via a novel eIF3a-Rheb- AMPK signaling axis.	[Ma, Shijie; Dong, Zizheng; Zhang, Jian-Ting] Univ Toledo, Dept Cell & Canc Biol, Coll Med & Life Sci, Toledo, OH 43614 USA; [Huang, Yanfei; Liu, Jing-Yuan] Univ Toledo, Dept Med, Coll Med & Life Sci, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, JT (corresponding author), Univ Toledo, Dept Cell & Canc Biol, Coll Med & Life Sci, Toledo, OH 43614 USA.	jianting.zhang@utoledo.edu	huang, yan/GWM-4747-2022		National Institutes of Health [R01 CA211904]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health grant (grant no.: R01 CA211904) .	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2020, BIOCHEM J, V477, P1939, DOI 10.1042/BCJ20200025; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Eichner LJ, 2019, CELL METAB, V29, P285, DOI 10.1016/j.cmet.2018.10.005; Eom M, 2008, PATHOL INT, V58, P226, DOI 10.1111/j.1440-1827.2008.02215.x; Fang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11662-3; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hindupur SK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0420-z; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laderoute KR, 2014, J BIOL CHEM, V289, P22850, DOI 10.1074/jbc.M114.576371; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Langendorf CG, 2020, J BIOL CHEM, V295, P16239, DOI 10.1074/jbc.RA120.013756; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ma SJ, 2022, ONCOGENE, V41, P2431, DOI 10.1038/s41388-022-02262-5; Martinez-Ordonez A, 2021, ONCOGENE, V40, P2725, DOI 10.1038/s41388-021-01740-6; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Qi J, 2016, CANCER RES, V76, P453, DOI 10.1158/0008-5472.CAN-15-1874; Rios M, 2014, EUR J CANCER, V50, P3187, DOI 10.1016/j.ejca.2014.09.014; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tumia R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00753; Vila IK, 2017, CANCER CELL, V31, P208, DOI 10.1016/j.ccell.2017.01.003; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yin JY, 2018, CANCER LETT, V412, P81, DOI 10.1016/j.canlet.2017.09.055; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	75	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102044	10.1016/j.jbc.2022.102044	http://dx.doi.org/10.1016/j.jbc.2022.102044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35595099	Green Published, gold			2022-12-28	WOS:000829549100009
J	Chen, LT; Li, YC; Sottas, C; Lazaris, A; Petrillo, SK; Metrakos, P; Li, L; Ishida, Y; Saito, T; Garza, S; Papadopoulos, V				Chen, Liting; Li, Yuchang; Sottas, Chantal; Lazaris, Anthoula; Petrillo, Stephanie K.; Metrakos, Peter; Li, Lu; Ishida, Yuji; Saito, Takeshi; Garza, Samuel; Papadopoulos, Vassilios			Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL; AUTOPHAGY; DYNAMICS; BIOLOGY; INNER	Mitochondrial ATPase ATAD3A is essential for cholesterol transport, mitochondrial structure, and cell survival. However, the relationship between ATAD3A and nonalcoholic fatty liver disease (NAFLD) is largely unknown. In this study, we found that ATAD3A was upregulated in the progression of NAFLD in livers from rats with diet-induced nonalcoholic steatohepatitis and in human livers from patients diagnosed with NAFLD. We used CRISPR-Cas9 to delete ATAD3A in Huh7 human hepatocellular carcinoma cells and used RNAi to silence ATAD3A expression in human hepatocytes isolated from humanized liver-chimeric mice to assess the influence of ATAD3A deletion on liver cells with free cholesterol (FC) overload induced by treatment with cholesterol plus 58035, an inhibitor of acetyl-CoA acetyltransferase. Our results showed that ATAD3A KO exacerbated FC accumulation under FC overload in Huh7 cells and also that triglyceride levels were significantly increased in ATAD3A KO Huh7 cells following inhibition of lipolysis mediated by upregulation of lipid droplet-binding protein perilipin-2. Moreover, loss of ATAD3A upregulated autophagosome-associated light chain 3-II protein and p62 in Huh7 cells and fresh human hepatocytes through blockage of autophagosome degradation. Finally, we show the mitophagy mediator, PTEN-induced kinase 1, was downregulated in ATAD3A KO Huh7 cells, suggesting that ATAD3A KO inhibits mitophagy. These results also showed that loss of ATAD3A impaired mitochondrial basal respiration and ATP production in Huh7 cells under FC overload, accompanied by down regulation of mitochondrial ATP synthase. Taken together, we conclude that loss of ATAD3A promotes the progression of NAFLD through the accumulation of FC, triglyceride, and damaged mitochondria in hepatocytes.	[Chen, Liting; Li, Yuchang; Sottas, Chantal; Li, Lu; Garza, Samuel; Papadopoulos, Vassilios] Univ Southern Calif Los Angeles, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Lazaris, Anthoula; Petrillo, Stephanie K.; Metrakos, Peter] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Lazaris, Anthoula; Petrillo, Stephanie K.; Metrakos, Peter] McGill Univ, Dept Surg, Montreal, PQ, Canada; [Ishida, Yuji; Saito, Takeshi] Univ Southern Calif Los Angeles, Keck Sch Med, Dept Med, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA; [Ishida, Yuji] PhoenixBio Co Ltd, Res & Dev Dept, Hiroshima, Hiroshima, Japan; [Ishida, Yuji] Univ Southern Calif Los Angeles, Res Ctr Liver Dis, Los Angeles, CA USA	McGill University; McGill University; PHOENIXBIO CO. LTD.	Papadopoulos, V (corresponding author), Univ Southern Calif Los Angeles, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.	vpapadop@usc.edu	Saito, Takeshi/N-2788-2014	Saito, Takeshi/0000-0002-6165-664X; Garza, Samuel/0000-0001-9688-5445; Lazaris, Anthoula/0000-0002-2173-7891	NIH [P30 DK048522]; USC School of Pharmacy; John Stauffer Dean's Chair in Pharmaceutical Sciences at USC	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC School of Pharmacy; John Stauffer Dean's Chair in Pharmaceutical Sciences at USC	We thank Mr Anthony Rodriguez (USC) for technical assistance with transmission electron microscopy and the Liver Histology Core of the USC Research Center for Liver Diseases for histology services (NIH grant No. P30 DK048522) . This work was supported by funds from the USC School of Pharmacy and the John Stauffer Dean's Chair in Pharmaceutical Sciences at USC.	Arguello G, 2015, BBA-MOL BASIS DIS, V1852, P1765, DOI 10.1016/j.bbadis.2015.05.015; Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chen DY, 2018, CELL BIOL INT, V42, P533, DOI 10.1002/cbin.10929; Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042; Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x; Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094; Fukushima M, 2005, IN VITRO CELL DEV-AN, V41, P321; Gerhold JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15292; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Grattagliano I, 2019, BIOCHEM PHARMACOL, V160, P34, DOI 10.1016/j.bcp.2018.11.020; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Huang T, 2020, INTERN MED J, V50, P1038, DOI 10.1111/imj.14709; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Jin Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113445; Kang SWS, 2019, AM J PHYSIOL-CELL PH, V317, pC942, DOI 10.1152/ajpcell.00051.2019; Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123, DOI 10.14670/HH-25.1123; Li YC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102457; Liu PY, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800164; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140; Pang LJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0136-y; Peralta S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217075; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rousseau D., 2019, J MED THER, V3, P1; Soto-Avellaneda A, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01389-2; Sugahara G, 2020, SEMIN LIVER DIS, V40, P189, DOI 10.1055/s-0040-1701444; Tateno C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142145; Teng Y, 2016, ONCOGENE, V35, P333, DOI 10.1038/onc.2015.86; Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113; Xu KD, 2010, J LIPID RES, V51, P2581, DOI 10.1194/jlr.M005702; Yamasaki C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237809; You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109	36	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102008	10.1016/j.jbc.2022.102008	http://dx.doi.org/10.1016/j.jbc.2022.102008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35513069	Green Published, gold			2022-12-28	WOS:000807750700007
J	Clayton, NS; Fox, M; Vicente-Garcia, JJ; Schroeder, CM; Littlewood, TD; Wilde, JI; Krishnan, K; Brown, MJB; Crafter, C; Mott, HR; Owen, D				Clayton, Natasha S.; Fox, Millie; Vicente-Garcia, Jose J.; Schroeder, Courtney M.; Littlewood, Trevor D.; Wilde, Jonathon, I; Krishnan, Kadalmani; Brown, Murray J. B.; Crafter, Claire; Mott, Helen R.; Owen, Darerca			Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal; tyrosine kinase domain; Src homology-3 (SH3) domain	ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; GTPASE ACTIVITY; P85-ALPHA; CANCER; 3-KINASE; P85; PHOSPHORYLATION; ACTIVATION; MECHANISMS	Activated Cdc42-associated kinase (ACK) is an oncogenic nonreceptor tyrosine kinase associated with poor prognosis in several human cancers. ACK promotes proliferation, in part by contributing to the activation of Akt, the major effector of class 1A phosphoinositide 3-kinases (PI3Ks), which transduce signals via membrane phosphoinositol lipids. We now show that ACK also interacts with other key components of class 1A PI3K signaling, the PI3K regulatory subunits. We demonstrate ACK binds to all five PI3K regulatory subunit isoforms and directly phosphorylates p85 alpha, p85/1, p50 alpha, and p55 alpha on Tyr607 (or analogous residues). We found that phosphorylation of p85/1 promotes cell proliferation in HEK293T cells. We demonstrate that ACK interacts with p85 alpha exclusively in nuclear-enriched cell fractions, where p85 alpha phosphorylated at Tyr607 (pTyr607) also resides, and identify an interaction between pTyr607 and the N-terminal SH2 domain that supports dimerization of the regulatory subunits. We infer from this that ACK targets p110-independent p85 and further postulate that these regulatory subunit dimers undertake novel nuclear functions underpinning ACK activity. We conclude that these dimers represent a previously undescribed mode of regulation for the class1A PI3K regulatory subunits and potentially reveal additional avenues for therapeutic intervention.	[Clayton, Natasha S.; Fox, Millie; Vicente-Garcia, Jose J.; Schroeder, Courtney M.; Littlewood, Trevor D.; Krishnan, Kadalmani; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, Cambridge, England; [Wilde, Jonathon, I; Brown, Murray J. B.] GlaxoSmithKline Med Res Ctr, Screening & Compound Profiling, Stevenage, Herts, England; [Crafter, Claire] AstraZeneca, Biosci, Oncol R&D, Res & Early Dev, Cambridge, England; [Clayton, Natasha S.] Sch Cellular & Mol Med, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Fox, Millie] Astrazeneca, Cell Engn, Discovery Sci, Cambridge, England; [Vicente-Garcia, Jose J.] GlaxoSmithKline, Stockley Pk West,1 3 Ironbridge Rd, Uxbridge UB11 1BT, Middx, England; [Schroeder, Courtney M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Wilde, Jonathon, I] Veracyte, Suite 300,6000 Shoreline Court, San Francisco, CA 94080 USA; [Krishnan, Kadalmani] Levim Biotech, 501 506,TICEL Biopk Phase 2,CSIR Rd, Chennai 600113, Tamil Nadu, India	University of Cambridge; GlaxoSmithKline; AstraZeneca; University of Bristol; AstraZeneca; GlaxoSmithKline; Fred Hutchinson Cancer Center	Mott, HR; Owen, D (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	hrm28@cam.ac.uk; do202@cam.ac.uk			BBSRC DTG/A studentships [BB/F017464/1, BB/A517685/1]; MRC iCASE [MR/N018354/1]; Churchill Scholarship by the Winston Churchill Foundation of the United States; CR-UK [C4750/A19013, C11309/A5148]; National Over-seas Scholarship, Government of India; Cambridge Commonwealth Scholarship	BBSRC DTG/A studentships; MRC iCASE; Churchill Scholarship by the Winston Churchill Foundation of the United States; CR-UK(Cancer Research UK); National Over-seas Scholarship, Government of India; Cambridge Commonwealth Scholarship	This research was supported by BBSRC DTG/A studentships (BB/F017464/1 and BB/A517685/1) to N. S. C. and J.V.-G.; an MRC iCASE (MR/N018354/1) to D.O. and C.C.; a Churchill Scholarship (awarded by the Winston Churchill Foundation of the United States) to C.S.; a CR-UK (C4750/A19013) programme grant to T. D. L.; a National Over-seas Scholarship, Government of India, and a Cambridge Commonwealth Scholarship to K. K. and a CR-UK project grant (C11309/A5148) to D. O. and H. R. M.	Ahmed I, 2004, BIOCHEM BIOPH RES CO, V314, P571, DOI 10.1016/j.bbrc.2003.12.137; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Fox M, 2020, BIOCHEM SOC T, V48, P1397, DOI 10.1042/BST20190845; Fox M, 2019, BIOCHEM SOC T, V47, P1715, DOI 10.1042/BST20190176; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; HAYASHI H, 1993, J BIOL CHEM, V268, P7107; Honorato RV, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.729513; Hoxhaj G, 2020, NAT REV CANCER, V20, P74, DOI 10.1038/s41568-019-0216-7; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Inaba S, 2017, J BIOL CHEM, V292, P1052, DOI 10.1074/jbc.M116.755173; LoPiccolo J, 2015, J BIOL CHEM, V290, P30390, DOI 10.1074/jbc.M115.689604; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Mahajan K, 2017, CANCER CELL, V31, P790, DOI 10.1016/j.ccell.2017.05.003; Mahajan K, 2012, J BIOL CHEM, V287, P22112, DOI 10.1074/jbc.M112.357384; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Mundi PS, 2016, BRIT J CLIN PHARMACO, V82, P943, DOI 10.1111/bcp.13021; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Siegal G, 1998, J MOL BIOL, V276, P461, DOI 10.1006/jmbi.1997.1562; Song L, 2011, ONCOGENE, V30, P1360, DOI 10.1038/onc.2010.506; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tsolakos N, 2018, P NATL ACAD SCI USA, V115, P12176, DOI 10.1073/pnas.1803446115; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; Yokoyama N, 2006, METHOD ENZYMOL, V406, P250, DOI 10.1016/S0076-6879(06)06018-6	46	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101916	10.1016/j.jbc.2022.101916	http://dx.doi.org/10.1016/j.jbc.2022.101916			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35429500	gold, Green Published			2022-12-28	WOS:000807778400002
J	Nagy, ZA; Heja, D; Bencze, D; Kiss, B; Boros, E; Szakacs, D; Fodor, K; Wilmanns, M; Kocsis, A; Dobo, J; Gal, P; Harmat, V; Pal, G				Nagy, Zoltan Attila; Heja, David; Bencze, Daniel; Kiss, Bence; Boros, Eszter; Szakacs, David; Fodor, Krisztian; Wilmanns, Matthias; Kocsis, Andrea; Dobo, Jozsef; Gal, Peter; Harmat, Veronika; Pal, Gabor			Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEINASE-INHIBITOR; ESCHERICHIA-COLI; POTENT INHIBITOR; COMPLEMENT-SYSTEM; CRYSTAL-STRUCTURE; SPECIFICITY; REVEALS; AND-2; PURIFICATION; CHYMOTRYPSIN	Ecotin is a homodimeric serine protease inhibitor produced by many commensal and pathogenic microbes. It functions as a virulence factor, enabling survival of various pathogens in the blood. The ecotin dimer binds two protease molecules, and each ecotin protomer has two protease-binding sites: site1 occupies the substrate-binding groove, whereas site2 engages a distinct secondary region. Owing to the twofold rotational symmetry within the ecotin dimer, sites 1 and 2 of a protomer bind to different protease molecules within the tetrameric complex. Escherichia coli ecotin inhibits trypsin-like, chymotrypsin-like, and elastase-like enzymes, including pancreatic proteases, leukocyte elastase, key enzymes of blood coagulation, the contact and complement systems, and other antimicrobial cascades. Here, we show that mannan-binding lectin-associated serine protease-1 (MASP-1) and MASP-2, essential activators of the complement lectin pathway, and MASP-3, an essential alternative pathway activator, are all inhibited by ecotin. Wedecipher in detail how the preorganization of site1 and site2 within the ecotin dimer contributes to the inhibition of each MASP enzyme. In addition, using mutated and monomeric ecotin variants, we show that site1, site2, and dimerization contribute to inhibition in a surprisingly target-dependent manner. We present the first ecotin:MASP-1 and ecotin:MASP-2 crystal structures, which provide additional insights and permit structural interpretation of the observed functional results. Importantly, we reveal that monomerization completely disables the MASP2-inhibitory, MASP-3-inhibitory, and lectin pathway-inhibitory capacity of ecotin. These findings provide new opportunities to combat dangerous multidrug-resistant pathogens through development of compounds capable of blocking ecotin dimer formation.	[Nagy, Zoltan Attila; Heja, David; Bencze, Daniel; Kiss, Bence; Boros, Eszter; Szakacs, David; Fodor, Krisztian; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Fodor, Krisztian; Wilmanns, Matthias] European Mol Biol Lab, Hamburg Unit, Hamburg, Germany; [Kocsis, Andrea; Dobo, Jozsef; Gal, Peter] Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, Budapest, Hungary; [Harmat, Veronika] ELKH, MTA ELTE Prot Modelling Res Grp, Budapest, Hungary	Eotvos Lorand University; European Molecular Biology Laboratory (EMBL); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network	Pal, G (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	gabor.pal@ttk.elte.hu		Dobo, Jozsef/0000-0001-9187-8502; Boros, Eszter/0000-0002-0639-4739; Nagy, Zoltan Attila/0000-0001-7687-1011; Bencze, Daniel/0000-0001-7169-9515; Heja, David/0000-0002-9283-500X	EMBO Short-Term Fellowship [ASTF 2.00-2011]	EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO))	The work of D. H. at EMBLHamburg was supported by an EMBO Short-Term Fellowship (grant no.: ASTF 2.00-2011).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Clark EA, 2011, J BIOL CHEM, V286, P24015, DOI 10.1074/jbc.M111.225730; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Dobo J, 2014, MOL IMMUNOL, V61, P69, DOI 10.1016/j.molimm.2014.05.013; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Gaboriaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067962; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; GREEN NM, 1953, BIOCHEM J, V54, P347, DOI 10.1042/bj0540347; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Ireland PM, 2014, MICROB PATHOGENESIS, V67-68, P55, DOI [10.1016/j.micpath.2014.01.001, 10]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Kopp ZA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00017; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laboissiere MCA, 2002, J BIOL CHEM, V277, P26623, DOI 10.1074/jbc.M203076200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Lynch NJ, 2005, J IMMUNOL, V174, P4998, DOI 10.4049/jimmunol.174.8.4998; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; MCGRATH ME, 1995, PROTEIN SCI, V4, P141; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Nagy ZA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008232; NAKAJIMA S, 1977, INT ARCH ALLER A IMM, V54, P428, DOI 10.1159/000231858; Nakao M, 2006, J IMMUNOL, V177, P5471, DOI 10.4049/jimmunol.177.8.5471; Narkio-Makela M, 1999, CLIN EXP IMMUNOL, V116, P401; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Oroszlan G, 2016, J IMMUNOL, V196, P857, DOI 10.4049/jimmunol.1501717; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; SEONG IS, 1994, J BIOL CHEM, V269, P21915; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verma S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00063; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SQ, 1998, J MOL BIOL, V279, P945, DOI 10.1006/jmbi.1998.1748; Zelek WM, 2018, IMMUNOBIOLOGY, V223, P744, DOI 10.1016/j.imbio.2018.07.016	63	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101985	10.1016/j.jbc.2022.101985	http://dx.doi.org/10.1016/j.jbc.2022.101985			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35483450	gold, Green Published			2022-12-28	WOS:000807755100004
J	Schiavi-Ehrenhaus, LJ; Romarowski, A; Jablonski, M; Krapf, D; Luque, GM; Buffone, MG				Schiavi-Ehrenhaus, Liza J.; Romarowski, Ana; Jablonski, Martina; Krapf, Dario; Luque, Guillermina M.; Buffone, Mariano G.			The early molecular events leading to COFILIN phosphorylation during mouse sperm capacitation are essential for acrosomal exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; GUINEA-PIG; HAMSTER SPERM; OKADAIC ACID; SRC KINASE; SLINGSHOT; LOCALIZATION; PHOSPHATASES; FAMILY; SPERMATOZOA	The actin cytoskeleton reorganization during sperm capacitation is essential for the occurrence of acrosomal exocytosis (AR) in several mammalian species. Here, we demonstrate that in mouse sperm, within the first minutes of exposure upon capacitating conditions, the activity of RHOA/C and RAC1 is essential for LIMK1 and COFILIN phosphorylation. However, we observed that the signaling pathway involving RAC1 and PAK4 is the main player in controlling actin polymerization in the sperm head necessary for the occurrence of AR. Moreover, we show that the transient phosphorylation of COFILIN is also influenced by the Slingshot family of protein phosphatases (SSH1). The activity of SSH1 is regulated by the dual action of two pathways. On one hand, RHOA/C and RAC1 activity promotes SSH1 phosphorylation (inactivation). On the other hand, the activating dephosphorylation is driven by okadaic acid-sensitive phosphatases. This regulatory mechanism is independent of the commonly observed activating mechanisms involving PP2B and emerges as a new finely tuned modulation that is, so far, exclusively observed in mouse sperm. However, persistent phosphorylation of COFILIN by SSH1 inhibition or okadaic acid did not altered actin polymerization and the AR. Altogether, our results highlight the role of small GTPases in modulating actin dynamics required for AR.	[Schiavi-Ehrenhaus, Liza J.; Jablonski, Martina; Luque, Guillermina M.; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, IBYME, Buenos Aires, DF, Argentina; [Romarowski, Ana] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Krapf, Dario] Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario IBR, Univ Nacl Rosario UNR, Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Massachusetts System; University of Massachusetts Amherst; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Luque, GM; Buffone, MG (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, IBYME, Buenos Aires, DF, Argentina.	gmluque@ibyme.conicet.gov; mgbuffone@ibyme.conicet.gov	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 2015-2294, 2017-3047, 2018-1988]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (PICT 2015-2294, 2017-3047, 2018-1988).	Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baltierrez-Hoyos R, 2012, REPRODUCTION, V144, P123, DOI 10.1530/REP-11-0433; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bastea LI, 2013, BIOCHEM J, V455, P251, DOI 10.1042/BJ20130281; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Cabello-Agueros JF, 2003, CELL MOTIL CYTOSKEL, V56, P94, DOI 10.1002/cm.10135; CAMATINI M, 1991, MOL REPROD DEV, V28, P62, DOI 10.1002/mrd.1080280110; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen SM, 2016, ANDROLOGY-US, V4, P1054, DOI 10.1111/andr.12239; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Delgado-Buenrostro NL, 2005, MOL REPROD DEV, V70, P198, DOI 10.1002/mrd.20192; Ducummon CC, 2006, ZYGOTE, V14, P249, DOI 10.1017/S0967199406003790; Elam WA, 2017, J BIOL CHEM, V292, P19565, DOI 10.1074/jbc.M117.808378; Finkelstein M, 2010, J BIOL CHEM, V285, P39702, DOI 10.1074/jbc.M110.170951; FLAHERTY SP, 1988, ANAT REC, V221, P599, DOI 10.1002/ar.1092210206; Gervasi MG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215897; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Hirohashi N, 2015, REPRODUCTION, V149, P657, DOI 10.1530/REP-15-0017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Itach SBS, 2012, DEV BIOL, V362, P154, DOI 10.1016/j.ydbio.2011.12.002; Ito C, 2016, ANAT SCI INT, V91, P128, DOI 10.1007/s12565-015-0323-9; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lee SY, 2017, PHARMACOL RES, V119, P422, DOI 10.1016/j.phrs.2017.03.003; Luque GM, 2021, FASEB J, V35, DOI 10.1096/fj.202002773RR; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Megnagi B, 2015, CELL TISSUE RES, V362, P665, DOI 10.1007/s00441-015-2229-1; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Ramirez-Ramirez D, 2020, J CELL BIOCHEM, V121, P2864, DOI 10.1002/jcb.29521; Reyes-Miguel T, 2020, REPRODUCTION, V160, P393, DOI 10.1530/REP-19-0577; Romarowski A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218958; Romarowski A, 2016, ADV ANAT EMBRYOL CEL, V220, P129, DOI 10.1007/978-3-319-30567-7_7; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Romarowski A, 2015, DEV BIOL, V405, P237, DOI 10.1016/j.ydbio.2015.07.008; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; TALBOT P, 1978, J EXP ZOOL, V204, P131, DOI 10.1002/jez.1402040112; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; YAGI A, 1992, ANAT RECORD, V233, P61, DOI 10.1002/ar.1092330109; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304; Zhao JW, 2012, AM J MED SCI, V344, P462, DOI 10.1097/MAJ.0b013e318244745b	61	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101988	10.1016/j.jbc.2022.101988	http://dx.doi.org/10.1016/j.jbc.2022.101988			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35487245	gold, Green Published			2022-12-28	WOS:000807755100011
J	Friedman, PA; Sneddon, WB; Mamonova, T; Montanez-Miranda, C; Ramineni, S; Harbin, NH; Squires, KE; Gefter, JV; Magyar, CE; Emlet, DR; Hepler, JR				Friedman, Peter A.; Sneddon, W. Bruce; Mamonova, Tatyana; Montanez-Miranda, Carolina; Ramineni, Suneela; Harbin, Nicholas H.; Squires, Katherine E.; Gefter, Julia, V; Magyar, Clara E.; Emlet, David R.; Hepler, John R.			RGS14 regulates PTH- and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE; SIGNALING 14; SYNAPTIC PLASTICITY; PROXIMAL TUBULES; I COTRANSPORTER; PDZ PROTEINS; TRANSPORT; GROWTH; COMPLEX; INHIBITION	Phosphate homeostasis, mediated by dietary intake, renal absorption, and bone deposition, is incompletely understood because of the uncharacterized roles of numerous implicated protein factors. Here, we identified a novel role for one such element, regulator of G protein signaling 14 (RGS14), suggested by genome-wide association studies to associate with dysregulated Pi levels. We show that human RGS14 possesses a carboxy-terminal PDZ ligand required for sodium phosphate cotransporter 2a (NPT2A) and sodium hydrogen exchanger regulatory factor-1 (NHERF1)-mediated renal Pi transport. In addition, we found using isotope uptake measurements combined with bioluminescence resonance energy transfer assays, siRNA knockdown, pull-down and overlay assays, and molecular modeling that secreted proteins parathyroid hormone (PTH) and fibroblast growth factor 23 inhibited Pi uptake by inducing dissociation of the NPT2A-NHERF1 complex. PTH failed to affect Pi transport in cells expressing RGS14, suggesting that it suppresses hormone-sensitive but not basal Pi uptake. Interestingly, RGS14 did not affect PTH-directed G protein activation or cAMP formation, implying a postreceptor site of action. Further pull-down experiments and direct binding assays indicated that NPT2A and RGS14 bind distinct PDZ domains on NHERF1. We showed that RGS14 expression in human renal proximal tubule epithelial cells blocked the effects of PTH and fibroblast growth factor 23 and stabilized the NPT2A-NHERF1 complex. In contrast, RGS14 genetic variants bearing mutations in the PDZ ligand disrupted RGS14 binding to NHERF1 and subsequent PTH-sensitive Pi transport. In conclusion, these findings identify RGS14 as a novel regulator of hormone-sensitive Pi transport. The results suggest that changes in RGS14 function or abundance may contribute to the hormone resistance and hyperphosphatemia observed in kidney diseases.	[Friedman, Peter A.; Sneddon, W. Bruce; Mamonova, Tatyana; Gefter, Julia, V] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15260 USA; [Montanez-Miranda, Carolina; Ramineni, Suneela; Harbin, Nicholas H.; Squires, Katherine E.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA; [Magyar, Clara E.] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Emlet, David R.] Univ Pittsburgh, Ctr Crit Care Nephrol, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA.; Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15260 USA.; Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA.	paf10@pitt.edu; jhepler@emory.edu		Sneddon, William/0000-0002-7852-8951; Magyar, Clara/0000-0003-2261-0187; Harm, Carolina/0000-0002-5913-1959	National Institutes of Health [DK105811, NS037112, NS102652, GM140632-A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grants DK105811 (to P. A. F.) ; NS037112 and NS102652 (to J. R. H.) ; and GM140632-A1 (to J. R.H. and P. A. F.) . The content is solely the responsibility of the au-thors and does not necessarily represent the official views of the National Institutes of Health.	Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Bonewald LF, 2013, PEDIATR NEPHROL, V28, P563, DOI 10.1007/s00467-012-2309-3; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Brown NE, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.249; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Case DA., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Christov M, 2018, BEST PRACT RES CL EN, V32, P685, DOI 10.1016/j.beem.2018.06.004; Clerin V, 2020, J CLIN INVEST, V130, DOI 10.1172/JCI135665; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; CUSTER M, 1993, PFLUG ARCH EUR J PHY, V424, P203, DOI 10.1007/BF00384343; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Emlet DR, 2017, AM J PHYSIOL-RENAL, V312, pF284, DOI 10.1152/ajprenal.00271.2016; Evans PR, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0353-17.2018; Evans PR, 2018, J PROTEOME RES, V17, P1700, DOI 10.1021/acs.jproteome.8b00027; Evans PR, 2015, PROG MOL BIOL TRANSL, V133, P169, DOI 10.1016/bs.pmbts.2015.03.006; Filipski KJ, 2018, ACS MED CHEM LETT, V9, P440, DOI 10.1021/acsmedchemlett.8b00013; Gattineni J, 2015, VITAM HORM, V98, P249, DOI 10.1016/bs.vh.2015.01.002; Gerber KJ, 2018, J BIOL CHEM, V293, P14616, DOI 10.1074/jbc.RA118.002816; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hernando N, 2021, PHYSIOL REV, V101, P1, DOI 10.1152/physrev.00008.2019; Ho BB, 2021, J MOL ENDOCRINOL, V66, pR23, DOI 10.1530/JME-20-0178; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hynes RO, 2011, CANCER CELL, V20, P689, DOI 10.1016/j.ccr.2011.11.022; Jiang L. I., 2007, J BIOL UDAYANA; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lang F, 2018, KIDNEY BLOOD PRESS R, V43, P1742, DOI 10.1159/000495393; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lek M., 2016, ANALYSIS-UK; Li Y, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0566-1; Long J, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22435; Mahajan A, 2016, AM J HUM GENET, V99, P636, DOI 10.1016/j.ajhg.2016.07.012; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mamonova T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031087; Mamonova T, 2017, BIOCHEMISTRY-US, V56, P2584, DOI 10.1021/acs.biochem.7b00078; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Orosz DE, 2004, IN VITRO CELL DEV-AN, V40, P22; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Robinson-Cohen C, 2017, J AM SOC NEPHROL, V28, P1553, DOI 10.1681/ASN.2016010069; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sneddon WB, 2016, J BIOL CHEM, V291, P18632, DOI 10.1074/jbc.M116.744052; Squires KE, 2018, PHARMACOL REV, V70, P446, DOI 10.1124/pr.117.015354; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Urabe Y., 2012, GENOME WIDE ASS STUD; Vatner DE, 2018, AGING CELL, V17, DOI 10.1111/acel.12751; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vistrup-Parry M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100473; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Yasui T, 2013, J HUM GENET, V58, P588, DOI 10.1038/jhg.2013.59; Zhang QM, 2019, J BIOL CHEM, V294, P4546, DOI 10.1074/jbc.RA119.007421; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	69	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101836	10.1016/j.jbc.2022.101836	http://dx.doi.org/10.1016/j.jbc.2022.101836			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35307350	gold, Green Published			2022-12-28	WOS:000793483000003
J	Li, CY; Chen, Q; Wu, JJ; Ren, J; Zhang, MF; Wang, HK; Li, JC; Tang, Y				Li, Chaoyi; Chen, Qian; Wu, Junjiao; Ren, Jie; Zhang, Mengfei; Wang, Huakun; Li, Jinchen; Tang, Yu			Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; CHINESE PATIENTS; MOLECULAR-BASIS; MUTATIONS; ALLELE; MITF; MELANOMA; MATURATION; STABILITY; LINK	Oculocutaneous albinism type 1 (OCA1), resulting from pathogenic variants in the tyrosinase (TYR) gene, refers to a group of phenotypically heterogeneous autosomal recessive disorders characterized by a partial or a complete absence of pigment in the skin/hair and is also associated with common developmental eye defects. In this study, we identified two novel compound heterozygous TYR variants from a Chinese hypopigmentary patient by whole-exome sequencing. Specif-ically, the two variants were c.-89T > G, located at the core of the initiator E-box (Inr E-box) of the TYR promoter, and p.S16Y (c.47C > A), located within the signal sequence. We performed both in silico analysis and experimental validation and verified these mutations as OCA1 variants that caused either impaired or complete loss of function of TYR. Mecha-nistically, the Inr E-box variant dampened TYR binding to microphthalmia-associated transcription factor, a master transcriptional regulator of the melanocyte development, whereas the S16Y variant contributed to endoplasmic reticu-lum retention, a common and principal cause of impaired TYR activity. Interestingly, we found that the Inr E-box variant creates novel protospacer adjacent motif sites, recognized by nucleases SpCas9 and SaCas9-KKH, respectively, without compromising the functional TYR coding sequence. We further used allele-specific genomic editing by CRISPR acti-vation to specifically target the variant promoter and success-fully activated its downstream gene expression, which could lead to potential therapeutic benefits. In conclusion, this study expands the spectrum of TYR variants, especially those within the promoter and noncoding regions, which can facilitate ge-netic counseling and clinical diagnosis of OCA1.	[Li, Chaoyi; Chen, Qian; Ren, Jie; Zhang, Mengfei; Wang, Huakun; Li, Jinchen; Tang, Yu] Xiangya Hosp, Dept Geriatr, Changsha, Peoples R China; [Li, Chaoyi; Chen, Qian; Ren, Jie; Zhang, Mengfei; Wang, Huakun; Li, Jinchen; Tang, Yu] Xiangya Hosp, Aging Res Ctr, Changsha, Peoples R China; [Li, Chaoyi; Chen, Qian; Wu, Junjiao; Ren, Jie; Zhang, Mengfei; Wang, Huakun; Li, Jinchen; Tang, Yu] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China; [Wu, Junjiao] Xiangya Hosp, Dept Rheumatol & Immunol, Changsha, Peoples R China; [Wu, Junjiao] Xiangya Hosp, Prov Clin Res Ctr Rheumat & Immunol Dis, Changsha, Peoples R China; [Tang, Yu] Cent South Univ, Biobank Xiangya Hosp, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Tang, Y (corresponding author), Xiangya Hosp, Dept Geriatr, Changsha, Peoples R China.; Tang, Y (corresponding author), Xiangya Hosp, Aging Res Ctr, Changsha, Peoples R China.; Tang, Y (corresponding author), Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China.; Tang, Y (corresponding author), Cent South Univ, Biobank Xiangya Hosp, Changsha, Peoples R China.	tangyu-sky@163.com	Tang, Yu/AFK-5483-2022	Tang, Yu/0000-0001-9709-9614	National Natural Sciences Foundation of China [81801200]; Hunan Provincial Natural Science Foundation of China [2019JJ40476]; Talents Startup Fund [2209090550]; Youth Science Foundation [2021Q04]; Central South University, Changsha, China.	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Talents Startup Fund; Youth Science Foundation; Central South University, Changsha, China.	This study was funded by the National Natural Sciences Foundation of China (grant no.: 81801200; to Y. T.) , Hunan Provincial Natural Science Foundation of China (grant no.: 2019JJ40476; to Y. T.) , Talents Startup Fund (grant no.: 2209090550; to Y. T.) , and Youth Science Foundation (grant no.: 2021Q04; to J. J. W.) of Xiangya Hospital, Central South University, Changsha, China.	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; Chaki M, 2011, J INVEST DERMATOL, V131, P260, DOI 10.1038/jid.2010.274; Chen HS, 2010, BIOCHEM BIOPH RES CO, V397, P70, DOI 10.1016/j.bbrc.2010.05.066; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolinska MB, 2017, PIGM CELL MELANOMA R, V30, P41, DOI 10.1111/pcmr.12546; Fang D, 2002, NUCLEIC ACIDS RES, V30, P3096, DOI 10.1093/nar/gkf424; French JD, 2020, TRENDS GENET, V36, P880, DOI 10.1016/j.tig.2020.07.004; Gargiulo A, 2009, MOL THER, V17, P1347, DOI 10.1038/mt.2009.112; Giannelli SG, 2018, HUM MOL GENET, V27, P761, DOI 10.1093/hmg/ddx438; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goding CR, 2019, GENE DEV, V33, P983, DOI 10.1101/gad.324657.119; Grill C, 2013, HUM MOL GENET, V22, P4357, DOI 10.1093/hmg/ddt285; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gu XJ, 2020, NEUROBIOL AGING, V94, DOI 10.1016/j.neurobiolaging.2020.05.005; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kawakami A, 2017, LAB INVEST, V97, P649, DOI 10.1038/labinvest.2017.9; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Kruijt CC, 2018, OPHTHALMOLOGY, V125, P1953, DOI 10.1016/j.ophtha.2018.08.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai XL, 2018, CHEM-EUR J, V24, P47, DOI 10.1002/chem.201704410; Lasseaux E, 2018, PIGM CELL MELANOMA R, V31, P466, DOI 10.1111/pcmr.12688; Li JC, 2018, NUCLEIC ACIDS RES, V46, pD1039, DOI 10.1093/nar/gkx1039; Li PJ, 2018, CRISPR J, V1, P55, DOI 10.1089/crispr.2017.0009; Mondal M, 2016, BRIT J DERMATOL, V175, P1232, DOI 10.1111/bjd.14977; Morice-Picard F, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12173; Norman CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04401-5; Ray K, 2007, PROG RETIN EYE RES, V26, P323, DOI 10.1016/j.preteyeres.2007.01.001; Sarkar D, 2015, EPIGENETICS-US, V10, P103, DOI 10.1080/15592294.2014.1003746; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Um JM, 2012, J EUR ACAD DERMATOL, V26, P1291, DOI 10.1111/j.1468-3083.2011.04286.x; Vetrini F, 2004, MOL CELL BIOL, V24, P6550, DOI 10.1128/mcb.24.15.6550-6559.2004; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Wei AH, 2015, J GENET GENOMICS, V42, P279, DOI 10.1016/j.jgg.2015.05.001; Wei AH, 2010, J INVEST DERMATOL, V130, P716, DOI 10.1038/jid.2009.339; Wu JJ, 2020, THERANOSTICS, V10, P3118, DOI 10.7150/thno.43298; Wu YZ, 2021, AM J HUM GENET, V108, P1891, DOI 10.1016/j.ajhg.2021.08.012; Yang Q, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0842-7; Zeng KX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0914-x; Zhao GH, 2020, CRISPR J, V3, P512, DOI 10.1089/crispr.2020.0071; Zheng HF, 2018, MOL THER-NUCL ACIDS, V11, P34, DOI 10.1016/j.omtn.2018.01.008	47	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101922	10.1016/j.jbc.2022.101922	http://dx.doi.org/10.1016/j.jbc.2022.101922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35413289	gold, Green Published			2022-12-28	WOS:000804923000008
J	Liu, YX; Wang, TV; Cui, YF; Li, CY; Jiang, LF; Rao, Y				Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Li, Chaoyi; Jiang, Lifen; Rao, Yi			STE20 phosphorylation of AMPK-related kinases revealed by biochemical purifications combined with genetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; UPSTREAM KINASE; LKB1; BETA; PAK1; SNF1; AUTOPHOSPHORYLATION; HOMEOSTASIS; PATHWAY; TARGET	We have recently purified mammalian sterile 20 (STE20)- like kinase 3 (MST3) as a kinase for the multifunctional kinases, AMP-activated protein kinase-related kinases (ARKs). However, unresolved questions from this study, such as remaining phosphorylation activities following deletion of the Mst3 gene from human embryonic kidney cells and mice, led us to conclude that there were additional kinases for ARKs. Further purification recovered Ca2+/calmodulin-dependent protein kinase kinases 1 and 2 (CaMKK1 and 2), and a third round of purification revealed mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5) as potential kinases of ARKs. We then demonstrated that MST3 and MAP4K5, both belonging to the STE20-like kinase family, could phosphorylate all 14 ARKs both in vivo and in vitro. Further examination of all 28 STE20 kinases detected variable phosphorylation activity on AMP-activated protein kinase (AMPK) and the salt-inducible kinase 3 (SIK3). Taken together, our results have revealed novel relationships between STE20 kinases and ARKs, with potential physiological and pathological implications.	[Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Rao, Yi] Peking Univ, Coll Chem & Chem Engn, Peking Tsinghua Ctr Life Sci,Sch Life Sci,Sch Pha, Hlth Sci Ctr,Lab Neurochem Biol,Dept Chem Biol,PK, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Rao, Yi] Chinese Inst Brain Res, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Rao, Yi] Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Rao, Yi] Changping Lab, Beijing, Peoples R China; [Li, Chaoyi; Jiang, Lifen] Shenzhen Bay Lab, Inst Mol Physiol, Shenzhen, Guangdong, Peoples R China	Peking University; Capital Medical University; Shenzhen Bay Laboratory	Rao, Y (corresponding author), Peking Univ, Coll Chem & Chem Engn, Peking Tsinghua Ctr Life Sci,Sch Life Sci,Sch Pha, Hlth Sci Ctr,Lab Neurochem Biol,Dept Chem Biol,PK, Beijing, Peoples R China.; Rao, Y (corresponding author), Chinese Inst Brain Res, Beijing, Peoples R China.; Rao, Y (corresponding author), Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China.; Rao, Y (corresponding author), Changping Lab, Beijing, Peoples R China.	yrao@pku.edu.cn						Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Li Q, 2018, DEV CELL, V45, P433, DOI 10.1016/j.devcel.2018.04.014; Li Y., 2021, BIORXIV, DOI [10.1101/2021.11.06. 467421, DOI 10.1101/2021.11.06.467421]; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lopez M, 2016, NAT REV ENDOCRINOL, V12, P421, DOI 10.1038/nrendo.2016.67; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Neumann D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082412; Park M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65647-0; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pombo CM, 2019, ENDOCRINOLOGY, V160, P1111, DOI 10.1210/en.2018-00898; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Quintero OA, 2013, J BIOL CHEM, V288, P37126, DOI 10.1074/jbc.M113.511014; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Russell FM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010186; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	49	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101928	10.1016/j.jbc.2022.101928	http://dx.doi.org/10.1016/j.jbc.2022.101928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35413284	Green Published, gold			2022-12-28	WOS:000817175700011
J	Gahloth, D; Fisher, K; Payne, KAP; Cliff, M; Levy, C; Leys, D				Gahloth, Deepankar; Fisher, Karl; Payne, Karl A. P.; Cliff, Matthew; Levy, Colin; Leys, David			Structural and biochemical characterization of the prenylated flavin mononucleotide-dependent indole-3-carboxylic acid decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLATION; BIOSYNTHESIS; DEGRADATION; RESOLUTION; BENZENE; MODELS; INDOLE; UBIX	The ubiquitous UbiD family of reversible decarboxylases is implicated in a wide range of microbial processes and depends on the prenylated flavin mononucleotide cofactor for catalysis. However, only a handful of UbiD family members have been characterized in detail, and comparison between these has suggested considerable variability in enzyme dynamics and mechanism linked to substrate specificity. In this study, we provide structural and biochemical insights into the indole-3carboxylic acid decarboxylase, representing an UbiD enzyme activity distinct from those previously studied. Structural insights from crystal structure determination combined with small-angle X-ray scattering measurements reveal that the enzyme likely undergoes an open-closed transition as a consequence of domain motion, an event that is likely coupled to catalysis. We also demonstrate that the indole-3-carboxylic acid decarboxylase can be coupled with carboxylic acid reductase to produce indole-3-carboxyaldehyde from indole + CO2 under ambient conditions. These insights provide further evidence for a common mode of action in the widespread UbiD enzyme family.	[Gahloth, Deepankar; Fisher, Karl; Payne, Karl A. P.; Cliff, Matthew; Levy, Colin; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	david.leys@manchester.ac.uk		Cliff, Matthew/0000-0002-7482-0234; Levy, Colin/0000-0002-9724-310X	European Research Council (ERC) [pre-FAB ADG_695013]	European Research Council (ERC)(European Research Council (ERC)European Commission)	The work was supported by European Research Council (ERC) grant pre-FAB ADG_695013. We thank Diamond Light Source for access (proposal number MX12788) for the data collection. We also thank Prof Toyokazy Yoshida (Gifu University) for providing us with the sequence of Arthrobacter nicotiana decarboxylase. We acknowledge Reynard Spiess (Manchester) for assistance in high resolution mass spectrophotometry.	Abu Laban N, 2010, ENVIRON MICROBIOL, V12, P2783, DOI 10.1111/j.1462-2920.2010.02248.x; Aleku GA, 2020, NAT CHEM BIOL, V16, P1255, DOI 10.1038/s41589-020-0603-0; Bailey SS, 2018, J BIOL CHEM, V293, P2272, DOI 10.1074/jbc.RA117.000881; Balaikaite A, 2020, ACS CHEM BIOL, V15, P2466, DOI 10.1021/acschembio.0c00456; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bergmann FD, 2011, ARCH MICROBIOL, V193, P241, DOI 10.1007/s00203-010-0667-4; Budovska M, 2013, BIOORGAN MED CHEM, V21, P6623, DOI 10.1016/j.bmc.2013.08.020; Costantini S, 2008, BIOINFORMATION, V2, P271, DOI 10.6026/97320630002271; Eerhart AJJE, 2012, ENERG ENVIRON SCI, V5, P6407, DOI 10.1039/c2ee02480b; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gahloth D, 2017, NAT CHEM BIOL, V13, P975, DOI [10.1038/nchembio.2434, 10.1038/NCHEMBIO.2434]; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Hu MX, 2010, INDIAN J MICROBIOL, V50, P362, DOI 10.1007/s12088-011-0142-1; Jensen ED, 2021, MICROB BIOTECHNOL, V14, P2617, DOI 10.1111/1751-7915.13774; Kawanabe K, 2021, J BIOSCI BIOENG, V132, P18, DOI 10.1016/j.jbiosc.2021.03.001; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Llevot A, 2016, MACROMOL RAPID COMM, V37, P9, DOI 10.1002/marc.201500474; Marshall S. A., 2019, METHODS; Marshall SA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25278-z; Marshall SA, 2017, ARCH BIOCHEM BIOPHYS, V632, P209, DOI 10.1016/j.abb.2017.07.014; Marshall SA, 2017, J BIOL CHEM, V292, P4623, DOI 10.1074/jbc.M116.762732; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meckenstock RU, 2016, J MOL MICROB BIOTECH, V26, P92, DOI 10.1159/000441358; Mori Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22504-6; Omura H, 1998, EUR J BIOCHEM, V253, P480, DOI 10.1046/j.1432-1327.1998.2530480.x; Payer SE, 2017, ANGEW CHEM INT EDIT, V56, P13893, DOI 10.1002/anie.201708091; Payne KAP, 2021, ACS CATAL, V11, P2865, DOI 10.1021/acscatal.0c05042; Payne KAP, 2019, ACS CATAL, V9, P2854, DOI 10.1021/acscatal.8b04862; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Weber HE, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03472-16; Werpy T., 2004, TOP VALUE ADDED CHEM, V1, DOI [DOI 10.2172/15008859, 10.2172/15008859]; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida T, 2002, BIOSCI BIOTECH BIOCH, V66, P2388, DOI 10.1271/bbb.66.2388	40	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101771	10.1016/j.jbc.2022.101771	http://dx.doi.org/10.1016/j.jbc.2022.101771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35218772	gold, Green Published			2022-12-28	WOS:000793617400009
J	Kushnareva, Y; Moraes, V; Suess, J; Peters, B; Newmeyer, DD; Kuwana, T				Kushnareva, Yulia; Moraes, Vivian; Suess, Julian; Peters, Bjoern; Newmeyer, Donald D.; Kuwana, Tomomi			Disruption of mitochondrial quality control genes promotes caspase-resistant cell survival following apoptotic stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 PROTEIN FAMILY; CANCER-CELLS; TRANSPORT; MITOPHAGY; AUTOPHAGY; MEMBRANE; STRESS; FUNDC1; ROLES	In cells undergoing cell-intrinsic apoptosis, mitochondrial outer membrane permeabilization (MOMP) typically marks an irreversible step in the cell death process. However, in some cases, a subpopulation of treated cells can exhibit a sublethal response, termed "minority MOMP. " In this phenomenon, the affected cells survive, despite a low level of caspase activation and subsequent limited activation of the endonuclease caspaseactivated DNase (DNA fragmentation factor subunit beta). Consequently, these cells can experience DNA damage, increasing the probability of oncogenesis. However, little is known about the minority MOMP response. To discover genes that affect the MOMP response in individual cells, we conducted an imaging-based phenotypic siRNA screen. We identified multiple candidate genes whose downregulation increased the heterogeneity of MOMP within single cells, among which were genes related to mitochondrial dynamics and mitophagy that participate in the mitochondrial quality control (MQC) system. Furthermore, to test the hypothesis that functional MQC is important for reducing the frequency of minority MOMP, we developed an assay to measure the clonogenic survival of caspase-engaged cells. We found that cells deficient in various MQC genes were indeed prone to aberrant post-MOMP survival. Our data highlight the important role of proteins involved in mitochondrial dynamics and mitophagy in preventing apoptotic dysregulation and oncogenesis.	[Kushnareva, Yulia; Moraes, Vivian; Peters, Bjoern; Newmeyer, Donald D.; Kuwana, Tomomi] La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Suess, Julian] Univ Konstanz, Dept Biochem Pharmacol, Constance, Germany	La Jolla Institute for Immunology; University of Konstanz	Kuwana, T (corresponding author), La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA.	tomomi@lji.org			SPARK award from the La Jolla Institute for Immunology Board of Directors;  [R21CA216304]	SPARK award from the La Jolla Institute for Immunology Board of Directors; 	This work was supported by R21CA216304 and a SPARK award from the La Jolla Institute for Immunology Board of Directors (to D. D. N.).	Ader NR, 2019, ELIFE, V8, DOI 10.7554/eLife.40712; Anderson CJ, 2020, CELL DEATH DIFFER, V27, P1896, DOI 10.1038/s41418-019-0469-4; Andrysik Z, 2013, CELL REP, V3, P1346, DOI 10.1016/j.celrep.2013.04.014; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309; Cherok E, 2017, MOL BIOL CELL, V28, P396, DOI 10.1091/mbc.E16-04-0208; Chiche J, 2010, J CELL PHYSIOL, V222, P648, DOI 10.1002/jcp.21984; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Etemad S, 2019, MECH AGEING DEV, V177, P22, DOI 10.1016/j.mad.2018.07.007; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gillies LA, 2015, MOL BIOL CELL, V26, P339, DOI 10.1091/mbc.E13-11-0638; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gomez-Suaga P, 2017, AUTOPHAGY, V13, P1250, DOI 10.1080/15548627.2017.1317913; Gong YN, 2019, FEBS J, V286, P430, DOI 10.1111/febs.14714; Gorgoglione R., 2019, Biochim; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Henrichs V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16972-5; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Jin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08367; Kuang ES, 2013, TRENDS BIOCHEM SCI, V38, P453, DOI 10.1016/j.tibs.2013.06.008; Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809; Kushnareva Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.160; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Kushnareva Y, 2010, ANN NY ACAD SCI, V1201, P50, DOI 10.1111/j.1749-6632.2010.05633.x; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kuwana T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27299; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Lartigue L, 2009, MOL BIOL CELL, V20, P4871, DOI 10.1091/mbc.E09-07-0649; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee CA, 2018, PROTEIN CELL, V9, P693, DOI 10.1007/s13238-017-0469-4; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li Y, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-019-09525-y, 10.1038/s41467-019-12385-1]; Li YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006183; Li YW, 2019, MOL MED REP, V19, P3367, DOI 10.3892/mmr.2019.10041; Lin SJ, 2014, MOL ENDOCRINOL, V28, P805, DOI 10.1210/me.2013-1422; Liu H., 2019, is owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics. Cell Death Differ, V27, P1965; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu S, 2011, MOL ENDOCRINOL, V25, P1301, DOI 10.1210/me.2010-0455; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Mi YJ, 2015, MOL REPROD DEV, V82, P907, DOI 10.1002/mrd.22536; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Murakawa T, 2019, CELL REP, V26, P338, DOI 10.1016/j.celrep.2018.12.050; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Norkett R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00449; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Park S. J., 2017, Cell Rep; Park Y. U., 2010, Proc. Natl. Acad. Sci. U; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Qin Y, 2014, HUM MOL GENET, V23, P2428, DOI 10.1093/hmg/ddt638; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Scott I, 2018, TRENDS CELL BIOL, V28, P346, DOI 10.1016/j.tcb.2018.01.007; Senapedis WT, 2011, MOL BIOL CELL, V22, P1791, DOI 10.1091/mbc.E10-10-0854; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Shen JL, 2016, ONCOTARGET, V7, P32088, DOI 10.18632/oncotarget.8525; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Softic S, 2019, CELL METAB, V30, P735, DOI 10.1016/j.cmet.2019.09.003; Stachel I., 2014, J. Biol; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Venco P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00185; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang TS, 2020, DEV CELL, V53, P627, DOI 10.1016/j.devcel.2020.05.014; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048; Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang QL, 2017, GENE, V596, P45, DOI 10.1016/j.gene.2016.10.005; Zhao YS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20346-2; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	110	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101835	10.1016/j.jbc.2022.101835	http://dx.doi.org/10.1016/j.jbc.2022.101835			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35304098	Green Published, gold, Green Submitted			2022-12-28	WOS:000793692600003
J	Lentini, JM; Bargabos, R; Chen, C; Fu, D				Lentini, Jenna M.; Bargabos, Rachel; Chen, Chen; Fu, Dragony			Methyltransferase METTL8 is required for 3-methylcytosine modification in human mitochondrial tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						m3C; 3-methylcytosine; METTL8; methyltransferase-like 8; mt; mitochondrial; MTS; mitochondrial targeting sequence; ORF; open reading frame; PHA; Positive Hybridization in the Absence of Modification; RFP; red fluorescent protein; RT; reverse transcriptase; sgRNAs; sequence guide RNAs	BINDING PROTEIN ABP140; POSTTRANSCRIPTIONAL MODIFICATIONS; ANTICODON; TRANSLATION; DEFICIENCY; TRNAS(SER); PREDICTION; LANDSCAPE; DOMAIN; M(3)C	A subset of eukaryotic tRNAs is methylated in the anticodon loop, forming 3-methylcytosine (m3C) modifications. In mammals, the number of tRNAs containing m3C modifications has been expanded to include mitochondrial (mt) tRNA-SerUGA and mt-tRNA-Thr-UGU. However, whereas the enzymes catalyzing m3C formation in nuclear-encoded tRNAs have been identified, the proteins responsible for m3C modification in mt-tRNAs are unknown. Here, we show that m3C formation in human mt-tRNAs is dependent upon the methyltransferase-Like 8 (METTL8) enzyme. We find that METTL8 is a mitochondria-associated protein that interacts with mitochondrial seryl-tRNA synthetase, as well as with mttRNAs containing m3C. We demonstrate that human cells deficient in METTL8 exhibit loss of m3C modification in mttRNAs, but not nuclear-encoded tRNAs. Consistent with the mitochondrial import of METTL8, the formation of m3C in METTL8-deficient cells could be rescued by re-expression of WT METTL8, but not by a METTL8 variant lacking the N-terminal mitochondrial localization signal. Notably, we found METTL8-deficiency in human cells causes alterations in the native migration pattern of mt-tRNA-Ser-UGA, suggesting a role for m3C in tRNA folding. Altogether, these findings demonstrate that METTL8 is required for m3C formation in mt-tRNAs and uncover a potential function for m3C modification in mitochondrial tRNA structure.	[Lentini, Jenna M.; Bargabos, Rachel; Chen, Chen; Fu, Dragony] Univ Rochester, Dept Biol, Ctr RNA Biol, Rochester, NY 14627 USA	University of Rochester	Fu, D (corresponding author), Univ Rochester, Dept Biol, Ctr RNA Biol, Rochester, NY 14627 USA.	dragonyfu@rochester.edu		Fu, Dragony/0000-0002-8725-8658; Chen, Chen/0000-0002-4803-0183; Lentini, Jenna/0000-0002-4069-4102	National Science Foundation CAREER Award [1552126]	National Science Foundation CAREER Award(National Science Foundation (NSF))	Funding and additional information-This work was supported by National Science Foundation CAREER Award 1552126 to D. F.	Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005; Arimbasseri AG, 2016, RNA, V22, P1400, DOI 10.1261/rna.056259.116; Arimbasseri AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005671; Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068; Auffinger P, 1999, J MOL BIOL, V292, P467, DOI 10.1006/jmbi.1999.3080; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Badri KR, 2008, MOL CELL BIOL, V28, P6358, DOI 10.1128/MCB.00333-08; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Colin E, 2021, HAEMATOLOGICA, V106, P3202, DOI 10.3324/haematol.2021.279138; Cui J, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1186; D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611; D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102; de Crecy-Lagard V, 2021, TRENDS MICROBIOL, V29, P41, DOI 10.1016/j.tim.2020.06.010; Dewe JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00214-17; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Grosjean H., 2005, FINE TUNING RNA FUNC, V24; Gu H, 2018, STEM CELL REP, V10, P1807, DOI 10.1016/j.stemcr.2018.03.022; Han L, 2017, RNA, V23, P406, DOI 10.1261/rna.059667.116; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Ignatova VV, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4551; Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Lamichhane TN, 2016, RNA, V22, P583, DOI 10.1261/rna.054064.115; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Lee SA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115432; Lentini JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16321-6; Lin H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04250-4; Mao S, 2021, ACS CHEM BIOL, V16, P76, DOI 10.1021/acschembio.0c00735; Noma A, 2011, RNA, V17, P1111, DOI 10.1261/rna.2653411; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Pereira M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123738; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phizicky EM, 2015, RNA, V21, P483, DOI 10.1261/rna.049932.115; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Vare VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029; Watanabe Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00109; Williford A., 2021, IMPLEMENTATION EVALU; Woodson SA, 2009, METHOD ENZYMOL, V469, P189, DOI 10.1016/S0076-6879(09)69009-1; Xu L, 2017, J BIOL CHEM, V292, P14695, DOI 10.1074/jbc.M117.798298; Yeon SY, 2018, PATHOL ONCOL RES, V24, P617, DOI 10.1007/s12253-017-0287-2; YOKOGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101; Zhang KJ, 2020, HUM MUTAT, V41, P600, DOI 10.1002/humu.23976; Zhang LH, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100968	60	3	3	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101788	10.1016/j.jbc.2022.101788	http://dx.doi.org/10.1016/j.jbc.2022.101788			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35247384	Green Published, gold			2022-12-28	WOS:000793502000010
J	Selles, B; Moseler, A; Caubriere, D; Sun, SK; Ziesel, M; Dhalleine, T; Heriche, M; Wirtz, M; Rouhier, N; Couturier, J				Selles, Benjamin; Moseler, Anna; Caubriere, Damien; Sun, Sheng-Kai; Ziesel, Morgane; Dhalleine, Tiphaine; Heriche, Mathilde; Wirtz, Markus; Rouhier, Nicolas; Couturier, Jeremy			The cytosolic Arabidopsis thaliana cysteine desulfurase ABA3 delivers sulfur to the sulfurtransferase STR18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR SULFURASE; FE-S CLUSTER; NIFS-LIKE DOMAIN; ESCHERICHIA-COLI; PROVIDES INSIGHT; OXIDATIVE STRESS; PROTEIN; SUFS; BIOSYNTHESIS; IDENTIFICATION	The biosynthesis of many sulfur-containing molecules depends on cysteine as a sulfur source. Both the cysteine desulfurase (CD) and rhodanese (Rhd) domain-containing protein families participate in the trafficking of sulfur for various metabolic pathways in bacteria and human, but their connection is not yet described in plants. The existence of natural chimeric proteins containing both CD and Rhd domains in specific bacterial genera, however, suggests a general interaction between these proteins. We report here the biochemical relationships between two cytosolic proteins from Arabidopsis thaliana, a Rhd domain-containing protein, the sulfurtransferase 18 (STR18), and a CD isoform referred to as ABA3, and compare these biochemical features to those of a natural CD-Rhd fusion protein from the bacterium Pseudorhodoferax sp. We observed that the bacterial enzyme is bifunctional exhibiting both CD and STR activities using L-cysteine and thiosulfate as sulfur donors but preferentially using L-cysteine to catalyze transpersulfidation reactions. In vitro activity assays and mass spectrometry analyses revealed that STR18 stimulates the CD activity of ABA3 by reducing the intermediate persulfide on its catalytic cysteine, thereby accelerating the overall transfer reaction. We also show that both proteins interact in planta and form an efficient sulfur relay system, whereby STR18 catalyzes transpersulfidation reactions from ABA3 to the model acceptor protein roGFP2. In conclusion, the ABA3- STR18 couple likely represents an uncharacterized pathway of sulfur trafficking in the cytosol of plant cells, independent of ABA3 function in molybdenum cofactor maturation.	[Selles, Benjamin; Moseler, Anna; Caubriere, Damien; Ziesel, Morgane; Dhalleine, Tiphaine; Heriche, Mathilde; Rouhier, Nicolas; Couturier, Jeremy] Univ Lorraine, IAM, INRAE, Nancy, France; [Sun, Sheng-Kai; Wirtz, Markus] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Couturier, Jeremy] Inst Univ France, Paris, France; [Selles, Benjamin] Univ Lorraine, CNRS, IMoPA, F-54000 Nancy, France; [Moseler, Anna] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Chem Sig, D-53113 Bonn, Germany; [Heriche, Mathilde] Univ Bourgogne Franche Comte, INRAE, Univ Bourgogne, Agroecol,AgroSup Dijon,CNRS, F-21000 Dijon, France	INRAE; Universite de Lorraine; Ruprecht Karls University Heidelberg; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Bonn; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Couturier, J (corresponding author), Univ Lorraine, IAM, INRAE, Nancy, France.; Couturier, J (corresponding author), Inst Univ France, Paris, France.	jeremy.couturier@univ-lorraine.fr	Wirtz, Markus/G-5917-2010	Wirtz, Markus/0000-0001-7790-4022; Moseler, Anna/0000-0003-4641-8093; SELLES, Benjamin/0000-0002-9260-9344; Sun, Shengkai/0000-0001-7688-3928; Couturier, Jeremy/0000-0003-3127-2669; Caubriere, Damien/0000-0001-7877-7838	Feodor Lynen Research Fellowship; Alexander von Humboldt Foundation; Lorraine University of Excellence (LUE)	Feodor Lynen Research Fellowship; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Lorraine University of Excellence (LUE)	Funding and additional information-A. M. is recipient of a Feodor Lynen Research Fellowship, and S. K. S. is a recipient of Humboldt Research Fellowship from the Alexander von Humboldt Foundation. The PhD salary of D. C. was provided by a funding from the Lorraine University of Excellence (LUE).	Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Black KA, 2015, BBA-MOL CELL RES, V1853, P1470, DOI 10.1016/j.bbamcr.2014.10.018; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Henne M, 2015, FEBS OPEN BIO, V5, P832, DOI 10.1016/j.fob.2015.10.001; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kaufholdt D, 2016, J PLANT PHYSIOL, V207, P42, DOI 10.1016/j.jplph.2016.10.002; Lehrke M, 2012, BIOCHEM J, V441, P823, DOI 10.1042/BJ20111170; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mao GH, 2011, J BIOL CHEM, V286, P7548, DOI 10.1074/jbc.M110.182865; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marelja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060869; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Moseler A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100429; Moseler A, 2020, NEW PHYTOL, V226, P967, DOI 10.1111/nph.15870; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Murthy N. M. U., 2007, CHARACTERIZATION ARA; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Roret T, 2014, ACTA CRYSTALLOGR F, V70, P1180, DOI 10.1107/S2053230X14017026; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selles B, 2019, J EXP BOT, V70, P4139, DOI 10.1093/jxb/erz213; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; Watanabe S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34862-1; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200; Zannini F, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100142; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhong R, 2010, PLANT J, V63, P44, DOI 10.1111/j.1365-313X.2010.04220.x	54	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101749	10.1016/j.jbc.2022.101749	http://dx.doi.org/10.1016/j.jbc.2022.101749			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35189141	gold, Green Published, Green Submitted			2022-12-28	WOS:000793502000004
J	Toyoda, S; Shin, J; Fukuhara, A; Otsuki, M; Shimomura, I				Toyoda, Shinichiro; Shin, Jihoon; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro			<p>Transforming growth factor beta 1 signaling links extracellular matrix remodeling to intracellular lipogenesis upon physiological feeding events</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIABETES-MELLITUS; MICE; GLUCOSE; WHITE; LIPODYSTROPHY; KNOCKOUT; LEPTIN	Adipose tissue dynamically changes its mass in response to external nutritional status, which plays an important role in maintaining the lipid homeostasis. Physiologically, feeding events are associated with the expansion of adipose tissue, but little is known about the detailed molecular mechanisms of this expansion. Here, using comprehensive transcriptome analysis, we found that levels of transforming growth factor beta 1 (TGF beta 1), a key regulator of extracellular matrix (ECM) remodeling, were increased in adipose tissue under feeding conditions and associated with the lipogenic pathway. In addition, TGF-beta receptors are highly expressed in adipose tissue, and pharmacological inhibition of TGF-beta 1 reduced adipose tissue mass and caused ectopic lipid accumulation in the liver. This reduced fat mass was associated with decreased gene expression in ECM remodeling and lipogenesis. Furthermore, similar results were observed in the adipose tissue of SMAD family member 3 knockout mice or upon systemic TGF-beta neutralization, with significant reductions in both ECM remodeling and lipogenesis-related genes. Mechanistically, we found that insulin-induced TGF-beta 1 and cell-autonomous action remodels the ECM of adipocytes, which controls the downstream focal adhesion kinase-AKT signaling cascades and enhances the lipogenic pathway. Of note, destruction of collagens or matrix metalloproteinase/a disintegrin and metalloprotease activities, critical components of ECM remodeling, blocked TGF-beta 1-mediated focal adhesion kinase-AKT signaling and the lipogenic pathway. Taken together, this study identifies a previously unknown lipogenic role of TGF-beta 1 by which adipocytes can expand to adapt to physiological feeding events.	[Toyoda, Shinichiro; Shin, Jihoon; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Shin, Jihoon] Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Suita, Osaka, Japan; [Fukuhara, Atsunori] Osaka Univ, Dept Adipose Management, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Shin, J (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.; Shin, J (corresponding author), Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Suita, Osaka, Japan.	shinjihoon0209@endmet.med.osaka-u.ac.jp	Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Shin, Jihoon/0000-0003-1294-0238				A.Feuchtinger, 2020, bioRxiv, DOI 10.1101/2020.06.29.178020; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; Birsoy K, 2013, J CELL SCI, V126, P1541, DOI 10.1242/jcs.104992; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Cautivo KM, 2016, MOL METAB, V5, P491, DOI 10.1016/j.molmet.2016.05.004; Chitraju C, 2019, J LIPID RES, V60, P1112, DOI 10.1194/jlr.M093112; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Fernandez S, 2019, CELL REP, V27, P2772, DOI 10.1016/j.celrep.2019.04.112; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao HQ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128405; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guilherme A, 2019, NAT REV ENDOCRINOL, V15, P207, DOI 10.1038/s41574-019-0165-y; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jacquinet A, 2014, EUR J MED GENET, V57, P230, DOI 10.1016/j.ejmg.2014.02.012; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kita S, 2019, J CLIN INVEST, V129, P4041, DOI 10.1172/JCI129193; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Le Dour C, 2017, J LIPID RES, V58, P151, DOI 10.1194/jlr.M071381; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Norgan NG, 1997, INT J OBESITY, V21, P738, DOI 10.1038/sj.ijo.0800473; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Okuno Y, 2018, DIABETES, V67, P1113, DOI 10.2337/db17-1032; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Petaisto T, 2020, J PHYSIOL-LONDON, V598, P3373, DOI 10.1113/JP279559; Petrus P, 2018, CELL REP, V25, P551, DOI 10.1016/j.celrep.2018.09.069; Roh HC, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101086; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sakaguchi M, 2017, CELL METAB, V25, P448, DOI 10.1016/j.cmet.2016.12.008; Schlaepfer DD, 1996, CELL STRUCT FUNCT, V21, P445, DOI 10.1247/csf.21.445; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Softic S, 2016, DIABETES, V65, P2187, DOI 10.2337/db16-0213; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Straub LG, 2019, NAT METAB, V1, P334, DOI 10.1038/s42255-019-0041-z; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Vogel P, 2011, VET PATHOL, V48, P642, DOI 10.1177/0300985810383870; Wankhade UD, 2018, MOL METAB, V16, P160, DOI 10.1016/j.molmet.2018.07.008; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013	66	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101748	10.1016/j.jbc.2022.101748	http://dx.doi.org/10.1016/j.jbc.2022.101748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35189145	Green Published, gold, Green Submitted			2022-12-28	WOS:000797895000007
J	Vasileva, E; Spadaro, D; Rouaud, F; King, JM; Flinois, A; Shah, J; Sluysmans, S; Mean, I; Jond, L; Turner, JR; Citi, S				Vasileva, Ekaterina; Spadaro, Domenica; Rouaud, Florian; King, Jonathan M.; Flinois, Arielle; Shah, Jimit; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Turner, Jerrold R.; Citi, Sandra			Cingulin binds to the ZU5 domain of scaffolding protein ZO-1 to promote its extended conformation, stabilization, and tight junction accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL JUNCTIONS; ACTIN; COMPLEX; EXPRESSION; IDENTIFICATION; LOCALIZATION; PARACINGULIN; POLYPEPTIDE; INTERACTS; MECHANISM	Zonula occludens-1 (ZO-1), the major scaffolding protein of tight junctions (TJs), recruits the cytoskeleton-associated proteins cingulin (CGN) and paracingulin (CGNL1) to TJs by binding to their N-terminal ZO-1 interaction motif. The conformation of ZO-1 can be either folded or extended, depending on cytoskeletal tension and intramolecular and intermolecular interactions, and only ZO-1 in the extended conformation recruits the transcription factor DbpA to TJs. However, the sequences of ZO-1 that interact with CGN and CGNL1 and the role of TJ proteins in ZO-1 TJ assembly are not known. Here, we used glutathione-S-transferase pulldowns and immunofluorescence microscopy to show that CGN and CGNL1 bind to the C-terminal ZU5 domain of ZO-1 and that this domain is required for CGN and CGNL1 recruitment to TJs and to phase-separated ZO-1 condensates in cells. We show that KO of CGN, but not CGNL1, results in decreased accumulation of ZO-1 at TJs. Furthermore, ZO-1 lacking the ZU5 domain showed decreased accumulation at TJs, was detectable along lateral contacts, had a higher mobile fraction than full-length ZO-1 by fluorescence recovery after photo bleaching analysis, and had a folded conformation, as determined by structured illumination microscopy of its N-terminal and C-terminal ends. The CGN-ZU5 interaction promotes the extended conformation of ZO-1, since binding of the CGN- ZO-1 interaction motif region to ZO-1 resulted in its interaction with DbpA in cells and in vitro. Together, these results show that binding of CGN to the ZU5 domain of ZO-1 promotes ZO-1 stabilization and accumulation at TJs by promoting its extended conformation.	[Vasileva, Ekaterina; Spadaro, Domenica; Rouaud, Florian; Flinois, Arielle; Shah, Jimit; Sluysmans, Sophie; Mean, Isabelle; Jond, Lionel; Citi, Sandra] Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland; [King, Jonathan M.; Turner, Jerrold R.] Brigham & Womens Hosp, Dept Pathol, Lab Mucosal Barrier Pathobiol, 75 Francis St, Boston, MA 02115 USA; [King, Jonathan M.; Turner, Jerrold R.] Harvard Med Sch, Boston, MA 02115 USA; [King, Jonathan M.] Trinity Univ, Biol Dept, San Antonio, TX USA	University of Geneva; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Trinity University	Citi, S (corresponding author), Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland.	Sandra.Citi@unige.ch	King, Jonathan/GXH-4010-2022	King, Jonathan/0000-0003-1791-0636; Flinois, Arielle/0000-0002-7763-5632; Sluysmans, Sophie/0000-0002-6094-5482	Swiss National Fund for Scientific Research [31003A_152899, 31003A_172809, 31003A_130520, 31003A_14997]; National Institutes of Health [R01DK61931, R01DK68271]; National Science Foundation [1229702]	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This study was supported by the Swiss National Fund for Scientific Research (N. 31003A_152899, N. 31003A_172809, N. 31003A_130520, and N.31003A_14997 [to S. C.]), by the National Institutes of Health (grants R01DK61931 and R01DK68271 [to J. R. T.]), and by the National Science Foundation (Major Research Instrumentation grant: no. 1229702 [to J. M. K.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2020, CURR BIOL, V30, pR83, DOI 10.1016/j.cub.2019.11.060; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Colom A., 2020, BIORXIV, DOI [10.1101/2020.05.14.095364, DOI 10.1101/2020.05.14.095364]; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fesenko I, 2000, MECH DEVELOP, V96, P51, DOI 10.1016/S0925-4773(00)00368-3; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Guerrera D, 2016, J BIOL CHEM, V291, P11016, DOI 10.1074/jbc.M115.712935; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Huo L, 2011, EMBO J, V30, P665, DOI 10.1038/emboj.2010.353; Itoh M, 2012, P NATL ACAD SCI USA, V109, P9905, DOI 10.1073/pnas.1115063109; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Maiers JL, 2013, J CELL SCI, V126, P3904, DOI 10.1242/jcs.126565; Mangan AJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12426; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Odenwald MA, 2018, J BIOL CHEM, V293, P17317, DOI 10.1074/jbc.RA118.003908; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Otani T, 2020, TRENDS CELL BIOL, V30, P805, DOI 10.1016/j.tcb.2020.08.004; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Paschoud S, 2012, J BIOL CHEM, V287, P13159, DOI 10.1074/jbc.M111.315622; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Rouaud F, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183399; Rouaud F, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1653748; Schwayer C, 2019, CELL, V179, P937, DOI 10.1016/j.cell.2019.10.006; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Sluysmans S, 2021, MOL BIOL CELL, V32, DOI 10.1091/mbc.E21-07-0355; Spadaro D, 2017, CURR BIOL, V27, P3783, DOI 10.1016/j.cub.2017.11.014; Spadaro D, 2014, J BIOL CHEM, V289, P22500, DOI 10.1074/jbc.M114.556449; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tsukita S, 2019, TRENDS BIOCHEM SCI, V44, P141, DOI 10.1016/j.tibs.2018.09.008; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Unbekandt M, 2014, J MOL MED, V92, P217, DOI 10.1007/s00109-014-1133-6; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasileva E, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1539596; Vasileva E, 2017, ANN NY ACAD SCI, V1405, P160, DOI 10.1111/nyas.13391; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Wittchen ES, 2000, J CELL BIOL, V151, P825, DOI 10.1083/jcb.151.4.825; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yano T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33418-7; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	57	2	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101797	10.1016/j.jbc.2022.101797	http://dx.doi.org/10.1016/j.jbc.2022.101797			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35259394	Green Published, Green Accepted, gold			2022-12-28	WOS:000793617400005
J	Munshi, MI; Yao, SJ; Ben Mamoun, C				Munshi, Muhammad I.; Yao, Sarah J.; Ben Mamoun, Choukri			Redesigning therapies for pantothenate kinase-associated neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DISEASE; ACCUMULATION; DEFICIENCY; HEMOGLOBIN; MUTATIONS	Pantothenate kinase-associated neurodegeneration (PKAN) is an incurable rare genetic disorder of children and young adults caused by mutations in the PANK2 gene, which encodes an enzyme critical for the biosynthesis of coenzyme A. Although PKAN affects only a small number of patients, it shares several hallmarks of more common neurodegenerative diseases of older adults such as Alzheimer's disease and Parkinson's disease. Advances in etiological understanding and treatment of PKAN could therefore have implications for our understanding of more common diseases and may shed new lights on the physiological importance of coenzyme A, a cofactor critical for the operation of various cellular metabolic processes. The large body of knowledge that accumulated over the years around PKAN pathology, including but not limited to studies of various PKAN models and therapies, has contributed not only to progress in our understanding of the disease but also, importantly, to the crystallization of key questions that guide future investigations of the disease. In this review, we will summarize this knowledge and demonstrate how it forms the backdrop to new avenues of research.	Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu		Munshi, Muhammad/0000-0002-6052-7002	National Institutes of Health [AI123321, AI138139, AI152220, AI136118]; Steven and Alexandra Cohen Foundation; Global Lyme Alliance; Blavatnik Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steven and Alexandra Cohen Foundation; Global Lyme Alliance; Blavatnik Fund	The research by C. B. M. is supported by grants AI123321, AI138139, AI152220, and AI136118 from the National Institutes of Health, the Steven and Alexandra Cohen Foundation, the Global Lyme Alliance, and the Blavatnik Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Cordoba M, 2019, MOL NEUROBIOL, V56, P3638, DOI 10.1007/s12035-018-1333-0; Ameri H, 2018, J CURR OPHTHALMOL, V30, P1, DOI 10.1016/j.joco.2018.01.006; Arber C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184104; Auciello G, 2020, J MED CHEM, V63, P15785, DOI 10.1021/acs.jmedchem.0c01531; Ayton S, 2020, MOL PSYCHIATR, V25, P2932, DOI 10.1038/s41380-019-0375-7; Balestrino R, 2020, EUR J NEUROL, V27, P27; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Brunetti D., 2013, BRAIN; Berti CC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010293; Chang XT, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01530-5; Chang XT, 2020, CNS NEUROSCI THER, V26, P754, DOI 10.1111/cns.13294; Chiu JE, 2019, J BIOL CHEM, V294, P14757, DOI 10.1074/jbc.RA119.009791; Combs B, 2016, METHODS MOL BIOL, V1382, P339, DOI 10.1007/978-1-4939-3271-9_25; Corbin DR, 2017, MOL GENET METAB, V120, P350, DOI 10.1016/j.ymgme.2017.02.001; Czumaj A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239057; Dangouloff T, 2019, THER CLIN RISK MANAG, V15, P1153, DOI 10.2147/TCRM.S172291; Dansie LE, 2014, BIOCHEM SOC T, V42, P1033, DOI 10.1042/BST20140096; Di Meo I, 2019, J INHERIT METAB DIS, V42, P49, DOI 10.1002/jimd.12026; Di Meo I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11564-8; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Freed J, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.21; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Haggerty DL, 2020, MOL THER-METH CLIN D, V17, P69, DOI 10.1016/j.omtm.2019.11.012; Hogarth P., 2017, CONSENSUS CLIN MANAG; Huang LL, 2016, NAT CHEM BIOL, V12, P621, DOI [10.1038/NCHEMBIO.2108, 10.1038/nchembio.2108]; Iankova V, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.629414; Jackowski S., 2015, BIOCHEMIST, V37, P4; Jeong SY, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910489; Khatri D, 2020, B EXP BIOL MED+, V170, P58, DOI 10.1007/s10517-020-05004-3; Klopstock T, 2021, MOVEMENT DISORD, V36, P1342, DOI 10.1002/mds.28392; Klopstock T, 2019, LANCET NEUROL, V18, P631, DOI 10.1016/S1474-4422(19)30142-5; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Lambrechts RA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910488; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099; LUCKENBACH MW, 1983, AM J OPHTHALMOL, V95, P369, DOI 10.1016/S0002-9394(14)78308-4; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1; Pattali R, 2019, GENE THER, V26, P287, DOI 10.1038/s41434-019-0085-4; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Rana A., 2010, P NATL ACAD SCI USA; Shah RC, 2011, NEUROLOGY, V77, P219, DOI 10.1212/WNL.0b013e318225aaa9; Sharma LK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06703-2; Shumar SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130013; Srinivasan B, 2015, NAT CHEM BIOL, V11, P784, DOI [10.1038/nchembio.1906, 10.1038/NCHEMBIO.1906]; Subramanian C, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165663; Varun P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00146; Woltjer RL, 2015, MOL GENET METAB, V116, P289, DOI 10.1016/j.ymgme.2015.10.012; Wu ZH, 2009, HUM MOL GENET, V18, P3659, DOI 10.1093/hmg/ddp314; Yao JW, 2019, PROTEIN SCI, V28, P1031, DOI 10.1002/pro.3611; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zano SP, 2015, MOL GENET METAB, V116, P281, DOI 10.1016/j.ymgme.2015.10.011; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200; Zizioli D., 2016, NEUROBIOL DIS	60	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101577	10.1016/j.jbc.2022.101577	http://dx.doi.org/10.1016/j.jbc.2022.101577			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35041826	gold, Green Published			2022-12-28	WOS:000791267400004
J	Widmark, A; Sagredo, EAA; Karlstroem, V; Behm, M; Biryukova, I; Friedlaender, MRR; Daniel, C; Oehman, M				Widmark, Albin; Sagredo, Eduardo A. A.; Karlstroem, Victor; Behm, Mikaela; Biryukova, Inna; Friedlaender, Marc R. R.; Daniel, Chammiran; oehman, Marie			ADAR1-and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRODUCIBLE CHANGES; GENE-CLUSTER; RNA; MICRORNAS; STRAND; DICER; IDENTIFICATION; EXPRESSION; CYTOSCAPE; ABUNDANCE	miRNAs are short noncoding RNA molecules that regulate gene expression by inhibiting translation or inducing degradation of target mRNAs. miRNAs are often expressed as polycistronic transcripts, so-called miRNA clusters, containing several miRNA precursors. The largest mammalian miRNA cluster, the miR-379-410 cluster, is expressed primarily during embryonic development and in the adult brain; however, downstream regulation of this cluster is not well understood. Here, we investigated adenosine deamination to inosine (RNA editing) in the miR-379-410 cluster by adenosine deaminase acting on RNA (ADAR) enzymes as a possible mechanism modulating the expression and activity of these miRNAs in a brain-specific manner. We show that the levels of editing in the majority of mature miRNAs are lower than the editing levels of the corresponding site in primary miRNA precursors. However, for one miRNA, miR-376b-3p, editing was significantly higher in the mature form than in the primary precursor. We found miR-376b-3p maturation is negatively regulated by ADAR2 in an editing activity-independent manner, whereas ADAR1-mediated and ADAR2-mediated editing were observed to be competitive. In addition, the edited miR-376b-3p targets a different set of mRNAs than unedited miR-376b-3p, including 4-aminobutyrate aminotransferase, encoding the enzyme responsible for the catabolism of the neurotransmitter gamma aminobutyric acid (GABA). Expression of edited miR-376b-3p led to increased intracellular GABA levels as well as increased cell surface presentation of GABA type A receptors. Our results indicate that both editing and editing-independent effects modulate the expression of miR-376b-3p, with the potential to regulate GABAergic signaling in the brain.	[Widmark, Albin; Sagredo, Eduardo A. A.; Karlstroem, Victor; Behm, Mikaela; Daniel, Chammiran; oehman, Marie] Stockholm Univ, Dept Mol Biosci, Stockholm, Sweden; [Sagredo, Eduardo A. A.; Biryukova, Inna; Friedlaender, Marc R. R.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Sci Life Lab, Stockholm, Sweden; [Behm, Mikaela] German Canc Res Ctr Deutsch Krebsforschungszentrum, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Stockholm University; Stockholm University	Widmark, A (corresponding author), Stockholm Univ, Dept Mol Biosci, Stockholm, Sweden.	albin.widmark@su.se		Friedlander, Marc/0000-0001-6577-4363; karlstrom, victor/0000-0002-6985-0308; Biryukova, Inna/0000-0003-0701-2808; Sagredo, Eduardo/0000-0001-9984-2985	Swedish Research Council [2015-04611, 2018-03823]; European Research Council [758397]; Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University	M. OE. has been supported by grant from the Swedish Research Council (grant no.: 2018-03823) . I. B. and M. R. F. acknowledge the following funding sources: Euro-pean Research Council starting grant (grant no.: 758397) , miRCell; Swedish Research Council (grant no.: 2015-04611) , MapToCleave; and funding from the Strategic Research Area (SFO) program of the Swedish Research Council through Stockholm University.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behm M, 2017, J CELL SCI, V130, P745, DOI 10.1242/jcs.200055; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Cruz PHC, 2020, RNA, V26, P454, DOI 10.1261/rna.072728.119; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kume H, 2014, NUCLEIC ACIDS RES, V42, P10050, DOI 10.1093/nar/gku662; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Lackinger M, 2019, EMBO REP, V20, DOI 10.15252/embr.201846429; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LS, 2018, GENOME RES, V28, P132, DOI 10.1101/gr.224386.117; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lundin E, 2020, BMC BIOL, V18, DOI 10.1186/s12915-019-0736-3; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Marty V, 2016, HUM MOL GENET, V25, P728, DOI 10.1093/hmg/ddv510; Marvin JS, 2019, NAT METHODS, V16, P763, DOI 10.1038/s41592-019-0471-2; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Michlewski G, 2019, RNA, V25, P1, DOI 10.1261/rna.068692.118; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tian S, 2020, RNA BIOL, V17, P264, DOI 10.1080/15476286.2019.1678364; van der Kwast RVCT, 2020, MOL THER-NUCL ACIDS, V21, P932, DOI 10.1016/j.omtn.2020.07.020; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00188; Whipple AJ, 2020, MOL CELL, V78, P85, DOI 10.1016/j.molcel.2020.01.020; Winter Jennifer, 2015, Neurogenesis (Austin), V2, pe1004970, DOI 10.1080/23262133.2015.1004970; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	52	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101682	10.1016/j.jbc.2022.101682	http://dx.doi.org/10.1016/j.jbc.2022.101682			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124003	Green Published, gold			2022-12-28	WOS:000789400700009
J	Cui, M; Xu, KM; Gada, KD; Shalomov, B; Ban, MCL; Eptaminitaki, GC; Kawano, T; Plant, LD; Dascal, N; Logothetis, DE				Cui, Meng; Xu, Keman; Gada, Kirin D.; Shalomov, Boris; Ban, Michelle; Eptaminitaki, Giasemi C.; Kawano, Takeharu; Plant, Leigh D.; Dascal, Nathan; Logothetis, Diomedes E.			A novel small-molecule selective activator of homomeric GIRK4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNELS; SODIUM-DEPENDENT ACTIVATION; AMINO-ACID RESIDUE; K+ CHANNEL; G-PROTEINS; MECHANISM; PIP2; MUTATIONS	G protein-sensitive inwardly rectifying potassium (GIRK) channels are important pharmaceutical targets for neuronal, cardiac, and endocrine diseases. Although a number of GIRK channel modulators have been discovered in recent years, most lack selectivity. GIRK channels function as either homomeric (i.e., GIRK2 and GIRK4) or heteromeric (e.g., GIRK1/2, GIRK1/ 4, and GIRK2/3) tetramers. Activators, such as ML297, ivermectin, and GAT1508, have been shown to activate heteromeric GIRK1/2 channels better than GIRK1/4 channels with varying degrees of selectivity but not homomeric GIRK2 and GIRK4 channels. In addition, VU0529331 was discovered as the first homomeric GIRK channel activator, but it shows weak selectivity for GIRK2 over GIRK4 (or G4) homomeric channels. Here, we report the first highly selective small-molecule activator targeting GIRK4 homomeric channels, 3hi2one-G4 (3-[2(3,4-dimethoxyphenyl)-2-oxoethyl]-3-hydroxy-1-(1-naphthylm ethyl)-1,3-dihydro-2H-indol-2-one). We show that 3hi2one-G4 does not activate GIRK2, GIRK1/2, or GIRK1/4 channels. Using molecular modeling, mutagenesis, and electrophysiology, we analyzed the binding site of 3hi2one-G4 formed by the trans membrane 1, transmembrane 2, and slide helix regions of the GIRK4 channel, near the phosphatidylinositol-4,5bisphosphate binding site, and show that it causes channel activation by strengthening channel-phosphatidylinositol-4,5-bisphosphate interactions. We also identify slide helix residue L77 in GIRK4, corresponding to residue I82 in GIRK2, as a major determinant of isoform-specific selectivity. We propose that 3hi2one-G4 could serve as a useful pharmaceutical probe in studying GIRK4 channel function and may also be pursued in drug optimization studies to tackle GIRK4-related diseases such as primary aldosteronism and late-onset obesity.	[Cui, Meng; Xu, Keman; Gada, Kirin D.; Ban, Michelle; Eptaminitaki, Giasemi C.; Kawano, Takeharu; Plant, Leigh D.; Logothetis, Diomedes E.] Bouve Coll Hlth Sci, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Cui, Meng; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Shalomov, Boris; Dascal, Nathan] Tel Aviv Univ, Sagol Sch Neurosci, Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Logothetis, Diomedes E.] Northeastern Univ, Coll Sci, Chem & Chem Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Tel Aviv University; Northeastern University	Cui, M; Logothetis, DE (corresponding author), Bouve Coll Hlth Sci, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Cui, M; Logothetis, DE (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Coll Sci, Chem & Chem Biol, Boston, MA 02115 USA.	m.cui@northeastern.edu; d.logothetis@northeastern.edu	; Dascal, Nathan/O-3915-2015	Eptaminitaki, Giasemi Chrysovalanti/0000-0001-9202-2183; XU, KEMAN/0000-0002-0816-1760; Dascal, Nathan/0000-0002-5397-4146; Gada, Kirin/0000-0002-8621-432X	National Institutes of Health [R01 HL059949-24]; Israel Science Foundation [2255/15, 1282/18]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation)	Acknowledgments Funding and additional information - The work was supported by the National Institutes of Health R01 HL059949-24 grant award (to D. E. L.) and Israel Science Foundation grants 2255/15 and 1282/18 (to N. D.) . The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; Barber DM, 2016, CHEM SCI, V7, P2347, DOI [10.1039/c5sc04084a, 10.1039/C5SC04084A]; Bodhinathan K, 2013, P NATL ACAD SCI USA, V110, P18309, DOI 10.1073/pnas.1311406110; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Chen IS, 2017, J PHYSIOL-LONDON, V595, P5895, DOI 10.1113/JP274871; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cui Meng, 2021, Handb Exp Pharmacol, V267, P277, DOI 10.1007/164_2021_501; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Fernandes-Rosa FL, 2017, J MOL ENDOCRINOL, V59, pR47, DOI 10.1530/JME-17-0035; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Idevall-Hagren O, 2014, METHODS MOL BIOL, V1148, P109, DOI 10.1007/978-1-4939-0470-9_8; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kozek KA, 2019, ACS CHEM NEUROSCI, V10, P358, DOI 10.1021/acschemneuro.8b00287; LEALPINTO E, 1995, J MEMBRANE BIOL, V146, P123; Li DL, 2019, J BIOL CHEM, V294, P18934, DOI 10.1074/jbc.RA119.010047; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; Meng XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29399; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Niu YM, 2020, ELIFE, V9, DOI [10.7554/elife.60552, 10.7554/eLife.60552]; Parmar J, 2008, J CLIN ENDOCR METAB, V93, P4542, DOI 10.1210/jc.2008-0903; Perry CA, 2008, P NATL ACAD SCI USA, V105, P8148, DOI 10.1073/pnas.0803261105; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shalomov B., 2019, BIORXIV, DOI [10.1101/866202, DOI 10.1101/866202]; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Styer AM, 2010, J BIOL CHEM, V285, P41290, DOI 10.1074/jbc.M110.178541; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wieting JM, 2017, ACS CHEM NEUROSCI, V8, P1873, DOI 10.1021/acschemneuro.7b00217; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Xu Y, 2020, J BIOL CHEM, V295, P3614, DOI 10.1074/jbc.RA119.011527; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yow TT, 2011, BRIT J PHARMACOL, V163, P1017, DOI 10.1111/j.1476-5381.2011.01315.x; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhao YL, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107770	45	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102009	10.1016/j.jbc.2022.102009	http://dx.doi.org/10.1016/j.jbc.2022.102009			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35525275	Green Published, gold			2022-12-28	WOS:000816927100006
J	Fan, LY; Sweet, DR; Fan, EK; Prosdocimo, DA; Madera, A; Jiang, Z; Padmanabhan, R; Haldar, SM; Vinayachandran, V; Jain, MK				Fan, Liyan; Sweet, David R.; Fan, Erica K.; Prosdocimo, Domenick A.; Madera, Annmarie; Jiang, Zhen; Padmanabhan, Roshan; Haldar, Saptarsi M.; Vinayachandran, Vinesh; Jain, Mukesh K.			Transcription factors KLF15 and PPAR? cooperatively orchestrate genome-wide regulation of lipid metabolism in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; EXPRESSION; HEALTH; GENES; BETA	Skeletal muscle dynamically regulates systemic nutrient homeostasis through transcriptional adaptations to physiological cues. In response to changes in the metabolic environment (e.g., alterations in circulating glucose or lipid levels), networks of transcription factors and coregulators are recruited to specific genomic loci to fine-tune homeostatic gene regulation. Elucidating these mechanisms is of particular interest as these gene regulatory pathways can serve as potential targets to treat metabolic disease. The zinc -finger transcription factor Kruppel-like factor 15 (KLF15) is a critical regulator of metabolic homeostasis; however, its genome-wide distribution in skeletal muscle has not been previously identified. Here, we characterize the KLF15 cistrome in vivo in skeletal muscle and find that the majority of KLF15 binding is localized to distal intergenic regions and associated with genes related to circadian rhythmicity and lipid metabolism. We also identify critical interdependence between KLF15 and the nuclear receptor PPAR delta in the regulation of lipid metabolic gene programs. We further demonstrate that KLF15 and PPAR delta colocalize genome-wide, physically interact, and are dependent on one another to exert their transcriptional effects on target genes. These findings reveal that skeletal muscle KLF15 plays a critical role in metabolic adaptation through its direct actions on target genes and interactions with other nodal transcription factors such as PPAR delta.	[Fan, Liyan; Sweet, David R.; Prosdocimo, Domenick A.; Madera, Annmarie; Padmanabhan, Roshan; Vinayachandran, Vinesh; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Fan, Liyan; Sweet, David R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA; [Fan, Erica K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, Pittsburgh, PA USA; [Prosdocimo, Domenick A.] Webb Law Firm, Pittsburgh, PA USA; [Jiang, Zhen; Haldar, Saptarsi M.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Haldar, Saptarsi M.] Univ Calif San Francisco, Dept Med, Div Cardiol, Sch Med, San Francisco, CA USA; [Fan, Liyan; Sweet, David R.; Prosdocimo, Domenick A.; Madera, Annmarie; Padmanabhan, Roshan; Vinayachandran, Vinesh; Jain, Mukesh K.] Univ Hosp Cleveland Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Haldar, Saptarsi M.] Amgen Res, South San Francisco, CA USA	Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University Hospitals of Cleveland	Vinayachandran, V; Jain, MK (corresponding author), Case Western Reserve Univ, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA.; Vinayachandran, V; Jain, MK (corresponding author), Univ Hosp Cleveland Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA.	vxv154@case.edu; mxj84@case.edu			NIH, United States [R35HL135789, R01HL086548, T32GM007250, T32HL134622, F30HL139014]; American Heart Association Established Investigator Award, United States; Leducq Foundation Transatlantic Network of Excellence; AHA-Allen Frontiers Award	NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award, United States(American Heart Association); Leducq Foundation Transatlantic Network of Excellence(Leducq Foundation); AHA-Allen Frontiers Award	This work was supported by NIH, United States grants R35HL135789 (M. K. J.) , R01HL086548 (M. K. J.) , T32GM007250 (L. F. and D. R. S.) , T32HL134622 (L. F.) , F30HL139014 (D. R. S.) . This work was also supported by American Heart Association Established Investigator Award, United States and AHA-Allen Frontiers Award (M. K. J.) and Leducq Foundation Transatlantic Network of Excellence (M. K. J.) .	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Cheng HS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205055; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; de Lange P, 2008, PPAR RES, V2008, DOI 10.1155/2008/172676; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Fan LY, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139496; Fan LY, 2018, PHARMACOL RES, V130, P123, DOI 10.1016/j.phrs.2017.12.018; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Goldstein I, 2015, TRENDS ENDOCRIN MET, V26, P699, DOI 10.1016/j.tem.2015.09.005; Goldstein I, 2017, GENOME RES, V27, P427, DOI 10.1101/gr.212175.116; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Hargreaves M, 2020, NAT METAB, V2, P817, DOI 10.1038/s42255-020-0251-4; Hsieh PN, 2019, ENDOCR REV, V40, P137, DOI 10.1210/er.2018-00151; Hsieh PN, 2018, CELL MOL LIFE SCI, V75, P403, DOI 10.1007/s00018-017-2606-x; Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jiang Z, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abj2917; Kim G, 2020, ENDOCRINOL METAB, V35, P1, DOI 10.3803/EnM.2020.35.1.1; Kinouchi K, 2018, CELL REP, V25, P3299, DOI 10.1016/j.celrep.2018.11.077; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu Y, 2013, J CLIN INVEST, V123, P4232, DOI 10.1172/JCI68552; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pilegaard H, 2003, DIABETES, V52, P657, DOI 10.2337/diabetes.52.3.657; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101926	10.1016/j.jbc.2022.101926	http://dx.doi.org/10.1016/j.jbc.2022.101926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35413288	gold, Green Published			2022-12-28	WOS:000829588600010
J	Liu, SL; Narvaez-Ortiz, HY; Miner, M; Kiemel, J; Oberhelman, N; Watt, A; Wagner, AR; Luan, Q; Helgeson, LA; Nolen, BJ				Liu, Su-Ling; Narvaez-Ortiz, Heidy Y.; Miner, Matt; Kiemel, Jack; Oberhelman, Nicholas; Watt, April; Wagner, Andrew R.; Luan, Qing; Helgeson, Luke A.; Nolen, Brad J.			Analysis of functional surfaces on the actin nucleation promoting factor Dip1 required for Arp2/3 complex activation and endocytic actin network assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN; N-WASP; LAMELLIPODIA; SPIN90; MECHANISM; DYNAMICS; PATCHES; SWITCH	Arp2/3 complex nucleates branched actin filaments that drive processes like endocytosis and lamellipodial protrusion. WISH/DIP/SPIN90 (WDS) proteins form a class of Arp2/3 complex activators or nucleation promoting factors (NPFs) that, unlike WASP family NPFs, activate Arp2/3 complex without requiring preformed actin filaments. Therefore, activation of Arp2/3 complex by WDS proteins is thought to produce the initial actin filaments that seed branching nucleation by WASP-bound Arp2/3 complexes. However, whether activation of Arp2/3 complex by WDS proteins is important for the initiation of branched actin assembly in cells has not been directly tested. Here, we used structure-based point mutations of the Schizosaccharomyces pombe WDS protein Dip1 to test the importance of its Arp2/3-activating activity in cells. Six of thirteen Dip1 mutants caused severe defects in Arp2/3 complex activation in vitro, and we found a strong correlation between the ability of mutants to activate Arp2/3 complex and to rescue endocytic actin assembly defects caused by deleting Dip1. These data support a model in which Dip1 activates Arp2/3 complex to produce actin filaments that initiate branched actin assembly at endocytic sites. Dip1 mutants that synergized with WASP in activating Arp2/3 complex in vitro showed milder defects in cells compared to those that did not, suggesting that in cells the two NPFs may coactivate Arp2/3 complex to initiate actin assembly. Finally, the mutational data reveal important complementary electrostatic contacts at the Dip1-Arp2/3 complex interface and corroborate the previously proposed wedge model, which describes how Dip1 binding triggers structural changes that activate Arp2/3 complex.	[Liu, Su-Ling; Narvaez-Ortiz, Heidy Y.; Miner, Matt; Kiemel, Jack; Oberhelman, Nicholas; Watt, April; Wagner, Andrew R.; Luan, Qing; Helgeson, Luke A.; Nolen, Brad J.] Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA	University of Oregon	Nolen, BJ (corresponding author), Univ Oregon, Inst Mol Biol, Dept Chem & Biochem, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Narvaez-Ortiz, Heidy/0000-0002-6434-6292; Watt, April/0000-0002-5145-5334	National Institutes of Health [R35-GM136319]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant number R35-GM136319 to Brad J. Nolen. We wish to thank all of the members of the Nolen lab for comments on the manuscript.	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Allwood EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163177; Arasada R, 2018, MOL BIOL CELL, V29, P295, DOI 10.1091/mbc.E17-06-0415; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balzer CJ, 2020, ELIFE, V9, DOI 10.7554/eLife.60419; Balzer CJ, 2019, CURR BIOL, V29, P3331, DOI 10.1016/j.cub.2019.08.023; Balzer CJ, 2018, CURR BIOL, V28, P3886, DOI 10.1016/j.cub.2018.10.045; Basu R, 2011, CURR BIOL, V21, P905, DOI 10.1016/j.cub.2011.04.047; Berro J, 2014, MOL BIOL CELL, V25, P3501, DOI 10.1091/mbc.E13-01-0004; Cao LY, 2020, NAT CELL BIOL, V22, P803, DOI 10.1038/s41556-020-0531-y; Chen Q, 2013, CURR BIOL, V23, P1154, DOI 10.1016/j.cub.2013.05.005; Cho IH, 2013, CELL MOL LIFE SCI, V70, P4369, DOI 10.1007/s00018-013-1391-4; Chou SZ, 2019, P NATL ACAD SCI USA, V116, P4265, DOI 10.1073/pnas.1807028115; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fokin AI, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd5956; Fukumi-Tominaga T, 2009, GENES CELLS, V14, P1197, DOI 10.1111/j.1365-2443.2009.01345.x; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2015, GENETICS, V199, P315, DOI 10.1534/genetics.112.145540; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim H, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0284-5; Kim Y, 2005, J NEUROSCI, V25, P9515, DOI 10.1523/JNEUROSCI.1643-05.2005; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; Luan Q, 2018, EMBO J, V37, DOI 10.15252/embj.2018100005; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Merino F, 2018, NAT STRUCT MOL BIOL, V25, P531, DOI 10.1038/s41594-018-0074-0; Narvaez-Ortiz HY, 2022, CURR BIOL, V32, P975, DOI 10.1016/j.cub.2022.01.004; Oh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082610; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; preprint Serwas D., 2021, PREPRINT, DOI [10.1101/2021.06.28.450262, DOI 10.1101/2021.06.28.450262]; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shaaban M, 2020, NAT STRUCT MOL BIOL, V27, P1009, DOI 10.1038/s41594-020-0481-x; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Siton-Mendelson O, 2017, TRENDS BIOCHEM SCI, V42, P414, DOI 10.1016/j.tibs.2017.03.002; Small JV, 2015, BIOCHEM SOC T, V43, P84, DOI 10.1042/BST20140184; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Sun YD, 2019, ELIFE, V8, DOI 10.7554/eLife.50749; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina T, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a018267; Wagner AR, 2013, CURR BIOL, V23, P1990, DOI 10.1016/j.cub.2013.08.029; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	49	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102019	10.1016/j.jbc.2022.102019	http://dx.doi.org/10.1016/j.jbc.2022.102019			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35533728	gold, Green Published			2022-12-28	WOS:000829588600007
J	Meyer, MJ; Schreier, PCF; Basaran, M; Vlasova, S; Seitz, T; Brockmoeller, J; Zdrazil, B; Tzvetkov, MV				Meyer, Marleen J.; Schreier, Pascale C. F.; Basaran, Mert; Vlasova, Stefaniia; Seitz, Tina; Brockmoeller, Juergen; Zdrazil, Barbara; V. Tzvetkov, Mladen			Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; SPECIES-DIFFERENCES; SUBSTRATE; RAT; EXPRESSION; POLYMORPHISMS; CLONING; ROCT1; PHARMACOKINETICS; IDENTIFICATION	Organic cation transporter 1 (OCT1) is a membrane transporter that affects hepatic uptake of cationic and weakly basic drugs. OCT1 transports structurally highly diverse substrates. The mechanisms conferring this polyspecificity are unknown. Here, we analyzed differences in transport kinetics between human and mouse OCT1 orthologs to identify amino acids that contribute to the polyspecificity of OCT1. Following stable transfection of HEK293 cells, we observed more than twofold differences in the transport kinetics of 22 out of 28 tested substrates. We found that the /12-adrenergic drug fenoterol was transported with eightfold higher affinity but at ninefold lower capacity by human OCT1. In contrast, the anticholinergic drug trospium was transported with 11-fold higher affinity but at ninefold lower capacity by mouse Oct1. Using human-mouse chimeric constructs and site-directed mutagenesis, we identified nonconserved amino acids Cys36 and Phe32 as responsible for the species-specific differences in fenoterol and trospium uptake. Substitution of Cys36 (human) to Tyr36 (mouse) caused a reversal of the affinity and capacity of fenoterol but not trospium uptake. Substitution of Phe32 to Leu32 caused reversal of trospium but not fenoterol uptake kinetics. Comparison of the uptake of structurally similar /12-adrenergics and molecular docking analyses indicated the second phenol ring, 3.3 to 4.8 angstrom from the protonated amino group, as essential for the affinity for fenoterol conferred by Cys36. This is the first study to report single amino acids as determinants of OCT1 polyspecificity. Our findings suggest ferrable between substrates or species.	[Meyer, Marleen J.; Schreier, Pascale C. F.; V. Tzvetkov, Mladen] Univ Med Greifswald, Inst Pharmacol, Ctr Drug Absorpt & Transport C DAT, Dept Gen Pharmacol, Greifswald, Germany; [Basaran, Mert; Vlasova, Stefaniia; Zdrazil, Barbara] Univ Vienna, Dept Pharmaceut Sci, Div Pharmaceut Chem, Vienna, Austria; [Brockmoeller, Juergen] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany	Greifswald Medical School; University of Vienna; University of Gottingen	Tzvetkov, MV (corresponding author), Univ Med Greifswald, Inst Pharmacol, Ctr Drug Absorpt & Transport C DAT, Dept Gen Pharmacol, Greifswald, Germany.	mladen.tzvetkov@uni-greifswald.de	; Zdrazil, Barbara/F-1021-2013	Tzvetkov, Mladen/0000-0003-1670-5534; Zdrazil, Barbara/0000-0001-9395-1515	Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald; DFG (German Research Foundation); University of Greifwald	Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald; DFG (German Research Foundation)(German Research Foundation (DFG)); University of Greifwald	This article contains supporting information. Acknowledgments-We acknowledge Kerstin Schmidt and Tina Sonnenberger (Greifswald) for their technical support in construct generation and uptake experiments. We further acknowledge Alz-beta Tuerkova for the technical support during initial computa-tional modeling efforts and Helen Massy for the support in the initial cloning of mouse and human orthologs and the generation of the low-resolution chimeras. We acknowledge Chemaxon, Budapest, Hungary (https:// www.chemaxon.com ) for providing the academic license for MarvinSketch. This project was funded by internal institutional resources of the Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald. We acknowledge support for the articel processing charge from the DFG (German Research Foundation) and the Open Access Publication Fund of the University of Greifwald.	Abebe BT, 2020, J CLIN PHARMACOL, V60, P312, DOI 10.1002/jcph.1523; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Beaudoin JJ, 2020, PHARMACOL THERAPEUT, V211, DOI 10.1016/j.pharmthera.2020.107542; Born SL, 1997, DRUG METAB DISPOS, V25, P1318; Boxberger KH, 2018, BIOCHEM PHARMACOL, V156, P371, DOI 10.1016/j.bcp.2018.08.028; Brosseau N, 2019, DRUG METAB REV, V51, P389, DOI 10.1080/03602532.2019.1670204; Burckhardt G, 2005, MOL PHARMACOL, V67, P1391, DOI 10.1124/mol.105.012161; Chen EC, 2017, J MED CHEM, V60, P2685, DOI 10.1021/acs.jmedchem.6b01317; Chen JY, 2017, BIOL CHEM, V398, P813, DOI 10.1515/hsz-2017-0129; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Dresser MJ, 2000, J PHARMACOL EXP THER, V292, P1146; Gebauer L, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114871; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gorboulev V, 2018, MOL PHARMACOL, V93, P402, DOI 10.1124/mol.117.110767; Green RM, 1999, HEPATOLOGY, V29, P1556, DOI 10.1002/hep.510290530; Haberkorn B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.662535; Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ioannides C., 1996, CYTOCHROMES P450 MET; Jensen O, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.674559; Jensen O, 2021, J MED CHEM, V64, P2762, DOI 10.1021/acs.jmedchem.0c02047; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Keller T, 2019, MOL PHARMACOL, V95, P169, DOI 10.1124/mol.118.113498; Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578; Koepsell H, 2019, BIOL CHEM, V400, P195, DOI 10.1515/hsz-2018-0191; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Matthaei J, 2016, CLIN PHARMACOL THER, V99, P633, DOI 10.1002/cpt.317; Meyer MJ, 2020, DRUG METAB DISPOS, V48, P1380, DOI 10.1124/dmd.120.000170; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morse BL, 2020, DRUG METAB DISPOS, V48, P93, DOI 10.1124/dmd.119.088781; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; OHMORI S, 1993, XENOBIOTICA, V23, P419, DOI 10.3109/00498259309057030; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt A, 2003, J NEUROSCI RES, V71, P701, DOI 10.1002/jnr.10521; Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sundelin EIO, 2017, CLIN PHARMACOL THER, V102, P841, DOI 10.1002/cpt.701; Takekuma Y, 2007, J PHARM PHARM SCI, V10, P71; Tzvetkov MV, 2012, PHARMACOGENOMICS J, V12, P22, DOI 10.1038/tpj.2010.75; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Tzvetkov MV, 2018, CLIN PHARMACOL THER, V103, P868, DOI 10.1002/cpt.812; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Varadi M., 2021, NUCL ACIDS RES; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101974	10.1016/j.jbc.2022.101974	http://dx.doi.org/10.1016/j.jbc.2022.101974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35469921	gold, Green Published			2022-12-28	WOS:000807750700014
J	Readnour, BM; Ayinuola, YA; Russo, BT; Liang, Z; Lee, SW; Ploplis, VA; Fischetti, VA; Castellino, FJ				Readnour, Bradley M.; Ayinuola, Yetunde A.; Russo, Brady T.; Liang, Zhong; Lee, Shaun W.; Ploplis, Victoria A.; Fischetti, Vincent A.; Castellino, Francis J.			Evolution of Streptococcus pyogenes has maximized the efficiency of the Sortase A cleavage motif for cell wall transpeptidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; HUMAN-PLASMINOGEN; BACKBONE DYNAMICS; VIRULENCE FACTORS; HTRA; SECRETION; SEQUENCE; STREPTOKINASES	Trafficking of M-protein (Mprt) from the cytosol of Group A Streptococcus pyogenes (GAS) occurs via Sec translocase membrane channels that associate with Sortase A (SrtA), an enzyme that catalyzes cleavage of Mprt at the proximal C-terminal [-LPST(355*)GEAA-] motif and subsequent transpeptidation of the Mprt-containing product to the cell wall (CW). These steps facilitate stable exposure of the N-terminus of Mprt to the extracellular milieu where it interacts with ligands. Previously, we found that inactivation of SrtA in GAS cells eliminated Mprt CW transpeptidation but effected little reduction in its cell surface exposure, indicating that the C-terminus of Mprt retained in the cytoplasmic membrane (CM) extends its N-terminus to the cell surface. Herein, we assessed the effects of mutating the Thr(355) residue in the WT SrtA consensus sequence (LPST(355*)GEAA-) in a specific Mprt, PAM. In vitro, we found that synthetic peptides with mutations (LPSX(355)GEAA) in the SrtA cleavage site displayed slower cleavage activities with rSrtA than the WT peptide. Aromatic residues at X had the lowest activities. Nonetheless, PAM/[Y(355)G] still transpeptidated the CW in vivo. However, when using isolated CMs from srtA-inactivated GAS cells, rapid cleavage of PAM/[LPSY(355)GEAA] occurred at E-357* but transpeptidation did not take place. These results show that another CM-resident enzyme nonproductively cleaved PAM/[LPSYGE(357*)AA]. However, SrtA associated with the translocon channel in vivo cleaved and transpeptidated PAM/ [LPSX(355*)GEAA] variants. These CM features allow diverse cleavage site variants to covalently attach to the CW despite the presence of other potent nonproductive CM proteases.	[Readnour, Bradley M.; Ayinuola, Yetunde A.; Russo, Brady T.; Liang, Zhong; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Readnour, Bradley M.; Russo, Brady T.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Rockefeller University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.; Castellino, FJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	fcasteli@nd.edu			NIH [HL013423]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant HL013423 by the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bao YJ, 2016, J BACTERIOL, V198, P1712, DOI 10.1128/JB.01019-15; Biagini M, 2015, MOL CELL PROTEOMICS, V14, P2138, DOI 10.1074/mcp.M114.045880; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fischetti VA., 2016, STREPTOCOCCUS PYOGEN; Fischetti VA, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0010-2018; Grandi Guido, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-36; Hu P, 2008, ARCH ORAL BIOL, V53, P150, DOI 10.1016/j.archoralbio.2007.08.008; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Jeffery CJ, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0523; Kumari P, 2021, BIOTECHNOL BIOENG, V118, P4577, DOI 10.1002/bit.27935; LAWRENCE PI, 1970, J BIOL CHEM, V245, P3660; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Muller M, 2001, PROG NUCLEIC ACID RE, V66, P107; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Poquet I, 2000, MOL MICROBIOL, V35, P1042, DOI 10.1046/j.1365-2958.2000.01757.x; Qiu CJ, 2019, J STRUCT BIOL, V206, P193, DOI 10.1016/j.jsb.2019.03.003; Raines RT, 2000, METHOD ENZYMOL, V326, P362; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Russo BT, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00096-20; Schneewind O, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0004-2018; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; Wang M, 2010, BIOPHYS J, V99, P302, DOI 10.1016/j.bpj.2010.04.019; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	45	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101940	10.1016/j.jbc.2022.101940	http://dx.doi.org/10.1016/j.jbc.2022.101940			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35430253	gold, Green Published			2022-12-28	WOS:000838892100003
J	Vigil, W; Tran, J; Niks, D; Schut, GJ; Ge, XX; Adams, MWW; Hille, R				Vigil, Wayne, Jr.; Tran, Jessica; Niks, Dimitri; Schut, Gerrit J.; Ge, Xiaoxuan; Adams, Michael W. W.; Hille, Russ			The reductive half-reaction of two bifurcating electron-transferring flavoproteins: Evidence for changes in flavin reduction potentials mediated by specific conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; FERREDOXIN; MECHANISM; SULFITE; COMPLEX; OXYGEN; NADH	The EtfAB components of two bifurcating flavoprotein systems, the crotonyl-CoA-dependent NADH:ferredoxin oxidoreductase from the bacterium Megasphaera elsdenii and the menaquinone-dependent NADH:ferredoxin oxidoreductase from the archaeon Pyrobaculum aerophilum, have been investigated. With both proteins, we find that removal of the electron-transferring flavin adenine dinucleotide (FAD) moiety from both proteins results in an uncrossing of the reduction potentials of the remaining bifurcating FAD; this significantly stabilizes the otherwise very unstable semiquinone state, which accumulates over the course of reductive titrations with sodium dithionite. Furthermore, reduction of both EtfABs depleted of their electron-transferring FAD by NADH was monophasic with a hyperbolic dependence of reaction rate on the concentration of NADH. On the other hand, NADH reduction of the replete proteins containing the electron-transferring FAD was multiphasic, consisting of a fast phase comparable to that seen with the depleted proteins followed by an intermediate phase that involves significant accumulation of FAD.-, again reflecting uncrossing of the half-potentials of the bifurcating FAD. This is then followed by a slow phase that represents the slow reduction of the electron-transferring FAD to FADH-, with reduction of the now fully reoxidized bifurcating FAD by a second equivalent of NADH. We suggest that the crossing and uncrossing of the reduction half-potentials of the bifurcating FAD is due to specific conformational changes that have been structurally characterized.	[Vigil, Wayne, Jr.; Tran, Jessica; Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Schut, Gerrit J.; Ge, Xiaoxuan; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of California System; University of California Riverside; University System of Georgia; University of Georgia	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Vigil Jr, Wayne/0000-0001-7021-1960	National Institutes of Health, United States [GM 135088]; National Science Foundation, United States [CHE 2101672]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, United States(National Science Foundation (NSF))	Work with the P. aerophilum EtfAB was supported by the National Institutes of Health, United States grant GM 135088 (to M. W. W. A. and R. H.); work with the M. elsdenii EtfAB was supported by the National Science Foundation, United States award CHE 2101672 (to R. H.).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliverti A, 1999, METH MOL B, V131, P9; BALLOU DP, 1974, ANAL CHEM, V46, P1248, DOI 10.1021/ac60345a034; Brereton PS, 1998, BIOCHEMISTRY-US, V37, P7351, DOI 10.1021/bi972864b; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Feng X, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016978118; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hoben JP, 2017, J BIOL CHEM, V292, P14039, DOI 10.1074/jbc.M117.794214; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MULLER F, 1969, J BIOL CHEM, V244, P4007; Niks D, 2019, METHODS MOL BIOL, V1876, P55, DOI 10.1007/978-1-4939-8864-8_4; PACE CP, 1987, BIOCHIM BIOPHYS ACTA, V911, P267, DOI 10.1016/0167-4838(87)90067-7; Palmer G., 1971, P 3 INT S FLAVINS FL; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Sucharitakul J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016017; Sucharitakul J, 2021, FEBS J, V288, P1008, DOI 10.1111/febs.15343; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Vigil W, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108793; WHITFIELD C, 1972, Federation Proceedings, V31, P447; WHITFIELD CD, 1974, J BIOL CHEM, V249, P2801	29	1	1	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101927	10.1016/j.jbc.2022.101927	http://dx.doi.org/10.1016/j.jbc.2022.101927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35429498	Green Published, gold			2022-12-28	WOS:000807755100003
J	He, JX; Zou, LN; Pareek, V; Benkovic, SJ				He, Jingxuan; Zou, Ling-Nan; Pareek, Vidhi; Benkovic, Stephen J.			Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEINS; AMPK ACTIVATION; SUBSTRATE; MECHANISM; ENZYMES; PHOSPHORIBOSYLAMINE; COPURIFICATION; ACCUMULATION; MITOCHONDRIA; BINDING	There is growing evidence that mammalian cells deploy a mitochondria-associated metabolon called the purinosome to perform channeled de novo purine biosynthesis (DNPB). However, the molecular mechanisms of this substrate channeling pathway are not well defined. Here, we present molecular evidence of protein-protein interactions (PPIs) between the human bifunctional phosphoribosylaminoimidazole carboxylase/succinocarboxamide synthetase (PAICS) and other known DNPB enzymes. We employed two orthogonal approaches: bimolecular fluorescence complementation, to probe PPIs inside live, intact cells, and co-immunoprecipitation using StrepTag-labeled PAICS that was reintegrated into the genome of PAICS-knockout HeLa cells (crPAICS). With the exception of amidophosphoribosyltransferase, the first enzyme of the DNPB pathway, we discovered PAICS interacts with all other known DNPB enzymes and with MTHFD1, an enzyme which supplies the 10-formyltetrahydrofolate cofactor essential for DNPB. We show these interactions are present in cells grown in both purine-depleted and purine-rich conditions, suggesting at least a partial assembly of these enzymes may be present regardless of the activity of the DNPB pathway. We also demonstrate that tagging of PAICS on its C terminus disrupts these interactions and that this disruption is correlated with disturbed DNPB activity. Finally, we show that crPAICS cells with reintegrated N-terminally tagged PAICS regained effective DNPB with metabolic signatures of channeled synthesis, whereas crPAICS cells that reintegrated C-terminally tagged PAICS exhibit reduced DNPB intermediate pools and a perturbed partitioning of inosine monophosphate into AMP and GMP. Our results provide molecular evidence in support of purinosomes and suggest perturbing PPIs between DNPB enzymes negatively impact metabolite flux through this important pathway.	[He, Jingxuan; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Zou, Ling-Nan; Pareek, Vidhi] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu		Pareek, Vidhi/0000-0003-1329-8021; He, Jingxuan/0000-0002-2130-3196	National Institutes of Health Grant [R01GM024129]; Huck Institutes ofthe Life Sciences, Penn State	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes ofthe Life Sciences, Penn State	This work was supported by National Institutes of Health Grant R01GM024129 (S. J. B.). L. Z.and V. P. acknowledgefinancial support from the Huck Institutes ofthe Life Sciences, Penn State. The content is solely the responsibilityof the authors and does not necessarily represent the official viewsof the National Institutes of Health.	Agarwal S, 2020, CANCERS, V12, DOI 10.3390/cancers12040772; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Asby DJ, 2015, CHEM BIOL, V22, P838, DOI 10.1016/j.chembiol.2015.06.008; Balleza E, 2018, NAT METHODS, V15, P47, DOI [10.1038/NMETH.4509, 10.1038/nmeth.4509]; Baresova V, 2016, MOL GENET METAB, V119, P270, DOI 10.1016/j.ymgme.2016.08.004; Bulock KG, 2002, J BIOL CHEM, V277, P22168, DOI 10.1074/jbc.M111964200; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Chakravarthi BVSK, 2017, PROSTATE, V77, P10, DOI 10.1002/pros.23243; Chan CY, 2018, P NATL ACAD SCI USA, V115, P13009, DOI 10.1073/pnas.1814042115; Cho KF, 2020, NAT PROTOC, V15, P3971, DOI 10.1038/s41596-020-0399-0; Cho KF, 2020, P NATL ACAD SCI USA, V117, P12143, DOI [10.1073/pnas.1919528117, 10.1073/pnas.1919528117/-/DCSupplemental]; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Gallenne T, 2017, ONCOTARGET, V8, P20572, DOI 10.18632/oncotarget.16244; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Gookin TE, 2014, PLANT J, V80, P553, DOI 10.1111/tpj.12639; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Han YS, 2019, ACS CHEM BIOL, V14, P619, DOI 10.1021/acschembio.8b00919; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Laursen T, 2016, SCIENCE, V354, P890, DOI 10.1126/science.aag2347; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Madrova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208947; MCCAIRNS E, 1983, J BIOL CHEM, V258, P1851; Ohashi K, 2014, METHODS MOL BIOL, V1174, P247, DOI 10.1007/978-1-4939-0944-5_17; Ohashi K, 2012, BIOTECHNIQUES, V52, P45, DOI 10.2144/000113777; Pareek V, 2021, MOL CELL, V81, P3775, DOI 10.1016/j.molcel.2021.08.030; Pareek V, 2020, SCIENCE, V368, P283, DOI 10.1126/science.aaz6465; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Romei MG, 2019, ANNU REV BIOPHYS, V48, P19, DOI 10.1146/annurev-biophys-051013-022846; ROWE PB, 1978, J BIOL CHEM, V253, P7711; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Schopp IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15690; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Skerlova J, 2020, J BIOL CHEM, V295, P11656, DOI 10.1074/jbc.RA120.013695; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wu F, 2015, ANGEW CHEM INT EDIT, V54, P1851, DOI 10.1002/anie.201409336; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; Zhang YJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15212; Zhou SY, 2019, GENE, V692, P1, DOI 10.1016/j.gene.2018.12.064	54	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101853	10.1016/j.jbc.2022.101853	http://dx.doi.org/10.1016/j.jbc.2022.101853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35331738	Green Published, gold			2022-12-28	WOS:000793483000004
J	Pletnev, PI; Shulenina, O; Evfratov, S; Treshin, V; Subach, MF; Serebryakova, MV; Osterman, IA; Paleskava, A; Bogdanov, AA; Dontsova, OA; Konevega, AL; Sergiev, PV				Pletnev, Philipp I.; Shulenina, Olga; Evfratov, Sergey; Treshin, Vsevolod; Subach, Maksim F.; Serebryakova, Marina V.; Osterman, Ilya A.; Paleskava, Alena; Bogdanov, Alexey A.; Dontsova, Olga A.; Konevega, Andrey L.; Sergiev, Petr, V			Ribosomal protein S18 acetyltransferase RimI is responsible for the acetylation of elongation factor Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL ACETYLATION; ESCHERICHIA-COLI; TRANSFER-RNA; EF-TU; CRYSTAL-STRUCTURE; MUTANT LACKING; GTP HYDROLYSIS; TRANSLATION; RESISTANCE; MECHANISM	N-terminal acetylation is widespread in the eukaryotic proteome but in bacteria is restricted to a small number of proteins mainly involved in translation. It was long known that elongation factor Tu (EF-Tu) is N-terminally acetylated, whereas the enzyme responsible for this process was unclear. Here, we report that RimI acetyltransferase, known to modify ribosomal protein S18, is likewise responsible for N-acetylation of the EF-Tu. With the help of inducible tufA expression plasmid, we demonstrated that the acetylation does not alter the stability of EF-Tu. Binding of aminoacyl tRNA to the recombinant EF-Tu in vitro was found to be unaffected by the acetylation. At the same time, with the help of fast kinetics methods, we demonstrate that an acetylated variant of EF-Tu more efficiently accelerates A-site occupation by aminoacyltRNA, thus increasing the efficiency of in vitro translation. Finally, we show that a strain devoid of RimI has a reduced growth rate, expanded to an evolutionary timescale, and might potentially promote conservation of the acetylation mechanism of S18 and EF-Tu. This study increased our understanding of the modification of bacterial translation apparatus.	[Pletnev, Philipp I.; Evfratov, Sergey; Treshin, Vsevolod; Subach, Maksim F.; Osterman, Ilya A.; Bogdanov, Alexey A.; Dontsova, Olga A.; Sergiev, Petr, V] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Pletnev, Philipp I.; Dontsova, Olga A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Functioning Living Syst, Moscow, Russia; [Shulenina, Olga; Paleskava, Alena; Konevega, Andrey L.] NRC Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina, Russia; [Shulenina, Olga; Konevega, Andrey L.] NRC Kurchatov Inst, Moscow, Russia; [Serebryakova, Marina V.; Osterman, Ilya A.; Dontsova, Olga A.; Sergiev, Petr, V] Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia; [Serebryakova, Marina V.; Bogdanov, Alexey A.; Dontsova, Olga A.; Sergiev, Petr, V] AN Belozersky Inst Physico Chem Biol, Dept RNA Struct & Funct, Moscow, Russia; [Paleskava, Alena; Konevega, Andrey L.] Peter Great St Petersburg Polytech Univ, Inst Biomed Syst & Biotechnol, Peter Great St, St Petersburg, Russia; [Sergiev, Petr, V] Lomonosov Moscow State Univ, Inst Funct Genom, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; National Research Centre - Kurchatov Institute; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University; Peter the Great St. Petersburg Polytechnic University; Lomonosov Moscow State University	Sergiev, PV (corresponding author), Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia.; Konevega, AL (corresponding author), NRC Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina, Russia.; Konevega, AL (corresponding author), NRC Kurchatov Inst, Moscow, Russia.; Sergiev, PV (corresponding author), Skolkovo Inst Sci & Technol, Ctr Life Sci, Moscow, Russia.; Sergiev, PV (corresponding author), AN Belozersky Inst Physico Chem Biol, Dept RNA Struct & Funct, Moscow, Russia.; Konevega, AL (corresponding author), Peter Great St Petersburg Polytech Univ, Inst Biomed Syst & Biotechnol, Peter Great St, St Petersburg, Russia.; Sergiev, PV (corresponding author), Lomonosov Moscow State Univ, Inst Funct Genom, Moscow, Russia.	konevega_al@pnpi.nrcki.ru; petya@genebee.msu.ru	Sergiev, Petr V/D-7493-2012	Sergiev, Petr V/0000-0001-8866-1863; Evfratov, Sergey/0000-0001-5561-8375; Pletnev, Philipp/0000-0002-7232-4421; Paleskava, Alena/0000-0001-8623-8404	Russian Science Foundation [21-64-00006]	Russian Science Foundation(Russian Science Foundation (RSF))	Funding and additional information-This work was supported by the Russian Science Foundation grant 21-64-00006 (to O. A. D.) .	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bond SR, 2012, NUCLEIC ACIDS RES, V40, pW209, DOI 10.1093/nar/gks396; Christensen DG, 2018, MBIO, V9, DOI 10.1128/mBio.01905-18; CUMBERLIDGE AG, 1979, J MOL BIOL, V131, P169, DOI 10.1016/0022-2836(79)90072-X; Cunha CE, 2013, TRANSLATION, V1, DOI 10.4161/trla.24315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Favrot L, 2016, BIOCHEMISTRY-US, V55, P989, DOI 10.1021/acs.biochem.5b01269; FURANO AV, 1975, P NATL ACAD SCI USA, V72, P4780, DOI 10.1073/pnas.72.12.4780; Gordiyenko Y, 2008, J MOL BIOL, V380, P404, DOI 10.1016/j.jmb.2008.04.067; Hoch PG, 2015, BIOCHIMIE, V117, P87, DOI 10.1016/j.biochi.2014.12.019; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; ISONO K, 1980, MOL GEN GENET, V177, P645; ISONO S, 1981, MOL GEN GENET, V183, P473, DOI 10.1007/BF00268767; Kazakov T, 2014, J BACTERIOL, V196, P3377, DOI 10.1128/JB.01584-14; Nguyen KT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0097-y; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; LAURSEN RA, 1981, J BIOL CHEM, V256, P8102; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Nesterchuk MV, 2011, ACTA NATURAE, V3, P22, DOI 10.32607/20758251-2011-3-2-22-33; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pletnev P, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00097; Roy-Chaudhuri B, 2008, MOL MICROBIOL, V68, P1547, DOI 10.1111/j.1365-2958.2008.06252.x; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Suzuki S, 2019, MICROBIOL-SGM, V165, P65, DOI 10.1099/mic.0.000737; TERHORST C, 1973, EUR J BIOCHEM, V34, P138, DOI 10.1111/j.1432-1033.1973.tb02740.x; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vinogradova DS, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000593; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; Wintermeyer W, 1979, Methods Enzymol, V59, P110; WITTMANNLIEBOLD B, 1978, FEBS LETT, V95, P91, DOI 10.1016/0014-5793(78)80059-3; YAGUCHI M, 1975, FEBS LETT, V59, P217, DOI 10.1016/0014-5793(75)80378-4; YOSHIKAWA A, 1987, MOL GEN GENET, V209, P481, DOI 10.1007/BF00331153; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	35	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101914	10.1016/j.jbc.2022.101914	http://dx.doi.org/10.1016/j.jbc.2022.101914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35398352	Green Published, gold			2022-12-28	WOS:000798082100003
J	Schnell, HM; Ang, J; Rawson, S; Jr, RMW; Micoogullari, Y; Hanna, J				Schnell, Helena M.; Ang, Jessie; Rawson, Shaun; Walsh Jr, Richard M.; Micoogullari, Yagmur; Hanna, John			Mechanism of proteasome gate modulation by assembly chaperones Pba1 and Pba2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; COMPLEX; YEAST	The active sites of the proteasome are housed within its central core particle (CP), a barrel-shaped chamber of four stacked heptameric rings, and access of substrates to the CP interior is mediated by gates at either axial end. These gates are constitutively closed and may be opened by the regulatory particle (RP), which binds the CP and facilitates substrate degradation. We recently showed that the heterodimeric CP assembly chaperones Pba1/2 also mediate gate opening through an unexpected structural arrangement that facilitates the insertion of the N terminus of Pba1 into the CP interior; however, the full mechanism of Pba1/2-mediated gate opening is unclear. Here, we report a detailed analysis of CP gate modulation by Pba1/2. The clustering of key residues at the interface between neighboring alpha-subunits is a critical feature of RP-mediated gate opening, and we find that Pba1/2 recapitulate this strategy. Unlike RP, which inserts at six alpha-subunit interfaces, Pba1/2 insert at only two alpha-subunit interfaces. Nevertheless, Pba1/2 are able to regulate six of the seven interfacial clusters, largely through direct interactions. The N terminus of Pba1 also physically interacts with the center of the gate, disrupting the intersubunit contacts that maintain the closed state. This novel mechanism of gate modulation appears to be unique to Pba1/2 and therefore likely occurs only during proteasome assembly. Our data suggest that release of Pba1/2 at the conclusion of assembly is what allows the nascent CP to assume its mature gate conformation, which is primarily closed, until activated by RP.	[Schnell, Helena M.; Ang, Jessie; Micoogullari, Yagmur; Hanna, John] Womens Hosp Med Ctr, Harvard Med Sch & Brigham, Dept Pathol, Boston, MA USA; [Rawson, Shaun; Walsh Jr, Richard M.] Blavatnik Inst, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA	Harvard University; Harvard Medical School	Hanna, J (corresponding author), Womens Hosp Med Ctr, Harvard Med Sch & Brigham, Dept Pathol, Boston, MA USA.	jwhanna@bwh.harvard.edu		Rawson, Shaun/0000-0002-2973-2630; Walsh, Richard/0000-0002-8939-8988; Schnell, Helena/0000-0002-7840-4473	National Institutes of Health [R01-GM144367, DP5-OD019800]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grants R01-GM144367 and DP5-OD019800 (to J. H.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand R., 2017, PROTOC EXCH, DOI [10.1038/protex.2017.021a, DOI 10.1038/PROTEX.2017.021A]; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Eisele MR, 2018, CELL REP, V24, P1301, DOI 10.1016/j.celrep.2018.07.004; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerra-Moreno A, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw4956; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Rego AT, 2019, MOL CELL, V76, P138, DOI 10.1016/j.molcel.2019.07.014; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schnell HM, 2021, NAT STRUCT MOL BIOL, V28, P418, DOI 10.1038/s41594-021-00583-9; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Takagi K, 2014, BIOCHEM BIOPH RES CO, V450, P1110, DOI 10.1016/j.bbrc.2014.06.119; Wani PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7384; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Weisshaar N, 2017, MOL BIOL CELL, V28, P716, DOI 10.1091/mbc.E16-10-0717; Wu W, 2018, GENES CELLS, V23, P839, DOI 10.1111/gtc.12631; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	31	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101906	10.1016/j.jbc.2022.101906	http://dx.doi.org/10.1016/j.jbc.2022.101906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35398095	Green Published, gold			2022-12-28	WOS:000798082100012
J	Chen, Y; Cao, BL; Zheng, WW; Sun, YN; Xu, TJ				Chen, Ya; Cao, Baolan; Zheng, Weiwei; Sun, Yuena; Xu, Tianjun			eIF3k inhibits NF-kappa B signaling by targeting MyD88 for ATG5-mediated autophagic degradation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; UBIQUITIN; RECOGNITION; TRANSLATION; APOPTOSIS; PROTEINS; CELLS; GENE; TRIF; RNA	Optimal activation of NF-kappa B signaling is crucial for the initiation of inflammatory responses and eliminating invading bacteria. Bacteria have likewise evolved the ability to evade immunity; however, mechanisms by which bacteria dysregulate host NF-kappa B signaling are unclear. In this study, we identify eukaryotic translation initiation factor eIF3k, a nonessential member of the eIF3 translation initiation complex, as a suppressor of the NF-kappa B pathway. Mechanistically, we show that eIF3k expression induced by Vibrio harveyi enhances E3 ligase Nrdp1-mediated K27-linked ubiquitination of MyD88, an upstream regulator of NF-kappa B pathway activation. Furthermore, we show that eIF3k acts as a bridge linking ubiquitin-tagged MyD88 and ATG5, an important mediator of autophagy. We demonstrate that the MyD88-eIF3k-ATG5 complex is transported to the autophagosome for degradation, and that innate immune signaling is subsequently terminated and does not attack invading V. harveyi. Therefore, our study identifies eIF3k as a specific inhibitor of the MyD88-dependent NF-kappa B pathway and suggests that eIF3k may act as a selective autophagic receptor that synergizes with ATG5 to promote the autophagic degradation of MyD88, which helps V. harveyi to evade innate immunity. We conclude that V. harveyi can manipulate a host's autophagy process to evade immunity in fish and also provide a new perspective on mammalian resistance to bacterial invasion.	[Chen, Ya; Cao, Baolan; Zheng, Weiwei; Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Sun, Yuena; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31822057) .	Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Case ED, 2014, CELL MICROBIOL, V16, P862, DOI 10.1111/cmi.12246; Cattie DJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006326; Choi JH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001981; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Di Padova F, 2018, EXPERT OPIN THER TAR, V22, P401, DOI 10.1080/14728222.2018.1464139; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gunther SD, 2020, NAT MICROBIOL, V5, P354, DOI 10.1038/s41564-019-0620-5; He X, 2019, EMBO J, V38, DOI 10.15252/embj.2018100978; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Jeong SJ, 2019, ANTIOXID REDOX SIGN, V31, P458, DOI 10.1089/ars.2018.7649; Jin SH, 2017, MOL CELL, V68, P308, DOI 10.1016/j.molcel.2017.09.005; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li P, 2020, AUTOPHAGY, V16, P1186, DOI 10.1080/15548627.2019.1659614; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mendoza-Barbera E, 2009, BIOCHEM BIOPH RES CO, V380, P183, DOI 10.1016/j.bbrc.2009.01.069; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Shen XY, 2004, FEBS LETT, V573, P139, DOI 10.1016/j.febslet.2004.07.071; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Suzuki J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32431-0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang WW, 2021, J IMMUNOL, V206, P2692, DOI 10.4049/jimmunol.2001404; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wierzbicki IH, 2019, CELL REP, V29, P2979, DOI 10.1016/j.celrep.2019.11.001; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; Wu YX, 2021, AUTOPHAGY, V17, P1379, DOI 10.1080/15548627.2020.1761653; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yan XL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00606; Yang Q, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006600; Yao L, 2020, MICROB PATHOGENESIS, V142, DOI 10.1016/j.micpath.2020.104051; Zeng Y, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009300; Zhang R, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007329; Zhao D, 2020, MOL CELL, V79, P963, DOI 10.1016/j.molcel.2020.07.019; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100414; Zheng WW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009438; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025	63	1	1	7	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101730	10.1016/j.jbc.2022.101730	http://dx.doi.org/10.1016/j.jbc.2022.101730			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35176284	Green Published, gold			2022-12-28	WOS:000789398100005
J	Hayashima, K; Katoh, H				Hayashima, Kazuki; Katoh, Hironori			Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; DRUG-RESISTANCE; TRANSPEPTIDASE; INHIBITION; DEATH; GLUTATHIONE	Ferroptosis is an iron-dependent mode of cell death caused by excessive oxidative damage to lipids. Lipid peroxidation is normally suppressed by glutathione peroxidase 4, which requires reduced glutathione. Cystine is a major resource for glutathione synthesis, especially in cancer cells. Therefore, cystine deprivation or inhibition of cystine uptake promotes ferroptosis in cancer cells. However, the roles of other molecules involved in cysteine deprivation-induced ferroptosis are unexplored. We report here that the expression of gamma-glutamyltransferase 1 (GGT1), an enzyme that cleaves extracellular glutathione, determines the sensitivity of glioblastoma cells to cystine deprivation-induced ferroptosis at high cell density (HD). In glioblastoma cells expressing GGT1, pharmacological inhibition or deletion of GGT1 suppressed the cell density-induced increase in intracellular glutathione levels and cell viability under cystine deprivation, which were restored by the addition of cysteinylglycine, the GGT product of glutathione cleavage. On the other hand, cystine deprivation induced glutathione depletion and ferroptosis in GGT1deficient glioblastoma cells even at an HD. Exogenous expression of GGT1 in GGT1-deficient glioblastoma cells inhibited cystine deprivation-induced glutathione depletion and ferroptosis at an HD. This suggests that GGT1 plays an important role in glioblastoma cell survival under cystine-limited and HD conditions. We conclude that combining GGT inhibitors with ferroptosis inducers may provide an effective therapeutic approach for treating glioblastoma.	[Hayashima, Kazuki; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Kyoto, Japan	Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Kyoto, Japan.	hirokato@pharm.kyoto-u.ac.jp			Japan Society for the Promotion of Science [18K06215, 21K06065]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Prof Junichi Miyazaki (Osaka University, Osaka, Japan) for the CAG promoter-containing vector. We also thank Dr Yohei Katoh and Prof Kazuhisa Nakayama (Kyoto University) for providing peSpCAS9(1.1)-2xsgRNA and pDonortBFP-NLS-Neo. This study was supported in part by Grants-inaid for Scientific Research from the Japan Society for the Promotion of Science (grant nos.: 18K06215 and 21K06065).	Bansal A, 2019, MOL CANCER RES, V17, P1881, DOI 10.1158/1541-7786.MCR-18-1204; Bansal A, 2018, J CELL BIOL, V217, P2291, DOI 10.1083/jcb.201804161; Batsios G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63160-y; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Corti A, 2010, ANTICANCER RES, V30, P1169; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Goji T, 2017, J BIOL CHEM, V292, P19721, DOI 10.1074/jbc.M117.814392; GRIFFITH OW, 1978, P NATL ACAD SCI USA, V75, P5405, DOI 10.1073/pnas.75.11.5405; Gujral TS, 2017, P NATL ACAD SCI USA, V114, pE3729, DOI 10.1073/pnas.1703096114; HANES CS, 1950, NATURE, V166, P288, DOI 10.1038/166288a0; HANIGAN MH, 1995, CARCINOGENESIS, V16, P181, DOI 10.1093/carcin/16.2.181; Hayashima K, 2021, BIOCHEM BIOPH RES CO, V539, P56, DOI 10.1016/j.bbrc.2020.12.075; Heisterkamp N, 2008, HUM GENET, V123, P321, DOI 10.1007/s00439-008-0487-7; Horie K, 2020, ONCOLOGY-BASEL, V98, P734, DOI 10.1159/000508688; Hughes CE, 2020, CELL, V180, P296, DOI 10.1016/j.cell.2019.12.035; Ji Y, 2016, AMINO ACIDS, V48, P149, DOI 10.1007/s00726-015-2071-5; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Kawakami K, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3301-x; KOBAYASHI H, 1992, CANCER CHEMOTH PHARM, V31, P6, DOI 10.1007/BF00695987; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu XG, 2021, GENES DIS, V8, P731, DOI 10.1016/j.gendis.2020.11.010; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEYTS ERD, 1992, TOXICOL APPL PHARM, V114, P56, DOI 10.1016/0041-008X(92)90096-B; Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x; Poltorack CD, 2022, FEBS J, V289, P374, DOI 10.1111/febs.15842; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Shimomura T, 2021, ACS SENSORS, V6, P2125, DOI 10.1021/acssensors.1c00496; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; Tan SK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00218; West MB, 2011, J BIOL CHEM, V286, P28876, DOI 10.1074/jbc.M111.248823; Westhoff MA, 2008, ONCOGENE, V27, P5169, DOI 10.1038/onc.2008.148; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Yamaguchi I, 2020, J BIOL CHEM, V295, P6936, DOI 10.1074/jbc.RA119.012213; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang WH, 2020, MOL CANCER RES, V18, P79, DOI 10.1158/1541-7786.MCR-19-0691; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	41	3	3	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101703	10.1016/j.jbc.2022.101703	http://dx.doi.org/10.1016/j.jbc.2022.101703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148992	Green Published, gold			2022-12-28	WOS:000821054100004
J	Liao, XW; Li, HA; Guo, Y; Yang, F; Chen, YS; He, XJ; Li, HY; Xia, W; Mao, ZW; Sun, HZ				Liao, Xiangwen; Li, Huinan; Guo, Yu; Yang, Fang; Chen, Yushou; He, Xiaojun; Li, Hongyan; Xia, Wei; Mao, Zong -Wan; Sun, Hongzhe			Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE DETERMINANTS; GLOBAL REGULATOR; CCPA; RESISTANCE; IDENTIFICATION; TRANSCRIPTION; HOMEOSTASIS; AFFINITY; SYSTEM; MGRA	Catabolite control protein A (CcpA) of the human pathogen Staphylococcus aureus is an essential DNA regulator for carbon catabolite repression and virulence, which facilitates bacterial survival and adaptation to a changing environment. Here, we report that copper (II) signaling mediates the DNA-binding capability of CcpA in vitro and in vivo. Copper (II) catalyzes the oxidation of two cysteine residues (Cys216 and Cys242) in CcpA to form intermolecular disulfide bonds between two CcpA dimers, which results in the formation and dissociation of a CcpA tetramer of CcpA from its cognate DNA promoter. We further demonstrate that the two cysteine residues on CcpA are important for S. aureus to resist host innate immunity, indi-cating that S. aureus CcpA senses the redox-active copper (II) ions as a natural signal to cope with environmental stress. Together, these findings reveal a novel regulatory mechanism for CcpA activity through copper (II)-mediated oxidation.	[Liao, Xiangwen; Li, Huinan; Guo, Yu; Yang, Fang; He, Xiaojun; Xia, Wei; Mao, Zong -Wan] Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou, Peoples R China; [Liao, Xiangwen; Chen, Yushou] Jiangxi Sci & Technol Normal Univ, Sch Pharm, Nanchang, Jiangxi, Peoples R China; [Guo, Yu] Chinese Acad Sci, Guangdong Key Lab Marine Mat Med,South China Sea, Innovat Acad South China Sea Ecol & Environm Engn, CAS Key Lab Trop Marine Bio Resources & Ecol, Guangzhou, Peoples R China; [Guo, Yu] Southern Marine Sci & Engn Guangdong Lab, Guangzhou, Peoples R China; [Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China	Sun Yat Sen University; Jiangxi Science & Technology Normal University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Southern Marine Science & Engineering Guangdong Laboratory; University of Hong Kong	Xia, W; Mao, ZW (corresponding author), Sun Yat Sen Univ, Sch Chem, MOE Key Lab Bioinorgan & Synthet Chem, Guangzhou, Peoples R China.; Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China.	xiawei5@mail.sysu.edu.cn; cesmzw@mail.sysu.edu.cn; hsun@hku.hk	何, 晓俊/GSJ-1063-2022; /D-3123-2009	/0000-0001-6697-6899	National Nat-ural Science Foundation of China [21837006, 22022706, 22077142, 91953117, 21877131]; Natural Science Foundation of Guang-dong Province, China [2019A1515011156]; Ministry of Educa-tion of China [IRT-17R111]; Fundamental Research Funds for the Central Universities	National Nat-ural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guang-dong Province, China(National Natural Science Foundation of Guangdong Province); Ministry of Educa-tion of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Acknowledgments-This work was supported by the National Nat-ural Science Foundation of China (21837006, 22022706, 22077142, 91953117 and 21877131) , Natural Science Foundation of Guang-dong Province, China (2019A1515011156) , the Ministry of Educa-tion of China (IRT-17R111) , and the Fundamental Research Funds for the Central Universities.	Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Chen WH, 2017, J AM CHEM SOC, V139, P3790, DOI 10.1021/jacs.6b13317; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Huang Q, 2020, ACS INFECT DIS, V6, P347, DOI 10.1021/acsinfecdis.9b00465; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishnamoorthy L, 2016, NAT CHEM BIOL, V12, P586, DOI [10.1038/NCHEMBIO.2098, 10.1038/nchembio.2098]; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Liao XW, 2017, CHEM SCI, V8, P8061, DOI 10.1039/c7sc02251d; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Pidwill GR, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.620339; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Riquelme SA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00385; Schumacher MA, 2006, J BIOL CHEM, V281, P6793, DOI 10.1074/jbc.M509977200; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tao X, 2020, CCS CHEM, V2, P946, DOI 10.31635/ccschem.020.202000219; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Tiwari N, 2020, P NATL ACAD SCI USA, V117, P10989, DOI 10.1073/pnas.1921307117; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Xiao T, 2018, NAT CHEM BIOL, V14, P655, DOI 10.1038/s41589-018-0062-z; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350	44	1	1	9	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101587	10.1016/j.jbc.2022.101587	http://dx.doi.org/10.1016/j.jbc.2022.101587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35032550	gold, Green Published			2022-12-28	WOS:000791267400011
J	Osuka, RF; Hirata, T; Nagae, M; Nakano, M; Shibata, H; Okamoto, R; Kizuka, Y				Osuka, Reina F.; Hirata, Tetsuya; Nagae, Masamichi; Nakano, Miyako; Shibata, Hiroyuki; Okamoto, Ryo; Kizuka, Yasuhiko			N-acetylglucosaminyltransferase-V requires a specific noncatalytic luminal domain for its activity toward glycoprotein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM REGION; GLYCOSYLATION; PURIFICATION; LOCALIZATION; REVEALS; ENZYMES; GLYCANS; POMGNT1; MUTANT; SPPL3	N-acetylglucosaminyltransferase-V (GnT-V or MGAT5) catalyzes the formation of an N-glycan beta 1,6-GlcNAc branch on selective target proteins in the Golgi apparatus and is involved in cancer malignancy and autoimmune disease etiology. Several three-dimensional structures of GnT-V were recently solved, and the recognition mechanism of the oligosaccharide sub-strate was clarified. However, it is still unclear how GnT-V selectively acts on glycoprotein substrates. In this study, we focused on an uncharacterized domain at the N-terminal side of the luminal region (N domain) of GnT-V, which was previ-ously identified in a crystal structure, and aimed to reveal its role in GnT-V action. Using lectin blotting and fluorescence assisted cell sorting analysis, we found that a GnT-V & UDelta;N mutant lacking the N domain showed impaired biosynthetic activity in cells, indicating that the N domain is required for efficient glycosylation. To clarify this mechanism, we measured the in vitro activity of purified GnT-V & UDelta;N toward various kinds of substrates (oligosaccharide, glycohexapeptide, and glycopro-tein) using HPLC and a UDP-Glo assay. Surprisingly, GnT-V & UDelta;N showed substantially reduced activity toward the glyco-protein substrates, whereas it almost fully maintained its ac-tivity toward the oligosaccharides and the glycopeptide substrates. Finally, docking models of GnT-V with substrate glycoproteins suggested that the N domain could interact with the substrate polypeptide directly. Our findings suggest that the N domain of GnT-V plays a critical role in the recognition of glycoprotein substrates, providing new insights into the mechanism of substrate-selective biosynthesis of N-glycans.	[Osuka, Reina F.; Kizuka, Yasuhiko] Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan; [Hirata, Tetsuya; Kizuka, Yasuhiko] Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan; [Nagae, Masamichi] Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, Suita, Japan; [Nagae, Masamichi] Osaka Univ, Immunol Frontier Res Ctr IFReC, Lab Mol Immunol, Suita, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Shibata, Hiroyuki; Okamoto, Ryo] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Japan	Gifu University; Gifu University; Osaka University; Osaka University; Hiroshima University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan.; Kizuka, Y (corresponding author), Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp		Nagae, Masamichi/0000-0002-5470-3807; Kizuka, Yasuhiko/0000-0002-3181-9743	Japan Society for the Promotion of Science (JSPS) [20H03207]; JST [[18070267]; Takeda Science Foundation; MEXT WISE program; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT WISE program; Tokyo Biochemical Research Foundation	This work was partially supported by a Grant-in-Aid for Scientific Research (B) to Y. K. [20H03207] , a Leading Initiative for Excellent Young Researchers (LEADER) project (Y. K.) from the Japan Society for the Promotion of Science (JSPS) , a CREST grant ( [18070267] to Y. K.) from JST, a grant from the Takeda Science Foundation to Y. K., Nagoya Uni-versity CIBoG program from MEXT WISE program to R. F. O., and a grant from the Tokyo Biochemical Research Foundation to Y. K.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Carvalho S, 2016, ONCOGENE, V35, P1619, DOI 10.1038/onc.2015.225; CHANEY W, 1989, J CELL BIOL, V109, P2089, DOI 10.1083/jcb.109.5.2089; Coddeville B, 1998, GLYCOCONJUGATE J, V15, P265, DOI 10.1023/A:1006997012617; Darby JF, 2020, ACS CATAL, V10, P8590, DOI 10.1021/acscatal.0c02222; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DO KY, 1994, J BIOL CHEM, V269, P23456; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Granovsky M, 2000, NAT MED, V6, P306; GREEN ED, 1988, J BIOL CHEM, V263, P18253; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hirata T, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129726; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murata K, 2000, CLIN CANCER RES, V6, P1772; Nagae M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020437; Nagae M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05931-w; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Okamoto R, 2014, ANGEW CHEM INT EDIT, V53, P5194, DOI 10.1002/anie.201400679; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rodriguez AC, 2015, J BIOL CHEM, V290, P22638, DOI 10.1074/jbc.M115.667006; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; TAKESADA H, 1992, J BIOCHEM-TOKYO, V112, P143, DOI 10.1093/oxfordjournals.jbchem.a123854; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tomida S, 2020, J BIOL CHEM, V295, P7992, DOI 10.1074/jbc.RA120.013079; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Weinstein J, 1996, J BIOL CHEM, V271, P27462, DOI 10.1074/jbc.271.44.27462; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yamamoto K, 1993, Methods Mol Biol, V14, P17; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	49	3	3	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101666	10.1016/j.jbc.2022.101666	http://dx.doi.org/10.1016/j.jbc.2022.101666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35104505	gold, Green Published			2022-12-28	WOS:000791230900006
J	Yang, J; Song, AS; Wiseman, RLC; Lander, G				Yang, Jie; Song, Albert S.; Wiseman, R. Luke C.; Lander, Gabriel			Cryo-EM structure of hexameric yeast Lon protease (PIM1) highlights the importance of conserved structural elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL LON; DNA; STRESS	Lon protease is a conserved ATP-dependent serine protease composed of an AAA+ domain that mechanically unfolds substrates and a serine protease domain that degrades these unfolded substrates. In yeast, dysregulation of Lon protease (PIM1) attenuates lifespan and leads to gross mitochondrial morphological perturbations. Although structures of the bacterial and human Lon protease reveal a hexameric assembly, yeast PIM1 was speculated to form a heptameric assembly and is uniquely characterized by a similar to 50-residue insertion between the ATPase and protease domains. To further understand the yeast-specific properties of PIM1, we determined a high resolution cryo-electron microscopy structure of PIM1 in a substrate-translocating state. Here, we reveal that PIM1 forms a hexamer, conserved with that of bacterial and human Lon proteases, wherein the ATPase domains form a canonical closed spiral that enables pore loop residues to translocate substrates to the protease chamber. In the substrate-translocating state, PIM1 protease domains form a planar protease chamber in an active conformation and are uniquely characterized by a similar to 15-residue C-terminal extension. These additional C-terminal residues form an alpha-helix located along the base of the protease domain. Finally, we did not observe density for the yeast-specific insertion between the ATPase and protease domains, likely due to high conformational flexibility. Biochemical studies to investigate the insertion using constructs that truncated or replaced the insertion with a glycineserine linker suggest that the yeast-specific insertion is dispensable for PIM1's enzymatic function. Altogether, our structural and biochemical studies highlight unique components of PIM1 machinery and demonstrate evolutionary conservation of Lon protease function.	[Yang, Jie; Song, Albert S.; Lander, Gabriel] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Song, Albert S.; Wiseman, R. Luke C.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Lander, G (corresponding author), Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wiseman, RLC (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	glander@scripps.edu; wiseman@scripps.edu		Song, Albert/0000-0003-3176-6829; YANG, JIE/0000-0001-6662-4236	National Institutes of Health (NIH) [NS095892]; NIH [F31AG071162, S10OD021634]; Olson-King Endowed Skaggs Fellowship from Scripps Research	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Olson-King Endowed Skaggs Fellowship from Scripps Research	This work is supported by the National Institutes of Health (NIH) (NS095892 to R. L. W. and G. C. L). A. S. S. is supported by the NIH F31AG071162 and the Olson-King Endowed Skaggs Fellowship from Scripps Research. Computational analyses of EM data were performed using shared instrumentation funded by NIH S10OD021634 to G. C. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Coscia F, 2021, FEBS LETT, V595, P2691, DOI 10.1002/1873-3468.14199; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; Goke A, 2020, MOL BIOL CELL, V31, P527, DOI 10.1091/mbc.E19-08-0470; Haynes, 2018, LEGACY ROLE DNA BIND, DOI [10.1101/317677., DOI 10.1101/317677]; Herzik MA, 2021, METHODS MOL BIOL, V2215, P125, DOI 10.1007/978-1-0716-0966-8_6; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Li SS, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101239; Li SS, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj7835; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; Moehle EA, 2019, J BIOL CHEM, V294, P5396, DOI 10.1074/jbc.TM117.000893; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Santra M, 2019, P NATL ACAD SCI USA, V116, P22173, DOI 10.1073/pnas.1906592116; Shin M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23495-0; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Teichmann U, 1996, J BIOL CHEM, V271, P10137, DOI 10.1074/jbc.271.17.10137; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Voos W, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020253; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	36	2	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101694	10.1016/j.jbc.2022.101694	http://dx.doi.org/10.1016/j.jbc.2022.101694			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143841	Green Published, gold			2022-12-28	WOS:000789400700017
J	Han, X; Ren, JL; Lohner, H; Yakoumatos, L; Liang, RQ; Wang, HZ				Han, Xiao; Ren, Junling; Lohner, Hannah; Yakoumatos, Lan; Liang, Ruqiang; Wang, Huizhi			SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; ACTIVATION; SERUM; CELLS; UBIQUITIN; COMPLEX; NEDD4-2; PHOSPHORYLATION	Serum- and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase that plays important roles in the cellular stress response. While SGK1 has been reported to restrain inflammatory immune responses, the molecular mechanisms involved remain elusive, especially in oral bacteria-induced inflammatory milieu. Here, we found that SGK1 curtails Porphyromonas gingivalis-induced inflammatory responses through maintaining levels of tumor necrosis factor receptor-associated factor (TRAF) 3, thereby suppressing NF kappa B signaling. Specifically, SGK1 inhibition significantly enhances production of proinflammatory cytokines, including tumor necrosis factor alpha, interleukin (IL)-6, IL-1 beta, and IL-8 in P. gingivalis-stimulated innate immune cells. The results were confirmed with siRNA and LysM-Cre-mediated SGK1 KO mice. Moreover, SGK1 deletion robustly increased NF-kappa B activity and c-Jun expression but failed to alter the activation of mitogen-activated protein kinase signaling pathways. Further mechanistic data revealed that SGK1 deletion elevates TRAF2 phosphorylation, leading to TRAF3 degradation in a proteasome-dependent manner. Importantly, siRNAmediated traf3 silencing or c-Jun overexpression mimics the effect of SGK1 inhibition on P. gingivalis-induced inflammatory cytokines and NF-kappa B activation. In addition, using a P. gingivalis infection-induced periodontal bone loss model, we found that SGK1 inhibition modulates TRAF3 and c-Jun expression, aggravates inflammatory responses in gingival tissues, and exacerbates alveolar bone loss. Altogether, we demonstrated for the first time that SGK1 acts as a rheostat to limit P. gingivalis-induced inflammatory immune responses and mapped out a novel SGK1-TRAF2/3-c-Jun-NF-kappa B signaling axis. These findings provide novel insights into the anti-inflammatory molecular mechanisms of SGK1 and suggest novel interventional targets to inflammatory diseases relevant beyond the oral cavity.	[Han, Xiao; Ren, Junling; Lohner, Hannah; Wang, Huizhi] Virginia Commonwealth Univ, Dept Oral & Craniofacial Mol Biol, VCU Philips Inst Oral Hlth Res, Richmond, VA 23284 USA; [Yakoumatos, Lan] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Liang, Ruqiang] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Virginia Commonwealth University; University of Louisville; University of California System; University of California Davis	Wang, HZ (corresponding author), Virginia Commonwealth Univ, Dept Oral & Craniofacial Mol Biol, VCU Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.	wangh3@vcu.edu		Lohner, Hannah/0000-0003-3421-8297; Wang, Huizhi/0000-0001-7692-2106; , xiao/0000-0002-5065-4489	US National Institutes of Health, National Institute of Dental and Craniofacial Research [DE026727, F31DE031968]; VCU Presidential Research Quest Fund award	US National Institutes of Health, National Institute of Dental and Craniofacial Research; VCU Presidential Research Quest Fund award	This research was supported by grants DE026727 (to H. W.) and F31DE031968 (to H. L.) from the US National Institutes of Health, National Institute of Dental and Craniofacial Research, and VCU Presidential Research Quest Fund award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Adamowicz K, 2012, MOL MED, V18, P1190, DOI 10.2119/molmed.2012.00180; Berker E, 2013, J PERIODONTOL, V84, P1337, DOI 10.1902/jop.2012.120422; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dhillon B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00104; Di Cristofano A, 2017, CURR TOP DEV BIOL, V123, P49, DOI 10.1016/bs.ctdb.2016.11.006; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Etemadi N, 2015, ELIFE, V4, DOI 10.7554/eLife.10592; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hajishengallis G, 2021, NAT REV IMMUNOL, V21, P426, DOI 10.1038/s41577-020-00488-6; Hajishengallis G, 2020, PERIODONTOL 2000, V82, P78, DOI 10.1111/prd.12313; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hroch M, 2012, J CHROMATOGR B, V880, P90, DOI 10.1016/j.jchromb.2011.11.022; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Lalani Almin I, 2015, Macrophage (Houst), V2, pe1009; Lang F, 2009, EXPERT OPIN THER TAR, V13, P1303, DOI 10.1517/14728220903260807; Li C, 2017, J PERIODONTOL, V88, pE129, DOI 10.1902/jop.2017.160815; Li JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10677-0; Li YJ, 2019, J IMMUNOL, V202, P2044, DOI 10.4049/jimmunol.1801286; Lin WJ, 2011, P NATL ACAD SCI USA, V108, P18354, DOI 10.1073/pnas.1109427108; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lu LH, 2020, FASEB J, V34, P9120, DOI 10.1096/fj.201902697RR; Lu XH, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0903-x; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Matthias J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau0683; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nakayama M, 2015, J BIOL CHEM, V290, P5190, DOI 10.1074/jbc.M114.591610; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30385; Parvatiyar K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05168-7; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pohl P, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02419-0; Ren JL, 2021, J IMMUNOL, V207, P268, DOI 10.4049/jimmunol.2001455; Schmid E, 2014, CELL PHYSIOL BIOCHEM, V34, P943, DOI 10.1159/000366311; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stafford P, 2013, MOL ORAL MICROBIOL, V28, P366, DOI 10.1111/omi.12030; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Workman LM, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00429-19; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xia Zong-Ping, 2005, Sci STKE, V2005, ppe7, DOI 10.1126/stke.2722005pe7; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu WZ, 2020, ADV PROTEIN CHEM STR, V120, P45, DOI 10.1016/bs.apcsb.2019.12.001; Yang DQ, 2020, MOL IMMUNOL, V118, P153, DOI 10.1016/j.molimm.2019.12.013; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Yang XD, 2015, IMMUNOL REV, V266, P56, DOI 10.1111/imr.12311; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou HX, 2015, FASEB J, V29, P3737, DOI 10.1096/fj.15-270462; Zhou Y, 2015, INFECT IMMUN, V83, P3195, DOI 10.1128/IAI.00302-15; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	76	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102036	10.1016/j.jbc.2022.102036	http://dx.doi.org/10.1016/j.jbc.2022.102036			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35588785	Green Published, gold			2022-12-28	WOS:000811813400002
J	Cohen, R; Mukai, C; Nelson, JL; Zenilman, SS; Sosnicki, DM; Travis, AJ				Cohen, Roy; Mukai, Chinatsu; Nelson, Jacquelyn L.; Zenilman, Shoshana S.; Sosnicki, Danielle M.; Travis, Alexander J.			A genetically targeted sensor reveals spatial and temporal dynamics of acrosomal calcium and sperm acrosome exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE-OPERATED CHANNELS; MOUSE SPERM; ZONA-PELLUCIDA; HUMAN SPERMATOZOA; PROGESTERONE; CAPACITATION; MOTILITY; MURINE; FERTILIZATION; CHOLESTEROL	Secretion of the acrosome, a single vesicle located rostrally in the head of a mammalian sperm, through a process known as "acrosome exocytosis" (AE), is essential for fertilization. However, the mechanisms leading to and regulating this complex process are controversial. In particular, poor understanding of Ca2+ dynamics between sperm subcellular compartments and regulation of membrane fusion mechanisms have led to competing models of AE. Here, we developed a transgenic mouse expressing an Acrosome-targeted Sensor for Exocytosis (AcroSensE) to investigate the spatial and temporal Ca2+ dynamics in AE in live sperm. AcroSensE combines a genetically encoded Ca2+ indicator (GCaMP) fused with an mCherry indicator to spatiotemporally resolve acrosomal Ca2+ rise (ACR) and membrane fusion events, enabling real-time study of AE. We found that ACR is dependent on extracellular Ca2+ and that ACR precedes AE. In addition, we show that there are intermediate steps in ACR and that AE correlates better with the ACR rate rather than absolute Ca2+ amount. Finally, we demonstrate that ACR and membrane fusion progression kinetics and spatial patterns differ with different stimuli and that sites of initiation of ACR and sites of membrane fusion do not always correspond. These findings support a model involving functionally redundant pathways that enable a highly regulated, multistep AE in heterogeneous sperm populations, unlike the previously proposed "acrosome reaction" model.	[Cohen, Roy; Mukai, Chinatsu; Nelson, Jacquelyn L.; Zenilman, Shoshana S.; Sosnicki, Danielle M.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Travis, Alexander J.] Cornell Univ, Coll Vet Med, Dept Publ & Ecosyst Hlth, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cohen, R (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	roy.cohen@cornell.edu		Sosnicki, Danielle/0000-0001-8480-0950	National Institutes of Health [R01-HD093827, R03HD090304]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01-HD093827 and R03HD090304 (A. J. T). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amatore C, 2009, BIOPHYS CHEM, V143, P124, DOI 10.1016/j.bpc.2009.04.007; Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Asano Atsushi, 2013, Commun Integr Biol, V6, pe27362, DOI 10.4161/cib.27362; Asano A, 2013, J BIOL CHEM, V288, P28104, DOI 10.1074/jbc.M113.450981; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Bhakta HH, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176966; Blackmore PF, 1999, STEROIDS, V64, P149, DOI 10.1016/S0039-128X(98)00109-3; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; Cardona C, 2017, MOL REPROD DEV, V84, P423, DOI 10.1002/mrd.22803; Chavez JC, 2018, J CELL PHYSIOL, V233, P4735, DOI 10.1002/jcp.26262; Cohen R, 2016, ADV ANAT EMBRYOL CEL, V220, P107, DOI 10.1007/978-3-319-30567-7_6; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Correia J, 2015, REPRODUCTION, V150, pR65, DOI 10.1530/REP-15-0102; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2012, CELL TISSUE RES, V349, P749, DOI 10.1007/s00441-012-1397-5; de Lamirande E, 1998, J ANDROL, V19, P215; Francavilla F, 2002, INT J ANDROL, V25, P106, DOI 10.1046/j.1365-2605.2002.00333.x; Grafen A, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00218; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Henderson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139273; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Hino T, 2011, ZYGOTE, V19, P315, DOI 10.1017/S0967199410000481; HOLT WV, 1984, J EXP ZOOL, V230, P473, DOI 10.1002/jez.1402300316; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; Mills TT, 2009, GEN PHYSIOL BIOPHYS, V28, P126, DOI 10.4149/gpb_2009_02_126; Molina LCP, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00387; Moody MA, 2017, MOL REPROD DEV, V84, P408, DOI 10.1002/mrd.22801; Morris J, 2015, MOL HUM REPROD, V21, P563, DOI 10.1093/molehr/gav019; Naaby-Hansen S, 2001, MOL HUM REPROD, V7, P923, DOI 10.1093/molehr/7.10.923; Nahecr RA, 2016, J BIOL CHEM, V291, P3076, DOI 10.1074/jbc.M115.677799; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; PITELKA DR, 1983, J CELL BIOL, V96, P613, DOI 10.1083/jcb.96.3.613; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schinfeld J, 2018, MOL REPROD DEV, V85, P654, DOI 10.1002/mrd.23057; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Sharara F, 2020, REPROD BIOMED ONLINE, V41, P69, DOI 10.1016/j.rbmo.2020.03.011; Shui B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00428; Sun XH, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0281-2; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Travis AJ, 2004, BIOL REPROD, V71, P139, DOI 10.1095/biolreprod.103.025809; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; UHLER ML, 1992, FERTIL STERIL, V58, P1191; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Williams KM, 2003, INT J ANDROL, V26, P366, DOI 10.1111/j.1365-2605.2003.00438.x; WOLF DE, 1990, P NATL ACAD SCI USA, V87, P6893, DOI 10.1073/pnas.87.17.6893	68	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101868	10.1016/j.jbc.2022.101868	http://dx.doi.org/10.1016/j.jbc.2022.101868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35346690	gold, Green Published			2022-12-28	WOS:000860390500008
J	Collins, GA; Sha, Z; Kuo, CL; Erbil, B; Goldberg, AL				Collins, Galen Andrew; Sha, Zhe; Kuo, Chueh-Ling; Erbil, Beyza; Goldberg, Alfred L.			Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ASSOCIATED DOMAINS; 26S PROTEASOME; UBA DOMAINS; NELFINAVIR; INHIBITION; BREAKDOWN; PROMOTE; CHAINS; DSK2P	Although several proteasome subunits have been shown to bind ubiquitin (Ub) chains, many ubiquitylated substrates also associate with 26S proteasomes via "shuttling factors." Unlike the well-studied yeast shuttling factors Rad23 and Dsk2, vertebrate homologs Ddi2 and Ddi1 lack a Ub-associated domain; therefore, it is unclear how they bind Ub. Here, we show that deletion of Ddi2 leads to the accumulation of Ub conjugates with K11/K48 branched chains. We found using affinity copurifications that Ddi2 binds Ub conjugates through its Ub-like domain, which is also required for Ddi2 binding to proteasomes. Furthermore, in cell extracts, adding Ub conjugates increased the amount of Ddi2 associated with proteasomes, and adding Ddi2 increased the binding of Ub conjugates to purified proteasomes. In addition, Ddi2 also contains a retroviral protease domain with undefined cellular roles. We show that blocking the endoprotease activity of Ddi2 either genetically or with the HIV protease inhibitor nelfinavir increased its binding to Ub conjugates but decreased its binding to proteasomes and reduced subsequent protein degradation by proteasomes leading to further accumulation of Ub conjugates. Finally, nelfinavir treatment required Ddi2 to induce the unfolded protein response. Thus, Ddi2 appears to function as a shuttling factor in endoplasmic reticulum- associated protein degradation and delivers K11/K48ubiquitylated proteins to the proteasome. We conclude that the protease activity of Ddi2 influences this shuttling factor activity, promotes protein turnover, and helps prevent endoplasmic reticulum stress, which may explain nelfinavir's ability to enhance cell killing by proteasome inhibitors.	[Collins, Galen Andrew; Sha, Zhe; Kuo, Chueh-Ling; Erbil, Beyza; Goldberg, Alfred L.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA USA; [Sha, Zhe] UCB, Cambridge, MA USA; [Kuo, Chueh-Ling] Totus Med, Cambridge, MA USA; [Erbil, Beyza] Labcorp Drug Dev, Munich, Germany	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA USA.	alfred_goldberg@hms.harvard.edu		Collins, Galen/0000-0002-3926-9483				Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Besche HC, 2012, METHODS MOL BIOL, V832, P423, DOI 10.1007/978-1-61779-474-2_29; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chowdhury AMMA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12675-y; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Collins GA, 2020, P NATL ACAD SCI USA, V117, P4664, DOI 10.1073/pnas.1915534117; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Dirac-Svejstrup AB, 2020, MOL CELL, V79, P332, DOI 10.1016/j.molcel.2020.05.035; Driessen C, 2018, BLOOD, V132, P2097, DOI 10.1182/blood-2018-05-851170; Driessen C, 2016, HAEMATOLOGICA, V101, P346, DOI 10.3324/haematol.2015.135780; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Fassmannova D, 2020, CANCERS, V12, DOI 10.3390/cancers12051065; Finley D, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033985; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Gu Y, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109775; Guan M, 2011, CLIN CANCER RES, V17, P1796, DOI 10.1158/1078-0432.CCR-10-3216; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hamel FG, 2006, DIABETES OBES METAB, V8, P661, DOI 10.1111/j.1463-1326.2005.00546.x; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hitz F, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0228-2; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2018, P NATL ACAD SCI USA, V115, pE11642, DOI 10.1073/pnas.1808731115; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Koltai Tomas, 2015, F1000Res, V4, P9, DOI 10.12688/f1000research.5827.1; Kottemann MC, 2018, MOL CELL, V69, P24, DOI 10.1016/j.molcel.2017.11.035; Krylov DM, 2001, CURR BIOL, V11, pR584, DOI 10.1016/S0960-9822(01)00357-8; Kuo CL, 2018, METHODS MOL BIOL, V1844, P277, DOI 10.1007/978-1-4939-8706-1_18; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015; Li JM, 2021, MOL CELL, V81, P4722, DOI 10.1016/j.molcel.2021.09.015; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Mendez-Lopez M, 2019, CLIN ADV HEMATOL ONC, V17, P615; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Motosugi R, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00030; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Newton K, 2012, METHODS MOL BIOL, V832, P185, DOI 10.1007/978-1-61779-474-2_13; Northrop A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010327; Nowicka U, 2015, STRUCTURE, V23, P542, DOI 10.1016/j.str.2015.01.010; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Piccinini M, 2005, ANTIVIR THER, V10, P215; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sha Z, 2018, METHODS MOL BIOL, V1844, P261, DOI 10.1007/978-1-4939-8706-1_17; Sha Z, 2016, CURR BIOL, V26, pR836, DOI 10.1016/j.cub.2016.08.030; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Siva M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30443; Tsuchiya H, 2017, MOL CELL, V66, P488, DOI 10.1016/j.molcel.2017.04.024; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yau RG, 2017, CELL, V171, P918, DOI 10.1016/j.cell.2017.09.040; Yip MCJ, 2020, P NATL ACAD SCI USA, V117, P7776, DOI 10.1073/pnas.1902298117; Zhao JH, 2016, NATURE, V529, pE1, DOI 10.1038/nature16472; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	64	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101875	10.1016/j.jbc.2022.101875	http://dx.doi.org/10.1016/j.jbc.2022.101875			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35358511	Green Published, gold			2022-12-28	WOS:000798082100013
J	Kulczyk, AW; Leustek, T				Kulczyk, Arkadiusz W.; Leustek, Thomas			You cannot oxidize what you cannot reach: Oxidative susceptibility of buried methionine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Oxidation of protein methionines to methionine sulfoxides can result in protein structural alterations with a wide variety of biological implications. Factors that determine susceptibility to oxidation are not well understood. The recent JBC Editors Pick by Walker et al. applied proteomic methodologies to show that the oxidative susceptibility of buried methionine residues is strongly correlated with folding stability of the contextual peptide. Proteome-wide analysis of oxidation-susceptible methionines promises to answer open questions about the biological functions of reversible methionine oxidation.	[Kulczyk, Arkadiusz W.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ USA; [Leustek, Thomas] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Leustek, T (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	leustek@sebs.rutgers.edu			Rutgers University; Plant Metabolic Engineering at Rutgers University	Rutgers University; Plant Metabolic Engineering at Rutgers University	Arkadiusz W. Kulczyk acknowledges ongoing start-up support from Rutgers University. Thomas Leustek acknowledges ongoing support from the Professor Charles Gilvarg Memorial Fund for Plant Metabolic Engineering at Rutgers University.	Henry C, 2021, ELIFE, V10, DOI 10.7554/eLife.63747; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Walker EJ, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101872; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; West GM, 2008, ANAL CHEM, V80, P4175, DOI 10.1021/ac702610a	6	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101973	10.1016/j.jbc.2022.101973	http://dx.doi.org/10.1016/j.jbc.2022.101973			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35461810	Green Published, gold			2022-12-28	WOS:000817175700005
J	Rajaram, K; Tewari, SG; Wallqvist, A; Prigge, ST				Rajaram, Krithika; Tewari, Shivendra G.; Wallqvist, Anders; Prigge, Sean T.			Metabolic changes accompanying the loss of fumarate hydratase and malate-quinone oxidoreductase in the asexual blood stage of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; BIOCHEMICAL-CHARACTERIZATION; ADENYLOSUCCINATE SYNTHETASE; GENOME SEQUENCE; PROTEIN; DRUG; SITE; INHIBITION; ATOVAQUONE; VALIDATION	In the glucose-rich milieu of red blood cells, asexually replicating malarial parasites mainly rely on glycolysis for ATP production, with limited carbon flux through the mitochondrial tricarboxylic acid (TCA) cycle. By contrast, gametocytes and mosquito-stage parasites exhibit an increased dependence on the TCA cycle and oxidative phosphorylation for more economical energy generation. Prior genetic studies supported these stage-specific metabolic preferences by revealing that six of eight TCA cycle enzymes are completely dispensable during the asexual blood stages of Plasmodium falciparum, with only fumarate hydratase (FH) and malate-quinone oxidoreductase (MQO) being refractory to deletion. Several hypotheses have been put forth to explain the possible essentiality of FH and MQO, including their participation in a malate shuttle between the mitochondrial matrix and the cytosol. However, using newer genetic techniques like CRISPR and dimerizable Cre, we were able to generate deletion strains of FH and MQO in P. falciparum. We employed metabolomic analyses to characterize a double knockout mutant of FH and MQO (Delta FM) and identified changes in purine salvage and urea cycle metabolism that may help to limit fumarate accumulation. Correspondingly, we found that the Delta FM mutant was more sensitive to exogenous fumarate, which is known to cause toxicity by modifying and inactivating proteins and metabolites. Overall, our data indicate that P. falciparum is able to adequately compensate for the loss of FH and MQO, rendering them unsuitable targets for drug development.	[Rajaram, Krithika; Prigge, Sean T.] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Tewari, Shivendra G.; Wallqvist, Anders] US Army Med Res & Dev Command, Dept Def Biotechnol High Performance Comp Software, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Tewari, Shivendra G.] Henry M Jackson Fdn Advancement Mil Med Inc, Bethesda, MD USA	Johns Hopkins University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Prigge, ST (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	sprigge2@jhu.edu	Prigge, Sean/GVS-9197-2022	Prigge, Sean/0000-0001-9684-1733; Rajaram, Krithika/0000-0003-4830-5471; Tewari, Shiv/0000-0003-0310-0915	National Institutes of Health [R01 AI125534]; Johns Hopkins Malaria Research Institute; Bloomberg Philanthropies; Network Science Initiative of the US ArmyMedical Research and Development Command, Maryland [W81XWH-15-C-0061]; National Institutes of Health training	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; Bloomberg Philanthropies; Network Science Initiative of the US ArmyMedical Research and Development Command, Maryland; National Institutes of Health training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant R01 AI125534 (to S. T. P.),the Johns Hopkins Malaria Research Institute, the Bloomberg Philanthropies, and the Network Science Initiative of the US ArmyMedical Research and Development Command, Ft. Detrick, Maryland (Award no.: W81XWH-15-C-0061; to S. T. P.). K. R. wassupported by the National Institutes of Health training grant T32AI007417. The content is solely the responsibility of the authorsand does not necessarily represent the official views of the National Institutes of Health. This article has been approved for publicrelease with unlimited distribution. The funders had no role instudy design, data collection and analysis, decision to publish, orpreparation of the article.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932; Birnbaum J, 2017, NAT METHODS, V14, P450, DOI 10.1038/nmeth.4223; Borst P, 2020, IUBMB LIFE, V72, P2241, DOI 10.1002/iub.2367; Bulusu V, 2011, J BIOL CHEM, V286, P9236, DOI 10.1074/jbc.M110.173328; Cobbold SA, 2016, CELL MICROBIOL, V18, P820, DOI 10.1111/cmi.12552; Cobbold SA, 2013, J BIOL CHEM, V288, P36338, DOI 10.1074/jbc.M113.503557; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Counihan NA, 2017, ELIFE, V6, DOI [10.7554/elife.23217, 10.7554/eLife.23217]; Eaazhisai K, 2004, J MOL BIOL, V335, P1251, DOI 10.1016/j.jmb.2003.11.036; Evers F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23919-x; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hartuti ED, 2018, BBA-BIOENERGETICS, V1859, P191, DOI 10.1016/j.bbabio.2017.12.004; Jayalakshmi R, 2002, PROTEIN EXPRES PURIF, V25, P65, DOI 10.1006/prep.2001.1610; Jayaraman V, 2018, J BIOL CHEM, V293, P5878, DOI [10.1074/jbc.m117.816298, 10.1074/jbc.M117.816298]; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; Ke H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214023; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Knuepfer E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03984-3; Krungkrai Jerapan, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P636; Lunev S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195011; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Mehrotra S, 2012, BBA-PROTEINS PROTEOM, V1824, P589, DOI 10.1016/j.bbapap.2012.01.007; Meireles P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04424-y; Mogi T, 2010, PARASITOL INT, V59, P305, DOI 10.1016/j.parint.2010.04.005; Niikura M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1898-5; Nilsen A, 2014, J MED CHEM, V57, P3818, DOI 10.1021/jm500147k; Nixon GL, 2013, FUTURE MED CHEM, V5, P1573, DOI [10.4155/fmc.13.180, 10.4155/fmc.13.121]; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Nozawa A, 2011, BIOCHEM BIOPH RES CO, V414, P612, DOI 10.1016/j.bbrc.2011.09.130; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Rajaram K, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00457-20; Raman J, 2004, MOL BIOCHEM PARASIT, V138, P1, DOI 10.1016/j.molbiopara.2004.06.013; Roberts AD, 2019, TRAFFIC, V20, P571, DOI 10.1111/tra.12656; Rudzinska M A, 1969, Int Rev Cytol, V25, P161, DOI 10.1016/S0074-7696(08)60203-X; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; SCHEIBEL LW, 1979, EXP PARASITOL, V47, P410, DOI 10.1016/0014-4894(79)90094-8; Setyowati E. A., 2019, Pharmacognosy Journal, V11, P1477; Sherman Irwin W., 1998, P135; Spalding MD, 2010, MOL BIOCHEM PARASIT, V172, P156, DOI 10.1016/j.molbiopara.2010.04.005; Srivastava A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004882; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Stickles AM, 2016, ANTIMICROB AGENTS CH, V60, P4853, DOI 10.1128/AAC.00791-16; Stocks PA, 2014, PARASITOLOGY, V141, P50, DOI 10.1017/S0031182013001571; Storm J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003876; Swift RP, 2021, EMBO J, V40, DOI 10.15252/embj.2020107247; Swift RP, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008316; Tewari SG, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03780-5; Tewari SG, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02392-20; Tewari SG, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03174-z; Tewari SG, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2720-3; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; TOMLINSON S, 1964, CLIN SCI, V26, P261; Tripathi AK, 2004, EUR J BIOCHEM, V271, P3488, DOI 10.1111/j.1432-1033.2004.04281.x; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Veetil VP, 2012, BIOCHEMISTRY-US, V51, P4237, DOI 10.1021/bi300430j; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; Wang XY, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060471; Werdenberg D, 2003, BIOPHARM DRUG DISPOS, V24, P259, DOI 10.1002/bdd.364; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12	69	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101897	10.1016/j.jbc.2022.101897	http://dx.doi.org/10.1016/j.jbc.2022.101897			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35398098	gold, Green Published			2022-12-28	WOS:000804923000010
J	Thines, L; Gorisse, L; Li, ZG; Sayedyahossein, S; Sacks, DB				Thines, Louise; Gorisse, Laetitia; Li, Zhigang; Sayedyahossein, Samar; Sacks, David B.			Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR LATS1; NDR PROTEIN-KINASE; CELL-PROLIFERATION; GROWTH; INDUCTION; REGULATOR; STABILITY; MECHANISM; COMPLEX; TAZ	The Hippo signaling pathway regulates tissue growth and cell fate, and its dysregulation can induce tumorigenesis. When Hippo is activated by cell-cell contact, extracellular signals, or cell polarity among others, the large tumor suppressor 1 (LATS1) kinase catalyzes inhibitory phosphorylation of the transcriptional coactivator Yes-associated protein (YAP) to maintain YAP in the cytoplasm or promote its degradation. Separately, calmodulin is a Ca2+-dependent protein that modulates the activity of target proteins and regulates several signaling cascades; however, its potential role in the Hippo pathway has not been identified. Here, using diverse experimental approaches, including in vitro binding analyses, kinase assays, RT-PCR, and confocal microscopy, we reveal that calmodulin promotes Hippo signaling. We show that purified YAP and LATS1 bind directly to calmodulin and form a Ca2+-dependent ternary complex in vitro. Importantly, Ca2+/calmodulin directly stimulated the activity of LATS1 kinase. In cultured mammalian cells, we demonstrated that endogenous YAP and LATS1 coimmunoprecipitate with endogenous calmodulin. In cells with activated Hippo signaling, we show that calmodulin antagonism significantly (i) decreases YAP phosphorylation, (ii) increases expression of two Hippo target genes (connective tissue growth factor [CTGF] and cysteine-rich angiogenic inducer 61 [CYR61]) that regulate cell proliferation and tumor progression, and (iii) enhances the interaction of YAP with its major transcription factor, thereby facilitating transcription of target genes. Collectively, our data demonstrate that calmodulin activates the Hippo kinase cascade and inhibits YAP activity via a direct interaction with LATS1 and YAP, thereby uncovering previously unidentified crosstalk between the Ca2+/calmodulin and Hippo signaling pathways.	[Thines, Louise; Gorisse, Laetitia; Li, Zhigang; Sayedyahossein, Samar; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Gorisse, Laetitia] Univ Reims, UMR CNRS 7369 MEDyC, Reims, France; [Sayedyahossein, Samar] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	National Institutes of Health (NIH) - USA; Universite de Reims Champagne-Ardenne; Western University (University of Western Ontario)	Sacks, DB (corresponding author), NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov		Sacks, David/0000-0003-3100-0735; Sayedyahossein, Samar/0000-0003-1773-4740	Intramural Research Program of the National Institutes of Health	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Michael Kruhlak, Andy Tran, and Langston Lim (Experimental Immunology Branch, National Institutes of Health) for expert assistance with confocal microscopy. This study was supported by the Intramural Research Program of the National Institutes of Health.	Adler J. J., 2013, PROC; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Barron DA, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-25; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chang SW, 2011, J VIROL, V85, P6750, DOI 10.1128/JVI.02453-10; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Amore A, 2020, CANCERS, V12, DOI 10.3390/cancers12092391; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; GULINO A, 1986, CANCER RES, V46, P6274; Guo QP, 2018, INT J ONCOL, V53, P592, DOI 10.3892/ijo.2018.4431; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KAKIUCHI S, 1970, BIOCHEM BIOPH RES CO, V41, P1104, DOI 10.1016/0006-291X(70)90199-3; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Liu ZJ, 2019, ONCOGENE, V38, P120, DOI 10.1038/s41388-018-0425-7; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Parvathaneni S, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100577; Pobbati AV, 2020, THERANOSTICS, V10, P3622, DOI 10.7150/thno.40889; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Saito N, 2017, ONCOTARGET, V8, P74006, DOI 10.18632/oncotarget.18598; Sharma RK, 2018, CELL CALCIUM, V75, P89, DOI 10.1016/j.ceca.2018.09.002; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; Villalobo A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030765; Villalobo A, 2018, BBA-MOL CELL RES, V1865, P507, DOI 10.1016/j.bbamcr.2017.12.004; WEI JW, 1983, CANCER CHEMOTH PHARM, V11, P86; Wei YJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.694828; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B., 2007, GENE DEV; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	57	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101839	10.1016/j.jbc.2022.101839	http://dx.doi.org/10.1016/j.jbc.2022.101839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35307353	gold, Green Published			2022-12-28	WOS:000794890400005
J	Ahn, E; Tang, T; Kim, B; Lee, HJ; Cho, US				Ahn, Eungjin; Tang, Tianyu; Kim, Byungchul; Lee, Hae June; Cho, Uhn-Soo			Development of an atmospheric plasma jet device for versatile treatment of electron microscope sample grids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYO-EM; CRYOELECTRON MICROSCOPY; METHANE MONOOXYGENASE	Atmospheric-pressure plasmas have been widely applied for surface modification and biomedical treatment because of their ability to generate highly reactive radicals and charged particles. In negative-stain electron microscopy (Neg-EM) and cryogenic electron microscopy (cryo-EM), plasmas have been used to generate hydrophilic surfaces and eliminate surface contaminants to embed specimens onto grids. In addition, plasma treatment is a prerequisite for negative-stain and Quantifoil grids, whose surfaces are coated with hydrophobic amorphous carbon. Although the conventional glow discharge system has been used successfully in this purpose, there has been no further effort to take an advantage from the recent progress in the plasma field. Here, we developed a nonthermal atmospheric plasma jet system as an alternative tool for treatment of surfaces. The low-temperature plasma is a nonequilibrium system that has been widely used in biomedical area. Unlike conventional glow discharge systems, the plasma jet system successfully cleans and introduces hydrophilicity on the grid surface in the ambient environment without a vacuum. Therefore, we anticipate that the plasma jet system will have numerous benefits, such as convenience and versatility, as well as having potential applications in surface modification for both negative-stain and cryo-EM grid treatment.	[Ahn, Eungjin; Kim, Byungchul; Cho, Uhn-Soo] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tang, Tianyu; Lee, Hae June] Pusan Natl Univ, Dept Elect Engn, Busan, South Korea	University of Michigan System; University of Michigan; Pusan National University	Cho, US (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.; Lee, HJ (corresponding author), Pusan Natl Univ, Dept Elect Engn, Busan, South Korea.	haejune@pusan.ac.kr; uhnsoo@umich.edu			NIH [DK111465/CA250329, U24GM129547]; PNU-RENovation (2020-2021); Office of Biological and Environmental Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PNU-RENovation (2020-2021); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the NIH DK111465/CA250329 (to U.-S. C). and PNU-RENovation (2020-2021, to H. L.). A portion of this research was supported by NIH grant U24GM129547, performed at the PNCC at OHSU, and accessed through EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armstrong M, 2020, BIOPHYS J, V118, P708, DOI 10.1016/j.bpj.2019.12.017; Arsiccio A, 2020, J AM CHEM SOC, V142, P5722, DOI 10.1021/jacs.9b13454; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Chen CF, 2011, NATURE, V471, P617, DOI 10.1038/nature09866; Choi JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27376; D'Imprima E, 2019, ELIFE, V8, DOI 10.7554/eLife.42747; Drulyte I, 2018, ACTA CRYSTALLOGR D, V74, P560, DOI 10.1107/S2059798318006496; Dubochet J, 2012, J MICROSC-OXFORD, V245, P221, DOI 10.1111/j.1365-2818.2011.03569.x; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Gudmundsson JT, 2007, PLASMA SOURCES SCI T, V16, P399, DOI 10.1088/0963-0252/16/2/025; Hsu SH, 2009, INT J DISTRIB SENS N, V5, P429, DOI 10.1080/15501320802473144; Klebl D. P., 2020, STRUCTURE 28; Kuhlbrandt W, 2014, ELIFE, V3, DOI 10.7554/eLife.03678; Lee HY, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aabd8c; Lee S, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11052390; Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003; Menzies KL, 2010, OPTOMETRY VISION SCI, V87, P387, DOI 10.1097/OPX.0b013e3181da863e; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Naydenova K, 2019, P NATL ACAD SCI USA, V116, P11718, DOI 10.1073/pnas.1904766116; Park J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39298; Passmore LA, 2016, METHOD ENZYMOL, V579, P51, DOI 10.1016/bs.mie.2016.04.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Russo CJ, 2014, NAT METHODS, V11, P649, DOI [10.1038/NMETH.2931, 10.1038/nmeth.2931]; SAMSON JAR, 1966, J OPT SOC AM, V56, P769, DOI 10.1364/JOSA.56.000769; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sun F, 2018, CHINESE PHYS B, V27, DOI 10.1088/1674-1056/27/6/063601; Tang TY, 2020, AIP ADV, V10, DOI 10.1063/5.0033907; Thompson RF, 2016, METHODS, V100, P3, DOI 10.1016/j.ymeth.2016.02.017; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	33	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101793	10.1016/j.jbc.2022.101793	http://dx.doi.org/10.1016/j.jbc.2022.101793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35248533	gold, Green Published			2022-12-28	WOS:000793560400001
J	Daude, N; Lau, A; Vanni, I; Kang, SG; Castle, AR; Wohlgemuth, S; Dorosh, L; Wille, H; Stepanova, M; Westaway, D				Daude, Nathalie; Lau, Agnes; Vanni, Ilaria; Kang, Sang-Gyun; Castle, Andrew R.; Wohlgemuth, Serene; Dorosh, Lyudmyla; Wille, Holger; Stepanova, Maria; Westaway, David			Prion protein with a mutant N-terminal octarepeat region undergoes cobalamin-dependent assembly into high-molecular weight complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; LIQUID PHASE-SEPARATION; COPPER-BINDING; FULL-LENGTH; RESOLUTION STRUCTURE; SECONDARY STRUCTURE; SCRAPIE; SITES; PRP; CLASSIFICATION	The cellular prion protein (PrPC) has a C-terminal globular domain and a disordered N-terminal region encompassing five octarepeats (ORs). Encounters between Cu(II) ions and four OR sites produce interchangeable binding geometries; however, the significance of Cu(II) binding to ORs in different combinations is unclear. To understand the impact of specific binding geometries, OR variants were designed that interact with multiple or single Cu(II) ions in specific locked coordinations. Unexpectedly, we found that one mutant produced detergent-insoluble, protease-resistant species in cells in the absence of exposure to the infectious prion protein isoform, scrapie-associated prion protein (PrPSc). Formation of these assemblies, visible as puncta, was reversible and dependent upon medium formulation. Cobalamin (Cbl), a dietary cofactor containing a corrin ring that coordinates a Co3+ ion, was identified as a key medium component, and its effect was validated by reconstitution experiments. Although we failed to find evidence that Cbl interacts with Cu-binding OR regions, we instead noted interactions of Cbl with the PrPC C-terminal domain. We found that some interactions occurred at a binding site of planar tetrapyrrole compounds on the isolated globular domain, but others did not, and N-terminal sequences additionally had a marked effect on their presence and position. Our studies define a conditional effect of Cbl wherein a mutant OR region can act in cis to destabilize a globular domain with a wild type sequence. The unexpected intersection between the properties of PrPSc's disordered region, Cbl, and conformational remodeling events may have implications for understanding sporadic prion disease that does not involve exposure to PrPSc.	[Daude, Nathalie; Lau, Agnes; Kang, Sang-Gyun; Castle, Andrew R.; Wohlgemuth, Serene; Wille, Holger; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Vanni, Ilaria] Ist Super Sanita, Dept Food Safety Nutr & Vet Publ Hlth, Rome, Italy; [Dorosh, Lyudmyla; Stepanova, Maria] Univ Alberta, Fac Engn, Elect & Comp Engn Dept, Edmonton, AB, Canada; [Wille, Holger] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Lau, Agnes] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower, Toronto, ON, Canada	University of Alberta; Istituto Superiore di Sanita (ISS); University of Alberta; University of Alberta; Krembil Research Institute; University of Toronto	Westaway, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	david.westaway@ualberta.ca	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706; Dorosh, Lyudmyla/0000-0002-5224-4045; Kang, Sang-Gyun/0000-0002-6875-113X; Castle, Andrew/0000-0003-2590-9555	National Sciences and Engineering Research Council; Alberta Innovates Health Solutions; University of Alberta; Canada Research Chairs; Canada Excellence Research Chairs programs; Alberta Prion Research Institute [20170016]	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions; University of Alberta(University of Alberta); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Excellence Research Chairs programs; Alberta Prion Research Institute	A. L. was funded by studentships from the National Sciences and Engineering Research Council, Alberta Innovates Health Solutions, and the University of Alberta, whereas D. W. was supported by the Canada Research Chairs and Canada Excellence Research Chairs programs, respectively. L. D. and M. S. were supported by the Alberta Prion Research Institute (grant no.: 20170016).	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Aronoff-Spencer E., 2000, BIOCHEMISTRY-US, V39; BAZAN JF, 1987, PROTEIN ENG, V1, P125, DOI 10.1093/protein/1.2.125; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; Benvegnu S, 2010, J COMP NEUROL, V518, P1879, DOI 10.1002/cne.22357; Biro JC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-15; BOCKMAN JM, 1985, NEW ENGL J MED, V312, P73, DOI 10.1056/NEJM198501103120202; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Boyko S, 2020, P NATL ACAD SCI USA, V117, P31882, DOI 10.1073/pnas.2012460117; Brazier MW, 2008, J BIOL CHEM, V283, P12831, DOI 10.1074/jbc.M709820200; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bryant DA, 2020, J BIOL CHEM, V295, P6888, DOI 10.1074/jbc.REV120.006194; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Castle AR, 2019, J BIOL CHEM, V294, P2642, DOI 10.1074/jbc.RA118.006367; Castle AR, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00019; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey WS, 2007, ANTIMICROB AGENTS CH, V51, P3887, DOI 10.1128/AAC.01599-06; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Cescatti M, 2016, J VIROL, V90, P6244, DOI 10.1128/JVI.00144-16; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHESEBRO B, 1993, DEV BIOL STAND, V80, P131; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Choi JM, 2020, ANNU REV BIOPHYS, V49, P107, DOI 10.1146/annurev-biophys-121219-081629; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Corley SM, 2008, BIOINFORM BIOL INSIG, V2, P383; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Garrec J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003057; Hamada Y.Z., 2017, J NANOMEDICINE RES, V5; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hastings J, 2016, NUCLEIC ACIDS RES, V44, pD1214, DOI 10.1093/nar/gkv1031; Hastings RL, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166837; HODGKIN DC, 1956, NATURE, V178, P64, DOI 10.1038/178064a0; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ironside JW, 2018, HAND CLINIC, V145, P393, DOI 10.1016/B978-0-12-802395-2.00028-6; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; James T. L., 1997, PROC NATL ACAD SCI S; Kamps J, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100860; Kang SG, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01132-y; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kraus A, 2021, MOL CELL, V81, P4540, DOI 10.1016/j.molcel.2021.08.011; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Lau A, 2012, BIOCHEMISTRY-US, V51, P9029, DOI 10.1021/bi301395w; Leach Scott P., 2006, Animal Health Research Reviews, V7, P97, DOI 10.1017/S1466252307001181; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li XL, 2009, MED MICROBIOL IMMUN, V198, P239, DOI 10.1007/s00430-009-0120-y; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Liberski PP, 2012, ADV EXP MED BIOL, V724, P128, DOI 10.1007/978-1-4614-0653-2_10; Liu L, 2011, J AM CHEM SOC, V133, P12229, DOI 10.1021/ja2045259; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Markham KA, 2019, BIOPHYS J, V116, P610, DOI 10.1016/j.bpj.2019.01.005; Martinez J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13623; Massignan T., 2016, CATIONIC TETRAPYRROL; Matos CO, 2020, FASEB J, V34, P365, DOI 10.1096/fj.201901897R; Mays CE, 2014, J CLIN INVEST, V124, P847, DOI 10.1172/JCI72241; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; McDonald A, 2013, J PHYS CHEM B, V117, P13822, DOI 10.1021/jp408239h; McDonald AJ, 2019, STRUCTURE, V27, P907, DOI 10.1016/j.str.2019.03.008; Mercer RCC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006826; Miles E W, 1977, Methods Enzymol, V47, P431; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Nicoll A. J., 2010, P NATL ACAD SCI; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pandey KK, 2010, J PHYS CHEM B, V114, P1127, DOI [10.1021/jp909945c, 10.1021/jp909945e]; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 2012, FOLIA NEUROPATHOL, V50, P20; Pedersen JT, 2013, ANAL CHEM, V85, P4215, DOI 10.1021/ac400023c; Pergami P, 1996, ANAL BIOCHEM, V236, P63, DOI 10.1006/abio.1996.0132; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccardo P., 1996, J NEUROPATH EXP NEUR; Pirisinu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20443; PRIOLA SA, 1994, INFECT AGENT DIS, V3, P54; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Pushie MJ, 2007, ANAL CHEM, V79, P5659, DOI 10.1021/ac070312l; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Salzano G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080770; Scalabrino G, 2012, EXP NEUROL, V233, P380, DOI 10.1016/j.expneurol.2011.11.003; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Serra F, 2017, BRAIN RES, V1659, P19, DOI 10.1016/j.brainres.2017.01.015; Spagnolli G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007864; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stevens DJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000390; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Stone LA, 2007, BIOCHEMISTRY-US, V46, P245, DOI 10.1021/bi061646s; Supattapone S., 2013, PRION, V6, P417; Tagliavini F., 2001, 7 KDA PRION PROTEIN; Tange H, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100367; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Treiber C, 2007, J BIOL INORG CHEM, V12, P711, DOI 10.1007/s00775-007-0220-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Trzesowska-Kruszynska A, 2012, J MOL STRUCT, V1017, P72, DOI 10.1016/j.molstruc.2012.03.003; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Walter ED, 2009, CURR PROTEIN PEPT SC, V10, P529, DOI 10.2174/138920309789352056; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; Will RG, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024364; Wille H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010020; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	118	0	0	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101770	10.1016/j.jbc.2022.101770	http://dx.doi.org/10.1016/j.jbc.2022.101770			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35271850	gold, Green Published			2022-12-28	WOS:000793560400007
J	Kelly, RL; Huehls, AM; Venkatachalam, A; Huntoon, CJ; Machida, YJ; Karnitz, LM				Kelly, Rebecca L.; Huehls, Amelia M.; Venkatachalam, Annapoorna; Huntoon, Catherine J.; Machida, Yuichi J.; Karnitz, Larry M.			Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; DNA-REPLICATION; INITIATION; ATR; PHOSPHORYLATION; PURIFICATION; EXPRESSION; SLD3; FORK	Replication stress impedes DNA polymerase progression causing activation of the ataxia telangiectasia and Rad3-related signaling pathway, which promotes the intra-S phase checkpoint activity through phosphorylation of checkpoint kinase 1 (Chk1). Chk1 suppresses replication origin firing, in part, by disrupting the interaction between the preinitiation complex components Treslin and TopBP1, an interaction that is mediated by TopBP1 BRCT domain-binding to two cyclindependent kinase (CDK) phosphorylation sites, T968 and S1000, in Treslin. Two nonexclusive models for how Chk1 regulates the Treslin-TopBP1 interaction have been proposed in the literature: in one model, these proteins dissociate due to a Chk1-induced decrease in CDK activity that reduces phosphorylation of the Treslin sites that bind TopBP1 and in the second model, Chk1 directly phosphorylates Treslin, resulting in dissociation of TopBP1. However, these models have not been formally examined. We show here that Treslin T968 phosphorylation was decreased in a Chk1-dependent manner, while Treslin S1000 phosphorylation was unchanged, demonstrating that T968 and S1000 are differentially regulated. However, CDK2-mediated phosphorylation alone did not fully account for Chk1 regulation of the Treslin-TopBP1 interaction. We also identified additional Chk1 phosphorylation sites on Treslin that contributed to disruption of the Treslin- TopBP1 interaction, including S1114. Finally, we showed that both of the proposed mechanisms regulate origin firing in cancer cell line models undergoing replication stress, with the relative roles of each mechanism varying among cell lines. This study demonstrates that Chk1 regulates Treslin through multiple mechanisms to promote efficient dissociation of Treslin and TopBP1 and furthers our understanding of Treslin regulation during the intra-S phase checkpoint.	[Kelly, Rebecca L.; Venkatachalam, Annapoorna; Machida, Yuichi J.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Huehls, Amelia M.; Huntoon, Catherine J.; Machida, Yuichi J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.; Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA.	karntiz.larry@mayo.edu		Machida, Yuichi/0000-0003-1414-0568	National Cancer Institute [R01 CA190473]; National Institutes of Health/General Medicine T32 Training Program [T32 GM072474]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/General Medicine T32 Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute (R01 CA190473) (L. M. K.) and a National Institutes of Health/General Medicine T32 Training Program Grant (T32 GM072474) (R. L. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arur S, 2014, NAT PROTOC, V9, P375, DOI 10.1038/nprot.2014.017; Besteiro MAG, 2015, MUTAT RES-REV MUTAT, V763, P168, DOI 10.1016/j.mrrev.2014.10.003; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Boos D, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030199; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Ciardo D, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020094; Ditano JP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86490-x; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Haland TW, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv744; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hughes BT, 2013, P NATL ACAD SCI USA, V110, P8954, DOI 10.1073/pnas.1302927110; Iyer DR, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020074; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kotsantis P, 2018, CANCER DISCOV, V8, P537, DOI 10.1158/2159-8290.CD-17-1461; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Liu K, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00599-19; Liu TZ, 2014, MOL CELL, V56, P681, DOI 10.1016/j.molcel.2014.10.007; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Miyazawa-Onami M, 2017, EMBO REP, V18, P1752, DOI 10.15252/embr.201744206; Moiseeva TN, 2018, DNA REPAIR, V72, P99, DOI 10.1016/j.dnarep.2018.09.003; Mu RL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00344-17; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Quinet A, 2017, METHOD ENZYMOL, V591, P55, DOI 10.1016/bs.mie.2017.03.019; Sakurikar N, 2016, ONCOTARGET, V7, P1380, DOI 10.18632/oncotarget.6364; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sansam CG, 2015, GENE DEV, V29, P555, DOI 10.1101/gad.246827.114; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	34	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101777	10.1016/j.jbc.2022.101777	http://dx.doi.org/10.1016/j.jbc.2022.101777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35231445	gold, Green Published			2022-12-28	WOS:000793617400010
J	Kelly, SL; Szyjka, CE; Strobel, EJ				Kelly, Skyler L.; Szyjka, Courtney E.; Strobel, Eric J.			Purification of synchronized Escherichia coli transcription elongation complexes by reversible immobilization on magnetic beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; RNA STRUCTURE-ANALYSIS; NASCENT RNA; QUANTITATIVE-ANALYSIS; BRANCHED PATHWAY; PAUSE SITE; POLYMERASE; RIBOSWITCH; PROMOTER; INITIATION	Synchronized transcription elongation complexes (TECs) are a fundamental tool for in vitro studies of transcription and RNA folding. Transcription elongation can be synchronized by omitting one or more nucleoside triphosphates from an in vitro transcription reaction so that RNA polymerase can only transcribe to the first occurrence of the omitted nucleotide(s) in the coding DNA strand. This approach was developed over four decades ago and has been applied extensively in biochemical investigations of RNA polymerase enzymes but has not been optimized for RNA-centric assays. In this work, we describe the development of a system for isolating synchronized TECs from an in vitro transcription reaction. Our approach uses a custom 50 leader sequence, called capture sequence 3-structure cassette 1 (C3-SC1), to reversibly capture synchronized TECs on magnetic beads. We first show, using electrophoretic mobility shift and high-resolution in vitro transcription assays, that complexes isolated by this procedure, called C3-SC1TECs, are >95% pure, >98% active, highly synchronous (94% of complexes chase in <15s upon addition of saturating nucleoside triphosphates), and compatible with solid-phase transcription; the yield of this purification is similar to 8%. We then show that C3-SC1TECs perturb, but do not interfere with, the function of ZTP (5-aminoimidazole-4-carboxamide riboside 50-triphosphate)-sensing and ppGpp (guanosine-30,50 bisdiphosphate)-sensing transcriptional riboswitches. For both riboswitches, transcription using C3-SC1TECs improved the efficiency of transcription termination in the absence of ligand but did not inhibit ligand-induced transcription antitermination. Given these properties, C3-SC1TECs will likely be useful for developing biochemical and biophysical RNA assays that require high-performance, quantitative bacterial in vitro transcription.	[Kelly, Skyler L.; Szyjka, Courtney E.; Strobel, Eric J.] Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Strobel, EJ (corresponding author), Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	estrobel@buffalo.edu		Szyjka, Courtney/0000-0001-9991-8038; Strobel, Eric/0000-0002-7082-2881	University at Buffalo	University at Buffalo	This work was supported by startup funding from the University at Buffalo (to E. J. S.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; CHAN CL, 1989, J BIOL CHEM, V264, P20796; Chatterjee S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023426118; Chauvier A, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2109026118j1of12, 10.1073/pnas.2109026118]; Chauvier A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106564118; Denny SK, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032300; Denny SK, 2018, CELL, V174, P377, DOI 10.1016/j.cell.2018.05.038; Drogalis LK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243155; Duss O, 2019, CELL, V179, P1357, DOI 10.1016/j.cell.2019.10.035; Duss O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07423-3; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Fukuda S, 2020, MOL CELL, V77, P241, DOI 10.1016/j.molcel.2019.10.006; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Henderson KL, 2017, P NATL ACAD SCI USA, V114, pE3032, DOI 10.1073/pnas.1618675114; Heyduk E, 2018, NUCLEIC ACIDS RES, V46, P4469, DOI 10.1093/nar/gky172; Imashimizu M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0666-5; JACQUES JP, 1991, GENE DEV, V5, P707, DOI 10.1101/gad.5.5.707; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Kokic G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20542-0; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Landick R, 1996, METHOD ENZYMOL, V274, P334; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Liu Y, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2115746119; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Murakami KS, 2017, P NATL ACAD SCI USA, V114, P8211, DOI 10.1073/pnas.1702741114; Nudler E, 2003, METHOD ENZYMOL, V371, P160; OLEJNIK J, 1995, P NATL ACAD SCI USA, V92, P7590, DOI 10.1073/pnas.92.16.7590; Passalacqua LFM, 2020, RNA, V26, P2062, DOI 10.1261/rna.076778.120; Pupov D, 2019, BIOCHEM BIOPH RES CO, V510, P122, DOI 10.1016/j.bbrc.2019.01.062; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Sen R, 2000, J BIOL CHEM, V275, P10899, DOI 10.1074/jbc.275.15.10899; Sherlock ME, 2018, P NATL ACAD SCI USA, V115, P6052, DOI 10.1073/pnas.1720406115; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Strobel E, 2021, BIO-PROTOCOL, V11, DOI 10.21769/BioProtoc.4141; Strobel EJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100812; Strobel EJ, 2020, J BIOL CHEM, V295, P6401, DOI 10.1074/jbc.RA120.012641; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Strobel EJ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx233; Susa M, 2002, J BIOL CHEM, V277, P15407, DOI 10.1074/jbc.M112481200; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Watters KE, 2016, NAT STRUCT MOL BIOL, V23, P1124, DOI 10.1038/nsmb.3316; Widom JR, 2018, MOL CELL, V72, P541, DOI 10.1016/j.molcel.2018.08.046; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Winkelman JT, 2020, MOL CELL, V79, P797, DOI 10.1016/j.molcel.2020.07.006; Zhang JW, 2016, TRENDS BIOCHEM SCI, V41, P293, DOI 10.1016/j.tibs.2015.12.009	61	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101789	10.1016/j.jbc.2022.101789	http://dx.doi.org/10.1016/j.jbc.2022.101789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35247385	Green Published, gold			2022-12-28	WOS:000823106100010
J	Kind, L; Raasakka, A; Molnes, J; Aukrust, I; Bjorkhaug, L; Njolstad, PR; Kursula, P; Arnesen, T				Kind, Laura; Raasakka, Arne; Molnes, Janne; Aukrust, Ingvild; Bjorkhaug, Lise; Njolstad, Pal Rasmus; Kursula, Petri; Arnesen, Thomas			Structural and biophysical characterization of transcription factor HNF-1A as a tool to study MODY3 diabetes variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POU-DOMAIN; PROTEIN; MUTATIONS; HOMEODOMAIN; FAMILY; GENE; DIMERIZATION; RECOGNITION; SCATTERING; STABILITY	Hepatocyte nuclear factor 1A (HNF-1A) is a transcription factor expressed in several embryonic and adult tissues, modulating the expression of numerous target genes. Pathogenic variants in the HNF1A gene are known to cause maturity onset diabetes of the young 3 (MODY3 or HNF1A MODY), a disease characterized by dominant inheritance, age of onset before 25 to 35 years of age, and pancreatic beta-cell dysfunction. A precise diagnosis can alter management of this disease, as insulin can be exchanged with sulfonylurea tablets and genetic counseling differs from polygenic forms of diabetes. Therefore, more knowledge on the mechanisms of HNF-1A function and the level of pathogenicity of the numerous HNF1A variants is required for precise diagnostics. Here, we structurally and biophysically characterized an HNF-1A protein containing both the DNA-binding domain and the dimerization domain, and determined the folding and DNA-binding capacity of two established MODY3 HNF-1A variant proteins (P112L, R263C) and one variant of unknown significance (N266S). All three variants showed reduced functionality compared to the WT protein. Furthermore, while the R263C and N266S variants displayed reduced binding to an HNF-1A target promoter, we found the P112L variant was unstable in vitro and in cells. Our results support and mechanistically explain disease causality for these investigated variants and present a novel approach for the dissection of structurally unstable and DNA-binding defective variants. This study indicates that structural and biochemical investigation of HNF-1A is a valuable tool in reliable variant classification needed for precision diabetes diagnostics and management.	[Kind, Laura; Raasakka, Arne; Kursula, Petri; Arnesen, Thomas] Univ Bergen, Dept Biomed, Bergen, Norway; [Molnes, Janne; Aukrust, Ingvild; Njolstad, Pal Rasmus] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Molnes, Janne; Aukrust, Ingvild] Haukeland Hosp, Dept Med Genet, Bergen, Norway; [Bjorkhaug, Lise] Western Norway Univ Appl Sci, Dept Safety Chem & Biomed Lab Sci, Bergen, Norway; [Njolstad, Pal Rasmus] Haukeland Hosp, Sect Endocrinol & Metab, Children & Youth Clin, Bergen, Norway; [Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Arnesen, Thomas] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital; University of Oulu; University of Oulu; University of Bergen; University of Bergen; Haukeland University Hospital	Kind, L; Arnesen, T (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Njolstad, PR (corresponding author), Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Njolstad, PR (corresponding author), Haukeland Hosp, Sect Endocrinol & Metab, Children & Youth Clin, Bergen, Norway.; Arnesen, T (corresponding author), Univ Bergen, Dept Biol Sci, Bergen, Norway.; Arnesen, T (corresponding author), Haukeland Hosp, Dept Surg, Bergen, Norway.	laura.kind@uib.no; Pal.Njolstad@uib.no; Thomas.arnesen@uib.no	Raasakka, Arne/AAA-5251-2020; Bjørkhaug, Lise/AAA-4356-2021; Kursula, Petri/K-1058-2012	Raasakka, Arne/0000-0002-9443-9959; Bjørkhaug, Lise/0000-0002-9695-4559; Kursula, Petri/0000-0001-8529-3751	Medical Faculty, University of Bergen, UiB, Norway; UiB Meltzer foundation project; Norwegian Graduate School in Biocatalysis; Norwegian Cancer Society [171752-PR-2009-0222]; European Research Council [293574]; Research Council of Norway [240413]; Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"); Novo Nordisk Foundation [54741]; Norwegian Diabetes Association; project CALIPSOplus from the EU Framework Programme for Research and Innovation HORIZON 2020 [730872]	Medical Faculty, University of Bergen, UiB, Norway; UiB Meltzer foundation project; Norwegian Graduate School in Biocatalysis; Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Norwegian Diabetes Association; project CALIPSOplus from the EU Framework Programme for Research and Innovation HORIZON 2020	This work was funded with a PhD fellowship by the Medical Faculty, University of Bergen, UiB, Norway (to L. K.) and by a UiB Meltzer foundation project grant (to L. K.). L. K. received a research visit grant from the Norwegian Graduate School in Biocatalysis. T. A. was supported by the Norwegian Cancer Society (Project 171752-PR-2009-0222). P. R. N. received funding from the European Research Council (AdG SELECTionPREDISPOSED #293574), the Research Council of Norway (FRIPRO grant #240413), the Western Norway Regional Health Authority (Strategic Fund "Personalized Medicine for Children and Adults"), the Novo Nordisk Foundation (grant #54741), and the Norwegian Diabetes Association. This work has been supported by the project CALIPSOplus under the Grant Agreement 730872 from the EU Framework Programme for Research and Innovation HORIZON 2020 (to P. K.).	Althari S, 2020, AM J HUM GENET, V107, P670, DOI 10.1016/j.ajhg.2020.08.016; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], PYMOL MOL GRAPHICS S; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Bayle JH, 2002, J BIOL CHEM, V277, P28884, DOI 10.1074/jbc.M201983200; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2005, DNA CELL BIOL, V24, P661, DOI 10.1089/dna.2005.24.661; Bjorkhaug L, 2000, BIOCHEM BIOPH RES CO, V279, P792, DOI 10.1006/bbrc.2000.4024; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; CESKA TA, 1993, EMBO J, V12, P1805, DOI 10.1002/j.1460-2075.1993.tb05828.x; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Chen S, 2006, CYTOGENET GENOME RES, V114, P131, DOI 10.1159/000093328; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DEFRANCESCO R, 1991, BIOCHEMISTRY-US, V30, P143, DOI 10.1021/bi00215a021; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Frietze S, 2011, SUBCELL BIOCHEM, V52, P261, DOI 10.1007/978-90-481-9069-0_12; Haliyur R, 2019, J CLIN INVEST, V129, P246, DOI 10.1172/JCI121994; Hammarstrom Martin, 2006, Journal of Structural and Functional Genomics, V7, P1, DOI 10.1007/s10969-005-9003-7; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; HURLEY JH, 1992, BIOPOLYMERS, V32, P1443, DOI 10.1002/bip.360321104; Iwasaki N, 1997, DIABETES, V46, P1504, DOI 10.2337/diabetes.46.9.1504; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Landrum M. J., 2018, NUCL ACIDS; Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malik V, 2018, CELL MOL LIFE SCI, V75, P1587, DOI 10.1007/s00018-018-2748-5; Manalastas-Cantos K., 2021, ATSAS 30; Miles AJ, 2018, PROTEIN SCI, V27, P1717, DOI 10.1002/pro.3474; Narayana N, 2006, J MOL BIOL, V362, P414, DOI 10.1016/j.jmb.2006.06.086; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Raasakka A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00084; Remenyi A, 2002, BIOCHEM PHARMACOL, V64, P979, DOI 10.1016/S0006-2952(02)01164-4; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; Schott O, 1997, J MOL BIOL, V267, P673, DOI 10.1006/jmbi.1997.0905; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thureau A, 2021, J APPL CRYSTALLOGR, V54, P1698, DOI 10.1107/S1600576721008736; Wang HY, 2002, DIABETES, V51, pS333, DOI 10.2337/diabetes.51.2007.S333; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yahaya T. O., 2020, OMAN MED J, V35, P126; Yang Q., 1999, BIOCHEM BIOPH RES CO; Yu M, 2008, NUCLEIC ACIDS RES, V36, P1209, DOI 10.1093/nar/gkm1131; Zhang HC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142244	61	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101803	10.1016/j.jbc.2022.101803	http://dx.doi.org/10.1016/j.jbc.2022.101803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35257744	Green Published, gold			2022-12-28	WOS:000793560400011
J	Kumar, VG; Ogden, DS; Isu, UH; Polasa, A; Losey, J; Moradi, M				Kumar, Vivek Govind; Ogden, Dylan S.; Isu, Ugochi H.; Polasa, Adithya; Losey, James; Moradi, Mahmoud			Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; CRYO-EM STRUCTURES; MOLECULAR-DYNAMICS; SARS CORONAVIRUS; RECEPTOR; TRANSPORTER; TRANSITION; REVEAL; S1	Within the last 2 decades, severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2) have caused two major outbreaks; yet, for reasons not fully understood, the coronavirus disease 2019 pandemic caused by SARS-CoV-2 has been significantly more widespread than the 2003 SARS epidemic caused by SARS-CoV-1, despite striking similarities between these two viruses. The SARS-CoV-1 and SARSCoV-2 spike proteins, both of which bind to host cell angiotensin-converting enzyme 2, have been implied to be a potential source of their differential transmissibility. However, the mechanistic details of prefusion spike protein binding to angiotensin-converting enzyme 2 remain elusive at the molecular level. Here, we performed an extensive set of equilibrium and nonequilibrium microsecond-level all-atom molecular dynamics simulations of SARS-CoV-1 and SARS-CoV-2 prefusion spike proteins to determine their differential dynamic behavior. Our results indicate that the active form of the SARS-CoV-2 spike protein is more stable than that of SARS-CoV-1 and the energy barrier associated with the activation is higher in SARS-CoV-2. These results suggest that not only the receptor-binding domain but also other domains such as the N-terminal domain could play a crucial role in the differential binding behavior of SARS-CoV-1 and SARS-CoV-2 spike proteins.	[Kumar, Vivek Govind; Ogden, Dylan S.; Isu, Ugochi H.; Polasa, Adithya; Losey, James; Moradi, Mahmoud] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Moradi, M (corresponding author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.	moradi@uark.edu		Polasa, Adithya/0000-0002-7764-6585; Govind Kumar, Vivek/0000-0002-9014-327X	National Science Foundation [CHE 1945465, OAC-1818253]; National Institutes of Health [R01GM116961]; Arkansas High Performance Computing Center - National Science Foundation; Arkansas Economic Development Commission	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas High Performance Computing Center - National Science Foundation(National Science Foundation (NSF)); Arkansas Economic Development Commission	This research is supported by the National Science Foundation grant (grant no.: CHE 1945465). Simulations in this study have been performed primarily using Anton 2, Frontera, and Longhorn. We acknowledge coronavirus disease 2019 (COVID-19) HPC Consortium for providing access to these resources. This research is part of the Frontera computing project at the Texas Advanced Computing Center, made possible by the National Science Foundation award (grant no.: OAC-1818253). Anton 2 computer time was provided by the Pittsburgh Supercomputing Center through grant R01GM116961 from the National Institutes of Health. The Anton 2 machine at Pittsburgh Supercomputing Center was generously made available by D.E. Shaw Research. This research is also supported by the Arkansas High Performance Computing Center, which is funded through multiple National Science Foundation grants and the Arkansas Economic Development Commission.	A.Punjani, 2020, bioRxiv, DOI 10.1101/2020.04.08.032466; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cao WP, 2021, BIOPHYS J, V120, P1011, DOI 10.1016/j.bpj.2021.02.007; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Cherry James D, 2004, Paediatr Respir Rev, V5, P262, DOI 10.1016/j.prrv.2004.07.009; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gary B., 2020, BIORXIV, DOI [10.1101/2020.12.20.422693, DOI 10.1101/2020.12.20.422693]; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152; Guo YJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100346; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Immadisetty K, 2017, J PHYS CHEM B, V121, P3644, DOI 10.1021/acs.jpcb.6b09733; Isabel S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70827-z; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Kaushal N, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070565; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Li ZL, 2021, BIOPHYS J, V120, P2828, DOI 10.1016/j.bpj.2021.05.026; Liu YM, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108016; Lu ML, 2020, CELL HOST MICROBE, V28, P880, DOI 10.1016/j.chom.2020.11.001; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Moradi M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861056; Moradi M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861055; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Moradi M, 2011, CHEM PHYS LETT, V518, P109, DOI 10.1016/j.cplett.2011.10.054; Moreira RA, 2020, NANOSCALE, V12, P16409, DOI 10.1039/d0nr03969a; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Patching SG, 2014, BBA-BIOMEMBRANES, V1838, P43, DOI 10.1016/j.bbamem.2013.04.028; Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Spinello A, 2020, J PHYS CHEM LETT, V11, P4785, DOI 10.1021/acs.jpclett.0c01148; Srivastava A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113401; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sztain T, 2021, NAT CHEM, V13, P963, DOI [10.1038/s41557-021-00758-3, 10.1101/2021.02.15.431212]; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Torrens-Fontanals M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165933; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Ubani A., 2020, MEDRXIV, DOI [10.1101/2020., DOI 10.1101/2020, 10.1101/2020]; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Xu C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5575; Zhao J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.602256; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	77	5	5	10	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101814	10.1016/j.jbc.2022.101814	http://dx.doi.org/10.1016/j.jbc.2022.101814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35278433	gold, Green Published			2022-12-28	WOS:000823106100015
J	Zhang, SY; Bai, P; Lei, D; Liang, YX; Zhen, S; Bakiasi, G; Pang, H; Choi, SH; Wang, CN; Tanzi, RE; Zhang, C				Zhang, Siyi; Bai, Ping; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Pang, Hao; Choi, Se Hoon; Wang, Changning; Tanzi, Rudolph E.; Zhang, Can			Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer's disease-related neuropathology in cell models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heimer ' s disease (AD) by targeting bromodomain containing	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; GAMMA-SECRETASE; IN-VITRO; BROMODOMAIN; APP; AUTOPHAGY; NEURONS; BACE1; INFLAMMATION	Epigenetic regulation plays substantial roles in human pathophysiology, which provides opportunities for intervention in human disorders through the targeting of epigenetic pathways. Recently, emerging evidence from preclinical studies suggested the potential in developing therapeutics of Alzheimer's disease (AD) by targeting bromodomain containing protein 4 (BRD4), an epigenetic regulatory protein. However, further characterization of AD-related pathological events is urgently required. Here, we investigated the effects of pharmacological degradation or inhibition of BRD4 on AD cell models. Interestingly, we found that both degradation and inhibition of BRD4 by ARV-825 and JQ1, respectively, robustly increased the levels of amyloid-beta (A beta), which has been associated with the neuropathology of AD. Subsequently, we characterized the mechanisms by which downregulation of BRD4 increases A beta levels. We found that both degradation and inhibition of BRD4 increased the levels of BACE1, the enzyme responsible for cleavage of the amyloid-beta protein precursor (APP) to generate A beta. Consistent with A beta increase, we also found that downregulation of BRD4 increased AD-related phosphorylated Tau (pTau) protein in our 3D-AD human neural cell culture model. Therefore, our results suggest that downregulation of BRD4 would not be a viable strategy for AD intervention. Collectively, our study not only shows that BRD4 is a novel epigenetic component that regulates BACE1 and A beta levels, but also provides novel and translational insights into the targeting of BRD4 for potential clinical applications.	[Zhang, Siyi; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Choi, Se Hoon; Tanzi, Rudolph E.; Zhang, Can] Massachusetts Gen Hosp, Genet & Aging Res Unit, McCance Ctr Brain Hlth, MassGen Inst Neurodegenerat Dis MIND,Dept Neurol, Charlestown, MA 02129 USA; [Zhang, Siyi; Bai, Ping; Lei, Dan; Liang, Yingxia; Zhen, Sherri; Bakiasi, Grisilda; Choi, Se Hoon; Wang, Changning; Tanzi, Rudolph E.; Zhang, Can] Harvard Med Sch, Charlestown, MA 02129 USA; [Zhang, Siyi; Pang, Hao] China Med Univ, Dept Forens Med, Shenyang, Peoples R China; [Bai, Ping; Wang, Changning] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; China Medical University; Harvard University; Massachusetts General Hospital	Zhang, C (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, McCance Ctr Brain Hlth, MassGen Inst Neurodegenerat Dis MIND,Dept Neurol, Charlestown, MA 02129 USA.; Wang, CN; Zhang, C (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.; Wang, CN (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA.	CWANG15@mgh.harvard.edu; Zhang.Can@mgh.harvard.edu	Ping, Bai/GSE-3343-2022	Ping, Bai/0000-0003-4587-8426; Zhen, Sherri/0000-0001-7263-9223	NIH [DA050860]; Cure Alzheimer's Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund	This research was supported by the NIH grant DA050860 and the Cure Alzheimer's Fund.	Ahmad SS, 2019, CNS NEUROL DISORD-DR, V18, P657, DOI 10.2174/1871527318666191011145941; Alqahtani A, 2019, FUTUR SCI OA, V5, DOI 10.4155/fsoa-2018-0115; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Bahn G, 2019, P NATL ACAD SCI USA, V116, P12516, DOI 10.1073/pnas.1819541116; Benito E, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.202; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brock B, 2008, J ALZHEIMERS DIS, V13, P71; Choi S. H., 2014, 3 DIMENSIONAL HUMAN; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Simone A, 2019, CHEMMEDCHEM, V14, P1067, DOI 10.1002/cmdc.201900174; Decker TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01943-6; Noblejas-Lopez MD, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1387-5; DeMars KM, 2019, NEUROCHEM INT, V127, P94, DOI 10.1016/j.neuint.2019.03.004; Feng TC, 2017, J BIOL CHEM, V292, P1679, DOI 10.1074/jbc.M116.766584; Filippakopoulos P., 2010, NATURE 468; Fuso A, 2007, J ALZHEIMERS DIS, V11, P275; Fyfe I, 2018, NAT REV NEUROL, V14, DOI 10.1038/nrneurol.2018.36; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gorvin CM, 2019, J BONE MINER RES, V34, P1324, DOI 10.1002/jbmr.3695; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169226; Jung KH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0260-5; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Kulikowski E, 2021, MED RES REV, V41, P223, DOI 10.1002/med.21730; Kwak SS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15120-3; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Latif AL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20378-8; Li PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10101-7; Liang YX, 2020, J ALZHEIMERS DIS, V76, P1071, DOI 10.3233/JAD-200128; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Lombardo Y, 2012, P NATL ACAD SCI USA, V109, P16558, DOI 10.1073/pnas.1206268109; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma C, 2019, ANGEW CHEM INT EDIT, V58, P18703, DOI 10.1002/anie.201912399; Magistri M, 2016, CURR ALZHEIMER RES, V13, P985, DOI 10.2174/1567205013666160427101832; Meakin PJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03755-2; Nativio R., 2018, DYSREGULATION EPIGEN; Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2; Olley G, 2018, NAT GENET, V50, P329, DOI 10.1038/s41588-018-0042-y; Plucinska K, 2016, DIABETOLOGIA, V59, P1513, DOI 10.1007/s00125-016-3960-1; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; Stratton MS, 2019, CIRC RES, V125, P662, DOI 10.1161/CIRCRESAHA.119.315125; Sun Y., 2020, FRONT PHARMACOL, V11; Thompson PJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194776; Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang HH, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0258-7; Wang JL, 2019, J CELL MOL MED, V23, P3214, DOI 10.1111/jcmm.14196; Ward J, 2017, DISCOV MED, V23, P121; Wen X, 2017, AUTOPHAGY, V13, P1801, DOI 10.1080/15548627.2017.1364334; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhang C, 2010, CURR ALZHEIMER RES, V7, P21, DOI 10.2174/156720510790274428; Zhang C., 2007, MOL NEURODEGENERATIO, V2; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	68	2	2	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101794	10.1016/j.jbc.2022.101794	http://dx.doi.org/10.1016/j.jbc.2022.101794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35248531	Green Published, gold			2022-12-28	WOS:000793560400004
J	Kawase, N; Sugihara, A; Kajiwara, K; Hiroshima, M; Akamatsu, K; Nada, S; Matsumoto, K; Ueda, M; Okada, M				Kawase, Naoyuki; Sugihara, Atsuya; Kajiwara, Kentaro; Hiroshima, Michio; Akamatsu, Kanako; Nada, Shigeyuki; Matsumoto, Kunio; Ueda, Masahiro; Okada, Masato			SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN-1; PLECKSTRIN HOMOLOGY DOMAIN; NUCLEOTIDE EXCHANGE FACTOR; RECEPTOR; EXPRESSION; CARCINOMA; INVASION; RAC	Cancer invasion and metastasis are the major causes of cancer patient mortality. Various growth factors, including hepatocyte growth factor (HGF), are known to promote cancer invasion and metastasis, but the regulatory mechanisms involved are not fully understood. Here, we show that HGF-promoted migration and invasion of breast cancer cells are regulated by CUB domain-containing protein 1 (CDCP1), a transmembrane activator of SRC kinase. In metastatic human breast cancer cell line MDA-MB-231, which highly expresses the HGF receptor MET and CDCP1, we show that CDCP1 knockdown attenuated HGF-induced MET activation, followed by suppression of lamellipodia formation and cell migration/invasion. In contrast, in the low invasive/nonmetastatic breast cancer cell line T47D, which had no detectable MET and CDCP1 expression, ectopic MET expression stimulated the HGF-dependent activation of invasive activity, and concomitant CDCP1 expression activated SRC and further promoted invasive activity. In these cells, CDCP1 expression dramatically activated HGF-induced membrane remodeling, which was accompanied by activation of the small GTPase Racl. Analysis of guanine nucleotide exchange factors revealed that ARHGEF7 was specifically required for CDCP1-dependent induction of HGF-induced invasive ability. Furthermore, immunofluorescence staining demonstrated that CDCP1 coaccumulated with ARHGEF7. Finally, we confirmed that the CDCP1-SRC axis was also crucial for HGF and ARHGEF7RAC1 signaling in MDA-MB-231 cells. Altogether, these results demonstrate that the CDCP1-SRC-ARHGEF7-RAC1 pathway plays an important role in the HGF-induced invasion of a subset of breast cancer cells.	[Kawase, Naoyuki; Sugihara, Atsuya; Kajiwara, Kentaro; Akamatsu, Kanako; Nada, Shigeyuki; Okada, Masato] Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan; [Hiroshima, Michio; Ueda, Masahiro] RIKEN, Ctr Biosyst Dynam Res, Lab Cell Signaling Dynam, Suita, Osaka, Japan; [Akamatsu, Kanako; Okada, Masato] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Oncogene Res, Suita, Osaka, Japan; [Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa, Japan; [Ueda, Masahiro] Osaka Univ, Grad Sch Frontier Biosci, Lab Single Mol Biol, Suita, Osaka, Japan; [Okada, Masato] Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka, Japan	Osaka University; RIKEN; Osaka University; Kanazawa University; Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan.; Okada, M (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Oncogene Res, Suita, Osaka, Japan.; Okada, M (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka, Japan.	okadam@biken.osaka-u.ac.jp		Nada, Shigeyuki/0000-0002-1103-6119; Kajiwara, Kentaro/0000-0001-7574-4010; Ueda, Masahiro/0000-0002-9354-3404	JPSP KAKENHI [19H03504, 19H04962, 19K07639]	JPSP KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JPSP KAKENHI (Grant numbers 19H03504 and 19H04962 to M. O., 19K07639, to K. K.).	Alajati A, 2015, CELL REP, V11, P564, DOI 10.1016/j.celrep.2015.03.044; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Campa F, 2006, CELL RES, V16, P759, DOI 10.1038/sj.cr.7310091; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Comoglio PM, 2018, NAT REV CANCER, V18, P341, DOI 10.1038/s41568-018-0002-y; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; He Y, 2016, ONCOGENE, V35, P468, DOI 10.1038/onc.2015.101; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Kajiwara K, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000832; Koh CG, 2001, J CELL SCI, V114, P4239; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Leroy C, 2015, ONCOGENE, V34, P5593, DOI 10.1038/onc.2015.19; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Matsumoto K, 2017, CANCER SCI, V108, P296, DOI 10.1111/cas.13156; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Munoz-Bellvis L, 2012, MODERN PATHOL, V25, P590, DOI 10.1038/modpathol.2011.195; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Omelchenko T, 2014, GENE DEV, V28, P2764, DOI 10.1101/gad.251371.114; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turdo F, 2016, ONCOTARGET, V7, P69649, DOI 10.18632/oncotarget.11935; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wang H, 2014, ONCOGENE, V33, P1558, DOI 10.1038/onc.2013.97; Weidner C, 1999, J NEUROSCI, V19, P10184; Wright HJ, 2016, ONCOGENE, V35, P4762, DOI 10.1038/onc.2016.7	41	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101630	10.1016/j.jbc.2022.101630	http://dx.doi.org/10.1016/j.jbc.2022.101630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085554	Green Published, gold			2022-12-28	WOS:000821051800012
J	Mizuno, T; Satoh, N; Horita, S; Tsukada, H; Takagi, M; Sato, Y; Kume, H; Nangaku, M; Nakamura, M				Mizuno, Tomohito; Satoh, Nobuhiko; Horita, Shoko; Tsukada, Hiroyuki; Takagi, Mayuko; Sato, Yusuke; Kume, Haruki; Nangaku, Masaomi; Nakamura, Motonobu			Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPAR gamma-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; BICARBONATE REABSORPTION; BIPHASIC REGULATION; HEART-FAILURE; FATTY-ACIDS; IN-VIVO; MECHANISMS; LIGANDS; NHE3; ROSIGLITAZONE	Oxidized phospholipids have been shown to exhibit pleiotropic effects in numerous biological contexts. For example, 1-O-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine (azPC), an oxidized phospholipid formed from alkyl phosphatidylcholines, is a peroxisome proliferator-activated receptor gamma (PPAR gamma) nuclear receptor agonist. Although it has been reported that PPAR gamma agonists including thiazolidinediones can induce plasma volume expansion by enhancing renal sodium and water retention, the role of azPC in renal transport functions is unknown. In the present study, we investigated the effect of azPC on renal proximal tubule (PT) transport using isolated PTs and kidney cortex tissues and also investigated the effect of azPC on renal sodium handling in vivo. We showed using a microperfusion technique that azPC rapidly stimulated Na+/HCO3- cotransporter 1 (NBCe1) and luminal Na+/H+ exchanger (NHE) activities in a dose-dependent manner at submicromolar concentrations in isolated PTs from rats and humans. The rapid effects (within a few minutes) suggest that azPC activates NBCe1 and NHE via nongenomic signaling. The stimulatory effects were completely blocked by specific PPAR gamma antagonist GW9662, ERK kinase inhibitor PD98059, and CD36 inhibitor sulfosuccinimidyl oleate. Treatment with an siRNA against PPAR gamma completely blocked the stimulation of both NBCe1 and NHE by azPC. Moreover, azPC induced ERK phosphorylation in rat and human kidney cortex tissues, which were completely suppressed by GW9662 and PD98059 treatments. These results suggest that azPC stimulates renal PT sodium-coupled bicarbonate transport via a CD36/PPAR gamma/ mitogen-activated protein/ERK kinase/ERK pathway. We conclude that the stimulatory effects of azPC on PT transport may be partially involved in volume expansion.	[Mizuno, Tomohito; Satoh, Nobuhiko; Horita, Shoko; Tsukada, Hiroyuki; Takagi, Mayuko; Nangaku, Masaomi; Nakamura, Motonobu] Univ Tokyo, Div Nephrol & Endocrinol, Tokyo, Japan; [Sato, Yusuke; Kume, Haruki] Univ Tokyo, Dept Urol, Tokyo, Japan	University of Tokyo; University of Tokyo	Nakamura, M (corresponding author), Univ Tokyo, Div Nephrol & Endocrinol, Tokyo, Japan.	nakamura-stm@umin.ac.jp	Horita, Shoko/AFK-0949-2022	Horita, Shoko/0000-0003-2103-3605; zhong cun, yuan xin/0000-0002-5379-4305; Nangaku, Masaomi/0000-0001-7401-2934	Daiichi Sankyo Co, Ltd [A20-1972]; Japan Society for the Promotion of Science KAKENHI [19K08671, 19K17698]	Daiichi Sankyo Co, Ltd(Daiichi Sankyo Company Limited); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr Masashi Suzuki for helpful discussions on this work. The study was supported by Daiichi Sankyo Co, Ltd (grant number: A20-1972) and Japan Society for the Promotion of Science KAKENHI (grant numbers: 19K08671 and 19K17698) .	Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Bailey MA, 2004, AM J PHYSIOL-RENAL, V287, pF789, DOI 10.1152/ajprenal.00033.2004; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Cantini G, 2010, EUR J CELL BIOL, V89, P645, DOI 10.1016/j.ejcb.2010.04.002; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Choi JY, 2000, J CLIN INVEST, V105, P1141, DOI 10.1172/JCI9260; Chou TC, 2014, BIOMEDICINE-TAIWAN, V4, P17, DOI 10.7603/s40681-014-0024-z; Collino M, 2005, KIDNEY INT, V68, P529, DOI 10.1111/j.1523-1755.2005.00430.x; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Davidson MA, 2018, CRIT REV TOXICOL, V48, P52, DOI 10.1080/10408444.2017.1351420; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Endo Y, 2011, CELL METAB, V13, P550, DOI 10.1016/j.cmet.2011.02.015; Frey B, 2000, J LIPID RES, V41, P1145; Gao X, 2014, INT J MOL MED, V34, P564, DOI 10.3892/ijmm.2014.1799; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Greig FH, 2012, FREE RADICAL BIO MED, V52, P266, DOI 10.1016/j.freeradbiomed.2011.10.481; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Guo YM, 2017, J AM SOC NEPHROL, V28, P2409, DOI 10.1681/ASN.2016080930; Horita S, 2002, HYPERTENSION, V40, P707, DOI 10.1161/01.HYP.0000036449.70110.DE; Horita S, 2015, PPAR RES, V2015, DOI 10.1155/2015/646423; Hsueh WA, 2001, DIABETES CARE, V24, P392, DOI 10.2337/diacare.24.2.392; Hua W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127507; Johnstone SR, 2009, AM J PATHOL, V175, P916, DOI 10.2353/ajpath.2009.090160; Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604; Kurtz I, 2014, COMPR PHYSIOL, V4, P1737, DOI 10.1002/cphy.c140021; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Li XC, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0668-z; Li Y, 2008, J AM SOC NEPHROL, V19, P252, DOI 10.1681/ASN.2007030289; Lo YF, 2011, KIDNEY INT, V79, P730, DOI 10.1038/ki.2010.523; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Marion-Letellier R, 2016, EUR J PHARMACOL, V785, P44, DOI 10.1016/j.ejphar.2015.11.004; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Morita H, 1998, J CARDIOVASC PHARM, V31, pS557, DOI 10.1097/00005344-199800001-00161; Muto S, 2001, EXP NEPHROL, V9, P191; Nakamura M, 2020, PHYSIOL INT, V107, P376, DOI 10.1556/2060.2020.00030; Nakamura M, 2020, KIDNEY INT, V97, P316, DOI 10.1016/j.kint.2019.08.021; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Pan WH, 1997, STROKE, V28, P88, DOI 10.1161/01.STR.28.1.88; Papageorgiou E, 2008, MOL MED, V14, P403, DOI 10.2119/2008-00021.Papageorgiou; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Parker MD, 2015, CELL MOL LIFE SCI, V72, P2061, DOI 10.1007/s00018-015-1848-8; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Pinto V, 2008, MOL CELL BIOCHEM, V310, P191, DOI 10.1007/s11010-007-9680-6; Pontsler AV, 2002, J BIOL CHEM, V277, P13029, DOI 10.1074/jbc.M109546200; Prevoo B, 2011, J PHARMACOL EXP THER, V338, P362, DOI 10.1124/jpet.111.179689; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Saad S, 2009, NEPHROL DIAL TRANSPL, V24, P1130, DOI 10.1093/ndt/gfn614; Sato K, 2004, HYPERTENS RES, V27, P417, DOI 10.1291/hypres.27.417; Satoh N, 2016, PFLUG ARCH EUR J PHY, V468, P1183, DOI 10.1007/s00424-016-1808-7; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shirai A, 2014, J AM SOC NEPHROL, V25, P1523, DOI 10.1681/ASN.2013060596; Soi V, 2017, ADV CHRONIC KIDNEY D, V24, P325, DOI 10.1053/j.ackd.2017.08.001; Song J, 2004, J PHARMACOL EXP THER, V308, P426, DOI 10.1124/jpet.103.058008; Thornell IM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00166; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Wang T, 2001, AM J PHYSIOL-RENAL, V281, pF1117, DOI 10.1152/ajprenal.2001.281.6.F1117; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Yamada Hideomi, 1996, American Journal of Physiology, V271, pF1068; Yang XC, 2017, NAT REV NEPHROL, V13, P769, DOI 10.1038/nrneph.2017.126; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200; Zheng YN, 2005, J AM SOC NEPHROL, V16, P2288, DOI 10.1681/ASN.2005020193; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061; Ziegler T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010050	71	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101681	10.1016/j.jbc.2022.101681	http://dx.doi.org/10.1016/j.jbc.2022.101681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124009	gold, Green Published			2022-12-28	WOS:000789400700004
J	Suzuki, K; Marin, MD; Konno, M; Bagherzadeh, R; Murata, T; Inoue, K				Suzuki, Kano; Marin, Maria del Carmen; Konno, Masae; Bagherzadeh, Reza; Murata, Takeshi; Inoue, Keiichi			Structural characterization of proton-pumping rhodopsin lacking a cytoplasmic proton donor residue by X-ray crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE; PURPLE MEMBRANE; BACTERIORHODOPSIN; TRANSLOCATION; INTERMEDIATE; PHOTOCYCLE; XANTHORHODOPSIN; REPLACEMENT; TRANSPORT	DTG/DTS rhodopsin, which was named based on a three residue motif (DTG or DTS) that is important for its function, is a light-driven proton-pumping microbial rhodopsin using a retinal chromophore. In contrast to other light-driven ion-pumping rhodopsins, DTG/DTS rhodopsin does not have a cytoplasmic proton donor residue, such as Asp, Glu, or Lys. Because of the lack of cytoplasmic proton donor residue, proton directly binds to the retinal chromophore from the cytoplasmic solvent. However, mutational experiments that showed the complicated effects of mutations were not able to clarify the roles played by each residue, and the detail of proton uptake pathway is unclear because of the lack of structural information. To understand the proton transport mechanism of DTG/ DTS rhodopsin, here we report the three-dimensional structure of one of the DTG/DTS rhodopsins, PspR from Pseudomonas putida, by X-ray crystallography. We show that the structure of the cytoplasmic side of the protein is significantly different from that of bacteriorhodopsin, the best characterized proton-pumping rhodopsin, and large cytoplasmic cavities were observed. We propose that these hydrophilic cytoplasmic cavities enable direct proton uptake from the cytoplasmic solvent without the need for a specialized cytoplasmic donor residue. The introduction of carboxylic residues homologous to the cytoplasmic donors in other proton-pumping rhodopsins resulted in higher pumping activity with less pH dependence, suggesting that DTG/DTS rhodopsins are advantageous for producing energy and avoiding intracellular alkalization in soil and plant-associated bacteria.	[Suzuki, Kano; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Marin, Maria del Carmen; Konno, Masae; Bagherzadeh, Reza; Inoue, Keiichi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan; [Konno, Masae] PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Kawaguchi, Saitama, Japan; [Murata, Takeshi] Chiba Univ, Membrane Prot Res & Mol Chiral Res Ctr, Chiba, Japan	Chiba University; University of Tokyo; Japan Science & Technology Agency (JST); Chiba University	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.; Inoue, K (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan.; Murata, T (corresponding author), Chiba Univ, Membrane Prot Res & Mol Chiral Res Ctr, Chiba, Japan.	t.murata@faculty.chiba-u.jp; inoue@issp.u-tokyo.ac.jp	Marin, Maria del Carmen/CAF-3433-2022; Konno, Masae/C-1066-2009	Marin, Maria del Carmen/0000-0001-6603-1692; Konno, Masae/0000-0002-0605-1816	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [JP20H05758]; Japan Society for the Promotion of Science KAKENHI [JP20F20081, JP18H05425, JP21H01875, JP20K21383]; Japan Agency for Medical Research and Development (AMED) [21fk0108092]	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology KAKENHI, Grant-in-aid for Transformative Research Areas (B) "Low-energy manipulation" (grant number: JP20H05758; to K. I.), Japan Society for the Promotion of Science KAKENHI, Grants-inaid (grant numbers: JP20F20081 [to M. d. C. M.], JP18H05425 [to T. M.], as well as JP21H01875 and JP20K21383 [to K. I.]), International Research Fellow of the Japan Society for the Promotion of Science (Postdoctoral Fellowships for Research in Japan; to M. d. C. M.), and the Japan Agency for Medical Research and Development (AMED) under grant no. 21fk0108092 to T. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balashov SP, 2013, J BIOL CHEM, V288, P21254, DOI 10.1074/jbc.M113.465138; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Besaw JE, 2020, J BIOL CHEM, V295, P14793, DOI 10.1074/jbc.RA120.014118; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; Dioumaev AK, 1999, BIOCHEMISTRY-US, V38, P10070, DOI 10.1021/bi990873+; Donahue CET, 2021, J AM CHEM SOC, V143, P18877, DOI 10.1021/jacs.1c02156; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fudim R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav4203; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Govorunova EG, 2016, BIOCHEMISTRY-MOSCOW+, V81, P928, DOI 10.1134/S0006297916090029; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Harris A, 2015, BBA-BIOENERGETICS, V1847, P1518, DOI 10.1016/j.bbabio.2015.08.003; Higuchi A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016328118; Inoue K, 2021, ADV EXP MED BIOL, V1293, P89, DOI 10.1007/978-981-15-8763-4_6; Inoue K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2441; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Irieda H, 2012, J BIOL CHEM, V287, P32485, DOI 10.1074/jbc.M112.390864; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2020, B CHEM SOC JPN, V93, P904, DOI 10.1246/bcsj.20200109; Kato HE, 2021, ADV EXP MED BIOL, V1293, P35, DOI 10.1007/978-981-15-8763-4_3; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lorenz-Fonfria VA, 2009, J AM CHEM SOC, V131, P5891, DOI 10.1021/ja900334c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Maliar N, 2020, DOKL BIOCHEM BIOPHYS, V495, P342, DOI 10.1134/S1607672920060162; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Mukherjee S, 2019, CURR OPIN STRUC BIOL, V57, P118, DOI 10.1016/j.sbi.2019.02.003; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Needham DM, 2019, P NATL ACAD SCI USA, V116, P20574, DOI 10.1073/pnas.1907517116; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Philosof A, 2017, CURR BIOL, V27, P1362, DOI 10.1016/j.cub.2017.03.052; Pushkarev A, 2018, NATURE, V558, P595, DOI 10.1038/s41586-018-0225-9; RACKER E, 1974, J BIOL CHEM, V249, P662; Rink T, 2000, BIOPHYS J, V78, P1519, DOI 10.1016/S0006-3495(00)76704-X; Rozenberg A, 2021, ANNU REV MICROBIOL, V75, P427, DOI 10.1146/annurev-micro-031721-020452; Rozenberg A, 2020, CURR BIOL, V30, P4910, DOI 10.1016/j.cub.2020.09.056; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; Shibata M, 2003, J AM CHEM SOC, V125, P13312, DOI 10.1021/ja037343s; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; Sudo Y, 2016, PHOTOCHEM PHOTOBIOL, V92, P420, DOI 10.1111/php.12585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vogt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16450; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zabelskii D, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02326-4; Zscherp C, 2001, BIOCHEM BIOPH RES CO, V283, P57, DOI 10.1006/bbrc.2001.4730; ZUCKERKANDL EMILE, 1965, P97	63	3	3	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101722	10.1016/j.jbc.2022.101722	http://dx.doi.org/10.1016/j.jbc.2022.101722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151692	Green Published, gold			2022-12-28	WOS:000789394500007
J	Huang, X; Swanson, R; Olson, ST				Huang, Xin; Swanson, Richard; Olson, Steven T.			Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; SERVER; IDENTIFICATION	Protein Z (PZ)-dependent protease inhibitor (ZPI) is a plasma anticoagulant protein of the serpin superfamily, which is activated by its cofactor, PZ, to rapidly inhibit activated factor X (FXa) on a procoagulant membrane surface. ZPI is also activated by heparin to inhibit free FXa at a physiologically significant rate. Here, we show that heparin binding to ZPI antagonizes PZ binding to and activation of ZPI. Virtual docking of heparin to ZPI showed that a heparin-binding site near helix H close to the PZ-binding site as well as a previously mapped site in helix C was both favored. Alanine scanning mutagenesis of the helix H and helix C sites demonstrated that both sites were critical for heparin activation. The binding of heparin chains 72 to 5-saccharides in length to ZPI was similarly effective in antagonizing PZ binding and in inducing tryptophan fluorescence changes in ZPI. Heparin binding to variant ZPIs with either the helix C sites or the helix H sites mutated showed that heparin interaction with the higher affinity helix C site most distant from the PZ-binding site was sufficient to induce these tryptophan fluorescence changes. Together, these findings suggest that heparin binding to a site on ZPI extending from helix C to helix H promotes ZPI inhibition of FXa and allosterically antagonizes PZ binding to ZPI through long-range conformational changes. Heparin antagonism of PZ binding to ZPI may serve to spare limiting PZ and allow PZ and heparin cofactors to target FXa at different sites of action.	[Huang, Xin] Univ Illinois, Dept Pharmacol & Regenerat Med, Chicago, IL 60680 USA; [Swanson, Richard; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huang, X (corresponding author), Univ Illinois, Dept Pharmacol & Regenerat Med, Chicago, IL 60680 USA.	xinhuang@uic.edu			National Institutes of Health, United States [R56 HL149881]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a grant from the National Institutes of Health, United States (grant no.: R56 HL149881; to X. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2017, J BIOL CHEM, V292, P14625, DOI 10.1074/jbc.M117.793901; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2012, BLOOD, V120, P1726, DOI 10.1182/blood-2012-03-419598; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Tollefsen DM, 1997, ADV EXP MED BIOL, V425, P35; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c	23	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102022	10.1016/j.jbc.2022.102022	http://dx.doi.org/10.1016/j.jbc.2022.102022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35551912	gold, Green Published			2022-12-28	WOS:000811813400011
J	Liang, Q; Jin, YQ; Xu, SW; Zhou, JZ; Mao, J; Ma, XH; Wang, M; Cong, YS				Liang, Qian; Jin, Yaqi; Xu, Shiwen; Zhou, Junzhi; Mao, Jian; Ma, Xiaohe; Wang, Miao; Cong, Yu-Sheng			Human UFSP1 translated from an upstream near-cognate initiation codon functions as an active UFM1-specific protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UFM1; ALPHA; CELLS; START; CUG	Ubiquitin-fold modifier 1 (UFM1) is a recently identified ubiquitin-like posttranslational modification with important biological functions. However, the regulatory mechanisms governing UFM1 modification of target proteins (UFMylation) and the cellular processes controlled by UFMylation remain largely unknown. It has been previously shown that a UFM1-specific protease (UFSP2) mediates the maturation of the UFM1 precursor and drives the de-UFMylation reaction. Furthermore, it has long been thought that UFSP1, an ortholog of UFSP2, is inactive in many organisms, including human, because it lacks an apparent protease domain when translated from the canonical start codon ((445)AUG). Here, we demonstrate using the combination of site-directed mutagenesis, CRISPR/Cas9-mediated genome editing, and mass spectrometry approaches that translation of human UFSP1 initiates from an upstream near-cognate codon, (217)CUG, via eukaryotic translation initiation factor eIF2A-mediated translational initiation rather than from the annotated (445)AUG, revealing the presence of a catalytic protease domain containing a Cys active site. Moreover, we show that both UFSP1 and UFSP2 mediate maturation of UFM1 and de-UFMylation of target proteins. This study demonstrates that human UFSP1 functions as an active UFM1-specific protease, thus contributing to our understanding of the UFMylation/de-UFMylation process.	[Liang, Qian; Jin, Yaqi; Xu, Shiwen; Zhou, Junzhi; Mao, Jian; Ma, Xiaohe; Wang, Miao; Cong, Yu-Sheng] Hangzhou Normal Univ, Sch Basic Med Sci, Key Lab Aging & Canc Biol Zhejiang Prov, Hangzhou, Peoples R China	Hangzhou Normal University	Cong, YS (corresponding author), Hangzhou Normal Univ, Sch Basic Med Sci, Key Lab Aging & Canc Biol Zhejiang Prov, Hangzhou, Peoples R China.	yscong@hznu.edu.cn			National Natural Science Foundation of China [32170776, 31730020, 31900520]; Hangzhou Science and Technology Bureau [20182014B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Science and Technology Bureau	Acknowledgments-We thank members of the Cong lab for helpful discussions. This work was supported by the National Natural Science Foundation of China (32170776, 31730020, 31900520) and the Hangzhou Science and Technology Bureau [20182014B01] .	Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; de Arce AJD, 2018, NUCLEIC ACIDS RES, V46, P985, DOI 10.1093/nar/gkx1114; Di Rocco M, 2018, CLIN GENET, V93, P671, DOI 10.1111/cge.13134; Egunsola AT, 2017, J CLIN INVEST, V127, P1475, DOI 10.1172/JCI90193; Gerakis Y, 2019, TRENDS CELL BIOL, V29, P974, DOI 10.1016/j.tcb.2019.09.005; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ishimura R, 2017, FEBS LETT, V591, P196, DOI 10.1002/1873-3468.12518; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Kim M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18026-2; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Liang JR, 2020, CELL, V180, P1160, DOI 10.1016/j.cell.2020.02.017; Liu J, 2020, NAT CELL BIOL, V22, P1056, DOI 10.1038/s41556-020-0559-z; Liu J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14377; Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135; Paix A, 2017, P NATL ACAD SCI USA, V114, pE10745, DOI 10.1073/pnas.1711979114; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Petrany MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20063-w; Qin B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09175-0; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Vagner S, 1996, J CELL BIOL, V135, P1391, DOI 10.1083/jcb.135.5.1391; Walczak CP, 2019, P NATL ACAD SCI USA, V116, P1299, DOI 10.1073/pnas.1816202116; Wang LH, 2020, CELL RES, V30, DOI 10.1038/s41422-019-0236-6; Wang ZF, 2019, NUCLEIC ACIDS RES, V47, P4124, DOI 10.1093/nar/gkz110; Yoo HM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00036; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51	38	1	1	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102016	10.1016/j.jbc.2022.102016	http://dx.doi.org/10.1016/j.jbc.2022.102016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35525273	Green Published, gold			2022-12-28	WOS:000829588600008
J	Murphy, JM; Jeong, K; Ahn, EYE; Lim, STS				Murphy, James M.; Jeong, Kyuho; Ahn, Eun-Young Erin; Lim, Ssang-Taek Steve			Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase 4/6 degradation and inhibits melanoma proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; BRAF; CDK4; D1; PHOSPHORYLATION; TRANSCRIPTION; RESISTANCE; PROMOTES; PHASE	Dysregulation of cyclin-dependent kinases (CDKs) can promote unchecked cell proliferation and cancer progression. Although focal adhesion kinase (FAK) contributes to regulating cell cycle progression, the exact molecular mechanism remains unclear. Here, we found that FAK plays a key role in cell cycle progression potentially through regulation of CDK4/6 protein expression. We show that FAK inhibition increased its nuclear localization and induced G1 arrest in B16F10 melanoma cells. Mechanistically, we demonstrate nuclear FAK associated with CDK4/6 and promoted their ubiquitination and proteasomal degradation through recruitment of CDC homolog 1 (CDH1), an activator and substrate recognition subunit of the anaphase-promoting complex/cyclosome E3 ligase complex. We found the FAK N-terminal FERM domain acts as a scaffold to bring CDK4/6 and CDH1 within close proximity. However, over-expression of nonnuclear-localizing mutant FAK FERM failed to function as a scaffold for CDK4/6 and CDH1. Furthermore, shRNA knockdown of CDH1 increased CDK4/6 protein expression and blocked FAK inhibitor-induced reduction of CDK4/6 in B16F10 cells. In vivo, we show that pharmacological FAK inhibition reduced B16F10 tumor size, correlating with increased FAK nuclear localization and decreased CDK4/6 expression compared with vehicle controls. In patient-matched healthy skin and melanoma biopsies, we found FAK was mostly inactive and nuclear localized in healthy skin, whereas melanoma lesions showed increased active cytoplasmic FAK and elevated CDK4 expression. Taken together, our data demonstrate that FAK inhibition blocks tumor proliferation by inducing G1 arrest, in part through decreased CDK4/6 protein stability by nuclear FAK.	[Murphy, James M.; Lim, Ssang-Taek Steve] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Jeong, Kyuho] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Ahn, Eun-Young Erin] Univ Alabama Birmingham, Dept Pathol, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of Alabama System; University of Alabama Birmingham	Lim, STS (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	stlim@uab.edu		Lim, Steve/0000-0003-0323-8607; Murphy, James/0000-0002-9690-0024	Mitchell Cancer Research grant; National Institutes of Health [R01 CA190688, R01 HL136432, R01 HL158875]; 2019 College of Medicine Intramural grant from the University of South Alabama	Mitchell Cancer Research grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2019 College of Medicine Intramural grant from the University of South Alabama	This work was supported by the Mitchell Cancer Research grant (to S.-T. S. L.), National Institutes of Health (grant nos.: R01 CA190688 [to E.-Y. E. A.], R01 HL136432 [to S.-T. S. L.], and R01 HL158875 [to S.-T. S. L.]), 2019 College of Medicine Intramural grant from the University of South Alabama (to S.-T. S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Chen GM, 2018, MOL CANCER THER, V17, P806, DOI 10.1158/1535-7163.MCT-17-0561; Chen HB, 2017, J BIOL CHEM, V292, P10131, DOI 10.1074/jbc.M116.773226; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dhillon S, 2015, DRUGS, V75, P543, DOI 10.1007/s40265-015-0379-9; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Eroglu Z, 2016, THER ADV MED ONCOL, V8, P48, DOI 10.1177/1758834015616934; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Gellrich FF, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010223; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; Griewank KG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt435; He LM, 2009, MOL ENDOCRINOL, V23, P1865, DOI 10.1210/me.2009-0057; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong K, 2022, CARDIOVASC RES, V118, P1150, DOI 10.1093/cvr/cvab132; Jeong K, 2019, CIRC RES, V125, P152, DOI 10.1161/CIRCRESAHA.118.314344; Julve M, 2021, EXPERT OPIN PHARMACO, V22, P351, DOI 10.1080/14656566.2020.1828348; Kahana O, 2002, ONCOGENE, V21, P3969, DOI 10.1038/sj.onc.1205472; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mamalis A, 2014, ARCH DERMATOL RES, V306, P511, DOI 10.1007/s00403-014-1457-7; Melnikova VO, 2004, ONCOGENE, V23, P2347, DOI 10.1038/sj.onc.1207405; Murphy JM, 2020, EXP MOL MED, V52, P877, DOI 10.1038/s12276-020-0447-4; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Proietti I, 2020, CANCERS, V12, DOI 10.3390/cancers12102801; REISMAN D, 1995, MOL ENDOCRINOL, V9, P1500, DOI 10.1210/me.9.11.1500; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Rotte A, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1259-z; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Young RJ, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12228; Zhang C, 2019, ONCOGENE, V38, P5905, DOI 10.1038/s41388-019-0850-2; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102013	10.1016/j.jbc.2022.102013	http://dx.doi.org/10.1016/j.jbc.2022.102013			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35525274	gold, Green Published			2022-12-28	WOS:000807755100014
J	Subramanian, C; Cuypers, MG; Radka, CD; White, SW; Rock, CO				Subramanian, Chitra; Cuypers, Maxime G.; Radka, Christopher D.; White, Stephen W.; Rock, Charles O.			Domain architecture and catalysis of the Staphylococcus aureus fatty acid kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING SUBUNIT; CRYSTAL-STRUCTURE; ACTIVE-SITE; SCATTERING; SUBSTRATE; REFINEMENT; RESIDUES; COENZYME; ATP	Fatty acid kinase (Fak) is a two-component enzyme that generates acyl-phosphate for phospholipid synthesis. Fak consists of a kinase domain protein (FakA) that phosphorylates a fatty acid enveloped by a fatty acid binding protein (FakB). The structural basis for FakB function has been established, but little is known about FakA. Here, we used limited proteolysis to define three separate FakA domains: the amino terminal FakA_N, the central FakA_L, and the carboxy terminal FakA_C. The isolated domains lack kinase activity, but activity is restored when FakA_N and FakA_L are present individually or connected as FakA_NL. The X-ray structure of the monomeric FakA_N captures the product complex with ADP and two Mg2+ ions bound at the nucleotide site. The FakA_L domain encodes the dimerization interface along with conserved catalytic residues Cys240, His282, and His284. AlphaFold analysis of FakA_L predicts the catalytic residues are spatially clustered and pointing away from the dimerization surface. Furthermore, the X-ray structure of FakA_C shows that it consists of two subdomains that are structurally related to FakB. Analytical ultracentrifugation demonstrates that FakA_C binds FakB, and site-directed mutagenesis confirms that a positively charged wedge on FakB meshes with a negatively charged groove on FakA_C. Finally, small angle X-ray scattering analysis is consistent with freely rotating FakA_N and FakA_C domains tethered by flexible linkers to FakA_L. These data reveal specific roles for the three independently folded FakA protein domains in substrate binding and catalysis.	[Subramanian, Chitra; Radka, Christopher D.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Cuypers, Maxime G.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.rock@stjude.org	Radka, Christopher D./AGX-1090-2022; Rock, Charles/N-2256-2018	Radka, Christopher D./0000-0002-6037-7710; Rock, Charles/0000-0001-8648-4189; Cuypers, Maxime/0000-0002-8826-2317; White, Stephen/0000-0001-8188-5944	NIH [OD018090, GM034496, AI166116, GM103622]; Cancer Center (CORE) Support Grant [CA21765]; American Lebanese Syrian Associated Charities; Department of Energy Office of Science [DE-AC0206CH11357]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE) Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Department of Energy Office of Science(United States Department of Energy (DOE))	This research was supported by NIH grants GM034496 (C. O. R.), AI166116 (C. D. R.), Cancer Center (CORE) Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The Advanced Photon Source is operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC0206CH11357. SEC-SAXS experiments were supported by NIH grant GM103622. Use of the Pilatus 3 1M detector was provided by support from NIH grant OD018090. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bachler C, 2005, J BIOL CHEM, V280, P18321, DOI 10.1074/jbc.M500279200; Broussard TC, 2016, J BIOL CHEM, V291, P6292, DOI 10.1074/jbc.M115.706820; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; DeMars Z, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00128-20; El Omari K, 2014, ACTA CRYSTALLOGR D, V70, P2197, DOI 10.1107/S139900471401339X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Grant TD, 2018, NAT METHODS, V15, P191, DOI [10.1038/NMETH.4581, 10.1038/nmeth.4581]; Gullett JM, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101676; Gullett JM, 2019, J BIOL CHEM, V294, P16416, DOI 10.1074/jbc.RA119.010659; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Heipieper HJ, 1996, APPL ENVIRON MICROB, V62, P2773, DOI 10.1128/AEM.62.8.2773-2777.1996; Honorato RV, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.729513; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; Johnson SK, 2003, PROTEIN EXPRES PURIF, V32, P1, DOI 10.1016/j.pep.2003.07.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; Krute CN, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00828-16; Langer GG, 2013, ACTA CRYSTALLOGR D, V69, P635, DOI 10.1107/S0907444913000565; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Li ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01821-9; Lu YJ, 2007, J BIOL CHEM, V282, P11339, DOI 10.1074/jbc.M700374200; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oberholzer AE, 2006, J MOL BIOL, V359, P539, DOI 10.1016/j.jmb.2006.03.057; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Subramanian C, 2019, J BIOL CHEM, V294, P9285, DOI 10.1074/jbc.RA119.008439; Thaker TM, 2013, J STRUCT BIOL, V181, P185, DOI 10.1016/j.jsb.2012.11.001; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Vangone A, 2017, PROTEINS, V85, P417, DOI 10.1002/prot.25198; Zhao H., 2013, CURR PROTOC PROTEIN, V20, P12, DOI DOI 10.1002/0471140864.PS2012S7; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	48	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101993	10.1016/j.jbc.2022.101993	http://dx.doi.org/10.1016/j.jbc.2022.101993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35490779	gold, Green Published			2022-12-28	WOS:000807755100006
J	Sure, F; Bertog, M; Afonso, S; Diakov, A; Rinke, R; Madej, MG; Wittmann, S; Gramberg, T; Korbmacher, C; Ilyaskin, AV				Sure, Florian; Bertog, Marko; Afonso, Sara; Diakov, Alexei; Rinke, Ralf; Madej, M. Gregor; Wittmann, Sabine; Gramberg, Thomas; Korbmacher, Christoph; Ilyaskin, Alexandr, V			Transmembrane serine protease 2 (TMPRSS2) proteolytically activates the epithelial sodium channel (ENaC) by cleaving the channel's gamma-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR FLUID CLEARANCE; SURFACE LIQUID VOLUME; NA+ CHANNEL; ELASTASE ACTIVATION; INHIBITORY PEPTIDE; XENOPUS-OOCYTES; T-COFFEE; CLEAVAGE; MOUSE; FURIN	The epithelial sodium channel (ENaC) is a heterotrimer consisting of alpha-, beta-, and gamma-subunits. Channel activation requires proteolytic release of inhibitory tracts from the extracellular domains of alpha-ENaC and gamma-ENaC; however, the proteases involved in the removal of the gamma-inhibitory tract remain unclear. In several epithelial tissues, ENaC is coexpressed with the transmembrane serine protease 2 (TMPRSS2). Here, we explored the effect of human TMPRSS2 on human alpha beta gamma-ENaC heterologously expressed in Xenopus laevis oocytes. We found that coexpression of TMPRSS2 stimulated ENaC-mediated whole-cell currents by approximately threefold, likely because of an increase in average channel open probability. Furthermore, TMPRSS2-dependent ENaC stimulation was not observed using a catalytically inactive TMPRSS2 mutant and was associated with fully cleaved gamma-ENaC in the intracellular and cell surface protein fractions. This stimulatory effect of TMPRSS2 on ENaC was partially preserved when inhibiting its proteolytic activity at the cell surface using aprotinin but was abolished when the gamma-inhibitory tract remained attached to its binding site following introduction of two cysteine residues (S155C-Q426C) to form a disulfide bridge. In addition, computer simulations and site-directed mutagenesis experiments indicated that TMPRSS2 can cleave gamma-ENaC at sites both proximal and distal to the gamma-inhibitory tract. This suggests a dual role of TMPRSS2 in the proteolytic release of the gamma-inhibitory tract. Finally, we demonstrated that TMPRSS2 knockdown in cultured human airway epithelial cells (H441) reduced baseline proteolytic activation of endogenously expressed ENaC. Thus, we conclude that TMPRSS2 is likely to contribute to proteolytic ENaC activation in epithelial tissues in vivo.	[Sure, Florian; Bertog, Marko; Afonso, Sara; Diakov, Alexei; Rinke, Ralf; Korbmacher, Christoph; Ilyaskin, Alexandr, V] Friedrich Alexander Univ Erlangen Nurnberg, Inst Cellular & Mol Physiol, Erlangen, Germany; [Madej, M. Gregor] Univ Regensburg, Dept Biophys Struct Biol 2, Regensburg, Germany; [Wittmann, Sabine; Gramberg, Thomas] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Clin & Mol Virol, Erlangen, Germany	University of Erlangen Nuremberg; University of Regensburg; University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Cellular & Mol Physiol, Erlangen, Germany.	christoph.korbmacher@fau.de		Sure, Florian/0000-0002-2255-5571; Bertog, Marko/0000-0002-1504-9582	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [387509280, SFB 1350]; Bayerisches Staatsministerium fur Wissenschaft und Kunst (Bavarian Ministry of Art and Science), project VI-CoronaForschung; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research, Germany) [SENSE-CoV2, 01KI20172A]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Bayerisches Staatsministerium fur Wissenschaft und Kunst (Bavarian Ministry of Art and Science), project VI-CoronaForschung; Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF))	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 387509280, SFB 1350 (subproject A4; to C. K.) and the Bayerisches Staatsministerium fur Wissenschaft und Kunst (Bavarian Ministry of Art and Science), project VI-CoronaForschung (subproject 07; to M. B. and T. G.). S. W. was supported by the Bundesministerium fur Bildung und Forschung (BMBF, Federal Ministry of Education and Research, Germany), project SENSE-CoV2, 01KI20172A.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Afar DEH, 2001, CANCER RES, V61, P1686; Aguiar JA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01123-2020; Anand D, 2022, ACTA PHYSIOL, V235, DOI 10.1111/apha.13811; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balchak DM, 2018, J BIOL CHEM, V293, P16217, DOI 10.1074/jbc.RA118.004362; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bohnert BN, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13286; Bohnert BN, 2018, KIDNEY INT, V93, P159, DOI 10.1016/j.kint.2017.07.023; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100313; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Essigke D, 2021, ACTA PHYSIOL, V232, DOI 10.1111/apha.13640; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; Frindt G, 2021, AM J PHYSIOL-RENAL, V320, pF485, DOI 10.1152/ajprenal.00536.2020; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gentzsch M, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa024; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Haerteis S, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13060; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2014, J BIOL CHEM, V289, P19067, DOI 10.1074/jbc.M113.538470; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Haerteis S, 2012, CELL PHYSIOL BIOCHEM, V29, P761, DOI 10.1159/000312590; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Herter S., 2005, CRYSTAL STRUCTURE EX; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; Ilyaskin AV, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100404; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Jacquinet E, 2000, FEBS LETT, V468, P93, DOI 10.1016/S0014-5793(00)01196-0; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kleyman TR, 2020, AM J PHYSIOL-CELL PH, V318, pC150, DOI 10.1152/ajpcell.00418.2019; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Krueger B, 2018, PFLUG ARCH EUR J PHY, V470, P649, DOI 10.1007/s00424-018-2115-2; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; Laporte M, 2017, CURR OPIN VIROL, V24, P16, DOI 10.1016/j.coviro.2017.03.018; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lucas JM, 2014, CANCER DISCOV, V4, P1310, DOI 10.1158/2159-8290.CD-13-1010; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Mansley MK, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912525; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Noori M, 2021, MOL BIOL REP, V48, P6655, DOI 10.1007/s11033-021-06642-0; Noreng S, 2020, ELIFE, V9, DOI 10.7554/eLife.59038; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ORCE GG, 1980, AM J PHYSIOL, V239, pF459, DOI 10.1152/ajprenal.1980.239.5.F459; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Posert R., 2020, FULL LENGTH HUMAN EN; Pruliere-Escabasse V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-141; Reihill JA, 2016, AM J RESP CRIT CARE, V194, P701, DOI 10.1164/rccm.201511-2216OC; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2021, COMPR PHYSIOL, V11, P2017, DOI 10.1002/cphy.c200012; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Szabo R, 2020, BIOCHEM SOC T, V48, P517, DOI 10.1042/BST20190675; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wichmann L, 2020, AM J PHYSIOL-REG I, V319, pR387, DOI 10.1152/ajpregu.00144.2020; Wichmann L, 2018, J BIOL CHEM, V293, P6647, DOI 10.1074/jbc.RA118.002543; Worner S, 2022, ACTA PHARMACOL SIN, V43, P111, DOI 10.1038/s41401-021-00628-1; Zhao RZ, 2020, BRIT J PHARMACOL, V177, P3091, DOI 10.1111/bph.15038	124	3	3	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102004	10.1016/j.jbc.2022.102004	http://dx.doi.org/10.1016/j.jbc.2022.102004			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35504352	Green Published, gold			2022-12-28	WOS:000807755100013
J	Tabassum, Z; Tseng, JH; Isemann, C; Tian, X; Chen, YJ; Herring, LE; Cohen, TJ				Tabassum, Zarin; Tseng, Jui-Heng; Isemann, Camryn; Tian, Xu; Chen, Youjun; Herring, Laura E.; Cohen, Todd J.			Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ASSOCIATED DOMAINS; POSTTRANSLATIONAL MODIFICATIONS; LYSINE METHYLATION; PHOSPHORYLATION; ACETYLATION; AGGREGATION; ACTIVATION; BINDING; SITES; NEUROTOXICITY	The posttranslational regulation of the neuronal proteome is critical for brain homeostasis but becomes dysregulated in the aged or diseased brain, in which abnormal posttranslational modifications (PTMs) are frequently observed. While the full extent of modified substrates that comprise the PTM-ome are slowly emerging, how the upstream enzymes catalyzing these processes are regulated themselves is not well understood, particularly in the context of neurodegeneration. Here, we describe the reciprocal regulation of a kinase, the micro tubule affinity-regulating kinase 2 (MARK2), and an acetyltransferase, CREB-binding protein (CBP), two enzymes known to extensively modify tau proteins in the progression of Alzheimer's disease. We found that MARK2 negatively regulates CBP and, conversely, CBP directly acetylates and inhibits MARK2 kinase activity. These findings highlight a reciprocal negative feedback loop between a kinase and an acetyltransferase, which has implications for how PTM interplay is coordinated on substrates including tau. Our study suggests that PTM profiles occur through the posttranslational control of the master PTM themselves.	[Tabassum, Zarin; Tseng, Jui-Heng; Isemann, Camryn; Tian, Xu; Chen, Youjun; Cohen, Todd J.] Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Herring, Laura E.] Univ N Carolina, Dept Pharmacol, UNC Prote Core Facil, Chapel Hill, NC 27515 USA; [Cohen, Todd J.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.; Cohen, TJ (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	toddcohen@neurology.unc.edu		Tabassum, Zarin/0000-0001-9007-2566	National Institutes of Health (NIH) [R01AG061188, R01NS105981, R21AG058080]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work is supported by the National Institutes of Health (NIH) grants R01AG061188, R01NS105981, and R21AG058080 (to T. J. C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrari S, 2014, MOL BIOL RES COMMUN, V3, P149; Alam J, 2019, CURR DRUG TARGETS, V20, P316, DOI 10.2174/1389450119666180820104723; Alquezar C, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.595532; Annadurai N, 2017, CELL MOL LIFE SCI, V74, P4159, DOI 10.1007/s00018-017-2574-1; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Blank MF, 2017, NUCLEIC ACIDS RES, V45, P2675, DOI 10.1093/nar/gkx053; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Chen X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0354-0; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Farina S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.693325; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Gu GJ, 2013, J ALZHEIMERS DIS, V33, P699, DOI 10.3233/JAD-2012-121357; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Huseby CJ, 2019, J ALZHEIMERS DIS, V71, P979, DOI 10.3233/JAD-190604; Hwang AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168913; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lee J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31785-9; Lee J, 2014, BIOCHEM BIOPH RES CO, V447, P121, DOI 10.1016/j.bbrc.2014.03.118; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lontay B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124282; Lu YN, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001096; Lund H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-22; Luo HB, 2014, P NATL ACAD SCI USA, V111, P16586, DOI 10.1073/pnas.1417548111; Malikov V, 2017, CELL REP, V20, P2792, DOI 10.1016/j.celrep.2017.08.076; Manzanza ND, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.690293; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Naqvi AA, 2020, CURR TOP MED CHEM, V20, P1059, DOI 10.2174/1568026620666200106125910; Nativio R, 2020, NAT GENET, V52, P1024, DOI 10.1038/s41588-020-0696-0; Nativio R, 2018, NAT NEUROSCI, V21, P497, DOI 10.1038/s41593-018-0101-9; Oba T, 2020, J BIOL CHEM, V295, P17138, DOI 10.1074/jbc.RA120.014420; Olzscha H, 2017, CELL CHEM BIOL, V24, P9, DOI 10.1016/j.chembiol.2016.11.009; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Portillo M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109035; Ramazi S, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00099-2; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Saha P, 2019, MECH AGEING DEV, V178, P72, DOI 10.1016/j.mad.2019.01.007; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Schaffert LN, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040232; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shafi S, 2021, CNS NEUROL DISORD-DR, V20, P54, DOI 10.2174/1871527319666200903162200; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Sternburg EL, 2022, TRENDS BIOCHEM SCI, V47, P6, DOI 10.1016/j.tibs.2021.07.004; Taylor BC, 2021, BIOCHEM J, V478, P511, DOI 10.1042/BCJ20200170; Thomas SN, 2012, ACTA NEUROPATHOL, V123, P105, DOI 10.1007/s00401-011-0893-0; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Wen J, 2021, J MOL CELL BIOL, V13, P774, DOI 10.1093/jmcb/mjab047; Wesseling H, 2020, CELL, V183, P1699, DOI 10.1016/j.cell.2020.10.029; Wu Z, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108138; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	72	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101977	10.1016/j.jbc.2022.101977	http://dx.doi.org/10.1016/j.jbc.2022.101977			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35469920	gold, Green Published			2022-12-28	WOS:000807778400004
J	Barley, TJ; Murphy, PR; Wang, XT; Bowman, BA; Mormol, JM; Mager, CE; Kirk, SG; Cash, CJ; Linn, SC; Meng, XM; Nelin, LD; Chen, BRDT; Hafner, M; Zhang, J; Liu, YS				Barley, Timothy J.; Murphy, Parker R.; Wang, Xiantao; Bowman, Bridget A.; Mormol, Justin M.; Mager, Carli E.; Kirk, Sean G.; Cash, Charles J.; Linn, Sarah C.; Meng, Xiaomei; Nelin, Leif D.; Chen, Bernadette; Hafner, Markus; Zhang, Jian; Liu, Yusen			Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; ANTIINFLAMMATORY CYTOKINES; MAPK PHOSPHATASE-1; KUPFFER CELLS; IFN-GAMMA; ALPHA; MKP-1; MACROPHAGES; MECHANISMS	Mitogen-activated protein kinase phosphatase 1 (Mkp-1) KO mice produce elevated cytokines and exhibit increased mortality and bacterial burden following systemic Escherichia coli infection. To understand how Mkp-1 affects immune defense, we analyzed the RNA-Seq datasets previously generated from control and E. coli-infected Mkp-1(+/+) and Mkp-1(-/-) mice. We found that E. coli infection markedly induced programmed death-ligand 1 (PD-L1) expression and that Mkp-1 deficiency further amplified PD-L1 expression. Administration of a PD L1-neutralizing monoclonal antibody (mAb) to Mkp-1(-/-) mice increased the mortality of the animals following E. coli infection, although bacterial burden was decreased. In addition, the PD-L1-neutralizing mAb increased serum interferon (IFN)-gamma and tumor necrosis factor alpha, as well as lung-and liver inducible nitric oxide synthase levels, suggesting an enhanced inflammatory response. Interestingly, neutralization of IFN-alpha/beta receptor 1 blocked PD-L1 induction in Mkp-1(-/-) mice following E. coli infection. PD-L1 was potently induced in macrophages by E. coli and lipopolysaccharide in vitro, and Mkp-1 deficiency exacerbated PD-L1 induction with little effect on the half-life of PD-L1 mRNA. In contrast, inhibitors of Janus kinase 1/2 and tyrosine kinase 2, as well as the IFN-alpha/beta receptor 1-neutralizing mAb, markedly attenuated PD-L1 induction. These results suggest that the beneficial effect of type I IFNs in E. coli-infected Mkp-1(-/-) mice is, at least in part, mediated by Janus kinase/signal transducer and activator of transcription-driven PD-L1 induction. Our studies also support the notion that enhanced PD-L1 expression contributes to the bactericidal defect of Mkp-1(-/-) mice.	[Barley, Timothy J.; Murphy, Parker R.; Bowman, Bridget A.; Mormol, Justin M.; Mager, Carli E.; Kirk, Sean G.; Cash, Charles J.; Meng, Xiaomei; Nelin, Leif D.; Chen, Bernadette; Liu, Yusen] Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Ctr Perinatal Res, Columbus, OH 43215 USA; [Wang, Xiantao; Hafner, Markus] Natl Inst Arthrit & Musculoskeletal & Skin Dis, NIH, Lab Muscle Stem Cells & Gene Regulat, Bethesda, MD USA; [Linn, Sarah C.] Ohio State Univ Coll Vet Med, Dept Vet Biosci, Combined Anat Pathol Residency Grad Program, Columbus, OH USA; [Linn, Sarah C.] Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Kidney & Urinary Tract Ctr, Columbus, OH USA; [Nelin, Leif D.; Chen, Bernadette; Liu, Yusen] Ohio State Univ Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Zhang, Jian] Univ Iowa Carver Coll Med, Dept Pathol, Iowa City, IA USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Iowa	Liu, YS (corresponding author), Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Ctr Perinatal Res, Columbus, OH 43215 USA.; Liu, YS (corresponding author), Ohio State Univ Coll Med, Dept Pediat, Columbus, OH 43210 USA.	yusen.liu@nationwidechildrens.org		Linn, Sarah/0000-0003-4337-2966; Mormol, Justin/0000-0001-6324-4393; Barley, Timothy/0000-0002-7005-6187	National Institutes of Health [AI124029, AI142885, AI121196, AI123253]; Genentech Veterinary Pathology Fellowship through Genentech, Inc; Ohio State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Veterinary Pathology Fellowship through Genentech, Inc; Ohio State University(Ohio State University)	This work was supported by grants from the National Institutes of Health (grant nos.: AI124029 and AI142885 [to Y. L.] and AI121196 and AI123253 [to J. Z.] ) . S. C. L. is supported by a Genentech Veterinary Pathology Fellowship through Genentech, Inc and The Ohio State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio-Vergara M, 2017, METHODS MOL BIOL, V1639, P161, DOI 10.1007/978-1-4939-7163-3_16; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02129; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Borchers A, 2010, GENES-BASEL, V1, P413, DOI 10.3390/genes1030413; Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dorfman K, 1996, ONCOGENE, V13, P925; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Hutchins NA, 2013, J LEUKOCYTE BIOL, V94, P963, DOI 10.1189/jlb.0113051; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janeway CA, 2005, IMMUNOBIOLOGY; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim VY, 2019, J IMMUNOL, V203, P2239, DOI 10.4049/jimmunol.1701686; Kirk SG, 2021, J IMMUNOL, V206, P2966, DOI 10.4049/jimmunol.2001468; KONO Y, 1994, ARCH BIOCHEM BIOPHYS, V311, P153, DOI 10.1006/abbi.1994.1220; Kovarik P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00652; Kumar A, 2001, J CARDIOTHOR VASC AN, V15, P485, DOI 10.1053/jcan.2001.25003; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lu CW, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1291106; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Matziouridou C, 2018, MUCOSAL IMMUNOL, V11, P774, DOI 10.1038/mi.2017.106; McMullin Bevin B, 2005, Respir Care, V50, P1451; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Morimoto Y, 2018, BIOCHEM BIOPH RES CO, V507, P330, DOI 10.1016/j.bbrc.2018.11.035; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Osum KC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26471-9; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Roussey JA, 2017, J IMMUNOL, V199, P3535, DOI 10.4049/jimmunol.1700840; Salkowski CA, 1997, J IMMUNOL, V158, P905; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; Stenzel W, 2005, J NEUROPATH EXP NEUR, V64, P27, DOI 10.1093/jnen/64.1.27; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Triantafyllou E, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140196; Tsiodras S, 2008, MAYO CLIN PROC, V83, P181; Wang JF, 2015, ANESTHESIOLOGY, V122, P852, DOI 10.1097/ALN.0000000000000525; WANG SD, 1994, J IMMUNOL, V152, P5014; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wang XX, 2009, J BIOL CHEM, V284, P27123, DOI 10.1074/jbc.M109.051235; Whibley N, 2015, J IMMUNOL, V195, P3781, DOI 10.4049/jimmunol.1500870; Xiao W, 2018, J IMMUNOL, V201, P264, DOI 10.4049/jimmunol.1800129; Yu H, 2011, CYTOKINE, V56, P245, DOI 10.1016/j.cyto.2011.06.006; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhu WM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/361501	68	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101938	10.1016/j.jbc.2022.101938	http://dx.doi.org/10.1016/j.jbc.2022.101938			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35429501	Green Published, gold			2022-12-28	WOS:000817175700014
J	Kim, SH; Kim, M; Park, D; Byun, S; Rhee, S				Kim, Sang-Hoon; Kim, Minjeong; Park, Daechan; Byun, Sujeong; Rhee, Sangkee			Substrate-binding loop interactions with pseudouridine trigger conformational changes that promote catalytic efficiency of pseudouridine kinase PUKI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA MODIFICATIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; GENE-EXPRESSION; RIBOKINASE; ACTIVATION; REVEALS; FEATURES; FAMILY	Pseudouridine, one major RNA modification, is catabolized into uracil , ribose-50-phosphate by two sequential enzy-matic reactions. In the first step, pseudouridine kinase (PUKI) phosphorylates pseudouridine to pseudouridine 50-mono -phosphate. High-fidelity catalysis of pseudouridine by PUKI prevents possible disturbance of in vivo pyrimidine homeo-stasis. However, the molecular basis of how PUKI selectively phosphorylates pseudouridine over uridine with > 100-fold greater efficiency despite minor differences in their Km values has not been elucidated. To investigate this selectivity, in this study we determined the structures of PUKI from Escherichia coli strain B (EcPUKI) in various ligation states. The structure of EcPUKI was determined to be similar to PUKI from Arabidopsis thaliana, including an alpha/beta core domain and beta-stranded small domain, with dimerization occurring via the beta-stranded small domain. In a binary complex, we show that Ser30 in the substrate-binding loop of the small domain mediates interactions with the hallmark N1 atom of pseu-douridine nucleobase, causing conformational changes in its quaternary structure. Kinetic and fluorescence spectroscopic analyses also showed that the Ser30-mediated interaction is a prerequisite for conformational changes and subsequent catalysis by EcPUKI. Furthermore, S30A mutation or EcPUKI complexed with other nucleosides homologous to pseudour-idine but lacking the pseudouridine-specific N1 atom did not induce such conformational changes, demonstrating the catalytic significance of the proposed Ser30-mediated interac-tion. These analyses provide structural and functional evidence for a pseudouridine-dependent conformational change of EcPUKI and its functional linkage to catalysis.	[Kim, Sang-Hoon; Byun, Sujeong; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Minjeong; Park, Daechan] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Park, Daechan] Ajou Univ, Dept Biol Sci, Suwon, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Ajou University; Ajou University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Rhee, S (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	srheesnu@snu.ac.kr		Rhee, Sangkee/0000-0002-8779-9737	National Research Foundation of Korea - Korea government (Ministry of Science and ICT) [2020R1A4A1018890, 2021R1A2C2092118]; Basic Science Research Program - Ministry of Education [2021R1A6A1A10044950]	National Research Foundation of Korea - Korea government (Ministry of Science and ICT)(National Research Foundation of Korea); Basic Science Research Program - Ministry of Education	We thank Jeongyun Lee for her assistance in the purification of enzyme for CD measurements. This work was sup-ported by the National Research Foundation of Korea grant funded by the Korea government (Ministry of Science and ICT) (grant nos.: 2020R1A4A1018890 and 2021R1A2C2092118 [to S. R.] ) and Basic Science Research Program funded by the Ministry of Education (grant no.: 2021R1A6A1A10044950 [to D. P.] ) .	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; BREITMAN TR, 1970, J BACTERIOL, V103, P263, DOI 10.1128/JB.103.1.263-264.1970; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; Chen MJ, 2020, PLANT CELL, V32, P722, DOI 10.1105/tpc.19.00639; Chen MJ, 2018, PLANT CELL, V30, P1511, DOI 10.1105/tpc.18.00236; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyler DE, 2019, P NATL ACAD SCI USA, V116, P23068, DOI 10.1073/pnas.1821754116; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kang PA, 2019, J STRUCT BIOL, V206, P110, DOI 10.1016/j.jsb.2019.02.007; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim SH, 2021, NUCLEIC ACIDS RES, V49, P491, DOI 10.1093/nar/gkaa1144; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li J, 2012, J STRUCT BIOL, V177, P578, DOI 10.1016/j.jsb.2011.12.010; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mallette E, 2018, J BIOL CHEM, V293, P19909, DOI 10.1074/jbc.RA118.005485; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Paul R, 2015, ADV EXP MED BIOL, V842, P293, DOI 10.1007/978-3-319-11280-0_19; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Sigrell JA, 1999, J MOL BIOL, V290, P1009, DOI 10.1006/jmbi.1999.2938; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5	39	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101869	10.1016/j.jbc.2022.101869	http://dx.doi.org/10.1016/j.jbc.2022.101869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35346685	Green Published, gold			2022-12-28	WOS:000798082100001
J	Wang, SY; Yu, HJ; Gao, J; Chen, JX; He, PC; Zhong, H; Tan, X; Staines, KA; Macrae, VE; Fu, XD; Jiang, L; Zhu, DX				Wang, Siying; Yu, Hongjiao; Gao, Jun; Chen, Jiaxin; He, Pengcheng; Zhong, Hui; Tan, Xiao; Staines, Katherine A.; Macrae, Vicky E.; Fu, Xiaodong; Jiang, Lei; Zhu, Dongxing			PALMD regulates aortic valve calcification via altered glycolysis and NF-Kappa B-mediated inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; DISEASE; CELLS; EXPRESSION; APOPTOSIS; STENOSIS; PATHWAY; NOTCH1; HEART; RUNX2	Recent genome-wide association and transcriptome-wide association studies have identified an association between the PALMD locus, encoding palmdelphin, a protein involved in myoblast differentiation, and calcific aortic valve disease (CAVD). Nevertheless, the function and underlying mecha-nisms of PALMD in CAVD remain unclear. We herein inves-tigated whether and how PALMD affects the pathogenesis of CAVD using clinical samples from CAVD patients and a hu-man valve interstitial cell (hVIC) in vitro calcification model. We showed that PALMD was upregulated in calcified regions of human aortic valves and calcified hVICs. Furthermore, silencing of PALMD reduced hVIC in vitro calcification, oste-ogenic differentiation, and apoptosis, whereas overexpression of PALMD had the opposite effect. RNA-Seq of PALMD-depleted hVICs revealed that silencing of PALMD reduced glycolysis and nuclear factor-kappa B (NF-kappa B)-mediated inflammation in hVICs and attenuated tumor necrosis factor alpha-induced monocyte adhesion to hVICs. Having established the role of PALMD in hVIC glycolysis, we examined whether glycolysis itself could regulate hVIC osteogenic differentiation and inflammation. Intriguingly, the inhibition of PFKFB3-mediated glycolysis significantly attenuated osteogenic differentiation and inflammation of hVICs. However, silencing of PFKFB3 inhibited PALMD-induced hVIC inflammation, but not oste-ogenic differentiation. Finally, we showed that the over-expression of PALMD enhanced hVIC osteogenic differentiation and inflammation, as opposed to glycolysis, through the activation of NF-kappa B. The present study demon-strates that the genome-wide association- and transcriptome-wide association-identified CAVD risk gene PALMD may promote CAVD development through regulation of glycolysis and NF-kappa B-mediated inflammation. We propose that targeting PALMD-mediated glycolysis may represent a novel therapeutic strategy for treating CAVD.	[Wang, Siying; Gao, Jun] Guangzhou Med Univ, Dept Basic Med Res, Affiliated Hosp 6, Qingyuan, Guangdong, Peoples R China; [Wang, Siying; Chen, Jiaxin; Zhong, Hui; Tan, Xiao; Fu, Xiaodong; Zhu, Dongxing] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou Inst Cardiovasc Dis, Sch Basic Med Sci,Guangdong Key Lab Vasc Dis,State, Guangzhou, Guangdong, Peoples R China; [Yu, Hongjiao] Guangzhou Med Univ, GMU GIBH Joint Sch Life Sci, Dept Biochem & Mol Biol, Guangzhou, Peoples R China; [He, Pengcheng; Jiang, Lei] Guangdong Acad Med Sci, Guangdong Prov Geriatr Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China; [He, Pengcheng; Jiang, Lei] Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangdong Prov Peoples Hosp, Dept Cardiol, Guangzhou, Peoples R China; [Staines, Katherine A.] Univ Brighton, Ctr Stress & Age Related Dis, Sch Pharm & Biomol Sci, Brighton, England; [Macrae, Vicky E.] Univ Edinburgh, Royal Dick Sch Vet Studies, Funct Genet & Dev, Edinburgh, Midlothian, Scotland; [Macrae, Vicky E.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Brighton; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Fu, XD; Zhu, DX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou Inst Cardiovasc Dis, Sch Basic Med Sci,Guangdong Key Lab Vasc Dis,State, Guangzhou, Guangdong, Peoples R China.; Jiang, L (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Geriatr Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China.; Jiang, L (corresponding author), Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangdong Prov Peoples Hosp, Dept Cardiol, Guangzhou, Peoples R China.	dongxing.zhu@gzhmu.edu.cn; fuxiaod@mail.gzhmu.edu.cn; jianglei@smu.edu.cn		zhu, dongxing/0000-0001-5419-438X; Staines, Katherine/0000-0002-8492-9778	National Natural Science Foundation of China [82170428, 81800428, 81800262]; 'Yangcheng Scholar' Grant of Guangzhou [202032768]; Guangdong Natural Science Foundation [2018A030310178]; Science and Technology Projects of Guangzhou [201904010289]; Science and Technology Planning Project of Guangzhou [201903010005]; Natural Science Foundation of Guangdong Province [2021A1515011121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Yangcheng Scholar' Grant of Guangzhou; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangzhou; Science and Technology Planning Project of Guangzhou; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by funding from the National Natural Science Foundation of China (No. 82170428, 81800428 to D. Z.), The 'Yangcheng Scholar' Grant of Guangzhou (No. 202032768 to D. Z.), Guangdong Natural Science Foundation (No. 2018A030310178 to D. Z.), and Science and Technology Projects of Guangzhou (No. 201904010289 to D. Z.). L. J. is supported by the National Natural Science Foundation of China (No. 81800262) and Science and Technology Planning Project of Guangzhou (No. 201903010005). P. H. is supported by Natural Science Foundation of Guangdong Province (No. 2021A1515011121).	Alushi B, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00685; Andreu N, 2001, GENE, V278, P33, DOI 10.1016/S0378-1119(01)00719-3; Bella JN, 2007, HYPERTENSION, V49, P453, DOI 10.1161/01.HYP.0000256957.10242.75; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Bravo-Jaimes K, 2020, PROG CARDIOVASC DIS, V63, P398, DOI 10.1016/j.pcad.2020.06.005; Cao YP, 2019, P NATL ACAD SCI USA, V116, P13394, DOI 10.1073/pnas.1821401116; Chen ZY, 2021, CARDIOVASC RES, V117, P820, DOI 10.1093/cvr/cvaa090; Chignon A, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102241; Cote N, 2013, INFLAMMATION, V36, P573, DOI 10.1007/s10753-012-9579-6; Cui L, 2017, J CELL PHYSIOL, V232, P2985, DOI 10.1002/jcp.25935; Dashzeveg N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.176; Ehrhardt C, 2013, CELL MICROBIOL, V15, P1198, DOI 10.1111/cmi.12108; Furmanik M, 2021, ARTERIOSCL THROM VAS, V41, P898, DOI 10.1161/ATVBAHA.120.315506; Galeone A, 2013, SCI WORLD J, DOI 10.1155/2013/875363; Galeone A, 2013, INT J CARDIOL, V169, P296, DOI 10.1016/j.ijcard.2013.09.012; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gee T, 2020, ARTERIOSCL THROM VAS, V40, P638, DOI 10.1161/ATVBAHA.119.313248; Guauque-Olarte S, 2015, CIRC-CARDIOVASC GENE, V8, P812, DOI 10.1161/CIRCGENETICS.115.001145; Hadji F, 2016, CIRCULATION, V134, P1848, DOI 10.1161/CIRCULATIONAHA.116.023116; Helgadottir A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03252-6; Hjortnaes J, 2015, ATHEROSCLEROSIS, V242, P251, DOI 10.1016/j.atherosclerosis.2015.07.008; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hu B, 2005, EUR J CELL BIOL, V84, P853, DOI 10.1016/j.ejcb.2005.07.002; Idelevich A, 2011, ARTERIOSCL THROM VAS, V31, pE55, DOI 10.1161/ATVBAHA.111.230904; Lin C, 2017, JOVE-J VIS EXP, DOI 10.3791/56126; Lindman BR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.6; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Majumdar U, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe3706; Nie YP, 2017, SCI REP-UK, V7, DOI 10.1038/srep41608; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Plunde O, 2020, CIRC-GENOM PRECIS ME, V13, P139, DOI 10.1161/CIRCGEN.119.002710; Poels K, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.581641; Probst V, 2006, CIRCULATION, V113, P856, DOI 10.1161/CIRCULATIONAHA.105.569467; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Qi T, 2017, J MOL ENDOCRINOL, V59, P49, DOI 10.1530/JME-17-0066; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rashdan NA, 2020, J BONE MINER RES, V35, P357, DOI 10.1002/jbmr.3888; Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Schnitzler JG, 2020, CIRC RES, V126, P1346, DOI 10.1161/CIRCRESAHA.119.316206; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; SKRTIC D, 1992, BONE MINER, V16, P109, DOI 10.1016/0169-6009(92)90881-D; Sun L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084433; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Theriault S, 2019, CIRC-GENOM PRECIS ME, V12, P431, DOI 10.1161/CIRCGEN.119.002617; Theriault S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03260-6; Weiss RM, 2013, CIRC RES, V113, P209, DOI 10.1161/CIRCRESAHA.113.300153; Xie J, 2011, INT J ONCOL, V38, P409, DOI 10.3892/ijo.2010.851; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yu SM, 2010, EXP MOL MED, V42, P777, DOI 10.3858/emm.2010.42.11.079; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003	54	2	2	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101887	10.1016/j.jbc.2022.101887	http://dx.doi.org/10.1016/j.jbc.2022.101887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35367413	gold, Green Published			2022-12-28	WOS:000804436700008
J	Bhatt, DP; Mills, CA; Anderson, KA; Henriques, BJ; Lucas, TG; Francisco, S; Liu, J; Ilkayeva, OR; Adams, AE; Kulkarni, SR; Backos, DS; Major, MB; Grimsrud, PA; Gomes, CM; Hirschey, MD				Bhatt, Dhaval P.; Mills, C. Allie; Anderson, Kristin A.; Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Liu, Juan; Ilkayeva, Olga R.; Adams, Alexander E.; Kulkarni, Shreyas R.; Backos, Donald S.; Major, Michael B.; Grimsrud, Paul A.; Gomes, Claudio M.; Hirschey, Matthew D.			Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-RESOLUTION METABOLOMICS; PROTEIN ACETYLATION; METABOLISM; SIRTUINS; REVEALS	A wide range of protein acyl modifications has been identified on enzymes across various metabolic processes; however, the impact of these modifications remains poorly understood. Protein glutarylation is a recently identified modification that can be nonenzymatically driven by glutaryl-CoA. In mammalian systems, this unique metabolite is only produced in the lysine and tryptophan oxidative pathways. To better understand the biology of protein glutarylation, we studied the relationship between enzymes within the lysine/tryptophan catabolic pathways, protein glutarylation, and regulation by the deglutarylating enzyme sirtuin 5 (SIRT5). Here, we identify glutarylation on the lysine oxidation pathway enzyme glutaryl-CoA dehydrogenase (GCDH) and show increased GCDH glutarylation when glutaryl-CoA production is stimulated by lysine catabolism. Our data reveal that glutarylation of GCDH impacts its function, ultimately decreasing lysine oxidation. We also demonstrate the ability of SIRT5 to deglutarylate GCDH, restoring its enzymatic activity. Finally, metabolomic and bioinformatic analyses indicate an expanded role for SIRT5 in regulating amino acid metabolism. Together, these data support a feedback loop model within the lysine/tryptophan oxidation pathway in which glutaryl-CoA is produced, in turn inhibiting and can be relieved by SIRT5 deacylation activity.	[Bhatt, Dhaval P.; Mills, C. Allie; Anderson, Kristin A.; Ilkayeva, Olga R.; Adams, Alexander E.; Kulkarni, Shreyas R.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27706 USA; [Bhatt, Dhaval P.; Major, Michael B.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Anderson, Kristin A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Pharmacol, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Canc Biol, Durham, NC 27706 USA; [Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Gomes, Claudio M.] Univ Lisbon, Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal; [Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Gomes, Claudio M.] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Lisbon, Portugal; [Ilkayeva, Olga R.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27706 USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Computat Chem & Biol Core Facil, Anschutz Med Campus, Aurora, CO USA	Duke University; Washington University (WUSTL); Duke University; Duke University; Duke University; Duke University; BIOISI; Universidade de Lisboa; Universidade de Lisboa; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	Hirschey, MD (corresponding author), Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Pharmacol, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Canc Biol, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27706 USA.	matthew.hirschey@duke.edu	Grimsrud, Paul A./GWZ-9287-2022; Gomes, Cláudio M./A-8152-2008; Henriques, Barbara/A-1814-2016	Grimsrud, Paul A./0000-0002-4706-914X; Gomes, Cláudio M./0000-0003-4662-6933; Henriques, Barbara/0000-0002-1724-9545	Ci?ncia e Tecnologia (FCT/MCTES, Portugal) [PTDC/BBB-BQB/5366/2014, SFRH/BPD/74475/2010, SFRH/BD/89690/2012]	Ci?ncia e Tecnologia (FCT/MCTES, Portugal)	Funding and additional information-This work was partly sup-ported by the Funda??o para a Ci?ncia e Tecnologia (FCT/MCTES, Portugal) through research grant PTDC/BBB-BQB/5366/2014 (to B. J. H.) and fellowship SFRH/BPD/74475/2010 (to B. J. H.) and SFRH/BD/89690/2012 (to T. G. L.) .	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Elkhwanky MS, 2018, ANTIOXID REDOX SIGN, V28, P662, DOI 10.1089/ars.2017.7270; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; Henriques BJ, 2011, FEBS LETT, V585, P505, DOI 10.1016/j.febslet.2011.01.002; Henriques BJ, 2009, J BIOL CHEM, V284, P4222, DOI 10.1074/jbc.M805719200; James AM, 2017, CELL REP, V18, P2105, DOI 10.1016/j.celrep.2017.02.018; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Kulkarni RA, 2017, CELL CHEM BIOL, V24, P231, DOI 10.1016/j.chembiol.2017.01.002; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Lucas TG, 2011, BBA-MOL BASIS DIS, V1812, P1658, DOI 10.1016/j.bbadis.2011.09.009; Madsen AS, 2016, J BIOL CHEM, V291, P7128, DOI 10.1074/jbc.M115.668699; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; NODA C, 1976, J BIOCHEM, V80, P1159, DOI 10.1093/oxfordjournals.jbchem.a131371; Osborne B, 2016, FREE RADICAL BIO MED, V100, P164, DOI 10.1016/j.freeradbiomed.2016.04.197; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Ribeiro JV, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2019.140269; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089	32	2	3	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101723	10.1016/j.jbc.2022.101723	http://dx.doi.org/10.1016/j.jbc.2022.101723			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35157847	gold, Green Published			2022-12-28	WOS:000797895000012
J	Lin, CH; Sun, Y; Chan, CSY; Wu, MR; Gu, L; Davis, AE; Gu, BK; Zhang, WL; Tanasa, B; Zhong, LR; Emerson, MM; Chen, L; Ding, JB; Wang, S				Lin, Cheng-Hui; Sun, Yue; Chan, Candace S. Y.; Wu, Man-Ru; Gu, Lei; Davis, Alexander E.; Gu, Baokun; Zhang, Wenlin; Tanasa, Bogdan; Zhong, Lei R.; Emerson, Mark M.; Chen, Lu; Ding, Jun B.; Wang, Sui			<p>Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; GENE-THERAPY; GANGLION-CELLS; UP-REGULATION; IN-VIVO; GLIA; GFAP; EXPRESSION	Adeno-associated viruses (AAVs) targeting specific cell types are powerful tools for studying distinct cell types in the central nervous system (CNS). Cis-regulatory modules (CRMs), e.g., enhancers, are highly cell-type-specific and can be integrated into AAVs to render cell type specificity. Chromatin accessibility has been commonly used to nominate CRMs, which have then been incorporated into AAVs and tested for cell type specificity in the CNS. However, chromatin accessibility data alone cannot accurately annotate active CRMs, as many chromatin-accessible CRMs are not active and fail to drive gene expression in vivo. Using available large-scale datasets on chromatin accessibility, such as those published by the ENCODE project, here we explored strategies to increase efficiency in identifying active CRMs for AAV-based cell-type specific labeling and manipulation. We found that prescreening of chromatin-accessible putative CRMs based on the density of cell-type-specific transcription factor binding sites (TFBSs) can significantly increase efficiency in identifying active CRMs. In addition, generation of synthetic CRMs by stitching chromatin-accessible regions flanking cell-type specific genes can render cell type specificity in many cases. Using these straightforward strategies, we generated AAVs that can target the extensively studied interneuron and glial cell types in the retina and brain. Both strategies utilize available genomic datasets and can be employed to generate AAVs targeting specific cell types in CNS without conducting comprehensive screening and sequencing experiments, making a step forward in cell-type-specific research.	[Lin, Cheng-Hui; Sun, Yue; Chan, Candace S. Y.; Wu, Man-Ru; Davis, Alexander E.; Gu, Baokun; Tanasa, Bogdan; Wang, Sui] Stanford Univ, Byers Eye Inst, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol, Stanford, CA 94305 USA; [Sun, Yue; Zhong, Lei R.; Chen, Lu; Ding, Jun B.] Stanford Univ, Dept Neurosurg, Stanford, CA USA; [Gu, Lei] Max Planck Inst Heart & Lung Res, Epigenet Lab, Bad Nauheim, Germany; [Zhang, Wenlin] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China; [Emerson, Mark M.] CUNY City Coll, Dept Biol, New York, NY USA; [Ding, Jun B.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA USA	Stanford University; Stanford University; Max Planck Society; Zhejiang University; City University of New York (CUNY) System; City College of New York (CUNY); Stanford University	Wang, S (corresponding author), Stanford Univ, Byers Eye Inst, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol, Stanford, CA 94305 USA.	suiwang@stanford.edu	Lin, Cheng-Hui/AAV-7085-2021; Ding, Jun/B-2513-2009	Lin, Cheng-Hui/0000-0002-1479-9533; Wang, Sui/0000-0003-1563-9117; /0000-0001-9667-7996; Chen, Lu/0000-0002-8097-2699; Ding, Jun/0000-0003-0690-1312; Sun, Yue/0000-0002-5681-130X	American Diabetes Association [1-16-INI-16]; NIH [5F32EY018287, MH086403, NS11566001]	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by American Diabetes Association (1-16-INI-16 to S. W.) , NIH 1R01EY03258501 (to S. W.) , NIH MH086403 (to L. C.) , NS11566001 (to L. C.) , NIH 5F32EY018287 (to M. M. E.) , and P30 to Stanford Ophthalmology (to S. W., C.-H. L., Y. S., C. S. Y. C, and A. E. D.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae JA, 2018, CELL, V173, P1293, DOI 10.1016/j.cell.2018.04.040; Balasubramanian Revathi, 2014, Curr Ophthalmol Rep, V2, P100; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Billings NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013739; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Chan CSY, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.187922; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Consortium E.P., 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; de Leeuw CN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0232-4; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Graybuck LT, 2020, BIORXIV, DOI [10.1101/525014, DOI 10.1101/525014]; Graybuck LT, 2021, NEURON, V109, P1449, DOI 10.1016/j.neuron.2021.03.011; Haery L, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00093; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Hocquemiller M, 2016, HUM GENE THER, V27, P478, DOI 10.1089/hum.2016.087; Hrvatin S, 2019, ELIFE, V8, DOI 10.7554/eLife.48089; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Juttner J, 2019, NAT NEUROSCI, V22, P1345, DOI 10.1038/s41593-019-0431-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Lykken EA, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9234-0; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mich JK, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108754; Ockuly JC, 2014, INVEST OPHTH VIS SCI, V55; Rheaume BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05134-3; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Vormstein-Schneider D, 2020, NAT NEUROSCI, V23, P1629, DOI 10.1038/s41593-020-0692-9; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yan WJ, 2020, J NEUROSCI, V40, P5177, DOI 10.1523/JNEUROSCI.0471-20.2020; Yao K, 2018, NATURE, V560, P484, DOI 10.1038/s41586-018-0425-3; Zhou HB, 2020, CELL, V181, P590, DOI 10.1016/j.cell.2020.03.024	45	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101674	10.1016/j.jbc.2022.101674	http://dx.doi.org/10.1016/j.jbc.2022.101674			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35148987	gold, Green Published			2022-12-28	WOS:000797895000011
J	Ristinmaa, AS; Coleman, T; Cesar, L; Weinmann, AL; Mazurkewich, S; Branden, G; Hasani, M; Larsbrink, J				Ristinmaa, Amanda Sorensen; Coleman, Tom; Cesar, Leona; Weinmann, Annika Langborg; Mazurkewich, Scott; Branden, Gisela; Hasani, Merima; Larsbrink, Johan			Structural diversity and substrate preferences of three tannase enzymes encoded by the anaerobic bacterium Clostridium butyricum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOLIC-COMPOUNDS; CRYSTAL-STRUCTURE; HYDROLASE; LEAVES; BARK	Tannins are secondary metabolites that are enriched in the bark, roots, and knots in trees and are known to hinder microbial attack. The biological degradation of water-soluble gallotannins, such as tannic acid, is initiated by tannase enzymes (EC 3.1.1.20), which are esterases able to liberate gallic acid from aromatic-sugar complexes. However, only few tannases have previously been studied in detail. Here, for the first time, we biochemically and structurally characterize three tannases from a single organism, the anaerobic bacterium Clostridium butyricum, which inhabits both soil and gut environments. The enzymes were named CbTan1-3, and we show that each one exhibits a unique substrate preference on a range of galloyl ester model substrates; CbTan1 and 3 demonstrated preference toward galloyl esters linked to glucose, while CbTan2 was more promiscuous. All enzymes were also active on oak bark extractives. Furthermore, we solved the crystal structure of CbTan2 and produced homology models for CbTan1 and 3. In each structure, the catalytic triad and gallatebinding regions in the core domain were found in very similar positions in the active site compared with other bacterial tannases, suggesting a similar mechanism of action among these enzymes, though large inserts in each enzyme showcase overall structural diversity. In conclusion, the varied structural features and substrate specificities of the C. butyricum tannases indicate that they have different biological roles and could further be used in development of new valorization strategies for renewable plant biomass.	[Ristinmaa, Amanda Sorensen; Coleman, Tom; Cesar, Leona; Mazurkewich, Scott; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden; [Weinmann, Annika Langborg] AstraZeneca, Pharmaceut Sci, Early Chem Dev, Gothenburg, Sweden; [Mazurkewich, Scott; Hasani, Merima; Larsbrink, Johan] Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Gothenburg, Sweden; [Cesar, Leona; Branden, Gisela] Univ Gothenburg, Dept Chem & Mol Biol, Medicinaregatan 9c, S-41390 Gothenburg, Sweden; [Hasani, Merima] Chalmers Univ Technol, Dept Chem & Chem Engn, Div Forest Prod & Chem Engn, Gothenburg, Sweden	Chalmers University of Technology; AstraZeneca; Chalmers University of Technology; University of Gothenburg; Chalmers University of Technology	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden.; Larsbrink, J (corresponding author), Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Gothenburg, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013	Larsbrink, Johan/0000-0001-8386-2914; Coleman, Tom/0000-0002-1890-5831; Cesar, Leona Carla/0000-0002-4480-2000; Sorensen Ristinmaa, Amanda/0000-0003-0120-0330	Swedish Energy Agency [2018-004339]; Swedish Research Council [2018-004339]; Carl Trygger Foundation [CTS 19:195]; Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Center (WWSC)	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Center (WWSC)	A. S. R. was funded by a research project grant for energy-oriented basic research from the Swedish Energy Agency and the Swedish Research Council awarded to J. L. (Dnr 2018-004339). T. C. was funded by a postdoctoral stipend grant from the Carl Trygger Foundation (number CTS 19:195) awarded to J. L. S. M., M. H., and J. L. would like to thank the Knut and Alice Wallenberg Foundation for support via the Wallenberg Wood Science Center (WWSC).	Abdal A. K, 2020, EURASIA J BIOSCI, V14, P259; Curiel JA, 2009, J AGR FOOD CHEM, V57, P6224, DOI 10.1021/jf901045s; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; BIANCO MA, 1994, J APPL TOXICOL, V14, P293, DOI 10.1002/jat.2550140409; Boer E, 2009, YEAST, V26, P323, DOI 10.1002/yea.1669; Cassir N, 2016, CLIN MICROBIOL INFEC, V22, P37, DOI 10.1016/j.cmi.2015.10.014; Chernonosov AA, 2017, REV BRAS FARMACOGN, V27, P576, DOI 10.1016/j.bjp.2017.07.001; Colby SM, 2020, ANAL CHEM, V92, P1720, DOI 10.1021/acs.analchem.9b02348; de las Rivas B, 2019, APPL MICROBIOL BIOT, V103, P603, DOI 10.1007/s00253-018-9519-y; Dilokpimol A, 2018, NEW BIOTECHNOL, V41, P9, DOI 10.1016/j.nbt.2017.11.004; Dong LB, 2021, ACTA CRYSTALLOGR D, V77, P267, DOI 10.1107/S2059798320016484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteban-Torres M, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.01558-18, 10.1128/AEM01558-18, 10.1128/aem.01558-18]; Feng SH, 2013, RENEW SUST ENERG REV, V26, P560, DOI 10.1016/j.rser.2013.06.024; Fernandes A, 2011, FOOD CHEM, V125, P1398, DOI 10.1016/j.foodchem.2010.10.016; Garcia-Villalba R, 2017, J FOOD COMPOS ANAL, V63, P38, DOI 10.1016/j.jfca.2017.07.034; Gellerstedt G, 2009, WOOD CHEM WOOD BIOTE, V1, P147; HAGERMAN AE, 1978, J AGR FOOD CHEM, V26, P809, DOI 10.1021/jf60218a027; HATHWAY DE, 1958, BIOCHEM J, V70, P34, DOI 10.1042/bj0700034; Jimenez N, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0154-8; Jimenez N, 2014, FOOD RES INT, V62, P397, DOI 10.1016/j.foodres.2014.03.042; Jimenez N, 2014, APPL MICROBIOL BIOT, V98, P6329, DOI 10.1007/s00253-014-5603-0; Jimenez N, 2014, APPL ENVIRON MICROB, V80, P2991, DOI 10.1128/AEM.00324-14; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanpiengjai A, 2019, PROTEIN EXPRES PURIF, V157, P36, DOI 10.1016/j.pep.2019.01.005; Kmezik C, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100500; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mazurkewich S, 2019, J BIOL CHEM, V294, P19978, DOI 10.1074/jbc.RA119.011435; Mancheno JM, 2022, MICROB BIOTECHNOL, V15, P648, DOI 10.1111/1751-7915.13732; Mirdita M, 2019, BIOINFORMATICS, V35, P2856, DOI 10.1093/bioinformatics/bty1057; Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081; Mitchell A. L., 2020, MGNIFY MICROBIOME AN; Munoz J, 2020, MICROB BIOTECHNOL, V13, P1733, DOI 10.1111/1751-7915.13577; Niehaus JU, 1997, PHYTOCHEMISTRY, V45, P1555, DOI 10.1016/S0031-9422(97)00261-6; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pan J, 2020, MAR DRUGS, V18, DOI 10.3390/md18110546; Poolsawat L, 2020, AQUACULT NUTR, V26, P657, DOI 10.1111/anu.13025; Ren B, 2013, J MOL BIOL, V425, P2737, DOI 10.1016/j.jmb.2013.04.032; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Selvakumar G., 2007, Indian Journal of Microbiology, V47, P267, DOI 10.1007/s12088-007-0049-z; Shao Y, 2020, MOLECULES, V25, DOI 10.3390/molecules25040952; Sharma S, 2000, ANAL BIOCHEM, V279, P85, DOI 10.1006/abio.1999.4405; Song XC, 2021, J AGR FOOD CHEM, V69, P10856, DOI 10.1021/acs.jafc.1c02845; Tomas-Cortazar J., 2018, MICROB; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Ueda S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-87; Venter P, 2019, ANAL CHIM ACTA, V1088, P150, DOI 10.1016/j.aca.2019.08.037; Watrelot AA, 2020, J AGR FOOD CHEM, V68, P13426, DOI 10.1021/acs.jafc.9b08221; Wu MB, 2015, APPL MICROBIOL BIOT, V99, P2663, DOI 10.1007/s00253-014-6085-9; Yao J, 2011, J AGR FOOD CHEM, V59, P3812, DOI 10.1021/jf104394m	55	0	0	10	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101758	10.1016/j.jbc.2022.101758	http://dx.doi.org/10.1016/j.jbc.2022.101758			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35202648	Green Published, gold			2022-12-28	WOS:000793617400013
J	Vogel, U; Beerens, K; Desmet, T				Vogel, Ulrike; Beerens, Koen; Desmet, Tom			Nucleotide sugar dehydratases: Structure, mechanism, substrate specificity, and application potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							D-GLUCOSE 4,6-DEHYDRATASE; DTDP-D-GLUCOSE; PSEUDAMINIC ACID BIOSYNTHESIS; L-RHAMNOSE BIOSYNTHESIS; CRYSTAL-STRUCTURE; UDP-GLCNAC; FUNCTIONAL-CHARACTERIZATION; C-6 DEHYDRATASE; CELL-WALL; LEGIONAMINIC ACID	Nucleotide sugar (NS) dehydratases play a central role in the biosynthesis of deoxy and amino sugars, which are involved in a variety of biological functions in all domains of life. Bacteria are true masters of deoxy sugar biosynthesis as they can produce a wide range of highly specialized monosaccharides. Indeed, deoxy and amino sugars play important roles in the virulence of gram-positive and gram-negative pathogenic species and are additionally involved in the biosynthesis of diverse macrolide antibiotics. The biosynthesis of deoxy sugars relies on the activity of NS dehydratases, which can be subdivided into three groups based on their structure and reaction mechanism. The best-characterized NS dehydratases are the 4,6-dehydratases that, together with the 5,6-dehydratases, belong to the NS-short-chain dehydrogenase/reductase superfamily. The other two groups are the less abundant 2,3-dehydratases that belong to the Nudix hydrolase superfamily and 3-dehydratases, which are related to aspartame aminotransferases. 4,6-Dehydratases catalyze the first step in all deoxy sugar biosynthesis pathways, converting nucleoside diphosphate hexoses to nucleoside diphosphate-4-keto-6-deoxy hexoses, which in turn are further deoxygenated by the 2,3- and 3-dehydratases to form dideoxy and trideoxy sugars. In this review, we give an overview of the NS dehydratases focusing on the comparison of their structure and reaction mechanisms, thereby highlighting common features, and investigating differences between closely related members of the same superfamilies.	[Vogel, Ulrike; Beerens, Koen; Desmet, Tom] Univ Ghent, Fac Biosci Engn, Ctr Synthet Biol CSB, Unit Biocatalysis & Enzyme Engn, Ghent, Belgium	Ghent University	Desmet, T (corresponding author), Univ Ghent, Fac Biosci Engn, Ctr Synthet Biol CSB, Unit Biocatalysis & Enzyme Engn, Ghent, Belgium.	tom.desmet@ugent.be	Desmet, Tom/I-3313-2012	Desmet, Tom/0000-0002-5788-3022; Vogel, Ulrike/0000-0002-8925-671X	Fund for Scientific Research Flanders (FWO-Vlaanderen) [G0A7520N]	Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO)	The authors gratefully acknowledge the Fund for Scientific Research Flanders (FWO-Vlaanderen) for financial support via the DeoxyBioCat project (grant no G0A7520N).	Agnihotri G, 2004, BIOCHEMISTRY-US, V43, P14265, DOI 10.1021/bi048841w; Agouridas C, 1998, J MED CHEM, V41, P4080, DOI 10.1021/jm980240d; Aguirrezabalaga I, 2000, ANTIMICROB AGENTS CH, V44, P1266, DOI 10.1128/AAC.44.5.1266-1275.2000; Alam J, 2004, BIOCHEMISTRY-US, V43, P16450, DOI 10.1021/bi0483763; Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Allard STM, 2004, J BIOL CHEM, V279, P2211, DOI 10.1074/jbc.M310134200; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Beerens K, 2022, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.784142; Beerens K, 2015, CARBOHYD RES, V414, P8, DOI 10.1016/j.carres.2015.06.006; Beerens K, 2013, APPL MICROBIOL BIOT, V97, P7733, DOI 10.1007/s00253-012-4635-6; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bilyk O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215958; Bischer AP, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00728-19; Bockhaus NJ, 2020, PROTEIN SCI, V29, P2164, DOI 10.1002/pro.3928; Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Borg AJE, 2021, CURR OPIN CHEM BIOL, V61, P43, DOI 10.1016/j.cbpa.2020.09.010; Bozzo GG, 2021, PLANT SCI, V308, DOI 10.1016/j.plantsci.2021.110904; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Caliot E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002756; Chen HW, 2000, P NATL ACAD SCI USA, V97, P11942, DOI 10.1073/pnas.210395097; Chen HW, 1999, J AM CHEM SOC, V121, P8124, DOI 10.1021/ja991713o; Chidwick HS, 2020, ORG BIOMOL CHEM, V18, P799, DOI 10.1039/c9ob02433f; Cho AR, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0582-8; Cook PD, 2008, J BIOL CHEM, V283, P4295, DOI 10.1074/jbc.M708893200; Cook PD, 2007, BIOCHEMISTRY-US, V46, P14215, DOI 10.1021/bi701686s; Cook PD, 2006, PROTEIN SCI, V15, P2093, DOI 10.1110/ps.062328306; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2004, FEBS LETT, V559, P136, DOI 10.1016/S0014-5793(04)00057-2; Creuzenet C, 2002, J BIOL CHEM, V277, P26769, DOI 10.1074/jbc.M202882200; Creuzenet C, 2001, MOL MICROBIOL, V41, P1295, DOI 10.1046/j.1365-2958.2001.02589.x; Da Costa M, 2021, BIOTECHNOL ADV, V48, DOI 10.1016/j.biotechadv.2021.107705; Delvaux NA, 2018, PROTEIN SCI, V27, P738, DOI 10.1002/pro.3368; Dinos GP, 2017, BRIT J PHARMACOL, V174, P2967, DOI 10.1111/bph.13936; Dong C, 2003, BIOCHEM SOC T, V31, P532, DOI 10.1042/BST0310532; Draeger G, 1999, J AM CHEM SOC, V121, P2611, DOI 10.1021/ja9837250; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Elshahawi SI, 2015, CHEM SOC REV, V44, P7591, DOI 10.1039/c4cs00426d; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Ferek JD, 2020, PROTEIN SCI, V29, P1148, DOI 10.1002/pro.3843; FOSTER DW, 1961, BIOCHIM BIOPHYS ACTA, V54, P376, DOI 10.1016/0006-3002(61)90386-9; Goel B, 2021, EUR J MED CHEM, V213, DOI 10.1016/j.ejmech.2021.113156; Gokey T, 2018, J STRUCT BIOL, V202, P175, DOI 10.1016/j.jsb.2018.01.006; Guberman M, 2019, CHEM SCI, V10, P5634, DOI 10.1039/c9sc00768g; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Hallis TM, 1998, BIOCHEMISTRY-US, V37, P4935, DOI 10.1021/bi9725529; Hassan MI, 2016, ANGEW CHEM INT EDIT, V55, P12018, DOI 10.1002/anie.201606006; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Hegeman AD, 2001, BIOCHEMISTRY-US, V40, P6598, DOI 10.1021/bi010441a; Hoffmeister D, 2000, CHEM BIOL, V7, P821, DOI 10.1016/S1074-5521(00)00029-6; Hong L, 2008, J AM CHEM SOC, V130, P4954, DOI 10.1021/ja0771383; Hong L, 2006, J AM CHEM SOC, V128, P14262, DOI 10.1021/ja0649670; Hwang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133790; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Jiang N, 2021, PLANT SCI, V302, DOI 10.1016/j.plantsci.2020.110687; Karlyshev AV, 2005, FEMS MICROBIOL REV, V29, P377, DOI 10.1016/j.femsre.2005.01.003; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kenyon JJ, 2017, FEMS MICROBIOL REV, V41, P200, DOI 10.1093/femsre/fux002; Koropatkin NM, 2005, ACTA CRYSTALLOGR D, V61, P365, DOI 10.1107/S0907444904033876; Kubiak RL, 2013, BIOCHEMISTRY-US, V52, P2078, DOI 10.1021/bi400176n; Langenhan JM, 2005, J NAT PROD, V68, P1696, DOI 10.1021/np0502084; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li H, 2016, HELICOBACTER, V21, P445, DOI 10.1111/hel.12301; Li J, 2018, CELL CHEM BIOL, V25, P499, DOI 10.1016/j.chembiol.2018.02.005; Li W, 2006, BIOCHEM BIOPH RES CO, V342, P170, DOI 10.1016/j.bbrc.2006.01.130; Li Z, 2015, J BIOL CHEM, V290, P691, DOI 10.1074/jbc.M114.612747; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2020, FEMS MICROBIOL REV, V44, P655, DOI 10.1093/femsre/fuz028; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MCCARTY M, 1952, J EXP MED, V96, P569, DOI 10.1084/jem.96.6.569; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mistou MY, 2016, FEMS MICROBIOL REV, V40, P464, DOI 10.1093/femsre/fuw006; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Morrison JP, 2010, BIOORGAN MED CHEM, V18, P8167, DOI 10.1016/j.bmc.2010.10.020; Morrison JP, 2008, BIOORG CHEM, V36, P312, DOI 10.1016/j.bioorg.2008.08.004; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Mulichak AM, 1999, P NATL ACAD SCI USA, V96, P13097, DOI 10.1073/pnas.96.23.13097; Mulrooney EF, 2005, J BIOL CHEM, V280, P19535, DOI 10.1074/jbc.M500612200; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pfeiffer M, 2019, ACS CATAL, V9, P2962, DOI 10.1021/acscatal.9b00064; Piacente F, 2015, INT J MOL SCI, V16, P29315, DOI 10.3390/ijms161226169; Reeves PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069306; Riegert AS, 2017, BIOCHEMISTRY-US, V56, P6030, DOI 10.1021/acs.biochem.7b00910; RIETSCHEL ET, 1990, ADV EXP MED BIOL, V256, P81; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Romo AJ, 2011, BBA-PROTEINS PROTEOM, V1814, P1534, DOI 10.1016/j.bbapap.2011.02.003; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Schoenhofen IC, 2017, METHOD ENZYMOL, V597, P187, DOI 10.1016/bs.mie.2017.06.042; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Shin WH, 2019, METHODS MOL BIOL, V1958, P1, DOI 10.1007/978-1-4939-9161-7_1; Simpson BW, 2019, NAT REV MICROBIOL, V17, P403, DOI 10.1038/s41579-019-0201-x; Smith P, 2006, ACTA CRYSTALLOGR F, V62, P231, DOI 10.1107/S1744309106003721; Smith P, 2008, BIOCHEMISTRY-US, V47, P6329, DOI 10.1021/bi702449p; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Thomes L, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.755577; Tiwari P, 2014, PROTEINS, V82, P2842, DOI 10.1002/prot.24647; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Ud-Din AIMS, 2018, CELL MOL LIFE SCI, V75, P1163, DOI 10.1007/s00018-017-2696-5; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; van der Beek SL, 2019, MOL MICROBIOL, V111, P951, DOI 10.1111/mmi.14197; van der Beek SL, 2015, MOL MICROBIOL, V98, P946, DOI 10.1111/mmi.13169; VERMA NK, 1988, J BACTERIOL, V170, P103, DOI 10.1128/jb.170.1.103-107.1988; Vijayakumar S, 2006, J BIOL CHEM, V281, P27733, DOI 10.1074/jbc.M511714200; Vogan EM, 2004, BIOCHEMISTRY-US, V43, P3057, DOI 10.1021/bi035547f; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wagstaff B, 2021, BIOCHEM J, V478, P685, DOI 10.1042/BCJ20200505; Wagstaff B, 2019, J BIOL CHEM, V294, P9172, DOI 10.1074/jbc.RA118.006440; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Williams GJ, 2008, CURR OPIN CHEM BIOL, V12, P556, DOI 10.1016/j.cbpa.2008.07.013; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P3759, DOI 10.1021/bi602352g; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Wyszynski FJ, 2010, CHEM SCI, V1, P581, DOI 10.1039/c0sc00325e; Yin S, 2016, PLANT PHYSIOL BIOCH, V109, P536, DOI 10.1016/j.plaphy.2016.10.029; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; Zhao ZK, 2020, PLANT PHYSIOL BIOCH, V155, P658, DOI 10.1016/j.plaphy.2020.08.011; Zolghadr B, 2015, EXTREMOPHILES, V19, P451, DOI 10.1007/s00792-015-0730-9	136	2	2	10	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101809	10.1016/j.jbc.2022.101809	http://dx.doi.org/10.1016/j.jbc.2022.101809			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35271853	gold, Green Published			2022-12-28	WOS:000823106100013
J	Kojima, K; Sunagawa, N; Mikkelsen, NE; Hansson, H; Karkehabadi, S; Samejima, M; Sandgren, M; Igarashi, K				Kojima, Keisuke; Sunagawa, Naoki; Mikkelsen, Nils Egil; Hansson, Henrik; Karkehabadi, Saeid; Samejima, Masahiro; Sandgren, Mats; Igarashi, Kiyohiko			Comparison of glycoside hydrolase family 3 beta-xylosidases from basidiomycetes and ascomycetes reveals evolutionarily distinct xylan degradation systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DATA-BANK; TRICHODERMA-REESEI; SUBSITE AFFINITIES; SUBSTRATE-SPECIFICITY; STRUCTURE REFINEMENT; DEGRADING ENZYMES; CCP4 SUITE; GLUCOSIDASE; GLUCURONOXYLAN; TRANSGLYCOSYLATION	Xylan is the most common hemicellulose in plant cell walls, though the structure of xylan polymers differs between plant species. Here, to gain a better understanding of fungal xylan degradation systems, which can enhance enzymatic saccharification of plant cell walls in industrial processes, we conducted a comparative study of two glycoside hydrolase family 3 (GH3) beta-xylosidases (Bxls), one from the basidiomycete Phanerochaete chrysosporium (PcBxl3), and the other from the ascomycete Trichoderma reesei (TrXyl3A). A comparison of the crystal structures of the two enzymes, both with saccharide bound at the catalytic center, provided insight into the basis of substrate binding at each subsite. PcBxl3 has a substrate binding pocket at subsite-1, while TrXyl3A has an extra loop that contains additional binding subsites. Furthermore, kinetic experiments revealed that PcBxl3 degraded xylooligosaccharides faster than TrXyl3A, while the K-M values of TrXyl3A were lower than those of PcBxl3. The relationship between substrate specificity and degree of polymerization of substrates suggested that PcBxl3 preferentially degrades xylobiose (X-2), while TrXyl3A degrades longer xylooligosaccharides. Moreover, docking simulation supported the existence of extended positive subsites of TrXyl3A in the extra loop located at the N-terminus of the protein. Finally, phylogenetic analysis suggests that wood-decaying basidiomycetes use Bxls such as PcBxl3 that act efficiently on xylan structures from woody plants, whereas molds use instead Bxls that efficiently degrade xylan from grass. Our results provide added insights into fungal efficient xylan degradation systems.	[Kojima, Keisuke; Sunagawa, Naoki; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan; [Mikkelsen, Nils Egil; Hansson, Henrik; Karkehabadi, Saeid; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Samejima, Masahiro] Shinshu Univ, Fac Engn, Nagano, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, Espoo, Finland	University of Tokyo; Swedish University of Agricultural Sciences; Shinshu University; VTT Technical Research Center Finland	Igarashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan.; Igarashi, K (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	aquarius@mail.ecc.u-tokyo.ac.jp		Sunagawa, Naoki/0000-0002-0382-6671; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534; Igarashi, Kiyohiko/0000-0001-5152-7177	Japan Society for the Promotion of Science (JSPS) [19H03013, 19K15884]; Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan [18H05494]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) 19H03013 (to K. I.) , a Grant-in-Aid for Early-Career Scientists 19K15884 (to N. S.) from the Japan Society for the Promotion of Science (JSPS) , and a Grant-in-Aid for Innovative Areas 18H05494 (to K. I.) from the Ministry of Education, Culture, Sports, and Technology (MEXT) , Japan.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson D. A., 2013, GENBANK NUCL ACIDS R, V41, p36?42; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BIELY P, 1985, FEBS LETT, V186, P80, DOI 10.1016/0014-5793(85)81343-0; Biely P, 2016, BIOTECHNOL ADV, V34, P1260, DOI 10.1016/j.biotechadv.2016.09.001; Biely P, 2014, FEBS J, V281, P3894, DOI 10.1111/febs.12925; Biely P, 2013, BBA-GEN SUBJECTS, V1830, P5075, DOI 10.1016/j.bbagen.2013.07.018; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; Bohne A, 1998, J MOL MODEL, V4, P33, DOI 10.1007/s008940050068; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bonnin E, 1997, ENZYME MICROB TECH, V20, P516, DOI 10.1016/S0141-0229(96)00188-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromley JR, 2013, PLANT J, V74, P423, DOI 10.1111/tpj.12135; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Busse-Wicher M, 2016, PLANT PHYSIOL, V171, P2418, DOI 10.1104/pp.16.00539; Carafa A, 2005, NEW PHYTOL, V168, P231, DOI 10.1111/j.1469-8137.2005.01483.x; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Herrmann MC, 1997, BIOCHEM J, V321, P375, DOI 10.1042/bj3210375; HIROMI K, 1970, BIOCHEM BIOPH RES CO, V40, P1, DOI 10.1016/0006-291X(70)91037-5; HIROMI K, 1983, MOL CELL BIOCHEM, V51, P79, DOI 10.1007/BF00215589; HIROMI K, 1973, BIOCHIM BIOPHYS ACTA, V302, P362, DOI 10.1016/0005-2744(73)90164-2; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Igarashi K., 2012, Journal of Applied Glycoscience, V59, P105, DOI 10.5458/jag.jag.JAG-2011_029; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; Ishiguro R, 2017, FEBS LETT, V591, P3926, DOI 10.1002/1873-3468.12911; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Keller PA, 1998, ACTA CRYSTALLOGR D, V54, P1105, DOI 10.1107/S0907444998008464; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Kulminskaya AA, 2001, EUR J BIOCHEM, V268, P6123, DOI 10.1046/j.0014-2956.2001.02558.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Martinez-Abad A, 2017, PLANT PHYSIOL, V175, P1579, DOI 10.1104/pp.17.01184; Matsuyama K, 2020, PLANT BIOTECHNOL-NAR, V37, P397, DOI 10.5511/plantbiotechnology.20.0713a; Matsuzawa T, 2019, J STRUCT BIOL, V205, P84, DOI 10.1016/j.jsb.2018.11.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Ogasawara W, 2006, APPL MICROBIOL BIOT, V72, P995, DOI 10.1007/s00253-006-0365-y; Opassiri R, 2004, BIOCHEM J, V379, P125, DOI 10.1042/BJ20031485; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RHO D, 1982, J BACTERIOL, V149, P47, DOI 10.1128/JB.149.1.47-53.1982; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sakuragi K, 2018, J WOOD SCI, V64, P845, DOI 10.1007/s10086-018-1770-4; Schroder SP, 2019, ACS CENTRAL SCI, V5, P1067, DOI 10.1021/acscentsci.9b00221; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tenkanen M, 1996, FEBS LETT, V399, P303, DOI 10.1016/S0014-5793(96)01313-0; TENKANEN M, 1992, ENZYME MICROB TECH, V14, P566, DOI 10.1016/0141-0229(92)90128-B; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurman-Rodrich J., 2017, THESIS U CAMBRIDGE; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351	67	0	0	11	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101670	10.1016/j.jbc.2022.101670	http://dx.doi.org/10.1016/j.jbc.2022.101670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120929	Green Published, gold			2022-12-28	WOS:000791230900001
J	Pimentel, SC; Upton, HE; Collins, K				Pimentel, Sydney C.; Upton, Heather E.; Collins, Kathleen			Separable structural requirements for cDNA synthesis, nontemplated extension, and template jumping by a non-LTR retroelement reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; INDEPENDENT DNA-SYNTHESIS; RNA; R2; RETROTRANSPOSON; IDENTIFICATION; BINDING; DOMAIN; ENDONUCLEASE; TELOMERASE	Broad evolutionary expansion of polymerase families has enabled specialization of their activities for distinct cellular roles. In addition to template-complementary synthesis, many polymerases extend their duplex products by nontemplated nucleotide addition (NTA). This activity is exploited for laboratory strategies of cloning and sequencing nucleic acids and could have important biological function, although the latter has been challenging to test without separation-of-function mutations. Several retroelement and retroviral reverse transcriptases (RTs) support NTA and also template jumping, by which the RT performs continuous complementary DNA (cDNA) synthesis using physically separate templates. Previous studies that aimed to dissect the relationship between NTA and template jumping leave open questions about structural requirements for each activity and their interdependence. Here, we characterize the structural requirements for cDNA synthesis, NTA, template jumping, and the unique terminal transferase activity of Bombyx mori R2 non-long terminal repeat retroelement RT. With sequence alignments and structure modeling to guide mutagenesis, we generated enzyme variants across motifs generally conserved or specific to RT subgroups. Enzyme variants had diverse NTA profiles not correlated with other changes in cDNA synthesis activity or template jumping. Using these enzyme variants and panels of activity assay conditions, we show that template jumping requires NTA. However, template jumping by NTA-deficient enzymes can be rescued using primer duplex with a specific length of 3' overhang. Our findings clarify the relationship between NTA and template jumping as well as additional activities of non-long terminal repeat RTs, with implications for the specialization of RT biological functions and laboratory applications.	[Pimentel, Sydney C.; Upton, Heather E.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu		Pimentel, Sydney/0000-0003-2634-4322	University of California, Berkeley (Bakar Fellows Program); National Institutes of Health [DP1HL156819]	University of California, Berkeley (Bakar Fellows Program)(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from University of California, Berkeley (Bakar Fellows Program) and the National Institutes of Health (DP1HL156819) to K. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arkhipova IR, 2017, MOBILE DNA-UK, V8, DOI 10.1186/s13100-017-0103-2; BASU A, 1990, J BIOL CHEM, V265, P17162; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Chen DY, 2001, BIOTECHNIQUES, V30, P574, DOI 10.2144/01303rr02; Chowdhury K, 1996, BIOCHEMISTRY-US, V35, P16610, DOI 10.1021/bi961462l; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Craig R., 2021, MOL BIOL EVOL, V28; Eickbush TH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0011-2014; Fujiwara H, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0001-2014; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gao LY, 2020, SCIENCE, V369, P1077, DOI 10.1126/science.aba0372; Ghanim GE, 2021, NATURE, V593, P449, DOI 10.1038/s41586-021-03415-4; Gholamalipour Y, 2018, NUCLEIC ACIDS RES, V46, P9253, DOI 10.1093/nar/gky796; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Govindaraju A, 2016, NUCLEIC ACIDS RES, V44, P3276, DOI 10.1093/nar/gkw134; He Y, 2021, NATURE, V593, P454, DOI 10.1038/s41586-021-03529-9; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Kazazian HH, 2017, NEW ENGL J MED, V377, P361, DOI 10.1056/NEJMra1510092; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Lentzsch AM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100971; Lentzsch AM, 2019, J BIOL CHEM, V294, P19764, DOI 10.1074/jbc.RA119.011337; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Mahbub MM, 2017, MOBILE DNA-UK, V8, DOI 10.1186/s13100-017-0097-9; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Martin-Alonso S, 2021, TRENDS BIOTECHNOL, V39, P194, DOI 10.1016/j.tibtech.2020.06.008; Menendez-Arias L, 2002, PROG NUCLEIC ACID RE, V71, P91, DOI 10.1016/S0079-6603(02)71042-8; Menendez-Arias L, 2017, VIRUS RES, V234, P153, DOI 10.1016/j.virusres.2016.12.019; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Moldovan JB, 2019, P NATL ACAD SCI USA, V116, P20612, DOI 10.1073/pnas.1805404116; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Ohtsubo Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41769; Oz-Gleenberg I, 2012, FEBS J, V279, P142, DOI 10.1111/j.1742-4658.2011.08406.x; Oz-Gleenberg I, 2011, BIOCHEM BIOPH RES CO, V408, P482, DOI 10.1016/j.bbrc.2011.04.063; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pradhan M, 2020, ANAL BIOCHEM, V603, DOI 10.1016/j.ab.2020.113809; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; Stamos JL, 2017, MOL CELL, V68, P926, DOI 10.1016/j.molcel.2017.10.024; Upton HE, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107900118; Wang MH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16234-4; Wulf MG, 2019, J BIOL CHEM, V294, P18220, DOI 10.1074/jbc.RA119.010676; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yang J, 1999, P NATL ACAD SCI USA, V96, P7847, DOI 10.1073/pnas.96.14.7847; YUE X, 1988, MOL BIOL EVOL, V5, P675; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhao C, 2016, NAT STRUCT MOL BIOL, V23, P558, DOI 10.1038/nsmb.3224; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	54	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101624	10.1016/j.jbc.2022.101624	http://dx.doi.org/10.1016/j.jbc.2022.101624			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35065960	Green Published, gold			2022-12-28	WOS:000821051800007
J	Askari, F; Rasheed, M; Kaur, R				Askari, Fizza; Rasheed, Mubashshir; Kaur, Rupinder			The yapsin family of aspartyl proteases regulate glucose homeostasis in Candida glabrata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-WALL; VIRULENCE; ALBICANS; TRANSPORTERS; PROTEINASES; MEMBRANE; SURVIVAL; SENSORS	Invasive candidiasis poses a major healthcare threat. The human opportunistic fungal pathogen Candida glabrata, which causes mucosal and deep-seated infections, is armed with distinct virulence attributes, including a family of 11 glycosylphosphatidylinositol-linked aspartyl proteases, CgYap-sins. Here, we have profiled total membrane proteomes of the C. glabrata wildtype and 11 proteases-deficient strain, Cgyps1-11 Delta, by mass spectrometry analysis and uncovered a novel role for fungal yapsins in glucose sensing and homeo-stasis. Furthermore, through label-free quantitative membrane proteome analysis, we showed differential abundance of 42% of identified membrane proteins, with electron transport chain and glycolysis proteins displaying lower and higher abundance in Cgyps1-11 Delta cells, compared with wildtype cells, respectively. We also demonstrated elevated glucose uptake and upregula-tion of genes that code for the low-glucose sensor CgSnf3, transcriptional regulators CgMig1 and CgRgt1, and hexose transporter CgHxt2/10 in the Cgyps1-11 Delta mutant. We further elucidated a potential underlying mechanism through genetic and transcript measurement analysis under low-and high-glucose conditions and found CgSNF3 deletion to rescue high glucose uptake and attenuated growth of the Cgyps1-11 Delta mutant in YPD medium, thereby linking CgYapsins with regulation of the CgSnf3-dependent low-glucose sensing pathway. Last, high ethanol production, diminished mito-chondrial membrane potential, and elevated susceptibility to oxidative phosphorylation inhibitors point toward increased fermentative and decreased respiratory metabolism in the Cgyps1-11 Delta mutant. Altogether, our findings revealed new possible glucose metabolism-regulatory roles for putative cell surface-associated CgYapsins and advanced our understanding of fungal carbohydrate homeostasis mechanisms.	[Askari, Fizza; Rasheed, Mubashshir; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Lab Fungal Pathogenesis, Hyderabad, India; [Askari, Fizza] Reg Ctr Biotechnol, Grad Studies, Faridabad, Haryana, India; [Rasheed, Mubashshir] Univ Exeter, MRC Ctr Med Mycol, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; University of Exeter	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Fungal Pathogenesis, Hyderabad, India.	rkaur@cdfd.org.in		Rasheed, Mubashshir/0000-0002-1597-6976	DBT/Wellcome Trust India Alliance Senior Fellowship [IA/S/15/1/501831]; University Grants Commission, New Delhi, India	DBT/Wellcome Trust India Alliance Senior Fellowship; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was fully supported by the DBT/Wellcome Trust India Alliance Senior Fellowship to R. K. (IA/S/15/1/501831; www.indiaalliance.org/).F.A.is a recipient of Research Fellowship sponsored by the University Grants Commission, New Delhi, India.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Astvad KMT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01564-17; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Battu A, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009355; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; Boonekamp FJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00504; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Cerulus B, 2018, ELIFE, V7, DOI 10.7554/eLife.39234; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Cormack BP, 1999, GENETICS, V151, P979; d'Enfert C, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov111; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dubinski AF, 2018, BBA-BIOENERGETICS, V1859, P445, DOI 10.1016/j.bbabio.2018.03.011; Ehrstrom S, 2006, OBSTET GYNECOL, V108, P1432, DOI 10.1097/01.AOG.0000246800.38892.fc; Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fernandes AR, 1998, ARCH MICROBIOL, V171, P6, DOI 10.1007/s002030050671; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Fukuda Y, 2013, INFECT IMMUN, V81, P1325, DOI 10.1128/IAI.00851-12; Gagnon-Arsenault I, 2006, FEMS YEAST RES, V6, P966, DOI 10.1111/j.1567-1364.2006.00129.x; Johnston L, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.733810; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Khatib R, 2016, MYCOSES, V59, P781, DOI 10.1111/myc.12531; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; Kumar K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020039; Lamoth F, 2018, J ANTIMICROB CHEMOTH, V73, pi4, DOI 10.1093/jac/dkx444; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; McCarty TP, 2016, INFECT DIS CLIN N AM, V30, P103, DOI 10.1016/j.idc.2015.10.013; Miyazaki T, 2011, FEMS YEAST RES, V11, P449, DOI 10.1111/j.1567-1364.2011.00734.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Ng TS, 2016, INFECT GENET EVOL, V40, P331, DOI 10.1016/j.meegid.2015.09.004; Ng TS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01334; Ng TS, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.25177; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Pais P, 2016, MOL CELL PROTEOMICS, V15, P57, DOI 10.1074/mcp.M114.045344; Palma M, 2009, FEMS YEAST RES, V9, P526, DOI 10.1111/j.1567-1364.2009.00511.x; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Pfaller MA, 2019, OPEN FORUM INFECT DI, V6, pS79, DOI 10.1093/ofid/ofy358; Quintin J, 2013, J IMMUNOL, V190, P2818, DOI 10.4049/jimmunol.1201861; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Rapala-Kozik M, 2018, MOL ORAL MICROBIOL, V33, P113, DOI 10.1111/omi.12206; Rasheed M, 2020, J PROTEOME RES, V19, P49, DOI 10.1021/acs.jproteome.9b00299; Rasheed M, 2018, J BIOL CHEM, V293, P6410, DOI [10.1074/jbc.M117.813741, 10.1074/jbc.m117.813741]; Ray D, 2007, DIABETES CARE, V30, P312, DOI 10.2337/dc06-1469; Rodrigues CF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010076; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Roy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121985; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Traven A, 2019, EMBO REP, V20, DOI 10.15252/embr.201947995; Tucey TM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008695; Tucey TM, 2018, CELL METAB, V27, P988, DOI 10.1016/j.cmet.2018.03.019; Van Ende M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00099; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2	60	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101593	10.1016/j.jbc.2022.101593	http://dx.doi.org/10.1016/j.jbc.2022.101593			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35051415	Green Published, gold			2022-12-28	WOS:000761380200003
J	Tang, MF; Chen, Z; Wang, C; Feng, X; Lee, N; Huang, M; Zhang, HM; Li, ST; Xiong, Y; Chen, JJ				Tang, Mengfan; Chen, Zhen; Wang, Chao; Feng, Xu; Lee, Namsoo; Huang, Min; Zhang, Huimin; Li, Siting; Xiong, Yun; Chen, Junjie			Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK REPAIR PATHWAY; HOMOLOGOUS RECOMBINATION; TELOMERE LENGTH; 53BP1; REPLICATION; RESECTION; PROTEIN; BRCA2; COMPLEX; RAD51	Replication timing regulatory factor 1 (RIF1) acts downstream of p53-binding protein 53BP1 to inhibit the resection of DNA broken ends, which plays critical roles in determining the DNA double-strand break repair pathway choice between nonhomologous end joining and homologous recombination (HR). However, the mechanism by which this choice is made is not yet clear. In this study, we identified that histone chaperone protein ASF1 associates with RIF1 and regulates RIF1-dependent functions in the DNA damage response. Similar to loss of RIF1, we found that loss of ASF1 resulted in resistance to poly (ADP-ribose) polymerase (PARP) inhibition in BRCA1-deficient cells with restored HR and decreased telomere fusion in telomeric repeat-binding protein 2 (TRF2)-depleted cells. Moreover, we showed that these functions of ASF1 are dependent on its interaction with RIF1 but not on its histone chaperone activity. Thus, our study supports a new role for ASF1 in dictating double-strand break repair choice. Considering that the status of 53BP1-RIF1 axis is important in determining the outcome of PARP inhibitor-based therapy in BRCA1- or HR-deficient cancers, the identification of ASF1 function in this critical pathway uncovers an interesting connection between these S-phase events, which may reveal new strategies to overcome PARP inhibitor resistance.	[Tang, Mengfan; Chen, Zhen; Wang, Chao; Feng, Xu; Lee, Namsoo; Huang, Min; Zhang, Huimin; Li, Siting; Xiong, Yun; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, Houston, TX 77030 USA.	jchen8@mdanderson.org			Cancer Prevention and Research Institute of Texas [RP160667, RP180813]; National Institutes of Health [R01CA210929, R01CA216911, R01CA216437]; Pamela and Wayne Garrison Distinguished Chair in Cancer Research	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pamela and Wayne Garrison Distinguished Chair in Cancer Research	This work was supported in part by the Cancer Prevention and Research Institute of Texas award RP180813 (to J. C.). In addition, many reagents used in this study were obtained in part with the support of the Cancer Prevention and Research Institute of Texas award RP160667 and National Institutes of Health grants (R01CA210929, R01CA216911, and R01CA216437) (to J. C.). J. C. also received support from the Pamela and Wayne Garrison Distinguished Chair in Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Batenburg NL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02114-x; Bhowmick R, 2019, CURR BIOL, V29, P1232, DOI 10.1016/j.cub.2019.02.037; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Daley JM, 2013, MOL CELL, V49, P840, DOI 10.1016/j.molcel.2013.02.019; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dev H, 2018, NAT CELL BIOL, V20, P954, DOI 10.1038/s41556-018-0140-1; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Garzon J, 2019, CELL REP, V27, P2558, DOI 10.1016/j.celrep.2019.05.002; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Haber JE, 2016, ANNU REV GENET, V50, P1, DOI 10.1146/annurev-genet-120215-035043; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Huang TH, 2020, MOL CELL, V77, P1153, DOI 10.1016/j.molcel.2020.02.019; Huang TH, 2018, CELL CYCLE, V17, P1413, DOI 10.1080/15384101.2018.1486165; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kedziora S, 2018, NUCLEIC ACIDS RES, V46, P3993, DOI 10.1093/nar/gky132; Klein KN, 2021, SCIENCE, V372, P371, DOI 10.1126/science.aba5545; Lee KY, 2017, MOL CELL, V68, P61, DOI 10.1016/j.molcel.2017.08.021; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu T, 2016, GENOM PROTEOM BIOINF, V14, P126, DOI 10.1016/j.gpb.2016.05.002; Marcand S, 1998, CIBA F SYMP, V211, P76; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mirman Z, 2018, NATURE, V560, P112, DOI 10.1038/s41586-018-0324-7; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; O'Driscoll M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012773; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang MF, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108018; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Wang C, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102946; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	73	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101979	10.1016/j.jbc.2022.101979	http://dx.doi.org/10.1016/j.jbc.2022.101979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35472331	Green Published, gold			2022-12-28	WOS:000807755100005
J	Wagatsuma, T; Shimotsuma, K; Sogo, A; Sato, R; Kubo, N; Ueda, S; Uchida, Y; Kinoshita, M; Kambe, T				Wagatsuma, Takumi; Shimotsuma, Keiko; Sogo, Akiko; Sato, Risa; Kubo, Naoya; Ueda, Sachiko; Uchida, Yasuo; Kinoshita, Masato; Kambe, Taiho			Zinc transport via ZNT5-6 and ZNT7 is critical for cell surface glycosylphosphatidylinositol-anchored protein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-CONVERTING-ENZYME; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; REQUIRING ECTOENZYMES; MUTATION; GENE; HYPERPHOSPHATASIA; SPHINGOMYELINASE; DEFICIENCY; ACTIVATION	Glycosylphosphatidylinositol (GPI)-anchored proteins play crucial roles in various enzyme activities, cell signaling and adhesion, and immune responses. While the molecular mechanism underlying GPI-anchored protein biosynthesis has been well studied, the role of zinc transport in this process has not yet been elucidated. Zn transporter (ZNT) proteins mobilize cytosolic zinc to the extracellular space and to intracellular compartments. Here, we report that the early secretory pathway ZNTs (ZNT5-ZNT6 heterodimers [ZNT5-6] and ZNT7-ZNT7 homodimers [ZNT7]), which supply zinc to the lumen of the early secretory pathway compartments are essential for GPI-anchored protein expression on the cell surface. We show, using overexpression and gene disruption/reexpression strategies in cultured human cells, that loss of ZNT5-6 and ZNT7 zinc transport functions results in significant reduction in GPI-anchored protein levels similar to that in mutant cells lacking phosphatidylinositol glycan anchor biosynthesis (PIG) genes. Furthermore, medaka fish with disrupted Znt5 and Znt7 genes show touch-insensitive phenotypes similar to zebrafish Pig mutants. These findings provide a previously unappreciated insight into the regulation of GPIanchored protein expression and protein quality control in the early secretory pathway.	[Wagatsuma, Takumi; Shimotsuma, Keiko; Kubo, Naoya; Ueda, Sachiko; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan; [Sogo, Akiko; Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Sato, Risa; Uchida, Yasuo] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan	Kyoto University; Kyoto University; Tohoku University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan.	kambe.taiho.7z@kyoto-u.ac.jp		Kinoshita, Masato/0000-0003-3936-7371; Kambe, Taiho/0000-0001-9757-063X; Uchida, Yasuo/0000-0001-9860-1979	Ministry of Education, Culture, Sports, Science, and Technology, Japan [JP19H05768]; Japan Society for the Promotion of Science [JP19H02883]; Kyoto Innovative Medical Technology Research and Development Support System; Mitsubishi Foundation; Kao Melanin Workshop; Lydia O'Leary Memorial Pias Dermatological Foundation; Nagase Science and Technology Foundation; Cosmetology Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto Innovative Medical Technology Research and Development Support System; Mitsubishi Foundation; Kao Melanin Workshop; Lydia O'Leary Memorial Pias Dermatological Foundation; Nagase Science and Technology Foundation; Cosmetology Research Foundation	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrated Bio-metal Science" (MEXT KAKENHI Grant Number JP19H05768) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number JP19H02883) from the Japan Society for the Promotion of Science; the Kyoto Innovative Medical Technology Research and Development Support System; the Mitsubishi Foundation; the Kao Melanin Workshop; the Cosmetology Research Foundation; Lydia O'Leary Memorial Pias Dermatological Foundation, and Nagase Science and Technology Foundation (to T. K.).	ARREAZA G, 1995, J BIOL CHEM, V270, P23641, DOI 10.1074/jbc.270.40.23641; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425; Bird AJ, 2020, CURR OPIN CHEM BIOL, V55, P145, DOI 10.1016/j.cbpa.2020.01.011; Carmean V, 2015, J NEUROPHYSIOL, V114, P1146, DOI 10.1152/jn.00355.2015; Couve A, 2014, EMBO J, V33, P2444, DOI 10.15252/embj.201489845; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukushi S, 2007, J VIROL, V81, P10831, DOI 10.1128/JVI.01143-07; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Hellman NE, 2002, J BIOL CHEM, V277, P1375, DOI 10.1074/jbc.M109123200; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Kambe T, 1998, BLOOD, V91, P1185, DOI 10.1182/blood.V91.4.1185; Kambe T, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100320; Kambe T, 2020, BIOCHEMISTRY-US, V59, P74, DOI 10.1021/acs.biochem.9b00924; Kambe T, 2016, ARCH BIOCHEM BIOPHYS, V611, P37, DOI 10.1016/j.abb.2016.03.035; Kinoshita M, 2000, DEV GROWTH DIFFER, V42, P469; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Lieberwirth JK, 2021, EUR J HUM GENET, V29, P808, DOI 10.1038/s41431-020-00803-8; Liu SS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02337-1; Liu YS, 2020, BIOCHEM SOC T, V48, P1129, DOI 10.1042/BST20191142; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Minato T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14867-z; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Murakami Y, 2020, DEV GROWTH DIFFER, V62, P554, DOI 10.1111/dgd.12700; Nakano Y, 2010, DEVELOPMENT, V137, P1689, DOI 10.1242/dev.047464; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Riordan JF, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-225; Rong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138553; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Suzuki E, 2020, J BIOL CHEM, V295, P5669, DOI 10.1074/jbc.RA120.012610; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Takahashi S, 2011, BIOMED RES-TOKYO, V32, P407, DOI 10.2220/biomedres.32.407; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Takeda T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0118-3; Tezuka K, 2022, J NEUROCHEM, V160, P662, DOI 10.1111/jnc.15578; Tsuji T, 2017, J BIOL CHEM, V292, P2159, DOI 10.1074/jbc.M116.763946; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Uchida Y, 2021, BIOL PHARM BULL, V44, P804, DOI 10.1248/bpb.b20-01043; Uchida Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68245-2; Ueda S, 2022, AM J PHYSIOL-CELL PH, V322, pC948, DOI 10.1152/ajpcell.00020.2022; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang YJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004641; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; Watanabe S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08429-1; WEI L, 1991, J BIOL CHEM, V266, P9002; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383	56	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102011	10.1016/j.jbc.2022.102011	http://dx.doi.org/10.1016/j.jbc.2022.102011			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35525268	Green Published, gold			2022-12-28	WOS:000811813400008
J	Boopathy, LRA; Jacob-Tomas, S; Alecki, C; Vera, M				Boopathy, Lokha R. Alagar; Jacob-Tomas, Suleima; Alecki, Celia; Vera, Maria			Mechanisms tailoring the expression of heat shock proteins to proteostasis challenges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HSP70 MESSENGER-RNA; GLOBAL CLIMATE-CHANGE; ELONGATION FACTOR-II; TRANSLATION INITIATION; STRESS GRANULE; GENE-EXPRESSION; QUALITY-CONTROL; 5'-UNTRANSLATED REGION; PREFERENTIAL TRANSLATION; CAENORHABDITIS-ELEGANS	All cells possess an internal stress response to cope with environmental and pathophysiological challenges. Upon stress, cells reprogram their molecular functions to activate a survival mechanism known as the heat shock response, which mediates the rapid induction of molecular chaperones such as the heat shock proteins (HSPs). This potent production overcomes the general suppression of gene expression and results in high levels of HSPs to subsequently refold or degrade misfolded proteins. Once the damage or stress is repaired or removed, cells terminate the production of HSPs and resume regular functions. Thus, fulfillment of the stress response requires swift and robust coordination between stress response activation and completion that is determined by the status of the cell. In recent years, single-cell fluorescence microscopy techniques have begun to be used in unravelling HSP-gene expression pathways, from DNA transcription to mRNA degradation. In this review, we will address the molecular mechanisms in different organisms and cell types that coordinate the expression of HSPs with signaling networks that act to reprogram gene transcription, mRNA translation, and decay and ensure protein quality control.	[Boopathy, Lokha R. Alagar; Jacob-Tomas, Suleima; Alecki, Celia; Vera, Maria] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University	Vera, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	maria.veraugalde@mcgill.ca		Alecki, Celia/0000-0003-3203-5104; Jacob-Tomas, Suleima/0000-0002-3900-7360	NSERC [04767]; FRQS through CRBS fellowship; FRQS postdoctoral fellowship [300232]; Vanier Canada Graduate Scholarship [CGV 1757]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQS through CRBS fellowship; FRQS postdoctoral fellowship; Vanier Canada Graduate Scholarship	This work is supported by NSERC grant RGPIN-2019 to 04767 to M. V., FRQS through CRBS fellowship to L. R. A. B., Vanier Canada Graduate Scholarship CGV 1757 to S. J. T., and FRQS postdoctoral fellowship 300232 to C. A.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Adivarahan S, 2018, MOL CELL, V72, P727, DOI 10.1016/j.molcel.2018.10.010; Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Aktas B. H., 2014, TRANSLATION ITS REGU, P195; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Alluri RK, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.672988; Alzahrani SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195349; AMIN V, 1995, NEUROSCI LETT, V200, P85, DOI 10.1016/0304-3940(95)12074-E; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson P, 2002, J CELL SCI, V115, P3227; Avila DS, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0097-2; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Batulan Z, 2003, J NEUROSCI, V23, P5789; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Berger MS, 2007, BIOL BULL-US, V212, P232, DOI 10.2307/25066605; Bjork JK, 2010, FEBS J, V277, P4126, DOI 10.1111/j.1742-4658.2010.07828.x; Bley N, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1275; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; BONANOUTZEDAKI SA, 1978, EUR J BIOCHEM, V84, P591, DOI 10.1111/j.1432-1033.1978.tb12202.x; Bond U, 2006, FEMS YEAST RES, V6, P160, DOI 10.1111/j.1567-1364.2006.00032.x; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Bresson S, 2020, MOL CELL, V80, P470, DOI 10.1016/j.molcel.2020.09.021; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Campanella C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092603; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chao YC, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-1593-y; Chen JJ, 2014, CURR OPIN HEMATOL, V21, P172, DOI 10.1097/MOH.0000000000000030; Chen YY, 2014, J BIOL CHEM, V289, P18914, DOI 10.1074/jbc.M114.574053; Chowdhary S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00292-17; Chung J, 2012, CURR OPIN HEMATOL, V19, P156, DOI 10.1097/MOH.0b013e328351c48b; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Cuesta R, 2000, GENE DEV, V14, P1460; Cugusi S, 2022, MOL CELL, V82, P1573, DOI 10.1016/j.molcel.2022.01.007; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de la Fuente M, 2012, FEBS LETT, V586, P4061, DOI 10.1016/j.febslet.2012.10.018; DEBENEDETTI A, 1986, J BIOL CHEM, V261, P5800; Deka K, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.74; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dever TE, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032649; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; DIDOMENICO BJ, 1982, P NATL ACAD SCI-BIOL, V79, P6181, DOI 10.1073/pnas.79.20.6181; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; Domnauer M, 2021, MOL CELL, V81, P3294, DOI 10.1016/j.molcel.2021.06.028; Dugger BN, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028035; DUMONTMISCOPEIN A, 1994, FEBS LETT, V356, P283, DOI 10.1016/0014-5793(94)01272-5; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Evgen'ev MB, 2017, J ALZHEIMERS DIS, V59, P1415, DOI 10.3233/JAD-170398; Farabaugh KT, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00521-16; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Franzmann TM, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034058; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gray CC, 1999, INT J BIOCHEM CELL B, V31, P559, DOI 10.1016/S1357-2725(99)00004-7; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; HAMMEL HT, 1968, ANNU REV PHYSIOL, V30, P641, DOI 10.1146/annurev.ph.30.030168.003233; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Hofmann GE, 2005, INTEGR COMP BIOL, V45, P247, DOI 10.1093/icb/45.2.247; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Huang HS, 2016, AUTOPHAGY, V12, P1687, DOI 10.1080/15548627.2016.1196313; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; Hubstenberger A, 2017, MOL CELL, V68, P144, DOI 10.1016/j.molcel.2017.09.003; Iserman C, 2020, CELL, V181, P818, DOI 10.1016/j.cell.2020.04.009; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jayaraj GG, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033951; Ji QQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102175118; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jobava R, 2021, MOL CELL, V81, P4191, DOI 10.1016/j.molcel.2021.09.029; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khanna N, 2014, CURR BIOL, V24, P1138, DOI 10.1016/j.cub.2014.03.053; Khong A, 2018, J CELL BIOL, V217, P4124, DOI 10.1083/jcb.201806183; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Kirstein J, 2017, AGING CELL, V16, P1414, DOI 10.1111/acel.12686; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Korneeva NL, 2016, J BIOL CHEM, V291, P3455, DOI 10.1074/jbc.M115.694190; Krakowiak J, 2018, ELIFE, V7, DOI 10.7554/eLife.31668; Kubarenko AV, 2005, MOL BIOL+, V39, P746; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Kumar S, 2016, CANCER LETT, V374, P156, DOI 10.1016/j.canlet.2016.01.056; Kuta R, 2020, CELL STRESS CHAPERON, V25, P173, DOI 10.1007/s12192-019-01064-1; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; LINDQUIST S, 1980, DEV BIOL, V77, P463, DOI 10.1016/0012-1606(80)90488-1; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lis JT, 2000, GENE DEV, V14, P792; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Liu QL, 2020, PROTEIN SCI, V29, P378, DOI 10.1002/pro.3725; Liu R, 2016, ACTA PHARMACOL SIN, V37, P285, DOI 10.1038/aps.2015.123; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Luo Y, 2018, BIOCHEMISTRY-US, V57, P2424, DOI 10.1021/acs.biochem.7b01162; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Macario AJL, 1999, MICROBIOL MOL BIOL R, V63, P923, DOI 10.1128/MMBR.63.4.923-967.1999; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mason PB, 1997, J BIOL CHEM, V272, P33227, DOI 10.1074/jbc.272.52.33227; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Mateju D, 2020, CELL, V183, P1801, DOI 10.1016/j.cell.2020.11.010; Matheny T, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00313-19; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; MCALISTER L, 1979, CURR GENET, V1, P63, DOI 10.1007/BF00413307; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; MOKDAD R, 1987, P NATL ACAD SCI USA, V84, P2658, DOI 10.1073/pnas.84.9.2658; Moon SL, 2019, NAT CELL BIOL, V21, P162, DOI 10.1038/s41556-018-0263-4; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morimoto RI, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a034074; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Muhlhofer M, 2019, CELL REP, V29, P4593, DOI 10.1016/j.celrep.2019.11.109; Mueller B, 2017, GENE DEV, V31, P451, DOI 10.1101/gad.293118.116; Nakai A, 2016, NAT STRUCT MOL BIOL, V23, P93, DOI 10.1038/nsmb.3165; Nava R, 2020, CELL STRESS CHAPERON, V25, P35, DOI 10.1007/s12192-019-01059-y; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pelletier J, 2019, ANNU REV BIOCHEM, V88, P307, DOI 10.1146/annurev-biochem-013118-111042; Penke B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010325; PETERSEN R, 1988, GENE, V72, P161, DOI 10.1016/0378-1119(88)90138-2; Petersen R. B., 1990, POSTTRANSCRIPTIONAL, P83; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pichon X, 2018, MOL CELL, V71, P468, DOI 10.1016/j.molcel.2018.07.022; Pohl C, 2019, SCIENCE, V366, P818, DOI 10.1126/science.aax3769; Pomatto LCD, 2017, J PHYSIOL-LONDON, V595, P7275, DOI 10.1113/JP275072; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ray J, 2019, P NATL ACAD SCI USA, V116, P19431, DOI 10.1073/pnas.1901244116; Rebeaud ME, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020885118; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Ruoff R, 2016, P NATL ACAD SCI USA, V113, P7545, DOI 10.1073/pnas.1605451113; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; San Gil R, 2020, J CELL SCI, V133, DOI 10.1242/jcs.243709; Sato H, 2020, ANNU REV BIOCHEM, V89, P159, DOI 10.1146/annurev-biochem-011520-104955; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shemesh N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22369-9; SIMCOX AA, 1985, MOL CELL BIOL, V5, P3397, DOI 10.1128/MCB.5.12.3397; SNUTCH TP, 1983, CAN J BIOCHEM CELL B, V61, P480, DOI 10.1139/o83-064; Sokabe M, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032706; Somero GN, 2020, J EXP ZOOL PART A, V333, P379, DOI 10.1002/jez.2344; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Standart N, 2018, TRENDS GENET, V34, P612, DOI 10.1016/j.tig.2018.05.005; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Suzuki Kanzo, 2020, Adv Pharmacol, V89, P79, DOI 10.1016/bs.apha.2020.04.005; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Takii R, 2019, EMBO J, V38, DOI 10.15252/embj.2019102566; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teranishi KS, 2007, COMP BIOCHEM PHYS D, V2, P53, DOI 10.1016/j.cbd.2006.11.002; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tomanek L, 2008, PHYSIOL BIOCHEM ZOOL, V81, P709, DOI 10.1086/590163; Tomanek L, 2014, J PROTEOMICS, V105, P92, DOI 10.1016/j.jprot.2014.04.009; Tutucci E, 2018, ANNU REV BIOPHYS, V47, P85, DOI 10.1146/annurev-biophys-070317-033037; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vandelli A, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167159; VAZQUEZ J, 1993, CHROMOSOMA, V102, P233, DOI 10.1007/BF00352397; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Vera M, 2014, CURR BIOL, V24, pR396, DOI 10.1016/j.cub.2014.03.070; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vihervaara A, 2018, NAT REV GENET, V19, P385, DOI 10.1038/s41576-018-0001-6; Vihervaara A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00151-0; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Vivinus S, 2001, EUR J BIOCHEM, V268, P1908, DOI 10.1046/j.1432-1327.2001.02064.x; Vries RGJ, 1997, J BIOL CHEM, V272, P32779, DOI 10.1074/jbc.272.52.32779; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang Y, 2019, ADV EXP MED BIOL, V1206, P527, DOI 10.1007/978-981-15-0602-4_25; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WEISSBACH H, 1974, CELL, V2, P137, DOI 10.1016/0092-8674(74)90088-9; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Yasuda S, 2020, NATURE, V578, P296, DOI 10.1038/s41586-020-1982-9; Yoshizawa F, 1997, BIOCHEM BIOPH RES CO, V240, P825, DOI 10.1006/bbrc.1997.7652; YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7; Yueh A, 2000, GENE DEV, V14, P414; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Yura T, 2019, GENES GENET SYST, V94, P103, DOI 10.1266/ggs.19-00005; Zander G, 2016, NATURE, V540, P593, DOI 10.1038/nature20572; Zhang XQ, 2018, NAT CHEM BIOL, V14, P909, DOI 10.1038/s41589-018-0120-6; Zhang XQ, 2015, NAT STRUCT MOL BIOL, V22, P404, DOI 10.1038/nsmb.3010; Zhao MJ, 2002, J BIOL CHEM, V277, P44539, DOI 10.1074/jbc.M208408200; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	253	9	9	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101796	10.1016/j.jbc.2022.101796	http://dx.doi.org/10.1016/j.jbc.2022.101796			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35248532	Green Published, gold			2022-12-28	WOS:000860390500003
J	Cornish, KAS; Lange, J; Aevarsson, A; Pohl, E				Cornish, Katy A. S.; Lange, Joanna; Aevarsson, Arnthor; Pohl, Ehmke			CPR-C4 is a highly conserved novel protease from the Candidate Phyla Radiation with remote structural homology to human vasohibins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND INTERACTIONS; MOLECULAR-GRAPHICS; CONFIDENCE; MECHANISM; GEOMETRY; AUTOPROC; LIMITS; SUITE; VIEW	The Candidate Phyla Radiation is a recently uncovered and vast expansion of the bacterial domain of life, made up of largely uncharacterized phyla that lack isolated representatives. This unexplored territory of genetic diversity presents an abundance of novel proteins with potential applications in the life-science sectors. Here, we present the structural and functional elucidation of CPR-C4, a hypothetical protein from the genome of a thermophilic Candidate Phyla Radiation organism, identified through metagenomic sequencing. Our analyses revealed that CPR-C4 is a member of a family of highly conserved proteins within the Candidate Phyla Radiation. The function of CPR-C4 as a cysteine protease was predicted through remote structural similarity to the Homo sapiens vasohibins and subsequently confirmed experimentally with fluorescence-based activity assays. Furthermore, detailed structural and sequence alignment analysis enabled identifi-cation of a noncanonical cysteine-histidine-leucine(carbonyl) catalytic triad. The unexpected structural and functional similarities between CPR-C4 and the human vasohibins suggest an evolutionary relationship undetectable at the sequence level alone.	[Cornish, Katy A. S.; Pohl, Ehmke] Univ Durham, Dept Chem, Lower Mountjoy, Durham, England; [Lange, Joanna] Bioprodict, Nijmegen, Netherlands; [Aevarsson, Arnthor] Matis ohf, Reykjavik, Iceland; [Pohl, Ehmke] Univ Durham, Dept Biosci, Upper Mountjoy, Durham, England	Durham University; Durham University	Pohl, E (corresponding author), Univ Durham, Dept Chem, Lower Mountjoy, Durham, England.; Pohl, E (corresponding author), Univ Durham, Dept Biosci, Upper Mountjoy, Durham, England.	ehmke.pohl@durham.ac.uk	Pohl, Ehmke/I-2408-2012	Pohl, Ehmke/0000-0002-9949-4471; Cornish, Katy/0000-0002-2075-1851	European Union [685778]	European Union(European Commission)	European Research Council, European Union's Horizon 2020 research and innovation program grant 685778 (K. A. S. C., J. L., A. A., and E. P.) .	Aevarsson A, 2021, FEMS MICROBIOL LETT, V368, DOI 10.1093/femsle/fnab067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Bruce D, 2019, JOVE-J VIS EXP, DOI 10.3791/58666; Castelle CJ, 2018, CELL, V172, P1181, DOI 10.1016/j.cell.2018.02.016; Cha SS, 2012, ACTA CRYSTALLOGR D, V68, P1253, DOI 10.1107/S0907444912024420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cramer P, 2021, NAT STRUCT MOL BIOL, V28, P704, DOI 10.1038/s41594-021-00650-1; Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gong J, 2014, SYST APPL MICROBIOL, V37, P35, DOI 10.1016/j.syapm.2013.08.007; Groftehauge MK, 2015, ACTA CRYSTALLOGR D, V71, P36, DOI 10.1107/S1399004714016617; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; He C, 2021, NAT MICROBIOL, V6, P354, DOI 10.1038/s41564-020-00840-5; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Li FX, 2019, NAT STRUCT MOL BIOL, V26, P583, DOI 10.1038/s41594-019-0242-x; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nieuwenhuis J, 2017, SCIENCE, V358, P1453, DOI 10.1126/science.aao5676; Pannu NS, 2011, ACTA CRYSTALLOGR D, V67, P331, DOI 10.1107/S0907444910052224; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Razzaq A, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00110; Rigoldi F, 2018, APL BIOENG, V2, DOI 10.1063/1.4997367; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schulz F, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0360-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slep KC, 2019, NAT STRUCT MOL BIOL, V26, P532, DOI 10.1038/s41594-019-0266-2; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; Uson I, 1999, ACTA CRYSTALLOGR D, V55, P1158, DOI 10.1107/S0907444999003972; Vonrhein C, 2018, ACTA CRYSTALLOGR A, V74, pA360, DOI 10.1107/S010876731809640X; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang N, 2019, NAT STRUCT MOL BIOL, V26, P571, DOI 10.1038/s41594-019-0241-y; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; ZAMOST BL, 1991, J IND MICROBIOL, V8, P71, DOI 10.1007/BF01578757	62	0	0	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101919	10.1016/j.jbc.2022.101919	http://dx.doi.org/10.1016/j.jbc.2022.101919			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35405098	Green Published, gold			2022-12-28	WOS:000804923000005
J	Flannagan, RS; Brozyna, JR; Kumar, B; Adolf, LA; Power, JJ; Heilbrornner, S; Heinrichs, DE				Flannagan, Ronald S.; Brozyna, Jeremy R.; Kumar, Brijesh; Adolf, Lea A.; Power, Jeffrey John; Heilbrornner, Simon; Heinrichs, David E.			In vivo growth of Staphylococcus lugdunensis is facilitated by the concerted function of heme and non-heme iron acquisition mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC GENOME ANNOTATION; SOFT-TISSUE INFECTIONS; STAPHYLOFERRIN B; TRANSFERRIN-IRON; BACTERIAL-GROWTH; AUREUS; BINDING; NOREPINEPHRINE; TRANSPORT; IDENTIFICATION	Staphylococcus lugdunensis has increasingly been recognized as a pathogen that can cause serious infection indicating this bacterium overcomes host nutritional immunity. Despite this, there exists a significant knowledge gap regarding the iron acquisition mechanisms employed by S. lugdunensis, especially during infection of the mammalian host. Here we show that S. lugdunensis can usurp hydroxamate siderophores and staphyloferrin A and B from Staphylococcus aureus. These transport activities all required a functional FhuC ATPase. Moreover, we show that the acquisition of catechol side-rophores and catecholamine stress hormones by S. lugdunensis required the presence of the sst-1 transporter-encoding locus, but not the sst-2 locus. Iron-dependent growth in acidic culture conditions necessitated the ferrous iron transport system encoded by feoAB. Heme iron was acquired via expression of the iron-regulated surface determinant (isd) locus. During systemic infection of mice, we demonstrated that while S. lugdunensis does not cause overt illness, it does colonize and proliferate to high numbers in the kidneys. By combining mutations in the various iron acquisition loci (isd, fhuC, sst-1, and feo), we demonstrate that only a strain deficient for all of these systems was attenuated in its ability to proliferate to high numbers in the murine kidney. We propose the concerted action of heme and non-heme iron acquisition systems also enable S. lugdunensis to cause human infection.	[Flannagan, Ronald S.; Brozyna, Jeremy R.; Kumar, Brijesh; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Adolf, Lea A.; Power, Jeffrey John; Heilbrornner, Simon] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Dept Infect Biol, Tubingen, Germany; [Heilbrornner, Simon] Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany; [Heilbrornner, Simon] Cluster Excellence EXC2124 Controlling Microbes Fi, Tubingen, Germany	Western University (University of Western Ontario); Eberhard Karls University of Tubingen; German Center for Infection Research	Heinrichs, DE (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	deh@uwo.ca		Brozyna, Jeremy/0000-0001-6954-6704; Power, Jeffrey/0000-0001-8666-6134; Flannagan, Ronald/0000-0002-3263-2227	Natural Sciences and Engineering Research Council (NSERC); Deutsche Forschungsgemeinschaft (DFG) [HE8381/3-1]; Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections; Queen Elizabeth II Graduate Scholarship in Science and Technology; High Performance and Cloud Computing Group at the Zentrum fur Datenverarbeitung of the University of Tubingen; state of Baden-Wurttemberg through bwHPC; German Research Foundation (DFG) [INST 37/935-1 FUGG]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections(German Research Foundation (DFG)); Queen Elizabeth II Graduate Scholarship in Science and Technology; High Performance and Cloud Computing Group at the Zentrum fur Datenverarbeitung of the University of Tubingen; state of Baden-Wurttemberg through bwHPC; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by an operating grant to D. E. H. from the Natural Sciences and Engineering Research Council (NSERC) . S. H. acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG) from an individual project grant (HE8381/3-1) . S. H. was supported by infrastructural funding from the Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections. J. R. B. was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology. The authors acknowledge support by the High Performance and Cloud Computing Group at the Zentrum fur Datenverarbeitung of the University of Tubingen, the state of Baden-Wurttemberg through bwHPC and the German Research Foundation (DFG) through grant no INST 37/935-1 FUGG.	Anderson MT, 2008, J BACTERIOL, V190, P3940, DOI 10.1128/JB.00086-08; Anguera I, 2005, HEART, V91, DOI 10.1136/hrt.2004.040659; Arias M, 2010, SCAND J INFECT DIS, V42, P879, DOI 10.3109/00365548.2010.509332; Arifin AJ, 2014, MICROBES INFECT, V16, P967, DOI 10.1016/j.micinf.2014.09.003; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Batko IZ, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00458-21; Beasley FC, 2011, INFECT IMMUN, V79, P2345, DOI 10.1128/IAI.00117-11; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bednarz A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47414-y; BEZKOROVAINY A, 1982, ADV EXP MED BIOL, V135, P139; Bocher S, 2009, J CLIN MICROBIOL, V47, P946, DOI 10.1128/JCM.01024-08; Brozyna JR, 2014, MICROBIOLOGYOPEN, V3, P182, DOI 10.1002/mbo3.162; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Farrand AJ, 2015, INFECT IMMUN, V83, P3578, DOI 10.1128/IAI.00397-15; Fervenza FC, 2008, AM J KIDNEY DIS, V52, P972, DOI 10.1053/j.ajkd.2008.07.012; Flannagan RS, 2021, BLOOD ADV, V5, P459, DOI 10.1182/bloodadvances.2020002833; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Grigg JC, 2010, J BIOL CHEM, V285, P34579, DOI 10.1074/jbc.M110.172924; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haft DH, 2018, NUCLEIC ACIDS RES, V46, pD851, DOI 10.1093/nar/gkx1068; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; Haley KP, 2011, J BACTERIOL, V193, P4749, DOI 10.1128/JB.00436-11; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Harper L, 2018, MBIO, V9, DOI 10.1128/mBio.02272-17; Haschka D, 2015, METALLOMICS, V7, P1036, DOI 10.1039/c4mt00328d; Heilbronner S, 2021, CLIN MICROBIOL REV, V34, DOI 10.1128/CMR.00205-20; Heilbronner S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006246; Heilbronner S, 2013, MICROBIOL-SGM, V159, P2141, DOI 10.1099/mic.0.070292-0; Heilbronner S, 2011, FEMS MICROBIOL LETT, V322, P60, DOI 10.1111/j.1574-6968.2011.02339.x; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Jochim A, 2020, ELIFE, V9, DOI 10.7554/eLife.57322; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Kelliher JL, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00102-20; Kleiner E, 2010, CLIN INFECT DIS, V51, P801, DOI 10.1086/656280; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuznetsov A, 2021, METHODS MOL BIOL, V2231, P261, DOI 10.1007/978-1-0716-1036-7_16; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Li WJ, 2021, NUCLEIC ACIDS RES, V49, pD1020, DOI 10.1093/nar/gkaa1105; Liesenborghs L, 2016, J INFECT DIS, V213, P1148, DOI 10.1093/infdis/jiv773; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Methner U, 2008, INT J MED MICROBIOL, V298, P429, DOI 10.1016/j.ijmm.2007.07.013; Miethke M, 2010, ANTIMICROB AGENTS CH, V54, P1580, DOI 10.1128/AAC.01158-09; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; Nath KA, 2013, AM J PHYSIOL-RENAL, V304, pF317, DOI 10.1152/ajprenal.00606.2012; Neal CP, 2001, FEMS MICROBIOL LETT, V194, P163, DOI 10.1016/S0378-1097(00)00523-1; Nelson CE, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00519-21; Obisesan AO, 2021, BIOCHEMISTRY-US, V60, P3337, DOI 10.1021/acs.biochem.1c00572; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Peltzer A., 2021, NAVY STEEL SWORDFISH, DOI [10.5281/ZENODO5289278, DOI 10.5281/ZENODO5289278]; Pishchany G, 2013, JOVE-J VIS EXP, DOI 10.3791/50072; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; R Development Core Team, 2009, R LANG ENV STAT COMP; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sheldon JR, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P43, DOI 10.1128/microbiolspec.VMBF-0010-2015; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; SILVA P, 1979, J CLIN INVEST, V64, P850, DOI 10.1172/JCI109533; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Sotutu V, 2002, PEDIATR INFECT DIS J, V21, P984, DOI 10.1097/00006454-200210000-00023; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Srole DN, 2021, J CELL PHYSIOL, V236, P4888, DOI 10.1002/jcp.30247; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tse H, 2010, J BACTERIOL, V192, P1471, DOI 10.1128/JB.01627-09; Tseng SP, 2015, J MICROBIOL IMMUNOL, V48, P397, DOI 10.1016/j.jmii.2013.11.006; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	89	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101823	10.1016/j.jbc.2022.101823	http://dx.doi.org/10.1016/j.jbc.2022.101823			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35283192	Green Submitted, gold, Green Published			2022-12-28	WOS:000804436700009
J	Girdhar, K; Thakur, S; Gaur, P; Choubey, A; Dogra, S; Dehury, B; Kumar, S; Biswas, B; Dwivedi, DK; Ghosh, S; Mondal, P				Girdhar, Khyati; Thakur, Shilpa; Gaur, Pankaj; Choubey, Abhinav; Dogra, Surbhi; Dehury, Budheswar; Kumar, Sunil; Biswas, Bidisha; Dwivedi, Durgesh Kumar; Ghosh, Subrata; Mondal, Prosenjit			Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-INTERACTING PROTEIN; PEPTIDE-1 RECEPTOR; INDUCED INTERNALIZATION	An absolute or relative deficiency of pancreatic beta-cells mass and functionality is a crucial pathological feature common to type 1 diabetes mellitus and type 2 diabetes mellitus. Glucagon-like-peptide-1 receptor (GLP1R) agonists have been the focus of considerable research attention for their ability to protect beta-cell mass and augment insulin secretion with no risk of hypoglycemia. Presently commercially available GLP1R agonists are peptides that limit their use due to cost, stability, and mode of administration. To address this drawback, strategically designed distinct sets of small molecules were docked on GLP1R ectodomain and compared with previously known small molecule GLP1R agonists. One of the small molecule PK2 (6-((1-(4-nitrobenzyl)-1H-1,2,3-triazol-4-yl)methyl)-6H-indolo[2,3-b]quinoxaline) displays stable binding with GLP1R ectodomain and induces GLP1R internalization and increasing cAMP levels. PK2 also increases insulin secretion in the INS-1 cells. The oral administration of PK2 protects against diabetes induced by multiple low-dose streptozotocin administration by lowering high blood glucose levels. Similar to GLP1R peptidic agonists, treatment of PK2 induces beta-cell replication and attenuate beta-cell apoptosis in STZ-treated mice. Mechanistically, this protection was associated with decreased thioredoxin-interacting protein expression, a potent inducer of diabetic beta-cell apoptosis and dysfunction. Together, this report describes a small molecule, PK2, as an orally active non-peptidic GLP1R agonist that has efficacy to preserve or restore functional beta-cell mass.	[Girdhar, Khyati; Thakur, Shilpa; Gaur, Pankaj; Choubey, Abhinav; Dogra, Surbhi; Biswas, Bidisha; Ghosh, Subrata; Mondal, Prosenjit] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Dehury, Budheswar] ICMR, Reg Med Res Ctr, Bioinformat Div, Bhubaneswar, India; [Kumar, Sunil] Indian Agr Stat Res Inst IASRI, ICAR, PUSA, New Delhi, India; [Dwivedi, Durgesh Kumar] Reg Ayurveda Res Inst, CCRAS, Pharmacol Div, Gwalior, Madhya Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Mondal, P (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.	prosenjit@iitmandi.ac.in	DEHURY, BUDHESWAR/G-9330-2017	DEHURY, BUDHESWAR/0000-0002-9726-8454; MONDAL, PROSENJIT/0000-0001-8566-249X; Gaur, Pankaj/0000-0003-2895-4634	University Grant Commision (UGC) , India [BT/PR27786/MED/30/1980/2018]; Department of Biotechnology (DBT) , Government of India [CRG/2019/004006]; Sci-ence and Engineering Board (SERB) Government of India, India	University Grant Commision (UGC) , India; Department of Biotechnology (DBT) , Government of India(Department of Biotechnology (DBT) India); Sci-ence and Engineering Board (SERB) Government of India, India	Funding and additional information-K. G. thanks the University Grant Commision (UGC) , India, for the research fellowship. P. M. would like to acknowledge support from the Department of Biotechnology (DBT) , Government of India (BT/PR27786/MED/30/1980/2018) for financial aid. This work was supported by Sci-ence and Engineering Board (SERB) Government of India, India (CRG/2019/004006) to P. M.	Atlas D., 2015, IDF DIAB ATL 10 ED 2, V7th; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Daniel PV, 2022, TOXICOL RES-UK, V11, P206, DOI 10.1093/toxres/tfab121; EASON CT, 1990, REGUL TOXICOL PHARM, V11, P288, DOI 10.1016/0273-2300(90)90028-A; Fletcher MM, 2016, BIOCHEM SOC T, V44, P582, DOI 10.1042/BST20150244; Girdhar K, 2019, J BIOMOL STRUCT DYN, V37, P3976, DOI 10.1080/07391102.2018.1532818; Jadhav Ashwini Khanderao, 2017, In Silico Pharmacology, V5, P4, DOI 10.1007/s40203-017-0024-2; Jones B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03941-2; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Liao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116805; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris LC, 2014, J MED CHEM, V57, P10192, DOI 10.1021/jm501375c; Samson SL, 2013, CURR OPIN ENDOCRINOL, V20, P87, DOI 10.1097/MED.0b013e32835edb32; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Thompson A, 2015, BIOCHEM PHARMACOL, V93, P72, DOI 10.1016/j.bcp.2014.10.015; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wang CH, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00087; Wang MW, 2010, ACTA PHARMACOL SIN, V31, P1026, DOI 10.1038/aps.2010.107; WANG RN, 1994, DIABETOLOGIA, V37, P1088; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977	29	1	1	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101889	10.1016/j.jbc.2022.101889	http://dx.doi.org/10.1016/j.jbc.2022.101889			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35378127	Green Published, gold			2022-12-28	WOS:000804436700006
J	Guo, LS				Guo, Lishu			Mitochondrial ATP synthase inhibitory factor 1 interacts with the p53-cyclophilin D complex and promotes opening of the permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; BOVINE F-1-ATPASE; SUBUNIT; IF1; CHANNEL; BAX; DIMERIZATION; ACTIVATION; APOPTOSIS; MEMBRANE	The mitochondrial permeability transition pore (PTP) is a Ca2+-dependent megachannel that plays an important role in mitochondrial physiology and cell fate. Cyclophilin D (CyPD) is a well-characterized PTP regulator, and its binding to the PTP favors pore opening. It has previously been shown that p53 physically interacts with CyPD and opens the PTP during necrosis. Accumulating studies also suggest that the F-ATP synthase contributes to the regulation and formation of the PTP. F-ATP synthase IF1 (mitochondrial ATP synthase inhibitory factor 1) is a natural inhibitor of F-ATP synthase activity; however, whether IF1 participates in the modulation of PTP opening is basically unknown. Here, we demonstrate using calcium retention capacity assay that IF1 overexpression promotes mitochondrial permeability transition via opening of the PTP. Intriguingly, we show that IF1 can interact with the p53-CyPD complex and facilitate cell death. We also demonstrate that the presence of IF1 is necessary for the formation of p53-CyPD complex. Therefore, we suggest that IF1 regulates the PTP via interaction with the p53-CyPD complex, and that IF1 is necessary for the inducing effect of p53-CyPD complex on PTP opening.	[Guo, Lishu] Fudan Univ, Ctr Mitochondrial Genet & Hlth, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci, Shanghai, Peoples R China; [Guo, Lishu] Tongji Univ, Canc Ctr, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China	Fudan University; Tongji University	Guo, LS (corresponding author), Fudan Univ, Ctr Mitochondrial Genet & Hlth, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci, Shanghai, Peoples R China.; Guo, LS (corresponding author), Tongji Univ, Canc Ctr, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China.	guolsh15@gmail.com		Guo, Lishu/0000-0002-1492-6766	Shanghai Sailing Program [20YF1453200]	Shanghai Sailing Program	Acknowledgments-This work was sponsored by the Shanghai Sailing Program (grant no.: 20YF1453200) .	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Antoniel M, 2018, EMBO REP, V19, P257, DOI 10.15252/embr.201744705; Bergeaud M, 2013, CELL CYCLE, V12, P2781, DOI 10.4161/cc.25870; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Carraro M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108095; Carraro M, 2018, CELL PHYSIOL BIOCHEM, V50, P1840, DOI 10.1159/000494864; Carrer A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25161-x; Carroll J, 2019, P NATL ACAD SCI USA, V116, P12816, DOI 10.1073/pnas.1904005116; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Connern CP, 1996, BIOCHEMISTRY-US, V35, P8172, DOI 10.1021/bi9525177; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Garcia-Bermudez J, 2015, CELL REP, V12, P2143, DOI 10.1016/j.celrep.2015.08.052; Giorgio V, 2019, BRIT J PHARMACOL, V176, P4247, DOI 10.1111/bph.14513; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Guo LS, 2021, BIOCHEM PHARMACOL, V188, DOI 10.1016/j.bcp.2021.114537; Guo LS, 2019, J BIOL CHEM, V294, P10987, DOI 10.1074/jbc.RA119.008775; Guo LS, 2018, J BIOL CHEM, V293, P14632, DOI 10.1074/jbc.RA118.004495; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Masoud R, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100143; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Meslar E, 2020, JAAPA-J AM ACAD PHYS, V33, P50, DOI 10.1097/01.JAA.0000718300.59420.6c; Mnatsakanyan N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13766-2; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Pinke G, 2020, NAT STRUCT MOL BIOL, V27, P1077, DOI 10.1038/s41594-020-0503-8; Piret JP, 2004, BIOCHEM PHARMACOL, V67, P611, DOI 10.1016/j.bcp.2003.09.026; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinson GC, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120164; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Urbani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12331-1; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Walker JE, 2020, P NATL ACAD SCI USA, V117, P2745, DOI 10.1073/pnas.1921409117; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yu MF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126915	52	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101858	10.1016/j.jbc.2022.101858	http://dx.doi.org/10.1016/j.jbc.2022.101858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35337801	gold, Green Published			2022-12-28	WOS:000793483000006
J	Hsu, MH; Johnson, EF				Hsu, Mei-Hui; Johnson, Eric F.			Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; ADULT HUMAN-LIVER; IN-VITRO; CYP3A4; INHIBITION; COMPLEX; METABOLISM; MICROSOMES; RITONAVIR; SOFTWARE	Cytochrome P450 3A4 and 3A5 catalyze the metabolic clearance of a large portion of therapeutic drugs. Azamulin is used as a selective inhibitor for 3A4 and 3A5 to define their roles in metabolism of new chemical entities during drug development. In contrast to 3A4, 3A5 exhibits homotropic cooperativity for the sequential binding of two azamulin molecules at concentrations used for inhibition. To define the underlying sites and mechanisms for cooperativity, an X-ray crystal structure of 3A5 was determined with two azamulin molecules in the active site that are stacked in an antiparallel orientation. One azamulin resides proximal to the heme in a pose similar to the 3A4-azamulin complex. Comparison to the 3A5 apo structure indicates that the distal azamulin in 3A5 ternary complex causes a significant induced fit that excludes water from the hydrophobic surfaces of binding cavity and the distal azamulin, which is augmented by the stacking interaction with the proximal azamulin. Homotropic cooperativity was not observed for the binding of related pleuromutilin antibiotics, tiamulin, retapamulin, and lefamulin, to 3A5, which are larger and unlikely to bind in the distal site in a stacked orientation. Formation of the 3A5 complex with two azamulin molecules may prevent time-dependent inhibition that is seen for 3A4 by restricting alternate product formation and/or access of reactive intermediates to vulnerable protein sites. These results also contribute to a better understanding of sites for cooperative binding and the differential structural plasticity of 3A5 and 3A4 that contribute to differential substrate and inhibitor binding.	[Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	johnson@scripps.edu			National Institute of General Medical Sciences of the National Institutes of Health [R01GM031001]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and additional information-Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM031001 to E. F. J. The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the official views of SSRL or their	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ai X, 2016, MOLECULES, V21, DOI 10.3390/molecules21111488; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Bhutani P, 2021, J MED CHEM, V64, P2339, DOI 10.1021/acs.jmedchem.0c01786; Bren U, 2012, J CHEM INF MODEL, V52, P1573, DOI 10.1021/ci300118x; Burk O, 2002, J BIOL CHEM, V277, P24280, DOI 10.1074/jbc.M202345200; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DEGROENE EM, 1995, BIOCHEM PHARMACOL, V50, P771, DOI 10.1016/0006-2952(95)00197-8; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Denisov IG, 2012, ARCH BIOCHEM BIOPHYS, V519, P91, DOI 10.1016/j.abb.2011.12.017; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eraikhuemen N, 2021, INFECT DIS THER, V10, P149, DOI 10.1007/s40121-020-00378-3; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hackett JC, 2018, J BIOL CHEM, V293, P4037, DOI 10.1074/jbc.RA117.000961; Hlavica P, 2017, J INORG BIOCHEM, V167, P100, DOI 10.1016/j.jinorgbio.2016.11.025; Hsu MH, 2019, J BIOL CHEM, V294, P8015, DOI 10.1074/jbc.RA119.007928; Hsu MH, 2018, MOL PHARMACOL, V93, P14, DOI 10.1124/mol.117.109744; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Koudriakova T, 1998, DRUG METAB DISPOS, V26, P552; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lim HK, 2005, DRUG METAB DISPOS, V33, P1211, DOI 10.1124/dmd.104.003475; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OMURA T, 1964, J BIOL CHEM, V239, P2379; Parmentier Y, 2017, XENOBIOTICA, V47, P562, DOI 10.1080/00498254.2016.1208854; Perloff ES, 2009, XENOBIOTICA, V39, P99, DOI 10.1080/00498250802638155; Sevrioukova IF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174245; Sevrioukova IF, 2013, BIOCHEMISTRY-US, V52, P4474, DOI 10.1021/bi4005396; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Stresser DM, 2004, DRUG METAB DISPOS, V32, P105, DOI 10.1124/dmd.32.1.105; Strickmann DB, 2021, J PHARMACEUT BIOMED, V205, DOI 10.1016/j.jpba.2021.114293; Sun FF, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02388-17, 10.1128/aac.02388-17]; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Williams JA, 2002, DRUG METAB DISPOS, V30, P883, DOI 10.1124/dmd.30.8.883; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yamazaki H, 2010, BRIT J CLIN PHARMACO, V69, P593, DOI 10.1111/j.1365-2125.2010.03656.x; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang GY, 2020, BIOORG CHEM, V105, DOI 10.1016/j.bioorg.2020.104398; Zweers-Zeilmaker WM, 1999, RES VET SCI, V66, P51, DOI 10.1053/rvsc.1998.0239	45	1	1	9	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101909	10.1016/j.jbc.2022.101909	http://dx.doi.org/10.1016/j.jbc.2022.101909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35398097	gold, Green Published			2022-12-28	WOS:000804436700005
J	Ikegaya, M; Moriya, T; Adachi, N; Kawasaki, M; Park, EY; Miyazaki, T				Ikegaya, Marina; Moriya, Toshio; Adachi, Naruhiko; Kawasaki, Masato; Park, Enoch Y.; Miyazaki, Takatsugu			Structural basis of the strict specificity of a bacterial GH31 a-1,3-glucosidase for nigerooligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEAM-INDUCED MOTION; ALPHA-GLUCOSIDASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; CRYO-EM; EVOLUTIONARY CONSERVATION; FAMILY 31; CD-HIT; HYDROLASE; PROTEIN	Carbohydrate-active enzymes are involved in the degradation, biosynthesis, and modification of carbohydrates and vary with the diversity of carbohydrates. The glycoside hydrolase (GH) family 31 is one of the most diverse families of carbohydrate-active enzymes, containing various enzymes that act on alpha-glycosides. However, the function of some GH31 groups remains unknown, as their enzymatic activity is difficult to estimate due to the low amino acid sequence similarity between characterized and uncharacterized members. Here, we performed a phylogenetic analysis and discovered a protein cluster (GH31_u1) sharing low sequence similarity with the reported GH31 enzymes. Within this cluster, we showed that a GH31_u1 protein from Lactococcus lactis (LlGH31_u1) and its fungal homolog demonstrated hydrolytic activities against nigerose [alpha-D-Glcp-(1 & RARR;3)-D-Glc]. The kcat/Km values of LlGH31_u1 against kojibiose and maltose were 13% and 2.1% of that against nigerose, indicating that LlGH31_u1 has a higher specificity to the alpha-1,3 linkage of nigerose than other characterized GH31 enzymes, including eukaryotic enzymes. Furthermore, the three-dimensional structures of LlGH31_u1 determined using X-ray crystallography and cryogenic electron microscopy revealed that LlGH31_u1 forms a hexamer and has a C-terminal domain comprising four alpha-helices, suggesting that it contributes to hexamerization. Finally, crystal structures in complex with nigerooligosaccharides and kojibiose along with mutational analysis revealed the active site residues involved in substrate recognition in this enzyme. This study reports the first structure of a bacterial GH31 alpha-1,3-glucosidase and provides new insight into the substrate specificity of GH31 enzymes and the physiological functions of bacterial and fungal GH31_u1 members.	[Ikegaya, Marina; Park, Enoch Y.; Miyazaki, Takatsugu] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka, Japan; [Moriya, Toshio; Adachi, Naruhiko; Kawasaki, Masato] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Kawasaki, Masato] Grad Univ Adv Studies Soken Dai, Sch High Energy Accelerator Sci, Dept Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Park, Enoch Y.; Miyazaki, Takatsugu] Shizuoka Univ, Res Inst Green Sci & Technol, Shizuoka, Japan	Shizuoka University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Shizuoka University	Miyazaki, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Shizuoka, Japan.; Miyazaki, T (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Shizuoka, Japan.	miyazaki.takatsugu@shizuoka.ac.jp	; Miyazaki, Takatsugu/M-1498-2016	Park, Enoch Y./0000-0002-7840-1424; Moriya, Toshio/0000-0001-7226-5487; Miyazaki, Takatsugu/0000-0003-1809-0641	Platform Project for Supporting Drug Discovery and Life Science Research [Basis of Supporting Innovative Drug Discovery and Life Science Research (BINDS) ] from AMED [JP21am0101071, 2932]	Platform Project for Supporting Drug Discovery and Life Science Research [Basis of Supporting Innovative Drug Discovery and Life Science Research (BINDS) ] from AMED	We thank the staff of the Photon Factory for their assistance with X-ray data collection as well as the staff of the cryo-EM facility in KEK for their assistance with cryo-EM data collection. We also thank Dr Ahmad Suparmin for preparing the cDNA of C. militaris, Enago ( www.enago.jp) for the English language review and Prof. Toshiya Senda for managing cryo-EM data collections. The X-ray crystallographic study was approved by the Photon Factory Program Advisory Committee (proposals 2019G097 and 2021G013) . This research was supported by Platform Project for Supporting Drug Discovery and Life Science Research [Basis of Supporting Innovative Drug Discovery and Life Science Research (BINDS) ] from AMED under Grant Number JP21am0101071 (support number 2932) .	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barrett K, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1436-5; Bounaix MS, 2009, J AGR FOOD CHEM, V57, P10889, DOI 10.1021/jf902068t; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Caputo AT, 2016, P NATL ACAD SCI USA, V113, pE4630, DOI 10.1073/pnas.1604463113; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chang ST, 2001, METHOD ENZYMOL, V330, P260; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cote GL, 2012, APPL MICROBIOL BIOT, V93, P2387, DOI 10.1007/s00253-011-3562-2; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Drula E, 2022, NUCLEIC ACIDS RES, V50, pD571, DOI 10.1093/nar/gkab1045; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Fisher OS, 2013, FEBS LETT, V587, P272, DOI 10.1016/j.febslet.2012.12.011; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garron ML, 2019, CURR OPIN CHEM BIOL, V53, P82, DOI 10.1016/j.cbpa.2019.08.004; Gozu Y, 2016, BIOSCI BIOTECH BIOCH, V80, P1562, DOI 10.1080/09168451.2016.1182852; GRAY GM, 1979, J BIOL CHEM, V254, P6038; Helbert W, 2019, P NATL ACAD SCI USA, V116, P6063, DOI 10.1073/pnas.1815791116; Higgins MA, 2021, ACS CHEM BIOL, V16, P701, DOI 10.1021/acschembio.0c00995; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ikegaya M, 2021, INSECT MOL BIOL, V30, P367, DOI 10.1111/imb.12701; Jones DR, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1027-x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang MS, 2009, BIOCHIMIE, V91, P1434, DOI 10.1016/j.biochi.2009.07.018; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larsbrink J, 2012, J BIOL CHEM, V287, P43288, DOI 10.1074/jbc.M112.416511; Lee BH, 2016, J AGR FOOD CHEM, V64, P6487, DOI 10.1021/acs.jafc.6b01816; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Light SH, 2017, STRUCTURE, V25, P295, DOI 10.1016/j.str.2016.12.007; Lodge JA, 2003, J BIOL CHEM, V278, P19151, DOI 10.1074/jbc.M211626200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Ma M, 2019, J AGR FOOD CHEM, V67, P3380, DOI 10.1021/acs.jafc.8b07087; Ma M, 2017, APPL MICROBIOL BIOT, V101, P6399, DOI 10.1007/s00253-017-8402-6; Malik A, 2009, FEMS MICROBIOL LETT, V300, P131, DOI 10.1111/j.1574-6968.2009.01772.x; MATSUI H, 1984, J BIOCHEM, V96, P993, DOI 10.1093/oxfordjournals.jbchem.a134958; Miyazaki T, 2020, FEBS LETT, V594, P2282, DOI 10.1002/1873-3468.13804; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Miyazaki T, 2013, FEBS J, V280, P4560, DOI 10.1111/febs.12424; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Okuyama M, 2017, BIOSCI BIOTECH BIOCH, V81, P1503, DOI 10.1080/09168451.2017.1320520; Okuyama M, 2016, CELL MOL LIFE SCI, V73, P2727, DOI 10.1007/s00018-016-2247-5; Okuyama M, 2011, BIOSCI BIOTECH BIOCH, V75, P2269, DOI 10.1271/bbb.110610; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Rahfeld P, 2019, J BIOL CHEM, V294, P16400, DOI 10.1074/jbc.RA119.010628; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rozeboom HJ, 2013, J BIOL CHEM, V288, P26764, DOI 10.1074/jbc.M113.485896; Satoh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20575; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Speciale G, 2016, NAT CHEM BIOL, V12, P215, DOI [10.1038/NCHEMBIO.2023, 10.1038/nchembio.2023]; Tagami T, 2016, J BIOL CHEM, V291, P16438, DOI 10.1074/jbc.M116.727305; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsutsumi K, 2020, FEBS J, V287, P1195, DOI 10.1111/febs.15074; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu J, 2020, BIOINFORMATICS, V36, P2068, DOI 10.1093/bioinformatics/btz908; Yoshimi A, 2016, BIOSCI BIOTECH BIOCH, V80, P1700, DOI 10.1080/09168451.2016.1177446; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	81	2	2	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101827	10.1016/j.jbc.2022.101827	http://dx.doi.org/10.1016/j.jbc.2022.101827			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35293315	Green Published, gold			2022-12-28	WOS:000798142000011
J	McGrath, SL; Huang, SH; Kobryn, K				McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri			The N-terminal domain of the Agrobacterium tumefaciens telomere resolvase, TelA, regulates its DNA cleavage and rejoining activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; BORRELIA-BURGDORFERI; BIDIRECTIONAL REPLICATION; ESCHERICHIA-COLI; PLASMID PROPHAGE; REST; PROTELOMERASE; RECOMBINASE; SEQUENCE; GENOME	Linear replicons can be found in a minority of prokaryotic organisms, including Borrelia species and Agrobacterium tumefaciens. The problem with replicating the lagging strand end of linear DNAs is circumvented in these organisms by the presence of covalently closed DNA hairpin telomeres at the DNA termini. Telomere resolvases are enzymes responsible for generating these hairpin telomeres from a dimeric replication intermediate through a two-step DNA cleavage and rejoining reaction referred to as telomere resolution. It was previously shown that the agrobacterial telomere resolvase, TelA, possesses ssDNA annealing activity in addition to telomere resolution activity. The annealing activity derives, chiefly, from the N-terminal domain. This domain is dispensable for telomere resolution. In this study, we used activity analyses of an N-terminal domain deletion mutant, domain add back experiments, and protein-protein interaction studies and we report that the N-terminal domain of TelA is involved in inhibitory interactions with the remainder of TelA that are relieved by the binding of divalent metal ions. We also found that the regulation of telomere resolution by the N-terminal domain of TelA extends to suppression of inappropriate enzymatic activity, including hairpin telomere fusion (reaction reversal) and recombination between replicated telomeres to form a Holliday junction.	[McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada.				University of Saskatchewan CoMRAD award; NSERC Discovery Grant [RGPIN 04382-2017]	University of Saskatchewan CoMRAD award; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	FS. L. M. was supported by a University of Saskatchewan CoMRAD award. K. K. was supported by an NSERC Discovery Grant (RGPIN 04382-2017) .	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bandy NJ, 2014, J BACTERIOL, V196, P2396, DOI 10.1128/JB.01435-13; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Cui TL, 2007, EMBO REP, V8, P181, DOI 10.1038/sj.embor.7400880; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dorokhov B. D., 2004, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P28; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; Huang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187382; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Huang WM, 2012, J BIOL CHEM, V287, P25551, DOI 10.1074/jbc.M112.369488; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kashammer L, 2019, MOL CELL, V76, P382, DOI 10.1016/j.molcel.2019.07.035; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0023-2014; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Lu C, 2015, CELL REP, V10, P29, DOI 10.1016/j.celrep.2014.12.001; Lucyshyn D, 2015, NUCLEIC ACIDS RES, V43, P6062, DOI 10.1093/nar/gkv497; McGrath SL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246212; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Shi K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001472; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Unnikrishnan A, 2020, P NATL ACAD SCI USA, V117, P24849, DOI 10.1073/pnas.2011448117	36	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101951	10.1016/j.jbc.2022.101951	http://dx.doi.org/10.1016/j.jbc.2022.101951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35447111	Green Published, gold			2022-12-28	WOS:000817175700008
J	Tamura, S; Mukaide, M; Katsuragi, Y; Fujii, W; Odaira, K; Suzuki, N; Tsukiji, N; Okamoto, S; Suzuki, A; Kanematsu, T; Katsumi, A; Takagi, A; Ikeda, K; Ueyama, J; Hirayama, M; Suzuki-Inoue, K; Matsushita, T; Kojima, T; Hayakawa, F				Tamura, Shogo; Mukaide, Masato; Katsuragi, Yumi; Fujii, Wataru; Odaira, Koya; Suzuki, Nobuaki; Tsukiji, Nagaharu; Okamoto, Shuichi; Suzuki, Atsuo; Kanematsu, Takeshi; Katsumi, Akira; Takagi, Akira; Ikeda, Katsuhide; Ueyama, Jun; Hirayama, Masaaki; Suzuki-Inoue, Katsue; Matsushita, Tadashi; Kojima, Tetsuhito; Hayakawa, Fumihiko			Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BONE-MARROW; STEM-CELLS; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; EMBRYONIC LETHALITY; RECEPTOR CLEC-2; ANGIOGENESIS; GROWTH; NICHE	Bone marrow development and endochondral bone formation occur simultaneously. During endochondral ossification, periosteal vasculatures and stromal progenitors invade the primary avascular cartilaginous anlage, which induces primitive marrow development. We previously determined that bone marrow podoplanin (PDPN)-expressing stromal cells exist in the perivascular microenvironment and promote megakaryopoiesis and erythropoiesis. In this study, we aimed to examine the involvement of PDPN-expressing stromal cells in postnatal bone marrow generation. Using histological analysis, we observed that periosteum-derived PDPN-expressing stromal cells infiltrated the cartilaginous anlage of the postnatal epiphysis and populated on the primitive vasculature of secondary ossification center. Furthermore, immunophenotyping and cellular characteristic analyses indicated that the PDPNexpressing stromal cells constituted a subpopulation of the skeletal stem cell lineage. In vitro xenovascular model cocultured with human umbilical vein endothelial cells and PDPN-expressing skeletal stem cell progenies showed that PDPN-expressing stromal cells maintained vascular integrity via the release of angiogenic factors and vascular basement membrane-related extracellular matrices. We show that in this process, Notch signal activation committed the PDPNexpressing stromal cells into a dominant state with basement membrane-related extracellular matrices, especially type IV collagens. Our findings suggest that the PDPN-expressing stromal cells regulate the integrity of the primitive vasculatures in the epiphyseal nascent marrow. To the best of our knowledge, this is the first study to comprehensively examine how PDPN-expressing stromal cells contribute to marrow development and homeostasis.	[Tamura, Shogo; Mukaide, Masato; Katsuragi, Yumi; Fujii, Wataru; Odaira, Koya; Ikeda, Katsuhide; Ueyama, Jun; Hirayama, Masaaki; Kojima, Tetsuhito; Hayakawa, Fumihiko] Nagoya Univ, Dept Integrated Hlth Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Suzuki, Nobuaki; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan; [Tsukiji, Nagaharu; Suzuki-Inoue, Katsue] Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, Kofu, Yamanashi, Japan; [Okamoto, Shuichi; Kanematsu, Takeshi; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Suzuki, Atsuo] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Katsumi, Akira] Natl Ctr Geriatr & Gerontol, Dept Hematol, Obu City, Japan; [Takagi, Akira] Shubun Univ, Dept Med Technol, Ichinomiya, Japan; [Kojima, Tetsuhito] Aichi Hlth Promot Fdn, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; University of Yamanashi; Nagoya University; Nagoya University; National Center for Geriatrics & Gerontology	Tamura, S (corresponding author), Nagoya Univ, Dept Integrated Hlth Sci, Grad Sch Med, Nagoya, Aichi, Japan.	stamura@met.nagoya-u.ac.jp	Ikeda, Katsuhide/GWZ-6640-2022	ODAIRA, Koya/0000-0001-8523-7119	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17H05073, 19K08853]; National Center for Geriatrics and Gerontology (NCGG) [30-11]; Takeda Science Foundation; SENSHIN Medical Research Foundation; Daiichi Sankyo; Chugai Pharmaceutical Co, Ltd; MSD; Astellas Pharma Inc	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Geriatrics and Gerontology (NCGG); Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi Sankyo(Daiichi Sankyo Company Limited); Chugai Pharmaceutical Co, Ltd; MSD; Astellas Pharma Inc(Astellas Pharmaceuticals)	This study was supported by grants-in-aid provided by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grant No. 17H05073: S. T and Grant No. 19K08853: A. K) , the National Center for Geriatrics and Gerontology (NCGG, the Research Funding for Longevity Sciences, Grant No. 30-11: A. K) , the Takeda Science Foundation (S. T) , and the SENSHIN Medical Research Foundation (S. T) . F. H. received research funding from Daiichi Sankyo, Chugai Pharmaceutical Co, Ltd, Astellas Pharma Inc, and MSD.	Ambrosi TH, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00189; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Baccin C, 2020, NAT CELL BIOL, V22, P38, DOI 10.1038/s41556-019-0439-6; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bianco Paolo, 2015, Development, V142, P1023, DOI 10.1242/dev.102210; Blache U, 2018, EMBO REP, V19, DOI 10.15252/embr.201845964; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; de Lageneste OD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03124-z; Deveza L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190909; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Gale N. W., 2004, PROC; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hanoun M, 2013, CELL STEM CELL, V12, P391, DOI 10.1016/j.stem.2013.03.012; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Isogai C, 2001, CANCER RES, V61, P5587; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Matsushita Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14029-w; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mizuhashi K, 2018, NATURE, V563, P254, DOI 10.1038/s41586-018-0662-5; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Murakami M, 2009, J MOL MED, V87, P571, DOI 10.1007/s00109-009-0463-2; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ortinau LC, 2019, CELL STEM CELL, V25, P784, DOI 10.1016/j.stem.2019.11.003; Otake S, 2021, J THROMB HAEMOST, V19, P1572, DOI 10.1111/jth.15317; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Quintero-Fabian S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01370; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suzuki-Inoue K., 2006, NOVEL-FORUM FICT; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tamura S, 2016, BLOOD, V127, P1701, DOI 10.1182/blood-2015-08-663708; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tournaire G, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115259; Tsukiji N, 2018, BLOOD, V132, P1167, DOI 10.1182/blood-2017-12-823369; Worthley D. L., 2015, GREMLIN 1 IDENTIFIES; Wu J., 2015, ARTERIOSCL THROM VAS; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yue R, 2016, CELL STEM CELL, V18, P782, DOI 10.1016/j.stem.2016.02.015; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	70	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101833	10.1016/j.jbc.2022.101833	http://dx.doi.org/10.1016/j.jbc.2022.101833			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35304101	Green Submitted, Green Published, gold			2022-12-28	WOS:000793483000002
J	Futerman, AH; Kim, JL; Mestre, B; Malitsky, S; Itkin, M; Kupervaser, M				Futerman, Anthony H.; Kim, Jiyoon L.; Mestre, Beatriz; Malitsky, Sergey; Itkin, Maxim; Kupervaser, Meital			Fatty acid transport protein 2 interacts with ceramide synthase 2 to promote ceramide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; FAMILY-MEMBERS; INHIBITION; GENES; IDENTIFICATION; METABOLISM; PHOSPHORYLATION; SPHINGOLIPIDS; NEUTROPHILS; CLONING	Dihydroceramide is a lipid molecule generated via the action of (dihydro)ceramide synthases (CerSs), which use two substrates, namely sphinganine and fatty acyl-CoAs. Sphinganine is generated via the sequential activity of two integral membrane proteins located in the endoplasmic reticulum. Less is known about the source of the fatty acyl-CoAs, although a number of cytosolic proteins in the pathways of acyl-CoA generation modulate ceramide synthesis via direct or indirect interaction with the CerSs. In this study, we demonstrate, by proteomic analysis of immunoprecipitated known as very long-chain acyl-CoA synthetase) directly interacts with CerS2 in mouse liver. Studies in cultured cells demonstrated that other members of the FATP family can also interact with CerS2, with the interaction dependent on both proteins being catalytically active. In addition, transfection of cells with FATP1, FATP2, or FATP4 increased ceramide levels although only FATP2 and 4 increased dihydroceramide levels, consistent with their known intracellular locations. Finally, we show that lipofermata, an FATP2 inhibitor which is believed to directly impact tumor cell growth via modulation of FATP2, decreased de novo dihydroceramide synthesis, suggesting that some of the proposed therapeutic effects of lipofermata may be mediated via (dihydro)ceramide rather than directly via acyl-CoA generation. In summary, our study reinforces the idea that manipulating the pathway of fatty acyl-CoA generation will impact a wide variety of down-stream lipids, not least the sphingolipids, which utilize two acyl-CoA moieties in the initial steps of their synthesis.	[Futerman, Anthony H.; Kim, Jiyoon L.; Kupervaser, Meital] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Mestre, Beatriz; Malitsky, Sergey] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel; [Itkin, Maxim] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.	tony.futerman@weizmann.ac.il	Itkin, Maxim/AFU-5181-2022	Itkin, Maxim/0000-0003-1348-2814; Kupervaser, Meital/0000-0002-1068-937X	Israel Science Foundation [1466/19]; Minerva Foundation; Walt and Rowena Shaw Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Walt and Rowena Shaw Foundation	We thank Dr Yael Pewzner-Yung for help with design of the coimmunoprecipitation experiments using CerS2 mouse null liver and Dr Tamir Dingjan for help with Figure 6. This work was supported by the Israel Science Foundation (grant number 1466/19) , the Minerva Foundation, and the Walt and Rowena Shaw Foundation. A. H. F. is the Joseph Meyerhoff Professor of Biochemistry at the Weizmann Institute of Science, Rehovot, Israel.	Ahowesso C, 2015, BIOCHEM PHARMACOL, V98, P167, DOI 10.1016/j.bcp.2015.09.004; Alicea GM, 2020, CANCER DISCOV, V10, P1282, DOI 10.1158/2159-8290.CD-20-0329; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bickert A, 2018, BBA-MOL CELL BIOL L, V1863, P734, DOI 10.1016/j.bbalip.2018.04.006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brachtendorf S, 2019, PROG LIPID RES, V74, P160, DOI 10.1016/j.plipres.2019.04.002; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Dingjan T, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202100021; Elinger D, 2019, J PROTEOME RES, V18, P1441, DOI 10.1021/acs.jproteome.8b00891; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Ferreira NS, 2017, J BIOL CHEM, V292, P7588, DOI 10.1074/jbc.M117.785345; Fresques T, 2015, J BIOL CHEM, V290, P1395, DOI 10.1074/jbc.M114.621086; Futerman A. H., 2021, SPHINGOLIPIDS, V9, P281; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Kim JL, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101517; Kim JL, 2021, CELL SIGNAL, V82, DOI 10.1016/j.cellsig.2021.109958; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lin MH, 2014, BBA-MOL CELL BIOL L, V1841, P362, DOI 10.1016/j.bbalip.2013.09.016; Magaye RR, 2019, CELL MOL LIFE SCI, V76, P1107, DOI 10.1007/s00018-018-2984-8; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sandoval A, 2008, ARCH BIOCHEM BIOPHYS, V477, P363, DOI 10.1016/j.abb.2008.06.010; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tomasello DL, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103551; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; WANG E, 1991, J BIOL CHEM, V266, P14486; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Wellenstein MD, 2019, CANCER CELL, V35, P827, DOI 10.1016/j.ccell.2019.05.007; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang MM, 2018, CANCER DISCOV, V8, P1006, DOI 10.1158/2159-8290.CD-17-1371	53	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101735	10.1016/j.jbc.2022.101735	http://dx.doi.org/10.1016/j.jbc.2022.101735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35181339	Green Published, gold			2022-12-28	WOS:000797895000006
J	Reardon, SD; Mishanina, TV				Reardon, Sean D.; Mishanina, Tatiana, V			Phosphorylation and acetylation of mitochondrial transcription factor A promote transcription processivity without compromising initiation or DNA compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MYCOBACTERIUM-TUBERCULOSIS; HUMAN TFAM; BINDING; REPLICATION; ORGANIZATION; MECHANISMS; NUCLEOIDS; DYNAMICS; CONTAIN	Mitochondrial transcription factor A (TFAM) plays important roles in mitochondrial DNA compaction, transcription initiation, and in the regulation of processes like transcription and replication processivity. It is possible that TFAM is locally regulated within the mitochondrial matrix via such mechanisms as phosphorylation by protein kinase A and nonenzymatic acetylation by acetyl-CoA. Here, we demonstrate that DNA-bound TFAM is less susceptible to these modifications. We confirmed using EMSAs that phosphorylated or acetylated TFAM compacted circular double-stranded DNA just as well as unmodified TFAM and provide an in-depth analysis of acetylated sites on TFAM. We show that both modifications of TFAM increase the processivity of mitochondrial RNA polymerase during transcription through TFAM-imposed barriers on DNA, but that TFAM bearing either modification retains its full activity in transcription initiation. We conclude that TFAM phosphorylation by protein kinase A and nonenzymatic acetylation by acetyl-CoA are unlikely to occur at the mitochondrial DNA and that modified free TFAM retains its vital functionalities like compaction and transcription initiation while enhancing transcription processivity.	[Reardon, Sean D.; Mishanina, Tatiana, V] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mishanina, TV (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tmishanina@ucsd.edu		Reardon, Sean/0000-0002-6439-4593	NIH/NIGMS (ESI) [R35 GM142785-01]; NIH Multi-Scale Analysis of Biological Structure and Function Training Grant [T32 EB009380]; Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship	NIH/NIGMS (ESI); NIH Multi-Scale Analysis of Biological Structure and Function Training Grant; Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship	This work was supported by NIH/NIGMS (ESI) R35 GM142785-01, UCSD institutional support and Yinan Wang Memorial Chancellor's Endowed Junior Faculty Fellowship to T. V. M., and NIH Multi-Scale Analysis of Biological Structure and Function Training Grant (T32 EB009380) to S. D. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Amer YO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218283; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Baeza J, 2020, J PROTEOME RES, V19, P2404, DOI 10.1021/acs.jproteome.0c00088; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bonekamp NA, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202101034; Bouchez C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040287; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Fang Y, 2020, MITOCHONDRION, V53, P99, DOI 10.1016/j.mito.2020.05.003; Farge G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112770; Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046; Ghosh S, 2016, MOL MICROBIOL, V100, P577, DOI 10.1111/mmi.13339; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gupta M, 2014, J BACTERIOL, V196, P2646, DOI 10.1128/JB.01625-14; Hebert-Chatelain E., 2016, CANNABINOID; Hennrich ML, 2013, J PROTEOME RES, V12, P2214, DOI 10.1021/pr400074f; Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; King GA, 2018, NUCLEIC ACIDS RES, V46, P3633, DOI 10.1093/nar/gky204; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Liu H, 2018, J PROTEOME RES, V17, P3143, DOI 10.1021/acs.jproteome.8b00260; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Lyonnais S., 2017, SCI; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Ngo Huu B, 2014, Nat Commun, V5, P3077, DOI 10.1038/ncomms4077; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157; Sardanelli AM, 1996, FEBS LETT, V396, P276, DOI 10.1016/0014-5793(96)01112-X; Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Technikova-Dobrova Z, 2001, BIOCHEMISTRY-US, V40, P13941, DOI 10.1021/bi011066p; Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008; West A. P., 2015, MITOCHONDRIAL DNA ST	46	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101815	10.1016/j.jbc.2022.101815	http://dx.doi.org/10.1016/j.jbc.2022.101815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35278431	gold, Green Published			2022-12-28	WOS:000793694800004
J	Shan, ZL; Ghadirian, N; Lyumkis, D; Horton, NC				Shan, Zelin; Ghadirian, Niloofar; Lyumkis, Dmitry; Horton, Nancy C.			Pretransition state and apo structures of the filament-forming enzyme SgrAI elucidate mechanisms of activation and substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RESTRICTION-ENDONUCLEASE; DNA-POLYMERASE-I; CRYO-EM; ECORV ENDONUCLEASE; METABOLIC ENZYMES; METAL-IONS; SEQUENCE SELECTIVITY; CRYSTAL-STRUCTURES; BASE-STACKING; CLEAVAGE	Enzyme filamentation is a widespread phenomenon that mediates enzyme regulation and function. For the filament forming sequence-specific DNA endonuclease SgrAI, the process of filamentation both accelerates its DNA cleavage activity and expands its DNA sequence specificity, thus allowing for many additional DNA sequences to be rapidly cleaved. Both outcomes-the acceleration of DNA cleavage and the expansion of sequence specificity-are proposed to regulate critical processes in bacterial innate immunity. However, the mechanistic bases underlying these events remain unclear. Herein, we describe two new structures of the SgrAI enzyme that shed light on its catalytic function. First, we present the cryo-EM structure of filamentous SgrAI bound to intact primary site DNA and Ca2+ resolved to similar to 2.5 angstrom within the catalytic center, which represents the trapped enzyme-DNA complex prior to the DNA cleavage reaction. This structure reveals important conformational changes that contribute to the catalytic mechanism and the binding of a second divalent cation in the enzyme active site, which is expected to contribute to increased DNA cleavage activity of SgrAI in the filamentous state. Second, we present an X-ray crystal structure of DNA-free (apo) SgrAI resolved to 2.0 angstrom resolution, which reveals a disordered loop involved in DNA recognition. Collectively, these multiple new observations clarify the mechanism of expansion of DNA sequence specificity of SgrAI, including the indirect readout of sequence-dependent DNA structure, changes in protein-DNA interactions, and the disorder-to-order transition of a crucial DNA recognition element.	[Shan, Zelin; Lyumkis, Dmitry] Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA; [Ghadirian, Niloofar] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Lyumkis, Dmitry] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Horton, Nancy C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Salk Institute; University of Arizona; Scripps Research Institute; University of Arizona	Lyumkis, D (corresponding author), Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Horton, NC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	dlyumkis@salk.edu; nhorton@email.arizona.edu			National Science Foundation [MCB-1934291]; Hearst Foundations	National Science Foundation(National Science Foundation (NSF)); Hearst Foundations	Research reported in this publication was supported by the National Science Foundation under grant no. MCB-1934291 (to N. C. H. and D. L.) and by the Hearst Foundations (to D. L.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; Aiyer S, 2021, METHODS MOL BIOL, V2215, P161, DOI 10.1007/978-1-0716-0966-8_8; Babic AC, 2008, J MOL BIOL, V383, P186, DOI 10.1016/j.jmb.2008.08.032; Baldwin PR, 2021, PROG BIOPHYS MOL BIO, V160, P53, DOI 10.1016/j.pbiomolbio.2020.06.003; Baldwin PR, 2020, PROG BIOPHYS MOL BIO, V150, P160, DOI 10.1016/j.pbiomolbio.2019.09.002; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; BRODY RS, 1981, BIOCHEMISTRY-US, V20, P1245, DOI 10.1021/bi00508a030; BROWN ID, 1988, ACTA CRYSTALLOGR B, V44, P545, DOI 10.1107/S0108768188007712; BURGERS PMJ, 1979, BIOCHEMISTRY-US, V18, P450, DOI 10.1021/bi00570a010; Carcamo WC, 2014, INT REV CEL MOL BIO, V308, P35, DOI 10.1016/B978-0-12-800097-7.00002-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AC, 2021, PROTEIN SCI, V30, P136, DOI 10.1002/pro.3967; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; DeLano W.L, PYMOL MOL GRAPHICS S; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Etzkorn C, 2004, J MOL BIOL, V343, P833, DOI 10.1016/j.jmb.2004.08.082; Etzkorn C, 2004, BIOCHEMISTRY-US, V43, P13256, DOI 10.1021/bi0490082; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fasman G. D, 1975, CRC HDB BIOCH MOL BI, V3rd; FOTHERGILL M, 1995, J AM CHEM SOC, V117, P11619, DOI 10.1021/ja00152a001; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grosse-Kunstleve RW, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-5; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Horton JR, 2000, J MOL BIOL, V300, P1049, DOI 10.1006/jmbi.2000.3938; Horton NC, 2008, RSC BIOMOL SCI, P333; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Horton NC, 1998, J BIOL CHEM, V273, P21721, DOI 10.1074/jbc.273.34.21721; Horton NC, 1998, J MOL BIOL, V277, P779, DOI 10.1006/jmbi.1998.1655; Horton NC, 2000, J AM CHEM SOC, V122, P3314, DOI 10.1021/ja993719j; Horton NC, 2002, BIOCHEMISTRY-US, V41, P10754, DOI 10.1021/bi020305l; Horton NC, 2002, NAT STRUCT BIOL, V9, P42, DOI 10.1038/nsb741; Horton NC, 1998, P NATL ACAD SCI USA, V95, P13489, DOI 10.1073/pnas.95.23.13489; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Little EJ, 2008, STRUCTURE, V16, P1828, DOI 10.1016/j.str.2008.09.009; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Lynch EM, 2020, CURR OPIN CELL BIOL, V66, P28, DOI 10.1016/j.ceb.2020.04.006; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Martin AM, 1999, BIOCHEMISTRY-US, V38, P8430, DOI 10.1021/bi9905359; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mizuuchi K, 1999, BIOCHEMISTRY-US, V38, P4640, DOI 10.1021/bi990054p; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2019, MOL BIOL CELL, V30, P2721, DOI 10.1091/mbc.E19-04-0224; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Park CK, 2020, NAT REV MOL CELL BIO, V21, P1, DOI 10.1038/s41580-019-0188-1; Park Chad K, 2019, Biophys Rev, V11, P927, DOI 10.1007/s12551-019-00602-6; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polley S, 2019, STRUCTURE, V27, P1497, DOI 10.1016/j.str.2019.08.001; Prouteau M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040160; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Sagendorf JM, 2020, NUCLEIC ACIDS RES, V48, pD277, DOI 10.1093/nar/gkz889; Sagendorf JM, 2017, NUCLEIC ACIDS RES, V45, pW89, DOI 10.1093/nar/gkx272; Sam MD, 2001, J MOL BIOL, V306, P851, DOI 10.1006/jmbi.2000.4434; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124783; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Simonet JC, 2020, MOL BIOL CELL, V31, P1201, DOI 10.1091/mbc.E18-10-0675; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAUTZ N, 1990, NUCLEIC ACIDS RES, V18, P3087, DOI 10.1093/nar/18.10.3087; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P1113, DOI 10.1021/bi00004a002; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	98	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101760	10.1016/j.jbc.2022.101760	http://dx.doi.org/10.1016/j.jbc.2022.101760			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35202658	Green Published, gold			2022-12-28	WOS:000793617400007
J	Bresque, M; Cal, K; Perez-Torrado, V; Colman, L; Rodriguez-Duarte, J; Vilaseca, C; Santos, L; Garat, MP; Ruiz, S; Evans, F; Dapueto, R; Contreras, P; Calliari, A; Escande, C				Bresque, Mariana; Cal, Karina; Perez-Torrado, Valentina; Colman, Laura; Rodriguez-Duarte, Jorge; Vilaseca, Cecilia; Santos, Leonardo; Garat, Maria Pia; Ruiz, Santiago; Evans, Frances; Dapueto, Rosina; Contreras, Paola; Calliari, Aldo; Escande, Carlos			SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; DEACETYLASE SIRT6; FATTY-ACIDS; ALPHA; OBESITY; DEGRADATION; ACTIVATION; EXPRESSION	Acute and chronic inflammations are key homeostatic events in health and disease. Sirtuins (SIRTs), a family of NAD-dependent protein deacylases, play a pivotal role in the regulation of these inflammatory responses. Indeed, SIRTs have anti-inflammatory effects through a myriad of signaling cascades, including histone deacetylation and gene silencing, p65/RelA deacetylation and inactivation, and nucleotide-binding oligomerization domain, leucine rich repeat, and pyrin domain-containing protein 3 inflammasome inhibition. Nevertheless, recent findings show that SIRTs, specifically SIRT6, are also necessary for mounting an active inflammatory response in macrophages. SIRT6 has been shown to positively regulate tumor necrosis factor alpha (TNF alpha) secretion by demyristoylating pro-TNF alpha in the cytoplasm. However, how SIRT6, a nuclear chromatin-binding protein, fulfills this function in the cytoplasm is currently unknown. Herein, we show by Western blot and immunofluorescence that in macrophages and fibroblasts there is a subpopulation of SIRT6 that is highly unstable and quickly degraded via the proteasome. Upon lipopolysaccharide stimulation in Raw 264.7, bone marrow, and peritoneal macrophages, this population of SIRT6 is rapidly stabilized and localizes in the cytoplasm, specifically in the vicinity of the endoplasmic reticulum, promoting TNF alpha secretion. Furthermore, we also found that acute SIRT6 inhibition dampens TNF alpha secretion both in vitro and in vivo, decreasing lipopolysaccharide-induced septic shock. Finally, we tested SIRT6 relevance in systemic inflammation using an obesity-induced chronic inflammatory in vivo model, where TNF alpha plays a key role, and we show that short-term genetic deletion of SIRT6 in macrophages of obese mice ameliorated systemic inflammation and hyperglycemia, suggesting that SIRT6 plays an active role in inflammation-mediated glucose intolerance during obesity.	[Bresque, Mariana; Cal, Karina; Perez-Torrado, Valentina; Colman, Laura; Santos, Leonardo; Garat, Maria Pia; Ruiz, Santiago; Dapueto, Rosina; Contreras, Paola; Calliari, Aldo; Escande, Carlos] Inst Pasteur Montevideo, INDICYO Program, Lab Metab Dis & Aging, Montevideo, Uruguay; [Bresque, Mariana; Rodriguez-Duarte, Jorge; Dapueto, Rosina] Inst Pasteur Montevideo, INDICYO Program, Lab Vasc Biol & Drug Dev, Montevideo, Uruguay; [Cal, Karina; Calliari, Aldo] Univ Republ UdelaR, Dept Biociencias, Fac Vet, Montevideo, Uruguay; [Perez-Torrado, Valentina] Univ Republ UdelaR, Dept Inmunobiol, Fac Med, Montevideo, Uruguay; [Perez-Torrado, Valentina] Univ Republ UdelaR, Area Inmunol, Dept Biociencias, Fac Quim, Montevideo, Uruguay; [Colman, Laura] Univ Republ UdelaR, Dept Quim Organ, Fac Quim, Montevideo, Uruguay; [Vilaseca, Cecilia; Contreras, Paola] Univ Republ UdelaR, Dept Fisiol, Fac Med, Montevideo, Uruguay; [Evans, Frances] Univ Republ UdelaR, Dept Histol & Embriol, Fac Med, Montevideo, Uruguay; [Evans, Frances] Inst Pasteur Montevideo, Lab Neuroinflammat & Gene Therapy, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Escande, C (corresponding author), Inst Pasteur Montevideo, INDICYO Program, Lab Metab Dis & Aging, Montevideo, Uruguay.	escande@pasteur.edu.uy	Ruíz, Santiago/HGU-6016-2022	Evans, Frances/0000-0002-7243-5295; Ruiz, Santiago/0000-0002-2626-6160	ANII [FCE_1_2014_1_104002, POS_NAC_2015_1_109950]; INNOVA II; FOCEM-Fondo para la Convergencia Estructural del Mercosur [COF 03/11]; CAP (UdelaR)	ANII; INNOVA II; FOCEM-Fondo para la Convergencia Estructural del Mercosur; CAP (UdelaR)	This work was supported by grants by ANII (grant nos.: FCE_1_2014_1_104002 and INNOVA II; to C. E.) and FOCEM-Fondo para la Convergencia Estructural del Mercosur (grant no.:COF 03/11). M. B. was supported by scholarships from ANII (grant no.: POS_NAC_2015_1_109950) and CAP (UdelaR).	Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Carreno M, 2020, J BIOL CHEM, V295, P18355, DOI 10.1074/jbc.RA120.014883; Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Dapueto R, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101833; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Enam C, 2018, ANNU REV BIOCHEM, V87, P725, DOI 10.1146/annurev-biochem-062917-012730; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Ferrara G, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01906-1; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iwahara T, 2012, MOL CELL BIOL, V32, P5022, DOI 10.1128/MCB.00822-12; Jiang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24371; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kitade M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00187; Kito Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62697-2; Lasiglie D, 2016, AGING-US, V8, P34, DOI 10.18632/aging.100870; Lee Y, 2017, DIABETES, V66, P2659, DOI 10.2337/db16-1446; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Pepin G, 2016, NUCLEIC ACIDS RES, V44, P5356, DOI 10.1093/nar/gkw405; Ronnebaum SM, 2013, MOL CELL BIOL, V33, P4461, DOI 10.1128/MCB.00480-13; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825; So KY, 2021, CELL BIOL TOXICOL, V37, P193, DOI 10.1007/s10565-020-09528-2; Sociali G, 2017, FASEB J, V31, P3138, DOI 10.1096/fj.201601294R; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667	33	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101711	10.1016/j.jbc.2022.101711	http://dx.doi.org/10.1016/j.jbc.2022.101711			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150745	Green Published, gold			2022-12-28	WOS:000821054100011
J	Fusi, L; Paudel, R; Meder, K; Schlosser, A; Schrama, D; Goebeler, M; Schmidt, M				Fusi, Lorenza; Paudel, Rupesh; Meder, Katharina; Schlosser, Andreas; Schrama, David; Goebeler, Matthias; Schmidt, Marc			Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER; FORKHEAD; DAF-16; IDENTIFICATION; ANGIOGENESIS; ACTIVATION; CHROMATIN; COFACTOR; TRIGGERS; BIM	Forkhead box O (FoxO) transcription factors are conserved proteins involved in the regulation of life span and age-related diseases, such as diabetes and cancer. Stress stimuli or growth factor deprivation promotes nuclear localization and activation of FoxO proteins, which-depending on the cellular context- can lead to cell cycle arrest or apoptosis. In endothelial cells (ECs), they further regulate angiogenesis and may promote inflammation and vessel destabilization implicating a role of FoxOs in vascular diseases. In several cancers, FoxOs exert a tumor-suppressive function by regulating proliferation and survival. We and others have previously shown that FoxOs can regulate these processes via two different mechanisms: by direct binding to forkhead-responsive elements at the promoter of target genes or by a poorly understood alternative process that does not require direct DNA binding and regulates key targets in primary human ECs. Here, we performed an interaction study in ECs to identify new nuclear FoxO3 interaction partners that might contribute to FoxO-dependent gene regulation. Mass spectrometry analysis of FoxO3-interacting proteins revealed transformation/transcription domain- associated protein (TRRAP), a member of multiple histone acetyltransferase complexes, as a novel binding partner of FoxO family proteins. We demonstrate that TRRAP is required to support FoxO3 transactivation and FoxO3-dependent G1 arrest and apoptosis in ECs via transcriptional activation of the cyclin-dependent kinase inhibitor p27kip1 and the proapoptotic TRRAP interaction could explain FoxO-induced alternative	[Fusi, Lorenza; Paudel, Rupesh; Meder, Katharina; Schrama, David; Goebeler, Matthias; Schmidt, Marc] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Schlosser, Andreas] Univ Wurzburg, Rudolf Virchow Ctr, Ctr Integrat & Translat Bioimaging, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Schmidt, M (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany.	schmidt_M11@ukw.de	Schmidt, Marc/E-8821-2010	Schmidt, Marc/0000-0002-8643-1615; Fusi, Lorenza/0000-0003-3488-5137; Paudel, Rupesh/0000-0001-6361-0162; Schrama, David/0000-0002-6931-8194	Deutsche Forschungsgemeinschaft (DFG) [DFG SCHM2460/3-1, DFG SCHM2460/2-1]; Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg [Z4/153]; Open Access Publication Fund of the University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg; Open Access Publication Fund of the University of Wuerzburg	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (grant nos.: DFG SCHM2460/3-1 and DFG SCHM2460/2-1; to M. S.) and the Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg (grant no.: Z4/153; to M. S.) In addition, this publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calissi G, 2021, NAT REV DRUG DISCOV, V20, P21, DOI 10.1038/s41573-020-0088-2; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Elias-Villalobos A, 2019, BIOCHEM SOC T, V47, P1597, DOI 10.1042/BST20180496; Finkbeiner MG, 2008, CELL CYCLE, V7, P3908, DOI 10.4161/cc.7.24.7354; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hornsveld M, 2018, SEMIN CANCER BIOL, V50, P90, DOI 10.1016/j.semcancer.2017.11.017; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Voss AK, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800078; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498	42	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101714	10.1016/j.jbc.2022.101714	http://dx.doi.org/10.1016/j.jbc.2022.101714			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151693	Green Published, gold			2022-12-28	WOS:000789394500001
J	Gullett, JM; Cuypers, MG; Grace, CR; Pant, S; Subramanian, C; Tajkhorshid, E; Rock, CO; White, SW				Gullett, Jessica M.; Cuypers, Maxime G.; Grace, Christy R.; Pant, Shashank; Subramanian, Chitra; Tajkhorshid, Emad; Rock, Charles O.; White, Stephen W.			Identification of structural transitions in bacterial fatty acid binding proteins that permit ligand entry and exit at membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CHEMICAL-EXCHANGE; LYSINE RESIDUES; APO; BACKBONE; RELAXATION; MECHANISMS; INSERTION; INSIGHTS; STATE	Fatty acid (FA) transfer proteins extract FA from membranes and sequester them to facilitate their movement through the cytosol. Detailed structural information is available for these soluble protein-FA complexes, but the structure of the protein conformation responsible for FA exchange at the membrane is unknown. Staphylococcus aureus FakB1 is a prototypical bacterial FA transfer protein that binds palmitate within a narrow, buried tunnel. Here, we define the conformational change from a "closed " FakB1 state to an "open " state that associates with the membrane and provides a path for entry and egress of the FA. Using NMR spectroscopy, we identified a conformationally flexible dynamic region in FakB1, and X-ray crystallography of FakB1 mutants captured the conformation of the open state. In addition, molecular dynamics simulations show that the new amphipathic alpha-helix formed in the open state inserts below the phosphate plane of the bilayer to create a diffusion channel for the hydrophobic FA tail to access the hydrocarbon core and place the carboxyl group at the phosphate layer. The membrane binding and catalytic properties of site-directed mutants were consistent with the proposed membrane docked structure predicted by our molecular dynamics simulations. Finally, the structure of the bilayer-associated conformation of FakB1 has local similarities with mammalian FA binding proteins and provides a conceptual framework for how these proteins interact with the membrane to create a diffusion channel from the FA location in the bilayer to the protein interior.	[Gullett, Jessica M.; Subramanian, Chitra; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Cuypers, Maxime G.; Grace, Christy R.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, NIH Ctr Macromol Modeling & Bioinformat, Dept Biochem,Theoreti & Computat Biophys Grp, Urbana, IL USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.; White, SW (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA.	charles.rock@stjude.org; stevew.white@stjude.org	; Rock, Charles/N-2256-2018	Royappa, Grace/0000-0002-1600-5610; Cuypers, Maxime/0000-0002-8826-2317; Rock, Charles/0000-0001-8648-4189; Pant, Shashank/0000-0002-8222-3616; Gullett, Jessica/0000-0003-3996-9110; White, Stephen/0000-0001-8188-5944	National Institutes of Health [GM034496, P41-GM104601, R01-GM123455]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; U.S. Department of Energy [W-31-109-Eng-38]; XSEDE allocation [MCA06N060];  [. W-31-109-Eng-38]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Energy(United States Department of Energy (DOE)); XSEDE allocation; 	This work was supported by National Institutes of Health grants GM034496 (C. O. R.) , and P41-GM104601 and R01-GM123455 (E. T.) , Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. Use of the Advanced Photon Source is supported by the U.S. Department of Energy under Contract No. W-31-109-Eng-38. The simulations reported in this study are supported by XSEDE allocation (grant MCA06N060 to E. T.) , Microsoft Azure, and Blue Waters at the National Supercomputing Application at the Uni-versity of Illinois at Urbana-Champaign. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bakowies D, 2002, J MOL BIOL, V315, P713, DOI 10.1006/jmbi.2001.5202; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Blanchard AE, 2014, BIOPHYS J, V107, P2112, DOI 10.1016/j.bpj.2014.09.013; Broussard TC, 2016, J BIOL CHEM, V291, P6292, DOI 10.1074/jbc.M115.706820; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericson ME, 2017, MBIO, V8, DOI 10.1128/mBio.00988-17; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Frank MW, 2020, MBIO, V11, DOI 10.1128/mBio.00920-20; Friedman R, 2006, BIOPHYS J, V90, P1535, DOI 10.1529/biophysj.105.071571; Gullett JM, 2019, J BIOL CHEM, V294, P16416, DOI 10.1074/jbc.RA119.010659; Guo Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143476; Herr FM, 1996, BIOCHEMISTRY-US, V35, P1296, DOI 10.1021/bi952204b; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li Y, 2015, PHYS CHEM CHEM PHYS, V17, P32257, DOI 10.1039/c5cp04784f; Likic VA, 1999, PROTEIN SCI, V8, P1649, DOI 10.1110/ps.8.8.1649; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Long D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006081; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Matsuoka D, 2015, J PHYS CHEM B, V119, P114, DOI 10.1021/jp510384f; Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307; Ohkubo YZ, 2012, BIOPHYS J, V102, P2130, DOI 10.1016/j.bpj.2012.03.015; Pant S, 2020, J COMPUT CHEM, V41, P489, DOI 10.1002/jcc.26109; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Pashkovskaya AA, 2018, BIOPHYS J, V114, P2142, DOI 10.1016/j.bpj.2018.04.011; Pogorelov TV, 2014, J PHYS CHEM B, V118, P1481, DOI 10.1021/jp4089113; SACCHETTINI JC, 1988, J BIOL CHEM, V263, P5815; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Soubias O, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd1882; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tsfadia Y, 2007, FEBS LETT, V581, P1243, DOI 10.1016/j.febslet.2007.02.033; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Xiao TS, 2020, BIOPHYS J, V118, P396, DOI 10.1016/j.bpj.2019.12.005; Xiao TS, 2016, ANGEW CHEM INT EDIT, V55, P6869, DOI 10.1002/anie.201601326; Zhang FL, 1997, J BIOMOL NMR, V9, P213, DOI 10.1023/A:1018666522787; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	49	2	2	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101676	10.1016/j.jbc.2022.101676	http://dx.doi.org/10.1016/j.jbc.2022.101676			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35122790	Green Published, gold			2022-12-28	WOS:000791230900015
J	Hensbergen, PJ; de Ru, AH; Friggen, AH; Corver, J; Smits, WK; van Veelen, PA				Hensbergen, Paul J.; de Ru, Arnoud H.; Friggen, Annemieke H.; Corver, Jeroen; Smits, Wiep Klaas; van Veelen, Peter A.			New insights into the type A glycan modification of Clostridioides difficile flagellar protein flagellin C by phosphoproteomics analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION; DIVERSITY; VIRULENCE	The type A glycan modification found in human pathogen Clostridioides difficile consists of a monosaccharide (GlcNAc) that is linked to an N-methylated threonine through a phosphodiester bond. This structure has previously been described on the flagellar protein flagellin C of several C. difficile strains and is important for bacterial motility. The study of post-translational modifications often relies on some type of enrichment strategy; however, a procedure for enrichment of this modification has not yet been demonstrated. In this study, we show that an approach that is commonly used in phosphoproteomics, Fe3+-immobilized metal affinity chromatography, also enriches for peptides with this unique post-translational modification. Using LC-MS/MS analyses of immobilized metal affinity chromatography-captured tryptic peptides, we observed not only type A-modified C. difficile flagellin peptides but also a variety of truncated/modified type A structures on these peptides. Using an elaborate set of mass spectrometry analyses, we demonstrate that one of these modifications consists of a type A structure containing a phosphonate (2-aminoethylphosphonate), a modification that is rarely observed and has hitherto not been described in C. difficile. In conclusion, we show that a common enrichment strategy results in reliable identification of peptides carrying a type A glycan modification, and that the results obtained can be used to advance models about its biosynthesis.	[Hensbergen, Paul J.; de Ru, Arnoud H.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Friggen, Annemieke H.; Corver, Jeroen; Smits, Wiep Klaas] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hensbergen, PJ (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands.	PJ.Hensbergen@lumc.nl	; Smits, Wiep Klaas/A-8366-2008	Corver, Jeroen/0000-0002-9262-5475; van Veelen, Peter/0000-0002-7898-9408; Smits, Wiep Klaas/0000-0002-7409-2847; Hensbergen, Paul/0000-0002-3193-5445	NWO Medium from the Dutch Research Council [91116004]	NWO Medium from the Dutch Research Council	We thank Dr Hans van Leeuwen for critically reading an earlier version of the article. This work was supported by the research program investment grant NWO Medium from the Dutch Research Council, with project number 91116004.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Bouche L, 2016, J BIOL CHEM, V291, P25439, DOI 10.1074/jbc.M116.749481; Caval T, 2019, MOL CELL PROTEOMICS, V18, P16, DOI 10.1074/mcp.RA118.000967; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Eckmair B, 2016, MOL CELL PROTEOMICS, V15, P573, DOI 10.1074/mcp.M115.051573; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Flack EKP, 2020, CHEMBIOCHEM, V21, P1397, DOI 10.1002/cbic.202000019; Frese CK, 2013, J PROTEOME RES, V12, P1520, DOI 10.1021/pr301130k; Ghodge SV, 2013, J AM CHEM SOC, V135, P16360, DOI 10.1021/ja409376k; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; HARD K, 1993, BIOCHEMISTRY-US, V32, P766, DOI 10.1021/bi00054a005; HORIGUCHI M, 1959, NATURE, V184, P901, DOI 10.1038/184901b0; Horsman GP, 2017, CHEM REV, V117, P5704, DOI 10.1021/acs.chemrev.6b00536; Jochimsen B, 2011, P NATL ACAD SCI USA, V108, P11393, DOI 10.1073/pnas.1104922108; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KELLYWINTENBERG K, 1993, J BACTERIOL, V175, P2458, DOI 10.1128/JB.175.8.2458-2461.1993; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Lastovickova M, 2020, J PROTEOME RES, V19, P1885, DOI 10.1021/acs.jproteome.9b00818; Macek B, 2019, NAT REV MICROBIOL, V17, P651, DOI 10.1038/s41579-019-0243-0; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Neta P, 2014, RAPID COMMUN MASS SP, V28, P2645, DOI 10.1002/rcm.7055; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; O'Neill EC, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6040045; ONDERDONK AB, 1977, J INFECT DIS, V136, P82, DOI 10.1093/infdis/136.1.82; Paschinger K, 2020, GLYCOCONJUGATE J, V37, P27, DOI 10.1007/s10719-019-09874-2; Pinkse Martijn W H, 2006, Drug Discov Today Technol, V3, P331, DOI 10.1016/j.ddtec.2006.09.009; Pirro M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105369; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; SMITS WK, 2022, MSPHERE, V0007; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stevenson E, 2015, TRENDS MICROBIOL, V23, P275, DOI 10.1016/j.tim.2015.01.004; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Urai M, 2009, CARBOHYD RES, V344, P2182, DOI 10.1016/j.carres.2009.08.001; van Eijk E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1252-7; Verma A, 2006, J BACTERIOL, V188, P4395, DOI 10.1128/JB.01642-05; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yu XM, 2013, P NATL ACAD SCI USA, V110, P20759, DOI 10.1073/pnas.1315107110; Zauner G, 2011, ELECTROPHORESIS, V32, P3456, DOI 10.1002/elps.201100247	39	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101622	10.1016/j.jbc.2022.101622	http://dx.doi.org/10.1016/j.jbc.2022.101622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35065968	gold, Green Published			2022-12-28	WOS:000821051800005
J	Zhang, J; Zhang, ZJ; Holst, S; Bloechl, C; Madunic, K; Wuhrer, M; Ten Dijke, P; Zhang, T				Zhang, Jing; Zhang, Zejian; Holst, Stephanie; Bloechl, Constantin; Madunic, Katarina; Wuhrer, Manfred; Ten Dijke, Peter; Zhang, Tao			Transforming growth factor-beta challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NON-SMAD; GENE-EXPRESSION; CANCER; GLYCOSYLATION; RECEPTOR; MIGRATION; PROTEINS; KINASE; METASTASIS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor prognosis and high mortality. Transforming growth factor-beta (TGF-beta) plays a key role in PDAC tumor progression, which is often associated with aberrant glycosylation. However, how PDAC cells respond to TGF-beta and the role of glycosylation therein is not well known. Here, we investigated the TGF-beta-mediated response and glycosylation changes in the PaTu-8955S (PaTu-S) cell line deficient in SMA-related and MAD-related protein 4 (SMAD4), a signal transducer of the TGF-beta signaling. PaTu-S cells responded to TGF-beta by upregulating SMAD2 phosphorylation and target gene expression. We found that TGF-beta induced expression of the mesenchymal marker N-cadherin but did not significantly affect epithelial marker E-cadherin expression. We also examined differences in N-glycans, O-glycans, and glycosphingolipid-linked glycans in PaTu-S cells upon TGF-beta stimulation. TGF-beta treatment primarily induced N-glycome aberrations involving elevated levels of branching, core fucosylation, and sialylation in PaTu-S cells, in agreement with TGF-beta-induced changes in the expression of glycosylation-associated genes. In addition, we observed differences in O glycosylation and glycosphingolipid glycosylation profiles after TGF-beta treatment, including lower levels of sialylated Tn antigen and neoexpression of globosides. Furthermore, the expression of transcription factor sex-determining region Y-related high-mobility group box 4 was upregulated upon TGF-beta stimulation, and its depletion blocked TGF-beta-induced N-glycomic changes. Thus, TGF-beta-induced N-glycosylation changes can occur in a sex-determining region Y-related high-mobility group box 4-dependent and SMAD4-independent manner in the pancreatic PaTu-S cancer cell line. Our results open up avenues to study the relevance of glycosylation in TGF-beta signaling in SMAD4-inactivated PDAC.	[Zhang, Jing; Ten Dijke, Peter] Oncode Inst, Leiden, Netherlands; [Zhang, Jing; Ten Dijke, Peter] Dept Cell Chem Biol, Leiden, Netherlands; [Zhang, Zejian; Holst, Stephanie; Bloechl, Constantin; Madunic, Katarina; Wuhrer, Manfred; Zhang, Tao] Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands; [Bloechl, Constantin] Salzburg Univ, Dept Biosci, Salzburg, Austria; [Zhang, Zejian] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med Res Ctr, Beijing, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Salzburg University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Ten Dijke, P (corresponding author), Oncode Inst, Leiden, Netherlands.; Ten Dijke, P (corresponding author), Dept Cell Chem Biol, Leiden, Netherlands.; Zhang, T (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands.	P.ten_Dijke@lumc.nl; T.Zhang@lumc.nl	Zhang, Zejian/GQG-9538-2022; Dijke, Peter ten/AAG-4660-2021; Zhang, Zejian/GQG-9492-2022	Dijke, Peter ten/0000-0002-7234-342X; Blochl, Constantin/0000-0003-3406-4232; Madunic, Katarina/0000-0002-9310-4110; Wuhrer, Manfred/0000-0002-0814-4995	Chinese Scholarship Council; Cancer Genomics Centre Netherlands; Austrian Science Fund (FWF) [W1213]	Chinese Scholarship Council(China Scholarship Council); Cancer Genomics Centre Netherlands; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Chinese Scholarship Council to J. Z., Cancer Genomics Centre Netherlands to P. t. D., and Austrian Science Fund (FWF, grant number: W1213) to C. B.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Anugraham M, 2015, RAPID COMMUN MASS SP, V29, P545, DOI 10.1002/rcm.7130; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bagati A, 2021, CANCER CELL, V39, P54, DOI 10.1016/j.ccell.2020.12.001; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; Budi EH, 2017, TRENDS CELL BIOL, V27, P658, DOI 10.1016/j.tcb.2017.04.005; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Dardare J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103534; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2019, DEV CELL, V49, P313, DOI 10.1016/j.devcel.2019.04.026; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Distler M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/474905; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Engle DD, 2019, SCIENCE, V364, P1156, DOI 10.1126/science.aaw3145; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Fink SP, 2003, ONCOGENE, V22, P1317, DOI 10.1038/sj.onc.1206128; Fischer CG, 2018, J PATHOL, V246, P395, DOI 10.1002/path.5154; Geyer PE, 2016, MOL CANCER THER, V15, P1008, DOI 10.1158/1535-7163.MCT-15-0633; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holst S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16811-6; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Huang CY, 2015, FEBS J, V282, P4295, DOI 10.1111/febs.13419; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; INOKUCHI J, 1990, CANCER RES, V50, P6731; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kabacaoglu D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01878; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim SJ, 2013, BIOCHEM J, V449, P241, DOI 10.1042/BJ20120189; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Leeming DJ, 2011, BIOMARKERS, V16, P193, DOI 10.3109/1354750X.2011.557440; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Madunic K, 2021, CELL MOL LIFE SCI, V78, P337, DOI 10.1007/s00018-020-03504-z; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Munkley J, 2019, ONCOL LETT, V17, P2569, DOI 10.3892/ol.2019.9885; Munkley J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030275; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Nie S, 2014, J PROTEOME RES, V13, P1873, DOI 10.1021/pr400967x; Niedergethmann M, 2002, PANCREAS, V25, P122, DOI 10.1097/00006676-200208000-00002; Nigjeh EN, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700064; Pan S, 2020, CANCER LETT, V469, P429, DOI 10.1016/j.canlet.2019.11.020; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Perkhofer L, 2021, GUT, V70, P606, DOI 10.1136/gutjnl-2019-319984; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Qian YZ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00958-3; Reitz D, 2015, J CLIN PATHOL, V68, P427, DOI 10.1136/jclinpath-2014-202451; Ren J, 2017, JOVE-J VIS EXP, DOI 10.3791/55459; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Saxena K, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100845; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stimmer L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-916; Storck W, 2012, BIOL CHEM, V393, P785, DOI 10.1515/hsz-2012-0165; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Varadaraj A, 2017, MOL BIOL CELL, V28, P1195, DOI 10.1091/mbc.E16-08-0601; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang MM, 2019, CLIN CHEM LAB MED, V57, P407, DOI 10.1515/cclm-2018-0379; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Yang YB, 1997, BIOCHEMISTRY-US, V36, P11923, DOI 10.1021/bi9710479; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang J, 2021, PROTEIN CELL, V12, P89, DOI 10.1007/s13238-020-00741-7; Zhang L, 2013, MOL CELL, V51, P559, DOI 10.1016/j.molcel.2013.07.014; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang T, 2020, MOL OMICS, V16, P355, DOI 10.1039/c9mo00180h; Zhang T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00732; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhang YM, 2015, INT J CLIN EXP MED, V8, P11683; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhao J, 2007, J PROTEOME RES, V6, P1126, DOI 10.1021/pr0604458	109	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101717	10.1016/j.jbc.2022.101717	http://dx.doi.org/10.1016/j.jbc.2022.101717			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151689	gold, Green Published			2022-12-28	WOS:000789394500010
J	Delgado, M; Rainwater, RR; Heflin, B; Urbaniak, A; Butler, K; Davidson, M; Protacio, RM; Baldini, G; Edwards, A; Reed, MR; Raney, KD; Chambers, TC				Delgado, Magdalena; Rainwater, Randall R.; Heflin, Billie; Urbaniak, Alicja; Butler, Kaitlynn; Davidson, Mari; Protacio, Reine M.; Baldini, Giulia; Edwards, Andrea; Reed, Megan R.; Raney, Kevin D.; Chambers, Timothy C.			Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; MITOTIC ARREST; GREAT DRUGS; INDUCED APOPTOSIS; KEY ROLE; BCL-XL; CANCER; PHOSPHORYLATION; MECHANISMS; MITOSIS	Microtubule targeting agents (MTAs) are widely used cancer chemotherapeutics which conventionally exert their effects during mitosis, leading to mitotic or postmitotic death. However, accumulating evidence suggests that MTAs can also generate death signals during interphase, which may represent a key mechanism in the clinical setting. We reported previously that vincristine and other microtubule destabilizers induce death not only in M phase but also in G1 phase in primary acute lymphoblastic leukemia cells. Here, we sought to investigate and compare the pathways responsible for phase-specific cell death. Primary acute lymphoblastic leukemia cells were subjected to centrifugal elutriation, and cell populations enriched in G1 phase (97%) or G2/M phases (80%) were obtained and treated with vincristine. We found death of M phase cells was associated with established features of mitochondrial-mediated apoptosis, including Bax activation, loss of mitochondrial transmembrane potential, caspase-3 activation, and nucleosomal DNA fragmentation. In contrast, death of G1 phase cells was not associated with pronounced Bax or caspase-3 activation but was associated with loss of mitochondrial transmembrane potential, parylation, nuclear translocation of apoptosis-inducing factor and endonuclease G, and supra-nucleosomal DNA fragmentation, which was enhanced by inhibition of autophagy. The results indicate that microtubule depolymerization induces distinct cell death pathways depending on during which phase of the cell cycle microtubule perturbation occurs. The observation that a specific type of drug can enter a single cell type and induce two different modes of death is novel and intriguing. These findings provide a basis for advancing knowledge of clinical mechanisms of MTAs.	[Delgado, Magdalena; Rainwater, Randall R.; Heflin, Billie; Urbaniak, Alicja; Butler, Kaitlynn; Davidson, Mari; Protacio, Reine M.; Baldini, Giulia; Edwards, Andrea; Reed, Megan R.; Raney, Kevin D.; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Delgado, Magdalena] UTSW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Edwards, Andrea] UTSW Med Ctr, Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu	Urbaniak, Alicja Joanna/J-2555-2019	Urbaniak, Alicja Joanna/0000-0002-0807-1263; Davidson, Mari/0000-0003-3949-8347; Reed, Megan/0000-0001-5086-7938; Protacio, Reine/0000-0003-4091-8724; Heflin, Billie/0000-0001-8774-4579	Winthrop P. Rockefeller Cancer Institute; NIH [GM081766]; Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIGMS Centers of Biomedical Research Excellence [P20GM103625]	Winthrop P. Rockefeller Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIGMS Centers of Biomedical Research Excellence	This work was supported by funds from the Winthrop P. Rockefeller Cancer Institute (T. C. C.), and in part by NIH Grant GM081766 and by the Center for Microbial Pathogenesis and Host Inflammatory Responses grant P20GM103625 through the NIGMS Centers of Biomedical Research Excellence.	Alford SE, 2015, CANCER RES, V75, P1366, DOI 10.1158/0008-5472.CAN-14-1849; Bah N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.251; Bochum Sylvia, 2018, Recent Results Cancer Res, V211, P217, DOI 10.1007/978-3-319-91442-8_15; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Carlson K, 2011, CLIN BREAST CANCER, V11, P73, DOI 10.1016/j.clbc.2011.03.006; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Choi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128834; Chu R, 2016, ONCOTARGET, V7, P78958, DOI 10.18632/oncotarget.12586; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Clarke PR, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1516450; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delgado M, 2019, BIOCHEM PHARMACOL, V162, P213, DOI 10.1016/j.bcp.2018.12.015; Delgado M, 2018, CELL CYCLE, V17, P1784, DOI 10.1080/15384101.2018.1496746; Delgado M, 2017, JOVE-J VIS EXP, DOI 10.3791/56418; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.360; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Furst R, 2013, PHARMAZIE, V68, P478, DOI 10.1691/ph.2013.6509; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kitagawa K, 2011, NAT REV CLIN ONCOL, V8, P228, DOI 10.1038/nrclinonc.2010.228-c1; Komlodi-Pasztor E, 2013, CLIN CANCER RES, V19, P1304, DOI 10.1158/1078-0432.CCR-12-2058; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Kothari A, 2016, CANCER RES, V76, P3553, DOI 10.1158/0008-5472.CAN-15-2104; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Larsen BD, 2017, FEBS J, V284, P1160, DOI 10.1111/febs.13970; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Mathiassen SG, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00051; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nijimeijer BA, 2009, EXP HEMATOL, V37, P376, DOI 10.1016/j.exphem.2008.11.002; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Sakurikar N, 2014, CANCER LETT, V343, P232, DOI 10.1016/j.canlet.2013.09.036; Sakurikar N, 2012, J BIOL CHEM, V287, P39193, DOI 10.1074/jbc.M112.391854; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Sloss O, 2016, ONCOTARGET, V7, P5176, DOI 10.18632/oncotarget.6894; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Steinmetz MO, 2018, TRENDS CELL BIOL, V28, P776, DOI 10.1016/j.tcb.2018.05.001; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tunquist BJ, 2013, CLIN CANCER RES, V19, P1302, DOI 10.1158/1078-0432.CCR-12-1041; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Upreti M, 2006, J BIOL CHEM, V281, P15941, DOI 10.1074/jbc.M512586200; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Whitaker RH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040346; Wissing MD, 2013, CLIN CANCER RES, V19, P1303, DOI 10.1158/1078-0432.CCR-12-2695	61	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101939	10.1016/j.jbc.2022.101939	http://dx.doi.org/10.1016/j.jbc.2022.101939			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35436470	Green Published, gold			2022-12-28	WOS:000838892100002
J	Kirschke, S; Ogunsulire, I; Selvakumar, B; Schumacher, N; Sezin, T; Rose-John, S; Scheffold, A; Garbers, C; Lokau, J				Kirschke, Sophia; Ogunsulire, Ireti; Selvakumar, Balachandar; Schumacher, Neele; Sezin, Tanya; Rose-John, Stefan; Scheffold, Alexander; Garbers, Christoph; Lokau, Juliane			The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL; PROTEOLYTIC CLEAVAGE; T-LYMPHOCYTES; RECEPTOR; DISINTEGRIN; ADAM-10; GROWTH; CD25; INFLAMMATION; EXPRESSION	The cytokine interleukin-2 (IL-2) plays a critical role in controlling the immune homeostasis by regulating the proliferation and differentiation of immune cells, especially T cells. IL-2 signaling is mediated via the IL-2 receptor (IL-2R) complex, which consists of the IL-2R alpha (CD25), the IL-2R beta, and the IL-2R gamma. While the latter are required for signal transduction, IL-2R alpha controls the ligand-binding affinity of the receptor complex. A soluble form of the IL-2R alpha (sIL-2R alpha) is found constitutively in human serum, though its levels are increased under various pathophysiological conditions. The sIL-2R alpha originates partly from activated T cells through proteolytic cleavage, but neither the responsible proteases nor stimuli that lead to IL-2R alpha cleavage are known. Here, we show that the metalloproteases ADAM10 and ADAM17 can cleave the IL-2R alpha and generate a soluble ectodomain, which functions as a decoy receptor that inhibits IL-2 signaling in T cells. We demonstrate that ADAM10 is mainly responsible for constitutive shedding of the IL-2R alpha, while ADAM17 is involved in IL-2R alpha cleavage upon T cell activation. In vivo, we found that mice with a CD4-specific deletion of ADAM10, but not ADAM17, show reduced steady-state sIL-2R alpha serum levels. We propose that the identification of proteases involved in sIL-2R alpha generation will allow for manipulation of IL-2R alpha cleavage, especially as constitutive and induced cleavage of IL-2R alpha are executed by different proteases, and thus offer a novel opportunity to alter IL-2 function.	[Kirschke, Sophia; Garbers, Christoph; Lokau, Juliane] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Kirschke, Sophia; Garbers, Christoph; Lokau, Juliane] Otto Von Guericke Univ, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Ogunsulire, Ireti; Selvakumar, Balachandar; Sezin, Tanya; Scheffold, Alexander] Univ Kiel, Inst Immunol, Kiel, Germany; [Ogunsulire, Ireti; Selvakumar, Balachandar; Sezin, Tanya; Scheffold, Alexander] UKSH Schleswig Holstein, Kiel, Germany; [Schumacher, Neele; Rose-John, Stefan] Univ Kiel, Biochem Inst, Kiel, Germany; [Sezin, Tanya] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10027 USA	Otto von Guericke University; Otto von Guericke University; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Columbia University; NewYork-Presbyterian Hospital	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.; Garbers, C (corresponding author), Otto Von Guericke Univ, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Scheffold, Alexander/S-2090-2016; Garbers, Christoph/D-9932-2015; Selvakumar, Balachandar/GWV-7844-2022	Scheffold, Alexander/0000-0002-0626-343X; Garbers, Christoph/0000-0003-4939-6950; 	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [125440785 -SFB 877]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Projektnummer 125440785 -SFB 877, projects A1 (to S. R.-J.), B15 (to A. S.), A10 (to C. G.) and A14 (to C. G. and S. R.-J.).	Agueznay NEH, 2007, CLIN EXP IMMUNOL, V150, P114, DOI 10.1111/j.1365-2249.2007.03464.x; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Capone C, 2016, ANN NEUROL, V79, P387, DOI 10.1002/ana.24573; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Damoiseaux J, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108515; Dik WA, 2020, NETH J MED, V78, P220; Erduran E, 1998, AM J HEMATOL, V57, P119, DOI 10.1002/(SICI)1096-8652(199802)57:2<119::AID-AJH5>3.0.CO;2-Z; Folgosa L, 2013, J IMMUNOL, V191, P5951, DOI 10.4049/jimmunol.1302042; Furue Masutaka, 1994, Journal of Dermatological Science, V7, P89, DOI 10.1016/0923-1811(94)90081-7; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GRUSS HJ, 1992, CANCER RES, V52, P3353; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Jackson HW, 2017, NAT REV CANCER, V17, P38, DOI 10.1038/nrc.2016.115; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kobayashi H, 1999, CYTOKINE, V11, P1065, DOI 10.1006/cyto.1999.0509; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; Link MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184320; Lokau J, 2020, CYTOKINE GROWTH F R, V55, P94, DOI 10.1016/j.cytogfr.2020.04.003; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Murakami J, 2019, MOL CLIN ONCOL, V11, P474, DOI 10.3892/mco.2019.1922; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qiao JL, 2018, INT IMMUNOPHARMACOL, V55, P63, DOI 10.1016/j.intimp.2017.12.004; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; RYFFEL B, 1995, IMMUNOPHARMACOLOGY, V30, P199, DOI 10.1016/0162-3109(95)00023-M; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Shatrova A. N., 2015, CELL TISSUE BIOL, V9, P364; Spolski R, 2018, NAT REV IMMUNOL, V18, P648, DOI 10.1038/s41577-018-0046-y; Toomer KH, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028597; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Yan I, 2016, J LEUKOCYTE BIOL, V99, P749, DOI 10.1189/jlb.3A0515-207R; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	53	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101910	10.1016/j.jbc.2022.101910	http://dx.doi.org/10.1016/j.jbc.2022.101910			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35398356	gold, Green Published			2022-12-28	WOS:000807755100008
J	Ma, XL; Wang, C; Zhou, B; Cheng, ZN; Mao, ZY; Tang, TS; Guo, CX				Ma, Xiaolu; Wang, Chen; Zhou, Bo; Cheng, Zina; Mao, Zhiyong; Tang, Tie-Shan; Guo, Caixia			DNA polymerase eta promotes nonhomologous end joining upon etoposide exposure dependent on the scaffolding protein Kap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-II; CELL-CYCLE; REPAIR; PCNA; SWITCH; REV1	DNA polymerase eta (Pol eta) is a eukaryotic member of the Y-family of DNA polymerase involved in translesion DNA synthesis and genome mutagenesis. Recently, several trans lesion DNA synthesis polymerases have been found to function in repair of DNA double-strand breaks (DSBs). However, the role of Pol eta in promoting DSB repair remains to be well defined. Here, we demonstrated that Pol eta could be targeted to etoposide (ETO)-induced DSBs and that depletion of Pol eta in cells causes increased sensitivity to ETO. Intriguingly, depletion of Pol eta also led to a nonhomologous end joining repair defect in a catalytic activity-independent manner. We further identified the scaffold protein Kap1 as a novel interacting partner of Pol eta, the depletion of which resulted in impaired formation of Pol eta and Rad18 foci after ETO treatment. Additionally, overexpression of Kap1 failed to restore Pol eta focus formation in Rad18-deficient cells after ETO treatment. Interestingly, we also found that Kap1 bound to Rad18 in a Pol eta-dependent manner, and moreover, depletion of Kap1 led to a significant reduction in Rad18-Pol eta association, indicating that Kap1 forms a ternary complex with Rad18 and Pol eta to stabilize Rad18-Pol eta association. Our findings demonstrate that Kap1 could regulate the role of Pol eta in ETO-induced DSB repair via facilitating Rad18 recruitment and stabilizing Rad18-Pol eta association.	[Ma, Xiaolu] Taiyuan Univ Technol, Coll Biomed Engn, Taiyuan, Peoples R China; [Ma, Xiaolu; Tang, Tie-Shan] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [Wang, Chen; Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai Matern & Infant Hosp 1,Clin & Translat R, Shanghai, Peoples R China; [Zhou, Bo; Cheng, Zina; Guo, Caixia] Chinese Acad Sci, Univ Chinese Acad Sci, China Natl Ctr Bioinformat, CAS Key Lab Genom & Precis Med,Beijing Inst Genom, Beijing, Peoples R China; [Tang, Tie-Shan] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Tang, Tie-Shan] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China	Taiyuan University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tongji University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Tang, TS (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China.; Guo, CX (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, China Natl Ctr Bioinformat, CAS Key Lab Genom & Precis Med,Beijing Inst Genom, Beijing, Peoples R China.; Tang, TS (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.; Tang, TS (corresponding author), Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China.	tangtsh@ioz.ac.cn; guocx@big.ac	Chen, Wang/GQH-6831-2022	Chen, Wang/0000-0003-2931-7856	National Key Research and Development Program of China [2018YFA0108500]; National Natural Science Foundation of China [31800684, 81921006, 82030033, 31970740]; Postdoctoral Research Foundation of China [2021M703206]; CAS Strategic Priority Research Program [XDPB2004]; Natural Science Foundation of Shanxi Province [201801D221281]; State Key Laboratory of Membrane Biology; CAS Key Laboratory of Genomic and Precision Medicine	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Research Foundation of China(China Postdoctoral Science Foundation); CAS Strategic Priority Research Program; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); State Key Laboratory of Membrane Biology; CAS Key Laboratory of Genomic and Precision Medicine	This research was supported by the National Key Research and Development Program of China (2018YFA0108500) , National Natural Science Foundation of China (31800684, 81921006, 82030033, 31970740) , Postdoctoral Research Foundation of China (2021M703206) , CAS Strategic Priority Research Program XDPB2004, Natural Science Foundation of Shanxi Province (201801D221281) , the State Key Laboratory of Membrane Biology, and CAS Key Laboratory of Genomic and Precision Medicine.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Arlett CF, 2008, BRIT J RADIOL, V81, P51, DOI 10.1259/bjr/27072321; Bergoglio V, 2013, J CELL BIOL, V201, P395, DOI 10.1083/jcb.201207066; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Busuttil RA, 2008, CANCER RES, V68, P2081, DOI 10.1158/0008-5472.CAN-07-6274; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen CY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010355; Chen LX, 2015, AM J PHYSIOL-CELL PH, V308, pC372, DOI 10.1152/ajpcell.00321.2014; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Despras E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13326; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guerillon C, 2020, J BIOL CHEM, V295, P8350, DOI 10.1074/jbc.RA120.013780; Hedglin M, 2015, ANNU REV BIOPHYS, V44, P207, DOI 10.1146/annurev-biophys-060414-033841; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kantidze OL, 2007, GENE, V391, P76, DOI 10.1016/j.gene.2006.12.006; Kuo CY, 2016, CELL CYCLE, V15, P787, DOI 10.1080/15384101.2016.1138184; Ma XL, 2020, ENVIRON MOL MUTAGEN, V61, P680, DOI 10.1002/em.22359; Ma XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02164-1; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rattray AJ, 2005, MOL CELL, V20, P658, DOI 10.1016/j.molcel.2005.11.018; Sebesta M, 2013, DNA REPAIR, V12, P691, DOI 10.1016/j.dnarep.2013.05.001; Sekimoto T, 2015, MOL CELL BIOL, V35, P699, DOI 10.1128/MCB.01153-14; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Stoll GA, 2019, P NATL ACAD SCI USA, V116, P15042, DOI 10.1073/pnas.1901318116; Tubbs AT, 2014, MOL CELL BIOL, V34, P2811, DOI 10.1128/MCB.00441-14; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Wang ZF, 2016, J CELL SCI, V129, P1223, DOI 10.1242/jcs.179408; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zhang C., 2022, MOL CELL, DOI [10.1016/j.molcel.2022.1001.1020, DOI 10.1016/J.MOLCEL.2022.1001.1020]; Zhang XL, 2013, DNA REPAIR, V12, P377, DOI 10.1016/j.dnarep.2013.02.008; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	44	0	0	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101861	10.1016/j.jbc.2022.101861	http://dx.doi.org/10.1016/j.jbc.2022.101861			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35339488	gold, Green Published			2022-12-28	WOS:000798142000012
J	Sanchez, AM; Jacewicz, A; Shuman, S				Sanchez, Ana M.; Jacewicz, Agata; Shuman, Stewart			Fission yeast Duf89 and Duf8901 are cobalt/nickel-dependent phosphatase-pyrophosphatases that act via a covalent aspartyl-phosphate intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; COMPLEX; REVEAL; GENE	Domain of Unknown Function 89 (DUF89) proteins are metal-dependent phosphohydrolases. Exemplary DUF89 enzymes differ in their metal and phosphosubstrate preferences. Here, we interrogated the activities and structures of two DUF89 paralogs from fission yeast-Duf89 and Duf8901. We find that Duf89 and Duf8901 are cobalt/nickel-dependent phosphohydrolases adept at hydrolyzing p-nitro-phenylphosphate and PPi. Crystal structures of metal-free Duf89 and Co2+-bound Duf8901 disclosed two enzyme con -formations that differed with respect to the position of a three-helix module, which is either oriented away from the active site in Duf89 or forms a lid over the active site in Duf8901. Lid closure results in a 16 movement of Duf8901 Asp195, vis-a -vis Asp199 in Duf89, that brings Asp195 into contact with an octahedrally coordinated cobalt. Reaction of Duf8901 with BeCl2 and NaF in the presence of divalent cations Co2+, Ni2+, or Zn2+ generated covalent Duf8901-(Asp248)-beryllium tri -fluoride (BeF3)center dot Co2+, Duf8901-(Asp248)-BeF3 center dot Ni2+, or Duf8901-(Asp248)-BeF3 center dot Zn2+ adducts, the structures of which suggest a two-step catalytic mechanism via formation and hydrolysis of an enzyme-(aspartyl)-phosphate intermediate. Alanine mutations of Duf8901 Asp248, Asn249, Lys401, Asp286, and Asp195 that interact with BeF3 center dot Co2+ squelched p- nitrophenylphosphatase activity. A 1.8 structure of a Duf8901-(Asp248)-AlF4-OH2 center dot Co2+ transition-state mimetic suggests an associative mechanism in which Asp195 and Asp363 orient and activate the water nucleophile. Whereas deletion of the duf89 gene elicited a phenotype in which expression of phosphate homeostasis gene pho1 was derepressed, deleting duf8901 did not, thereby hinting that the DUF89 paralogs have distinct functional repertoires in vivo.	[Sanchez, Ana M.; Jacewicz, Agata; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA; [Sanchez, Ana M.] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.	shumans@mskcc.org		Sanchez, Ana/0000-0002-9119-7624	National Institutes of Health [R35-GM126945]; National Science Foundation graduate research fellowship [1746057]; NIH [P30 GM124165]; Department of Energy [DE-AC02-06CH11357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE))	This work was supported by the National Institutes of Health grant R35-GM126945 (to S. S.) . A. M. S. is supported by the National Science Foundation graduate research fellowship (grant no.: 1746057) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The NE-CAT beamline and the Advanced Photon Source at Argonne National Laboratory are sup-ported by NIH grant P30 GM124165 and Department of Energy Contract No. DE-AC02-06CH11357, respectively.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baxter NJ, 2008, J AM CHEM SOC, V130, P3952, DOI 10.1021/ja078000n; Bitto E, 2005, ACTA CRYSTALLOGR F, V61, P630, DOI 10.1107/S1744309105017690; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Dennis TN, 2020, J STRUCT BIOL, V212, DOI 10.1016/j.jsb.2020.107576; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FANKHAUSER H, 1995, J BIOL CHEM, V270, P28457; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang LL, 2016, NAT CHEM BIOL, V12, P621, DOI [10.1038/NCHEMBIO.2108, 10.1038/nchembio.2108]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Miao Y, 2016, P NATL ACAD SCI USA, V113, P7148, DOI 10.1073/pnas.1601774113; Nahas JV, 2018, G3-GENES GENOM GENET, V8, P2333, DOI 10.1534/g3.118.200303; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; Sanchez AM, 2019, NUCLEIC ACIDS RES, V47, P8452, DOI 10.1093/nar/gkz567; Sanchez AM, 2018, P NATL ACAD SCI USA, V115, pE10652, DOI 10.1073/pnas.1810711115; Schwer B, 2022, MBIO, V13, DOI 10.1128/mbio.03476-21; Shuman S, 2020, NUCLEIC ACIDS RES, V48, P8243, DOI 10.1093/nar/gkaa630	23	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101851	10.1016/j.jbc.2022.101851	http://dx.doi.org/10.1016/j.jbc.2022.101851			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35314193	Green Published, gold			2022-12-28	WOS:000798142000004
J	Mohamed-Raseek, N; Miller, AF				Mohamed-Raseek, Nishya; Miller, Anne-Frances			Contrasting roles for two conserved arginines: Stabilizing flavin semiquinone or quaternary structure, in bifurcating electron transfer flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; HYDROGEN-BONDING INTERACTIONS; MEGASPHAERA-ELSDENII; REDOX PROPERTIES; DEHYDROGENASE; FAD; BINDING; PURIFICATION; MECHANISM; COFACTOR	d Bifurcating electron transfer flavoproteins (Bf ETFs) are important redox enzymes that contain two flavin adenine dinucleotide (FAD) cofactors, with contrasting reactivities and complementary roles in electron bifurcation. However, for both the "electron transfer" (ET) and the "bifurcating" (Bf) FADs, the only charged amino acid within 5 angstrom of the flavin is a conserved arginine (Arg) residue. To understand how the two sites produce different reactivities utilizing the same residue, we investigated the consequences of replacing each of the Arg residues with lysine, glutamine, histidine, or alanine. We show that absence of a positive charge in the ET site diminishes accumulation of the anionic semiquinone (ASQ) that enables the ET flavin to act as a single electron carrier, due to depression of the oxidized versus. ASQ reduction midpoint potential, E degrees(OX/ASQ). Perturbation of the ET site also affected the remote Bf site, whereas abrogation of Bf FAD binding accelerated chemical modification of the ET flavin. In the Bf site, removal of the positive charge impaired binding of FAD or AMP, resulting in unstable protein. Based on pH dependence, we propose that the Bf site Arg interacts with the phosphate(s) of Bf FAD or AMP, bridging the domain interface via a conserved peptide loop ("zipper") and favoring nucleotide binding. We further propose a model that rationalizes conservation of the Bf site Arg even in non-Bf ETFs, as well as AMP's stabilizing role in the latter, and provides a mechanism for coupling Bf flavin redox changes to domain-scale motion.	[Mohamed-Raseek, Nishya; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afmill3r2@gmail.com		Mohamed Raseek, Nishya/0000-0002-5086-1410	National Science Foundation [CLP-1808433, CLP-2108134]	National Science Foundation(National Science Foundation (NSF))	The authors are grateful to the National Science Foundation for support under awards numbers CLP-1808433 and CLP-2108134. The authors thank H. D. Duan for providing R165K-and R165H-RpaETF constructs, T. Creamer for access to the CD spectrapolarimeter, A. Sebesta and B. Gess for maintenance of vital research infrastructure, S. Wang and A. Iyer for access to mass spectrometry, K. Ranguelova for guidance with EPR, and M. Ilham.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Augustin P, 2018, J BIOL CHEM, V293, P2829, DOI 10.1074/jbc.RA117.000846; Bradley LH, 2001, BIOCHEMISTRY-US, V40, P8686, DOI 10.1021/bi010571j; Burgess S. G, 2008, PROBING DYNAMIC INTE; Cerda JF, 2008, ORG BIOMOL CHEM, V6, P2204, DOI 10.1039/b801952e; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Clark W. M., 1960, OXIDATION REDUCTION; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Demmer JK, 2018, FEBS LETT, V592, P332, DOI 10.1002/1873-3468.12971; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Duan HD, 2020, J BIOL CHEM, V295, P12618, DOI 10.1074/jbc.RA120.013174; Duan HD, 2018, J BIOL CHEM, V293, P4688, DOI 10.1074/jbc.RA117.000707; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; Feng X, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016978118; Ghisla S., 1976, FLAVINS FLAVOPROTEIN, P334; Griffin KJ, 1997, BIOCHEMISTRY-US, V36, P4194, DOI 10.1021/bi962572v; He TF, 2013, BIOCHEMISTRY-US, V52, P9120, DOI 10.1021/bi401137u; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; Jang MH, 2000, J BIOL CHEM, V275, P12546, DOI 10.1074/jbc.275.17.12546; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; Kar RK, 2021, J PHYS CHEM B, V125, P12654, DOI 10.1021/acs.jpcb.1c07306; Kayastha K, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108796; Ku HK, 2013, ANAL BIOCHEM, V434, P178, DOI 10.1016/j.ab.2012.10.045; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; LEHMAN TC, 1992, ARCH BIOCHEM BIOPHYS, V292, P594, DOI 10.1016/0003-9861(92)90036-V; Lei CH, 1996, ANAL CHIM ACTA, V332, P73, DOI 10.1016/0003-2670(96)82792-9; Lostao A, 1997, BIOCHEMISTRY-US, V36, P14334, DOI 10.1021/bi971384h; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MASSEY V, 1962, J BIOL CHEM, V237, P2347; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; MAYHEW SG, 1974, EUR J BIOCHEM, V44, P579, DOI 10.1111/j.1432-1033.1974.tb03515.x; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miller AF, 2019, METHOD ENZYMOL, V620, P365, DOI 10.1016/bs.mie.2019.03.017; Mohamed-Raseek N, 2019, CHEM SCI, V10, P7762, DOI 10.1039/c9sc00942f; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; O'Neill H, 1998, J BIOL CHEM, V273, P21015, DOI 10.1074/jbc.273.33.21015; Oja SM, 2014, ANAL CHEM, V86, P6040, DOI 10.1021/ac501194j; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robbins JM, 2018, BIOCHEMISTRY-US, V57, P5818, DOI 10.1021/acs.biochem.8b00571; Robbins JM, 2017, BIOCHEMISTRY-US, V56, P3800, DOI 10.1021/acs.biochem.7b00335; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1997, J BIOCHEM, V121, P477; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; SCHUMAN M, 1971, BIOCHIM BIOPHYS ACTA, V227, P500, DOI 10.1016/0005-2744(71)90003-9; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Stanley RJ, 2001, ANTIOXID REDOX SIGN, V3, P847, DOI 10.1089/15230860152665028; Sucharitakul J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016017; Sucharitakul J, 2021, FEBS J, V288, P1008, DOI 10.1111/febs.15343; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Thorpe C, 1991, CHEM BIOCH FLAVOENZY, P471; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; TWIGG RS, 1945, NATURE, V155, P401, DOI 10.1038/155401a0; Vdovin A, 2013, CHEM PHYS, V422, P195, DOI 10.1016/j.chemphys.2012.11.001; Vigil W, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108793; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312; YAGI K, 1980, BIOCHEMISTRY-US, V19, P1553, DOI 10.1021/bi00549a003; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200	72	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101733	10.1016/j.jbc.2022.101733	http://dx.doi.org/10.1016/j.jbc.2022.101733			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35176283	gold, Green Published			2022-12-28	WOS:000823106100002
J	Wang, GF; Dong, QC; Bai, Y; Gu, J; Tao, QP; Yue, JJ; Zhou, R; Niu, XY; Zhu, L; Song, CW; Zheng, T; Wang, D; Jin, YW; Liu, HN; Cao, C; Liu, X				Wang, Guang-Fei; Dong, Qincai; Bai, Yu; Gu, Jing; Tao, Qingping; Yue, Junjie; Zhou, Rui; Niu, Xiayang; Zhu, Lin; Song, Caiwei; Zheng, Tong; Wang, Di; Jin, Yanwen; Liu, Hainan; Cao, Cheng; Liu, Xuan			c-Abl kinase-mediated phosphorylation of gamma-tubulin promotes gamma-tubulin ring complexes assembly and microtubule nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAINS; TYROSINE KINASE; F-ACTIN; CENTROSOME; PROTEIN; GENE; CELL; MALFORMATIONS; LOCALIZATION; DYNAMICS	Cytoskeletal microtubules (MTs) are nucleated from gamma-tubulin ring complexes (gamma TuRCs) located at MT organizing centers (MTOCs), such as the centrosome. However, the exact regulatory mechanism of gamma TuRC assembly is not fully understood. Here, we showed that the nonreceptor tyrosine kinase c-Abl was associated with and phosphorylated gamma-tubulin, the essential component of the gamma TuRC, mainly on the Y443 residue by in vivo (immunofluorescence and immunoprecipitation) or in vitro (surface plasmon resonance) detection. We further demonstrated that phosphorylation deficiency significantly impaired gamma TuRC assembly, centrosome construction, and MT nucleation. c-Abl/Arg deletion and gamma-tubulin Y443F mutation resulted in an abnormal morphology and compromised spindle function during mitosis, eventually causing uneven chromosome segregation. Our findings reveal that gamma TuRC assembly and nucleation function are regulated by Abl kinase-mediated gamma-tubulin phosphorylation, revealing a fundamental mechanism that contributes to the maintenance of MT function.	[Wang, Guang-Fei; Dong, Qincai; Yue, Junjie; Zhu, Lin; Song, Caiwei; Zheng, Tong; Jin, Yanwen; Liu, Hainan; Cao, Cheng; Liu, Xuan] Beijing Inst Biotechnol, Dept Genet Engn, Beijing, Peoples R China; [Bai, Yu; Gu, Jing; Tao, Qingping; Zhou, Rui; Niu, Xiayang; Wang, Di] Anhui Univ, Inst Phys Sci, Hefei, Peoples R China	Anhui University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Liu, HN; Cao, C; Liu, X (corresponding author), Beijing Inst Biotechnol, Dept Genet Engn, Beijing, Peoples R China.	jerrylhn@126.com; caoc@nic.bmi.ac.cn; liux931932@163.com	Cao, Cheng/GNP-6156-2022	Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Cheng Cao reports financial support was provided by National Natural Science Foundation of China. Guang-Fei Wang reports financial support was provided by China Postdoctoral Science Foundation.	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Bastians Holger, 2015, Recent Results Cancer Res, V200, P95, DOI 10.1007/978-3-319-20291-4_5; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Diaz-Corrales FJ, 2005, NEUROSCIENCE, V133, P117, DOI 10.1016/j.neuroscience.2005.01.044; Eklund G, 2014, J BIOL CHEM, V289, P21360, DOI 10.1074/jbc.M114.562389; Estrada LD, 2011, CURR ALZHEIMER RES, V8, P643; Fuller SD, 1995, CURR BIOL, V5, P1384, DOI 10.1016/S0960-9822(95)00276-4; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Gonfloni Stefania, 2012, Int J Cell Biol, V2012, P683097, DOI 10.1155/2012/683097; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Hu YH, 2019, J CELL BIOL, V218, P3986, DOI 10.1083/jcb.201812144; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Ivanova EL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10081-8; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; KIPREOS ET, 1992, SCIENCE, V256, P382, DOI 10.1126/science.256.5055.382; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Magiera M. M., 2018, EXCESSIVE TUBULIN PO; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Moudjou M, 1996, J CELL SCI, V109, P875; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shang YH, 2005, J CELL BIOL, V171, P1035, DOI 10.1083/jcb.200508184; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Wieczorek M, 2020, CELL, V180, P165, DOI 10.1016/j.cell.2019.12.007; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	48	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101778	10.1016/j.jbc.2022.101778	http://dx.doi.org/10.1016/j.jbc.2022.101778			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35231444	Green Published, gold			2022-12-28	WOS:000793692600010
J	Byts, N; Sharma, S; Malm, T; Kaakinen, M; Korhonen, P; Jaakkonen, L; Keuters, M; Huuskonen, M; Pietilae, I; Koistinaho, J; Koivunen, P; Myllyharju, J				Byts, Nadiya; Sharma, Subodh; Malm, Tarja; Kaakinen, Mika; Korhonen, Paula; Jaakkonen, Laura; Keuters, Meike; Huuskonen, Mikko; Pietilae, Ilkka; Koistinaho, Jari; Koivunen, Peppi; Myllyharju, Johanna			Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERY OCCLUSION; AGED MICE; HYPOXIA; STROKE; MECHANISMS; TRANSIENT	Hypoxia-inducible factor prolyl 4-hydroxylases (HIF-P4Hs) regulate the hypoxic induction of > 300 genes required for survival and adaptation under oxygen deprivation. Inhibition of HIF-P4H-2 has been shown to be protective in focal cerebral ischemia rodent models, while that of HIF-P4H-1 has no effects and inactivation of HIF-P4H-3 has adverse effects. A trans membrane prolyl 4-hydroxylase (P4H-TM) is highly expressed in the brain and contributes to the regulation of HIF, but the outcome of its inhibition on stroke is yet unknown. To study this, we subjected WT and P4htm(-/- )mice to permanent middle cerebral artery occlusion (pMCAO). Lack of P4H-TM had no effect on lesion size following pMCAO, but increased inflam-matory microgliosis and neutrophil infiltration was observed in the P4htm-/- cortex. Furthermore, both the permeability of blood brain barrier and ultrastructure of cerebral tight junctions were compromised in P4htm(-/-) mice. At the molecular level, P4H-TM deficiency led to increased expression of proinflammatory genes and robust activation of protein kinases in the cortex, while expression of tight junction proteins and the neuroprotective growth factors erythropoietin and vascular endothelial growth factor was reduced. Our data provide the first evidence that P4H-TM inactivation has no protective effect on infarct size and increases inflammatory microgliosis and neutrophil infiltration in the cortex at early stage after pMCAO. When considering HIF-P4H inhibitors as potential therapeutics in stroke, the current data support that isoenzyme-selective inhibitors that do not target P4H-TM or HIF-P4H-3 would be preferred.	[Byts, Nadiya; Sharma, Subodh; Kaakinen, Mika; Jaakkonen, Laura; Pietilae, Ilkka; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland; [Malm, Tarja; Korhonen, Paula; Keuters, Meike; Huuskonen, Mikko; Koistinaho, Jari] Univ Eastern Finland, A I Virtanen Inst Mol Sci, Kuopio, Finland; [Keuters, Meike; Koistinaho, Jari] Univ Helsinki, Helsinki Inst Life Sci, Neurosci Ctr, Helsinki, Finland	University of Oulu; University of Eastern Finland; University of Helsinki	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland.	johanna.myllyharju@oulu.fi		Koistinaho, Jari/0000-0001-6559-1153; Keuters, Meike Hedwig/0000-0003-4216-1024; Sharma, Subodh/0000-0001-7033-0927; Korhonen, Paula/0000-0001-5856-1474	Academy of Finland [133075, 218129, 278343, 296498]; Academy of Finland Center of Excellence 2012 to 2017 Grant [251314]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; European Union [607962]	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence 2012 to 2017 Grant(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; European Union(European Commission)	This study was supported by the Academy of Finland through Grants 133075 (T. M.), 218129 (P. K.), 278343 (J. K.), 296498 (J. M.) and Academy of Finland Center of Excellence 2012 to 2017 Grant 251314 (J. M.), the S. Juselius Foundation (P. K. and J. M.), the Jane and Aatos Erkko Foundation (P. K. and J. M.), FibroGen, Inc (J. M.), and the European Union Seventh Framework Program FP7 Grant 607962 (nEUROinflammation) (J. K.).	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Byts N, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0253-20.2020; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chan MC, 2016, MOL ASPECTS MED, V47-48, P54, DOI 10.1016/j.mam.2016.01.001; Chen RL, 2012, J PHYSIOL-LONDON, V590, P4079, DOI 10.1113/jphysiol.2012.232884; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; Dhungana H, 2013, AGING CELL, V12, P842, DOI 10.1111/acel.12106; Dhungana H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-102; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Endres M., 2008, Cerebrovasc. Dis., V25; Gehringer M, 2015, EXPERT OPIN THER PAT, V25, P849, DOI 10.1517/13543776.2015.1039984; Greenberg DA, 2015, STROKE, V46, pE101, DOI 10.1161/STROKEAHA.114.007641; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Haronen H, 2017, HUM MOL GENET, V26, P2076, DOI 10.1093/hmg/ddx101; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Huuskonen MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33176; Hyvarinen J, 2010, J BIOL CHEM, V285, P42023, DOI 10.1074/jbc.M110.145904; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jurga AM, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00198; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0403-6; Kietzmann T, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00011; Kiriakidis S, 2017, KIDNEY INT, V92, P900, DOI 10.1016/j.kint.2017.03.008; Klotzsche-von Ameln A., 2013, Mol. Cancer Res., V11; Koepsell H., 2020, Pflugers Arch., V472; Koistinaho M., 2002, Proc. Natl. Acad.; Koivunen P., 2007, J. Biol. Chem., V282; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Leinonen H., 2016, Lack of P4H-TM in mice results; Leinonen H, 2019, NEUROPHARMACOLOGY, V153, P63, DOI 10.1016/j.neuropharm.2019.04.023; Li L., 2016, Neurobiol. Dis., V91; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Mocco J., 2006, Circ. Res.; Mukandala G, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6010006; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Payabvash S., 2011, Stroke, V42; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sanghani NS, 2019, ADV CHRONIC KIDNEY D, V26, P253, DOI 10.1053/j.ackd.2019.04.004; Santillan A, 2014, J NEUROSCI METH, V222, P106, DOI 10.1016/j.jneumeth.2013.11.008; Schdel J., 2013, Biol. Chem., V394; Selvaraju V, 2014, ANTIOXID REDOX SIGN, V20, P2631, DOI 10.1089/ars.2013.5186; Shah D, 2015, J BIOL CHEM, V290, P29642, DOI 10.1074/jbc.M115.690784; Shah FA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01178; Short KM, 2010, KIDNEY INT, V77, P1132, DOI 10.1038/ki.2010.42; Shuaib A., 2002, Stroke, V33; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Son M, 2015, IMMUNOL RES, V63, P101, DOI 10.1007/s12026-015-8705-6; Speer R, 2016, ADV EXP MED BIOL, V903, P221, DOI 10.1007/978-1-4899-7678-9_16; Taylor CT, 2016, J CLIN INVEST, V126, P3716, DOI 10.1172/JCI84433; Wei KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058995; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; Zhou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184049	74	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101721	10.1016/j.jbc.2022.101721	http://dx.doi.org/10.1016/j.jbc.2022.101721			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151685	Green Published, gold			2022-12-28	WOS:000789394500008
J	Johnson, OT; Nadel, CM; Carroll, EC; Arhar, T; Gestwicki, JE				Johnson, Oleta T.; Nadel, Cory M.; Carroll, Emma C.; Arhar, Taylor; Gestwicki, Jason E.			Two distinct classes of cochaperones compete for the EEVD motif in heat shock protein 70 to tune its chaperone activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							J-PROTEINS; J-DOMAIN; HSP70; MECHANISM; DISAGGREGATION; IDENTIFICATION; HYDROLYSIS; COMPLEXES; BINDING; BAG-1	Chaperones of the heat shock protein 70 (Hsp70) family engage in protein-protein interactions with many cochaper-ones. One "hotspot " for cochaperone binding is the EEVD motif, found at the extreme C terminus of cytoplasmic Hsp70s. This motif is known to bind tetratricopeptide repeat domain cochaperones, such as the E3 ubiquitin ligase CHIP. In addi-tion, the EEVD motif also interacts with a structurally distinct domain that is present in class B J-domain proteins, such as DnaJB4. These observations suggest that CHIP and DnaJB4 might compete for binding to Hsp70's EEVD motif; however, the molecular determinants of such competition are not clear. Using a collection of EEVD-derived peptides, including muta-tions and truncations, we explored which residues are critical for binding to both CHIP and DnaJB4. These results revealed that some features, such as the C-terminal carboxylate, are important for both interactions. However, CHIP and DnaJB4 also had unique preferences, especially at the isoleucine posi-tion immediately adjacent to the EEVD. Finally, we show that competition between these cochaperones is important in vitro, as DnaJB4 limits the ubiquitination activity of the Hsp70- CHIP complex, whereas CHIP suppresses the client refolding activity of the Hsp70-DnaJB4 complex. Together, these data suggest that the EEVD motif has evolved to support diverse protein-protein interactions, such that competition between cochaperones may help guide whether Hsp70-bound proteins are folded or degraded.	[Johnson, Oleta T.; Nadel, Cory M.; Carroll, Emma C.; Arhar, Taylor; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA USA; [Arhar, Taylor] Beloit Coll, Dept Chem, Beloit, WI USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of California System; University of California San Francisco; Beloit College; University of California System; University of California San Francisco	Arhar, T; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA USA.; Arhar, T (corresponding author), Beloit Coll, Dept Chem, Beloit, WI USA.; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA.	arhart@beloit.edu; jason.gestwicki@ucsf.edu		Carroll, Emma/0000-0002-6766-4245; Nadel, Cory/0000-0001-6827-3302	NIH [K12GM081266, NS059690, AG068125]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge support from the NIH (O. T. J. K12GM081266; J. E. G. NS059690 and AG068125). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arhar T, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101282; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Assimon V. A., 2015, Biochemistry, V54; Backe SJ, 2020, J BIOL CHEM, V295, P11099, DOI 10.1074/jbc.REV120.011833; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bernadotte A, 2018, FEBS OPEN BIO, V8, P1830, DOI 10.1002/2211-5463.12521; Bhattacharya K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19783-w; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brinker A., 2002, J. Biol. Chem., V277; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chand K., 2021, Cell Stress Chaperones, V26; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Connarn JN, 2014, J BIOL CHEM, V289, P2908, DOI 10.1074/jbc.M113.519421; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Costanzo M., 2010, Thegenetic; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Faust O, 2020, NATURE, V587, P489, DOI 10.1038/s41586-020-2906-4; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freilich R, 2018, ACCOUNTS CHEM RES, V51, P940, DOI 10.1021/acs.accounts.8b00036; Gestwicki JE, 2019, J BIOL CHEM, V294, P2151, DOI 10.1074/jbc.TM118.002813; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hennessy F, 2000, CELL STRESS CHAPERON, V5, P347, DOI 10.1379/1466-1268(2000)005<0347:AOTLOC>2.0.CO;2; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang Y., 2019, Science, V365; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Kundrat L., 2010, Biochemistry, V49; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li J., 2006, Biochem.J., V398; Li J., 2005, Biochem. J., V386; Li J., 2003, Structure, V11; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lizama BN, 2018, J NEUROSCI, V38, P6825, DOI 10.1523/JNEUROSCI.0699-18.2018; Lott A, 2020, PROTEIN SCI, V29, P2422, DOI 10.1002/pro.3969; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miao WL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11552-8; Mok S. A., 2018, Mappinginteractions with the chaperone; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Otero JH, 2014, J BIOL CHEM, V289, P27504, DOI 10.1074/jbc.M114.587147; Petrucelli L., 2004, CHIP and Hsp70 regulatetau ubiquitination, degradation and aggregation; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qian XG, 2002, BIOCHEM J, V361, P27, DOI 10.1042/0264-6021:3610027; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Ravalin M, 2019, NAT CHEM BIOL, V15, P786, DOI 10.1038/s41589-019-0322-6; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Rosser M. F., 2007, J. Biol.Chem., V282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shimamoto S, 2013, J BIOL CHEM, V288, P7158, DOI 10.1074/jbc.M112.436758; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P1015, DOI 10.1021/bi9720484; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Suzuki H, 2010, BIOCHEMISTRY-US, V49, P8577, DOI 10.1021/bi100876n; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; WALL D, 1994, J BIOL CHEM, V269, P5446; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Weber B, 2020, J PEPT SCI, V26, DOI 10.1002/psc.3235; Wentink AS, 2020, NATURE, V587, P483, DOI 10.1038/s41586-020-2904-6; Xu Z., 2006, Biochemistry, V45; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Yu HY, 2015, FEBS LETT, V589, P2825, DOI 10.1016/j.febslet.2015.07.040; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang H., 2015, Structure, V23; Zhang M., 2005, Mol. Cell, V20; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	83	2	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101697	10.1016/j.jbc.2022.101697	http://dx.doi.org/10.1016/j.jbc.2022.101697			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148989	gold, Green Published			2022-12-28	WOS:000789400700012
J	Kimura, T; Hayama, Y; Okuzaki, D; Nada, S; Okada, M				Kimura, Tetsuya; Hayama, Yoshitomo; Okuzaki, Daisuke; Nada, Shigeyuki; Okada, Masato			The Ragulator complex serves as a substrate-specific mTORC1 scaffold in regulating the nuclear translocation of transcription factor EB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAG GTPASES; AMINO; TFEB	The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is activated by intracellular nutritional sufficiency and extracellular growth signals. It has been reported that mTORC1 acts as a hub that integrates these inputs to orchestrate a number of cellular responses, including translation, nucleotide synthesis, lipid synthesis, and lysosome biogenesis. However, little is known about specific control of mTORC1 signaling downstream of this complex. Here, we demonstrate that Ragulator, a heteropentameric protein complex required for mTORC1 activation in response to amino acids, is critical for inhibiting the nuclear translocation of transcription factor EB (TFEB). We established a unique RAW264.7 clone that lacked Ragulator but retained total mTORC1 activity. In a nutrition-sufficient state, the nuclear translocation of TFEB was markedly enhanced in the clone despite total mTORC1 kinase activity. In addition, as a cellular phenotype, the number of lysosomes was increased by tenfold in the Ragulator-deficient clone compared with that of control cells. These findings indicate that mTORC1 essentially requires the Ragulator complex for regulating the subcellular distribution of TFEB. Our findings also suggest that other scaffold proteins may be associated with mTORC1 for the specific regulation of downstream signaling.	[Kimura, Tetsuya; Nada, Shigeyuki; Okada, Masato] WPI Immunol Frontier Res Ctr, Dept Oncogene Res, Suita, Osaka, Japan; [Hayama, Yoshitomo] Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka, Japan; [Okuzaki, Daisuke] WPI Immunol Frontier Res Ctr, Single Cell Genom, Human Immunol, Suita, Osaka, Japan; [Okuzaki, Daisuke] Res Inst Microbial Dis, Genome Informat Res Ctr, Suita, Osaka, Japan; [Okuzaki, Daisuke] Inst Open & Transdisciplinary Res Initiat, Suita, Osaka, Japan; [Nada, Shigeyuki; Okada, Masato] Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan	Osaka University	Kimura, T (corresponding author), WPI Immunol Frontier Res Ctr, Dept Oncogene Res, Suita, Osaka, Japan.	tetsuyakimura@biken.osaka-u.ac.jp		Nada, Shigeyuki/0000-0002-1103-6119	JSPS KAKENHI [18K16200]; Takeda Science Foundation; Mitsubishi Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	The authors acknowledge Ms Hiroko Ohmori of the Central Laboratory of WPI Immunology Frontier Research Center, Osaka University, for assisting in the studies on electron microscopy. This study was supported by the JSPS KAKENHI Grant-in-aid for Young Scientists (grant number: 18K16200) , Visionary Research Grant from Takeda Science Foundation, Research Grant in the Natural Sciences (young scientist grant) from the Mitsubishi Foundation, and a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Di Malta C, 2017, SCIENCE, V356, P1188, DOI 10.1126/science.aag2553; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Hayama Y, 2018, J IMMUNOL, V200, P3790, DOI 10.4049/jimmunol.1701283; Jung S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00966; Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Lotfi P, 2018, AUTOPHAGY, V14, P1419, DOI 10.1080/15548627.2018.1474313; Marques ARA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221739; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101744	10.1016/j.jbc.2022.101744	http://dx.doi.org/10.1016/j.jbc.2022.101744			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35183507	Green Published, gold			2022-12-28	WOS:000789398100007
J	Urena, F; Ma, C; Hoffmann, FW; Urschitz, J; Moisyadi, S; Khadka, VS; Deng, YP; Hoffmann, PR; Nunes, LGA				Urena, Frank; Ma, Chi; Hoffmann, FuKun W.; Urschitz, Johann; Moisyadi, Stefan; Khadka, Vedbar S.; Deng, Youping; Hoffmann, Peter R.; Nunes, Lance G. A.			T-cell activation decreases miRNA-15a/16 levels to promote MEK1-ERK1/2-Elk1 signaling and proliferative capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MIR-15/16; PIGGYBAC; ELK-1; PATHOGENESIS; EXPRESSION; PATHWAYS; LIGATION; MICRORNA	While miRs have been extensively studied in the context of malignancy and tumor progression, their functions in regulating T-cell activation are less clear. In initial studies, we found reduced levels of miR-15a/16 at 3 to 18 h post-T-cell receptor (TCR) stimulation, suggesting a role for decreased levels of this miR pair in shaping T-cell activation. To further explore this, we developed an inducible miR15a/16 transgenic mouse model to determine how elevating miR-15a/16 levels during early stages of activation would affect T-cell proliferation and to identify TCR signaling pathways regulated by this miR pair. Doxycycline (DOX)-induced expression of miR-15a/ 16 from 0 to 18 h post-TCR stimulation decreased ex vivo T-cell proliferation as well as in vivo antigen-specific T-cell proliferation. We also combined bioinformatics and proteomics approaches to identify the mitogen-activated protein kinase kinase 1 (MEK1) (Map2k1) as a target of miR-15a/16. MEK1 targeting by miR-15a/16 was confirmed using miR mimics that decreased Map2k1 mRNA containing the 30-UTR target nucleotide sequence (UGCUGCUA) but did not decrease Map2k1 containing a mutated control sequence (AAAAA AAA). Phosphorylation of downstream signaling molecules, extracellular signal-regulated protein kinase 1/2 (ERK1/2) and Elk1, was also decreased by DOX-induced miR-15a/16 expression. In addition to MEK1, ERK1 was subsequently found to be targeted by miR-15a/16, with DOX-induced miR15a/16 reducing total ERK1 levels in T cells. These findings show that TCR stimulation reduces miR-15a/16 levels at early stages of T-cell activation to facilitate increased MEK1 and ERK1, which promotes the sustained MEK1-ERK1/2-Elk1 signaling required for optimal proliferation.	[Urena, Frank; Ma, Chi; Hoffmann, FuKun W.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI USA; [Urena, Frank] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI USA; [Urschitz, Johann; Moisyadi, Stefan; Nunes, Lance G. A.] Univ Hawaii, Dept Anat Physiol & Biochem, John A Burns Schoolof Med, Honolulu, HI USA; [Khadka, Vedbar S.; Deng, Youping] Univ Hawaii, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA	University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii System	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI USA.	peterrh@hawaii.edu	; Khadka, Vedbar/O-4156-2018	/0000-0002-0589-2963; Khadka, Vedbar/0000-0002-8652-2904	National Institutes of Health [R01AI147496, P20GM103466, P20GM103457, R24GM137786]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health grants R01AI147496, P20GM103466, P20GM103457, and R24GM137786. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dzafo E, 2021, IMMUNOL REV, V300, P181, DOI 10.1111/imr.12932; Tapeh BEG, 2020, J CELL PHYSIOL, V235, P8461, DOI 10.1002/jcp.29689; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Gagnon JD, 2019, CELL REP, V28, P2169, DOI 10.1016/j.celrep.2019.07.064; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang EY, 2015, FUTURE ONCOL, V11, P2351, DOI 10.2217/fon.15.101; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Liang QL, 2010, J IMMUNOL, V185, P5704, DOI 10.4049/jimmunol.1000690; Lovat F, 2020, P NATL ACAD SCI USA, V117, P12332, DOI 10.1073/pnas.2003597117; Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112; Ma C, 2021, MOL METAB, V47, DOI 10.1016/j.molmet.2021.101170; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Mut M, 2012, INT J BIOCHEM CELL B, V44, P302, DOI 10.1016/j.biocel.2011.10.025; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Pekarsky Y, 2015, CELL DEATH DIFFER, V22, P6, DOI 10.1038/cdd.2014.87; Pekarsky Y, 2018, CELL DEATH DIFFER, V25, P21, DOI 10.1038/cdd.2017.159; RAO VN, 1994, ONCOGENE, V9, P1855; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scherm MG, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01325-9; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Tagawa H, 2013, CANCER SCI, V104, P801, DOI 10.1111/cas.12160; Teteloshvili Nato, 2015, Microrna, V4, P117; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Urschitz J, 2010, P NATL ACAD SCI USA, V107, P8117, DOI 10.1073/pnas.1003674107; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	33	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101634	10.1016/j.jbc.2022.101634	http://dx.doi.org/10.1016/j.jbc.2022.101634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085550	Green Published, gold			2022-12-28	WOS:000789261900013
J	Walklate, J; Kao, KRY; Regnier, M; Geeves, MAA				Walklate, Jonathan; Kao, Kerry; Regnier, Michael; Geeves, Michael A. A.			Exploring the super-relaxed state of myosin in myofibrils from fast-twitch, slow-twitch, and cardiac muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP TURNOVER; MECHANISM; HEADS; CONFORMATION; MOLECULE; KINETICS; CONTRACTILITY; TEMPERATURE; INHIBITION; EXPRESSION	Muscle myosin heads, in the absence of actin, have been shown to exist in two states, the relaxed (turnover similar to 0.05 s(-1)) and super-relaxed states (SRX, 0.005 s(-1)) using a simple fluo-rescent ATP chase assay (Hooijman, P. et al (2011) Biophys. J. 100, 1969-1976). Studies have normally used purified proteins, myosin filaments, or muscle fibers. Here we use muscle myofibrils, which retain most of the ancillary proteins and 3-D architecture of muscle and can be used with rapid mixing methods. Recording timescales from 0.1 to 1000 s provides a precise measure of the two populations of myosin heads present in relaxed myofibrils. We demonstrate that the population of SRX states is formed from rigor cross bridges within 0.2 s of relaxing with fluorescently labeled ATP, and the population of SRX states is relatively constant over the temperature range of 5 & nbsp;C-30 & nbsp;C. The SRX population is enhanced in the presence of mavacamten and reduced in the presence of deoxy-ATP. Compared with myofibrils from fast-twitch muscle, slow twitch muscle, and cardiac muscles, myofibrils require a tenfold lower concentration of mavacamten to be effective, and mavacamten induced a larger increase in the population of the SRX state. Mavacamten is less effective, however, at stabilizing the SRX state at physiological temperatures than at 5 & nbsp;C. These assays require small quantities of myofibrils, making them suitable for studies of model organism muscles, human biopsies, or human-derived iPSCs.	[Walklate, Jonathan; Geeves, Michael A. A.] Univ Kent, Sch Biosci, Div Nat Sci, Canterbury, Kent, England; [Kao, Kerry; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA USA	University of Kent; University of Washington; University of Washington Seattle	Geeves, MAA (corresponding author), Univ Kent, Sch Biosci, Div Nat Sci, Canterbury, Kent, England.	m.a.geeves@kent.ac.uk		Geeves, Michael/0000-0002-9364-8898	European Unions Horizon 2020 research and innovation programme [777204]; NIH [RM1 GM131981, R01HL128368]	European Unions Horizon 2020 research and innovation programme; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 777204 (M. A. G., M. R) . Additional funding was provided by NIH R01HL128368 (M. R.) and NIH RM1 GM131981 (M. R.) .	Alamo L, 2016, J MOL BIOL, V428, P1142, DOI 10.1016/j.jmb.2016.01.027; Anderson RL, 2018, P NATL ACAD SCI USA, V115, pEB143, DOI 10.1073/pnas.1809540115; Caremani M, 2019, J GEN PHYSIOL, V151, P1272, DOI 10.1085/jgp.201912424; Chu SM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101157; Cooke Roger, 2011, Biophys Rev, V3, P33; Fusi L, 2015, BIOPHYS J, V109, P783, DOI 10.1016/j.bpj.2015.06.038; Gollapudi SK, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016506; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; JACKSON AP, 1988, BIOCHEM J, V251, P527, DOI 10.1042/bj2510527; Kawas RF, 2017, J BIOL CHEM, V292, P16571, DOI 10.1074/jbc.M117.776815; Korte FS, 2011, J MOL CELL CARDIOL, V51, P894, DOI 10.1016/j.yjmcc.2011.08.026; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Lee KH, 2018, P NATL ACAD SCI USA, V115, pE1991, DOI 10.1073/pnas.1715247115; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lionne C, 2003, J MUSCLE RES CELL M, V24, P139, DOI 10.1023/A:1026045328949; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Ma WK, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012780; Ma WK, 2020, J PHYSIOL-LONDON, V598, P5165, DOI 10.1113/JP280402; MA YZ, 1994, BIOPHYS J, V66, P1542, DOI 10.1016/S0006-3495(94)80945-2; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; MYBURGH KH, 1995, J GEN PHYSIOL, V106, P957, DOI 10.1085/jgp.106.5.957; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; Nag S, 2021, ELIFE, V10, DOI 10.7554/eLife.63703; Nelson SR, 2020, BIOPHYS J, V119, P1050, DOI 10.1016/j.bpj.2020.07.036; Nowakowski SG, 2013, P NATL ACAD SCI USA, V110, P6187, DOI 10.1073/pnas.1220693110; Nyitrai M, 2003, BIOPHYS J, V85, P1053, DOI 10.1016/S0006-3495(03)74544-5; Padron R, 2020, P NATL ACAD SCI USA, V117, P11865, DOI 10.1073/pnas.1921312117; Palpant NJ, 2015, DEVELOPMENT, V142, P3198, DOI 10.1242/dev.117010; Park-Holohan SJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023706118; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Rohde JA, 2018, P NATL ACAD SCI USA, V115, pE7486, DOI 10.1073/pnas.1720342115; Scarff CA, 2020, NATURE, V588, P515, DOI 10.1038/s41586-020-2990-5; Scellini B, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012789; Schmid M, 2021, BIOL OPEN, V10, DOI 10.1242/bio.057646; Schoffstall B, 2006, BIOPHYS J, V91, P2216, DOI [10.1529/biophysj.105.079061, 10.1529/biophysj.107.079061]; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Sitbon YH, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012801; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Tikunov BA, 2001, J APPL PHYSIOL, V90, P1927, DOI 10.1152/jappl.2001.90.5.1927; Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339; Toniolo L, 2005, J EXP BIOL, V208, P4243, DOI 10.1242/jeb.01904; Walklate J, 2019, ANAL BIOCHEM, V581, DOI 10.1016/j.ab.2019.06.009; Walklate J, 2015, ANAL BIOCHEM, V476, P11, DOI 10.1016/j.ab.2015.01.020; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wilson C, 2014, BIOPHYS J, V107, P1637, DOI 10.1016/j.bpj.2014.07.075; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xu S, 2003, BIOCHEMISTRY-US, V42, P390, DOI 10.1021/bi026085t; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; Yang SX, 2020, NATURE, V588, P521, DOI 10.1038/s41586-020-3007-0	53	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101640	10.1016/j.jbc.2022.101640	http://dx.doi.org/10.1016/j.jbc.2022.101640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090895	Green Published, gold, Green Accepted			2022-12-28	WOS:000789261900005
J	Liu, JH; Zhao, Y; Ding, Z; Zhao, Y; Chen, TT; Ge, WH; Zhang, JF				Liu, Junhao; Zhao, Yang; Ding, Zhao; Zhao, Yue; Chen, Tingting; Ge, Wenhao; Zhang, Jianfa			Iron accumulation with age alters metabolic pattern and circadian clock gene expression through the reduction of AMP-modulated histone methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIC RESTRICTION; LIPID-PEROXIDATION; OXIDATIVE STRESS; SLEEP DISORDERS; BLOOD-DONATION; HEME; OVERLOAD; HEPCIDIN; DISRUPTION; DEFICIENCY	Iron accumulates with age in mammals, and its possible implications in altering metabolic responses are not fully understood. Here, we report that both high-iron diet and advanced age in mice consistently altered gene expression of many pathways, including those governing the oxidative stress response and the circadian clock. We used a metabolomic approach to reveal similarities between metabolic profiles and the daily oscillation of clock genes in old and iron-overloaded mouse livers. In addition, we show that phlebotomy decreased iron accumulation in old mice, partially restoring the metabolic patterns and amplitudes of the oscillatory expression of clock genes Per1 and Per2. We further identified that the transcriptional regulation of iron occurred through a reduction in AMPmodulated methylation of histone H3K9 in the Per1 and H3K4 in the Per2 promoters, respectively. Taken together, our results indicate that iron accumulation with age can affect metabolic patterns and the circadian clock.	[Liu, Junhao; Zhao, Yang; Ding, Zhao; Chen, Tingting; Ge, Wenhao; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China; [Zhao, Yue] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Nanjing University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China.	jfzhang@njust.edu.cn	Zhao, Yue/AAJ-4026-2021	Zhao, Yue/0000-0003-2869-5257	National Natural Science Foundation of China fund [31861163004, 31871178]; Fundamental Research Funds for the Central Universities [30920031102]	National Natural Science Foundation of China fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research work was supported by the National Natural Science Foundation of China fund (grant nos.: 31861163004 and 31871178) and the Fundamental Research Funds for the Central Universities (grant nos.: 30920031102).	ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1; Amer J, 2003, EUR J HAEMATOL, V70, P84, DOI 10.1034/j.1600-0609.2003.00011.x; Amer J, 2004, CYTOM PART A, V60A, P73, DOI 10.1002/cyto.a.20017; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Berdoukas V, 2015, FREE RADICAL BIO MED, V88, P3, DOI 10.1016/j.freeradbiomed.2015.07.019; BLIWISE DL, 1993, SLEEP, V16, P40, DOI 10.1093/sleep/16.1.40; Boult J, 2008, CLIN CANCER RES, V14, P379, DOI 10.1158/1078-0432.CCR-07-1054; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; Castro-Caraballo F, 1992, Invest Clin, V33, P121; Chen YW, 2013, CANCER-AM CANCER SOC, V119, P4259, DOI 10.1002/cncr.28356; Constante M, 2006, AM J PHYSIOL-GASTR L, V291, pG229, DOI 10.1152/ajpgi.00092.2006; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Ellervik C, 2013, DIABETES CARE, V36, P2646, DOI 10.2337/dc12-2032; Equitani F, 2008, DIABETES CARE, V31, P3, DOI 10.2337/dc07-0939; ETHIER MF, 1989, MECH AGEING DEV, V50, P159, DOI 10.1016/0047-6374(89)90011-0; Fenton RA, 2012, J CELL PHYSIOL, V227, P3709, DOI 10.1002/jcp.24079; Fernandez-Real JM, 2002, DIABETES CARE, V25, P2249, DOI 10.2337/diacare.25.12.2249; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Horl WH, 2014, NEPHROL DIAL TRANSPL, V29, P1141, DOI 10.1093/ndt/gft467; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Huang D, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12816; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Jung M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01171; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kalpravidh RW, 2013, SCI WORLD J, DOI 10.1155/2013/543973; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Kitanishi K, 2008, BIOCHEMISTRY-US, V47, P6157, DOI 10.1021/bi7023892; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korolnek T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00126; Krebs NF, 2000, J NUTR, V130, p358S, DOI 10.1093/jn/130.2.358S; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lynch G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00143; Madeddu C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01294; MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mehta KJ, 2019, WORLD J GASTROENTERO, V25, P521, DOI 10.3748/wjg.v25.i5.521; Mercadante CJ, 2019, HAEMATOLOGICA, V104, P678, DOI 10.3324/haematol.2018.198382; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mpoya A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1112-4; Parayath NN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19486-2; Pra D, 2009, NUTR CANCER, V61, P415, DOI 10.1080/01635580902803701; Praharaj SK, 2018, INDIAN J PSYCHIAT, V60, P383, DOI 10.4103/0019-5545.224477; Prajapati M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100835; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rigas AS, 2019, TRANSFUSION MED, V29, P65, DOI 10.1111/tme.12478; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Salonen JT, 1998, AM J EPIDEMIOL, V148, P445; Santos MM, 2000, AM J PATHOL, V157, P1883, DOI 10.1016/S0002-9440(10)64827-4; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Schoenfeld JD, 2017, CANCER CELL, V31, P487, DOI 10.1016/j.ccell.2017.02.018; Schwartz AJ, 2019, J CLIN INVEST, V129, P336, DOI 10.1172/JCI122359; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Tarasiuk A, 2003, ARCH PEDIAT ADOL MED, V157, P463, DOI 10.1001/archpedi.157.5.463; Terman DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052543; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; TUREK FW, 1995, NEUROSCI BIOBEHAV R, V19, P53, DOI 10.1016/0149-7634(94)00030-5; Ullum H, 2015, TRANSFUSION, V55, P2479, DOI 10.1111/trf.13205; Vahidnia F, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/814842; van Jaarsveld H, 2002, ATHEROSCLEROSIS, V161, P395, DOI 10.1016/S0021-9150(01)00638-4; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Wallen GR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-207; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118101; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Xu JZ, 2012, INT J MOL SCI, V13, P2368, DOI 10.3390/ijms13022368; Yang X, 2019, DIABETOLOGIA, V62, P2106, DOI 10.1007/s00125-019-04971-1; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yunce Muharrem, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P653, DOI 10.1515/jbcpp-2015-0111; Zhou YF, 2018, HEPATOLOGY, V67, P21, DOI 10.1002/hep.29499	99	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101968	10.1016/j.jbc.2022.101968	http://dx.doi.org/10.1016/j.jbc.2022.101968			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35460695	Green Published, gold			2022-12-28	WOS:000838892100014
J	Tian, QW; Wu, JT; Xu, HF; Hu, ZL; Huo, YA; Wang, LY				Tian, Qingwei; Wu, Jingting; Xu, Haifeng; Hu, Zhangli; Huo, Yangao; Wang, Liyan			Cryo-EM structure of the fatty acid reductase LuxC-LuxE complex provides insights into bacterial bioluminescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-PROTEIN SYNTHETASE; CRYSTAL-STRUCTURE; OXIDOREDUCTASE; THIOESTERASE; SYSTEM; OPERON	The discovery of reduced flavin mononucleotide and fatty aldehydes as essential factors of light emission facilitated study of bacterial luminescence. Although the molecular mechanisms underlying bacterial luminescence have been studied for more than 60 years, the structure of the bacterial fatty acid reductase complex remains unclear. Here, we report the cryo-EM structure of the Photobacterium phosphoreum fatty acid reductase complex LuxC-LuxE to a resolution of 2.79 angstrom. We show that the active site Lys238/Arg355 pair of LuxE is >30 angstrom from the active site Cys296 of LuxC, implying that catalysis relies on a large conformational change. Furthermore, mutagenesis and biochemical experiments support that the L-shaped cleft inside LuxC plays an important role in substrate binding and reaction. We obtained a series of mutants with significantly improved activity as measured by in vitro bioluminescence assays and demonstrated that the double mutant W111A/F483K displayed the highest activity (370% of the WT). Our results indicated that the activity of LuxC significantly affects the bacterial bioluminescence reaction. Finally, we expressed this mutated lux operon in Escherichia coli but observed that the in vivo concentrations of ATP and NADPH limited the enzyme activity; thus, we conclude that the luminous intensity mainly depends on the level of metabolic energy.	[Tian, Qingwei; Wu, Jingting; Hu, Zhangli; Wang, Liyan] Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China; [Tian, Qingwei; Hu, Zhangli] Shenzhen Univ, Coll Phys & Optoelect Engn, Key Lab Optoelect Devices & Syst, Shenzhen, Peoples R China; [Xu, Haifeng; Huo, Yangao] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing, Peoples R China; [Xu, Haifeng] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China	Shenzhen University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, LY (corresponding author), Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen, Peoples R China.; Huo, YA (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing, Peoples R China.	huoyangao@moon.ibp.ac.cn; lwang@szu.edu.cn			National Key Research and Development Project [2018YFA0902504, 2019YFC0312501]; Science and Technology Project of Shenzhen City Shenzhen Bureau of Science, Technology [JCYJ20180305123659726]	National Key Research and Development Project; Science and Technology Project of Shenzhen City Shenzhen Bureau of Science, Technology	We would like to thank the Kobilka Cryo-Electron Microscopy Center, The Chinese University of Hong Kong, Shenzhen for our cryoelectron microscopy and we would be grateful to Zheng Liu for his help of samples preparation and Cryo-EM operation. This research was financially supported by the National Key Research and Development Project 2018YFA0902504 and 2019YFC0312501; the Science and Technology Project of Shenzhen City Shenzhen Bureau of Science, Technology, and Information under Grant JCYJ20180305123659726.	Brodl E, 2018, COMPUT STRUCT BIOTEC, V16, P551, DOI 10.1016/j.csbj.2018.11.003; Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRI SR, 1991, J BIOL CHEM, V266, P12852; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; Gregor C, 2019, P NATL ACAD SCI USA, V116, P26491, DOI 10.1073/pnas.1913616116; Gregor C, 2018, P NATL ACAD SCI USA, V115, P962, DOI 10.1073/pnas.1715946115; Gupta RK, 2003, FEMS YEAST RES, V4, P305, DOI 10.1016/S1567-1356(03)00174-0; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Kaku T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94551-4; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Keller MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5439; Kotlobay AA, 2019, P NATL ACAD SCI USA, V116, P18911, DOI 10.1073/pnas.1902095116; Kotlobay AA, 2018, P NATL ACAD SCI USA, V115, P12728, DOI 10.1073/pnas.1803615115; Krichevsky A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015461; Kurvet I, 2011, SENSORS-BASEL, V11, P7865, DOI 10.3390/s110807865; Law A, 2011, J BIOL CHEM, V286, P15577, DOI 10.1074/jbc.M111.219683; LAWSON DM, 1994, BIOCHEMISTRY-US, V33, P9382, DOI 10.1021/bi00198a003; Lee CY, 1997, BBA-PROTEIN STRUCT M, V1338, P215, DOI 10.1016/S0167-4838(96)00203-8; Li J, 2000, BBA-PROTEIN STRUCT M, V1481, P237, DOI 10.1016/S0167-4838(00)00131-X; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin JW, 1996, BIOCHEM BIOPH RES CO, V228, P764, DOI 10.1006/bbrc.1996.1729; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morgan CA, 2015, CHEM-BIOL INTERACT, V234, P29, DOI 10.1016/j.cbi.2014.10.028; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RIENDEAU D, 1982, J BIOL CHEM, V257, P6908; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Syed AJ, 2021, CHEM SOC REV, V50, P5668, DOI 10.1039/d0cs01492c; ULITZUR S, 1979, P NATL ACAD SCI USA, V76, P265, DOI 10.1073/pnas.76.1.265; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Vannier T, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa018; WALL L, 1986, BIOCHEMISTRY-US, V25, P4315, DOI 10.1021/bi00363a021; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	38	0	0	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102006	10.1016/j.jbc.2022.102006	http://dx.doi.org/10.1016/j.jbc.2022.102006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35504354	Green Published, gold			2022-12-28	WOS:000807750700009
J	Zhang, NN; Wu, J; Zhang, SP; Yuan, MR; Xu, H; Li, J; Zhang, PP; Wang, MZ; Kempher, ML; Tao, XY; Zhang, LQ; Ge, HH; He, YX				Zhang, Nannan; Wu, Jin; Zhang, Siping; Yuan, Maoran; Xu, Hang; Li, Jie; Zhang, Pingping; Wang, Mingzhu; Kempher, Megan L.; Tao, Xuanyu; Zhang, Li-Qun; Ge, Honghua; He, Yong-Xing			Molecular basis for coordinating secondary metabolite production by bacterial and plant signaling molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETR FAMILY; PSEUDOMONAS-AERUGINOSA; BIOLOGICAL-CONTROL; STRUCTURAL BASIS; GENE-CLUSTER; BIOSYNTHESIS; 2,4-DIACETYLPHLOROGLUCINOL; PROTEIN; IDENTIFICATION; PERSPECTIVES	The production of secondary metabolites is a major mechanism used by beneficial rhizobacteria to antagonize plant pathogens. These bacteria have evolved to coordinate the production of different secondary metabolites due to the heavy metabolic burden imposed by secondary metabolism. However, for most secondary metabolites produced by bacteria, it is not known how their biosynthesis is coordinated. Here, we showed that PhlH from the rhizobacterium Pseudomonas fluorescens is a TetR-family regulator coordinating the expression of enzymes related to the biosynthesis of several secondary metabolites, including 2,4-diacetylphloroglucinol (2,4-DAPG), mupirocin, and pyoverdine. We present structures of PhlH in both its apo form and 2,4-DAPG-bound form and elucidate its ligand-recognizing and allosteric switching mechanisms. Moreover, we found that dissociation of 2,4-DAPG from the ligand-binding domain of PhlH was sufficient to allosterically trigger a pendulum-like movement of the DNA-binding domains within the PhlH dimer, leading to a closed-to-open conformational transition. Finally, molecular dynamics simulations confirmed that two distinct conformational states were stabilized by specific hydrogen bonding interactions and that disruption of these hydrogen bonds had profound effects on the conformational transition. Our findings not only reveal a well-conserved route of allosteric signal transduction in TetR-family regulators but also provide novel mechanistic insights into bacterial metabolic coregulation.	[Zhang, Nannan; Wu, Jin; Yuan, Maoran; Li, Jie; Zhang, Pingping; Wang, Mingzhu; Ge, Honghua] Anhui Univ, Sch Life Sci, Hefei, Peoples R China; [Zhang, Nannan; Zhang, Pingping] Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei, Anhui, Peoples R China; [Wu, Jin; Yuan, Maoran; Li, Jie; Wang, Mingzhu; Ge, Honghua] Anhui Univ, Informat Mat & Intelligent Sensing Lab Anhui Prov, Inst Mat Sci & Informat Technol, Hefei, Anhui, Peoples R China; [Zhang, Siping; Xu, Hang; He, Yong-Xing] Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou, Peoples R China; [Kempher, Megan L.; Tao, Xuanyu] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK USA; [Kempher, Megan L.; Tao, Xuanyu] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Zhang, Li-Qun] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China	Anhui University; Anhui University; Anhui University; Lanzhou University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; China Agricultural University	Zhang, NN; Ge, HH (corresponding author), Anhui Univ, Sch Life Sci, Hefei, Peoples R China.; Zhang, NN (corresponding author), Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei, Anhui, Peoples R China.; Ge, HH (corresponding author), Anhui Univ, Informat Mat & Intelligent Sensing Lab Anhui Prov, Inst Mat Sci & Informat Technol, Hefei, Anhui, Peoples R China.; He, YX (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Cell Act & Stress Adaptat, Sch Life Sci, Lanzhou, Peoples R China.	zhangnn@ahu.edu.cn; hhge@ahu.edu.cn; heyx@lzu.edu.cn	Zhang, Li/GWM-7501-2022	Ge, Honghua/0000-0001-7176-6853	National Natural Science Foundation of China [31970103, 31971422]; Key Research and Development Plan Project of Anhui Province [202004a06020035]; Anhui Natural Science Foundation of China [2108085MC76]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan Project of Anhui Province; Anhui Natural Science Foundation of China(Natural Science Foundation of Anhui Province)	This work was supported by the grants from the National Natural Science Foundation of China (grant Nos. 31970103 and 31971422), Key Research and Development Plan Project of Anhui Province (grant No. 202004a06020035), and Anhui Natural Science Foundation of China (grant No. 2108085MC76).	Abbas A, 2004, MICROBIOL-SGM, V150, P2443, DOI 10.1099/mic.0.27033-0; Achkar J, 2005, J AM CHEM SOC, V127, P5332, DOI 10.1021/ja042340g; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Guo DD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01423; Gurney R, 2011, APPL MICROBIOL BIOT, V90, P11, DOI 10.1007/s00253-011-3128-3; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Haas D, 2000, CURR OPIN BIOTECH, V11, P290, DOI 10.1016/S0958-1669(00)00098-7; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Huang XQ, 2004, FEMS MICROBIOL LETT, V232, P197, DOI 10.1016/S0378-1097(04)00074-6; Kapoor I, 2020, ELIFE, V9, DOI 10.7554/eLife.57824; Khan SR, 2005, J BACTERIOL, V187, P6517, DOI 10.1128/JB.187.18.6517-6527.2005; Lara J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17504-x; Latour X, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111746; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lucke M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.589416; Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Pavkov-Keller T, 2019, CHEMBIOCHEM, V20, P88, DOI 10.1002/cbic.201800462; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Siddiqui Z. A., 2006, PGPR BIOCONTROL BIOF; Tengerdy RP, 1998, J BIOTECHNOL, V66, P91, DOI 10.1016/S0168-1656(98)00138-2; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/nchembio.1366, 10.1038/NCHEMBIO.1366]; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09479-1; Wang Y, 2019, ENVIRON MICROBIOL, V21, P1740, DOI 10.1111/1462-2920.14538; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Wells G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189331; Williams M. A, 2008, PROTEIN SCI ENCYCL, DOI 10.1002/; Yan X, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.01419-17, 10.1128/AEM.01419-17]; Yeo HK, 2017, NUCLEIC ACIDS RES, V45, P4244, DOI 10.1093/nar/gkx009; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu XQ, 2020, ENVIRON MICROBIOL, V22, P5073, DOI 10.1111/1462-2920.15052; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Zhou SS, 2021, NATURE, V590, P463, DOI 10.1038/s41586-021-03195-x	55	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102027	10.1016/j.jbc.2022.102027	http://dx.doi.org/10.1016/j.jbc.2022.102027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35568198	gold, Green Published			2022-12-28	WOS:000811813400012
J	Kim, SB; Zoepfl, M; Samanta, P; Zhang, FM; Xia, K; Thara, R; Linhardt, RJ; Doerksen, RJ; McVoy, MA; Pomin, VH				Kim, Seon Beom; Zoepfl, Mary; Samanta, Priyanka; Zhang, Fuming; Xia, Ke; Thara, Reena; Linhardt, Robert J.; Doerksen, Robert J.; McVoy, Michael A.; Pomin, Vitor H.			Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; MILD ACID-HYDROLYSIS; BETA-GALACTAN; HEPARIN; SARS-COV-2; POLYSACCHARIDES; CORONAVIRUS; MECHANISMS; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES	Sulfation pattern and molecular weight (MW) play a key role in the biological actions of sulfated glycans. Besides anticoagulant effects, certain sulfated glycans can also exhibit antiSARS-CoV-2 properties. To develop a more selective antiviral carbohydrate, an efficient strategy to separate these two actions is required. In this work, low MW fractions derived from the red alga Botryocladia occidentalis sulfated galactan (BoSG) were generated, structurally characterized, and tested for activity against SARS-CoV-2 and blood coagulation. The lowest MW fraction was found to be primarily composed of octasaccharides of monosulfated monosaccharides. Unlike heparin or native BoSG, we found that hydrolyzed BoSG products had weak anticoagulant activities as seen by aPTT and inhibitory assays using purified cofactors. In contrast, lower MW BoSG-derivatives retained anti-SARS-CoV-2 activity using SARS-CoV-2 spike (S)-protein pseudotyped lentivirus vector in HEK-293T-hACE2 cells monitored by GFP. Surface plasmon resonance confirmed that longer chains are necessary for BoSG to interact with coagulation cofactors but is not required for interactions with certain S-protein variants. We observed distinct affinities of BoSG derivatives for the S-proteins of different SARS-CoV-2 strains, including WT, N501Y mutants, and stronger affinity for the N501Y-containing variants. Docking of the four possible monosulfated BoSG di	[Kim, Seon Beom; Samanta, Priyanka; Thara, Reena; Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Dept BioMol Sci, University, MS 38677 USA; [Zoepfl, Mary; McVoy, Michael A.] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA; [Zhang, Fuming; Xia, Ke; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA	University of Mississippi; Virginia Commonwealth University; Rensselaer Polytechnic Institute; University of Mississippi	Pomin, VH (corresponding author), Univ Mississippi, Dept BioMol Sci, University, MS 38677 USA.; Pomin, VH (corresponding author), Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA.	vpomin@olemiss.edu	Kim, Seon Beom/AGP-7639-2022	Kim, Seon Beom/0000-0001-8015-1404; Zoepfl, Mary/0000-0003-4821-0907; xia, ke/0000-0001-9699-9901	AACP 2019 New Investigator Award; National Institutes of Health [1P20GM130460-01A1-7936, 1R03NS110996-01A1, S10OD028523]; University of Mississippi; National Science Foundation GlycoMIP [DMR 1933525]; Children's Hospital Foundation Research Fund; Virginia Commonwealth University COVID-19 Rapid Research Funding program	AACP 2019 New Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi; National Science Foundation GlycoMIP; Children's Hospital Foundation Research Fund; Virginia Commonwealth University COVID-19 Rapid Research Funding program	This work was supported by funds from the AACP 2019 New Investigator Award (V. H. P.) , the National Institutes of Health [1P20GM130460-01A1-7936 (R. J. D. and V. H. P.) , 1R03NS110996-01A1 (V. H. P.) , and S10OD028523 (F. Z. and R. J. L.) ] , the University of Mississippi (V. H. P.) , the National Science Foundation GlycoMIP DMR 1933525 (F. Z. and R. J. L.) , and by funds from the Children's Hospital Foundation Research Fund (M. A. M.) and the Virginia Commonwealth Uni-versity COVID-19 Rapid Research Funding program (M. A. M.) . The content of the information does not necessarily reflect the position or the policy of the sponsors and no official endorsement should be inferred. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	A. J. Greaney, 2021, bioRxiv, DOI 10.1101/2020.12.31.425021; ALBANO RM, 1990, CARBOHYD RES, V208, P163, DOI 10.1016/0008-6215(90)80096-L; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Aranda P, 2020, RECENT PAT NANOTECH, V14, P328, DOI 10.2174/1872210514666201021145735; Barahona T, 2012, CARBOHYD RES, V347, P114, DOI 10.1016/j.carres.2011.11.014; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Beaudet JM, 2011, J PHARM SCI-US, V100, P3396, DOI 10.1002/jps.22527; Bezerra F. F., 2019, ENZYMATIC TECHNOLOGI, P111; Bezerra FF, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.107407; Carvalhal F, 2019, MAR DRUGS, V17, DOI 10.3390/md17030170; Castro MO, 2009, J BIOL CHEM, V284, P18790, DOI 10.1074/jbc.M109.005702; Chen XY, 2020, INT J BIOL MACROMOL, V164, P331, DOI 10.1016/j.ijbiomac.2020.07.106; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; CURRY N, 1973, ARCH INTERN MED, V132, P744, DOI 10.1001/archinte.132.5.744; de Siqueira IC, 2021, INT J INFECT DIS, V108, P252, DOI 10.1016/j.ijid.2021.05.010; Dwivedi R, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101207; Dwivedi R, 2020, MAR DRUGS, V18, DOI 10.3390/md18100514; Echternach M, 2020, AM J RESP CRIT CARE, V202, P1584, DOI 10.1164/rccm.202009-3438LE; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; Farias WRL, 2001, THROMB HAEMOSTASIS, V86, P1540, DOI 10.1055/s-0037-1616760; Farias WRL, 2000, J BIOL CHEM, V275, P29299, DOI 10.1074/jbc.M002422200; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Fonseca RJC, 2008, THROMB HAEMOSTASIS, V99, P539, DOI 10.1160/TH07-10-0603; Fujino T, 2021, EMERG INFECT DIS, V27, P1243, DOI 10.3201/eid2704.210138; GASTEIGER J, 1978, TETRAHEDRON LETT, P3181; GINSBERG JS, 1989, CHEST, V95, pS156, DOI 10.1378/chest.95.2.156S; GINSBERG JS, 1990, THROMB HAEMOSTASIS, V64, P286; Glauser BF, 2013, ADV CLIN CHEM, V62, P269, DOI 10.1016/B978-0-12-800096-0.00007-X; Glauser BF, 2009, THROMB HAEMOSTASIS, V102, P1183, DOI 10.1160/TH09-04-0273; Grubaugh ND, 2020, NAT MICROBIOL, V5, P529, DOI 10.1038/s41564-020-0690-4; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Huang HY, 2021, CELL DEATH DIFFER, V28, P2840, DOI 10.1038/s41418-021-00846-4; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Jin WH, 2020, INT J BIOL MACROMOL, V163, P1649, DOI 10.1016/j.ijbiomac.2020.09.184; KING DJ, 1984, ANN INTERN MED, V100, P535, DOI 10.7326/0003-4819-100-4-535; Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li JW, 2022, SPECTROCHIM ACTA A, V267, DOI 10.1016/j.saa.2021.120595; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Liu Z, 2020, SSRN ELECT J, DOI [DOI 10.2139/SSRN.3551329, 10.2139/ssrn.3551329]; Marques J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24368; Maxwell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045474; Melo FR, 2008, BBA-GEN SUBJECTS, V1780, P1047, DOI 10.1016/j.bbagen.2008.05.006; Melo FR, 2008, THROMB HAEMOSTASIS, V99, P531, DOI 10.1160/TH07-10-0649; Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200; Moghaddar M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9102167; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mourao PAS, 2015, MAR DRUGS, V13, P2770, DOI 10.3390/md13052770; Mycroft-West CJ, 2020, THROMB HAEMOSTASIS, V120, P1700, DOI 10.1055/s-0040-1721319; OKELLY R, 1983, J CLIN ENDOCR METAB, V56, P108, DOI 10.1210/jcem-56-1-108; Peng MH, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110499; Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; Pomin VH, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14080714; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; Pomin VH, 2011, ANAL CHEM, V83, P1162, DOI 10.1021/ac1031176; Prajapat M, 2021, INDIAN J PHARMACOL, V53, P310, DOI 10.4103/ijp.ijp_483_21; Queiroz INL, 2016, GLYCOBIOLOGY, V26, P1257, DOI 10.1093/glycob/cww080; Queiroz INL, 2015, GLYCOBIOLOGY, V25, P535, DOI 10.1093/glycob/cwu184; Quindere ALG, 2014, J THROMB HAEMOST, V12, P43, DOI 10.1111/jth.12448; Ramesh S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101195; Ray B, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13010136; Romano C. M., 2021, BRAZIL REV I MED TRO, V63; Salih AEM, 2021, MAR DRUGS, V19, DOI 10.3390/md19080406; Sampaio TBP, 2020, INT J BIOL MACROMOL, V158, P471, DOI 10.1016/j.ijbiomac.2020.04.085; Shahhosseini N, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9050926; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Singh AK, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102329; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; TSOU CL, 1951, BIOCHEM J, V49, P362, DOI 10.1042/bj0490362; Vandyck K, 2021, CURR OPIN VIROL, V49, P36, DOI 10.1016/j.coviro.2021.04.006; Vasconcelos AA, 2018, MAR DRUGS, V16, DOI 10.3390/md16090304; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WARKENTIN TE, 1989, ANNU REV MED, V40, P31; Woods R., 2005, COMPLEX CARBOHYDRATE; Zoepfl M, 2021, ANTIVIR RES, V190, DOI 10.1016/j.antiviral.2021.105077; ZUCKER S, 1985, BIOCHIM BIOPHYS ACTA, V828, P196, DOI 10.1016/0167-4838(85)90057-3	87	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101856	10.1016/j.jbc.2022.101856	http://dx.doi.org/10.1016/j.jbc.2022.101856			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35337800	gold, Green Published			2022-12-28	WOS:000798142000005
J	Wu, YFO; Miller, RA; Alberico, EO; Huang, YAP; Bryant, AT; Nelson, NT; Jonasson, EM; Goodson, HV				Wu, Yueh-Fu O.; Miller, Rachel A.; Alberico, Emily O.; Huang, Yaobing A. P.; Bryant, Annamarie T.; Nelson, Nora T.; Jonasson, Erin M.; Goodson, Holly, V			The CLIP-170 N-terminal domain binds directly to both F-actin and microtubules in a mutually exclusive manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END-TRACKING; STRUCTURAL BASIS; PROTEIN EB1; CAPTURE; TUBULIN; COMPLEX; IQGAP1	The cooperation between the actin and microtubule (MT) cytoskeletons is important for cellular processes such as cell migration and muscle cell development. However, a full understanding of how this cooperation occurs has yet to be sufficiently developed. The MT plus-end tracking protein CLIP-170 has been implicated in this actin-MT coordination by associating with the actin-binding signaling protein IQGAP1 and by promoting actin polymerization through binding with formins. Thus far, the interactions of CLIP-170 with actin were assumed to be indirect. Here, we demonstrate using high-speed cosedimentation assays that CLIP-170 can bind to filamentous actin (F-actin) directly. We found that the affinity of this binding is relatively weak but strong enough to be significant in the actin-rich cortex, where actin concentrations can be extremely high. Using CLIP-170 fragments and mutants, we show that the direct CLIP-170-F-actin interaction is independent of the FEED domain, the region that mediates formin-dependent actin polymerization, and that the CLIP-170 F-actin-binding region overlaps with the MT-binding region. Consistent with these observations, in vitro competition assays indicate that CLIP-170-F-actin and CLIP-170-MT interactions are mutually exclusive. Taken together, these observations lead us to speculate that direct CLIP-170-F-actin interactions may function to reduce the stability of MTs in actin-rich regions of the cell, as previously proposed for MT end-binding protein 1.	[Wu, Yueh-Fu O.; Miller, Rachel A.; Alberico, Emily O.; Huang, Yaobing A. P.; Bryant, Annamarie T.; Nelson, Nora T.; Jonasson, Erin M.; Goodson, Holly, V] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wu, Yueh-Fu O.; Huang, Yaobing A. P.; Bryant, Annamarie T.; Goodson, Holly, V] Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN 46556 USA; [Goodson, Holly, V] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Goodson, HV (corresponding author), Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN 46556 USA.; Goodson, HV (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	hgoodson@nd.edu		Miller, Rachel/0000-0002-9433-0339; Bryant, Annamarie/0000-0002-4383-0894	American Heart Association predoctoral fellowship [17PRE33670896]; National Science Foundation [1817966, 1244593]	American Heart Association predoctoral fellowship(American Heart Association); National Science Foundation(National Science Foundation (NSF))	This research was funded by an American Heart Association predoctoral fellowship (grant no.: 17PRE33670896; to Y.-F. O. W.) and National Science Foundation grants (grant nos.: MCB #1817966 and MCB #1244593; to H. V. G.).	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Alberico EO, 2016, J MOL BIOL, V428, P1304, DOI 10.1016/j.jmb.2016.01.032; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Barlan K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a025817; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Chatfield C., 1995, PROBLEM SOLVING STAT; Chen YD, 2019, J BIOL CHEM, V294, P918, DOI 10.1074/jbc.RA118.006125; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dogterom M, 2019, NAT REV MOL CELL BIO, V20, P38, DOI 10.1038/s41580-018-0067-1; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Gupta KK, 2010, J MOL BIOL, V395, P1049, DOI 10.1016/j.jmb.2009.11.014; Gupta KK, 2009, J BIOL CHEM, V284, P6735, DOI 10.1074/jbc.M807675200; Henty-Ridilla JL, 2016, SCIENCE, V352, P1004, DOI 10.1126/science.aaf1709; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Juanes MA, 2019, J CELL BIOL, V218, P3415, DOI 10.1083/jcb.201904165; Juanes MA, 2017, J CELL BIOL, V216, P2859, DOI 10.1083/jcb.201702007; Juanes MA, 2020, CURR BIOL, V30, DOI 10.1016/j.cub.2020.08.094; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li GL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1859284; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Lomakin AJ, 2009, DEV CELL, V17, P323, DOI 10.1016/j.devcel.2009.07.010; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; Seetharaman S, 2020, TRENDS CELL BIOL, V30, P720, DOI 10.1016/j.tcb.2020.06.004; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wojnacki Jose, 2014, Small GTPases, V5, pe28430; Wu YFO, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260401	53	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101820	10.1016/j.jbc.2022.101820	http://dx.doi.org/10.1016/j.jbc.2022.101820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35283190	gold, Green Published			2022-12-28	WOS:000860390500004
J	Kadyrova, LY; Dahal, BK; Gujar, V; Daley, JM; Sung, P; Kadyrov, FA				Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Gujar, Vaibhavi; Daley, James M.; Sung, Patrick; Kadyrov, Farid A.			The nuclease activity of DNA2 promotes exonuclease 1-independent mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; MUTL-ALPHA; MUTATION AVOIDANCE; END-RESECTION; YEAST; REPLICATION; POLYMERASE; MECHANISM; CANCER; EXO1	The DNA mismatch repair (MMR) system is a major DNA repair system that corrects DNA replication errors. In eukaryotes, the MMR system functions via mechanisms both dependent on and independent of exonuclease 1 (EXO1), an enzyme that has multiple roles in DNA metabolism. Although the mechanism of EXO1-dependent MMR is well understood, less is known about EXO1-independent MMR. Here, we provide genetic and biochemical evidence that the DNA2 nuclease/helicase has a role in EXO1-independent MMR. Biochemical reactions reconstituted with purified human proteins demonstrated that the nuclease activity of DNA2 promotes an EXO1-independent MMR reaction via a mismatch excision-independent mechanism that involves DNA polymerase 8. We show that DNA polymerase epsilon is not able to replace DNA polymerase 8 in the DNA2-promoted MMR reaction. Unlike its nuclease activity, the helicase activity of DNA2 is dispensable for the ability of the protein to enhance the MMR reaction. Further examination established that DNA2 acts in the EXO1-independent MMR reaction by increasing the strand-displacement activity of DNA polymerase 8. These data reveal a mechanism for EXO1-independent mismatch repair.	[Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Gujar, Vaibhavi; Kadyrov, Farid A.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA; [Daley, James M.; Sung, Patrick] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; University of Texas Health San Antonio	Kadyrov, FA (corresponding author), Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			National Institute of General Medical Sciences of the National Institutes of Health [R01GM132128]; National Cancer Institute of the National Institutes of Health [R35CA241801]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM132128 (to F. A. K.) and by the National Cancer Institute of the National Institutes of Health under Award Number R35CA241801 (to P. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Blanko ER, 2016, J BIOL CHEM, V291, P9203, DOI 10.1074/jbc.M115.713271; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Calil FA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25866-z; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chakraborty U, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow071; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Ganai RA, 2016, NUCLEIC ACIDS RES, V44, P8229, DOI 10.1093/nar/gkw556; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2017, P NATL ACAD SCI USA, V114, P4930, DOI 10.1073/pnas.1702561114; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Ijsselsteijn R, 2020, DNA REPAIR, V93, DOI 10.1016/j.dnarep.2020.102923; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kadyrova LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003899; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kratz K, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00303-21; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Lahue Robert S, 2020, Neuronal Signal, V4, pNS20200010, DOI 10.1042/NS20200010; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liberti SE, 2013, DNA REPAIR, V12, P92, DOI 10.1016/j.dnarep.2012.11.001; Liu SB, 2015, EMBO J, V34, P1829, DOI 10.15252/embj.201489865; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Lujan S. A., 2014, GENOME RES 24; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Manhart CM, 2016, DNA REPAIR, V38, P84, DOI 10.1016/j.dnarep.2015.11.024; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McKinney JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13878-9; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ortega J, 2021, CELL RES, V31, P542, DOI 10.1038/s41422-021-00468-y; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pannafino G, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040948; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Pinto C, 2016, ELIFE, V5, DOI 10.7554/eLife.18574; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Reyes GX, 2021, CURR BIOL, V31, P1268, DOI 10.1016/j.cub.2020.12.018; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; Smogorzewska A., 2010, MOL; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Stone JE, 2006, GENETICS, V173, P1223, DOI 10.1534/genetics.106.055616; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhang Y, 2012, MOL CELL, V48, P254, DOI 10.1016/j.molcel.2012.08.002; Zhao XN, 2021, J HUNTINGTONS DIS, V10, P149, DOI 10.3233/JHD-200423; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	88	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101831	10.1016/j.jbc.2022.101831	http://dx.doi.org/10.1016/j.jbc.2022.101831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35300981	Green Published, gold			2022-12-28	WOS:000793617400003
J	Shen, GY; Liu, X; Lei, W; Duan, R; Yao, ZQ				Shen, Gengyang; Liu, Xin; Lei, Wei; Duan, Rong; Yao, Zhenqiang			Plumbagin is a NF-kappa B-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE TURNOVER MARKERS; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; CANCELLOUS BONE; CELL-GROWTH; IN-VIVO; NIK; ACTIVATION	Osteoporosis is caused by enhanced bone resorption and relatively reduced bone formation. There is an unmet need to develop new agents with both antiresorptive and anabolic effects to treat osteoporosis, although drugs with either effect alone are available. A small molecular compound, plumbagin, was reported to inhibit receptor activator of nuclear factor kappa-B ligand-induced osteoclast (OC) differentiation by inhibiting I kappa Ba phosphorylation-mediated canonical NF-kappa B activation. However, the key transcriptional factor RelA/p65 in canonical NF -kappa B pathway functions to promote OC precursor survival but not terminal OC differentiation. Here, we found that plumbagin inhibited the activity of NF -kappa B inducing kinase, the key molecule that controls noncanonical NF -kappa B signaling, in an ATP/ ADP-based kinase assay. Consistent with this, plumbagin inhibited processing of NF-kappa B2 p100 to p52 in the progenitor cells of both OCs and osteoblasts (OBs). Interestingly, plumbagin not only inhibited OC but also stimulated OB differentiation in vitro. Importantly, plumbagin prevented trabecular bone loss in ovariectomized mice. This was associated with decreased OC surfaces on trabecular surface and increased parameters of OBs, including OB surface on trabecular surface, bone formation rate, and level of serum osteocalcin, compared to vehicle-treated mice. In summary, we conclude that plumbagin is a NF -kappa B inducing kinase inhibitor with dual anabolic and antiresorptive effects on bone and could represent a new class of agent for the prevention and treatment of osteoporosis.	[Yao, Zhenqiang] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Yao, ZQ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu			Core Services at Center for Musculoskeletal Research [NIH/NIAMS P30 AR069655]; National Institutes of Health [R01 AG049994]; New York State Department of Health Research Project [C34928GG]	Core Services at Center for Musculoskeletal Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health Research Project	We sincerely thank the Core Services at Center for Musculoskeletal Research (NIH/NIAMS P30 AR069655) and Lindsay Schnur for the support in micro-CT imaging and analysis. This study was funded by the National Institutes of Health grant R01 AG049994 and New York State Department of Health Research Project #C34928GG.	Anastasilakis AD, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010152; Aspenberg P, 2014, ACTA ORTHOP, V85, P1, DOI 10.3109/17453674.2013.859423; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brightbill HD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02672-0; Canbek U, 2019, J ORTHOP SURG-HONG K, V27, DOI 10.1177/2309499019875262; Capriani C, 2012, J BONE MINER RES, V27, P2419, DOI 10.1002/jbmr.1800; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chavassieux P, 2019, J BONE MINER RES, V34, P1597, DOI 10.1002/jbmr.3735; Cheng J, 2021, RSC MED CHEM, V12, P552, DOI 10.1039/d0md00361a; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Davis JL, 2019, J BONE MINER RES, V34, P2087, DOI 10.1002/jbmr.3819; DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Eastell R, 2017, LANCET DIABETES ENDO, V5, P908, DOI 10.1016/S2213-8587(17)30184-5; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Heim N, 2019, DENTOMAXILLOFAC RAD, V48, DOI 10.1259/dmfr.20190132; Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; Iwaniec UT, 2006, J BONE MINER RES, V21, P1068, DOI 10.1359/JBMR.060402; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kuo TR, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0097-4; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Leder BZ, 2017, BONE, V98, P54, DOI 10.1016/j.bone.2017.03.006; Lei W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64018-z; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Li ZQ, 2020, J MED CHEM, V63, P4388, DOI 10.1021/acs.jmedchem.0c00396; Lloyd AA, 2017, P NATL ACAD SCI USA, V114, P8722, DOI 10.1073/pnas.1704460114; Looker AC, 2010, J BONE MINER RES, V25, P64, DOI 10.1359/jbmr.090706; MacKenzie SA, 2019, BONE JOINT J, V101B, P1285, DOI 10.1302/0301-620X.101B10.BJJ-2019-0599.R2; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; Mortier J, 2010, BIOORG MED CHEM LETT, V20, P4515, DOI 10.1016/j.bmcl.2010.06.027; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Odqvist L, 2013, CLIN CANCER RES, V19, P2319, DOI 10.1158/1078-0432.CCR-12-3151; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Ponnapakkam T, 2014, DRUG DISCOV TODAY, V19, P204, DOI 10.1016/j.drudis.2013.07.015; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Ramadass V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145164; Ren XM, 2017, FASEB J, V31, P711, DOI 10.1096/fj.201600840R; Seo Y, 2012, MOL ENDOCRINOL, V26, P414, DOI 10.1210/me.2011-1241; Shoback D., 2020, J CLIN ENDOCR METAB, V105; Sleeman A, 2019, AM J HEALTH-SYST PH, V76, P130, DOI 10.1093/ajhp/zxy022; Solling ASK, 2019, DRUG AGING, V36, P625, DOI 10.1007/s40266-019-00675-8; Soysa NS, 2010, J BONE MINER RES, V25, P809, DOI 10.1359/jbmr.091030; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sung B, 2012, MOL CANCER THER, V11, P350, DOI 10.1158/1535-7163.MCT-11-0731; Takakura N, 2020, BONE, V135, DOI 10.1016/j.bone.2020.115316; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yan W, 2014, ACTA PHARMACOL SIN, V35, P124, DOI 10.1038/aps.2013.152; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Yao ZQ, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11010132; Yao ZQ, 2021, METHODS MOL BIOL, V2230, P457, DOI 10.1007/978-1-0716-1028-2_29; Yao ZQ, 2017, J BIOL CHEM, V292, P10169, DOI 10.1074/jbc.M116.771816; Yao ZQ, 2014, J BONE MINER RES, V29, P866, DOI 10.1002/jbmr.2108; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yi XJ, 2021, J BONE MINER RES, V36, P2426, DOI 10.1002/jbmr.4447; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; ZHOU H, 1994, J BONE MINER RES, V9, P1489	79	2	2	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101767	10.1016/j.jbc.2022.101767	http://dx.doi.org/10.1016/j.jbc.2022.101767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35235833	Green Published, gold			2022-12-28	WOS:000793692600008
J	Wear, MP; Jacobs, E; Wang, SQ; McConnell, SA; Bowen, A; Strother, C; Cordero, RJB; Crawford, CJ; Casadevall, A				Wear, Maggie P.; Jacobs, Ella; Wang, Siqing; McConnell, Scott A.; Bowen, Anthony; Strother, Camilla; Cordero, Radames J. B.; Crawford, Conor J.; Casadevall, Arturo			Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE CAPSULE; IMMUNE-RESPONSE; DISRUPTION; VIRULENCE; ANTIBODY; CELLS	The polysaccharide capsule of fungal pathogen Cryptococcus neoformans is a critical virulence factor that has historically evaded complete characterization. Cryptococcal polysaccharides are known to either remain attached to the cell as capsular polysaccharides (CPSs) or to be shed into the extracellular space as exopolysaccharides (EPSs). While many studies have examined the properties of EPS, far less is known about CPS. In this work, we detail the development of new physical and enzymatic methods for the isolation of CPS which can be used to explore the architecture of the capsule and isolated capsular material. We show that sonication or Glucanex enzyme cocktail digestion yields soluble CPS preparations, while use of a French pressure cell press or Glucanex digestion followed by cell disruption removed the capsule and produced cell wall-associated polysaccharide aggregates that we call "capsule ghosts", implying an inherent organization that allows the CPS to exist independent of the cell wall surface. Since sonication and Glucanex digestion were noncytotoxic, it was also possible to observe the cryptococcal cells rebuilding their capsule, revealing the presence of reducing end glycans throughout the capsule. Finally, analysis of dimethyl sulfoxideextracted and sonicated CPS preparations revealed the conservation of previously identified glucuronoxylomannan motifs only in the sonicated CPS. Together, these observations provide new insights into capsule architecture and synthesis, consistent with a model in which the capsule is assembled from the cell wall outward using smaller polymers, which are then compiled into larger ones.	[Wear, Maggie P.; Jacobs, Ella; Wang, Siqing; McConnell, Scott A.; Bowen, Anthony; Strother, Camilla; Cordero, Radames J. B.; Crawford, Conor J.; Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Crawford, Conor J.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Max Planck Society	Wear, MP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	mwear1@jhu.edu	Bowen, Anthony/O-4982-2015; Cordero, Radames JB/F-6912-2011	Bowen, Anthony/0000-0003-1064-8372; Crawford, Conor/0000-0002-1314-1019; Wear, Maggie/0000-0002-8581-7831; Cordero, Radames JB/0000-0002-3026-7094; McConnell, Scott/0000-0001-9997-5278	National Institutes of Health (NIH) [AI007417]; NIH [AI138953, AI052733, AI152078, HL059842]; Irish Research Council Postgraduate Award [GOIPG/2016/998]; Johns Hopkins University Center for AIDS Research [P30AI094189]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council Postgraduate Award(Irish Research Council for Science, Engineering and Technology); Johns Hopkins University Center for AIDS Research	S. A. M. and M. P. W. were supported in part by the National Institutes of Health (NIH) Grant AI007417. E. J. was supported in part by NIH grant AI138953 to 01AI. C. J. C. was funded by Irish Research Council Postgraduate Award GOIPG/2016/998. RJBC was supported by the Johns Hopkins University Center for AIDS Research (P30AI094189). A. C. was supported in part by NIH Grants AI052733 to 16, AI152078 to 01, and HL059842 to 19. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Aksenov S I, 1973, Life Sci Space Res, V11, P55; Apar DK, 2008, CHEM BIOCHEM ENG Q, V22, P113; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Cleare W, 1999, MED MYCOL, V37, P235, DOI 10.1046/j.1365-280X.1999.00226.x; COOK W L, 1970, Sabouraudia, V7, P257; Cordero RJB, 2013, EUKARYOT CELL, V12, P1383, DOI 10.1128/EC.00163-13; Cordero RJB, 2013, J IMMUNOL, V190, P317, DOI 10.4049/jimmunol.1202324; Crawford CJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016198118; Crawford CJ, 2020, J BIOL CHEM, V295, P4327, DOI 10.1074/jbc.RA119.012251; Dragotakes Q, 2018, JOVE-J VIS EXP, DOI 10.3791/56957; Fonseca F. L., 2009, EUKARYOT; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Garcia-Rubio R, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02993; Gates MA, 2004, MOL MICROBIOL, V52, P13, DOI 10.1111/j.1365-2958.2003.03957.x; Jalan N, 2013, CARBOHYD POLYM, V96, P365, DOI 10.1016/j.carbpol.2013.03.057; JOERSBO M, 1992, PHYSIOL PLANTARUM, V85, P230, DOI 10.1034/j.1399-3054.1992.850215.x; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; Liu D, 2013, INNOV FOOD SCI EMERG, V18, P132, DOI 10.1016/j.ifset.2013.02.006; Makuuchi K, 2010, RADIAT PHYS CHEM, V79, P267, DOI 10.1016/j.radphyschem.2009.10.011; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Maxson ME, 2007, EUKARYOT CELL, V6, P95, DOI 10.1128/EC.00306-06; Maxson ME, 2007, FUNGAL GENET BIOL, V44, P180, DOI 10.1016/j.fgb.2006.07.010; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; MILNER HW, 1950, SCIENCE, V111, P633, DOI 10.1126/science.111.2893.633; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Piccioni M, 2013, INFECT IMMUN, V81, P90, DOI 10.1128/IAI.00553-12; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Rakesh V, 2008, J PHYS CHEM B, V112, P8514, DOI 10.1021/jp8018205; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; Robertson EJ, 2014, J INFECT DIS, V209, P74, DOI 10.1093/infdis/jit435; Rosas AL, 2000, J IMMUNOL METHODS, V244, P69, DOI 10.1016/S0022-1759(00)00255-6; SIMPSON KL, 1963, J BACTERIOL, V86, P1126, DOI 10.1128/JB.86.5.1126-1127.1963; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; VARTIVARIAN SE, 1989, J BACTERIOL, V171, P6850, DOI 10.1128/jb.171.12.6850-6852.1989; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; YASUOKA A, 1994, MICROBIOL IMMUNOL, V38, P851, DOI 10.1111/j.1348-0421.1994.tb02137.x; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848; Zaragoza O, 2006, MOL MICROBIOL, V59, P67, DOI 10.1111/j.1365-2958.2005.04928.x; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	49	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101769	10.1016/j.jbc.2022.101769	http://dx.doi.org/10.1016/j.jbc.2022.101769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35218774	Green Submitted, gold, Green Published			2022-12-28	WOS:000793694800001
J	Yu, YB; Li, Y; Peng, HX; Song, QX; Da, XW; Li, H; He, ZH; Ren, X; Xu, CQ; Yao, YF; Wang, QK				Yu, Yubing; Li, Yong; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.			Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin alpha 7 on vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; INSIGHTS	Angiogenic factor AGGF1 (AngioGenic factor with G-patch and FHA (Forkhead-Associated) domain 1) blocks neointimal formation (formation of a new or thickened layer of arterial intima) after vascular injury by regulating phenotypic switching of vascular smooth muscle cells (VSMCs). However, the AGGF1 receptor on VSMCs and the underlying molecular mechanisms of its action are unknown. In this study, we used functional analysis of serial AGGF1 deletions to reveal the critical AGGF1 domain involved in VSMC phenotypic switching. This domain was required for VSMC phenotypic switching, proliferation, cell cycle regulation, and migration, as well as the regulation of cell cycle inhibitors cyclin D, p27, and p21. This domain also contains an RDDAPAS motif via which AGGF1 interacts with integrin alpha 7 (ITGA7), but not alpha 8. In addition, we show that AGGF1 enhanced the expression of contractile markers MYH11, alpha-SMA, and SM22 and inhibited MEK1/2, ERK1/2, and ELK phosphorylation in VSMCs, and that these effects were inhibited by knockdown of ITGA7, but not by knockdown of ITGA8. In vivo, deletion of the VSMC phenotypic switching domain in mice with vascular injury inhibited the functions of AGGF1 in upregulating alpha-SMA and SM22, inhibiting MEK1/2, ERK1/2, and ELK phosphorylation, in VSMC proliferation, and in blocking neointimal formation. Finally, we show the inhibitory effect of AGGF1 on neointimal formation was blocked by lentivirus-delivered shRNA targeting ITGA7. Our data demonstrate that AGGF1 interacts with its receptor integrin alpha 7 on VSMCs, and this interaction is required for AGGF1 signaling in VSMCs and for attenuation of neointimal formation after vascular injury.	[Yu, Yubing; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.] Huazhong Univ Sci & Technol, Minist Educ, Ctr Human Genome Res, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Yu, Yubing; Peng, Huixin; Song, Qixue; Da, Xingwen; Li, Hui; He, Zuhan; Ren, Xiang; Xu, Chengqi; Yao, Yufeng; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China; [Li, Yong] Guilin Med Univ, Coll Biotechnol, Guilin, Guangxi, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guilin Medical University	Xu, CQ; Yao, YF; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Ctr Human Genome Res, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.; Xu, CQ; Yao, YF; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	cqxu@mail.hust.edu.cn; yaoyfeng@hust.edu.cn; qingwang118@qq.com		Xu, Chengqi/0000-0002-4269-6830	National Natural Science Foundation of China [81630002, 82000439]; Fundamental Research Funds for the Central Universities' (HUST) [2172020kfyXJJS116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities' (HUST)(Fundamental Research Funds for the Central Universities)	We thank other members of the Center for Human Genome Research at HUST for their generous help and assistance. This study was supported by the National Natural Science Foundation of China grants 81630002 and 82000439 and the Fundamental Research Funds for the Central Universities' (HUST No. 2172020kfyXJJS116).	Agostoni P, 2006, AM HEART J, V151, P682, DOI 10.1016/j.ahj.2005.05.001; Anderson LL, 2016, AM HEART J, V176, P1, DOI 10.1016/j.ahj.2016.02.017; Callebaut I, 2005, BIOINFORMATICS, V21, P699, DOI 10.1093/bioinformatics/bti065; Chao JT, 2006, AM J PHYSIOL-CELL PH, V290, pC972, DOI 10.1152/ajpcell.00136.2005; Cingi E, 2004, NUCL MED COMMUN, V25, P479, DOI 10.1097/01.mnm.0000123392.39137.b6; Collaborators GMM., 2016, LANCET, V388, P1725, DOI DOI 10.1016/S0140-6736(16)31575-6; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Hsieh MJ, 2018, HEART LUNG CIRC, V27, P588, DOI 10.1016/j.hlc.2017.04.013; Huang Y, 2016, J BIOL CHEM, V291, P11030, DOI 10.1074/jbc.M115.695080; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Manninen A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600022; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rupp PA, 2001, CIRC RES, V89, P566, DOI 10.1161/hh1901.097747; Sanz-Gonzalez SM, 2007, CARDIOVASC RES, V75, P803, DOI 10.1016/j.cardiores.2007.05.002; Si WX, 2021, CANCER LETT, V497, P28, DOI 10.1016/j.canlet.2020.10.014; Song Y, 2016, MOL MED REP, V13, P1147, DOI 10.3892/mmr.2015.4649; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Sun Y, 2017, DRUG DEVELOP RES, V78, P283, DOI 10.1002/ddr.21399; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang JJ, 2021, ARTERIOSCL THROM VAS, V41, P2756, DOI 10.1161/ATVBAHA.121.316867; Welser JV, 2007, CIRC RES, V101, P672, DOI 10.1161/CIRCRESAHA.107.151415; Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889; Zamir E, 2001, J CELL SCI, V114, P3583; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003; Zhou BS, 2017, ARTERIOSCL THROM VAS, V37, P675, DOI 10.1161/ATVBAHA.117.308992	30	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101759	10.1016/j.jbc.2022.101759	http://dx.doi.org/10.1016/j.jbc.2022.101759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35202649	Green Published, gold			2022-12-28	WOS:000823106100006
J	Robles, JP; Zamora, M; Adan-Castro, E; Siqueiros-Marquez, L; de la Escalera, GM; Clapp, C				Robles, Juan Pablo; Zamora, Magdalena; Adan-Castro, Elva; Siqueiros-Marquez, Lourdes; de la Escalera, Gonzalo Martinez; Clapp, Carmen			The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha 5 beta 1 and NF-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CELLS; MECHANISMS; MICE	Vascular endothelial cells (ECs) form a critical interface between blood and tissues that maintains whole-body homeostasis. In COVID-19, disruption of the EC barrier results in edema, vascular inflammation, and coagulation, hallmarks of this severe disease. However, the mechanisms by which ECs are dysregulated in COVID-19 are unclear. Here, we show that the spike protein of SARS-CoV-2 alone activates the EC inflammatory phenotype in a manner dependent on integrin alpha 5 beta 1 signaling. Incubation of human umbilical vein ECs with whole spike protein, its receptor-binding domain, or the integrin-binding tripeptide RGD induced the nuclear translocation of NF-kappa B and subsequent expression of leukocyte adhesion molecules (VCAM1 and ICAM1), coagulation factors (TF and FVIII), proinflammatory cytokines (TNF alpha, IL-1 beta, and IL-6), and ACE2, as well as the adhesion of peripheral blood leukocytes and hyperpermeability of the EC monolayer. In addition, inhibitors of integrin alpha 5 beta 1 activation prevented these effects. Furthermore, these vascular effects occur in vivo, as revealed by the intravenous administration of spike, which increased expression of ICAM1, VCAM1, CD45, TNF alpha, IL-1 beta, and IL-6 in the lung, liver, kidney, and eye, and the intravitreal injection of spike, which disrupted the barrier function of retinal capillaries. We suggest that the spike protein, through its RGD motif in the receptor-binding domain, binds to integrin alpha 5 beta 1 in ECs to activate the NF-kappa B target gene expression programs responsible for vascular leakage and leukocyte adhesion. These findings uncover a new direct action of SARS-CoV-2 on EC dysfunction and introduce integrin alpha 5 beta 1 as a promising target for treating vascular inflammation in COVID-19.	[Robles, Juan Pablo; Zamora, Magdalena; Adan-Castro, Elva; Siqueiros-Marquez, Lourdes; de la Escalera, Gonzalo Martinez; Clapp, Carmen] Univ Nacl Autonoma Mex UNAM, Inst Neurobiol, Queretaro, Mexico		Robles, JP (corresponding author), Univ Nacl Autonoma Mex UNAM, Inst Neurobiol, Queretaro, Mexico.	juanpabloroblesa@gmail.com	Clapp, Carmen/P-5128-2014	Clapp, Carmen/0000-0002-7670-6718; Zamora, Magdalena/0000-0001-5579-1004; Robles, Juan Pablo/0000-0001-8429-1914; Martinez de la Escalera, Gonzalo/0000-0002-4309-3476; Siqueiros-Marquez, Lourdes/0000-0001-9528-8489	"Consejo Nacional de Ciencia y Tecnologia" (CONACYT) [A1-S-9620B, 289568]; CONACYT [768182]	"Consejo Nacional de Ciencia y Tecnologia" (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported from "Consejo Nacional de Ciencia y Tecnologia" (CONACYT) grants A1-S-9620B and 289568 to C. C. M. Z. is a doctoral student from "Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM)" and received fellowship 768182 from CONACYT.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Al-Yafeai Z, 2018, ARTERIOSCL THROM VAS, V38, P2601, DOI 10.1161/ATVBAHA.118.311705; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amruta N, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119881; Avolio E, 2021, CLIN SCI, V135, P2668, DOI 10.1042/CS20210735; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bermejo-Martin JF, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110400; Besse B, 2013, ANN ONCOL, V24, P90, DOI 10.1093/annonc/mds281; Biancatelli RMLC, 2021, AM J PHYSIOL-LUNG C, V321, pL477, DOI 10.1152/ajplung.00223.2021; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Elezkurtaj S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82862-5; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Gianni T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004477; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; Hakanpaa L, 2018, P NATL ACAD SCI USA, V115, pE6467, DOI 10.1073/pnas.1722317115; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jin YF, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00454-7; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kawanami D, 2004, BIOCHEM BIOPH RES CO, V314, P415, DOI 10.1016/j.bbrc.2003.12.104; Khan S, 2021, ELIFE, V10, DOI [10.7554/eLife.68563, 10.1101/2021.03.16.435700]; Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002; Lei YY, 2021, CIRC RES, V128, P1323, DOI 10.1161/CIRCRESAHA.121.318902; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li F, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166260; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Lv XL, 2019, VET MICROBIOL, V233, P147, DOI 10.1016/j.vetmic.2019.04.029; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Meyer K, 2021, J VIROL, V95, DOI 10.1128/JVI.00794-21; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Ogata AF, 2022, CLIN INFECT DIS, V74, P715, DOI 10.1093/cid/ciab465; Ou ZW, 2021, AM J PHYSIOL-HEART C, V320, pH734, DOI 10.1152/ajpheart.00518.2020; Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Raghavan S, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.687783; Ramirez M, 2011, INVEST OPHTH VIS SCI, V52, P8944, DOI 10.1167/iovs.11-8190; Rojas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084357; Rossi AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88944-8; Semeraro F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/582060; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shirato K, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06187; Siddiqi HK, 2021, TRENDS CARDIOVAS MED, V31, P1, DOI 10.1016/j.tcm.2020.10.005; Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759; TEIXEIRA MM, 1993, BRIT J PHARMACOL, V110, P1515, DOI 10.1111/j.1476-5381.1993.tb13994.x; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Tresoldi I, 2020, J MED VIROL, V92, P1741, DOI 10.1002/jmv.25831; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vrints CJM, 2021, ACTA CARDIOL, V76, P109, DOI 10.1080/00015385.2020.1846921; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	59	20	20	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101695	10.1016/j.jbc.2022.101695	http://dx.doi.org/10.1016/j.jbc.2022.101695			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143839	Green Published, gold			2022-12-28	WOS:000789400700011
J	Tsutsumi, R; Chaya, T; Tsujii, T; Furukawa, T				Tsutsumi, Ryotaro; Chaya, Taro; Tsujii, Toshinori; Furukawa, Takahisa			The carboxyl-terminal region of SDCCAG8 comprises a functional module essential for cilia formation as well as organ development and homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL-CELL KINASE; NEURONAL MIGRATION; VESICLE DOCKING; PRC1 COMPONENT; GENE; PROTEIN; MAK; ICK; NEPHRONOPHTHISIS; MUTATION	In humans, ciliary dysfunction causes ciliopathies, which present as multiple organ defects, including developmental and sensory abnormalities. Sdccag8 is a centrosomal/basal body protein essential for proper cilia formation. Gene mutations in SDCCAG8 have been found in patients with ciliopathies manifesting a broad spectrum of symptoms, including hypogonadism. Among these mutations, several that are predicted to truncate the SDCCAG8 carboxyl (C) terminus are also associated with such symptoms; however, the underlying mechanisms are poorly understood. In the present study, we identified the Sdccag8 C-terminal region (Sdccag8-C) as a module that interacts with the ciliopathy proteins, Ick/Cilk1 and Mak, which were shown to be essential for the regulation of ciliary protein trafficking and cilia length in mammals in our previous studies. We found that Sdccag8-C is essential for Sdccag8 localization to centrosomes and cilia formation in cultured cells. We then generated a mouse mutant in which Sdccag8-C was truncated (Sdccag8(Delta C/Delta C) mice) using a CRISPR-mediated stop codon knock-in strategy. In Sdccag8(Delta C/Delta C) mice, we observed abnormalities in cilia formation and ciliopathy-like organ phenotypes, including cleft palate, polydactyly, retinal degeneration, and cystic kidney, which partially overlapped with those previously observed in Ick- and Mak-deficient mice. Furthermore, Sdccag8(Delta C/Delta C) mice exhibited a defect in spermatogenesis, which was a previously uncharacterized phenotype of Sdccag8 dysfunction. Together, these results shed light on the molecular and pathological mechanisms underlying ciliopathies observed in patients with SDCCAG8 mutations and may advance our understanding of protein-protein interaction networks involved in cilia development.	[Tsutsumi, Ryotaro; Chaya, Taro; Tsujii, Toshinori; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan	Osaka University	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [20J12966]; Takeda Science Foundation; Uehara Memorial Foundation; Cell Science Research Foundation; Suzuken Memorial Foundation;  [21H02657];  [20K07326]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Suzuken Memorial Foundation; ; 	We thank M. Kadowaki, A. Tani, T. Kon, M. Wakabayashi, S. Gion, T. Nakayama, M. Nakamura, K. Yoshida, and M. Nishi for technical assistance. This work was supported by Grant-in-Aid for Scientific Research (B) (21H02657), (C) (20K07326), and JSPS Fellows (20J12966) from the Japan Society for the Promotion of Science, The Takeda Science Foundation, The Uehara Memorial Foundation, The Cell Science Research Foundation, and Suzuken Memorial Foundation.	Airik R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156081; Airik R, 2014, J AM SOC NEPHROL, V25, P2573, DOI 10.1681/ASN.2013050565; Bahmanpour Z, 2021, INT OPHTHALMOL, V41, P389, DOI 10.1007/s10792-020-01588-x; Bailey JN, 2018, NEW ENGL J MED, V378, P1018, DOI 10.1056/NEJMoa1700175; Billingsley G, 2012, OPHTHALMIC GENET, V33, P150, DOI 10.3109/13816810.2012.689411; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chaya T, 2021, J BIOCHEM, V169, P633, DOI 10.1093/jb/mvab024; Chaya T, 2019, EMBO J, V38, DOI 10.15252/embj.2018101409; Chaya T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05543-2; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Flynn M, 2020, HUM MOL GENET, V29, P407, DOI 10.1093/hmg/ddz292; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Insolera R, 2014, NEURON, V83, P805, DOI 10.1016/j.neuron.2014.06.029; Irie S, 2015, MOL CELL BIOL, V35, P2583, DOI 10.1128/MCB.00048-15; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kamio T, 2010, BIOSCI BIOTECH BIOCH, V74, P1466, DOI 10.1271/bbb.100044; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Kozuka T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38910-2; Kubo S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83781-1; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lovera M, 2021, TRENDS CELL BIOL, V31, P876, DOI 10.1016/j.tcb.2021.06.001; Luo FL, 2018, NEPHROLOGY, V23, P904, DOI 10.1111/nep.13393; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Maurya AK, 2019, CURR BIOL, V29, P1286, DOI 10.1016/j.cub.2019.02.062; McConnachie DJ, 2021, AM J KIDNEY DIS, V77, P410, DOI 10.1053/j.ajkd.2020.08.012; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okamoto S, 2017, J NEUROSCI, V37, P2073, DOI 10.1523/JNEUROSCI.3067-16.2017; Omori Y, 2017, P NATL ACAD SCI USA, V114, pE8264, DOI 10.1073/pnas.1707021114; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Oud Machteld M, 2016, Cilia, V5, P8, DOI 10.1186/s13630-016-0029-1; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Sugiyama T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78452-6; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Taylor SP, 2016, HUM MOL GENET, V25, P3998, DOI 10.1093/hmg/ddw240; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Tsutsumi R, 2018, GENE EXPR PATTERNS, V29, P18, DOI 10.1016/j.gep.2018.04.005; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Ueno A, 2018, CELL REP, V22, P3548, DOI 10.1016/j.celrep.2018.03.007; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Watanabe Y, 2019, TOHOKU J EXP MED, V249, P29, DOI 10.1620/tjem.249.29; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Yamamura T, 2017, CLIN EXP NEPHROL, V21, P136, DOI 10.1007/s10157-016-1256-x; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111	60	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101686	10.1016/j.jbc.2022.101686	http://dx.doi.org/10.1016/j.jbc.2022.101686			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35131266	gold, Green Published			2022-12-28	WOS:000789400700015
J	Ulatowski, L; Ghelfi, M; West, R; Atkinson, J; Finno, CJ; Manor, D				Ulatowski, L.; Ghelfi, Mikel; West, Ryan; Atkinson, J.; Finno, C. J.; Manor, D.			The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LOW-DENSITY-LIPOPROTEIN; ALPHA-TOCOPHEROL; E-DEFICIENCY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; CHOLESTEROL-METABOLISM	Alpha-tocopherol (vitamin E) is an essential nutrient that functions as a major lipid-soluble antioxidant in humans. The alpha-tocopherol transfer protein (TTP) binds alpha-tocopherol with high affinity and selectivity and regulates whole-body distribution of the vitamin. Heritable mutations in the TTPA gene result in familial vitamin E deficiency, elevated indices of oxidative stress, and progressive neurodegeneration that manifest primarily in spinocerebellar ataxia. Although the essential role of vitamin E in neurological health has been recognized for over 50 years, the mechanisms by which this essential nutrient is transported in the central nervous system are poorly understood. Here we found that, in the murine cerebellum, TTP is selectively expressed in glial fibrillary acidic protein-positive astrocytes, where it facilitates efflux of vitamin E to neighboring neurons. We also show that induction of oxidative stress enhances the transcription of the TtpA gene in cultured cerebellar astrocytes. Furthermore, secretion of vitamin E from astrocytes is mediated by an ABC-type transporter, and uptake of the vitamin into neurons involves the low-density lipoprotein receptor-related protein 1. Taken together, our data indicate that TTP-expressing astrocytes control the delivery of vitamin E from astrocytes to neurons, and that this process is homeostatically responsive to oxidative stress. These are the first observations that address the detailed molecular mechanisms of vitamin E transport in the central nervous system, and these results have important implications for understanding the molecular underpinnings of oxidative stress-related neurodegenerative diseases.	[Ulatowski, L.] Ursuline Coll, Dept Biol, Pepper Pike, OH USA; [Ghelfi, Mikel; West, Ryan; Atkinson, J.] Brock Univ, Dept Chem, St Catharines, ON, Canada; [Finno, C. J.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA USA; [Manor, D.] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Manor, D.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Manor, D.] Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Ursuline College; Brock University; University of California System; University of California Davis; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Manor, D (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	dxm178@case.edu		Atkinson, Jeffrey/0000-0003-3710-4893; ulatowski, lynn/0000-0002-1495-293X	National Institutes of Health [DK067494, DK125115, T32DK007319]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health awards DK067494 and DK125115 (to D. M.) and T32DK007319 (to L. U.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Asmis R, 1997, EUR J BIOCHEM, V250, P600, DOI 10.1111/j.1432-1033.1997.0600a.x; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; BJORNEBOE A, 1991, J NUTR, V121, P1208, DOI 10.1093/jn/121.8.1208; Bourdel-Marchasson I, 2001, AGE AGEING, V30, P235, DOI 10.1093/ageing/30.3.235; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; BURTON GW, 1983, CIBA F SYMP, V101, P4; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; BUTTRISS JL, 1988, BIOCHIM BIOPHYS ACTA, V962, P81, DOI 10.1016/0005-2760(88)90098-7; CACCAMO DV, 1989, ACTA NEUROPATHOL, V79, P248, DOI 10.1007/BF00294658; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Chung S, 2016, J BIOL CHEM, V291, P17028, DOI 10.1074/jbc.M116.734210; COHN W, 1992, BIOCHEM J, V287, P247, DOI 10.1042/bj2870247; Copp RP, 1999, BRAIN RES, V822, P80, DOI 10.1016/S0006-8993(99)01090-2; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Etminan M, 2005, LANCET NEUROL, V4, P362, DOI 10.1016/S1474-4422(05)70097-1; Etzl RP, 2012, J PERINAT MED, V40, P373, DOI 10.1515/jpm-2011-0307; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fariss MW, 2003, TOXICOLOGY, V189, P129, DOI 10.1016/S0300-483X(03)00158-6; Finno CJ, 2018, FREE RADICAL BIO MED, V120, P289, DOI 10.1016/j.freeradbiomed.2018.02.037; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Glaso M, 2004, J Nutr Health Aging, V8, P407; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Gohil K, 2003, FREE RADICAL BIO MED, V35, P1343, DOI 10.1016/S0891-5849(03)00509-4; Gosselet F, 2009, BRAIN RES, V1249, P34, DOI 10.1016/j.brainres.2008.10.036; Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Guerineau NC, 1997, J NEUROSCI METH, V73, P169, DOI 10.1016/S0165-0270(97)02224-3; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Huebbe P, 2010, MOL NUTR FOOD RES, V54, P623, DOI 10.1002/mnfr.200900398; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; JEANDEL C, 1989, GERONTOLOGY, V35, P275, DOI 10.1159/000213037; JimenezJimenez FJ, 1997, J NEURAL TRANSM, V104, P703, DOI 10.1007/BF01291887; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kolleck I, 1999, FREE RADICAL BIO MED, V27, P882, DOI 10.1016/S0891-5849(99)00139-2; Larnaout A, 1997, ACTA NEUROPATHOL, V93, P633, DOI 10.1007/s004010050662; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Marras C, 2009, MOVEMENT DISORD, V24, P2370, DOI 10.1002/mds.22828; Martin KR, 1997, P SOC EXP BIOL MED, V214, P367, DOI 10.3181/00379727-214-44105; Miller GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047402; Montine TJ, 1998, ANN NEUROL, V44, P410, DOI 10.1002/ana.410440322; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Morley S, 2010, J BIOL CHEM, V285, P35578, DOI 10.1074/jbc.M110.169664; MULLER DPR, 1982, ANN NY ACAD SCI, V393, P133, DOI 10.1111/j.1749-6632.1982.tb31239.x; NALECZ KA, 1992, EUR J BIOCHEM, V209, P37, DOI 10.1111/j.1432-1033.1992.tb17258.x; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Pham DQ, 2005, ANN PHARMACOTHER, V39, P2065, DOI 10.1345/aph.1G271; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Roghani M, 2001, BRAIN RES, V892, P211, DOI 10.1016/S0006-8993(00)03296-0; RUNGE P, 1986, BRIT J OPHTHALMOL, V70, P166, DOI 10.1136/bjo.70.3.166; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schuelke M, 1999, J PEDIATR-US, V134, P240, DOI 10.1016/S0022-3476(99)70424-5; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Sokol R J, 1990, Adv Pediatr, V37, P119; SOKOL RJ, 1993, GASTROENTEROLOGY, V104, P1727, DOI 10.1016/0016-5085(93)90652-S; SOKOL RJ, 1985, NEW ENGL J MED, V313, P1580, DOI 10.1056/NEJM198512193132505; SOKOL RJ, 1987, GASTROENTEROLOGY, V93, P975, DOI 10.1016/0016-5085(87)90559-2; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sutherland L, 2008, CELL MOL NEUROBIOL, V28, P949, DOI 10.1007/s10571-008-9269-y; Tachibana M, 2019, J CLIN INVEST, V129, P1272, DOI 10.1172/JCI124853; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; THELLMAN CA, 1985, J NUTR, V115, P1673, DOI 10.1093/jn/115.12.1673; TOHGI H, 1994, NEUROSCI LETT, V174, P73, DOI 10.1016/0304-3940(94)90122-8; TRABER MG, 1994, AM J CLIN NUTR, V59, P1270, DOI 10.1093/ajcn/59.6.1270; TRABER MG, 1984, AM J CLIN NUTR, V40, P747, DOI 10.1093/ajcn/40.4.747; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1988, LIPIDS, V23, P791, DOI 10.1007/BF02536223; Ulatowski L, 2014, NEUROSCIENCE, V260, P120, DOI 10.1016/j.neuroscience.2013.12.001; Ulatowski L, 2013, ANNU REV NUTR, V33, P87, DOI 10.1146/annurev-nutr-071812-161252; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vatassery GT, 2007, BBA-MOL BASIS DIS, V1772, P797, DOI 10.1016/j.bbadis.2007.04.006; Vatassery GT, 2006, J NEUROSCI RES, V84, P1335, DOI 10.1002/jnr.21037; Vatassery GT, 2009, J NEUROL SCI, V283, P195, DOI 10.1016/j.jns.2009.02.350; VATASSERY GT, 1992, ANN NY ACAD SCI, V669, P97; VATASSERY GT, 1984, BIOCHIM BIOPHYS ACTA, V792, P118, DOI 10.1016/0005-2760(84)90211-X; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang H, 2011, AM J EPIDEMIOL, V173, P595, DOI 10.1093/aje/kwq416; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; West R, 2010, J ORG CHEM, V75, P2883, DOI 10.1021/jo100095n; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Yokota T, 2000, J NEUROL NEUROSUR PS, V68, P521, DOI 10.1136/jnnp.68.4.521; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhang WX, 2009, LIPIDS, V44, P631, DOI 10.1007/s11745-009-3310-x	114	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101712	10.1016/j.jbc.2022.101712	http://dx.doi.org/10.1016/j.jbc.2022.101712			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150738	Green Published, gold			2022-12-28	WOS:000821054100012
J	Zhang, SH; Wang, RR; Wang, XY; Guo, XL; Du, YY; Guo, X; Zong, XL; Zhu, CH; Zhou, XL				Zhang, Shenghong; Wang, Ranran; Wang, Xinyue; Guo, Xueling; Du, Yanyan; Guo, Xin; Zong, Xinlan; Zhu, Changhui; Zhou, Xiaolei			HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER plus breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; REDOX; IRE1; ENVIRONMENT; PROTECTION; APOPTOSIS; CELLS; UPR; BAX	Endocrine-therapy-resistant estrogen receptor-positive (ER+) breast cancer cells often exhibit an augmented capacity to maintain endoplasmic reticulum (EnR) homeostasis under adverse conditions. Oncoprotein hepatitis B X-interacting protein (HBXIP) is a known transcriptional coactivator that promotes cancer development. However, it is unclear whether HBXIP participates in maintaining EnR homeostasis and promoting drug resistance in ER+ breast cancer. Here, we report that tamoxifen-resistant (TmaR) breast cancer cells exhibit increased expression of HBXIP, which acts as an inactivator of the unfolded protein response (UPR) to diminish tamoxifeninduced EnR stress. We show that HBXIP deficiency promotes EnR-associated degradation, enhances UPR-element reporter activity and cellular oxidative stress, and ultimately attenuates the growth of TmaR cells in vitro and in vivo. Mechanistically, we demonstrate that HBXIP acts as a chaperone of UPR transducer inositol-requiring enzyme 1a and diminishes production of reactive oxygen species (ROS) in TamR breast cancer cells. Upon loss of HBXIP expression, tamoxifen treatment hyperactivates IRE1 alpha and its downstream proapoptotic pathways and simultaneously induces accumulation of intracellular ROS. This elevated ROS programmatically activates the other two branches of the UPR, mediated by PKR-like ER kinase and activating transcription factor 6 alpha. Clinical investigations and Kaplan-Meier plotter analysis revealed that HBXIP is highly expressed in TamR breast cancer tissues. Furthermore, reinforced HBXIP expression is associated with a high recurrence and poor relapse-free survival rates in tamoxifen monotherapy ER+ breast cancer patients. These findings indicate that HBXIP is a regulator of EnR homeostasis and a potential target for TamR breast cancer therapy.	[Zhang, Shenghong; Wang, Ranran; Wang, Xinyue; Guo, Xueling; Zong, Xinlan; Zhu, Changhui; Zhou, Xiaolei] Hebei Univ Sci & Technol, Coll Food Sci & Biol, Shijiazhuang, Peoples R China; [Du, Yanyan] Hebei Med Univ, Hosp 4, Dept Clin Lab, Shijiazhuang, Peoples R China; [Guo, Xin] Kanazawa Med Univ, Dept Pathol, Uchinada, Ishikawa, Japan; [Guo, Xin] Kanazawa Med Univ Hosp, Dept Pathol, Uchinada, Ishikawa, Japan; [Guo, Xin] Kanazawa Med Univ, Lab Med, Uchinada, Ishikawa, Japan	Hebei University of Science & Technology; Hebei Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University	Zhou, XL (corresponding author), Hebei Univ Sci & Technol, Coll Food Sci & Biol, Shijiazhuang, Peoples R China.	foxlei@live.cn			Na-tional Natural Scientific Foundation [81602428]; Natural Sci-ence Foundation of Hebei Province of China [H2019208221, H2020208018]; Colleges and Universities in Hebei Province Science and Technology Research Project [QN2019169]	Na-tional Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Natural Sci-ence Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Colleges and Universities in Hebei Province Science and Technology Research Project	The authors thank professor Lihong Ye and Weiying Zhang for excellent technical support and contribution to experiments. This project was supported by grants from the Na-tional Natural Scientific Foundation (No. 81602428) , Natural Sci-ence Foundation of Hebei Province of China (No. H2019208221 and No. H2020208018) , Colleges and Universities in Hebei Province Science and Technology Research Project (No. QN2019169) .	Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Andersson H, 2010, DRUG METAB DISPOS, V38, P200, DOI 10.1124/dmd.109.029488; Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Cao SL, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.620514; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Clarke Robert, 2011, Horm Mol Biol Clin Investig, V5, P35, DOI 10.1515/HMBCI.2010.073; Delaunay-Moisan A, 2015, FREE RADICAL BIO MED, V83, P341, DOI 10.1016/j.freeradbiomed.2015.02.019; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Fang RP, 2020, ONCOGENE, V39, P2290, DOI 10.1038/s41388-019-1146-2; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; He Y, 2012, DEV CELL, V23, P1141, DOI 10.1016/j.devcel.2012.11.006; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Higa A, 2012, CELL SIGNAL, V24, P1548, DOI 10.1016/j.cellsig.2012.03.011; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Li YH, 2016, CANCER RES, V76, P293, DOI 10.1158/0008-5472.CAN-14-3607; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu BW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0577-5; Liu YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14190-2; Luo DH, 2008, J BIOL CHEM, V283, P11905, DOI 10.1074/jbc.M710557200; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Margittai E, 2015, FREE RADICAL BIO MED, V83, P331, DOI 10.1016/j.freeradbiomed.2015.01.032; McCloy RA, 2013, BRIT J CANCER, V109, P3034, DOI 10.1038/bjc.2013.693; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mishra RR, 2018, CLIN CANCER RES, V24, P1987, DOI 10.1158/1078-0432.CCR-17-2776; Nagy A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84787-5; Park JS, 2016, FREE RADICAL RES, V50, P1408, DOI 10.1080/10715762.2016.1253073; Phillips AM, 2018, ELIFE, V7, DOI 10.7554/eLife.38795; Pinkaew D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00029-1; Riaz TA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051160; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salaroglio IC, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0657-0; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Sundaram A, 2017, ELIFE, V6, DOI 10.7554/eLife.27187; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang Y, 2014, CANCER LETT, V352, P169, DOI 10.1016/j.canlet.2014.05.007; Xiu MX, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111045; Yoneda A, 2020, MOL CANCER RES, V18, P847, DOI 10.1158/1541-7786.MCR-19-0673; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005; Zhao Y, 2016, CANCER RES, V76, P4696, DOI 10.1158/0008-5472.CAN-15-1734; Zhou XL, 2019, ONCOGENE, V38, P4028, DOI 10.1038/s41388-019-0698-5; Zhou XL, 2018, ACTA PHARMACOL SIN, V39, P459, DOI 10.1038/aps.2017.157; Zhu YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03951-0	57	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101644	10.1016/j.jbc.2022.101644	http://dx.doi.org/10.1016/j.jbc.2022.101644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093383	gold, Green Published			2022-12-28	WOS:000789261900012
J	Bahng, S; Kumar, R; Marians, KJ				Bahng, Soon; Kumar, Rupesh; Marians, Kenneth J.			Intersubunit and intrasubunit interactions driving the MukBEF ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; TOPOISOMERASE IV INTERACTION; CONDENSIN COMPLEX; HUMAN COHESIN; COMPACTS DNA; PROTEIN; LOCALIZATION; ORGANIZATION; HOMODIMER; MUKF	MukBEF, a structural maintenance of chromosome-like protein complex consisting of an ATPase, MukB, and two interacting subunits, MukE and MukF, functions as the bacterial condensin. It is likely that MukBEF compacts DNA via an ATP hydrolysis-dependent DNA loop-extrusion reaction similar to that demonstrated for the yeast structural maintenance of chromosome proteins condensin and cohesin. MukB also interacts with the ParC subunit of the cellular chromosomal decatenase topoisomerase IV, an interaction that is required for proper chromosome condensation and segregation in Escherichia coli, although it suppresses the MukB ATPase activity. Other structural determinants and interactions that regulate the ATPase activity of MukBEF are not clear. Here, we have investigated the MukBEF ATPase activity, identifying intersubunit and intrasubunit interactions by protein-protein crosslinking and site-specific mutagenesis. We show that interactions between the hinge of MukB and its neck region are essential for the ATPase activity, that the ParC subunit of topoisomerase IV inhibits the MukB ATPase by preventing this interaction, that MukE interaction with DNA is likely essential for viability, and that interactions between MukF and the MukB neck region are necessary for ATPase activity and viability.	[Bahng, Soon; Kumar, Rupesh; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health [R35 GM126907]; Cancer Center Support grant (National Cancer Institute) [P30CA008748]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant (National Cancer Institute)	These studies were supported by the National Institutes of Health grant (R35 GM126907; to K. J. M.) and the Cancer Center Support grant (National Cancer Institute grant number: P30CA008748; to Memorial Sloan Kettering Cancer Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Burmann F, 2021, MOL CELL, V81, P4891, DOI 10.1016/j.molcel.2021.10.011; Burmann F, 2019, NAT STRUCT MOL BIOL, V26, P227, DOI 10.1038/s41594-019-0196-z; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; C. H. Haering, 2021, bioRxiv, DOI 10.1101/2021.10.29.466147; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Davidson IF, 2021, NAT REV MOL CELL BIO, V22, P445, DOI 10.1038/s41580-021-00349-7; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; El Sayyed H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006025; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Graham M., 2019, BIORXIV, DOI [10.1101/561829, DOI 10.1101/561829]; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Kim E, 2020, NATURE, V579, P438, DOI 10.1038/s41586-020-2067-5; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Kumar R, 2022, NUCLEIC ACIDS RES, V50, P2621, DOI 10.1093/nar/gkab1027; Kumar R, 2017, J BIOL CHEM, V292, P16921, DOI 10.1074/jbc.M117.803346; Kumar R, 2017, J BIOL CHEM, V292, P16904, DOI 10.1074/jbc.M117.803312; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Makela J, 2020, MOL CELL, V78, P250, DOI 10.1016/j.molcel.2020.02.003; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Pong H, 1999, METH MOL B, V94, P163; Prince Josh P, 2021, Nat Commun, V12, P6721, DOI 10.1038/s41467-021-27107-9; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Vos SM, 2013, EMBO J, V32, P2950, DOI 10.1038/emboj.2013.218; Wells JN, 2017, CURR BIOL, V27, pR17, DOI 10.1016/j.cub.2016.11.050; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Zawadzka K, 2018, ELIFE, V7, DOI 10.7554/eLife.31522; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034	45	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101964	10.1016/j.jbc.2022.101964	http://dx.doi.org/10.1016/j.jbc.2022.101964			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452680	Green Published, gold, Green Submitted			2022-12-28	WOS:000838892100013
J	Serganov, AA; Udi, Y; Stein, ME; Patel, V; Fridy, PC; Rice, CM; Saeed, M; Jacobs, EY; Chait, BT; Rout, MP				Serganov, Artem A.; Udi, Yael; Stein, Milana E.; Patel, Valay; Fridy, Peter C.; Rice, Charles M.; Saeed, Mohsan; Jacobs, Erica Y.; Chait, Brian T.; Rout, Michael P.			Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION INITIATION; NUCLEAR-PORE COMPLEX; FG NUCLEOPORIN NUP98; RNA EXPORT FACTOR; FACTOR 4G EIF4G; MESSENGER-RNA; VIRAL SUBVERSION; LOCALIZATION; CLEAVAGE; PROTEINS	Picornaviruses are small RNA viruses that hijack host cell machinery to promote their replication. During infection, these viruses express two proteases, 2Apro and 3Cpro, which process viral proteins. They also subvert a number of host functions, including innate immune responses, host protein synthesis, and intracellular transport, by utilizing poorly understood mechanisms for rapidly and specifically targeting critical host proteins. Here, we used proteomic tools to characterize 2Apro interacting partners, functions, and targeting mechanisms. Our data indicate that, initially, 2Apro primarily targets just two cellular proteins: eukaryotic translation initiation factor eIF4G (a critical component of the protein synthesis machinery) and Nup98 (an essential component of the nuclear pore complex, responsible for nucleocytoplasmic transport). The protease appears to employ two different cleavage mechanisms; it likely interacts with eIF3L, utilizing the eIF3 complex to proteolytically access the eIF4G protein but also directly binds and degrades Nup98. This Nup98 cleavage results in only a marginal effect on nuclear import of proteins, while nuclear export of proteins and mRNAs were more strongly affected. Collectively, our data indicate that 2Apro selectively inhibits protein translation, key nuclear export pathways, and cellular mRNA localization early in infection to benefit viral replication at the expense of particular cell functions.	[Serganov, Artem A.; Udi, Yael; Stein, Milana E.; Patel, Valay; Fridy, Peter C.; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Rice, Charles M.; Saeed, Mohsan] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Saeed, Mohsan] Boston Univ Sch Med, Dept Biochem, Boston, MA 02118 USA; [Saeed, Mohsan] Boston Univ, Boston Univ Sch Med, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA; [Jacobs, Erica Y.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Jacobs, Erica Y.] St Johns Univ, Chem Dept, Jamaica, NY 11439 USA	Rockefeller University; Rockefeller University; Boston University; Boston University; Rockefeller University; Saint John's University	Udi, Y; Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.; Saeed, M (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Saeed, M (corresponding author), Boston Univ Sch Med, Dept Biochem, Boston, MA 02118 USA.; Saeed, M (corresponding author), Boston Univ, Boston Univ Sch Med, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.; Jacobs, EY; Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA.; Jacobs, EY (corresponding author), St Johns Univ, Chem Dept, Jamaica, NY 11439 USA.	yudi@rockefeller.edu; msaeed1@bu.edu; jacobse@stjohns.edu; chait@rockefeller.edu; rout@rockefeller.edu		Stein, Milana/0000-0001-6540-4389; Patel, Valay/0000-0002-1787-5116; Jacobs, Erica/0000-0002-5018-0711; Udi, Yael/0000-0001-8451-2246; Saeed, Mohsan/0000-0001-8505-7054; Fridy, Peter/0000-0002-8208-9154	National Institutes of Health (NIH) [P41 GM109824, R01 CA228351, R01 GM112108]; NIH NIAID [R01 AI091707]; Institut Merieux grant; Leukemia and Lym-phoma Society Translational Research Program [6601-20]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut Merieux grant; Leukemia and Lym-phoma Society Translational Research Program	This work was supported by grants the National Institutes of Health (NIH) P41 GM109824 (B. T. C., M. P. R.) , NIH R01 CA228351 (M. P. R.) , NIH R01 GM112108 (M. P. R.) , NIH NIAID grant R01 AI091707 (C. M. R.) , an Institut Merieux grant (M. S. and C. M. R.) , and the Leukemia and Lym-phoma Society Translational Research Program Grant Number 6601-20. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abkallo HM, 2011, DRUG DISCOV THER, V5, P286, DOI 10.5582/ddt.2011.v5.6.286; Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Addetia A, 2021, MBIO, V12, DOI 10.1128/mBio.00065-21; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723; Ann S, 2017, ELIFE, V6, DOI 10.7554/eLife.30244; Aumayr M, 2017, VIROLOGY, V511, P123, DOI 10.1016/j.virol.2017.08.020; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Bai XT, 2012, J VIROL, V86, P4559, DOI 10.1128/JVI.06361-11; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Borghese F, 2011, J VIROL, V85, P9614, DOI 10.1128/JVI.00480-11; Bosch B, 2021, CELL, V184, P4579, DOI 10.1016/j.cell.2021.06.033; Bovee ML, 1998, VIROLOGY, V245, P241, DOI 10.1006/viro.1998.9172; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea Ileana M, 2011, Cold Spring Harb Protoc, V2011, DOI [10.1101/pdb.prot5611, 10.1101/pdb.prot5610]; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Dicks MDJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007408; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Dougherty JD, 2015, VIRUSES-BASEL, V7, P6127, DOI 10.3390/v7122922; Fan Y, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00396; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hanson PJ, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00265; Hugel S, 2014, MOL CELL PROTEOMICS, V13, P1286, DOI 10.1074/mcp.M112.026856; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kane M, 2018, ELIFE, V7, DOI 10.7554/eLife.35738; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; LaCava J, 2016, JOVE-J VIS EXP, DOI 10.3791/54518(2016); LaCava John, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top077545; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019; Luo Y, 2016, NAT MICROBIOL, V1, DOI 10.1038/NMICROBIOL.2016.68; Martinez-Salas E, 2015, VIRUS RES, V206, P62, DOI 10.1016/j.virusres.2015.01.012; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nakano K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00330; Novoa I, 1999, MOL CELL BIOL, V19, P2445; Obado SO, 2016, METHODS MOL BIOL, V1411, P67, DOI 10.1007/978-1-4939-3530-7_3; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2015, J VIROL, V89, P11069, DOI 10.1128/JVI.00956-15; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Quan BL, 2014, P NATL ACAD SCI USA, V111, P9127, DOI 10.1073/pnas.1409076111; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Ren Y, 2010, P NATL ACAD SCI USA, V107, P10406, DOI 10.1073/pnas.1005389107; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Saeed M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008927; Shen QT, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100856; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stuwe T, 2012, J MOL BIOL, V419, P330, DOI 10.1016/j.jmb.2012.03.024; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Taha MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091465; Tang JW, 2017, VIRULENCE, V8, P1062, DOI 10.1080/21505594.2017.1308620; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Visser LJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00222-19; Walker E, 2016, J VIROL, V90, P11032, DOI 10.1128/JVI.00974-16; Walker EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071316; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Watters K, 2017, J VIROL, V91, DOI 10.1128/JVI.02472-16; Welch K, 1999, MOL CELL BIOL, V19, P8400; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yang XD, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006901; Yarbrough ML, 2014, TRAFFIC, V15, P127, DOI 10.1111/tra.12137; Zamora M, 2002, J VIROL, V76, P165, DOI 10.1128/JVI.76.1.165-177.2002; Zell R, 2018, ARCH VIROL, V163, P299, DOI 10.1007/s00705-017-3614-8; Zhang K, 2019, NAT MICROBIOL, V4, P1671, DOI 10.1038/s41564-019-0482-x	85	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101882	10.1016/j.jbc.2022.101882	http://dx.doi.org/10.1016/j.jbc.2022.101882			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35367208	gold, Green Published			2022-12-28	WOS:000829588600001
J	Wu, G; Li, CY; Tao, JL; Liu, ZJ; Li, XX; Zang, ZY; Fu, C; Wei, JY; Yang, YX; Zhu, Q; Zhang, JQ; Shen, M; Liu, HL				Wu, Gang; Li, Chengyu; Tao, Jingli; Liu, Zhaojun; Li, Xiaoxuan; Zang, Ziyu; Fu, Chen; Wei, Jiayuan; Yang, Yaxing; Zhu, Qian; Zhang, Jia-Qing; Shen, Ming; Liu, Honglin			FSH mediates estradiol synthesis in hypoxic granulosa cells by activating glycolytic metabolism through the HIF-1 alpha-AMPK-GLUT1 signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; AMPK; ESTROGEN; CANCER; INHIBITION; HORMONE	Owing to the avascular environment within ovarian follicles, granulosa cells (GCs) are believed to live in a hypoxic niche. Follicle-stimulating hormone (FSH)-mediated steroidogenesis is crucial for normal growth and maturation of ovarian follicles, but it remains unclear how FSH stimulates estradiol (E2) synthesis under hypoxic conditions. Here, we aimed to explore whether FSH affects the ATP production required for estrogen synthesis from the perspective of glucose metabolism. It was observed that the levels of both E2 and HIF-1 alpha were markedly increased in a dose-dependent manner in mouse ovarian GCs after the injection of FSH in vivo, indicating that hypoxia/HIF1 alpha may be relevant to FSH-induced E2 synthesis. By treating hypoxic GCs with FSH in vitro, we further revealed that the activation of the AMP-activated protein kinase (AMPK)- GLUT1 pathway, which in turn stimulates ATP generation, may be essential for FSH-mediated E2 production during hypoxia. In contrast, inhibition of AMPK or GLUT1 with siRNAs/antagonist both repressed glycolysis, ATP production, and E2 synthesis despite FSH treatment. Moreover, blocking HIF-1 alpha activity using siRNAs/PX-478 suppressed AMPK activation, GLUT1 expression, and E2 levels in FSH-treated GCs. Finally, the in vitro findings were verified in vivo, which showed markedly increased AMPK activity, GLUT1 expression, glycolytic flux, ATP levels, and E2 concentrations in ovarian GCs following FSH injection. Taken together, these findings uncovered a novel mechanism for FSH-regulating E2 synthesis in hypoxic GCs by activating glycolytic metabolism through the HIF-1 alpha-AMPK-GLUT1 pathway.	[Wu, Gang; Li, Chengyu; Tao, Jingli; Liu, Zhaojun; Li, Xiaoxuan; Zang, Ziyu; Fu, Chen; Wei, Jiayuan; Yang, Yaxing; Zhu, Qian; Shen, Ming; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Zhang, Jia-Qing] Henan Acad Agr Sci, Inst Anim Husb & Vet Sci, Zhengzhou, Peoples R China	Nanjing Agricultural University; Henan Academy of Agricultural Sciences	Shen, M; Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China.	shenm2015@njau.edu.cn; liuhonglin@njau.edu.cn	liu, zhao/GXV-6141-2022; liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31972564, 31972571, 31630072, 31601939]; Priority Academic Program Development of Jiangsu Higher Education Institutions [DKQB201903]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX20_0602]; National Major Project for Breeding of Transgenic Pigs [2016ZX08006001-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Postgraduate Research & Practice Innovation Program of Jiangsu Province; National Major Project for Breeding of Transgenic Pigs	This work was supported by The National Natural Science Foundation of China (No. 31972564; No. 31972571; No. 31630072; No.31601939), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. DKQB201903), Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX20_0602), and the National Major Project for Breeding of Transgenic Pigs (2016ZX08006001-003).	Ahmadian M., 2011, DESNUTRINATGL IS REG; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Baba T, 2017, HUM REPROD, V32, P2456, DOI 10.1093/humrep/dex322; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Dengler F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072428; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kido T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03985; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Li CY, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa038; Li CY, 2020, FASEB J, V34, P3631, DOI 10.1096/fj.201901808RRR; Liu T, 2021, INT J MOL MED, V47, DOI 10.3892/ijmm.2021.4906; Liu ZJ, 2020, THERIOGENOLOGY, V154, P120, DOI 10.1016/j.theriogenology.2020.05.019; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Melkonian, 2021, STATPEARLS; Nagao A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020238; Nishimura R, 2016, REPROD FERT DEVELOP, V28, P1479, DOI 10.1071/RD15010; Oktem O, 2017, HUM REPROD, V32, P643, DOI 10.1093/humrep/dex010; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shoham Z, 1996, FERTIL STERIL, V65, P687; Tan CD, 2012, BRIT J PHARMACOL, V167, P368, DOI 10.1111/j.1476-5381.2012.01993.x; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wu LX, 2015, MOL MED REP, V12, P7153, DOI 10.3892/mmr.2015.4268; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Wu XG, 2021, NEUROSURG REV, V44, P411, DOI 10.1007/s10143-019-01228-8; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068; Zhou JW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.24; Zhu YM, 2017, AM J CANCER RES, V7, P1198; Zhu Y, 2019, WOUND REPAIR REGEN, V27, P324, DOI 10.1111/wrr.12708	34	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101830	10.1016/j.jbc.2022.101830	http://dx.doi.org/10.1016/j.jbc.2022.101830			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35300979	gold, Green Published			2022-12-28	WOS:000794890400006
J	Rao, TC; Beggs, RR; Ankenbauer, KE; Hwang, J; Ma, VPY; Salaita, K; Bellis, SL; Mattheyses, AL				Rao, Tejeshwar C.; Beggs, Reena R.; Ankenbauer, Katherine E.; Hwang, Jihye; Ma, Victor Pui-Yan; Salaita, Khalid; Bellis, Susan L.; Mattheyses, Alexa L.			ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; PROTECTS TUMOR-CELLS; OVARIAN-CANCER; SIALIC-ACID; SIGNAL-TRANSDUCTION; TYROSINE KINASES; EGFR LIGANDS; CROSS-TALK; N-GLYCANS; INTEGRIN	Heterogeneity within the glycocalyx influences cell adhesion mechanics and signaling. However, the role of specific glycosylation subtypes in influencing cell mechanics via alterations of receptor function remains unexplored. It has been shown that the addition of sialic acid to terminal glycans impacts growth, development, and cancer progression. In addition, the sialyltransferase ST6Gal-I promotes epidermal growth factor receptor (EGFR) activity, and we have shown EGFR is an 'allosteric mechano-organizer' of integrin tension. Here, we investigated the impact of ST6Gal-I on cell mechanics. Using DNA-based tension gauge tether probes of variable thresholds, we found that high ST6Gal-I activity promotes increased integrin forces and spreading in Cos-7 and OVCAR3, OVCAR5, and OV4 cancer cells. Further, employing inhibitors and function-blocking antibodies against beta 1, beta 3, and beta 5 integrins and ST6Gal-I targets EGFR, tumor necrosis factor receptor, and Fas cell surface death receptor, we validated that the observed phenotypes are EGFR-specific. We found that while tension, contractility, and adhesion are extracellularsignal-regulated kinase pathway-dependent, spreading, proliferation, and invasion are phosphoinositide 3-kinase-Akt serine/threonine kinase dependent. Using total internal reflection fluorescence microscopy and flow cytometry, we also show that high ST6Gal-I activity leads to sustained EGFR membrane retention, making it a key regulator of cell mechanics. Our findings suggest a novel sialylation-dependent mechanism orchestrating cellular mechanics and enhancing cell motility via EGFR signaling.	[Rao, Tejeshwar C.; Beggs, Reena R.; Ankenbauer, Katherine E.; Hwang, Jihye; Bellis, Susan L.; Mattheyses, Alexa L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Ma, Victor Pui-Yan; Salaita, Khalid] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; Emory University	Mattheyses, AL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	mattheyses@uab.edu	Rao, Tejeshwar/AAI-9877-2020	Rao, Tejeshwar/0000-0002-3285-1630; Hwang, Jihye/0000-0001-8224-0240; Mattheyses, Alexa L/0000-0002-5119-7750; Salaita, Khalid/0000-0003-4138-3477	National Science Foundation (NSF) CAREER [1832100]; National Institutes of Health (NIH) [R01GM131099]; NIH [U01CA233581, R01CA225177]; National Cancer Institute (NCI) [K00CA223074]	National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding to A. L. M. from the National Science Foundation (NSF) CAREER (1832100), to A. L. M. and K. S. from the National Institutes of Health (NIH) (R01GM131099), to S. L. B. from the NIH (U01CA233581 and R01CA225177), and to V. P.-Y. M. from the National Cancer Institute (NCI) (K00CA223074). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Arkhipov A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003742; Blayney J. K., 2016, NUCLEIC; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Britain CM, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.014126; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Broders-Bondon F, 2018, J CELL BIOL, V217, P1571, DOI 10.1083/jcb.201701039; Buffone A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910070; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Butler PJ, 2019, BIORHEOLOGY, V56, P101, DOI 10.3233/BIR-190212; Caldieri G, 2018, PROG MOL SUBCELL BIO, V57, P235, DOI 10.1007/978-3-319-96704-2_9; Carey SP, 2012, CRIT REV ONCOL HEMAT, V83, P170, DOI 10.1016/j.critrevonc.2011.11.005; Chen YF, 2017, MATRIX BIOL, V60-61, P70, DOI 10.1016/j.matbio.2016.07.002; Chiasson-MacKenzie C, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9473; Cooper J, 2019, CANCER CELL, V35, P347, DOI 10.1016/j.ccell.2019.01.007; Cornelison R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102171; Cosgun ZC, 2020, AM J PATHOL, V190, P732, DOI 10.1016/j.ajpath.2019.07.021; D'Addio M, 2020, GLYCOBIOLOGY, V30, P490, DOI 10.1093/glycob/cwaa008; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Dorsett KA, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0574-5; Eberwein P, 2015, BBA-MOL CELL RES, V1853, P2183, DOI 10.1016/j.bbamcr.2015.06.004; Francavilla C, 2016, NAT STRUCT MOL BIOL, V23, P608, DOI 10.1038/nsmb.3218; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gargalionis AN, 2018, J CELL MOL MED, V22, P704, DOI 10.1111/jcmm.13452; Garnham R, 2019, ONCOL LETT, V18, P983, DOI 10.3892/ol.2019.10458; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Granovsky M, 2000, NAT MED, V6, P306; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphries JD, 2019, CURR OPIN CELL BIOL, V56, P14, DOI 10.1016/j.ceb.2018.08.004; Irani MA, 2017, PROTEINS, V85, P1529, DOI 10.1002/prot.25314; Jalal S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.220780; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jones RB, 2018, J BIOL CHEM, V293, P5659, DOI 10.1074/jbc.RA117.001194; Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4; Kanyo N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-80033-6; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kechagia JZ, 2019, NAT REV MOL CELL BIO, V20, P457, DOI 10.1038/s41580-019-0134-2; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Kuo JCH, 2018, NAT PHYS, V14, P658, DOI 10.1038/s41567-018-0186-9; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li D, 2012, ONCOTARGETS THER, V5, P271, DOI 10.2147/OTT.S35322; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liu QQ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1208-x; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Ma VPY, 2016, ANGEW CHEM INT EDIT, V55, P5488, DOI 10.1002/anie.201600351; Makale Milan, 2007, Birth Defects Research, V81, P329, DOI 10.1002/bdrc.20110; Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]; Monne HMS, 2013, BIOPHYS J, V104, p251A; Monteiro AI, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5045231; Mosayebi M, 2015, ACS NANO, V9, P11993, DOI 10.1021/acsnano.5b04726; Murugaesu N, 2014, CANCER DISCOV, V4, P304, DOI 10.1158/2159-8290.CD-13-0287; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Panciera T, 2020, NAT MATER, V19, P797, DOI 10.1038/s41563-020-0615-x; Park JJ, 2013, GUT LIVER, V7, P629, DOI 10.5009/gnl.2013.7.6.629; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Pavelka M., 2010, FUNCTIONAL ULTRASTRU, P164, DOI [10.1007/978-3-211-99390-3_86, DOI 10.1007/978-3-211-99390-3_86]; Pietrobono S, 2021, CANCERS, V13, DOI 10.3390/cancers13092014; Randles MJ, 2020, MATRIX BIOL, V90, P61, DOI 10.1016/j.matbio.2020.02.005; Rao TC, 2020, J CELL SCI, V133, DOI 10.1242/jcs.238840; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Salomon-Perzynski A, 2017, ARCH GYNECOL OBSTET, V295, P569, DOI 10.1007/s00404-017-4292-1; Samarzija I, 2020, CANCERS, V12, DOI 10.3390/cancers12071910; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Stuart AD, 2007, J GEN VIROL, V88, P177, DOI 10.1099/vir.0.82158-0; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki O, 2015, INT J ONCOL, V46, P973, DOI 10.3892/ijo.2015.2818; Swain PS, 2002, BIOPHYS J, V82, P2928, DOI 10.1016/S0006-3495(02)75633-6; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Tao Y, 2019, CYTOTECHNOLOGY, V71, P1155, DOI 10.1007/s10616-019-00352-z; Tee YH, 2015, NAT CELL BIOL, V17, P445, DOI 10.1038/ncb3137; Thomas JR, 2019, ESSAYS BIOCHEM, V63, P553, DOI 10.1042/EBC20190025; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vasudevan HN, 2016, CURR TOP DEV BIOL, V117, P393, DOI 10.1016/bs.ctdb.2015.10.016; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Wang XF, 2015, BIOPHYS J, V109, P2259, DOI 10.1016/j.bpj.2015.10.029; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wei AW, 2016, ONCOTARGET, V7, P65374, DOI 10.18632/oncotarget.11699; Wichert B, 2018, GLYCOBIOLOGY, V28, P898, DOI 10.1093/glycob/cwy065; Wu YS, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.540332; Xie H., 1998, J CELL SCI; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang ZJ, 2018, GLYCOCONJUGATE J, V35, P139, DOI 10.1007/s10719-018-9820-0; Zhou XM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020273	113	4	4	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101726	10.1016/j.jbc.2022.101726	http://dx.doi.org/10.1016/j.jbc.2022.101726			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35157848	gold, Green Published			2022-12-28	WOS:000793694800006
J	Verma, G; Bowen, A; Gheibi, S; Hamilton, A; Muthukumar, S; Cataldo, LR; Asplund, O; Esguerra, J; Karagiannopoulos, A; Lyons, C; Cowan, E; Bellodi, C; Prasad, R; Fex, M; Mulder, H				Verma, Gaurav; Bowen, Alexander; Gheibi, Sevda; Hamilton, Alexander; Muthukumar, Sowndarya; Cataldo, Luis Rodrigo; Asplund, Olof; Esguerra, Jonathan; Karagiannopoulos, Alexandros; Lyons, Claire; Cowan, Elaine; Bellodi, Cristian; Prasad, Rashmi; Fex, Malin; Mulder, Hindrik			Ribosomal biogenesis regulator DIMT1 controls beta-cell protein synthesis, mitochondrial function, and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								We previously reported that loss of mitochondrial transcription factor B1 (TFB1M) leads to mitochondrial dysfunction and is involved in the pathogenesis of type 2 diabetes (T2D). Whether defects in ribosomal processing impact mitochondrial function and could play a pathogenetic role in beta-cells and T2D is not known. To this end, we explored expression and the functional role of dimethyladenosine transferase 1 homolog (DIMT1), a homolog of TFB1M and a ribosomal RNA (rRNA) methyltransferase implicated in the control of rRNA. Expression of DIMT1 was increased in human islets from T2D donors and correlated positively with expression of insulin mRNA, but negatively with insulin secretion. We show that silencing of DIMT1 in insulin-secreting cells impacted mitochondrial function, leading to lower expression of mitochondrial OXPHOS proteins, reduced oxygen consumption rate, dissipated mitochondrial membrane potential, and a slower rate of ATP production. In addition, the rate of protein synthesis was retarded upon DIMT1 deficiency. Consequently, we found that DIMT1 deficiency led to perturbed insulin secretion in rodent cell lines and islets, as well as in a human beta-cell line. We observed defects in rRNA processing and reduced interactions between NIN1 (RPN12) binding protein 1 homolog (NOB-1) and pescadillo ribosomal biogenesis factor 1 (PES-1), critical ribosomal subunit RNA proteins, the dysfunction of which may play a part in disturbing protein synthesis in beta-cells. In conclusion, DIMT1 deficiency perturbs protein synthesis, resulting in mitochondrial dysfunction and disrupted insulin secretion, both potential pathogenetic processes in T2D.	[Verma, Gaurav; Bowen, Alexander; Gheibi, Sevda; Hamilton, Alexander; Cataldo, Luis Rodrigo; Karagiannopoulos, Alexandros; Lyons, Claire; Cowan, Elaine; Prasad, Rashmi; Fex, Malin; Mulder, Hindrik] Lund Univ, Lund Univ Diabet Ctr, Malmo, Sweden; [Muthukumar, Sowndarya; Cowan, Elaine] Lund Univ, Fac Med, Lund Stem Cell Ctr, Dept Lab Med, Lund, Sweden; [Esguerra, Jonathan; Karagiannopoulos, Alexandros] Lund Univ Diabet Ctr, Unit Islet Cell Exocytosis, Malmo, Sweden; [Bellodi, Cristian; Prasad, Rashmi] Lund Univ Diabet Ctr, Unit Genom Diabet & Endocrinol, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University	Mulder, H (corresponding author), Lund Univ, Lund Univ Diabet Ctr, Malmo, Sweden.	hindrik.mulder@med.lu.se	Verma, Gaurav/F-5696-2015; Prasad, Rashmi B/GRJ-5491-2022; Bellodi, Cristian/N-2341-2015	Prasad, Rashmi B/0000-0002-4400-6741; Bellodi, Cristian/0000-0001-8047-5329; Muthukumar, Sowndarya/0000-0002-9110-722X; Cowan, Elaine/0000-0003-3939-8864; Mulder, Hindrik/0000-0002-6593-8417	European Unions Horizons 2020 Research and Innovation Program [667191]; Swedish Research Council [2009-1039]; LUDC-IRC [IRC15-0067]; LUDC [349-2006-237]	European Unions Horizons 2020 Research and Innovation Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); LUDC-IRC; LUDC	The authors thank Lund University of Diabetes Centre, Lund University, Malmo, Sweden. The work is supported by European Unions Horizons 2020 Research and Innovation Program under grant agreement No. 667191. It was also funded by Swedish Research Council (Dnr 2009-1039) , LUDC-IRC (Dnr IRC15-0067) , and LUDC (349-2006-237) . Laila Jacobsson is acknowledged for providing all the laboratory facilities. The authors thank Peter Spegel for his input on the study.	Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Shanik M. H., 2008, PLOS BIOL, V8	3	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101692	10.1016/j.jbc.2022.101692	http://dx.doi.org/10.1016/j.jbc.2022.101692			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148993	Green Published, gold			2022-12-28	WOS:000789400700008
J	Yan, QN; Gao, HQ; Yao, Q; Ling, K; Xiao, GZ				Yan, Qinnan; Gao, Huanqing; Yao, Qing; Ling, Kun; Xiao, Guozhi			Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTDINS(4,5)P-2 SYNTHESIS; DIFFERENTIATION; HOMEOSTASIS; EXPRESSION; ISOFORMS	Phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) is a lipid kinase that plays a pivotal role in the regulation of receptor-mediated calcium signaling in multiple tissues; however, its role in the skeleton is not clear. Here, we show that while deleting Pip5k1c expression in the mesenchymal stem cells using Prx1-Cre transgenic mice does not impair the intramembranous and endochondral ossification during skeletal development, it does cause osteopenia in adult mice, but not rapidly growing young mice. We found Pip5k1c loss dramatically decreases osteoblast formation and osteoid and mineral deposition, leading to reduced bone formation. Furthermore, Pip5k1c loss inhibits osteoblastic, but promotes adipogenic, differentiation of bone marrow stromal cells. Pip5k1c deficiency also impairs cytoplasmic calcium influx and inactivates the calcium/calmodulin-dependent protein kinase, which regulates levels of transcription factor Runx2 by modulating its stability and subsequent osteoblast and bone formation. In addition, Pip5k1c loss reduces levels of the receptor activator of nuclear factor -KB ligand, but not that of osteoprotegerin, its decoy receptor, in osteoblasts in bone and in sera. Finally, we found Pip5k1c loss impairs the ability of bone marrow stromal cells to support osteoclast formation of bone marrow monocytes and reduces the osteoclast precursor population in bone marrow, resulting in reduced osteoclast formation and bone resorption. We conclude Pip5k1c deficiency causes a low-turnover osteopenia in mice, with impairment of bone formation being greater than that of bone resorption. Collectively, we uncover a novel function and mechanism of Pip5k1c in the control of bone mass and identify a potential therapeutic target for osteoporosis.	[Yan, Qinnan; Gao, Huanqing; Yao, Qing; Xiao, Guozhi] Southern Univ Sci & Technol, Sch Med, Dept Biochem, Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Shenzhen, Peoples R China; [Ling, Kun] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Southern University of Science & Technology; Mayo Clinic	Xiao, GZ (corresponding author), Southern Univ Sci & Technol, Sch Med, Dept Biochem, Guangdong Prov Key Lab Cell Microenvironm & Dis Re, Shenzhen, Peoples R China.	xiaogz@sustech.edu.cn			National Key Research and Development Program of China [2019YFA0906004]; National Natural Science Foundation of China [81991513, 81870532, 81630066]; Guangdong Provincial Science and Technology Innovation Council [2017B030301018, 20180302174246105]; Shenzhen Municipal Science and Technology Innovation Council [20200925150409001]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Innovation Council; Shenzhen Municipal Science and Technology Innovation Council	We thank Dr Huiling Cao of Southern University of Science and Technology (SUSTech) for critical reading of this article. We acknowledge the assistance of Core Research Facilities of SUSTech. This work was supported, in part, by the National Key Research and Development Program of China Grants (2019YFA0906004) , the National Natural Science Foundation of China Grants (81991513, 81870532, 81630066) , the Guangdong Provincial Science and Technology Innovation Council Grant (2017B030301018, 20180302174246105) , and the Shenzhen Municipal Science and Technology Innovation Council Grant (20200925150409001) .	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao HL, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0073-8; Cao HL, 2013, J BIOL CHEM, V288, P30399, DOI 10.1074/jbc.M113.469973; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fu XK, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00328-y; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Huang J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10753-5; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Legate KR, 2012, J CELL SCI, V125, P5636, DOI 10.1242/jcs.102145; Lei YM, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00108-y; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131692; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14186-y; Zhu K, 2015, J BIOL CHEM, V290, P8081, DOI 10.1074/jbc.M114.603985; Zhu TT, 2013, J BIOL CHEM, V288, P5268, DOI 10.1074/jbc.M112.446054	32	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101639	10.1016/j.jbc.2022.101639	http://dx.doi.org/10.1016/j.jbc.2022.101639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090892	gold, Green Published			2022-12-28	WOS:000789261900006
J	Olney, SG; Chien, PT; Kearns, DB				Olney, Stephen G.; Chien, Peter; Kearns, Daniel B.			SmiA is a hybrid priming/scaffolding adaptor for the LonA protease in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWARMING DIFFERENTIATION; REGULATED PROTEOLYSIS; ESCHERICHIA-COLI; RECOGNITION; DEGRADATION; PROTEINS; YJBH; MECHANISM; SIGMA(S); MOTILITY	Regulatory proteolysis targets properly folded clients via a combination of cis-encoded degron sequences and trans-expressed specificity factors called adaptors. SmiA of Bacillus subtilis was identified as the first adaptor protein for the Lon family of proteases, but the mechanism of SmiAdependent proteolysis is unknown. Here, we develop a fluorescence-based assay to measure the kinetics of SmiAdependent degradation of its client SwrA and show that SmiA-SwrA interaction and the SwrA degron were both necessary, but not sufficient, for proteolysis. Consistent with a scaffolding adaptor mechanism, we found that stoichiometric excess of SmiA caused substrate-independent inhibition of LonA-dependent turnover. Furthermore, SmiA was strictly required even when SwrA levels were high suggesting that a local increase in substrate concentration mediated by the scaffold was not sufficient for proteolysis. Moreover, SmiA function could not be substituted by thermal denaturation of the substrate, consistent with a priming adaptor mechanism. Taken together, we conclude that SmiA functions via a mechanism that is a hybrid between scaffolding and priming models.	[Olney, Stephen G.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Chien, Peter] Univ Massachusetts Amherst, Dept Biochem & Mol Biol, Amherst, MA USA	Indiana University System; Indiana University Bloomington; University of Massachusetts System; University of Massachusetts Amherst	Kearns, DB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dbkearns@indiana.edu			National Institutes of Health [R35 GM130320, R35 GM131783]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by the National Institutes of Health grants R35 GM130320 (to P. C.) and R35 GM131783 (to D. B. K.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Chan CM, 2014, MOL MICROBIOL, V93, P426, DOI 10.1111/mmi.12671; Chan CM, 2012, MICROBIOL-SGM, V158, P1268, DOI 10.1099/mic.0.057661-0; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; GRANT GF, 1969, J BACTERIOL, V99, P116, DOI 10.1128/JB.99.1.116-124.1969; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur Eyal, 2013, Subcell Biochem, V66, P35, DOI 10.1007/978-94-007-5940-4_2; Gur E, 2012, PROTEIN SCI, V21, P268, DOI 10.1002/pro.2013; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hughes AC, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00659-17; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Jonas K, 2013, CELL, V154, P623, DOI 10.1016/j.cell.2013.06.034; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kommineni S, 2011, J BACTERIOL, V193, P2133, DOI 10.1128/JB.01350-10; Kuhlmann NJ, 2017, CURR OPIN MICROBIOL, V36, P118, DOI 10.1016/j.mib.2017.03.013; Kuroda A, 2006, BIOSCI BIOTECH BIOCH, V70, P325, DOI 10.1271/bbb.70.325; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Mahmoud SA, 2018, ANNU REV BIOCHEM, V87, P677, DOI 10.1146/annurev-biochem-062917-012848; Mordini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085065; Mukherjee S, 2015, P NATL ACAD SCI USA, V112, P250, DOI 10.1073/pnas.1417419112; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Puri N, 2017, MOL CELL, V66, P672, DOI 10.1016/j.molcel.2017.05.016; Ropelewska M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.585717; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Senesi S, 2004, J BACTERIOL, V186, P1158, DOI 10.1128/JB.186.4.1158-1164.2004; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Turgay K, 1998, EMBO J, V17, P6730; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zeinert RD, 2020, MOL CELL, V79, P758, DOI 10.1016/j.molcel.2020.07.011; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	54	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7								10.1016/j.jbc.2022.102045	http://dx.doi.org/10.1016/j.jbc.2022.102045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35595098	Green Published, gold			2022-12-28	WOS:000829549100012
J	Erath, J; Djuranovic, S				Erath, Jessey; Djuranovic, Sergej			Association of the receptor for activated C-kinase 1 with ribosomes in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MALARIA PARASITES; HOST ERYTHROCYTE; QUALITY-CONTROL; SWISS-MODEL; RACK1; TRANSLATION; DATABASE; RNA; PREDICTION	The receptor for activated C-kinase 1 (RACK1), a highly conserved eukaryotic protein, is known to have many varying biological roles and functions. Previous work has established RACK1 as a ribosomal protein, with defined regions important for ribosome binding in eukaryotic cells. In Plasmodium falciparum, RACK1 has been shown to be required for parasite growth, however, conflicting evidence has been presented about RACK1 ribosome binding and its role in mRNA translation. Given the importance of RACK1 as a regulatory component of mRNA translation and ribosome quality control, the case could be made in parasites that RACK1 either binds or does not bind the ribosome. Here, we used bioinformatics and transcription analyses to further characterize the P. falciparum RACK1 protein. Based on homology modeling and structural analyses, we generated a model of P. falciparum RACK1. We then explored mutant and chimeric human and P. falciparum RACK1 protein binding properties to the human and P. falciparum ribosome. We found that WT, chimeric, and mutant RACK1 exhibit distinct ribosome interactions suggesting different binding characteristics for P. falciparum and human RACK1 proteins. The ribosomal binding of RACK1 variants in human and parasite cells shown here demonstrates that although RACK1 proteins have highly conserved sequences and structures across species, ribosomal binding is affected by species-specific alterations to this protein. In conclusion, we show that in the case of P. falciparum, contrary to the structural data, RACK1 is found to bind ribosomes and actively translating polysomes in parasite cells.	[Erath, Jessey; Djuranovic, Sergej] Washington Univ Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL)	Djuranovic, S (corresponding author), Washington Univ Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA.	sergej.djuranovic@wustl.edu		Erath, Jessey/0000-0001-8802-635X; Djuranovic, Sergej/0000-0002-9417-0822	NIH [R01 GM112824, R01 GM136823]; NIH [R01 GM112824, R01 GM136823, R01 MH116999, T32 GM007067]; Washington University LEAP Gap Fund [1014]; Washington University Institute of Clinical and Translational Sciences; NIH/National Center for Advancing Translational Sciences (NCATS) [UL1TR002345]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University LEAP Gap Fund; Washington University Institute of Clinical and Translational Sciences; NIH/National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Slavica Pavlovic Djuranovic, and members of Daniel Goldberg?s and Sergej Djuranovic?s lab for helpful comments. Funding and additional information: This work is supported by NIH R01 GM112824, NIH R01 GM136823, and NIMH R01 MH116999 to S. D., and NIH T32 GM007067 and NIMH R01 MH116999 to J. E. We are also thankful to WUCCI center of Washington University on the help with this project. The Washington University LEAP Gap Fund supported this project through the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship under award number #1014, the Washington University Institute of Clinical and Translational Sciences, and the NIH/National Center for Advancing Translational Sciences (NCATS) grant UL1TR002345. The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Blomqvist K, 2017, MOL BIOCHEM PARASIT, V211, P62, DOI 10.1016/j.molbiopara.2016.10.002; Bradford W, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003768; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Bunnik EM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1014-0; Caro F, 2014, ELIFE, V3, DOI 10.7554/eLife.04106; Carrillo DR, 2012, ACTA CRYSTALLOGR F, V68, P867, DOI 10.1107/S1744309112027480; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gallo S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00230-18; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hale VL, 2017, P NATL ACAD SCI USA, V114, P3439, DOI 10.1073/pnas.1619441114; Hanson J, 2017, BIOINFORMATICS, V33, P685, DOI 10.1093/bioinformatics/btw678; Heffernan R, 2017, BIOINFORMATICS, V33, P2842, DOI 10.1093/bioinformatics/btx218; Ikeuchi K, 2016, FEBS LETT, V590, P3254, DOI 10.1002/1873-3468.12366; Jain BP, 2018, PROTEIN J, V37, P391, DOI 10.1007/s10930-018-9785-7; Jha S, 2017, NATURE, V546, P651, DOI 10.1038/nature22814; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Johnson AG, 2019, RNA, V25, P881, DOI 10.1261/rna.071217.119; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lacsina JR, 2011, MOL BIOCHEM PARASIT, V179, P42, DOI 10.1016/j.molbiopara.2011.05.003; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Nielsen MH, 2017, CELL SIGNAL, V35, P272, DOI 10.1016/j.cellsig.2017.01.026; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rollins MG, 2019, J CELL SCI, V132, DOI 10.1242/jcs.228908; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; SMITH BL, 1992, BIOCHEM BIOPH RES CO, V188, P1235, DOI 10.1016/0006-291X(92)91363-U; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Sugiyama T, 2019, CELL REP, V26, P3400, DOI 10.1016/j.celrep.2019.02.067; Sun M, 2015, NUCLEIC ACIDS RES, V43, P10515, DOI 10.1093/nar/gkv991; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200; von Bohl A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0967-x; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yuan L, 2017, FUNGAL GENET BIOL, V99, P52, DOI 10.1016/j.fgb.2017.01.003; Zanghi G, 2018, CELL REP, V22, P2951, DOI 10.1016/j.celrep.2018.02.075; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	63	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101954	10.1016/j.jbc.2022.101954	http://dx.doi.org/10.1016/j.jbc.2022.101954			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35452681	Green Published, gold			2022-12-28	WOS:000804798000003
J	Nagata, K; Hishikawa, D; Sagara, H; Saito, M; Watanabe, S; Shimizu, T; Shindou, H				Nagata, Katsuyuki; Hishikawa, Daisuke; Sagara, Hiroshi; Saito, Masamichi; Watanabe, Sumiko; Shimizu, Takao; Shindou, Hideo			Lysophosphatidylcholine acyltransferase 1 controls mitochondrial reactive oxygen species generation and survival of retinal photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSICAL-PROPERTIES; ACYL-COA; DEGENERATION; METABOLISM; RHODOPSIN; PROLIFERATION; DESATURASE; EXPRESSION; RECEPTORS; PROTECTS	Due to their high energy demands and characteristic morphology, retinal photoreceptor cells require a specialized lipid metabolism for survival and function. Accordingly, dysregulation of lipid metabolism leads to the photoreceptor cell death and retinal degeneration. Mice bearing a frameshift mutation in the gene encoding lysophosphatidylcholine acyltransferase 1 (Lpcat1), which produces saturated phosphatidylcholine (PC) composed of two saturated fatty acids, has been reported to cause spontaneous retinal degeneration in mice; however, the mechanism by which this mutation affects degeneration is unclear. In this study, we performed a detailed characterization of LPCAT1 in the retina and found that genetic deletion of Lpcat1 induces light-independent and photoreceptor-specific apoptosis in mice. Lipidomic analyses of the retina and isolated photoreceptor outer segment (OS) suggested that loss of Lpcat1 not only decreased saturated PC production but also affected membrane lipid composition, presumably by altering saturated fatty acyl-CoA availability. Furthermore, we demonstrated that Lpcat1 deletion led to increased mitochondrial reactive oxygen species levels in photoreceptor cells, but not in other retinal cells, and did not affect the OS structure or trafficking of OS-localized proteins. These results suggest that the LPCAT1-dependent production of saturated PC plays critical roles in photoreceptor maturation. Our findings highlight the therapeutic potential of saturated fatty acid metabolism in photoreceptor cell degeneration-related retinal diseases.	[Nagata, Katsuyuki; Hishikawa, Daisuke; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Saito, Masamichi] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan.; Shindou, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan.	hshindou@ri.ncgm.go.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Sagara, HIroshi/0000-0003-3473-9850	AMED-CREST, Japan [21gm0910011]; AMED-PCREATE, Japan [21cm0106116]; AMED Program for Basic and Clinical Research on Hepatitis [21fk0210091h]; Takeda Science Foundation, Japan [15668360]	AMED-CREST, Japan; AMED-PCREATE, Japan; AMED Program for Basic and Clinical Research on Hepatitis; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This study was supported by AMED-CREST, Japan 21gm0910011 (Hideo Shindou), AMED-PCREATE, Japan 21cm0106116 (Hideo Shindou), AMED Program for Basic and Clinical Research on Hepatitis 21fk0210091h (Hideo Shindou), and Takeda Science Foundation, Japan 15668360 (T. S.).	Akagi S, 2016, FASEB J, V30, P2027, DOI 10.1096/fj.201500149; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bi JF, 2019, CELL METAB, V30, P525, DOI 10.1016/j.cmet.2019.06.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19665; Cheng X, 2020, CELL METAB, V32, P229, DOI 10.1016/j.cmet.2020.06.002; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Eberle D, 2011, INVEST OPHTH VIS SCI, V52, P6462, DOI 10.1167/iovs.11-7399; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Fu ZJ, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000618; Fu ZJ, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910473; Geller SF, 2003, ADV EXP MED BIOL, V533, P249; Grunin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29046; Hamano F, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100303; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOLLEY R N, 1976, Annals of Ophthalmology, V8, P469; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Pan WW, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01765-3; Sander CL, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202101063; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Uematsu M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02679-w; Valentine WJ, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101470; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Yanagida K, 2020, DEV CELL, V52, P779, DOI 10.1016/j.devcel.2020.01.016	49	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101958	10.1016/j.jbc.2022.101958	http://dx.doi.org/10.1016/j.jbc.2022.101958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35452679	Green Published, Green Submitted, gold			2022-12-28	WOS:000807755100012
J	Shen, BB; Zhang, YX				Shen, Beibei; Zhang, Yunxin			A mechanochemical model of the forward/backward movement of motor protein kinesin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECK LINKER; 8-NM STEP; FORCE; MECHANISM; DYNAMICS; BINDING; CYCLE; ATP	Kinesin-1 is an ATP-driven, two-headed motor protein that transports intracellular cargoes (loads) along microtubules. The movement of kinesin-1 has generally been modeled according to its correlation with ATP cleavage (forward movement), synthesis (backward movement), or unproductive cleavage (futile consumption). Based on recent experimental observations, we formulate a mechanochemical model for this movement in which the forward/backward/futile cycle can be realized through multiple biochemical pathways. Our results show that the backward motion of kinesin-1 occurs mainly through backward sliding along the microtubule and is usually also coupled with ATP hydrolysis. We also found that with a low external load, about 80% of ATP is wasted (futile consumption) by kinesin-1. Furthermore, at high ATP concentrations or under high external loads, both heads of kinesin-1 are always in the ATP- or ADP . Pi-binding state and tightly bound to the microtubule, while at low ATP concentrations and low loads, kinesin-1 is mainly in the one-head-bound state. Unless the external load is near the stall force, the motion of kinesin-1 is almost deterministic.	[Shen, Beibei; Zhang, Yunxin] Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai, Peoples R China	Fudan University	Zhang, YX (corresponding author), Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai, Peoples R China.	xyz@fudan.edu.cn						Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Chowdhury D, 2013, PHYS REP, V529, P1, DOI 10.1016/j.physrep.2013.03.005; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Gardiner C., 2010, STOCHASTIC METHODS H; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Higuchi H, 2004, EMBO J, V23, P2993, DOI 10.1038/sj.emboj.7600306; Howard J., 2001, MECH MOTOR PROTEINS; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; Kolomeisky AB, 2015, MOTOR PROTEINS AND MOLECULAR MOTORS, P1, DOI 10.1201/b18426; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Mugnai ML, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.025001; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Parrondo JMR, 2002, APPL PHYS A-MATER, V75, P179, DOI 10.1007/s003390201332; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toleikis A, 2020, BIOPHYS J, V119, P1984, DOI 10.1016/j.bpj.2020.09.034; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhang YX, 2008, BIOPHYS CHEM, V136, P19, DOI 10.1016/j.bpc.2008.04.002; Zhang YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032717; Zhang YX, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011923	42	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101948	10.1016/j.jbc.2022.101948	http://dx.doi.org/10.1016/j.jbc.2022.101948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447112	Green Published, gold			2022-12-28	WOS:000838892100007
J	Zhang, Y; Dong, DD; Xu, XT; He, H; Zhu, Y; Lei, TW; Ou, HL				Zhang, Yun; Dong, Doudou; Xu, Xiaoting; He, Hui; Zhu, Yuan; Lei, Tingwen; Ou, Hailong			Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING CASCADE; LOCALIZATION; HDL; ACTIVATION; PHAGOCYTOSIS; MEMBRANE; RECEPTOR; PATHWAY; INSULIN; RISK	Oxidized high-density lipoprotein (oxHDL) reduces the ability of cells to mediate reverse cholesterol transport and also shows atherogenic properties. Palmitoylation of cluster of differentiation 36 (CD36), an important receptor mediating lipoprotein uptake, is required for fatty acid endocytosis. However, the relationship between oxHDL and CD36 has not been described in mechanistic detail. Here, we demonstrate using acyl-biotin exchange analysis that oxHDL activates CD36 by increasing CD36 palmitoylation, which promotes efficient uptake in macrophages. This modification increased CD36 incorporation into plasma lipid rafts and activated downstream signaling mediators, such as Lyn, Fyn, and c-Jun N-terminal kinase, which elicited enhanced oxHDL uptake and foam cell formation. Furthermore, blocking CD36 palmitoylation with the pharmacological inhibitor 2-bromopalmitate decreased cell surface translocation and lowered oxHDL uptake in oxHDLtreated macrophages. We verified these results by transfecting oxHDL-induced macrophages with vectors expressing wildtype or mutant CD36 (mCD36) in which the cytoplasmic palmitoylated cysteine residues were replaced. We show that cells containing mCD36 exhibited less palmitoylated CD36, disrupted plasma membrane trafficking, and reduced protein tion at the aortic root in mice receiving the mCD36 vector was decreased, suggesting that CD36 palmitoylation is responsible for lipid uptake in vivo. Finally, our data indicated that palmitoylation of CD36 was dependent on DHHC6 (Asp-His-Hisincreased the CD36/caveolin-1 interaction and membrane targeting in cells exposed to oxHDL. Altogether, our study uncovers a causal link between oxHDL and CD36 palmitoylation and provides insight into foam cell formation and atherogenesis.	[Zhang, Yun; Dong, Doudou; Xu, Xiaoting; He, Hui; Zhu, Yuan; Lei, Tingwen; Ou, Hailong] Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang, Guizhou, Peoples R China	Guizhou Medical University	Ou, HL (corresponding author), Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang, Guizhou, Peoples R China.	ouhailong@gmc.edu.cn		Ou, Hailong/0000-0001-7298-1977	National Natural Science Foundation of China [81760088, 32060219]; Guizhou Provincial Natural Science Foundation [[2022] 038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Provincial Natural Science Foundation	Funding and additional information-This work was supported by the National Natural Science Foundation of China (grant nos.: 81760088 and 32060219; to H. O.) and Guizhou Provincial Natural Science Foundation (grant no.: [2022] 038; to H. O.) .	Assinger A, 2008, FEBS LETT, V582, P778, DOI 10.1016/j.febslet.2008.02.001; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Cheng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21808; Fairbank M, 2012, FEBS LETT, V586, P2488, DOI 10.1016/j.febslet.2012.06.011; Fredericks GJ, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010004; Fredericks GJ, 2014, P NATL ACAD SCI USA, V111, P16478, DOI 10.1073/pnas.1417176111; Ganesan R, 2018, J LEUKOCYTE BIOL, V103, P867, DOI 10.1002/JLB.2A1017-407RR; Gerbod-Giannone MC, 2019, BBA-GEN SUBJECTS, V1863, P830, DOI 10.1016/j.bbagen.2019.01.005; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hao JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18565-8; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Hurtado I, 1996, ATHEROSCLEROSIS, V125, P39, DOI 10.1016/0021-9150(96)05840-6; Ito F, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050362; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kresanov P, 2013, FREE RADICAL BIO MED, V65, P1284, DOI 10.1016/j.freeradbiomed.2013.09.023; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Li XP, 2000, INT J CARDIOL, V73, P231, DOI 10.1016/S0167-5273(00)00221-7; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lu Y, 2019, SCIENCE, V366, P460, DOI 10.1126/science.aau6391; Luiken JJFP, 2016, BBA-MOL BASIS DIS, V1862, P2253, DOI 10.1016/j.bbadis.2016.09.004; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nakajima T, 1995, BIOCHEM BIOPH RES CO, V217, P407, DOI 10.1006/bbrc.1995.2791; Nakajima T, 2000, ANN CLIN BIOCHEM, V37, P179, DOI 10.1258/0004563001899186; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Sawada N, 2020, J LIPID RES, V61, P816, DOI 10.1194/jlr.RA119000312; Shu HY, 2022, CARDIOVASC RES, V118, P115, DOI 10.1093/cvr/cvaa319; Soumyarani VS, 2014, J BIOCHEM MOL TOXIC, V28, P481, DOI 10.1002/jbt.21588; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Thorne RF, 2007, FEBS LETT, V581, P1227, DOI 10.1016/j.febslet.2007.02.043; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; van Oort MM, 2014, ARCH PHYSIOL BIOCHEM, V120, P40, DOI 10.3109/13813455.2013.876049; Wang J, 2019, CELL REP, V26, P209, DOI 10.1016/j.celrep.2018.12.022; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wu JX, 2015, ANTIOXID REDOX SIGN, V22, P308, DOI 10.1089/ars.2013.5743; Yang G, 2011, J NEUROSCI, V31, P11980, DOI 10.1523/JNEUROSCI.2510-11.2011; Zhang MA, 2010, DIABETES-METAB RES, V26, P455, DOI 10.1002/dmrr.1102; Zhao L, 2018, J HEPATOL, V69, P705, DOI 10.1016/j.jhep.2018.04.006	45	2	2	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102000	10.1016/j.jbc.2022.102000	http://dx.doi.org/10.1016/j.jbc.2022.102000			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35500650	gold, Green Published			2022-12-28	WOS:000807750700006
J	Grellet, E; L'Hote, I; Goulet, A; Imbert, I				Grellet, Emeline; L'Hote, India; Goulet, Adeline; Imbert, Isabelle			Replication of the coronavirus genome: A paradox among positive-strand RNA viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESPIRATORY SYNDROME-CORONAVIRUS; SARS-CORONAVIRUS; VIRAL-RNA; ENZYMATIC-ACTIVITIES; STRUCTURAL BASIS; POLYMERASE; PROTEIN; COMPLEX; EXORIBONUCLEASE; TRANSCRIPTION	Coronavirus (CoV) genomes consist of positive-sense singlestranded RNA and are among the largest viral RNAs known to date (similar to 30 kb). As a result, CoVs deploy sophisticated mechanisms to replicate these extraordinarily large genomes as well as to transcribe subgenomic messenger RNAs. Since 2003, with the emergence of three highly pathogenic CoVs (SARS-CoV, MERS-CoV, and SARS-CoV-2), significant progress has been made in the molecular characterization of the viral proteins and key mechanisms involved in CoV RNA genome replication. For example, to allow for the maintenance and integrity of their large RNA genomes, CoVs have acquired RNA proofreading 3050 exoribonuclease activity (in nonstructural protein nsp14). In order to replicate the large genome, the viral-RNA-dependent RNA polymerase (RdRp; in nsp12) is supplemented by a processivity factor (made of the viral complex nsp7/nsp8), making it the fastest known RdRp. Lastly, a viral structural protein, the nucleocapsid (N) protein, which is primarily involved in genome encapsidation, is required for efficient viral replication and transcription. Therefore, CoVs are a paradox among positive-strand RNA viruses in the sense that they use both a processivity factor and have proofreading activity reminiscent of DNA organisms in addition to structural proteins that mediate efficient RNA synthesis, commonly used by negative-strand RNA viruses. In this review, we present a historical perspective of these unsuspected discoveries and detail the current knowledge on the core replicative machinery deployed by CoVs.	[Grellet, Emeline; L'Hote, India; Goulet, Adeline; Imbert, Isabelle] Aix Marseille Univ, Ctr Natl Rech Sci, AMU CNRS UMR 7255, LISM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Imbert, I (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci, AMU CNRS UMR 7255, LISM, Marseille, France.	isabelle.imbert@univ-amu.fr	IMBERT, Isabelle/B-1247-2018	IMBERT, Isabelle/0000-0001-5630-9945; Goulet, Adeline/0000-0002-5971-9488				Adedeji AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036521; Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Al-Tawfiq JA, 2014, INT J INFECT DIS, V20, P42, DOI 10.1016/j.ijid.2013.12.003; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Becares M, 2016, J VIROL, V90, P5399, DOI 10.1128/JVI.03259-15; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Brockway SM, 2003, J VIROL, V77, P10515, DOI 10.1128/JVI.77.19.10515-10527.2003; Campagnola G, 2015, J VIROL, V89, P275, DOI 10.1128/JVI.01574-14; Case JB, 2018, J VIROL, V92, DOI 10.1128/JVI.01531-17; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Chen Y, 2013, J VIROL, V87, P6296, DOI 10.1128/JVI.00061-13; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Cheng A, 2005, VIROLOGY, V335, P165, DOI 10.1016/j.virol.2005.02.017; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cong YY, 2020, J VIROL, V94, DOI 10.1128/JVI.01925-19; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Decroly E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002059; Deming DJ, 2007, J VIROL, V81, P10280, DOI 10.1128/JVI.00017-07; Domingo E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008271; Domingo E, 2016, CURR TOP MICROBIOL, V392, P1, DOI 10.1007/82_2015_453; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; Fernandez-Leiro R, 2017, NAT STRUCT MOL BIOL, V24, P140, DOI 10.1038/nsmb.3348; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; Fiorini F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02793-6; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4847, DOI 10.1093/nar/17.12.4847; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Graham RL, 2012, NAT MED, V18, P1820, DOI 10.1038/nm.2972; Gribble J, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009226; Hackbart M, 2020, P NATL ACAD SCI USA, V117, P8094, DOI 10.1073/pnas.1921485117; Hao W, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006474; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hayn M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109126; Hertzig T, 2004, J GEN VIROL, V85, P1717, DOI 10.1099/vir.0.80044-0; Hillen HS, 2020, NATURE, V584, P154, DOI 10.1038/s41586-020-2368-8; Hsu JCC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101161118; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Jia ZH, 2019, NUCLEIC ACIDS RES, V47, P6538, DOI 10.1093/nar/gkz409; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kindler E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006195; Kindler E, 2014, CURR OPIN MICROBIOL, V20, P69, DOI 10.1016/j.mib.2014.05.005; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Konkolova E, 2020, J STRUCT BIOL, V211, DOI 10.1016/j.jsb.2020.107548; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; Krichel B, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1004; Lehmann KC, 2016, VIROLOGY, V487, P68, DOI 10.1016/j.virol.2015.10.002; Lehmann KC, 2015, NUCLEIC ACIDS RES, V43, P8416, DOI 10.1093/nar/gkv838; Lehmann KC, 2015, VIRUS RES, V202, P12, DOI 10.1016/j.virusres.2014.12.001; Li Y, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109391; Lin S, 2021, NUCLEIC ACIDS RES, V49, P5382, DOI 10.1093/nar/gkab320; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Ma YY, 2015, P NATL ACAD SCI USA, V112, P9436, DOI 10.1073/pnas.1508686112; MAKINO S, 1986, J VIROL, V57, P729, DOI 10.1128/JVI.57.3.729-737.1986; Malik YA, 2020, MALAYS J PATHOL, V42, P3; Malone B, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2102516118, 10.1101/2021.03.13.435256]; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; N. H. Moeller, 2021, bioRxiv, DOI 10.1101/2021.04.02.438274; Narayanan K, 2015, VIRUS RES, V202, P89, DOI 10.1016/j.virusres.2014.11.019; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Ogando NS, 2020, J VIROL, V94, DOI 10.1128/JVI.01246-20; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Peng Q, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100080; Peng Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107774; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Regoes RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2047; Saberi A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007314; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sexton NR, 2016, J VIROL, V90, P7415, DOI 10.1128/JVI.00080-16; Seybert A, 2005, J VIROL, V79, P696, DOI 10.1128/JVI.79.2.696-704.2005; Shannon A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18463-z; Siddell SG, 2019, ARCH VIROL, V164, P943, DOI 10.1007/s00705-018-04136-2; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Slanina H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022310118; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Stewart H, 2018, J VIROL, V92, DOI 10.1128/JVI.00589-18; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Sutton G, 2004, STRUCTURE, V12, P341, DOI 10.1016/j.str.2004.01.016; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tvarogova J, 2019, J VIROL, V93, DOI 10.1128/JVI.00291-19; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; van Marle G, 1999, J VIROL, V73, P5274, DOI 10.1128/JVI.73.7.5274-5281.1999; Velthuis AJWT, 2012, NUCLEIC ACIDS RES, V40, P1737, DOI 10.1093/nar/gkr893; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; Viehweger A, 2019, GENOME RES, V29, P1545, DOI 10.1101/gr.247064.118; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Wang Q, 2020, CELL, V182, P417, DOI 10.1016/j.cell.2020.05.034; Wolff G, 2020, SCIENCE, V369, P1395, DOI 10.1126/science.abd3629; Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Xiao YB, 2012, J VIROL, V86, P4444, DOI 10.1128/JVI.06635-11; Yan LM, 2021, CELL, V184, P3474, DOI 10.1016/j.cell.2021.05.033; Yan LM, 2021, CELL, V184, P184, DOI 10.1016/j.cell.2020.11.016; Yan LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19770-1; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Yang YL, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108161; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Zhang R, 2015, J VIROL, V89, P3598, DOI 10.1128/JVI.03535-14; Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	132	2	2	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101923	10.1016/j.jbc.2022.101923	http://dx.doi.org/10.1016/j.jbc.2022.101923			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35413290	Green Published, gold			2022-12-28	WOS:000817175700004
J	Lockey, C; Young, H; Brown, J; Dixon, AM				Lockey, Christine; Young, Hannah; Brown, Jessica; Dixon, Ann M.			Characterization of interactions within the Ig alpha/Ig beta transmembrane domains of the human B-cell receptor provides insights into receptor assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B29 CD79B GENE; ANTIGEN RECEPTOR; LIPID RAFTS; HELIX; IMMUNOGLOBULIN; ASSOCIATION; EXPRESSION; DIMERIZATION; RETENTION; MUTATIONS	The B-cell receptor (BCR), a complex comprised of a membrane-associated immunoglobulin and the Ig alpha/beta heterodimer, is one of the most important immune receptors in humans and controls B-cell development, activity, selection, and death. BCR signaling plays key roles in autoimmune diseases and lymphoproliferative disorders, yet, despite the clinical significance of this protein complex, key regions (i.e., the transmembrane domains) have yet to be structurally characterized. The mechanism for BCR signaling also remains unclear and has been variously described by the mutually exclusive cross-linking and dissociation activation models. Common to these models is the significance of local plasma membrane composition, which implies that interactions between BCR transmembrane domains (TMDs) play a role in receptor functionality. Here we used an in vivo assay of TMD oligomerization called GALLEX alongside spectroscopic and computational methods to characterize the structures and interactions of human Ig alpha and Ig beta TMDs in detergent micelles and natural membranes. We observed weak self-association of the Ig beta TMD and strong self-association of the Ig alpha TMD, which scanning mutagenesis revealed was entirely stabilized by an E-X-10-P motif. We also demonstrated strong heterotypic interactions between the Ig alpha and Ig beta TMDs both in vitro and in vivo, which scanning mutagenesis and computational models suggest is multiconfigurational but can accommodate distinct interaction sites for self-interactions and heterotypic interactions of the Ig alpha TMD. Taken together, these results demonstrate that the TMDs of the human BCR are sites of strong protein-protein interactions that may direct BCR assembly, endoplasmic reticulum retention, and immune signaling.	[Lockey, Christine; Young, Hannah; Brown, Jessica; Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry, W Midlands, England	University of Warwick	Dixon, AM (corresponding author), Univ Warwick, Dept Chem, Coventry, W Midlands, England.	ann.dixon@warwick.ac.uk	Dixon, Ann M/I-3696-2012	Dixon, Ann M/0000-0002-5261-304X; Lockey, Christine/0000-0001-6352-722X	Medical Research Council [MR/P022995/1]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in full by a grant from the Medical Research Council (MR/P022995/1) to AMD.	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Alfarano A, 1999, BLOOD, V93, P2327, DOI 10.1182/blood.V93.7.2327.407a08_2327_2335; Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Breeze E., 2016, P NATL ACAD SCI; BROUNS GS, 1995, INT IMMUNOL, V7, P359, DOI 10.1093/intimm/7.3.359; Busman-Sahay K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054938; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Dylke J, 2007, IMMUNOL LETT, V112, P47, DOI 10.1016/j.imlet.2007.06.005; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Friess MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02947; Gottwick C, 2019, P NATL ACAD SCI USA, V116, P13468, DOI 10.1073/pnas.1907481116; GRUPP SA, 1993, J BIOL CHEM, V268, P25776; He XC, 2018, EMBO J, V37, DOI 10.15252/embj.201797980; Indraccolo S, 2002, EUR J IMMUNOL, V32, P1530, DOI 10.1002/1521-4141(200206)32:6<1530::AID-IMMU1530>3.0.CO;2-#; Jang C, 2010, IMMUNOL LETT, V134, P75, DOI 10.1016/j.imlet.2010.09.001; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lockey C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62557-z; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Maity P. C., 2015, IMMUNOLOGY, V8, P1; Maslennikov I., 2010, PROC NATL ACAD SCI S; Matsuuchi L, 2001, CURR OPIN IMMUNOL, V13, P270, DOI 10.1016/S0952-7915(00)00215-6; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Nash A, 2015, BBA-BIOMEMBRANES, V1848, P1248, DOI 10.1016/j.bbamem.2015.02.020; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Sarkander J, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.81; Schamel WWA, 2000, MOL IMMUNOL, V37, P253, DOI 10.1016/S0161-5890(00)00025-0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Siegers GM, 2006, INT IMMUNOL, V18, P1385, DOI 10.1093/intimm/dxl072; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Thompson AA, 1999, LEUKEMIA LYMPHOMA, V32, P561, DOI 10.3109/10428199909058414; Thompson AA, 1997, BLOOD, V90, P1387, DOI 10.1182/blood.V90.4.1387.1387_1387_1394; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yang JY, 2016, CURR TOP MICROBIOL, V393, P27, DOI 10.1007/82_2015_482; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	55	0	0	10	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101843	10.1016/j.jbc.2022.101843	http://dx.doi.org/10.1016/j.jbc.2022.101843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35307351	Green Published, Green Accepted, gold			2022-12-28	WOS:000793483000001
J	Mabanglo, MF; Houry, WA				Mabanglo, Mark F.; Houry, Walid A.			Recent structural insights into the mechanism of ClpP protease regulation by AAA plus chaperones and small molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KILLS MYCOBACTERIUM-TUBERCULOSIS; ACYLDEPSIPEPTIDE ANALOGS; SUBSTRATE RECOGNITION; QUALITY-CONTROL; ATP; DEGRADATION; ADAPTER; TRANSLOCATION; SPECIFICITY; PROTEINS	ClpP is a highly conserved serine protease that is a critical enzyme in maintaining protein homeostasis and is an important drug target in pathogenic bacteria and various cancers. In its functional form, ClpP is a self-compartmentalizing protease composed of two stacked heptameric rings that allow protein degradation to occur within the catalytic chamber. ATPase chaperones such as ClpX and ClpA are hexameric ATPases that form larger complexes with ClpP and are responsible for the selection and unfolding of protein substrates prior to their degradation by ClpP. Although individual structures of ClpP and ATPase chaperones have offered mechanistic insights into their function and regulation, their structures together as a complex have only been recently determined to high resolution. Here, we discuss the cryoelectron microscopy structures of ClpP-ATPase complexes and describe findings previously inaccessible from individual Clp structures, including how a hexameric ATPase and a tetradecameric ClpP protease work together in a functional complex. We then discuss the consensus mechanism for substrate unfolding and translocation derived from these structures, consider alternative mechanisms, and present their strengths and limitations. Finally, new insights into the allosteric control of ClpP gained from studies using small molecules and gain or loss-of-function mutations are explored. Overall, this review aims to underscore the multilayered regulation of ClpP that may present novel ideas for structure-based drug design.	[Mabanglo, Mark F.; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Houry, Walid A.] Univ Toronto, Dept Chem, Toronto, ON, Canada	University of Toronto; University of Toronto	Houry, WA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Houry, WA (corresponding author), Univ Toronto, Dept Chem, Toronto, ON, Canada.	walid.houry@utoronto.ca			Precision Medicine Initiative (PRiME) fellowship at the University of Toronto [PRMF2019-007]; Canadian Institutes of Health Research Project [PJT-173345]; Canadian Cancer Society Innova-tion Grant [706282]	Precision Medicine Initiative (PRiME) fellowship at the University of Toronto; Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Innova-tion Grant	MFM was supported by the Precision Medicine Initiative (PRiME) fellowship at the University of Toronto (internal fellowship number PRMF2019-007) . This work was supported by the Canadian Institutes of Health Research Project grant (PJT-173345) and Canadian Cancer Society Innova-tion Grant (grant #706282) to W. A. H.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Alexopoulos JA, 2012, J STRUCT BIOL, V179, P202, DOI 10.1016/j.jsb.2012.05.003; Alhuwaider AAH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00049; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Benaroudj N., 2011, BMC BIOCH, V12, P61; Bhandari V, 2018, ACS CHEM BIOL, V13, P1413, DOI 10.1021/acschembio.8b00124; Binepal G, 2020, ACS INFECT DIS, V6, P3224, DOI 10.1021/acsinfecdis.0c00599; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Brotz-Oesterhelt H, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.690902; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Brown Gandt A., 2018, ANTIMICROB AGENTS CH, V62, P1221; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Carney DW, 2014, J AM CHEM SOC, V136, P1922, DOI 10.1021/ja410385c; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Choules MP, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02204-18, 10.1128/AAC.02204-18]; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Cormio A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126228; Dahmen M, 2015, ANGEW CHEM INT EDIT, V54, P3598, DOI 10.1002/anie.201409325; Diaz-Saez L, 2017, PROTEINS, V85, P188, DOI 10.1002/prot.25197; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Dougan D. A., 2013, REGULATED PROTEOLYSI; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Effantin G, 2010, STRUCTURE, V18, P553, DOI 10.1016/j.str.2010.02.016; Famulla K, 2016, MOL MICROBIOL, V101, P194, DOI 10.1111/mmi.13362; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Fei X, 2020, ELIFE, V9, DOI 10.7554/eLife.61496; Fei X, 2020, ELIFE, V9, DOI 10.7554/eLife.52774; Felix J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw3818; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gates SN, 2020, PROTEIN SCI, V29, P407, DOI 10.1002/pro.3743; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Gersch M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7320; Gersch M, 2014, J AM CHEM SOC, V136, P1360, DOI 10.1021/ja4082793; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goodreid JD, 2016, J MED CHEM, V59, P624, DOI 10.1021/acs.jmedchem.5b01451; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Hackl MW, 2015, J AM CHEM SOC, V137, P8475, DOI 10.1021/jacs.5b03084; Hammerling BC, 2014, J MOL CELL CARDIOL, V75, P122, DOI 10.1016/j.yjmcc.2014.07.013; Illigmann A, 2021, MICROB PHYSIOL, V31, P260, DOI 10.1159/000517718; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Iosefson O, 2015, CELL REP, V12, P1032, DOI 10.1016/j.celrep.2015.07.007; Iosefson O, 2015, NAT CHEM BIOL, V11, P201, DOI 10.1038/nchembio.1732; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Ishizawa J, 2019, CANCER CELL, V35, P721, DOI 10.1016/j.ccell.2019.03.014; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Ju Y, 2021, DRUG DISCOV TODAY, V26, P2190, DOI 10.1016/j.drudis.2021.05.014; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Kim S, 2020, ELIFE, V9, DOI 10.7554/eLife.61451; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Knuppertz L, 2017, AGING CELL, V16, P704, DOI 10.1111/acel.12600; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Lee S, 2019, CELL REP, V26, P29, DOI 10.1016/j.celrep.2018.12.037; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Leung E, 2011, CHEM BIOL, V18, P1167, DOI 10.1016/j.chembiol.2011.07.023; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Li M, 2016, J BIOL CHEM, V291, P7465, DOI 10.1074/jbc.M115.700344; Liu KY, 2014, CRIT REV BIOCHEM MOL, V49, P400, DOI 10.3109/10409238.2014.925421; Lopez KE, 2020, NAT STRUCT MOL BIOL, V27, P406, DOI 10.1038/s41594-020-0409-5; Lowth BR, 2012, J STRUCT BIOL, V179, P193, DOI 10.1016/j.jsb.2012.06.001; Luo J, 2020, PEERJ, V8, DOI 10.7717/peerj.8754; Lytvynenko I, 2019, CELL, V178, P76, DOI 10.1016/j.cell.2019.05.002; Mabanglo MF, 2022, CURR OPIN CHEM BIOL, V66, DOI 10.1016/j.cbpa.2021.07.003; Mabanglo MF, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0656-3; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Majumder P, 2019, P NATL ACAD SCI USA, V116, P534, DOI 10.1073/pnas.1817752116; Malik IT, 2017, NAT PROD REP, V34, P815, DOI 10.1039/c6np00125d; Malik IT, 2020, CHEMBIOCHEM, V21, P1997, DOI 10.1002/cbic.201900787; MARTIN A, 2005, GFF, V437, P1115, DOI DOI 10.1038/NATURE04031; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Maurer M, 2019, CELL CHEM BIOL, V26, P1169, DOI 10.1016/j.chembiol.2019.05.008; Moreno-Cinos C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092232; Ni TF, 2016, ACS CHEM BIOL, V11, P1964, DOI 10.1021/acschembio.6b00390; Nishimura K, 2015, BBA-BIOENERGETICS, V1847, P915, DOI 10.1016/j.bbabio.2014.11.012; Nouri K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03062-z; Olivares A. O., 2017, P NATL ACAD SCI USA, V114, pE6306; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Pan S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50505-5; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ripstein ZA, 2020, J AM CHEM SOC, V142, P20519, DOI 10.1021/jacs.0c09474; Ripstein ZA, 2020, ELIFE, V9, DOI 10.7554/eLife.52158; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rizzolo K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20553-x; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Rondelli CM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100972; Sabath N, 2020, P NATL ACAD SCI USA, V117, P31902, DOI 10.1073/pnas.2018138117; San Martin A, 2017, P NATL ACAD SCI USA, V114, P9864, DOI 10.1073/pnas.1705916114; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Saunders RA, 2020, P NATL ACAD SCI USA, V117, P28005, DOI 10.1073/pnas.2010804117; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, P NATL ACAD SCI USA, V111, pE4587, DOI 10.1073/pnas.1417120111; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Shin M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23495-0; Shorter J, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00085; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Sivertsson E. M., 2019, SCI REP, V9, P2421; Sowole MA, 2013, J MOL BIOL, V425, P4508, DOI 10.1016/j.jmb.2013.08.005; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; Timms RT, 2020, BIOCHEM SOC T, V48, P1557, DOI 10.1042/BST20191094; Tsai FTF, 2020, ELIFE, V9, DOI 10.7554/eLife.56501; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Uchihashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04587-w; Vahidi S., 2018, P NATL ACAD SCI USA, V115, pE6447; Vahidi S, 2020, P NATL ACAD SCI USA, V117, P5895, DOI 10.1073/pnas.1921630117; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Vasudevan D, 2013, J BIOL CHEM, V288, P30883, DOI 10.1074/jbc.M113.493767; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; Voos W, 2016, ESSAYS BIOCHEM, V60, P213, DOI 10.1042/EBC20160009; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Whitman JC, 2018, HEMATOL TRANSF CELL, V40, P182, DOI 10.1016/j.htct.2018.03.001; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Wolf NM, 2019, ACS INFECT DIS, V5, P829, DOI 10.1021/acsinfecdis.8b00276; Wong KS, 2018, CELL CHEM BIOL, V25, P1017, DOI 10.1016/j.chembiol.2018.05.014; Yien Y. Y., 2017, P NATL ACAD SCI USA, V114, pE8045; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zeiler E, 2013, P NATL ACAD SCI USA, V110, P11302, DOI 10.1073/pnas.1219125110	145	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101781	10.1016/j.jbc.2022.101781	http://dx.doi.org/10.1016/j.jbc.2022.101781			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35245501	Green Published, gold			2022-12-28	WOS:000793483000011
J	Rosenberg, GM; Murray, KA; Salwinski, L; Hughes, MP; Abskharon, R; Eisenberg, DS				Rosenberg, Gregory M.; Murray, Kevin A.; Salwinski, Lukasz; Hughes, Michael P.; Abskharon, Romany; Eisenberg, David S.			Bioinformatic identification of previously unrecognized amyloidogenic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-SEPARATION; BETA-SHEET; COMPLEXITY; MUTATIONS; DOMAINS; RICH	Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intrinsically disordered and function in selfassociation. The question therefore arises whether a search for pathogenic mutations in LCDs of the human proteome can lead to identification of other proteins associated with amyloid disease. Here, we take a computational approach to identify documented pathogenic mutations within LCDs that may favor amyloid formation. Using this approach, we identify numerous known amyloidogenic mutations, including several such mutations within proteins previously unidentified as amyloidogenic. Among the latter group, we focus on two mutations within the TRK-fused gene protein (TFG), known to play roles in protein secretion and innate immunity, which are associated with two different peripheral neuropathies. We show that both mutations increase the propensity of TFG to form amyloid fibrils. We therefore conclude that TFG is a novel amyloid protein and propose that the diseases associated with its mutant forms may be amyloidoses.	[Rosenberg, Gregory M.; Murray, Kevin A.; Salwinski, Lukasz; Hughes, Michael P.; Abskharon, Romany; Eisenberg, David S.] UCLA, Mol Biol Inst, Dept Chem & Biochem, DOE Inst, Los Angeles, CA 90095 USA; [Hughes, Michael P.] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN USA; [Rosenberg, Gregory M.; Murray, Kevin A.; Salwinski, Lukasz; Hughes, Michael P.; Abskharon, Romany; Eisenberg, David S.] UCLA, Mol Biol Inst, Dept Biol Chem, DOE Inst, Los Angeles, CA 90095 USA; [Rosenberg, Gregory M.; Murray, Kevin A.; Salwinski, Lukasz; Hughes, Michael P.; Abskharon, Romany; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; St Jude Children's Research Hospital; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Eisenberg, DS (corresponding author), UCLA, Mol Biol Inst, Dept Chem & Biochem, DOE Inst, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), UCLA, Mol Biol Inst, Dept Biol Chem, DOE Inst, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), UCLA, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Hughes, Michael/0000-0002-6239-4151; Salwinski, Lukasz/0000-0003-4522-1969	National Institutes of Health (NIH) National Center for Advancing Translational Sci-ence University of California Los Angeles Clinical and Translational Science Institute [UL1TR001881]; NIH [R01GM123126, 2R01AG048120, R01AG07895]	National Institutes of Health (NIH) National Center for Advancing Translational Sci-ence University of California Los Angeles Clinical and Translational Science Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgments-We thank Myra Rosenberg for aesthetic help with figures. This research was supported by the National Institutes of Health (NIH) National Center for Advancing Translational Sci-ence University of California Los Angeles Clinical and Translational Science Institute (grant number: UL1TR001881) and NIH (grant numbers: R01GM123126, 2R01AG048120, and R01AG07895) .	Amberger JS, 2019, NUCLEIC ACIDS RES, V47, pD1038, DOI 10.1093/nar/gky1151; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Brumshtein B, 2018, J BIOL CHEM, V293, P19659, DOI 10.1074/jbc.RA118.004142; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Franzmann TM, 2019, J BIOL CHEM, V294, P7128, DOI 10.1074/jbc.TM118.001190; Gobl C, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101316; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Ishiura H, 2012, AM J HUM GENET, V91, P320, DOI 10.1016/j.ajhg.2012.07.014; Johnson A, 2015, EMBO J, V34, P811, DOI 10.15252/embj.201489032; Kato M, 2022, RNA, V28, P3, DOI 10.1261/rna.078990.121; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedia N, 2019, P NATL ACAD SCI USA, V116, P16835, DOI 10.1073/pnas.1908263116; Keith JL, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000394; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Li Y, 2013, PROTEINS, V81, P1862, DOI 10.1002/prot.24338; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Murray DT, 2018, P NATL ACAD SCI USA, V115, pE9782, DOI 10.1073/pnas.1806174115; Murray K. A., NAT STRUCT MOL BIOL; Murray KA, 2022, ACS NANO, V16, P2154, DOI 10.1021/acsnano.1c08043; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Nolan M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0358-8; Nomura T, 2014, J BIOL CHEM, V289, P1192, DOI 10.1074/jbc.M113.516492; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Robinson DO, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037598; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Sawaya MR, 2021, CELL, V184, P4857, DOI 10.1016/j.cell.2021.08.013; Scharner J, 2011, HUM MUTAT, V32, P152, DOI 10.1002/humu.21361; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Seidler PM, 2019, J BIOL CHEM, V294, P16451, DOI 10.1074/jbc.RA119.009688; Sysoev VO, 2020, P NATL ACAD SCI USA, V117, P23510, DOI 10.1073/pnas.2010000117; Tsai PC, 2014, NEUROLOGY, V83, P903, DOI 10.1212/WNL.0000000000000758; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zhou XM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022121118	45	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101920	10.1016/j.jbc.2022.101920	http://dx.doi.org/10.1016/j.jbc.2022.101920			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35405097	Green Published, gold			2022-12-28	WOS:000804923000007
J	Agashe, P; Kuzminov, A				Agashe, Pooja; Kuzminov, Andrei			Nitric oxide precipitates catastrophic chromosome fragmentation by bolstering both hydrogen peroxide and Fe(II) Fenton reactants in E. coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; ESCHERICHIA-COLI; REACTIVE OXYGEN; FREE-IRON; PHAGOCYTE OXIDASE; SINGLE MACROPHAGE; REAL-TIME; CATALASE; FERRITIN; FUR	Immune cells kill invading microbes by producing reactive oxygen and nitrogen species, primarily hydrogen peroxide (H2O2) and nitric oxide (NO). We previously found that NO inhibits catalases in Escherichia coli, stabilizing H2O2 around treated cells and promoting catastrophic chromosome fragmentation via continuous Fenton reactions generating hydroxyl radicals. Indeed, H2O2-alone treatment kills catalasedeficient (katEG) mutants similar to H2O2+NO treatment. However, the Fenton reaction, in addition to H2O2 , requires Fe(II), which H2O2 excess instantly converts into Fenton-inert Fe(III). For continuous Fenton when H2O2 is stable, a supply of reduced iron becomes necessary. We show here that this supply is ensured by Fe(II) recruitment from ferritins and Fe(III) reduction by flavin reductase. Our observations also concur with NO-mediated respiration inhibition that drives Fe(III) reduction. We modeled this NO-mediated inhibition via inactivation of ndh and nuo respiratory enzymes responsible for the step of NADH oxidation, which results in increased NADH pools driving flavin reduction. We found that, like the katEG mutant, the ndh nuo double mutant is similarly sensitive to H2O2-alone and H2O2+NO treatments. Moreover, the quadruple katEG ndh nuo mutant lacking both catalases and efficient respiration was rapidly killed by H2O2-alone, but this killing was delayed by NO, rather than potentiated by it. Taken together, we conclude that NO boosts the levels of both H2O2 and Fe(II) Fenton reactants, making continuous hydroxyl radical production feasible and resulting in irreparable oxidative damage to the chromosome.	[Agashe, Pooja; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kuzminov, A (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.	kuzminov@illinois.edu			NIH [GM132484]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH grant GM132484. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Adolfsen KJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00081-19; Agashe P, 2021, GENETICS, V218, DOI 10.1093/genetics/iyab057; Amatore C, 2006, CHEMBIOCHEM, V7, P653, DOI 10.1002/cbic.200500359; Amatore C, 2008, CHEMBIOCHEM, V9, P1472, DOI 10.1002/cbic.200700746; Amatore C, 2010, ANAL CHEM, V82, P1411, DOI 10.1021/ac902486x; ANANTHASWAMY HN, 1977, J BACTERIOL, V130, P187, DOI 10.1128/JB.130.1.187-191.1977; ANDERSEN KB, 1977, J BIOL CHEM, V252, P4151; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822; Beckman J. S., 1996, AM J PHYSIOL, V271, pC1424; BERGLIN EH, 1985, INFECT IMMUN, V49, P538, DOI 10.1128/IAI.49.3.538-543.1985; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bradley JM, 2020, J BIOL CHEM, V295, P17602, DOI 10.1074/jbc.REV120.007746; BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x; Brunelli L, 2001, FREE RADICAL BIO MED, V30, P709, DOI 10.1016/S0891-5849(00)00512-8; Clark D, 2000, MOL PLANT MICROBE IN, V13, P1380, DOI 10.1094/MPMI.2000.13.12.1380; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; DEMPLE B, 1983, J BACTERIOL, V153, P1079, DOI 10.1128/JB.153.2.1079-1082.1983; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Figueiredo MCO, 2012, ANAEROBE, V18, P454, DOI 10.1016/j.anaerobe.2012.06.001; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Hoerter JD, 2005, J PHOTOCH PHOTOBIO B, V79, P151, DOI 10.1016/j.jphotobiol.2005.01.003; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; Hurst RD, 2003, SENSORS-BASEL, V3, P321, DOI 10.3390/s30800321; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jacques J. F., 2006, ESCHERICHIA COLI MOL, V62, P1181; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Khan SR, 2013, ANAL BIOCHEM, V443, P269, DOI 10.1016/j.ab.2013.06.001; KLEBANOFF SJ, 1993, FREE RADICAL BIO MED, V14, P351, DOI 10.1016/0891-5849(93)90084-8; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; LOEWEN PC, 1985, ARCH BIOCHEM BIOPHYS, V243, P144, DOI 10.1016/0003-9861(85)90782-9; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; Mahaseth T, 2017, MUTAT RES-REV MUTAT, V773, P274, DOI 10.1016/j.mrrev.2016.08.006; Mahaseth T, 2016, DNA REPAIR, V41, P42, DOI 10.1016/j.dnarep.2016.03.012; Mahaseth T, 2015, MOL MICROBIOL, V96, P349, DOI 10.1111/mmi.12938; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Miller J. H, 1972, EXPT MOL GENETICS; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Ouameur AA, 2005, DNA CELL BIOL, V24, P394, DOI 10.1089/dna.2005.24.394; PACELLI R, 1995, J EXP MED, V182, P1469, DOI 10.1084/jem.182.5.1469; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Prolo C, 2014, BIOFACTORS, V40, P215, DOI 10.1002/biof.1150; PRUSS BM, 1994, J BACTERIOL, V176, P2143; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Purwar N, 2011, BIOCHEMISTRY-US, V50, P4491, DOI 10.1021/bi200130r; REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T; REIF DW, 1990, ARCH BIOCHEM BIOPHYS, V283, P537, DOI 10.1016/0003-9861(90)90680-W; Satoh J, 2019, J GEN APPL MICROBIOL, V65, P308, DOI 10.2323/jgam.2019.03.001; SCHELLHORN HE, 1995, FEMS MICROBIOL LETT, V131, P113, DOI 10.1111/j.1574-6968.1995.tb07764.x; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Sen A, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00235-20; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; SIRIVECH S, 1974, BIOCHEM J, V143, P311, DOI 10.1042/bj1430311; Sivaloganathan DM, 2020, METHODS MOL BIOL, V2088, P161, DOI 10.1007/978-1-0716-0159-4_8; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Woodmansee AN, 2003, MOL MICROBIOL, V49, P11, DOI 10.1046/j.1365-2958.2003.03530.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Zhang XW, 2019, ANGEW CHEM INT EDIT, V58, P7753, DOI 10.1002/anie.201902734; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhou YJ, 2011, APPL ENVIRON MICROB, V77, P6133, DOI 10.1128/AEM.00630-11; ZHU L, 1992, ARCH BIOCHEM BIOPHYS, V298, P452, DOI 10.1016/0003-9861(92)90434-X	88	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101825	10.1016/j.jbc.2022.101825	http://dx.doi.org/10.1016/j.jbc.2022.101825			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35288189	Green Published, gold			2022-12-28	WOS:000793617400008
J	Li, Q; Zhong, XF; Yao, WC; Yu, JL; Wang, C; Li, ZY; Lai, SQ; Qu, FL; Fu, XY; Huang, XJ; Zhang, DW; Liu, YJ; Li, HY				Li, Qian; Zhong, Xiaofang; Yao, Weicheng; Yu, Junli; Wang, Chao; Li, Zongyan; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Zhang, Dawei; Liu, Yujie; Li, Haiyan			Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; BREAST-CANCER; CELLS; B7-H3; EXPRESSION; PROLIFERATION; ACTIVATION; TARGETS; GROWTH	Despite the enormous successes of anti-PD-1/PD-L1 immunotherapy in multiple other cancer types, the overall response rates of breast cancer remain suboptimal. Therefore, exploring additional immune checkpoint molecules for potential cancer treatment is crucial. B7H3, a T-cell coinhibitory molecule, is specifically overexpressed in breast cancer compared with normal breast tissue and benign lesions, making it an attractive therapeutic target. However, the mechanism by which B7H3 contributes to the cancer phenotype is unclear. Here we show that the expression of B7H3 is negatively related to the number of CD8+ T cells in breast tumor sites. In addition, analysis of the differentially expressed B7H3 reveals that it is inversely correlated to autophagic flux both in breast cancer cell lines and clinical tumor tissues. Furthermore, block of autophagy by bafilomycin A1 (Baf A1) increases B7H3 levels and attenuates CD8(+) T cell activation, while promotion of autophagy by V9302, a small-molecule inhibitor of glutamine metabolism, decreases B7H3 expression and enhances granzyme B (GzB) production of CD8(+) T cells via regulation of reactive oxygen species (ROS) accumulation. We demonstrate that combined treatment with V9302 and anti-PD-1 monoclonal antibody (mAb) enhances antitumor immunity in syngeneic mouse models. Collectively, our findings unveil the beneficial effect of V9302 in boosting antitumor immune response in breast cancer and illustrate that anti-PD-1 together with V9302 treatment may provide synergistic effects in the treatment of patients insensitive to anti-PD-1 therapy.	[Li, Qian; Zhong, Xiaofang; Yu, Junli; Wang, Chao; Li, Zongyan; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Zhang, Dawei; Li, Haiyan] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Peoples R China; [Li, Qian; Zhong, Xiaofang; Yu, Junli; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Li, Haiyan] Sun Yat Sen Univ, Dept Breast Surg, Affiliated Hosp 6, Guangzhou, Peoples R China; [Yao, Weicheng; Liu, Yujie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China; [Wang, Chao] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China; [Li, Zongyan; Zhang, Dawei] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hepatobiliary Surg, Guangzhou, Peoples R China; [Liu, Yujie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, DW; Li, HY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Peoples R China.; Li, HY (corresponding author), Sun Yat Sen Univ, Dept Breast Surg, Affiliated Hosp 6, Guangzhou, Peoples R China.; Liu, YJ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China.	zhangdaweiwinner@163.com; liuyujie554@163.com; lihy27@mail.sysu.edu.cn		li, zong yan/0000-0002-8196-7269	Guangdong Science and Technology Department [2020A1515010425, 2019A1515010146]; Guangzhou Science and Technology Project [805275295029]; National Natural Science Foundation of China [81672622]; Dongguan Science and Technology of Social Development Program [20211800904582]	Guangdong Science and Technology Department; Guangzhou Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dongguan Science and Technology of Social Development Program	We thank Dr Jianjian Wu for assistance with sample staining. We thank all the patients who agreed to participate in the trial. This work was supported by grants from Guangdong Science and Technology Department (2020A1515010425, 2019A1515010146), Guangzhou Science and Technology Project (805275295029), and National Natural Science Foundation of China (81672622), Dongguan Science and Technology of Social Development Program (20211800904582).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Andrews LP, 2019, NAT IMMUNOL, V20, P1425, DOI 10.1038/s41590-019-0512-0; Bachawal SV, 2015, CANCER RES, V75, P2501, DOI 10.1158/0008-5472.CAN-14-3361; Bernhardt S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0905-7; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Byun JK, 2020, MOL CELL, V80, P592, DOI 10.1016/j.molcel.2020.10.015; Cai D., 2020, CELL MOL IMMUNOL, V17; Chen G, 2020, BIOCHEM BIOPH RES CO, V531, P282, DOI 10.1016/j.bbrc.2020.06.154; Clarke R, 2021, CANCER DRUG RESIST, V4, P762, DOI 10.20517/cdr.2021.33; Denkert C., 2015, TUMOR; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; Edwards DN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140100; El-Ansari R, 2019, BREAST CANCER RES TR, V175, P27, DOI 10.1007/s10549-018-05111-w; Emens LA, 2021, JNCI-J NATL CANCER I, V113, P1005, DOI 10.1093/jnci/djab004; Emens LA, 2019, JAMA ONCOL, V5, P74, DOI 10.1001/jamaoncol.2018.4224; Ewens A, 2005, ANTICANCER RES, V25, P3905; Flem-Karlsen K, 2018, TRENDS CANCER, V4, P401, DOI 10.1016/j.trecan.2018.03.010; Ganesan B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67101-7; Hegde S, 2021, IMMUNITY, V54, P875, DOI 10.1016/j.immuni.2021.04.004; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kim K., 2014, P NATL ACAD SCI USA; Le Naour A, 2020, CANCER MED-US, V9, P8074, DOI 10.1002/cam4.3295; Lee YH, 2017, CELL RES, V27, P1034, DOI 10.1038/cr.2017.90; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu J, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-020-01024-8; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Loi S., 2014, TUMOR INFILTRATING; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Ma GF, 2020, MOL CANCER RES, V18, P324, DOI 10.1158/1541-7786.MCR-19-0517; Mehazri L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073387; Munoz-Rojas AR, 2021, NAT REV IMMUNOL, V21, P597, DOI 10.1038/s41577-021-00519-w; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nanda R., 2016, J CLIN ONCOL, V34; Oh MH, 2020, J CLIN INVEST, V130, P3865, DOI 10.1172/JCI131859; Qin S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1091-2; Ren W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.222; Rugo HS, 2018, CLIN CANCER RES, V24, P2804, DOI 10.1158/1078-0432.CCR-17-3452; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schmid P, 2020, NEW ENGL J MED, V382, P810, DOI 10.1056/NEJMoa1910549; Schmid P, 2020, LANCET ONCOL, V21, P44, DOI 10.1016/S1470-2045(19)30689-8; Schulte M., 2018, NAT MED; Seaman S, 2017, CANCER CELL, V31, P501, DOI 10.1016/j.ccell.2017.03.005; Sharma NS, 2020, J CLIN INVEST, V130, P451, DOI 10.1172/JCI127515; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Signorelli S, 2019, TRENDS PLANT SCI, V24, P413, DOI 10.1016/j.tplants.2019.02.001; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Tan HWS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00369-y; Wang Cheng, 2021, Cell Stem Cell, V28, P1597, DOI 10.1016/j.stem.2021.04.011; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Yang S, 2020, INT J BIOL SCI, V16, P1767, DOI 10.7150/ijbs.41105; Yang WH, 2021, TRENDS CANCER, V7, P790, DOI 10.1016/j.trecan.2021.04.003; Yonesaka K., 2018, CLIN CANC RES 24; Zhang H, 2021, PATHOL RES PRACT, V224, DOI 10.1016/j.prp.2021.153525; Zhou FF, 2021, BIOMATERIALS, V265, DOI 10.1016/j.biomaterials.2020.120421; Zhou J, 2022, AUTOPHAGY, V18, P1240, DOI 10.1080/15548627.2021.1984656; Zhu XW, 2019, BIOCHEM BIOPH RES CO, V508, P1067, DOI 10.1016/j.bbrc.2018.12.055	62	7	8	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101753	10.1016/j.jbc.2022.101753	http://dx.doi.org/10.1016/j.jbc.2022.101753			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35189139	gold, Green Published			2022-12-28	WOS:000793692600005
J	Puangmalai, N; Sengupta, U; Bhatt, N; Gaikwad, S; Montalbano, M; Bhuyan, A; Garcia, S; McAllen, S; Sonawane, M; Jerez, C; Zhao, YX; Kayed, R				Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Bhuyan, Arijit; Garcia, Stephanie; McAllen, Salome; Sonawane, Minal; Jerez, Cynthia; Zhao, Yingxin; Kayed, Rakez			<p>Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer's disease & nbsp;</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; A-BETA; DISEASE; PROTEIN; AUTOPHAGY; STRESS; NEURONS; NEURODEGENERATION; IDENTIFICATION	Ubiquitin-modified tau aggregates are abundantly found in human brains diagnosed with Alzheimer's disease (AD) and other tauopathies. Soluble tau oligomers (TauO) are the most neurotoxic tau species that propagate pathology and elicit cognitive deficits, but whether ubiquitination contributes to tau formation and spreading is not fully understood. Here, we observed that K63-linked, but not K48-linked, ubiquitinated TauO accumulated at higher levels in AD brains compared with age-matched controls. Using mass spectrometry analyses, we identified 11 ubiquitinated sites on AD brain-derived TauO (AD TauO). We found that K63-linked TauO are associated with enhanced seeding activity and propagation in human tau expressing primary neuronal and tau biosensor cells. Additionally, exposure of tau-inducible HEK cells to AD TauO with different ubiquitin linkages (wild type, K48, and K63) resulted in enhanced formation and secretion of K63-linked TauO, which was associated with impaired proteasome and lysosome functions. Multipathway analysis also revealed the involvement of K63-linked TauO in cell survival pathways, which are impaired in AD. Collectively, our study highlights the significance of selective TauO ubiquitination, which could influence tau aggregation, accumulation, and subsequent pathological propagation. The insights gained from this study hold great promise for targeted therapeutic intervention in AD and related tauopathies.& nbsp;	[Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Puangmalai, Nicha; Sengupta, Urmi; Bhatt, Nemil; Gaikwad, Sagar; Montalbano, Mauro; Sonawane, Minal; Jerez, Cynthia; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Bhuyan, Arijit] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Garcia, Stephanie] Univ Texas Hlth Sci Ctr, Sch Dent, Houston, TX USA; [McAllen, Salome] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Zhao, Yingxin] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kayed, R (corresponding author), Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	rakayed@utmb.edu	GAIKWAD, SAGAR/AAO-6607-2021	GAIKWAD, SAGAR/0000-0003-2040-1357; Bhuyan, Arijit/0000-0002-6774-4456	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institute of Health [R01AG054025, R01NS094557, RFA1AG055771, R01AG060718]; American Heart Association [17CSA33620007];  [T32 AG058522]	Mitchell Center for Neurodegenerative Diseases; Gillson Longenbaugh Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); 	Funding and additional information-This research work was supported by Mitchell Center for Neurodegenerative Diseases, the Gillson Longenbaugh Foundation and National Institute of Health grants: R01AG054025, R01NS094557, RFA1AG055771, R01AG060718, and the American Heart Association collaborative grant 17CSA33620007 (R. K.); U.S. supported by T32 AG058522.	Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013; Abreha MH, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800108; Abskharon R, 2020, J BIOL CHEM, V295, P10662, DOI 10.1074/jbc.RA120.013638; Albert M., 2019, Prevention of tau seeding and propagation by immunotherapy with a central tau; Alquezar C, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.595532; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Chen XH, 2018, MED SCI MONITOR, V24, P5035, DOI 10.12659/MSM.907809; Chen X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0354-0; Chen XQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00659; Chu DD, 2019, ACS CHEM NEUROSCI, V10, P931, DOI 10.1021/acschemneuro.8b00457; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66; De La-Rocque S, 2021, J NEUROCHEM, V156, P563, DOI 10.1111/jnc.15144; Dujardin S, 2020, NAT MED, V26, P1256, DOI 10.1038/s41591-020-0938-9; Farmer KM, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01012-6; Ferreon JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051360; Galasko D, 1997, NEUROLOGY, V48, P632, DOI 10.1212/WNL.48.3.632; Galves M, 2019, TRENDS BIOCHEM SCI, V44, P872, DOI 10.1016/j.tibs.2019.04.007; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Harris LD, 2020, ADV EXP MED BIOL, V1233, P195, DOI 10.1007/978-3-030-38266-7_8; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Holmes BB, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024026; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Horie K., 2020, BRAIN, V144, P515, DOI [DOI 10.1093/brain/awaa373, 10.1093/brain/awaa373]; Ihara Y., 2012, Cold Spring Harb Perspect. Med., V2; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Kontaxi C, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00056; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Lasagna-Reeves C. A., 2011, J BIOL CHEMCURR NEUR, V20, P158; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Liu J, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00203; Lo Cascio F, 2020, J BIOL CHEM, V295, P14807, DOI 10.1074/jbc.RA120.014630; Maher P., 2014, BIOPROTOC, V4, P1028; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Martinisi Alfonso, 2021, Brain, V144, P963, DOI 10.1093/brain/awaa445; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nilson AN, 2017, J ALZHEIMERS DIS, V55, P1083, DOI 10.3233/JAD-160912; Paine S, 2009, NEUROSCI LETT, V460, P205, DOI 10.1016/j.neulet.2009.05.074; Petrucelli L., 2004, Hum; Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9; Puangmalai N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2503-3; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Roberts M, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0884-2; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shaw L. M., 2009, Cerebrospinal fluid biomarker signature in Alzheimer; Siddiqui WA, 2015, ARCH TOXICOL, V89, P289, DOI 10.1007/s00204-014-1448-7; Silva MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16984-1; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trzeciakiewicz H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44102; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Wegmann S, 2021, CURR OPIN NEUROBIOL, V69, P131, DOI 10.1016/j.conb.2021.03.003; Wu XL, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02399-2; Wu YL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00114; Xu J., 2019, Commun; Yadikar H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205213; Zhang PF, 2014, CELL SIGNAL, V26, P556, DOI 10.1016/j.cellsig.2013.11.026; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao YX, 2013, METHODS, V61, P313, DOI 10.1016/j.ymeth.2013.02.001; Zheng J, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00896-8; Zhou L., 2017, Tau association with synaptic vesicles	90	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101766	10.1016/j.jbc.2022.101766	http://dx.doi.org/10.1016/j.jbc.2022.101766			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202653	Green Published, gold			2022-12-28	WOS:000793502000006
J	Fuchsbauer, O; Silva, IL; Cascales, E; Roussel, A; Leone, P				Fuchsbauer, Olivier; Silva, Ignacio Lunar; Cascales, Eric; Roussel, Alain; Leone, Philippe			Structural and functional analyses of the Porphyromonas gingivalis type IX secretion system PorN protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIDING MOTILITY; PERIODONTAL-DISEASE; SIGNAL; GENERATION; COMPONENT; PHYLUM; GENES	Porphyromonas gingivalis, the major human pathogen bacterium associated with periodontal diseases, secretes virulence factors through the Bacteroidetes-specific type IX secretion system (T9SS). Effector proteins of the T9SS are recognized by the complex via their conserved C-terminal domains (CTDs). Among the 18 proteins essential for T9SS function in P. gingivalis, PorN is a periplasmic protein that forms large ring-shaped structures in association with the PorK outer membrane lipoprotein. PorN also mediates contacts with the PorM subunit of the PorLM energetic module, and with the effector's CTD. However, no information is available on the PorN structure and on the implication of PorN domains for T9SS assembly and effector recognition. Here we present the crystal structure of PorN at 2.0-angstrom resolution, which represents a novel fold with no significant similarity to any known structure. In agreement with in silico analyses, we also found that the N- and C-terminal regions of PorN are intrinsically disordered. Our functional studies showed that the N-terminal disordered region is involved in PorN dimerization while the C-terminal disordered region is involved in the interaction with PorK. Finally, we determined that the folded PorN central domain is involved in the interaction with PorM, as well as with the effector's CTD. Altogether, these results lay the foundations for a more comprehensive model of T9SS architecture and effector transport.	[Fuchsbauer, Olivier; Roussel, Alain; Leone, Philippe] Aix Marseille Univ, Architecture & Fonct Macromol Biol, Marseille, France; [Fuchsbauer, Olivier; Roussel, Alain; Leone, Philippe] CNRS, Architecture & Fonct Macromol Biol, UMR 7257, Marseille, France; [Silva, Ignacio Lunar; Cascales, Eric] Aix Marseille Univ, CNRS, Inst Microbiol Bioenergies & Biotechnol, Lab Ingn Syst Macromol,UMR7255, Marseille 20, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Leone, P (corresponding author), Aix Marseille Univ, Architecture & Fonct Macromol Biol, Marseille, France.; Leone, P (corresponding author), CNRS, Architecture & Fonct Macromol Biol, UMR 7257, Marseille, France.	pilippe.leone@univ-amu.fr			Centre National de la Recherche Scientifique; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-15-CE11-0019, ANR-20-CE11-0011]; Excellence Initiative of Aix-Marseille Universite, a French "Investissements d'Avenir" programme [A*MIDEX AAP-ID-17-33]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); Excellence Initiative of Aix-Marseille Universite, a French "Investissements d'Avenir" programme(French National Research Agency (ANR))	This work was funded by the Centre National de la Recherche Scientifique, the Aix-Marseille Universite, and grants from the Agence Nationale de la Recherche (ANR-15-CE11-0019 [to E. C.] and ANR-20-CE11-0011 [to P. L.]) and from the Excellence Initiative of Aix-Marseille Universite, a French "Investissements d'Avenir" programme (A*MIDEX AAP-ID-17-33) to E. C. The PhD thesis of I. L. S. has been funded by the ANR-15-CE11-0019 grant.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Eriksson K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050630; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garcia RI, 2001, PERIODONTOL 2000, V25, P21, DOI 10.1034/j.1600-0757.2001.22250103.x; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Gorasia D., 2020, STRUCTURE ORG TYPE 9, DOI [10.1101/2020.05.13.094771, DOI 10.1101/2020.05.13.094771]; Gorasia DG, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081173; Gorasia DG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005820; Gorasia DG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005152; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; James RH, 2021, NAT MICROBIOL, V6, P221, DOI 10.1038/s41564-020-00823-6; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Lartigue A, 2003, ACTA CRYSTALLOGR D, V59, P919, DOI 10.1107/S090744490300413X; Lasica AM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00215; Leone P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02784-7; Madej M, 2021, MBIO, V12, DOI 10.1128/mBio.02262-20; McBride MJ, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0002-2018; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Montgomery AB, 2016, ANN RHEUM DIS, V75, P1255, DOI 10.1136/annrheumdis-2015-207656; Nelson SS, 2008, J BACTERIOL, V190, P2851, DOI 10.1128/JB.01904-07; Olsen I, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1487742; Perricone C, 2019, CURR OPIN RHEUMATOL, V31, P517, DOI 10.1097/BOR.0000000000000638; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sato K, 2020, BIOCHEM BIOPH RES CO, V532, P114, DOI 10.1016/j.bbrc.2020.08.018; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Shrivastava A, 2015, CURR BIOL, V25, P338, DOI 10.1016/j.cub.2014.11.045; Silva IL, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166836; Singhrao SK, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/137357; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Veith PD, 2017, MOL MICROBIOL, V106, P35, DOI 10.1111/mmi.13752; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Vincent M. S., 2018, BIORXIV, DOI [10.1101/483123, DOI 10.1101/483123]; Vincent MS, 2017, J BIOL CHEM, V292, P3252, DOI 10.1074/jbc.M116.765081; Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	54	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101618	10.1016/j.jbc.2022.101618	http://dx.doi.org/10.1016/j.jbc.2022.101618			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35065963	Green Published, gold			2022-12-28	WOS:000821051800001
J	Kar, S; Sen, S; Maji, S; Saraf, D; Ruturaj; Paul, R; Dutt, S; Mondal, B; Rodriguez-Boulan, E; Schreiner, R; Sengupta, D; Gupta, A				Kar, Sumanta; Sen, Samarpita; Maji, Saptarshi; Saraf, Deepashri; Ruturaj; Paul, Rupam; Dutt, Sohini; Mondal, Basudeb; Rodriguez-Boulan, Enrique; Schreiner, Ryan; Sengupta, Durba; Gupta, Arnab			Copper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ENDOCYTOSIS; MOLECULAR-DYNAMICS; CU-BINDING; N-TERMINUS; HUMAN CTR1; MODEL; PROTEIN; CELLS; HCTR1; IDENTIFICATION	Copper(I) is an essential metal for all life forms. Though Cu(II) is the most abundant and stable state, its reduction to Cu(I) via an unclear mechanism is prerequisite for its bioutilization. In eukaryotes, the copper transporter-1(CTR1) is the primary high-affinity copper importer, although its mechanism and role in Cu(II) reduction remain uncharacterized. Here we show that extracellular amino-terminus of human CTR1 contains two methionine-histidine clusters and neighboring aspartates that distinctly bind Cu(I) and Cu(II) preceding its import. We determined that hCTR1 localizes at the basolateral membrane of polarized MDCK-II cells and that its endocytosis to Common-Recycling-Endosomes is regulated by reduction of Cu(II) to Cu(I) and subsequent Cu(I) coordination by the methionine cluster. We demonstrate the transient binding of both Cu(II) and Cu(I) during the reduction process is facilitated by aspartates that also act as another crucial determinant of hCTR1 endocytosis. Mutating the first Methionine cluster ((7)Met-Gly-Met(9)) and Asp(13)( )abrogated copper uptake and endocytosis upon copper treatment. This phenotype could be reverted by treating the cells with reduced and nonreoxidizable Cu(I). We show that histidine clusters, on other hand, bind Cu(II) and are crucial for hCTR1 functioning at limiting copper. Finally, we show that two N-terminal His-Met-Asp clusters exhibit functional complementarity, as the second cluster is sufficient to preserve copper-induced CTR1 endocytosis upon complete deletion of the first cluster. We propose a novel and detailed mechanism by which the two His-Met-Asp residues of hCTR1 amino-terminus not only bind copper, but also maintain its reduced state, crucial for intracellular uptake.	[Kar, Sumanta; Sen, Samarpita; Maji, Saptarshi; Ruturaj; Paul, Rupam; Dutt, Sohini; Gupta, Arnab] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, W Bengal, India; [Saraf, Deepashri; Sengupta, Durba] CSIR, Natl Chem Lab, Phys & Mat Chem Div, Pune, Maharashtra, India; [Mondal, Basudeb] Indian Inst Sci Educ & Res Kolkata, Dept Chem Sci, Mohanpur, W Bengal, India; [Rodriguez-Boulan, Enrique; Schreiner, Ryan] Weill Cornell Med, Margaret Dyson Vis Res Inst, Dept Ophthalmol, New York, NY USA; [Dutt, Sohini] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Indian Institute of Science Education & Research (IISER) - Kolkata; Cornell University; University System of Maryland; University of Maryland College Park	Gupta, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, W Bengal, India.; Sengupta, D (corresponding author), CSIR, Natl Chem Lab, Phys & Mat Chem Div, Pune, Maharashtra, India.	d.sengupta@ncl.res.in; arnab.gupta@iiserkol.ac.in	Saraf, Deepashri/GYR-3455-2022; Mondal, Basudeb/GLN-3201-2022	Mondal, Basudeb/0000-0002-6676-9846; Paul, Rupam/0000-0001-5859-7952; Kar, Sumanta/0000-0002-3368-8986; MAJI, SAPTARSHI/0000-0002-8198-2426; Schreiner, Ryan/0000-0002-7457-6606	DBT-Wellcome Trust India Alliance Fellowship [IA/I/16/1/502369]; Early Career Research Award from SERB, Department of Science and Technology (DST), Government of India [ECR/2015/000220]; IISER-K; Council of Scientific and Industrial Research (CSIR), India; Intramural Institute funding (IISER-K); KVPY fellowships from the Government of India	DBT-Wellcome Trust India Alliance Fellowship; Early Career Research Award from SERB, Department of Science and Technology (DST), Government of India; IISER-K; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Intramural Institute funding (IISER-K); KVPY fellowships from the Government of India	This work is supported by DBT-Wellcome Trust India Alliance Fellowship (IA/I/16/1/502369), Early Career Research Award (ECR/2015/000220) from SERB, Department of Science and Technology (DST), Government of India, and IISER-K intramural funding to A. G. S. K., R. P., S. M., B. M. are supported by a predoctoral fellowship from Council of Scientific and Industrial Research (CSIR), India. The predoctoral fellowship for Ruturaj is supported by Intramural Institute funding (IISER-K). S. S. is supported by KVPY fellowships from the Government of India.	Abada Paolo, 2010, Metal-Based Drugs, P317581, DOI 10.1155/2010/317581; Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Arredondo M, 2003, AM J PHYSIOL-CELL PH, V284, pC1525, DOI 10.1152/ajpcell.00480.2002; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bay AEP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11550; Bay AEP, 2013, EMBO J, V32, P2125, DOI 10.1038/emboj.2013.130; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertinato J, 2015, ENCY FOOD HLTH, P321; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Broyden C. G., 1973, Journal of the Institute of Mathematics and Its Applications, V12, P223; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Chowdhury R, 2021, CHEM-ASIAN J, V16, P1634, DOI 10.1002/asia.202100268; Clifford RJ, 2016, J CELL SCI, V129, P1711, DOI 10.1242/jcs.173351; Curnock R, 2020, J CELL SCI, V133, DOI 10.1242/jcs.249201; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Galler T, 2020, CHEM COMMUN, V56, P12194, DOI 10.1039/d0cc04693k; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; Gonzalez P, 2018, CHEM-EUR J, V24, P8029, DOI 10.1002/chem.201705398; Gravotta D, 2019, MOL BIOL CELL, V30, P1716, DOI 10.1091/mbc.E18-12-0811; GUNDERSEN D, 1993, J CELL BIOL, V121, P335, DOI 10.1083/jcb.121.2.335; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kirsipuu T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62560-4; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Larson CA, 2010, BIOCHEM PHARMACOL, V80, P448, DOI 10.1016/j.bcp.2010.04.030; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Liang ZD, 2014, J BIOL INORG CHEM, V19, P17, DOI 10.1007/s00775-013-1051-z; Liao QH, 2015, J PHYS CHEM LETT, V6, P2657, DOI 10.1021/acs.jpclett.5b01122; LINDER MC, 1991, BIOCH COPPER, P1; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Magistrato A, 2019, CURR OPIN STRUC BIOL, V58, P26, DOI 10.1016/j.sbi.2019.05.002; Mandal T, 2020, J MEMBRANE BIOL, V253, P459, DOI 10.1007/s00232-020-00139-w; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Perdew JP, 1999, PHYS REV LETT, V82, P2544, DOI 10.1103/PhysRevLett.82.2544; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Pushie MJ, 2015, INORG CHEM, V54, P8544, DOI 10.1021/acs.inorgchem.5b01162; Ren F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09376-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Schwab S, 2016, J INORG BIOCHEM, V158, P70, DOI 10.1016/j.jinorgbio.2015.12.021; Shenberger Y, 2015, J PHYS CHEM B, V119, P4824, DOI 10.1021/acs.jpcb.5b00091; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soll SJ, 2010, P NATL ACAD SCI USA, V107, P19496, DOI 10.1073/pnas.1012344107; Song IS, 2004, MOL CANCER THER, V3, P1543; Stefaniak E, 2018, METALLOMICS, V10, P1723, DOI 10.1039/c8mt00274f; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Vetterling W.T., 1988, NUMERICAL RECIPES C; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wezynfeld NE, 2019, INORG CHEM, V58, P7488, DOI 10.1021/acs.inorgchem.9b00711; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yang Y, 2019, CHEM COMMUN, V55, P11107, DOI 10.1039/c9cc04859f; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	90	1	1	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101631	10.1016/j.jbc.2022.101631	http://dx.doi.org/10.1016/j.jbc.2022.101631			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35090891	Green Published, gold			2022-12-28	WOS:000821051800013
J	Ma, LL; Lu, HY; Tian, ZZ; Yang, MT; Ma, J; Shang, GH; Liu, YL; Xie, MJ; Wang, GG; Wu, W; Zhang, ZD; Dai, SD; Chen, ZZ				Ma, Lulu; Lu, Hongyun; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Dai, Shaodong; Chen, Zhongzhou			Structural insights into the interactions and epigenetic functions of human nucleic acid repair protein ALKBH6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; RNA DEMETHYLASE; MUTATIONAL LANDSCAPE; CANCER PROGRESSION; DNA; METHYLATION; DAMAGE; EXPRESSION; SUBSTRATE; BACTERIAL	Human AlkB homolog 6, ALKBH6, plays key roles in nucleic acid damage repair and tumor therapy. However, no precise structural and functional information are available for this protein. In this study, we determined atomic resolution crystal structures of human holo-ALKBH6 and its complex with ligands. AlkB members bind nucleic acids by NRLs (nucleotide recognition lids, also called Flips), which can recognize DNA/ RNA and flip methylated lesions. We found that ALKBH6 has unusual Flip1 and Flip2 domains, distinct from other AlkB family members both in sequence and conformation. Moreover, we show that its unique Flip3 domain has multiple unreported functions, such as discriminating against double stranded nucleic acids, blocking the active center, binding other proteins, and in suppressing tumor growth. Structural analyses and substrate screening reveal how ALKBH6 discriminates between different types of nucleic acids and may also function as a nucleic acid demethylase. Structure-based interacting partner screening not only uncovered an unidentified interaction of transcription repressor ZMYND11 and ALKBH6 in tumor suppression but also revealed cross talk between histone modification and nucleic acid modification in epigenetic regulation. Taken together, these results shed light on the molecular mechanism underlying ALKBH6-associated nucleic acid damage repair and tumor therapy.	[Ma, Lulu; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Ma, Lulu; Tian, Zizi; Yang, Meiting; Ma, Jun; Shang, Guohui; Liu, Yunlong; Xie, Mengjia; Wang, Guoguo; Wu, Wei; Zhang, Ziding; Chen, Zhongzhou] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, Beijing, Peoples R China; [Lu, Hongyun] Beijing Technol & Business Univ, Sch Food & Hlth, Beijing, Peoples R China; [Dai, Shaodong] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	China Agricultural University; China Agricultural University; Beijing Technology & Business University; University of Colorado System; University of Colorado Anschutz Medical Campus	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Chen, ZZ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, Beijing, Peoples R China.	chenzhongzhou@cau.edu.cn			National Key Research and Development Program of China [2018YFE0113100]; National Natural Science Foundation of China [31872713, 32071210]; Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant [2022SKLAB6-1]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant	We would like to thank the staff of beamlines BL17U1, BL19U1, and BL19U2 at the Shanghai Synchrotron Radiation Facility for the excellent technical assistance. This work was supported by National Key Research and Development Program of China (2018YFE0113100) , National Natural Science Foundation of China (31872713 and 32071210) , and Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant (2022SKLAB6-1) . Funding for open access charge: National Key Research and Development Program of China (2018YFE0113100) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cha S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2209-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZJ, 2019, NUCLEIC ACIDS RES, V47, P2533, DOI 10.1093/nar/gky1250; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hayward N. K., 2017, NATURE; Herceg Z., 2018, ROADMAP INVESTIGATIN; Hu JZ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00500; Huong TT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186707; Janin M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01192-8; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin TC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40991; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Lee JK, 2017, NAT GENET, V49, P594, DOI 10.1038/ng.3806; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Liu CX, 2014, INT J CLIN EXP PATHO, V7, P690; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu Zhe, 2018, Oncotarget, V9, P27412, DOI 10.18632/oncotarget.25287; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; McMillan EA, 2018, CELL, V173, P864, DOI 10.1016/j.cell.2018.03.028; Mimaki S., 2016, IN PRESS; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Mishina Y, 2004, NUCLEIC ACIDS RES, V32, P1548, DOI 10.1093/nar/gkh319; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nayar U, 2019, NAT GENET, V51, P207, DOI 10.1038/s41588-018-0287-5; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perry GS, 2021, J MED CHEM, V64, P16974, DOI 10.1021/acs.jmedchem.1c01694; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pilzys T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49550-x; Rabbie R, 2021, BRIT J CANCER, V124, P156, DOI 10.1038/s41416-020-01090-2; Ruan DY, 2021, ONCOGENE, V40, P5168, DOI 10.1038/s41388-021-01916-0; Seidlitz T, 2019, GUT, V68, P207, DOI 10.1136/gutjnl-2017-314549; South A. P., 2014, NOTCH1; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Tian LF, 2020, CELL RES, V30, P272, DOI 10.1038/s41422-019-0233-9; Tian ZZ, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0150-6; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Vinayanuwattikun C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31628; Voegele N., [No title captured]; Wang GQ, 2014, J BIOL CHEM, V289, P27924, DOI 10.1074/jbc.M114.590505; Wang JY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01450-1; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xiao MZ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110645; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xu BF, 2021, CELL MOL LIFE SCI, V78, P129, DOI 10.1007/s00018-020-03594-9; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yoshikawa Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.554570; Zhang LS, 2021, NAT CELL BIOL, V23, P684, DOI 10.1038/s41556-021-00709-7; Zhang M, 2020, CELL RES, V30, P197, DOI 10.1038/s41422-019-0237-5; Zhao SY, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.635808; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zou SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6696	76	0	0	10	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101671	10.1016/j.jbc.2022.101671	http://dx.doi.org/10.1016/j.jbc.2022.101671			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120926	gold, Green Published			2022-12-28	WOS:000791230900009
J	Mbah, NE; Lyssiotis, CA				Mbah, Nneka E.; Lyssiotis, Costas A.			Metabolic regulation of ferroptosis in the tumor microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-DEATH; LIPID-PEROXIDATION; CANCER-CELLS; PROMOTES FERROPTOSIS; MOLECULAR-PATTERNS; OXIDATIVE STRESS; OXIDIZED LIPIDS; HIPPO PATHWAY; MECHANISMS; IDENTIFICATION	Ferroptosis is an iron-dependent, nonapoptotic form of regulated cell death triggered by impaired redox and antioxidant machinery and propagated by the accumulation of toxic lipid peroxides. A compendium of experimental studies suggests that ferroptosis is tumor-suppressive. Sensitivity or resistance to ferroptosis can be regulated by cell-autonomous and non-cell-autonomous metabolic mechanisms. This includes a role for ferroptosis that extends beyond the tumor cells themselves, mediated by components of the tumor microenvironment, including T cells and other immune cells. Herein, we review the intrinsic and extrinsic factors that promote the sensitivity of cancer cells to ferroptosis and conclude by describing approaches to harness the full utility of ferroptotic agents as therapeutic options for cancer therapy.	[Mbah, Nneka E.; Lyssiotis, Costas A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lyssiotis, Costas A.] Univ Michigan, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lyssiotis, Costas A.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lyssiotis, CA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI 48109 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	dyssiot@med.umich.edu	Lyssiotis, Costas A/AAI-1923-2019	Lyssiotis, Costas A/0000-0001-9309-6141	NIH/NCI [R37CA237421, R01CA248160, R01CA244931]; Michael Mosier Defeat DIPG Foundation; ChadTough Foundation	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michael Mosier Defeat DIPG Foundation; ChadTough Foundation	C. A. L. is supported by grants from the NIH/NCI (R37CA237421, R01CA248160, R01CA244931). N. E. M. was supported by grants from the Michael Mosier Defeat DIPG Foundation and ChadTough Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboelella NS, 2021, CANCERS, V13, DOI 10.3390/cancers13050986; Albaugh VL, 2017, J SURG ONCOL, V115, P273, DOI 10.1002/jso.24490; Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Angeli JPF, 2019, NAT REV CANCER, V19, P405, DOI 10.1038/s41568-019-0149-1; Arensman MD, 2019, P NATL ACAD SCI USA, V116, P9533, DOI 10.1073/pnas.1814932116; Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872; Bai T, 2019, J CELL MOL MED, V23, P7349, DOI 10.1111/jcmm.14594; BANNAI S, 1980, J BIOL CHEM, V255, P2372; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Canli O, 2017, CANCER CELL, V32, P869, DOI 10.1016/j.ccell.2017.11.004; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Chen GQ, 2020, CELL DEATH DIFFER, V27, P242, DOI 10.1038/s41418-019-0352-3; Chen X, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.637162; Cheng Q, 2021, J OBSTET GYNAECOL RE, V47, P2481, DOI 10.1111/jog.14779; Conlon M, 2021, NAT CHEM BIOL, V17, P665, DOI 10.1038/s41589-021-00751-4; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; Daher B, 2019, CANCER RES, V79, P3877, DOI 10.1158/0008-5472.CAN-18-3855; Dai EY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20154-8; Dai EY, 2020, AUTOPHAGY, V16, P2069, DOI 10.1080/15548627.2020.1714209; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Du J, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03996-y; Efimova I, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001369; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Fan ZW, 2017, LIGHT-SCI APPL, V6, DOI 10.1038/lsa.2017.4; Feng H, 2020, CELL REP, V30, P3411, DOI 10.1016/j.celrep.2020.02.049; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gaschler MM, 2018, NAT CHEM BIOL, V14, P507, DOI 10.1038/s41589-018-0031-6; Gaschler MM, 2018, ACS CHEM BIOL, V13, P1013, DOI 10.1021/acschembio.8b00199; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo JP, 2018, CANCER RES TREAT, V50, P445, DOI 10.4143/crt.2016.572; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hassannia B, 2018, J CLIN INVEST, V128, P3341, DOI 10.1172/JCI99032; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Hernandez C, 2016, ONCOGENE, V35, P5931, DOI 10.1038/onc.2016.104; Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366; Hsiao C, 2016, BIOTECHNOL J, V11, P662, DOI 10.1002/biot.201500374; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kerins MJ, 2018, ANTIOXID REDOX SIGN, V29, P1756, DOI 10.1089/ars.2017.7176; Kim EH, 2018, CANCER LETT, V432, P180, DOI 10.1016/j.canlet.2018.06.018; Kim MJ, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020083; Kim SH, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00067; Koppula P, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0288-x; Kremer DM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24859-2; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kshattry S, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0088-z; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Lang XT, 2019, CANCER DISCOV, V9, P1673, DOI 10.1158/2159-8290.CD-19-0338; Lee H, 2020, MOL CELL ONCOL, V7, DOI 10.1080/23723556.2020.1761242; Lee H, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0461-8; Lei G, 2021, ONCOGENE, V40, P3533, DOI 10.1038/s41388-021-01790-w; Lei G, 2020, CELL RES, V30, P146, DOI 10.1038/s41422-019-0263-3; Leu JIJ, 2019, P NATL ACAD SCI USA, V116, P8390, DOI 10.1073/pnas.1821277116; Liu Y, 2021, CANCER GENE THER, V28, P55, DOI 10.1038/s41417-020-0182-y; Louandre C, 2015, CANCER LETT, V356, P971, DOI 10.1016/j.canlet.2014.11.014; Luo X, 2021, CELL DEATH DIFFER, V28, P1971, DOI 10.1038/s41418-020-00719-2; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Ma XZ, 2021, CELL METAB, V33, P1001, DOI 10.1016/j.cmet.2021.02.015; Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002; Magtanong L, 2019, CELL CHEM BIOL, V26, P420, DOI 10.1016/j.chembiol.2018.11.016; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mao C, 2021, NATURE, V593, P586, DOI 10.1038/s41586-021-03539-7; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; McCullagh EA, 2014, BEHAV BRAIN RES, V265, P1, DOI 10.1016/j.bbr.2014.02.010; Miess H, 2018, ONCOGENE, V37, P5435, DOI 10.1038/s41388-018-0315-z; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Nagane M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195151; Otsuki Y, 2020, CANCER SCI, V111, P127, DOI 10.1111/cas.14224; Perez MA, 2020, DEV CELL, V54, P447, DOI 10.1016/j.devcel.2020.06.019; Perillo B, 2020, EXP MOL MED, V52, P192, DOI 10.1038/s12276-020-0384-2; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roh JL, 2017, REDOX BIOL, V11, P254, DOI 10.1016/j.redox.2016.12.010; Roh JL, 2016, CANCER LETT, V381, P96, DOI 10.1016/j.canlet.2016.07.035; Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sharbeen G, 2021, CANCER RES, V81, P3461, DOI 10.1158/0008-5472.CAN-20-2496; Shi X, 2016, J LIPID RES, V57, P265, DOI 10.1194/jlr.M064808; Shibata Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225931; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Song XX, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108767; Soula M, 2020, NAT CHEM BIOL, V16, P1351, DOI 10.1038/s41589-020-0613-y; Srinivasan B, 2015, NAT CHEM BIOL, V11, P784, DOI [10.1038/nchembio.1906, 10.1038/NCHEMBIO.1906]; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sui SY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1564-7; Sullivan MR, 2019, ELIFE, V8, DOI 10.7554/eLife.44235; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Takahashi N, 2020, MOL CELL, V80, DOI 10.1016/j.molcel.2020.10.010; Tang R, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00946-7; To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032; Tousignant KD, 2020, CANCER METAB, V8, DOI 10.1186/s40170-020-00217-6; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ubellacker JM, 2020, NATURE, V585, P113, DOI 10.1038/s41586-020-2623-z; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Voorde JV, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7314; Wang H, 2020, EUR J CELL BIOL, V99, DOI 10.1016/j.ejcb.2019.151058; Wang K, 2021, CELL DEATH DIFFER, V28, P1222, DOI 10.1038/s41418-020-00644-4; Wang K, 2019, DRUG DES DEV THER, V13, P2135, DOI 10.2147/DDDT.S199459; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Wen QR, 2019, BIOCHEM BIOPH RES CO, V510, P278, DOI 10.1016/j.bbrc.2019.01.090; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Wu SJ, 2019, CANCER MED-US, V8, P2252, DOI 10.1002/cam4.2101; Wu WL, 2020, MOL CELL, V80, P760, DOI 10.1016/j.molcel.2020.11.022; Wu YN, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.571127; Xu SA, 2021, IMMUNITY, V54, P1561, DOI 10.1016/j.immuni.2021.05.003; Yan HF, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00428-9; Yang JJ, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-02012-7; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Ye LF, 2020, ACS CHEM BIOL, V15, P469, DOI 10.1021/acschembio.9b00939; Yee PP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19193-y; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang Y, 2019, CELL CHEM BIOL, V26, P623, DOI 10.1016/j.chembiol.2019.01.008; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao YB, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108487; Zhou JY, 2019, J CELL MOL MED, V23, P4854, DOI 10.1111/jcmm.14356; Zou YL, 2020, NATURE, V585, P603, DOI 10.1038/s41586-020-2732-8	142	9	9	10	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101617	10.1016/j.jbc.2022.101617	http://dx.doi.org/10.1016/j.jbc.2022.101617			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065965	Green Published, gold			2022-12-28	WOS:000789396300008
J	Minogue, PJ; Tong, JJ; Wichmann, K; Mysliwiec, H; Ebihara, L; Beyer, EC; Berthoud, VM				Minogue, Peter J.; Tong, Jun-Jie; Wichmann, Kelly; Mysliwiec, Hubert; Ebihara, Lisa; Beyer, Eric C.; Berthoud, Viviana M.			Cataract-linked serine mutations in the gap junction protein connexin50 expose a sorting signal that promotes its lysosomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT; PHOSPHORYLATION; MICROPHTHALMIA; MEMBRANE; CHANNELS; GROWTH; LEADS	Many human connexin50 (Cx50) mutants have been linked to cataracts including two carboxyl terminus serine mutants that are known phosphorylation sites in the lens (Cx50S258F and Cx50S259Y). To examine the behavior of these mutants and the role of phosphorylation at these positions, we stably transfected HeLa cells with cataract-linked and phosphorylation-mimicking (Cx50S258D and Cx50S259D) Cx50 mutants. We observed that gap junctional plaques were rarely detected in Cx50S258Fexpressing and Cx50S259Y-expressing cells compared with wild-type cells. In contrast, gap junction abundance and size were greatly increased for Cx50S258D and Cx50S259D mutants. Cx50S258F and Cx50S259Y supported very low levels of gap junctional coupling, whereas Cx50S258D and Cx50S259D supported extensive intercellular communication. Furthermore, Cx50 levels as detected by immunoblotting were lower in Cx50S258F and Cx50S259Y mutants than in the wild-type or the aspartate substitution mutants, and chloroquine or ammonium chloride treatment significantly increased Cx50S258F and Cx50S259Y protein levels, implying participation of the lysosome in their increased degradation. Alanine substitution of amino acids within a predicted tyrosine-based sorting signal in Cx50S258F and Cx50S259Y increased levels of gap junctional plaques and intercellular transfer of neurobiotin. These results suggest that the absence of phosphorylatable serines at these positions exposes a sorting signal leading to lysosomal degradation of Cx50, whereas phosphorylation at these sites conceals this signal and allows targeting of Cx50 to the plasma membrane and stabilization of gap junction plaques. We propose that in the lens, degradation of Cx50S258F and Cx50S259Y decreases Cx50 levels at the plasma membrane and consequently Cx50 function, leading to cataracts.	[Minogue, Peter J.; Wichmann, Kelly; Mysliwiec, Hubert; Beyer, Eric C.; Berthoud, Viviana M.] Univ Chicago, Dept Pediat, Chicago, IL USA; [Tong, Jun-Jie; Ebihara, Lisa] Rosalind Franklin Univ Med & Sci, Ctr Prote & Mol Therapeut, N Chicago, IL USA; [Ebihara, Lisa] Rosalind Franklin Univ Med & Sci, Discipline Physiol & Biophys, N Chicago, IL USA	University of Chicago; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL USA.	vberthou@peds.bsd.uchicago.edu		Beyer, Eric/0000-0001-8044-1356; Mysliwiec, Hubert/0000-0002-1294-1014; Ebihara, Lisa/0000-0002-1989-0686	National Institutes of Health [R01-EY030914, R01-EY026902]; Ted Mullins Fund for Cancer Research; University of Chicago	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Mullins Fund for Cancer Research; University of Chicago(University of Chicago)	This work was supported by the National Institutes of Health grants (R01-EY030914 [to E. C. B. and V. M. B.] and R01-EY026902 [to L. E.] ) . K. W. was supported by the Ted Mullins Fund for Cancer Research. H. M. was supported by a Jeff Metcalf Fellowship from the University of Chicago. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldo GJ, 2001, J GEN PHYSIOL, V118, P447, DOI 10.1085/jgp.118.5.447; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Berthoud VM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165822; Berthoud VM, 2019, INVEST OPHTH VIS SCI, V60, P2336, DOI 10.1167/iovs.18-26459; Berthoud VM, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0116-6; Berthoud VM, 2016, J BIOL CHEM, V291, P17569, DOI 10.1074/jbc.M115.707950; Berthoud VM, 2013, INVEST OPHTH VIS SCI, V54, P7614, DOI 10.1167/iovs.13-13188; Berthoud VM, 2003, EUR J CELL BIOL, V82, P209, DOI 10.1078/0171-9335-00316; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen JH, 2014, EYE, V28, P1511, DOI 10.1038/eye.2014.158; Delmar M, 2012, CURR OPIN CARDIOL, V27, P236, DOI 10.1097/HCO.0b013e328352220e; EBIHARA L, 1992, METHOD ENZYMOL, V207, P376; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; Ehrlich A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115734; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Fong JT, 2013, MOL BIOL CELL, V24, P2834, DOI 10.1091/mbc.E13-02-0111; Gao XB, 2010, CURR EYE RES, V35, P597, DOI 10.3109/02713681003725831; Gu SM, 2019, INVEST OPHTH VIS SCI, V60, P4021, DOI 10.1167/iovs.18-26270; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liu YY, 2015, J GENET, V94, P221; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Minogue PJ, 2019, MOL VIS, V25, P535; Minogue PJ, 2013, J BIOL CHEM, V288, P20427, DOI 10.1074/jbc.M113.452847; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Myers JB, 2018, NATURE, V564, P372, DOI 10.1038/s41586-018-0786-7; Rong P, 2002, DEVELOPMENT, V129, P167; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shearer D, 2008, INVEST OPHTH VIS SCI, V49, P1553, DOI 10.1167/iovs.07-1193; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Wang Z, 2013, INVEST OPHTH VIS SCI, V54, P1135, DOI 10.1167/iovs.12-11168; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Xu XR, 1999, INVEST OPHTH VIS SCI, V40, P1844	42	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101673	10.1016/j.jbc.2022.101673	http://dx.doi.org/10.1016/j.jbc.2022.101673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120923	gold, Green Published			2022-12-28	WOS:000791230900007
J	Yakobov, N; Mahmoudi, N; Grob, G; Yokokawa, D; Saga, Y; Kushiro, T; Worrell, D; Roy, H; Schaller, H; Senger, B; Huck, L; Gascon, GR; Becker, HD; Fischer, F				Yakobov, Nathaniel; Mahmoudi, Nassira; Grob, Guillaume; Yokokawa, Daisuke; Saga, Yusuke; Kushiro, Tetsuo; Worrell, Danielle; Roy, Herve; Schaller, Hubert; Senger, Bruno; Huck, Laurence; Gascon, Gisela Riera; Becker, Hubert D.; Fischer, Frederic			RNA-dependent synthesis of ergosteryl-3 beta-O-glycine in Ascomycota expands the diversity of steryl-amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE FUSION; FUNCTIONAL-ANALYSIS; PEPTIDE RESISTANCE; CHOLESTEROL; SYNTHETASES; PHOSPHATIDYLGLYCEROL; BIOSYNTHESIS; GLYCOSIDES; ERGOSTEROL; GLUCOSIDE	A wide range of bacteria possess virulence factors such as aminoacyl-tRNA transferases (ATTs) that are capable of rerouting aminoacyl-transfer RNAs away from protein synthesis to conjugate amino acids onto glycerolipids. We recently showed that, although these pathways were thought to be restricted to bacteria, higher fungi also possess ergosteryl-3 beta-O-L-aspartate synthases (ErdSs), which transfer the L-Asp moiety of aspartyl-tRNA(Asp) onto the 3 beta-OH group of ergosterol (Erg), yielding ergosteryl-3 beta-O-L-aspartate (Erg-Asp). Here, we report the discovery, in fungi, of a second type of fungal sterol-specific ATTs, namely, ergosteryl-3 beta-O-glycine (Erg-Gly) synthase (ErgS). ErgS consists of a freestanding DUF2156 domain encoded by a gene distinct from and paralogous to that of ErdS. We show that the enzyme only uses GlytRNA(Gly) produced by an independent glycyl-tRNA synthetase (GlyRS) to transfer glycine onto the 3 beta-OH of Erg, producing Erg-Gly. Phylogenomics analysis also show that the Erg-Gly synthesis pathway exists only in Ascomycota, including species of biotechnological interest, and more importantly, in human pathogens, such as Aspergillus fumigatus. The discovery of a second type of Erg-aa not only expands the repertoire of this particular class of fungal lipids but suggests that Erg-aa synthases might constitute a genuine subfamily of lipid modifying ATTs.	[Yakobov, Nathaniel; Mahmoudi, Nassira; Grob, Guillaume; Senger, Bruno; Huck, Laurence; Gascon, Gisela Riera; Becker, Hubert D.; Fischer, Frederic] Univ Strasbourg, UMR 7156, CNRS, Genet Mol Genom Microbiol, Strasbourg, France; [Yokokawa, Daisuke; Saga, Yusuke; Kushiro, Tetsuo] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan; [Worrell, Danielle; Roy, Herve] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Schaller, Hubert] Univ Strasbourg, Plant Isoprenoid Biol PIB Team, Inst Biol Mol Plantes, CNRS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Meiji University; State University System of Florida; University of Central Florida; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mahmoudi, N; Becker, HD; Fischer, F (corresponding author), Univ Strasbourg, UMR 7156, CNRS, Genet Mol Genom Microbiol, Strasbourg, France.	nmahmoudikaidi@unistra.fr; h.becker@unistra.fr; frfischer@unistra.fr		Yakobov, Nathaniel/0000-0001-9074-1651; Senger, Bruno/0000-0002-5157-7307	Agence Nationale de la Recherche [ANR-20-CE44-0002]; Fondation pour la Recherche Medicale (FRM) [DBF20160635713]; "MitoCross'' Laboratory of Excellence [ANR-10-IDEX-0002-02]; University of Strasbourg; CNRS; French Ministere de l'Enseignement Superieur et de la Recherche; FRM [DBF20160635713]; ANR [ANR-20-CE44-0002]; Meiji University; Japan Society for the Promotion of Science [21K05406]; National Institutes of Health [1R21AI144481-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); "MitoCross'' Laboratory of Excellence; University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Enseignement Superieur et de la Recherche; FRM(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); Meiji University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported as the "N-FLAMS" project by the Agence Nationale de la Recherche (ANR-20-CE44-0002), by the Fondation pour la Recherche Medicale (FRM, DBF20160635713), by the "MitoCross'' Laboratory of Excellence funding (Labex, ANR-10-IDEX-0002-02), by the University of Strasbourg and by the CNRS (H. D. B., F. F., N. M., N. Y., G. G., B. S., L. H., H. S.). N. Y. was supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche, N. M. by a postdoctoral fellowship from the FRM (DBF20160635713) and ANR (ANR-20-CE44-0002). Funding was also provided by Meiji University, as well as Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (Grant Number 21K05406 to T. K.). H. R. and D. W. were supported by a National Institutes of Health Grant: 1R21AI144481-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Alcazar-Fuoli L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00439; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Arendt W, 2013, J BIOL CHEM, V288, P24717, DOI 10.1074/jbc.M113.482935; Bailly M, 2008, METHODS, V44, P146, DOI 10.1016/j.ymeth.2007.11.012; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Czolkoss S., 2019, MOL MICROBIOL; De Craene JO, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030634; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Dubchak I., 2014, NUCL ACIDS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; ERIANI G, 1995, J MOL EVOL, V40, P499; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Farnoud AM, 2015, CURR TOP MEMBR, V75, P233, DOI 10.1016/bs.ctm.2015.03.005; Favrot L, 2016, BIOCHEMISTRY-US, V55, P989, DOI 10.1021/acs.biochem.5b01269; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fields RN, 2018, RNA BIOL, V15, P480, DOI 10.1080/15476286.2017.1356980; Fischer F, 2012, NUCLEIC ACIDS RES, V40, P4965, DOI 10.1093/nar/gks167; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goswami S K, 1970, J Chromatogr, V53, P389, DOI 10.1016/S0021-9673(01)98486-9; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Hebecker S, 2015, P NATL ACAD SCI USA, V112, P10691, DOI 10.1073/pnas.1511167112; Hemmerle Marine, 2020, Enzymes, V48, P117, DOI 10.1016/bs.enz.2020.04.003; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Jorda T, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070795; Kaminski DM, 2014, EUR BIOPHYS J BIOPHY, V43, P453, DOI 10.1007/s00249-014-0983-8; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KERN D, 1979, BIOCHIMIE, V61, P1257; Kikuma T, 2017, BIOSCI BIOTECH BIOCH, V81, P384, DOI 10.1080/09168451.2016.1240603; Korber M, 2017, BBA-MOL CELL BIOL L, V1862, P1534, DOI 10.1016/j.bbalip.2017.09.002; Kuroki Y, 2002, FEMS MICROBIOL LETT, V209, P277, DOI 10.1016/S0378-1097(02)00551-7; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Morioka S, 2013, APPL MICROBIOL BIOT, V97, P4013, DOI 10.1007/s00253-012-4470-9; Moutiez M, 2017, CHEM REV, V117, P5578, DOI 10.1021/acs.chemrev.6b00523; Mueller JW, 2015, ENDOCR REV, V36, P526, DOI 10.1210/er.2015-1036; Nazarko TY, 2007, AUTOPHAGY, V3, P263, DOI 10.4161/auto.3907; Nes WD, 2011, CHEM REV, V111, P6423, DOI 10.1021/cr200021m; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Normile TG, 2020, J FUNGI, V6, DOI 10.3390/jof6010025; Panwar SL, 2008, BIOSCIENCE REP, V28, P217, DOI 10.1042/BSR20080071; Rella A, 2016, PROG LIPID RES, V61, P63, DOI 10.1016/j.plipres.2015.11.003; Rodrigues ML, 2018, MBIO, V9, DOI 10.1128/mBio.01755-18; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Shimamura M, 2020, BIOCHEM J, V477, P4243, DOI 10.1042/BCJ20200532; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Slavetinsky C, 2017, BBA-MOL CELL BIOL L, V1862, P1310, DOI 10.1016/j.bbalip.2016.11.013; Smith AM, 2015, MOL MICROBIOL, V98, P681, DOI 10.1111/mmi.13150; Smith AM, 2013, J BIOL CHEM, V288, P22768, DOI 10.1074/jbc.M113.484402; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Tsakos M, 2015, NAT PROD REP, V32, P605, DOI 10.1039/c4np00106k; Weichert M., 2016, P NATL ACAD SCI USA; Weichert M, 2020, GENETICS, V216, P1103, DOI 10.1534/genetics.120.303623; Yakobov N, 2020, P NATL ACAD SCI USA, V117, P14948, DOI 10.1073/pnas.2003266117; Yamashita SI, 2007, AUTOPHAGY, V3, P35, DOI 10.4161/auto.3311; Yokokawa D, 2021, STEROIDS, V169, DOI 10.1016/j.steroids.2021.108823; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	71	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101657	10.1016/j.jbc.2022.101657	http://dx.doi.org/10.1016/j.jbc.2022.101657			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35131263	gold, Green Published			2022-12-28	WOS:000794865600012
J	Tang, JH; Deng, HY; Wang, ZX; Zha, HY; Liao, Q; Zhu, CC; Chen, XY; Sun, XY; Jia, SK; Ouyang, G; Liu, X; Xiao, WH				Tang, Jinhua; Deng, Hongyan; Wang, Zixuan; Zha, Huangyuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan			EGLN1 prolyl hydroxylation of hypoxia-induced transcription factor HIF1 alpha is repressed by SET7-catalyzed lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-HYDROXYLATION; GLUCOSE-METABOLISM; HIF-ALPHA; METHYLTRANSFERASE; P53	Egg-laying defective nine 1 (EGLN1) functions as an oxygen sensor to catalyze prolyl hydroxylation of the transcription factor hypoxia-inducible factor-1 alpha under normoxia conditions, leading to its proteasomal degradation. Thus, EGLN1 plays a central role in the hypoxia-inducible factor-mediated hypoxia signaling pathway; however, the posttranslational modifications that control EGLN1 function remain largely unknown. Here, we identified that a lysine monomethylase, SET7, catalyzes EGLN1 methylation on lysine 297, resulting in the repression of EGLN1 activity in catalyzing prolyl hydroxylation of hypoxia-inducible factor-1 alpha. Notably, we demonstrate that the methylation mimic mutant of EGLN1 loses the capability to suppress the hypoxia signaling pathway, leading to the enhancement of cell proliferation and the oxygen consumption rate. Collectively, our data identify a novel modification of EGLN1 that is critical for inhibiting its enzymatic activity and which may benefit cellular adaptation to conditions of hypoxia.	[Tang, Jinhua; Wang, Zixuan; Zha, Huangyuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Tang, Jinhua; Wang, Zixuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Deng, Hongyan] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Liu, Xing; Xiao, Wuhan] Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China; [Xiao, Wuhan] Hubei Hongshan Lab, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Chinese Academy of Sciences	Liu, X; Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.; Liu, X; Xiao, WH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Liu, X; Xiao, WH (corresponding author), Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China.; Xiao, WH (corresponding author), Hubei Hongshan Lab, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn; liuxing@ihb.ac.cn			NSFC, China [31830101, 31721005]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDA24010308]; National Key Research and Development Program of China, China [2018YFD0900602]	NSFC, China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences, China; National Key Research and Development Program of China, China	This work was supported by NSFC, China [31830101 and 31721005 to W. X.]; the Strategic Priority Research Program of the Chinese Academy of Sciences, China (XDA24010308 to W. X.); the National Key Research and Development Program of China, China (2018YFD0900602, to W. X.).	Abu-Remaileh M, 2014, CELL DEATH DIFFER, V21, P1805, DOI 10.1038/cdd.2014.95; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Corrado C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165611; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dey A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8534; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Guo JP, 2016, SCIENCE, V353, P929, DOI 10.1126/science.aad5755; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Lin XH, 2020, GENOM PROTEOM BIOINF, V18, P289, DOI 10.1016/j.gpb.2019.04.005; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pradhan S, 2009, EPIGENETICS, V4, P282; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; Yang M, 2014, HYPOXIA, V2, P127, DOI 10.2147/HP.S47968; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang J, 2018, SCIENCE, V361, P290, DOI 10.1126/science.aap8411; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	43	0	0	6	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101961	10.1016/j.jbc.2022.101961	http://dx.doi.org/10.1016/j.jbc.2022.101961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452683	gold, Green Published			2022-12-28	WOS:000838892100012
J	Xu, X; Wu, GY				Xu, Xin; Wu, Guangyu			Human C1orf27 protein interacts with ?(2A)-adrenergic receptor and regulates its anterograde transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; COUPLED RECEPTOR; ENDOPLASMIC-RETICULUM; ADRENERGIC-RECEPTOR; ALPHA(2)-ADRENERGIC RECEPTORS; MEMBRANE-TRAFFICKING; ANGIOTENSIN-II; EXPORT; MOTIF; LOCALIZATION	The molecular mechanisms underlying the anterograde surface transport of G protein-coupled receptors (GPCRs) after their synthesis in the endoplasmic reticulum (ER) are not well defined. In C. elegans, odorant response abnormal 4 has been implicated in the delivery of olfactory GPCRs to the cilia of chemosensory neurons. However, the function and regulation of its human homolog, C1orf27, in GPCR transport or in general membrane trafficking remain unknown. Here, we demonstrate that siRNA-mediated knockdown of C1orf27 markedly impedes the ER-to-Golgi export kinetics of newly synthesized alpha 2A-adrenergic receptor (alpha 2A-AR), a prototypic GPCR, with the half-time being prolonged by more than 65%, in mammalian cells in retention using the selective hooks assays. Using modified bioluminescence resonance energy transfer assays and ELISAs, we also show that C1orf27 knockdown significantly inhibits the surface transport of alpha 2AAR. Similarly, C1orf27 knockout by CRISPR-Cas9 markedly suppresses the ER-Golgi-surface transport of alpha 2A-AR. In addition, we demonstrate that C1orf27 depletion attenuates the export of beta 2-AR and dopamine D2 receptor but not of epidermal growth factor receptor. We further show that C1orf27 physically associates with alpha 2A-AR, specifically via its third intracellular loop and C terminus. Taken together, these data demonstrate an important role of C1orf27 in the trafficking of nascent GPCRs from the ER to the cell surface through the Golgi and provide novel insights into the regulation of the biosynthesis and anterograde transport of the GPCR family members.	[Xu, Xin; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu			National Institutes of Health [R35GM136397]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health grant R35GM136397 to G. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Awabdh S, 2012, J NEUROSCI, V32, P14227, DOI 10.1523/JNEUROSCI.6329-11.2012; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chen CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004082; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Khater M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100805; Kim KA, 2003, J NEUROSCI, V23, P2075; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kunselman JM, 2021, CURR OPIN CELL BIOL, V71, P158, DOI 10.1016/j.ceb.2021.03.002; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lehman CW, 2005, GENOMICS, V85, P386, DOI 10.1016/j.ygeno.2004.11.009; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Li YW, 1998, J NEUROPHYSIOL, V79, P583, DOI 10.1152/jn.1998.79.2.583; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Pao CS, 2005, J BIOL CHEM, V280, P11052, DOI 10.1074/jbc.M412996200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sauvageau E, 2014, TRAFFIC, V15, P383, DOI 10.1111/tra.12148; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Shiwarski DJ, 2019, MOL BIOL CELL, V30, P680, DOI 10.1091/mbc.E18-05-0292; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Shiwarski DJ, 2017, J NEUROSCI, V37, P3741, DOI 10.1523/JNEUROSCI.2923-16.2017; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Timmons SD, 2004, BRAIN RES, V1014, P184, DOI 10.1016/j.brainres.2004.04.025; Ulloa-Aguirre A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212329; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wei Z, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100517; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xu X, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103643; Zhang MX, 2019, TRAFFIC, V20, P110, DOI 10.1111/tra.12624; Zhang MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37921; Zhang MX, 2016, MOL CELL BIOL, V36, P1152, DOI 10.1128/MCB.00009-16; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	62	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102021	10.1016/j.jbc.2022.102021	http://dx.doi.org/10.1016/j.jbc.2022.102021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35551911	gold, Green Published			2022-12-28	WOS:000829588600003
J	Jean-Charles, PY; Rajiv, V; Sarker, S; Han, SG; Bai, YS; Masoudi, A; Shenoy, SK				Jean-Charles, Pierre-Yves; Rajiv, Vishwaesh; Sarker, Subhodeep; Han, Sangoh; Bai, Yushi; Masoudi, Ali; Shenoy, Sudha K.			A single phenylalanine residue in beta-arrestin2 critically regulates its binding to G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEINS; BETA-ARRESTIN; ENDOCYTIC TRAFFICKING; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; UBIQUITINATION; ROLES; DEUBIQUITINASE; IDENTIFICATION; MECHANISM	Arrestins and their yeast homologs, arrestin-related trafficking adaptors (ARTs), share a stretch of 29 amino acids called the ART motif. However, the functionality of that motif is unknown. We now report that deleting this motif prevents agonist-induced ubiquitination of beta-arrestin2 (beta-arr2) and blocks its association with activated G protein-coupled re-ceptors (GPCRs). Within the ART motif, we have identified a conserved phenylalanine residue, Phe116, that is critical for the formation of beta-arr2-GPCR complexes. beta-arr2 Phe116Ala mutant has negligible effect on blunting beta 2-adrenergic receptor- induced cAMP generation unlike beta-arr2, which promotes rapid desensitization. Furthermore, available structures for inactive and inositol hexakisphosphate 6-activated forms of bovine beta-arr2 revealed that Phe116 is ensconced in a hydrophobic pocket, whereas the adjacent Phe117 and Phe118 residues are not. Mutagenesis of Phe117 and Phe118, but not Phe116, pre-serves GPCR interaction of beta-arr2. Surprisingly, Phe116 is dispensable for the association of beta-arr2 with its non-GPCR partners. beta-arr2 Phe116Ala mutant presents a significantly reduced protein half-life compared with beta-arr2 and undergoes constitutive Lys-48-linked polyubiquitination, which tags pro-teins for proteasomal degradation. We also found that Phe116 is critical for agonist-dependent beta-arr2 ubiquitination with Lys-63-polyubiquitin linkages that are known mediators of protein scaffolding and signal transduction. Finally, we have shown that beta-arr2 Phe116Ala interaction with activated beta 2-adrenergic re-ceptor can be rescued with an in-frame fusion of ubiquitin. Taken together, we conclude that Phe116 preserves structural stability of beta-arr2, regulates the formation of beta-arr2-GPCR complexes that inhibit G protein signaling, and promotes sub-sequent ubiquitin-dependent beta-arr2 localization and trafficking.	[Jean-Charles, Pierre-Yves; Rajiv, Vishwaesh; Sarker, Subhodeep; Han, Sangoh; Bai, Yushi; Masoudi, Ali; Shenoy, Sudha K.] Duke Univ Med Ctr, Dept Med, Div Cardiol, Durham, NC USA; [Shenoy, Sudha K.] Duke Univ Med Ctr, Dept Cell Biol, Durham, NC USA; [Jean-Charles, Pierre-Yves] Barry Univ, Dept Biol, Miami Shores, FL 33161 USA; [Sarker, Subhodeep] EY Global Delivery Serv India LLP, Sect Noida 142, 12th,15th, 16th Floor,Tower C,Advant Navis Busines, Noida 201301, Uttar Pradesh, India	Duke University; Duke University	Shenoy, SK (corresponding author), Duke Univ Med Ctr, Dept Med, Div Cardiol, Durham, NC USA.; Shenoy, SK (corresponding author), Duke Univ Med Ctr, Dept Cell Biol, Durham, NC USA.	skshenoy@dm.duke.edu		Sarker, Subhodeep/0000-0002-2222-2072	National Institutes of Health [HL160029]; Edna and Fred L. Mandel Jr Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edna and Fred L. Mandel Jr Foundation	Funding and additional information-This work was supported by the National Institutes of Health (grant no.: HL160029) (to S. K. S.) as well as by a Seed Award funding support (to S. K. S.) from the Edna and Fred L. Mandel Jr Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; Ahn S, 2020, CELL, V182, P1362, DOI 10.1016/j.cell.2020.07.034; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Chen QY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01218-8; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Gorelik M, 2017, BIOENG TRANSL MED, V2, P31, DOI 10.1002/btm2.10044; Gurevich VV, 2019, MOL CELL ENDOCRINOL, V484, P34, DOI 10.1016/j.mce.2019.01.019; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P339, DOI 10.1016/bs.pmbts.2016.04.003; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Jean-Charles PY, 2016, J CELL PHYSIOL, V231, P2071, DOI 10.1002/jcp.25317; Jean-Charles PY, 2016, J BIOL CHEM, V291, P7450, DOI 10.1074/jbc.M115.687129; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Kumari P, 2017, MOL BIOL CELL, V28, P1003, DOI 10.1091/mbc.E16-12-0818; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Nagi K, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109759; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nogues L, 2011, J BIOL CHEM, V286, P1165, DOI 10.1074/jbc.M110.203406; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Skieterska K, 2016, CELL SIGNAL, V28, P1001, DOI 10.1016/j.cellsig.2016.05.003; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhan Xuanzhi, 2015, Curr Protoc Pharmacol, V68, DOI 10.1002/0471141755.ph0212s68; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	73	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101837	10.1016/j.jbc.2022.101837	http://dx.doi.org/10.1016/j.jbc.2022.101837			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35307348	gold, Green Published			2022-12-28	WOS:000798082100008
J	Milanini, J; Magdeleine, M; Fuggetta, N; Ikhlef, S; Brau, F; Abelanet, S; Alpy, F; Tomasetto, C; Drin, G				Milanini, Julie; Magdeleine, Maud; Fuggetta, Nicolas; Ikhlef, Souade; Brau, Frederic; Abelanet, Sophie; Alpy, Fabien; Tomasetto, Catherine; Drin, Guillaume			In situ artificial contact sites (ISACS) between synthetic and endogenous organelle membranes allow for quantification of protein-tethering activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; FFAT MOTIF; GOLGI-APPARATUS; BINDING PROTEIN; LIPID TRANSFER; VAP; ER; REQUIRES; STARD3	Membrane contact sites are specialized areas where the membranes of two distinct organelles are physically connected and allow for the exchange of molecules and for signaling processes. Understanding the mechanisms whereby proteins localize to and function in these structures is of special interest; however, methods allowing for reconstitution of these contact sites are few and only based on synthetic membranes and recombinant proteins. Here, we devised a strategy to create in situ artificial contact sites between synthetic and endogenous organelle membranes. Liposomes functionalized with a peptide containing a two phenylalanines in an acidic tract (FFAT) motif were added to adherent cells whose plasma membrane was perforated. Confocal and super-resolution microscopy revealed that these liposomes associated with the endoplasmic reticulum via the specific interaction of the FFAT motif with endoplasmic reticulum-resident vesicle-associated membrane protein-associated proteins. This approach allowed for quantification of the attachment properties of peptides corresponding to FFAT motifs derived from distinct proteins and of a protein construct derived from steroidogenic acute regulatory protein-related lipid transfer domain-3. Collectively, these data indicate that the creation of in situ artificial contact sites represents an efficient approach for studying the membranet-ethering activity of proteins and for designing membrane contact site reconstitution assays in cellular contexts.	[Milanini, Julie; Magdeleine, Maud; Fuggetta, Nicolas; Ikhlef, Souade; Brau, Frederic; Abelanet, Sophie; Drin, Guillaume] Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire IPMC, Valbonne, France; [Alpy, Fabien; Tomasetto, Catherine] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire IGBMC, U1258,INSERM,UMR7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Drin, G (corresponding author), Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire IPMC, Valbonne, France.	drin@ipmc.cnrs.fr	Tomasetto, Catherine Laure/J-2783-2014	Tomasetto, Catherine Laure/0000-0002-1811-5848; FUGGETTA, Nicolas/0000-0002-8508-3188	CNRS, France; Universite Cote d'Azur, France; Agence Nationale de la Recherche, France [ANR-19-CE44-0003]	CNRS, France(Centre National de la Recherche Scientifique (CNRS)); Universite Cote d'Azur, France; Agence Nationale de la Recherche, France(French National Research Agency (ANR))	We acknowledge the flow cytometry and microscopy facility from the Institut de Pharmacologie Moleculaire et Cellulaire, which is part of the GIS IBiSA platform MICA (Microscopie Imagerie Cote d'Azur). We thank P. Eberling (IGBMC [Institut de Genetique et de Biologie Moleculaire et Cellulaire] peptide synthesis facility) for the peptide syntheses. This work was supported by the CNRS, France; Universite Cote d'Azur, France; and by a grant from the Agence Nationale de la Recherche, France (grant no.: ANR-19-CE44-0003).	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Bian X, 2019, NAT CHEM BIOL, V15, P830, DOI 10.1038/s41589-019-0325-3; Cabukusta B, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108475; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Delfosse V., 2020, CONTACT, V3, DOI DOI 10.1177/2515256420946627; Di Mattia T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104369; Di Mattia T, 2018, EMBO REP, V19, DOI 10.15252/embr.201745453; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; James C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071780; Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5; Johnson B, 2019, CHANNELS, V13, P88, DOI 10.1080/19336950.2019.1568824; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kamemura K, 2019, J BIOCHEM, V165, P391, DOI 10.1093/jb/mvz011; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; Li CL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.627700; Lipp NF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00663; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Magdeleine M, 2016, ELIFE, V5, DOI 10.7554/eLife.16988; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Osawa T, 2019, NAT STRUCT MOL BIOL, V26, P281, DOI 10.1038/s41594-019-0203-4; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Petkovic M, 2021, GENE DEV, V35, P449, DOI 10.1101/gad.346759.120; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Prinz WA, 2020, NAT REV MOL CELL BIO, V21, P7, DOI 10.1038/s41580-019-0180-9; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scorrano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09253-3; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139; Wilhelm LP, 2017, EMBO J, V36, P1412, DOI 10.15252/embj.201695917; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yadav S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207985	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101780	10.1016/j.jbc.2022.101780	http://dx.doi.org/10.1016/j.jbc.2022.101780			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35231443	Green Published, gold			2022-12-28	WOS:000860390500002
J	Pena-Diaz, S; Pujols, J; Vasili, E; Pinheiro, F; Santos, J; Manglano-Artunedo, Z; Outeiro, TF; Ventura, S				Pena-Diaz, Samuel; Pujols, Jordi; Vasili, Eftychia; Pinheiro, Francisca; Santos, Jaime; Manglano-Artunedo, Zoe; Outeiro, Tiago F.; Ventura, Salvador			The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple alpha-synuclein strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMER MODULATOR; DISEASE; PRION; PROGRESSION; ANLE138B	Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, as well as the accumulation of intraneuronal proteinaceous inclusions known as Lewy bodies and Lewy neurites. The major protein component of Lewy inclusions is the intrinsically disordered protein alpha-synuclein (alpha-Syn), which can adopt diverse amyloid structures. Different conformational strains of alpha-Syn have been proposed to be related to the onset of distinct synucleinopathies; however, how specific amyloid fibrils cause distinctive pathological traits is not clear. Here, we generated three different alpha-Syn amyloid conformations at different pH and salt concentrations and analyzed the activity of SynuCleanD (SC-D), a small aromatic molecule, on these strains. We show that incubation of alpha-Syn with SC-D reduced the formation of aggregates and the seeded polymerization of alpha-Syn in all cases. Moreover, we found that SC-D exhibited a general fibril disaggregation activity. Finally, we demonstrate that treatment with SC-D also reduced strain-specific intracellular accumulation of phosphorylated alpha-Syn inclusions. Taken together, we conclude that SC-D may be a promising hit compound to inhibit polymorphic alpha-Syn aggregation.	[Pena-Diaz, Samuel; Pujols, Jordi; Pinheiro, Francisca; Santos, Jaime; Manglano-Artunedo, Zoe; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Pena-Diaz, Samuel; Pujols, Jordi; Pinheiro, Francisca; Santos, Jaime; Manglano-Artunedo, Zoe; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Vasili, Eftychia; Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Dept Expt Neurodegenerat, Gottingen, Germany; [Vasili, Eftychia; Outeiro, Tiago F.] Max Planck Inst Expt Med, Gottingen, Germany; [Outeiro, Tiago F.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Outeiro, Tiago F.] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Gottingen, Germany; [Ventura, Salvador] ICREA, Passeig Lluis Co 23, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Gottingen; Max Planck Society; Newcastle University - UK; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); ICREA	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain.; Ventura, S (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain.; Ventura, S (corresponding author), ICREA, Passeig Lluis Co 23, Barcelona, Spain.	salvador.ventura@uab.es	Vasili, Eftychia/HHZ-4192-2022; Pinheiro, Francisca/U-1397-2019	Vasili, Eftychia/0000-0001-9150-0104; Pinheiro, Francisca/0000-0003-3778-1528; Santos, Jaime/0000-0001-9045-7765; Pena Diaz, Samuel/0000-0002-2902-823X	Spanish Ministry of Science and Innovation [PID2019-105017RB-I00]; ICREA (ICREA-Academia); Fundacion La Marato de TV3 [20144330]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany''s Excellence Strategy [EXC 2067/1-390729940, SFB1286]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA (ICREA-Academia)(ICREA); Fundacion La Marato de TV3; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany''s Excellence Strategy(German Research Foundation (DFG))	S. V. was supported by the Spanish Ministry of Science and Innovation (PID2019-105017RB-I00) , ICREA (ICREA-Academia 2015 and 2020) , and the Fundacion La Marato de TV3 (Ref. 20144330) . T. F. O. was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germanys Excellence Strategy (EXC 2067/1-390729940) and by SFB1286 (Project B8) .	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Alafuzoff I, 2018, HAND CLINIC, V145, P339, DOI 10.1016/B978-0-12-802395-2.00024-9; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; BETHLEM J, 1960, J NEUROL NEUROSUR PS, V23, P74, DOI 10.1136/jnnp.23.1.74; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Crespo R, 2016, J BIOL CHEM, V291, P2018, DOI 10.1074/jbc.M115.699348; Delenclos M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0455-3; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Diaz-Caballero M, 2018, ACS NANO, V12, P5394, DOI 10.1021/acsnano.8b00417; Dominguez-Meijide A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69744-y; Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743; Gallardo J, 2020, ACS CHEM NEUROSCI, V11, P872, DOI 10.1021/acschemneuro.9b00527; Gribaudo S, 2019, STEM CELL REP, V12, P230, DOI 10.1016/j.stemcr.2018.12.007; Guerrero-Ferreira R, 2019, ELIFE, V8, DOI 10.7554/eLife.48907; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Lau A, 2020, NAT NEUROSCI, V23, P21, DOI 10.1038/s41593-019-0541-x; Levin J, 2014, ACTA NEUROPATHOL, V127, P779, DOI 10.1007/s00401-014-1265-3; Limbocker R, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.680026; Limbocker R, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01140-8; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Moree B, 2015, J BIOL CHEM, V290, P27582, DOI 10.1074/jbc.M114.636027; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Pena-Diaz S, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00306; Perni M, 2018, ACS CHEM BIOL, V13, P2308, DOI 10.1021/acschembio.8b00466; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Pujols J, 2018, P NATL ACAD SCI USA, V115, P10481, DOI 10.1073/pnas.1804198115; Pujols J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030478; Roeters SJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41051; Santos J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010145; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shahnawaz M, 2020, NATURE, V578, P273, DOI 10.1038/s41586-020-1984-7; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki G, 2020, ELIFE, V9, DOI 10.7554/eLife.56825; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tatenhorst L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0310-y; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vaikath NN, 2019, NEUROPATH APPL NEURO, V45, P597, DOI 10.1111/nan.12531; Vasili E, 2022, MOL NEUROBIOL, V59, P1273, DOI 10.1007/s12035-021-02713-2; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Walker DG, 2013, EXP NEUROL, V240, P190, DOI 10.1016/j.expneurol.2012.11.020; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Woerman AL, 2019, ACTA NEUROPATHOL, V137, P437, DOI 10.1007/s00401-019-01959-4; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471	54	1	1	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101902	10.1016/j.jbc.2022.101902	http://dx.doi.org/10.1016/j.jbc.2022.101902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35390347	Green Published, gold			2022-12-28	WOS:000798082100010
J	Sagae, T; Yokogawa, M; Sawazaki, R; Ishii, Y; Hosoda, N; Hoshino, SI; Imai, S; Shimada, I; Osawa, M				Sagae, Takeru; Yokogawa, Mariko; Sawazaki, Ryoichi; Ishii, Yuichiro; Hosoda, Nao; Hoshino, Shin-ichi; Imai, Shunsuke; Shimada, Ichio; Osawa, Masanori			Paip2A inhibits translation by competitively binding to the RNA recognition motifs of PABPC1 and promoting its dissociation from the poly(A) tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A)-BINDING PROTEIN; REPRESSOR PAIP2; MESSENGER-RNA; DOMAIN; IDENTIFICATION; RESTRICTION; TERMINATION; COMPLEX	Eukaryotic mRNAs possess a poly(A) tail at their 3'-end, to which poly(A)-binding protein C1 (PABPC1) binds and recruits other proteins that regulate translation. Enhanced poly(A)-dependent translation, which is also PABPC1 dependent, promotes cellular and viral proliferation. PABP-interacting protein 2A (Paip2A) effectively represses poly(A)-dependent translation by causing the dissociation of PABPC1 from the poly(A) tail; however, the underlying mechanism remains unknown. This study was conducted to investigate the functional mechanisms of Paip2A action by characterizing the PABPC1-poly(A) and PABPC1-Paip2A interactions. Isothermal titration calorimetry and NMR analyses indicated that both interactions predominantly occurred at the RNA recognition motif (RRM) 2-RRM3 regions of PABPC1, which have comparable affinities for poly(A) and Paip2A (dissociation constant, K-d = 1 nM). However, the K-d values of isolated RRM2 were 200 and 4 mu M in their interactions with poly(A) and Paip2A, respectively; K-d values of 5 and 1 mu M were observed for the interactions of isolated RRM3 with poly(A) and Paip2A, respectively. NMR analyses also revealed that Paip2A can bind to the poly(A)-binding interfaces of the RRM2 and RRM3 regions of PABPC1. Based on these results, we propose the following functional mechanism for Paip2A: Paip2A initially binds to the RRM2 region of poly(A)-bound PABPC1, and RRM2-anchored Paip2A effectively displaces the RRM3 region from poly(A), resulting in dissociation of the whole PABPC1 molecule. Together, our findings provide insight into the translation repression effect of Paip2A and may aid in the development of novel anticancer and/or antiviral drugs.	[Sagae, Takeru; Yokogawa, Mariko; Sawazaki, Ryoichi; Ishii, Yuichiro; Osawa, Masanori] Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan; [Hosoda, Nao; Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Imai, Shunsuke; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Imai, Shunsuke; Shimada, Ichio] RIKEN, Ctr Biosyst Dynam Res, Tsurumi Ku, Yokohama, Kanagawa, Japan	Keio University; Nagoya City University; University of Tokyo; RIKEN	Osawa, M (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan.	osawa-ms@pha.keio.ac.jp	Osawa, Masanori/GRS-5726-2022	Imai, Shunsuke/0000-0001-9346-2359; Osawa, Masanori/0000-0002-1285-4316; Yokogawa, Mariko/0000-0003-3448-7112	Japan Society for the Promotion of Science KAKENHI grant [JP17H03978, JP19H04973]; Platform Project for Supporting Drug Discovery and Life Science Research; Japan Agency for Medical Research and Development (AMED) [JP21 AM0101071, 1392]; Vehicle Racing Commemorative Foundation; Takeda Science Foundation; Sumitomo Foundation; Sato Pharmaceutical Research Grant	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Vehicle Racing Commemorative Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Sato Pharmaceutical Research Grant	This research was supported in part by the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: JP17H03978 and JP19H04973 [to M. O.]), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) from the Japan Agency for Medical Research and Development (AMED) under grant numbers JP21 AM0101071 (support number: 1392), a grant from The Vehicle Racing Commemorative Foundation (to M. O.), Takeda Science Foundation (to M. Y. and M. O.), grant for Basic Science Research Projects from the Sumitomo Foundation (to M. Y.), and Sato Pharmaceutical Research Grant (to T. S).	BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Barraud P, 2013, J BIOMOL NMR, V55, P119, DOI 10.1007/s10858-012-9696-4; Berlow RB, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2117338119; Berlow RB, 2017, NATURE, V543, P447, DOI 10.1038/nature21705; Chorghade S, 2017, ELIFE, V6, DOI 10.7554/eLife.24139; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dominguez C, 2011, PROG NUCL MAG RES SP, V58, P1, DOI 10.1016/j.pnmrs.2010.10.001; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Gryk MR, 1998, J MOL BIOL, V280, P879, DOI 10.1006/jmbi.1998.1731; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Iwaoka R, 2017, MOLECULES, V22, DOI 10.3390/molecules22071207; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; McKinney C, 2013, GENE DEV, V27, P1809, DOI 10.1101/gad.221341.113; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; NIETFELD W, 1990, EMBO J, V9, P3699, DOI 10.1002/j.1460-2075.1990.tb07582.x; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Perez C, 2011, J VIROL, V85, P156, DOI 10.1128/JVI.01778-10; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Rosenfeld AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025116; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; Sawazaki R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19659-6; Svitkin Yuri V., 2004, V257, P155; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	30	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101844	10.1016/j.jbc.2022.101844	http://dx.doi.org/10.1016/j.jbc.2022.101844			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35307347	Green Published, gold			2022-12-28	WOS:000794890400004
J	Wan, HX; Chen, XY; Zhang, FL; Chen, J; Chu, FL; Sellers, ZM; Xu, F; Dong, H				Wan, Hanxing; Chen, Xiong Ying; Zhang, Fenglian; Chen, Jun; Chu, Fenglan; Sellers, Zachary M.; Xu, Feng; Dong, Hui			Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+; ACTIVATION; EXPRESSION; MECHANISM; PROTECTS; CANCER	Although capsaicin has been studied extensively as an activator of the transient receptor potential vanilloid cation channel subtype 1 (TRPV1) channels in sensory neurons, little is known about its TRPV1-independent actions in gastrointestinal health and disease. Here, we aimed to investigate the pharmacological actions of capsaicin as a food additive and medication on intestinal ion transporters in mouse models of ulcerative colitis (UC). The short-circuit current (I-sc) of the intestine from WT, TRPV1-, and TRPV4-KO mice were measured in Ussing chambers, and Ca2+ imaging was performed on small intestinal epithelial cells. We also performed Western blots, immunohistochemistry, and immunofluorescence on intestinal epithelial cells and on intestinal tissues following UC induction with dextran sodium sulfate. We found that capsaicin did not affect basal intestinal I-sc but significantly inhibited carbachol-and caffeine-induced intestinal I-sc in WT mice. Capsaicin similarly inhibited the intestinal I-sc in TRPV1 KO mice, but this inhibition was absent in TRPV4 KO mice. We also determined that Ca2+ influx via TRPV4 was required for cholinergic signaling-mediated intestinal anion secretion, which was inhibited by capsaicin. Moreover, the glucose-induced jejunal I-sc via Na+/glucose cotransporter was suppressed by TRPV4 activation, which could be relieved by capsaicin. Capsaicin also stimulated ouabain-and amiloridesensitive colonic I-sc. Finally, we found that dietary capsaicin ameliorated the UC phenotype, suppressed hyperaction of TRPV4 channels, and rescued the reduced ouabain-and amiloride-sensitive I-sc. We therefore conclude that capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption predominantly by blocking TRPV4 channels to exert its beneficial anti-colitic action.	[Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Zhang, Fenglian; Chen, Jun; Chu, Fenglan; Dong, Hui] Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Sellers, Zachary M.] Stanford Univ, Sch Med, Pediat Gastroenterol Hepatol & Nutr, Palo Alto, CA 94304 USA; [Dong, Hui] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA	Chongqing Medical University; Army Medical University; Stanford University; University of California System; University of California San Diego	Xu, F; Dong, H (corresponding author), Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.; Dong, H (corresponding author), Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China.; Dong, H (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	xufeng9899@163.com; h2dong@ucsd.edu	Sellers, Zachary/AAI-1356-2020	Sellers, Zachary/0000-0001-5352-7760	National Natural Science Foundation of China [81972328, 81873544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding and additional information-These studies were supported by research grants from the National Natural Science Foundation of China (81972328 to X. H. W and No. 81873544 to H. D) .	Abdel-Salam OME, 1997, J PHYSIOL-PARIS, V91, P151, DOI 10.1016/S0928-4257(97)89479-X; Bader S, 2017, BRIT J PHARMACOL, V174, P880, DOI 10.1111/bph.13761; Baumgart DC, 2021, NEW ENGL J MED, V385, P1302, DOI 10.1056/NEJMra1907607; Bouyer PG, 2013, AM J PHYSIOL-GASTR L, V304, pG142, DOI 10.1152/ajpgi.00483.2011; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Ferreira LGB, 2020, EUR J PHARMACOL, V887, DOI 10.1016/j.ejphar.2020.173356; Chang JT, 2020, NEW ENGL J MED, V383, P2652, DOI 10.1056/NEJMra2002697; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Domotor A, 2006, EUR J PHARMACOL, V534, P280, DOI 10.1016/j.ejphar.2006.01.017; Domotor Andras, 2005, Inflammopharmacology, V13, P161, DOI 10.1163/156856005774423737; du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI 10.1177/0271678X20943823; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Engel MA, 2012, J GASTROENTEROL, V47, P256, DOI 10.1007/s00535-011-0495-6; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; GOSO C, 1993, EUR J PHARMACOL, V249, P185, DOI 10.1016/0014-2999(93)90431-G; Harraz OF, 2018, ELIFE, V7, DOI 10.7554/eLife.38689; Hirota CL, 2009, BRIT J PHARMACOL, V156, P1085, DOI 10.1111/j.1476-5381.2009.00122.x; HOLZER P, 1989, GASTROENTEROLOGY, V96, P1425, DOI 10.1016/0016-5085(89)90508-8; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Kankanamge D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100702; KAWADA T, 1984, TOXICOL APPL PHARM, V72, P449, DOI 10.1016/0041-008X(84)90121-2; Keita AV, 2018, J CROHNS COLITIS, V12, P1200, DOI 10.1093/ecco-jcc/jjy045; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Lee J, 2012, AUTON NEUROSCI-BASIC, V166, P72, DOI 10.1016/j.autneu.2011.07.008; Leung FW, 2008, LIFE SCI, V83, P1, DOI 10.1016/j.lfs.2008.04.018; Matsumoto K, 2018, BRIT J PHARMACOL, V175, P84, DOI 10.1111/bph.14072; Meir M, 2019, J CLIN INVEST, V129, P2824, DOI 10.1172/JCI120261; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Motte J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1165-x; Ng SC, 2019, AM J GASTROENTEROL, V114, P107, DOI 10.1038/s41395-018-0233-2; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rajendran VM, 2015, J BIOL CHEM, V290, P25487, DOI 10.1074/jbc.M115.654277; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Richards BL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008921.pub2; Rizopoulos T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060061; Rogalski SL, 2001, J BIOL CHEM, V276, P14855, DOI 10.1074/jbc.M010097200; Rollyson W, 2014, FASEB J, V28; Rollyson WD, 2014, J CONTROL RELEASE, V196, P96, DOI 10.1016/j.jconrel.2014.09.027; Rosca AE, 2020, MOLECULES, V25, DOI 10.3390/molecules25235681; Saha P, 2015, BBA-BIOMEMBRANES, V1848, P702, DOI 10.1016/j.bbamem.2014.11.005; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Singh U, 2014, PROG DRUG RES, V68, P147, DOI 10.1007/978-3-0348-0828-6_6; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; SULPICE JC, 1994, J BIOL CHEM, V269, P6347; Tuo BG, 2012, AM J PHYSIOL-ENDOC M, V303, pE111, DOI 10.1152/ajpendo.00575.2011; Wan HX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02562-x; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yamawaki H, 2014, AM J PHYSIOL-GASTR L, V307, pG33, DOI 10.1152/ajpgi.00105.2013; Yasuda M, 2011, J PHARMACOL SCI, V116, P274, DOI 10.1254/jphs.11037FP; Yu SY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1708-9; Zhang FL, 2019, BRIT J PHARMACOL, V176, P1700, DOI 10.1111/bph.14640; Zhang LY, 2022, J ADV RES, V39, P291, DOI 10.1016/j.jare.2021.11.001; Zheng WW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017762118	60	2	2	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101847	10.1016/j.jbc.2022.101847	http://dx.doi.org/10.1016/j.jbc.2022.101847			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35314195	gold, Green Published			2022-12-28	WOS:000793483000008
J	Saragovi, A; Zilberman, T; Yasur, G; Turjeman, K; Abramovich, I; Kuchersky, M; Gottlieb, E; Barenholz, Y; Berger, M				Saragovi, A.; Zilberman, T.; Yasur, G.; Turjeman, K.; Abramovich, I.; Kuchersky, M.; Gottlieb, E.; Barenholz, Y.; Berger, M.			Analysis of cellular water content in T cells reveals a switch from slow metabolic water gain to rapid water influx prior to cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR WATER; VOLUME; TEMPERATURE; MECHANISM; MASS	Cell growth is driven by the acquisition and synthesis of both dry biomass and water mass. In this study, we examine the increase of water mass in T cell during cell growth. We found that T-cell growth is characterized by an initial phase of slow increase in cellular water, followed by a second phase of rapid increase in water content. To study the origin of the water gain, we developed a novel methodology we call cold aqua trap isotope ratio mass spectrometry, which allows analysis of the isotope composition of intracellular water. Applying cold aqua trap-isotope ratio mass spectrometry, we discovered that glycolysis-coupled metabolism of water accounts on average for 11 fl out of the 20 fl of water gained per cell during the initial slow phase. In addition, we show that at the end of the rapid phase before initiation of cell division, a water influx occurs, increasing the cellular water mass by threefold. Thus, we conclude that activated T cells switch from metabolizing water to rapidly taking up water from the extracellular medium prior to cell division. Our work provides a method to analyze cell water content as well as insights into the ways cells regulate their water mass.	[Saragovi, A.; Kuchersky, M.; Berger, M.] Hebrew Univ Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Med Sch, Jerusalem, Israel; [Zilberman, T.; Yasur, G.] Geol Survey Israel, Dept Geochem, Jerusalem IL-9692100, Israel; [Turjeman, K.; Barenholz, Y.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada IMR, Hadassah Med Sch, Dept Biochem & Mol Biol,Lab Membrane & Liposome Re, Jerusalem, Israel; [Abramovich, I.; Gottlieb, E.] Techn Israel Inst Technol, Fac Med, Ruth & Bruce Rappaport, Haifa, Israel	Geological Survey Israel; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Saragovi, A; Berger, M (corresponding author), Hebrew Univ Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Med Sch, Jerusalem, Israel.	amijaisar@gmail.com; michaelb@ekmd.huji.ac.il	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956; Turjeman, Keren/0000-0002-2062-2662	Israel Science Foundation [1596/17]; German-Israeli Foundation [I-224-414.11-2017]	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	Acknowledgments-This work was supported by grants from the Israel Science Foundation (grant no.: 1596/17) and the German-Israeli Foundation (grant no.: I-224-414.11-2017) .	Abir-Awan M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071589; Alberti S, 2017, CURR BIOL, V27, pR1097, DOI 10.1016/j.cub.2017.08.069; Aponte-Santamaria C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04180-z; Ayalon A, 1998, J HYDROL, V207, P18, DOI 10.1016/S0022-1694(98)00119-X; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chapman NM, 2018, CANCER IMMUNOL RES, V6, P502, DOI 10.1158/2326-6066.CIR-17-0605; Cohen R, 2012, J CONTROL RELEASE, V160, P346, DOI 10.1016/j.jconrel.2011.12.030; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Delgado FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067590; EASTEAL AJ, 1984, J PHYS CHEM-US, V88, P6060, DOI 10.1021/j150668a065; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Goldsmith Y, 2017, EARTH PLANET SC LETT, V457, P302, DOI 10.1016/j.epsl.2016.10.017; Ho SN, 2006, J CELL PHYSIOL, V206, P9, DOI 10.1002/jcp.20445; Hoffmann EK, 2011, ACTA PHYSIOL, V202, P465, DOI 10.1111/j.1748-1716.2010.02190.x; Ibata K, 2011, BIOPHYS J, V101, P2277, DOI 10.1016/j.bpj.2011.08.045; Ionenko IF, 2010, BIOL PLANTARUM, V54, P488, DOI 10.1007/s10535-010-0086-z; Koch AL, 1996, J MICROBIOL METH, V27, P49, DOI 10.1016/0167-7012(96)00928-1; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kreuzer-Martin HW, 2005, P NATL ACAD SCI USA, V102, P17337, DOI 10.1073/pnas.0506531102; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Mackay GM, 2015, METHOD ENZYMOL, V561, P171, DOI 10.1016/bs.mie.2015.05.016; Martinez-Martin D, 2017, NATURE, V550, P500, DOI 10.1038/nature24288; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Nicchia GP, 2000, GLIA, V31, P29, DOI 10.1002/(SICI)1098-1136(200007)31:1<29::AID-GLIA30>3.0.CO;2-3; Olgun A, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-9; PIVARNIK JM, 1984, J APPL PHYSIOL, V56, P613, DOI 10.1152/jappl.1984.56.3.613; Platonova A, 2015, BBA-BIOMEMBRANES, V1848, P2337, DOI 10.1016/j.bbamem.2015.07.005; Sachs F, 2015, J GEN PHYSIOL, V145, P373, DOI 10.1085/jgp.201411297; Schmoller KM, 2015, TRENDS CELL BIOL, V25, P793, DOI 10.1016/j.tcb.2015.10.006; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Soveral G, 2006, MICROBIOL-SGM, V152, P1515, DOI 10.1099/mic.0.28679-0; Tasnim H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01571; TEAGUE TK, 1993, CYTOMETRY, V14, P772, DOI 10.1002/cyto.990140710; Walker G, 2001, CURR PLANT SCI BIOT, V40, P57	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101795	10.1016/j.jbc.2022.101795	http://dx.doi.org/10.1016/j.jbc.2022.101795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35248530	gold, Green Published			2022-12-28	WOS:000797895000004
J	Sarker, A; Rathore, AS; Khalid, MF; Gupta, RD				Sarker, Animesh; Rathore, Abhishek Singh; Khalid, Md Fahim; Gupta, Rinkoo Devi			Structure-guided affinity maturation of a single-chain variable fragment antibody against the Fu-bc epitope of the dengue virus envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; DEPENDENT ENHANCEMENT; CONSERVED RESIDUES; FUSION-LOOP; IN-VITRO; INFECTION; GLYCOPROTEIN; EFFICACY	Dengue is one of the most dominant arthropod-borne viral diseases, infecting at least 390 million people every year throughout the world. Despite this, there is no effective treatment against dengue, and the only available vaccine has already been withdrawn owing to the significant adverse effects. Therefore, passive immunotherapy using monoclonal antibodies is now being sought as a therapeutic option. To date, many dengue monoclonal antibodies have been identified, most of which are serotype-specific, and only a few of which are cross-reactive. Furthermore, antibodies that cross-react within serotypes are weakly neutralizing and frequently induce antibody-dependent enhancement, which promotes viral entry and replication. Therefore, broadly neutralizing antibodies with no risk of antibody-dependent enhancement are required for the treatment of dengue. Here, we developed a single-chain variable fragment (scFv) antibody from an anti-fusion loop E53 antibody (PDB: 2IGF). We introduced previously predicted favorable complementarity-determining region (CDR) mutations into the gene encoding the scFv antibody for affinity maturation, and the resultant variants were tested in vitro against the highly conserved fusion and bc epitope of the dengue virus envelope protein. We show some of these scFv variants with two to three substitution mutations in three different CDRs possess affinity constants (K-D) ranging from 20 to 200 nM. The scFv-mutant15, containing D31L, Y105W, and S227W substitutions, showed the lowest affinity constant, (K-D = 24 +/- 7 nM), approximately 100-fold lower than its parental construct. We propose that the scFv-derivative antibody may be a good candidate for the development of an effective and safe immunotherapy.	[Sarker, Animesh; Rathore, Abhishek Singh; Khalid, Md Fahim; Gupta, Rinkoo Devi] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	South Asian University (SAU)	Gupta, RD (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	dgupta@sau.ac.in			SERB [EMR/2016/007246]; South Asian University	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); South Asian University	R. D. G. thanks SERB for funding (Project Number: EMR/2016/007246). A. S., A. S. R., and M. F. K. are thankful to South Asian University for PhD fellowships.	Bhatt S., 2013, GLOBAL DISTRIBUTION; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BRANDT WE, 1982, INFECT IMMUN, V36, P1036, DOI 10.1128/IAI.36.3.1036-1041.1982; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Caskey M., 2015, VIRAEMIA; Castao-Osorio J. C., 2018, DENGUE FEVER A RESIL, DOI [10.5772/intechopen.80820, DOI 10.5772/INTECHOPEN.80820]; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Deb Paroma, 2021, Biosaf Health, V3, P87, DOI 10.1016/j.bsheal.2021.02.001; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T., 2006, ANTIBODY RECOGNITION; Ramadhany R, 2015, ANTIVIR RES, V124, P61, DOI 10.1016/j.antiviral.2015.10.012; Ramos EL, 2015, J INFECT DIS, V211, P1038, DOI 10.1093/infdis/jiu539; Rathore AS, 2020, APPL MICROBIOL BIOT, V104, P4333, DOI 10.1007/s00253-020-10541-y; Rathore AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209576; Sarker A, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1053-9; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Wang M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00157; Winkler AM, 2015, CURR OPIN HEMATOL, V22, P521, DOI 10.1097/MOH.0000000000000191; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	34	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101772	10.1016/j.jbc.2022.101772	http://dx.doi.org/10.1016/j.jbc.2022.101772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35218775	gold, Green Published			2022-12-28	WOS:000793560400009
J	Fleet, JC; Aldea, D; Chen, L; Christakos, S; Verzi, M				Fleet, James C.; Aldea, Dennis; Chen, Lei; Christakos, Sylvia; Verzi, Michael			Regulatory domains controlling high intestinal vitamin D receptor gene expression are conserved in mouse and human	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-ABSORPTION; 1,25-DIHYDROXYVITAMIN-D; RAT; AGE; RESISTANCE; RESPONSIVENESS; IDENTIFICATION; POLYMORPHISMS; PRINCIPLES; CELLS	Vitamin D receptor (VDR) levels are highest in the intestine where it mediates 1,25 dihydroxyvitamin D-induced gene expression. However, the mechanisms controlling high intestinal VDR gene expression are unknown. Here, we used Assay for Transposase-Accessible Chromatin using Sequencing (ATAC-Seq) to identify the regulatory sites controlling intestine-specific Vdr gene expression in the small intestine (villi and crypts) and colon of developing, adult, and aged mice. We identified 17 ATAC peaks in a 125 kb region from intron 3 to -55.8 kb from exon 1 of the Vdr gene. Interestingly, many of these peaks were missing/reduced in the developing intestine. peaks for intestinal transcription factors (TFs) were present within the ATAC peaks and at HiChIP looping attachments that connected the ATAC/TF ChIP peaks to the transcription start site and CCCTF-binding factor sites at the borders of the Vdr gene regulatory domain. Intestine-specific regulatory sites were identified by comparing ATAC peaks to DNAse-Seq data from other tissues that revealed tissue-specific, evolutionary conserved, and species-specific peaks. Bioinformatics analysis of human DNAse-Seq peaks revealed polymorphisms that disrupt TF-binding sites. Our analysis shows that mouse intestinal Vdr gene regulation requires a complex interaction of multiple distal regulatory regions and is controlled by a combination of intestinal TFs. These intestinal regulatory sites are well conserved in humans suggesting that they may be key components of VDR regulation in both mouse and human intestines.	[Fleet, James C.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Aldea, Dennis; Chen, Lei; Verzi, Michael] Rutgers State Univ, Dept Genet, New Brunswick, NJ USA; [Christakos, Sylvia] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA	University of Texas System; University of Texas Austin; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Fleet, JC (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	james.fleet@austin.utexas.edu	; Fleet, James/D-2628-2017	Aldea, Dennis/0000-0002-0809-6030; Chen, Lei/0000-0001-7812-508X; Fleet, James/0000-0002-0142-9517	National Institutes of Diabetes and Digestive and Kidney Diseases [R01 DK112365]	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a multi-principal investigator award from the National Institutes of Diabetes and Digestive and Kidney Diseases (grant no.: R01 DK112365; to S. C., J. C. F., and M. V.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Aronson BE, 2014, BBA-GENE REGUL MECH, V1839, P1273, DOI 10.1016/j.bbagrm.2014.05.018; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; BRUMBAUGH PF, 1974, J BIOL CHEM, V249, P1251; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cartwright JA, 2018, J VET INTERN MED, V32, P764, DOI 10.1111/jvim.15052; Chen L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22761-5; Chen L, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108679; Chen L, 2019, NAT GENET, V51, P777, DOI 10.1038/s41588-019-0384-0; EBELING PR, 1992, J CLIN ENDOCR METAB, V75, P176, DOI 10.1210/jc.75.1.176; Fleet JC, 2017, MOL CELL ENDOCRINOL, V453, P36, DOI 10.1016/j.mce.2017.04.008; Gearing LJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215495; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053, DOI 10.1210/endo-126-2-1053; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lee SM, 2015, J BIOL CHEM, V290, P18199, DOI 10.1074/jbc.M115.665794; Lee SM, 2014, ENDOCRINOLOGY, V155, P2064, DOI 10.1210/en.2014-1107; Li SS, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00372-20; Liel Y, 1999, ENDOCRINOLOGY, V140, P280, DOI 10.1210/en.140.1.280; MASSARO ER, 1983, AM J PHYSIOL, V244, pE230, DOI 10.1152/ajpendo.1983.244.3.E230; MASSARO ER, 1983, P NATL ACAD SCI-BIOL, V80, P2549, DOI 10.1073/pnas.80.9.2549; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Pattanaungkul S, 2000, J CLIN ENDOCR METAB, V85, P4023, DOI 10.1210/jc.85.11.4023; Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379; PIERCE EA, 1988, ARCH BIOCHEM BIOPHYS, V261, P241, DOI 10.1016/0003-9861(88)90338-4; Pike JW, 2017, ENDOCRIN METAB CLIN, V46, P815, DOI 10.1016/j.ecl.2017.07.001; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rispal J, 2020, STEM CELL REV REP, V16, P1062, DOI 10.1007/s12015-020-10055-0; San Roman AK, 2015, STEM CELL REP, V5, P673, DOI 10.1016/j.stemcr.2015.09.006; Saxena M, 2017, GENE DEV, V31, P2391, DOI 10.1101/gad.308536.117; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Shao A, 2001, J BONE MINER RES, V16, P615, DOI 10.1359/jbmr.2001.16.4.615; Solomon NS, 2001, PEDIATR RES, V49, P782, DOI 10.1203/00006450-200106000-00012; Song YR, 2007, ENDOCRINOLOGY, V148, P1396, DOI 10.1210/en.2006-1109; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; TAKAMOTO S, 1990, BIOCHIM BIOPHYS ACTA, V1034, P22, DOI 10.1016/0304-4165(90)90148-P; Torkko KC, 2008, CLIN CANCER RES, V14, P3223, DOI 10.1158/1078-0432.CCR-07-4894; Verzi MP, 2013, MOL CELL BIOL, V33, P281, DOI 10.1128/MCB.01185-12; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; Wang YJ, 2012, KIDNEY INT, V81, P993, DOI 10.1038/ki.2011.463; WATERMAN MS, 1987, J MOL BIOL, V197, P723, DOI 10.1016/0022-2836(87)90478-5; Wood RJ, 1998, ENDOCRINOLOGY, V139, P3843, DOI 10.1210/en.139.9.3843; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zhang L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18670-7; Zhou Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15089	55	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101616	10.1016/j.jbc.2022.101616	http://dx.doi.org/10.1016/j.jbc.2022.101616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065959	gold, Green Published			2022-12-28	WOS:000789396300010
J	Hirata, T; Kobayashi, A; Furuse, T; Yamada, I; Tamura, M; Tomita, H; Tokoro, Y; Ninomiya, A; Fujihara, Y; Ikawa, M; Maeda, Y; Murakami, Y; Kizuka, Y; Kinoshita, T				Hirata, Tetsuya; Kobayashi, Atsushi; Furuse, Tamio; Yamada, Ikuko; Tamura, Masaru; Tomita, Hiroyuki; Tokoro, Yuko; Ninomiya, Akinori; Fujihara, Yoshitaka; Ikawa, Masahito; Maeda, Yusuke; Murakami, Yoshiko; Kizuka, Yasuhiko; Kinoshita, Taroh			Loss of the N-acetylgalactosamine side chain of the GPI-anchor impairs bone formation and brain functions and accelerates the prion disease pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT ANTIGEN; CENTRAL-NERVOUS-SYSTEM; ALKALINE-PHOSPHATASE; TOXOPLASMA-GONDII; KURU PLAQUES; LIPID RAFTS; SIALIC-ACID; PROTEIN; SCRAPIE; PRP	Glycosylphosphatidylinositol (GPI) is a posttranslational glycolipid modification of proteins that anchors proteins in lipid rafts on the cell surface. Although some GPI-anchored proteins (GPI-APs), including the prion protein PrPC, have a glycan side chain composed of N-acetylgalactosamine (GalNAc)-galactose-sialic acid on the core structure of GPI glycolipid, in vivo functions of this GPI-GalNAc side chain are largely unresolved. Here, we investigated the physiological and pathological roles of the GPI-GalNAc side chain in vivo by knocking out its initiation enzyme, PGAP4, in mice. We show that Pgap4 mRNA is highly expressed in the brain, particularly in neurons, and mass spectrometry analysis confirmed the loss of the GalNAc side chain in PrPC GPI in PGAP4-KO mouse brains. Furthermore, PGAP4-KO mice exhibited various phenotypes, including an elevated blood alkaline phosphatase level, impaired bone formation, decreased locomotor activity, and impaired memory, despite normal expression levels and lipid raft association of various GPI-APs. Thus, we conclude that the GPI-GalNAc side chain is required for in vivo functions of GPI-APs in mammals, especially in bone and the brain. Moreover, PGAP4-KO mice were more vulnerable to prion diseases and died earlier after intracerebral inoculation of the pathogenic prion strains than wildtype mice, highlighting the protective roles of the GalNAc side chain against prion diseases.	[Hirata, Tetsuya; Tokoro, Yuko; Kizuka, Yasuhiko] Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan; [Kobayashi, Atsushi] Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Furuse, Tamio; Yamada, Ikuko; Tamura, Masaru] RIKEN BioResource Res Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Tomita, Hiroyuki] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Ninomiya, Akinori] Core Instrumentat Facil, Suita, Osaka, Japan; [Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Dept Expt Genome Res, Suita, Osaka, Japan	Gifu University; Hokkaido University; RIKEN; Gifu University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan.; Kinoshita, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.; Kinoshita, T (corresponding author), Dept Expt Genome Res, Suita, Osaka, Japan.	kizuka@gifu-u.ac.jp; tkinoshi@biken.osaka-u.ac.jp	Furuse, Tamio/I-2163-2019; ikawa, masahito/A-5315-2009; Fujihara, Yoshitaka/G-2043-2011	Furuse, Tamio/0000-0002-9276-6040; ikawa, masahito/0000-0001-9859-6217; Fujihara, Yoshitaka/0000-0001-8332-3507; Kizuka, Yasuhiko/0000-0002-3181-9743	Japan Science and Technology (JST) [20K15746, JPMJAX201B]; Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science (JSPS) [20H03207]; CREST grant from JST [18070267]; Takeda Science Foundation; Tokyo Biochemical Research Foundation	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST grant from JST; Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation	This work was partially supported by a Grant-in-Aid for Early-Career Scientists to T. H. (20K15746) , an ACT-X grant (JPMJAX201B to T. H.) from Japan Science and Technology (JST) , Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists to T. H. and a grant from Kato Memorial Bioscience Foundation to T. H., a Grant-in-Aid for Sci-entific Research (B) to Y. K. (20H03207) , a Leading Initiative forExcellent Young Researchers (LEADER) project (Y. K.) from the Japan Society for the Promotion of Science (JSPS) , a CREST grant (18070267 to Y. K.) from JST, a grant from the Takeda Science Foundation to Y. K., and a grant from the Tokyo Biochemical Research Foundation to Y. K.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CHANDLER RL, 1961, LANCET, V1, P1378; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Horn D, 2014, EUR J HUM GENET, V22, P762, DOI 10.1038/ejhg.2013.241; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Karp NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15475; Kasahara K, 2002, NEUROCHEM RES, V27, P823, DOI 10.1023/A:1020265225916; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; Knaus A, 2019, AM J HUM GENET, V105, P395, DOI 10.1016/j.ajhg.2019.06.009; Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5; Kobayashi A, 2020, J BIOL CHEM, V295, P7789, DOI 10.1074/jbc.RA120.013444; Liu YS, 2020, BIOCHEM SOC T, V48, P1129, DOI 10.1042/BST20191142; Lukacs M, 2020, HUM MOL GENET, V29, P1205, DOI 10.1093/hmg/ddaa046; Lukacs M, 2019, ELIFE, V8, DOI 10.7554/eLife.45248; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; Michalovicz LT, 2019, J NEUROCHEM, V150, P420, DOI 10.1111/jnc.14800; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; MUKASA R, 1995, ARCH BIOCHEM BIOPHYS, V318, P182, DOI 10.1006/abbi.1995.1219; Munesue Y, 2018, NEUROSCI LETT, V668, P43, DOI 10.1016/j.neulet.2018.01.014; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; Murakami Y, 2019, AM J HUM GENET, V105, P384, DOI 10.1016/j.ajhg.2019.05.019; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Qiu SF, 2010, BIOL PSYCHIAT, V68, P197, DOI 10.1016/j.biopsych.2010.02.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangel A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-8; Rodriguez de Los Santos M., 2021, P NATL ACAD SCI USA, V118; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Smith HL, 2020, NEURON, V105, P855, DOI 10.1016/j.neuron.2019.12.014; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Tan RPA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00378; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Wang YT, 2013, J BIOL CHEM, V288, P25490, DOI 10.1074/jbc.M113.492611; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wang YC, 2019, J BIOL CHEM, V294, P5038, DOI 10.1074/jbc.RA119.007472; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	77	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101720	10.1016/j.jbc.2022.101720	http://dx.doi.org/10.1016/j.jbc.2022.101720			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151686	gold, Green Published			2022-12-28	WOS:000789394500005
J	Hsu, CW; Sowers, ML; Baljinnyam, T; Herring, JL; Hackfeld, LC; Tang, H; Zhang, KL; Sowers, LC				Hsu, Chia Wei; Sowers, Mark L.; Baljinnyam, Tuvshintugs; Herring, Jason L.; Hackfeld, Linda C.; Tang, Hui; Zhang, Kangling; Sowers, Lawrence C.			Measurement of deaminated cytosine adducts in DNA using a novel hybrid thymine DNA glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; P53 GENE; HYDROLYTIC DEAMINATION; SUBSTRATE RECOGNITION; N-GLYCOSYLASE; URACIL; 5-METHYLCYTOSINE; MUTATIONS; RESIDUES; METHYLATION	The hydrolytic deamination of cytosine and 5-methylcytosine drives many of the transition mutations observed in human cancer. The deamination-induced mutagenic intermediates include either uracil or thymine adducts mispaired with guanine. While a substantial array of methods exist to measure other types of DNA adducts, the cytosine deamination adducts pose unusual analytical problems, and adequate methods to measure them have not yet been developed. We describe here a novel hybrid thymine DNA glycosylase (TDG) that is comprised of a 29-amino acid sequence from human TDG linked to the catalytic domain of a thymine glycosylase found in an archaeal thermophilic bacterium. Using defined-sequence oligonucleotides, we show that hybrid TDG has robust mispair-selective activity against deaminated U:G and T:G mispairs. We have further developed a method for separating glycosylase-released free bases from oligonucleotides and DNA followed by GC-MS/MS quantification. Using this approach, we have measured for the first time the levels of total uracil, U:G, and T:G pairs in calf thymus DNA. The method presented here will allow the measurement of the formation, persistence, and repair of a biologically important class of deaminated cytosine adducts.	[Hsu, Chia Wei; Sowers, Mark L.; Baljinnyam, Tuvshintugs; Herring, Jason L.; Hackfeld, Linda C.; Tang, Hui; Zhang, Kangling; Sowers, Lawrence C.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hsu, Chia Wei; Sowers, Mark L.] Univ Texas Med Branch, MD PhD Combined Degree Program, Galveston, TX USA; [Sowers, Lawrence C.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sowers, LC (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Sowers, LC (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	lasowers@UTMB.edu		Sowers, Mark/0000-0001-6474-017X; Hsu, Chia Wei/0000-0001-8863-462X	University of Texas Medical Branch; National Institutes of Health [SF30 CA225116]	University of Texas Medical Branch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C. W. H. and M. L. S. were supported in part by the University of Texas Medical Branch physician-scientist training program. C. W. H. was supported in part by the National Institutes of Health (grant no.: SF30 CA225116) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbeithuber B, 2016, DNA RES, V23, P547, DOI 10.1093/dnares/dsw038; Beckman KB, 2000, FREE RADICAL BIO MED, V29, P357, DOI 10.1016/S0891-5849(00)00316-6; Begley TJ, 1999, PROTEIN ENG, V12, P333, DOI 10.1093/protein/12.4.333; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BLOUNT BC, 1994, ANAL BIOCHEM, V219, P195, DOI 10.1006/abio.1994.1257; Briggs AW, 2012, METHODS MOL BIOL, V840, P143, DOI 10.1007/978-1-61779-516-9_18; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Coey CT, 2016, NUCLEIC ACIDS RES, V44, P10248, DOI 10.1093/nar/gkw768; Cooper David N, 2010, Hum Genomics, V4, P406; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; DUBE DK, 1979, BIOCHIM BIOPHYS ACTA, V561, P369, DOI 10.1016/0005-2787(79)90145-X; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Galashevskaya A, 2013, DNA REPAIR, V12, P699, DOI 10.1016/j.dnarep.2013.05.002; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Horst JP, 1996, EMBO J, V15, P5459, DOI 10.1002/j.1460-2075.1996.tb00929.x; Iengar P, 2012, NUCLEIC ACIDS RES, V40, P6401, DOI 10.1093/nar/gks290; IVARIE R, 1987, NUCLEIC ACIDS RES, V15, P9975, DOI 10.1093/nar/15.23.9975; Jang HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060148; Jaruga P, 2008, FREE RADICAL BIO MED, V45, P1601, DOI 10.1016/j.freeradbiomed.2008.09.019; Jumpathong W, 2015, P NATL ACAD SCI USA, V112, pE4845, DOI 10.1073/pnas.1503945112; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kim S, 2017, J MOL DIAGN, V19, P137, DOI 10.1016/j.jmoldx.2016.09.006; KIRK JTO, 1967, BIOCHEM J, V105, P673, DOI 10.1042/bj1050673; Kladova OA, 2020, BIOCHEMISTRY-MOSCOW+, V85, P480, DOI 10.1134/S0006297920040082; Lewis CA, 2016, P NATL ACAD SCI USA, V113, P8194, DOI 10.1073/pnas.1607580113; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu PF, 2002, CHEM RES TOXICOL, V15, P1001, DOI 10.1021/tx020030a; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Mashiyama ST, 2008, ANAL BIOCHEM, V372, P21, DOI 10.1016/j.ab.2007.08.034; MCHUGH PJ, 1995, NUCLEIC ACIDS RES, V23, P1664, DOI 10.1093/nar/23.10.1664; Mechetin GV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093118; Minko IG, 2020, DNA REPAIR, V85, DOI 10.1016/j.dnarep.2019.102741; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; Olinski R, 2010, MUTAT RES-REV MUTAT, V705, P239, DOI 10.1016/j.mrrev.2010.08.001; PHILIPPSEN P, 1975, EUR J BIOCHEM, V57, P55, DOI 10.1111/j.1432-1033.1975.tb02276.x; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; Ren J, 2002, ANAL CHEM, V74, P295, DOI 10.1021/ac010556k; RICHARDS RG, 1984, ADV ENZYME REGUL, V22, P157, DOI 10.1016/0065-2571(84)90013-X; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Rogstad DK, 2002, BIOCHEMISTRY-US, V41, P8093, DOI 10.1021/bi012180a; Sangaraju D, 2014, J AM SOC MASS SPECTR, V25, P1124, DOI 10.1007/s13361-014-0916-x; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Schuermann D, 2016, NUCLEIC ACIDS RES, V44, P2187, DOI 10.1093/nar/gkv1520; SHEN JC, 1992, NUCLEIC ACIDS RES, V20, P5119, DOI 10.1093/nar/20.19.5119; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SOWERS LC, 1989, MUTAT RES, V215, P131, DOI 10.1016/0027-5107(89)90225-X; STURM KS, 1981, NUCLEIC ACIDS RES, V9, P4537, DOI 10.1093/nar/9.18.4537; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Totsuka Y, 2021, CANCER SCI, V112, P7, DOI 10.1111/cas.14666; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WANG RYH, 1982, BIOCHIM BIOPHYS ACTA, V697, P371, DOI 10.1016/0167-4781(82)90101-4; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730; You CJ, 2016, ACCOUNTS CHEM RES, V49, P205, DOI 10.1021/acs.accounts.5b00437	65	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101638	10.1016/j.jbc.2022.101638	http://dx.doi.org/10.1016/j.jbc.2022.101638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085553	gold, Green Published			2022-12-28	WOS:000789261900015
J	Ohara-Nemoto, Y; Shimoyama, Y; Ono, T; Sarwar, MT; Nakasato, M; Sasaki, M; Nemoto, TK				Ohara-Nemoto, Yuko; Shimoyama, Yu; Ono, Toshio; Sarwar, Mohammad Tanvir; Nakasato, Manami; Sasaki, Minoru; Nemoto, Takayuki K.			Expanded substrate specificity supported by P1' and P2' residues enables bacterial dipeptidyl-peptidase 7 to degrade bioactive peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; CRYSTAL-STRUCTURE; PERIODONTITIS; PROTEASE; BACTEREMIA; DPP11; RISK; IV	Dipeptide production from extracellular proteins is crucial for Porphyromonas gingivalis, a pathogen related to chronic periodontitis, because its energy production is entirely dependent on the metabolism of amino acids predominantly incorporated as dipeptides. These dipeptides are produced by periplasmic dipeptidyl-peptidase (DPP)4, DPP5, DPP7, and DPP11. Although the substrate specificities of these four DPPs cover most amino acids at the penultimate position from the N terminus (P1), no DPP is known to cleave penultimate Gly, Ser, Thr, or His. Here, we report an expanded substrate preference of bacterial DPP7 that covers those residues. MALDI-TOF mass spectrometry analysis demonstrated that DPP7 effi- ciently degraded incretins and other gastrointestinal peptides, which were successively cleaved at every second residue, including Ala, Gly, Ser, and Gln, as well as authentic hydrophobic residues. Intravenous injection of DPP7 into mice orally administered glucose caused declines in plasma glucagon-like peptide-1 and insulin, accompanied by increased blood glucose levels. A newly developed coupled enzyme reaction system that uses synthetic fluorogenic peptides revealed that the P1' and P2' residues of substrates significantly elevated kcat values, providing an expanded substrate preference. This activity enhancement was most effective toward the substrates with nonfavorable but nonrepulsive P1 residues in DPP7. Enhancement of k(cat) by prime-side residues was also observed in DPP11 but not DPP4 and DPP5. Based on this expanded substrate specificity, we demonstrate that a combination of DPPs enables proteolytic liberation of all types of N-terminal dipeptides and ensures P. gingivalis growth and pathogenicity.& nbsp;	[Ohara-Nemoto, Yuko; Ono, Toshio; Sarwar, Mohammad Tanvir; Nemoto, Takayuki K.] Nagasaki Univ, Dept Oral Mol Biol, Course Med & Dent Sci, Grad Sch Biomed Sci, Nagasaki, Japan; [Shimoyama, Yu; Sasaki, Minoru] Iwate Med Univ, Dept Microbiol, Div Mol Microbiol, Yahaba, Iwate, Japan; [Nakasato, Manami] Iwate Med Univ, Dept Conservat Dent, Div Periodontol, Sch Dent, Morioka, Iwate, Japan; [Sarwar, Mohammad Tanvir] Islamic Univ, Fac Biol Sci, Dept Appl Nutr & Food Technol, Kushtia 7003, Bangladesh	Nagasaki University; Iwate Medical University; Iwate Medical University; Islamic University	Nemoto, TK (corresponding author), Nagasaki Univ, Dept Oral Mol Biol, Course Med & Dent Sci, Grad Sch Biomed Sci, Nagasaki, Japan.	tnemoto@nagasaki-u.ac.jp		Shimoyama, Yu/0000-0002-4143-6519; Ohara-Nemoto, Yuko/0000-0002-2822-7296	Japan Society for the Promotion of Science KAKENHI [JP19K10045, JP19K10071, JP19K19005]; Kyushu Dental Association	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyushu Dental Association	Funding and additional information-This study was supported by the Japan Society for the Promotion of Science KAKENHI grants (JP19K10045 to T. K. N., JP19K10071 to Y. O.-N., and JP19K19005 to M. N.) and a grant from the Kyushu Dental Association (to T. K. N.) .	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Bezerra GA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03220-y; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gallwitz B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00389; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Genco RJ, 2010, NAT REV CARDIOL, V7, P479, DOI 10.1038/nrcardio.2010.120; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hack K, 2017, J THROMB HAEMOST, V15, P487, DOI 10.1111/jth.13605; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; MENTLEIN R, 1988, FEBS LETT, V234, P251, DOI 10.1016/0014-5793(88)80092-9; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Nemoto TK, 2021, MOL ORAL MICROBIOL, V36, P145, DOI 10.1111/omi.12317; Nemoto TK, 2018, ANAL BIOCHEM, V548, P78, DOI 10.1016/j.ab.2018.02.008; Nemoto TK, 2016, J BIOL CHEM, V291, P5913, DOI 10.1074/jbc.M115.687566; Nemoto TK, 2016, JPN DENT SCI REV, V52, P22, DOI 10.1016/j.jdsr.2015.08.002; Ohara-Nemoto Y, 2020, FEMS MICROBIOL LETT, V367, DOI 10.1093/femsle/fnaa204; Ohara-Nemoto Y, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny221; Ohara-Nemoto Y, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00277-17; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Rea D, 2017, EUR J MED CHEM, V139, P482, DOI 10.1016/j.ejmech.2017.08.024; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sakamoto Y., 2014, SCI; Sarwar MT, 2020, BIOL CHEM, V401, P629, DOI 10.1515/hsz-2019-0387; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; Tabeta K, 2014, JPN DENT SCI REV, V50, P55, DOI 10.1016/j.jdsr.2014.03.001; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; TANGLARSEN J, 1995, J PERIODONTAL RES, V30, P390, DOI 10.1111/j.1600-0765.1995.tb01292.x; Teixeira FB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00327	47	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101585	10.1016/j.jbc.2022.101585	http://dx.doi.org/10.1016/j.jbc.2022.101585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35032549	Green Published, gold			2022-12-28	WOS:000791267400012
J	Tang, H; Zhu, RC; Waldman, M; Zhu, QS				Tang, Hong; Zhu, Richard; Waldman, Meryl; Zhu, Quansheng			Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(2) RECEPTOR; ANTI-PLA2R ANTIBODIES; SPONTANEOUS REMISSION; PLA2R AUTOANTIBODIES; MANNOSE RECEPTOR; IDENTIFICATION; EXPRESSION; DIAGNOSIS; BINDING; PROTEIN	Anti-phospholipase A2 receptor autoantibody (PLA2R-Ab) plays a critical role in the pathogenesis of primary membranous nephropathy (PMN), an autoimmune kidney disease charac-terized by immune deposits in the glomerular subepithelial spaces and proteinuria. However, the mechanism of how PLA2R-Abs interact with the conformational epitope(s) of PLA2R has remained elusive. PLA2R is a single transmembrane helix receptor containing ten extracellular domains that begin with a CysR domain followed by a FnII and eight CTLD do-mains. Here, we examined the interactions of PLA2R-Ab with the full PLA2R protein, N-terminal domain truncations, and C-terminal domain deletions under either denaturing or physio-logical conditions. Our data demonstrate that the PLA2R-Abs against the dominant epitope (the N-terminal CysR-CTLD1 triple domain) possess weak cross-reactivities to the C-termi-nal domains beyond CTLD1. Moreover, both the CysR and CTLD1 domains are required to form a conformational epitope for PLA2R-Ab interaction, with FnII serving as a linker domain. Upon close examination, we also observed that pa-tients with newly diagnosed PMN carry two populations of PLA2R-Abs in sera that react to the denatured CysR-CTLD3 (the PLA2R-Ab(1)) and denatured CysR-CTLD1 (the PLA2R-Ab(2)) domain complexes on Western blots, respectively. Furthermore, the PLA2R-Ab(1) appeared at an earlier time point than PLA2R-Ab(2) in patients, whereas the increased levels of PLA2R-Ab(2) coincided with the worsening of proteinuria. In summary, our data support that an integrated folding of the three PLA2R N-terminal domains, CysR, FnII, and CTLD1, is a prerequisite to forming the PLA2R conformational epitope and that the dominant epitope-reactive PLA2R-Ab(2) plays a critical role in PMN clinical progression.	[Tang, Hong; Zhu, Richard; Zhu, Quansheng] ImmunoWork, Monrovia, CA USA; [Waldman, Meryl] NIH, Clin Res Ctr, Kidney Dis Sect, NIDDK, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhu, QS (corresponding author), ImmunoWork, Monrovia, CA USA.	qzhu@immunowork.com			National Institute of Diabetes and Digestive and Kidney Diseases	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was also supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases (to M. W.) .	Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; Burbelo PD, 2020, J AM SOC NEPHROL, V31, P208, DOI 10.1681/ASN.2019050538; Cao LX, 2015, P NATL ACAD SCI USA, V112, P7237, DOI 10.1073/pnas.1505924112; Couser WG, 2017, CLIN J AM SOC NEPHRO, V12, P983, DOI 10.2215/CJN.11761116; Debiec H, 2011, AM J TRANSPLANT, V11, P2144, DOI 10.1111/j.1600-6143.2011.03643.x; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Dong Y, 2017, J MOL BIOL, V429, P3825, DOI 10.1016/j.jmb.2017.10.019; Duquesnoy RJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00469; Fresquet M, 2015, J AM SOC NEPHROL, V26, P302, DOI 10.1681/ASN.2014050502; He YN, 2011, P NATL ACAD SCI USA, V108, P12431, DOI 10.1073/pnas.1106925108; Heymann JAW, 1997, P NATL ACAD SCI USA, V94, P4966, DOI 10.1073/pnas.94.10.4966; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2015, NEPHROL DIAL TRANSPL, V30, P1862, DOI 10.1093/ndt/gfv228; Hoxha E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110681; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Jullien P, 2017, CLIN KIDNEY J, V10, P209, DOI 10.1093/ckj/sfw121; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kao LY, 2015, J AM SOC NEPHROL, V26, P291, DOI 10.1681/ASN.2013121315; Kumar S, 2001, BIOPHYS J, V80, P2439, DOI 10.1016/S0006-3495(01)76213-3; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Reinhard L, 2020, J AM SOC NEPHROL, V31, P197, DOI 10.1681/ASN.2019030273; Rivera-Calzada A, 2003, EMBO REP, V4, P807, DOI 10.1038/sj.embor.embor898; Ronco P, 2015, LANCET, V385, P1983, DOI 10.1016/S0140-6736(15)60731-0; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; Seitz-Polski B, 2018, J AM SOC NEPHROL, V29, P401, DOI 10.1681/ASN.2017070734; Seitz-Polski B, 2016, J AM SOC NEPHROL, V27, P1517, DOI 10.1681/ASN.2014111061; Tambur AR, 2014, TRANSPLANTATION, V98, P157, DOI 10.1097/TP.0000000000000220; Timmermans SAMEG, 2015, AM J NEPHROL, V42, P70, DOI 10.1159/000437236; Van de Logt AE, 2021, KIDNEY INT REP, V6, P1677, DOI 10.1016/j.ekir.2021.04.002; Van de Logt AE, 2019, KIDNEY INT, V96, P1292, DOI 10.1016/j.kint.2019.07.014; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Waldman M, 2016, KIDNEY INT REP, V1, P73, DOI 10.1016/j.ekir.2016.05.002; Yu BW, 2019, J STRUCT BIOL, V207, P295, DOI 10.1016/j.jsb.2019.06.007; Zhu Quansheng, 2016, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V16, P4, DOI 10.2174/1871522215666150910205702	39	2	3	7	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101605	10.1016/j.jbc.2022.101605	http://dx.doi.org/10.1016/j.jbc.2022.101605			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065076	gold, Green Published			2022-12-28	WOS:000789396300004
J	Butrin, A; Butrin, A; Wawrzak, Z; Moran, GR; Liu, DL				Butrin, Arseniy; Butrin, Anastassiya; Wawrzak, Zdzislaw; Moran, Graham R.; Liu, Dali			Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATOR; HEPATOCELLULAR-CARCINOMA; IN-VITRO; CRYSTAL-STRUCTURE; GYRATE ATROPHY; LIVER; ACID; RAT; ASSOCIATION; MANAGEMENT	Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and occurs predominantly in patients with underlying chronic liver diseases. Over the past decade, human ornithine aminotransferase (hOAT), which is an enzyme that catalyzes the metabolic conversion of ornithine into an intermediate for proline or glutamate synthesis, has been found to be overexpressed in HCC cells. hOAT has since emerged as a promising target for novel anticancer therapies, especially for the ongoing rational design effort to discover mechanism-based inactivators (MBIs). Despite the significance of hOAT in human metabolism and its clinical potential as a drug target against HCC, there are significant knowledge deficits with regard to its catalytic mechanism and structural characteristics. Ongoing MBI design efforts require in-depth knowledge of the enzyme active site, in particular, pKa values of potential nucleophiles and residues necessary for the molecular recognition of ligands. Here, we conducted a study detailing the fundamental active-site properties of hOAT using stopped-flow spectrophotometry and X-ray crystallography. Our results quantitatively revealed the pH dependence of the multistep reaction mechanism and illuminated the roles of ornithine alpha-amino and delta-amino groups in substrate recognition and in facilitating catalytic turnover. These findings provided insights of the catalytic mechanism that could benefit the rational design of MBIs against hOAT. In addition, substrate recognition and turnover of several fragment-sized alternative substrates of hOATs, which could serve as structural templates for MBI design, were also elucidated.	[Butrin, Arseniy; Butrin, Anastassiya; Moran, Graham R.; Liu, Dali] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL USA	Loyola University Chicago; Northwestern University	Moran, GR; Liu, DL (corresponding author), Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA.	gmoran3@luc.edu; dliu@luc.edu	Liu, Dali/D-2571-2014	Liu, Dali/0000-0002-7587-703X	National Institutes of Health; National Cancer Institute [1R01CA260250-01]; Arthur J. Schmitt Foundation; Loyola University College of Arts and Sciences; National Science Foundation [1904480]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthur J. Schmitt Foundation; Loyola University College of Arts and Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health, National Cancer Institute grant 1R01CA260250-01 (to D. L.), funding from the Arthur J. Schmitt Foundation (to A. B.), and funds from the Loyola University College of Arts and Sciences and National Science Foundation grant 1904480 (to G. R. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Butrin A, 2021, ACS CHEM BIOL, V16, P67, DOI 10.1021/acschembio.0c00728; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; de Rosamel L, 2017, EXPERT OPIN EMERG DR, V22, P175, DOI 10.1080/14728214.2017.1336538; Dreffs A, 2018, CURR EYE RES, V43, P902, DOI 10.1080/02713683.2018.1458882; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fallingborg J, 1999, DAN MED BULL, V46, P183; Ginguay A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010018; Hamm LL, 2015, CLIN J AM SOC NEPHRO, V10, P2232, DOI 10.2215/CJN.07400715; Hao GY, 2018, RSC ADV, V8, P22182, DOI 10.1039/c8ra02095g; Hayashi H, 1997, BIOCHEMISTRY-US, V36, P13558, DOI 10.1021/bi971638z; Hennig M., 1994, ADV LIF SCI-SERIES, V1st, P29; HERZFELD A, 1968, J BIOL CHEM, V243, P3327; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kohler ES, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-107; Leathers JS, 2019, J CLIN GASTROENTEROL, V53, P464, DOI 10.1097/MCG.0000000000001085; Lide D.R., 2005, CRC HDB CHEM PHYS IN; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Markova M, 2005, J BIOL CHEM, V280, P36409, DOI 10.1074/jbc.M506977200; Mascarenhas R, 2017, BIOCHEMISTRY-US, V56, P4951, DOI 10.1021/acs.biochem.7b00499; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milgrom DP, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0143-4; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; Montioli R, 2021, BBA-PROTEINS PROTEOM, V1869, DOI 10.1016/j.bbapap.2020.140555; Moschitto MJ, 2019, J AM CHEM SOC, V141, P10711, DOI 10.1021/jacs.9b03254; MUECKLER MM, 1982, J BIOL CHEM, V257, P7178; PARK R, 1979, AM J PHYSIOL, V236, pF240, DOI 10.1152/ajprenal.1979.236.3.F240; PERAINO C, 1963, BIOCHIM BIOPHYS ACTA, V73, P222; PERAINO C, 1972, BIOCHIM BIOPHYS ACTA, V289, P117, DOI 10.1016/0005-2744(72)90114-3; Personeni N, 2017, J ONCOL PRACT, V13, P368, DOI 10.1200/JOP.2017.024604; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMESH V, 1991, MOL BIOL MED, V8, P81; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sayiner M, 2019, DIGEST DIS SCI, V64, P910, DOI 10.1007/s10620-019-05537-2; Schiroli D, 2015, BBA-PROTEINS PROTEOM, V1854, P1200, DOI 10.1016/j.bbapap.2015.02.023; Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583; Shen SD, 2021, J AM CHEM SOC, V143, P8689, DOI 10.1021/jacs.1c02456; Sherman M, 2012, HEPATOLOGY, V56, P793, DOI 10.1002/hep.25869; Shirmanova MV, 2015, BBA-GEN SUBJECTS, V1850, P1905, DOI 10.1016/j.bbagen.2015.05.001; Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289; Tomlinson C, 2011, PEDIATR RES, V69, P46, DOI 10.1203/PDR.0b013e3181fc6ab7; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WANG T, 1995, NAT GENET, V11, P185, DOI 10.1038/ng1095-185; WILLIAMS JA, 1982, BIOCHEM J, V201, P221, DOI 10.1042/bj2010221; Wu GY, 2004, J NUTR, V134, p2783S, DOI 10.1093/jn/134.10.2783S; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhu W, 2021, J AM CHEM SOC, V143, P8193, DOI 10.1021/jacs.1c03572; Zhu W, 2020, J AM CHEM SOC, V142, P4892, DOI 10.1021/jacs.0c00193; Zigmond E, 2015, ACS MED CHEM LETT, V6, P840, DOI 10.1021/acsmedchemlett.5b00153	52	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101969	10.1016/j.jbc.2022.101969	http://dx.doi.org/10.1016/j.jbc.2022.101969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35460691	gold, Green Published			2022-12-28	WOS:000807755100010
J	Prather, ER; Gavrilin, MA; Wewers, MD				Prather, Evan R.; Gavrilin, Mikhail A.; Wewers, Mark D.			The central inflammasome adaptor protein ASC activates the inflammasome after transition from a soluble to an insoluble state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECK-LIKE PROTEIN; HUMAN MONOCYTES; CELL-DEATH; CASPASE-1; MECHANISM; APOPTOSIS; RELEASE; MACROPHAGES; FAMILY	Apoptosis-associated speck-like protein containing a caspase recruitment domain (CARD) (ASC) is a 22 kDa protein that functions as the central adaptor for inflammasome assembly. ASC forms insoluble specks in monocytes undergoing pyroptosis, and the polymerization of ASC provides a template of CARDs that leads to proximity-mediated autoactivation of caspase-1 in canonical inflammasomes. However, specks are insoluble protein complexes, and solubility is typically important for protein function. Therefore, we sought to define whether ASC specks comprise active inflammasome complexes or are simply the end stage of exhausted ASC polymers. Using a THP-1 cell-lysing model of caspase-1 activation that is ASC dependent, we compared caspase-1 activation induced by preassembled insoluble ASC specks and soluble monomeric forms of ASC. Unexpectedly, after controlling for the concentration dependence of ASC oligomerization, we found that only insoluble forms of ASC promoted caspase-1 autocatalysis. This link to insolubility was recapitulated with recombinant ASC. We show that purified recombinant ASC spontaneously precipitated and was functional, whereas the maltose-binding protein-ASC fusion to ASC (promoting enhanced solubility) was inactive until induced to insolubility by binding to amylose beads. This functional link to insolubility also held true for the Y146A mutation of the CARD of ASC, which avoids insolubility and caspase-1 activation. Thus, we conclude that the role of ASC insolubility in inflammasome function is inextricably linked to its pyrin domain-mediated and CARD-mediated polymerizations. These findings will support future studies into the molecular mechanisms controlling ASC solubility.	[Prather, Evan R.; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA	Ohio State University	Gavrilin, MA (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA.	Mikhail.A.Gavrilin@gmail.com; Wewers.2@osu.edu			US National Institutes of Health [HL-076278]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by US National Institutes of Health grant (grant no.: HL-076278; to M. D. W.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Carty M, 2019, IMMUNITY, V50, P1412, DOI 10.1016/j.immuni.2019.04.005; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Compan V, 2015, J IMMUNOL, V194, P1261, DOI 10.4049/jimmunol.1301676; Conos SA, 2016, CELL DEATH DIFFER, V23, P1827, DOI 10.1038/cdd.2016.69; Diamond CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07081-3; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gavrilin MA, 2021, J IMMUNOL, V206, P1329, DOI 10.4049/jimmunol.2000969; Gavrilin MA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00461; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Nagar A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.752482; Nambayan RJT, 2019, J BIOL CHEM, V294, P439, DOI 10.1074/jbc.RA118.004407; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Shamaa OR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142203; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Wewers MD, 1997, J IMMUNOL, V159, P5964; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	36	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102024	10.1016/j.jbc.2022.102024	http://dx.doi.org/10.1016/j.jbc.2022.102024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35568196	Green Published, gold			2022-12-28	WOS:000829588600002
J	Stephan, G; Frenster, JD; Liebscher, I; Placantonakis, DG				Stephan, Gabriele; Frenster, Joshua D.; Liebscher, Ines; Placantonakis, Dimitris G.			Activation of the adhesion G protein-coupled receptor GPR133 by antibodies targeting its N-terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST; GPCRS; EXPOSURE; DOMAIN	We recently demonstrated that GPR133 (ADGRD1), an adhesion G protein-coupled receptor involved in raising cytosolic cAMP levels, is necessary for growth of glioblastoma (GBM) and is de novo expressed in GBM relative to normal brain tissue. Our previous work suggested that dissociation of autoproteolytically generated N-terminal and C-terminal fragments of GPR133 at the plasma membrane correlates with receptor activation and signaling. To promote the goal of developing biologics that modulate GPR133 function, we investigated the effects of antibodies against the N-terminus of GPR133 on receptor signaling. Here, we show that treatment of HEK293T cells overexpressing GPR133 with these antibodies increased cAMP levels in a concentration-dependent manner. Analysis of culture medium following antibody treatment further indicated the presence of complexes of these antibodies with the autoproteolytically cleaved N-terminal fragments of GPR133. In addition, cells expressing a cleavage-deficient mutant of GPR133 (H543R) did not respond to antibody stimulation, suggesting that the effect is cleavage dependent. Finally, we demonstrate the antibody-mediated stimulation of WT GPR133, but not the cleavage-deficient H543R mutant, was reproducible in patient-derived GBM cells. These findings provide a paradigm for modulation of GPR133 function with biologics and support the hypothesis that the intramolecular cleavage in the N-terminus modulates receptor activation and signaling.	[Stephan, Gabriele; Frenster, Joshua D.; Placantonakis, Dimitris G.] NYU Grossman Sch Med, Dept Neurosurg, New York, NY 10016 USA; [Liebscher, Ines] Univ Leipzig, Inst Biochem, Rudolf Schonheimer Mol Biochem, Leipzig, Germany; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Brain & Spine Tumor Ctr, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA	Leipzig University	Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Dept Neurosurg, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Brain & Spine Tumor Ctr, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA.	dimitris.placantonakis@nyulangone.org		Frenster, Joshua/0000-0003-2401-1575	NIH/NINDS, United States [R01 NS102665]; NYSTEM, United States (NY State Stem Cell Science) [IIRP C32595GG]; NIH/NIBIB, United States [R01 EB028774]; NIH/NCI, United States [R21CA263402]; NIH/NCATS, United States [2UL1TR001445]; NYU Grossman School of Medicine, United States; DFG (German Research Foundation) , Germany [STE 2843/1-1]; German Research Foundation; European Union, European Union (European Social Fund, European Union);  [209933838];  [421152132 B05];  [246212759]	NIH/NINDS, United States; NYSTEM, United States (NY State Stem Cell Science); NIH/NIBIB, United States; NIH/NCI, United States; NIH/NCATS, United States; NYU Grossman School of Medicine, United States; DFG (German Research Foundation) , Germany(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); European Union, European Union (European Social Fund, European Union); ; ; 	This study was supported by NIH/NINDS, United States R01 NS102665 and NYSTEM, United States (NY State Stem Cell Science) IIRP C32595GG to D. G. P. D. G. P was also supported by NIH/NIBIB, United States R01 EB028774, NIH/NCI, United States R21CA263402, NIH/NCATS, United States 2UL1TR001445, NYU Grossman School of Medicine, United States, and DFG (German Research Foundation) , Germany FOR2149. G. S. was supported by a DFG postdoctoral fellowship (STE 2843/1-1) . I. L. was funded by the German Research Foundation (CRC1052 project number 209933838, CRC1423 project number 421152132 B05, FOR2149 project number 246212759, P5) and the European Union, European Union (European Social Fund, European Union) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bayin NS, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.63; Beliu G, 2021, MOL CELL, V81, P905, DOI 10.1016/j.molcel.2020.12.042; Bhudia N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57989-6; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Favara DM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85408-x; Fischer L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2937-2; Frenster J. D., 2020, NEUROONCOL ADV, V2; Frenster JD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100798; Frenster JD, 2018, METHODS MOL BIOL, V1741, P63, DOI 10.1007/978-1-4939-7659-1_4; Frenster JD, 2017, NEUROSURGERY, V64, P177, DOI 10.1093/neuros/nyx227; Gad AA, 2020, ACS PHARMACOL TRANSL, V3, P29, DOI 10.1021/acsptsci.9b00093; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hayflick JS, 2000, J RECEPT SIGNAL TR R, V20, P119, DOI 10.3109/10799890009150640; Kaczmarek I, 2022, BIOL CHEM, V403, P195, DOI 10.1515/hsz-2021-0146; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Krishnan A, 2016, HANDB EXP PHARMACOL, V234, P15, DOI 10.1007/978-3-319-41523-9_2; Langenhan T, 2020, BASIC CLIN PHARMACOL, V126, P5, DOI 10.1111/bcpt.13223; Liebscher I, 2015, CELL REP, V10, P1021, DOI 10.1016/j.celrep.2015.01.065; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Muller A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005624; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Scholz N, 2019, ANN NY ACAD SCI, V1456, P80, DOI 10.1111/nyas.14192; Scholz N, 2017, ELIFE, V6, DOI 10.7554/eLife.28360; Stephan G., 2021, NEUROONCOL ADV, V3; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Vizurraga A, 2020, J BIOL CHEM, V295, P14065, DOI 10.1074/jbc.REV120.007423; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220	36	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101949	10.1016/j.jbc.2022.101949	http://dx.doi.org/10.1016/j.jbc.2022.101949			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35447113	Green Published, gold			2022-12-28	WOS:000807778400001
J	Huang, CA; Lu, JX; Ma, XJ; Qiang, JL; Wang, CC; Liu, C; Fang, YS; Zhang, YY; Jiang, L; Li, D; Zhang, SN				Huang, Chengan; Lu, Jinxia; Ma, Xiaojuan; Qiang, Jiali; Wang, Chuchu; Liu, Cong; Fang, Yanshan; Zhang, Yaoyang; Jiang, Lin; Li, Dan; Zhang, Shengnan			The mouse nicotinamide mononucleotide adenylyltransferase chaperones diverse pathological amyloid client proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; A-BETA; MOLECULAR CHAPERONES; DROSOPHILA MODEL; DISEASE; ALZHEIMERS; TAU; NEURODEGENERATION; NMNAT; IDENTIFICATION	Molecular chaperones safeguard cellular protein homeostasis and obviate proteotoxicity. In the process of aging, as chaperone networks decline, aberrant protein amyloid aggregation accumulates in a mechanism that underpins neurodegeneration, leading to pathologies such as Alzheimer's disease and Parkinson's disease. Thus, it is important to identify and characterize chaperones for preventing such protein aggregation. In this work, we identified that the NAD(+) synthase-nicotinamide mononucleotide adenylyltransferase (NMNAT) 3 from mouse (mN3) exhibits potent chaperone activity to antagonize aggregation of a wide spectrum of pathological amyloid client proteins including alpha-synuclein, Tau (K19), amyloid beta, and islet amyloid polypeptide. By combining NMR spectroscopy, cross-linking mass spectrometry, and computational modeling, we further reveal that mN3 uses different region of its amphiphilic surface near the active site to directly bind different amyloid client proteins. Our work demonstrates a client recognition mechanism of NMNAT via which it chaperones different amyloid client proteins against pathological aggregation and implies a potential protective role for NMNAT in different amyloid-associated diseases.	[Huang, Chengan; Lu, Jinxia; Li, Dan] Shanghai Jiao Tong Univ, Biox Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China; [Huang, Chengan; Lu, Jinxia; Li, Dan] Shanghai Jiao Tong Univ, Biox Renji Hosp Res Ctr, Renji Hosp, Sch Med, Shanghai, Peoples R China; [Ma, Xiaojuan; Qiang, Jiali; Wang, Chuchu; Liu, Cong; Fang, Yanshan; Zhang, Yaoyang; Zhang, Shengnan] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai, Peoples R China; [Ma, Xiaojuan; Qiang, Jiali; Wang, Chuchu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Lin] UCLA, Mol Biol Inst, Dept Neurol, Los Angeles, CA USA; [Jiang, Lin] UCLA, Brain Res Inst, Los Angeles, CA USA; [Li, Dan] Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shanghai Jiao Tong University	Li, D (corresponding author), Shanghai Jiao Tong Univ, Biox Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China.; Li, D (corresponding author), Shanghai Jiao Tong Univ, Biox Renji Hosp Res Ctr, Renji Hosp, Sch Med, Shanghai, Peoples R China.; Zhang, SN (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai, Peoples R China.; Li, D (corresponding author), Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study, Shanghai, Peoples R China.	lidan2017@sjtu.edu.cn; zhangshengnan@sioc.ac.cn		liu, cong/0000-0003-3425-6672; Fang, Yanshan/0000-0002-4123-0174	National Natural Science Foundation (NSF) of China [32170683, 82188101, 32171236, 31872716]; Science and Technology Commission of Shanghai Municipality (STCSM) [20XD1425000, 2019SHZDZX02]; CAS project for Young Scientists in Basic research [YSBR-009]; Shanghai Pilot Program for Basic Research - Chinese Academy of Science, Shanghai Branch [CYJ-SHFY-2022-005]; Joint Funds of the National Natural Science Foundation of China [U1932204]	National Natural Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); CAS project for Young Scientists in Basic research; Shanghai Pilot Program for Basic Research - Chinese Academy of Science, Shanghai Branch; Joint Funds of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank staff members of the National Facility for Protein Science in Shanghai, Zhangjiang Laboratory, China for providing technical support and assistance in NMR and BLI data collection. We thank the Cryo-Electron Microscopy center at Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry for help with data collection. This work was supported by the National Natural Science Foundation (NSF) of China (Grant No. 32170683, 82188101, 32171236, and 31872716) , the Science and Technology Commission of Shanghai Municipality (STCSM) (Grant No. 20XD1425000 and 2019SHZDZX02) , the CAS project for Young Scientists in Basic research (Grant No. YSBR-009) , the Shanghai Pilot Program for Basic Research - Chinese Academy of Science, Shanghai Branch (Grant No. CYJ-SHFY-2022-005) , and the Joint Funds of the National Natural Science Foundation of China (Grant No. U1932204) .	Ali YO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002472; Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Ali YO, 2012, HUM MOL GENET, V21, P237, DOI 10.1093/hmg/ddr449; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barghorn Stefan, 2004, V299, P35; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Brazill JM, 2017, CURR OPIN GENET DEV, V44, P156, DOI 10.1016/j.gde.2017.03.014; Camilleri A, 2014, CNS NEUROSCI THER, V20, P591, DOI 10.1111/cns.12264; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cieri D, 2018, BBA-MOL BASIS DIS, V1864, P3247, DOI 10.1016/j.bbadis.2018.07.011; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Diane A, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101313; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Gong Zhou, 2015, Biophys Rep, V1, P127, DOI 10.1007/s41048-015-0015-y; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackrel ME, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00099; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jia CY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01124; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Liu ZY, 2020, NAT STRUCT MOL BIOL, V27, P363, DOI 10.1038/s41594-020-0399-3; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Ma XJ, 2020, ELIFE, V9, DOI 10.7554/eLife.51859; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Park JH, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0349-x; Rao JN, 2009, J MOL BIOL, V390, P516, DOI 10.1016/j.jmb.2009.05.058; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Rossi F, 2018, BEHAV BRAIN RES, V339, P140, DOI 10.1016/j.bbr.2017.11.030; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wentink AS, 2020, NATURE, V587, P483, DOI 10.1038/s41586-020-2904-6; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	55	0	0	9	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101912	10.1016/j.jbc.2022.101912	http://dx.doi.org/10.1016/j.jbc.2022.101912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35398355	gold, Green Published			2022-12-28	WOS:000804923000004
J	Li, ZH; Kwon, SM; Li, DC; Li, LH; Peng, XW; Zhang, JR; Sueyoshi, T; Raufman, JP; Negishi, M; Wang, XW; Wang, HB				Li, Zhihu; Kwon, So Mee; Li, Daochuan; Li, Linhao; Peng, Xiwei; Zhang, Junran; Sueyoshi, Tatsuya; Raufman, Jean-Pierre; Negishi, Masahiko; Wang, Xin Wei; Wang, Hongbing			Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X RECEPTOR; NUCLEAR RECEPTOR; ENHANCER MODULE; CAR; ACTIVATION; EXPRESSION; INDUCTION; TUMORS; GENES; MICE	The constitutive androstane receptor (CAR) is a nuclear receptor that plays a crucial role in regulating xenobiotic meta-bolism and detoxification, energy homeostasis, and cell prolif-eration by modulating the transcription of numerous target genes. CAR activation has been established as the mode of action by which phenobarbital-like nongenotoxic carcinogens promote liver tumor formation in rodents. This paradigm, however, appears to be unrelated to the function of human CAR (hCAR) in hepatocellular carcinoma (HCC), which remains poorly under-stood. Here, we show that hCAR expression is significantly lower in HCC than that in adjacent nontumor tissues and, importantly, reduced hCAR expression is associated with a worse HCC prognosis. We also show overexpression of hCAR in human hepatoma cells (HepG2 and Hep3B) profoundly suppressed cell proliferation, cell cycle progression, soft-agar colony formation, and the growth of xenografts in nude mice. RNA-Seq analysis revealed that the expression of erythropoietin (EPO), a pleio-tropic growth factor, was markedly repressed by hCAR in hep-atoma cells. Addition of recombinant EPO in HepG2 cells partially rescued hCAR-suppressed cell viability. Mechanisti-cally, we showed that overexpressing hCAR repressed mitogenic EPO-EPO receptor signaling through dephosphorylation of signal transducer and activator of transcription 3, AKT, and extracellular signal-regulated kinase 1/2. Furthermore, we found that hCAR downregulates EPO expression by repressing the expression and activity of hepatocyte nuclear factor 4 alpha, a key transcription factor regulating EPO expression. Collectively, our results suggest that hCAR plays a tumor suppressive role in HCC development, which differs from that of rodent CAR and offers insight into the hCAR-hepatocyte nuclear factor 4 alpha- EPO axis in human liver tumorigenesis.	[Li, Zhihu; Li, Daochuan; Li, Linhao; Wang, Hongbing] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 20742 USA; [Kwon, So Mee; Wang, Xin Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD USA; NCI, Liver Canc Program, Ctr Canc Res, NIH, Bethesda, MD USA; [Zhang, Junran] Ohio State Univ, Dept Radiat Oncol, James Comprehens Canc Ctr, Columbus, OH USA; [Zhang, Junran] Ohio State Univ, Coll Med, Columbus, OH USA; [Sueyoshi, Tatsuya; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC USA; [Raufman, Jean-Pierre] Univ Maryland, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA; [Raufman, Jean-Pierre] VA Maryland Healthcare Syst, Biomed Lab Res & Dev, Off Res & Dev, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Maryland; University of Maryland Baltimore	Wang, HB (corresponding author), Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 20742 USA.	hongbing.wang@rx.umaryland.edu	Wang, Xin Wei/B-6162-2009	Wang, Xin Wei/0000-0001-9735-606X; Peng, Xiwei/0000-0002-2177-4350	National Institutes of Health, United States [R01 CA262084, GM121550, ZIA-BC010313, ZIA-BC010876, ZIA BC 010877, ZIA BC 011870, Z01ES1005-01]; Intramural Research Program of the National Institutes of Health, United States [BX004890]; Department of Veterans Affairs Biomedical Laboratory Research and Development Program, United States	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development Program, United States(US Department of Veterans Affairs)	This work was partly sup-ported by the National Institutes of Health, United States, grants R01 CA262084 and GM121550 (to H. W.) . S. M. K. and X. W. W. were supported by the grants ZIA-BC010313, ZIA-BC010876, ZIA BC 010877, and ZIA BC 011870, and T. S. and M. N. by Z01ES1005-01 from the Intramural Research Program of the National Institutes of Health, United States. J.-P. R. was supported by grant BX004890 from the Department of Veterans Affairs Biomedical Laboratory Research and Development Program, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aapro M, 2012, BRIT J CANCER, V106, P1249, DOI 10.1038/bjc.2012.42; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Auerbach SS, 2005, MOL PHARMACOL, V68, P1239, DOI 10.1124/mol.105.013417; Bunn HF, 1998, J EXP BIOL, V201, P1197; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen T, 2010, J PHARMACOL EXP THER, V332, P106, DOI 10.1124/jpet.109.159210; Debeljak N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00563; DIWAN BA, 1992, CARCINOGENESIS, V13, P1893, DOI 10.1093/carcin/13.10.1893; Ebert BL, 1999, BLOOD, V94, P1864; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fukumasu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099484; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gentile D, 2020, LIVER CANCER, V9, P15, DOI 10.1159/000503719; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kachaylo EM, 2012, EUR J PHARMACOL, V679, P139, DOI 10.1016/j.ejphar.2012.01.007; Ke SZ, 2017, HEPATOLOGY, V65, P134, DOI 10.1002/hep.28889; Kosaka M, 2012, NUCLEIC ACID THER, V22, P335, DOI 10.1089/nat.2012.0354; Lake BG, 2015, PEST MANAG SCI, V71, P829, DOI 10.1002/ps.3854; Li DC, 2015, BIOCHEM PHARMACOL, V98, P190, DOI 10.1016/j.bcp.2015.08.087; Li HS, 2009, DRUG METAB DISPOS, V37, P1098, DOI 10.1124/dmd.108.026005; Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287; Li ZH, 2017, J BIOL CHEM, V292, P13890, DOI 10.1074/jbc.M117.783860; Mackowiak B, 2018, DRUG METAB DISPOS, V46, P1361, DOI 10.1124/dmd.118.081042; Mackowiak B, 2016, BBA-GENE REGUL MECH, V1859, P1130, DOI 10.1016/j.bbagrm.2016.02.006; Matsuyama M, 2000, J SURG ONCOL, V75, P197, DOI 10.1002/1096-9098(200011)75:3<197::AID-JSO8>3.0.CO;2-I; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; OLSEN JH, 1995, CANCER RES, V55, P294; Parpart S, 2014, HEPATOLOGY, V60, P872, DOI 10.1002/hep.27200; PARZEFALL W, 1991, CANCER RES, V51, P1143; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Tang XJ, 2016, DRUG METAB DISPOS, V44, P1643, DOI 10.1124/dmd.116.070243; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Wang HB, 2003, CLIN PHARMACOKINET, V42, P1331, DOI 10.2165/00003088-200342150-00003; Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200; WARD JM, 1988, CANCER LETT, V39, P9, DOI 10.1016/0304-3835(88)90035-3; Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514; Yamada T, 2014, TOXICOL SCI, V142, P137, DOI 10.1093/toxsci/kfu173; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yueh MF, 2014, P NATL ACAD SCI USA, V111, P17200, DOI 10.1073/pnas.1419119111; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557	51	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101885	10.1016/j.jbc.2022.101885	http://dx.doi.org/10.1016/j.jbc.2022.101885			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35367211	gold, Green Published			2022-12-28	WOS:000804436700003
J	Lin, CH; Lin, YC; Yang, SB; Chen, PC				Lin, Ching-Han; Lin, Yu-Chi; Yang, Shi-Bing; Chen, Pei-Chun			Carbamazepine promotes surface expression of mutant Kir6.2-A28V ATP-sensitive potassium channels by modulating Golgi retention and autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; CORRECT TRAFFICKING DEFECTS; BETA-CELL; SULFONYLUREA RECEPTOR-1; K+ CHANNELS; MUTATIONS; PROTEIN; IDENTIFICATION; MECHANISM; SUBUNITS	Pancreatic beta-cells express ATP-sensitive potassium (K-ATP) channels, consisting of octamer complexes containing four sulfonylurea receptor 1 (SUR1) and four Kir6.2 subunits. Loss of K-ATP channel function causes persistent hyperinsulinemic hypoglycemia of infancy (PHHI), a rare but debilitating condition if not treated. We previously showed that the sodium channel blocker carbamazepine (Carb) corrects K-ATP channel surface expression defects induced by PHHI-causing mutations in SUR1. In this study, we show that Carb treatment can also ameliorate the trafficking deficits associated with a recently discovered PHHI-causing mutation in Kir6.2 (Kir6.2-A28V). In human embryonic kidney 293 or INS-1 cells expressing this mutant K-ATP channel (SUR1 and Kir6.2-A28V), biotinylation and immunostaining assays revealed that Carb can increase surface expression of the mutant KATP channels. We further examined the subcellular distributions of mutant K-ATP channels before and after Carb treatment; without Carb treatment, we found that mutant K-ATP channels were aberrantly accumulated in the Golgi apparatus. However, after Carb treatment, coimmunoprecipitation of mutant K-ATP channels and Golgi marker GM130 was diminished, and K-ATP staining was also reduced in lysosomes. Intriguingly, Carb treatment also simultaneously increased autophagic flux and p62 accumulation, suggesting that autophagy-dependent degradation of the mutant channel was not only stimulated but also interrupted. In summary, our data suggest that surface expression of Kir6.2A28V K-ATP channels is rescued by Carb treatment via promotion of mutant K-ATP channel exit from the Golgi apparatus and reduction of autophagy-mediated protein degradation.	[Lin, Ching-Han; Chen, Pei-Chun] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan; [Lin, Yu-Chi] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan, Taiwan; [Yang, Shi-Bing] Inst Biomed Sci, Acad Sin, Taipei, Taiwan; [Chen, Pei-Chun] Natl Cheng Kung Univ, Grad Inst Basic Med, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University	Chen, PC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan.; Yang, SB (corresponding author), Inst Biomed Sci, Acad Sin, Taipei, Taiwan.; Chen, PC (corresponding author), Natl Cheng Kung Univ, Grad Inst Basic Med, Coll Med, Tainan, Taiwan.	sbyang@ibms.sinica.edu.tw; pcchen@mail.ncku.edu.tw	Yang, Shi-Bing/C-8308-2011	Yang, Shi-Bing/0000-0001-8061-3963	NCKUH [11004016]; Ministry of Science and Technology (MOST) [MOST107-2320-B-006-014, MOST108-2320-B-006-0002, MOST109-2320-B-006-018-MY3, 106-2320-B-001-013, 107-2320-B-001-026-MY3, 110-2314-B-001-007]; Institute of Biomedical Sciences at Academia Sinica	NCKUH; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Institute of Biomedical Sciences at Academia Sinica	For this research, C.-H. L. received support from NCKUH-11004016. This work was sup-ported by the Ministry of Science and Technology (MOST; MOST107-2320-B-006-014, MOST108-2320-B-006-0002, and MOST109-2320-B-006-018-MY3 grants [to P.-C. C.] ; 106-2320-B-001-013, 107-2320-B-001-026-MY3, and 110-2314-B-001-007 grants [to S.-B. Y.] ) , and the Institute of Biomedical Sciences at Academia Sinica.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chen PC, 2013, J BIOL CHEM, V288, P20942, DOI 10.1074/jbc.M113.470948; Cooper PE, 2017, J BIOL CHEM, V292, P17387, DOI 10.1074/jbc.M117.804971; Devaraneni PK, 2015, J BIOL CHEM, V290, P7980, DOI 10.1074/jbc.M114.634576; Fehmann HC, 1997, PEPTIDES, V18, P1267, DOI 10.1016/S0196-9781(97)00135-6; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Goel Prabudh, 2012, J Indian Assoc Pediatr Surg, V17, P99, DOI 10.4103/0971-9261.98119; Goldenberg Marvin M, 2010, P T, V35, P392; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Hegazy Marihan, 2020, Curr Protoc Cell Biol, V89, pe115, DOI 10.1002/cpcb.115; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Martin GM, 2019, ELIFE, V8, DOI 10.7554/eLife.46417; Martin GM, 2016, J BIOL CHEM, V291, P21971, DOI 10.1074/jbc.M116.749366; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Obata H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112483; Parys JB, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-17; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pipatpolkai T, 2020, NAT REV ENDOCRINOL, V16, P378, DOI 10.1038/s41574-020-0351-y; Reimann F, 2003, J PHYSIOL-LONDON, V547, P159, DOI 10.1113/jphysiol.2002.031625; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Siwecka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184354; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Thayer DA, 2016, J PHYSIOL-LONDON, V594, P6701, DOI 10.1113/JP272394; Vajravelu ME, 2018, CURR OPIN PEDIATR, V30, P568, DOI 10.1097/MOP.0000000000000645; Webster JM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01047; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yang YY, 2017, CHANNELS, V11, P636, DOI 10.1080/19336950.2017.1393131; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou Q, 2014, CHANNELS, V8, P376, DOI 10.4161/chan.29117	42	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101904	10.1016/j.jbc.2022.101904	http://dx.doi.org/10.1016/j.jbc.2022.101904			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35398096	Green Published, gold			2022-12-28	WOS:000804436700001
J	Liu, LP; Lucas, RM; Nanson, JD; Li, Y; Whitfield, J; Curson, JEB; Tuladhar, N; Alexandrov, K; Mobli, M; Sweet, MJ; Kobe, B; Stow, JL; Luo, L				Liu, Liping; Lucas, Richard M.; Nanson, Jeffrey D.; Li, Yan; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Alexandrov, Kirill; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin			The transmembrane adapter SCIMP recruits tyrosine kinase Syk to phosphorylate Toll-like receptors to mediate selective inflammatory outputs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; TIR-DOMAIN; PULL-DOWN; LPS; RECOGNITION; DECTIN-1; SIGNAL; INDUCTION; RESPONSES; REVEALS	Innate immune signaling by Toll-like receptors (TLRs) involves receptor phosphorylation, which helps to shape and drive key inflammatory outputs, yet our understanding of the kinases and mechanisms that mediate TLR phosphorylation is incomplete. Spleen tyrosine kinase (Syk) is a nonreceptor protein tyrosine kinase, which is known to relay adaptive and innate immune signaling, including from TLRs. However, TLRs do not contain the conserved dual immunoreceptor tyrosine based activation motifs that typically recruit Syk to many other receptors. One possibility is that the Syk-TLR association is indirect, relying on an intermediary scaffolding protein. We previously identified a role for the palmitoylated trans membrane adapter protein SCIMP in scaffolding the Src tyrosine kinase Lyn, for TLR phosphorylation, but the role of SCIMP in mediating the interaction between Syk and TLRs has not yet been investigated. Here, we show that SCIMP recruits Syk in response to lipopolysaccharide-mediated TLR4 activation. We also show that Syk contributes to the phosphorylation of SCIMP and TLR4 to enhance their binding. Further evidence pinpoints two specific phosphorylation sites in SCIMP critical for its interaction with Syk-SH2 domains in the absence of immunoreceptor tyrosine-based activation motifs. Finally, using inhibitors and primary macrophages from SCIMP-/-mice, we confirm a functional role for SCIMP-mediated Syk interaction in modulating TLR4 phosphorylation, signaling, and cytokine outputs. In conclusion, we identify SCIMP as a novel, immune-specific Syk scaffold, which can contribute to inflammation through selective TLR-driven inflammatory responses.	[Liu, Liping; Lucas, Richard M.; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin] Inst Mol Biosci, Brisbane, Qld, Australia; [Liu, Liping; Lucas, Richard M.; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin] IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia; [Nanson, Jeffrey D.; Li, Yan; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Alexandrov, Kirill] Queensland Univ Technol, Sch Biol & Environm Sci, Ctr Agr & Bioecon, CSIRO QUT Synthet Biol Alliance, Brisbane, Qld, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT); University of Queensland	Stow, JL; Luo, L (corresponding author), Inst Mol Biosci, Brisbane, Qld, Australia.; Stow, JL; Luo, L (corresponding author), IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia.	j.stow@imb.uq.edu.au; l.luo@imb.uq.edu.au	; Kobe, Bostjan/D-1292-2009; Luo, Lin/B-7845-2016; Sweet, Matthew/F-2229-2011	Nanson, Jeff/0000-0003-1306-1948; Lucas, Richard/0000-0001-8798-6172; Kobe, Bostjan/0000-0001-9413-9166; Luo, Lin/0000-0001-5556-7096; Sweet, Matthew/0000-0002-0406-8139; Liu, Liping/0000-0003-2369-7771	Australian Research Council DECRA Fellowship [DE180100524]; National Health and Medical Research Council of Australia Investigator Grant [APP1176209, APP1138723, APP1194406]; National Health and Medical Research Council of Australia Project Grant [APP1159106]	Australian Research Council DECRA Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	and additional information-This work was supported by Australian Research Council DECRA Fellowship DE180100524 (L. Luo.) , National Health and Medical Research Council of Australia Investigator Grant APP1176209 and Project grant APP1138723 (J. L. S.) , National Health and Medical Research Council of Australia Project Grant APP1159106 (L. Luo and J. L. S) , and National Health and Medical Research Council of Australia Investigator Grant APP1194406 (M. J. S.) .	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Biswas C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200913; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Curson JEB, 2022, IMMUNOL CELL BIOL, V100, P267, DOI 10.1111/imcb.12540; Curson JEB, 2018, J LEUKOCYTE BIOL, V103, P1011, DOI 10.1002/JLB.2RI1117-474R; Deng GM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00078; Dozmorov MG, 2014, EPIGENETICS-US, V9, P276, DOI 10.4161/epi.27021; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Jang TH, 2014, J MOL BIOL, V426, P3305, DOI 10.1016/j.jmb.2014.07.024; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Kralova J, 2016, J BIOL CHEM, V291, P16530, DOI 10.1074/jbc.M116.717157; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Liu DL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0512-1; Lucas RM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109662; Luo L, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239194; Luo L, 2020, J LEUKOCYTE BIOL, V107, P251, DOI 10.1002/JLB.2MA0819-138RR; Luo L, 2017, IMMUNOL CELL BIOL, V95, P564, DOI 10.1038/icb.2017.10; Luo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14133; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Mitchell J, 2018, BIOCHEM PHARMACOL, V147, P119, DOI 10.1016/j.bcp.2017.11.015; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Stepanek O, 2013, J IMMUNOL, V190, P1807, DOI 10.4049/jimmunol.1202401; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strich JR, 2021, J INFECT DIS, V223, P981, DOI 10.1093/infdis/jiaa789; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; Verstak B, 2014, J LEUKOCYTE BIOL, V96, P427, DOI 10.1189/jlb.2A0913-487R; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101857	10.1016/j.jbc.2022.101857	http://dx.doi.org/10.1016/j.jbc.2022.101857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35337798	Green Published, gold			2022-12-28	WOS:000798142000007
J	Thirouin, ZS; Figueiredo, M; Hleihil, M; Gill, R; Bosshard, G; McKinney, RA; Tyagarajan, SK				Thirouin, Zahra S.; Figueiredo, Marta; Hleihil, Mohammad; Gill, Raminder; Bosshard, Giovanna; McKinney, R. Anne; Tyagarajan, Shiva K.			Trophic factor BDNF inhibits GABAergic signaling by facilitating dendritic enrichment of SUMO E3 ligase PIAS3 and altering gephyrin scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SUMOYLATION; CONJUGATION; RECEPTORS; SYNAPSES; NEURONS; DOMAIN; BRAIN; AGGREGATION; ACTIVATION; MUTATION	Posttranslational addition of a small ubiquitin-like modifier (SUMO) moiety (SUMOylation) has been implicated in pathologies such as brain ischemia, diabetic peripheral neuropathy, and neurodegeneration. However, nuclear enrichment of SUMO pathway proteins has made it difficult to ascertain how ion channels, proteins that are typically localized to and function at the plasma membrane, and mitochondria are SUMOylated. Here, we report that the trophic factor, brain-derived neurotrophic factor (BDNF) regulates SUMO proteins both spatially and temporally in neurons. We show that BDNF signaling via the receptor tropomyosin-related kinase B facilitates nuclear exodus of SUMO proteins and subsequent enrichment within dendrites. Of the various SUMO E3 ligases, we found that PIAS-3 dendrite enrichment in response to BDNF signaling specifically modulates subsequent ERK1/2 kinase pathway signaling. In addition, we found the PIAS-3 RING and Ser/Thr domains, albeit in opposing manners, functionally inhibit GABA-mediated inhibition. Finally, using oxygen-glucose deprivation as an in vitro model for ischemia, we show that BDNF-tropomyosin-related kinase B signaling negatively impairs clustering of the main scaffolding protein at GABAergic postsynapse, gephyrin, whereby reducing GABAergic neurotransmission postischemia. SUMOylation-defective gephyrin K148R/K724R mutant transgene expression reversed these ischemia-induced changes in gephyrin cluster density. Taken together, these data suggest that BDNF signaling facilitates the temporal relocation of nuclear-enriched SUMO proteins to dendrites to influence post-synaptic protein SUMOylation.	[Thirouin, Zahra S.; Figueiredo, Marta; Hleihil, Mohammad; Bosshard, Giovanna; Tyagarajan, Shiva K.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Gill, Raminder; McKinney, R. Anne] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Thirouin, Zahra S.] McGill Univ, Hlth Ctr, Ctr Res Neurosci, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada; [Thirouin, Zahra S.] Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada	University of Zurich; McGill University; McGill University; McGill University	Tyagarajan, SK (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	tyagarajan@pharma.uzh.ch	; Tyagarajan, Shiva/P-3135-2015	Thirouin, Zahra/0000-0002-7103-4799; Tyagarajan, Shiva/0000-0003-0074-1805	Swiss National Science Foundation [31003A_159867, 310030_192522]; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This study was funded by Swiss National Science Foundation grants 31003A_159867 and 310030_192522 and University of Zurich internal funding to S. K. T. Canadian Institute Health CIHR. MOP 13361 (RAM).	Agarwal N, 2020, NEURON, V107, P1141, DOI 10.1016/j.neuron.2020.06.037; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Craig TJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17669; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; de Groot C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007073; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gee CE, 2006, EUR J NEUROSCI, V23, P2595, DOI 10.1111/j.1460-9568.2006.04786.x; Ghosh H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13365; Guo C, 2014, IUBMB LIFE, V66, P71, DOI 10.1002/iub.1244; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Panzanelli P., 2011, J PHYSL; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Proenca CC, 2016, J NEUROCHEM, V138, P397, DOI 10.1111/jnc.13676; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Santos XR, 2015, J NEUROSCI, V35, P3319, DOI 10.1523/JNEUROSCI.4521-14.2015; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Sundvall M., 2012, THE J; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanabe M, 1998, EUR J NEUROSCI, V10, P2037, DOI 10.1046/j.1460-9568.1998.00215.x; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Tyagarajan S. K., 2011, PROC NATL; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Villa KL, 2016, NEURON, V89, P756, DOI 10.1016/j.neuron.2016.01.010; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x	46	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101840	10.1016/j.jbc.2022.101840	http://dx.doi.org/10.1016/j.jbc.2022.101840			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35307349	Green Published, gold			2022-12-28	WOS:000794890400001
J	Amaya, JA; Lamb, DC; Kelly, SL; Caffrey, P; Murarka, VC; Poulos, TL				Amaya, Jose A.; Lamb, David C.; Kelly, Steven L.; Caffrey, Patrick; Murarka, Vidhi C.; Poulos, Thomas L.			Structural analysis of P450 AmphL from Streptomyces nodosus provides insights into substrate selectivity of polyene macrolide antibiotic biosynthetic P450s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEERED MOLECULAR-DYNAMICS; CYTOCHROME P450CAM; BINDING; FORCE; SITE	AmphL is a cytochrome P450 enzyme that catalyzes the C8 oxidation of 8-deoxyamphotericin B to the polyene macrolide antibiotic, amphotericin B. To understand this substrate selectivity, we solved the crystal structure of AmphL to a resolution of 2.0 angstrom in complex with amphotericin B and performed molecular dynamics (MD) simulations. A detailed comparison with the closely related P450, PimD, which catalyzes the epoxidation of 4,5-desepoxypimaricin to the macrolide antibiotic, pimaricin, reveals key catalytic structural features responsible for stereo- and regio-selective oxidation. Both P450s have a similar access channel that runs parallel to the active site I helix over the surface of the heme. Molecular dynamics simulations of substrate binding reveal PimD can "pull" substrates further into the P450 access channel owing to additional electrostatic interactions between the protein and the carboxyl group attached to the hemiketal ring of 4,5-desepoxypimaricin. This substrate interaction is absent in AmphL although the additional substrate -OH groups in 8-deoxyamphotericin B help to correctly position the substrate for C8 oxidation. Simulations of the oxy-complex indicates that these -OH groups may also participate in a proton relay network required for O-2 activation as has been suggested for two other macrolide P450s, PimD and P450eryF. These findings provide experimentally testable models that can potentially contribute to a new generation of novel macrolide antibiotics with enhanced antifungal and/or antiprotozoal efficacy.	[Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA; [Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Lamb, David C.; Kelly, Steven L.] Swansea Univ, Fac Hlth Med & Life Sci, Swansea, W Glam, Wales; [Caffrey, Patrick] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Swansea University; University College Dublin	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.; Poulos, TL (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA.; Poulos, TL (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.	poulos@uci.edu		Amaya, Jose A./0000-0001-7826-0185; Murarka, Vidhi/0000-0002-3471-9211; Caffrey, Patrick/0000-0002-0132-2410	NIH [GM131920]; European Regional Development Fund/Welsh European Funding Office via the BEACON project	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Regional Development Fund/Welsh European Funding Office via the BEACON project	Funding and additional information-Work at UCI was supported by NIH grant GM131920 (T. L. P.). Funding at Swansea University was supported by the European Regional Development Fund/Welsh European Funding Office via the BEACON project (S. L. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Caffrey P, 2016, APPL MICROBIOL BIOT, V100, P3893, DOI 10.1007/s00253-016-7474-z; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; GERBER NC, 1994, J BIOL CHEM, V269, P4260; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Ho K, 2020, J PHYS CHEM B, V124, P5338, DOI 10.1021/acs.jpcb.0c02009; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mermelstein DJ, 2018, J COMPUT CHEM, V39, P1354, DOI 10.1002/jcc.25187; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Santos-Aberturas J, 2015, CHEMCATCHEM, V7, P490, DOI 10.1002/cctc.201402773; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhang ZS, 2016, BIOPHYS CHEM, V211, P28, DOI 10.1016/j.bpc.2016.01.003	26	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101746	10.1016/j.jbc.2022.101746	http://dx.doi.org/10.1016/j.jbc.2022.101746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35189143	Green Published, gold			2022-12-28	WOS:000793502000015
J	Liu, YT; Lee, AG; Nguyen, AW; Maynard, JA				Liu, Yutong; Lee, Alison G.; Nguyen, Annalee W.; Maynard, Jennifer A.			An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC ANTIBODIES; GAMMA RECEPTORS; HUMAN IGG1; IN-VIVO; EXPRESSION; BINDING; AFFINITY; SPECIFICITY; VARIANTS; PROTEIN	Despite the exquisite specificity and high affinity of antibody based cancer therapies, treatment side effects can occur since the tumor-associated antigens targeted are also present on healthy cells. However, the low pH of the tumor microenvironment provides an opportunity to develop conditionally active antibodies with enhanced tumor specificity. Here, we engineered the human IgG1 Fc domain to enhance pH-selective binding to the receptor Fc gamma RIIIa and subsequent antibody-dependent cellular cytotoxicity (ADCC). We displayed the Fc domain on the surface of mammalian cells and generated a site-directed library by altering Fc residues at the Fc-Fc gamma RIIIa interface to support interactions with positively charged histidine residues. We then used a competitive staining and flow cytometric selection strategy to isolate Fc variants exhibiting reduced Fc gamma RIIIa affinities at neutral pH, but physiological affinities at the tumor-typical pH 6.5. We demonstrate that antibodies composed of Fab arms binding the breast cell epithelial marker Her2 and the lead Fc variant, termed acid-Fc, exhibited an ,~& nbsp;2-fold pH-selectivity for Fc gamma RIIIa binding based on the ratio of equilibrium dissociation constants K-d,K-7.4/K-d,K-6.5, due to a faster dissociation rate at pH 7.4. Finally, in vitro ADCC assays with human Fc gamma RIIIa-positive natural killer and Her2-positive target cells demonstrated similar activities for anti-Her2 antibodies bearing the wild-type or acid-Fc at pH 6.5, but nearly 20-fold reduced ADCC for acidFc at pH 7.4, based on EC50 ratios. This work shows the promise of mammalian cell display for Fc engineering and the feasibility of pH-selective Fc activation to provide a second dimension of selective tumor cell targeting.	[Liu, Yutong; Nguyen, Annalee W.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Lee, Alison G.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nguyen, AW; Maynard, JA (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	annalee@utexas.edu; maynard@che.utexas.edu		Lee, Alison/0000-0001-8305-3332; Liu, Yutong/0000-0003-0626-8094	Cancer Prevention and Research Institute of Texas grant [RP180690]; Welch Foundation [F-1767]	Cancer Prevention and Research Institute of Texas grant; Welch Foundation(The Welch Foundation)	This work was supported by the Cancer Prevention and Research Institute of Texas grant RP180690 to A. W. N and J. A. M. and Welch Foundation grant F-1767 to J. A. M.	Ackerman M. E., 2011, J IMMU; Ahmed AA, 2016, J STRUCT BIOL, V194, P78, DOI 10.1016/j.jsb.2016.02.001; Andreev OA, 2010, MOL MEMBR BIOL, V27, P341, DOI 10.3109/09687688.2010.509285; Avery LB, 2016, MABS-AUSTIN, V8, P1064, DOI 10.1080/19420862.2016.1193660; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Brinkhaus M, 2020, J IMMUNOL, V205, P3456, DOI 10.4049/jimmunol.2000961; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Castelli DD, 2014, MAGN RESON MED, V71, P326, DOI 10.1002/mrm.24664; Challa DK, 2014, CURR TOP MICROBIOL, V382, P249, DOI 10.1007/978-3-319-07911-0_12; Chen D, 2021, THERANOSTICS, V11, P1901, DOI 10.7150/thno.51299; Corbet C, 2017, NAT REV CANCER, V17, P577, DOI 10.1038/nrc.2017.77; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dempsey N, 2021, BREAST CANCER RES TR, V188, P21, DOI 10.1007/s10549-021-06280-x; Desnoyers LR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006682; EAGLE H, 1971, SCIENCE, V174, P500, DOI 10.1126/science.174.4008.500; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; Hatjiharissi E., 2007, AUGMENTED; Holcmann M, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1004969; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Johnston RJ, 2019, NATURE, V574, P565, DOI 10.1038/s41586-019-1674-5; Jung ST, 2013, ACS CHEM BIOL, V8, P368, DOI 10.1021/cb300455f; Kamat V, 2017, ANAL BIOCHEM, V536, P16, DOI 10.1016/j.ab.2017.08.002; Kamata-Sakurai M, 2021, CANCER DISCOV, V11, P158, DOI 10.1158/2159-8290.CD-20-0328; Kang TH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00562; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kroetsch A, 2019, MABS-AUSTIN, V11, P411, DOI 10.1080/19420862.2018.1545510; Kunaparaju R, 2005, BIOTECHNOL BIOENG, V91, P670, DOI 10.1002/bit.20534; Lazar G. A., 2006, PROC NATL ACAD; Lee C.-H., 2017, IGG FC DOMAINS BIND; Lee CH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13108-2; Liu RN, 2020, ANTIBODIES, V9, DOI 10.3390/antib9040064; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Nguyen AW, 2018, PROTEIN ENG DES SEL, V31, P91, DOI 10.1093/protein/gzy004; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn Falk, 2012, Cancer Immun, V12, P13; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Robinson JI, 2018, P NATL ACAD SCI USA, V115, pE72, DOI 10.1073/pnas.1707856115; Romain G, 2014, BLOOD, V124, P3241, DOI 10.1182/blood-2014-04-569061; Rugo H. S., 2021, EFFICACY; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Scott Andrew M, 2012, Cancer Immun, V12, P14; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Sulea T, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1682866; Tobias R., 2019, FORTEBIO APPL NOTE, P12; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Wagner EK, 2019, J BIOL CHEM, V294, P5790, DOI 10.1074/jbc.RA118.007187; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Webb AH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3418-y; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wei D, 2019, MOL IMAGING BIOL, V21, P1020, DOI 10.1007/s11307-019-01335-4; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8	67	0	0	7	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101798	10.1016/j.jbc.2022.101798	http://dx.doi.org/10.1016/j.jbc.2022.101798			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35248534	gold, Green Published			2022-12-28	WOS:000793694800005
J	Divorty, N; Jenkins, L; Ganguly, A; Butcher, AJ; Hudson, BD; Schulz, S; Tobin, AB; Nicklin, SA; Milligan, G				Divorty, Nina; Jenkins, Laura; Ganguly, Amlan; Butcher, Adrian J.; Hudson, Brian D.; Schulz, Stefan; Tobin, Andrew B.; Nicklin, Stuart A.; Milligan, Graeme			Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ARRESTIN RECRUITMENT; SELECTIVE AGONISTS; IDENTIFICATION; MECHANISM; DETERMINES; BIOSENSOR; BINDING; SITES	G protein-coupled receptor 35 (GPR35) is poorly charac-terized but nevertheless has been revealed to have diverse roles in areas including lower gut inflammation and pain. The development of novel reagents and tools will greatly enhance analysis of GPR35 functions in health and disease. Here, we used mass spectrometry, mutagenesis, and [P-32] orthophosphate labeling to identify that all five hydroxy-amino acids in the C-terminal tail of human GPR35a became phosphorylated in response to agonist occupancy of the receptor and that, apart from Ser(294), each of these contributed to interactions with arretin-3, which inhibits further G protein-coupled receptor signaling. We found that Ser(303) was key to such interactions; the serine corresponding to human GPR35a residue 303 also played a dominant role in arrestin-3 interactions for both mouse and rat GPR35. We also demonstrated that fully phospho-site-deficient mutants of human GPR35a and mouse GPR35 failed to interact effectively with arrestin-3, and the human phospho-deficient variant was not internalized from the surface of cells in response to agonist treatment. Even in cells stably expressing species orthologues of GPR35, a substantial proportion of the expressed protein(s) was determined to be immature. Finally, phospho-site-specific antisera targeting the region encompassing Ser(303) in human (Ser(301) in mouse) GPR35a identified only the mature forms of GPR35 and provided effective sensors of the activation status of the receptors both in immunoblotting and immunocytochemical studies. Such antisera may be useful tools to evaluate target engagement in drug discovery and target validation programs.	[Divorty, Nina; Jenkins, Laura; Ganguly, Amlan; Hudson, Brian D.; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland; [Divorty, Nina; Nicklin, Stuart A.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Butcher, Adrian J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Schulz, Stefan] 7TM Antibodies GmbH, Jena, Germany; [Schulz, Stefan] Univ Hosp Jena, Inst Pharmacol & Toxicol, Jena, Germany	University of Glasgow; University of Glasgow; University of Cambridge; Friedrich Schiller University of Jena	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk		Ganguly, Amlan/0000-0002-2507-022X; Jenkins, Laura/0000-0003-1382-8547	Biotechnology and Biosciences Research Council [BB/P000649/1, BB/P00069X/1]; British Heart Foundation [RE/13/5/30177/]; Wellcome Trust [099787/Z/12/Z/]; Commonwealth Scholarship [BDCA2019-6]	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Commonwealth Scholarship	These studies were supported by Biotechnology and Biosciences Research Council grants BB/P000649/1 (to G. M.) and BB/P00069X/1 (to A. B. T.) and the British Heart Foundation (RE/13/5/30177/) (S. A. N.). N. D. was supported by a Wellcome Trust studentship (099787/Z/12/Z/) and A. G. by a Commonwealth Scholarship (reference number BDCA2019-6).	Alexander S. P. H., 2019, CONCISE GUIDE PHARM; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Aydin Y, 2021, FEBS J, V288, P2529, DOI 10.1111/febs.15811; Bouzo-Lorenzo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22495; Bradley SJ, 2020, NAT CHEM BIOL, V16, P240, DOI 10.1038/s41589-019-0453-9; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Che T, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.aav0320; Fang Y, 2007, SENSORS-BASEL, V7, P2316, DOI 10.3390/s7102316; Fernandez TJ, 2020, PROTEIN SCI, V29, P1345, DOI 10.1002/pro.3872; Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g; Grundmann M, 2017, HANDB EXP PHARMACOL, V238, P339, DOI 10.1007/164_2015_42; Gurevich VV, 2020, PHARMACOL THERAPEUT, V211, DOI 10.1016/j.pharmthera.2020.107540; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Jenkins L, 2012, J PHARMACOL EXP THER, V343, P683, DOI 10.1124/jpet.112.198945; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Latorraca NR, 2020, CELL, V183, P1813, DOI 10.1016/j.cell.2020.11.014; Latorraca NR, 2018, NATURE, V557, P452, DOI 10.1038/s41586-018-0077-3; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lowe JD, 2015, MOL PHARMACOL, V88, P347, DOI 10.1124/mol.115.098293; Mackenzie A. E., 2014, MOL; Mackenzie AE, 2019, FASEB J, V33, P5005, DOI 10.1096/fj.201801956R; Marti-Solano M, 2020, NATURE, V587, P650, DOI 10.1038/s41586-020-2888-2; McCallum JE, 2015, J VASC RES, V52, P383, DOI 10.1159/000444754; Milligan G, 2018, BRIT J PHARMACOL, V175, P2543, DOI 10.1111/bph.14042; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Milligan G, 2011, TRENDS PHARMACOL SCI, V32, P317, DOI 10.1016/j.tips.2011.02.002; Neetoo-Isseljee Z, 2013, J PHARMACOL EXP THER, V344, P568, DOI 10.1124/jpet.112.201798; Park JY, 2016, ARCH PHARM RES, V39, P293, DOI 10.1007/s12272-016-0712-1; Perez-Riverol Y., 2019, PRIDE DATABASE RELAT; Plouffe B., 2016, MAPPING PHYSIOLOGICA; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Quon T, 2020, ACS PHARMACOL TRANSL, V3, P801, DOI 10.1021/acsptsci.0c00079; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Seyedabadi M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020218; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Southern C, 2013, J BIOMOL SCREEN, V18, P599, DOI 10.1177/1087057113475480; Sulon Sarah M, 2021, Curr Opin Endocr Metab Res, V16, P56, DOI 10.1016/j.coemr.2020.09.002; Sun YV, 2008, GENET EPIDEMIOL, V32, P350, DOI 10.1002/gepi.20309; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Wei L, 2018, ACS MED CHEM LETT, V9, P422, DOI 10.1021/acsmedchemlett.7b00510; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Zhao P., 2010, TARGETING ORPHAN REC; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zindel D, 2016, BIOCHEM J, V473, P4173, DOI 10.1042/BCJ20160740	57	5	5	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101655	10.1016/j.jbc.2022.101655	http://dx.doi.org/10.1016/j.jbc.2022.101655			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101446	gold, Green Published, Green Accepted			2022-12-28	WOS:000794865600004
J	Grba, DN; Blaza, JN; Bridges, HR; Agip, ANA; Yin, Z; Murai, M; Miyoshi, H; Hirst, J				Grba, Daniel N.; Blaza, James N.; Bridges, Hannah R.; Agip, Ahmed-Noor A.; Yin, Zhan; Murai, Masatoshi; Miyoshi, Hideto; Hirst, Judy			Cryo-electron microscopy reveals how acetogenins inhibit mitochondrial respiratory complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEAM-INDUCED MOTION; 49 KDA SUBUNIT; CRYSTAL-STRUCTURE; QUINONE BINDING; PROTON PUMP; UBIQUINONE; VALIDATION; REDUCTION; MECHANISM; VISUALIZATION	Mitochondrial complex I (NADH:ubiquinone oxidoreductase), a crucial enzyme in energy metabolism, captures the redox potential energy from NADH oxidation/ubiquinone reduction to create the proton motive force used to drive ATP synthesis in oxidative phosphorylation. High-resolution single particle electron cryo-EM analyses have provided detailed structural knowledge of the catalytic machinery of complex I, but not of the molecular principles of its energy transduction mechanism. Although ubiquinone is considered to bind in a long channel at the interface of the membrane-embedded and hydrophilic domains, with channel residues likely involved in coupling substrate reduction to proton translocation, no structures with the channel fully occupied have yet been described. Here, we report the structure (determined by cryoEM) of mouse complex I with a tight-binding natural product acetogenin inhibitor, which resembles the native substrate, bound along the full length of the expected ubiquinonebinding channel. Our structure reveals the mode of acetogenin binding and the molecular basis for structure-activity relationships within the acetogenin family. It also shows that acetogenins are such potent inhibitors because they are highly hydrophobic molecules that contain two specific hydrophilic moieties spaced to lock into two hydrophilic regions of the otherwise hydrophobic channel. The central hydrophilic section of the channel does not favor binding of the isoprenoid chain when the native substrate is fully bound but stabilizes the ubiquinone/ubiquinol headgroup as it transits to/from the active site. Therefore, the amphipathic nature of the channel supports both tight binding of the amphipathic inhibitor and rapid exchange of the ubiquinone/ubiquinol substrate and product.	[Grba, Daniel N.; Blaza, James N.; Bridges, Hannah R.; Agip, Ahmed-Noor A.; Yin, Zhan; Hirst, Judy] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Agip, Ahmed-Noor A.] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Yin, Zhan] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; Kyoto University; Max Planck Society; University of Cambridge	Hirst, J (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.	jh@mrc-mbu.cam.ac.uk	; Hirst, Judy/F-4803-2011	YIN, ZHAN/0000-0002-3846-0147; Grba, Daniel/0000-0003-2915-951X; Hirst, Judy/0000-0001-8667-6797; Murai, Masatoshi/0000-0001-6601-2854; Blaza, Jamie/0000-0001-5420-2116; Bridges, Hannah/0000-0001-6890-6050; Miyoshi, Hideto/0000-0002-1792-554X	Medical Research Council [MC_U105663141, MC_UU_00015/2]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding and additional information-This work was supported by the Medical Research Council (MC_U105663141 and MC_UU_00015/2 to J. H.) .	Abe M, 2008, BIOCHEMISTRY-US, V47, P6260, DOI 10.1021/bi800506s; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barrachina I., 2007, GUANACONE TYPE; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Bridges HR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18950-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung I, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg4000; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Gamiz-Hernandez AP, 2017, J AM CHEM SOC, V139, P16282, DOI 10.1021/jacs.7b08486; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grba DN, 2020, NAT STRUCT MOL BIOL, V27, P892, DOI 10.1038/s41594-020-0473-x; Gutierrez-Fernandez J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17957-0; Haapanen O, 2021, CURR OPIN ELECTROCHE, V29, DOI 10.1016/j.coelec.2021.100741; Haapanen O, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148287; Haapanen O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07930-1; Hamada T, 2004, BIOCHEMISTRY-US, V43, P3651, DOI 10.1021/bi030242m; Hattne J, 2018, STRUCTURE, V26, P759, DOI 10.1016/j.str.2018.03.021; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Kaila VRI, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0916; Kakutani N, 2010, BIOCHEMISTRY-US, V49, P4794, DOI 10.1021/bi100454b; Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Klusch N, 2021, PLANT CELL, V33, P2072, DOI 10.1093/plcell/koab092; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Kuwabara K, 2000, EUR J BIOCHEM, V267, P2538, DOI 10.1046/j.1432-1327.2000.01263.x; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Vilas JL, 2018, STRUCTURE, V26, P337, DOI 10.1016/j.str.2017.12.018; Maldonado M, 2020, ELIFE, V9, DOI 10.7554/eLife.56664; Masuya T, 2014, BIOCHEMISTRY-US, V53, P7816, DOI 10.1021/bi501342w; Masuya T, 2014, BIOCHEMISTRY-US, V53, P2307, DOI 10.1021/bi500205x; Meyer MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07564; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murai M, 2016, BIOCHEMISTRY-US, V55, P3189, DOI 10.1021/acs.biochem.6b00190; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; Parey K, 2020, CURR OPIN STRUC BIOL, V63, P1, DOI 10.1016/j.sbi.2020.01.004; Parey K, 2018, ELIFE, V7, DOI 10.7554/eLife.39213; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2020, NAT METHODS, V17, P328, DOI 10.1038/s41592-020-0731-1; Ramirez-Aportela E, 2020, BIOINFORMATICS, V36, P765, DOI 10.1093/bioinformatics/btz671; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Sekiguchi K, 2009, BBA-BIOENERGETICS, V1787, P1106, DOI 10.1016/j.bbabio.2009.02.016; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Takada M, 2000, BBA-BIOENERGETICS, V1460, P302, DOI 10.1016/S0005-2728(00)00156-0; Teixeira MH, 2019, BBA-BIOENERGETICS, V1860, P541, DOI 10.1016/j.bbabio.2019.05.004; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Uno S, 2020, J BIOL CHEM, V295, P2449, DOI 10.1074/jbc.RA119.012347; Uno SP, 2019, J BIOL CHEM, V294, P679, DOI 10.1074/jbc.RA118.006056; Warnau J, 2018, P NATL ACAD SCI USA, V115, pE8413, DOI 10.1073/pnas.1805468115; Yoga EG, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148153; Yoga EG, 2019, BBA-BIOENERGETICS, V1860, P573, DOI 10.1016/j.bbabio.2019.06.006; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	73	8	8	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101602	10.1016/j.jbc.2022.101602	http://dx.doi.org/10.1016/j.jbc.2022.101602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35063503	gold, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000791267400003
J	Kobayashi, K; Shimizu, H; Tanaka, N; Kuramochi, K; Nakai, H; Nakajima, M; Taguchi, H				Kobayashi, Kaito; Shimizu, Hisaka; Tanaka, Nobukiyo; Kuramochi, Kouji; Nakai, Hiroyuki; Nakajima, Masahiro; Taguchi, Hayao			Characterization and structural analyses of a novel glycosyltransferase acting on the beta-1,2-glucosidic linkages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-GLUCOSAMINIDASE; CYCLIC BETA-1,2-GLUCAN; VIRULENCE FACTOR; ENZYMES; PURIFICATION; GLUCANS; GALACTOSIDASES; HYDROLASES	The IALB_1185 protein, which is encoded in the gene cluster for endo-beta-1,2-glucanase homologs in the genome of Ignavibacterium album, is a glycoside hydrolase family (GH) 35 protein. However, most known GH35 enzymes are beta-galactosidases, which is inconsistent with the components of this gene cluster. Thus, IALB_1185 is expected to possess novel enzymatic properties. Here, we showed using recombinant IALB_1185 that this protein has glycosyltransferase activity toward beta-1,2-glucooligosaccharides, and that the kinetic parameters for beta-1,2-glucooligosaccharides are not within the ranges for general GH enzymes. When various aryl-and alkyl-glucosides were used as acceptors, glycosyltransfer products derived from these acceptors were subsequently detected. Kinetic analysis further revealed that the enzyme has wide aglycone specificity regardless of the anomer, and that the beta-1,2-linked glucose dimer sophorose is an appropriate donor. In the complex of wild-type IALB_1185 with sophorose, the electron density of sophorose was clearly observed at subsites -1 and +1, whereas in the E343Q mutant- sophorose complex, the electron density of sophorose was clearly observed at subsites +1 and +2. This observation suggests that binding at subsites -1 and +2 competes through Glu102, which is consistent with the preference for sophorose as a donor and unsuitability of beta-1,2-glucooligosaccharides as acceptors. A pliable hydrophobic pocket that can accommodate various aglycone moieties was also observed in the complex structures with various glucosides. Overall, our biochemical and structural data are indicative of a novel enzymatic reaction. We propose that IALB_1185 be redefined beta-1,2-glucooligosaccharide:D-glucoside beta-D-glucosyltransferase as a systematic name and beta-1,2-glucosyltransferase as an accepted name.	[Kobayashi, Kaito; Shimizu, Hisaka; Tanaka, Nobukiyo; Kuramochi, Kouji; Nakajima, Masahiro; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba, Japan; [Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata, Japan	Tokyo University of Science; Niigata University	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba, Japan.	m-nakajima@rs.tus.ac.jp	Kobayashi, Kaito/AAQ-8970-2020	Kobayashi, Kaito/0000-0002-2662-2452; Kuramochi, Kouji/0000-0003-0571-9703	JSPS KAKENHI [20K05830]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We appreciate the help of all the staff at the Photon Factory for the X-ray data collection (Proposal No. 2016G619). This work was supported in part by JSPS KAKENHI Grant Number 20K05830.	Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Abe K, 2018, J BIOL CHEM, V293, P8812, DOI 10.1074/jbc.RA117.001536; Abe K, 2017, J BIOL CHEM, V292, P7487, DOI 10.1074/jbc.M116.762724; AMEMURA A, 1986, J GEN MICROBIOL, V132, P2443; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Ayoub R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213712; Brahmachari G, 2011, ARCH PHARM, V344, P5, DOI 10.1002/ardp.201000181; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; BUNDLE DR, 1988, INFECT IMMUN, V56, P1101, DOI 10.1128/IAI.56.5.1101-1106.1988; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; Claus S, 2017, APPL MICROBIOL BIOT, V101, P7811, DOI 10.1007/s00253-017-8519-7; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; DELL A, 1983, CARBOHYD RES, V117, P185, DOI 10.1016/0008-6215(83)88086-0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felse PA, 2007, ENZYME MICROB TECH, V40, P316, DOI 10.1016/j.enzmictec.2006.04.013; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P1079, DOI 10.1007/s00253-008-1795-5; Gummadi S., 2013, SPRINGERBRIEFS MICRO, P15; Guo B, 2016, APPL MICROBIOL BIOT, V100, P4959, DOI 10.1007/s00253-016-7342-x; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hillebrand S, 2004, J AGR FOOD CHEM, V52, P7331, DOI 10.1021/jf0487957; HISAMATSU M, 1982, J GEN MICROBIOL, V128, P1873; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; IMANARI T, 1971, AGR BIOL CHEM TOKYO, V35, P321, DOI 10.1080/00021369.1971.10859919; Ishiguro R, 2017, FEBS LETT, V591, P3926, DOI 10.1002/1873-3468.12911; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Kobayashi K, 2019, BIOSCI BIOTECH BIOCH, V83, P1867, DOI 10.1080/09168451.2019.1630257; KOIZUMI K, 1984, J CHROMATOGR, V299, P215, DOI 10.1016/S0021-9673(01)97833-1; Kondo T, 2020, APPL MICROBIOL BIOT, V104, P1135, DOI 10.1007/s00253-019-10299-y; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu B, 2006, BIOTECHNOL LETT, V28, P1655, DOI 10.1007/s10529-006-9137-0; Liu Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00024; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mahdi JG, 2006, CELL PROLIFERAT, V39, P147, DOI 10.1111/j.1365-2184.2006.00377.x; MENDOZA NS, 1983, J FERMENT TECHNOL, V61, P473; Mine S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102460; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2021, ANAL BIOCHEM, V632, DOI 10.1016/j.ab.2021.114366; Nakajima M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42671; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nerinckx W, 2005, FEBS LETT, V579, P302, DOI 10.1016/j.febslet.2004.12.021; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Qin Z, 2017, J BIOL CHEM, V292, P1666, DOI 10.1074/jbc.M116.762419; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; REESE ET, 1961, CAN J MICROBIOL, V7, P309, DOI 10.1139/m61-038; Rico-Diaz A, 2017, FEBS J, V284, P1815, DOI 10.1111/febs.14083; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roset MS, 2006, J BACTERIOL, V188, P5003, DOI 10.1128/JB.00086-06; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Shimizu H, 2018, BIOCHEMISTRY-US, V57, P3849, DOI 10.1021/acs.biochem.8b00385; Suarez ER, 2008, CARBOHYD RES, V343, P2623, DOI 10.1016/j.carres.2008.07.009; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Tanaka N, 2019, J BIOL CHEM, V294, P7942, DOI 10.1074/jbc.RA118.007087; Tanaka T, 2003, J BACTERIOL, V185, P5175, DOI 10.1128/JB.185.17.5175-5181.2003; Tattini M, 2014, J PHOTOCH PHOTOBIO B, V140, P28, DOI 10.1016/j.jphotobiol.2014.06.012; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589	66	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101606	10.1016/j.jbc.2022.101606	http://dx.doi.org/10.1016/j.jbc.2022.101606			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065074	gold, Green Published			2022-12-28	WOS:000789396300002
J	Tehlan, A; Bhowmick, K; Kumar, A; Subbarao, N; Dhar, SK				Tehlan, Ankita; Bhowmick, Krishanu; Kumar, Amarjeet; Subbarao, Naidu; Dhar, Suman Kumar			The tetrameric structure of Plasmodium falciparum phosphoglycerate mutase is critical for optimal enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYTIC-ENZYMES; HOST-CELL; EXPRESSION; OLIGOMERIZATION; METABOLISM; GROWTH; TRANSFORMATION; LOCALIZATION; DISSOCIATION; DIMERIZATION	The glycolytic enzyme phosphoglycerate mutase (PGM) is of utmost importance for overall cellular metabolism and has emerged as a novel therapeutic target in cancer cells. This enzyme is also conserved in the rapidly proliferating malarial parasite Plasmodium falciparum, which have a similar metabolic framework as cancer cells and rely on glycolysis as the sole energy-yielding process during intraerythrocytic development. There is no redundancy among the annotated PGM enzymes in Plasmodium, and PfPGM1 is absolutely required for the parasite survival as evidenced by conditional knockdown in our study. A detailed comparison of PfPGM1 with its counterparts followed by in-depth structure-function analysis revealed unique attributes of this parasitic protein. Here, we report for the first time the importance of oligomerization for the optimal functioning of the enzyme in vivo, as earlier studies in eukaryotes only focused on the effects in vitro. We show that single point mutation of the amino acid residue W68 led to complete loss of tetramerization and diminished catalytic activity in vitro. Additionally, ectopic expression of the WT PfPGM1 protein enhanced parasite growth, whereas the monomeric form of PfPGM1 failed to provide growth advantage. Furthermore, mutation of the evolutionarily conserved residue K100 led to a drastic reduction in enzymatic activity. The indispensable nature of this parasite enzyme highlights the potential of PfPGM1 as a therapeutic target against malaria, and targeting the interfacial residues critical for oligomerization can serve as a focal point for promising drug development strategies that may not be restricted to malaria only.	[Tehlan, Ankita; Bhowmick, Krishanu; Dhar, Suman Kumar] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India; [Kumar, Amarjeet; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Dhar, SK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India.	skdhar@mail.jnu.ac.in	Bhowmick, Krishanu/CEH-1458-2022; Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Bhowmick, Krishanu/0000-0001-6213-8230; Kumar, Amarjeet/0000-0001-7740-9881	Department of Biotechnology [BT/PR15639/Med/29/1145/2016]; Department of Science and Technology, SERB; CSIR, India	Department of Biotechnology; Department of Science and Technology, SERB(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	S. K. D. acknowledges the Department of Biotechnology (BT/PR15639/Med/29/1145/2016) and Department of Science and Technology, SERB, Govt. of India (DPRP) for financial assistance. A. T. acknowledges CSIR, India for fellowship.	Alam Asrar, 2014, Malar Res Treat, V2014, P451065, DOI 10.1155/2014/451065; Bachman J, 2013, METHOD ENZYMOL, V529, P241, DOI 10.1016/B978-0-12-418687-3.00019-7; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Banu K, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny182; Batugedara G, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000327; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhowmick K, 2020, J CELL SCI, V133, DOI 10.1242/jcs.236489; Bhowmick K, 2014, FEMS MICROBIOL LETT, V351, P78, DOI 10.1111/1574-6968.12343; Blackburn EA, 2014, BIOCHEM BIOPH RES CO, V450, P936, DOI 10.1016/j.bbrc.2014.06.113; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; BRITTON HG, 1972, BIOCHEM J, V130, P397, DOI 10.1042/bj1300397; Burda PC, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107817; Burley SK, 2021, NUCLEIC ACIDS RES, V49, pD437, DOI 10.1093/nar/gkaa1038; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Caruthers J. M., 2004, Structural Genomics of Pathogenic Protozoa Consortium (SGPP), DOI 10.2210/pdb1XQ9/pdb; Chander M, 1999, J STRUCT BIOL, V126, P156, DOI 10.1006/jsbi.1999.4112; Chaneton B, 2012, CANCER CELL, V22, P565, DOI 10.1016/j.ccr.2012.10.014; Dar A, 2009, EUKARYOT CELL, V8, P1759, DOI 10.1128/EC.00149-09; de Atauri P, 2005, BBA-MOL BASIS DIS, V1740, P403, DOI 10.1016/j.bbadis.2004.11.023; Delto CF, 2015, STRUCTURE, V23, P364, DOI 10.1016/j.str.2014.11.016; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Evans MJ, 2007, MOL BIOSYST, V3, P495, DOI 10.1039/b705113a; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Florentin A, 2017, CELL REP, V21, P1746, DOI 10.1016/j.celrep.2017.10.081; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Ghashghaeinia M, 2019, CELL CYCLE, V18, P1316, DOI 10.1080/15384101.2019.1618125; Gizak A, 2015, ONCOTARGET, V6, P17237, DOI 10.18632/oncotarget.4044; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gruring C, 2012, METHOD ENZYMOL, V506, P81, DOI 10.1016/B978-0-12-391856-7.00029-9; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Harlow E., 1988, ANTIBODIES LAB MANUA; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Huang K, 2019, CELL METAB, V30, P1107, DOI 10.1016/j.cmet.2019.09.014; Huang K, 2019, EUR J MED CHEM, V168, P45, DOI 10.1016/j.ejmech.2019.01.085; Jankowska-Dollken M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54854-z; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jiang XL, 2014, INT J CANCER, V135, P1991, DOI 10.1002/ijc.28637; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Koike R, 2009, PROTEIN SCI, V18, P2060, DOI 10.1002/pro.218; Kondoh H, 2005, CANCER RES, V65, P177; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Liang Q, 2021, ACTA PHARMACOL SIN, V42, P115, DOI 10.1038/s41401-020-0399-1; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu XL, 2018, ONCOL RES, V26, P1123, DOI 10.3727/096504018X15166223632406; Liu ZG, 2018, ONCOL LETT, V15, P8935, DOI 10.3892/ol.2018.8477; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maier AG, 2019, TRENDS PARASITOL, V35, P481, DOI 10.1016/j.pt.2018.11.010; Mehra P, 2005, BIOCHEM BIOPH RES CO, V337, P955, DOI 10.1016/j.bbrc.2005.09.131; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Miao J, 2010, MOL MICROBIOL, V78, P883, DOI 10.1111/j.1365-2958.2010.07371.x; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Mikawa T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101306; Miranda E, 2013, J AM CHEM SOC, V135, P10418, DOI 10.1021/ja402993u; Moll K., 2013, METHODS MALARIA RES, V6th, DOI DOI 10.1007/S00436-008-0981-9; Nagar S, 2014, METHODS MOL BIOL, V1113, P1, DOI 10.1007/978-1-62703-758-7_1; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Oslund RC, 2017, NAT CHEM BIOL, V13, P1081, DOI [10.1038/NCHEMBIO.2453, 10.1038/nchembio.2453]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Rigden DJ, 1998, J MOL BIOL, V276, P449, DOI 10.1006/jmbi.1997.1554; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; ROTH E, 1990, BLOOD CELLS, V16, P453; SAKODA S, 1988, J BIOL CHEM, V263, P16899; Salcedo-Sora JE, 2014, TRENDS PARASITOL, V30, P170, DOI 10.1016/j.pt.2014.02.001; Schneider MP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006659; Sharif F, 2019, IUBMB LIFE, V71, P1418, DOI 10.1002/iub.2100; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Takahashi Y, 1998, EUR J BIOCHEM, V254, P497, DOI 10.1046/j.1432-1327.1998.2540497.x; Thezenas ML, 2013, J PROTEOME RES, V12, P1211, DOI 10.1021/pr300858g; TSUJINO S, 1993, AM J HUM GENET, V52, P472; Verma V, 2016, NUCLEIC ACIDS RES, V44, P3288, DOI 10.1093/nar/gkw148; Wang HL, 2016, PARASITE, V23, DOI 10.1051/parasite/2016012; WHITE MF, 1993, BIOCHEM J, V295, P743, DOI 10.1042/bj2950743; WHITE MF, 1993, BIOCHEM J, V291, P479, DOI 10.1042/bj2910479; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wisniewski JR, 2015, J PROTEOME RES, V14, P3263, DOI 10.1021/acs.jproteome.5b00276; Xu HY, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100572; Zhang D, 2017, ONCOGENE, V36, P2900, DOI 10.1038/onc.2016.446; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	89	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101713	10.1016/j.jbc.2022.101713	http://dx.doi.org/10.1016/j.jbc.2022.101713			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150741	gold, Green Published			2022-12-28	WOS:000821054100013
J	Lee, H; Sun, R; Niehrs, C				Lee, Hyeyoon; Sun, Rui; Niehrs, Christof			Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; ENDOCYTOSIS; ORGANIZER; MEMBRANE; LGR5	Signaling by bone morphogenetic proteins (BMPs) plays pivotal roles in embryogenesis, adult tissue homeostasis, and disease. Recent studies revealed that the well-established WNT agonist R-spondin 2 (RSPO2) is also a BMP receptor (BMP receptor type 1A) antagonist, with roles in early Xenopus embryogenesis and human acute myeloid leukemia (AML). To uncouple the BMP antagonist function from the WNT agonist function and to promote development of AML therapeutics, here we identified a 10-mer peptide (RW) derived from the thrombospondin 1 domain of RSPO2, which specifically prevents binding between RSPO2 and BMP receptor type 1A without altering WNT signaling. We also show that a corresponding RW dendrimer (RWd) exhibiting improved half-life relieves inhibition of BMP receptor signaling by RSPO2 in human AML cells, reduces cell growth, and induces differentiation. Moreover, microinjection of RWd in Xenopus embryos ventralizes the dorsoventral embryonic patterning by upregulating BMP signaling without affecting WNT signaling. Our study corroborates the function of RSPO2 as a BMP receptor antagonist and provides a proof of concept for pharmacologically uncoupling BMP antagonist from WNT agonist functions of RSPO2 using the inhibitor peptide RWd with enhanced target selectivity and limited side effects.	[Lee, Hyeyoon; Sun, Rui; Niehrs, Christof] Deutsch Krebsforschungszentrum DKFZ, Div Mol Embryol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol IMB, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Mol Embryol, DKFZ ZMBH Alliance, Heidelberg, Germany.; Niehrs, C (corresponding author), Inst Mol Biol IMB, Mainz, Germany.	niehrs@dkfz-heidelberg.de			Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB1324-B01]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) to C. N. (grant no.: SFB1324-B01).	Antebi YE, 2017, CELL, V170, P1184, DOI 10.1016/j.cell.2017.08.015; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chang CB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021923; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cui J, 2021, J MED CHEM, V64, P12572, DOI 10.1021/acs.jmedchem.1c00395; Cunningham AD, 2017, CURR OPIN STRUC BIOL, V44, P59, DOI 10.1016/j.sbi.2016.12.009; Davenport AP, 2020, NAT REV DRUG DISCOV, V19, P389, DOI 10.1038/s41573-020-0062-z; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dubey R, 2020, ELIFE, V9, DOI 10.7554/eLife.54469; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Han T, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15945; Hao HX, 2016, CANCERS, V8, DOI 10.3390/cancers8060054; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim JE, 2012, J BIOMED MATER RES A, V100A, P1488, DOI 10.1002/jbm.a.34089; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Klauzinska M, 2012, J CELL PHYSIOL, V227, P1960, DOI 10.1002/jcp.22924; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Lee H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19373-w; Li Ming, 2008, Yichuan, V30, P885, DOI 10.3724/SP.J.1005.2008.00885; Lowery JW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7290686; Lu HY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00315-3; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nanki K, 2018, CELL, V174, P856, DOI 10.1016/j.cell.2018.07.027; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; de Vega MJP, 2007, CURR TOP MED CHEM, V7, P33; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Sadler Kristen, 2002, J Biotechnol, V90, P195; Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Salik B, 2020, CANCER CELL, V38, P263, DOI 10.1016/j.ccell.2020.05.014; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shimer AL, 2009, INJURY, V40, P32; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Sun Aihua, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P125; Sun R, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109559; Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; Tong Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49758-x; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yu SM, 2021, BIOCONJUGATE CHEM, V32, P376, DOI 10.1021/acs.bioconjchem.1c00008; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zhang HB, 2019, J CELL BIOCHEM, V120, P5813, DOI 10.1002/jcb.27867; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YC, 2020, ANNU REV PHYSIOL, V82, P251, DOI 10.1146/annurev-physiol-021119-034500; Zylbersztejn F, 2018, EXP HEMATOL, V61, P36, DOI 10.1016/j.exphem.2018.02.005	66	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101586	10.1016/j.jbc.2022.101586	http://dx.doi.org/10.1016/j.jbc.2022.101586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35032551	gold, Green Published			2022-12-28	WOS:000761380200004
J	Zhang, Y; Wang, Y; Zheng, GX; Liu, Y; Li, JH; Huang, HH; Xu, CH; Zeng, YL; Zhang, XY; Qin, JZ; Dai, CS; Hambrock, HO; Hartmann, U; Feng, B; Mak, KK; Liu, YH; Lan, HY; Huang, Y; Zheng, ZH; Xia, Y				Zhang, Yu; Wang, Yang; Zheng, Guoxun; Liu, Yang; Li, Jinhong; Huang, Huihui; Xu, Chunhua; Zeng, Yelin; Zhang, Xiaoyi; Qin, Jinzhong; Dai, Chunsun; Hambrock, Harald O.; Hartmann, Ursula; Feng, Bo; Mak, Kingston Kinglun; Liu, Youhua; Lan, Hui-Yao; Huang, Yu; Zheng, Zhi-Hua; Xia, Yin			Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/beta-catenin signaling in obstructed kidneys in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC PROTEIN; FIBROBLAST ACTIVATION; URETERAL OBSTRUCTION; PROMOTES ARTHRITIS; TGF-BETA; INJURY; ACTIVIN; BINDING; MECHANISMS; EXPRESSION	Follistatin (FS)-like 1 (FSTL1) is a member of the FS-SPARC (secreted protein, acidic and rich in cysteine) family of secreted and extracellular matrix proteins. The functions of FSTL1 have been studied in heart and lung injury as well as in wound healing; however, the role of FSTL1 in the kidney is largely unknown. Here, we show using single-cell RNA-Seq that Fstl1 was enriched in stromal cells in obstructed mouse kidneys. In addition, immunofluorescence demonstrated that FSTL1 expression was induced in fibro-blasts during kidney fibrogenesis in mice and human patients. We demonstrate that FSTL1 overexpression increased renal fibrosis and activated the Wnt/beta-catenin signaling pathway, known to promote kidney fibrosis, but not the transforming growth factor beta (TGF-beta), Notch, Hedgehog, or Yes-associated protein (YAP) signaling pathways in obstructed mouse kidneys, whereas inhibition of FSTL1 lowered Wnt/beta-catenin signaling. Importantly, we show that FSTL1 interacted with Wnt ligands and the Frizzled (FZD) receptors but not the coreceptor lipoprotein receptor-related protein 6 (LRP6). Specifically, we found FSTL1 interacted with Wnt3a through its extracellular calcium-binding (EC) domain and von Willebrand factor type C-like (VWC) domain, and with FZD4 through its EC domain. Furthermore, we show that FSTL1 increased the association of Wnt3a with FZD4 and promoted Wnt/beta-catenin signaling and fibrogenesis. The EC domain interacting with both Wnt3a and FZD4 also enhanced Wnt3a signaling. Therefore, we conclude that FSTL1 is a novel extracellular enhancer of the Wnt/beta-catenin pathway.	[Zhang, Yu; Wang, Yang; Xu, Chunhua; Zeng, Yelin; Zhang, Xiaoyi; Feng, Bo; Xia, Yin] Chinese Univ Hong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Zheng, Guoxun] Shanghai Tech Univ, iHuman Inst, Shanghai, Peoples R China; [Liu, Yang; Li, Jinhong; Zheng, Zhi-Hua] Sun Yat sen Univ, Affiliated Hosp 7, Ctr Nephrol & Urol, Dept Nephrol, Shenzhen, Peoples R China; [Huang, Huihui] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing, Peoples R China; [Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Peoples R China; [Hambrock, Harald O.; Hartmann, Ursula] Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany; [Mak, Kingston Kinglun] Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou, Peoples R China; [Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Lan, Hui-Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Peoples R China; [Lan, Hui-Yao; Xia, Yin] Chinese Univ Hong Kong, Guangdong Prov Peoples Hosp, Guangdong Hong Kong Joint Lab Immune & Genet Kidne, Hong Kong, Guangdong, Peoples R China; [Lan, Hui-Yao; Xia, Yin] Chinese Univ Hong Kong, Guangdong Acad Med Sci, Hong Kong, Peoples R China	Chinese University of Hong Kong; ShanghaiTech University; Sun Yat Sen University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Nanjing University; Nanjing Medical University; University of Cologne; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Chinese University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese University of Hong Kong	Xia, Y (corresponding author), Chinese Univ Hong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China.; Zheng, ZH (corresponding author), Sun Yat sen Univ, Affiliated Hosp 7, Ctr Nephrol & Urol, Dept Nephrol, Shenzhen, Peoples R China.; Xia, Y (corresponding author), Chinese Univ Hong Kong, Guangdong Prov Peoples Hosp, Guangdong Hong Kong Joint Lab Immune & Genet Kidne, Hong Kong, Guangdong, Peoples R China.; Xia, Y (corresponding author), Chinese Univ Hong Kong, Guangdong Acad Med Sci, Hong Kong, Peoples R China.	zhzhihua@mail.sysu.edu.cn; Xia.Yin@cuhk.edu.hk	Xia, Yin/M-5440-2018; Huang, Yu/K-2866-2017; Lan, Hui-yao/C-9734-2015	Xia, Yin/0000-0003-0315-7532; Huang, Yu/0000-0002-1277-6784; Liu, Youhua/0000-0002-4740-805X; Lan, Hui-yao/0000-0003-4283-9755; Zheng, Zhihua/0000-0003-1025-5384	Hong Kong PhD Fellowship; Health and Medical Research Funds [05161376, 08190376]; Hong Kong Food and Health Bureau; General Research Funds [14164817, RGC-SRFS2021-4S04, C4024-16W]; Hong Kong Research Grants Council; Ministry of Science and Technology of China [2018YFC1312704]; Research Grants Council of Hong Kong [14163317, 14117418, 14104019, C7018-16G]; Guangdong-Hong Kong-Macao-Joint Labo-ratory Program; Guangdong Science and Technology Department [2019B121205005]	Hong Kong PhD Fellowship; Health and Medical Research Funds; Hong Kong Food and Health Bureau; General Research Funds; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Guangdong-Hong Kong-Macao-Joint Labo-ratory Program; Guangdong Science and Technology Department	Dr Y. Z. was supported by Hong Kong PhD Fellowship. This work was supported by Health and Medical Research Funds (grant nos.: 05161376 and 08190376) , Hong Kong Food and Health Bureau (to Dr Y. X.) ; General Research Funds (grant nos.: 14164817, RGC-SRFS2021-4S04, and C4024-16W) , the Hong Kong Research Grants Council, and Research Fund (grant no.: 2018YFC1312704) from the Ministry of Science and Technology of China (to Dr Y. H.) ; and the Research Grants Council of Hong Kong (grant nos.: 14163317, 14117418, 14104019, and C7018-16G) , and the Guangdong-Hong Kong-Macao-Joint Laboratory Program (grant no.: 2019B121205005) from Guangdong Science and Technology Department (to Dr H.-Y. L.) .	Adams DC, 2010, AM J PHYSIOL-RENAL, V299, pF1320, DOI 10.1152/ajprenal.00325.2010; Andreichenko IN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246301; Arvaniti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26235; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Chaly Y, 2014, IMMUNOL RES, V59, P266, DOI 10.1007/s12026-014-8526-z; Chaly Y, 2012, ARTHRITIS RHEUM-US, V64, P1082, DOI 10.1002/art.33422; Cheng SQ, 2019, CANCER BIOL THER, V20, P328, DOI 10.1080/15384047.2018.1529101; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Clutter SD, 2009, J IMMUNOL, V182, P234, DOI 10.4049/jimmunol.182.1.234; Conway BR, 2020, J AM SOC NEPHROL, V31, P2833, DOI 10.1681/ASN.2020060806; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Dong YY, 2015, J EXP MED, V212, P235, DOI 10.1084/jem.20121878; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Feng Y, 2018, J AM SOC NEPHROL, V29, P182, DOI 10.1681/ASN.2017040391; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Gerlach JP, 2018, P NATL ACAD SCI USA, V115, pE3996, DOI 10.1073/pnas.1721321115; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Hayakawa S, 2015, J AM SOC NEPHROL, V26, P636, DOI 10.1681/ASN.2014020210; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Huang HH, 2018, KIDNEY INT, V93, P855, DOI 10.1016/j.kint.2017.09.030; Huang SZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005233; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu WJ, 2018, P NATL ACAD SCI USA, V115, pE1475, DOI 10.1073/pnas.1716959115; Liu WJ, 2013, J BIOL CHEM, V288, P31528, DOI 10.1074/jbc.M113.517573; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Maksimowski NA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179513; Maruyama S, 2016, EMBO MOL MED, V8, P949, DOI 10.15252/emmm.201506151; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Munoz-Felix JM, 2015, PHARMACOL THERAPEUT, V156, P44, DOI 10.1016/j.pharmthera.2015.10.003; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Ni S, 2019, J CELL PHYSIOL, V234, P454, DOI 10.1002/jcp.26580; Nie E, 2019, ONCOGENE, V38, P2706, DOI 10.1038/s41388-018-0596-2; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Schneyer AL, 2008, ENDOCRINOLOGY, V149, P4589, DOI 10.1210/en.2008-0259; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shimano M, 2011, P NATL ACAD SCI USA, V108, pE899, DOI 10.1073/pnas.1108559108; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Sundaram GM, 2017, J EXP MED, V214, P2889, DOI 10.1084/jem.20170354; Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Vallon M, 2018, CELL REP, V25, P339, DOI 10.1016/j.celrep.2018.09.045; Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372; Wu Y, 2010, MECH DEVELOP, V127, P183, DOI 10.1016/j.mod.2009.12.003; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Xiao LX, 2016, J AM SOC NEPHROL, V27, P1727, DOI 10.1681/ASN.2015040449; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhou D, 2016, LAB INVEST, V96, P156, DOI 10.1038/labinvest.2015.153; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zhou JL, 2006, GENE, V372, P191, DOI 10.1016/j.gene.2005.12.020	66	3	3	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102010	10.1016/j.jbc.2022.102010	http://dx.doi.org/10.1016/j.jbc.2022.102010			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8MA	35525270	Green Published, gold			2022-12-28	WOS:000829549100004
J	Desrochers, GF; Filip, R; Bastianelli, M; Stern, T; Pezacki, JP				Desrochers, Genevieve F.; Filip, Roxana; Bastianelli, Micheal; Stern, Tiffany; Pezacki, John Paul			microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; GENE; METABOLISM; EXPRESSION; MECHANISMS; PROFILES; REVEALS; CLUSTER	miRNAs are short, noncoding RNAs that negatively and specifically regulate protein expression, the cumulative effects of which can result in broad changes to cell systems and architecture. The miRNA miR-27b is known to regulate lipid regulatory pathways in the human liver and is also induced by the hepatitis C virus (HCV). However, the functional targets of miR-27b are not well established. Herein, an activity-based protein profiling method using a serine hydrolase probe, coupled with stable isotope labeling and mass spectrometry identified direct and indirect targets of miR-27b. The hepatic lipase C (LIPC) stood out as both highly dependent on miR-27b and as a major modulator of lipid pathway misregulation. Modulation of miR-27b using both exogenous miRNA mimics and inhibitors demonstrated that transcription factors Jun, PPARa, and HNF4a, all of which also influence LIPC levels and activity, are regulated by miR-27b. LIPC was furthermore shown to affect the progress of the life cycle of HCV and to decrease levels of intracellular triglycerides, upon which HCV is known to depend. In summary, this work has demonstrated that miR-27b mediates HCV infection by downregulating LIPC, thereby reducing triglyceride degradation, which in turn increases cellular lipid levels.	[Desrochers, Genevieve F.; Filip, Roxana; Stern, Tiffany; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Bastianelli, Micheal; Pezacki, John Paul] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Pezacki, JP (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada.; Pezacki, JP (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	john.pezacki@uottawa.ca		Stern, Tiffany/0000-0002-4275-6602	Fonds de recherche du Quebec, Nature et Technologies; NSERC CGS graduate scholarship	Fonds de recherche du Quebec, Nature et Technologies; NSERC CGS graduate scholarship	G. F. D. was supported by a scholarship from the Fonds de recherche du Quebec, Nature et Technologies. R. F. was supported by an NSERC CGS graduate scholarship.	Aguilar AL, 2017, ACS CHEM BIOL, V12, P611, DOI 10.1021/acschembio.6b01089; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008; Bassendine MF, 2013, SEMIN IMMUNOPATHOL, V35, P87, DOI 10.1007/s00281-012-0356-2; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brunham LR, 2015, PROG LIPID RES, V58, P14, DOI 10.1016/j.plipres.2015.01.001; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Castano C, 2018, P NATL ACAD SCI USA, V115, P12158, DOI 10.1073/pnas.1808855115; Chen DN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0211-4; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Chen XJ, 2018, MOL MED REP, V17, P5081, DOI 10.3892/mmr.2018.8538; Chiyomaru T, 2015, INT J ONCOL, V46, P487, DOI 10.3892/ijo.2014.2752; Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; Desrochers GF, 2019, CURR TOP MICROBIOL, V420, P131, DOI 10.1007/82_2018_139; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; Drewes T, 1996, MOL CELL BIOL, V16, P925; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Filip R, 2021, CELL CHEM BIOL, V28, P202, DOI 10.1016/j.chembiol.2020.12.009; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He SJ, 2016, MOL MED REP, V13, P2801, DOI 10.3892/mmr.2016.4851; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hu L, 2019, ANTI-CANCER DRUG, V30, P186, DOI 10.1097/CAD.0000000000000711; Huang JY, 2021, J GASTROINTEST SURG, V25, P900, DOI 10.1007/s11605-020-04550-5; Hunerdosse D, 2014, CURR OPIN BIOTECH, V28, P116, DOI 10.1016/j.copbio.2014.02.001; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kida K, 2011, PHARM RES-DORDR, V28, P2467, DOI 10.1007/s11095-011-0473-y; KUUSI T, 1979, BIOCHEM J, V181, P245, DOI 10.1042/bj1810245; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Levy G, 2016, NAT CHEM BIOL, V12, P1037, DOI [10.1038/NCHEMBIO.2193, 10.1038/nchembio.2193]; Li QS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01954-x; Liu BY, 2017, ARCH ORAL BIOL, V83, P92, DOI 10.1016/j.archoralbio.2017.07.009; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lizio M, 2019, NUCLEIC ACIDS RES, V47, pD752, DOI 10.1093/nar/gky1099; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Luo Y, 2018, ONCOTARGET, V9, P3830, DOI 10.18632/oncotarget.23237; Mirzaei H, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2088; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Murata Yuka, 2019, Biomed Res Int, V2019, P2916243, DOI 10.1155/2019/2916243; Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Oka K, 1996, GENE, V180, P69, DOI 10.1016/S0378-1119(96)00408-8; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Poon VY, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3139-7; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Sharifzadeh S, 2019, CURR TOP MICROBIOL, V420, P23, DOI 10.1007/82_2018_135; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Shinohara Y, 2013, HEPATOL RES, V43, P1190, DOI 10.1111/hepr.12072; Shrivastava S, 2015, GENES DIS, V2, P35, DOI 10.1016/j.gendis.2015.01.001; Singaravelu R, 2015, NAT CHEM BIOL, V11, P988, DOI 10.1038/nchembio.1940; Singaravelu R, 2015, ACS INFECT DIS, V1, P130, DOI 10.1021/acsinfecdis.5b00019; Singaravelu R, 2014, CURR OPIN VIROL, V7, P1, DOI 10.1016/j.coviro.2014.03.004; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Sirvent A, 2004, J LIPID RES, V45, P2110, DOI 10.1194/jlr.M400221-JLR200; Stoll G, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1571389; Strmiskova M, 2016, ACS INFECT DIS, V2, P773, DOI 10.1021/acsinfecdis.6b00084; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Sun XF, 2016, TUMOR BIOL, V37, P15325, DOI 10.1007/s13277-016-5444-9; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-140; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; van Deursen D, 2008, MOL CELL ENDOCRINOL, V294, P37, DOI 10.1016/j.mce.2008.07.004; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Witzigmann D, 2020, ADV DRUG DELIVER REV, V159, P344, DOI 10.1016/j.addr.2020.06.026; WOLLE J, 1993, J LIPID RES, V34, P2169; Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169; Worrell BT, 2013, SCIENCE, V340, P457, DOI 10.1126/science.1229506; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Xie W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157085; Zhu HT, 2017, LIVER INT, V37, P888, DOI 10.1111/liv.13356; Zhuo LJ, 2013, ONCOL REP, V29, P555, DOI 10.3892/or.2012.2155	79	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101983	10.1016/j.jbc.2022.101983	http://dx.doi.org/10.1016/j.jbc.2022.101983			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35483451	Green Published, gold			2022-12-28	WOS:000811813400010
J	Fernandez, S; Wofford, JD; Shepherd, RE; Vali, SW; Dancis, A; Lindahl, PA				Fernandez, Salvador; Wofford, Joshua D.; Shepherd, Rachel E.; Vali, Shaik Waseem; Dancis, Andrew; Lindahl, Paul A.			Yeast cells depleted of the frataxin homolog Yfh1 redistribute cellular iron: Studies using Mossbauer spectroscopy and mathematical modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CELLS; INTACT MITOCHONDRIA; OXIDATIVE STRESS; DEFICIENT; PROTEIN; GENES; MANGANESE; STORAGE; ACCUMULATION; ACTIVATION	The neurodegenerative disease Friedreich's ataxia arises from a deficiency of frataxin, a protein that promotes iron- sulfur cluster (ISC) assembly in mitochondria. Here, primarily using Mossbauer spectroscopy, we investigated the iron content of a yeast strain in which expression of yeast frataxin homolog 1 (Yfh1), oxygenation conditions, iron concentrations, and metabolic modes were varied. We found that aerobic fermenting Yfh1-depleted cells grew slowly and accumulated Fe-III nanoparticles, unlike WT cells. Under hypoxic conditions, the same mutant cells grew at rates similar to WT cells, had similar iron content, and were dominated by Fe-II rather than Fe(III )nanoparticles. Furthermore, mitochondria from mutant hypoxic cells contained approximately the same levels of ISCs as WT cells, confirming that Yfh1 is not required for ISC assembly. These cells also did not accumulate excessive iron, indicating that iron accumulation into yfh1-deficient mitochondria is stimulated by O-2. In addition, in aerobic WT cells, we found that vacuoles stored Fe-III, whereas under hypoxic fermenting conditions, vacuolar iron was reduced to Fe-II. Under respiring conditions, vacuoles of Yfh1-deficient cells contained Fe-III, and nanoparticles accumulated only under aerobic conditions. Taken together, these results informed a mathematical model of iron trafficking and regulation in cells that could semiquantitatively simulate the Yfh1-deficiency phenotype. Simulations suggested partially independent regulation in which cellular iron import is regulated by ISC activity in mitochondria, mitochondrial iron import is regulated by a mitochondrial Fe-II pool, and vacuolar iron import is regulated by cytosolic Fe-II and mitochondrial ISC activity.	[Fernandez, Salvador; Shepherd, Rachel E.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Wofford, Joshua D.] Charleston Southern Univ, Coll Sci & Math, Dept Chem, Charleston, SC USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Dancis, Andrew] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Pennsylvania; Pennsylvania Medicine	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Lindahl, PA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu			National Science Foundation, United States [MCB-1817389]; National Institutes of Health, United States [GM127021, GM107542]; Robert A. Welch Foundation [A1170]; Welch Foundation	National Science Foundation, United States(National Science Foundation (NSF)); National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation)	FundiThis work was supported by the National Science Foundation, United States (MCB-1817389) , the National Institutes of Health, United States (GM127021 to P. A. L. and GM107542 to A. D.) , and the Robert A. Welch Foundation, United States (A1170) . The content is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health, the NSF, or the Welch Foundation.	Ast T, 2019, CELL, V177, P1507, DOI 10.1016/j.cell.2019.03.045; Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Cockrell AL, 2011, BIOCHEMISTRY-US, V50, P10275, DOI 10.1021/bi2014954; Cook A, 2017, BRIT MED BULL, V124, P19, DOI 10.1093/bmb/ldx034; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Holmes-Hampton GP, 2010, BIOCHEMISTRY-US, V49, P4227, DOI 10.1021/bi1001823; Hudder BN, 2007, J BIOL INORG CHEM, V12, P1029, DOI 10.1007/s00775-007-0275-1; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kim J. E., 2021, SACCHAROMYCES CEREVI, V296; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Martelli A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00130; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2011, BIOCHEMISTRY-US, V50, P2660, DOI 10.1021/bi102015s; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Moore MJ, 2018, BIOCHEMISTRY-US, V57, P672, DOI 10.1021/acs.biochem.7b01034; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2015, EUR J CELL BIOL, V94, P292, DOI 10.1016/j.ejcb.2015.05.003; Nguyen TQ, 2020, METALLOMICS, V12, P1094, DOI 10.1039/c9mt00312f; Nguyen TQ, 2019, METALLOMICS, V11, P1298, DOI 10.1039/c9mt00104b; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pandey A, 2018, CELL CHEM BIOL, V25, P738, DOI 10.1016/j.chembiol.2018.04.002; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Park J, 2014, BIOCHEMISTRY-US, V53, P3940, DOI 10.1021/bi500148y; Park J, 2013, METALLOMICS, V5, P656, DOI 10.1039/c3mt00041a; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Ramos-Alonso L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.582830; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Seguin A, 2011, J BIOL CHEM, V286, P6071, DOI 10.1074/jbc.M110.163253; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Surovstev IV, 2007, J THEOR BIOL, V244, P154, DOI 10.1016/j.jtbi.2006.07.020; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Wofford JD, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-019-0702-2; Wofford JD, 2019, J BIOL CHEM, V294, P50, DOI 10.1074/jbc.RA118.005233; Wofford JD, 2015, J BIOL CHEM, V290, P26968, DOI 10.1074/jbc.M115.676668; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	57	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101921	10.1016/j.jbc.2022.101921	http://dx.doi.org/10.1016/j.jbc.2022.101921			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35413285	gold, Green Published			2022-12-28	WOS:000807750700005
J	Hernandez, AJ; Lee, SJ; Thompson, NJ; Griffith, JD; Richardson, CC				Hernandez, Alfredo J.; Lee, Seung-Joo; Thompson, Noah J.; Griffith, Jack D.; Richardson, Charles C.			Residues located in the primase domain of the bacteriophage T7 primase-helicase are essential for loading the hexameric complex onto DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 4 PROTEIN; NUCLEOTIDE-BINDING SITE; RNA-POLYMERASE DOMAIN; CRYSTAL-STRUCTURE; PRIMER SYNTHESIS; LINKER REGION; RING HELICASE; UNIQUE LOOP; IN-VITRO; RECOGNITION	The T7 primase-helicase plays a pivotal role in the replication of T7 DNA. Using affinity isolation of peptide-nucleic acid crosslinks and mass spectrometry, we identify protein regions in the primase-helicase and T7 DNA polymerase that form contacts with the RNA primer and DNA template. The contacts between nucleic acids and the primase domain of the primasehelicase are centered in the RNA polymerase subdomain of the primase domain, in a cleft between the N-terminal subdomain and the topoisomerase-primase fold. We demonstrate that residues along a beta sheet in the N-terminal subdomain that contacts the RNA primer are essential for phage growth and primase activity in vitro. Surprisingly, we found mutations in the primase domain that had a dramatic effect on the helicase. Substitution of a residue conserved in other DnaG-like enzymes, R84A, abrogates both primase and helicase enzymatic activities of the T7 primase-helicase. Alterations in this residue also decrease binding of the primase-helicase to ssDNA. However, mass photometry measurements show that these mutations do not interfere with the ability of the protein to form the active hexamer.	[Hernandez, Alfredo J.; Lee, Seung-Joo; Richardson, Charles C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thompson, Noah J.; Griffith, Jack D.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC USA	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Richardson, CC (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Hernandez, Alfredo J/ABC-8311-2020	Hernandez, Alfredo J/0000-0002-0903-8932	royalty funds; National Institutes of Health [5R01ES031635]	royalty funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by royalty funds (C. C. R.) and National Institutes of Health Grant 5R01ES031635 (J. D. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chowdhury K, 2000, P NATL ACAD SCI USA, V97, P12469, DOI 10.1073/pnas.230448397; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Hernandez AJ, 2020, J BIOL CHEM, V295, P9542, DOI 10.1074/jbc.RA120.013738; Hernandez AJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55312; Hernandez AJ, 2016, P NATL ACAD SCI USA, V113, P5916, DOI 10.1073/pnas.1604894113; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kato M, 2001, J BIOL CHEM, V276, P21809, DOI 10.1074/jbc.M101470200; KIM YT, 1992, J BIOL CHEM, V267, P15022; KOLODNER R, 1978, J BIOL CHEM, V253, P566; Kornberg A., 1992, DNA REPLICATION; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kulczyk AW, 2016, ENZYMES, V39, P89, DOI 10.1016/bs.enz.2016.02.001; Kulczyk AW, 2017, P NATL ACAD SCI USA, V114, pE1848, DOI 10.1073/pnas.1701252114; Kulczyk AW, 2012, P NATL ACAD SCI USA, V109, P9408, DOI 10.1073/pnas.1207033109; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Qiu HB, 2009, J PROTEOME RES, V8, P1983, DOI 10.1021/pr8009319; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; TABOR S, 1989, J BIOL CHEM, V264, P6447; Yang W, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0118-2; Yao Nina Y, 2021, Subcell Biochem, V96, P233, DOI 10.1007/978-3-030-58971-4_5; Yi GH, 2009, J MOL BIOL, V391, P314, DOI 10.1016/j.jmb.2009.05.065; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	57	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101996	10.1016/j.jbc.2022.101996	http://dx.doi.org/10.1016/j.jbc.2022.101996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35500649	gold, Green Published			2022-12-28	WOS:000816927100002
J	Tsai, WH; Grauffel, C; Huang, MY; Postic, S; Rupnik, MS; Lim, C; Yang, SB				Tsai, Wen-Hao; Grauffel, Cedric; Huang, Ming-Yueh; Postic, Sandra; Rupnik, Marjan Slak; Lim, Carmay; Yang, Shi-Bing			Allosteric coupling between transmembrane segment 4 and the selectivity filter of TALK1 potassium channels regulates their gating by extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE BACKGROUND K-2P; K+ CHANNEL; 2-PORE DOMAIN; FUNCTIONAL HETERODIMERS; MOLECULAR-DYNAMICS; HILL COEFFICIENTS; CRYSTAL-STRUCTURE; MECHANISM; TRAAK; MODALITIES	Opening of two-pore domain K+ channels (K2Ps) is regulated by various external cues, such as pH, membrane tension, or temperature, which allosterically modulate the selectivity filter (SF) gate. However, how these cues cause conformational changes in the SF of some K2P channels remains unclear. Herein, we investigate the mechanisms by which extracellular pH affects gating in an alkaline-activated K2P channel, TALK1, using electrophysiology and molecular dynamics (MD) simulations. We show that R233, located at the N-terminal end of transmembrane segment 4, is the primary pHo sensor. This residue distally regulates the orientation of the carbonyl group at the S1 potassium-binding site through an interacting network composed of residues on transmembrane segment 4, the pore helix domain 1, and the SF. Moreover, in the presence of divalent cations, we found the acidic pH-activated R233E mutant recapitulates the network interactions of protonated R233. Intriguingly, our data further suggested stochastic coupling between R233 and the SF gate, which can be described by an allosteric gating model. We propose that this allosteric model could predict the hybrid pH sensitivity in heterodimeric channels with alkaline-activated and acidic-activated K2P subunits.	[Tsai, Wen-Hao; Grauffel, Cedric; Lim, Carmay; Yang, Shi-Bing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Tsai, Wen-Hao; Yang, Shi-Bing] Natl Yang Ming Chiao Tung Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan; [Tsai, Wen-Hao; Yang, Shi-Bing] Acad Sinica, Taipei, Taiwan; [Huang, Ming-Yueh] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Postic, Sandra; Rupnik, Marjan Slak] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, Maribor, Slovenia; [Rupnik, Marjan Slak] Alma Mater Europaea, European Ctr Maribor, Maribor, Slovenia	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Medical University of Vienna; University of Maribor	Yang, SB (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Yang, SB (corresponding author), Natl Yang Ming Chiao Tung Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan.; Yang, SB (corresponding author), Acad Sinica, Taipei, Taiwan.	sbyang@ibms.sinica.edu.tw	Lim, Carmay/N-9648-2015; Yang, Shi-Bing/C-8308-2011; Slak Rupnik, Marjan/E-6246-2015	Lim, Carmay/0000-0001-9077-7769; Postic, Sandra/0000-0003-3759-1564; Yang, Shi-Bing/0000-0001-8061-3963; Slak Rupnik, Marjan/0000-0002-3744-4882	Institute of Biomedical Sciences at Academia Sinica; Ministry of Science and Technology, Taiwan [107-2923-B001-001MY3, 106-2320-B-001-013, 107-2320-B-001-026-MY3]	Institute of Biomedical Sciences at Academia Sinica; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Institute of Biomedical Sciences at Academia Sinica and the Ministry of Science and Technology, Taiwan (107-2923-B001-001MY3, 106-2320-B-001-013 and 107-2320-B-001-026-MY3 to S. B. Y.).	Abeliovich H, 2016, J MATH BIOL, V73, P1399, DOI 10.1007/s00285-016-1001-9; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Brennecke JT, 2018, BIOPHYS J, V114, P1336, DOI 10.1016/j.bpj.2018.01.030; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng Q, 2010, BIOPHYS J, V99, pL29, DOI 10.1016/j.bpj.2010.05.018; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Gonzalez W, 2013, J BIOL CHEM, V288, P5984, DOI 10.1074/jbc.M112.445528; Graff SM, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.138057; Han J, 2003, AM J PHYSIOL-CELL PH, V285, pC529, DOI 10.1152/ajpcell.00601.2002; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; Jekhmane S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07973-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Khoubza L., 2021, BIORXIV, DOI [10.1101/2021.11.08.467666, DOI 10.1101/2021.11.08.467666]; Lengyel M, 2016, J BIOL CHEM, V291, P13649, DOI 10.1074/jbc.M116.719039; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Levitz J, 2016, P NATL ACAD SCI USA, V113, P4194, DOI 10.1073/pnas.1522459113; Li BB, 2020, NATURE, V586, P457, DOI 10.1038/s41586-020-2770-2; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Lolicato M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc9174; Lolicato M, 2017, NATURE, V547, P364, DOI 10.1038/nature22988; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; McClenaghan C, 2016, J GEN PHYSIOL, V147, P497, DOI 10.1085/jgp.201611601; Miranda WE, 2020, P NATL ACAD SCI USA, V117, P2795, DOI 10.1073/pnas.1909196117; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pau V, 2017, NAT STRUCT MOL BIOL, V24, P857, DOI 10.1038/nsmb.3457; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Vierra NC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan2883; Vierra NC, 2015, DIABETES, V64, P3818, DOI 10.2337/db15-0280; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Xu YY, 2019, J STRUCT BIOL-X, V3, DOI 10.1016/j.yjsbx.2019.100009; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zhang Y., 2021, MEMBRANES BASEL, V11, P190; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	51	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101998	10.1016/j.jbc.2022.101998	http://dx.doi.org/10.1016/j.jbc.2022.101998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35500647	gold, Green Published			2022-12-28	WOS:000811813400009
J	Flova, JS; Habibi, NR; Yap, JQ; Cleary, SR; Fang, X; Kekenes-Huskey, PM; Espinoza-Fonseca, LM; Bossuyt, JB; Robia, SL				Flova, Jaroslava Se; Habibi, Nima R.; Yap, John Q.; Cleary, Sean R.; Fang, Xuan; Kekenes-Huskey, Peter M.; Espinoza-Fonseca, L. Michel; Bossuyt, Julie B.; Robia, Seth L.			Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; P-TYPE ATPASE; NA+/K+-ATPASE; PHOSPHOLAMBAN OLIGOMERIZATION; ERYTHROCYTE CA-2+-ATPASE; TRANSMEMBRANE PROTEINS; CARDIAC-GLYCOSIDES; CRYSTAL-STRUCTURE; NA/K-ATPASE; PHOSPHOLEMMAN	The sodium-potassium ATPase (Na/K-ATPase, NKA) establishes ion gradients that facilitate many physiological functions including action potentials and secondary transport processes. NKA comprises a catalytic subunit (alpha) that in-teracts closely with an essential subunit (beta) and regulatory transmembrane micropeptides called FXYD proteins. In the heart, a key modulatory partner is the FXYD protein phos-pholemman (PLM, FXYD1), but the stoichiometry of the alpha-beta-PLM regulatory complex is unknown. Here, we used fluorescence lifetime imaging and spectroscopy to inves-tigate the structure, stoichiometry, and affinity of the NKA-regulatory complex. We observed a concentration-dependent binding of the subunits of NKA-PLM regulatory complex, with avid association of the alpha subunit with the essential beta subunit as well as lower affinity alpha-alpha and alpha- PLM interactions. These data provide the first evidence that, in intact live cells, the regulatory complex is composed of two alpha subunits associated with two beta subunits, decorated with two PLM regulatory subunits. Docking and molecular dynamics (MD) simulations generated a structural model of the complex that is consistent with our experimental observations. We propose that alpha-alpha subunit interactions support conformational coupling of the catalytic subunits, which may enhance NKA turnover rate. These observations provide insight into the pathophysiology of heart failure, wherein low NKA expression may be insufficient to support formation of the complete regulatory complex with the stoichiometry (alpha-beta-PLM)2.	[Flova, Jaroslava Se; Yap, John Q.; Cleary, Sean R.; Fang, Xuan; Kekenes-Huskey, Peter M.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60660 USA; [Habibi, Nima R.; Bossuyt, Julie B.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Espinoza-Fonseca, L. Michel] Univ Michigan, Ctr Arrhythmia Res, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA	Loyola University Chicago; University of California System; University of California Davis; University of Michigan System; University of Michigan	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60660 USA.; Bossuyt, JB (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	jbossuyt@ucdavis.edu; srobia@luc.edu	Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Yap, John/0000-0003-4185-2480	American Heart Association Postdoctoral Fellowship [830562]; National Institute of Health [HL092321, HL143816, R35 GM124977, R01GM120142, R01HL142282-04]	American Heart Association Postdoctoral Fellowship(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This research was supported by American Heart Association Postdoctoral Fellowship 830562 (to J. S.) and the National Institute of Health grants HL092321 and HL143816 (to S. L. R.) , R35 GM124977 (to P.M. K.-H.) , R01GM120142 (to L. M. E.-F.) , and R01HL142282-04 (to J. B. B.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrol N, 2015, J BIOL CHEM, V290, P7130, DOI 10.1074/jbc.M114.630319; Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; ASKARI A, 1987, J BIOENERG BIOMEMBR, V19, P359, DOI 10.1007/BF00768539; Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Boldyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P821, DOI 10.1023/A:1011964832767; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Bovo E, 2020, BIOPHYS J, V119, P1456, DOI 10.1016/j.bpj.2020.08.025; Cechova P, 2016, J CHEM INF MODEL, V56, P2434, DOI 10.1021/acs.jcim.6b00353; Chan H, 2010, J MOL MICROB BIOTECH, V19, P5, DOI 10.1159/000319588; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Clarke RJ, 2007, BIOPHYS J, V93, P4187, DOI 10.1529/biophysj.107.111591; Clarke RJ, 2007, BIOCHEMISTRY-US, V46, P7034, DOI 10.1021/bi700619s; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; Desta IT, 2020, STRUCTURE, V28, P1071, DOI 10.1016/j.str.2020.06.006; Digitalis Investigation Group, 1997, NEW ENGL J MED, V336, P525, DOI DOI 10.1056/NEJM199702203360801; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Froehlich JP, 1997, ANN NY ACAD SCI, V834, P280, DOI 10.1111/j.1749-6632.1997.tb52259.x; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; GANJEIZADEH M, 1995, J BIOL CHEM, V270, P15707, DOI 10.1074/jbc.270.26.15707; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; H. S.Young, 2019, bioRxiv, DOI 10.1101/2019.12.19.883355; Himes RD, 2016, BIOCHEMISTRY-US, V55, P6196, DOI 10.1021/acs.biochem.6b00633; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Kanai R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020438118; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Laviv T, 2016, NAT METHODS, V13, P989, DOI [10.1038/NMETH.4046, 10.1038/nmeth.4046]; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Okkeri J, 2002, EUR J BIOCHEM, V269, P1579, DOI 10.1046/j.1432-1033.2002.02810.x; OTTOLENGHI P, 1983, BIOCHIM BIOPHYS ACTA, V727, P89, DOI 10.1016/0005-2736(83)90372-3; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; REPKE KRH, 1973, ACTA BIOL MED GER, V31, pK19; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Santoro L, 2011, CEPHALALGIA, V31, P808, DOI 10.1177/0333102411399351; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schlingmann KP, 2018, AM J HUM GENET, V103, P808, DOI 10.1016/j.ajhg.2018.10.004; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Singh RB, 2010, CAN J PHYSIOL PHARM, V88, P388, DOI 10.1139/Y10-012; Song H, 2014, J PHYSIOL-LONDON, V592, P941, DOI 10.1113/jphysiol.2013.266866; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Spadaro M, 2004, NEUROGENETICS, V5, P177, DOI 10.1007/s10048-004-0183-2; STEIN WD, 1973, P NATL ACAD SCI USA, V70, P275, DOI 10.1073/pnas.70.1.275; Tian C, 2020, J CHEM THEORY COMPUT, V16, P528, DOI 10.1021/acs.jctc.9b00591; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; VANDERKOOI JM, 1977, BIOCHEMISTRY-US, V16, P1262, DOI 10.1021/bi00626a003; Wong A, 2008, SOLID STATE NUCL MAG, V33, P72, DOI 10.1016/j.ssnmr.2008.04.003; Yap JQ, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012633; Zacchia M, 2016, KIDNEY DIS-BASEL, V2, P72, DOI 10.1159/000446268	75	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101865	10.1016/j.jbc.2022.101865	http://dx.doi.org/10.1016/j.jbc.2022.101865			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35339486	Green Published, gold			2022-12-28	WOS:000804436700010
J	Gada, KD; Kawano, T; Plant, LD; Logothetis, DE				Gada, Kirin D.; Kawano, Takeharu; Plant, Leigh D.; Logothetis, Diomedes E.			An optogenetic tool to recruit individual PKC isozymes to the cell surface and promote specific phosphorylation of membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; ACTIVATION	The PKC family consists of several closely related kinases. These enzymes regulate the function of proteins through the phosphorylation of hydroxyl groups on serines and/or threonines. The selective activation of individual PKC isozymes has proven challenging because of a lack of specific activator molecules. Here, we developed an optogenetic blue light- activated PKC isozyme that harnesses a plant-based dimerization system between the photosensitive cryptochrome-2 (CRY2) and the N terminus of the transcription factor calcium and integrin-binding protein 1 (CIB1) (N-terminal region of the CRY2-binding domain of CIB1). We show that tagging CRY2 with the catalytic domain of PKC isozymes can efficiently promote its translocation to the cell surface upon blue light exposure. We demonstrate this system using PKC epsilon and show that this leads to robust activation of a K+ channel (G protein-gated inwardly rectifying K+ channels 1 and 4), previously shown to be activated by PKC epsilon. We anticipate that this approach can be utilized for other PKC isoforms to provide a reliable and direct stimulus for targeted membrane protein phosphorylation by the relevant PKCs.	[Gada, Kirin D.; Kawano, Takeharu; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Bouve Coll Hlth Sci, Ctr Drug Discovery, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Gada, Kirin D.; Kawano, Takeharu; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Coll Sci, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; Northeastern University	Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Dept Chem & Chem Biol, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Coll Sci, Boston, MA 02115 USA.	d.logothetis@northeastern.edu			National Institutes of Health R01 [HL059949-23]	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 grant (grant no.: HL059949-23) to D. E. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kanno T, 2009, J CELL PHYSIOL, V221, P183, DOI 10.1002/jcp.21838; Kikkawa U, 2019, IUBMB LIFE, V71, P697, DOI 10.1002/iub.1963; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; Newton AC, 2018, SEMIN CANCER BIOL, V48, P18, DOI 10.1016/j.semcancer.2017.04.017; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ningoo M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100726; Schleifenbaum A, 2004, J AM CHEM SOC, V126, P11786, DOI 10.1021/ja0460155; Xu Y, 2020, J BIOL CHEM, V295, P3614, DOI 10.1074/jbc.RA119.011527	12	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101893	10.1016/j.jbc.2022.101893	http://dx.doi.org/10.1016/j.jbc.2022.101893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35367414	Green Published, gold			2022-12-28	WOS:000804436700007
J	Pedley, AM; Boylan, JP; Chan, CY; Kennedy, EL; Kyoung, M; Benkovic, SJ				Pedley, Anthony M.; Boylan, Jack P.; Chan, Chung Yu; Kennedy, Erin L.; Kyoung, Minjoung; Benkovic, Stephen J.			Purine biosynthetic enzymes assemble into liquid-like condensates dependent on the activity of chaperone protein HSP90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; PHASE-SEPARATION; STRESS GRANULES; RNA GRANULES; PURINOSOME; AGGREGATION; METABOLISM; TRANSITION; PREDICTION; COMPLEXES	Enzymes within the de novo purine biosynthetic pathway spatially organize into dynamic intracellular assemblies called purinosomes. The formation of purinosomes has been correlated with growth conditions resulting in high purine demand, and therefore, the cellular advantage of complexation has been hypothesized to enhance metabolite flux through the pathway. However, the properties of this cellular structure are unclear. Here, we define the purinosome in a transient expression system as a biomolecular condensate using fluorescence microscopy. We show that purinosomes, as denoted by formylglycinamidine ribonucleotide synthase granules in purine-depleted HeLa cells, are spherical and appear to coalesce when two come into contact, all liquid-like characteristics that are consistent with previously reported condensates. We further explored the biophysical and biochemical means that drive the liquid-liquid phase separation of these structures. We found that the process of enzyme condensation into purinosomes is likely driven by the oligomeric state of the pathway enzymes and not a result of intrinsic disorder, the presence of low-complexity domains, the assistance of RNA scaffolds, or changes in intracellular pH. Finally, we demonstrate that the heat shock protein 90 KDa helps to regulate the physical properties of the condensate and maintain their liquid-like state inside HeLa cells. We show that disruption of heat shock protein 90 KDa activity induced the transformation of formylglycinamidine ribonucleotide synthase clusters into more irregularly shaped condensates, suggesting that its chaperone activity is essential for purinosomes to retain their liquid-like properties. This refined view of the purinosome nize into dynamic condensates within human cells.	[Pedley, Anthony M.; Boylan, Jack P.; Chan, Chung Yu; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kennedy, Erin L.; Kyoung, Minjoung] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore County	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu	; Chan, Chung Yu/D-1003-2015	Pedley, Anthony/0000-0003-1034-5072; Boylan, Jack/0000-0002-7933-8850; Chan, Chung Yu/0000-0001-6726-5087; Benkovic, Stephen/0000-0003-3680-3481	Huck Institutes of the Life Sciences at Penn State (Huck Innovative and Transformative Seed Fund) [R01GM024129, R01GM134086, T32GM066706, R25GM55036]	Huck Institutes of the Life Sciences at Penn State (Huck Innovative and Transformative Seed Fund)	Funding and additional information-Financial support for this study was provided by the Huck Institutes of the Life Sciences at Penn State (Huck Innovative and Transformative Seed Fund grant to A. M. P.) and The National Institutes of Health (grant nos.: R01GM024129 [to S. J. B.] , R01GM134086 [to M. K.] , T32GM066706 [to E. L. K.] , and R25GM55036 [to E. L. K.] ) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2019, METHOD ENZYMOL, V628, P1, DOI 10.1016/bs.mie.2019.06.013; Aulas A, 2017, J CELL SCI, V130, P927, DOI 10.1242/jcs.199240; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Baresova V, 2016, MOL GENET METAB, V119, P270, DOI 10.1016/j.ymgme.2016.08.004; Bracha D, 2019, NAT BIOTECHNOL, V37, P1435, DOI 10.1038/s41587-019-0341-6; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Calvo-Vidal MN, 2021, CANCER RES, V81, P5202, DOI 10.1158/0008-5472.CAN-21-2734; Case LB, 2019, ANNU REV BIOPHYS, V48, P465, DOI 10.1146/annurev-biophys-052118-115534; Chan CY, 2018, P NATL ACAD SCI USA, V115, P13009, DOI 10.1073/pnas.1814042115; Chan CY, 2015, P NATL ACAD SCI USA, V112, P1368, DOI 10.1073/pnas.1423009112; Darling AL, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11060990; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Doigneaux C, 2020, J BIOL CHEM, V295, P9551, DOI 10.1074/jbc.RA119.012175; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Huang Feiran, 2013, Methods Mol Biol, V991, P211, DOI 10.1007/978-1-62703-336-7_20; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kilic S, 2019, EMBO J, V38, DOI 10.15252/embj.2018101379; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kyoung M, 2015, BIOCHEMISTRY-US, V54, P870, DOI 10.1021/bi501480d; Liao YC, 2019, CELL, V179, P147, DOI 10.1016/j.cell.2019.08.050; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu ZY, 2020, NAT STRUCT MOL BIOL, V27, P363, DOI 10.1038/s41594-020-0399-3; Martin EW, 2018, BIOCHEMISTRY-US, V57, P2478, DOI 10.1021/acs.biochem.8b00008; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MAYER D, 1990, J CANCER RES CLIN, V116, P251, DOI 10.1007/BF01612899; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Michl J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0393-7; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; NATSUMEDA Y, 1984, CANCER RES, V44, P2475; Oshidari R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14546-z; Pareek V, 2021, MOL CELL, V81, P3775, DOI 10.1016/j.molcel.2021.08.030; Pareek V, 2020, SCIENCE, V368, P283, DOI 10.1126/science.aaz6465; Pedley AM, 2018, BIOCHEMISTRY-US, V57, P3217, DOI 10.1021/acs.biochem.8b00140; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prouteau M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040160; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Reineke LC, 2018, J CELL SCI, V131, DOI 10.1242/jcs.220244; Royer LA, 2015, NAT METHODS, V12, P480, DOI 10.1038/nmeth.3372; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Soding J, 2020, TRENDS CELL BIOL, V30, P4, DOI 10.1016/j.tcb.2019.10.006; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Thomas J. A., 1979, BIOCHEMISTRY-US, V18, p2210?2218; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wang K, 2020, J MOL BIOL, V432, P2141, DOI 10.1016/j.jmb.2020.02.013; Weirich KL, 2017, P NATL ACAD SCI USA, V114, P2131, DOI 10.1073/pnas.1616133114; Werley CA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17607-5; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xue S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5349; Yamada S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101058; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701	68	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101845	10.1016/j.jbc.2022.101845	http://dx.doi.org/10.1016/j.jbc.2022.101845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35307352	gold, Green Published			2022-12-28	WOS:000793483000010
J	Singh, A; Kumar, P; Sarvagalla, S; Bharadwaj, T; Nayak, N; Coumar, MS; Giri, R; Garg, N				Singh, Ashutosh; Kumar, Prateek; Sarvagalla, Sailu; Bharadwaj, Taniya; Nayak, Namyashree; Coumar, Mohane Selvaraj; Giri, Rajanish; Garg, Neha			Functional inhibition of c-Myc using novel inhibitors identified through "hot spot" targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; INTRINSICALLY DISORDERED PROTEINS; SMALL-MOLECULE INHIBITORS; FREE-ENERGIES; STEM-CELLS; MM-PBSA; ONCOPROTEIN; BINDING; PREDICTION; DISRUPTION	Protein-protein interactions drive various biological processes in healthy as well as disease states. The transcription factor c-Myc plays a crucial role in maintaining cellular homeostasis, and its deregulated expression is linked to various human cancers; therefore, it can be considered a viable target for cancer therapeutics. However, the structural heterogeneity of c-Myc due to its disordered nature poses a major challenge to drug discovery. In the present study, we used an in silico alanine scanning mutagenesis approach to identify "hot spot" residues within the c-Myc/Myc-associated factor X interface, which is highly disordered and has not yet been systematically analyzed for potential small molecule binding sites. We then used the information gained from this analysis to screen potential inhibitors using a conformation ensemble approach. The fluorescence-based biophysical experiments showed that the identified hit molecules displayed noncovalent interactions with these hot spot residues, and further cell-based experiments showed substantial in vitro potency against diverse c-Myc-expressing cancer/stem cells by deregulating c-Myc activity. These biophysical and computational studies demonstrated stable binding of the hit compounds with the disordered c-Myc protein. Collectively, our data indicated effective drug targeting of the disordered c-Myc protein via the determination of hot spot residues in the c-Myc/Myc-associated factor X heterodimer.	[Singh, Ashutosh; Kumar, Prateek; Bharadwaj, Taniya; Nayak, Namyashree; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Sarvagalla, Sailu] Indian Inst Sci Educ & Res IISER Tirupati, Div Biol, Tirupati, Andhra Pradesh, India; [Coumar, Mohane Selvaraj] Pondicherry Univ, Ctr Bioinformat, Sch Life Sci, Kalapet, Puducherry, India; [Garg, Neha] Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Institute of Science Education & Research (IISER) - Tirupati; Pondicherry University; Banaras Hindu University (BHU)	Garg, N (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India.	nehagarg@bhu.ac.in	Garg, Neha/AAG-5180-2020; Singh, Ashutosh/T-7221-2018	Garg, Neha/0000-0003-2227-8292; Kumar, Prateek/0000-0001-7392-5045; Singh, Ashutosh/0000-0003-0193-9346	Science and Engineering Research Board grant, India [ECR/2017/00092]; Institute of Eminence Scheme, Banaras Hindu University	Science and Engineering Research Board grant, India; Institute of Eminence Scheme, Banaras Hindu University	N. G. acknowledges the Science and Engineering Research Board grant, India (ECR/2017/00092) and the seed grant under the Institute of Eminence Scheme, Banaras Hindu University for financial support.	Amaro RE, 2018, BIOPHYS J, V114, P2271, DOI 10.1016/j.bpj.2018.02.038; Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Balaei F, 2019, J PHARMACEUT BIOMED, V162, P1, DOI 10.1016/j.jpba.2018.09.009; Blundell TL, 2000, BIOL CHEM, V381, P955, DOI 10.1515/BC.2000.117; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carabet LA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010120; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Choi SH, 2017, ACS CHEM BIOL, V12, P2715, DOI 10.1021/acschembio.7b00799; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Coude MM, 2015, ONCOTARGET, V6, P17698, DOI 10.18632/oncotarget.4131; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Falcon WE, 2019, J PHYS CHEM B, V123, P5189, DOI 10.1021/acs.jpcb.8b11491; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Giri R, 2021, CELL MOL LIFE SCI, V78, P1655, DOI 10.1007/s00018-020-03603-x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Handoko L, 2018, EPIGENETICS-US, V13, P410, DOI 10.1080/15592294.2018.1469891; Harris CC, 2006, P NATL ACAD SCI USA, V103, P1659, DOI 10.1073/pnas.0510948103; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Ibarra AA, 2019, ACS CHEM BIOL, V14, P2252, DOI 10.1021/acschembio.9b00560; Jin F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003249; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim WT, 2017, BMB REP, V50, P285, DOI 10.5483/BMBRep.2017.50.6.039; Klein MA, 2014, ACS MED CHEM LETT, V5, P838, DOI 10.1021/ml500235d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lakowicz J. R, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4_8, DOI 10.1007/978-0-387-46312-4_8, 10.1007/978-0-387-46312-4]; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Liu QY, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0665-8; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manoranjan B, 2012, PEDIATR RES, V71, P516, DOI 10.1038/pr.2011.62; Martins SA, 2013, J CHEM THEORY COMPUT, V9, P1311, DOI 10.1021/ct4000372; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Sarvagalla S, 2016, RSC ADV, V6, P31947, DOI 10.1039/c5ra22927h; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shibata M, 2019, CANCERS, V11, DOI 10.3390/cancers11050732; Singh A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100903; Singh A, 2022, J BIOMOL STRUCT DYN, V40, P4507, DOI 10.1080/07391102.2020.1858966; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Sun HR, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01104; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky V. N., 2013, BRENNERS ENCY GENETI, P124, DOI DOI 10.1016/B978-0-12-374984-0.01698-3; Uversky VN, 2012, EXPERT OPIN DRUG DIS, V7, P475, DOI 10.1517/17460441.2012.686489; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Walcher L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01280; Yu BX, 2013, ACS CHEM BIOL, V8, P524, DOI 10.1021/cb300564v; Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022; Zhang HL, 2019, ONCOL LETT, V17, P4487, DOI 10.3892/ol.2019.10081; Zhao JH, 2016, PHARMACOL THERAPEUT, V160, P145, DOI 10.1016/j.pharmthera.2016.02.008	72	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101898	10.1016/j.jbc.2022.101898	http://dx.doi.org/10.1016/j.jbc.2022.101898			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35378126	gold, Green Published			2022-12-28	WOS:000860390500013
J	Umano, A; Fang, K; Qu, Z; Scaglione, JB; Altinok, S; Treadway, CJ; Wick, ET; Paulakonis, E; Karunanayake, C; Chou, S; Bardakjian, TM; Gonzalez-Alegre, P; Page, RC; Schisler, JC; Brown, NG; Yan, D; Scaglione, KM				Umano, A.; Fang, K.; Qu, Z.; Scaglione, J. B.; Altinok, S.; Treadway, C. J.; Wick, E. T.; Paulakonis, E.; Karunanayake, C.; Chou, S.; Bardakjian, T. M.; Gonzalez-Alegre, P.; Page, R. C.; Schisler, J. C.; Brown, N. G.; Yan, D.; Scaglione, K. M.			The molecular basis of spinocerebellar ataxia type 48 caused by a de novo mutation in the ubiquitin ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-CHAPERONE CHIP; PROTEIN-QUALITY-CONTROL; CONFERS PROTECTION; E3 LIGASE; COMPLEX; HSC70; IDENTIFICATION; AUTOPHAGY; DEFECTS; UBE2W	The spinocerebellar ataxias (SCAs) are a class of incurable diseases characterized by degeneration of the cerebellum that results in movement disorder. Recently, a new heritable form of SCA, spinocerebellar ataxia type 48 (SCA48), was attributed to dominant mutations in STIP1 homology and U box-containing 1 (STUB1); however, little is known about how these mutations cause SCA48. STUB1 encodes for the protein C terminus of Hsc70 interacting protein (CHIP), an E3 ubiquitin ligase. CHIP is known to regulate proteostasis by recruiting chaperones via a N-terminal tetratricopeptide repeat domain and recruiting E2 ubiquitin-conjugating enzymes via a C-terminal U-box domain. These interactions allow CHIP to mediate the ubiq-uitination of chaperone-bound, misfolded proteins to promote their degradation via the proteasome. Here we have identified a novel, de novo mutation in STUB1 in a patient with SCA48 encoding for an A52G point mutation in the tetratricopeptide repeat domain of CHIP. Utilizing an array of biophysical, biochemical, and cellular assays, we demonstrate that the CHIPA52G point mutant retains E3-ligase activity but has decreased affinity for chaperones. We further show that this mutant decreases cellular fitness in response to certain cellular stressors and induces neurodegeneration in a transgenic Cae-norhabditis elegans model of SCA48. Together, our data identify the A52G mutant as a cause of SCA48 and provide molecular insight into how mutations in STUB1 cause SCA48.	[Umano, A.; Fang, K.; Qu, Z.; Yan, D.; Scaglione, K. M.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Altinok, S.; Treadway, C. J.; Wick, E. T.; Paulakonis, E.; Schisler, J. C.; Brown, N. G.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC USA; [Treadway, C. J.; Wick, E. T.; Paulakonis, E.; Brown, N. G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC USA; [Karunanayake, C.; Page, R. C.] Miami Univ, Dept Chem & Biochem, Oxford, OH USA; [Chou, S.; Gonzalez-Alegre, P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI USA; [Chou, S.; Bardakjian, T. M.; Gonzalez-Alegre, P.] Univ Penn, Dept Neurol, Philadelphia, PA USA; [Scaglione, K. M.] Duke Univ, Dept Neurol, Durham, NC 27708 USA; [Scaglione, K. M.] Duke Univ, Duke Ctr Neurodegenerat & Neurotherapeut, Durham, NC 27708 USA; [Scaglione, J. B.] ScitoVation, Durham, NC USA; [Bardakjian, T. M.] Novartis Pharmaceut, Basel, Switzerland; [Gonzalez-Alegre, P.] Spark Therapeut, Philadelphia, PA USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Miami University; Medical College of Wisconsin; University of Pennsylvania; Duke University; Duke University; Novartis	Scaglione, KM (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Scaglione, KM (corresponding author), Duke Univ, Dept Neurol, Durham, NC 27708 USA.; Scaglione, KM (corresponding author), Duke Univ, Duke Ctr Neurodegenerat & Neurotherapeut, Durham, NC 27708 USA.	matt.scaglione@duke.edu		Fang, Kuili/0000-0002-4215-8768; Altinok, Selin/0000-0002-4908-7763; Umano, Anna/0000-0002-4150-2424; Brown, Nicholas/0000-0002-6141-0164; Zhongwei, Qu/0000-0002-6994-0530	National Institutes of Health [R35GM119544, R01 NS112191]; National Ataxia Foundation; Translating Duke Health [R35GM128855, R35GM128595, R01 AG066710, R01AG061188]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; Translating Duke Health	This work was supported by the National Institutes of Health grants R35GM119544 and R01 NS112191, a Research Seed Grant from the National Ataxia Foundation, and a Translating Duke Health Award to K. M. S.; R35GM128855 to N. G. B; and R35GM128595 R. C. P.; and R01 AG066710 and R01AG061188 to J. C. S.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; BRENNER S, 1974, GENETICS, V77, P71; Brodnanova M, 2021, EUR J PHARMACOL, V902, DOI 10.1016/j.ejphar.2021.174073; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chen HY, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-021-00763-1; Chidawanyika T, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0135-5; Cocozza S, 2020, MOV DISORD CLIN PRAC, V7, P733, DOI 10.1002/mdc3.12992; Cocozza S, 2020, NEURORADIOLOGY, V62, P1095, DOI 10.1007/s00234-020-02427-7; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; De Michele G, 2020, NEUROL SCI, V41, P2423, DOI 10.1007/s10072-020-04408-3; De Michele G, 2020, NEUROGENETICS, V21, P145, DOI 10.1007/s10048-020-00603-8; De Michele G, 2019, PARKINSONISM RELAT D, V65, P91, DOI 10.1016/j.parkreldis.2019.05.001; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Dubey J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00343; Genis D, 2018, NEUROLOGY, V91, pE1988, DOI 10.1212/WNL.0000000000006550; Heimdal K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0146-0; Ising C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0153-x; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kanack A, 2020, BIOCHEMISTRY-US, V59, P2078, DOI 10.1021/acs.biochem.0c00084; Kanack AJ, 2018, J BIOL CHEM, V293, P2735, DOI 10.1074/jbc.RA117.000477; Kopp Y, 2017, ELIFE, V6, DOI 10.7554/eLife.29388; Lezi E, 2018, NEURON, V97, P125, DOI 10.1016/j.neuron.2017.12.001; Lieto M, 2020, EUR J NEUROL, V27, P498, DOI 10.1111/ene.14094; Madrigal SC, 2019, J BIOL CHEM, V294, P19236, DOI 10.1074/jbc.RA119.011173; Magri S, 2022, GENET MED, V24, P29, DOI 10.1016/j.gim.2021.08.003; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mengel D, 2021, J NEUROL, V268, P3845, DOI 10.1007/s00415-021-10524-7; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Mol MO, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000417; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nadel CM, 2020, ANAL BIOCHEM, V611, DOI 10.1016/j.ab.2020.113947; Olszewska DA, 2020, MOV DISORD CLIN PRAC, V7, P735, DOI 10.1002/mdc3.12993; Pakdaman Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115870; Pakdaman Y, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170251; Palvadeau R, 2020, NEUROGENETICS, V21, P51, DOI 10.1007/s10048-019-00595-0; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ravel JM, 2021, J NEUROL, V268, P1927, DOI 10.1007/s00415-020-10348-x; Ronnebaum Sarah M, 2014, Hum Genome Var, V1, P14018, DOI 10.1038/hgv.2014.18; Roux T, 2020, GENET MED, DOI 10.1038/s41436-020-0899-x; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Synofzik M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-57; Tawo R, 2017, CELL, V169, P470, DOI 10.1016/j.cell.2017.04.003; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; Wang B, 2016, J BIOL CHEM, V291, P3030, DOI 10.1074/jbc.M115.676601; Welsh KA, 2022, EMBO J, V41, DOI 10.15252/embj.2021108823; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003	58	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101899	10.1016/j.jbc.2022.101899	http://dx.doi.org/10.1016/j.jbc.2022.101899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35398354	gold, Green Published			2022-12-28	WOS:000804923000012
J	Arellano-Saab, A; McErlean, CSP; Lumba, S; Savchenko, A; Stogios, PJ; McCourt, P				Arellano-Saab, Amir; McErlean, Christopher S. P.; Lumba, Shelley; Savchenko, Alexei; Stogios, Peter J.; McCourt, Peter			A novel strigolactone receptor antagonist provides insights into the structural inhibition, conditioning, and germination of the crop parasite Striga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUICIDAL GERMINATION; SORGHUM; HERMONTHICA; SENSITIVITY; SELECTIVITY; HORMONE; MODEL; DAD2	Crop parasites of the Striga genera are a major biological deterrent to food security in Africa and are one of the largest obstacles to poverty alleviation on the continent. Striga seeds germinate by sensing small-molecule hormones, strigolactones (SLs), that emanate from host roots. Although SL receptors (Striga hermonthica HYPOSENSITIVE TO LIGHT [ShHTL]) have been identified, discerning their function has been diffi- cult because these parasites cannot be easily grown under laboratory conditions. Moreover, many Striga species are obligate outcrossers that are not transformable, hence not amenable to genetic analysis. By combining phenotypic screening with ShHTL structural information and hybrid drug discovery methods, we discovered a potent SL perception inhibitor for Striga, dormirazine (DOZ). Structural analysis of this piperazine-based antagonist reveals a novel binding mechanism, distinct from that of known SLs, blocking access of the hormone to its receptor. Furthermore, DOZ reduces the flexibility of protein-protein interaction domains important for receptor signaling to downstream partners. In planta, we show, via temporal additions of DOZ, that SL receptors are required at a specific time during seed conditioning. This conditioning is essential to prime seed germination at the right time; thus, this SL-sensitive stage appears to be critical for adequate receptor signaling. Aside from uncovering a function for ShHTL during seed conditioning, these results suggest that future Ag-Biotech Solutions to Striga infestations will need to carefully time the application of antagonists to exploit receptor availability and outcompete natural SLs, critical elements for successful parasitic plant invasions. favor turb Striga germination crops also that seeds tions, targets. drolases siveness which season called expression, seeds embryo	[Arellano-Saab, Amir; Lumba, Shelley; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Arellano-Saab, Amir; Savchenko, Alexei; Stogios, Peter J.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McErlean, Christopher S. P.] Univ Sydney, Sch Chem, Camperdown, NSW, Australia; [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Toronto; University of Toronto; University of Sydney; University of Calgary	McCourt, P (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Stogios, PJ (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	p.stogios@utoronto.ca; peter.mccourt@utoronto.ca		McErlean, Chris/0000-0001-8930-7495; Arellano-Saab, Amir/0000-0002-3497-4538; McCourt, Peter/0000-0002-5905-7170	Mexican National Council of Science and Technology (CONACyT); Mitacs Globalink Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC) [06752]; NSERC Accelerator Supplement [507992]; NSERC Research Tools and Instruments grant [00356]; New Frontiers in Research Fund [NFRFE-2018-00118]; NSERC [04298]	Mexican National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mitacs Globalink Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Accelerator Supplement; NSERC Research Tools and Instruments grant; New Frontiers in Research Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding and additional information-A. A.-S. was partially funded by the Mexican National Council of Science and Technology (CONACyT) and by a Mitacs Globalink Graduate Scholarship. This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (grant no.: 06752), an NSERC Accelerator Supplement (grant no.: 507992), an NSERC Research Tools and Instruments grant (grant no.: 00356), a New Frontiers in Research Fund (grant no.: NFRFE-2018-00118) awarded to S. L., as well as an NSERC Discovery grant (grant no.: 04298) awarded to P. M.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arellano-Saab A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103175118; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Bai N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37072-x; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Bunsick M, 2020, NAT PLANTS, V6, P646, DOI 10.1038/s41477-020-0653-z; Burger M, 2020, PLANT DIRECT, V4, DOI 10.1002/pld3.263; Burger M, 2019, CELL REP, V26, P855, DOI 10.1016/j.celrep.2019.01.003; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; Dubach JM, 2017, NAT CHEM BIOL, V13, P168, DOI [10.1038/NCHEMBIO.2248, 10.1038/nchembio.2248]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Aparicio M, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9091184; Flematti GR, 2016, PLANTA, V243, P1361, DOI 10.1007/s00425-016-2523-5; Garcia-Contreras R, 2012, FEBS J, V279, P4145, DOI 10.1111/febs.12007; Gobena D, 2017, P NATL ACAD SCI USA, V114, P4471, DOI 10.1073/pnas.1618965114; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gurney AL, 1999, NEW PHYTOL, V143, P573, DOI 10.1046/j.1469-8137.1999.00467.x; Hameed US, 2018, EMBO REP, V19, DOI 10.15252/embr.201745619; Hamiaux C, 2018, J BIOL CHEM, V293, P6530, DOI 10.1074/jbc.RA117.001154; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hearne SJ, 2009, PEST MANAG SCI, V65, P603, DOI 10.1002/ps.1735; Holbrook-Smith D, 2016, NAT CHEM BIOL, V12, P724, DOI 10.1038/nchembio.2129; Hu LY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239013; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee HW, 2020, J BIOL CHEM, V295, P4181, DOI 10.1074/jbc.RA119.011509; Lumba S, 2017, TRENDS BIOCHEM SCI, V42, P556, DOI 10.1016/j.tibs.2017.04.006; Mashiguchi K, 2021, PLANT J, V105, P335, DOI 10.1111/tpj.15059; Matusova R, 2004, SEED SCI RES, V14, P335, DOI 10.1079/SSR2004187; McEneny-King A, 2015, BIOORG MED CHEM LETT, V25, P297, DOI 10.1016/j.bmcl.2014.11.046; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miyakawa T, 2020, CELL MOL LIFE SCI, V77, P1103, DOI 10.1007/s00018-019-03318-8; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Mohemed N, 2016, PEST MANAG SCI, V72, P2082, DOI 10.1002/ps.4426; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakamura H, 2019, MOL PLANT, V12, P44, DOI 10.1016/j.molp.2018.10.006; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Pinzi L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184331; Samejima H, 2016, PEST MANAG SCI, V72, P2035, DOI 10.1002/ps.4215; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Schrdinger, 2015, PYMOL MOL GRAPHICS S; Skarina T, 2014, METHODS MOL BIOL, V1140, P159, DOI 10.1007/978-1-4939-0354-2_12; Takahashi I, 2018, J EXP BOT, V69, P2241, DOI 10.1093/jxb/ery126; Takeuchi J, 2018, PLANT CELL PHYSIOL, V59, P1545, DOI 10.1093/pcp/pcy087; Tippe DE, 2017, FIELD CROP RES, V214, P14, DOI 10.1016/j.fcr.2017.08.013; Tippe DE, 2017, CROP PROT, V99, P93, DOI 10.1016/j.cropro.2017.05.007; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Uraguchi D, 2018, SCIENCE, V362, P1301, DOI 10.1126/science.aau5445; Wang YP, 2021, PLANT PHYSIOL, V185, P1411, DOI 10.1093/plphys/kiaa048; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06452-2; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Yoneyama K, 2010, PLANT CELL PHYSIOL, V51, P1095, DOI 10.1093/pcp/pcq055; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zwanenburg B, 2016, PEST MANAG SCI, V72, P2016, DOI 10.1002/ps.4222	61	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101734	10.1016/j.jbc.2022.101734	http://dx.doi.org/10.1016/j.jbc.2022.101734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35181340	gold, Green Published			2022-12-28	WOS:000793502000007
J	Gauberg, J; Elkhatib, W; Smith, CL; Singh, A; Senatore, A				Gauberg, Julia; Elkhatib, Wassim; Smith, Carolyn L.; Singh, Anhadvir; Senatore, Adriano			Divergent Ca2+/calmodulin feedback regulation of Ca(V)1 and Ca(V)2 voltage-gated calcium channels evolved in the common ancestor of Placozoa and Bilateria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NEGATIVELY CHARGED RESIDUES; CA2+ CHANNEL; BETA-SUBUNIT; DEPENDENT INACTIVATION; FUNCTIONAL EXPRESSION; CA2+-DEPENDENT INACTIVATION; DIHYDROPYRIDINE BINDING; CALMODULIN REGULATION; TRICHOPLAX-ADHAERENS	Ca(V)1 and Ca(V)2 voltage-gated calcium channels evolved from an ancestral Ca(V)1/2 channel via gene duplication somewhere near the stem animal lineage. The divergence of these channel types led to distinguishing functional properties that are conserved among vertebrates and bilaterian invertebrates and contribute to their unique cellular roles. One key difference pertains to their regulation by calmodulin (CaM), wherein bilaterian Ca(V)1 channels are uniquely subject to pronounced, buffer-resistant Ca2+/CaM-dependent inactivation, permitting negative feedback regulation of calcium influx in response to local cytoplasmic Ca2+ rises. Early diverging, nonbilaterian invertebrates also possess Ca(V)1 and Ca(V)2 channels, but it is unclear whether they share these conserved functional features. The most divergent animals to possess both Ca(V)1 and Ca(V)2 channels are placozoans such as Trichoplax adhaerens, which separated from other animals over 600 million years ago shortly after their emergence. Hence, placozoans can provide important insights into the early evolution of Ca(V)1 and Ca(V)2 channels. Here, we build upon previous characterization of Trichoplax Ca-V channels by determining the cellular expression and ion-conducting properties of the Ca(V)1 channel orthologue, TCa(V)1. We show that TCa(V)1 is expressed in neuroendocrine-like gland cells and contractile dorsal epithelial cells. In vitro, this channel conducts dihydropyridineinsensitive, high-voltage-activated Ca2+ currents with kinetics resembling those of rat Ca(V)1.2 but with left-shifted voltage sensitivity for activation and inactivation. Interestingly, TCa(V)1, inactivation, indicating that this functional divergence evolved prior to the emergence of bilaterian animals and may have signaling within various cellular contexts.	[Gauberg, Julia; Elkhatib, Wassim; Singh, Anhadvir; Senatore, Adriano] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Smith, Carolyn L.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	University of Toronto; University Toronto Mississauga; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Senatore, A (corresponding author), Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada.	adriano.senatore@utoronto.ca			NSERC Discovery Grant [RGPIN-2016-06023]; Canadian Foundation for Innovation Grant [35297]; Ontario Early Researcher Award [ER17-13-247]; NSERC Canadian Graduate Scholarship; Intramural Research Program of the NIH, NINDS	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Grant; Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Intramural Research Program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was funded by an NSERC Discovery Grant (RGPIN-2016-06023), a Canadian Foundation for Innovation Grant (35297), and an Ontario Early Researcher Award (ER17-13-247) to Adriano Senatore, an NSERC Canadian Graduate Scholarship to J. G., and the Intramural Research Program of the NIH, NINDS to C. L. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Armon S, 2018, P NATL ACAD SCI USA, V115, pE10333, DOI 10.1073/pnas.1802934115; Banerjee R, 2018, P NATL ACAD SCI USA, V115, pE3026, DOI 10.1073/pnas.1716381115; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Blesneac I, 2015, P NATL ACAD SCI USA, V112, P13705, DOI 10.1073/pnas.1511740112; Bourdin B, 2017, J BIOL CHEM, V292, P17236, DOI 10.1074/jbc.M117.806893; Byczkowicz N, 2019, ELIFE, V8, DOI 10.7554/eLife.42766; Canti C., 2005, P NATL ACAD SCI; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Catterall WA, 2019, IUPHARBPS GUIDE PHAR, V2019, DOI [10.2218/gtopdb/F80/2019.4, DOI 10.2218/GTOPDB/F80/2019.4]; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Chan JD, 2017, BBA-MOL CELL RES, V1864, P1036, DOI 10.1016/j.bbamcr.2016.10.010; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chi CH, 2017, IBRO REP, V2, P63, DOI 10.1016/j.ibror.2017.03.002; Cottrell GS, 2018, J NEUROSCI, V38, P9186, DOI 10.1523/JNEUROSCI.3572-15.2018; Dafi O, 2004, BIOPHYS J, V87, P3181, DOI 10.1529/biophysj.104.045559; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dawson TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092941; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; ECKERT R, 1981, J PHYSIOL-LONDON, V314, P265, DOI 10.1113/jphysiol.1981.sp013706; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eitel M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005359; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fernandez-Valverde SL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1588-z; Ferreira G, 2003, BIOPHYS J, V84, P3662, DOI 10.1016/S0006-3495(03)75096-6; Fuller MD, 2014, J GEN PHYSIOL, V143, P315, DOI 10.1085/jgp.201311075; Gauberg J, 2020, J BIOL CHEM, V295, P18553, DOI 10.1074/jbc.RA120.015725; Gauberg J, 2021, METHODS MOL BIOL, V2219, P277, DOI 10.1007/978-1-0716-0974-3_18; Gul IS, 2018, GENOME BIOL EVOL, V10, P909, DOI 10.1093/gbe/evy040; Guzman C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18774; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hering S, 2018, PFLUG ARCH EUR J PHY, V470, P1291, DOI 10.1007/s00424-018-2163-7; Hofer NT, 2021, CHANNELS, V15, P38, DOI 10.1080/19336950.2020.1859260; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Jeziorski MC, 1999, RECEPTOR CHANNEL, V6, P375; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kamm K., 2018, SCI REP-UK, V8, P1; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kapli P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5162; KASS RS, 1987, CIRC RES, V61, P1; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kohn AB, 2003, PARASITOLOGY, V127, P349, DOI 10.1017/S003118200300386X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lacinova L, 2005, ARCH BIOCHEM BIOPHYS, V437, P42, DOI 10.1016/j.abb.2005.02.025; Laine V, 2011, J BIOL CHEM, V286, P36180, DOI 10.1074/jbc.M111.256149; Leys SP, 2015, J EXP BIOL, V218, P581, DOI 10.1242/jeb.110817; Li X, 2015, P NATL ACAD SCI USA, V112, pE1010, DOI 10.1073/pnas.1422941112; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu Z, 2003, J PHYSIOL-LONDON, V553, P473, DOI 10.1113/jphysiol.2003.051110; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; Mahapatra S, 2012, CELL CALCIUM, V51, P321, DOI 10.1016/j.ceca.2012.01.005; Mayorova TD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02735-9; Mayorova TD, 2019, BIOL OPEN, V8, DOI 10.1242/bio.045674; Mayorova TD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190905; Mehta A., 2016, CLONING CHARACTERIZA; Michailidis IE, 2014, NEURON, V82, P1045, DOI 10.1016/j.neuron.2014.04.017; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Moroz LL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.669087; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pozdnyakov I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21897-7; RAVENS U, 1990, N-S ARCH PHARMACOL, V341, P232; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Romanova DY, 2020, BIOCHEM BIOPH RES CO, V532, P120, DOI 10.1016/j.bbrc.2020.08.020; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebe-Pedros A, 2018, NAT ECOL EVOL, V2, P1176, DOI 10.1038/s41559-018-0575-6; Segura E, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183439; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2017, J EXP BIOL, V220, P3381, DOI 10.1242/jeb.162396; Senatore A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00481; Senatore A, 2014, J BIOL CHEM, V289, P11952, DOI 10.1074/jbc.M114.551473; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Simms BA, 2014, PFLUG ARCH EUR J PHY, V466, P1793, DOI 10.1007/s00424-013-1423-9; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Smith CL, 2017, J GEN PHYSIOL, V149, P483, DOI 10.1085/jgp.201611683; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stephens GJ, 2019, CHANNELS, V13, P120, DOI 10.1080/19336950.2019.1600968; Stephens RF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00153; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; TAMM SL, 1981, J CELL BIOL, V89, P495, DOI 10.1083/jcb.89.3.495; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Thorington GU, 2020, BIOL BULL-US, V238, P180, DOI 10.1086/708947; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Tuluc P, 2009, BIOPHYS J, V96, P35, DOI 10.1016/j.bpj.2008.09.027; Tyson J.R, 2013, WILEY INTERDISCIP RE, V2, P181, DOI DOI 10.1002/wmts.91; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weir K, 2020, ELIFE, V9, DOI 10.7554/eLife.57578; Whelan NV, 2017, NAT ECOL EVOL, V1, P1737, DOI 10.1038/s41559-017-0331-3; Wong Y-Y, 2019, RES SQUARE, DOI [10.21203/ rs.2.14504/v1thorn, DOI 10.21203/RS.2.14504/V1, 10.21203/rs.2.14504/v1]; Yamaguchi H, 1999, P NATL ACAD SCI USA, V96, P1357, DOI 10.1073/pnas.96.4.1357; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; Zarin T, 2019, ELIFE, V8, DOI 10.7554/eLife.46883; Zhao YY, 2019, CELL, V177, P1495, DOI 10.1016/j.cell.2019.04.043	133	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101741	10.1016/j.jbc.2022.101741	http://dx.doi.org/10.1016/j.jbc.2022.101741			32	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35182524	gold, Green Published			2022-12-28	WOS:000793560400003
J	Higuchi, K; Sugiyama, K; Tomabechi, R; Kishimoto, H; Inoue, K				Higuchi, Kei; Sugiyama, Koki; Tomabechi, Ryuto; Kishimoto, Hisanao; Inoue, Katsuhisa			Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL COMPONENT; PROTEIN; IDENTIFICATION; LOCALIZATION; MEMBRANE; LACTATE; HEALTH; RAT; CL	Monocarboxylate transporter 7 (MCT7) is an orphan transporter expressed in the liver, brain, and in several types of cancer cells. It has also been reported to be a survival factor in melanoma and breast cancers. However, this survival mechanism is not yet fully understood due to MCT7's unidentified substrate(s) and characterize the transport mechanisms by analyzing amino acid transport in HEK293T cells and polarized Caco-2 cells. Analysis of amino acids revealed significant rapid reduction in taurine from cells transfected with enhanced green fluorescent protein-tagged MCT7. We found that taurine uptake and efflux by MCT7 was pH-independent and that the uptake was not saturated in the presence of taurine excess of 200 mM. Furthermore, we found that monocarboxylates and acidic amino acids inhibited MCT7-mediated taurine uptake. These results imply that MCT7 may be a low-affinity facilitative taurine transporter. We also found that MCT7 was localized at the basolateral membrane in polarized Caco-2 cells and that the induction of MCT7 expression in polarized Caco2 cells enhanced taurine permeation. Finally, we demonstrated that interactions of MCT7 with ancillary proteins basigin/ CD147 and embigin/GP70 enhanced MCT7-mediated taurine transport. In summary, these findings reveal that taurine is a novel substrate of MCT7 and that MCT7-mediated taurine transport might contribute to the efflux of taurine from cells.	[Higuchi, Kei; Sugiyama, Koki; Tomabechi, Ryuto; Kishimoto, Hisanao; Inoue, Katsuhisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Inoue, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biopharmaceut, Hachioji, Tokyo, Japan.	kinoue@toyaku.ac.jp		Higuchi, Kei/0000-0001-8440-8078				Abplanalp J, 2013, HUM MOL GENET, V22, P3218, DOI 10.1093/hmg/ddt175; Anderson CMH, 2009, J PHYSIOL-LONDON, V587, P731, DOI 10.1113/jphysiol.2008.164228; Busslinger GA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108819; Cedernaes J, 2011, BIOCHEM BIOPH RES CO, V411, P702, DOI 10.1016/j.bbrc.2011.07.005; Dai W, 2020, MOL CARCINOGEN, V59, P640, DOI 10.1002/mc.23191; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Felmlee MA, 2020, PHARMACOL REV, V72, P466, DOI 10.1124/pr.119.018762; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hammes TO, 2012, DIGEST DIS SCI, V57, P675, DOI 10.1007/s10620-011-1931-4; Hugo SE, 2012, GENE DEV, V26, P282, DOI 10.1101/gad.180968.111; Jones RS, 2016, CLIN PHARMACOL THER, V100, P454, DOI 10.1002/cpt.418; Kim K. S., 1983, ARCH PHARM RES, V6, P109; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kuo KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039641; Lobo MVT, 2000, HISTOCHEM J, V32, P53, DOI 10.1023/A:1003910429346; Murakami S, 2018, AMINO ACIDS, V50, P1279, DOI 10.1007/s00726-018-2605-8; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nielsen CU, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13467; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Pasantes-Morales H., 1989, CRC HDB FREE REDICAL, P105; PORTMAN OW, 1955, J BIOL CHEM, V213, P733; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Ramadan T, 2006, J CELL PHYSIOL, V206, P771, DOI 10.1002/jcp.20531; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Takahashi M, 2020, DRUG METAB PHARMACOK, V35, P281, DOI 10.1016/j.dmpk.2020.01.008; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang N, 2021, CELL, V184, P370, DOI 10.1016/j.cell.2020.11.043; Yanagita T, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-38; Yu Yang, 2016, Metab Eng Commun, V3, P64, DOI 10.1016/j.meteno.2016.03.001; Zhang B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16334-1	35	2	2	7	8	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101800	10.1016/j.jbc.2022.101800	http://dx.doi.org/10.1016/j.jbc.2022.101800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35257743	gold, Green Published			2022-12-28	WOS:000797895000003
J	Rahim, M; Nakhe, AY; Banerjee, DR; Overway, EM; Bosma, KJ; Rosch, JC; Oeser, JK; Wang, B; Lippmann, ES; Jacobson, DA; Brien, RMO'; Young, JD				Rahim, Mohsin; Nakhe, Arya Y.; Banerjee, Deveena R.; Overway, Emily M.; Bosma, Karin J.; Rosch, Jonah C.; Oeser, James K.; Wang, Bo; Lippmann, Ethan S.; Jacobson, David A.; Brien, Richard M. O. '; Young, Jamey D.			Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G6PC2 GENE; ISOTOPOMER; PATHWAYS; ISLETS; NADPH; RATES; LINES	Elevated fasting blood glucose (FBG) is associated with increased risks of developing type 2 diabetes (T2D) and cardiovascular-associated mortality. G6PC2 is predominantly expressed in islets, encodes a glucose-6-phosphatase catalytic subunit that converts glucose-6-phosphate (G6P) to glucose, and has been linked with variations in FBG in genome-wide association studies. Deletion of G6pc2 in mice has been shown to lower FBG without affecting fasting plasma insulin levels in vivo. At 5 mM glucose, pancreatic islets from G6pc2 knockout (KO) mice exhibit no glucose cycling, increased glycolytic flux, and enhanced glucose-stimulated insulin secretion (GSIS). However, the broader effects of G6pc2 KO on beta-cell metabolism and redox regulation are unknown. Here we used CRISPR/Cas9 gene editing and metabolic flux analysis in beta TC3 cells, a murine pancreatic beta-cell line, to examine the role of G6pc2 in regulating glycolytic and mitochondrial fluxes. We found that deletion of G6pc2 led to X60% increases in glycolytic and citric acid cycle (CAC) fluxes at both 5 and 11 mM glucose concentrations. Furthermore, intracellular insulin content and GSIS were enhanced by approximately two-fold, along with increased cytosolic redox potential and reductive carboxylation flux. Normalization of fluxes relative to net glucose uptake revealed upregulation in two NADPHproducing pathways in the CAC. These results demonstrate but also, independently, citric acid cycle activity in beta-cells. Overall, our findings implicate G6PC2 as a potential therawhich could benefit individuals with prediabetes, T2D, and obesity.	[Rahim, Mohsin; Rosch, Jonah C.; Wang, Bo; Lippmann, Ethan S.; Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN USA; [Nakhe, Arya Y.; Banerjee, Deveena R.; Overway, Emily M.; Bosma, Karin J.; Oeser, James K.; Jacobson, David A.; Brien, Richard M. O. '; Young, Jamey D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA; [Lippmann, Ethan S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA; [Lippmann, Ethan S.] Vanderbilt Univ, Dept Neurol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Young, JD (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN USA.; Young, JD (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA.	j.d.young@vanderbilt.edu		Hawes, Emily/0000-0002-3266-3824; Bosma, Karin/0000-0002-1221-1169; Jacobson, David A./0000-0003-1816-5375; Rahim, Mohsin/0000-0001-8407-5621	Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563]; Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant [T32 DK101003]	Vanderbilt Molecular Endocrinology Training Program; Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant	K. J. B. and E. M. O. were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. D. R. B. was supported by the Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant T32 DK101003.	Antoniewicz MR, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0060-y; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Berger C, 2020, PFLUG ARCH EUR J PHY, V472, P1249, DOI 10.1007/s00424-020-02383-4; Bock T, 1999, APMIS, V107, P791, DOI 10.1111/j.1699-0463.1999.tb01474.x; Boortz KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162439; Bosma KJ, 2020, MOL METAB, V41, DOI 10.1016/j.molmet.2020.101043; Bosma KJ, 2020, J MOL ENDOCRINOL, V64, P235, DOI 10.1530/JME-20-0031; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Campbell JE, 2021, NAT REV MOL CELL BIO, V22, P142, DOI 10.1038/s41580-020-00317-7; Chung RH, 2021, DIABETOLOGIA, V64, P1613, DOI 10.1007/s00125-021-05449-9; Cole JT, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00051; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Gooding JR, 2015, CELL REP, V13, P157, DOI 10.1016/j.celrep.2015.08.072; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jesinkey SR, 2019, CELL REP, V28, P759, DOI 10.1016/j.celrep.2019.06.058; Krebs H A, 1969, Adv Enzyme Regul, V7, P397, DOI 10.1016/0065-2571(69)90030-2; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lewandowski SL, 2020, CELL METAB, V32, P736, DOI 10.1016/j.cmet.2020.10.007; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li X, 2009, DIABETES, V58, P2946, DOI 10.2337/db09-0228; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Malinowski R. M., 2020, SCI REP-UK, V10, P1; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Morsi M, 2020, ENDOCR CONNECT, V9, P769, DOI 10.1530/EC-20-0289; Mugabo Y, 2017, J BIOL CHEM, V292, P7407, DOI 10.1074/jbc.M116.763060; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Murphy TA, 2013, BIOTECHNOL BIOENG, V110, P1748, DOI 10.1002/bit.24836; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Overway E. M., 2021, J BIOL CHEM, V298; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Rahim M, 2022, METAB ENG, V69, P275, DOI 10.1016/j.ymben.2021.12.009; Ren JQ, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-1; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spegel P, 2013, BIOCHEM J, V450, P595, DOI 10.1042/BJ20121349; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Veiga-da-Cunha M, 2019, P NATL ACAD SCI USA, V116, P1241, DOI 10.1073/pnas.1816143116; Wall ML, 2015, DIABETES, V64, P2129, DOI 10.2337/db14-0745; Wheeler E, 2017, HUM MOL GENET, V26, pR172, DOI 10.1093/hmg/ddx293; WOLF BA, 1986, J BIOL CHEM, V261, P6284; Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087; Xu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10337-7; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young Jamey D, 2014, Methods Mol Biol, V1083, P85, DOI 10.1007/978-1-62703-661-0_7; Zhang GF, 2021, CELL METAB, V33, P804, DOI 10.1016/j.cmet.2020.11.020	62	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101729	10.1016/j.jbc.2022.101729	http://dx.doi.org/10.1016/j.jbc.2022.101729			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35176280	gold, Green Published			2022-12-28	WOS:000797895000010
J	Wischhof, L; Adhikari, A; Mondal, M; Marsal-Cots, A; Biernat, J; Mandelkow, EM; Mandelkow, E; Ehninger, D; Nicotera, P; Bano, D				Wischhof, Lena; Adhikari, Aasha; Mondal, Mrityunjoy; Marsal-Cots, Anaies; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard; Ehninger, Dan; Nicotera, Pierluigi; Bano, Daniele			Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; DENDRITIC SPINES; BINDING-PROTEIN; AUTOPHAGY; PHOSPHORYLATION; EXPRESSION; IRBIT; BETA; TAUOPATHY	Microtubule-associated protein tau is a naturally unfolded protein that can modulate a vast array of physiological processes through direct or indirect binding with molecular partners. Aberrant tau homeostasis has been implicated in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease. In this study, we performed an unbiased high-content protein profiling assay by incubating recombinant human tau on microarrays containing thousands of human polypeptides. Among the putative tau-binding partners, we identify SAH hydrolase-like protein 1/inositol 1,4,5-trisphosphate receptor (IP3R)-binding protein (AHCYL1/IRBIT), a member of the SAH hydrolase family and a previously described modulator of IP3R activity. Using coimmunoprecipitation assays, we show that endogenous as well as overexpressed tau can physically interact with AHCYL1/IRBIT in brain tissues and cultured cells. Proximity ligation assay experiments demonstrate that tau overexpression may modify the close localization of AHCYL1/IRBIT to IP3R at the endoplasmic reticulum. Together, our experimental evidence indicates that tau interacts with AHCYL1/IRBIT and potentially modulates AHCYL1/IRBIT function.	[Wischhof, Lena; Adhikari, Aasha; Mondal, Mrityunjoy; Marsal-Cots, Anaies; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard; Ehninger, Dan; Nicotera, Pierluigi; Bano, Daniele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard] CAESAR Res Ctr, Bonn, Germany; [Mandelkow, Eckhard] Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Bonn	Bano, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	daniele.bano@dzne.de		Biernat, Jacek/0000-0003-4237-3975; Mondal, Mrityunjoy/0000-0003-2973-4633; Bano, Daniele/0000-0002-9617-5504	Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC2151-390873048]; Innovative Medicines Initiative (European Union) 2 joint undertaking [821522]; European Union; European Federation of Pharmaceutical Industries and Associations; Katharina-Hardt-Stiftung; Cure Alzheimer's Fund	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Innovative Medicines Initiative (European Union) 2 joint undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations; Katharina-Hardt-Stiftung; Cure Alzheimer's Fund	L. W., P. N., and D. B. are members of the Deutsche Forschungsgemeinschaft Cluster of Excellence ImmunoSensation funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy (EXC2151-390873048). D. B. is a member of the Mitochondrial Dysfunction in Parkinson's Consortium (PD-MitoQUANT). PD-MitoQUANT has received funding from the Innovative Medicines Initiative (European Union) 2 joint undertaking under grant agreement no. 821522. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations. E. M. and E. M. M. were supported by Katharina-Hardt-Stiftung and Cure Alzheimer's Fund.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2014, BBA-MOL CELL RES, V1843, P2195, DOI 10.1016/j.bbamcr.2014.01.031; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Arendt T, 2013, AM J PHYSIOL-REG I, V305, pR478, DOI 10.1152/ajpregu.00117.2013; Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; BAUDIER J, 1988, J BIOL CHEM, V263, P5876; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bertan F., 2021, CELL REP METHODS, V1; Bonneau B, 2016, ELIFE, V5, DOI 10.7554/eLife.19896; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cieri D., 2018, BIOCH BIOPHYS ACTA M; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Houck AL, 2016, J EXP NEUROSCI, V10, P31, DOI 10.4137/JEN.S25100; Huang W., 2021, AUTOPHAGY, V16, P1; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iovino M, 2015, BRAIN, V138, DOI 10.1093/brain/awv222; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Ittner L. M., 2010, DENDRITIC FUNCTION T; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniyappan S, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00389-1; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Lee G, 1998, J CELL SCI, V111, P3167; LEE G, 1992, J CELL SCI, V102, P227; Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731; Mertens J, 2013, AM J PATHOL, V182, P1769, DOI 10.1016/j.ajpath.2013.01.043; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rossi G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00192; Sallaberry CA, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.725241; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tracy T. E., CELL; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	68	0	0	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101774	10.1016/j.jbc.2022.101774	http://dx.doi.org/10.1016/j.jbc.2022.101774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35218773	Green Published, gold			2022-12-28	WOS:000793692600004
J	Blandino-Rosano, M; Llacer, PR; Lin, AS; Reddy, JK; Bernal-Mizrachi, E				Blandino-Rosano, Manuel; Llacer, Pau Romaguera; Lin, Ashley; Reddy, Janardan K.; Bernal-Mizrachi, Ernesto			Trimethylguanosine synthase 1 is a novel regulator of pancreatic beta-cell mass and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SMALL-NUCLEAR; GLUCOSE-METABOLISM; GROWTH ARREST; CAP STRUCTURE; DNA-DAMAGE; PROTEIN; RNA; HYPERMETHYLATION; DEFECTS	Type 2 diabetes is a metabolic disorder associated with abnormal glucose homeostasis and is characterized by intrinsic defects in il-cell function and mass. Trimethylguanosine synthase 1 (TGS1) is an evolutionarily conserved enzyme that methylates small nuclear and nucleolar RNAs and that is involved in pre-mRNA splicing, transcription, and ribosome production. However, the role of TGS1 in il-cells and glucose homeostasis had not been explored. Here, we show that TGS1 is upregulated by insulin and upregulated in islets of Langerhans from mice exposed to a high-fat diet and in human il-cells from type 2 diabetes donors. Using mice with conditional (beta TGS1KO) and inducible (MIP-Cre(ERT)-TGS1KO) TGS1 deletion, we determined that TGS1 regulates il-cell mass and function. Using unbiased approaches, we identified a link between TGS1 and endoplasmic reticulum stress and cell cycle arrest, as well as and how TGS1 regulates il-cell apoptosis. We also found that deletion of TGS1 results in an increase in the unfolded protein response by increasing XBP-1, ATF-4, and the phosphorylation of eIF2a, in addition to promoting several changes in cell cycle inhibitors and activators such as p27 and Cyclin D2. This study establishes TGS1 as a key player regulating il-cell mass and function. We propose that these observations can be used as a stepping-stone for the design of novel strategies focused on TGS1 as a therapeutic target for the treatment of diabetes.	[Blandino-Rosano, Manuel; Llacer, Pau Romaguera; Lin, Ashley; Bernal-Mizrachi, Ernesto] Univ Miami, Miller Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Blandino-Rosano, Manuel; Bernal-Mizrachi, Ernesto] Miami VA Hlth Care Syst, Miami, FL 33125 USA; [Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL USA	University of Miami; Northwestern University; Feinberg School of Medicine	Blandino-Rosano, M (corresponding author), Univ Miami, Miller Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA.; Blandino-Rosano, M (corresponding author), Miami VA Hlth Care Syst, Miami, FL 33125 USA.	mblandino@med.miami.edu		Blandino-Rosano, Manuel/0000-0002-1712-8233	Na-tional Institute of Health (NIDDK) [R01-DK073716, DK084236]	Na-tional Institute of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Acknowledgments-The present studies were funded by the Na-tional Institute of Health (NIDDK) Grant R01-DK073716 and DK084236. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MK, 2017, CARDIOVASCULAR RESP; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Bowerman M, 2014, HUM MOL GENET, V23, P3432, DOI 10.1093/hmg/ddu052; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FISCHER U, 1990, SCIENCE, V249, P786, DOI 10.1126/science.2143847; Girard C, 2006, NUCLEIC ACIDS RES, V34, P2925, DOI 10.1093/nar/gkl374; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; Herrera PL, 1998, MOL CELL ENDOCRINOL, V140, P45, DOI 10.1016/S0303-7207(98)00028-8; Jia YZ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051485; Jia YZ, 2012, MECH DEVELOP, V129, P193, DOI 10.1016/j.mod.2012.08.002; Kain V, 2015, SCI REP-UK, V5, DOI 10.1038/srep15197; Kapadia B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083787; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee J., 2016, RPL13A SMALL NUCLEOL; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Monecke T, 2009, NUCLEIC ACIDS RES, V37, P3865, DOI 10.1093/nar/gkp249; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Wurth L, 2014, NUCLEIC ACIDS RES, V42, P8663, DOI 10.1093/nar/gku580	38	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101592	10.1016/j.jbc.2022.101592	http://dx.doi.org/10.1016/j.jbc.2022.101592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35041827	Green Published, gold			2022-12-28	WOS:000791267400007
J	Mathew, MP; Abramowitz, LK; Donaldson, JG; Hanover, JA				Mathew, Mohit P.; Abramowitz, Lara K.; Donaldson, Julie G.; Hanover, John A.			Nutrient-responsive O-GlcNAcylation dynamically modulates the secretion of glycan-binding protein galectin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Endomembrane glycosylation and cytoplasmic O-GlcNAcyla-tion each play essential roles in nutrient sensing, and character-istic changes in glycan patterns have been described in disease states such as diabetes and cancer. These changes in glycosylation have important functional roles and can drive disease progression. However, little is known about the molecular mechanisms un-derlying how these signals are integrated and transduced into biological effects. Galectins are proteins that bind glycans and that are secreted by a poorly characterized nonclassical secretory mechanism. Once outside the cell, galectins bind to the terminal galactose residues of cell surface glycans and modulate numerous extracellular functions, such as clathrin-independent endocytosis (CIE). Originating in the cytoplasm, galectins are predicted sub-strates for O-GlcNAc addition and removal; and as we have shown, galectin 3 isa substrate for O-GlcNAc transferase. In this study, we also show that galectin 3 secretion is sensitive to changes in O-GlcNAc levels. We determined using immunoprecipitation and Western blotting that there is a significant difference in O-GlcNAcylation status between cytoplasmic and secreted galectin 3. We observed dramatic alterations in galectin 3 secre-tion in response to nutrient conditions, which were dependent on dynamic O-GlcNAcylation. Importantly, we showed that these O-GlcNAc-driven alterations in galectin 3 secretion also facili-tated changes in CIE. These results indicate that dynamic O-GlcNAcylation of galectin 3 plays a role in modulating its secretion and can tune its function in transducing nutrient-sensing information coded in cell surface glycosylation into bio-logical effects.	[Mathew, Mohit P.; Abramowitz, Lara K.; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, Bethesda, MD 20892 USA; [Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hanover, JA (corresponding author), NIDDK, Lab Cell & Mol Biol, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NHLBI, National Institutes of Health [Hl006130]; NIDDK, National Institutes of Health [ZIADK060103]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The mass spectrometry experiments were carried out by Yanling Yang and Marjan Gucek at the Proteomics Core Facility, NHLBI, NIH, Bethesda, Maryland, USA. Recombinant OGT was expressed and purified by Agata Steenackers. This work was supported by NHLBI, National Institutes of Health, intramural research program grant Hl006130 and 6by NIDDK, National In-stitutes of Health, intramural research program grant ZIADK060103. The content is solely the responsibility of the au-thors and does not necessarily represent the official views of the National Institutes of Health.	Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017	2	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101743	10.1016/j.jbc.2022.101743	http://dx.doi.org/10.1016/j.jbc.2022.101743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35183508	Green Published, gold			2022-12-28	WOS:000789398100002
J	Van, HT; Harkins, PR; Patel, A; Jain, AK; Lu, Y; Bedford, MT; Santos, MA				Van, Hieu T.; Harkins, Peter R.; Patel, Avni; Jain, Abhinav K.; Lu, Yue; Bedford, Mark T.; Santos, Margarida A.			Methyl-lysine readers PHF20 and PHF20L1 define two distinct gene expression-regulating NSL complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSAGE COMPENSATION; PROTEIN; MOF; DOMAIN; DNA; DROSOPHILA; BINDING; IDENTIFICATION; TRANSCRIPTION; ACETYLATION	The methyl-lysine readers plant homeodomain finger protein 20 (PHF20) and its homolog PHF20-like protein 1 (PHF20L1) are known components of the nonspecific lethal (NSL) complex that regulates gene expression through its histone acetyltransferase activity. In the current model, both PHF homologs coexist in the same NSL complex, although this was not formally tested; nor have the functions of PHF20 and PHF20L1 regarding NSL complex integrity and transcriptional regulation been investigated. Here, we perform an in-depth biochemical and functional characterization of PHF20 and PHF20L1 in the context of the NSL complex. Using mass spectrometry, genome-wide chromatin analysis, and proteindomain mapping, we identify the existence of two distinct NSL complexes that exclusively contain either PHF20 or PHF20L1. We show that the C-terminal domains of PHF20 and PHF20L1 are essential for complex formation with NSL, and the Tudor 2 domains are required for chromatin binding. The genome-wide chromatin landscape of PHF20-PHF20L1 shows that these proteins bind mostly to the same genomic regions, at promoters of highly expressed/housekeeping genes. Yet, deletion of PHF20 and PHF20L1 does not abrogate gene expression or impact the recruitment of the NSL complex to those target gene promoters, suggesting the existence of an alternative mechanism that compensates for the transcription of genes whose sustained expression is important for critical cellular functions. This work shifts the current paradigm and lays the foundation for studies on the differential roles of PHF20 and PHF20L1 in regulating NSL complex activity in physiological and diseases states.	[Van, Hieu T.; Harkins, Peter R.; Patel, Avni; Jain, Abhinav K.; Lu, Yue; Bedford, Mark T.; Santos, Margarida A.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Van, Hieu T.; Jain, Abhinav K.; Lu, Yue; Bedford, Mark T.; Santos, Margarida A.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Van, Hieu T.] Univ Texas MD Anderson Canc Ctr, Grad Program Genet & Epigenet, UTHealth Grad Sch, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Santos, MA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.; Santos, MA (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA.	mialmeidasantos@mdanderson.org	Van, Hieu Thuan/GMX-1075-2022; Santos, Margarida/GWR-2285-2022	Van, Hieu Thuan/0000-0002-3328-915X; Jain, Abhinav/0000-0003-3268-514X	Center for Cancer Epigenetics Award; Andrew Sabin Family Fellow Award; American Society of Hematology Junior Faculty Scholar Award; CPRIT First time Tenure Track Faculty Award [RR150039]; CPRIT scholar in cancer research	Center for Cancer Epigenetics Award; Andrew Sabin Family Fellow Award; American Society of Hematology Junior Faculty Scholar Award; CPRIT First time Tenure Track Faculty Award; CPRIT scholar in cancer research	This work was supported by a Center for Cancer Epigenetics Award (to H. T. V.) , an Andrew Sabin Family Fellow Award, an American Society of Hematology Junior Faculty Scholar Award, and a CPRIT First time Tenure Track Faculty Award (grant no.: RR150039; to M. A. S.) . M. A. S. is a CPRIT scholar in cancer research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams-Cioaba MA, 2012, FEBS LETT, V586, P859, DOI 10.1016/j.febslet.2012.02.012; Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Augello MA, 2019, CANCER CELL, V35, P603, DOI [10.1016/j.ccell.2019.04.012, 10.1016/j.ccell.2019.03.001]; Badeaux AI, 2012, J BIOL CHEM, V287, P429, DOI 10.1074/jbc.M111.271163; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; BELOTE JM, 1980, GENETICS, V96, P165; Bone JR, 1996, GENETICS, V144, P705; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carr SM, 2017, CELL DEATH DIFFER, V24, P2139, DOI 10.1038/cdd.2017.135; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Cui G., 2012, NAT STRUCT MOL BIOL; Esteve PO, 2014, J BIOL CHEM, V289, P8277, DOI 10.1074/jbc.M113.525279; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Fischer U, 2001, CLIN EXP IMMUNOL, V126, P206, DOI 10.1046/j.1365-2249.2001.01635.x; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gaub A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16103-0; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gupta A., 2014, MOF PHOSPHORYLATION; Heisel SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002164; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; HILFIKER A, 1994, EMBO J, V13, P3542, DOI 10.1002/j.1460-2075.1994.tb06661.x; Hou YQ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0356; Jain AK, 2016, MOL CELL, V64, P967, DOI 10.1016/j.molcel.2016.10.039; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein BJ, 2016, CELL REP, V17, P1158, DOI 10.1016/j.celrep.2016.09.056; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li L, 2021, NAT GENET, V53, P994, DOI 10.1038/s41588-021-00864-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv MQ, 2020, J PHYS CHEM LETT, V11, P7932, DOI 10.1021/acs.jpclett.0c02039; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Nielsen PR, 2005, J BIOL CHEM, V280, P32326, DOI 10.1074/jbc.M501347200; Park S, 2012, J BIOL CHEM, V287, P11151, DOI 10.1074/jbc.M111.333922; Perez-Riverol Y., 2019, RESOURCES; Radzisheuskaya A, 2021, MOL CELL, V81, P1749, DOI 10.1016/j.molcel.2021.02.012; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Schapira M, 2017, NAT REV DRUG DISCOV, V16, P773, DOI 10.1038/nrd.2017.179; Schulte I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-719; Sharma G. G., 2010, MOL CELL BIOL; Sheikh BN, 2019, EMBO REP, V20, DOI 10.15252/embr.201847630; Su J., 2020, NATURE 577; TANAKA A, 1976, GENETICS, V84, P257; Taniwaki M, 2006, INT J ONCOL, V29, P567; Wang QQ, 2018, LAB INVEST, V98, P1627, DOI 10.1038/s41374-018-0106-8; Wible DJ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0110-1; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Zhang CX, 2019, J BIOL CHEM, V294, P476, DOI 10.1074/jbc.RA118.005336; Zhang CX, 2018, J BIOL CHEM, V293, P3663, DOI 10.1074/jbc.RA117.000342; Zhang T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3062; Zhang X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10810; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003940	61	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101588	10.1016/j.jbc.2022.101588	http://dx.doi.org/10.1016/j.jbc.2022.101588			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35033534	Green Published, gold			2022-12-28	WOS:000791267400005
J	Yadav, RP; Boyd, K; Artemyev, NO				Yadav, Ravi P.; Boyd, Kimberly; Artemyev, Nikolai O.			Molecular insights into the maturation of phosphodiesterase 6 by the specialized chaperone complex of HSP90 with AIPL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; PROTEIN-LIKE 1; CYCLIC-GMP PHOSPHODIESTERASE; ROD CGMP-PHOSPHODIESTERASE; PROLINE-RICH DOMAIN; GAMMA-SUBUNIT; BETA-SUBUNIT; IN-VIVO; GENE; MUTATION	Phosphodiesterase 6 (PDE6) is a key effector enzyme in vertebrate phototransduction, and its maturation and function are known to critically depend on a specialized chaperone, aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1). Defects in PDE6 and AIPL1 underlie several severe retinal diseases, including retinitis pigmentosa and Leber congenital amaurosis. Here, we characterize the complex of AIPL1 with HSP90 and demonstrate its essential role in promoting the functional conformation of nascent PDE6. Our analysis suggests that AIPL1 preferentially binds to HSP90 in the closed state with a stoichiometry of 1:2, with the tetratricopeptide repeat domain and the tetratricopeptide repeat helix 7 extension of AIPL1 being the main contributors to the AIPL1/HSP90 interface. We demonstrate that mutations of these determinants markedly diminished both the affinity of AIPL1 for HSP90 and the ability of AIPL1 to cochaperone the maturation of PDE6 in a heterologous expression system. In addition, the FK506-binding protein (FKBP) domain of AIPL1 encloses a unique prenyl-binding site that anchors AIPL1 to post-translational lipid modifications of PDE6. A mouse model with rod PDE6 lacking farnesylation of its PDE6A subunit revealed normal expression, trafficking, and signaling of the enzyme. Furthermore, AIPL1 was unexpectedly capable of inducing the maturation of unprenylated cone PDE6C, whereas mutant AIPL1 deficient in prenyl binding competently cochaperoned prenylated PDE6C. Thus, we conclude neither sequestration of the prenyl modifications is required for PDE6 maturation to proceed, nor is the FKBP-lipid interaction involved in the conformational switch of the enzyme into the functional state.	[Yadav, Ravi P.; Boyd, Kimberly; Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.; Artemyev, NO (corresponding author), Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu			National Institutes of Health [RO1 EY-10843]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant RO1 EY-10843 to N. O. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; BAEHR W, 1979, J BIOL CHEM, V254, P1669; CATTY P, 1992, J BIOL CHEM, V267, P19489; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cote RH, 2021, PFLUG ARCH EUR J PHY, V473, P1377, DOI 10.1007/s00424-021-02562-x; Cull MG, 2000, METHOD ENZYMOL, V326, P430; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; Frederick JM, 2020, BIOL CHEM, V401, P573, DOI 10.1515/hsz-2019-0375; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Gopalakrishna KN, 2017, CELL SIGNAL, V37, P74, DOI 10.1016/j.cellsig.2017.06.002; Gopalakrishna KN, 2016, J BIOL CHEM, V291, P16282, DOI 10.1074/jbc.M116.737593; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; Gulati S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4322; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kerov V, 2018, J NEUROSCI, V38, P6145, DOI 10.1523/JNEUROSCI.3818-16.2018; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lee K, 2021, MOL CELL, V81, P3496, DOI 10.1016/j.molcel.2021.07.023; Li J, 2013, BIOCHEMISTRY-US, V52, P2089, DOI 10.1021/bi301648q; Linnert M, 2013, BIOCHEMISTRY-US, V52, P2097, DOI 10.1021/bi301649m; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Majumder A, 2015, J NEUROSCI, V35, P9225, DOI 10.1523/JNEUROSCI.3563-14.2015; Majumder A, 2013, P NATL ACAD SCI USA, V110, P12468, DOI 10.1073/pnas.1222666110; Majumder A, 2013, J BIOL CHEM, V288, P21320, DOI 10.1074/jbc.M113.476242; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Miura H, 2018, NAT PROTOC, V13, P195, DOI 10.1038/nprot.2017.153; Oroz J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06880-0; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sacristan-Reviriego A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74516-9; Sacristan-Reviriego A, 2017, HUM MOL GENET, V26, P4465, DOI 10.1093/hmg/ddx334; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sonn-Segev A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15642-w; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Yadav RP, 2019, J BIOL CHEM, V294, P15795, DOI 10.1074/jbc.RA119.010666; Yadav RP, 2017, P NATL ACAD SCI USA, V114, pE6536, DOI 10.1073/pnas.1704782114; Yadav RP, 2015, J NEUROCHEM, V135, P165, DOI 10.1111/jnc.13223; Yu LP, 2019, BIOMOL NMR ASSIGN, V13, P79, DOI 10.1007/s12104-018-9856-x; Yu LP, 2017, BIOMOL NMR ASSIGN, V11, P111, DOI 10.1007/s12104-017-9730-2	53	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101620	10.1016/j.jbc.2022.101620	http://dx.doi.org/10.1016/j.jbc.2022.101620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35065964	gold, Green Published			2022-12-28	WOS:000821051800003
J	Uzarska, MA; Grochowina, I; Soldek, J; Jelen, M; Schilke, B; Marszalek, J; Craig, EA; Dutkiewicz, R				Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			During FeS cluster biogenesis, ferredoxin and frataxin use overlapping binding sites on yeast cysteine desulfurase Nfs1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN; BACTERIAL FRATAXIN; SCAFFOLD PROTEIN; ISD11; COMPLEX; CHAPERONES; ELECTRON; REDUCTASE; WEB	In mitochondria, cysteine desulfurase (Nfs1) plays a central role in the biosynthesis of iron-sulfur (FeS) clusters, cofactors critical for activity of many cellular proteins. Nfs1 functions both as a sulfur donor for cluster assembly and as a binding platform for other proteins functioning in the process. These include not only the dedicated scaffold protein (Isu1) on which FeS clusters are synthesized but also accessory FeS cluster biogenesis proteins frataxin (Yfh1) and ferredoxin (Yah1). Yfh1 has been shown to activate cysteine desulfurase enzymatic activity, whereas Yah1 supplies electrons for the persulfide reduction. While Yfh1 interaction with Nfs1 is well understood, the Yah1-Nfs1 interaction is not. Here, based on the results of biochemical experiments involving purified WT and variant proteins, we report that in Saccharomyces cerevisiae, Yah1 and Yfh1 share an evolutionary conserved interaction site on Nfs1. Consistent with this notion, Yah1 and Yfh1 can each displace the other from Nfs1 but are inefficient competitors when a variant with an altered interaction site is used. Thus, the binding mode of Yah1 and Yfh1 interacting with Nfs1 in mitochondria of S. cerevisiae resembles the mutually exclusive binding of ferredoxin and frataxin with cysteine desulfurase reported for the bacterial FeS cluster assembly system. Our findings are consistent with the generally accepted scenario that the mitochondrial FeS cluster assembly system was inherited from bacterial ancestors of mitochondria.	[Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Uzarska, Marta A.; Grochowina, Igor; Soldek, Joanna; Jelen, Marcin; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Med Univ Gdansk, Gdansk, Poland; [Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Wisconsin System; University of Wisconsin Madison	Marszalek, J; Dutkiewicz, R (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland.; Marszalek, J; Dutkiewicz, R (corresponding author), Med Univ Gdansk, Gdansk, Poland.; Marszalek, J; Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	jaroslaw.marszalek@ug.edu.pl; ecraig@wisc.edu; rafal.dutkiewicz@ug.edu.pl	Dutkiewicz, Rafal/ABE-6979-2020	Dutkiewicz, Rafal/0000-0003-4150-0450; Grochowina, Igor/0000-0003-2825-5315; Soldek, Joanna/0000-0002-4536-1606; Marszalek, Jaroslaw/0000-0002-6978-1189; Craig, Elizabeth/0000-0002-9381-4307	Polish National Science Center [UMO-2015/19/B/NZ1/00237]; TEAM program [POIR.04.04.00-00-4114/17-00]; European Union under the European Regional Development Fund; National Institutes of Health [R35GM127009]	Polish National Science Center; TEAM program; European Union under the European Regional Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Polish National Science Center Grant UMO-2015/19/B/NZ1/00237 (to R. D.), and the work of M. A. U. and I. G. was supported by POIR.04.04.00-00-4114/17-00 project carried out within the TEAM program cofinanced by the European Union under the European Regional Development Fund (to J. M.) and by the National Institutes of Health R35GM127009 (to E. A. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Altenhoff AM, 2018, NUCLEIC ACIDS RES, V46, pD477, DOI 10.1093/nar/gkx1019; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delewski W, 2016, MOL BIOL EVOL, V33, P643, DOI 10.1093/molbev/msv254; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Dutkiewicz R, 2018, J BIOL INORG CHEM, V23, P569, DOI 10.1007/s00775-017-1504-x; Dutkiewicz R, 2017, METHOD ENZYMOL, V595, P161, DOI 10.1016/bs.mie.2017.07.004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fox NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09989-y; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gervason S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11470-9; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Heller Kira, 2010, PLoS Biol, V8, pe1000353, DOI 10.1371/journal.pbio.1000353; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540; Lin CW, 2020, J AM CHEM SOC, V142, P6018, DOI 10.1021/jacs.9b11454; Maio N, 2020, TRENDS BIOCHEM SCI, V45, P411, DOI 10.1016/j.tibs.2020.02.001; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Tran NH, 2019, NAT METHODS, V16, P63, DOI 10.1038/s41592-018-0260-3; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Patra S, 2019, P NATL ACAD SCI USA, V116, P19421, DOI 10.1073/pnas.1909535116; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saha PP, 2015, J BIOL CHEM, V290, P25876, DOI 10.1074/jbc.M115.678508; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tomiczek B, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007913; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Van Vranken JG, 2018, MOL CELL, V71, P567, DOI 10.1016/j.molcel.2018.06.039; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Weiler BD, 2020, P NATL ACAD SCI USA, V117, P20555, DOI 10.1073/pnas.2003982117; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	62	1	1	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101570	10.1016/j.jbc.2022.101570	http://dx.doi.org/10.1016/j.jbc.2022.101570			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026224	gold, Green Published			2022-12-28	WOS:000761371500007
J	Dubey, S; Jaiswal, B; Gupta, A				Dubey, Shraddha; Jaiswal, Bharti; Gupta, Ashish			TIP60 acts as a regulator of genes involved in filopodia formation and cell migration during wound healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; FOCAL ADHESIONS; STRESS FIBERS; RHO-KINASE; BINDING; REPAIR; RECOGNITION; PROTRUSION; EXPRESSION; INTEGRIN	Wound healing is a complex phenomenon that requires coordination of numerous molecular and cellular changes to facilitate timely and efficient repair of the damaged tissue. Although many of these molecular pathways have been detailed, others remain to be elucidated. In the present work, we show for the first time, roles for the acetyltransferase TIP60 and nuclear receptor transcription factor PXR in this process, participating in wound healing by altering actin dynamics and cellular motility. We found that in response to wound-injury, TIP60 induces rapid formation of filopodia at the wounded cell front, leading to enhanced cell migration and faster closure of the wound. Further, qPCR analysis revealed heightened expression of Cdc42 and ROCK1 genes, key regulators involved in filopodia formation and actin reorganization, exclusively in TIP60-PXR-expressing cells upon wound-induction. We also performed ChIP assays to confirm the context-specific binding of TIP60 on the ROCK1 promoter and demonstrated that the TIP60 chromodomain is essential for loading of the TIP60- PXR complex onto the chromatin. Results from immunoprecipitation assays revealed that during the wounded condition, TIP60 alters the chromatin microenvironment by specifically acetylating histones H2B and H4, thereby modulating the expression of target genes. Overall, findings of this study show that TIP60 is a novel regulator of the wound healing process by regulating the expression of wound repair-related genes.	[Dubey, Shraddha; Gupta, Ashish] Shiv Nadar Univ, Dept Life Sci, Epigenet & Human Dis Lab, Greater Noida, Uttar Pradesh, India; [Jaiswal, Bharti] Inst Stem Cell Sci & Regenerat Med inStem, Integrat Chem Biol, Bangalore, India	Shiv Nadar University; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Gupta, A (corresponding author), Shiv Nadar Univ, Dept Life Sci, Epigenet & Human Dis Lab, Greater Noida, Uttar Pradesh, India.	ag315@snu.edu.in			Indian Council of Medical Research (ICMR), India [BMS/ADHOC/CMB/2015-0817/JUN-16/1/UP/PVT]; ICMR	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); ICMR(Indian Council of Medical Research (ICMR))	This work was supported by a grant from Indian Council of Medical Research (ICMR) , India BMS/ADHOC/CMB/2015-0817/JUN-16/1/UP/PVT to A. G. S. D. acknowledge ICMR for Senior Research Fellowship. Funding agency has no role in design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Pellicioli ACA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.028002; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Bakshi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03783-w; Biro M, 2014, BRIT J PHARMACOL, V171, P5491, DOI 10.1111/bph.12658; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Brandt K, 2015, GROWTH HORM IGF RES, V25, P34, DOI 10.1016/j.ghir.2014.11.001; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Caceres M, 2014, J DENT RES, V93, P691, DOI 10.1177/0022034514533126; Chang K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00300; Chesik D, 2010, J NEUROCHEM, V113, P1319, DOI 10.1111/j.1471-4159.2010.06703.x; Chu TC, 2015, REGEN MED, V10, P193, DOI [10.2217/rme.14.86, 10.2217/RME.14.86]; Devreotes P, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a005959; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gantwerker EA, 2011, FACIAL PLAST SURG CL, V19, P441, DOI 10.1016/j.fsc.2011.06.009; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hess CT, 2011, ADV SKIN WOUND CARE, V24, P192, DOI 10.1097/01.ASW.0000396300.04173.ec; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jaiswal B, 2018, ENDOCRINOLOGY, V159, P2199, DOI 10.1210/en.2017-03190; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JYUNG RW, 1994, SURGERY, V115, P233; Kang SU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187978; Karnam K, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165903; Kim CH, 2015, BIOSCI BIOTECH BIOCH, V79, P532, DOI 10.1080/09168451.2014.993914; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kodama S, 2015, MOL PHARMACOL, V88, P746, DOI 10.1124/mol.115.099341; Kodama S, 2011, J BIOL CHEM, V286, P3570, DOI 10.1074/jbc.M110.179812; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li L, 2013, BURNS TRAUMA, V1, DOI 10.4103/2321-3868.113331; Lv L, 2011, BRAIN RES, V1396, P60, DOI 10.1016/j.brainres.2011.03.040; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martins MD, 2021, J BIOPHOTONICS, V14, DOI 10.1002/jbio.202000274; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mikami T, 2015, BIOL RES, V48, DOI [10.1186/S40659-015-0039-2, 10.1186/s40659-015-0039-2]; Myint KZ, 2018, ONCOL LETT, V15, P3031, DOI 10.3892/ol.2017.7706; Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x; Nascimento-Filho CHV, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02303-1; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qiao EQ, 2013, ONCOL LETT, V5, P1093, DOI 10.3892/ol.2013.1149; Raja, 2007, Front Biosci, V12, P2849; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saso J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094698; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Srinivasan S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56447-2; Sundaram GM, 2018, FEBS J, V285, P4516, DOI 10.1111/febs.14586; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; TSUBOI R, 1995, J INVEST DERMATOL, V104, P199, DOI 10.1111/1523-1747.ep12612755; Wang G, 2010, REGEN MED, V5, P201, DOI 10.2217/RME.09.91; Wang JW, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1454-z; Wang PH, 2018, J CHIN MED ASSOC, V81, P94, DOI 10.1016/j.jcma.2017.11.002; Wei L, 2016, ARCH IMMUNOL THER EX, V64, P259, DOI 10.1007/s00005-015-0382-6; Zhang YZ, 2018, FEBS LETT, V592, P1221, DOI 10.1002/1873-3468.13021	63	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102015	10.1016/j.jbc.2022.102015	http://dx.doi.org/10.1016/j.jbc.2022.102015			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U5GJ	35525269	Green Published, gold			2022-12-28	WOS:000823188800008
J	Cross, AR; Roy, S; Vega, MV; Rejzek, M; Nepogodiev, SA; Cliff, M; Salmon, D; Isupov, MN; Field, RA; Prior, JL; Harmer, NJ				Cross, Alice R.; Roy, Sumita; Vega, Mirella Vivoli; Rejzek, Martin; Nepogodiev, Sergey A.; Cliff, Matthew; Salmon, Debbie; Isupov, Michail N.; Field, Robert A.; Prior, Joann L.; Harmer, Nicholas J.		GoVV Consortium	Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-I; Q-FEVER; DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASE; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURE; ENZYME; RMLC; GENE; LIPOPOLYSACCHARIDE; ANTIBIOTICS	The sugars streptose and dihydrohydroxystreptose (DHHS) are unique to the bacteria Streptomyces griseus and Coxiella burnetii, respectively. Streptose forms the central moiety of the antibiotic streptomycin, while DHHS is found in the O-antigen of the zoonotic pathogen C. burnetii. Biosynthesis of these sugars has been proposed to follow a similar path to that of TDP-rhamnose, catalyzed by the enzymes RmlA, RmlB, RmlC, and RmlD, but the exact mechanism is unclear. Streptose and DHHS biosynthesis unusually requires a ring contraction step that could be performed by orthologs of RmlC or RmlD. Genome sequencing of S. griseus and C. burnetii has identified StrM and CBU1838 proteins as RmlC orthologs in these respective species. Here, we demonstrate that both enzymes can perform the RmlC 3 ",5 "double epimerization activity necessary to support TDP-rhamnose biosynthesis in vivo. This is consistent with the ring contraction step being performed on a double epimerized substrate. We further demonstrate that proton exchange is faster at the 3 "-position than the 5 " -position, in contrast to a previously studied ortholog. We additionally solved the crystal structures of CBU1838 and StrM in complex with TDP and show that they form an active site highly similar to those of the previously characterized enzymes RmlC, EvaD, and ChmJ. These results support the hypothesis that streptose and DHHS are biosynthesized using the TDP pathway and that an RmlD paralog most likely performs ring contraction following double epimerization. This work will support the elucidation of the full pathways for biosynthesis of these unique sugars.	[Cross, Alice R.; Roy, Sumita; Vega, Mirella Vivoli; Cliff, Matthew; Harmer, Nicholas J.] Univ Exeter, Living Syst Inst, Exeter, Devon, England; [Cross, Alice R.; Roy, Sumita; Vega, Mirella Vivoli; Salmon, Debbie; Isupov, Michail N.; Harmer, Nicholas J.] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Rejzek, Martin; Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk,Colney Lane, Norwich, Norfolk, England; [Field, Robert A.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Prior, Joann L.] Dstl, Salisbury, Wilts, England; [Vega, Mirella Vivoli] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Exeter; University of Exeter; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Manchester; Defence Science & Technology Laboratory; University of Bristol	Harmer, NJ (corresponding author), Univ Exeter, Living Syst Inst, Exeter, Devon, England.; Harmer, NJ (corresponding author), Univ Exeter, Dept Biosci, Exeter, Devon, England.	N.J.Harmer@exeter.ac.uk		Rejzek, Martin/0000-0002-5091-544X; Roy, Sumita/0000-0003-2091-0688; Isupov, Michail/0000-0001-6842-4289; Cliff, Matthew/0000-0002-7482-0234; Field, Rob/0000-0001-8574-0275	BBSRC grant [BB/N001591/1, BB/M016404/1]; Dstl grant [DSTLX-1000098217]; UK BBSRC Institute Strategic Program on Molecules from Nature -Products and Pathways [BBS/E/J/000PR9790]; John Innes Foundation; Innovate UK: IBCatalyst [BB/M02903411]	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dstl grant; UK BBSRC Institute Strategic Program on Molecules from Nature -Products and Pathways(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Innovate UK: IBCatalyst(UK Research & Innovation (UKRI)Innovate UK)	S. R., M. V. V., R. A. F., and N. J. H. were funded by BBSRC grant BB/N001591/1. A. R. C. and N. J. H. were funded by BBSRC grant BB/M016404/1 and by Dstl grant DSTLX-1000098217. Work at the John Innes Centre (M. R., S.A. N., R. A. F.) was supported by the UK BBSRC Institute Strategic Program on Molecules from Nature -Products and Pathways [BBS/E/J/000PR9790] and the John Innes Foundation, and the Innovate UK: IBCatalyst (Grant BB/M02903411).	AMANO K, 1987, J BIOL CHEM, V262, P4740; Anastacio S, 2016, TRANSBOUND EMERG DIS, V63, pE293, DOI 10.1111/tbed.12275; Anderson V. E., 1992, CURR OPIN STRUC BIOL, V2, P757; Arcus VL, 2016, BIOCHEMISTRY-US, V55, P1681, DOI 10.1021/acs.biochem.5b01094; Beare PA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006922; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Boden K, 2015, EUR J CLIN MICROBIOL, V34, P1017, DOI 10.1007/s10096-015-2321-1; BRUTON J, 1966, J BIOL CHEM, V241, P3142; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christendat D, 2000, J BIOL CHEM, V275, P24608, DOI 10.1074/jbc.C000238200; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; Cross AR, 2019, MICROBES INFECT, V21, P10, DOI 10.1016/j.micinf.2018.06.001; Dhaked DK, 2019, PROG BIOPHYS MOL BIO, V145, P52, DOI 10.1016/j.pbiomolbio.2018.12.004; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4; DOWNS CM, 1968, ZBL BAKT PARASIT, V206, P329; Duncan C, 2012, VECTOR-BORNE ZOONOT, V12, P192, DOI 10.1089/vbz.2011.0715; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Edgar R. C., 2021, BIORXIV; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Flores-Ramirez G, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-67; Giraud MF, 2000, NAT STRUCT BIOL, V7, P398; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gonzalez-Barrio D, 2019, TRANSBOUND EMERG DIS, V66, P662, DOI 10.1111/tbed.13085; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; HACKSTADT T, 1986, INFECT IMMUN, V52, P337, DOI 10.1128/IAI.52.1.337-340.1986; Huddleston JP, 2021, BIOCHEMISTRY-US, V60, P1552, DOI 10.1021/acs.biochem.1c00183; Jakimowicz P, 2006, PROTEINS, V63, P261, DOI 10.1002/prot.20818; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kantardjieff KA, 2004, ACTA CRYSTALLOGR D, V60, P895, DOI 10.1107/S0907444904005323; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KAZAR J, 1982, B WORLD HEALTH ORGAN, V60, P389; Kersh GJ, 2011, VECTOR-BORNE ZOONOT, V11, P1433, DOI 10.1089/vbz.2011.0670; Kharel MK, 2010, CHEMBIOCHEM, V11, P523, DOI 10.1002/cbic.200900673; Kirkpatrick PN, 2000, CHEM COMMUN, P1565, DOI 10.1039/b004463f; Koller F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91421-x; Kubiak RL, 2012, BIOCHEMISTRY-US, V51, P9375, DOI 10.1021/bi3012737; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li ZZ, 2017, GLYCOBIOLOGY, V27, P358, DOI 10.1093/glycob/cww136; Li Z, 2017, J BIOL CHEM, V292, P7636, DOI 10.1074/jbc.M117.777417; Merkel AB, 2004, J BIOL CHEM, V279, P32684, DOI 10.1074/jbc.M404091200; Million M, 2017, EMERG INFECT DIS, V23, P856, DOI 10.3201/eid2305.151159; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mori M, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-017-0248-y; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reeves PM, 2017, HUM VACC IMMUNOTHER, V13, P2977, DOI 10.1080/21645515.2017.1371377; Ryan ED, 2018, VET REC, V182, DOI 10.1136/vr.104663; Salinger AJ, 2015, PROTEIN SCI, V24, P1633, DOI 10.1002/pro.2747; Samuel J.E., 2019, US patent application, Patent No. [US10967055B2, 10967055]; Savino S, 2019, NAT CATAL, V2, P1115, DOI 10.1038/s41929-019-0382-8; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Scholzen A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00207; SCHRAMEK S, 1985, EUR J BIOCHEM, V148, P455, DOI 10.1111/j.1432-1033.1985.tb08861.x; Seddon Owen, 2016, J Heart Valve Dis, V25, P375; Shornikov A, 2017, ACTA CRYSTALLOGR F, V73, P664, DOI 10.1107/S2053230X17015849; Sivendran S, 2010, BIOORGAN MED CHEM, V18, P896, DOI 10.1016/j.bmc.2009.11.033; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taurel AF, 2012, VET MICROBIOL, V159, P432, DOI 10.1016/j.vetmic.2012.04.027; Thoden JB, 2015, BIOCHEMISTRY-US, V54, P4495, DOI 10.1021/acs.biochem.5b00541; Tickle I.J., 2018, STARANISO; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Van Overtveldt S, 2015, BIOTECHNOL ADV, V33, P1814, DOI 10.1016/j.biotechadv.2015.10.010; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; WAHL HP, 1979, BIOCHIM BIOPHYS ACTA, V568, P243, DOI 10.1016/0005-2744(79)90291-2; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zuckerman Jane N, 2003, Travel Med Infect Dis, V1, P219, DOI 10.1016/j.tmaid.2003.10.001	82	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101903	10.1016/j.jbc.2022.101903	http://dx.doi.org/10.1016/j.jbc.2022.101903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35398092	Green Published, gold			2022-12-28	WOS:000798142000014
J	Kour, S; Rana, S; Kubica, SP; Kizhake, S; Ahmad, M; Munoz-Trujillo, C; Klinkebiel, D; Singh, S; Mallareddy, JR; Chandra, S; Woods, NT; Karpf, AR; Natarajan, A				Kour, Smit; Rana, Sandeep; Kubica, Sydney P.; Kizhake, Smitha; Ahmad, Mudassier; Munoz-Trujillo, Catalina; Klinkebiel, David; Singh, Sarbjit; Mallareddy, Jayapal Reddy; Chandra, Surabhi; Woods, Nicholas T.; Karpf, Adam R.; Natarajan, Amarnath			Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; INDUCED DEGRADATION; STATISTICAL-MODEL; BREAST-CANCER; PRO-SURVIVAL; ATF6; XBP1; PERK; PHOSPHORYLATION	The unfolded protein response (UPR) is an adaptation mechanism activated to resolve transient accumulation of unfolded/misfolded proteins in the endoplasmic reticulum. Failure to resolve the transient accumulation of such proteins results in UPR-mediated programmed cell death. Loss of tumor suppressor gene or oncogene addiction in cancer cells can result in sustained higher basal UPR levels; however, it is not clear if these higher basal UPR levels in cancer cells can be exploited as a therapeutic strategy. We hypothesized that covalent modification of surface-exposed cysteine (SEC) residues could simulate unfolded/misfolded proteins to activate the UPR, and that higher basal UPR levels in cancer cells would provide the necessary therapeutic window. To test this hypothesis, here we synthesized analogs that can covalently modify multiple SEC residues and evaluated them as UPR activators. We identified a spirocyclic dimer, SpiD7, and evaluated its effects on UPR activation signals, that is, XBP1 splicing, phosphorylation of eIF2 alpha, and a decrease in ATF 6 levels, in normal and cancer cells, which were further confirmed by RNA-Seq analyses. We found that SpiD7 selectively induced caspase-mediated apoptosis in cancer cells, whereas normal cells exhibited robust XBP1 splicing, indicating adaptation to stress. Furthermore, SpiD7 inhibited the growth of high-grade serous carcinoma cell lines similar to 3-15-fold more potently than immortalized fallopian tube epithelial (paired normal control) cells and reduced clonogenic growth of high-grade serous carcinoma cell lines. Our results suggest that induction of the UPR by covalent modification of SEC residues represents a cancer cell vulnerability and can be exploited to discover novel therapeutics.	[Kour, Smit; Rana, Sandeep; Kubica, Sydney P.; Kizhake, Smitha; Ahmad, Mudassier; Munoz-Trujillo, Catalina; Klinkebiel, David; Singh, Sarbjit; Mallareddy, Jayapal Reddy; Woods, Nicholas T.; Karpf, Adam R.; Natarajan, Amarnath] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Chandra, Surabhi] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System	Natarajan, A (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	anatarajan@unmc.edu		kour, smit/0000-0003-2355-2169; Mallareddy, Jayapal Reddy/0000-0003-0440-6617; Natarajan, Amarnath/0000-0001-5067-0203	UNMC fellowship	UNMC fellowship	Smit Kour was supported by UNMC fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Barger CJ, 2021, ELIFE, V10, DOI 10.7554/eLife.55070; Barger CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35567-1; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bryant VC, 2012, BIOORG MED CHEM LETT, V22, P245, DOI 10.1016/j.bmcl.2011.11.025; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carlberg M, 1996, CARCINOGENESIS, V17, P2589, DOI 10.1093/carcin/17.12.2589; Chen MZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00203-5; Chen QY, 2011, BIOORG MED CHEM LETT, V21, P1929, DOI 10.1016/j.bmcl.2011.02.055; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chui MH, 2019, CANCER RES, V79, P5536, DOI 10.1158/0008-5472.CAN-18-3029; Contreras JI, 2018, ACS CHEM BIOL, V13, P1148, DOI 10.1021/acschembio.8b00077; Cromm PM, 2017, CELL CHEM BIOL, V24, P1181, DOI 10.1016/j.chembiol.2017.05.024; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; Garg Abhishek D, 2015, Mol Cell Oncol, V2, pe975089, DOI 10.4161/23723556.2014.975089; Gil HN, 2018, BIOORG MED CHEM LETT, V28, P2969, DOI 10.1016/j.bmcl.2018.07.003; Gonzalez-Teuber V, 2019, TRENDS PHARMACOL SCI, V40, P684, DOI 10.1016/j.tips.2019.07.003; Grandjean JMD, 2020, J BIOL CHEM, V295, P15692, DOI 10.1074/jbc.REV120.010218; Gustafson JL, 2015, ANGEW CHEM INT EDIT, V54, P9659, DOI 10.1002/anie.201503720; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King HM, 2021, BIOORG MED CHEM LETT, V43, DOI 10.1016/j.bmcl.2021.128061; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kour S, 2022, RSC CHEM BIOL, V3, P32, DOI 10.1039/d1cb00183c; Kour S, 2019, MOL PHARMACOL, V96, P419, DOI 10.1124/mol.119.116855; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lim SM, 2015, BIOORG MED CHEM LETT, V25, P3382, DOI 10.1016/j.bmcl.2015.04.103; Liu YJ, 2019, CANCER RES, V79, P2923, DOI 10.1158/0008-5472.CAN-18-2540; Liu Y, 2010, CHEM-EUR J, V16, P8433, DOI 10.1002/chem.200902505; Logue SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05763-8; Long MJC, 2012, CHEM BIOL, V19, P629, DOI 10.1016/j.chembiol.2012.04.008; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nietzold F, 2019, CHEM COMMUN, V55, P14351, DOI 10.1039/c9cc07795b; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Paxman R, 2018, ELIFE, V7, DOI 10.7554/eLife.37168; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pessetto ZY, 2012, BREAST CANCER RES TR, V134, P511, DOI 10.1007/s10549-012-2079-4; Rajule R, 2012, BIOORGAN MED CHEM, V20, P2227, DOI 10.1016/j.bmc.2012.02.022; Rana S, 2020, CHEM BIOL DRUG DES, V96, P773, DOI 10.1111/cbdd.13684; Rana S, 2019, BIOORG MED CHEM LETT, V29, P1375, DOI 10.1016/j.bmcl.2019.03.035; Rana S, 2018, BIOORG MED CHEM LETT, V28, P3736, DOI 10.1016/j.bmcl.2018.10.020; Rana S, 2016, J MED CHEM, V59, P5121, DOI 10.1021/acs.jmedchem.6b00400; Rana S, 2013, ORG BIOMOL CHEM, V11, P244, DOI 10.1039/c2ob27008k; Robb CM, 2018, ONCOTARGET, V9, P5216, DOI 10.18632/oncotarget.23749; Robb CM, 2017, CHEM COMMUN, V53, P7577, DOI 10.1039/c7cc03879h; Rubner S, 2018, ANGEW CHEM INT EDIT, V57, P17043, DOI 10.1002/anie.201809640; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Samanta S, 2021, CANCER RES, V81, P1883, DOI 10.1158/0008-5472.CAN-20-1540; Samanta S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59116-x; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08152-3; Shi Y, 2016, ACS CHEM BIOL, V11, P3328, DOI 10.1021/acschembio.6b00656; Smolewski P, 2002, J IMMUNOL METHODS, V265, P111, DOI 10.1016/S0022-1759(02)00074-1; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; Tae HS, 2012, CHEMBIOCHEM, V13, P538, DOI 10.1002/cbic.201100793; Tameire F, 2015, SEMIN CANCER BIOL, V33, P3, DOI 10.1016/j.semcancer.2015.04.002; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Vitale M, 2019, ELIFE, V8, DOI 10.7554/eLife.41168; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yefidoff-Freedman R, 2017, J MED CHEM, V60, P5392, DOI 10.1021/acs.jmedchem.7b00059; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang SX, 2019, CHEM-ASIAN J, V14, P904, DOI 10.1002/asia.201900150; Zhang W., 2020, CANCERS, V12, P1; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	75	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101890	10.1016/j.jbc.2022.101890	http://dx.doi.org/10.1016/j.jbc.2022.101890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35378132	gold, Green Published			2022-12-28	WOS:000860390500012
J	Roig-Zamboni, V; Barelier, S; Dixon, R; Galley, NF; Ghanem, A; Cahuzac, H; Nguyen, QP; Salamaga, B; Davis, PJ; Bourne, Y; Mesnage, S; Vincent, F				Roig-Zamboni, Veronique; Barelier, Sarah; Dixon, Robert; Galley, Nicola F.; Ghanem, Amani; Cahuzac, Heloize; Nguyen, Quoc Phong; Salamaga, Bartlomiej; Davis, Peter J.; Bourne, Yves; Mesnage, Stephane; Vincent, Florence			Molecular basis for substrate recognition and septum cleavage by AtlA, the major N-acetylglucosaminidase of Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN HYDROLASE; PROTEIN	The cleavage of septal peptidoglycan at the end of cell division facilitates the separation of the two daughter cells. The hydrolases involved in this process (called autolysins) are potentially lethal enzymes that can cause cell death; their activity, therefore, must be tightly controlled during cell growth. In Enterococcus faecalis, the N-acetylglucosaminidase AtlA plays a predominant role in cell separation. atlA mutants form long cell chains and are significantly less virulent in the zebrafish model of infection. The attenuated virulence of atlA mutants is underpinned by a limited dissemination of bacterial chains in the host organism and a more efficient uptake by phagocytes that clear the infection. AtlA has structural homologs in other important pathogens, such as Listeria monocytogenes and Salmonella typhimurium, and therefore represents an attractive model to design new inhibitors of bacterial pathogenesis. Here, we provide a 1.45 & Aring; crystal structure of the E. faecalis AtlA catalytic domain that reveals a closed conformation of a conserved beta-hairpin and a complex network of hydrogen bonds that bring two catalytic residues to the ideal distance for an inverting mechanism. Based on the model of the AtlA-substrate complex, we identify key residues critical for substrate recognition and septum cleavage during bacterial growth. We propose that this work will provide useful information for the rational design of specific inhibitors targeting this enterococcal virulence factor and its orthologs in other pathogens.	[Roig-Zamboni, Veronique; Barelier, Sarah; Ghanem, Amani; Nguyen, Quoc Phong; Bourne, Yves; Vincent, Florence] Aix Marseille Univ, CNRS, AFMB, Marseille, France; [Galley, Nicola F.; Cahuzac, Heloize; Salamaga, Bartlomiej; Davis, Peter J.; Mesnage, Stephane] Univ Sheffield, Sch Biosci, Sheffield, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Sheffield	Vincent, F (corresponding author), Aix Marseille Univ, CNRS, AFMB, Marseille, France.; Mesnage, S (corresponding author), Univ Sheffield, Sch Biosci, Sheffield, England.	s.mesnage@sheffield.ac.uk; fvincent.cnrs@univ-amu.fr	MESNAGE, Stephane/H-7156-2019	Galley, Nicola/0000-0001-7630-2601; MESNAGE, Stephane/0000-0003-1648-4890; vincent, Florence/0000-0002-8564-4184; barelier, sarah/0000-0002-1084-6312; Nguyen, Phong Quoc/0000-0001-5968-9170	Royal Society [IEC\R2\170260]	Royal Society(Royal Society of London)	This work was supported by an International Exchange grant from the Royal Society (to S. M. and F. V.) (grant no.: IEC\R2\170260).	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bradley CR, 1996, J HOSP INFECT, V34, P191, DOI 10.1016/S0195-6701(96)90065-1; Bravetti AL, 2009, ANTIMICROB AGENTS CH, V53, P1667, DOI 10.1128/AAC.00692-08; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Drula E, 2022, NUCLEIC ACIDS RES, V50, pD571, DOI 10.1093/nar/gkab1045; Dubee V, 2011, ANTIMICROB AGENTS CH, V55, P910, DOI 10.1128/AAC.01230-10; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grabski A, 2005, NAT METHODS, V2, P233, DOI [DOI 10.1038/NMETH0305-233, 10.1038/nmeth0305-233]; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lipski A, 2015, GLYCOBIOLOGY, V25, P319, DOI 10.1093/glycob/cwu113; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramos Y., 2021, PLOS PATHOG, V17; Salamaga B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006526; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Webb B., 2016, CURR PROTOC BIOINF, V54; Zaloba P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149204	30	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101915	10.1016/j.jbc.2022.101915	http://dx.doi.org/10.1016/j.jbc.2022.101915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35398351	Green Submitted, Green Published, Green Accepted, gold			2022-12-28	WOS:000804923000013
J	Shemirani, R; Lin, G; Uyghurturk, DA; Le, MC; Nakano, Y				Shemirani, Rozana; Lin, Gan; Uyghurturk, Dawud Abduweli; Le, Michael; Nakano, Yukiko			An miRNA derived from amelogenin exon4 regulates expression of transcription factor Runx2 by directly targeting activators Nfia and Prkch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; AMELOBLAST; ENAMEL; PROTEIN; MINERALIZATION; REPRESSION; PEPTIDE; CELLS	Amel, the gene encoding the amelogenin protein involved in enamel formation, is highly alternatively spliced. When exon4 is excised, it can form a mature miRNA (miR-exon4) that has previously been suggested to indirectly regulate expression of the Runt-related transcription factor 2 (Runx2) involved in bone development in ameloblasts and osteoblasts. However, the precise mechanism of this regulation is unclear. In this study, we aimed to identify direct targets of miR-exon4. The transcription factor family nuclear factor I/A (NFI/A) is known to negatively regulate expression of Runx2 and is among the most highly predicted direct targets of miR-exon4 that link to Runx2. Immunostaining detected NFI/A in osteoblasts and ameloblasts in vivo, and reporter assays confirmed direct interaction of the Nfia 30-UTR and miR-exon4. In addition, silencing of Nfia in MC3T3-E1-M14 osteoblasts resulted in subsequent downregulation of Runx2. In a monoclonal sub clone (mi2) of MC3T3-E1 cells wherein mature miR-exon4 was functionally inhibited, we observed significantly downregulated Runx2 expression. We showed that NFI/A was significantly upregulated in mi2 cells at both mRNA and protein levels. Furthermore, quantitative proteomics and pathway analysis of gene expression in mi2 cells suggested that miR-exon4 could directly target Prkch (protein kinase C-eta), possibly leading to RUNX2 regulation through mechanistic target of rapamycin kinase activation. Reporter assays also confirmed the direct interaction of miR-exon4 and the 3'-UTR of Prkch, and Western blot analysis confirmed significantly upregulated mechanistic target of rapamycin kinase phosphorylation in mi2 cells. Taken together, we conclude that Nfia and Prkch expression negatively correlates with miR-exon4-mediated Runx2 regulation in vivo and in vitro, suggesting miR-exon4 directly targets Nfia and Prkch to regulate Runx2.	[Shemirani, Rozana; Lin, Gan; Uyghurturk, Dawud Abduweli; Nakano, Yukiko] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA; [Le, Michael] Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, San Francisco, CA USA; [Nakano, Yukiko] Univ Calif San Francisco, Ctr Childrens Oral Hlth Res, Sch Dent, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nakano, Y (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA.; Nakano, Y (corresponding author), Univ Calif San Francisco, Ctr Childrens Oral Hlth Res, Sch Dent, San Francisco, CA USA.	Yukiko.Nakano@ucsf.edu		Nakano, Yukiko/0000-0002-1799-1205	School of Dentistry; Department of Orofacial Sciences; UCSF Center for Children's Oral Health Research; National Institute of Dental and Craniofacial Research [5R01DE027366]	School of Dentistry; Department of Orofacial Sciences; UCSF Center for Children's Oral Health Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by funding from the School of Dentistry (to Y. N.) , the Department of Orofacial Sciences (to Y. N.) , the UCSF Center for Children's Oral Health Research (to Y. N.) , and the National Institute of Dental and Craniofacial Research; grant no.: 5R01DE027366; to Y. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Chen JQ, 2018, BONE RES, V6, DOI 10.1038/s41413-017-0004-5; Chu Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27873-5; da Cunha LF, 2014, CASE REP DENT, V2014, DOI 10.1155/2014/901071; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Fukuta Y, 2001, J Oral Sci, V43, P85; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Jacques J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099626; Jegat Nadege, 2007, Head Face Med, V3, P40, DOI 10.1186/1746-160X-3-40; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Le MH, 2016, J DENT RES, V95, P423, DOI 10.1177/0022034515622443; Le TQ, 2007, J DENT RES, V86, P1095, DOI 10.1177/154405910708601114; Lee DS, 2018, CELL TISSUE RES, V374, P531, DOI 10.1007/s00441-018-2901-3; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee HK, 2010, J CELL BIOCHEM, V111, P755, DOI 10.1002/jcb.22766; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu X., 2013, 2013 ICME INT C COMP; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Marsico A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r84; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Oh HJ, 2012, J CELL BIOCHEM, V113, P877, DOI 10.1002/jcb.23421; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Shapiro JL, 2006, DNA CELL BIOL, V25, P1, DOI 10.1089/dna.2006.25.1; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Sire JY, 2012, J DENT RES, V91, P84, DOI 10.1177/0022034511423399; Takahashi S, 2007, BIOCHEM BIOPH RES CO, V353, P405, DOI 10.1016/j.bbrc.2006.12.053; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang XP, 2005, J DENT RES, V84, P138, DOI 10.1177/154405910508400206; Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058; Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045; YAMAMOTO H, 1989, ORAL SURG ORAL MED O, V68, P195, DOI 10.1016/0030-4220(89)90192-8; Yan FF, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.192948; Ye L, 2006, J DENT RES, V85, P814, DOI 10.1177/154405910608500907; Yin KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-998; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103994	51	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101807	10.1016/j.jbc.2022.101807	http://dx.doi.org/10.1016/j.jbc.2022.101807			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35271849	gold, Green Published			2022-12-28	WOS:000798082100011
J	Liu, YL; Yang, XJ; Zhou, MQ; Yang, YX; Li, FZ; Yan, XM; Zhang, MM; Wei, ZG; Qin, S; Min, JR				Liu, Yanli; Yang, Xiajie; Zhou, Mengqi; Yang, Yinxue; Li, Fangzhou; Yan, Xuemei; Zhang, Mengmeng; Wei, Zhengguo; Qin, Su; Min, Jinrong			Structural basis for the recognition of methylated histone H3 by the Arabidopsis LHP1 chromodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROME SHADOW DOMAIN; FLOWERING TIME; DNA METHYLATION; HINGE REGION; BINDING-SITE; RNA-BINDING; LYSINE 9; HETEROCHROMATIN; HP1; PROTEIN	Arabidopsis LHP1 (LIKE HETEROCHROMATIN PROTEIN 1), a unique homolog of HP1 in Drosophila, plays important roles in plant development, growth, and architecture. In contrast to specific binding of the HP1 chromodomain to methylated H3K9 histone tails, the chromodomain of LHP1 has been shown to bind to both methylated H3K9 and H3K27 histone tails, and LHP1 carries out its function mainly via its interaction with these two epigenetic marks. However, the molecular mechanism for the recognition of methylated histone H3K9/27 by the LHP1 chromodomain is still unknown. In this study, we characterized the binding ability of LHP1 to histone H3K9 and H3K27 peptides and found that the chromodomain of LHP1 binds to histone H3K9me2/3 and H3K27me2/3 peptides with comparable affinities, although it exhibited no binding or weak binding to unmodified or monomethylated H3K9/K27 peptides. Our crystal structures of the LHP1 chromodomain in peptide-free and peptide-bound forms coupled with mutagenesis studies reveal that the chromodomain of LHP1 bears a slightly different chromodomain architecture and recognizes methylated H3K9 and H3K27 peptides via a hydrophobic clasp, similar to the chromodomains of human Polycomb proteins, which could not be explained only based on primary structure analysis. Our binding and structural studies of the LHP1 chromodomain illuminate a conserved ligand interaction mode between chromodomains of both animals and plants, and shed light on further functional study of the LHP1 protein.	[Liu, Yanli; Yang, Yinxue; Yan, Xuemei; Zhang, Mengmeng] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Yang, Xiajie; Zhou, Mengqi; Li, Fangzhou; Min, Jinrong] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China; [Wei, Zhengguo] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Jiangsu, Peoples R China; [Qin, Su] Southern Univ Sci & Technol, Life Sci Res Ctr, Shenzhen, Guangdong, Peoples R China	Soochow University - China; Central China Normal University; Soochow University - China; Southern University of Science & Technology	Liu, YL (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China.; Min, JR (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	ylliu18@suda.edu.cn; minjinrong@ccnu.edu.cn	zhou, mengqi/GYV-1993-2022	Liu, Yanli/0000-0003-0197-7617	Synchrotron Radiation Facility; National Natural Science Foundation of China [31500615]; Priority Academic Program Development of the Jiangsu Higher Education Institutes, China (PAPD); Sixtalent Professorship of Jiangsu province, China [SWYY-104]	Synchrotron Radiation Facility; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of the Jiangsu Higher Education Institutes, China (PAPD); Sixtalent Professorship of Jiangsu province, China	We would like to thank Dr Wolfram Tempel of University of Toronto, Zeyuan Guan of Huazhong Agricultural University, and Huan Zhou of SSRF beamline BL17U1 for assistance in data collection, Wolfram Tempel for structure determination, and Aiping Dong for reviewing the crystallographic models. We also thank the research associates at Center for Protein Research (CPR), Huazhong Agricultural University, for technical support. This work was carried out with the support of Shanghai Synchrotron Radiation Facility, beamline 17U1 (proposal 2019-SSRF-PT-010749). This work was supported by the National Natural Science Foundation of China grants (31500615), the Priority Academic Program Development of the Jiangsu Higher Education Institutes, China (PAPD), and Sixtalent Professorship of Jiangsu province, China (SWYY-104).	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Berry S, 2017, GENE DEV, V31, P2115, DOI 10.1101/gad.305227.117; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Dong C, 2020, CELL CHEM BIOL, V27, P827, DOI 10.1016/j.chembiol.2020.05.007; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gaudin V, 2001, DEVELOPMENT, V128, P4847; HAUGHN GW, 1991, PLANT PHYSIOL, V97, P217, DOI 10.1104/pp.97.1.217; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsson AS, 1998, GENETICS, V149, P597; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Li ZF, 2016, J INTEGR PLANT BIOL, V58, P959, DOI 10.1111/jipb.12485; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu YL, 2017, J BIOL CHEM, V292, P5655, DOI 10.1074/jbc.M116.768374; Liu YL, 2016, BIOCHEM J, V473, P1663, DOI 10.1042/BCJ20160123; Liu YL, 2016, J BIOL CHEM, V291, P9000, DOI 10.1074/jbc.M116.718973; Liu YL, 2014, PHARMACOL THERAPEUT, V143, P275, DOI 10.1016/j.pharmthera.2014.03.007; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Qin S, 2014, TRENDS BIOCHEM SCI, V39, P536, DOI 10.1016/j.tibs.2014.09.001; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Veluchamy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158936; Wang H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005771; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yu Y, 2004, PLANT J, V40, P699, DOI 10.1111/j.1365-313X.2004.02240.x; Zemach A, 2006, PLANT CELL, V18, P133, DOI 10.1105/tpc.105.036855; Zhang MM, 2021, BIOCHEM BIOPH RES CO, V569, P199, DOI 10.1016/j.bbrc.2021.07.017; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhao S, 2019, CELL RES, V29, P54, DOI 10.1038/s41422-018-0104-9; Zhou Y, 2017, P NATL ACAD SCI USA, V114, P4833, DOI 10.1073/pnas.1620955114; Zhu Y, 2020, J INTEGR PLANT BIOL, V62, P812, DOI 10.1111/jipb.12841	68	0	0	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101623	10.1016/j.jbc.2022.101623	http://dx.doi.org/10.1016/j.jbc.2022.101623			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35074427	Green Published, gold			2022-12-28	WOS:000821051800006
J	Malek, M; Wawrzyniak, AM; Ebner, M; Puchkov, D; Haucke, V				Malek, Mouhannad; Wawrzyniak, Anna M.; Ebner, Michael; Puchkov, Dmytro; Haucke, Volker			Inositol triphosphate-triggered calcium release from the endoplasmic reticulum induces lysosome biogenesis via TFEB/TFE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE 5-PHOSPHATASE; TFEB; CALCINEURIN; AUTOPHAGY; INHIBITOR; MTOR	Lysosomes serve as dynamic regulators of cell and organismal physiology by integrating the degradation of macromolecules with receptor and nutrient signaling. Previous studies have established that activation of the transcription factor EB (TFEB) and transcription factor E3 (TFE3) induces the expression of lysosomal genes and proteins in signaling inactive starved cells, that is, under conditions when activity of the master regulator of nutrient-sensing signaling mechanistic target of rapamycin complex 1 is repressed. How lysosome biogenesis is triggered in signaling-active cells is incompletely understood. Here, we identify a role for calcium release from the lumen of the endoplasmic reticulum in the control of lysosome biogenesis that is independent of mechanistic target of rapamycin complex 1. We show using functional imaging that calcium efflux from endoplasmic reticulum stores induced by inositol triphosphate accumulation upon depletion of inositol polyphosphate-5phosphatase A, an inositol 5-phosphatase downregulated in cancer and defective in spinocerebellar ataxia, or receptor mediated phospholipase C activation leads to the induction of lysosome biogenesis. This mechanism involves calcineurin and the nuclear translocation and elevated transcriptional activity of TFEB/TFE3. Our findings reveal a crucial function for inositol polyphosphate-5-phosphatase A-mediated triphosphate hydrolysis in the control of lysosome biogenesis via TFEB/TFE3, thereby contributing to our understanding how cells are able to maintain their lysosome content under conditions of active receptor and nutrient signaling.	[Malek, Mouhannad; Wawrzyniak, Anna M.; Ebner, Michael; Puchkov, Dmytro; Haucke, Volker] Leibniz Forschungsinst Mol Pharmakol FMP, Dept Mol Pharmacol & Cell Biol, Berlin, Germany; [Haucke, Volker] Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin	Haucke, V (corresponding author), Leibniz Forschungsinst Mol Pharmakol FMP, Dept Mol Pharmacol & Cell Biol, Berlin, Germany.; Haucke, V (corresponding author), Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany.	haucke@fmp-berlin.de		malek, mouhannad/0000-0002-7523-7593	Leibniz SAW Program; Deutsche Forschungsgemeinschaft [HA2686/21-1]	Leibniz SAW Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by grants from the Leibniz SAW Program and the Deutsche Forschungsgemeinschaft (FOR 2625-Mechanisms of Lysosomal Homeostasis; grant no.: HA2686/21-1) (to V. H.) .	Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Erdmann F, 2010, J BIOL CHEM, V285, P1888, DOI 10.1074/jbc.M109.024844; Erneux Christophe, 2015, Advances in Biological Regulation, V60, P135, DOI 10.1016/j.jbior.2015.09.004; Garrity AG, 2016, ELIFE, V5, DOI 10.7554/eLife.15887; Golyan FF, 2021, ADV MED SCI-POLAND, V66, P231, DOI 10.1016/j.advms.2021.03.004; Kohn EA, 2003, CANCER RES, V63, P31; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu Q, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14931-8; Lopez-Hernandez T, 2020, NAT CELL BIOL, V22, P815, DOI 10.1038/s41556-020-0535-7; Malek Mouhannad, 2021, Metabolights, DOI 10.1038/s41467-021-22882-x; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Perera RM, 2019, ANNU REV CANC BIOL, V3, P203, DOI 10.1146/annurev-cancerbio-030518-055835; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Peretti D, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00371; Puertollano R, 2018, EMBO J, V37, DOI 10.15252/embj.201798804; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sekulic A, 2010, CANCER PREV RES, V3, P1277, DOI 10.1158/1940-6207.CAPR-10-0058; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shao Rong, 2021, Biochem J, V478, P1159, DOI 10.1042/BCJ20200676; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Wu HX, 2018, SCIENCE, V361, pCP15, DOI 10.1126/science.aan5835; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yao WT, 2019, NATURE, V568, P410, DOI 10.1038/s41586-019-1062-1	33	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101740	10.1016/j.jbc.2022.101740	http://dx.doi.org/10.1016/j.jbc.2022.101740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35182526	Green Published, gold			2022-12-28	WOS:000789398100003
J	Marino, SF; Jerke, U; Rolle, S; Daumke, O; Kettritz, R				Marino, Stephen F.; Jerke, Uwe; Rolle, Susanne; Daumke, Oliver; Kettritz, Ralph			Competitively disrupting the neutrophil-specific receptor-autoantigen CD177:proteinase 3 membrane complex reduces anti-PR3 antibody-induced neutrophil activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-3 EXPRESSION; SURFACE EXPRESSION; CD177; PROTEASE; CLEAVAGE; SUBSET; PR3	CD177 is a neutrophil-specific receptor presenting the proteinase 3 (PR3) autoantigen on the neutrophil surface. CD177 expression is restricted to a neutrophil subset, resulting in CD177(pos)/mPR3(high) and CD177(neg)/mPR3(low) populations. The CD177(pos)/mPR3(high) subset has implications for antineutrophil cytoplasmic autoantibody (ANCA)-associated autoimmune vasculitis, wherein patients harbor PR3-specific ANCAs that activate neutrophils for degranulation. Here, we generated high-affinity anti-CD177 monoclonal antibodies, some of which interfered with PR3 binding to CD177 (PR3 "blockers ") as determined by surface plasmon resonance spectroscopy and used them to test the effect of competing PR3 from the surface of CD177(pos) neutrophils. Because intact anti-CD177 antibodies also caused neutrophil activation, we prepared nonactivating Fab fragments of a PR3 blocker and nonblocker that bound specifically to CD177(pos) neutrophils. We observed that Fab blocker clone 40, but not nonblocker clone 80, dose-dependently reduced anti-PR3 antibody binding to CD177(pos) neutrophils. Importantly, preincubation with clone 40 significantly reduced respiratory burst in primed neutrophils challenged with either monoclonal antibodies to PR3 or PR3-ANCA immunoglobulin G from ANCA-associated autoimmune vasculitis patients. After separating the two CD177/mPR3 neutrophil subsets from individual donors by magnetic sorting, we found that PR3-ANCAs provoked significantly more superoxide production in CD177(pos)/mPR3(high) than in CD177(neg)/mPR3(low )neutrophils, and that anti-CD177 Fab clone 40 reduced the superoxide production of CD177(pos) cells to the level of the CD177(neg) cells. Our data demonstrate the importance of the CD177:PR3 membrane complex in maintaining a high ANCA epitope density and thereby underscore the contribution of CD177 to the severity of PR3-ANCA diseases.	[Marino, Stephen F.; Jerke, Uwe; Rolle, Susanne; Kettritz, Ralph] Charite Univ Med Berlin, Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Helmholtz Assoc MDC, Berlin, Germany; [Daumke, Oliver] MDC, Struct Biol Membrane Associated Proc, Berlin, Germany; [Kettritz, Ralph] Charite Campus Virchow, Nephrol & Intens Care Med, Berlin, Germany; [Marino, Stephen F.] German Fed Inst Risk Assessment, Dept Biol Safety, Diedersdorfer Weg 1, D-12277 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Federal Institute for Risk Assessment	Marino, SF (corresponding author), Charite Univ Med Berlin, Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Helmholtz Assoc MDC, Berlin, Germany.; Marino, SF (corresponding author), German Fed Inst Risk Assessment, Dept Biol Safety, Diedersdorfer Weg 1, D-12277 Berlin, Germany.	stmarino@gmx.de		Kettritz, Ralph/0000-0001-5821-6718; Marino, Stephen/0000-0001-5696-9679; Jerke, Uwe/0000-0001-6887-8010	Else Kroner Fresenius Stiftung [2013_A73]; Deutsche Forschungsgemeinschaft [246135856]	Else Kroner Fresenius Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Else Kroener Fresenius Stiftung grant 2013_A73 (to R. K. and S. F. M.) and Deutsche Forschungsgemeinschaft (project number: 246135856; to R. K.) .	Abdgawad M, 2010, CLIN EXP IMMUNOL, V161, P89, DOI 10.1111/j.1365-2249.2010.04154.x; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Eulenberg-Gustavus C, 2017, J EXP MED, V214, P2089, DOI 10.1084/jem.20161093; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, ARTHRITIS RHEUM-US, V60, P1548, DOI 10.1002/art.24442; Jerke U, 2017, SCI REP-UK, V7, DOI 10.1038/srep43328; Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Kuckleburg CJ, 2013, ARTERIOSCL THROM VAS, V33, P275, DOI 10.1161/ATVBAHA.112.300474; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Schreiber A, 2004, KIDNEY INT, V65, P2172, DOI 10.1111/j.1523-1755.2004.00640.x; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Vogt KL, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12967; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Witko-Sarsat V, 2002, J BIOL CHEM, V277, P47338, DOI 10.1074/jbc.M202789200	23	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101598	10.1016/j.jbc.2022.101598	http://dx.doi.org/10.1016/j.jbc.2022.101598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35063507	gold, Green Published, Green Accepted			2022-12-28	WOS:000791267400013
J	McAlary, L; Shephard, VK; Wright, GSA; Yerbury, JJ				McAlary, L.; Shephard, V. K.; Wright, G. S. A.; Yerbury, J. J.			A copper chaperone-mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DISEASE; INDUCED HEARING-LOSS; MOUSE MODEL; DECREASED STABILITY; DISULFIDE BOND; DOUBLE-BLIND; IN-VIVO; SOD1; ALS	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease in which motor neurons progressively and rapidly degenerate, eventually leading to death. The first protein found to contain ALS-associated mutations was copper/zinc superoxide dismutase 1 (SOD1), which is conformationally stable when it contains its metal ligands and has formed its native intramolecular disulfide. Mutations in SOD1 reduce protein folding stability via disruption of metal binding and/or disulfide formation, resulting in misfolding, aggregation, and ultimately cellular toxicity. A great deal of effort has focused on preventing the misfolding and aggregation of SOD1 as a potential therapy for ALS; however, the results have been mixed. Here, we utilize a small-molecule polytherapy of diacetylbis(N(4)-methylthiosemicarbazonato)copper(II) (CuATSM) and ebselen to mimic the metal delivery and disulfide bond promoting activity of the cellular chaperone of SOD1, the "copper chaperone for SOD1. " Using microscopy with automated image analysis, we find that polytherapy using CuATSM and ebselen is highly effective and acts in synergy to reduce inclusion formation in a cell model of SOD1 aggregation for multiple ALS-associated mutants. Polytherapy reduces mutant SOD1-associated cell death, as measured by live-cell microscopy. Measuring dismutase activity via zymography and immunoblotting for disulfide formation showed that poly therapy promoted more effective maturation of transfected SOD1 variants beyond either compound alone. Our data suggest that a polytherapy of CuATSM and ebselen may merit more study as an effective method of treating SOD1-associated ALS.	[McAlary, L.; Shephard, V. K.; Yerbury, J. J.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [McAlary, L.; Shephard, V. K.; Yerbury, J. J.] Univ Wollongong, Fac Sci Med & Hlth Mol Horizons, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [Wright, G. S. A.] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Biochem & Syst Biol, Liverpool, Lancashire, England	University of Wollongong; University of Wollongong; University of Liverpool	McAlary, L; Yerbury, JJ (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Chem & Mol Biosci, Wollongong, NSW, Australia.; McAlary, L; Yerbury, JJ (corresponding author), Univ Wollongong, Fac Sci Med & Hlth Mol Horizons, Sch Chem & Mol Biosci, Wollongong, NSW, Australia.	lmcalary@uow.edu.au; jyerbury@uow.edu.au		McAlary, Luke/0000-0002-1764-3809	Motor Neurone Disease Association, UK [Wright/Oct18/969-799]	Motor Neurone Disease Association, UK	L. M. is the Bill Gole MND Fellow (Motor Neurone Disease Research Australia) . G. S. A. W. is funded by the Motor Neurone Disease Association, UK, Wright/Oct18/969-799.	Amporndanai K, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102980; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Antonyuk S, 2005, PROTEIN SCI, V14, P1201, DOI 10.1110/ps.041256705; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benatar M, 2018, NEUROLOGY, V90, pE565, DOI 10.1212/WNL.0000000000004960; Broom HR, 2015, PROTEIN SCI, V24, P2081, DOI 10.1002/pro.2803; Cao JQ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0299-8; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Capper MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04114-x; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chantadul V, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0826-3; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crosby K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206751; Crown A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227655; Crown AM, 2019, G3-GENES GENOM GENET, V9, P719, DOI 10.1534/g3.118.200787; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Donnelly DP, 2018, J AM CHEM SOC, V140, P7377, DOI 10.1021/jacs.8b01136; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Duval MG, 2019, NEUROBIOL DIS, V124, P297, DOI 10.1016/j.nbd.2018.11.025; Farrawell NE, 2019, ACS CHEM NEUROSCI, V10, P1555, DOI 10.1021/acschemneuro.8b00527; Farrawell NE, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209122; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Gill C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43164-z; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hilton JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep42292; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Keskin I, 2019, ACTA NEUROPATHOL, V138, P85, DOI 10.1007/s00401-019-01986-1; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kil J, 2017, LANCET, V390, P969, DOI 10.1016/S0140-6736(17)31791-9; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Lange DJ, 2013, AMYOTROPH LAT SCL FR, V14, P199, DOI 10.3109/17482968.2012.724074; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Luchinat E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17815-y; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Malik R, 2019, J BIOL CHEM, V294, P3501, DOI 10.1074/jbc.RA118.005940; McAlary L, 2019, CNS DRUGS, V33, P883, DOI 10.1007/s40263-019-00657-9; McAlary L, 2019, NEURAL REGEN RES, V14, P1511, DOI 10.4103/1673-5374.255962; McAlary L, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00499; McAlary L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03275; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Oh-hashi K, 2020, APPL BIOCHEM BIOTECH, V190, P674, DOI 10.1007/s12010-019-03114-x; Parker SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042277; Pokrishevsky E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32835-y; Proctor EA, 2016, P NATL ACAD SCI USA, V113, P614, DOI 10.1073/pnas.1516725113; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rando A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210752; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sala FA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000141; Sea K, 2015, J BIOL CHEM, V290, P2405, DOI 10.1074/jbc.M114.588798; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Son M, 2009, NEUROBIOL DIS, V34, P155, DOI 10.1016/j.nbd.2009.01.005; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Vieira FG, 2017, IBRO REP, V2, P47, DOI 10.1016/j.ibror.2017.03.001; Whiten DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31138; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Wright GSA, 2019, Q REV BIOPHYS, V52, DOI 10.1017/S003358351900012X; Wright GSA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2750; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Yerbury JJ, 2020, TRENDS NEUROSCI, V43, P274, DOI 10.1016/j.tins.2020.03.002; Zhu C, 2018, P NATL ACAD SCI USA, V115, P4661, DOI 10.1073/pnas.1800187115	88	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101612	10.1016/j.jbc.2022.101612	http://dx.doi.org/10.1016/j.jbc.2022.101612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065969	Green Submitted, gold, Green Published			2022-12-28	WOS:000789396300001
J	Noce, BD; da Silva, RM; Uhl, MVD; Konnai, S; Ohashi, K; Calixto, C; Arcanjo, A; de Abreu, LA; Vaz, ID; de Carvalho, SS; Logullo, C				Noce, Baerbara Della; da Silva, Renato Martins; Uhl, Marcelle Vianna de Carvalho; Konnai, Satoru; Ohashi, Kazuhiko; Calixto, Christiano; Arcanjo, Angelica; de Abreu, Leonardo Araujo; Vaz Jr, Itabajara da Silva; de Carvalho, Stephani Serafim; Logullo, Carlos			Redox imbalance induces remodeling of glucose metabolism in Rhipicephalus microplus embryonic cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOOPHILUS MICROPLUS; OXIDATIVE STRESS; HARD TICK; CANCER; DROSOPHILA; GROWTH; PROTEINASE; INSULIN; MODEL; GLUCONEOGENESIS	Carbohydrate metabolism not only functions in supplying cellular energy but also has an important role in maintaining physiological homeostasis and in preventing oxidative damage caused by reactive oxygen species. Previously, we showed that arthropod embryonic cell lines have high tolerance to H2O2 exposure. Here, we describe that Rhipicephalus microplus tick embryonic cell line (BME26) employs an adaptive glucose metabolism mechanism that confers tolerance to hydrogen peroxide at concentrations too high for other organisms. This adaptive mechanism sustained by glucose metabolism remodeling promotes cell survival and redox balance in BME26 cell line after millimolar H2O2 exposure. The present work shows that this tick cell line could tolerate high H2O2 concentrations by initiating a carbohydrate-related adaptive response. We demonstrate that gluconeogenesis was induced as a compensation strategy that involved, among other molecules, the metabolic enzymes NADP-ICDH, G6PDH, and PEPCK. We also found that this phenomenon was coupled to glycogen accumulation and glucose uptake, supporting the pentose phosphate pathway to sustain NADPH production and leading to cell survival and proliferation. Our findings suggest that the described response is not atypical, being also observed in cancer cells, which highlights the importance of this model to all proliferative cells. We propose that these results will be useful in generating basic biological information to support the development of new strategies for disease treatment and parasite control.	[Noce, Baerbara Della; da Silva, Renato Martins; Uhl, Marcelle Vianna de Carvalho; Calixto, Christiano; Arcanjo, Angelica; de Abreu, Leonardo Araujo; de Carvalho, Stephani Serafim; Logullo, Carlos] NUPEM UFRJ, Rio Janeiro & Lab Integrado Bioquim Hatisaburo Ma, IBqM UFRJ, Lab Bioquim Artropodes Hematofagos, Macae, RJ, Brazil; [Noce, Baerbara Della; da Silva, Renato Martins; Uhl, Marcelle Vianna de Carvalho; Calixto, Christiano; Arcanjo, Angelica; de Abreu, Leonardo Araujo; Vaz Jr, Itabajara da Silva; de Carvalho, Stephani Serafim; Logullo, Carlos] Inst Nacl Ciencia & Tecnol Entomol Mol, IBqM UFRJ, Rio De Janeiro, RJ, Brazil; [Konnai, Satoru; Ohashi, Kazuhiko] Hokkaido Univ, Lab Infect Dis, Sapporo, Japan; [Vaz Jr, Itabajara da Silva] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RJ, Brazil; [Vaz Jr, Itabajara da Silva] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RJ, Brazil	Hokkaido University; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Logullo, C (corresponding author), NUPEM UFRJ, Rio Janeiro & Lab Integrado Bioquim Hatisaburo Ma, IBqM UFRJ, Lab Bioquim Artropodes Hematofagos, Macae, RJ, Brazil.; Logullo, C (corresponding author), Inst Nacl Ciencia & Tecnol Entomol Mol, IBqM UFRJ, Rio De Janeiro, RJ, Brazil.	carlos.logullo@bioqmed.ufrj.br	Silva Vaz Jr., Itabajara/A-5943-2009	Silva Vaz Jr., Itabajara/0000-0003-0309-9328; Satoru, Konnai/0000-0002-3230-7109; Serafim de Carvalho, Stephanie/0000-0002-0790-899X	Coordenaco de Aperfeicoamento de Pessoal de Nivel Superior-Brazil [001]; CNPq-Instituto Nacional de Ciencia e Tecnologia de Entomologia Molecular; FAPERJ	Coordenaco de Aperfeicoamento de Pessoal de Nivel Superior-Brazil; CNPq-Instituto Nacional de Ciencia e Tecnologia de Entomologia Molecular; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors are grateful to Brazilian agencies for supporting this project. This study was funded in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES) -Finance Code 001, CNPq-Instituto Nacional de Ciencia e Tecnologia de Entomologia Molecular and FAPERJ.	Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985; BRAND K, 1986, IMMUNOBIOLOGY, V173, P23, DOI 10.1016/S0171-2985(86)80086-9; Cadena-Herrera Daniela, 2015, Biotechnol Rep (Amst), V7, P9, DOI 10.1016/j.btre.2015.04.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carvalho-Santos Z, 2020, NAT METAB, V2, P958, DOI 10.1038/s42255-020-0266-x; Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; da Silva RM, 2015, INT J MOL SCI, V16, P1821, DOI 10.3390/ijms16011821; Das R., 2015, PLOS ONE, V9; de Abreu LA, 2013, BBA-GEN SUBJECTS, V1830, P2574, DOI 10.1016/j.bbagen.2012.12.016; de Abreu LA, 2009, COMP BIOCHEM PHYS B, V153, P185, DOI 10.1016/j.cbpb.2009.02.016; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Della Noce B., 2019, SCI REP-UK, V9, P1; Devilliers M., 2019, BIORXIV, DOI [10.1101/606699, DOI 10.1101/606699]; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esteves E., 2009, VET; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; EXTON JH, 1967, J BIOL CHEM, V242, P2622; Fabres A, 2010, PARASITOLOGY, V137, P1537, DOI 10.1017/S0031182010000284; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P217, DOI 10.1002/arch.940140403; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; GUTZEIT HO, 1994, EUR J CELL BIOL, V63, P52; GUTZEIT HO, 1993, ROUX ARCH DEV BIOL, V202, P181, DOI 10.1007/BF00365309; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Hambarde S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058261; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herranz H, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040015; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kumar JS, 2012, MOL CELL BIOCHEM, V367, P141, DOI 10.1007/s11010-012-1327-6; LAMBERS H, 1983, PHYSIOL PLANTARUM, V58, P556, DOI 10.1111/j.1399-3054.1983.tb05742.x; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Logullo C, 1998, PARASITOLOGY, V116, P525, DOI 10.1017/S0031182098002698; Logullo C, 2009, VET PARASITOL, V161, P261, DOI 10.1016/j.vetpar.2009.01.029; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Molinaro A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68721-9; Monge-Fuentes V, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0031-x; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pakpour N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076535; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perillo B, 2020, EXP MOL MED, V52, P192, DOI 10.1038/s12276-020-0384-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl PC, 2014, VET PARASITOL, V204, P316, DOI 10.1016/j.vetpar.2014.05.042; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Ren SX, 2018, J CELL BIOL, V217, P517, DOI 10.1083/jcb.201706027; Rzezniczak TZ, 2012, G3-GENES GENOM GENET, V2, P1613, DOI 10.1534/g3.112.003715; Salvemini D, 2002, FREE RADICAL BIO MED, V33, P1173, DOI 10.1016/S0891-5849(02)00961-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takahashi N., 2018, CANC CELL 33; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thompson MB, 1997, COMP BIOCHEM PHYS A, V118, P647, DOI 10.1016/S0300-9629(97)00081-9; Vleck C.M., 1991, P285, DOI 10.1017/CBO9780511585739.019; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; YAMAMOTO Y, 1993, COMP BIOCHEM PHYS B, V106, P35, DOI 10.1016/0305-0491(93)90004-O; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	74	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101599	10.1016/j.jbc.2022.101599	http://dx.doi.org/10.1016/j.jbc.2022.101599			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35063504	Green Published, gold			2022-12-28	WOS:000791267400001
J	Shandell, MA; Capatina, AL; Lawrence, SM; Brackenbury, WJ; Lagos, D				Shandell, Mia A.; Capatina, Alina L.; Lawrence, Samantha M.; Brackenbury, William J.; Lagos, Dimitris			Inhibition of the Na+/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE JAK1; INTERFERON-GAMMA; ION CHANNELS; INDOLEAMINE 2,3-DIOXYGENASE; K+-ATPASE; CRYSTAL-STRUCTURE; SODIUM-PUMP; OUABAIN	Despite extensive basic and clinical research on immune checkpoint regulatory pathways, little is known about the effects of the ionic tumor microenvironment on immune check-point expression and function. Here we describe a mechanistic link between Na+/K+-ATPase (NKA) inhibition and activity of the immune checkpoint protein indoleamine-pyrrole 2',3'-dioxygenase 1 (IDO1). We found that IDO1 was necessary and sufficient for production of kynurenine, a downstream tryptophan metabolite, in cancer cells. We developed a spectrophotometric assay to screen a library of 31 model ion transport-targeting compounds for potential effects on IDO1 function in A549 lung and MDA-MB-231 breast cancer cells. This revealed that the cardiac glycosides ouabain and digoxin inhibited kynurenine production at concentrations that did not affect cell survival. NKA inhibition by ouabain and digoxin resulted in increased intracellular Na+ levels and down-regulation of IDO1 mRNA and protein levels, which was consistent with the reduction in kynurenine levels. Knockdown of ATP1A1, the alpha 1 subunit of the NKA and target of cardiac glycosides, increased Na+ levels to a lesser extent than cardiac glycoside treatment and did not affect IDO1 expression. However, ATP1A1 knockdown significantly enhanced the effect of cardiac glycosides on IDO1 expression and kynurenine production. Mechanistically, we show that cardiac glycoside treatment resulted in curtailing the length of phosphorylation-mediated stabilization of STAT1, a transcriptional regulator of IDO1 expression, an effect enhanced by ATP1A1 knockdown. Our findings reveal cross talk between ionic modulation via cardiac glycosides and immune checkpoint protein expression in cancer cells with broad mechanistic and clinical implications.	[Shandell, Mia A.; Capatina, Alina L.; Lawrence, Samantha M.; Brackenbury, William J.] Univ York, Dept Biol, York, N Yorkshire, England; [Shandell, Mia A.; Lagos, Dimitris] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Shandell, Mia A.; Capatina, Alina L.; Brackenbury, William J.; Lagos, Dimitris] Univ York, York Biomed Res Inst, York, N Yorkshire, England; [Lawrence, Samantha M.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Lawrence, Samantha M.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England	University of York - UK; University of Hull; University of York - UK; University of York - UK; University of Leeds; University of Leeds	Lagos, D (corresponding author), Univ York, Hull York Med Sch, York, N Yorkshire, England.; Lagos, D (corresponding author), Univ York, York Biomed Res Inst, York, N Yorkshire, England.	dimitris.lagos@york.ac.uk	; Brackenbury, William/D-8029-2014	Shandell, Mia/0000-0002-7864-758X; Brackenbury, William/0000-0001-6882-3351	MRC Confidence in Concept Award [MC/PC/16064]; BBSRC [BB/J014443/1]; Wellcome Trust Institutional Strategic Support Fund through the Centre for Future Health at the University of York [WT204829]	MRC Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Institutional Strategic Support Fund through the Centre for Future Health at the University of York(Wellcome Trust)	This work was supported by an MRC Confidence in Concept Award (MC/PC/16064; managed by the University of York) to D. L. and W. J. B. M. A. S. was funded by an MRC Confidence in Concept Award (MC/PC/16064; managed by University of York). A. L. C. is funded by the BBSRC White Rose doctoral training partnership (BB/J014443/1). S. M. L. was supported by a Wellcome Trust Institutional Strategic Support Fund Grant (WT204829) through the Centre for Future Health at the University of York.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; AlberatiGiani D, 1996, J NEUROCHEM, V66, P996; Aperia A, 2016, AM J PHYSIOL-CELL PH, V310, pC491, DOI 10.1152/ajpcell.00359.2015; Askari A, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.505; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Balzan S, 2000, LIFE SCI, V67, P1921, DOI 10.1016/S0024-3205(00)00779-7; Banerjee M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29995-2; Banzola I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01051; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Blair AB, 2019, J CLIN INVEST, V129, P1742, DOI 10.1172/JCI124077; Brackenbury WJ, 2016, PERSP TRANS CELL BIO, P131, DOI 10.1016/B978-0-12-802002-9.00006-6; Campbell TM, 2013, J CELL SCI, V126, P4939, DOI 10.1242/jcs.130013; Capatina Alina L, 2022, Rev Physiol Biochem Pharmacol, V183, P1, DOI 10.1007/112_2020_46; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Clausen MV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00371; Clifford RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084306; D Basu G, 2006, J IMMUNOL, V177, P2391, DOI 10.4049/jimmunol.177.4.2391; Djamgoz MBA, 2019, CANCERS, V11, DOI 10.3390/cancers11111675; DORNAND J, 1986, IMMUNOBIOLOGY, V171, P436, DOI 10.1016/S0171-2985(86)80075-4; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Gable ME, 2014, BIOCHEM BIOPH RES CO, V446, P1151, DOI 10.1016/j.bbrc.2014.03.071; Galindo CA, 2004, NEUROCHEM RES, V29, P659, DOI 10.1023/B:NERE.0000018836.82122.23; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p; Humeau J, 2018, CELL CALCIUM, V70, P3, DOI 10.1016/j.ceca.2017.07.006; Iamshanova O, 2016, EUR BIOPHYS J BIOPHY, V45, P765, DOI 10.1007/s00249-016-1173-7; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Karitskaya I, 2010, PFLUG ARCH EUR J PHY, V460, P777, DOI 10.1007/s00424-010-0843-z; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee SY, 2009, J IMMUNOTHER, V32, P22, DOI 10.1097/CJI.0b013e31818ac2f7; Leslie TK, 2019, BBA-REV CANCER, V1872, DOI 10.1016/j.bbcan.2019.07.001; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu J, 2000, J BIOL CHEM, V275, P27838; Mailankot M, 2010, INT J BIOCHEM CELL B, V42, P1446, DOI 10.1016/j.biocel.2010.04.014; Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mohammed FH, 2016, INT J ONCOL, V48, P73, DOI 10.3892/ijo.2015.3239; Moretti S, 2017, J BIOL CHEM, V292, P1785, DOI 10.1074/jbc.M116.745448; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mycielska ME, 2005, J PHYSIOL-LONDON, V563, P393, DOI 10.1113/jphysiol.2004.079491; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; Nie Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61920-4; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Ouwerkerk R, 2007, BREAST CANCER RES TR, V106, P151, DOI 10.1007/s10549-006-9485-4; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Popov S, 2012, AM J PHYSIOL-HEART C, V303, pH57, DOI 10.1152/ajpheart.00512.2011; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Prevarskaya N, 2018, PHYSIOL REV, V98, P559, DOI 10.1152/physrev.00044.2016; REDONDO JM, 1986, FEBS LETT, V206, P199, DOI 10.1016/0014-5793(86)80980-2; Repke K R, 1993, Prog Med Chem, V30, P135, DOI 10.1016/S0079-6468(08)70377-1; Riess C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00055; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Sekine A, 2016, NEUROCHEM RES, V41, P2256, DOI 10.1007/s11064-016-1940-y; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Shen JJ, 2020, ACTA PHARMACOL SIN, V41, P110, DOI 10.1038/s41401-019-0290-0; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; SKRIVER E, 1981, FEBS LETT, V131, P219, DOI 10.1016/0014-5793(81)80371-7; SPECIALE C, 1989, J NEUROSCI, V9, P2066; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Venkateswaran N, 2019, GENE DEV, V33, P1236, DOI 10.1101/gad.327056.119; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Weigand KM, 2012, BBA-BIOMEMBRANES, V1818, P1269, DOI 10.1016/j.bbamem.2012.01.015; Wu J, 2013, BIOCHEMISTRY-US, V52, P9059, DOI 10.1021/bi4011804; Wu Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705750; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yang M, 2020, J CELL PHYSIOL, V235, P3950, DOI 10.1002/jcp.29290; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Yosef E, 2016, J BIOL CHEM, V291, P11736, DOI 10.1074/jbc.M116.721084; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00320; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; ZSNAGY I, 1981, J CELL BIOL, V90, P769, DOI 10.1083/jcb.90.3.769; Zuo YB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14948-z	96	4	4	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101707	10.1016/j.jbc.2022.101707	http://dx.doi.org/10.1016/j.jbc.2022.101707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150740	gold, Green Published, Green Accepted			2022-12-28	WOS:000821054100007
J	Tooker, BC; Kandel, SE; Work, HM; Lampe, JN				Tooker, Brian C.; Kandel, Sylvie E.; Work, Hannah M.; Lampe, Jed N.			Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CYSTIC-FIBROSIS; HETEROTROPIC COOPERATIVITY; SUBSTRATE-INHIBITION; STRUCTURAL BASIS; HOMOTROPIC COOPERATIVITY; CHOLESTEROL CATABOLISM; MIDAZOLAM METABOLISM; BIOFILM FORMATION; PROVIDES INSIGHT	Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen that is highly prevalent in individuals with cystic fibrosis (CF). A major problem in treating CF patients infected with P. aeruginosa is the development of antibiotic resistance. Therefore, the identification of novel P. aeruginosa antibiotic drug targets is of the utmost urgency. The genome of P. aeruginosa contains four putative cytochrome P450 enzymes (CYPs) of unknown function that have never before been characterized. Analogous to some of the CYPs from Mycobacterium tuberculosis, these P. aeruginosa CYPs may be important for growth and colonization of CF patients' lungs. In this study, we cloned, expressed, and characterized CYP168A1 from P. aeruginosa and identified it as a subterminal fatty acid hydroxylase. Spectral binding data and computational modeling of substrates and inhibitors suggest that CYP168A1 has a large, expansive active site and preferentially binds long chain fatty acids and large hydrophobic inhibitors. Furthermore, metabolic experiments confirm that the enzyme is capable of hydroxylating arachidonic acid, an important inflammatory signaling molecule present in abundance in the CF lung, to 19-hydroxyeicosatetraenoic acid (19-HETE; K-m = 41 mu M, V-max = 220 pmol/min/nmol P450), a potent vasodilator, which may play a role in the pathogen's ability to colonize the lung. Additionally, we found that the in vitro metabolism of arachidonic acid is subject to substrate inhibition and is also inhibited by the presence of the antifungal agent ketoconazole. This study identifies a new metabolic pathway in this important human pathogen that may be of utility in treating P. aeruginosa infections.	[Tooker, Brian C.; Kandel, Sylvie E.; Work, Hannah M.; Lampe, Jed N.] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Lampe, JN (corresponding author), Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	jed.lampe@cuanschutz.edu		Tooker, Brian/0000-0002-0018-3658; Kandel, Sylvie/0000-0002-8059-8035; Lampe, Jed/0000-0003-0794-2263	University of Colorado; Skaggs School of Pharmacy; 2021-22 Skaggs Scholar Award	University of Colorado; Skaggs School of Pharmacy; 2021-22 Skaggs Scholar Award	We would like to gratefully acknowledge Michael Armstrong of the CU Skaggs School of Pharmacy and Pharmaceutical Sciences Mass Spectroscopy facility for assistance provided in confirming the CYP168A1 lauric acid metabolites. The research described in this manuscript was generously funded through a University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences Faculty Start-up Package and the 2021-22 Skaggs Scholar Award.	Adris P, 2007, TOXICOL IN VITRO, V21, P1663, DOI 10.1016/j.tiv.2007.07.009; Alvarez-Alvarez R, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0373-7; Auvin S, 2005, PEDIATR RES, V58, P211, DOI 10.1203/01.PDR.0000169979.27641.40; Tooker BC, 2021, bioRxiv, DOI 10.1101/2021.10.19.465045; Baker LY, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1259-8; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Berry SB, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00537; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; Bukhdruker S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207683; BURET A, 1993, AM REV RESPIR DIS, V148, P793, DOI 10.1164/ajrccm/148.3.793; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; CARLSTEDTDUKE J, 1986, P NATL ACAD SCI USA, V83, P9202, DOI 10.1073/pnas.83.23.9202; Carroll MA, 1996, AM J PHYSIOL-REG I, V271, pR863, DOI 10.1152/ajpregu.1996.271.4.R863; Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234; Child SA, 2020, J INORG BIOCHEM, V209, DOI 10.1016/j.jinorgbio.2020.111116; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ESCALANTE B, 1988, BIOCHEM BIOPH RES CO, V152, P1269, DOI 10.1016/S0006-291X(88)80422-4; Faure E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02416; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Flitter BA, 2017, P NATL ACAD SCI USA, V114, P136, DOI 10.1073/pnas.1610242114; Follmer AH, 2018, J AM CHEM SOC, V140, P16222, DOI 10.1021/jacs.8b09441; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Ghorbani P, 2015, EUR RESPIR J, V46, P1033, DOI 10.1183/09031936.00143614; GONVINDARAJ S, 1994, BIOCHEM BIOPH RES CO, V203, P1745, DOI 10.1006/bbrc.1994.2388; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang L, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.00826-21; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Kandel S, 2005, J BIOL CHEM, V280, P35881, DOI 10.1074/jbc.M500918200; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Kim V, 2020, ARCH BIOCHEM BIOPHYS, V692, DOI 10.1016/j.abb.2020.108544; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; LEVISTRE R, 1993, BIOCHIM BIOPHYS ACTA, V1181, P233, DOI 10.1016/0925-4439(93)90026-W; Li JH, 2021, J CHEM INF MODEL, V61, P2418, DOI 10.1021/acs.jcim.1c00266; Li YP, 2020, J APPL MICROBIOL, V128, P151, DOI 10.1111/jam.14470; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105506; Lund-Palau H, 2016, EXPERT REV RESP MED, V10, P685, DOI 10.1080/17476348.2016.1177460; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Malwal SR, 2021, ACS INFECT DIS, V7, P2492, DOI 10.1021/acsinfecdis.1c00259; McDonald MG, 2017, DRUG METAB DISPOS, V45, P1364, DOI 10.1124/dmd.117.078188; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; Montero M, 2010, EUR J CLIN MICROBIOL, V29, P335, DOI 10.1007/s10096-009-0850-1; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Muller CS, 2015, BIOCHEMISTRY-US, V54, P711, DOI 10.1021/bi5011656; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Nelson David R., 2009, Human Genomics, V4, P59; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Patteson JB, 2018, BIOCHEMISTRY-US, V57, P61, DOI 10.1021/acs.biochem.7b00943; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Portet S, 2020, INFECT DIS MODEL, V5, P111, DOI 10.1016/j.idm.2019.12.010; Powell WS, 2015, BBA-MOL CELL BIOL L, V1851, P340, DOI 10.1016/j.bbalip.2014.10.008; Puchkaev AV, 2002, J AM CHEM SOC, V124, P12682, DOI 10.1021/ja0282036; Qhanya LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142100; Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200; Ranasinghe C, 1998, INSECT BIOCHEM MOLEC, V28, P571, DOI 10.1016/S0965-1748(98)00045-9; Rao J, 2011, CELL IMMUNOL, V270, P95, DOI 10.1016/j.cellimm.2011.04.011; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Roberts AG, 2016, BBA-GEN SUBJECTS, V1860, P669, DOI 10.1016/j.bbagen.2015.12.014; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P10804, DOI 10.1021/bi200924t; Roussel F, 2000, ARCH BIOCHEM BIOPHYS, V374, P269, DOI 10.1006/abbi.1999.1599; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schultz ANO, 2017, PEDIATR PULM, V52, P319, DOI 10.1002/ppul.23638; Scotet V, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060589; Shoieb SM, 2019, CHEM-BIOL INTERACT, V299, P140, DOI 10.1016/j.cbi.2018.12.004; Shoieb SM, 2018, DRUG METAB DISPOS, V46, P1157, DOI 10.1124/dmd.118.082073; SORRELL TC, 1992, INFECT IMMUN, V60, P1779, DOI 10.1128/IAI.60.5.1779-1785.1992; Stein SE., 1990, NATL I STANDARDS TEC; Stockli M, 2019, MOL MICROBIOL, V112, P605, DOI 10.1111/mmi.14277; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Strohmaier SJ, 2020, DRUG METAB DISPOS, V48, P432, DOI 10.1124/dmd.120.090555; Sun YX, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.618265; Thornton JM, 2021, PROSTAG OTH LIPID M, V152, DOI 10.1016/j.prostaglandins.2020.106505; Tooker B. C, 2021, FASEB J, V35, P2588; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tunaru S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163633; Ugalde SO, 2019, APPL MICROBIOL BIOT, V103, P3597, DOI 10.1007/s00253-019-09697-z; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Vugt-Lussenburg BMA, 2006, BIOCHEM BIOPH RES CO, V346, P810, DOI 10.1016/j.bbrc.2006.05.179; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; White J.R., 2020, MED MICROECOL, V4, P100005, DOI [10.1016/j.medmic.2020.100005, DOI 10.1016/J.MEDMIC.2020.100005]; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wilson M. G, 2021, STATPEARLS, P201; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winstanley C, 2016, TRENDS MICROBIOL, V24, P327, DOI 10.1016/j.tim.2016.01.008; Wlodarczyk A, 2016, METAB ENG, V33, P1, DOI 10.1016/j.ymben.2015.10.009; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Yaghi A, 2001, J PHARMACOL EXP THER, V297, P479; Yamazaki H, 2013, CHEM RES TOXICOL, V26, P486, DOI 10.1021/tx400008g; Yasutake Y, 2010, J BIOL CHEM, V285, P31193, DOI 10.1074/jbc.M110.147009; Yoshino M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1082-8; Zhou SS, 2019, ACS CHEM BIOL, V14, P1305, DOI 10.1021/acschembio.9b00270; ZURIER RB, 1993, PROSTAG LEUKOTR ESS, V48, P57, DOI 10.1016/0952-3278(93)90010-T	118	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101629	10.1016/j.jbc.2022.101629	http://dx.doi.org/10.1016/j.jbc.2022.101629			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085556	gold, Green Published			2022-12-28	WOS:000821051800011
J	Agajanian, MJ; Potjewyd, FM; Bowman, BM; Solomon, S; LaPak, KM; Bhatt, DP; Smith, JL; Goldfarb, D; Axtman, AD; Major, MB				Agajanian, Megan J.; Potjewyd, Frances M.; Bowman, Brittany M.; Solomon, Smaranda; LaPak, Kyle M.; Bhatt, Dhaval P.; Smith, Jeffery L.; Goldfarb, Dennis; Axtman, Alison D.; Major, Michael B.			Protein proximity networks and functional evaluation of the casein kinase 1 gamma family reveal unique roles for CK1?3 in WNT signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED REGIONS; PHOSPHORYLATION; LRP6; INHIBITION; ACTIVATION; REDUNDANCY; ELEMENTS; DOMAIN; CELLS; AXIN	Aberrant activation or suppression of WNT/beta-catenin signaling contributes to cancer initiation and progression, neurodegeneration, and bone disease. However, despite great need and more than 40 years of research, targeted therapies for the WNT pathway have yet to be fully realized. Kinases are considered exceptionally druggable and occupy key nodes within the WNT signaling network, but several pathway relevant kinases remain understudied and "dark. " Here, we studied the function of the casein kinase 1 gamma (CSNK1 gamma) subfamily of human kinases and their roles in WNT signaling. miniTurbo-based proximity biotinylation and mass spectrometry analysis of CSNK1 gamma 1, CSNK1 gamma 2, and CSNK1 gamma 3 revealed numerous components of the beta-catenin-dependent and beta-catenin-independent WNT pathways. In gain-of function experiments, we found that CSNK1 gamma 3 but not CSNK1 gamma 1 or CSNK1 gamma 2 activated beta-catenin-dependent WNT signaling, with minimal effect on other signaling pathways. We also show that within the family, CSNK1 gamma 3 expression uniquely induced low-density lipoprotein receptor-related protein 6 phosphorylation, which mediates downstream WNT signaling transduction. Conversely, siRNA-mediated silencing of CSNK1 gamma 3 alone had no impact on WNT signaling, though cosilencing of all three family members decreased WNT pathway activity. Finally, we characterized two moderately selective and potent small-molecule inhibitors of the CSNK1 gamma family. We show that these inhibitors and a CSNK1 gamma 3 kinase- dead mutant suppressed but did not eliminate WNT-driven low-density lipoprotein receptor-related protein 6 phosphorylation and beta-catenin stabilization. Our data suggest that while CSNK1 gamma 3 expression uniquely drives pathway activity, potential functional redundancy within the family necessitates loss of all three family members to suppress the WNT signaling pathway.	[Agajanian, Megan J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Agajanian, Megan J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Agajanian, Megan J.; Bowman, Brittany M.; LaPak, Kyle M.; Bhatt, Dhaval P.; Goldfarb, Dennis; Major, Michael B.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Potjewyd, Frances M.; Smith, Jeffery L.; Axtman, Alison D.] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Solomon, Smaranda; Goldfarb, Dennis] Washington Univ, Sch Med, Inst Informat, St Louis, MO USA; [Major, Michael B.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Agajanian, Megan J.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Bowman, Brittany M.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Stanford University; University of Michigan System; University of Michigan	Major, MB (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Major, MB (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	bmajor@wustl.edu		Major, Michael/0000-0002-6753-8513; Solomon, Smaranda/0000-0003-1071-5360; Potjewyd, Frances/0000-0003-4241-9873; Smith, Jeffery L/0000-0003-2189-0420	HHMI Gilliam Fellowship; National Institutes of Health (NIH) National Cancer Institute Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Fellowship) [5F99CA245724-02]; NIH Illuminating the Druggable Genome Program [U24DK116204]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Genentech; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD); Janssen; Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer [115766]; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome; NC Biotechnology Center Institutional Support Grant; NIH;  [106169/ZZ14/Z];  [2018-IDG-1030];  [U54AG065187]	HHMI Gilliam Fellowship; National Institutes of Health (NIH) National Cancer Institute Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Fellowship); NIH Illuminating the Druggable Genome Program; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Genentech(Roche HoldingGenentech); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome; NC Biotechnology Center Institutional Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; 	M. J. A. was funded by HHMI Gilliam Fellowship and the National Institutes of Health (NIH) National Cancer Institute Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Fellowship [5F99CA245724-02] ) . This work was supported in part by a grant from the NIH Illuminating the Druggable Genome Program (U24DK116204) . The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Genentech, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant no. 115766) , Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome (106169/ZZ14/Z) . Research reported in this publication was supported in part by the NC Biotechnology Center Institutional Support Grant 2018-IDG-1030, and NIH U54AG065187. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agajanian MJ, 2019, CELL REP, V26, P79, DOI 10.1016/j.celrep.2018.12.023; Akritopoulou-Zanze I., 2007, US patent, Patent No. [US-9163007-B2, 9163007]; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Babu MM, 2016, BIOCHEM SOC T, V44, P1185, DOI 10.1042/BST20160172; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Berginski ME, 2021, NUCLEIC ACIDS RES, V49, pD529, DOI 10.1093/nar/gkaa853; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bosc N, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1413-y; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Chandrasekharan B, 2021, BIOCHEM BIOPH RES CO, V534, P720, DOI 10.1016/j.bbrc.2020.11.011; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; Cruciat CM, 2014, CURR OPIN CELL BIOL, V31, P46, DOI 10.1016/j.ceb.2014.08.003; Daly CS, 2017, ONCOGENE, V36, P1793, DOI 10.1038/onc.2016.342; Daulat AM, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800487; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; del Valle-Perez B, 2011, MOL CELL BIOL, V31, P2877, DOI 10.1128/MCB.01466-10; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Du CX, 2021, FUTURE MED CHEM, V13, P505, DOI 10.4155/fmc-2020-0215; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Huang HB, 2012, ACS MED CHEM LETT, V3, P1059, DOI 10.1021/ml300278f; Huang JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40716; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kelly LK, 2016, CELL REP, V16, P344, DOI 10.1016/j.celrep.2016.06.010; Lebensohn AM, 2016, ELIFE, V5, DOI 10.7554/eLife.21459; Lee SY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2146-4; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li DR, 2020, ELIFE, V9, DOI 10.7554/eLife.61564; Li S., 2020, J CELL BIOL, V219; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Madan B, 2016, P NATL ACAD SCI USA, V113, pE2945, DOI 10.1073/pnas.1605691113; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Strassburger K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0198149; Swarup S, 2015, DEVELOPMENT, V142, P1502, DOI 10.1242/dev.116715; Tamir TY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.241356; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010; Walker MP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005654; Wall VE, 2014, METHODS MOL BIOL, V1116, P193, DOI 10.1007/978-1-62703-764-8_14; Wang LM, 2009, MOL ENDOCRINOL, V23, P1455, DOI 10.1210/me.2009-0084; Wang YT, 2014, J IMMUNOL, V192, P1855, DOI 10.4049/jimmunol.1302552; Wells C, 2020, ACS MED CHEM LETT, V11, P340, DOI 10.1021/acsmedchemlett.9b00399; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	75	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101986	10.1016/j.jbc.2022.101986	http://dx.doi.org/10.1016/j.jbc.2022.101986			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35487243	Green Published, Green Submitted, gold			2022-12-28	WOS:000807778400006
J	Ferreira, JC; Fadl, S; Rabeh, WM				Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.			Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; INDUCED DIMERIZATION; 3C-LIKE PROTEINASE; M-PRO; SARS; INHIBITOR; MECHANISM; DESIGN	3C-like protease (3CLpro) processes and liberates functional viral proteins essential for the maturation and infectivity of severe acute respiratory syndrome coronavirus 2, the virus responsible for COVID-19. It has been suggested that 3CLpro is catalytically active as a dimer, making the dimerization interface a target for antiviral development. Guided by structural analysis, here we introduced single amino acid substitutions at nine residues at three key sites of the dimer interface to assess their impact on dimerization and activity. We show that at site 1, alanine substitution of S1 or E166 increased by twofold or reduced relative activity, respectively. At site 2, alanine substitution of S10 or E14 eliminated activity, whereas K12A exhibited similar to 60% relative activity. At site 3, alanine substitution of R4, E290, or Q299 eliminated activity, whereas S139A exhibited 46% relative activity. We further found that the oligomerization states of the dimer interface mutants varied; the inactive mutants R4A, R4Q, S10A/C, E14A/ D/Q/S, E290A, and Q299A/E were present as dimers, demonstrating that dimerization is not an indication of catalytically active 3CLpro. In addition, present mostly as monomers, K12A displayed residual activity, which could be attributed to the conspicuous amount of dimer present. Finally, differential scanning calorimetry did not reveal a direct relationship between the thermodynamic stability of mutants with oligomerization or catalytic activity. These results provide insights on two allosteric sites, R4/E290 and S10/E14, that may promote the design of antiviral compounds that target the dimer interface rather than the active site of severe acute respiratory syndrome coronavirus 2 3CLpro.	[Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates		Rabeh, WM (corresponding author), New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates.	wael.rabeh@nyu.edu		rabeh, wael/0000-0001-6071-8581	New York University Abu Dhabi [ADC05]	New York University Abu Dhabi	This work was supported by New York University Abu Dhabi through research funds to the laboratory of Prof Rabeh in addition to the COVID-19 Facilitator Research Fund (grant number: ADC05) . This research was partially carried out using the Core Technology Platforms resources at New York University Abu Dhabi.	A. A.Golosov, 2020, bioRxiv, DOI 10.1101/2020.09.07.286344; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Aggarwal M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14753; Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Barrila J, 2010, BIOCHEMISTRY-US, V49, P4308, DOI 10.1021/bi1002585; Chang GG, 2010, MOLECULAR BIOLOGY OF THE SARS-CORONAVIRUS, P115, DOI 10.1007/978-3-642-03683-5_8; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chen S, 2008, J BIOCHEM, V143, P525, DOI 10.1093/jb/mvm246; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Douangamath A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18709-w; El-Baba TJ, 2020, ANGEW CHEM INT EDIT, V59, P23544, DOI 10.1002/anie.202010316; Ferreira GM, 2021, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2021.1970626; Ferreira JC, 2021, FASEB J, V35, DOI 10.1096/fj.202100994; Ferreira JC, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.692168; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Ho BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144865; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12; Kumar R, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00505-20; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Li QX, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081250; Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941; Lin PY, 2008, ARCH BIOCHEM BIOPHYS, V472, P34, DOI 10.1016/j.abb.2008.01.023; McCartney CSE, 2019, METHODS MOL BIOL, V1915, P39, DOI 10.1007/978-1-4939-8988-1_4; Nawaz MH, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171666; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Rabaan Ali A, 2020, Infez Med, V28, P174; Ramos-Guzman CA, 2021, ACS CATAL, V11, P4157, DOI 10.1021/acscatal.0c05522; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Simon L, 2010, J ORG CHEM, V75, P1831, DOI 10.1021/jo901503d; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Su HX, 2020, ACTA PHARMACOL SIN, V41, P1167, DOI 10.1038/s41401-020-0483-6; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Vuong W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18096-2; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Xia B, 2011, PROTEIN CELL, V2, P282, DOI 10.1007/s13238-011-1034-1; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07	58	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102023	10.1016/j.jbc.2022.102023	http://dx.doi.org/10.1016/j.jbc.2022.102023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35568197	gold, Green Published			2022-12-28	WOS:000829588600014
J	Krakovka, S; Ranjbarian, F; Lujan, LA; Saura, A; Larsen, NB; Jimenez-Gonzalez, A; Reggenti, A; Lujan, HD; Svard, SG; Hofer, A				Krakovka, Sascha; Ranjbarian, Farahnaz; Lujan, Lucas A.; Saura, Alicia; Larsen, Nicolai B.; Jimenez-Gonzalez, Alejandro; Reggenti, Anna; Lujan, Hugo D.; Svard, Staffan G.; Hofer, Anders			Giardia intestinalis thymidine kinase is a high-affinity enzyme crucial for DNA synthesis and an exploitable target for drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFRACTORY GIARDIASIS; ANTIGENIC VARIATION; METRONIDAZOLE; SALVAGE; PHARMACOKINETICS; ZIDOVUDINE; RESISTANCE; DIFFERENTIATION; LAMBLIA; PROTEIN	Giardiasis is a diarrheal disease caused by the unicellular parasite Giardia intestinalis, for which metronidazole is the main treatment option. The parasite is dependent on exogenous deoxyribonucleosides for DNA replication and thus is also potentially vulnerable to deoxyribonucleoside analogs. Here, we characterized the G. intestinalis thymidine kinase, a divergent member of the thymidine kinase 1 family that consists of two weakly homologous parts within one polypeptide. We found that the recombinantly expressed enzyme is monomeric, with 100-fold higher catalytic efficiency for thymidine compared to its second-best substrate, deoxyuridine, and is furthermore subject to feedback inhibition by dTTP. This efficient substrate discrimination is in line with the lack of thymidylate synthase and dUTPase in the parasite, which makes deoxy-UMP a dead-end product that is potentially harmful if converted to deoxy-UTP. We also found that the antiretroviral drug azidothymidine (AZT) was an equally good substrate as thymidine and was active against WT as well as metronidazole-resistant G. intestinalis trophozoites. This drug inhibited DNA synthesis in the parasite and efficiently decreased cyst production in vitro, which suggests that it could reduce infectivity. AZT also showed a good effect in G. intestinalis-infected gerbils, reducing both the number of trophozoites in the small intestine and the number of viable cysts in the stool. Taken together, these results suggest that the absolute dependency of the parasite on thymidine kinase for its DNA synthesis can be exploited by AZT, which has promise as a future medication effective against metronidazole-refractory giardiasis.	[Krakovka, Sascha; Jimenez-Gonzalez, Alejandro; Svard, Staffan G.] Uppsala Univ, Dept Cell & Mol Biol, BMC, Uppsala, Sweden; [Ranjbarian, Farahnaz; Reggenti, Anna; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Lujan, Lucas A.; Saura, Alicia; Lujan, Hugo D.] Univ Catolica Cordoba UCC, Ctr Invest & Desarrollo Immunol & Enfermedades In, Consejo Nacl Invest Cient & Tecn CONICET, Cordoba, Argentina; [Larsen, Nicolai B.] Statens Serum Inst, Copenhagen S, Denmark	Uppsala University; Umea University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Statens Serum Institut	Svard, SG (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Uppsala, Sweden.; Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	staffan.svard@icm.uu.se; anders.hofer@umu.se		Krakovka, Sascha/0000-0002-4757-1551; Jimenez-Gonzalez, Alejandro/0000-0003-3493-4154; Larsen, Nicolai Balle/0000-0001-5105-7056; Lujan, Lucas Agustin/0000-0003-4235-4301	Swedish Research Council [2019-01242, 201805814]; Fondo Para la Investigacion Cientifica y Tecnologica, Argentina [PICT-13469, PICT-2703]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [D4408]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Fondo Para la Investigacion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Swedish Research Council (2019-01242 to A. H. and 201805814 to S. G. S.), Fondo Para la Investigacion Cientifica y Tecnologica, Argentina (PICT-13469 and PICT-2703 to H. D. L.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (D4408 to H. D. L.).	ALDRITT SM, 1985, J EXP MED, V161, P437, DOI 10.1084/jem.161.3.437; Bartelt Luther A, 2015, F1000Prime Rep, V7, P62, DOI 10.12703/P7-62; BAUM KF, 1989, J BIOL CHEM, V264, P21087; Canete R, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2019.12.017; Caron Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101420; Carter ER, 2018, CLIN MICROBIOL INFEC, V24, P37, DOI 10.1016/j.cmi.2017.05.028; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Eckhardt B.J., 2017, INFECT DIS-NOR, P1293; Einarsson E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/j.mib.2016.07.019; Einarsson E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004571; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; Goolsby TA, 2018, INT J ANTIMICROB AG, V51, P319, DOI 10.1016/j.ijantimicag.2017.08.033; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hausen MA, 2006, EXP PARASITOL, V113, P135, DOI 10.1016/j.exppara.2005.12.009; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hendrickx S, 2019, PARASITOL RES, V118, P2743, DOI 10.1007/s00436-019-06443-2; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim N, 2009, NATURE, V459, P1150, DOI 10.1038/nature08033; KLECKER RW, 1987, CLIN PHARMACOL THER, V41, P407, DOI 10.1038/clpt.1987.49; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LAOWORAWIT P, 1993, MOL BIOCHEM PARASIT, V60, P37, DOI 10.1016/0166-6851(93)90026-T; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; Morch K, 2008, J INFECTION, V56, P268, DOI 10.1016/j.jinf.2008.01.013; Muller J, 2018, INT J PARASITOL-DRUG, V8, P271, DOI 10.1016/j.ijpddr.2018.04.008; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; PEREZREYES E, 1980, MOL PHARMACOL, V17, P239; Peters TE, 2021, TRAVEL MED INFECT DI, V43, DOI 10.1016/j.tmaid.2021.102090; POSNER MR, 1992, CANCER, V70, P2929, DOI 10.1002/1097-0142(19921215)70:12<2929::AID-CNCR2820701233>3.0.CO;2-W; Poulin R, 2015, PARASITOLOGY, V142, pS6, DOI 10.1017/S0031182013001674; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; RALPH ED, 1974, ANTIMICROB AGENTS CH, V6, P691, DOI 10.1128/AAC.6.6.691; Ranjbarian F, 2022, NUCLEIC ACIDS RES, V50, DOI 10.1093/nar/gkab1117; Ranjbarian F, 2012, J BIOL CHEM, V287, P17628, DOI 10.1074/jbc.M112.340059; Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141; Bachur TPR, 2008, BRAZ J INFECT DIS, V12, P115, DOI 10.1590/S1413-86702008000200004; Rogawski ET, 2017, J PEDIATR INFECT DIS, V6, P153, DOI 10.1093/jpids/piw082; SCHUPP DG, 1987, J PARASITOL, V73, P723, DOI 10.2307/3282401; Serradell MC, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00773-17; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Shaima SN, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8121186; Sorensen CG, 2020, J NEUROL, V267, P1, DOI 10.1007/s00415-018-9147-6; Sperling R, 1998, Infect Dis Obstet Gynecol, V6, P197, DOI 10.1155/S1064744998000404; Tejman-Yarden N, 2011, ANTIMICROB AGENTS CH, V55, P4643, DOI 10.1128/AAC.00384-11; UPCROFT JA, 1993, PARASITOL TODAY, V9, P187, DOI 10.1016/0169-4758(93)90144-5; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; WANG CC, 1983, J EXP MED, V158, P1703, DOI 10.1084/jem.158.5.1703; Wattanagoon Y, 2000, ANTIMICROB AGENTS CH, V44, P1986, DOI 10.1128/AAC.44.7.1986-1989.2000; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102	56	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102028	10.1016/j.jbc.2022.102028	http://dx.doi.org/10.1016/j.jbc.2022.102028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35568200	Green Published, gold			2022-12-28	WOS:000811813400005
J	Ruszkiewicz, JA; Buerkle, A; Mangerich, A				Ruszkiewicz, Joanna A.; Buerkle, Alexander; Mangerich, Aswin			Fueling genome maintenance: On the versatile roles of NAD(+) in preserving DNA integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ETHYLNITROSOUREA-INDUCED CARCINOGENESIS; NICOTINAMIDE-ADENINE-DINUCLEOTIDE; INDUCED CHROMOSOMAL INSTABILITY; BONE-MARROW POLY(ADP-RIBOSE); NUCLEOTIDE EXCISION-REPAIR; DEPENDENT GENE-EXPRESSION; MEDIATED CELL-DEATH; ADP-RIBOSYLATION; HOMOLOGOUS RECOMBINATION; OXIDATIVE STRESS	NAD(+) is a versatile biomolecule acting as a master regulator and substrate in various cellular processes, including redox regulation, metabolism, and various signaling pathways. In this article, we concisely and critically review the role of NAD(+) in mechanisms promoting genome maintenance. Numerous NAD(+)-dependent reactions are involved in the preservation of genome stability, the cellular DNA damage response, and other pathways regulating nucleic acid metabolism, such as gene expression and cell proliferation pathways. Of note, NAD(+) serves as a substrate to ADP-ribosyltransferases, sirtuins, and potentially also eukaryotic DNA ligases, all of which regulate various aspects of DNA integrity, damage repair, and gene expression. Finally, we critically analyze recent developments in the field as well as discuss challenges associated with therapeutic actions intended to raise NAD(+) levels.	[Ruszkiewicz, Joanna A.; Buerkle, Alexander; Mangerich, Aswin] Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany	University of Konstanz	Ruszkiewicz, JA; Buerkle, A; Mangerich, A (corresponding author), Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany.	joanna.ruszkiewicz@uni-konstanz.de; alexander.buerkle@uni-konstanz.de; aswin.mangerich@uni-konstanz.de		Mangerich, Aswin/0000-0001-9742-2338	German Ministry of Defense [E/U2AD/ID015/IF561, E/U2CB/EA199/EF552]; German Research Foundation (DFG) [MA-4905/4-1]	German Ministry of Defense; German Research Foundation (DFG)(German Research Foundation (DFG))	Acknowledgments - The experimental work in our group has been supported by grants from the German Ministry of Defense (grant numbers: E/U2AD/ID015/IF561 and E/U2CB/EA199/EF552) as well as the German Research Foundation (DFG, grant number: MA-4905/4-1) .	Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Lagunas-Rangel FA, 2019, DNA REPAIR, V80, P85, DOI 10.1016/j.dnarep.2019.06.009; Altmann T, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0520-1; Altmeyer M, 2013, MOL CELL, V52, P206, DOI 10.1016/j.molcel.2013.08.025; Aredia F, 2014, BIOCHEM PHARMACOL, V92, P157, DOI 10.1016/j.bcp.2014.06.021; Azarm K, 2020, GENE DEV, V34, P285, DOI 10.1101/gad.334730.119; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGER NA, 1980, BIOCHEM BIOPH RES CO, V95, P67, DOI 10.1016/0006-291X(80)90705-6; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bi FC, 2017, CURR PHARM DESIGN, V23, P2117, DOI 10.2174/1381612822666161025145639; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Blank MF, 2017, TRANSCR-AUSTIN, V8, P67, DOI 10.1080/21541264.2016.1276658; Blank MF, 2017, NUCLEIC ACIDS RES, V45, P2675, DOI 10.1093/nar/gkx053; Bock FJ, 2015, MOL CELL, V58, P959, DOI 10.1016/j.molcel.2015.01.037; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Boyonoski AC, 2002, J NUTR, V132, P115, DOI 10.1093/jn/132.1.115; Boyonoski AC, 2002, J NUTR, V132, P108, DOI 10.1093/jn/132.1.108; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Buonvicino D, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100855; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chen AC, 2015, NEW ENGL J MED, V373, P1618, DOI 10.1056/NEJMoa1506197; Chen SH, 2019, NUCLEIC ACIDS RES, V47, P1321, DOI 10.1093/nar/gky1202; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Chini CCS, 2021, CELL METAB, V33, P1076, DOI 10.1016/j.cmet.2021.04.003; Chowdhry S, 2019, NATURE, V569, P570, DOI 10.1038/s41586-019-1150-2; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Cohen MS, 2020, GENE DEV, V34, P254, DOI 10.1101/gad.335109.119; Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x; Curtin NJ, 2020, NAT REV DRUG DISCOV, V19, P711, DOI 10.1038/s41573-020-0076-6; Dantas TJ, 2011, J CELL BIOL, V193, P307, DOI 10.1083/jcb.201012093; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; Davies CA, 1999, ELECTROPHORESIS, V20, P2111; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Deshpande RA, 2017, NUCLEIC ACIDS RES, V45, P5255, DOI 10.1093/nar/gkx173; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Dollerup OL, 2019, J CLIN ENDOCR METAB, V104, P5703, DOI 10.1210/jc.2019-01081; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Eisemann T, 2020, CELL MOL LIFE SCI, V77, P19, DOI 10.1007/s00018-019-03366-0; Eker APM, 2009, CELL MOL LIFE SCI, V66, P968, DOI 10.1007/s00018-009-8735-0; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Feng XJ, 2020, AGING-US, V12, P4178, DOI 10.18632/aging.102862; Fischbach A, 2018, NUCLEIC ACIDS RES, V46, P804, DOI 10.1093/nar/gkx1205; Fons NR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11732-6; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Girardi E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19871-x; Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Gujar AD, 2016, P NATL ACAD SCI USA, V113, pE8247, DOI 10.1073/pnas.1610921114; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Head PE, 2017, J BIOL CHEM, V292, P9919, DOI 10.1074/jbc.M116.772566; Helassa N., 2019, FASEB J, V33, P14602, DOI DOI 10.1096/fj.201901662R; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Hopp AK, 2021, MOL CELL, V81, P340, DOI 10.1016/j.molcel.2020.12.034; Hou TY, 2020, NUCLEIC ACIDS RES, V48, P2982, DOI 10.1093/nar/gkaa006; Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hurtado-Bages S, 2020, MOL METAB, V38, DOI 10.1016/j.molmet.2020.01.014; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim DS, 2020, GENE DEV, V34, P302, DOI 10.1101/gad.334433.119; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Kirkland James B, 2012, Subcell Biochem, V56, P21, DOI 10.1007/978-94-007-2199-9_2; Kiss A, 2020, CANCERS, V12, DOI 10.3390/cancers12051180; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kory N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe5310; Kosciuk T, 2019, CURR OPIN CHEM BIOL, V51, P18, DOI 10.1016/j.cbpa.2019.01.023; Kostecki LM, 2007, MUTAT RES-FUND MOL M, V625, P50, DOI 10.1016/j.mrfmmm.2007.05.008; Kreuz S, 2016, EPIGENOMICS-UK, V8, P843, DOI 10.2217/epi-2016-0002; Kruger A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15858-w; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Kulikova V, 2019, METABOLITES, V9, DOI 10.3390/metabo9120293; Kulikova V, 2015, J BIOL CHEM, V290, P27124, DOI 10.1074/jbc.M115.664458; Kulkarni CA, 2019, ANTIOXID REDOX SIGN, V31, P623, DOI 10.1089/ars.2018.7722; Langelier MF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03234-8; Lee HC, 2019, J BIOL CHEM, V294, P19831, DOI 10.1074/jbc.REV119.009635; Lee IH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0302-7; LEHMAN IR, 1974, SCIENCE, V186, P790; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li J, 2017, SCIENCE, V355, P1312, DOI 10.1126/science.aad8242; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; Luongo TS, 2020, NATURE, V588, P174, DOI 10.1038/s41586-020-2741-7; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; Madabushi A, 2013, BIOCHEM J, V456, P89, DOI 10.1042/BJ20130670; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martin IV, 2002, GENOME BIOL, V3; Martin-Hernandez K, 2017, SEMIN CELL DEV BIOL, V63, P92, DOI 10.1016/j.semcdb.2016.09.009; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Masri S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005685; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Matta E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60631-0; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Munnur D, 2019, NUCLEIC ACIDS RES, V47, P5658, DOI 10.1093/nar/gkz305; Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4; Nagy Z, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005791; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Nicolae CM, 2015, NUCLEIC ACIDS RES, V43, P3143, DOI 10.1093/nar/gkv147; Nicolae CM, 2014, J BIOL CHEM, V289, P13627, DOI 10.1074/jbc.M114.556340; O'Sullivan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08859-x; Okamoto Keiji, 2018, Oncotarget, V9, P35844, DOI 10.18632/oncotarget.26312; Okur MN, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-019-0040-z; Onn L, 2020, ELIFE, V9, DOI 10.7554/eLife.51636; Pahi ZG, 2020, CANCERS, V12, DOI 10.3390/cancers12010183; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; Pereira JM, 2018, CELL REP, V23, P1124, DOI 10.1016/j.celrep.2018.03.116; Perillo B, 2020, EXP MOL MED, V52, P192, DOI 10.1038/s12276-020-0384-2; Petr MA, 2020, TRENDS CELL BIOL, V30, P117, DOI 10.1016/j.tcb.2019.12.001; Piacente F, 2017, CANCER RES, V77, P3857, DOI 10.1158/0008-5472.CAN-16-3079; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Quenet D, 2008, FASEB J, V22, P3853, DOI 10.1096/fj.08-113464; Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rank L, 2016, NUCLEIC ACIDS RES, V44, P10386, DOI 10.1093/nar/gkw859; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Reber JM, 2021, NUCLEIC ACIDS RES, V49, P8432, DOI 10.1093/nar/gkab618; RECHSTEINER M, 1976, J CELL PHYSIOL, V88, P207, DOI 10.1002/jcp.1040880210; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Roos WP, 2016, NUCLEIC ACIDS RES, V44, P10017, DOI 10.1093/nar/gkw922; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; Rybanska I, 2013, ONCOGENE, V32, P1761, DOI 10.1038/onc.2012.199; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sampath D, 2015, PHARMACOL THERAPEUT, V151, P16, DOI 10.1016/j.pharmthera.2015.02.004; Saville KM, 2020, DNA REPAIR, V93, DOI 10.1016/j.dnarep.2020.102930; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schmidt MS, 2019, NAT METAB, V1, P660, DOI 10.1038/s42255-019-0085-0; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schuhwerk H, 2017, NUCLEIC ACIDS RES, V45, P11174, DOI 10.1093/nar/gkx717; Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Sharif T, 2019, ANTIOXID REDOX SIGN, V30, P906, DOI 10.1089/ars.2017.7478; Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI [10.1056/NEJMoa1616361, 10.1056/nejmoa1616361]; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Singh CK, 2018, ANTIOXID REDOX SIGN, V28, P643, DOI 10.1089/ars.2017.7290; Sirover MA, 2018, CANCER METAST REV, V37, P665, DOI 10.1007/s10555-018-9764-7; Slade D, 2019, BIOCHEM PHARMACOL, V167, P33, DOI 10.1016/j.bcp.2019.03.028; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Sociali G, 2019, FASEB J, V33, P3704, DOI 10.1096/fj.201800321R; Spronck JC, 2003, NUTR CANCER, V45, P124, DOI 10.1207/S15327914NC4501_14; Spronck JC, 2002, MUTAT RES-FUND MOL M, V508, P83, DOI 10.1016/S0027-5107(02)00188-4; Spronck JC, 2007, NUTR CANCER, V57, P88, DOI 10.1080/01635580701268337; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; Stewart TA, 2015, BBA-BIOMEMBRANES, V1848, P2502, DOI 10.1016/j.bbamem.2014.08.016; Sun CK, 2020, EMBO J, V39, DOI 10.15252/embj.2019103420; Sun X, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22863-0; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Szanto M, 2012, CELL MOL LIFE SCI, V69, P4079, DOI 10.1007/s00018-012-1003-8; Tang M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1118; Tedeschi PM, 2016, CLIN CANCER RES, V22, P5189, DOI 10.1158/1078-0432.CCR-16-1129; Tsai YC, 2014, MOL CELL PROTEOMICS, V13, P73, DOI 10.1074/mcp.M113.031377; Tummala KS, 2014, CANCER CELL, V26, P826, DOI 10.1016/j.ccell.2014.10.002; Utani K, 2018, NUCLEUS-PHILA, V9, P261, DOI 10.1080/19491034.2018.1456218; Vachharajani VT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8167273; van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005; Van Meter M, 2016, CELL REP, V16, P2641, DOI 10.1016/j.celrep.2016.08.006; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vazquez BN, 2017, NUCLEUS-PHILA, V8, P107, DOI 10.1080/19491034.2016.1264552; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang JQ, 2013, J BIOL CHEM, V288, P3070, DOI 10.1074/jbc.M112.407726; Wang YJ, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102651; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weidele K, 2017, DNA REPAIR, V52, P12, DOI 10.1016/j.dnarep.2017.02.001; WEITBERG AB, 1989, MUTAT RES, V216, P197, DOI 10.1016/0165-1161(89)90005-8; Wilk A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57506-9; Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216; Xie N, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00311-7; Xie S, 2015, MOL CELL, V60, P163, DOI 10.1016/j.molcel.2015.07.031; Xu Z, 2015, CELL CYCLE, V14, P269, DOI 10.4161/15384101.2014.980641; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037; Yan QS, 2013, MOL CELL BIOL, V33, P845, DOI 10.1128/MCB.00990-12; Yanagisawa S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193921; Yasuda T, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007277; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yount AL, 2015, EXP CELL RES, V334, P70, DOI 10.1016/j.yexcr.2014.12.015; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zarkovic G, 2018, NUCLEIC ACIDS RES, V46, P2417, DOI 10.1093/nar/gkx1318; Zhan T, 2021, TOXICOL LETT, V349, P115, DOI 10.1016/j.toxlet.2021.05.013; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang H, 2016, CELL CYCLE, V15, P2089, DOI 10.1080/15384101.2016.1184517; Zhang H, 2016, CELL REP, V14, P1435, DOI 10.1016/j.celrep.2016.01.018; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110; Zhang T, 2012, J BIOL CHEM, V287, P12405, DOI 10.1074/jbc.M111.304469; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhao BL, 2020, NUCLEIC ACIDS RES, V48, P12746, DOI 10.1093/nar/gkaa1118; Zhu Y, 2019, PHARMACOL THERAPEUT, V200, P27, DOI 10.1016/j.pharmthera.2019.04.002; Ziegler M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11060880; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	251	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102037	10.1016/j.jbc.2022.102037	http://dx.doi.org/10.1016/j.jbc.2022.102037			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35595095	gold, Green Published			2022-12-28	WOS:000816927100008
J	Smith, LB; Duge, E; Valenzuela-Leon, PC; Brooks, S; Martin-Martin, I; Ackerman, H; Calvo, E				Smith, Leticia Barion; Duge, Emma; Valenzuela-Leon, Paola Carolina; Brooks, Steven; Martin-Martin, Ines; Ackerman, Hans; Calvo, Eric			Novel salivary antihemostatic activities of long-form D7 proteins from the malaria vector Anopheles gambiae facilitate hematophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XA-DIRECTED ANTICOAGULANT; YELLOW-FEVER MOSQUITO; AMINE-BINDING PROTEIN; FEMALE MOSQUITO; FACTOR-XII; ACTIVATION; THROMBIN; GLANDS; INHIBITION; EXPRESSION	To successfully feed on blood, hematophagous arthropods must combat the host's natural hemostatic and inflammatory responses. Salivary proteins of blood-feeding insects such as mosquitoes contain compounds that inhibit these common host defenses against blood loss, including vasoconstriction, platelet aggregation, blood clotting, pain, and itching. The D7 proteins are some of the most abundantly expressed proteins in female mosquito salivary glands and have been implicated in inhibiting host hemostatic and inflammatory responses. Anopheles gambiae, the primary vector of malaria, expresses three D7 long-form and five D7 short-form proteins. Previous studies have characterized the AngaD7 short-forms, but the D7 long-form proteins have not yet been characterized in detail. Here, we characterized the A. gambiae D7 long-forms by first determining their binding kinetics to hemostatic agonists such as leukotrienes and serotonin, which are potent activators of vasoconstriction, edema formation, and postcapillary venule leakage, followed by ex vivo functional assays. We found that AngaD7L1 binds leukotriene C4 and thromboxane A2 analog U-46619; AngaD7L2 weakly binds leukotrienes B4 and D4; and AngaD7L3 binds serotonin. Subsequent functional assays confirmed AngaD7L1 inhibits U-46619-induced platelet agserotonin-induced platelet aggregation and vasoconstriction. It is therefore possible that AngaD7L proteins counteract host hemostasis by scavenging these mediators. Finally, we demonstrate that AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway by interacting with factors XII, XIIa, and XI. The uncovering of these interactions in the present study will be essential for compreinterface.	[Smith, Leticia Barion; Duge, Emma; Valenzuela-Leon, Paola Carolina; Brooks, Steven; Martin-Martin, Ines; Ackerman, Hans; Calvo, Eric] NIAID, NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Calvo, E (corresponding author), NIAID, NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA.	calvo@niaid.nih.gov	Martin Martin, Ines/I-9358-2012	Martin Martin, Ines/0000-0002-0956-7324; Duge, Emma/0000-0001-9098-7053; Valenzuela Leon, Paola/0000-0002-5740-5178; Smith, Leticia/0000-0002-8798-326X; Brooks, Steven/0000-0001-7357-1419; Calvo, Eric/0000-0001-7880-2730	Division of Intramural Research Program of the NIH/NIAID [AI001246]	Division of Intramural Research Program of the NIH/NIAID	We thank Andre Laughing house, Kevin Lee,and Yonas Gebremicale for excellent mosquito rearing. This research was supported by the Division of Intramural Research Program of the NIH/NIAID (AI001246).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Bolla M, 2004, HYPERTENSION, V43, P1264, DOI 10.1161/01.HYP.0000127438.39744.07; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2011, J BIOL CHEM, V286, P27998, DOI 10.1074/jbc.M111.247924; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Isawa H, 2002, J BIOL CHEM, V277, P27651, DOI 10.1074/jbc.M203505200; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Malafronte RD, 2003, INSECT BIOCHEM MOLEC, V33, P63, DOI 10.1016/S0965-1748(02)00168-6; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Martin-Martin I, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101372; Martin-Martin I, 2021, FEBS J, V288, P2014, DOI 10.1111/febs.15524; Martin-Martin I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16665-z; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rojkjaer R, 1997, EUR J BIOCHEM, V247, P491, DOI 10.1111/j.1432-1033.1997.00491.x; Scarpassa VM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5545-0; Shahid M., 2009, OPEN IMMUNOL J, V2, P9, DOI [10.2174/1874226200902010009, DOI 10.2174/1874226200902010009]; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123; Suwan N, 2002, INSECT MOL BIOL, V11, P223, DOI 10.1046/j.1365-2583.2002.00329.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Vanhoutte P. M., 1986, NATO ASI SERIES ED, P135; Wolf K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147664; World Health Organization, 2019, REP EP	43	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101971	10.1016/j.jbc.2022.101971	http://dx.doi.org/10.1016/j.jbc.2022.101971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35460690	Green Published, gold			2022-12-28	WOS:000804798000002
J	Khatiwada, B; Nguyen, TT; Purslow, JA; Venditti, V				Khatiwada, Balabhadra; Nguyen, Trang T.; Purslow, Jeffrey A.; Venditti, Vincenzo			Solution structure ensemble of human obesity-associated protein FTO reveals druggable surface pockets at the interface between the N- and C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; BINDING-SITE; FAT MASS; DYNAMICS; RNA; DNA; DEMETHYLASE; RELAXATION; REPAIR	The fat mass and obesity-associated FTO protein catalyzes demethylation of the N-6-methyladenosine, an epigenetic mark that controls several metabolic pathways by modulating the transcription, translation, and cellular localization of RNA molecules. Since the discovery that its overexpression links to the development of obesity and cancer, FTO was the target of screening campaigns and structure-based drug design efforts. Although several FTO inhibitors were generated, these often lack potency or selectivity. Herein, we investigate the structure and dynamics of human FTO in solution. We show that the structure of the catalytic N-terminal domain is unstable in the absence of the C-terminal domain, which explains why the isolated N-terminal domain is incompetent for catalysis and suggests that the domain interaction represents a target for the development of specific inhibitors. Then, by using NMR relaxation measurements, we show that the interface between the FTO structural domains, the active site, and several peripheral loops undergo conformational dynamics on both the picosecond-nanosecond and microsecond-millisecond time scales. Consistent with this, we found that the backbone amide residual dipolar couplings measured for FTO in phage pf1 are inconsistent with the static crystal structure of the enzyme. Finally, we generated a conformational ensemble for apo FTO that satisfies the solution NMR data by combining the experimental residual dipolar couplings with accelerated molecular dynamics simulations. Altogether, the structural ensemble reported in this work provides an atomic-resolution model of apo FTO and reveals transient surface pockets at the domain interface that represent potential targets for the design of allosteric inhibitors.	[Khatiwada, Balabhadra; Nguyen, Trang T.; Purslow, Jeffrey A.; Venditti, Vincenzo] Iowa State Univ, Dept Chem, Ames, IA USA; [Venditti, Vincenzo] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA	Iowa State University; Iowa State University	Venditti, V (corresponding author), Iowa State Univ, Dept Chem, Ames, IA USA.; Venditti, V (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA.	venditti@iastate.edu	Khatiwada, Balabhadra/GLR-8057-2022	Purslow, Jeffrey/0000-0001-8828-0809; Khatiwada, Balabhadra/0000-0002-2467-6270	National Institute of General Medical Sciences [R35GM133488]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and additional information-This work was supported by funds from the National Institute of General Medical Sciences (grant no.: R35GM133488 [to V. V.] ) .	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Bleijlevens B, 2012, BIOCHEMISTRY-US, V51, P3334, DOI 10.1021/bi201699e; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Cho CH, 1999, J PHYS CHEM B, V103, P1991, DOI 10.1021/jp9842953; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Das M, 2018, CHEM-ASIAN J, V13, P2854, DOI 10.1002/asia.201800729; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng XL, 2018, CURR OPIN GENET DEV, V48, P1, DOI 10.1016/j.gde.2017.10.005; Dotas RR, 2020, J MOL BIOL, V432, P4481, DOI 10.1016/j.jmb.2020.05.024; Ergel B, 2014, J BIOL CHEM, V289, P29584, DOI 10.1074/jbc.M114.575647; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; He W, 2015, J MED CHEM, V58, P7341, DOI 10.1021/acs.jmedchem.5b00702; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276; Huff S, 2021, ACS CHEM BIOL, V16, P324, DOI 10.1021/acschembio.0c00841; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Khatiwada B, 2020, PROTEIN EXPRES PURIF, V167, DOI 10.1016/j.pep.2019.105540; Kwok CT, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0410-6; Lacabanne D, 2018, J BIOMOL NMR, V71, P141, DOI 10.1007/s10858-017-0156-z; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Li XT, 2021, NEW J CHEM, V45, P8993, DOI 10.1039/d1nj00117e; Lisi GP, 2016, CHEM REV, V116, P6323, DOI 10.1021/acs.chemrev.5b00541; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nguyen TT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100298118; Peng SM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau7116; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prakash M, 2021, J MED CHEM, V64, P15810, DOI 10.1021/acs.jmedchem.1c01107; Purslow JA, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi8215; Purslow JA, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.699203; Purslow JA, 2018, BIOPHYS J, V115, P1895, DOI 10.1016/j.bpj.2018.10.004; Qiao Y, 2016, BIOCHEMISTRY-US, V55, P1516, DOI 10.1021/acs.biochem.6b00023; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shishodia S, 2021, J MED CHEM, V64, P16609, DOI 10.1021/acs.jmedchem.1c01204; Singh A, 2021, JOVE-J VIS EXP, DOI 10.3791/62395; Tan AH, 2015, INT J CLIN EXP PATHO, V8, P13405; Tan FH, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01952-4; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Toh JDW, 2015, CHEM SCI, V6, P112, DOI 10.1039/c4sc02554g; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Venditti V, 2016, CHEM REV, V116, P6305, DOI 10.1021/acs.chemrev.5b00592; Volkamer A, 2012, BIOINFORMATICS, V28, P2074, DOI 10.1093/bioinformatics/bts310; Wang RY, 2018, MOL PHARMACEUT, V15, P4092, DOI 10.1021/acs.molpharmaceut.8b00522; Wang TL, 2015, J AM CHEM SOC, V137, P13736, DOI 10.1021/jacs.5b06690; Wang Y, 2019, J MOL RECOGNIT, V32, DOI 10.1002/jmr.2800; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Xu D, 2017, ONCOL REP, V38, P2285, DOI 10.3892/or.2017.5904; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Zhang X., 2019, P NATL ACAD SCI USA, V116; Zheng GQ, 2014, CHEM REV, V114, P4602, DOI 10.1021/cr400432d	61	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101907	10.1016/j.jbc.2022.101907	http://dx.doi.org/10.1016/j.jbc.2022.101907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35398093	Green Published, gold			2022-12-28	WOS:000798082100007
J	Nosbisch, JL; Bear, JE; Haugh, JM				Nosbisch, Jamie L.; Bear, James E.; Haugh, Jason M.			A kinetic model of phospholipase C-?1 linking structure-based insights to dynamics of enzyme autoinhibition and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDUCED ACTIVATION; SH2 DOMAINS; C-GAMMA; BINDING; CHEMOTAXIS; C-GAMMA-1; RECEPTOR; SITE	Phospholipase C-gamma 1 (PLC-gamma 1) is a receptor-proximal enzyme that promotes signal transduction through PKC in mammalian cells. Because of the complexity of PLC-gamma 1 regulation, a two-state (inactive/active) model does not account for the intricacy of activation and inactivation steps at the plasma membrane. Here, we introduce a structure-based kinetic model of PLC-gamma 1, considering interactions of its regulatory Src homology 2 (SH2) domains and perturbation of those dynamics upon phosphorylation of Tyr783, a hallmark of activation. For PLC-gamma 1 phosphorylation to dramatically enhance enzyme activation as observed, we found that high intramolecular affinity of the C-terminal SH2 (cSH2) domain-pTyr783 interaction is critical, but this affinity need not outcompete the autoinhibitory interaction of the cSH2 domain. Under conditions for which steady-state PLC-gamma 1 activity is sensitive to the rate of Tyr783 phosphorylation, maintenance of the active state is surprisingly insensitive to the phosphorylation rate, since pTyr783 is well protected by the cSH2 domain while the enzyme is active. In contrast, maintenance of enzyme activity is sensitive to the rate of PLC-gamma 1 membrane (re)binding. Accordingly, we found that hypothetical PLC-gamma 1 mutations that either weaken autoinhibition or strengthen membrane binding influence the activation kinetics differently, which could inform the characterization of oncogenic variants. Finally, we used this newly informed kinetic scheme to refine a spatial model of PLC/PKC polarization during chemotaxis. The refined model showed improved stability of the polarized pattern while corroborating previous qualitative predictions. As demonstrated here for PLC-gamma 1, this approach may be adapted to model the dynamics of other receptor-and membrane-proximal enzymes.	[Nosbisch, Jamie L.] North Carolina State Univ, Biomath Grad Program, Raleigh, NC USA; [Bear, James E.] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC USA; [Haugh, Jason M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu		Haugh, Jason/0000-0002-2476-4027				Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Blinov ML, 2017, BIOPHYS J, V113, P1365, DOI 10.1016/j.bpj.2017.08.022; Devreotes PN, 2017, ANNU REV CELL DEV BI, V33, P103, DOI 10.1146/annurev-cellbio-100616-060739; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Hajicek N, 2019, ELIFE, V8, DOI 10.7554/eLife.51700; Hajicek N, 2013, BIOCHEMISTRY-US, V52, P4810, DOI 10.1021/bi400433b; Harris LA, 2016, BIOINFORMATICS, V32, P3366, DOI 10.1093/bioinformatics/btw469; Haugh JM, 1997, BIOPHYS J, V72, P2014, DOI 10.1016/S0006-3495(97)78846-5; Jadwin JA, 2018, J BIOL CHEM, V293, P623, DOI 10.1074/jbc.M117.794412; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; JONES GA, 1993, J BIOL CHEM, V268, P20845; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Liu Y, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102607; Mohan K, 2017, BIOPHYS J, V113, P185, DOI 10.1016/j.bpj.2017.05.035; Nosbisch JL, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007708, 10.1371/journal.pcbi.1007708.r001, 10.1371/journal.pcbi.1007708.r002, 10.1371/journal.pcbi.1007708.r003, 10.1371/journal.pcbi.1007708.r004, 10.1371/journal.pcbi.1007708.r005]; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tripathi N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194721; Yang Yong Ryoul, 2012, Adv Biol Regul, V52, P138; Zheng YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119739	27	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101886	10.1016/j.jbc.2022.101886	http://dx.doi.org/10.1016/j.jbc.2022.101886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35367415	gold, Green Published			2022-12-28	WOS:000804923000014
J	Sakari, M; Tran, MT; Rossjohn, J; Pulliainen, AT; Beddoe, T; Littler, DR				Sakari, Moona; Tran, Mai T.; Rossjohn, Jamie; Pulliainen, Arto T.; Beddoe, Travis; Littler, Dene R.			Crystal structures of pertussis toxin with NAD(+) and analogs provide structural insights into the mechanism of its cytosolic ADP-ribosylation activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDETELLA-PERTUSSIS; TRANSITION-STATE; S1 SUBUNIT; ENZYMATIC-ACTIVITIES; CATALYTIC DOMAIN; INHIBITORS; COMPLEX; PARP; RIBOSYLTRANSFERASE; CYSTEINE-41	Bordetella pertussis is the causative agent of whooping cough, a highly contagious respiratory disease. Pertussis toxin (PT), a major virulence factor secreted by B. pertussis, is an AB5-type protein complex topologically related to cholera toxin. The PT protein complex is internalized by host cells and follows a retrograde trafficking route to the endoplasmic reticulum, where it subsequently dissociates. The released enzymatic S1 subunit is then translocated from the endoplasmic reticulum into the cytosol and subsequently ADP-ribosylates the inhibitory alpha-subunits (G alpha i) of heterotrimeric G proteins, thus promoting dysregulation of G protein-coupled receptor signaling. However, the mechanistic details of the ADP-ribosylation activity of PT are not well understood. Here, we describe crystal structures of the S1 subunit in complex with nicotinamide adenine dinucleotide (NAD+), with NAD+ hydrolysis products ADP-ribose and nicotinamide, with NAD+ analog PJ34, and with a novel NAD+ analog formed upon S1 subunit crystallization with 3-amino benzamide and NAD+, which we name benzamide amino adenine dinucleotide. These crystal structures provide unprecedented insights into pre-and post-NAD+ hydrolysis steps of the ADP-ribosyltransferase activity of PT. We propose that these data may aid in rational drug design approaches and further development of PT-specific small-molecule inhibitors.	[Sakari, Moona; Pulliainen, Arto T.] Univ Turku, Inst Biomed, Res Unit Infect & Immun, Turku, Finland; [Tran, Mai T.; Rossjohn, Jamie; Littler, Dene R.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Tran, Mai T.; Rossjohn, Jamie; Littler, Dene R.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff, S Glam, Wales; [Beddoe, Travis] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia; [Beddoe, Travis] La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic, Australia	University of Turku; Monash University; Monash University; Cardiff University; La Trobe University; La Trobe University	Pulliainen, AT (corresponding author), Univ Turku, Inst Biomed, Res Unit Infect & Immun, Turku, Finland.; Littler, DR (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Littler, DR (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Beddoe, T (corresponding author), La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia.; Beddoe, T (corresponding author), La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic, Australia.	arto.pulliainen@utu.fi; t.beddoe@latrobe.edu.au; dene.littler@monash.edu		Pulliainen, Arto Tapio/0000-0002-9361-8963; Sakari, Moona/0000-0002-9842-739X	Academy of Finland [295296, 329252]; Sigrid Juselius Foundation; Instruct ERIC; Finnish Society of Sciences and Letters; University of Turku, Turku, Finland; Turku Doctoral Programme of Molecular Medicine (TuDMM); Finnish Cultural Foundation; Turku University Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instruct ERIC; Finnish Society of Sciences and Letters; University of Turku, Turku, Finland; Turku Doctoral Programme of Molecular Medicine (TuDMM); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Foundation	This research was undertaken in part using the MX1 beamline at the Australian Synchrotron, part of ANSTO. J. R. is an NHMRC Fellow. The exotoxin research in the laboratory of Arto Tapio Pulliainen (A. T. P.) has received financial support from Academy of Finland (grants no. 295296 and 329252, to A. T. P.) , Sigrid Juselius Foundation (to A. T. P.) , Instruct ERIC (to A. T. P.) , the Finnish Society of Sciences and Letters (to A. T. P.) , University of Turku, Turku, Finland (to A. T. P.) , Turku Doctoral Programme of Molecular Medicine (TuDMM) (to Moona Sakari, M. S.) , the Finnish Cultural Foundation (to M.S.) , and Turku University Foundation (to M.S.) . The funders have had no role in study designs, data collection and interpretations, or the decisions to submit the results for publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANTOINE R, 1994, J BIOL CHEM, V269, P6450; Ashok Y, 2020, ACS INFECT DIS, V6, P588, DOI 10.1021/acsinfecdis.9b00412; Ausar SF, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01153-3; AVIGAN J, 1992, BIOCHEMISTRY-US, V31, P7736, DOI 10.1021/bi00148a039; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Banerjee T, 2016, INFECT IMMUN, V84, P3388, DOI 10.1128/IAI.00732-16; BROWN DR, 1991, DEV BIOLOGICALS, V73, P63; Carbonetti NH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-7; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84817-2; Ernst K, 2018, TOXINS, V10, DOI 10.3390/toxins10050181; FERRO AM, 1978, P NATL ACAD SCI USA, V75, P809, DOI 10.1073/pnas.75.2.809; HALL E, 1994, J MED MICROBIOL, V40, P205, DOI 10.1099/00222615-40-3-205; Han S, 2002, INT J MED MICROBIOL, V291, P523; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karlberg T, 2012, J BIOL CHEM, V287, P24077, DOI 10.1074/jbc.M112.379289; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; KASLOW HR, 1989, J BIOL CHEM, V264, P6386; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Littler DR, 2017, J BIOL CHEM, V292, P15143, DOI 10.1074/jbc.M117.796094; LOCHT C, 1995, BIOCHIMIE, V77, P333, DOI 10.1016/0300-9084(96)88143-0; LOCHT C, 1989, P NATL ACAD SCI USA, V86, P3075, DOI 10.1073/pnas.86.9.3075; LOCHT C, 1990, J BIOL CHEM, V265, P4552; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Mateo J, 2019, ANN ONCOL, V30, P1437, DOI 10.1093/annonc/mdz192; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Morrow DA, 2009, J THROMB THROMBOLYS, V27, P359, DOI 10.1007/s11239-008-0230-1; MOSS J, 1979, J BIOL CHEM, V254, P6270; Nguyen AW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0966; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; OPPENHEIMER NJ, 1978, J BIOL CHEM, V253, P4907; Pande AH, 2006, BIOCHEMISTRY-US, V45, P13734, DOI 10.1021/bi061175+; PARTON R, 1994, J MED MICROBIOL, V40, P307, DOI 10.1099/00222615-40-5-307; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; PITTMAN M, 1984, PEDIATR INFECT DIS J, V3, P467, DOI 10.1097/00006454-198409000-00019; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Plaut RD, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw065; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Qi XF, 2019, NATURE, V571, P279, DOI 10.1038/s41586-019-1286-0; Sakari M, 2022, ACS INFECT DIS, V8, P433, DOI 10.1021/acsinfecdis.1c00296; SATO H, 1984, INFECT IMMUN, V46, P415, DOI 10.1128/IAI.46.2.415-421.1984; Scanlon K, 2019, TOXINS, V11, DOI 10.3390/toxins11070373; Scheuring J, 1997, BIOCHEMISTRY-US, V36, P4526, DOI 10.1021/bi962841h; Scheuring J, 1997, BIOCHEMISTRY-US, V36, P8215, DOI 10.1021/bi970379a; Scheuring J, 1998, BIOCHEMISTRY-US, V37, P2748, DOI 10.1021/bi972594x; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; TUOMANEN E, 1985, J INFECT DIS, V152, P118, DOI 10.1093/infdis/152.1.118; Ulloa-Gutierrez R, 2011, EXPERT REV VACCINES, V10, P49, DOI 10.1586/ERV.10.156; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; WEST RE, 1985, J BIOL CHEM, V260, P4428; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yeh Sylvia H, 2003, Expert Rev Vaccines, V2, P113, DOI 10.1586/14760584.2.1.113	68	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101892	10.1016/j.jbc.2022.101892	http://dx.doi.org/10.1016/j.jbc.2022.101892			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35378130	Green Published, Green Accepted, gold			2022-12-28	WOS:000798082100006
J	Espinoza-Corral, R; Lundquist, PK				Espinoza-Corral, Roberto; Lundquist, Peter K.			The plastoglobule-localized protein AtABC1K6 is a Mn2+-dependent kinase necessary for timely transition to reproductive growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JASMONIC ACID; LEAF SENESCENCE; ARABIDOPSIS; CHLOROPLAST; GENE; QUANTIFICATION; METABOLISM; EXPRESSION; GENOMICS; REVEALS	The Absence of bc(1) Complex (ABC1) is an ancient, atypical protein kinase family that emerged prior to the archaeal-eubacterial divergence. Loss-of-function mutants in ABC1 genes are linked to respiratory defects in microbes and humans and to compromised photosynthetic performance and stress tolerance in plants. However, demonstration of protein kinase activity remains elusive, hampering their study. Here, we investigate a homolog from Arabidopsis thaliana, AtABC1K6, and demonstrate in vitro autophosphorylation activity, which we replicate with a human ABC1 ortholog. We also show that AtABC1K6 protein kinase activity requires an atypical buffer composition, including Mn2+ as a divalent cation cofactor and a low salt concentration. AtABC1K6 associates with plastoglobule lipid droplets of A. thaliana chloroplasts, along with five paralogs. We show that the protein kinase activity associated with isolated A. thaliana plastoglobules was inhibited at higher salt concentrations, but could accommodate Mg2+ as well as Mn2+, indicating salt sensitivity, but not the requirement for Mn2+, may be a general characteristic of ABC1 proteins. Finally, loss of functional AtABC1K6 impairs the developmental transition from vegetative to reproductive growth. This phenotype was complemented by the wild-type sequence of AtABC1K6, but not by a kinase-dead point mutant in the unique Ala-triad of the ATP-binding pocket, demonstrating the physiological relevance of the protein's kinase activity. We suggest that ABC1s are bona fide protein kinases with a unique regulatory mechanism. Our results open the door to detailed functional and mechanistic studies of ABC1 proteins and plastoglobules.	[Espinoza-Corral, Roberto; Lundquist, Peter K.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Espinoza-Corral, Roberto; Lundquist, Peter K.] Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Espinoza-Corral, R; Lundquist, PK (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.; Espinoza-Corral, R; Lundquist, PK (corresponding author), Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA.	espino95@msu.edu; pklundqu@msu.edu		Espinoza-Corral, Roberto/0000-0002-5895-7978; Lundquist, Peter/0000-0001-8390-8089	USDA Umbrella Program [MICL02633]; AgBioResearch startup funds; Michigan State University	USDA Umbrella Program; AgBioResearch startup funds; Michigan State University	Funding and additional information-This work was supported by the USDA Umbrella Program (MICL02633), AgBioResearch startup funds, and Michigan State University startup funds to P. K. L.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Aubry S, 2020, PLANT PHYSIOL, V182, P776, DOI 10.1104/pp.19.01115; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bruschweiler R, 2003, PROTEINS, V50, P26, DOI 10.1002/prot.10250; Cardazzo B, 1998, GENE, V221, P117, DOI 10.1016/S0378-1119(98)00417-X; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eisenhut M, 2018, MOL PLANT, V11, P955, DOI 10.1016/j.molp.2018.04.008; Espinoza-Corral R, 2021, PLANT J, V106, P1571, DOI 10.1111/tpj.15253; Espinoza-Corral R, 2019, J EXP BOT, V70, P3981, DOI 10.1093/jxb/erz177; Evans IM, 2010, PLANT BIOLOGY, V12, P1, DOI 10.1111/j.1438-8677.2009.00206.x; Fang HX, 2020, FOOD CHEM, V309, DOI 10.1016/j.foodchem.2019.125737; Guiamet JJ, 1999, PLANT CELL PHYSIOL, V40, P986, DOI 10.1093/oxfordjournals.pcp.a029632; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hu YR, 2017, J EXP BOT, V68, P1361, DOI 10.1093/jxb/erx004; Humphrey SJ, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0014-9; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kanev GK, 2019, TRENDS PHARMACOL SCI, V40, P818, DOI 10.1016/j.tips.2019.09.002; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; Kunz HH, 2014, P NATL ACAD SCI USA, V111, P7480, DOI 10.1073/pnas.1323899111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; Liu L, 2016, MICRON, V80, P135, DOI 10.1016/j.micron.2015.10.007; Lundquist PK, 2013, PLANT CELL, V25, P1818, DOI 10.1105/tpc.113.111120; Lundquist PK, 2012, TRENDS PLANT SCI, V17, P546, DOI 10.1016/j.tplants.2012.05.010; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Martinis J, 2014, PLANT J, V77, P269, DOI 10.1111/tpj.12385; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; Modi V, 2019, P NATL ACAD SCI USA, V116, P6818, DOI 10.1073/pnas.1814279116; Ono K, 2019, J PLANT PHYSIOL, V238, P53, DOI 10.1016/j.jplph.2019.05.004; PALMER DA, 1995, MOL PLANT MICROBE IN, V8, P683, DOI 10.1094/MPMI-8-0683; Pralon T, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00337; Pralon T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0477-4; Puthiyaveetil S, 2008, P NATL ACAD SCI USA, V105, P10061, DOI 10.1073/pnas.0803928105; Puthiyaveetil S, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.20; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shan XY, 2011, PLANT PHYSIOL, V155, P751, DOI 10.1104/pp.110.166595; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Springer A, 2016, P NATL ACAD SCI USA, V113, P3383, DOI 10.1073/pnas.1525747113; Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Tamary E, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.127; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Taylor SS, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100746; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; TUQUET C, 1980, CYTOBIOS, V29, P43; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ullah A, 2019, SENESCENCE SIGNALLING AND CONTROL IN PLANTS, P111, DOI 10.1016/B978-0-12-813187-9.00007-X; Ung PMU, 2018, CELL CHEM BIOL, V25, P916, DOI 10.1016/j.chembiol.2018.05.002; van Wijk KJ, 2017, ANNU REV PLANT BIOL, V68, P253, DOI 10.1146/annurev-arplant-043015-111737; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wang S, 2014, CHEM COMMUN, V50, P14117, DOI 10.1039/c4cc05375c; WU WH, 1992, PLANT PHYSIOL, V98, P666, DOI 10.1104/pp.98.2.666; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zhang XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45704-z; Zhu XY, 2015, PLANT J, V84, P597, DOI 10.1111/tpj.13030	72	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101762	10.1101/2021.10.28.466314	http://dx.doi.org/10.1101/2021.10.28.466314			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202657	Green Submitted			2022-12-28	WOS:000793502000014
J	Malecki, JM; Davydova, E; Falnes, PO				Malecki, Jedrzej M.; Davydova, Erna; Falnes, Pal O.			Protein methylation in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELECTRON-TRANSFER FLAVOPROTEIN; EPSILON-N-TRIMETHYLLYSINE; ADP/ATP CARRIER PROTEIN; AMINO-ACID-SEQUENCE; CYTOCHROME-C; LYSINE METHYLTRANSFERASE; CITRATE SYNTHASE; COMPLEX-I; POSTTRANSLATIONAL MODIFICATIONS; GLOBAL ANALYSIS	Many proteins are modified by posttranslational methylation, introduced by a number of methyltransferases (MTases). Protein methylation plays important roles in modulating protein function and thus in optimizing and regulating cellular and physiological processes. Research has mainly focused on nuclear and cytosolic protein methylation, but it has been known for many years that also mitochondrial proteins are methylated. During the last decade, significant progress has been made on identifying the MTases responsible for mitochondrial protein methylation and addressing its functional significance. In particular, several novel human MTases have been uncovered that methylate lysine, arginine, histidine, and glutamine residues in various mitochondrial substrates. Several of these substrates are key components of the bioenergetics machinery, e.g., respiratory Complex I, citrate synthase, and the ATP synthase. In the present review, we report the status of the field of mitochondrial protein methylation, with a particular emphasis on recently discovered human MTases. We also discuss evolutionary aspects and functional significance of mitochondrial protein methylation and present an outlook for this emergent research field.	[Malecki, Jedrzej M.; Davydova, Erna; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway	University of Oslo	Malecki, JM; Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway.	j.m.malecki@ibv.uio.no; pal.falnes@ibv.uio.no		Davydova, Erna/0000-0001-7072-4539; Falnes, Pal/0000-0001-8114-6025; Malecki, Jedrzej/0000-0003-0825-7962	Research Council of Norway [FRIPRO-301049, FRIPRO-240009]; Norwegian Cancer Society [107744-PR-2007-0132]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	Research on mitochondrial protein methylation in our laboratory was supported by grants from the Research Council of Norway (FRIPRO-301049 and FRIPRO-240009) and the Norwegian Cancer Society (107744-PR-2007-0132).	Alston CL, 2016, J MED GENET, V53, P634, DOI 10.1136/jmedgenet-2015-103576; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; BREMS DN, 1981, J BIOL CHEM, V256, P1688; Brenner C, 2011, ONCOGENE, V30, P883, DOI 10.1038/onc.2010.501; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Cherney MM, 2013, BIOCHEMISTRY-US, V52, P837, DOI 10.1021/bi301599g; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20670-7; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; DELANGE RJ, 1970, J BIOL CHEM, V245, P3325; DELANGE RJ, 1969, J BIOL CHEM, V244, P1385; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; DIMARIA P, 1979, J BIOL CHEM, V254, P4645; Dimitrova E, 2015, EMBO REP, V16, P1620, DOI 10.15252/embr.201541113; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; DURBAN E, 1978, J BIOL CHEM, V253, P1427; Elurbe DM, 2016, BBA-BIOENERGETICS, V1857, P971, DOI 10.1016/j.bbabio.2016.03.027; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Faria Jerusa Araujo Quintao Arantes, 2013, J Cancer Sci Ther, V5, P58; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Fletcher SC, 2020, BIOCHEM SOC T, V48, P1843, DOI 10.1042/BST20190333; FRERMAN FE, 1988, BIOCHEM SOC T, V16, P416, DOI 10.1042/bst0160416; Graille M, 2012, BIOCHIMIE, V94, P1533, DOI 10.1016/j.biochi.2012.01.005; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885; Hameed UFS, 2018, CELL REP, V24, P1996, DOI 10.1016/j.celrep.2018.07.075; Hart-Smith G, 2016, MOL CELL PROTEOMICS, V15, P989, DOI 10.1074/mcp.M115.055384; Haws SA, 2020, TRENDS BIOCHEM SCI, V45, P731, DOI 10.1016/j.tibs.2020.04.002; Hedger G, 2016, BIOCHEMISTRY-US, V55, P6238, DOI 10.1021/acs.biochem.6b00751; Henriques BJ, 2021, GENE, V776, DOI 10.1016/j.gene.2021.145407; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang JW, 2021, EXP MOL MED, V53, P788, DOI 10.1038/s12276-021-00613-y; Ishizawa T, 2008, BIOCHEM BIOPH RES CO, V373, P99, DOI 10.1016/j.bbrc.2008.05.176; Jakobsson ME, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05646-y; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11464; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kapell S, 2021, NAR GENOM BIOINFORM, V3, DOI 10.1093/nargab/lqab045; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KATZ ML, 1994, J BIOL CHEM, V269, P9906; Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KIM CS, 1980, BIOCHIM BIOPHYS ACTA, V622, P144, DOI 10.1016/0005-2795(80)90166-X; Kudithipudi S, 2016, CELL CHEM BIOL, V23, P1049, DOI 10.1016/j.chembiol.2016.07.013; Kwiatkowski S, 2020, CURR PROTEIN PEPT SC, V21, P675, DOI 10.2174/1389203721666200318161330; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; LANOUE KF, 1972, J BIOL CHEM, V247, P667; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; LIAO HH, 1979, J BACTERIOL, V138, P853, DOI 10.1128/JB.138.3.853-860.1979; Liu F, 2020, OPHTHAL PHYSL OPT, V40, P271, DOI 10.1111/opo.12683; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2019, J BIOL CHEM, V294, P11654, DOI 10.1074/jbc.RA119.009045; Malecki J, 2017, J BIOL CHEM, V292, P17950, DOI 10.1074/jbc.M117.808451; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2016, J BIOL CHEM, V291, P9581, DOI 10.1074/jbc.M115.709261; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Malecki JM, 2021, NUCLEIC ACIDS RES, V49, P3185, DOI 10.1093/nar/gkab088; Malecki JM, 2019, J BIOL CHEM, V294, P1128, DOI 10.1074/jbc.RA118.005473; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Niu YL, 2013, J BIOL CHEM, V288, P13728, DOI 10.1074/jbc.M113.452979; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Olsen JB, 2016, MOL CELL PROTEOMICS, V15, P892, DOI 10.1074/mcp.M115.053280; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PARK KS, 1987, J BIOL CHEM, V262, P14702; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Rowe EM, 2019, BRAIN RES, V1707, P164, DOI 10.1016/j.brainres.2018.11.024; Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025; SANTIAGO E, 1973, BIOCHEM BIOPH RES CO, V53, P439, DOI 10.1016/0006-291X(73)90681-5; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19615-4; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031; SRERE PA, 1974, LIFE SCI, V15, P1695, DOI 10.1016/0024-3205(74)90172-6; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Torija P, 2006, J CELL SCI, V119, P1154, DOI 10.1242/jcs.02819; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walpole TB, 2015, MOL CELL PROTEOMICS, V14, P828, DOI 10.1074/mcp.M114.047456; Wang BJ, 2017, INVEST OPHTH VIS SCI, V58, P4182, DOI 10.1167/iovs.16-20941; Wang KY, 2016, ANAL CHEM, V88, P11319, DOI 10.1021/acs.analchem.6b02872; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Willemen HLDM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003452; Winter DL, 2015, PROTEOMICS, V15, P2166, DOI 10.1002/pmic.201400521; Wu ZX, 2015, MOL CELL PROTEOMICS, V14, P329, DOI 10.1074/mcp.M114.044255; Young DJ, 2010, RNA, V16, P1146, DOI 10.1261/rna.1970310; Zempel KEC, 2016, J PROTEOME RES, V15, P4436, DOI 10.1021/acs.jproteome.6b00521; Zhang LS, 2021, NAT CELL BIOL, V23, P684, DOI 10.1038/s41556-021-00709-7; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zoabi M, 2020, J BIOL CHEM, V295, P11822, DOI 10.1074/jbc.RA120.014505	136	0	0	8	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101791	10.1016/j.jbc.2022.101791	http://dx.doi.org/10.1016/j.jbc.2022.101791			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35247388	Green Published, gold			2022-12-28	WOS:000823106100011
J	Zhao, YH; Yue, SC; Zhou, X; Guo, J; Ma, SY; Chen, Q				Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang			O-GlcNAc transferase promotes the nuclear localization of the focal adhesion-associated protein Zyxin to regulate UV-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNACYLATION; PHOSPHORYLATION; MECHANISM; SENSOR; STABILITY; MEMBRANE; REVEALS; SITES; HIPPO; STATE	Zyxin is a zinc-binding phosphoprotein known to regulate cell migration, adhesion, and cell survival. Zyxin also plays a role in signal transduction between focal adhesions and the nuclear compartment. However, the mechanism of Zyxin shuttling to nucleus is still unclear. Here, we identify that the GlcNAc transferase (O-linked GlcNAc [O-GlcNAc] transferase) can O-GlcNAcylate Zyxin and regulate its nuclear localization. We show that O-GlcNAc transferase O-GlcNAcylates Zyxin at two residues, serine 169 (Ser-169) and Ser-246. In addition, O-GlcNAcylation of Ser-169, but not Ser-246, enhances its interaction with 14-3-3 gamma, which is a phosphoserine/threoninebinding protein and is reported to bind with phosphorylated Zyxin. Furthermore, we found that 14-3-3 gamma could promote the nuclear localization of Zyxin after Ser-169 O-GlcNAcylation by affecting the function of the N-terminal nuclear export signal sequence; functionally, UV treatment increases the O-GlcNAcylation of Zyxin, which may enhance the nuclear location of Zyxin. Finally, Zyxin in the nucleus maintains homeodomaininteracting protein kinase 2 stability and promotes UV-induced cell death. In conclusion, we uncover that the nuclear localization of Zyxin can be regulated by its O-GlcNAcylation, and that this protein may regulate UV-induced cell death.	[Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang] Wuhan Univ, Zhongnan Hosp, Med Res Inst, Dept Radiat & Med Oncol, Wuhan, Peoples R China; [Zhao, Yuhang; Yue, Shichao; Zhou, Xin; Guo, Jing; Ma, Shuyun; Chen, Qiang] Wuhan Univ, Med Res Inst, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Chen, Q (corresponding author), Wuhan Univ, Zhongnan Hosp, Med Res Inst, Dept Radiat & Med Oncol, Wuhan, Peoples R China.; Chen, Q (corresponding author), Wuhan Univ, Med Res Inst, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China.	C52616@hotmail.com			National Key Research and Development Program of China [2018YFC1003400]; National Natural Science Foundation of China [32170698, 31770868]; Wuhan University [2042018kf0215]; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan University; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University	Q. C. is supported by grants from the National Key Research and Development Program of China (grant no.: 2018YFC1003400), the National Natural Science Foundation of China (grant nos.: 32170698 and 31770868), Wuhan University (grant no.: 2042018kf0215), and Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (grant no.: TFJC2018005).	Babu SS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003173; Belgardt E, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109662; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Chan CB, 2007, CELL DEATH DIFFER, V14, P1688, DOI 10.1038/sj.cdd.4402179; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Crone J, 2011, CANCER RES, V71, P2350, DOI 10.1158/0008-5472.CAN-10-3486; Damayanti NP, 2017, ANALYST, V142, P2713, DOI 10.1039/c7an00471k; De Leon CA, 2017, BIOCHEMISTRY-US, V56, P3507, DOI 10.1021/acs.biochem.7b00268; Degenhardt YY, 2001, J VIROL, V75, P11791, DOI 10.1128/JVI.75.23.11791-11802.2001; DOrazi G., 2002, HOMEODOMAIN INTERACT; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Golsteyn RM, 1997, J CELL SCI, V110, P1893; Gorelik A, 2019, NAT STRUCT MOL BIOL, V26, P1071, DOI 10.1038/s41594-019-0325-8; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Kiss A, 2015, INTEGR BIOL-UK, V7, P1171, DOI 10.1039/c4ib00291a; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Liebl MC, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900127; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Ma B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11123; Mason DE, 2019, J CELL BIOL, V218, P1369, DOI 10.1083/jcb.201806065; Niebuhr K., 1997, EMBO J; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Parshina EA, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108396; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Sabino F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02883-2; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Siddiqui MQ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052647; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smith MA, 2014, TRENDS CELL BIOL, V24, P575, DOI [10.1016/J.tcb.2014.04.009, 10.1016/j.tcb.2014.04.009]; Sun XY, 2020, DEV CELL, V55, P468, DOI 10.1016/j.devcel.2020.09.022; Toleman CA, 2018, P NATL ACAD SCI USA, V115, P5956, DOI 10.1073/pnas.1722437115; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850; Wong KKL, 2020, P NATL ACAD SCI USA, V117, P2004, DOI 10.1073/pnas.1912894117; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Youn H, 2013, CANCER LETT, V331, P192, DOI 10.1016/j.canlet.2012.12.019; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhou J., 2018, P NATL ACAD SCI	55	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101776	10.1016/j.jbc.2022.101776	http://dx.doi.org/10.1016/j.jbc.2022.101776			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35227760	Green Published, gold			2022-12-28	WOS:000793692600009
J	Zheng, WW; Chang, RJ; Luo, Q; Liu, GL; Xu, TJ				Zheng, Weiwei; Chang, Renjie; Luo, Qiang; Liu, Guiliang; Xu, Tianjun			The long noncoding RNA MIR122HG is a precursor for miR-122-5p and negatively regulates the TAK1-induced innate immune response in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; CELL VIABILITY; HOST; TAK1; PROLIFERATION; INVASION; CANCER; AXIS; EXPRESSION; INFECTION	Long noncoding RNAs (lncRNAs) are a diverse subset of RNA species of noncoding transcripts that are usually longer than 200 nt. However, the biological role and function of many lncRNAs have not been fully identified. It has been shown that one potential function of lncRNAs is to act as a precursor miRNA and promote the production of multiple miRNAs. However, the function of the miiuy croaker lncRNA MIR122HG has not been explored. In the present study, we show that this differentially expressed teleost fish lncRNA can act as the host gene of miR-122-5p, regulate its expression, and indirectly regulate the expression of potential inflammatory target protein transforming growth factor-beta-activated kinase 1. We show that MIR122HG can negatively regulate the transforming growth factor-beta-activated kinase 1-triggered NF-kappa B and interferon regulatory factor 3 signaling pathways and subsequently attenuate the innate immune response. In addition, MIR122HG can promote the replication of Siniperca chuatsi rhabdovirus and exacerbate the pathological effects caused by viral infection. We conclude that the study of lncRNA-miRNA-mRNA interaction through bioinformatics analysis or experimental-supported analysis can provide information for further elucidation of the functions of fish lncRNAs in innate immunity.	[Zheng, Weiwei; Chang, Renjie; Luo, Qiang; Liu, Guiliang; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no.: 31822057).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Bao SY, 2018, FISH SHELLFISH IMMUN, V74, P450, DOI 10.1016/j.fsi.2018.01.005; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chu Q., 2020, MIICHTHYS MIIUY SCI, V64, P1; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2020, REV AQUACULT, V12, P2177, DOI 10.1111/raq.12428; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982; Ding FN, 2019, FEBS OPEN BIO, V9, P1869, DOI 10.1002/2211-5463.12730; Faghihi M. A., 2008, NAT MED; Hatinguais R, 2020, CURR TOP MICROBIOL, V425, P187, DOI 10.1007/82_2020_201; Huang B, 2019, FISH SHELLFISH IMMUN, V94, P373, DOI 10.1016/j.fsi.2019.09.037; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Jiang HJ, 2018, INT J BIOL MACROMOL, V111, P623, DOI 10.1016/j.ijbiomac.2018.01.022; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang L, 2020, ACTA BIOCH BIOPH SIN, V52, P883, DOI 10.1093/abbs/gmaa061; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Levin RS, 2016, P NATL ACAD SCI USA, V113, pE4776, DOI 10.1073/pnas.1608355113; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Liang M, 2019, ANIM CELLS SYST, V23, P128, DOI 10.1080/19768354.2019.1591506; Liu G, 2016, ONCOL RES, V23, P99, DOI 10.3727/096504015X14496932933575; Liu SB, 2019, FISH SHELLFISH IMMUN, V92, P224, DOI 10.1016/j.fsi.2019.06.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YY, 2017, NAT MED, V23, P1331, DOI 10.1038/nm.4424; Luo H, 2019, MOL IMMUNOL, V105, P46, DOI 10.1016/j.molimm.2018.11.011; Meng L, 2020, ACTA BIOCH BIOPH SIN, V52, P49, DOI 10.1093/abbs/gmz141; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Peng F, 2021, DEV COMP IMMUNOL, V121, DOI 10.1016/j.dci.2021.104073; Rao YL, 2019, FISH SHELLFISH IMMUN, V93, P492, DOI 10.1016/j.fsi.2019.08.005; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Taylor DH, 2015, MOL REPROD DEV, V82, P932, DOI 10.1002/mrd.22581; Truscott M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004493; Wang S, 2019, CANCER MANAG RES, V11, P9701, DOI 10.2147/CMAR.S225742; Wang Z, 2020, J CELL PHYSIOL, V235, P2825, DOI 10.1002/jcp.29188; Wu XC, 2017, NEURO-ONCOLOGY, V19, P1195, DOI 10.1093/neuonc/nox017; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yan XL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00606; Yu YP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01764; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zheng WW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009438; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100304; Zhou YL, 2017, EUR J IMMUNOL, V47, P1414, DOI 10.1002/eji.201746959; Zou T, 2016, MOL CELL BIOL, V36, P1332, DOI 10.1128/MCB.01030-15	51	4	4	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101773	10.1016/j.jbc.2022.101773	http://dx.doi.org/10.1016/j.jbc.2022.101773			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35218771	Green Published, gold			2022-12-28	WOS:000793694800002
J	Linsdell, P; Irving, CL; Cowley, EA				Linsdell, Paul; Irving, Christina L.; Cowley, Elizabeth A.			Functionally additive fixed positive and negative charges in the CFTR channel pore control anion binding and conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE REGIONS; OUTER MOUTH; SITE; IDENTIFICATION; ARCHITECTURE; SELECTIVITY; VESTIBULE; PERMEANT; LOCATION; ROLES	Ion channels use charged amino-acid residues to attract oppositely charged permeant ions into the channel pore. In the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel, a number of arginine and lysine residues have been shown to be important for Cl- permeation. Among these, two in close proximity in the pore-Lys(95) and Arg(134)-are indispensable for anion binding and high Cl- conductance, suggesting that high positive charge density is required for pore function. Here we used mutagenesis and functional characterization to show that a nearby pore-lining negatively charged residue (Glu(92)) plays a functionally additive role with these two positive charges. While neutralization of this negative charge had little effect on anion binding or Cl- conductance, such neutralization was able to reverse the detrimental effects of removing the positive charge at either Lys(95) or Arg(134), as well as the similar effects of introducing a negative charge at a neighboring residue (Ser(1141)). Furthermore, neutralization of Glu(92) greatly increased the susceptibility of the channel to blockage by divalent S2O32- anions, mimicking the effect of introducing additional positive charge in this region; this effect was reversed by concurrent neutralization of either Lys(95) or Arg(134). Across a panel of mutant channels that introduced or removed fixed charges at these four positions, we found that many pore properties are dependent on the overall charge or charge density. We propose that the CFTR pore uses a com-bination of positively and negatively charged residues to optimize the anion binding and Cl- conductance properties of the channel.	[Linsdell, Paul; Irving, Christina L.; Cowley, Elizabeth A.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	paul.linsdell@dal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN/05124-2017]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN/05124-2017) to P. L.	Accardi A, 2015, J PHYSIOL-LONDON, V593, P4129, DOI 10.1113/JP270575; Boiteux C, 2019, NEUROSCI LETT, V700, P3, DOI 10.1016/j.neulet.2018.05.036; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; Farkas B, 2020, CELL MOL LIFE SCI, V77, P765, DOI 10.1007/s00018-019-03211-4; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Li MS, 2018, J BIOL CHEM, V293, P5649, DOI 10.1074/jbc.RA117.001373; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162413; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 2021, CELL BIOCHEM BIOPHYS, V79, P863, DOI 10.1007/s12013-021-00998-7; Linsdell P, 2021, CELL MOL LIFE SCI, V78, P5213, DOI 10.1007/s00018-021-03859-x; Linsdell P, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183558; Linsdell P, 2018, CHANNELS, V12, P284, DOI 10.1080/19336950.2018.1502585; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Linsdell P, 2016, BBA-BIOMEMBRANES, V1858, P740, DOI 10.1016/j.bbamem.2016.01.009; Linsdell P, 2015, BBA-BIOMEMBRANES, V1848, P1573, DOI 10.1016/j.bbamem.2015.04.004; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Prins S, 2020, J BIOL CHEM, V295, P16529, DOI 10.1074/jbc.RA120.014061; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang G, 2016, FEBS J, V283, P2458, DOI 10.1111/febs.13752; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	34	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101659	10.1016/j.jbc.2022.101659	http://dx.doi.org/10.1016/j.jbc.2022.101659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101441	gold, Green Published			2022-12-28	WOS:000794865600011
J	Ma, ZX; Holland, AA; Szlamkowicz, I; Anagnostopoulos, V; Nogueira, MLCD; Caranto, JDL; Davidson, V				Ma, Zhongxin; Holland, Ashley A.; Szlamkowicz, Ilana; Anagnostopoulos, Vasileios; Nogueira, Maria Luiza Caldas D.; Caranto, Jonathan D. L.; Davidson, Victor			The hemerythrin-like diiron protein from Mycobacterium kansasii is a nitric oxide peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REDUCTIVE NITROSYLATION; CRYSTAL-STRUCTURE; REACTIVE OXYGEN; DIOXYGENASE; IRON; FLAVOHEMOGLOBIN; TUBERCULOSIS; MACROPHAGES; SUBSTRATE	The hemerythrin-like protein from Mycobacterium kansasii (Mka HLP) is a member of a distinct class of oxo-bridged diiron proteins that are found only in mycobacterial species that cause respiratory disorders in humans. Because it had been shown to exhibit weak catalase activity and a change in absorbance on exposure to nitric oxide (NO), the reactivity of Mka HLP toward NO was examined under a variety of conditions. Under anaerobic conditions, we found that NO was converted to nitrite (NO2-) via an intermediate, which absorbed light at 520 nm. Under aerobic conditions NO was converted to nitrate (NO3-). In each of these two cases, the maximum amount of nitrite or nitrate formed was at best stoichiometric with the concentration of Mka HLP. When incubated with NO and H2O2, we observed NO peroxidase activity yielding nitrite and water as reaction products. Steady-state kinetic analysis of NO consumption during this reaction yielded a K-m for NO of 0.44 mu M and a k(cat)/K-m of 2.3 x 10(5) M(-1)s(-1). This high affinity for NO is consistent with a physiological role for Mka HLP in deterring nitrosative stress. This is the first example of a peroxidase that uses an oxo-bridged diiron center and a rare example of a peroxidase utilizing NO as an electron donor and cosubstrate. This activity provides a mechanism by which the infectious Mycobacterium may combat against the cocktail of NO and superoxide (O-2(center dot-)) generated by macrophages to defend against bacteria, as well as to produce NO2- to adapt to hypoxic conditions.	[Ma, Zhongxin; Nogueira, Maria Luiza Caldas D.; Davidson, Victor] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA; [Holland, Ashley A.; Szlamkowicz, Ilana; Anagnostopoulos, Vasileios; Nogueira, Maria Luiza Caldas D.; Caranto, Jonathan D. L.] Univ Cent Florida, Dept Chem, Orlando, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Davidson, V (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA.; Caranto, JDL (corresponding author), Univ Cent Florida, Dept Chem, Orlando, FL USA.	jonathan.caranto@ucf.edu; victor.davidson@ucf.edu	NOGUEIRA, MARIA LUIZA CALDAS/ABD-4713-2020	NOGUEIRA, MARIA LUIZA CALDAS/0000-0003-2548-6564; Caranto, Jonathan/0000-0002-9196-5275; Szlamkowicz, Ilana/0000-0002-6308-0226	National Institute of General Medical Sciences of the National Institutes of Health [R35GM130173]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R35GM130173 (V. L. D.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Alvarez-Carreno C, 2018, PROTEIN SCI, V27, P848, DOI 10.1002/pro.3374; Alvarez-Carreno C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157904; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; FORD PC, 1993, FEBS LETT, V326, P1, DOI 10.1016/0014-5793(93)81748-O; Ford PC, 2005, CHEM REV, V105, P2439, DOI 10.1021/cr0307289; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; Kao WC, 2008, J INORG BIOCHEM, V102, P1607, DOI 10.1016/j.jinorgbio.2008.02.008; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lehnert N, 2019, ACS CATAL, V9, P10499, DOI 10.1021/acscatal.9b03219; Lo FC, 2016, CHEM-EUR J, V22, P9768, DOI 10.1002/chem.201600990; Ma ZX, 2020, ACS OMEGA, V5, P23385, DOI 10.1021/acsomega.0c03338; Ma ZX, 2020, BIOCHEM J, V477, P567, DOI 10.1042/BCJ20190827; Ma ZX, 2018, J BIOL CHEM, V293, P1590, DOI 10.1074/jbc.RA117.000421; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nogueira MLC, 2021, ARCH BIOCHEM BIOPHYS, V705, DOI 10.1016/j.abb.2021.108917; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Romao CV, 2016, J BIOL INORG CHEM, V21, P39, DOI 10.1007/s00775-015-1329-4; Ruiz JC, 2014, J INORG BIOCHEM, V133, P73, DOI 10.1016/j.jinorgbio.2014.01.015; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Wang J, 2016, MOL MICROBIOL, V100, P877, DOI 10.1111/mmi.13356	37	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101696	10.1016/j.jbc.2022.101696	http://dx.doi.org/10.1016/j.jbc.2022.101696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35150744	gold, Green Published			2022-12-28	WOS:000789400700007
J	Shao, YA; Wang, ZH; Chen, KY; Li, DD; Lv, ZM; Zhang, CD; Zhang, WW; Li, CH				Shao, Yina; Wang, Zhenhui; Chen, Kaiyu; Li, Dongdong; Lv, Zhimeng; Zhang, Chundan; Zhang, Weiwei; Li, Chenghua			Xenophagy of invasive bacteria is differentially activated and modulated via a TLR-TRAF6-Beclin1 axis in echinoderms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; UBIQUITIN-PROTEASOME; LIPID-A; AUTOPHAGY; RECOGNITION; TRAF6; LIPOPOLYSACCHARIDE; TLR; MECHANISMS; EXPRESSION	In marine environments, organisms are confronted with numerous microbial challenges, although the differential regulation of xenophagy in response to different pathogenic bacte-rial species remains relatively unknown. Here, we addressed this issue using Apostichopus japonicus as a model. We identified 39 conserved autophagy-related genes by genome-wide screening, which provided a molecular basis for autophagy regulation in sea cucumbers. Furthermore, xenophagy of two Gram-negative bacteria, Vibrio splendidus and Escherichia coli, but not a Gram-positive bacteria, Micrococcus luteus, was observed in different autophagy assays. Surprisingly, a significantly higher autophagy capacity was found in the E. coli-challenged group than in the V. splendidus-challenged group. To confirm these findings, two different lipopolysaccharides, LPSV. splendidus and LPSE. coli, were isolated; we found that these LPS species differentially activated coelomocyte xenophagy. To explore the molecular mechanism mediating differential levels of xenophagy, we used an siRNA knockdown assay and confirmed that LPSV. splendidus-mediated xenophagy was dependent on an AjTLR3-mediated pathway, whereas LPSE. coli-mediated xenophagy was dependent on AjToll. Moreover, the activation of different AjTLRs resulted in AjTRAF6 ubiquitination and sub-sequent activation of K63-linked ubiquitination of AjBeclin1. Inversely, the LPSV. splendidus-induced AjTLR3 pathway simultaneously activated the expression of AjA20, which reduced the extent of K63-linked ubiquitination of AjBeclin1 and impaired the induction of autophagy; however, this finding was no t evident with LPSE. coli. Our present results provide the first evidence showing that xenophagy could be differentially induced by different bacterial species to yield differential autophagy levels in echinoderms.	[Shao, Yina; Wang, Zhenhui; Chen, Kaiyu; Li, Dongdong; Lv, Zhimeng; Zhang, Chundan; Zhang, Weiwei; Li, Chenghua] Ningbo Univ, State Key Lab Qual & Safety Agroprod, Ningbo, Peoples R China; [Li, Chenghua] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Li, Chenghua] Ningbo Univ, State Prov Joint Lab Marine Biotechnol & Engn, Ningbo, Peoples R China	Ningbo University; Qingdao National Laboratory for Marine Science & Technology; Ningbo University	Li, CH (corresponding author), Ningbo Univ, State Key Lab Qual & Safety Agroprod, Ningbo, Peoples R China.; Li, CH (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Li, CH (corresponding author), Ningbo Univ, State Prov Joint Lab Marine Biotechnol & Engn, Ningbo, Peoples R China.	lichenghua@nbu.edu.cn			National Nat-ural Science Foundation of China [32073003]; Natural Science Foundation of Zhejiang Province [LZ19C190001]; K. C. Wong Magna Fund in Ningbo University; Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University	National Nat-ural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund in Ningbo University; Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University	This work was supported by the National Natural Science Foundation of China (32073003) , Natural Science Foundation of Zhejiang Province (LZ19C190001) , K. C. Wong Magna Fund in Ningbo University and the Bio-ultrastructure Analysis Laboratory of the Key Laboratory of Applied Marine Biotechnology of the Ministry of Education, Ningbo University.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Chan ST, 2016, J VIROL, V90, P10928, DOI 10.1128/JVI.01365-16; Che ZJ, 2019, DEV COMP IMMUNOL, V99, DOI 10.1016/j.dci.2019.103404; Chen KY, 2021, AQUACULTURE, V532, DOI 10.1016/j.aquaculture.2020.736022; Chen KY, 2020, DEV COMP IMMUNOL, V104, DOI 10.1016/j.dci.2019.103541; Chen M, 2017, AUTOPHAGY, V13, P1813, DOI 10.1080/15548627.2017.1356550; Cong YY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.240440; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dinkins C, 2015, IMMUNOL CELL BIOL, V93, P11, DOI 10.1038/icb.2014.88; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fusco C., 2018, TRIM50 REGULATES BEC; Gibson JF, 2021, AUTOPHAGY, V17, P1448, DOI 10.1080/15548627.2020.1765521; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Greenfield LK, 2013, TRENDS MICROBIOL, V21, P602, DOI 10.1016/j.tim.2013.09.004; Grumati P, 2018, J BIOL CHEM, V293, P5404, DOI 10.1074/jbc.TM117.000117; Han QX, 2016, REV FISH SCI AQUAC, V24, P326, DOI 10.1080/23308249.2016.1193472; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hu ZG, 2020, FISH SHELLFISH IMMUN, V99, P257, DOI 10.1016/j.fsi.2020.02.013; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Juarez E, 2012, EUR J IMMUNOL, V42, P880, DOI 10.1002/eji.201142105; Juretschke T, 2019, METHODS MOL BIOL, V1880, P691, DOI 10.1007/978-1-4939-8873-0_46; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15290-z; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Li XZ, 2016, PARASITOLOGY, V143, P639, DOI 10.1017/S0031182015001985; Li YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0030-5; Liu W, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Maruyama T, 2018, J ANTIBIOT, V71, P72, DOI 10.1038/ja.2017.104; Mizushima N, 2020, CURR OPIN CELL BIOL, V63, P1, DOI 10.1016/j.ceb.2019.12.001; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Norris MH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005571; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Paul PK, 2011, AUTOPHAGY, V7, P555, DOI 10.4161/auto.7.5.15102; Puri C, 2018, AUTOPHAGY, V14, P1475, DOI 10.1080/15548627.2018.1482148; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reggiori F, 2017, J MOL BIOL, V429, P486, DOI 10.1016/j.jmb.2017.01.002; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sharma V, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00056; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Verstak B, 2014, J LEUKOCYTE BIOL, V96, P427, DOI 10.1189/jlb.2A0913-487R; Wang J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-255; Wang ZH, 2018, INT J BIOL MACROMOL, V113, P1167, DOI 10.1016/j.ijbiomac.2018.03.033; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yan K, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12778; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004; Zhan ZZ, 2014, AUTOPHAGY, V10, P257, DOI 10.4161/auto.27162; Zhang PJ, 2015, GENETICS, V201, P1397, DOI 10.1534/genetics.115.178871; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhang XJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003790; Zhang YF, 2019, NAT IMMUNOL, V20, P433, DOI 10.1038/s41590-019-0324-2; Zhao Y, 2014, CHIN J OCEANOL LIMN, V32, P1248, DOI 10.1007/s00343-015-4004-2	76	4	4	8	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101667	10.1016/j.jbc.2022.101667	http://dx.doi.org/10.1016/j.jbc.2022.101667			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120925	Green Published, gold			2022-12-28	WOS:000791230900014
J	Shi, S; Ma, B; Sun, FD; Qu, C; Li, G; Shi, DH; Liu, WX; Zhang, HL; An, HL				Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; Li, Gen; Shi, Donghong; Liu, Wenxin; Zhang, Hailin; An, Hailong			Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE; ICI-204,219; ANTAGONIST; EXPRESSION; MODEL	Lung cancer has the highest mortality among cancers worldwide due to its high incidence and lack of the effective cures. We have previously demonstrated that the membrane ion channel TMEM16A is a potential drug target for the treatment of lung adenocarcinoma and have identified a pocket of inhibitor binding that provides the basis for screening covery strategies are lengthy and costly, and the unpredictable side effects lead to a high failure rate in drug development. Therefore, finding new therapeutic directions for already marketed drugs may be a feasible strategy to obtain safe and effective therapeutic drugs. Here, we screened a library of over 1400 Food and Drug Administration-approved drugs through virtual screening and activity testing. We identified a drug candidate, Zafirlukast (ZAF), clinically approved for the treatment of asthma, that could inhibit the TMEM16A channel in a lations and site-directed mutagenesis experiments showed that ZAF can bind to S387/N533/R535 in the nonselective inhibitor binding pocket, thereby blocking the channel pore. Furthermore, we demonstrate ZAF can target TMEM16A channel to inhibit the proliferation and migration of lung adenocarcinoma LA795 cells. In vivo experiments showed that ZAF can significantly inhibit lung adenocarcinoma tumor growth in mice. Taken together, we identified ZAF as a novel TMEM16A channel inhibitor with excellent anticancer activity, and as such, it represents a promising candidate for future preclinical and clinical studies.	[Shi, Sai; Ma, Biao; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys Hebei Prov, Tianjin, Peoples R China; [Liu, Wenxin] Tianjin Med Univ Canc Inst & Hosp, Dept Gynecol Oncol, Tianjin, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China	Hebei University of Technology; Hebei University of Technology; Hebei University of Technology; Tianjin Medical University; Hebei Medical University	An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys Hebei Prov, Tianjin, Peoples R China.	hailong_an@hebut.edu.cn			National Natural Science Foundation of China [81830061]; Natural Science Foundation of Tianjin of China [19JCYBJC28300]; Natural Science Foundation of Hebei Province of China [H2020202005]; Tianjin Municipal Education Commission of China [2019ZD033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin of China(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Tianjin Municipal Education Commission of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81830061 to H. A.) , the Natural Science Foundation of Tianjin of China (Grant No. 19JCYBJC28300 to H. A.) , the Natural Science Foundation of Hebei Province of China (Grant No. H2020202005 to H. A.) , and the Tianjin Municipal Education Commission of China (Grant No. 2019ZD033 to W. L.)	Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Case D. A., 2016, AMBER 2016; CP Wild, 2014, WORLD CANC REPORT 20; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Ferlay J, 2021, INT J CANCER, V149, P778, DOI 10.1002/ijc.33588; Figueroa EE, 2019, AM J PHYSIOL-CELL PH, V317, pC857, DOI 10.1152/ajpcell.00281.2019; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gobel T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00263; Guo S, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.643489; Guo S, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104721; Guo S, 2019, J CELL PHYSIOL, V234, P8698, DOI 10.1002/jcp.27529; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Holbrook LM, 2021, BRIT J PHARMACOL, V178, P550, DOI 10.1111/bph.15291; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jia LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136584; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; KRELL RD, 1990, AM REV RESPIR DIS, V141, P978, DOI 10.1164/ajrccm/141.4_Pt_1.978; Li PF, 2014, J CHEM THEORY COMPUT, V10, P289, DOI 10.1021/ct400751u; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Luginina A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2518; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Nguyen TM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00583; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.442; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi S, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101016; Shi S, 2020, ARCH BIOCHEM BIOPHYS, V695, DOI 10.1016/j.abb.2020.108650; Shi S, 2020, COMPUT STRUCT BIOTEC, V18, P714, DOI 10.1016/j.csbj.2020.03.015; Silverman RA, 2004, CHEST, V126, P1480, DOI 10.1378/chest.126.5.1480; Sleire L, 2017, PHARMACOL RES, V124, P74, DOI 10.1016/j.phrs.2017.07.013; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0720-x; Wang TY, 2021, BRIT J PHARMACOL, V178, P4137, DOI 10.1111/bph.15606; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang X, 2017, BRIT J PHARMACOL, V174, P2334, DOI 10.1111/bph.13841	49	3	3	9	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101731	10.1016/j.jbc.2022.101731	http://dx.doi.org/10.1016/j.jbc.2022.101731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35176281	gold, Green Published			2022-12-28	WOS:000789398100009
J	Wada, J; Rathnayake, U; Jenkins, LM; Singh, A; Mohammadi, M; Appella, E; Randazzo, PA; Samelson, LE				Wada, Junya; Rathnayake, Udumbara; Jenkins, Lisa M.; Singh, Avinash; Mohammadi, Moosa; Appella, Ettore; Randazzo, Paul A.; Samelson, Lawrence E.			In vitro reconstitution reveals cooperative mechanisms of adapter protein-mediated activation of phospholipase C-gamma 1 in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; SIGNALING COMPLEXES; MULTIPOINT BINDING; SH3 DOMAIN; SLP-76; RECEPTOR; LAT; GADS; ITK; OLIGOMERIZATION	Activation of T cells upon engagement of the T cell antigen receptor rapidly leads to a number of phosphorylation and plasma membrane recruitment events. For example, trans location of phospholipase-C gamma 1 (PLC-gamma 1) to the plasma membrane and its association with the transmembrane adapter protein LAT and two other adapter proteins, Gads and SLP-76, are critical events in the early T cell activation process. We have previously characterized the formation of a tetrameric LAT-Gads-SLP-76-PLC-gamma 1 complex by reconstitution in vitro and have also characterized the thermodynamics of tetramer formation. In the current study, we define how PLC-gamma 1 recruitment to liposomes, which serve as a plasma membrane surrogate, and PLC-gamma 1 activation are regulated both independently and additively by recruitment of PLC-gamma 1 to phosphorylated LAT, by formation of the LATGads-SLP-76-PLC-gamma 1 tetramer, and by tyrosine phosphorylation of PLC-gamma 1. The recently solved structure of PLC-gamma 1 indicates that, in the resting state, several PLC-gamma 1 domains inhibit its enzymatic activity and contact with the plasma membrane. We propose the multiple cooperative steps that we observed likely lead to conformational alterations in the regulatory domains of PLC-gamma 1, enabling contact with its membrane substrate, disinhibition of PLC-gamma 1 enzymatic activity, and production of the phosphoinositide cleavage products necessary for T cell activation.	[Wada, Junya; Rathnayake, Udumbara; Randazzo, Paul A.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Bethesda, MD USA; [Jenkins, Lisa M.; Appella, Ettore] NCI, Ctr Canc Res, Lab Cell Biol, Bethesda, MD USA; [Singh, Avinash; Mohammadi, Moosa] New York Univ, Langone Med Ctr, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; NYU Langone Medical Center	Samelson, LE (corresponding author), NCI, Lab Cellular & Mol Biol, Bethesda, MD USA.	samelsonl@helix.nih.gov	Mohammadi, Moosa/ABA-6745-2020	Mohammadi, Moosa/0000-0003-2434-9437	NIH [NIH RO1 DE013686]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M. M. was supported by an NIH grant, NIH RO1 DE013686.	Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Beach D, 2007, J BIOL CHEM, V282, P2937, DOI 10.1074/jbc.M606697200; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Francois P, 2016, J STAT PHYS, V162, P1130, DOI 10.1007/s10955-015-1444-1; Ganti RS, 2020, P NATL ACAD SCI USA, V117, P26020, DOI 10.1073/pnas.2008303117; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Hajicek N, 2019, ELIFE, V8, DOI 10.7554/eLife.51700; Hallumi E, 2021, J IMMUNOL, V206, P2322, DOI 10.4049/jimmunol.2001053; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang ZF, 2016, MOL CELL, V61, P98, DOI 10.1016/j.molcel.2015.11.010; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Katan M, 2020, PROG LIPID RES, V80, DOI 10.1016/j.plipres.2020.101065; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Liu HB, 2013, J BIOL CHEM, V288, P29539, DOI 10.1074/jbc.M112.424846; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Liu Y, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102607; Manna A, 2018, P NATL ACAD SCI USA, V115, pE11914, DOI 10.1073/pnas.1817142115; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; N Peterson Scott, 2012, Curr Chem Genomics, V6, P8, DOI 10.2174/1875397301206010008; Prole DL, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035063; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Sauer K., 2009, CURR PROTOC IMMUNOL; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08064-2; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	46	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101680	10.1016/j.jbc.2022.101680	http://dx.doi.org/10.1016/j.jbc.2022.101680			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124007	gold, Green Published			2022-12-28	WOS:000789400700013
J	Gonzalez-Gil, A; Porell, RN; Fernandes, SM; Maenpaa, E; Li, TA; Li, T; Wong, PC; Aoki, K; Tiemeyer, M; Yu, ZJ; Orsburn, BC; Bumpus, NN; Matthews, RT; Schnaar, RL				Gonzalez-Gil, Anabel; Porell, Ryan N.; Fernandes, Steve M.; Maenpaa, Eila; Li, T. August; Li, Tong; Wong, Philip C.; Aoki, Kazuhiro; Tiemeyer, Michael; Yu, Zaikuan J.; Orsburn, Benjamin C.; Bumpus, Namandje N.; Matthews, Russell T.; Schnaar, Ronald L.			Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE-BETA; KERATAN SULFATE; COMMON VARIANTS; MICE DEFICIENT; MAST-CELLS; REVEALS; RECOGNITION; CD2AP; EPHA1; SELF	Alzheimer's disease (AD) is characterized by accumulation of misfolded proteins. Genetic studies implicate microglia, brain-resident phagocytic immune cells, in AD pathogenesis. As positive effectors, microglia clear toxic proteins, whereas as negative effectors, they release proinflammatory mediators. An imbalance of these functions contributes to AD progression. Polymorphisms of human CD33, an inhibitory microglial receptor, are linked to AD susceptibility; higher CD33 expression correlates with increased AD risk. CD33, also called Siglec-3, is a member of the sialic acid-binding immunoglobulin-type lectin (Siglec) family of immune regulatory receptors. Siglec-mediated inhibition is initiated by binding to complementary sialoglycan ligands in the tissue environment. Here, we identify a single sialoglycoprotein in human cerebral cortex that binds CD33 as well as Siglec-8, the most abundant Siglec on human microglia. The ligand, which we term receptor protein tyrosine phosphatase zeta (RPTP zeta)(S3L), is composed of sialylated keratan sulfate chains carried on a minor isoform/glycoform of RPTP zeta (phosphacan) and is found in the extracellular milieu of the human brain parenchyma. Brains from human AD donors had twofold higher levels of RPTP zeta(S3L) than age-matched control donors, raising the possibility that RPTP zeta(S3L) overexpression limits misfolded protein clearance contributing to AD pathology. Mice express the same structure, a sialylated keratan sulfate RPTP zeta isoform, that binds mouse Siglec-F and crossreacts with human CD33 and Siglec-8. Brains from mice engineered to lack RPTP zeta, the sialyltransferase St3gal4, or the keratan sulfate sulfotransferase Chst1 lacked Siglec binding, establishing the ligand structure. The unique CD33 and Siglec-8 ligand, RPTP zeta(S3L), may contribute to AD progression.	[Gonzalez-Gil, Anabel; Porell, Ryan N.; Fernandes, Steve M.; Maenpaa, Eila; Li, T. August; Yu, Zaikuan J.; Orsburn, Benjamin C.; Bumpus, Namandje N.; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wong, Philip C.; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	schnaar@jhu.edu		Porell, Ryan/0000-0003-3332-6819; Alvarenga, Anabel/0000-0002-1618-8920	National Institute on Aging, National Institutes of Health (NIH) [AG062342, AG068089]; NIH [K12HL141952, T32-GM008763, T32GM080189]	National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute on Aging, National Institutes of Health (NIH) grants AG062342 and AG068089 and NIH training grants K12HL141952 (to A. G.-G.), T32-GM008763 (T. A. L.), and T32GM080189 (to R. N. P. and E. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aires V, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.684430; Alsema AM, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00134; Butler CA, 2021, J NEUROCHEM, V158, P297, DOI 10.1111/jnc.15349; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Betancourt LH, 2018, J PROTEOME RES, V17, P2556, DOI 10.1021/acs.jproteome.8b00228; Bhattacherjee A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0698-6; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bull C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026102118; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Caterson B, 2018, GLYCOBIOLOGY, V28, P182, DOI 10.1093/glycob/cwy003; Chatila ZK, 2021, NEUROSCIENTIST, DOI 10.1177/10738584211024531; Chouhan J.K., 2017, DRUG DISCOV TODAY DI, V25-26, P45, DOI [10.1016/j.ddmod.2018.10.004, DOI 10.1016/J.DDMOD.2018.10.004]; Duan ST, 2021, J IMMUNOL, V206, P2290, DOI 10.4049/jimmunol.1901212; Duan ST, 2020, ANNU REV IMMUNOL, V38, P365, DOI 10.1146/annurev-immunol-102419-035900; Duan ST, 2019, J CLIN INVEST, V129, P1387, DOI 10.1172/JCI125456; Eill GJ, 2020, J BIOL CHEM, V295, P955, DOI 10.1074/jbc.RA119.010830; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; ERONEN I, 1985, BIOCHIM BIOPHYS ACTA, V843, P155, DOI 10.1016/0304-4165(85)90063-7; Funderburgh JL, 2002, IUBMB LIFE, V54, P187, DOI 10.1080/15216540214932; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Gonzalez-Gil A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051260; Gonzalez-Gil A, 2021, J ALLERGY CLIN IMMUN, V147, P1442, DOI 10.1016/j.jaci.2020.08.001; Gonzalez-Gil A, 2018, GLYCOBIOLOGY, V28, P786, DOI 10.1093/glycob/cwy057; Griciuc A, 2021, CURR OPIN NEUROL, V34, P228, DOI 10.1097/WCO.0000000000000911; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Johansson MEV, 2012, METHODS MOL BIOL, V842, P109, DOI 10.1007/978-1-61779-513-8_6; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; Kikly KK, 2000, J ALLERGY CLIN IMMUN, V105, P1093, DOI 10.1067/mai.2000.107127; Kiwamoto T, 2014, J ALLERGY CLIN IMMUN, V133, P240, DOI 10.1016/j.jaci.2013.05.018; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Lewcock JW, 2020, NEURON, V108, P801, DOI 10.1016/j.neuron.2020.09.029; Li T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12082; Lindahl B, 1996, J BIOL CHEM, V271, P16991, DOI 10.1074/jbc.271.29.16991; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Morshed N, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209819; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Propster JM, 2016, P NATL ACAD SCI USA, V113, pE4170, DOI 10.1073/pnas.1602214113; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Scheltens P, 2021, LANCET, V397, P1577, DOI 10.1016/S0140-6736(20)32205-4; Schwabe T, 2020, NEUROBIOL DIS, V143, DOI 10.1016/j.nbd.2020.104962; Shen HH, 2018, P NATL ACAD SCI USA, V115, P9813, DOI 10.1073/pnas.1815273115; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Varki A., 2017, ESSENTIALS GLYCOBIOL, VThird, P453; Yu HF, 2017, GLYCOBIOLOGY, V27, P657, DOI 10.1093/glycob/cwx026; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhang Z, 2017, P NATL ACAD SCI USA, V114, pE2947, DOI 10.1073/pnas.1615036114	58	1	1	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101960	10.1016/j.jbc.2022.101960	http://dx.doi.org/10.1016/j.jbc.2022.101960			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35452678	Green Published, gold			2022-12-28	WOS:000807755100007
J	Shibuya, K; Ebihara, K; Ebihara, C; Sawayama, N; Isoda, M; Yamamuro, D; Takahashi, M; Nagashima, S; Ishibashi, S				Shibuya, Koji; Ebihara, Ken; Ebihara, Chihiro; Sawayama, Nagisa; Isoda, Masayo; Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Ishibashi, Shun			AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE; IDENTIFICATION; DYSFUNCTION; CLEAVAGE; MODELS; CDC48; MICE; RBD2; SCAP	Valosin-containing protein (VCP) is a member of AAAATPase superfamily involved in various cellular functions. To investigate the pathophysiological role of VCP in metabolic disorders, we generated knock-in mice bearing an A232E mutation in VCP, a known human VCP pathogenic variant. When heterozygous mutant mice (A232E/+) were fed a high-fat diet, we observed that fatty liver was ameliorated and the proteolytic processing of the transcription factor sterol regulatory element-binding protein 1 (SREBP1) was impaired. Further coimmunoprecipitation analysis in wildtype mice revealed interactions of VCP with SREBP1 and a rhomboid protease, RHBDL4, in the liver, and these interactions were attenuated in A232E/+ mice. Consistent with these results, we show that knockdown or chemical inhibition of VCP or RHBDL4 in human hepatocytes impaired the proteolytic processing of SREBP1. Finally, we found that knockdown of E3 ligases such as glycoprotein 78 and HMG-CoA reductase degradation protein 1 disrupted the interaction of VCP with SREBP1 and impaired the proteolytic processing of SREBP1. These results suggest that VCP recognizes ubiquitinylated SREBP1 and recruits it to RHBDL4 to promote its proteolytic processing. The present study reveals a novel proteolytic processing pathway of SREBP1 and may lead to development of new therapeutic strategies to treat fatty liver diseases.	[Shibuya, Koji; Ebihara, Ken; Ebihara, Chihiro; Sawayama, Nagisa; Isoda, Masayo; Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Ishibashi, Shun] Jichi Med Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Shimotsuke, Tochigi, Japan	Jichi Medical University	Ebihara, K (corresponding author), Jichi Med Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Shimotsuke, Tochigi, Japan.	kebihara@jichi.ac.jp		Nagashima, Shuichi/0000-0003-2509-8588				Burr R, 2017, J BIOL CHEM, V292, P16333, DOI 10.1074/jbc.M117.802025; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Hodson L, 2019, P NUTR SOC, V78, P126, DOI 10.1017/S0029665118002653; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Ide Y, 2019, JACC-BASIC TRANSL SC, V4, P701, DOI 10.1016/j.jacbts.2019.06.001; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Marjot T, 2020, ENDOCR REV, V41, P66, DOI 10.1210/endrev/bnz009; Matthews KA, 2010, GENETICS, V185, P189, DOI 10.1534/genetics.110.114975; Monnerie H, 2017, J NEUROCHEM, V140, P53, DOI 10.1111/jnc.13721; Nakakuki S., 2021, BIORXIV, DOI [10.1101/457590, DOI 10.1101/457590]; Nakano M, 2017, EBIOMEDICINE, V22, P225, DOI 10.1016/j.ebiom.2017.07.024; Nakano N, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00096; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Peng J, 2018, CELL PHYSIOL BIOCHEM, V47, P784, DOI 10.1159/000490030; Pennisi G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224334; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Tang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20037; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tong ZT, 2014, MOL CELL PROTEOMICS, V13, P2871, DOI 10.1074/mcp.M114.040774; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wei JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06091-7; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Yoshino S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70689-5; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112	37	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101936	10.1016/j.jbc.2022.101936	http://dx.doi.org/10.1016/j.jbc.2022.101936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35430252	gold, Green Published			2022-12-28	WOS:000807750700013
J	Navas, LE; Zahn, M; Bajwa, H; Grigg, JC; Wolf, ME; Chan, ACK; Murphy, MEP; McGeehan, JE; Eltis, LD				Navas, Laura E.; Zahn, Michael; Bajwa, Harbir; Grigg, Jason C.; Wolf, Megan E.; Chan, Anson C. K.; Murphy, Michael E. P.; McGeehan, John E.; Eltis, Lindsay D.			Characterization of a phylogenetically distinct extradiol dioxygenase involved in the bacterial catabolism of lignin-derived aromatic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; MICROBIAL-DEGRADATION; RHODOCOCCUS; BIPHENYL; PURIFICATION; METABOLISM; STEROIDS; PRODUCT; PATHWAY; RHA1	The actinobacterium Rhodococcus jostii RHA1 grows on a remarkable variety of aromatic compounds and has been studied for applications ranging from the degradation of polychlorinated biphenyls to the valorization of lignin, an underutilized component of biomass. In RHA1, the catabolism of two classes of lignin-derived compounds, alkylphenols and alkylguaiacols, involves a phylogenetically distinct extradiol dioxygenase, AphC, previously misannotated as BphC, an enzyme involved in biphenyl catabolism. To better understand the role of AphC in RHA1 catabolism, we first showed that purified AphC had highest apparent specificity for 4-propylcatechol (kcat/KM X106 M-1 s(-1)), and its apparent specificity for 4-alkylated substrates followed the trend for alkylguaiacols: propyl > ethyl > methyl > phenyl > unsubstituted. We also show AphC only poorly cleaved 3-phenylcatechol, the preferred substrate of BphC. Moreover, AphC and BphC cleaved 3-phenylcatechol and 4-phenylcatechol with different regiospecificities, likely due to the substrates' binding mode. A crystallographic structure of the AphC.4-ethylcatechol binary complex to 1.59 & ANGS; resolution revealed that the catechol is bound to the active site iron in a bidentate manner and that the substrate's alkyl side chain is accommodated by a hydrophobic pocket. Finally, we show RHA1 grows on a mixture of 4-ethylguaiacol and guaiacol, simultaneously catabolizing these substrates through meta -cleavage and ortho-cleavage pathways, respectively, suggesting that the specificity of AphC helps to prevent the routing of catechol through the Aph pathway. Overall, this study contributes to our understanding of the bacterial catabolism of aromatic compounds derived from lignin, and the determinants of specificity in extradiol dioxygenases.	[Navas, Laura E.; Bajwa, Harbir; Grigg, Jason C.; Wolf, Megan E.; Chan, Anson C. K.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Zahn, Michael; McGeehan, John E.] Univ Portsmouth, Sch Biol Sci, Ctr Enzyme Innovat, Portsmouth, Hants, England	University of British Columbia; University of Portsmouth	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada.	leltis@mail.ubc.ca		Grigg, Jason/0000-0002-5627-273X; McGeehan, John/0000-0002-6750-1462; Zahn, Michael/0000-0002-5709-8665; Bajwa, Harbir/0000-0003-2725-031X; Navas, Laura/0000-0002-8303-8439	Natural Sciences and Engineering Research Council of Canada [STPGP 506595, DG 171359, DG 04802]; Canada Research Chair; Research England	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Research England(UK Research & Innovation (UKRI))	This study was supported by the following grants from the Natural Sciences and Engineering Research Council of Canada: STPGP 506595 to 17 and DG 171359 to L. D. E.; and DG 04802 to M. E. P. M. L. D. E. is the recipient of a Canada Research Chair. M. Z. and J. E. M. acknowledge Research England for E3 funding.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; CATELANI D, 1971, BIOCHEM J, V121, P89, DOI 10.1042/bj1210089; CATELANI D, 1973, BIOCHEM J, V134, P1063, DOI 10.1042/bj1341063; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Chen HP, 2012, APPL ENVIRON MICROB, V78, P586, DOI 10.1128/AEM.06876-11; Cho JH, 2009, J BIOL CHEM, V284, P34321, DOI 10.1074/jbc.M109.031054; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DAGLEY S, 1960, NATURE, V188, P560, DOI 10.1038/188560a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eltis L.D., 2018, LIGNIN VALORIZATION, P290, DOI [10.1039/9781788010351-00290, DOI 10.1039/9781788010351-00290]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fetherolf MM, 2020, P NATL ACAD SCI USA, V117, P25771, DOI 10.1073/pnas.1916349117; Fielding AJ, 2014, J BIOL INORG CHEM, V19, P491, DOI 10.1007/s00775-014-1122-9; Fortin PD, 2005, J BIOL CHEM, V280, P42307, DOI 10.1074/jbc.M510456200; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Goncalves ER, 2006, APPL ENVIRON MICROB, V72, P6183, DOI 10.1128/AEM.00947-06; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Levy-Booth DJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01862; Liao YH, 2020, SCIENCE, V367, P1385, DOI 10.1126/science.aau1567; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Patrauchan MA, 2005, J BACTERIOL, V187, P4050, DOI 10.1128/JB.187.12.4050-4063.2005; Sakai M, 2002, J BIOSCI BIOENG, V93, P421, DOI 10.1263/jbb.93.421; Sambrock J., 1990, MOL CLONING MANUAL L; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; SETO M, 1995, APPL ENVIRON MICROB, V61, P4510, DOI 10.1128/AEM.61.12.4510-4513.1995; Syed Ibrahim B., 2010, [Crystal structure of 2,3-Dihydroxy biphenyl dioxygenase from Rhodo-coccus sp. (strain RHA1), PDB], DOI 10.2210/pdb3lm4/pdb; Takeo M, 2007, BIOSCI BIOTECH BIOCH, V71, P1668, DOI 10.1271/bbb.70079; Tickle I.J., 2018, STARANISO; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yam KC, 2011, CAN J MICROBIOL, V57, P155, DOI 10.1139/W10-115; Yam KC, 2010, MICROBIOL MONOGR, V16, P133, DOI 10.1007/978-3-642-12937-7_6	44	0	0	7	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101871	10.1016/j.jbc.2022.101871	http://dx.doi.org/10.1016/j.jbc.2022.101871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35346686	gold, Green Published			2022-12-28	WOS:000798142000010
J	Sayyed, UMH; Mahalakshmi, R				Sayyed, Ulfat Mohd Hanif; Mahalakshmi, Radhakrishnan			Mitochondrial protein translocation machinery: From TOM structural biogenesis to functional regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OUTER-MEMBRANE PROTEIN; INTERMEMBRANE SPACE PROTEINS; IMPORT RECEPTORS TOM20; DISULFIDE RELAY SYSTEM; SMALL TIM PROTEINS; PREPROTEIN TRANSLOCASE; PRECURSOR PROTEINS; INNER MEMBRANE; CORE COMPLEX; PRESEQUENCE TRANSLOCASE	The human mitochondrial outer membrane is biophysically unique as it is the only membrane possessing transmembrane beta-barrel proteins (mitochondrial outer membrane proteins, mOMPs) in the cell. The most vital of the three mOMPs is the core protein of the translocase of the outer mitochondrial membrane (TOM) complex. Identified first as MOM38 in Neurospora in 1990, the structure of Tom40, the core 19-stranded beta-barrel translocation channel, was solved in 2017, after nearly three decades. Remarkably, the past four years have witnessed an exponential increase in structural and functional studies of yeast and human TOM complexes. In addition to being conserved across all eukaryotes, the TOM complex is the sole ATP-independent import machinery for nearly all of the 1000 to 1500 known mitochondrial proteins. Recent cryo-EM structures have provided detailed insight into both possible assembly mechanisms of the TOM core complex and organizational dynamics of the import machinery and now reveal novel regulatory interplay with other mOMPs. Functional characterization of the TOM complex using biochemical and structural approaches has also revealed mechanisms for substrate recognition and at least five defined import pathways for precursor proteins. In this review, we discuss the discovery, recently solved structures, molecular function, and regulation of the TOM complex and its constituents, along with the implications these advances have for alleviating human diseases.	[Sayyed, Ulfat Mohd Hanif; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Mol Biophys Lab, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Mol Biophys Lab, Bhopal, India.	maha@iiserb.ac.in	Mahalakshmi, Radhakrishnan/B-3143-2008	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Council of Scientific and Industrial Research (CSIR), India; Department of Biotechnology [BT/PR28858/BRB/10/1718/2018]; India Alliance grants [IA/I/14/1/501305, IA/S/20/2/505182]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; India Alliance grants	U. M. H. S. is supported by a research fellowship from the Council of Scientific and Industrial Research (CSIR), India. R. M. is a DBT -Wellcome Trust India Alliance Senior fellow. This work is supported by the India Alliance grants IA/I/14/1/501305 and IA/S/20/2/505182, and the Department of Biotechnology grant BT/PR28858/BRB/10/1718/2018, to R. M.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Albrecht R, 2006, EMBO REP, V7, P1233, DOI 10.1038/sj.embor.7400828; Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Araiso Y, 2019, NATURE, V575, P395, DOI 10.1038/s41586-019-1680-7; Backes S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108936; Backes S, 2019, MOL BIOL EVOL, V36, P742, DOI 10.1093/molbev/msz011; Backes S, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00083; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bausewein T, 2017, CELL, V170, P693, DOI 10.1016/j.cell.2017.07.012; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Bykov YS, 2020, TRENDS BIOCHEM SCI, V45, P650, DOI 10.1016/j.tibs.2020.04.001; Callegari S, 2020, BIOL CHEM, V401, P709, DOI 10.1515/hsz-2020-0101; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chaturvedi D, 2017, BBA-BIOMEMBRANES, V1859, P2467, DOI 10.1016/j.bbamem.2017.09.020; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dekker PJT, 1996, BIOL CHEM, V377, P535; Dembowski M, 2001, J BIOL CHEM, V276, P17679, DOI 10.1074/jbc.M009653200; den Brave F, 2021, BIOCHEM J, V478, P3125, DOI 10.1042/BCJ20190584; Diederichs KA, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166894; Diederichs KA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17144-1; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Dimmer KS, 2012, J CELL SCI, V125, P3464, DOI 10.1242/jcs.103804; Drwesh L, 2020, BIOL CHEM, V401, P677, DOI 10.1515/hsz-2019-0440; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Edwards R, 2020, BIOL CHEM, V401, P737, DOI 10.1515/hsz-2020-0114; Elkouzi A, 2019, NAT REV NEUROL, V15, P204, DOI 10.1038/s41582-019-0155-7; Ellenrieder L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13021; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Gabriel Kipros, 2007, V390, P99; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gebert N, 2008, EMBO REP, V9, P548, DOI 10.1038/embor.2008.49; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Gomes F, 2017, J BIOL CHEM, V292, P17011, DOI 10.1074/jbc.M117.788588; Gomkale R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26016-1; Gornicka A, 2014, MOL BIOL CELL, V25, P3999, DOI 10.1091/mbc.E14-06-1155; Guan ZY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00252-7; Gupta A, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148323; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hansen KG, 2019, PROTEIN J, V38, P330, DOI 10.1007/s10930-019-09819-6; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Harsman A, 2011, EUR J CELL BIOL, V90, P721, DOI 10.1016/j.ejcb.2011.04.012; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hohr AIC, 2018, SCIENCE, V359, P289, DOI 10.1126/science.aah6834; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Ieva R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3853; Imai K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-79; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Jores T, 2018, J CELL BIOL, V217, P3091, DOI 10.1083/jcb.201712029; Jores T, 2017, FEBS LETT, V591, P2671, DOI 10.1002/1873-3468.12726; Jores T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12036; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KIEBLER M, 1993, J MEMBRANE BIOL, V135, P191; Doan KN, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107567; Komiya T, 1997, EMBO J, V16, P4267, DOI 10.1093/emboj/16.14.4267; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kreimendahl S, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00888-z; Kreimendahl S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197262; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Kruger V, 2017, J CELL BIOL, V216, P3485, DOI 10.1083/jcb.201706043; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lu H, 2004, J BIOL CHEM, V279, P18959, DOI 10.1074/jbc.M313046200; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Malhotra K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700532; Marom M, 2011, J BIOL CHEM, V286, P43809, DOI 10.1074/jbc.M111.261040; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Michaelis G, 2005, GENE, V354, P58, DOI 10.1016/j.gene.2005.04.020; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Moitra A, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.732742; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Morgenstern M, 2017, CELL REP, V19, P2836, DOI 10.1016/j.celrep.2017.06.014; Moulin C, 2019, BBA-MOL CELL RES, V1866, P930, DOI 10.1016/j.bbamcr.2019.02.012; Namba T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1386; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Nargang FE, 1998, MOL CELL BIOL, V18, P3173, DOI 10.1128/MCB.18.6.3173; Needs HI, 2021, LIFE-BASEL, V11, DOI 10.3390/life11050432; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009; Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Palmer CS, 2021, J CELL SCI, V134, DOI 10.1242/jcs.252197; Palmer CS, 2021, FEBS LETT, V595, P1107, DOI 10.1002/1873-3468.14022; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Pfitzner AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep39053; Pitt AS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051164; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rapaport D, 1998, MOL CELL BIOL, V18, P5256, DOI 10.1128/MCB.18.9.5256; Rapaport D, 1998, J BIOL CHEM, V273, P8806, DOI 10.1074/jbc.273.15.8806; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rapaport D, 2019, NAT STRUCT MOL BIOL, V26, P1083, DOI 10.1038/s41594-019-0346-3; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; ROISE D, 1988, J BIOL CHEM, V263, P4509; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Sakaue H, 2019, MOL CELL, V73, P1044, DOI 10.1016/j.molcel.2019.01.003; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schmitt S, 2005, J BIOL CHEM, V280, P14499, DOI 10.1074/jbc.M413667200; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Sirrenberg C, 1997, J BIOL CHEM, V272, P29963, DOI 10.1074/jbc.272.47.29963; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; Song JY, 2014, EMBO REP, V15, P670, DOI 10.1002/embr.201338142; Stan T, 2000, EMBO J, V19, P4895, DOI 10.1093/emboj/19.18.4895; Sucec I, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.762005; Sucec I, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd0263; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Takeda H, 2021, NATURE, V590, P163, DOI 10.1038/s41586-020-03113-7; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Truscott KN, 2001, REV PHYSIOL BIOCH P, V143, P81, DOI 10.1007/BFb0115593; Tucker K, 2019, NAT STRUCT MOL BIOL, V26, P1158, DOI 10.1038/s41594-019-0339-2; van der Laan M, 2006, FEMS YEAST RES, V6, P849, DOI 10.1111/j.1567-1364.2006.00134.x; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; Vitali DG, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100779; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wang Q, 2021, SCIENCE, V373, P1377, DOI 10.1126/science.abh0704; Wang S., 2021, BIORXIV, DOI [10.1101/2021.1109.1128.462098, DOI 10.1101/2021.1109.1128.462098]; Wang WH, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00198-2; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Weinhaupl K, 2018, CELL, V175, P1365, DOI 10.1016/j.cell.2018.10.039; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Yamano K, 2010, J BIOL CHEM, V285, P41222, DOI 10.1074/jbc.M110.163238; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019; Zhou S, 2021, CELL RES, V31, P821, DOI 10.1038/s41422-020-00452-y	189	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101870	10.1016/j.jbc.2022.101870	http://dx.doi.org/10.1016/j.jbc.2022.101870			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35346689	gold, Green Published			2022-12-28	WOS:000860390500009
J	Schwank, K; Schmid, C; Fremter, T; Milkereit, P; Griesenbeck, J; Tschochner, H				Schwank, Katrin; Schmid, Catharina; Fremter, Tobias; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert			RNA polymerase I (Pol I) lobe-binding subunit Rpa12.2 promotes RNA cleavage and proofreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL FIDELITY; A12.2 SUBUNIT; NUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; ELONGATION; TFIIS; RPB9; ARCHITECTURE; MECHANISMS; TERMINATION	Elongating nuclear RNA polymerases (Pols) frequently pause, backtrack, and are then reactivated by endonucleolytic cleavage. Pol backtracking and RNA cleavage are also crucial for proofreading, which contributes to transcription fidelity. RNA polymerase I (Pol I) of the yeast Saccharomyces cerevisiae synthesizes exclusively 35S rRNA, the precursor transcript of mature ribosomal 5.8S, 18S, and 25S rRNA. Pol I contains the specific heterodimeric subunits Rpa34.5/49 and subunit Rpa12.2, which have been implicated in RNA cleavage and elongation activity, respectively. These subunits are associated with the Pol I lobe structure and encompass different structural domains, but the contribution of these domains to RNA elongation is unclear. Here, we used Pol I mutants or reconstituted Pol I enzymes to study the effects of these subunits and/or their distinct domains on RNA cleavage, backtracking, and transcription fidelity in defined in vitro systems. Our findings suggest that the presence of the intact C-terminal domain of Rpa12.2 is sufficient to support the cleavage reaction, but that the N-terminal domains of Rpa12.2 and the heterodimer facilitate backtracking and RNA cleavage. Since both N-terminal and C-terminal domains of Rpa12.2 were also required to faithfully incorporate NTPs in the growing RNA chain, efficient backtracking and RNA cleavage might be a prerequisite for transcription fidelity. We propose that RNA Pols containing efficient RNA cleavage activity are able to add and remove nucleotides until the matching nucleotide supports RNA chain elongation, whereas cleavage-deficient enzymes can escape this proofreading process by incorporating incorrect nucleotides.	[Schwank, Katrin; Schmid, Catharina; Fremter, Tobias; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert] Univ Regensburg, Lehrstuhl Biochemie 3, Regensburg Ctr Biochem RCB, Regensburg, Germany	University of Regensburg	Milkereit, P; Griesenbeck, J; Tschochner, H (corresponding author), Univ Regensburg, Lehrstuhl Biochemie 3, Regensburg Ctr Biochem RCB, Regensburg, Germany.	philipp.milkereit@ur.de; joachim.griesenbeck@ur.de; herbert.tschochner@ur.de		Griesenbeck, Joachim/0000-0002-7817-6095	Deutsche For-schungsgemeinschaft [SFB 960]	Deutsche For-schungsgemeinschaft(German Research Foundation (DFG))	Acknowledgments-We are grateful to members of the chair Biochemistry III and especially to Christoph Engel and the members of his group for critical discussion. Michael Pilsl?s advice for development and improvement of methods is greatly appreciated. This work was supported through grants of the Deutsche For-schungsgemeinschaft (grant no.: SFB 960) .	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Appling FD, 2018, BIOPHYS J, V114, P2507, DOI 10.1016/j.bpj.2018.04.015; Appling FD, 2017, BIOCHEMISTRY-US, V56, P5654, DOI 10.1021/acs.biochem.7b00370; Appling FD, 2015, BIOPHYS J, V109, P2382, DOI 10.1016/j.bpj.2015.10.037; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Burke D., 2000, METHODS YEAST GENETI; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gout JF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701484; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Knippa K, 2013, BIOCHEMISTRY-US, V52, P7807, DOI 10.1021/bi4009566; Knutson BA, 2020, BIOCHEM SOC T, V48, P1917, DOI 10.1042/BST20190848; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kujirai T, 2020, CURR OPIN STRUC BIOL, V61, P42, DOI 10.1016/j.sbi.2019.10.007; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Luse DS, 2011, RNA BIOL, V8, P581, DOI 10.4161/rna.8.4.15389; Merkl P, 2014, MOL CELL BIOL, V34, P3817, DOI 10.1128/MCB.00395-14; Merkl PE, 2020, J BIOL CHEM, V295, P4782, DOI 10.1074/jbc.RA119.011827; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; Gonzalez MN, 2021, NAT REV MOL CELL BIO, V22, P3, DOI 10.1038/s41580-020-00308-8; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Roldan E, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.062411; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Scull CE, 2021, BIOPHYS J, V120, P1883, DOI 10.1016/j.bpj.2021.03.007; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Xu L, 2015, CRIT REV BIOCHEM MOL, V50, P503, DOI 10.3109/10409238.2015.1087960; Xu L, 2014, DNA REPAIR, V19, P71, DOI 10.1016/j.dnarep.2014.03.024; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zhao D, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00335-5	59	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101862	10.1016/j.jbc.2022.101862	http://dx.doi.org/10.1016/j.jbc.2022.101862			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35341765	Green Published, gold			2022-12-28	WOS:000817175700010
J	Sur, S; Steele, R; Ko, BCB; Zhang, JS; Ray, RB				Sur, Subhayan; Steele, Robert; Ko, Ben C. B.; Zhang, Jinsong; Ray, Ratna B.			Long noncoding RNA ELDR promotes cell cycle progression in normal oral keratinocytes through induction of a CTCF-FOXM1-AURKA signaling axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; CANCER; FOXM1; EXPRESSION; PACKAGE; CTCF; OVEREXPRESSION; PROGRAM; DRIVEN; GROWTH	Long noncoding RNAs (lncRNAs) have gained widespread attention as a new layer of regulation in biological processes during development and disease. The lncRNA ELDR (EGFR long noncoding downstream RNA) was recently shown to be highly expressed in oral cancers as compared to adjacent nontumor tissue, and we previously reported that ELDR may be an oncogene as inhibition of ELDR reduces tumor growth in oral cancer models. Furthermore, overexpression of ELDR induces proliferation and colony formation in normal oral keratinocytes (NOKs). In this study, we examined in further detail how ELDR drives the neoplastic transformation of normal keratinocytes. We performed RNA-seq analysis on NOKs stably expressing ELDR (NOK-ELDR), which revealed that ELDR enhances the expression of cell cycle-related genes. Expression of Aurora kinase A and its downstream targets Polo-like kinase 1, cell division cycle 25C, cyclin-dependent kinase 1, and cyclin B1 (CCNB1) are significantly increased in NOK-ELDR cells, suggesting induction of G2/M progression. We further identified CCCTC-binding factor (CTCF) as a binding partner of ELDR in NOK-ELDR cells. We show that ELDR stabilizes CTCF and increases its expression. Finally, we demonstrate the ELDR-CTCF axis upregulates transcription factor Forkhead box M1, which induces Aurora kinase A expression and downstream G2/M transition. These findings provide mechanistic insights into the role of the lncRNA ELDR as a potential driver of oral cancer during neoplastic trans-formation of normal keratinocytes.	[Sur, Subhayan; Steele, Robert; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Ko, Ben C. B.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China; [Zhang, Jinsong] St Louis Univ, Dept Pharmacol, St Louis, MO USA; [Zhang, Jinsong] St Louis Univ, Dept Physiol, St Louis, MO USA	Saint Louis University; Hong Kong Polytechnic University; Saint Louis University; Saint Louis University	Ray, RB (corresponding author), St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.	ratna.ray@health.slu.edu	Ko, Chi-bun/ACH-7514-2022; Sur, Subhayan/GLR-4605-2022	Sur, Subhayan/0000-0002-4208-9694; Zhang, Jinsong/0000-0002-8798-7316; Ko, Ben Chi Bun/0000-0003-2027-5899	National Institutes of Health [R01 DE024942]; Saint Louis University Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University Cancer Center	This work was supported by research grant R01 DE024942 from the National Institutes of Health, and Saint Louis University Cancer Center Seed Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken SJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1484-3; Puig-Butille JA, 2017, J INVEST DERMATOL, V137, P1297, DOI 10.1016/j.jid.2017.01.021; Aznaourova M, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.527484; Bailey CG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123832; Bhan S, 2012, ONCOL REP, V28, P1498, DOI 10.3892/or.2012.1934; Carelli S, 2019, RNA BIOL, V16, P1471, DOI 10.1080/15476286.2019.1637698; Chow A., 2010, NEW ED, V3, P7; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Du RJ, 2021, MOL CANCER, V20, DOI 10.1186/s12943-020-01305-3; Gartel AL, 2017, CANCER RES, V77, P3135, DOI 10.1158/0008-5472.CAN-16-3566; Gavilan E, 2015, SCI REP-UK, V5, DOI 10.1038/srep10027; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gloss BS, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0087-0; Goff LA, 2015, P NATL ACAD SCI USA, V112, P6855, DOI 10.1073/pnas.1411263112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou DW, 2018, BIOCHEM BIOPH RES CO, V507, P83, DOI 10.1016/j.bbrc.2018.10.170; Irimie AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122620; Jaiswal N., 2014, J PROTEINS PROTEOMIC, V5, P1; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Krayzler E, 2015, CANCER GENOM PROTEOM, V12, P73; Lai QH, 2020, AGING-US, V12, P16270, DOI 10.18632/aging.103648; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liao GB, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0266-6; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Nishiyama K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0893-2; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piboonniyom SO, 2003, CANCER RES, V63, P476; Qi CF, 2012, INT J MOL SCI, V13, P6204, DOI 10.3390/ijms13056204; Ray RB, 1998, GENE, V208, P331, DOI 10.1016/S0378-1119(98)00030-4; Ren G, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0347-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldana-Meyer R, 2019, MOL CELL, V76, P412, DOI 10.1016/j.molcel.2019.08.015; Sanz-Gomez N, 2020, CELL DEATH DIFFER, V27, P2451, DOI 10.1038/s41418-020-0515-2; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sekiya T, 2017, FEBS OPEN BIO, V7, P397, DOI 10.1002/2211-5463.12189; [Сергушичев А.А. Sergushichev A.A.], 2016, [Научно-технический вестник информационных технологий, механики и оптики, Scientific and Technical Journal of Information Technologies Mechanics and Optics, Nauchno-tekhnicheskii vestnik informatsionnykh tekhnologii, mekhaniki i optiki], V16, P956, DOI 10.17586/2226-1494-2016-16-5-956-959; Shih JW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15874; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Steinauer N, 2019, BLOOD ADV, V3, P1379, DOI 10.1182/bloodadvances.2018028514; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur S, 2020, EMBO REP, V21, DOI 10.15252/embr.202051042; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Tichon A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12209; Tsou HH, 2021, CANCERS, V13, DOI 10.3390/cancers13143544; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022; Weth O, 2011, BIOCHEM CELL BIOL, V89, P459, DOI [10.1139/O11-033, 10.1139/o11-033]; Wierstra I, 2013, ADV CANCER RES, V119, P191, DOI 10.1016/B978-0-12-407190-2.00016-2; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang B, 2017, J PATHOL, V243, P418, DOI 10.1002/path.4976; Zhang L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1021-3; Zhao SL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/986048	61	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5								10.1016/j.jbc.2022.101895	http://dx.doi.org/10.1016/j.jbc.2022.101895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35378133	gold, Green Published			2022-12-28	WOS:000798082100014
J	Walker, EJ; Bettinger, JQ; Welle, KA; Hryhorenko, JR; Vargas, AMM; O'Connell, MR; Ghaemmaghami, S				Walker, Ethan J.; Bettinger, John Q.; Welle, Kevin A.; Hryhorenko, Jennifer R.; Vargas, Adrian M. Molina; O'Connell, Mitchell R.; Ghaemmaghami, Sina			Protein folding stabilities are a major determinant of oxidation rates for buried methionine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ANTIOXIDANT DEFENSE; CONFORMATIONAL STABILITY; MASS-SPECTROMETRY; SULFOXIDE; ROLES; FLEXIBILITY; REDUCTASES; PREVENTION	The oxidation of protein-bound methionines to form methionine sulfoxides has a broad range of biological ramifi-cations, making it important to delineate factors that influence methionine oxidation rates within a given protein. This is especially important for biopharmaceuticals, where oxidation can lead to deactivation and degradation. Previously, neighboring residue effects and solvent accessibility have been shown to impact the susceptibility of methionine residues to oxidation. In this study, we provide proteome-wide evidence that oxidation rates of buried methionine residues are also strongly influenced by the thermodynamic folding stability of proteins. We surveyed the Escherichia coli proteome using several proteomic methodologies and globally measured oxidation rates of methionine residues in the presence and absence of tertiary structure, as well as the folding stabilities of methionine-containing domains. These data indicated that buried methionines have a wide range of protection factors against oxidation that correlate strongly with folding stabilities. Consistent with this, we show that in comparison to E. coli, the proteome of the thermophile Thermus thermophilus is significantly more stable and thus more resistant to methionine oxidation. To demonstrate the utility of this correlation, we used native methionine oxidation rates to survey the folding stabilities of E. coli and T. thermophilus proteomes at various temperatures and propose a model that relates the temperature dependence of the folding stabilities of these two species to their optimal growth temperatures. Overall, these results indicate that oxidation rates of buried methionines from the native state of proteins can be used as a metric of folding stability.	[Walker, Ethan J.; Bettinger, John Q.; Ghaemmaghami, Sina] Univ Rochester, Dept Biol, New York, NY USA; [Walker, Ethan J.; O'Connell, Mitchell R.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, New York, NY USA; [Welle, Kevin A.; Hryhorenko, Jennifer R.; Ghaemmaghami, Sina] Univ Rochester, Univ Rochester Mass Spectrometry Resource Lab, New York, NY USA; [Vargas, Adrian M. Molina] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, New York, NY USA; [Vargas, Adrian M. Molina; O'Connell, Mitchell R.] Univ Rochester, Ctr RNA Biol, New York, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Ghaemmaghami, S (corresponding author), Univ Rochester, Dept Biol, New York, NY USA.; Ghaemmaghami, S (corresponding author), Univ Rochester, Univ Rochester Mass Spectrometry Resource Lab, New York, NY USA.	sina.ghaemmaghami@rochester.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; Walker, Ethan/0000-0002-4376-7864; O'Connell, Mitchell/0000-0002-8642-3973; MOLINA VARGAS, ADRIAN MOISES/0000-0003-4090-1180; Bettinger, John/0000-0003-2534-0880	National Institutes of Health [R35 GM119502, S10 OD025242, R35 GM133462]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by grants from the National Institutes of Health (R35 GM119502 and S10 OD025242 to S. G, and R35 GM133462 to M. R. O?C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aledo JC, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1848-9; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bettinger JQ, 2020, J PROTEOME RES, V19, P624, DOI 10.1021/acs.jproteome.9b00505; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chu JW, 2004, BIOCHEMISTRY-US, V43, P1019, DOI 10.1021/bi0356000; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Delmar JA, 2021, MOL THER-METH CLIN D, V21, P466, DOI 10.1016/j.omtm.2021.03.023; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fremont S, 2017, J CELL SCI, V130, P1509, DOI 10.1242/jcs.202028; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Griffiths SW, 2002, BIOCHEMISTRY-US, V41, P6245, DOI 10.1021/bi025599p; Griffiths SW, 2002, J CHROMATOGR A, V942, P133, DOI 10.1016/S0021-9673(01)01350-4; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Manavalan B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36992-y; Manta B, 2017, FREE RADICAL BIO MED, V109, P141, DOI 10.1016/j.freeradbiomed.2017.02.010; Mateus A, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-017-0122-4; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Mulinacci F, 2011, J PHARM SCI-US, V100, P451, DOI 10.1002/jps.22293; Pace C N, 1986, Methods Enzymol, V131, P266; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pan B, 2006, BIOCHEMISTRY-US, V45, P15430, DOI 10.1021/bi061855c; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Salas CO, 2020, BIOCHEM SOC T, V48, P613, DOI 10.1042/BST20190866; Sankar K, 2018, MABS-AUSTIN, V10, P1281, DOI 10.1080/19420862.2018.1518887; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SCHONEICH C, 1993, BIOCHIM BIOPHYS ACTA, V1158, P307, DOI 10.1016/0304-4165(93)90030-C; Sharp JS, 2004, ANAL CHEM, V76, P672, DOI 10.1021/ac0302004; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; Thirumangalathu R, 2007, BIOCHEMISTRY-US, V46, P6213, DOI 10.1021/bi700321g; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Veredas FJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40403; VONECKARDSTEIN A, 1991, J LIPID RES, V32, P1465; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; West GM, 2008, ANAL CHEM, V80, P4175, DOI 10.1021/ac702610a; Xu KR, 2012, PROTEIN PEPTIDE LETT, V19, P688, DOI 10.2174/092986612800494084; Yang R, 2017, MABS-AUSTIN, V9, P646, DOI 10.1080/19420862.2017.1290753; Yin J, 2004, PHARM RES-DORDR, V21, P2377, DOI 10.1007/s11095-004-7692-4; Younan ND, 2012, J BIOL CHEM, V287, P28263, DOI 10.1074/jbc.M112.354779; Zang L, 2012, J CHROMATOGR B, V895, P71, DOI 10.1016/j.jchromb.2012.03.016; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	59	2	2	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101872	10.1016/j.jbc.2022.101872	http://dx.doi.org/10.1016/j.jbc.2022.101872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35346688	Green Published, gold, Green Submitted			2022-12-28	WOS:000798082100002
J	Zancla, A; Mozetic, P; Orsini, M; Forte, G; Rainer, A				Zancla, Andrea; Mozetic, Pamela; Orsini, Monica; Forte, Giancarlo; Rainer, Alberto			A primer to traction force microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SUBSTRATE STIFFNESS; FOCAL ADHESIONS; MATRIX; CELLS; TALIN; YAP; DYNAMICS; RIGIDITY; STRESS; TOOL	Traction force microscopy (TFM) has emerged as a versatile technique for the measurement of single-cell-generated forces. TFM has gained wide use among mechanobiology laboratories, and several variants of the original methodology have been proposed. However, issues related to the experimental setup and, most importantly, data analysis of cell traction datasets may restrain the adoption of TFM by a wider community. In this review, we summarize the state of the art in TFM-related research, with a focus on the analytical methods underlying data analysis. We aim to provide the reader with a friendly compendium underlying the potential of TFM and emphasizing the methodological framework required for a thorough understanding of experimental data. We also compile a list of data analytics tools freely available to the scientific community for the furtherance of knowledge on this powerful technique.	[Zancla, Andrea; Orsini, Monica] Univ Roma Tre, Dept Engn, Rome, Italy; [Zancla, Andrea; Rainer, Alberto] Univ Campus Biomed Roma, Dept Engn, Rome, Italy; [Mozetic, Pamela; Rainer, Alberto] CNR, Inst Nanotechnol NANOTEC, Lecce, Italy; [Mozetic, Pamela] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, Milan, Italy; [Forte, Giancarlo] St Annes Univ Hosp, Ctr Translat Med CTM, Int Clin Res Ctr ICRC, Brno, Czech Republic	Roma Tre University; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Nanotecnologia (NANOTEC-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; St Anne's University Hospital Brno (FNUSA-ICRC)	Rainer, A (corresponding author), Univ Campus Biomed Roma, Dept Engn, Rome, Italy.; Rainer, A (corresponding author), CNR, Inst Nanotechnol NANOTEC, Lecce, Italy.; Forte, G (corresponding author), St Annes Univ Hosp, Ctr Translat Med CTM, Int Clin Res Ctr ICRC, Brno, Czech Republic.	giancarlo.forte@fnusa.cz; a.rainer@unicampus.it		Zancla, Andrea/0000-0001-7900-6787	"Tecnopolo per la medicina di precisione" (TecnoMed Puglia)Regione Puglia [2117, CUP: B84I18000540002]; "Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione" (TECNOMED)-FISR/MIUR-CNR: delibera CIPE [3449, CUP: B83B17000010001]; European Regional Development Fund Project ENOCH [CZ.02.1.01/0.0/0.0/16_019/0000868]; European Social Fund; European Regional Development Fund-Project MAGNET [CZ.02.1.01/0.0/0.0/15_003/0000492]	"Tecnopolo per la medicina di precisione" (TecnoMed Puglia)Regione Puglia; "Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione" (TECNOMED)-FISR/MIUR-CNR: delibera CIPE; European Regional Development Fund Project ENOCH; European Social Fund(European Social Fund (ESF)); European Regional Development Fund-Project MAGNET	P. M. and A. R. acknowledge the "Tecnopolo per la medicina di precisione" (TecnoMed Puglia)Regione Puglia: DGR n.2117 dated 21/11/2018 (CUP: B84I18000540002) and "Tecnopolo di Nanotecnologia e Fotonica per la Medicina di Precisione" (TECNOMED)-FISR/MIUR-CNR: delibera CIPE n.3449 dated 07/08/2017 (CUP: B83B17000010001). G. F. was supported by the European Regional Development Fund Project ENOCH (No. CZ.02.1.01/0.0/0.0/16_019/0000868) and by the European Social Fund and European Regional Development Fund-Project MAGNET (CZ.02.1.01/0.0/0.0/15_003/0000492).	Ambrosi D, 2009, J MATH BIOL, V58, P163, DOI 10.1007/s00285-008-0167-1; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barbieri L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22377-9; Barrasa-Fano J, 2021, SOFTWAREX, V15, DOI 10.1016/j.softx.2021.100723; Basoli F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01449; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bergert M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12814; Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112; Broders-Bondon F, 2018, J CELL BIOL, V217, P1571, DOI 10.1083/jcb.201701039; Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Carey SP, 2012, CRIT REV ONCOL HEMAT, V83, P170, DOI 10.1016/j.critrevonc.2011.11.005; Choudhury AR, 2019, CANCER MICROENVIRON, V12, P17, DOI 10.1007/s12307-019-00222-4; Cirka H, 2016, BIOPHYS J, V110, P1845, DOI 10.1016/j.bpj.2016.02.036; Colin-York H, 2019, NANO LETT, V19, P4427, DOI 10.1021/acs.nanolett.9b01196; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Du LT, 2016, CANCER MED-US, V5, P1962, DOI 10.1002/cam4.719; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Ergir E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01417; Fang YQ, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042404; Farooque TM, 2014, BIOMATERIALS, V35, P2558, DOI 10.1016/j.biomaterials.2013.12.092; Feng XZ, 2016, COMPUT MECH, V58, P91, DOI 10.1007/s00466-016-1283-1; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd; Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074; Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j; Gupta M, 2015, METHOD CELL BIOL, V125, P289, DOI 10.1016/bs.mcb.2014.10.009; Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009; Han SJ, 2015, NAT METHODS, V12, P653, DOI [10.1038/NMETH.3430, 10.1038/nmeth.3430]; Hansen P. C., 1994, Numerical Algorithms, V6, P1, DOI 10.1007/BF02149761; Hansen PC, 2001, ADV COMP BIOENG, V5, P119; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Heintzmann R, 2017, CHEM REV, V117, P13890, DOI 10.1021/acs.chemrev.7b00218; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; Holenstein CN, 2017, SCI REP-UK, V7, DOI 10.1038/srep41633; Huang YF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36896-x; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hytonen VP, 2016, EXP CELL RES, V343, P35, DOI 10.1016/j.yexcr.2015.10.027; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x; Jorge-Penas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144184; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Kaylan KB, 2017, JOVE-J VIS EXP, DOI 10.3791/55362; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Kronenberg NM, 2017, NAT CELL BIOL, V19, P864, DOI 10.1038/ncb3561; Kulkarni AH, 2018, SOFT MATTER, V14, P4687, DOI 10.1039/c7sm02214j; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Lagares D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3765; Landau LD., 1986, THEORY ELASTICITY, V3; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425; Li Z, 2017, NANOSCALE, V9, P19039, DOI 10.1039/c7nr06284b; Liangguo W., 1988, ACTA MECH SINICA-PRC, V4, P138; Liehm P, 2018, BIOPHYS J, V114, P2180, DOI 10.1016/j.bpj.2018.03.034; Maki K, 2017, BIOCHEM BIOPH RES CO, V484, P372, DOI 10.1016/j.bbrc.2017.01.127; Martiel JL, 2015, METHOD CELL BIOL, V125, P269, DOI 10.1016/bs.mcb.2014.10.008; Martino F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00824; Mekhdjian AH, 2017, MOL BIOL CELL, V28, P1467, DOI 10.1091/mbc.E16-09-0654; Mulligan JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40608-4; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Munoz JJ, 2016, INT J NUMER ANAL MOD, V13, P763; Nardone G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15321; Pagliari S, 2021, CELL DEATH DIFFER, V28, P1193, DOI 10.1038/s41418-020-00643-5; Pasqualini FS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194706; Perestrelo AR, 2021, CIRC RES, V128, P24, DOI 10.1161/CIRCRESAHA.120.317685; Peschetola V, 2013, CYTOSKELETON, V70, P201, DOI 10.1002/cm.21100; Plotnikov SV, 2014, METHOD CELL BIOL, V123, P367, DOI 10.1016/B978-0-12-420138-5.00020-3; Polacheck WJ, 2016, NAT METHODS, V13, P415, DOI [10.1038/NMETH.3834, 10.1038/nmeth.3834]; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rahikainen R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03335-2; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Razafiarison T, 2018, P NATL ACAD SCI USA, V115, P4631, DOI 10.1073/pnas.1704543115; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Roca-Cusachs P, 2017, NAT CELL BIOL, V19, P742, DOI 10.1038/ncb3564; Rocha MS, 2015, INTEGR BIOL-UK, V7, P967, DOI 10.1039/c5ib00127g; Rodriguez ML, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027145; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Saez A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194119; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz KM, 2015, P NATL ACAD SCI USA, V112, pE3757, DOI 10.1073/pnas.1511304112; Schwarz US, 2015, BBA-MOL CELL RES, V1853, P3095, DOI 10.1016/j.bbamcr.2015.05.028; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Shiu JY, 2018, NAT CELL BIOL, V20, P262, DOI 10.1038/s41556-017-0030-y; Spill F, 2018, COMPUT STRUCT BIOTEC, V16, P237, DOI 10.1016/j.csbj.2018.07.002; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stehbens SJ, 2014, METHOD CELL BIOL, V123, P335, DOI 10.1016/B978-0-12-420138-5.00018-5; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Style RW, 2014, SOFT MATTER, V10, P4047, DOI 10.1039/c4sm00264d; Sune-Aunon A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1771-0; Takigawa T, 1996, POLYM GELS NETW, V4, P1, DOI 10.1016/0966-7822(95)00013-5; Tavares S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15237; TELLES JCF, 1981, INT J SOLIDS STRUCT, V17, P1149, DOI 10.1016/0020-7683(81)90094-9; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tikhonov A. N., 1995, NUMERICAL METHODS SO, DOI [DOI 10.1007/978-94-015-8480-7, 10.1007/978-94-015-8480-7]; Toepfer CN, 2019, CIRC RES, V124, P1172, DOI 10.1161/CIRCRESAHA.118.314505; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Verbruggen S., 2018, MECHANOBIOLOGY HLTH; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Westerweel J, 1997, MEAS SCI TECHNOL, V8, P1379, DOI 10.1088/0957-0233/8/12/002; Xiao F, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5005525; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9; Yan LB, 2014, ARCH BIOCHEM BIOPHYS, V562, P31, DOI 10.1016/j.abb.2014.07.024; Yang MT, 2007, ADV MATER, V19, P3119, DOI 10.1002/adma.200701956; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yoshie H, 2018, BIOPHYS J, V114, P2194, DOI 10.1016/j.bpj.2018.02.045; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720	127	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101867	10.1016/j.jbc.2022.101867	http://dx.doi.org/10.1016/j.jbc.2022.101867			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35351517	gold, Green Published			2022-12-28	WOS:000860390500007
J	Ahmed, S; Manjunath, K; Chattopadhyay, G; Varadarajan, R				Ahmed, Shahbaz; Manjunath, Kavyashree; Chattopadhyay, Gopinath; Varadarajan, Raghavan			Identification of stabilizing point mutations through mutagenesis of destabilized protein libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE DISPLAY; DIRECTED EVOLUTION; IN-VIVO; SEQUENCE; ANTIBODIES; EXPRESSION; GENERATION; SECRETION; DESIGN; ASSAY	Although there have been recent transformative advances in the area of protein structure prediction, prediction of point mutations that improve protein stability remains challenging. It is possible to construct and screen large mutant libraries for improved activity or ligand binding. However, reliable screens for mutants that improve protein stability do not yet exist, especially for proteins that are well folded and relatively stable. Here, we demonstrate that incorporation of a single, specific, destabilizing mutation termed parent inactivating mutation into each member of a single-site saturation mutagenesis library, followed by screening for suppressors, allows for robust and accurate identification of stabilizing mutations. We carried out fluorescence-activated cell sorting of such a yeast surface display, saturation suppressor library of the bacterial toxin CcdB, followed by deep sequencing of sorted populations. We found that multiple stabilizing mutations could be identified after a single round of sorting. In addition, multiple libraries with different parent inactivating mutations could be pooled and simultaneously screened to further enhance the accuracy of identification of stabilizing mutations. Finally, we show that individual stabilizing mutations could be combined to result in a multi-mutant that demonstrated an increase in thermal melting temperature of about 20 degrees C, and that displayed enhanced tolerance to high temperature exposure. We conclude that as this method is robust and employs small library sizes, it can be readily extended to other display and screening formats to rapidly isolate stabilized protein mutants.	[Ahmed, Shahbaz; Chattopadhyay, Gopinath; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [Manjunath, Kavyashree] Inst Stem Cell Sci & Regenerat Med, Ctr Chem Biol & Therapeut, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India.	varadar@iisc.ac.in		Manjunath, Kavyashree/0000-0002-1838-5362; Chattopadhyay, Gopinath/0000-0002-6408-1968	Department of Science and Technology, Government of India [EMR/2017/004054]; Department of Biotechnology [BT/COE/34/SP15219/2015]; Ministry of Science and Technology, Government of India; Bill and Melinda Gates Foundation (USA) [INV-005948]; Council of Scientific & Industrial Research [SPM-07/079(0218)/2015EMR-I]; Department of Science and Technology (DST) Science and Engineering Research Board [PDF/2017/002641]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology; Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India); Bill and Melinda Gates Foundation (USA)(Bill & Melinda Gates Foundation); Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST) Science and Engineering Research Board(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funding and additional information-This work was funded by grants to R. V. from the Department of Science and Technology, grant number-EMR/2017/004054, DT.15/12/2018), Government of India; Department of Biotechnology, grant no. BT/COE/34/SP15219/2015 DT, 20/11/2015, Ministry of Science and Technology, Government of India and Bill and Melinda Gates Foundation (USA) (INV-005948). S. A. acknowledges the Council of Scientific & Industrial Research for his fellowship (SPM-07/079(0218)/2015EMR-I). K. M. is thankful to the Department of Science and Technology (DST) Science and Engineering Research Board for financial support, sanction order no: PDF/2017/002641. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; Ahmed S, 2022, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.800819; Ahmed S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.765211; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BLACKLOW SC, 1991, BIOCHEMISTRY-US, V30, P8470, DOI 10.1021/bi00098a026; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Cao HL, 2019, J CHEM INF MODEL, V59, P1508, DOI 10.1021/acs.jcim.8b00697; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chattopadhyay G, 2019, PROTEIN SCI, V28, P1127, DOI 10.1002/pro.3622; Chen YT, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008543; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; G. Chattopadhyay, 2022, bioRxiv, DOI 10.1101/2021.11.18.469098; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Golinski AW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026658118; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; HERMES JD, 1990, P NATL ACAD SCI USA, V87, P696, DOI 10.1073/pnas.87.2.696; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Kemble H, 2019, EVOL APPL, V12, P1721, DOI 10.1111/eva.12846; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; LEHTOVAARA PM, 1988, PROTEIN ENG, V2, P63, DOI 10.1093/protein/2.1.63; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Mimmi S, 2019, TRENDS PHARMACOL SCI, V40, P87, DOI 10.1016/j.tips.2018.12.005; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Park S, 2006, PROTEIN ENG DES SEL, V19, P211, DOI 10.1093/protein/gzl003; Pavoor TV, 2012, PROTEIN ENG DES SEL, V25, P625, DOI 10.1093/protein/gzs041; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Sahoo A, 2015, ELIFE, V4, DOI 10.7554/eLife.09532; Savojardo C, 2016, BIOINFORMATICS, V32, P2542, DOI 10.1093/bioinformatics/btw192; Schwimmer LJ, 2013, J IMMUNOL METHODS, V391, P60, DOI 10.1016/j.jim.2013.02.010; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Tripathi A, 2016, MOL BIOL EVOL, V33, P2960, DOI 10.1093/molbev/msw182; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wrenbeck EE, 2017, CURR OPIN STRUC BIOL, V45, P36, DOI 10.1016/j.sbi.2016.11.001; Wu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0223-x; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zutz A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26337-1	54	3	3	9	14	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101785	10.1016/j.jbc.2022.101785	http://dx.doi.org/10.1016/j.jbc.2022.101785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35247389	Green Accepted, Green Submitted, Green Published, gold			2022-12-28	WOS:000793502000012
J	Ishigami, I; Russi, S; Cohen, A; Yeh, SR; Rousseau, DL				Ishigami, Izumi; Russi, Silvia; Cohen, Aina; Yeh, Syun-Ru; Rousseau, Denis L.			Temperature-dependent structural transition following X-ray-induced metal center reduction in oxidized cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CRYORADIOLYTIC REDUCTION; PROTON TRANSLOCATION; RADIATION-DAMAGE; HEME-PROTEINS; ACTIVE-SITE; CRYSTALLOGRAPHY; RESOLUTION; MECHANISM; O-2	Cytochrome c oxidase (CcO) is the terminal enzyme in the electron transfer chain in the inner membrane of mitochondria. It contains four metal redox centers, two of which, Cu-B and heme alpha(3), form the binuclear center (BNC), where dioxygen is reduced to water. Crystal structures of CcO in various forms have been reported, from which ligand-binding states of the BNC and conformations of the protein matrix surrounding it have been deduced to elucidate the mechanism by which the oxygen reduction chemistry is coupled to proton translocation. However, metal centers in proteins can be susceptible to X-rayinduced radiation damage, raising questions about the reliability of conclusions drawn from these studies. Here, we used microspectroscopy-coupled X-ray crystallography to interrogate how the structural integrity of bovine CcO in the fully oxidized state (O) is modulated by synchrotron radiation. Spectroscopic data showed that, upon X-ray exposure, O was converted to a hybrid O* state where all the four metal centers were reduced, but the protein matrix was trapped in the genuine O conformation and the ligands in the BNC remained intact. Annealing the O* crystal above the glass transition temperature induced relaxation of the O* structure to a new R* structure, wherein the protein matrix converted to the fully reduced R conformation with the exception of helix X, which partly remained in the O conformation because of incomplete dissociation of the ligands from the BNC. We conclude from these data that reevaluation of reported CcO structures obtained with synchrotron light sources is merited.	[Ishigami, Izumi; Yeh, Syun-Ru; Rousseau, Denis L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Russi, Silvia; Cohen, Aina] Stanford Univ, SLAC Natl Accelerator Lab, Struct Mol Biol, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	Yeshiva University; Albert Einstein College of Medicine; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Yeh, SR; Rousseau, DL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	syun-ru.yeh@einsteinmed.edu; denis.rousseau@einsteinmed.edu		Cohen, Aina/0000-0003-2414-9427; Yeh, Syun-Ru/0000-0002-9858-386X; Ishigami, Izumi/0000-0001-6929-1908	National Institutes of Health National Institute of General Medical Sciences [R01 GM126297, R21 GM127944, R01 GM115773]	National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health National Institute of General Medical Sciences grants R01 GM126297 (to D. L. R. and S.-R. Y.), R21 GM127944 (to D. L. R.), and R01 GM115773 (to S.-R. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Andersson R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04817-z; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; ARGADE PV, 1986, BIOPHYS J, V50, P613, DOI 10.1016/S0006-3495(86)83500-7; BABCOCK GT, 1993, J BIOENERG BIOMEMBR, V25, P71, DOI 10.1007/BF00762849; BAKER GM, 1987, J BIOL CHEM, V262, P595; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Denisov IG, 2007, RADIAT PHYS CHEM, V76, P714, DOI 10.1016/j.radphyschem.2006.03.002; Du WGH, 2020, INORG CHEM, V59, P8906, DOI 10.1021/acs.inorgchem.0c00724; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engler N, 2000, BIOPHYS J, V78, P2081, DOI 10.1016/S0006-3495(00)76755-5; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferguson-Miller S, 2012, BBA-BIOENERGETICS, V1817, P489, DOI 10.1016/j.bbabio.2011.11.018; Garman EF, 2006, ACTA CRYSTALLOGR D, V62, P32, DOI 10.1107/S0907444905034207; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; Ishigami I, 2019, P NATL ACAD SCI USA, V116, P3572, DOI 10.1073/pnas.1814526116; Ishigami I, 2017, P NATL ACAD SCI USA, V114, P8011, DOI 10.1073/pnas.1705628114; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P769, DOI 10.1016/j.bbabio.2010.12.016; Kim E, 2004, CHEM REV, V104, P1077, DOI 10.1021/cr0206162; Kitagawa T, 1998, J BIOENERG BIOMEMBR, V30, P71, DOI 10.1023/A:1020511612194; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu B, 2009, BIOCHEMISTRY-US, V48, P820, DOI 10.1021/bi801759a; Liu JA, 2011, P NATL ACAD SCI USA, V108, P1284, DOI 10.1073/pnas.1012846108; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Pfanzagl V, 2020, J BIOL CHEM, V295, P13488, DOI 10.1074/jbc.RA120.014087; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rousseau DL, 1999, NATURE, V400, P412, DOI 10.1038/22664; Shimada A, 2020, J BIOL CHEM, V295, P5818, DOI 10.1074/jbc.RA119.009596; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Tiefenbrunn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022348; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Ueno G, 2019, J SYNCHROTRON RADIAT, V26, P912, DOI 10.1107/S1600577519006805; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 2018, BBA-BIOENERGETICS, V1859, P692, DOI 10.1016/j.bbabio.2018.03.009; Wikstrom M, 2012, BBA-BIOENERGETICS, V1817, P468, DOI 10.1016/j.bbabio.2011.10.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yano N, 2016, J BIOL CHEM, V291, P23882, DOI 10.1074/jbc.M115.711770; Yi J, 2010, BIOCHEMISTRY-US, V49, P5969, DOI 10.1021/bi100801g; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a	55	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101799	10.1016/j.jbc.2022.101799	http://dx.doi.org/10.1016/j.jbc.2022.101799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35257742	gold, Green Published			2022-12-28	WOS:000823106100012
J	Ponzar, NL; Tajwar, R; Pozzi, N; Tavis, JE				Ponzar, Nathan L.; Tajwar, Razia; Pozzi, Nicola; Tavis, John E.			Alpha-hydroxytropolones are noncompetitive inhibitors of human RNase H1 that bind to the active site and modulate substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; B-VIRUS REPLICATION; RIBONUCLEASE-H; RNA/DNA HYBRID; METAL-IONS; DESTABILIZATION; MITOCHONDRIAL; SPECIFICITY; STABILITY; BLOCKING	The ribonucleases H (RNases H) of HIV and hepatitis B virus are type 1 RNases H that are promising drug targets because inhibiting their activity blocks viral replication. Eukaryotic ribonuclease H1 (RNase H1) is an essential protein and a probable off-target enzyme for viral RNase H inhibitors. alpha-hydroxytropolones (alpha HTs) are a class of anti-RNase H inhibitors that can inhibit the HIV, hepatitis B virus, and human RNases H1; however, it is unclear how these inhibitors could be developed to distinguish between these enzymes. To accelerate the development of selective RNase H inhibitors, we performed biochemical and kinetic studies on the human enzyme, which was recombinantly expressed in Escherichia coli. Size-exclusion chromatography showed that free RNase H1 is monomeric and forms a 2:1 complex with a substrate of 12 bp. FRET heteroduplex cleavage assays were used to test inhibition of RNase H1 in steady-state kinetics by two structurally diverse alpha HTs, 110 and 404. We determined that turnover rate was reduced, but inhibition was not competitive with substrate, despite inhibitor binding to the active site. Given the compounds' reversible binding to the active site, we concluded that traditional noncompetitive and mixed inhibition mechanisms are unlikely. Instead, we propose a model in which, by binding to the active site, alpha HTs stabilize an inactive enzyme-substrate-inhibitor complex. This new model clarifies the mechanism of action of alpha HTs against RNase H1 and will aid the development of RNase H inhibitors selective for the viral enzymes.	[Ponzar, Nathan L.; Tajwar, Razia; Tavis, John E.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Ponzar, Nathan L.; Tajwar, Razia; Pozzi, Nicola; Tavis, John E.] St Louis Univ, Inst Drug & Biotherapeut Innovat, St Louis, MO 63103 USA; [Pozzi, Nicola] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Tavis, John E.] Liver Ctr, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Saint Louis University	Tavis, JE (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.; Tavis, JE (corresponding author), St Louis Univ, Inst Drug & Biotherapeut Innovat, St Louis, MO 63103 USA.; Tavis, JE (corresponding author), Liver Ctr, St Louis, MO 63103 USA.	john.tavis@health.slu.edu	Pozzi, Nicola/AAC-1771-2021	Pozzi, Nicola/0000-0003-2309-7100; Tavis, John/0000-0002-8711-4240	US Department of Defense grant [W81XWH-18-1-0307]	US Department of Defense grant(United States Department of Defense)	This work was funded by the US Department of Defense grant (grant no.: W81XWH-18-1-0307 [to J. E. T.]).	Cao LL, 2014, CURR MED CHEM, V21, P1956, DOI 10.2174/0929867321666140120121158; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Didierjean J, 2005, ANTIMICROB AGENTS CH, V49, P4884, DOI 10.1128/AAC.49.12.4884-4894.2005; Edwards T. C., 2017, INHIBITION HEPATITIS; Edwards TC, 2019, EXPERT OPIN THER TAR, V23, P559, DOI 10.1080/14728222.2019.1619697; Edwards TC, 2019, ANTIVIR RES, V164, P70, DOI 10.1016/j.antiviral.2019.02.005; Gaidamakov SA, 2005, NUCLEIC ACIDS RES, V33, P2166, DOI 10.1093/nar/gki510; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; HIRAI M, 1970, B CHEM SOC JPN, V43, P778, DOI 10.1246/bcsj.43.778; Holt IJ, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.06.001; Hu Y, 2013, ANTIVIR RES, V99, P221, DOI 10.1016/j.antiviral.2013.06.007; Hyjek M, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102672; Jarmoskaite I, 2020, ELIFE, V9, DOI 10.7554/eLife.57264; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kocyla A, 2017, J INORG BIOCHEM, V176, P53, DOI 10.1016/j.jinorgbio.2017.08.006; Kumar G, 2021, NUCLEIC ACIDS RES, V49, P1609, DOI 10.1093/nar/gkaa1294; Lee H, 2022, NUCLEIC ACIDS RES, V50, P1801, DOI 10.1093/nar/gkab1064; Li QL, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104777; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Lima WF, 2003, J BIOL CHEM, V278, P49860, DOI 10.1074/jbc.M306543200; Lu GF, 2015, ANTIMICROB AGENTS CH, V59, P1070, DOI 10.1128/AAC.04617-14; Michaelis L, 1913, BIOCHEM Z, V49, P333; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2008, EMBO J, V27, P1172, DOI 10.1038/emboj.2008.44; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Parajuli S, 2017, J BIOL CHEM, V292, P15216, DOI 10.1074/jbc.M117.787473; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Samara NL, 2018, NAT STRUCT MOL BIOL, V25, P715, DOI 10.1038/s41594-018-0099-4; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Strelow J., 2012, ASSAY GUIDANCE MANUA; Tavis JE, 2014, ANTIMICROB AGENTS CH, V58, P7451, DOI 10.1128/AAC.03875-14; Tian L, 2018, P NATL ACAD SCI USA, V115, P507, DOI 10.1073/pnas.1719746115; Tramontano E, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104613; Yamasaki K, 1995, BIOCHEMISTRY-US, V34, P16552, DOI 10.1021/bi00051a003; Zhang Z, 2006, J BIOL CHEM, V281, P35794, DOI 10.1074/jbc.M608031200	40	0	0	7	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101790	10.1016/j.jbc.2022.101790	http://dx.doi.org/10.1016/j.jbc.2022.101790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35247386	gold, Green Published			2022-12-28	WOS:000793617400002
J	Sepich-Poore, C; Zheng, Z; Schmitt, E; Wen, KL; Zhang, ZS; Cui, XL; Dai, Q; Zhu, AC; Zhang, LD; Castillo, AS; Tan, HY; Peng, JM; Zhuang, XX; He, C; Nachtergaele, S				Sepich-Poore, Caraline; Zheng, Zhong; Schmitt, Emily; Wen, Kailong; Zhang, Zijie Scott; Cui, Xiao-Long; Dai, Qing; Zhu, Allen C.; Zhang, Linda; Castillo, Arantxa Sanchez; Tan, Haiyan; Peng, Junmin; Zhuang, Xiaoxi; He, Chuan; Nachtergaele, Sigrid			The METTL5-TRMT112 N-6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN; IDENTIFICATION; MUTATIONS; INSIGHTS; TCOF1; FTSJ1; CLIP	Ribosomal RNAs (rRNAs) have long been known to carry chemical modifications, including 20O-methylation, pseudouridylation, N6-methyladenosine (m6A), and N6,6-dimethyladenosine. While the functions of many of these modifications are unclear, some are highly conserved and occur in regions of the ribosome critical for mRNA decoding. Both 28S rRNA and 18S rRNA carry single m6A sites, and while the methyltransferase ZCCHC4 has been identified as the enzyme responsible for the 28S rRNA m6A modification, the methyltransferase responsible for the 18S rRNA m6A modification has remained unclear. Here, we show that the METTL5-TRMT112 methyltransferase complex installs the m6A modification at position 1832 of human 18S rRNA. Our work supports findings that TRMT112 is required for METTL5 stability and reveals that human METTL5 mutations associated with microcephaly and intellectual disability disrupt this interaction. We show that loss of METTL5 in human cancer cell lines and in mice regulates gene expression at the translational level; additionally, Mettl5 knockout mice display reduced body size and evidence of metabolic defects. While recent work has focused heavily on m6A modifications in mRNA and their roles in mRNA processing and translation, we demonstrate here that deorphanizing putative methyltransferase enzymes can reveal previously unappreciated regulatory roles for m6A in noncoding RNAs.	[Sepich-Poore, Caraline; Zheng, Zhong; Schmitt, Emily; Zhang, Zijie Scott; Cui, Xiao-Long; Dai, Qing; Zhu, Allen C.; Zhang, Linda; Castillo, Arantxa Sanchez; He, Chuan; Nachtergaele, Sigrid] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Sepich-Poore, Caraline; Zheng, Zhong; Schmitt, Emily; Zhang, Zijie Scott; Cui, Xiao-Long; Zhu, Allen C.; Zhang, Linda; Castillo, Arantxa Sanchez; He, Chuan; Nachtergaele, Sigrid] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Sepich-Poore, Caraline; Zhu, Allen C.; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Sepich-Poore, Caraline; Zhu, Allen C.] Univ Chicago, Med Scientist Training Program, Chicago, IL USA; [Wen, Kailong; Zhuang, Xiaoxi] Univ Chicago, Dept Neurobiol, Chicago, IL USA; [Tan, Haiyan; Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metabol, Memphis, TN USA; [Tan, Haiyan; Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN USA; [Tan, Haiyan; Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN USA; [He, Chuan] Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Zhang, Zijie Scott] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresource, Kunming, Yunnan, Peoples R China; [Zhang, Zijie Scott] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Nachtergaele, Sigrid] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; University of Chicago; Yunnan University; Yunnan University; Yale University	He, C; Nachtergaele, S (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.; He, C; Nachtergaele, S (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Nachtergaele, S (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	chuanhe@uchicago.edu; sigrid.nachtergaele@yale.edu	Peng, Junmin/N-2614-2018; CUI, XIAOLONG/GRF-0957-2022	Peng, Junmin/0000-0003-0472-7648; CUI, XIAOLONG/0000-0002-1345-2271; Zhu, Allen/0000-0002-1490-7063; Sepich, Caraline/0000-0002-1853-4647	National Institutes of Health NHGRI [RM1 HG008935, R01DA043361]; NIH Medical Scientist Training Program [T32GM007281]; NCI [F30 CA253987, NCI F30 CA247175]; William Raveis Charitable Fund Breakthrough Scientist of the Damon Runyon-Dale F. Frey Award [DFS-34-19]; Damon Runyon Cancer Research Foundation [DRG-2215-15]	National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William Raveis Charitable Fund Breakthrough Scientist of the Damon Runyon-Dale F. Frey Award; Damon Runyon Cancer Research Foundation	The work was supported by the National Institutes of Health NHGRI RM1 HG008935 to C. H. and R01DA043361 to X .Z. C. S.-P. and A. C. Z were supported by NIH Medical Scientist Training Program grant T32GM007281 and by NCI F30 CA253987 (C. S.-P.) and NCI F30 CA247175 (A. C. Z.) . C. H. is an investigator of the Howard Hughes Medical Institute (HHMI) . S. N. is the William Raveis Charitable Fund Breakthrough Scientist of the Damon Runyon-Dale F. Frey Award (DFS-34-19) and was previously an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2215-15) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Ameismeier M, 2018, NATURE, V558, P249, DOI 10.1038/s41586-018-0193-0; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bowman M, 2012, EUR J HUM GENET, V20, P769, DOI 10.1038/ejhg.2012.2; Danan C, 2016, METHODS MOL BIOL, V1358, P153, DOI 10.1007/978-1-4939-3067-8_10; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farley-Barnes KI, 2019, TRENDS GENET, V35, P754, DOI 10.1016/j.tig.2019.07.004; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu H., 2019, Mol. Psychiatry, V24, P1027; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ignatova VV, 2020, GENE DEV, V34, P715, DOI [10.1101/gad.333369.119, 10.1126/sciadv.aaz4551]; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kusevic D, 2016, J BIOL CHEM, V291, P6124, DOI 10.1074/jbc.M115.711952; Leetsi L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090422; Leismann J, 2020, EMBO REP, V21, DOI 10.15252/embr.201949443; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberman N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4370; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1808-4; Liu Q, 2020, NUCLEIC ACIDS RES, V48, pW218, DOI 10.1093/nar/gkaa395; Lomakin IB, 2017, CELL REP, V20, P521, DOI 10.1016/j.celrep.2017.06.025; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma HH, 2019, NAT CHEM BIOL, V15, P88, DOI 10.1038/s41589-018-0184-3; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Piekna-Przybylska D., 2008, Nucleic Acids Res., V36, pD178; Pinto R, 2020, NUCLEIC ACIDS RES, V48, P830, DOI 10.1093/nar/gkz1147; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ramser J, 2004, J MED GENET, V41, P679, DOI 10.1136/jmg.2004.019000; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richard EM, 2019, AM J HUM GENET, V105, P869, DOI 10.1016/j.ajhg.2019.09.007; Rong BW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108544; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schindelin J., 2012, CELL REP, V12, P1089; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seimetz J, 2019, METHODS, V155, P131, DOI 10.1016/j.ymeth.2018.11.015; Sendinc E, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00186-6; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; Splendore A, 2000, HUM MUTAT, V16, P315, DOI 10.1002/1098-1004(200010)16:4<315::AID-HUMU4>3.0.CO;2-H; Sun S., 2020, Front. Genet., V11; Tahmasebi S, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00709; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Wang L, 2022, GENES DIS, V9, P268, DOI 10.1016/j.gendis.2020.07.004; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Weisser M, 2017, MOL CELL, V67, P447, DOI 10.1016/j.molcel.2017.06.032; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Xing M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949863; Xu L, 2017, J BIOL CHEM, V292, P14695, DOI 10.1074/jbc.M117.798298; Yelick PC, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1025185; Zhang Z., 2020, Nat; Zhou HQ, 2019, NAT METHODS, V16, P1281, DOI 10.1038/s41592-019-0550-4; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	64	8	8	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101590	10.1016/j.jbc.2022.101590	http://dx.doi.org/10.1016/j.jbc.2022.101590			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35033535	Green Published, gold			2022-12-28	WOS:000791267400006
J	Smithson, M; Irwin, R; Williams, G; Alexander, KL; Smythies, LE; Nearing, M; McLeod, MC; Al Diffalha, S; Bellis, SL; Hardiman, KM				Smithson, Mary; Irwin, Regina; Williams, Gregory; Alexander, Katie L.; Smythies, Lesley E.; Nearing, Marie; McLeod, M. Chandler; Al Diffalha, Sameer; Bellis, Susan L.; Hardiman, Karin M.			Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; SIALYLATION; ADENOCARCINOMA; ACTIVATION; SURVIVAL; THERAPY	Locally advanced rectal cancer is typically treated with chemoradiotherapy followed by surgery. Most patients do not display a complete response to chemoradiotherapy, but resistance mechanisms are poorly understood. ST6GAL-1 is a sialyltransferase that adds the negatively charged sugar, sialic acid (Sia), to cell surface proteins in the Golgi, altering their function. We therefore hypothesized that ST6GAL-1 could mediate resistance to chemoradiation in rectal cancer by inhibiting apoptosis. Patient-derived xenograft and organoid models of rectal cancer and rectal cancer cell lines were assessed for ST6GAL-1 protein with and without chemoradiation treatment. ST6GAL-1 mRNA was assessed in untreated human rectal adenocarcinoma by PCR assays. Samples were further assessed by Western blotting, Caspase-Glo apoptosis assays, and colony formation assays. The presence of functional ST6GAL-1 was assessed via flow cytometry using the Sambucus nigra lectin, which specifically binds cell surface alpha 2,6-linked Sia, and via lectin precipitation. In patient-derived xenograft models of rectal cancer, we found that ST6GAL-1 protein was increased after chemoradiation in a subset of samples. Rectal cancer cell lines demonstrated increased ST6GAL-1 protein and cell surface Sia after chemoradiation. ST6GAL-1 was also increased in rectal cancer organoids after treatment. ST6GAL1 knockdown in rectal cancer cell lines resulted in increased apoptosis and decreased survival after treatment. We concluded that ST6GAL-1 promotes resistance to chemoradiotherapy by inhibiting apoptosis in rectal cancer cell lines. More research will be needed to further elucidate the importance and mechanism of ST6GAL-1-mediated resistance.	[Smithson, Mary; Irwin, Regina; Williams, Gregory; McLeod, M. Chandler; Hardiman, Karin M.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Alexander, Katie L.; Smythies, Lesley E.; Nearing, Marie] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Al Diffalha, Sameer] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL USA; [Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Hardiman, Karin M.] Birmingham Vet Affairs Med Ctr, Dept Surg, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Smithson, M (corresponding author), Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA.	mgrabowsky@uabmc.edu		Smithson, Mary/0000-0002-7683-1033	National Institutes of Health [U01 CA233581, R01 CA225177]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-K. M. H. was funded by the National Institutes of Health (grant no.: K08CA190645) . S. L. B. was funded by the National Institutes of Health (grant nos.: U01 CA233581 and R01 CA225177) . The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AASHEIM HC, 1993, EUR J BIOCHEM, V213, P467, DOI 10.1111/j.1432-1033.1993.tb17783.x; Alexander K. L., 2020, J BIOL CHEM; Bettoni F, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00974; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Chakraborty A, 2018, J BIOL CHEM, V293, P984, DOI 10.1074/jbc.M117.808584; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Dall'Olio F, 2004, GLYCOBIOLOGY, V14, P39, DOI 10.1093/glycob/cwh002; Dorsett KA, 2021, GLYCOBIOLOGY, V31, P530, DOI 10.1093/glycob/cwaa110; Ferrandon S, 2020, CANCER RES, V80, P334, DOI 10.1158/0008-5472.CAN-19-1161; Frydrych LM, 2019, NEOPLASIA, V21, P1051, DOI 10.1016/j.neo.2019.08.004; Gebner P., 1993, CANCER LETT, V75, P143; Habr-Gama A, 2006, COLORECTAL DIS, V8, P21, DOI 10.1111/j.1463-1318.2006.01066.x; Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Jimenez L., 2020, PREDICTION POOR RESP; Kamran SC, 2019, CLIN CANCER RES, V25, P5561, DOI 10.1158/1078-0432.CCR-19-0908; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Recchi MA, 1998, CANCER RES, V58, P4066; Rodrigues JG, 2021, CELL ONCOL, V44, P835, DOI 10.1007/s13402-021-00606-z; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Shin BY, 2018, J EXP MED, V215, P1803, DOI 10.1084/jem.20172335; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Smith JJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1632-z; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Ziemke EK, 2016, CLIN CANCER RES, V22, P405, DOI 10.1158/1078-0432.CCR-15-0829	29	4	4	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101594	10.1016/j.jbc.2022.101594	http://dx.doi.org/10.1016/j.jbc.2022.101594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35041825	Green Published, gold			2022-12-28	WOS:000791267400009
J	Walters, GC; Usachev, YM				Walters, Grant C.; Usachev, Yuriy M.			MCU (mitochondrial Ca2+ uniporter) makes the calcium go round	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION	Store-operated Ca2+ entry (SOCE) is a major mechanism controlling Ca2+ signaling and Ca2+-dependent functions and has been implicated in immunity, cancer, and organ development. SOCE-dependent cytosolic Ca2+ signals are affected by mitochondrial Ca2+ transport through several competing mechanisms. However, how these mechanisms interact in shaping Ca2+ dynamics and regulating Ca2+-dependent functions remains unclear. In a recent issue, Yoast et al. shed light on these questions by defining multiple roles of the mitochondrial Ca2+ uniporter in regulating SOCE, Ca2+ dynamics, transcription, and lymphocyte activation.	[Walters, Grant C.; Usachev, Yuriy M.] Univ Iowa, Iowa Neurosci Inst, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Usachev, YM (corresponding author), Univ Iowa, Iowa Neurosci Inst, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA.	yuriy-usachev@uiowa.edu		Walters, Grant/0000-0001-5081-3104; Usachev, Yuriy/0000-0002-6948-4627	National Institutes of Health [NS096246, DK116624, NS125884, GM067795]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants (grant nos.: NS096246, DK116624, and NS125884 [to Y. M. U.]). This work was supported by a predoctoral fellowship through the National Institutes of Health T32 grant (grant no.: GM067795 to G. C. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; Emrich S. M., 2021, ANNU REV PHYSIOL, DOI [10.1146/annurevphysiol-052521-013426, DOI 10.1146/ANNUREVPHYSIOL-052521-013426]; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Yoast RE, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101174	10	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101604	10.1016/j.jbc.2022.101604	http://dx.doi.org/10.1016/j.jbc.2022.101604			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35051417	Green Published, gold			2022-12-28	WOS:000761380200002
J	Farci, D; Haniewicz, P; de Sanctis, D; Iesu, L; Kereiche, S; Winterhalter, M; Piano, D				Farci, Domenica; Haniewicz, Patrycja; de Sanctis, Daniele; Iesu, Luca; Kereiche, Sami; Winterhalter, Mathias; Piano, Dario			The cryo-EM structure of the S-layer deinoxanthin-binding complex of Deinococcus radiodurans informs properties of its environmental interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; MICROSCOPE; RESOLUTION; UNIT; HPI	The radiation-resistant bacterium Deinococcus radiodurans is known as the world's toughest bacterium. The S-layer of D. radiodurans, consisting of several proteins on the surface of the cellular envelope and intimately associated with the outer membrane, has therefore been useful as a model for structural and functional studies. Its main proteinaceous unit, the S-layer deinoxanthin-binding complex (SDBC), is a hetero-oligomeric assembly known to contribute to the resistance against environmental stress and have porin functional features; however, its precise structure is unknown. Here, we resolved the structure of the SDBC at -2.5 angstrom resolution by cryo-EM and assigned the sequence of its main subunit, the protein DR_2577. This structure is characterized by a pore region, a massive beta-barrel organization, a stalk region consisting of a trimeric coiled coil, and a collar region at the base of the stalk. We show that each monomer binds three Cu ions and one Fe ion and retains one deinoxanthin molecule and two phosphoglycolipids, all exclusive to D. radiodurans. Finally, electrophysiological characterization of the SDBC shows that it exhibits transport properties with several amino acids. Taken together, these results highlight the SDBC as a robust structure displaying both protection and sieving functions that facilitates exchanges with the environment.	[Farci, Domenica; Haniewicz, Patrycja; Piano, Dario] Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Warsaw, Poland; [Farci, Domenica] Umea Univ, Dept Chem, Umea, Sweden; [de Sanctis, Daniele] European Synchrotron Radiat Facil ESRF, Struct Biol Grp, Grenoble, France; [Iesu, Luca; Piano, Dario] Univ Cagliari, Dept Life & Environm Sci, Lab Plant Physiol & Photobiol, Cagliari, Italy; [Kereiche, Sami] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Winterhalter, Mathias] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany	Warsaw University of Life Sciences; Umea University; European Synchrotron Radiation Facility (ESRF); University of Cagliari; Charles University Prague; Jacobs University	Farci, D; Piano, D (corresponding author), Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Warsaw, Poland.; Farci, D (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.; Piano, D (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Lab Plant Physiol & Photobiol, Cagliari, Italy.	dario.piano@unica.it; domenica.farci@umu.se	; de Sanctis, Daniele/G-9169-2015	Farci, Domenica/0000-0002-3691-2699; Iesu, Luca/0000-0002-4055-7909; Haniewicz, Patrycja/0000-0002-6298-7184; de Sanctis, Daniele/0000-0003-0391-8290	National Science Center (Poland); Sonata BIS 7 Program (2017) [PRO-2017/26/E/NZ1/00344]; Czech Science Foundation [1825144Y]; Harmonia 10 Program (2018) [PRO-2018/30/M/NZ1/00284]	National Science Center (Poland)(National Science Centre, Poland); Sonata BIS 7 Program (2017); Czech Science Foundation(Grant Agency of the Czech Republic); Harmonia 10 Program (2018)	This work was supported by the National Science Center (Poland) with the Sonata BIS 7 Program (2017) Grant PRO-2017/26/E/NZ1/00344 and the Harmonia 10 Program (2018) Grant PRO-2018/30/M/NZ1/00284 (both to D. P., D. F., and P. H.), the Czech Science Foundation Grant 1825144Y (to S. K.).	Adamec F, 2020, PHOTOCH PHOTOBIO SCI, V19, P495, DOI 10.1039/d0pp00031k; ANDERSON R, 1985, J BIOL CHEM, V260, P2219; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; BAUMEISTER W, 1986, J MOL BIOL, V187, P241, DOI 10.1016/0022-2836(86)90231-7; Bharat TAM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.59; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farci D, 2021, STRUCTURE, V29, P1279, DOI 10.1016/j.str.2021.06.014; Farci D, 2020, J BIOL CHEM, V295, P4224, DOI 10.1074/jbc.RA119.012174; Farci D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01450; Farci D, 2018, PHOTOCH PHOTOBIO SCI, V17, P81, DOI 10.1039/c7pp00240h; Farci D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00155; Farci D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00414; Farci D, 2014, BBA-BIOMEMBRANES, V1838, P1978, DOI 10.1016/j.bbamem.2014.02.014; Ferrara LGM, 2016, J MOL BIOL, V428, P4528, DOI 10.1016/j.jmb.2016.09.021; GENTNER NE, 1975, RADIAT RES, V61, P204, DOI 10.2307/3574039; Handing KB, 2018, NAT PROTOC, V13, P1062, DOI 10.1038/nprot.2018.018; HUANG Y, 1995, J BACTERIOL, V177, P2567, DOI 10.1128/jb.177.9.2567-2571.1995; HUANG Y, 1991, J BACTERIOL, V173, P457, DOI 10.1128/jb.173.2.457-462.1991; Kumar J, 2021, MICROB PHYSIOL, V31, P1, DOI 10.1159/000512018; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lister TE, 2001, LANGMUIR, V17, P2624, DOI 10.1021/la001448g; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Muller DJ, 1997, J STRUCT BIOL, V119, P149, DOI 10.1006/jsbi.1997.3878; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rothfuss H, 2006, MICROBIOL-SGM, V152, P2779, DOI 10.1099/mic.0.28971-0; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Singh PR, 2012, J PHYS CHEM B, V116, P4433, DOI 10.1021/jp2123136; Sleytr UB, 1997, TRENDS BIOTECHNOL, V15, P20, DOI 10.1016/S0167-7799(96)10063-9; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; YAN H, 1989, J BIOL CHEM, V264, P18667; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	37	3	3	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102031	10.1016/j.jbc.2022.102031	http://dx.doi.org/10.1016/j.jbc.2022.102031			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35577074	Green Published, gold			2022-12-28	WOS:000829588600004
J	Gao, XK; Bonzerato, CG; Wojcikiewicz, RJH				Gao, Xiaokong; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.			Binding of the erlin1/2 complex to the third intralumenal loop of IP(3)R1 triggers its ubiquitin-proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE; CANCER; RECEPTORS; CHANNELS; CA2+	Long-term activation of inositol 1,4,5-trisphosphate receptors (IP3Rs) leads to their degradation by the ubiquitin-proteasome pathway. The first and rate-limiting step in this process is thought to be the association of conformationally active IP3Rs with the erlin1/2 complex, an endoplasmic reticulum-located oligomer of erlin1 and erlin2 that recruits the E3 ubiquitin ligase RNF170, but the molecular determinants of this interaction remain unknown. Here, through mutation of IP3R1, we show that the erlin1/2 complex interacts with the IP3R1 intralumenal loop 3 (IL3), the loop between transmembrane (TM) helices 5 and 6, and in particular, with a region close to TM5, since mutation of amino acids D-2471 and R-2472 can specifically block erlin1/2 complex association. Surprisingly, we found that additional mutations in IL3 immediately adjacent to TM5 (e.g., D2465N) almost completely abolish IP3R1 Ca2+ channel activity, indicating that the integrity of this region is critical to IP3R1 function. Finally, we demonstrate that inhibition of the ubiquitin-activating enzyme UBE1 by the small-molecule inhibitor TAK-243 completely blocked IP3R1 ubiquitination and degradation without altering erlin1/2 complex association, confirming that association of the erlin1/2 complex is the primary event that initiates IP3R1 processing and that IP3R1 ubiquitination mediates IP3R1 degradation. Overall, these data localize the erlin1/2 complex-binding site on IP3R1 to IL3 and show that the region immediately adjacent to TM5 is key to the events that facilitate channel opening.	[Gao, Xiaokong; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Bonzerato, Caden/0000-0001-6380-8320				Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Baker JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0404-4; Baker MR, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02156-4; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Christianson JC, 2022, EMBO J, V41, DOI 10.15252/embj.2021109845; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; Daumke O, 2022, CELL RES, V32, P117, DOI 10.1038/s41422-021-00605-7; Fan GZ, 2018, CELL RES, V28, P1158, DOI 10.1038/s41422-018-0108-5; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kumari D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081185; Lemberg MK, 2021, MOL CELL, V81, P2507, DOI 10.1016/j.molcel.2021.05.004; Lesueur LL, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.4; Lin QS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89402; Liu WG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082894; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Ma CY, 2022, CELL RES, V32, P176, DOI 10.1038/s41422-021-00598-3; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1038/nrclinonc.2016.206, 10.1007/s12079-011-0121-7]; Mikoshiba Katsuhiko, 2015, Adv Biol Regul, V57, P217, DOI 10.1016/j.jbior.2014.10.001; Naranjo D, 2016, J GEN PHYSIOL, V148, P277, DOI 10.1085/jgp.201611625; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Prole DL, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035063; Schulman JJ, 2016, J BIOL CHEM, V291, P11820, DOI 10.1074/jbc.M115.711242; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Terry LE, 2020, J BIOL CHEM, V295, P18160, DOI 10.1074/jbc.RA120.015683; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wojcikiewicz Richard J H, 2018, Messenger (Los Angel), V6, P45, DOI 10.1166/msr.2018.1073; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Woll KA, 2022, PHYSIOL REV, V102, P209, DOI 10.1152/physrev.00033.2020; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Wright FA, 2018, J BIOL CHEM, V293, P15706, DOI 10.1074/jbc.RA118.004547; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Xu Q, 2004, MOL CANCER THER, V3, P1263; Zhu CC, 1999, J BIOL CHEM, V274, P3476, DOI 10.1074/jbc.274.6.3476	52	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102026	10.1016/j.jbc.2022.102026	http://dx.doi.org/10.1016/j.jbc.2022.102026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35568199	gold, Green Published			2022-12-28	WOS:000811243600005
J	Rider, SD; Gadgil, RY; Hitch, DC; Damewood, FJ; Zavada, N; Shanahan, M; Alhawach, V; Shrestha, R; Shin-ya, K; Leffak, M				Rider, S. Dean, Jr.; Gadgil, Rujuta Yashodhan; Hitch, David C.; Damewood, French J.; Zavada, Nathen; Shanahan, Matilyn; Alhawach, Venicia; Shrestha, Resha; Shin-ya, Kazuo; Leffak, Michael			Stable G-quadruplex DNA structures promote replication-dependent genome instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK-INDUCED REPLICATION; C-MYC GENE; MYOTONIC-DYSTROPHY; INTERACTIVE AGENT; REPEAT; ORIGIN; TELOMESTATIN; REPAIR; ACTIVATION; MECHANISMS	G-quadruplex (G4)-prone structures are abundant in mammalian genomes, where they have been shown to influence DNA replication, transcription, and genome stability. In this article, we constructed cells with a single ectopic homopurine/homopyrimidine repeat tract derived from the polycystic kidney disease type 1 (PKD1) locus, which is capable of forming triplex (H3) and G4 DNA structures. We show that ligand stabilization of these G4 structures results in deletions of the G4 consensus sequence, as well as kilobase deletions spanning the G4 and ectopic sites. Furthermore, we show that DNA double-strand breaks at the ectopic site are dependent on the nuclease Mus81. Hypermutagenesis during sister chromatid repair extends several kilobases from the G4 site and breaks at the G4 site resulting in microhomology-mediated translocations. To determine whether H3 or G4 structures are responsible for homopurine/homopyrimidine tract instability, we derived constructs and cell lines from the PKD1 repeat, which can only form H3 or G4 structures. Under normal growth conditions, we found that G4 cell lines lost the G4 consensus sequence early during clonal outgrowth, whereas H3 cells showed DNA instability early during outgrowth but only lost reporter gene expression after prolonged growth. Thus, both the H3 and G4 non-B conformation DNAs exhibit genomic instability, but they respond differently to endogenous replication stress. Our results show that the outcomes of replication-dependent double-strand breaks at non-B-DNAs model the instability observed in microhomology-mediated break-induced replication (BIR). Marked variability in the frequency of mutagenesis during BIR suggests possible dynamic heterogeneity in the BIR replisome.	[Rider, S. Dean, Jr.; Gadgil, Rujuta Yashodhan; Hitch, David C.; Damewood, French J.; Zavada, Nathen; Shanahan, Matilyn; Alhawach, Venicia; Shrestha, Resha; Leffak, Michael] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan	University System of Ohio; Wright State University Dayton; National Institute of Advanced Industrial Science & Technology (AIST)	Leffak, M (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Michael.leffak@wright.edu		Zavada, Nathen/0000-0002-5595-5491; Leffak, Michael/0000-0002-6328-785X	Wright State University Biomedical Sciences PhD program	Wright State University Biomedical Sciences PhD program	V. A. and R. S. were supported by the Wright State University Biomedical Sciences PhD program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Bahrambeigi V, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0676-0; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Barthelemy J, 2017, NUCLEIC ACIDS RES, V45, P509, DOI 10.1093/nar/gkw1091; Barthelemy J, 2016, NUCLEIC ACIDS RES, V44, P6803, DOI 10.1093/nar/gkw433; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brosh RM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00372; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen XM, 2013, NUCLEIC ACIDS RES, V41, P6460, DOI 10.1093/nar/gkt368; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; De Magis A, 2019, P NATL ACAD SCI USA, V116, P816, DOI 10.1073/pnas.1810409116; Donnianni RA, 2019, MOL CELL, V76, P371, DOI 10.1016/j.molcel.2019.07.033; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Gadgil RY, 2020, J BIOL CHEM, V295, P15378, DOI 10.1074/jbc.RA120.013495; Gazy I, 2019, DNA REPAIR, V74, P63, DOI 10.1016/j.dnarep.2018.12.004; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Guo JZ, 2016, CELL RES, V26, P775, DOI 10.1038/cr.2016.66; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hiatt SM, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2021.100023; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; KIT S, 1961, J MOL BIOL, V3, P711, DOI 10.1016/S0022-2836(61)80075-2; Kononenko AV, 2018, NAT STRUCT MOL BIOL, V25, P669, DOI 10.1038/s41594-018-0094-9; Kramara J, 2018, TRENDS GENET, V34, P518, DOI 10.1016/j.tig.2018.04.002; Kramara J, 2017, NAT STRUCT MOL BIOL, V24, P11, DOI 10.1038/nsmb.3361; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lee WTC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22830-9; Lewis TW, 2019, NUCLEIC ACIDS RES, V47, P3503, DOI 10.1093/nar/gkz026; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2013, MOL CELL BIOL, V33, P571, DOI 10.1128/MCB.01265-12; Liu GQ, 2012, J BIOL CHEM, V287, P33412, DOI 10.1074/jbc.M112.402503; Liu GQ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-7; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lokanga RA, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.708860; Lyu J, 2022, NUCLEIC ACIDS RES, V50, DOI 10.1093/nar/gkab1073; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MCWHINNEY C, 1995, DNA CELL BIOL, V14, P565, DOI 10.1089/dna.1995.14.565; MCWHINNEY C, 1990, NUCLEIC ACIDS RES, V18, P1233, DOI 10.1093/nar/18.5.1233; McWhinney C., 1988, CANC CELLS, P467; Miyazaki T, 2012, CLIN CANCER RES, V18, P1268, DOI 10.1158/1078-0432.CCR-11-1795; Naiman K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21198-0; Nakamura T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03785-8; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Patel HP, 2004, NUCLEIC ACIDS RES, V32, P1460, DOI 10.1093/nar/gkh312; Prorok P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11104-0; Sakofsky CJ, 2017, CRIT REV BIOCHEM MOL, V52, P395, DOI 10.1080/10409238.2017.1314444; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Shalaby T, 2010, MOL CANCER THER, V9, P167, DOI 10.1158/1535-7163.MCT-09-0586; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Spivakovsky-Gonzalez E, 2021, GENETICS, V219, DOI 10.1093/genetics/iyab125; Sundararajan R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001339; Sundararajan R, 2010, GENETICS, V184, P65, DOI 10.1534/genetics.109.111039; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Usdin K, 2015, CRIT REV BIOCHEM MOL, V50, P142, DOI 10.3109/10409238.2014.999192; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Waltz SE, 1996, NUCLEIC ACIDS RES, V24, P1887, DOI 10.1093/nar/24.10.1887; Wang WT, 2021, MOL CELL, V81, P2975, DOI 10.1016/j.molcel.2021.05.024; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	75	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101947	10.1016/j.jbc.2022.101947	http://dx.doi.org/10.1016/j.jbc.2022.101947			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35447109	gold, Green Published			2022-12-28	WOS:000807755100001
J	Luis, COD; Ryan, TJ				Luis, Clara Ortega-de San; Ryan, Tomas J.			Understanding the physical basis of memory: Molecular mechanisms of the engram	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; DENDRITIC SPINES; PERINEURONAL NETS; NEURONAL ENSEMBLES; SILENT SYNAPSES; EXTRACELLULAR-MATRIX; SYNAPTIC PLASTICITY; DNA METHYLATION; MESSENGER-RNA	Memory, defined as the storage and use of learned information in the brain, is necessary to modulate behavior and critical for animals to adapt to their environments and survive. Despite being a cornerstone of brain function, questions surrounding the molecular and cellular mechanisms of how information is encoded, stored, and recalled remain largely unanswered. One widely held theory is that an engram is formed by a group of neurons that are active during learning, which undergoes biochemical and physical changes to store information in a stable state, and that are later reactivated during recall of the memory. In the past decade, the development of engram labeling methodologies has proven useful to investigate the biology of memory at the molecular and cellular levels. Engram technology allows the study of individual memories associated with particular experiences and their evolution over time, with enough experimental resolution to discriminate between different memory processes: learning (encoding), consolidation (the passage from short-term to long-term memories), and storage (the maintenance of memory in the brain). Here, we review the current understanding of memory formation at a molecular and cellular level by focusing on insights provided using engram technology.	[Luis, Clara Ortega-de San; Ryan, Tomas J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Luis, Clara Ortega-de San; Ryan, Tomas J.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Ryan, Tomas J.] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Ryan, Tomas J.] Canadian Inst Adv Res CIFAR, Child & Brain Dev Program, Toronto, ON, Canada	Trinity College Dublin; Trinity College Dublin; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Canadian Institute for Advanced Research (CIFAR)	Luis, COD; Ryan, TJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.; Luis, COD; Ryan, TJ (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland.; Ryan, TJ (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Ryan, TJ (corresponding author), Canadian Inst Adv Res CIFAR, Child & Brain Dev Program, Toronto, ON, Canada.	ortegadc@tcd.ie; tomas.ryan@tcd.ie	Ortega-de San Luis, Clara/A-4754-2017	Ortega-de San Luis, Clara/0000-0002-8365-2762; Ryan, Tomas/0000-0003-0121-8514	European Research Council; Irish Research Council; Lister Institute of Preventive Medicine; Science Foundation Ireland	European Research Council(European Research Council (ERC)European Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology); Lister Institute of Preventive Medicine; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We are supported by the European Research Council, Science Foundation Ireland, the Irish Research Council, and Lister Institute of Preventive Medicine. We thank Paul Conway for proofreading and Ryan Lab members for scientific discussions.	Abdou K, 2018, SCIENCE, V360, P1227, DOI 10.1126/science.aat3810; Abraham WC, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0048-y; Adamsky A, 2018, CELL, V174, P59, DOI 10.1016/j.cell.2018.05.002; Adamsky A, 2018, NEUROSCIENCE, V370, P14, DOI 10.1016/j.neuroscience.2017.05.033; Agi E, 2020, CURR OPIN NEUROBIOL, V63, P1, DOI 10.1016/j.conb.2020.01.002; Akhlaghpour H, 2022, J THEOR BIOL, V537, DOI 10.1016/j.jtbi.2021.110984; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2018, GLIA, V66, P1244, DOI 10.1002/glia.23250; Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Allison DW, 1998, J NEUROSCI, V18, P2423; Aoued HS, 2019, BIOL PSYCHIAT, V85, P248, DOI 10.1016/j.biopsych.2018.07.028; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Asok A, 2019, TRENDS NEUROSCI, V42, P14, DOI 10.1016/j.tins.2018.10.005; Attardo A, 2015, NATURE, V523, P592, DOI 10.1038/nature14467; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bachiller S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00488; Baluska F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00902; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00143; Bayer KU, 2019, NEURON, V103, P380, DOI 10.1016/j.neuron.2019.05.033; Bedecarrats A, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0038-18.2018; Ben Zablah Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.594998; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; BENZER S, 1959, P NATL ACAD SCI USA, V45, P1607, DOI 10.1073/pnas.45.11.1607; Blackiston Douglas J, 2015, Commun Integr Biol, V8, pe1073424, DOI 10.1080/19420889.2015.1073424; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Boyden E. S., 2021, BIORXIV, DOI [10.1101/2021.10.13.464006, DOI 10.1101/2021.10.13.464006]; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Bukalo O, 2007, J NEUROSCI, V27, P6019, DOI 10.1523/JNEUROSCI.1022-07.2007; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; Campbell RR, 2019, NAT REV NEUROSCI, V20, P133, DOI 10.1038/s41583-019-0121-9; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Carstens KE, 2016, J NEUROSCI, V36, P6312, DOI 10.1523/JNEUROSCI.0245-16.2016; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052434; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Castello-Waldow TP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000928; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chapouthier Georges, 2004, Neural Plasticity, V11, P151, DOI 10.1155/NP.2004.151; Chawla MK, 2013, NEUROBIOL AGING, V34, P1184, DOI 10.1016/j.neurobiolaging.2012.10.017; Chen MB, 2020, NATURE, V587, P437, DOI 10.1038/s41586-020-2905-5; Chen SP, 2014, ELIFE, V3, DOI 10.7554/eLife.03896; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Choi JH, 2018, SCIENCE, V360, P430, DOI 10.1126/science.aas9204; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cisneros-Franco J Miguel, 2020, Handb Clin Neurol, V173, P75, DOI 10.1016/B978-0-444-64150-2.00009-5; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Day JJ, 2013, NAT NEUROSCI, V16, P1445, DOI 10.1038/nn.3504; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; De No RL, 1938, J NEUROPHYSIOL, V1, P207; DeFelipe J, 2012, FRONT NEUROANAT, V6, DOI [10.3389/fnana.2012.00022, 10.3389/fnsyn.2012.00002, 10.3389/fnana.2012.00005]; DeNardo LA, 2019, NAT NEUROSCI, V22, P460, DOI 10.1038/s41593-018-0318-7; Deng W, 2013, ELIFE, V2, DOI 10.7554/eLife.00312; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Descalzi G, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0495-2; Descartes Rene, 2008, MEDITATIONS 1 PHILOS; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Dudai Y., 2007, SCI MEMORY CONCEPTS, P1; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Erwin SR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107551; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fernandez-Albert J, 2019, NAT NEUROSCI, V22, P1718, DOI 10.1038/s41593-019-0476-2; Finkenstadt PM, 2000, J NEUROCHEM, V75, P1754, DOI 10.1046/j.1471-4159.2000.0751754.x; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gallistel CR, 2021, COGNITION, V213, DOI 10.1016/j.cognition.2020.104533; Gallistel CR, 2017, TRENDS COGN SCI, V21, P498, DOI 10.1016/j.tics.2017.04.012; Gallistel CR, 2013, ANNU REV PSYCHOL, V64, P169, DOI 10.1146/annurev-psych-113011-143807; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gershman SJ, 2021, ELIFE, V10, DOI 10.7554/eLife.61907; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gold AR, 2021, BIOCHEM BIOPH RES CO, V564, P103, DOI 10.1016/j.bbrc.2021.04.125; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode TD, 2020, NEURON, V107, P805, DOI 10.1016/j.neuron.2020.07.011; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Grinman E, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf0605; Grinman E, 2019, NEUROBIOL LEARN MEM, V163, DOI 10.1016/j.nlm.2019.107034; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Guo NN, 2018, NAT MED, V24, P438, DOI 10.1038/nm.4491; Gupta-Agarwal S, 2012, J NEUROSCI, V32, P5440, DOI 10.1523/JNEUROSCI.0147-12.2012; Guskjolen A, 2018, CURR BIOL, V28, P2283, DOI 10.1016/j.cub.2018.05.059; Hainmueller T, 2020, NAT REV NEUROSCI, V21, P153, DOI 10.1038/s41583-019-0260-z; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hassan BA, 2015, CELL, V163, P285, DOI 10.1016/j.cell.2015.09.031; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; HILLE B, 1978, BIOPHYS J, V22, P283, DOI 10.1016/S0006-3495(78)85489-7; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hudspeth A. J, 2013, PRINCIPLES NEURAL SC, VFifth; Hussain NK, 2015, P NATL ACAD SCI USA, V112, pE5883, DOI 10.1073/pnas.1518382112; Hyden H, 1967, Nord Med, V77, P205; Hylin MJ, 2013, LEARN MEMORY, V20, P267, DOI 10.1101/lm.030197.112; Choi DI, 2021, NEURON, V109, P2717, DOI 10.1016/j.neuron.2021.07.003; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Jaeger BN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05418-8; Jing M, 2018, NAT BIOTECHNOL, V36, P726, DOI 10.1038/nbt.4184; Jirenhed DA, 2017, P NATL ACAD SCI USA, V114, P6127, DOI 10.1073/pnas.1621132114; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansson F, 2014, P NATL ACAD SCI USA, V111, P14930, DOI 10.1073/pnas.1415371111; Josselyn SA, 2020, SCIENCE, V367, P39, DOI 10.1126/science.aaw4325; Josselyn SA, 2018, ANNU REV NEUROSCI, V41, P389, DOI 10.1146/annurev-neuro-080317-061956; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; KANDEL ER, 1965, J PHYSIOL-LONDON, V181, P1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Karaca KG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14498-4; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kim CK, 2020, CELL, V183, P2003, DOI 10.1016/j.cell.2020.11.015; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kim TH, 2022, CELL, V185, P9, DOI 10.1016/j.cell.2021.12.007; Kim WB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15121-2; Kim WB, 2017, NEURON, V95, P1129, DOI 10.1016/j.neuron.2017.08.004; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Kol A, 2021, CURR OPIN NEUROBIOL, V67, P131, DOI 10.1016/j.conb.2020.10.022; Kol A, 2020, NAT NEUROSCI, V23, P1229, DOI 10.1038/s41593-020-0679-6; Kommaddi RP, 2018, J NEUROSCI, V38, P1085, DOI 10.1523/JNEUROSCI.2127-17.2017; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Koya E, 2012, NAT NEUROSCI, V15, P1556, DOI 10.1038/nn.3232; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Kozlova I, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.592126; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Kyrke-Smith M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00369; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Landry CD, 2013, TRENDS NEUROSCI, V36, P535, DOI 10.1016/j.tins.2013.05.004; Langille JJ, 2020, NEUROBIOL LEARN MEM, V169, DOI 10.1016/j.nlm.2020.107164; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee D, 2017, NAT BIOTECHNOL, V35, P858, DOI 10.1038/nbt.3902; Lefebvre JL, 2017, SEMIN CELL DEV BIOL, V69, P111, DOI 10.1016/j.semcdb.2017.07.040; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liau WS, 2021, RNA BIOL, V18, P1025, DOI 10.1080/15476286.2020.1868165; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2018, NAT NEUROSCI, V21, P309, DOI [10.1038/S41593-018-0076-6, 10.1038/s41593-018-0076-6]; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Lv L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11328-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Marco A, 2020, NAT NEUROSCI, V23, P1606, DOI 10.1038/s41593-020-00717-0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Marvin JS, 2019, NAT METHODS, V16, P763, DOI 10.1038/s41592-019-0471-2; Marvin JS, 2018, NAT METHODS, V15, P936, DOI 10.1038/s41592-018-0171-3; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCCONNELL JV, 1959, J COMP PHYSIOL PSYCH, V52, P1, DOI 10.1037/h0048028; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MENDEL G, 1951, J HERED, V42, P3; Mercer TR, 2008, NEUROSCIENTIST, V14, P434, DOI 10.1177/1073858408319187; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Miller RR, 2021, NEUROBIOL LEARN MEM, V181, DOI 10.1016/j.nlm.2021.107426; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Morris RGM, 1999, BRAIN RES BULL, V50, P437, DOI 10.1016/S0361-9230(99)00182-3; Moser EI, 2017, NAT NEUROSCI, V20, P1448, DOI 10.1038/nn.4653; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Muslimov IA, 1998, J CELL BIOL, V141, P1601, DOI 10.1083/jcb.141.7.1601; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; Nonaka A, 2014, J NEUROSCI, V34, P9305, DOI 10.1523/JNEUROSCI.4233-13.2014; Odell SC, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107789; Ohkawa N, 2015, CELL REP, V11, P261, DOI 10.1016/j.celrep.2015.03.017; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Oliveira AMM, 2016, LEARN MEMORY, V23, P587, DOI 10.1101/lm.042739.116; Pan S, 2020, NAT NEUROSCI, V23, P487, DOI 10.1038/s41593-019-0582-1; Park AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.27872; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Pelucchi S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030908; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Perusini JN, 2017, HIPPOCAMPUS, V27, P1110, DOI 10.1002/hipo.22756; Pignatelli M, 2019, NEURON, V101, P274, DOI 10.1016/j.neuron.2018.11.029; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2009, SCIENCE, V325, P1214, DOI 10.1126/science.1179697; Poll S, 2020, NAT NEUROSCI, V23, P952, DOI 10.1038/s41593-020-0652-4; Prasada S, 2021, COGNITION, V214, DOI 10.1016/j.cognition.2021.104751; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Queenan BN, 2017, ANN NY ACAD SCI, V1396, P108, DOI 10.1111/nyas.13348; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Raman DV, 2021, ELIFE, V10, DOI [10.7554/eLife.62912, 10.7554/eLife.62912.sa1, 10.7554/eLife.62912.sa2]; Ramirez S, 2015, NATURE, V522, P335, DOI 10.1038/nature14514; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Ramon Y Cajal S., 1888, Rev trimestral de histol normal y patolog Ano, VI, P1; Rao-Ruiz P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09960-x; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Roy DS, 2017, P NATL ACAD SCI USA, V114, pE9972, DOI 10.1073/pnas.1714248114; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Ryan TJ, 2022, NAT REV NEUROSCI, V23, P173, DOI 10.1038/s41583-021-00548-3; Ryan TJ, 2021, CURR OPIN NEUROBIOL, V67, P215, DOI 10.1016/j.conb.2021.01.006; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; Sakurai K, 2016, NEURON, V92, P739, DOI 10.1016/j.neuron.2016.10.015; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sanchez MI, 2020, P NATL ACAD SCI USA, V117, P33186, DOI 10.1073/pnas.2006521117; Sandi C, 2003, BIOL PSYCHIAT, V54, P599, DOI 10.1016/S0006-3223(03)00182-3; Sanes JR, 2020, CELL, V181, P536, DOI 10.1016/j.cell.2020.04.008; Schacter D. L., 2020, MEMORY SYSTEMS 1994; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Semon R., 1904, THE MNEME; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sherrington C, 1906, INTEGRATIVE ACTION N; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Shomrat T, 2013, J EXP BIOL, V216, P3799, DOI 10.1242/jeb.087809; Shrestha P, 2020, NAT NEUROSCI, V23, P281, DOI 10.1038/s41593-019-0568-z; Smalheiser NR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0504; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Smith K., 2021, DESCARTES THEORY IDE; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Sorensen AT, 2016, ELIFE, V5, DOI 10.7554/eLife.13918; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Squire LR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021766; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; Steadman PE, 2020, NEURON, V105, P150, DOI 10.1016/j.neuron.2019.10.013; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sweatt J., 2012, EPIGENETIC REGULATIO; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Tanaka KZ, 2021, NEUROSCI RES, V165, P1, DOI 10.1016/j.neures.2020.05.002; Tanaka KZ, 2018, SCIENCE, V361, P392, DOI 10.1126/science.aat5397; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Thompson EH, 2018, P NATL ACAD SCI USA, V115, P607, DOI 10.1073/pnas.1713530115; Titley HK, 2017, NEURON, V95, P19, DOI 10.1016/j.neuron.2017.05.021; Togashi H, 2009, CELL ADHES MIGR, V3, P29, DOI 10.4161/cam.3.1.6773; Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2; Tonegawa S, 2015, CURR OPIN NEUROBIOL, V35, P101, DOI 10.1016/j.conb.2015.07.009; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Trouche S, 2013, NEURON, V80, P1054, DOI 10.1016/j.neuron.2013.07.047; Tsien RY, 2013, P NATL ACAD SCI USA, V110, P12456, DOI 10.1073/pnas.1310158110; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1974, AM SCI, V62, P74; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vetere G, 2019, NAT NEUROSCI, V22, P933, DOI 10.1038/s41593-019-0389-0; Vlasov K, 2018, METHOD ENZYMOL, V603, P181, DOI 10.1016/bs.mie.2018.01.022; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wang H, 2018, CURR OPIN NEUROBIOL, V50, P171, DOI 10.1016/j.conb.2018.03.010; Wang WJ, 2019, NAT CHEM BIOL, V15, P101, DOI 10.1038/s41589-018-0207-0; Wang W, 2017, NAT BIOTECHNOL, V35, P864, DOI 10.1038/nbt.3909; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Whitaker LR, 2018, LEARN MEMORY, V25, P455, DOI 10.1101/lm.046698.117; Whitaker LR, 2016, BIOL PSYCHIAT, V80, P246, DOI 10.1016/j.biopsych.2015.08.006; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu YX, 2017, CURR OPIN CHEM BIOL, V39, P1, DOI 10.1016/j.cbpa.2017.04.005; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAREMBA S, 1989, NEURON, V2, P1207, DOI 10.1016/0896-6273(89)90305-X; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhang HR, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.729076; Zhao BH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12436-7; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou YM, 2019, NAT NEUROSCI, V22, P1986, DOI 10.1038/s41593-019-0524-y; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	317	0	0	17	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101866	10.1016/j.jbc.2022.101866	http://dx.doi.org/10.1016/j.jbc.2022.101866			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35346687	Green Published, gold			2022-12-28	WOS:000860390500006
J	Tsai, SJ; Ai, YW; Guo, CX; Gould, SJ				Tsai, Shang Jui; Ai, Yiwei; Guo, Chenxu; Gould, Stephen J.			Degron tagging of BleoR and other antibiotic-resistance genes selects for higher expression of linked transgenes and improved exosome engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DELIVERY; MESSENGER-RNA; PROTEINS; CLONING; VIRUS; BIOGENESIS; ENHANCER; VECTORS; MARKER	Five antibiotic resistance (AR) genes have been used to select for transgenic eukaryotic cell lines, with the BleoR, PuroR, HygR, NeoR, and BsdR cassettes conferring resistance to zeocin, puromycin, hygromycin, geneticin/G418, and blasticidin, respectively. We recently demonstrated that each AR gene establishes a distinct threshold of transgene expression below which no cell can survive, with BleoR selecting for the highest level of transgene expression, nearly similar to 10-fold higher than in cells selected using the NeoR or BsdR markers. Here, we tested the hypothesis that there may be an inverse proportionality between AR protein function and the expression of linked, transgene-encoded, recombinant proteins. Specifically, we fused each AR protein to proteasome-targeting degron tags, used these to select for antibiotic-resistant cell lines, and then measured the expression of the linked, recombinant protein, mCherry, as a proxy marker of transgene expression. In each case, degron-tagged AR proteins selected for higher mCherry expression than their cognate WT AR proteins. ER50BleoR selected for the highest level of mCherry expression, greater than twofold higher than BleoR or any other AR gene. Interestingly, use of ER50BleoR as the selectable marker translated to an even higher, 3.5-fold increase in the exosomal loading of the exosomal cargo protein, CD63/Y235A. Although a putative CD63-binding peptide, CP05, has been used to decorate exosome membranes in a technology known as "exosome painting," we show here that CP05 binds equally well to CD63(-/-) cells, WT 293F cells, and CD63-overexpressing cells, indicating that CP05 may bind membranes nonspecifically. These results are of high significance for cell engineering and especially for exosome engineering.	[Tsai, Shang Jui; Ai, Yiwei; Guo, Chenxu; Gould, Stephen J.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21218 USA.	sgould@jhmi.edu		Tsai, Shang-Jui/0000-0002-9602-2823; Guo, Chenxu/0000-0002-9651-4203	Capricor; Johns Hopkins University; National Institutes of Health	Capricor; Johns Hopkins University(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted with support from Capricor, Johns Hopkins University, and the National Institutes of Health (grant no.: UG3CA241687-02)	Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Dhara VG, 2018, BIODRUGS, V32, P571, DOI 10.1007/s40259-018-0319-9; Diamond Michael, 2021, Res Sq, DOI 10.21203/rs.3.rs-228079/v1; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Dong X, 2021, THERANOSTICS, V11, P5107, DOI 10.7150/thno.54755; Dooley K, 2021, MOL THER, V29, P1729, DOI 10.1016/j.ymthe.2021.01.020; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fonseca JP, 2019, ACS SYNTH BIOL, V8, P2593, DOI 10.1021/acssynbio.9b00322; Fordjour F. K., 2019, BIORXIV, DOI [10.1101/545228v1, DOI 10.1101/545228V1, 10.1101/545228, DOI 10.1101/545228]; Gan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029421; Gao XJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0195; Gaspar V, 2015, EXPERT OPIN BIOL TH, V15, P353, DOI 10.1517/14712598.2015.996544; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; Ghilardi N, 2020, ANNU REV IMMUNOL, V38, P249, DOI 10.1146/annurev-immunol-101619-031510; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Guo CX, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100838; Huang KYA, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009352; Imai J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225606; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; JOYNER A, 1982, P NATL ACAD SCI-BIOL, V79, P1573, DOI 10.1073/pnas.79.5.1573; KASTER KR, 1983, NUCLEIC ACIDS RES, V11, P6895, DOI 10.1093/nar/11.19.6895; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Kjaer J, 2018, J VIROL, V92, DOI 10.1128/JVI.02218-17; Kurosaki T, 2019, NAT REV MOL CELL BIO, V20, P406, DOI 10.1038/s41580-019-0126-2; Luke GA, 2010, BIOTECHNOL GENET ENG, V26, P223; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; Ochmann MT, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010076; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Segel M, 2021, SCIENCE, V373, P882, DOI 10.1126/science.abg6155; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen BY, 2011, J BIOL CHEM, V286, P44162, DOI 10.1074/jbc.M111.274803; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Tipanee J, 2017, HUM GENE THER, V28, P1087, DOI 10.1089/hum.2017.128; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; VARA J, 1985, GENE, V33, P197, DOI 10.1016/0378-1119(85)90094-0; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Wang T, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.659783; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zuo BF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15569-2	47	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101846	10.1016/j.jbc.2022.101846	http://dx.doi.org/10.1016/j.jbc.2022.101846			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35314197	gold, Green Published			2022-12-28	WOS:000804923000011
J	Bai, N; Riching, KM; Makaju, A; Wu, H; Acker, TM; Ou, SC; Zhang, YR; Shen, XM; Bulloch, DN; Rui, H; Gibson, BW; Daniels, DL; Urh, M; Rock, BM; Humphreys, SC				Bai, Nan; Riching, Kristin M.; Makaju, Aman; Wu, Hao; Acker, Timothy M.; Ou, Shu-Ching; Zhang, Yaru; Shen, Xiaomeng; Bulloch, Daryl N.; Rui, Huan; Gibson, Bradford W.; Daniels, Danette L.; Urh, Marjeta; Rock, Brooke M.; Humphreys, Sara C.			Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DEGRADATION; ARCHITECTURE; RECOGNITION; ACTIVATION; DESIGN; SCF	PROteolysis TArgeting Chimeras (PROTACs) are heterobifunctional small molecules that can simultaneously recruit target proteins and E3 ligases to form a ternary complex, promoting target protein ubiquitination and degradation via the Ubiquitin-Proteasome System (UPS). PROTACs have gained increasing attention in recent years due to certain advantages over traditional therapeutic modalities and enabling targeting of previously "undruggable " proteins. To better understand the mechanism of PROTAC-induced Target Protein Degradation (TPD), several computational approaches have recently been developed to study and predict ternary complex formation. However, mounting evidence suggests that ubiquitination can also be a rate-limiting step in PROTAC-induced TPD. Here, we propose a structure-based computational approach to predict target protein ubiquitination induced by cereblon (CRBN)-based PROTACs by leveraging available structural information of the CRL4A ligase complex (CRBN/ DDB1/CUL4A/Rbx1/NEDD8/E2/Ub). We generated ternary complex ensembles with Rosetta, modeled multiple CRL4A ligase complex conformations, and predicted ubiquitination efficiency by separating the ternary ensemble into productive and unproductive complexes based on the proximity of the ubiquitin to accessible lysines on the target protein. We validated our CRL4A ligase complex models with published ternary complex structures and additionally employed our modeling workflow to predict ubiquitination efficiencies and sites of a series of cyclin-dependent kinases (CDKs) after treatment with TL12-186, a pan-kinase PROTAC. Our predictions are consistent with CDK ubiquitination and site directed mutagenesis of specific CDK lysine residues as measured using a NanoBRET ubiquitination assay in HEK293 cells. This work structurally links PROTAC-induced ternary formation and ubiquitination, representing an important step toward prediction of target "degradability. "	[Bai, Nan; Wu, Hao; Acker, Timothy M.; Shen, Xiaomeng; Rock, Brooke M.; Humphreys, Sara C.] Amgen Res, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA; [Riching, Kristin M.; Daniels, Danette L.; Urh, Marjeta] Promega Corp, Res & Dev Dept, Madison, WI 53711 USA; [Makaju, Aman; Bulloch, Daryl N.; Gibson, Bradford W.] Amgen Res, Discovery Attribute Sci, San Francisco, CA USA; [Ou, Shu-Ching; Rui, Huan] Amgen Res, Discovery Attribute Sci, Thousand Oaks, CA USA; [Zhang, Yaru] Amgen Res, Oncol, Thousand Oaks, CA USA	Promega Corporation	Bai, N; Humphreys, SC (corresponding author), Amgen Res, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA.; Riching, KM (corresponding author), Promega Corp, Res & Dev Dept, Madison, WI 53711 USA.	nbai@amgen.com; Kristin.Riching@promega.com; shumph01@amgen.com		Riching, Kristin/0000-0003-4646-1067; Bai, Nan/0000-0002-2222-0472; Bulloch, Daryl/0000-0002-3885-2343	Amgen; Promega	Amgen(Amgen); Promega	This study was funded jointly by Amgen and Promega where relevant, according to the author guidelines.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baek K, 2021, CURR OPIN STRUC BIOL, V67, P101, DOI 10.1016/j.sbi.2020.10.007; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Bai N, 2021, J CHEM INF MODEL, V61, P1368, DOI 10.1021/acs.jcim.0c01451; Bondeson DP, 2018, CELL CHEM BIOL, V25, P78, DOI 10.1016/j.chembiol.2017.09.010; Chung CW, 2020, ACS CHEM BIOL, V15, P2316, DOI 10.1021/acschembio.0c00266; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dragovich PS, 2021, J MED CHEM, V64, P2576, DOI 10.1021/acs.jmedchem.0c01846; Drummond ML, 2020, J CHEM INF MODEL, V60, P5234, DOI 10.1021/acs.jcim.0c00897; Drummond ML, 2019, J CHEM INF MODEL, V59, P1634, DOI 10.1021/acs.jcim.8b00872; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eron SJ, 2021, ACS CHEM BIOL, V16, P2228, DOI 10.1021/acschembio.1c00376; Farnaby W, 2019, NAT CHEM BIOL, V15, P672, DOI 10.1038/s41589-019-0294-6; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/nchembio.2329, 10.1038/NCHEMBIO.2329]; HaileMariam M, 2018, J PROTEOME RES, V17, P2917, DOI 10.1021/acs.jproteome.8b00505; Han BM, 2020, J BIOL CHEM, V295, P15280, DOI 10.1074/jbc.RA120.014715; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Harper JW, 2021, ANNU REV BIOCHEM, V90, P403, DOI 10.1146/annurev-biochem-090120-013613; Henneberg LT, 2021, CELL CHEM BIOL, V28, P889, DOI 10.1016/j.chembiol.2021.03.009; Horn-Ghetko D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03197-9; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Hughes SJ, 2017, ESSAYS BIOCHEM, V61, P505, DOI 10.1042/EBC20170041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kaiho-Soma A, 2021, MOL CELL, V81, P1411, DOI 10.1016/j.molcel.2021.01.023; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Landrum G., 2006, RDKIT OPEN SOURCE CH; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebraud H, 2016, ACS CENTRAL SCI, V2, P927, DOI 10.1021/acscentsci.6b00280; Lumpkin RJ, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.RA120.002414; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MacPherson T., 2021, BIORXIV, DOI [10.1101/461830, DOI 10.1101/461830]; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; New York NY, 2021, MAESTR; Nowak RP, 2018, NAT CHEM BIOL, V14, P706, DOI 10.1038/s41589-018-0055-y; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pettersson Mariell, 2019, Drug Discov Today Technol, V31, P15, DOI 10.1016/j.ddtec.2019.01.002; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reichermeier K. M., 2020, THESIS CALTECH; Riching KM, 2021, SLAS DISCOV, V26, P560, DOI 10.1177/2472555220973602; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Roy MJ, 2019, ACS CHEM BIOL, V14, P361, DOI 10.1021/acschembio.9b00092; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schapira M, 2019, NAT REV DRUG DISCOV, V18, P949, DOI 10.1038/s41573-019-0047-y; Testa A, 2020, ANGEW CHEM INT EDIT, V59, P1727, DOI 10.1002/anie.201914396; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Udeshi ND, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14175-1; Vieux EF, 2021, SLAS DISCOV, V26, P547, DOI 10.1177/24725552211000673; Zaidman D, 2020, J CHEM INF MODEL, V60, P4894, DOI 10.1021/acs.jcim.0c00589; Zhang W., 2021, BIORXIV, DOI [10.1101/462040, DOI 10.1101/462040]; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zorba A, 2018, P NATL ACAD SCI USA, V115, pE7285, DOI 10.1073/pnas.1803662115	57	3	3	11	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101653	10.1016/j.jbc.2022.101653	http://dx.doi.org/10.1016/j.jbc.2022.101653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35101445	Green Published, gold			2022-12-28	WOS:000793617400012
J	Liu, R; Song, YR; Li, CX; Zhang, ZJ; Xue, ZY; Huang, QC; Yu, LCY; Zhu, DJ; Cao, ZW; Lu, AP; Lu, C; Liu, YY				Liu, Rui; Song, Yurong; Li, Chenxi; Zhang, Zhengjia; Xue, Zeyu; Huang, Qingcai; Yu, Liuchunyang; Zhu, Dongjie; Cao, Zhiwen; Lu, Aiping; Lu, Cheng; Liu, Yuanyan			The naturally occurring flavonoid nobiletin reverses methotrexate resistance via inhibition of P-glycoprotein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; ABC TRANSPORTERS; CANCER; METABOLISM; TARGET; CELLS	Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). However, after long-term treatment, some patients develop resistance. P-glycoprotein (P-gp), as an indispensable drug transporter, is essential for mediating this MTX resistance. In addition, nobiletin (NOB), a naturally occurring polymethoxylated flavonoid, has also been shown to reverse P-gp-mediated MTX resistance in RA groups; however, the precise role of NOB in this process is still unclear. Here, we administered MTX and NOB alone or in combination to collagen II-induced arthritic (CIA) mice and evaluated disease severity using the arthritis index, synovial histopathological changes, immunohistochemistry, and P-gp expression. In addition, we used conventional RNA-seq to identify targets and possible pathways through which NOB reverses MTX-induced drug resistance. We found that NOB in combination with MTX could enhance its performance in synovial tissue and decrease P-gp expression in CIA mice compared to MTX treatment alone. In vitro, in MTX-resistant fibroblast-like synoviocytes from CIA cells (CIA-FLS/MTX), we show that NOB treatment downregulated the PI3K/AKT/HIF-1 alpha pathway, thereby reducing the synthesis of the P-gp protein. In addition, NOB significantly inhibited glycolysis and metabolic activity of CIA-FLS/MTX cells, which could reduce the production of ATP and block P-gp, ultimately decreasing the efflux of MTX and maintaining its anti-RA effects. In conclusion, this study shows that NOB overcomes MTX resistance in CIA-FLS/MTX cells through the PI3K/AKT/HIF-1a pathway, simultaneously influencing metabolic processes and inhibiting P-gp-induced drug efflux.	[Liu, Rui; Song, Yurong; Li, Chenxi; Zhang, Zhengjia; Xue, Zeyu; Huang, Qingcai; Yu, Liuchunyang; Zhu, Dongjie; Cao, Zhiwen; Liu, Yuanyan] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Lu, Cheng] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing University of Chinese Medicine; Hong Kong Baptist University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Liu, YY (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.; Lu, AP (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China.; Lu, C (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.	lap64067611@126.com; lv_cheng0816@163.com; yyliu_1980@163.com			Beijing Natural Science Foundation [7202111]; National Science and Technology Major Project [2018ZX10101001-005-003]; Fundamental Research Funds for the Central public welfare research institutes [Z0653/Z0656]; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine [ZYYCXTD-D-202005]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science and Technology Major Project; Fundamental Research Funds for the Central public welfare research institutes; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine	This work was supported by Beijing Natural Science Foundation (7202111), National Science and Technology Major Project (2018ZX10101001-005-003), the Fundamental Research Funds for the Central public welfare research institutes (Z0653/Z0656), and Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-D-202005). All special thanks for the longterm subsidy mechanism from the Ministry of Finance and the Ministry of Education of PRC for BUCM.	Alexa-Stratulat T, 2019, DRUG RESIST UPDATE, V46, DOI 10.1016/j.drup.2019.100643; Asgari Y, 2015, GENOMICS, V105, P275, DOI 10.1016/j.ygeno.2015.03.001; Ashrafizadeh M, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050110; Briz O, 2019, EXPERT OPIN DRUG MET, V15, P577, DOI 10.1080/17425255.2019.1631285; Calabrese LH, 2016, ARTHRIT CARE RES, V68, P723, DOI 10.1002/acr.22865; Chen JH, 2021, ARTHRITIS RHEUMATOL, V73, P1810, DOI 10.1002/art.41748; de Oliveira PG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01743; Dong C, 2020, AM J CANCER RES, V10, P263; Feng SL, 2020, ACTA PHARMACOL SIN B, V10, P327, DOI 10.1016/j.apsb.2019.07.007; Fletcher JI, 2016, DRUG RESIST UPDATE, V26, P1, DOI 10.1016/j.drup.2016.03.001; Gifford AJ, 1998, INT J CANCER, V78, P176, DOI 10.1002/(SICI)1097-0215(19981005)78:2<176::AID-IJC10>3.3.CO;2-F; GROFF GD, 1983, SEMIN ARTHRITIS RHEU, V12, P333, DOI 10.1016/0049-0172(83)90014-8; He D, 2019, PHYTOTHER RES, V33, P1122, DOI 10.1002/ptr.6306; Hua SS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00184; Huang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2918796; Priya MJ, 2022, J BIOMOL STRUCT DYN, V40, P4273, DOI 10.1080/07391102.2020.1855249; Kaihara K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083898; Lee JH, 2019, CANCERS, V11, DOI 10.3390/cancers11020254; Li GQ, 2013, MOL CELL BIOCHEM, V372, P221, DOI 10.1007/s11010-012-1463-z; Liu ZB, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.172939; Long QZ, 2013, ANTI-CANCER DRUG, V24, P810, DOI 10.1097/CAD.0b013e328363046d; Marki-Zay J, 2013, CLIN EXP RHEUMATOL, V31, P779; Masoumi M, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107064; McGarry T, 2018, ARTHRITIS RHEUMATOL, V70, P1959, DOI 10.1002/art.40569; Miyoshi M, 2018, METHODS MOL BIOL, V1868, P3, DOI 10.1007/978-1-4939-8802-0_1; Muhammad II, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010167; Norris MD, 1996, INT J CANCER, V65, P613; Storelli F, 2021, CLIN PHARMACOL THER, V110, P432, DOI 10.1002/cpt.2227; Takase-Minegishi K, 2018, RHEUMATOLOGY, V57, P49, DOI 10.1093/rheumatology/kex036; Tripathi SC, 2017, CANCER RES, V77, P4414, DOI 10.1158/0008-5472.CAN-16-2874; Tsujimura S, 2018, MOD RHEUMATOL, V28, P276, DOI 10.1080/14397595.2017.1341458; Wang TT, 2021, CLIN REV ALLERG IMMU, V60, P55, DOI 10.1007/s12016-020-08821-6; Xu SW, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104660; Zhang ZQ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03123-3	34	1	1	9	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101756	10.1016/j.jbc.2022.101756	http://dx.doi.org/10.1016/j.jbc.2022.101756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35202652	gold, Green Published			2022-12-28	WOS:000823106100005
J	Schwarzbaum, PJ; Schachter, J; Bredeston, LM				Schwarzbaum, Pablo J.; Schachter, Julieta; Bredeston, Luis M.			The broad range di- and tri-nucleotide exchanger SLC35B1 displays asymmetrical affinities for ATP transport across the ER membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT SUBCELLULAR COMPARTMENTS; ENDOPLASMIC-RETICULUM; NUCLEOSIDE DIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; GALACTOSE TRANSPORTER; SUGAR TRANSPORTERS; SECRETORY PATHWAY; EXTRACELLULAR ATP; STRUCTURAL BASIS; UDP	In eukaryotic cells, uptake of cytosolic ATP into the endoplasmic reticulum (ER) lumen is critical for the proper functioning of chaperone proteins. The human transport protein SLC35B1 was recently postulated to mediate ATP/ADP exchange in the ER; however, the underlying molecular mechanisms mediating ATP uptake are not completely understood. Here, we extensively characterized the transport kinetics of human SLC35B1 expressed in yeast that was purified and reconstituted into liposomes. Using [alpha 32P]ATP uptake assays, we tested the nucleotide concentration dependence of ATP/ ADP exchange activity on both sides of the membrane. We found that the apparent affinities of SLC35B1 for ATP/ADP on the internal face were approximately 13 times higher than those on the external side. Because SLC35B1-containing liposomes were preferentially inside-out oriented, these results suggest a low-affinity external site and a high-affinity internal site in the ER. Three different experimental approaches indicated that ATP/ADP exchange by SLC35B1 was not strict, and that other di-and tri-nucleotides could act as suitable counter substrates for ATP, although mononucleotides and nucleotide sugars were not transported. Finally, bioinformatic analysis and site-directed mutagenesis identified that conserved residues K117 and K120 from transmembrane helix 4 and K277 from transmembrane helix 9 play critical roles in transport. The fact that SLC35B1 can promote ATP transport in exchange for ADP or UDP suggest a more direct coupling between ATP import requirements and the need for eliminating ADP and UDP, which are generated as side products of reactions taking place in the ER-lumen.	[Schwarzbaum, Pablo J.; Schachter, Julieta; Bredeston, Luis M.] Univ Buenos Aires CONICET, Fac Farm & Bioquim, Dept Quim Biol IQUIFIB, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Schwarzbaum, PJ; Bredeston, LM (corresponding author), Univ Buenos Aires CONICET, Fac Farm & Bioquim, Dept Quim Biol IQUIFIB, Buenos Aires, Argentina.	pjs@qb.ffyb.uba.ar; bredes@qb.ffyb.uba.ar	Schachter, Julieta/GLR-1361-2022	Bredeston, Luis/0000-0002-1272-8344; Schachter, Julieta/0000-0001-7704-4958	University of Buenos Aires [UBACYT20020170100152BA]	University of Buenos Aires(University of Buenos Aires)	Funding and additional information-This study was supported by the University of Buenos Aires (grant UBACYT20020170100152BA to P. J. S.) .	Toscanini MA, 2019, J BIOL CHEM, V294, P10042, DOI 10.1074/jbc.RA119.008827; Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Bredeston LM, 2005, J BIOL CHEM, V280, P32168, DOI 10.1074/jbc.M507035200; Bredeston LM, 2017, GLYCOBIOLOGY, V27, P64, DOI 10.1093/glycob/cww092; Castro O, 1999, MOL BIOL CELL, V10, P1019, DOI 10.1091/mbc.10.4.1019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; Csala M, 2007, BBA-BIOMEMBRANES, V1768, P1325, DOI 10.1016/j.bbamem.2007.03.009; D'Alessio C, 2005, J BIOL CHEM, V280, P40417, DOI 10.1074/jbc.M503149200; D'Alessio C, 2003, J BIOL CHEM, V278, P22379, DOI 10.1074/jbc.M300892200; de Campos RP, 2021, PURINERG SIGNAL, V17, P467, DOI 10.1007/s11302-021-09795-6; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; Depaoli MR, 2019, BIOL REV, V94, P610, DOI 10.1111/brv.12469; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hoffmann C, 2013, PLANT CELL, V25, P2647, DOI 10.1105/tpc.113.113605; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim J, 2019, NATURE, V576, P315, DOI 10.1038/s41586-019-1795-x; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Kochendorfer KU, 1999, EMBO J, V18, P1506, DOI 10.1093/emboj/18.6.1506; Kunji ERS, 2016, BBA-MOL CELL RES, V1863, P2379, DOI 10.1016/j.bbamcr.2016.03.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Denis MFL, 2013, BBA-GEN SUBJECTS, V1830, P4692, DOI 10.1016/j.bbagen.2013.05.033; Lee Y, 2017, NAT PLANTS, V3, P825, DOI 10.1038/s41477-017-0022-8; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; MAYINGER P, 1993, EMBO J, V12, P659, DOI 10.1002/j.1460-2075.1993.tb05699.x; Mifsud J, 2013, MOL MEMBR BIOL, V30, P160, DOI 10.3109/09687688.2012.745175; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Muraoka M, 2007, J BIOL CHEM, V282, P24615, DOI 10.1074/jbc.M611358200; Nakanishi H, 2001, YEAST, V18, P543, DOI 10.1002/yea.707; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nji E, 2019, NAT STRUCT MOL BIOL, V26, P415, DOI 10.1038/s41594-019-0225-y; Ondo K, 2020, BIOCHEM PHARMACOL, V175, DOI 10.1016/j.bcp.2020.113916; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; PERKINS WR, 1993, CHEM PHYS LIPIDS, V64, P197, DOI 10.1016/0009-3084(93)90066-C; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Rautengarten C, 2019, HUM MOL GENET, V28, P3543, DOI 10.1093/hmg/ddz200; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; Reyes F, 2006, J BIOL CHEM, V281, P9145, DOI 10.1074/jbc.M512210200; Reyes F, 2010, PLANT J, V61, P423, DOI 10.1111/j.1365-313X.2009.04066.x; Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025; Russell D. W., 2012, MOL CLONING LAB MANU, V4th; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tsuchiya H, 2016, NATURE, V534, P417, DOI 10.1038/nature17991; Walia G, 2018, XENOBIOTICA, V48, P882, DOI 10.1080/00498254.2017.1376260; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Yong J, 2019, ELIFE, V8, DOI 10.7554/eLife.49682; Zimmermann R., 2020, CONTACT, V3, p251525642092679, DOI [10.1177/2515256420926795, DOI 10.1177/2515256420926795]	58	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101537	10.1016/j.jbc.2021.101537	http://dx.doi.org/10.1016/j.jbc.2021.101537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35041824	Green Published, gold			2022-12-28	WOS:000797895000008
J	Cecchini, G				Cecchini, Gary			Complexities of complex II: Sulfide metabolism in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE; REDUCTASE	High levels of H2S produced by gut microbiota can block oxygen utilization by inhibiting mitochondrial complex IV. Kumar et al. have shown how cells respond to this inhibition by using the mitochondrial sulfide oxidation pathway and reverse electron transport. The reverse activity of mitochondrial complex II (succinate-quinone oxidoreductase, i.e., fumarate reduction) generates oxidized coenzyme Q, which is then reduced by the mitochondrial sulfide quinone oxidoreductase to oxidize H2S. This newly identified redox circuitry points to the importance of complex II reversal in mitochondria during periods of hypoxia and cellular stress.	[Cecchini, Gary] San Francisco VA Hlth Care Syst, Mol Biol Div, San Francisco, CA 94121 USA; [Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cecchini, G (corresponding author), San Francisco VA Hlth Care Syst, Mol Biol Div, San Francisco, CA 94121 USA.; Cecchini, G (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	Gary.Cecchini@ucsf.edu		Cecchini, Gary/0000-0002-0571-1747	Department of Veterans Affairs [1K6BX004215]; NIH [GM61606]	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G. C. is the recipient of a Senior Research Career Scientist award 1K6BX004215 from the Department of Veterans Affairs and this work is also supported by NIH Award GM61606. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boukalova S., 2018, NAT; Chouchani E. T., 2014, ISCHAEMIC; Kumar R, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101435; Landry AP, 2021, CHEMBIOCHEM, V22, P949, DOI 10.1002/cbic.202000661; Libiad M, 2019, J BIOL CHEM, V294, P12077, DOI 10.1074/jbc.RA119.009442; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MASSEY V, 1957, J BIOL CHEM, V228, P263; Mentel M, 2014, BIOESSAYS, V36, P924, DOI 10.1002/bies.201400060; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Spinelli J. B., 2021, FUMARATE IS TERMINAL	10	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101661	10.1016/j.jbc.2022.101661	http://dx.doi.org/10.1016/j.jbc.2022.101661			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101450	gold, Green Published			2022-12-28	WOS:000794865600005
J	Du, S; Wang, GP; Zhang, ZY; Ma, CY; Gao, N; Xiao, JY				Du, Shuo; Wang, Guopeng; Zhang, Zhiying; Ma, Chengying; Gao, Ning; Xiao, Junyu			Structural insights into how GlcNAc-1-phosphotransferase directs lysosomal protein transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; GAMMA-SUBUNITS; MUTATIONS; DOMAINS; IDENTIFICATION; RECOGNITION; ALPHA	GlcNAc-1-phosphotransferase catalyzes the initial step in the formation of the mannose-6-phosphate tag that labels similar to 60 lysosomal proteins for transport. Mutations in GlcNAc-1-phosphotransferase are known to cause lysosomal storage disorders such as mucolipidoses. However, the molecular mechanism of GlcNAc-1-phosphotransferase activity remains unclear. Mammalian GlcNAc-1-phosphotransferases are alpha 2 beta 2 gamma 2 hexamers in which the core catalytic alpha- and beta-subunits are derived from the GNPTAB (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) gene. Here, we present the cryo-electron microscopy structure of the Drosophila melanogaster GNPTAB homolog, DmGNPTAB. We identified four conserved regions located far apart in the sequence that fold into the catalytic domain, which exhibits structural similarity to that of the UDP-glucose glycoprotein glucosyltransferase. Comparison with UDP-glucose glycoprotein glucosyltransferase also revealed a putative donor substrate-binding site, and the functional requirements of critical residues in human GNPTAB were validated using GNPTAB-knockout cells. Finally, we show that DmGNPTAB forms a homodimer that is evolutionarily conserved and that perturbing the dimer interface undermines the maturation and activity of human GNPTAB. These results provide important insights into GlcNAc-l-phosphotransferase function and related diseases.	[Du, Shuo; Zhang, Zhiying; Xiao, Junyu] Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Du, Shuo; Wang, Guopeng; Zhang, Zhiying; Ma, Chengying; Gao, Ning; Xiao, Junyu] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Ma, Chengying; Gao, Ning] Peking Univ, State Key Lab Membrane Biol, Beijing, Peoples R China; [Ma, Chengying; Gao, Ning; Xiao, Junyu] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Xiao, Junyu] Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Xiao, JY (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.; Gao, N; Xiao, JY (corresponding author), Peking Univ, Sch Life Sci, Beijing, Peoples R China.; Gao, N (corresponding author), Peking Univ, State Key Lab Membrane Biol, Beijing, Peoples R China.; Gao, N; Xiao, JY (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Xiao, JY (corresponding author), Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China.	gaon@pku.edu.cn; junyuxiao@pku.edu.cn		Zhang, zhiying/0000-0002-5690-9796	National Key Research and Development Program of China [2017YFA0505200, 2019YFA0508904]; National Science Foundation of China [31822014, 31725007, 31630087]; Qidong-SLS Innovation Fund	National Key Research and Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qidong-SLS Innovation Fund	The work was supported by the National Key Research and Development Program of China (2017YFA0505200 to J. X., 2019YFA0508904 to N. G.), the National Science Foundation of China (31822014 to J. X., 31725007 and 31630087 to N. G.), and the Qidong-SLS Innovation Fund to J. X. and N. G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Danyukova T, 2020, HUM MUTAT, V41, P133, DOI 10.1002/humu.23928; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Encarnacao M, 2011, J BIOL CHEM, V286, P5311, DOI 10.1074/jbc.M110.202382; Flint M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08135-4; Frigerio-Domingues C, 2017, MOL GENET GENOM MED, V5, P95, DOI 10.1002/mgg3.276; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Liu L, 2017, FEBS LETT, V591, P47, DOI 10.1002/1873-3468.12525; Ludwig NF, 2017, INT J BIOCHEM CELL B, V92, P90, DOI 10.1016/j.biocel.2017.09.006; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Roversi P, 2017, P NATL ACAD SCI USA, V114, P8544, DOI 10.1073/pnas.1703682114; Satoh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12283-w; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P99; Tagliabracci VS, 2016, METHODS MOL BIOL, V1496, P197, DOI 10.1007/978-1-4939-6463-5_16; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; Velho RV, 2019, HUM MUTAT, V40, P842, DOI 10.1002/humu.23748; Velho RV, 2016, FEBS LETT, V590, P4287, DOI 10.1002/1873-3468.12456; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	34	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101702	10.1016/j.jbc.2022.101702	http://dx.doi.org/10.1016/j.jbc.2022.101702			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148990	Green Published, gold			2022-12-28	WOS:000821054100003
J	El Atab, O; Kocabey, AE; Asojo, OA; Schneiter, R				El Atab, Ola; Kocabey, Aslihan Ekim; Asojo, Oluwatoyin A.; Schneiter, Roger			Prostate secretory protein 94 inhibits sterol binding and export by the mammalian CAP protein CRISP2 in a calcium-sensitive manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-MICROSEMINOPROTEIN; FUNCTIONAL-CHARACTERIZATION; HUMAN SPERMATOZOA; CRYSTAL-STRUCTURE; SEMINAL PLASMA; YEAST PROTEIN; CANCER; SUPERFAMILY; RECEPTOR; GROWTH	Members of the CAP protein superfamily are present in all kingdoms of life and have been implicated in many different processes, including pathogen defense, immune evasion, sperm maturation, and cancer progression. Most CAP proteins are secreted glycoproteins and share a unique conserved alpha beta alpha sandwich fold. The precise mode of action of this class of proteins, however, has remained elusive. Saccharomyces cerevisiae has three CAP family members, termed pathogen related in yeast (Pry). We have previously shown that Pry1 and Pry2 export sterols in vivo and that they bind sterols in vitro. This sterol binding and export function of yeast Pry proteins is conserved in the mammalian CRISP proteins and other CAP superfamily members. CRISP3 is an abundant protein of the human seminal plasma and interacts with prostate secretory protein of 94 amino acids (PSP94), another major protein component in the seminal plasma. Here we examine whether the interaction between CRISP proteins and PSP94 affects the sterol binding function of CAP family members. We show that coexpression of PSP94 with CAP proteins in yeast abolished their sterol export function and the interaction between PSP94 and CAP proteins inhibits sterol binding in vitro. In addition, mutations that affect the formation of the PSP94-CRISP2 heteromeric complex restore sterol binding. Of interest, we found the interaction of PSP94 with CRISP2 is sensitive to high calcium concentrations. The observation that PSP94 modulates the sterol binding function of CRISP2 in a calcium-dependent manner has potential implications for the role of PSP94 and CRISP2 in prostate physiology and progression of prostate cancer.	[El Atab, Ola; Kocabey, Aslihan Ekim; Schneiter, Roger] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Asojo, Oluwatoyin A.] Hampton Univ, Dept Chem & Biochem, Hampton, VA USA	University of Fribourg; Hampton University	Schneiter, R (corresponding author), Univ Fribourg, Dept Biol, Fribourg, Switzerland.	roger.schneiter@unifr.ch	; Asojo, Oluwatoyin/C-2005-2012	Schneiter, Roger/0000-0002-9102-8396; Asojo, Oluwatoyin/0000-0002-4043-2700; El Atab, Ola/0000-0003-3118-0828	Swiss National Science Foundation [31003A_173003, 310030L_182725]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Acknowledgments-We thank R. Darwiche for initial pilot experi-ments, members of the laboratory for helpful discussions, and Stephanie Cottier for comments on the manuscript. This work was supported by the Swiss National Science Foundation (Grant 31003A_173003, and 310030L_182725) .	Anklesaria JH, 2018, FRONT BIOSCI-LANDMRK, V23, P535, DOI 10.2741/4604; Anklesaria JH, 2016, J CHROMATOGR B, V1039, P59, DOI 10.1016/j.jchromb.2016.10.032; Anklesaria JH, 2016, J PEPT SCI, V22, P383, DOI 10.1002/psc.2878; Ardura JA, 2020, CANCERS, V12, DOI 10.3390/cancers12051071; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Breed AA, 2013, BBA-GEN SUBJECTS, V1830, P3019, DOI 10.1016/j.bbagen.2013.01.015; Byrne KS, 2019, ANN ONCOL, V30, P983, DOI 10.1093/annonc/mdz121; Cantacessi C, 2012, MOL CELL PROBE, V26, P54, DOI 10.1016/j.mcp.2011.10.001; Carvajal G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35719-3; Chao CF, 1996, BIOCHEM BIOPH RES CO, V218, P623, DOI 10.1006/bbrc.1996.0110; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Darwiche R., 2016, J STEROIDS HORM SCI, V7, P2; Darwiche R, 2018, FEBS LETT, V592, P1304, DOI 10.1002/1873-3468.12909; Darwiche R, 2017, J BIOL CHEM, V292, P8304, DOI 10.1074/jbc.M117.781880; Darwiche R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28838; Demirci A, 2018, UROL CASE REP, V20, P88, DOI 10.1016/j.eucr.2018.07.014; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gaikwad AS, 2020, HUM REPROD UPDATE, V26, P689, DOI 10.1093/humupd/dmaa016; Gamir J, 2017, PLANT J, V89, P502, DOI 10.1111/tpj.13398; GARDE S, 1993, PROSTATE, V22, P225, DOI 10.1002/pros.2990220305; Garde SV, 1999, PROSTATE, V38, P118, DOI 10.1002/(SICI)1097-0045(19990201)38:2<118::AID-PROS5>3.0.CO;2-G; Ghasriani H, 2009, BIOCHEM BIOPH RES CO, V378, P235, DOI 10.1016/j.bbrc.2008.11.040; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Hagerwall AMLE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002625; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085179; Joeckel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-42; Kosari F, 2002, CANCER EPIDEM BIOMAR, V11, P1419; Kumar A, 2010, J MOL BIOL, V397, P947, DOI 10.1016/j.jmb.2010.02.035; Laurence M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00080; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Lin HM, 2021, CANCERS, V13, DOI 10.3390/cancers13194964; Marin-Aguilera M., 2015, ONCOTARGET; MIZUKI N, 1992, MAMM GENOME, V3, P274, DOI 10.1007/BF00292155; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Mostaghel EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030062; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Pathak BR, 2010, ASIAN J ANDROL, V12, P677, DOI 10.1038/aja.2010.56; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Shioi N, 2019, J BIOL CHEM, V294, P1250, DOI 10.1074/jbc.RA118.006840; Shukeir N, 2003, CANCER RES, V63, P2072; SIMMONS RB, 1990, MYCOL RES, V94, P1146, DOI 10.1016/S0953-7562(09)81349-X; Skara L, 2021, CANCERS, V13, DOI 10.3390/cancers13184696; Sutcliffe S, 2014, PROSTATE, V74, P569, DOI 10.1002/pros.22778; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; Tadokoro T, 2020, TOXINS, V12, DOI 10.3390/toxins12030175; Theelen B, 2018, MED MYCOL, V56, pS10, DOI 10.1093/mmy/myx134; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Udby L, 2005, BIOCHEM BIOPH RES CO, V333, P555, DOI 10.1016/j.bbrc.2005.05.139; Valtonen-Andre C, 2008, J ANDROL, V29, P330, DOI 10.2164/jandrol.107.003616; Vaughan-Shaw PG, 2017, BRIT J CANCER, V116, P1092, DOI 10.1038/bjc.2017.44; Wang H, 2004, J MOL MED, V82, P317, DOI 10.1007/s00109-004-0526-3; Whitaker HC, 2010, PROSTATE, V70, P333, DOI 10.1002/pros.21059; Xu XQ, 2012, J BIOL CHEM, V287, P10967, DOI 10.1074/jbc.M112.340471; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224	62	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101600	10.1016/j.jbc.2022.101600	http://dx.doi.org/10.1016/j.jbc.2022.101600			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35063506	gold, Green Published			2022-12-28	WOS:000791267400014
J	Liu, JN; Lu, F; Chen, YH; Plow, E; Qin, J				Liu, Jiamnin; Lu, Fan; Chen, Yinghua; Plow, Edward; Qin, Jun			Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE; CORONAVIRUS	Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is broadly accepted that SARS-CoV-2 utilizes its spike protein to recognize the extracellular domain of angiotensin-converting enzyme 2 (ACE2) to enter cells for viral infection. However, other mechanisms of SARS-CoV-2 cell entry may occur. We show quantitatively that the SARS-CoV-2 spike protein also binds to the extracellular domain of broadly expressed integrin alpha 5 beta 1 with an affinity comparable to that of SARS-CoV-2 binding to ACE2. More importantly, we provide direct evidence that such binding promotes the internalization of SARS-CoV-2 into non-ACE2 cells in a manner critically dependent upon the activation of the integrin. Our data demonstrate an alternative pathway for the cell entry of SARS-CoV-2, suggesting that upon initial ACE2-mediated invasion of the virus in the respiratory system, which is known to trigger an immune response and secretion of cytokines to activate integrin, the integrin-mediated cell invasion of SARS-CoV-2 into the respiratory system and other organs becomes effective, thereby promoting further infection and progression of COVID-19.	[Liu, Jiamnin; Lu, Fan; Plow, Edward; Qin, Jun] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA; [Lu, Fan; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chen, Yinghua] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Qin, J (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA.; Qin, J (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	qinj@ccf.org		Liu, Jianmin/0000-0003-1883-9165; Chen, Yinghua/0000-0001-6295-7068	National Institutes of Health, United States [R01 HL58758, P01s HL73311, P01HL154811]; AHA, United States, Career Development [18CDA34110364]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA, United States, Career Development	The work was supported by the National Institutes of Health, United States, grants R01 HL58758 to J. Q., P01s HL73311 and P01HL154811 to E. P. and J. Q., and AHA, United States, Career Development grant #18CDA34110364 to J. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, United States.	A. Riad, 2021, bioRxiv, DOI 10.1101/2021.03.14.435180; Andrews M. G., 2021, BIORXIV, DOI [10.1101/2021.01.17.427024v1, DOI 10.1101/2021.01.17.427024V1, 10.1101/2021.01.17.427024, DOI 10.1101/2021.01.17.427024]; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Beddingfield BJ, 2021, JACC-BASIC TRANSL SC, V6, P1, DOI 10.1016/j.jacbts.2020.10.003; Bojadzic D, 2021, ACS INFECT DIS, V7, P1519, DOI 10.1021/acsinfecdis.1c00070; Bojadzic D, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.600372; Buszko M, 2021, NAT IMMUNOL, V22, P404, DOI 10.1038/s41590-021-00901-9; Caccuri F, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9071438; Chertow D., 2022, RES SQ, DOI [10.21203/rs.3.rs-1139035/v1, DOI 10.21203/RS.3.RS-1139035/V1]; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Evans JP, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100847; Gaestel M, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMc2036236; Gao S, 2021, J INFECTION, V83, P511, DOI 10.1016/j.jinf.2021.07.007; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kotecha A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15408; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Luan JW, 2020, J INFECTION, V81, P337, DOI 10.1016/j.jinf.2020.03.046; Maginnis MS, 2018, J MOL BIOL, V430, P2590, DOI 10.1016/j.jmb.2018.06.024; Makowski L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020146; Mezu-Ndubuisi OJ, 2021, PEDIATR RES, V89, P1619, DOI 10.1038/s41390-020-01177-9; Nader D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253347; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Nolte MA, 2021, TRENDS BIOCHEM SCI, V46, P124, DOI 10.1016/j.tibs.2020.09.001; Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645; Puray-Chavez M, 2021, CELL REP, V36, DOI [10.1016/j.celrep.2021.109364, 10.1101/2021.03.01.433431]; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Schumacher S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe9716; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shayakhmetov DM, 2005, J VIROL, V79, P1053, DOI 10.1128/JVI.79.2.1053-1061.2005; Shen D, 2017, J BIOL CHEM, V292, P18848, DOI 10.1074/jbc.M116.773713; Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759; Simons P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99893-7; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Winkler ES, 2022, J VIROL, V96, DOI 10.1128/JVI.01511-21; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yan SJ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00912; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	52	12	12	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101710	10.1016/j.jbc.2022.101710	http://dx.doi.org/10.1016/j.jbc.2022.101710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150743	gold, Green Published			2022-12-28	WOS:000821054100010
J	Protze, J; Naas, S; Krueger, R; Stoehr, C; Kraus, A; Grampp, S; Wiesener, M; Schiffer, M; Hartmann, A; Wullich, B; Schoedel, J				Protze, Johanna; Naas, Stephanie; Krueger, Rene; Stoehr, Christine; Kraus, Andre; Grampp, Steffen; Wiesener, Michael; Schiffer, Mario; Hartmann, Arndt; Wullich, Bernd; Schoedel, Johannes			The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; TARGET GENE; HIF; PBRM1; 2P21	Evolution of clear cell renal cell carcinoma is guided by dysregulation of hypoxia-inducible transcription factor (HIF) pathways following loss of the von Hippel-Lindau tumor suppressor protein. Renal cell carcinoma (RCC)-associated polymorphisms influence HIF-DNA interactions at enhancers of important oncogenes thereby modulating the risk of developing renal cancer. A strong signal of genome-wide association with RCC was determined for the single nucleotide polymorphism (SNP) rs4903064, located on chr14q.24.2 within an intron of DPF3, encoding for Double PHD Fingers 3, a member of chromatin remodeling complexes; however, it is unclear how the risk allele operates in renal cells. In this study, we used tissue specimens and primary renal cells from a large cohort of RCC patients to examine the function of this polymorphism. In clear cell renal cell carcinoma tissue, isolated tumor cells as well as in primary renal tubular cells, in which HIF was stabilized, we determined genotype-specific increases of DPF3 mRNA levels and identified that the risk SNP resides in an active enhancer region, creating a novel HIF-binding motif. We then confirmed allele-specific HIF binding to this locus using chromatin immunoprecipitation of HIF subunits. Consequentially, HIF-mediated DPF3 regulation was dependent on the presence of the risk allele. Finally, we show that DPF3 deletion in proximal tubular cells retarded cell growth, indicating potential roles for DPF3 in cell proliferation. Our analyses suggest that the HIF pathway differentially operates on a SNP-induced hypoxia-response element at 14q24.2, thereby affecting DPF3 expression, which increases the risk of developing renal cancer.	[Protze, Johanna; Naas, Stephanie; Krueger, Rene; Kraus, Andre; Grampp, Steffen; Wiesener, Michael; Schiffer, Mario; Schoedel, Johannes] Universitatsklinikum Erlangen & Friedrich Alexande, Dept Nephrol & Hypertens, Erlangen, Germany; [Hartmann, Arndt] Universitatsklinikum Erlangen & Friedrich Alexande, Inst Pathol, Erlangen, Germany; [Hartmann, Arndt; Wullich, Bernd] Comprehens Canc Ctr Erlangen EMN CCC ER EMN, Universitatsklinikum Erlangen, Erlangen, Germany; [Wullich, Bernd] Universitatsklinikum Erlangen & Friedrich Alexande, Dept Urol & Pediat Urol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schoedel, J (corresponding author), Universitatsklinikum Erlangen & Friedrich Alexande, Dept Nephrol & Hypertens, Erlangen, Germany.	johannes.schoedel@uk-erlangen.de		Schiffer, Mario/0000-0002-8414-1470; Stoehr, Christine/0000-0001-7501-4886	Interdisciplinary Centre for Clinical Research at the Universitatsklinikum Erlangen [D35]; German Research Foundation [387509280, SFB 1350]; Core Unit for Next Generation Sequencing at the Universitatsklinikum Erlangen; Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen	Interdisciplinary Centre for Clinical Research at the Universitatsklinikum Erlangen; German Research Foundation(German Research Foundation (DFG)); Core Unit for Next Generation Sequencing at the Universitatsklinikum Erlangen; Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen	We thank Stephanie Palffy, Astrid EbenauEggers, Barbara Teschemacher, Johanna Stockert, and Margot Rehm for excellent technical assistance. We thank the Core Unit for Next Generation Sequencing and the Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen for their support. J. P. performed parts of this work in fulfillment of the requirements for obtaining the degree "Dr. med." This study was funded by the Interdisciplinary Centre for Clinical Research (D35) at the Universitatsklinikum Erlangen and the German Research Foundation (Projektnummer 387509280; SFB 1350).	Castro-Giner F, 2015, NAT REV CANCER, V15, P680, DOI 10.1038/nrc3999; Colli LM, 2021, AM J HUM GENET, V108, P1590, DOI 10.1016/j.ajhg.2021.07.009; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Grampp S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006872; Grampp S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13183; Han SS, 2012, HUM MOL GENET, V21, P1190, DOI 10.1093/hmg/ddr551; Hoefflin R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17873-3; Jasinski-Bergner S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008805; Keller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043584; Laskar RS, 2019, EUR J HUM GENET, V27, P1589, DOI 10.1038/s41431-019-0455-9; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lauer V, 2020, J BIOL CHEM, V295, P4065, DOI 10.1074/jbc.RA119.009827; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; REMMELE W, 1987, PATHOLOGE, V8, P138; Scelo G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15724; Schick S, 2019, NAT GENET, V51, P1399, DOI 10.1038/s41588-019-0477-9; Schmid V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55098-7; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Theodorou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076155; van den Heuvel CNAM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00117; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Yao XS, 2017, CANCER DISCOV, V7, P1284, DOI 10.1158/2159-8290.CD-17-0375; Young AP, 2008, CELL CYCLE, V7, P1709, DOI 10.4161/cc.7.12.6124; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	37	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101699	10.1016/j.jbc.2022.101699	http://dx.doi.org/10.1016/j.jbc.2022.101699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148991	Green Published, gold			2022-12-28	WOS:000789400700001
J	Xia, PJ; Dutta, A; Gupta, K; Batish, M; Parashar, V				Xia, Pengjun; Dutta, Anirudha; Gupta, Kushol; Batish, Mona; Parashar, Vijay			Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAS SYSTEMS; SPACER ACQUISITION; ANTIVIRAL DEFENSE; MECHANISTIC BASIS; PAM RECOGNITION; RNA CLEAVAGE; DNA CLEAVAGE; TARGET RNA; COMPLEX; INTERFERENCE	RNA interference by type III CRISPR systems results in the synthesis of cyclic oligoadenylate (cOA) second messengers, which are known to bind and regulate various CARF domain-containing nuclease receptors. The CARF domain-containing Csa3 family of transcriptional factors associated with the DNA-targeting type I CRISPR systems regulate expression of various CRISPR and DNA repair genes in many prokaryotes. In this study, we extend the known receptor repertoire of cOA messengers to include transcriptional factors by demonstrating specific binding of cyclic tetra-adenylate ( cA4) to Saccharolobus solfataricus Csa3 (Csa3(Sso)). Our 2.0-angstrom resolution X-ray crystal structure of cA4-bound full-length Csa3(Sso) reveals the binding of its CARF domain to an elongated conformation of cA4. Using cA4 binding affinity analyses of Csa3(Sso) mutants targeting the observed Csa3(Sso)center dot cA4 structural interface, we identified a Csa3-specific cA4 binding motif distinct from a more widely conserved cOA-binding CARF motif. Using a rational surface engineering approach, we increased the cA4 binding affinity of Csa3(Sso) up to similar to 145-fold over the wildtype, which has potential applications for future second messenger-driven CRISPR gene expression and editing systems. Our in-solution Csa3(Sso) structural analysis identified cA4-induced allosteric and asymmetric conformational rearrangement of its C-terminal winged helix-turn-helix effector domains, which could potentially be incompatible to DNA binding. However, specific in vitro binding of the purified Csa3(Sso) to its putative promoter (P-Cas4a) was found to be cA4 independent, suggesting a complex mode of Csa3(Sso) regulation. Overall, our results support cA4-and Csa3-mediated cross talk between type III and type I CRISPR systems.	[Xia, Pengjun; Batish, Mona; Parashar, Vijay] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Dutta, Anirudha; Batish, Mona; Parashar, Vijay] Univ Delaware, Dept Med & Mol Sci, Newark, DE 19716 USA; [Gupta, Kushol] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Delaware; University of Delaware; University of Pennsylvania; Pennsylvania Medicine	Parashar, V (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.; Parashar, V (corresponding author), Univ Delaware, Dept Med & Mol Sci, Newark, DE 19716 USA.	parashar@udel.edu	Gupta, Kushol/GOE-5620-2022; Batish, Mona/AAG-8296-2019	Gupta, Kushol/0000-0002-7006-2667; Batish, Mona/0000-0001-9039-6149; Parashar, Vijay/0000-0002-7518-0400	National Institutes of Health [R35GM119504]; Johnson Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Foundation	This research was supported by National Institutes of Health Grant R35GM119504 (to V. P.) . K. G. acknowledges the support of the Johnson Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Athukoralage JS, 2021, RNA, V27, P855, DOI 10.1261/rna.078739.121; Athukoralage JS, 2020, ELIFE, V9, DOI 10.7554/eLife.57627; Athukoralage JS, 2020, ELIFE, V9, DOI 10.7554/eLife.55852; Athukoralage JS, 2020, NATURE, V577, P572, DOI 10.1038/s41586-019-1909-5; Athukoralage JS, 2019, J MOL BIOL, V431, P2894, DOI 10.1016/j.jmb.2019.04.041; Athukoralage JS, 2018, NATURE, V562, P277, DOI 10.1038/s41586-018-0557-5; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Batish Mona, 2019, Curr Protoc Neurosci, V89, pe79, DOI 10.1002/cpns.79; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DiFabio J., 2017, AIP CONF P, V1741; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Garcia-Doval C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15334-5; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gussow AB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17652-0; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hastings J, 2016, NUCLEIC ACIDS RES, V44, pD1214, DOI 10.1093/nar/gkv1031; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; He F, 2017, NUCLEIC ACIDS RES, V45, P1902, DOI 10.1093/nar/gkw1265; Hidalgo-Cantabrana C, 2020, BIOCHEM SOC T, V48, P15, DOI 10.1042/BST20190119; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jia N, 2019, MOL CELL, V75, P944, DOI 10.1016/j.molcel.2019.06.014; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Koonin EV, 2018, ACS CHEM BIOL, V13, P309, DOI 10.1021/acschembio.7b00713; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li YJ, 2017, NUCLEIC ACIDS RES, V45, P11305, DOI 10.1093/nar/gkx791; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Liu T, 2017, NUCLEIC ACIDS RES, V45, P8978, DOI 10.1093/nar/gkx612; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Lowey B, 2020, CELL, V182, P38, DOI 10.1016/j.cell.2020.05.019; Majumdar S, 2015, RNA, V21, P1147, DOI 10.1261/rna.049130.114; Makarova KS, 2020, NUCLEIC ACIDS RES, V48, P8828, DOI 10.1093/nar/gkaa635; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2013, RNA BIOL, V10, P671, DOI 10.4161/rna.24154; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon SA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14222-x; Mo CY, 2021, NATURE, V592, P611, DOI 10.1038/s41586-021-03440-3; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Molina R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12244-z; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Niewoehner O, 2017, CELL HOST MICROBE, V22, P258, DOI 10.1016/j.chom.2017.08.019; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan SF, 2019, RNA BIOL, V16, P1166, DOI 10.1080/15476286.2019.1618693; Peng WF, 2013, RNA BIOL, V10, P738, DOI 10.4161/rna.23798; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Pyenson NC, 2017, CELL HOST MICROBE, V22, P343, DOI 10.1016/j.chom.2017.07.016; Quax TEF, 2013, J VIROL, V87, P8419, DOI 10.1128/JVI.01020-13; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Rostol JT, 2021, NATURE, V590, DOI 10.1038/s41586-021-03206-x; Rouillon C, 2018, ELIFE, V7, DOI 10.7554/eLife.36734; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Silas S, 2017, ELIFE, V6, DOI 10.7554/eLife.27601; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Watson BNJ, 2021, CELL HOST MICROBE, V29, P715, DOI 10.1016/j.chom.2021.03.018; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Yamano T, 2017, MOL CELL, V67, P633, DOI 10.1016/j.molcel.2017.06.035; Ye Q, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02038; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yu ZX, 2021, SCI CHINA LIFE SCI, V64, P678, DOI 10.1007/s11427-020-1745-0; Zhang J, 2013, BIOCHEM SOC T, V41, P1422, DOI 10.1042/BST20130031; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zink IA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111523	107	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101591	10.1016/j.jbc.2022.101591	http://dx.doi.org/10.1016/j.jbc.2022.101591			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1YB	35038453	gold, Green Published			2022-12-28	WOS:000761423400007
J	Hitschler, L; Lang, TR				Hitschler, Lisa; Lang, Thorsten			The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by alpha-secretase ADAM10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CONVERTING-ENZYME; GAMMA-SECRETASE; BETA; MEMBRANE; CLEAVAGE; DISINTEGRIN; INHIBITORS; PEPTIDE; IDENTIFICATION	Neurotoxic amyloid 11-peptides are thought to be a causative agent of Alzheimer's disease in humans. The production of amyloid 11-peptides from amyloid precursor protein (APP) could be diminished by enhancing alpha-processing; however, the physical interactions between APP and alpha-secretases are not well understood. In this study, we employed super-resolution light microscopy to examine in cell-free plasma membranes the abundance and association of APP and alpha-secretases ADAM10 (a disintegrin and metalloproteinase) and ADAM17. We found that both secretase molecules localize similarly closely to APP (within <= 50 nm). However, when cross-linking APP with antibodies directed against the GFP tag of APP, in confocal microscopy, we observed that only ADAM10 coaggregated with APP. Furthermore, we mapped the involved protein domain by using APP variants with an exchanged transmembrane segment or lacking cytoplasmic/extracellular domains. We identified that the transmembrane domain of APP is required for association with alpha-secretases and, as analyzed by Western blot, for alpha-processing. We propose that the transmembrane domain of APP interacts either directly or indirectly with ADAM10, but not with ADAM17, explaining the dominant role of ADAM10 in alpha-processing of APP. Further understanding of this interaction may facilitate the development of a therapeutic strategy based on promoting APP cleavage by alpha-secretases.	[Hitschler, Lisa; Lang, Thorsten] Univ Bonn, Life & Med Sci LIMES Inst, Dept Membrane Biochem, Bonn, Germany	University of Bonn	Lang, TR (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Dept Membrane Biochem, Bonn, Germany.	thorsten.lang@uni-bonn.de			German Research Foundation (Deutsche For-schungsgemeinschaft) [LA 1272/9-1]	German Research Foundation (Deutsche For-schungsgemeinschaft)(German Research Foundation (DFG))	Funding and additional information-T. L. was supported by grants from the German Research Foundation (Deutsche For-schungsgemeinschaft; grant no.: LA 1272/9-1) . The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	[Anonymous], 2021, ALZHEIMERS DEMENT, V17, P327, DOI 10.1002/alz.12328; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Ben Khalifa N, 2010, CELL ADHES MIGR, V4, P268, DOI 10.4161/cam.4.2.11476; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Blacker M, 2002, J NEUROCHEM, V83, P1349, DOI 10.1046/j.1471-4159.2002.01228.x; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; de Coninck D., 2020, THESIS U BONN; de Coninck D, 2018, BIOPHYS J, V114, P1128, DOI 10.1016/j.bpj.2018.01.009; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Finke JM, 2020, MED MICROBIOL IMMUN, V209, P447, DOI 10.1007/s00430-020-00683-1; Finke J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62202-9; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; Graham WV, 2017, ANNU REV MED, V68, P413, DOI 10.1146/annurev-med-042915-103753; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Homsi Y, 2014, BIOPHYS J, V107, P100, DOI 10.1016/j.bpj.2014.05.028; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Knopman DS, 2019, NEW ENGL J MED, V380, P1476, DOI 10.1056/NEJMe1903193; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Merklinger E, 2016, J MEMBRANE BIOL, V249, P41, DOI 10.1007/s00232-015-9845-2; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Nguyen PH, 2021, CHEM REV, V121, P2545, DOI 10.1021/acs.chemrev.0c01122; Ochiishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22712; Panza F, 2009, DRUG AGING, V26, P537, DOI 10.2165/11315770-000000000-00000; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schneider F, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101891; Schreiber A, 2012, BIOPHYS J, V102, P1411, DOI 10.1016/j.bpj.2012.02.031; Seipold L, 2017, BBA-MOL CELL RES, V1864, P217, DOI 10.1016/j.bbamcr.2016.11.003; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Smith KM, 2002, J CELL BIOL, V159, P893, DOI 10.1083/jcb.200206023; Stawikowska R, 2013, J BIOL CHEM, V288, P22871, DOI 10.1074/jbc.M113.462267; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ugbaja SC, 2021, BIOPHYS CHEM, V270, DOI 10.1016/j.bpc.2020.106536; WANG R, 1991, J BIOL CHEM, V266, P16960; Wang X, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00431; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	68	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101911	10.1016/j.jbc.2022.101911	http://dx.doi.org/10.1016/j.jbc.2022.101911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35398353	gold, Green Published			2022-12-28	WOS:000807750700011
J	Zhong, XD; Wang, T; Zhang, WJ; Wang, MW; Xie, Y; Dai, L; He, XW; Madhusudhan, T; Zeng, HS; Wang, HJ				Zhong, Xiaodan; Wang, Tao; Zhang, Wenjun; Wang, Mengwen; Xie, Yang; Dai, Lei; He, Xingwei; Madhusudhan, Thati; Zeng, Hesong; Wang, Hongjie			ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RSK; EXPRESSION; INHIBITORS; YBX1; YB-1	Diabetic cardiomyopathy (DCM) is a major complication of diabetes, but its underlying mechanisms still remain unclear. The multifunctional protein Y-box binding protein-1 (YB-1) plays an important role in cardiac pathogenesis by regulating cardiac apoptosis, cardiac fibrosis, and pathological remodeling, whereas its role in chronic DCM requires further investigation. Here, we report that the phosphorylation of YB-1 at serine102 (S102) was markedly elevated in streptozotocininduced diabetic mouse hearts and in high glucose-treated cardiomyocytes, whereas total YB-1 protein levels were significantly reduced. Coimmunoprecipitation experiments showed that YB-1 interacts with the deubiquitinase otubain-1, but hyperglycemia-induced phosphorylation of YB-1 at S102 diminished this homeostatic interaction, resulting in ubiquitination and degradation of YB-1. Mechanistically, the high glucose-induced phosphorylation of YB-1 at S102 is dependent on the upstream extracellular signal-regulated kinase (ERK)/ Ras/mitogen-activated protein kinase (p90 ribosomal S6 kinase [RSK]) signaling pathway. Accordingly, pharmacological inhibition of the ERK pathway using the upstream kinase inhibitor U0126 ameliorated features of DCM compared with vehicle treated diabetic mice. We demonstrate that ERK inhibition with U0126 also suppressed the phosphorylation of the downstream RSK and YB-1 (S102), which stabilized the interaction between YB-1 and otubain-1 and thereby preserved YB-1 protein expression in diabetic hearts. Taken together, we propose that targeting the ERK/RSK/YB-1 pathway could be a potential therapeutic approach for treating DCM.	[Zhong, Xiaodan; Wang, Tao; Zhang, Wenjun; Wang, Mengwen; Xie, Yang; Dai, Lei; He, Xingwei; Zeng, Hesong; Wang, Hongjie] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China; [Zhong, Xiaodan; Zhang, Wenjun; Wang, Mengwen; Xie, Yang; Dai, Lei; He, Xingwei; Zeng, Hesong; Wang, Hongjie] Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China; [Wang, Tao] Weifang Med Univ, Dept Cardiol, Affiliated Hosp, Weifang, Shandong, Peoples R China; [Madhusudhan, Thati] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany	Huazhong University of Science & Technology; Weifang Medical University; Johannes Gutenberg University of Mainz	Zeng, HS; Wang, HJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China.; Zeng, HS; Wang, HJ (corresponding author), Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China.	zenghs@tjh.tjmu.edu.cn; hongjie.wang@tjh.tjmu.edu.cn		Zhong, Xiaodan/0000-0001-5268-3905	National Natural Science Foundation of China [81600301, 81873523, 82070490, 81800411]; Health Science Technology Development Program of Shandong Province [2018WS050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Science Technology Development Program of Shandong Province	This work was supported by the National Natural Science Foundation of China (grant Nos.: 81600301 [to H. W.] ; 81873523 and 82070490 [to H. Z.] ; and 81800411 [to X. H.] ) and Medicine and Health Science Technology Development Program of Shandong Province (grant No.: 2018WS050 [to T. W.] ) .	Budkina KS, 2020, BIOCHEMISTRY-MOSCOW+, V85, P1, DOI 10.1134/S0006297920140011; Cao XM, 2020, J CELL PHYSIOL, V235, P8187, DOI 10.1002/jcp.29474; Choong OK, 2019, THERANOSTICS, V9, P6550, DOI 10.7150/thno.35218; David JJ, 2012, EXP BIOL MED, V237, P593, DOI 10.1258/ebm.2012.011137; Ding XT, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104598; Dong W, 2015, J AM SOC NEPHROL, V26, P2789, DOI 10.1681/ASN.2014080846; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Gao DY, 2021, J ONCOL, V2021, DOI 10.1155/2021/9913015; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kamalov G, 2005, BIOCHEM BIOPH RES CO, V334, P239, DOI 10.1016/j.bbrc.2005.06.082; Liao LZ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010224; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Liu QQ, 2016, EXP CELL RES, V349, P230, DOI 10.1016/j.yexcr.2016.10.011; Ludwik KA, 2016, MOL CANCER THER, V15, P2598, DOI 10.1158/1535-7163.MCT-16-0106; Martin M, 2017, J BIOL CHEM, V292, P3433, DOI 10.1074/jbc.M116.740258; Mehta S, 2020, CANCERS, V12, DOI 10.3390/cancers12092473; Miyoshi S, 2012, INT J ONCOL, V41, P449, DOI 10.3892/ijo.2012.1462; Mordovkina D, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040591; Nie Q, 2016, CURR MOL MED, V16, P906, DOI 10.2174/1566524016666161223105555; Prabhu L, 2015, GENES DIS, V2, P240, DOI 10.1016/j.gendis.2015.05.001; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Ritchie RH, 2020, CIRC RES, V126, P1501, DOI 10.1161/CIRCRESAHA.120.315913; Roffe M, 2015, CELL SIGNAL, V27, P1630, DOI 10.1016/j.cellsig.2015.04.004; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Saldana M, 2019, ENDOCR-RELAT CANCER, V26, pR1, DOI 10.1530/ERC-18-0264; Sechi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33879-w; Sivakumar D, 2020, J BIOL CHEM, V295, P6972, DOI 10.1074/jbc.RA120.013073; Smith JA, 2005, CANCER RES, V65, P1027; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Suresh PS, 2018, EUR J CELL BIOL, V97, P163, DOI 10.1016/j.ejcb.2018.02.003; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tiwari A, 2020, CANCERS, V12, DOI 10.3390/cancers12102795; Tiwari A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082441; Toulany M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2845; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; Wang T, 2021, INT J BIOL SCI, V17, P2984, DOI 10.7150/ijbs.60459; Xue XX, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07509-6; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zhang JF, 2020, NUCLEIC ACIDS RES, V48, P9361, DOI 10.1093/nar/gkaa619; Zhong XD, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.758158; Zhu Q, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101303	43	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101989	10.1016/j.jbc.2022.101989	http://dx.doi.org/10.1016/j.jbc.2022.101989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35490780	gold, Green Published			2022-12-28	WOS:000811243600004
J	Chen, QJ; Bates, AM; Hanquier, JN; Simpson, E; Rusch, DB; Podicheti, R; Liu, YL; Wek, RC; Cornett, EM; Georgiadis, MM				Chen, Qiujia; Bates, Alison M.; Hanquier, Jocelyne N.; Simpson, Edward; Rusch, Douglas B.; Podicheti, Ram; Liu, Yunlong; Wek, Ronald C.; Cornett, Evan M.; Georgiadis, Millie M.			Structural and genome-wide analyses suggest that transposon-derived protein SETMAR alters transcription and splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; METNASE; GENE; REPLICATION; BINDING; HSMAR1; REPAIR; INTEGRATION; ISOFORMS; DOMAIN	Extensive portions of the human genome have unknown function, including those derived from transposable elements. One such element, the DNA transposon Hsmar1, entered the primate lineage approximately 50 million years ago leaving behind terminal inverted repeat (TIR) sequences and a single intact copy of the Hsmar1 transposase, which retains its ancestral TIR-DNA-binding activity, and is fused with a lysine methyltransferase SET domain to constitute the chimeric SETMAR gene. Here, we provide a structural basis for recognition of TIRs by SETMAR and investigate the function of SETMAR through genome-wide approaches. As elucidated in our 2.37 angstrom crystal structure, SETMAR forms a dimeric complex with each DNA-binding domain bound specifically to TIRDNA through the formation of 32 hydrogen bonds. We found that SETMAR recognizes primarily TIR sequences (5000 sites) within the human genome as assessed by chromatin immunoprecipitation sequencing analysis. In two SETMAR KO cell lines, we identified 163 shared differentially expressed genes and 233 shared alternative splicing events. Among these genes are several pre-mRNA-splicing factors, transcription factors, and genes associated with neuronal function, and one alternatively spliced primate-specific gene, TMEM14B, which has been identified as a marker for neocortex expansion associated with brain evolution. Taken together, our results suggest a model in which SETMAR impacts differential expression and alternative splicing of genes associated with transcription and neuronal function, potenin simian primate development.	[Chen, Qiujia; Bates, Alison M.; Wek, Ronald C.; Cornett, Evan M.; Georgiadis, Millie M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hanquier, Jocelyne N.; Cornett, Evan M.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Simpson, Edward; Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Rusch, Douglas B.; Podicheti, Ram] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Georgiadis, MM (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	mgeorgia@iu.edu		Hanquier, Jocelyne/0000-0001-7195-482X; Bates, Alison/0000-0001-5567-0624	National Institutes of Health [R35GM136331, R01CA151367]; Indiana University School of Medicine; Indiana University-Purdue University at Indianapolis; Paul & Carole Stark Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University School of Medicine; Indiana University-Purdue University at Indianapolis; Paul & Carole Stark Fellowship	This work was supported by the National Institutes of Health award (grant nos.: R35GM136331 [to R. C. W.] and R01CA151367 [to M. M. G.]) and awards from the Indiana University School of Medicine and Indiana University-Purdue University at Indianapolis (to M. M. G.). J. N. H. is supported by a Paul & Carole Stark Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the officials of the National Institutes of Health, Indiana University School of Medicine, or Indiana UniversityPurdue University at Indianapolis.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoine-Lorquin A, 2021, GENOMICS, V113, P1589, DOI 10.1016/j.ygeno.2021.03.032; Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Bricogne G., 2016, BUSTER VERSION 2 10; Carlson SM, 2015, J BIOL CHEM, V290, P12040, DOI 10.1074/jbc.M115.641530; Carlson SM, 2014, J MOL BIOL, V426, P3350, DOI 10.1016/j.jmb.2014.04.024; Chen QJ, 2016, ACTA CRYSTALLOGR F, V72, P713, DOI 10.1107/S2053230X16012723; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Cornett EM, 2019, MOL CELL, V75, P1092, DOI 10.1016/j.molcel.2019.08.026; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Droit A., 2014, RGADEM NOVO MOTIF DI; Dussaussois-Montagne A, 2017, ONCOTARGET, V8, P9835, DOI 10.18632/oncotarget.14218; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Goodwin KD, 2010, BIOCHEMISTRY-US, V49, P5705, DOI 10.1021/bi100171x; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Jeyaratnam DC, 2014, EXP HEMATOL, V42, P448, DOI 10.1016/j.exphem.2014.02.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Liu J, 2017, CELL STEM CELL, V21, P635, DOI 10.1016/j.stem.2017.08.013; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miskei M, 2021, COMPUT STRUCT BIOTEC, V19, P4032, DOI 10.1016/j.csbj.2021.07.010; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Oh S, 2019, BBA-REV CANCER, V1871, P406, DOI 10.1016/j.bbcan.2019.04.002; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Ruiz-Velasco M, 2017, CELL SYST, V5, P628, DOI 10.1016/j.cels.2017.10.018; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Tellier M, 2019, DNA REPAIR, V80, P26, DOI 10.1016/j.dnarep.2019.06.006; Tellier M, 2019, NUCLEIC ACIDS RES, V47, P122, DOI 10.1093/nar/gky937; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	59	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101894	10.1016/j.jbc.2022.101894	http://dx.doi.org/10.1016/j.jbc.2022.101894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35378129	Green Published, gold			2022-12-28	WOS:000798142000003
J	Zhang, L; Wang, XQ; Chen, JX; Kleyman, TR; Sheng, SH				Zhang, Lei; Wang, Xueqi; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu			Accessibility of ENaC extracellular domain central core residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; ALPHA-SUBUNIT; HISTIDINE-RESIDUES; SELF-INHIBITION; GAMMA-SUBUNIT; BINDING; IDENTIFICATION; ACTIVATION; COMPLEX	The epithelial Na+ channel (ENaC)/degenerin family has a similar extracellular architecture, where specific regulatory factors interact and alter channel gating behavior. The extra cellular palm domain serves as a key link to the channel pore. In this study, we used cysteine-scanning mutagenesis to assess the functional effects of Cys-modifying reagents on palm domain beta 10 strand residues in mouse ENaC. Of the 13 ENaC alpha subunit mutants with Cys substitutions examined, only mutants at sites in the proximal region of beta 10 exhibited changes in channel activity in response to methanethiosulfonate reagents. Additionally, Cys substitutions at three proximal sites of beta and gamma subunit beta 10 strands also rendered mutant channels methanethiosulfonate-responsive. Moreover, multiple Cys mutants were activated by low concentrations of thiophilic Cd2+. Using the Na+ self-inhibition response to assess ENaC gating behavior, we identified four alpha, two beta, and two gamma subunit beta 10 strand mutations that changed the Na+ self-inhibition response. Our results suggest that the proximal regions of beta 10 strands in all three subunits are accessible to small aqueous compounds and Cd(2+ )and have a role in modulating ENaC gating. These results are consistent with a structural model of mouse ENaC that predicts the presence of aqueous tunnels adjacent to the proximal part of beta 10 and with previously resolved structures of a related family member where palm domain structural transitions were observed with channels in an open or closed state.	[Zhang, Lei; Wang, Xueqi; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Zhang, Lei; Wang, Xueqi] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Hunan Key Lab Kidney Dis & Blood Purificat, Changsha, Hunan, Peoples R China; [Zhang, Lei; Wang, Xueqi] Cent South Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Kleyman, Thomas R.] Univ Pittsburgh, Cell Biol, Pittsburgh, PA 15260 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Wang, Xueqi] Capital Med Univ, Beijing Friendship Hosp, Dept Nephrol, Beijing 10050, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.; Kleyman, TR (corresponding author), Univ Pittsburgh, Cell Biol, Pittsburgh, PA 15260 USA.; Kleyman, TR (corresponding author), Univ Pittsburgh, Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 HL147818, P30 DK079307]; Xiangya Scholar Fund; Third Xiangya Hospital, Central South University, China	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xiangya Scholar Fund; Third Xiangya Hospital, Central South University, China	This work was supported by National Institutes of Health Grants R01 HL147818 and P30 DK079307 and the Xiangya Scholar Fund (to L. Z. and X. W.) from The Third Xiangya Hospital, Central South University, China.	Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kleyman TR, 2020, AM J PHYSIOL-CELL PH, V318, pC150, DOI 10.1152/ajpcell.00418.2019; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Linsdell Paul, 2015, BioMolecular Concepts, V6, P191, DOI 10.1515/bmc-2015-0013; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Mutchler SM, 2021, HYPERTENSION, V77, P759, DOI 10.1161/HYPERTENSIONAHA.120.14481; Nie HG, 2010, AM J PHYSIOL-RENAL, V298, pF323, DOI 10.1152/ajprenal.00307.2009; Noreng S, 2020, ELIFE, V9, DOI 10.7554/eLife.59038; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Pitzer AL, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01067-9; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ray EC, 2016, AM J PHYSIOL-RENAL, V311, pF908, DOI 10.1152/ajprenal.00426.2016; Renauld S, 2008, CELL PHYSIOL BIOCHEM, V22, P101, DOI 10.1159/000149787; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Salih M, 2017, J AM SOC NEPHROL, V28, P3290, DOI 10.1681/ASN.2016111163; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schrodinger LLC, 2021, PYMOL MOL GRAPHICS S; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Sheng SH, 2018, J BIOL CHEM, V293, P17582, DOI 10.1074/jbc.RA118.003618; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Wichmann L, 2019, J BIOL CHEM, V294, P12507, DOI 10.1074/jbc.RA119.008255; Wu YY, 2019, ELIFE, V8, DOI 10.7554/eLife.45851; Yoder N, 2020, ELIFE, V9, DOI 10.7554/eLife.56527; Yoder N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202134; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	55	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101860	10.1016/j.jbc.2022.101860	http://dx.doi.org/10.1016/j.jbc.2022.101860			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35339489	gold, Green Published			2022-12-28	WOS:000798142000001
J	Bansal, A; Mostafa, MM; Kooi, C; Sasse, SK; Michi, AN; Shah, SV; Leigh, R; Gerber, AN; Newton, R				Bansal, Akanksha; Mostafa, Mahmoud M.; Kooi, Cora; Sasse, Sarah K.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Gerber, Anthony N.; Newton, Robert			Interplay between nuclear factor-KB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY GENE-EXPRESSION; INNATE IMMUNE-SYSTEM; THERAPEUTIC TARGET; BINDING-SITES; KINASE; TRANSCRIPTION; REPRESSION; ROLES; MECHANISMS	While glucocorticoids act via the glucocorticoid receptor (GR; NR3C1) to reduce the expression of many inflammatory genes, repression is not an invariable outcome. Here, we explore synergy occurring between synthetic glucocorticoids (dexamethasone and budesonide) and proinflammatory cyto-kines (IL1B and TNF) on the expression of the toll-like re-ceptor 2 (TLR2). This effect is observed in epithelial cell lines and both undifferentiated and differentiated primary human bronchial epithelial cells (pHBECs). In A549 cells, IL1B-plus-glucocorticoid-induced TLR2 expression required nuclear factor (NF)-KB and GR. Likewise, in A549 cells, BEAS-2B cells, and pHBECs, chromatin immunoprecipitation identified GR-and NF-KB/p65-binding regions X32 kb (R1) and X7.3 kb (R2) upstream of the TLR2 gene. Treatment of BEAS-2B cells with TNF or/and dexamethasone followed by global run-on sequencing confirmed transcriptional activity at these re-gions. Furthermore, cloning R1 or R2 into luciferase reporters revealed transcriptional activation by budesonide or IL1B, respectively, while R1+R2 juxtaposition enabled synergistic activation by IL1B and budesonide. In addition, small-molecule inhibitors and siRNA knockdown showed p38a MAPK to negatively regulate both IL1B-induced TLR2 expression and R1+R2 reporter activity. Finally, agonism of IL1B-plus-dexamethasone-induced TLR2 in A549 cells and pHBECs stimulated NF-KB-and interferon regulatory factor-dependent reporter activity and chemokine release. We conclude that glucocorticoid-plus-cytokine-driven synergy at TLR2 involves GR and NF-KB acting via specific enhancer regions, which combined with the inhibition of p38a MAPK promotes TLR2 expression. Subsequent inflammatory effects that occur following TLR2 agonism may be pertinent in severe neutrophilic asthma or chronic obstructive pulmonary dis-ease, where glucocorticoid-based therapies are less efficacious.	[Bansal, Akanksha; Mostafa, Mahmoud M.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bansal, Akanksha; Mostafa, Mahmoud M.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Snyder Inst Chron Dis, Dept Med, Calgary, AB, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Gerber, Anthony N.] Univ Colorado, Dept Med, Aurora, CO USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada.	rnewton@ucalgary.ca			Canadian Institutes of Health Research (CIHR) [MOP 125918, PJT 156310]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04549]; Eyes High Doctoral Scholarship in Women's Health from University of Calgary; Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; NSERC; Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Eyes High Doctoral Scholarship in Women's Health from University of Calgary; Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards	This work was supported by the following: R. N. grants: Canadian Institutes of Health Research (CIHR) (MOP 125918, PJT 156310) and Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (RGPIN-2016-04549); A. B. studentships: Eyes High Doctoral Scholarship and Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; M. M. M. studentships: NSERC Postgraduate Scholarship -Doctoral, Queen Elizabeth II Doctoral scholarship, and The Lung Association-Alberta & NWT studentship awards. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Ambrosini G, 2018, BIOINFORMATICS, V34, P2483, DOI 10.1093/bioinformatics/bty127; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Cruz-Topete D, 2015, NEUROIMMUNOMODULAT, V22, P20, DOI 10.1159/000362724; D'lppolito AM, 2018, CELL SYST, V7, P146, DOI 10.1016/j.cels.2018.06.007; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Hoppstadter J., 2019, FRONT IMMUNOL; Hsieh C. L., 2014, PROC NATL ACAD; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kis K, 2006, INT IMMUNOPHARMACOL, V6, P358, DOI 10.1016/j.intimp.2005.08.022; Klassen C, 2017, J IMMUNOL, V199, P48, DOI 10.4049/jimmunol.1601691; Kukushkin A. N., 2002, ONCOGENE 21; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Liu DR, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-30; Liu SY, 2019, BRIT J PHARMACOL, V176, P1793, DOI 10.1111/bph.14656; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Maruyama A, 2014, NUCLEIC ACIDS RES, V42, P13599, DOI 10.1093/nar/gku1169; McDowell IC, 2018, GENOME RES, V28, P1272, DOI 10.1101/gr.233346.117; Michi AN, 2021, AM J PHYSIOL-LUNG C, V321, pL263, DOI 10.1152/ajplung.00141.2021; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Mostafa MM, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015755; Mostafa MM, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0467-2; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 1996, BIOCHEM BIOPH RES CO, V218, P518, DOI 10.1006/bbrc.1996.0093; Newton Robert, 2006, Drug Discov Today Dis Mech, V3, P53, DOI 10.1016/j.ddmec.2006.02.007; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Newton R, 2017, J BIOL CHEM, V292, P7163, DOI 10.1074/jbc.R117.777318; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Proud PC, 2021, EBIOMEDICINE, V63, DOI 10.1016/j.ebiom.2020.103153; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rider CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116773; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sasse SK, 2019, GENOME RES, V29, P1753, DOI 10.1101/gr.248187.119; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shah S, 2016, J BIOL CHEM, V291, P21802, DOI 10.1074/jbc.M116.728964; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; Su Q, 2017, J STEROID BIOCHEM, V171, P201, DOI 10.1016/j.jsbmb.2017.03.023; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Warner SM, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1120-0; Winder AA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-96; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	94	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101747	10.1016/j.jbc.2022.101747	http://dx.doi.org/10.1016/j.jbc.2022.101747			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35189144	gold, Green Published			2022-12-28	WOS:000793617400001
J	Baymiller, M; Nordick, B; Forsyth, CM; Martinis, SA				Baymiller, Max; Nordick, Benjamin; Forsyth, Connor M.; Martinis, Susan A.			Tissue-specific alternative splicing separates the catalytic and cell signaling functions of human leucyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL FUNCTION; MTORC1; AMINOACYLATION; FRAGMENT; BINDING; DOMAIN; SRSF1	The aminoacyl-tRNA synthetases are an ancient and ubiq-uitous component of all life. Many eukaryotic synthetases balance their essential function, preparing aminoacyl-tRNA for use in mRNA translation, with diverse roles in cell signaling. Herein, we use long-read sequencing to discover a leukocyte-specific exon skipping event in human leucyl-tRNA synthetase (LARS). We show that this highly expressed splice variant, LSV3, is regulated by serine-arginine-rich splicing factor 1 (SRSF1) in a cell-type-specific manner. LSV3 has a 71 amino acid deletion in the catalytic domain and lacks any tRNA leucylation activity in vitro. However, we demonstrate that this LARS splice variant retains its role as a leucine sensor and signal transducer for the proliferation-promoting mTOR kinase. This is despite the exon deletion in LSV3 including a portion of the previously mapped Vps34-binding domain used for one of two distinct pathways from LARS to mTOR. In conclusion, alternative splicing of LARS has separated the ancient catalytic activity of this housekeeping enzyme from its more recent evolutionary role in cell signaling, providing an opportunity for functional specificity in human immune cells.	[Baymiller, Max; Nordick, Benjamin; Forsyth, Connor M.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nordick, Benjamin] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; [Forsyth, Connor M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Knoxville; Northwestern University; Feinberg School of Medicine	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	martinis@illinois.edu		Baymiller, Max/0000-0003-2438-243X; Nordick, Benjamin/0000-0001-6213-9137; Forsyth, Connor/0000-0002-2576-861X	W. M. Keck Foundation; National Institutes of Health [T32-GM136629]	W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This research was supported by a grant to S. A. M. from the W. M. Keck Foundation. M. B. was supported by National Institutes of Health #T32-GM136629. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; D'Hulst G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13889-6; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Davis C. A., 2018, ENCYCLOPEDIA; Dong XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0181-6; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Giudice G, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw035; Gonzalez-Garay ML, 2016, TRANSL BIOINFORM, V9, P141, DOI 10.1007/978-94-017-7450-5_6; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jobin PG, 2020, J BIOL CHEM, V295, P2186, DOI 10.1074/jbc.RA119.010486; Kaisers W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061110; Katsuyama T, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109339; Kim S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109031; Kono M, 2018, ARTHRITIS RHEUMATOL, V70, P2046, DOI 10.1002/art.40585; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee M., 2018, P NATL ACAD SCI, VU; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Liu RJ, 2020, NUCLEIC ACIDS RES, V48, P4946, DOI 10.1093/nar/gkaa189; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Mascarenhas A. P., 2009, V22, P155; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Ofir-Birin Y., 2013, MOL; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Pang YLJ, 2009, BIOCHEMISTRY-US, V48, P8958, DOI 10.1021/bi901111y; Park M. C., 2012, PROC NATL ACAD SCI S; Paz S, 2021, CYTOKINE GROWTH F R, V57, P19, DOI 10.1016/j.cytogfr.2020.10.008; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wei ZY, 2016, NUCLEIC ACIDS RES, V44, P1247, DOI 10.1093/nar/gkw002; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Yoon I., 2020, GLUCOSE DEPENDENT CO; Yoon MS, 2016, CELL REP, V16, P1510, DOI 10.1016/j.celrep.2016.07.008; Zhang W, 2020, CELL MOL IMMUNOL, V17, P1063, DOI 10.1038/s41423-019-0281-6; Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4; Zhenyukh O, 2017, FREE RADICAL BIO MED, V104, P165, DOI 10.1016/j.freeradbiomed.2017.01.009	52	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101757	10.1016/j.jbc.2022.101757	http://dx.doi.org/10.1016/j.jbc.2022.101757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202654	Green Published, gold			2022-12-28	WOS:000793502000009
J	Kavoor, A; Kelly, P; Ibba, M				Kavoor, Arundhati; Kelly, Paul; Ibba, Michael			Escherichia coli alanyl-tRNA synthetase maintains proofreading activity and translational accuracy under oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; MASS-SPECTROMETRY; QUALITY-CONTROL; MISTRANSLATION; MISACYLATION; MUTAGENESIS; METHIONINE; MECHANISM; PROTEINS; DISEASE	Aminoacyl-tRNA synthetases (aaRSs) are enzymes that synthesize aminoacyl-tRNAs to facilitate translation of the genetic code. Quality control by aaRS proofreading and other mechanisms maintains translational accuracy, which promotes cellular viability. Systematic disruption of proofreading, as recently demonstrated for alanyl-tRNA synthetase (AlaRS), leads to dysregulation of the proteome and reduced viability. Recent studies showed that environmental challenges such as exposure to reactive oxygen species can also alter aaRS synthetic and proofreading functions, prompting us to investigate if oxidation might positively or negatively affect AlaRS activity. We found that while oxidation leads to modification of several residues in Escherichia coli AlaRS, unlike in other aaRSs, this does not affect proofreading activity against the noncognate substrates serine and glycine and only results in a 1.6-fold decrease in efficiency of cognate Ala-tRNAAla formation. Mass spectrometry analysis of oxidized AlaRS revealed that the critical proofreading residue in the editing site, Cys666, and three methionine residues (M217 in the active site, M658 in the editing site, and M785 in the C-Ala domain) were modified to cysteine sulfenic acid and methionine sulfoxide, respectively. Alanine scanning mutagenesis showed that none of the identified residues were solely responsible for the change in cognate tRNAAla aminoacylation observed under oxidative stress, suggesting that these residues may act as reactive oxygen species "sinks" to protect catalytically critical sites from oxidative proofreading is resistant to oxidative damage, providing an important mechanism of stress resistance that helps to maintain proteome integrity and cellular viability.	[Kavoor, Arundhati; Kelly, Paul; Ibba, Michael] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Ibba, Michael] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chapman University System; Chapman University	Ibba, M (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.; Ibba, M (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.; Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.; Ibba, M (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	ibba@chapman.edu			National Science Foundation [MCB-1715840]	National Science Foundation(National Science Foundation (NSF))	Funding and additional information-This work was supported by the National Science Foundation (MCB-1715840 to M. I.) .	Alcock LJ, 2018, CHEM SOC REV, V47, P231, DOI 10.1039/c7cs00607a; Baez NOD, 2015, FREE RADICAL BIO MED, V80, P191, DOI 10.1016/j.freeradbiomed.2014.09.016; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bullwinkle TJ, 2016, P NATL ACAD SCI USA, V113, P2252, DOI 10.1073/pnas.1525206113; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Escobar-Alvarez E, 2017, FREE RADICAL BIO MED, V112, P60, DOI 10.1016/j.freeradbiomed.2017.07.014; Ezraty B, 2017, NAT REV MICROBIOL, V15, P385, DOI 10.1038/nrmicro.2017.26; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Gray VE, 2017, GENETICS, V207, P53, DOI 10.1534/genetics.117.300064; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Hu QH, 2020, ACS CATAL, V10, P10229, DOI 10.1021/acscatal.0c02381; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Imlay JA, 2019, ENVIRON MICROBIOL, V21, P521, DOI 10.1111/1462-2920.14445; JASIN M, 1984, CELL, V36, P1089, DOI 10.1016/0092-8674(84)90059-X; Johnson JM, 2013, BIOCHEMISTRY-US, V52, P4399, DOI 10.1021/bi400079h; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kelly P, 2020, GENES-BASEL, V11, DOI 10.3390/genes11101222; Kelly P, 2019, MBIO, V10, DOI 10.1128/mBio.02921-19; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Mohler K., 2017, NUCL ACIDS RES 45; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Nawrot B, 2011, CELL MOL LIFE SCI, V68, P4023, DOI 10.1007/s00018-011-0773-8; Pasman Z, 2011, BIOCHEMISTRY-US, V50, P1474, DOI 10.1021/bi1013535; Sanford B, 2012, BIOCHEMISTRY-US, V51, P2146, DOI 10.1021/bi300097g; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharp JS, 2006, BIOCHEMISTRY-US, V45, P6260, DOI 10.1021/bi060470r; SHI JP, 1994, BIOCHEMISTRY-US, V33, P5312, DOI 10.1021/bi00183a039; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Srinivas Pooja, 2021, Nucleic Acids Res, V49, P11800, DOI 10.1093/nar/gkab856; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Steiner RE, 2019, P NATL ACAD SCI USA, V116, P10058, DOI 10.1073/pnas.1901634116; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Verrastro I, 2015, BIOMOLECULES, V5, P378, DOI 10.3390/biom5020378; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Wu J, 2014, NUCLEIC ACIDS RES, V42, P6523, DOI 10.1093/nar/gku271; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Zhang H., 2021, NUCLEIC ACIDS RES, V49, P9953	52	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101601	10.1016/j.jbc.2022.101601	http://dx.doi.org/10.1016/j.jbc.2022.101601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35065077	gold, Green Published			2022-12-28	WOS:000791267400015
J	Niu, CY; Sun, XY; Hu, F; Tang, XW; Wang, KW				Niu, Canyang; Sun, Xiaoying; Hu, Fang; Tang, Xiaowen; Wang, KeWei			Molecular determinants for the chemical activation of the warmth-sensitive TRPV3 channel by the natural monoterpenoid carvacrol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-AMINOETHOXYDIPHENYL BORATE; OLMSTED SYNDROME; MISSENSE MUTATION; STRUCTURAL BASIS; ION CHANNELS; HAIR-GROWTH; HEAT; MECHANISM; INHIBITION; BOY	Transient receptor potential vanilloid 3 (TRPV3), robustly expressed in the skin, is a nonselective calcium-permeable cation channel activated by warm temperature, voltage, and certain chemicals. Natural monoterpenoid carvacrol from plant oregano is a known skin sensitizer or allergen that specifically activates TRPV3 channel. However, how carvacrol activates TRPV3 mechanistically remains to be understood. Here, we describe the molecular determinants for chemical activation of TRPV3 by the agonist carvacrol. Patch clamp recordings reveal that carvacrol activates TRPV3 in a concentration-dependent manner, with an EC50 of 0.2 mM, by increasing the probability of single-channel open conformation. Molecular docking of carvacrol into cryo-EM structure of TRPV3 combined with site-directed mutagenesis further identified a unique binding pocket formed by the channel S2-S3 linker important for mediating this interaction. Within the binding pocket consisting of four residues (11e505, Leu508, Arg509, and Asp512), we report that Leu508 is the most critical residue for the activation of TRPV3 by carvacrol, but not 2-APB, a widely used nonspecific agonist and TRP channel modulator. Our findings demonstrate a direct binding of carvacrol to TRPV3 by targeting the channel S2-S3 linker that serves as a critical domain for chemical-mediated activation of TRPV3. We also propose that carvacrol can function as a molecular tool in the design of novel specific TRPV3 modulators for the further understanding of TRPV3 channel pharmacology.	[Niu, Canyang; Sun, Xiaoying; Hu, Fang; Wang, KeWei] Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China; [Sun, Xiaoying; Hu, Fang; Tang, Xiaowen; Wang, KeWei] Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China; [Tang, Xiaowen] Qingdao Univ, Dept Med Chem, Sch Pharm, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wang, KW (corresponding author), Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China.; Tang, XW; Wang, KW (corresponding author), Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China.; Tang, XW (corresponding author), Qingdao Univ, Dept Med Chem, Sch Pharm, Qingdao, Peoples R China.	xwtang1219@qdu.edu.cn; wangkw@qdu.edu.cn			National Natural Science Foundation of China [81903734, 81973299]; Ministry of Science and Technology of China [2018ZX09711001004-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (81903734 and 81973299) and the Ministry of Science and Technology of China (2018ZX09711001004-006).	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui TT, 2018, ACTA PHARMACOL SIN, V39, P331, DOI 10.1038/aps.2017.152; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Duchatelet S, 2014, JAMA DERMATOL, V150, P303, DOI 10.1001/jamadermatol.2013.8709; Eytan O, 2014, J INVEST DERMATOL, V134, P1752, DOI 10.1038/jid.2014.37; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hanson SM, 2015, BIOPHYS J, V108, P1425, DOI 10.1016/j.bpj.2015.02.013; He YQ, 2015, J INVEST DERMATOL, V135, P907, DOI 10.1038/jid.2014.429; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Imura K, 2007, BIOCHEM BIOPH RES CO, V363, P479, DOI 10.1016/j.bbrc.2007.08.170; Kariminejad A, 2014, CLIN EXP DERMATOL, V39, P492, DOI 10.1111/ced.12318; Kuhn FJP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07652-4; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lievremont JP, 2005, MOL PHARMACOL, V68, P758, DOI 10.1124/mol.105.012856; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu Q, 2021, ELIFE, V10, DOI 10.7554/eLife.68128; McGoldrick LL, 2018, NATURE, V553, P233, DOI 10.1038/nature25182; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nadezhdin KD, 2021, NAT STRUCT MOL BIOL, V28, P564, DOI 10.1038/s41594-021-00615-4; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Qu YX, 2019, MOL PHARMACOL, V96, P393, DOI 10.1124/mol.119.116962; Shioya Takanobu, 2008, Folia Pharmacologica Japonica, V131, P417, DOI 10.1254/fpj.131.417; Singh AK, 2019, NAT STRUCT MOL BIOL, V26, P994, DOI 10.1038/s41594-019-0318-7; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Nguyen THD, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01776-0; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Wen H, 2018, BIOPHYS J, V114, P40, DOI 10.1016/j.bpj.2017.10.034; Wen H, 2016, PROTEINS, V84, P1938, DOI 10.1002/prot.25177; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245; Zhang H, 2019, J PHARMACOL EXP THER, V368, P21, DOI 10.1124/jpet.118.254045; Zheng Wenjun, 2019, Temperature (Austin), V6, P120, DOI 10.1080/23328940.2019.1578634; Zubcevic L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07117-w	46	2	2	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101706	10.1016/j.jbc.2022.101706	http://dx.doi.org/10.1016/j.jbc.2022.101706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150742	Green Published, gold			2022-12-28	WOS:000821054100006
J	Wang, CC; Hao, KY; Dong, LX; Wang, JN; Zhao, LC; Xu, LJ; Xia, Y; Jiang, Q; Qin, JZ				Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Xia, Yin; Jiang, Qing; Qin, Jinzhong			The MuvB complex safeguards embryonic stem cell identity through regulation of the cell cycle machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-MYB; TRANSCRIPTION; GENES; IDENTIFICATION; PHASE; LIN54; LIN-9	Increasing evidences indicate that unlimited capacity for self-renewal and pluripotency, two unique properties of embryonic stem cells (ESCs), are intrinsically linked to cell cycle control. However, the precise mechanisms coordinating cell fate decisions and cell cycle regulation remain to be fully explored. Here, using CRISPR/Cas9-mediated genome editing, we show that in ESCs, deficiency of components of the cell cycle regulatory MuvB complex Lin54 or Lin52, but not Lin9 or Lin37, triggers G2/M arrest, loss of pluripotency, and spontaneous differentiation. Further dissection of these phenotypes demonstrated that this cell cycle arrest is accompanied by the gradual activation of mesoendodermal lineage-specifying genes. Strikingly, the abnormalities observed in Lin54-null ESCs were partially but significantly rescued by ectopic coexpression of genes encoding G2/M proteins Cyclin B1 and Cdk1. Thus, our study provides new insights into the mechanisms by which the MuvB complex determines cell fate through regulation of the cell cycle machinery.	[Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Qin, Jinzhong] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China; [Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Qin, Jinzhong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China; [Qin, Jinzhong] Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Peoples R China	Nanjing University; Nanjing University; Chinese University of Hong Kong; Nanjing University; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Peoples R China.	qinjz@nju.edu.cn	Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31970810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31970810) to J. Q.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Guiley KZ, 2018, P NATL ACAD SCI USA, V115, P10016, DOI 10.1073/pnas.1808136115; Huang YK, 2021, STEM CELL REP, V16, P566, DOI 10.1016/j.stemcr.2021.01.009; Huang YK, 2018, CELL REP, V22, P3032, DOI 10.1016/j.celrep.2018.02.072; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Marceau AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12301; Matsuo T, 2012, CELL CYCLE, V11, P3227, DOI 10.4161/cc.21569; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Qin JZ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5689; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Schmit F, 2009, FEBS J, V276, P5703, DOI 10.1111/j.1742-4658.2009.07261.x; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Walston H, 2021, ANNU REV GENET, V55, P309, DOI 10.1146/annurev-genet-071819-103836; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131	29	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101701	10.1016/j.jbc.2022.101701	http://dx.doi.org/10.1016/j.jbc.2022.101701			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148988	gold, Green Published			2022-12-28	WOS:000821054100002
J	Ma, XF; Wang, TT; Wang, WH; Guan, L; Guo, CR; Li, XH; Lei, YT; Fan, YZ; Yang, XN; Hattori, M; Nureki, O; Zhu, MX; Yu, Y; Tian, Y; Wang, J				Ma, Xue-Fei; Wang, Ting-Ting; Wang, Wen-Hui; Guan, Li; Guo, Chang-Run; Li, Xing-Hua; Lei, Yun-Tao; Fan, Ying-Zhe; Yang, Xiao-Na; Hattori, Motoyuki; Nureki, Osamu; Zhu, Michael X.; Yu, Ye; Tian, Yun; Wang, Jin			The long beta 2,3-sheets encoded by redundant sequences play an integral role in the channel function of P2X7 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT BRIDGE STABILIZES; ION-CHANNEL; MOLECULAR-MECHANISM; P-2X RECEPTOR; ATP; SIGNAL; ACTIVATION; EXPRESSION; DISEASE; P2X(4)	P2X receptors are a class of nonselective cation channels widely distributed in the immune and nervous systems, and their dysfunction is a significant cause of tumors, inflammation, leukemia, and immune diseases. P2X7 is a unique member of the P2X receptor family with many properties that differ from other subtypes in terms of primary sequence, the architecture of N- and C-terminals, and channel function. Here, we suggest that the observed lengthened beta 2- and beta 3-sheets and their linker (loop beta 2,3), encoded by redundant sequences, play an indispensable role in the activation of the P2X7 receptor. We show that deletion of this longer structural element leads to the loss of P2X7 function. Furthermore, by combining mutagenesis, chimera construction, surface expression, and protein stability analysis, we found that the deletion of the longer beta 2,3-loop affects P2X7 surface expression but, more importantly, that this loop affects channel gating of P2X7. We propose that the longer beta 2,3-sheets may have a negative regulatory effect on a loop on the head domain and on the structural element formed by E171 and its surrounding regions. Understanding the role of the unique structure of the P2X7 receptor in the gating process will aid in the development of selective drugs targeting this subtype.	[Ma, Xue-Fei; Tian, Yun] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Peoples R China; [Ma, Xue-Fei; Wang, Ting-Ting; Wang, Wen-Hui; Guan, Li; Guo, Chang-Run; Li, Xing-Hua; Lei, Yun-Tao; Yang, Xiao-Na; Yu, Ye; Wang, Jin] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China; [Ma, Xue-Fei; Wang, Ting-Ting; Wang, Wen-Hui; Guan, Li; Guo, Chang-Run; Li, Xing-Hua; Lei, Yun-Tao; Yang, Xiao-Na; Yu, Ye; Wang, Jin] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Shanghai, Peoples R China; [Hattori, Motoyuki] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Shanghai Key Lab Bioact Small Mol, Dept Physiol & Neurobiol,Sch Life Sci,State Key L, Shanghai, Peoples R China; [Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA	Hunan Agricultural University; China Pharmaceutical University; China Pharmaceutical University; Shanghai University of Traditional Chinese Medicine; Fudan University; University of Tokyo; University of Texas System; University of Texas Health Science Center Houston	Tian, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Peoples R China.; Yu, Y; Wang, J (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China.; Yu, Y; Wang, J (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Peoples R China.	yuye@cpu.edu.cn; tianyun79616@163.com; wangjin@cpu.edu.cn		Hattori, Motoyuki/0000-0002-5327-5337	Natural Science Foundation of Jiangsu Province [BK20202002]; National Natural Science Foundation of China [32000869, 31971042, 81603409, 31900808, 81902480, 31971146]; Innovation and Entrepreneurship Talent Program of Jiangsu Province; State Key Laboratory of Utilization of Woody Oil Resource [2019XK2002]; Hunan Provincial Natural Science Foundation of China [2018JJ1012]; Hunan "Huxiang" High-level Talent Program (2021); China Pharmaceutical University; Innovative Research Team of High-level Local Universities in Shanghai; key laboratory program of the Education Commission of Shanghai Municipality [ZDSYS14005]; Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-2105]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation and Entrepreneurship Talent Program of Jiangsu Province; State Key Laboratory of Utilization of Woody Oil Resource; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan "Huxiang" High-level Talent Program (2021); China Pharmaceutical University; Innovative Research Team of High-level Local Universities in Shanghai; key laboratory program of the Education Commission of Shanghai Municipality; Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University	This study was supported with funds from the Natural Science Foundation of Jiangsu Province (BK20202002 to Y. Y.), National Natural Science Foundation of China with grant numbers 32000869 (J. W.), 31971042 (Y. T.), 81603409 (Y. -Z. F.), 31900808 (X-. N. Y.), 81902480 (W-. H. W.), and 31971146 (Y. Y.), Innovation and Entrepreneurship Talent Program of Jiangsu Province (Y. Y. and J. W.), State Key Laboratory of Utilization of Woody Oil Resource with grant number 2019XK2002 (Y. Y.), Hunan Provincial Natural Science Foundation of China (2018JJ1012 to Y. T.), Hunan "Huxiang" High-level Talent Program (2021 to Y. Y) and "Xing Yao" Leading Scholars of China Pharmaceutical University (2021) (Y. Y). This work was also supported by the Innovative Research Team of High-level Local Universities in Shanghai and a key laboratory program of the Education Commission of Shanghai Municipality (ZDSYS14005) and by the Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University (No. SKLGE-2105).	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Allsopp RC, 2015, J BIOL CHEM, V290, P14556, DOI 10.1074/jbc.M115.642033; Amadio S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01529; Amores-Iniesta J, 2017, CELL REP, V21, P3414, DOI 10.1016/j.celrep.2017.11.079; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Beamer E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00021; Bhattacharya A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00030; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Calzaferri F, 2020, MED RES REV, V40, P2427, DOI 10.1002/med.21710; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen PF, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100655; Chen X, 2014, NEUROSCIENCE, V279, P94, DOI 10.1016/j.neuroscience.2014.08.036; Collo G, 1996, J NEUROSCI, V16, P2495; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Gelin Christine F, 2020, Prog Med Chem, V59, P63, DOI 10.1016/bs.pmch.2019.11.002; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Letavic MA, 2017, J MED CHEM, V60, P4559, DOI 10.1021/acs.jmedchem.7b00408; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Li B, 2018, SCI BULL, V63, P1616, DOI 10.1016/j.scib.2018.11.016; Liang X, 2015, J BIOL CHEM, V290, P7930, DOI 10.1074/jbc.M114.627810; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; NUTTLE LC, 1994, J BIOL CHEM, V269, P13988; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Sun LF, 2019, J BIOL CHEM, V294, P19589, DOI 10.1074/jbc.RA119.009959; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Wang J, 2018, P NATL ACAD SCI USA, V115, P4939, DOI 10.1073/pnas.1800907115; Wang J, 2017, J BIOL CHEM, V292, P7619, DOI 10.1074/jbc.M116.771121; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Zhao WS, 2016, J BIOL CHEM, V291, P7990, DOI 10.1074/jbc.M115.711127; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	47	0	0	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102002	10.1016/j.jbc.2022.102002	http://dx.doi.org/10.1016/j.jbc.2022.102002			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35504351	gold, Green Published			2022-12-28	WOS:000811813400001
J	Jiang, HJ; Chiang, CY; Chen, Z; Nathan, S; D'Agostino, G; Paulo, JA; Song, G; Zhu, H; Gabelli, SB; Cole, PA				Jiang, Hanjie; Chiang, Claire Y.; Chen, Zan; Nathan, Sara; D'Agostino, Gabriel; Paulo, Joao A.; Song, Guang; Zhu, Heng; Gabelli, Sandra B.; Cole, Philip A.			Enzymatic analysis of WWP2 E3 ubiquitin ligase using protein microarrays identifies autophagy-related substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; NEDD4 FAMILY; INSIGHTS; UBIQUITYLATION; RNA; RECRUITMENT; ACTIVATION; MECHANISMS; RECEPTORS; CATALYSIS	WWP2 is a HECT E3 ligase that targets protein Lys residues for ubiquitination and is comprised of an N-terminal C2 domain, four central WW domains, and a C-terminal catalytic HECT domain. The peptide segment between the middle WW domains, the 2,3-linker, is known to autoinhibit the catalytic domain, and this autoinhibition can be relieved by phosphorylation at Tyr369. Several protein substrates of WWP2 have been identified, including the tumor suppressor lipid phos-phatase PTEN, but the full substrate landscape and biological functions of WWP2 remain to be elucidated. Here, we used protein microarray technology and the activated enzyme phosphomimetic mutant WWP2(Y369E )to identify potential WWP2 substrates. We identified 31 substrate hits for WWP2(Y369E )using protein microarrays, of which three were known autophagy receptors (NDP52, OPTN, and SQSTM1). These three hits were validated with in vitro and cell-based transfection assays and the Lys ubiquitination sites on these proteins were mapped by mass spectrometry. Among the mapped ubiquitin sites on these autophagy receptors, many had been previously identified in the endogenous proteins. Finally, we observed that WWP2 KO SH-SH5Y neuroblastoma cells using CRISPR-Cas9 showed a defect in mitophagy, which could be rescued by WWP2(Y369E )transfection. These studies suggest that WWP2-mediated ubiquitination of the autophagy receptors NDP52, OPTN, and SQSTM1 may positively contribute to the regulation of autophagy	[Jiang, Hanjie; Chiang, Claire Y.; D'Agostino, Gabriel; Cole, Philip A.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Jiang, Hanjie; Chiang, Claire Y.; D'Agostino, Gabriel; Cole, Philip A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jiang, Hanjie; Chen, Zan; Song, Guang; Zhu, Heng; Cole, Philip A.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Chen, Zan; Paulo, Joao A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Chen, Zan; Nathan, Sara; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zhu, Heng; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cole, PA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Cole, PA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Cole, PA (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pacole@bwh.harvard.edu	Jiang, Hanjie/AAT-8422-2021	Chiang, Claire/0000-0002-0999-9856; Jiang, Hanjie/0000-0001-6090-4552	National Institutes of Health [R01CA74305, R01 GM136148, R01GM132129, GM67945]; NIH training [T32GM095450]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by National Institutes of Health Grant R01CA74305 (P. A. C.) . This work was partially funded by R01 GM136148 (S. B. G.) as well as R01GM132129 and GM67945 (J. A. P.) . This work was also sup-ported by NIH training T32GM095450 for work by G. D. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Aslam B, 2017, J CHROMATOGR SCI, V55, P182, DOI 10.1093/chromsci/bmw167; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Caron P, 2019, GENE DEV, V33, P684, DOI 10.1101/gad.321943.118; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Chen Z, 2016, BIOCHEMISTRY-US, V55, P3658, DOI 10.1021/acs.biochem.6b00448; Chhangani D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05077; Dempsey DR, 2018, J AM CHEM SOC, V140, P9374, DOI 10.1021/jacs.8b05098; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Farre JC, 2016, NAT REV MOL CELL BIO, V17, P537, DOI 10.1038/nrm.2016.74; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Harper JW, 2021, ANNU REV BIOCHEM, V90, P403, DOI 10.1146/annurev-biochem-090120-013613; Heo JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay4624; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Huang X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2142-8; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jia XM, 2021, EXP CELL RES, V402, DOI 10.1016/j.yexcr.2021.112506; Jiang Hanjie, 2021, Curr Protoc, V1, pe14, DOI 10.1002/cpz1.14; Jiang HJ, 2019, J BIOL CHEM, V294, P17421, DOI 10.1074/jbc.RA119.009211; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kirkin V, 2019, MOL CELL, V76, P268, DOI 10.1016/j.molcel.2019.09.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee DE, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2242-5; Lee Y, 2017, CELL REP, V19, P188, DOI 10.1016/j.celrep.2017.03.030; Lee YR, 2019, SCIENCE, V364, P651, DOI 10.1126/science.aau0159; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Lin Q, 2017, J CELL SCI, V130, P3839, DOI 10.1242/jcs.207068; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nazio F, 2016, J CELL BIOL, V215, P841, DOI 10.1083/jcb.201605089; Onishi M, 2021, EMBO J, V40, DOI 10.15252/embj.2020104705; Palacios-Moreno J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004130; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Persaud A, 2011, METHODS MOL BIOL, V759, P215, DOI 10.1007/978-1-61779-173-4_13; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Qian H, 2020, J TRANSL INTERN MED, V8, P71, DOI 10.2478/jtim-2020-0012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sanarico AG, 2018, LEUKEMIA, V32, P911, DOI 10.1038/leu.2017.342; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Soond SM, 2011, ONCOGENE, V30, P2451, DOI 10.1038/onc.2010.617; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Syu GD, 2020, MOL CELL PROTEOMICS, V19, P916, DOI 10.1074/mcp.R120.001936; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Uzoma Ijeoma, 2013, Genomics Proteomics & Bioinformatics, V11, P18, DOI 10.1016/j.gpb.2012.12.005; Wang H, 2016, FASEB J, V30, P2549, DOI 10.1096/fj.201500119; Wang YY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.228072; Wang Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11224-7; Weber J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00370; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xie WH, 2022, CELL DEATH DIFFER, V29, P40, DOI 10.1038/s41418-021-00833-9; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	83	0	0	8	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101854	10.1016/j.jbc.2022.101854	http://dx.doi.org/10.1016/j.jbc.2022.101854			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35331737	gold, Green Published			2022-12-28	WOS:000793483000009
J	Liberato, MV; Campos, BM; Tomazetto, G; Crouch, LI; Garcia, W; Zeri, ACD; Bolam, DN; Squina, FM				Liberato, Marcelo Vizona; Campos, Bruna Medeia; Tomazetto, Geizecler; Crouch, Lucy Isobel; Garcia, Wanius; de Mattos Zeri, Ana Carolina; Bolam, David Nichol; Squina, Fabio Marcio			<p>Unique properties of a Dictyostelium discoideum carbohydrate-binding module expand our understanding of CBM-ligand interactions</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING; MOLECULAR-BASIS; RECOGNITION; SPECIFICITY; DOMAIN; PROMISCUITY	Deciphering how enzymes interact, modify, and recognize carbohydrates has long been a topic of interest in academic, pharmaceutical, and industrial research. Carbohydrate-binding modules (CBMs) are noncatalytic globular protein domains attached to carbohydrate-active enzymes that strengthen enzyme affinity to substrates and increase enzymatic efficiency via targeting and proximity effects. CBMs are considered auspicious for various biotechnological purposes in textile, food, and feed industries, representing valuable tools in basic science research and biomedicine. Here, we present the first crystallo-graphic structure of a CBM8 family member (CBM8), DdCBM8, from the slime mold Dictyostelium discoideum, which was identified attached to an endo-beta-1,4-glucanase (glycoside hy-drolase family 9). We show that the planar carbohydrate-binding site of DdCBM8, composed of aromatic residues, is similar to type A CBMs that are specific for crystalline (multichain) poly-saccharides. Accordingly, pull-down assays indicated that DdCBM8 was able to bind insoluble forms of cellulose. However, affinity gel electrophoresis demonstrated that DdCBM8 also bound to soluble (single chain) polysaccharides, especially glu-comannan, similar to type B CBMs, although it had no apparent affinity for oligosaccharides. Therefore, the structural charac-teristics and broad specificity of DdCBM8 represent exceptions to the canonical CBM classification. In addition, mutational analysis identified specific amino acid residues involved in ligand recognition, which are conserved throughout the CBM8 family. This advancement in the structural and functional character-ization of CBMs contributes to our understanding of carbohydrate-active enzymes and protein-carbohydrate in-teractions, pushing forward protein engineering strategies and enhancing the potential biotechnological applications of glyco-side hydrolase accessory modules.	[Liberato, Marcelo Vizona; Squina, Fabio Marcio] Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Campos, Bruna Medeia] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Tomazetto, Geizecler] Aarhus Univ, Dept Biol & Chem Engn BCE, Aarhus, Denmark; [Crouch, Lucy Isobel] Univ Birmingham, Inst Microbiol & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Campinas, SP, Brazil; [de Mattos Zeri, Ana Carolina] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Luz Sincrotron LNLS, Campinas, SP, Brazil; [Bolam, David Nichol] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne, Tyne & Wear, England	Universidade de Sorocaba; Aarhus University; University of Birmingham; Laboratorio Nacional de Luz Sincrotron (LNLS); Newcastle University - UK	Squina, FM (corresponding author), Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil.	fibio.squina@gmail.com	Squina, Fabio/J-8130-2012	Squina, Fabio/0000-0002-8154-7459	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2013/06336-0, 2014/04105-4, 2015/14009-5, 2015/50590-4, 2015/23279-6, 2017/17275-3, 2020/15595-3, 2020/05784-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [305740/2017-2, 428527/2018-3, 422132/2018-7, 305816/2020-9, 306279/2020-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant nos.: FAPESP 2013/06336-0, 2014/04105-4, 2015/14009-5, 2015/50590-4, 2015/23279-6, 2017/17275-3, 2020/15595-3, and 2020/05784-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 305740/2017-2, 428527/2018-3, 422132/2018-7, 305816/2020-9, and 306279/2020-7), Brazil.	A Linares-Pasten J, 2014, CURR BIOTECHNOL, V3; Abbott W, 2018, GLYCOBIOLOGY, V28, P3, DOI 10.1093/glycob/cwx089; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Araki R, 2004, FEBS LETT, V561, P155, DOI 10.1016/S0014-5793(04)00160-7; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Campos BM, 2016, J BIOL CHEM, V291, P23734, DOI 10.1074/jbc.M116.744383; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Duan CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19392; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kameshwar AKS, 2016, INT J BIOL SCI, V12, P156, DOI 10.7150/ijbs.13537; Kim S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-14; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liberato MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep23473; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martin-Gonzalez J, 2021, MICROB BIOTECHNOL, V14, P111, DOI 10.1111/1751-7915.13692; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire BE, 2022, MICROB CELL FACT, V21, DOI 10.1186/s12934-022-01753-0; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Mei XW, 2020, CARBOHYD POLYM, V246, DOI 10.1016/j.carbpol.2020.116645; Mello BL, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0036-9; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Nagl M, 2022, CELLULOSE, V29, P2579, DOI 10.1007/s10570-021-04386-5; Okazaki F, 2002, J BACTERIOL, V184, P2399, DOI 10.1128/JB.184.9.2399-2403.2002; Oliveira C, 2015, BIOTECHNOL ADV, V33, P358, DOI 10.1016/j.biotechadv.2015.02.006; Pinto ERP, 2015, J MATER CHEM C, V3, P11581, DOI 10.1039/c5tc02359a; Pires VMR, 2017, J BIOL CHEM, V292, P4847, DOI 10.1074/jbc.M116.767541; Qin Z, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125037; RAMALINGAM R, 1992, J BACTERIOL, V174, P7834, DOI 10.1128/JB.174.23.7834-7837.1992; Schaf J, 2019, INT J DEV BIOL, V63, P541, DOI 10.1387/ijdb.190228rw; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; Venditto I, 2016, P NATL ACAD SCI USA, V113, P7136, DOI 10.1073/pnas.1601558113; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	49	0	0	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101891	10.1016/j.jbc.2022.101891	http://dx.doi.org/10.1016/j.jbc.2022.101891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35378128	gold, Green Published			2022-12-28	WOS:000798142000009
J	Marsango, S; Ward, RJ; Jenkins, L; Butcher, AJ; Al Mahmud, Z; Dwomoh, L; Nagel, F; Schulz, S; Tikhonova, IG; Tobin, AB; Milligan, G				Marsango, Sara; Ward, Richard J.; Jenkins, Laura; Butcher, Adrian J.; Al Mahmud, Zobaer; Dwomoh, Louis; Nagel, Falko; Schulz, Stefan; Tikhonova, Irina G.; Tobin, Andrew B.; Milligan, Graeme			Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR; GPR84; AGONISTS	GPR84 is an immune cell-expressed, proinflammatory receptor currently being assessed as a therapeutic target in conditions including fibrosis and inflammatory bowel disease. Although it was previously shown that the orthosteric GPR84 activators 2-HTP and 6-OAU promoted its interactions with arrestin-3, a G protein-biased agonist DL 175 did not. Here, we show that replacement of all 21 serine and threonine residues within i-loop 3 of GPR84, but not the two serines in the C-terminal tail, eliminated the incorporation of [P-32] and greatly reduced receptor- arrestin-3 interactions promoted by 2-HTP. GPR84 was phosphorylated constitutively on residues Ser(221) and Ser(224), while various other amino acids are phosphorylated in response to 2-HTP. Consistent with this, an antiserum able to identify pSer(221)/pSer(224 )recognized GPR84 from cells treated with and without activators, whereas an antiserum able to identify pThr(263)/pThr(264) only recognized GPR84 after exposure to 2-HTP and not DL-175. Two distinct GPR84 antagonists as well as inhibition of G protein- coupled receptor kinase 2/3 prevented phosphorylation of pThr(263)/pThr(264), but neither strategy affected constitutive phosphorylation of Ser(221)/Ser(224). Furthermore, mutation of residues Thr263 and Thr264 to alanine generated a variant of GPR84 also limited in 2-HTP-induced interactions with arrestin-2 and-3. By contrast, this mutant was unaffected in its capacity to reduce cAMP levels. Taken together, these results define a key pair of threonine residues, regulated only by subsets of GPR84 small molecule activators and by GRK2/3 that define effective interactions with arrestins and provide novel tools to monitor the phosphorylation and functional status of GPR84.	[Marsango, Sara; Ward, Richard J.; Jenkins, Laura; Al Mahmud, Zobaer; Dwomoh, Louis; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Inst Mol, Coll Med, Ctr Translat Pharmacol, Glasgow City, Scotland; [Butcher, Adrian J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Nagel, Falko; Schulz, Stefan] 7TM Antibodies GmbH, Jena, Germany; [Schulz, Stefan] Univ Hosp Jena, Inst Pharmacol & Toxicol, Jena, Germany; [Tikhonova, Irina G.] Queens Univ Belfast, Med Biol Ctr, Sch Pharm, Belfast, North Ireland	University of Glasgow; University of Cambridge; Friedrich Schiller University of Jena; Queens University Belfast	Milligan, G (corresponding author), Univ Glasgow, Inst Mol, Coll Med, Ctr Translat Pharmacol, Glasgow City, Scotland.	Graeme.Milligan@glasgow.ac.uk		Dwomoh, Louis/0000-0001-7024-6450	Biotechnology and Biosciences Research Council [BB/T000562/1, BB/R007101/1]; Medical Research Council [MC_PC_17160, EP/T022175/1]; ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares; European COST Action [CA18133]	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares; European COST Action	This work was funded by each of the Biotechnology and Biosciences Research Council (grant reference BB/T000562/1) to G. M. and A. B. T., and grant reference BB/R007101/1 to I. G. T., an ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares to G. M. and A. B. T., and the Medical Research Council (Confidence in Concept, grant number MC_PC_17160 [to G. M.] ) . This project made use of computational time on Kelvin-2 (grant no. EP/T022175/1) G. M., A. B. T., and I. G. T. participate in the European COST Action CA18133 (ERNEST) .	Al Mahmud Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18159-3; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Cao YB, 2019, METHODS MOL BIOL, V1957, P59, DOI 10.1007/978-1-4939-9158-7_3; Chen LH, 2020, J MED CHEM, V63, P15399, DOI 10.1021/acs.jmedchem.0c01378; Divorty N, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101655; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaidarov I, 2018, PHARMACOL RES, V131, P185, DOI 10.1016/j.phrs.2018.02.021; Glide, 2020, MACROMODEL SCHROD RE, DOI DOI 10.1021/jm0306430; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Jenkins L, 2021, ACS PHARMACOL TRANSL, V4, P1598, DOI 10.1021/acsptsci.1c00151; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kliewer A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08162-1; Kliewer A, 2017, TRENDS PHARMACOL SCI, V38, P621, DOI 10.1016/j.tips.2017.04.002; Kose M, 2020, J MED CHEM, V63, P2391, DOI 10.1021/acs.jmedchem.9b01339; Kryshtafovych A, 2021, PROTEINS, V89, P1607, DOI 10.1002/prot.26237; Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0; Liu Y, 2016, ACS MED CHEM LETT, V7, P579, DOI 10.1021/acsmedchemlett.6b00025; Lowe JD, 2015, MOL PHARMACOL, V88, P347, DOI 10.1124/mol.115.098293; Lucy D, 2019, ACS CHEM BIOL, V14, P2055, DOI 10.1021/acschembio.9b00533; Mancini SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38539-1; Mann A, 2015, BRIT J PHARMACOL, V172, P311, DOI 10.1111/bph.12627; Marsango S, 2022, BRIT J PHARMACOL, V179, P3529, DOI 10.1111/bph.15248; Matthees ESF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.687489; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nikaido Y, 2015, J BIOCHEM, V157, P311, DOI 10.1093/jb/mvu075; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pillaiyar T, 2018, ACS OMEGA, V3, P3365, DOI 10.1021/acsomega.7b02092; Pillaiyar T, 2017, J MED CHEM, V60, P3636, DOI 10.1021/acs.jmedchem.6b01593; Recio C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01419; Seyedabadi M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020218; Sulon Sarah M, 2021, Curr Opin Endocr Metab Res, V16, P56, DOI 10.1016/j.coemr.2020.09.002; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tikhonova IG, 2017, HANDB EXP PHARMACOL, V236, P57, DOI 10.1007/164_2016_52; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wanka L, 2022, BIOL CHEM, V403, P133, DOI 10.1515/hsz-2021-0128; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wojciechowicz ML, 2020, NAT REV DRUG DISCOV, V19, P374, DOI 10.1038/d41573-020-00029-9; Zurkovsky L, 2017, NEUROPHARMACOLOGY, V121, P20, DOI 10.1016/j.neuropharm.2017.04.021	43	5	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101932	10.1016/j.jbc.2022.101932	http://dx.doi.org/10.1016/j.jbc.2022.101932			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35427647	Green Published, Green Accepted, gold			2022-12-28	WOS:000804923000001
J	Castiglioni, VG; Ramalho, JJ; Kroll, JR; Stucchi, R; van Beuzekom, H; Schmidt, R; Altelaar, M; Boxem, M				Castiglioni, Victoria G.; Ramalho, Joao J.; Kroll, Jason R.; Stucchi, Riccardo; van Beuzekom, Hanna; Schmidt, Ruben; Altelaar, Maarten; Boxem, Mike			Identification and characterization of Crumbs polarity complex proteins in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA STARDUST; TIGHT JUNCTIONS; CELL POLARITY; PHOTORECEPTOR MORPHOGENESIS; TRANSMEMBRANE PROTEIN; RETINITIS-PIGMENTOSA; MPZ-1 INTERACT; HOMOLOG; PATJ; PALS1	Crumbs proteins are evolutionarily conserved trans-membrane proteins with essential roles in promoting the formation of the apical domain in epithelial cells. The short intracellular tail of Crumbs proteins are known to interact with several proteins, including the scaffolding protein PALS1 (protein associated with LIN7, Stardust in Drosophila). PALS1 in turn binds to a second scaffolding protein PATJ (PALS1-associated tight junction protein) to form the core Crumbs/ PALS1/PATJ complex. While essential roles in epithelial organization have been shown for Crumbs proteins in Drosophila and mammalian systems, the three Caenorhabditis elegans crumbs genes are dispensable for epithelial polarization and development. Here, we investigated the presence and function of PALS1 and PATJ orthologs in C. elegans. We identified MAGU-2 as the C. elegans ortholog of PALS1 and show that MAGU-2 interacts with all three Crumbs proteins and localizes to the apical membrane domain of intestinal epithelial cells in a Crumbs-dependent fashion. Similar to crumbs mutants, magu-2 deletion showed no epithelial polarity defects. We also identified MPZ-1 as a candidate ortholog of PATJ based on the physical interaction with MAGU-2 and sequence similarity with PATJ proteins. However, MPZ-1 is not broadly expressed in epithelial tissues and, therefore, not likely a core component of the C. elegans Crumbs complex. Finally, we show over-expression of the Crumbs proteins EAT-20 or CRB-3 can lead to apical membrane expansion in the intestine. Our results shed light on the composition of the C. elegans Crumbs com-plex and indicate that the role of Crumbs proteins in promoting apical domain formation is conserved.	[Castiglioni, Victoria G.; Ramalho, Joao J.; Kroll, Jason R.; van Beuzekom, Hanna; Schmidt, Ruben; Boxem, Mike] Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands; [Stucchi, Riccardo] Univ Utrecht, Div Cell Biol Neurobiol & Biophys, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands; [Stucchi, Riccardo; Altelaar, Maarten] Univ Utrecht, Div Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Stucchi, Riccardo; Altelaar, Maarten] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Ramalho, Joao J.] Wageningen Univ & Res, Lab Biochem, Wageningen, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research	Boxem, M (corresponding author), Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci,Inst Biodynam & Biocomplex, Utrecht, Netherlands.	m.boxem@uu.nl	; Boxem, Mike/B-8857-2011	Kroll, Jason/0000-0002-8229-7412; Boxem, Mike/0000-0003-3966-4173; Ramalho, Joao/0000-0002-1367-6275; Castiglioni, Victoria G/0000-0001-9884-2537; Stucchi, Riccardo/0000-0003-3793-634X	Netherlands Organization for Scientific Research (NWO)-ALW Open Program [824.14.021, NWO-VICI 016.VICI.170.165]	Netherlands Organization for Scientific Research (NWO)-ALW Open Program(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO)-ALW Open Program 824.14.021 and NWO-VICI 016.VICI.170.165 grants to M. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves C. H., 2013, Loss of CRB2; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bit-Avragim N, 2008, J CELL SCI, V121, P2503, DOI 10.1242/jcs.033167; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; BRENNER S, 1974, GENETICS, V77, P71; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000041; Cherra SJ, 2020, J NEUROGENET, V34, P298, DOI 10.1080/01677063.2020.1726915; Cho SH, 2012, HUM MOL GENET, V21, P2663, DOI 10.1093/hmg/dds091; de Almeida FN, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.175497; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dillon J, 2018, INVERTEBR NEUROSCI, V18, DOI 10.1007/s10158-018-0218-2; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Friedland A. E., 2013, Nat. Methods, V10, P741; Ghanta KS, 2020, GENETICS, V216, P643, DOI 10.1534/genetics.120.303564; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris T. W., 2020, Nucleic Acids Res; Hong Y, 2003, P NATL ACAD SCI USA, V100, P12712, DOI 10.1073/pnas.2135347100; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Koorman T, 2016, NAT CELL BIOL, V18, P337, DOI 10.1038/ncb3300; Kumichel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094038; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Lin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031499; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mellacheruvu D., 2013, The CRAPome; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Park B, 2011, J NEUROSCI, V31, P17230, DOI 10.1523/JNEUROSCI.4430-11.2011; Penalva C, 2012, DEVELOPMENT, V139, P4549, DOI 10.1242/dev.085449; Perez-Mockus G, 2017, J CELL BIOL, V216, P1405, DOI 10.1083/jcb.201611196; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J BIOL CHEM, V277, P27501, DOI 10.1074/jbc.M201177200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schwartz ML, 2016, GENETICS, V202, P1277, DOI 10.1534/genetics.115.184275; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Sen A, 2012, J CELL BIOL, V199, P685, DOI 10.1083/jcb.201206064; Shibata Y, 2000, GENETICS, V154, P635; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanoue A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00159-z; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tilston-Lnel A. M., 2016, J. Mol; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; van de Pavert S. A., 2004, Crumbs homologue 1 is required for maintenance of photoreceptor cell polarization and adhesion during light exposure; van den Hurk JAJM, 2005, MOL VIS, V11, P263; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Waaijers S., 2016, A; Waaijers S, 2015, BIOL OPEN, V4, P276, DOI 10.1242/bio.201410744; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Wen WY, 2018, J MOL BIOL, V430, P3504, DOI 10.1016/j.jmb.2017.09.013; Whiteman EL, 2014, MOL CELL BIOL, V34, P43, DOI 10.1128/MCB.00999-13; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Yin Y, 2014, REPROD DOMEST ANIM, V49, P824, DOI 10.1111/rda.12374; Zhou WK, 2012, DEVELOPMENT, V139, P2891, DOI 10.1242/dev.083162; Zou J, 2013, INT J DEV NEUROSCI, V31, P770, DOI 10.1016/j.ijdevneu.2013.09.005	89	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101786	10.1016/j.jbc.2022.101786	http://dx.doi.org/10.1016/j.jbc.2022.101786			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35247383	gold, Green Published			2022-12-28	WOS:000793692600002
J	Jin, CS; Teneberg, S				Jin, Chunsheng; Teneberg, Susann			Characterization of novel nonacid glycosphingolipids as biomarkers of human gastric adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP ANTIGENS; HELICOBACTER-PYLORI; MASS-SPECTROMETRY; TN ANTIGEN; BINDING GANGLIOSIDES; CANCER; EXPRESSION; GLYCOLIPIDS; ADHESIN; GLYCOPROTEIN	degenerative changes appear leading to premalignant conditions as atrofic gastritis, metaplasia, and dysplasia. binding of bacterial adhesins to carbohydrate receptors on the gastric epithelium. A number of different carbohydrate receptor been reported (reviewed in Ref. (2)). Despite the multitude of candidate H. pylori glycan receptors, only three carbohydratebinding adhesins have been characterized to date; the blood group antigen-binding BabA adhesin, the sialic acid-binding SabA adhesin, and the LabA adhesin (reviewed in Ref. (3)). adhesin BabA (4). H. pylori strains expressing BabA together with VacA and CagA (triple-positive strains) are highly associated with severe gastric diseases, as peptic ulcer or gastric adenocarcinoma. BabA mediates the initial attachment of H. pylori to the human gastric mucosa. The first observation recognized by H. pylori BabA was followed by a division of BabA-producing H. pylori strains into specialist and generalist strains, depending on their mode of binding to Leb and related carbohydrate sequences (5). BabA of specialist strains binds	[Jin, Chunsheng; Teneberg, Susann] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Cancer Foundation [20 0759 PjF 01 H]	Swedish Cancer Foundation	This work was supported by the Swedish Cancer Foundation (grant no.: 20 0759 PjF 01 H; to S. T.).	Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; Benktander J, 2018, VIRULENCE, V9, P738, DOI 10.1080/21505594.2018.1440171; Benktander J, 2012, J BIOL CHEM, V287, P31712, DOI 10.1074/jbc.M112.387654; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BREIMER ME, 1980, CANCER RES, V40, P897; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Ciopraga J, 2000, J BIOCHEM, V128, P855, DOI 10.1093/oxfordjournals.jbchem.a022824; DAVID L, 1992, APMIS, V100, P162; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Doohan D, 2021, TOXINS, V13, DOI 10.3390/toxins13070485; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; HAKOMORI S, 1977, P NATL ACAD SCI USA, V74, P3023, DOI 10.1073/pnas.74.7.3023; Hakomori S., 1989, GANGLIOSIDES CANC, P57; HATTORI H, 1987, CANCER RES, V47, P1968; HATTORI H, 1981, BIOCHIM BIOPHYS ACTA, V666, P361, DOI 10.1016/0005-2760(81)90295-2; HIROHASHI S, 1985, P NATL ACAD SCI USA, V82, P7039, DOI 10.1073/pnas.82.20.7039; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Jacob F., 2014, GLYCOSPHINGOLIPID P1; Javaheri A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.189; Jin CS, 2018, J BIOL CHEM, V293, P17248, DOI 10.1074/jbc.RA118.004854; Johansson MM, 2015, GLYCOCONJUGATE J, V32, P393, DOI 10.1007/s10719-015-9604-8; KANNAGI R, 1982, CANCER RES, V42, P5249; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Kawaguchi T, 2006, BREAST CANCER RES TR, V98, P31, DOI 10.1007/s10549-005-9115-6; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; Koniger V, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.188; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; LEVINE P, 1976, ANN NY ACAD SCI, V277, P428, DOI 10.1111/j.1749-6632.1976.tb41719.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MATIASGUIU X, 1988, PATHOL RES PRACT, V183, P476, DOI 10.1016/S0344-0338(88)80096-7; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; Mthembu YH, 2020, MOL OMICS, V16, P243, DOI 10.1039/c9mo00175a; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Padda J, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15165; Paraskevopoulou V., 2021, STRUCTURAL BINDING C; Pearce OMT, 2018, GLYCOBIOLOGY, V28, P670, DOI 10.1093/glycob/cwy023; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Roche N, 2001, GLYCOBIOLOGY, V11, P935, DOI 10.1093/glycob/11.11.935; Roche N, 2007, MICROBES INFECT, V9, P605, DOI 10.1016/j.micinf.2007.01.023; Rossez Y, 2014, J INFECT DIS, V210, P1286, DOI 10.1093/infdis/jiu239; SAKAMOTO J, 1989, CANCER RES, V49, P745; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Teneberg S, 2009, TOP CURR CHEM, V288, P121, DOI 10.1007/128_2008_14; TORRADO J, 1992, GASTROENTEROLOGY, V102, P424, DOI 10.1016/0016-5085(92)90086-E; UEMURA K, 1989, JPN J EXP MED, V59, P239; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Victorzon M, 1996, INT J CANCER, V65, P295, DOI 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; YAMADA T, 1995, CANCER, V76, P1529, DOI 10.1002/1097-0142(19951101)76:9<1529::AID-CNCR2820760905>3.0.CO;2-G	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101732	10.1016/j.jbc.2022.101732	http://dx.doi.org/10.1016/j.jbc.2022.101732			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35176282	Green Published, gold			2022-12-28	WOS:000793694800008
J	Prusa, J; Zhu, DX; Flynn, AJ; Jensen, D; Manzano, AR; Galburt, EA; Stallings, CL				Prusa, Jerome; Zhu, Dennis X.; Flynn, Aidan J.; Jensen, Drake; Manzano, Ana Ruiz; Galburt, Eric A.; Stallings, Christina L.			Molecular dissection of RbpA-mediated regulation of fidaxomicin sensitivity in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; SIGMA-SUBUNIT; OPEN COMPLEXES; LID ELEMENT; TRANSCRIPTION; CARD; STABILIZES; BINDING; PROTEIN	RNA polymerase (RNAP) binding protein A (RbpA) is essential for mycobacterial viability and regulates transcription initiation by increasing the stability of the RNAP-promoter open complex (RPo). RbpA consists of four domains: an N-terminal tail (NTT), a core domain (CD), a basic linker, and a sigma interaction domain. We have previously shown that truncation of the RbpA NTT and CD increases RPo stabilization by RbpA, implying that these domains inhibit this activity of RbpA. Previously published structural studies showed that the NTT and CD are positioned near multiple RNAP-sigma(A) holoenzyme functional domains and predict that the RbpA NTT contributes specific amino acids to the binding site of the antibiotic fidaxomicin (Fdx), which inhibits the formation of the RPo complex. Furthermore, deletion of the NTT results in decreased Mycobacterium smegmatis sensitivity to Fdx, but whether this is caused by a loss in Fdx binding is unknown. We generated a panel of rbpA mutants and found that the RbpA NTT residues predicted to directly interact with Fdx are partially responsible for RbpA-dependent Fdx activity in vitro, while multiple additional RbpA domains contribute to Fdx activity in vivo. Specifically, our results suggest that the RPostabilizing activity of RbpA decreases Fdx activity in vivo. In support of the association between RPo stability and Fdx activity, we find that another factor that promotes RP(o-)stability in bacteria, CarD, also impacts to Fdx sensitivity. Our findings highlight how RbpA and other factors may influence RNAP dynamics to affect Fdx sensitivity.	[Prusa, Jerome; Zhu, Dennis X.; Flynn, Aidan J.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Jensen, Drake; Manzano, Ana Ruiz; Galburt, Eric A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stallings, CL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	stallings@wustl.edu		Jensen, Drake/0000-0002-4227-8241; Flynn, Aidan/0000-0003-0607-9381	NIH NIGMS [GM007067, GM107544, GM134362]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; Stephen I. Morse Graduate Fellowship; NIH NIAID [T32A1007172]; Gary K. Ackers Fellowship; Elliot L. Elson Education and Training Fellowship	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Stephen I. Morse Graduate Fellowship; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gary K. Ackers Fellowship; Elliot L. Elson Education and Training Fellowship	This work was supported by the NIH NIGMS grant GM107544 awarded to E. A. G. and C. L. S., NIH NIGMS grant GM134362 awarded to E. A. G., and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award awarded to C. L. S. J. P. is supported by NIH NIGMS grant GM007067 and a Stephen I. Morse Graduate Fellowship. D. X. Z. is supported by NIH NIAID grant T32A1007172. D. J. is supported by the Gary K. Ackers Fellowship and Elliot L. Elson Education and Training Fellowship. This publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2014, TUBERCULOSIS, V94, P397, DOI 10.1016/j.tube.2014.03.008; Bortoluzzi A, 2013, J BIOL CHEM, V288, P14438, DOI 10.1074/jbc.M113.459883; Boyaci H, 2019, NATURE, V565, P382, DOI 10.1038/s41586-018-0840-5; Boyaci H, 2018, ELIFE, V7, DOI 10.7554/eLife.34823; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Davis E, 2015, NUCLEIC ACIDS RES, V43, P433, DOI 10.1093/nar/gku1231; Dove SL, 2003, MOL MICROBIOL, V48, P863, DOI 10.1046/j.1365-2958.2003.03467.x; Galburt EA, 2018, P NATL ACAD SCI USA, V115, pE11604, DOI 10.1073/pnas.1809454115; Garner AL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00698-16; Garner AL, 2014, MOL MICROBIOL, V93, P682, DOI 10.1111/mmi.12681; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hu YB, 2014, NUCLEIC ACIDS RES, V42, P10399, DOI 10.1093/nar/gku742; Hu YB, 2012, NUCLEIC ACIDS RES, V40, P6547, DOI 10.1093/nar/gks346; Hubin EA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16072; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Hubin EA, 2015, P NATL ACAD SCI USA, V112, P7171, DOI 10.1073/pnas.1504942112; Jensen D, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00512-20; Jensen D, 2019, NUCLEIC ACIDS RES, V47, P6685, DOI 10.1093/nar/gkz449; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lin W, 2018, MOL CELL, V70, P60, DOI 10.1016/j.molcel.2018.02.026; Morichaud Z, 2016, J MOL BIOL, V428, P463, DOI 10.1016/j.jmb.2015.12.017; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Perumal AS, 2018, NUCLEIC ACIDS RES, V46, P10106, DOI 10.1093/nar/gky714; Prusa J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00690-17; Pupov D, 2018, NUCLEIC ACIDS RES, V46, P11477, DOI 10.1093/nar/gky919; Pupov D, 2014, NUCLEIC ACIDS RES, V42, P4494, DOI 10.1093/nar/gkt1384; Rammohan J, 2016, NUCLEIC ACIDS RES, V44, P7304, DOI 10.1093/nar/gkw577; Rammohan J, 2015, NUCLEIC ACIDS RES, V43, P3272, DOI 10.1093/nar/gkv078; Shi W, 2020, EMBO J, V39, DOI 10.15252/embj.2020104389; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Stefan MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78269-3; Tabib-Salazar A, 2013, NUCLEIC ACIDS RES, V41, P5679, DOI 10.1093/nar/gkt277; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vishwakarma RK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01798; Weiss LA, 2012, J BACTERIOL, V194, P5621, DOI 10.1128/JB.00879-12; Yuzenkova Y, 2011, EMBO J, V30, P3766, DOI 10.1038/emboj.2011.252; Zhu DX, 2019, P NATL ACAD SCI USA, V116, P13573, DOI 10.1073/pnas.1900176116	40	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101752	10.1016/j.jbc.2022.101752	http://dx.doi.org/10.1016/j.jbc.2022.101752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35189142	Green Published, gold			2022-12-28	WOS:000793560400010
J	Vega, M; Chen, Y; Shi, YJ; Gera, J; Lichtenstein, A				Vega, Mario; Chen, Yu; Shi, Yijiang; Gera, Joseph; Lichtenstein, Alan			Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CASCADE; BETA-TRCP; ACTIVATION; DEGRADATION; APOPTOSIS	DEPTOR is a 48 kDa protein upregulated in multiple myeloma (MM) cells. DEPTOR inhibits mTOR and, by repressing a negative feedback loop, promotes AKT activation. We previously identified a compound that binds to DEPTOR in MM cells and induces its proteasomal degradation. To identify the mechanism of degradation, here, we screened for drug-induced posttranslational modifications and identified reduced phosphorylation of DEPTOR on serine 235 (S235). We show that an S235 phosphomimetic DEPTOR mutant was resistant to degradation, confirming the importance of this posttranslational modification. In addition, a DEPTOR mutant with a serine-to-alanine substitution at S235 could only be expressed upon concurrent proteasome inhibition. Thus, S235 phosphorylation regulates DEPTOR stability. Screening the DEPTOR interactome identified that the association of USP-7 deubiquitinase with DEPTOR was dependent upon S235 phosphorylation. Inhibition of USP-7 activity resulted in DEPTOR polyubiquitination and degradation. A scansite search suggested that ERK1 may be responsible for S235 phosphorylation, which was confirmed through the use of inhibitors, ERK1 knockdown, and an in vitro kinase assay. Inhibition of ERK1 also downregulated AKT phosphorylation. To test if DEPTOR phosphorylation mediated this crosstalk, MM cells were transfected with WT or phosphomimetic DEPTOR and exposed to ERK inhibitors. Although WT DEPTOR had no effect on the inhibition of AKT phosphorylation, the phosphomimetic DEPTOR prevented inhibition. These results indicate that ERK1 maintains AKT activity in MM cells via phosphorylation of DEPTOR. We propose that DEPTOR-dependent crosstalk provides MM cells with a viability-promoting signal (through AKT) when proliferation is stimulated (through ERK).	[Vega, Mario; Shi, Yijiang; Gera, Joseph; Lichtenstein, Alan] Greater Los Angeles VA UCLA Healthcare Ctr, Hematol Oncol, Los Angeles, CA 90073 USA; [Chen, Yu] Univ Calif Los Angeles, Mol Instrumentat Ctr, Los Angeles, CA USA; [Chen, Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lichtenstein, A (corresponding author), Greater Los Angeles VA UCLA Healthcare Ctr, Hematol Oncol, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Vega, Mario I/0000-0002-3932-2483; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [RO1CA217820, RO1CA21426, RO1CA211562]; Research funds of the Veteran's Administration	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research funds of the Veteran's Administration	Supported by the National Institutes of Health grants RO1CA217820 (to J. G.), RO1CA21426 (to A. L.), RO1CA211562 (to A. L.) and Research funds of the Veteran's Administration (to J. G. and A. L.). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Bruneau S, 2013, BLOOD, V122, P1833, DOI 10.1182/blood-2013-03-488486; Carbonneau M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12700; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; DAEIPOUR M, 1993, J IMMUNOL, V150, P4743; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gonzalez-Teran B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10477; Hoang B, 2016, MOL CANCER RES, V14, P397, DOI 10.1158/1541-7786.MCR-15-0422; Hu LP, 2003, BLOOD, V101, P3126, DOI 10.1182/blood-2002-08-2640; KUMAR G, 1994, J IMMUNOL, V153, P4436; Le J, 2017, BIOORG MED CHEM LETT, V27, P4714, DOI 10.1016/j.bmcl.2017.09.002; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata A, 1997, CLIN CANCER RES, V3, P1017; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Shi Y, 2016, ONCOGENE, V35, P1015, DOI 10.1038/onc.2015.156; Shi YJ, 2016, CANCER RES, V76, P5822, DOI 10.1158/0008-5472.CAN-16-1019; Vega MI, 2019, MOL CANCER THER, V18, P1822, DOI 10.1158/1535-7163.MCT-19-0115; Yang J, 2012, LEUKEMIA, V26, P2114, DOI 10.1038/leu.2012.71; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101750	10.1016/j.jbc.2022.101750	http://dx.doi.org/10.1016/j.jbc.2022.101750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35216969	gold, Green Published			2022-12-28	WOS:000823106100004
J	Nedaei, H; Rezaei-Ghaleh, N; Giller, K; Becker, S; Karami, L; Moosavi-Movahedi, AA; Griesinger, C; Saboury, AA				Nedaei, Hadi; Rezaei-Ghaleh, Nasrollah; Giller, Karin; Becker, Stefan; Karami, Leila; Moosavi-Movahedi, Ali Akbar; Griesinger, Christian; Saboury, Ali Akbar			The calcium-free form of atorvastatin inhibits amyloid-beta(1-42) aggregation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA PEPTIDE AGGREGATION; AMYLOID-BETA; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; MICE INVOLVEMENT; STATINS; CURCUMIN; BINDING; TAU; STRATEGIES	Alzheimer's disease is characterized by the presence of extraneuronal amyloid plaques composed of amyloid-beta (A beta) fibrillar aggregates in the brains of patients. In mouse models, it has previously been shown that atorvastatin (Ator), a cholesterol-lowering drug, has some reducing effect on the production of cerebral A beta. A meta-analysis on humans showed moderate effects in the short term but no improvement in the Alzheimer's Disease Assessment Scale-Cognitive Subscale behavioral test. Here, we explore a potential direct effect of Ator on A beta 42 aggregation. Using NMR-based monomer consumption assays and CD spectroscopy, we observed a promoting effect of Ator in its original form (Ator-calcium) on A beta 42 aggregation, as expected because of the presence of calcium ions. The effect was reversed when applying a CaCO3- based calcium ion scavenging method, which was validated by the aforementioned methods as well as thioflavin-T fluorescence assays and transmission electron microscopy. We found that the aggregation was inhibited significantly when the concentration of calcium-free Ator exceeded that of A beta by at least a factor of 2. The H-1-N-15 heteronuclear single quantum correlation and saturation-transfer difference NMR data suggest that calcium-free Ator exerts its effect through interaction with the (KLVF19)-K-16 binding site on the A beta peptide via its aromatic rings as well as hydroxyl and methyl groups. On the other hand, molecular dynamics simulations confirmed that the increasing concentration of Ator is necessary for the inhibition of the conformational transition of A beta from an alpha-helix-dominant to a beta-sheet-dominant structure.	[Nedaei, Hadi; Moosavi-Movahedi, Ali Akbar; Saboury, Ali Akbar] Univ Tehran, Inst Biochem & Biophys IBB, Dept Biophys, Tehran, Iran; [Rezaei-Ghaleh, Nasrollah; Giller, Karin; Becker, Stefan; Griesinger, Christian] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Rezaei-Ghaleh, Nasrollah] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Karami, Leila] Kharazmi Univ, Dept Cell & Mol Biol, Tehran, Iran	University of Tehran; Max Planck Society; Heinrich Heine University Dusseldorf; Kharazmi University	Saboury, AA (corresponding author), Univ Tehran, Inst Biochem & Biophys IBB, Dept Biophys, Tehran, Iran.; Griesinger, C (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	cigr@nmr.mpibpc.mpg.de; saboury@ut.ac.ir	Nedaei, Hadi/U-9929-2019	Saboury, Ali Akbar/0000-0003-0604-9465; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Becker, Stefan/0000-0003-2041-5740	University of Tehran; Deutsche Forschungsgemeinschaft (German Research Foundation) [RE 3655/2-1, RE 3655/2-3]	University of Tehran(University of Tehran); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	Financial support from the University of Tehran to H. N. is acknowledged. N. R.-G. acknowledges the Deutsche Forschungsgemeinschaft (German Research Foundation) for research grants RE 3655/2-1 and RE 3655/2-3.	Al-Edresi S, 2020, NEUROBIOL AGING, V94, P24, DOI 10.1016/j.neurobiolaging.2020.04.012; Armiento V, 2020, ANGEW CHEM INT EDIT, V59, P3372, DOI 10.1002/anie.201906908; Baghallab I, 2018, J ALZHEIMERS DIS, V66, P1235, DOI 10.3233/JAD-180582; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Biovia D.S., 2017, DISCOVERY STUDIO VIS, P936; Bu XL, 2016, MOL NEUROBIOL, V53, P3565, DOI 10.1007/s12035-015-9301-4; Busche MA, 2020, NAT NEUROSCI, V23, P1183, DOI 10.1038/s41593-020-0687-6; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Chuang E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.189928; Cibickova L, 2009, STEROIDS, V74, P13, DOI 10.1016/j.steroids.2008.08.007; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; Corrao G, 2013, ATHEROSCLEROSIS, V230, P171, DOI 10.1016/j.atherosclerosis.2013.07.009; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Curry H., 1944, Q APPL MATH, V2, P258, DOI [DOI 10.1090/QAM/10667, 10.1090/qam/10667]; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W.L., 2002, CCP4 NEWSLETTER PROC, V40, P82; Du WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07992; Du XG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0107-y; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fassbender K, 2002, NEUROLOGY, V59, P1257, DOI 10.1212/WNL.59.8.1257; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Galanakis PA, 2011, BIOPOLYMERS, V96, P316, DOI 10.1002/bip.21558; Geylis V, 2005, NEUROBIOL AGING, V26, P597, DOI 10.1016/j.neurobiolaging.2004.06.008; Giorgetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092677; Hernandez AM, 2018, EMBO MOL MED, V10, P32, DOI 10.15252/emmm.201707825; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; Huber CM, 2018, J ALZHEIMERS DIS, V61, P265, DOI 10.3233/JAD-170490; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung VWS, 2013, J ELECTROCHEM SOC, V160, pG3097, DOI 10.1149/2.014307jes; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Ji HF, 2008, ACTA PHARMACOL SIN, V29, P143, DOI 10.1111/j.1745-7254.2008.00752.x; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Jokar S, 2020, BIOORG CHEM, V102, DOI 10.1016/j.bioorg.2020.104050; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025; Kelly JW, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aax0914; Kueper JK, 2018, J ALZHEIMERS DIS, V63, P423, DOI 10.3233/JAD-170991; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kurata T, 2013, NEUROL RES, V35, P193, DOI 10.1179/1743132812Y.0000000127; Kurata T, 2011, BRAIN RES, V1371, P161, DOI 10.1016/j.brainres.2010.11.067; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lee JH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052341; Li G, 2013, J PHYS CHEM B, V117, P6603, DOI 10.1021/jp311350r; Lindahl E., 2020, GRO MACS 2019 6 MANU, DOI [10.5281/zenodo.3685925, DOI 10.5281/ZENODO.3685925]; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu FF, 2011, J PHYS CHEM B, V115, P11879, DOI 10.1021/jp202640b; Liu FF, 2009, J PHYS CHEM B, V113, P11320, DOI 10.1021/jp905580j; Lue LF, 2017, NEUROL THER, V6, pS25, DOI 10.1007/s40120-017-0074-8; Macke T. J., 2010, AMBERTOOLS USERS MAN; Martins WC, 2015, NEUROTOX RES, V28, P32, DOI 10.1007/s12640-015-9527-y; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Nath S, 2011, MOL CELL NEUROSCI, V46, P516, DOI 10.1016/j.mcn.2010.12.004; Nie Q, 2011, ACTA PHARMACOL SIN, V32, P545, DOI 10.1038/aps.2011.14; Niu Z, 2020, CHEMBIOCHEM, V21, P2495, DOI 10.1002/cbic.202000143; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Polyak BT., 1969, USSR COMP MATH MATH, V9, P94, DOI [10.1016/0041-5553(69)90035-4, DOI 10.1016/0041-5553(69)90035-4]; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Rajasekhar K, 2015, CHEM COMMUN, V51, P13434, DOI 10.1039/c5cc05264e; Rao PPN, 2015, CHEM BIOL DRUG DES, V86, P813, DOI 10.1111/cbdd.12552; Rezaei-Ghaleh N, 2011, BIOPHYS J, V101, P1202, DOI 10.1016/j.bpj.2011.06.062; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Rygiel K, 2016, INDIAN J PHARMACOL, V48, P629, DOI 10.4103/0253-7613.194867; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Sahoo BR, 2020, CHEM COMMUN, V56, P4627, DOI 10.1039/d0cc01551b; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Sarkar B., 2014, ANGEW CHEM INT EDIT, V126, P7008; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stellato F, 2017, BIOPHYS CHEM, V229, P110, DOI 10.1016/j.bpc.2017.05.005; Tanaka F, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115676; Tolar M, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00663-w; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Wang Q., 2015, ACS CHEM NEUROSCI, V4, P1004; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Xin SH, 2018, NEUROTOX RES, V34, P733, DOI 10.1007/s12640-018-9895-1; Xuan K, 2020, NEUROL SCI, V41, P1391, DOI 10.1007/s10072-020-04243-6; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yanagisawa D, 2015, NEUROBIOL AGING, V36, P201, DOI 10.1016/j.neurobiolaging.2014.07.041; Young LM, 2017, CURR OPIN CHEM BIOL, V39, P90, DOI 10.1016/j.cbpa.2017.06.008; Zhao LD, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0533-3	93	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101662	10.1016/j.jbc.2022.101662	http://dx.doi.org/10.1016/j.jbc.2022.101662			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35104501	gold, Green Published			2022-12-28	WOS:000794865600002
J	Tran, HNTL; McMahon, KR; Deuis, J; Vetter, II; Schroeder, C				Tran, Hue N. T. L.; McMahon, Kirsten R.; Deuis, Jennifer; Vetter, Irina I.; Schroeder, Christina			Structural and functional insights into the inhibition of human voltage-gated sodium channels by mu-conotoxin KIIIA disulfide isomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; CONUS-STRIATUS; NEUROPATHIC PAIN; BOND FORMATION; CYSTINE KNOT; NA-V; PEPTIDE; BLOCK; TOXINS; NA(V)1.7	mu-Conotoxins are components of cone snail venom, well-known for their analgesic activity through potent inhibition of voltage-gated sodium channel (Na-V) subtypes, including Na(V)1.7. These small, disulfide-rich peptides are typically stabilized by three disulfide bonds arranged in a 'native' CysI-CysIV, CysII-CysV, CysIII-CysVI pattern of disulfide connectivity. However, mu-conotoxin KIIIA, the smallest and most studied mu-conotoxin with inhibitory activity at Na(V)1.7, forms two distinct disulfide bond isomers during thermodynamic oxidative folding, including Isomer 1 (CysI-CysV, CysII-CysIV, CysIII-CysVI) and Isomer 2 (CysI-CysVI, CysII-CysIV, CysIII-CysV), but not the native mu-conotoxin arrangement. To date, there has been no study on the structure and activity of KIIIA comprising the native mu-conotoxin disulfide bond arrangement. Here, we evaluated the synthesis, potency, sodium channel subtype selectivity, and 3D structure of the three isomers of KIIIA. Using a regioselective disulfide bond-forming strategy, we synthetically produced the three mu-conotoxin KIIIA isomers displaying distinct bioactivity and Na-V subtype selectivity across human NaV channel subtypes 1.2, 1.4, and 1.7. We show that Isomer 1 inhibits NaV subtypes with a rank order of potency of Na(V)1.4 > 1.2 > 1.7 and Isomer 2 in the order of Na(V)1.4 approximate to 1.2 > 1.7, while the native isomer inhibited Na(V)1.4 > 1.7 approximate to 1.2. The three KIIIA isomers were further evaluated by NMR solution structure analysis and molecular docking with hNa(V)1.2. Our study highlights the importance of investigating alternate disulfide isomers, as disulfide connectivity affects not only the overall structure of the peptides but also the potency and subtype selectivity of mu-conotoxins targeting therapeutically relevant Na-V subtypes.	[Tran, Hue N. T. L.; McMahon, Kirsten R.; Vetter, Irina I.; Schroeder, Christina] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Vetter, Irina I.] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia; [Schroeder, Christina] NCI, Ctr Canc Res, NIH, Frederick, MD USA	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vetter, II; Schroeder, C (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.; Vetter, II (corresponding author), Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia.; Schroeder, C (corresponding author), NCI, Ctr Canc Res, NIH, Frederick, MD USA.	i.vetter@imb.uq.edu.au; christina.schroeder@nih.gov	Deuis, Jennifer/R-2440-2017; Schroeder, Christina/K-2042-2014	Deuis, Jennifer/0000-0002-5107-8938; Tran, Hue Ngoc Thi/0000-0001-5181-1899; Schroeder, Christina/0000-0002-6737-6374	Career Development Fellowship [APP1162503]; Australian Research Council (ARC) [FT160100055]; Australian Government Research Training Program Scholarships through the University of Queensland; Early Career Fellowship [APP1139961]	Career Development Fellowship; Australian Research Council (ARC)(Australian Research Council); Australian Government Research Training Program Scholarships through the University of Queensland(Australian Government); Early Career Fellowship	This work was funded by a Career Development Fellowship (APP1162503) awarded to I. V. andan Early Career Fellowship (APP1139961) awarded to J. R. D. C. I. S was an Australian Research Council (ARC) Future Fellow(FT160100055). Australian Government Research Training Program Scholarships supported H. N. T. T. and K. L. M. through the University of Queensland.	Agwa AJ, 2020, J BIOL CHEM, V295, P5067, DOI 10.1074/jbc.RA119.012281; Agwa AJ, 2018, BIOCONJUGATE CHEM, V29, P3309, DOI 10.1021/acs.bioconjchem.8b00505; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Barton ME, 2004, EPILEPSY RES, V59, P1, DOI 10.1016/j.eplepsyres.2003.12.010; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Boulegue C., 2007, CHEMINFORM, V38, P24; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Dekan Z, 2014, ANGEW CHEM INT EDIT, V53, P2931, DOI 10.1002/anie.201310103; Denis B, 2000, J PEPT SCI, V6, P372, DOI 10.1002/1099-1387(200008)6:8<372::AID-PSC264>3.3.CO;2-1; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Eliasen R, 2012, PEPTIDES, V37, P144, DOI 10.1016/j.peptides.2012.06.016; Gajewiak J, 2014, P NATL ACAD SCI USA, V111, P2758, DOI 10.1073/pnas.1324189111; Gali H, 2002, BIOCONJUGATE CHEM, V13, P224, DOI 10.1021/bc010062u; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; Green BR, 2014, FUTURE MED CHEM, V6, P1677, DOI [10.4155/fmc.14.107, 10.4155/FMC.14.107]; Hains BC, 2003, J NEUROSCI, V23, P8881; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Hoffmann T, 2018, PAIN, V159, P496, DOI 10.1097/j.pain.0000000000001119; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jin AH, 2017, ANGEW CHEM INT EDIT, V56, P14973, DOI 10.1002/anie.201708927; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; Knuhtsen A., 2020, PEPTIDE SCI, V113, P1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lehmann-Horn Frank, 2002, Curr Neurol Neurosci Rep, V2, P61, DOI 10.1007/s11910-002-0055-9; Markgraf R, 2012, BRIT J PHARMACOL, V167, P576, DOI 10.1111/j.1476-5381.2012.02004.x; Maxwell M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01333; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; McMahon KL, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100391; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namadurai S., 2015, BIOL OPEN, V5, P1; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pan XJ, 2019, SCIENCE, V363, P1309, DOI 10.1126/science.aaw2999; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Schroeder CI, 2008, J BIOL CHEM, V283, P21621, DOI 10.1074/jbc.M802852200; Schulz A, 2005, BIOPOLYMERS, V80, P34, DOI 10.1002/bip.20193; Seong B. L., 2001, BIOTECHNOL BIOPROC E, V6, P244; Sharpe IA, 2003, J BIOL CHEM, V278, P40317, DOI 10.1074/jbc.M213030200; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shon KJ, 1998, J NEUROSCI, V18, P4473; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Szabo I, 2007, BIOPOLYMERS, V88, P20, DOI 10.1002/bip.20616; Takahata T, 2003, LIFE SCI, V72, P2391, DOI 10.1016/S0024-3205(03)00121-8; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Tran HNT, 2020, BIOCONJUGATE CHEM, V31, P64, DOI 10.1021/acs.bioconjchem.9b00744; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Vetter I, 2012, BIOCHEM PHARMACOL, V84, P540, DOI 10.1016/j.bcp.2012.05.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Wu FZ, 2017, J ORG CHEM, V82, P3506, DOI 10.1021/acs.joc.6b03078; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2013, BRIT J PHARMACOL, V168, P1597, DOI 10.1111/bph.12051; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	96	1	1	7	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101728	10.1016/j.jbc.2022.101728	http://dx.doi.org/10.1016/j.jbc.2022.101728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35167877	Green Published, gold			2022-12-28	WOS:000789398100001
J	Lim, SY; Yamaguchi, K; Itakura, M; Chikazawa, M; Matsuda, T; Uchida, K				Lim, Sei-Young; Yamaguchi, Kosuke; Itakura, Masanori; Chikazawa, Miho; Matsuda, Tomonari; Uchida, Koji			Unique B-1 cells specific for both N-pyrrolated proteins and DNA evolve with apolipoprotein E deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-M ANTIBODIES; GLYCATION END-PRODUCTS; ANTI-DNA; B-CELLS; GENE UTILIZATION; SEQUENCE; MURINE; MICE; REPERTOIRES; CDR3	Lysine N-pyrrolation, a posttranslational modification, which converts lysine residues to N-epsilon-pyrrole-L-lysine, imparts electronegative properties to proteins, causing them to mimic DNA. Apolipoprotein E (apoE) has been identified as a soluble receptor for pyrrolated proteins (pyrP), and accelerated lysine N-pyrrolation has been observed in apoE-deficient (apoE(-/-)) hyperlipidemic mice. However, the impact of pyrP accumulation consequent to apoE deficiency on the innate immune response remains unclear. Here, we investigated B-1a cells known to produce germline-encoded immunoglobulin M (IgM) from mice deficient in apoE and identified a particular cell population that specifically produces IgM antibodies against pyrP and DNA. We demonstrated an expansion of B-1a cells involved in IgM production in the peritoneal cavity of apoE(-/-) mice compared with wild-type mice, consistent with a progressive increase of IgM response in the mouse sera. We found that pyrP exhibited preferential binding to B-1a cells and facilitated the production of IgM. B cell receptor analysis of pyrP-specific B-1a cells showed restricted usage of gene segments selected from the germline gene set; most sequences contained high levels of non-templated-nucleotide additions (N-additions) that could contribute to junctional diversity of B cell receptors. Finally, we report that a subset of monoclonal IgM antibodies against pyrP/DNA established from the apoE(-/-) mice also contained abundant N-additions. These results suggest that the accumulation of pyrP due to apoE deficiency may influence clonal diversity in the pyrP-specific B cell repertoire. The discovery of these unique B-1a cells for pyrP/DNA provides a key link connecting covalent protein modification, lipoprotein metabolism, and innate immunity.	[Lim, Sei-Young; Yamaguchi, Kosuke; Itakura, Masanori; Chikazawa, Miho; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), Japan Agcy Med Res & Dev, CREST, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp		Chikazawa, Miho/0000-0002-7447-8387	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported in part by a Grant-in-Aid for Scientific Research (S) (JP17H06170) (K. U.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (K. U.).	AHMED SA, 1989, J IMMUNOL, V142, P2647; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Bello-Gil D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01449; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Chikazawa M, 2020, J BIOL CHEM, V295, P7697, DOI 10.1074/jbc.RA120.013179; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EILAT D, 1988, J IMMUNOL, V141, P1745; Endo R, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100648; Feeney A J, 1992, Int Rev Immunol, V8, P113, DOI 10.3109/08830189209055567; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Frohlich J, 2015, ARCH PHARM, V348, P589, DOI 10.1002/ardp.201500114; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hara Y, 2013, ANAL CHIM ACTA, V793, P107, DOI 10.1016/j.aca.2013.07.024; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; HIDALGO FJ, 1995, CHEM PHYS LIPIDS, V77, P1; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Hirose S, 2019, J BIOL CHEM, V294, P11035, DOI 10.1074/jbc.RA118.006629; Holodick NE, 2014, J IMMUNOL, V192, P2432, DOI 10.4049/jimmunol.1300247; Huang CA, 1996, EUR J IMMUNOL, V26, P2537, DOI 10.1002/eji.1830261039; Hutchinson MA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.695220; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Jethwa HS, 2000, J IMMUNOL, V165, P3890, DOI 10.4049/jimmunol.165.7.3890; Kantor A B, 1996, Semin Immunol, V8, P29, DOI 10.1006/smim.1996.0005; Krishnan MR, 1998, SCAND J IMMUNOL, V48, P223; Krishnan MR, 1996, J IMMUNOL, V157, P2430; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Ma ZJ, 2008, CLIN IMMUNOL, V127, P168, DOI 10.1016/j.clim.2008.01.002; MARNETT LJ, 1980, CANCER RES, V40, P276; MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Prohaska TA, 2018, J IMMUNOL, V200, P1702, DOI 10.4049/jimmunol.1700568; REES MS, 1993, SYNTHETIC COMMUN, V23, P757, DOI 10.1080/00397919308009836; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Salomon RG, 1997, CHEM RES TOXICOL, V10, P536, DOI 10.1021/tx960157y; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsuji N, 2020, J IMMUNOL, V205, P741, DOI 10.4049/jimmunol.1901302; Wang YH, 2012, BIOCHEM BIOPH RES CO, V423, P805, DOI 10.1016/j.bbrc.2012.06.044; Wloch MK, 1997, J IMMUNOL, V158, P4500; Wloch MK, 1996, EUR J IMMUNOL, V26, P2225, DOI 10.1002/eji.1830260939; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0	63	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101582	10.1016/j.jbc.2022.101582	http://dx.doi.org/10.1016/j.jbc.2022.101582			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031322	gold, Green Published			2022-12-28	WOS:000761371500012
J	Zhou, YZ; Zheng, R; Liu, SX; Disoma, C; Du, A; Li, SQ; Chen, ZP; Dong, ZJ; Zhang, YX; Li, SJ; Liu, PJ; Razzaq, A; Chen, X; Liao, YJ; Tao, SY; Liu, YX; Xu, LN; Zhang, QJ; Peng, J; Deng, X; Li, SN; Jiang, TJ; Xia, ZX				Zhou, Yuzheng; Zheng, Rong; Liu, Sixu; Disoma, Cyrollah; Du, Ashuai; Li, Shiqin; Chen, Zongpeng; Dong, Zijun; Zhang, Yongxing; Li, Sijia; Liu, Pinjia; Razzaq, Aroona; Chen, Xuan; Liao, Yujie; Tao, Siyi; Liu, Yuxin; Xu, Lunan; Zhang, Qianjun; Peng, Jian; Deng, Xu; Li, Shanni; Jiang, Taijiao; Xia, Zanxian			Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PAPAIN-LIKE PROTEASE; SARS; APOPTOSIS; PATHOGENESIS; PNEUMONIA; TRANSMISSION; PROTEOLYSIS; EVOLUTION	With the outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), coronaviruses have begun to attract great attention across the world. Of the known human coronaviruses, however, Middle East respiratory syndrome coronavirus (MERS-CoV) is the most lethal. Coronavirus proteins can be divided into three groups: nonstructural proteins, structural proteins, and accessory proteins. While the number of each of these proteins varies greatly among different coronaviruses, accessory proteins are most closely related to the pathogenicity of the virus. We found for the first time that the ORF3 accessory protein of MERS-CoV, which closely resembles the ORF3a proteins of severe acute respiratory syndrome coronavirus and SARS-CoV-2, has the ability to induce apoptosis in cells in a dose-dependent manner. Through bioinformatics analysis and validation, we revealed that ORF3 is an unstable protein and has a shorter half-life in cells compared to that of severe acute respiratory syndrome coronavirus and SARS-CoV-2 ORF3a proteins. After screening, we identified a host E3 ligase, HUWE1, that specifically induces MERS-CoV ORF3 protein ubiquitination and degradation through the ubiquitin-proteasome system. This results in the diminished ability of ORF3 to induce apoptosis, which might partially explain the lower spread of MERS-CoV compared to other coronaviruses. In summary, this study reveals a pathological function of MERS-CoV ORF3 protein and identifies a potential host antiviral protein, HUWE1, with an ability to antagonize MERS-CoV pathogenesis by inducing ORF3 degradation, thus enriching our knowledge of the pathogenesis of MERS-CoV and suggesting new targets and strategies for clinical development of drugs for MERS-CoV treatment.	[Zhou, Yuzheng; Zheng, Rong; Liu, Sixu; Disoma, Cyrollah; Du, Ashuai; Li, Shiqin; Chen, Zongpeng; Zhang, Yongxing; Li, Sijia; Liu, Pinjia; Razzaq, Aroona; Chen, Xuan; Liao, Yujie; Tao, Siyi; Liu, Yuxin; Xu, Lunan; Li, Shanni; Xia, Zanxian] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Peoples R China; [Dong, Zijun] Hunan Normal Univ, Sch Med, Dept Basic Med, Changsha, Peoples R China; [Zhang, Qianjun] Cent South Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Peoples R China; [Peng, Jian] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China; [Deng, Xu] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China; [Jiang, Taijiao] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China; [Xia, Zanxian] Cent South Univ, Hunan Key Lab Med Genet, Hunan Key Lab Anim Models Human Dis, Sch Life Sci, Changsha, Peoples R China; [Xia, Zanxian] Cent South Univ, Ctr Med Genet, Sch Life Sci, Changsha, Peoples R China	Central South University; Hunan Normal University; Central South University; Central South University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University; Central South University	Xia, ZX (corresponding author), Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Peoples R China.; Xia, ZX (corresponding author), Cent South Univ, Hunan Key Lab Med Genet, Hunan Key Lab Anim Models Human Dis, Sch Life Sci, Changsha, Peoples R China.; Xia, ZX (corresponding author), Cent South Univ, Ctr Med Genet, Sch Life Sci, Changsha, Peoples R China.	xiazanxian@sklmg.edu.cn	Disoma, Cyrollah/ABC-7475-2020	Disoma, Cyrollah/0000-0002-7916-6606	National Key Research and Development Program of China [2021YFC2300103, 2016YFD0500300]; National Natural Science Foundation of China [U21A20384, 82072293]; Key Research and Development Program of Hunan Province [2020SK2054]; Zhejiang University special scientific research fund for COVID-19 prevention and control [2020XGZX033]; Changsha special scientific research fund for COVID-19 prevention and control [kq2001030]; Central South University Graduate Research Innovation Project [2018zzts387]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Hunan Province; Zhejiang University special scientific research fund for COVID-19 prevention and control; Changsha special scientific research fund for COVID-19 prevention and control; Central South University Graduate Research Innovation Project	This work was supported by the National Key Research and Development Program of China (2021YFC2300103 and 2016YFD0500300), the National Natural Science Foundation of China (U21A20384 and 82072293), the Key Research and Development Program of Hunan Province (2020SK2054), Zhejiang University special scientific research fund for COVID-19 prevention and control (2020XGZX033), Changsha special scientific research fund for COVID-19 prevention and control (kq2001030), and the Central South University Graduate Research Innovation Project (2018zzts387).	Aleidi SM, 2015, J BIOL CHEM, V290, P24604, DOI 10.1074/jbc.M115.675579; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bose R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17902-0; Burslem GM, 2020, CELL, V181, P102, DOI 10.1016/j.cell.2019.11.031; Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093; Chan CM, 2009, INT J BIOCHEM CELL B, V41, P2232, DOI 10.1016/j.biocel.2009.04.019; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111; Chu H, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8577; COLLINS M, 1995, AM J RESP CRIT CARE, V152, pS20, DOI 10.1164/ajrccm/152.4_Pt_2.S20; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; de Wispelaere M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11429-w; Dominguez Andres Ana, 2020, bioRxiv, DOI 10.1101/2020.08.18.256776; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fernandes MHV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00363; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Garant KA, 2016, ONCOGENE, V35, P771, DOI 10.1038/onc.2015.136; Guan W. J., 2020, N ENGL; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Guo Y, 2020, J CLIN INVEST, V130, P6301, DOI 10.1172/JCI138234; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jensen SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02697; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Karuppannan AK, 2011, VIROLOGY, V410, P248, DOI 10.1016/j.virol.2010.11.009; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Le TM, 2007, FEBS J, V274, P4211, DOI 10.1111/j.1742-4658.2007.05947.x; Leung A, 2018, GENOME RES, V28, P1791, DOI 10.1101/gr.233585.117; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matthews KL, 2014, J GEN VIROL, V95, P874, DOI 10.1099/vir.0.062059-0; Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17; Michel CJ, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01402-1; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Oh SJ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030530; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264; Ren YJ, 2020, CELL MOL IMMUNOL, V17, P881, DOI 10.1038/s41423-020-0485-9; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Singh S, 2021, PHARMACOL THERAPEUT, V224, DOI 10.1016/j.pharmthera.2021.107809; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Strappazzon F, 2020, CELL DEATH DIFFER, V27, P1155, DOI 10.1038/s41418-019-0404-8; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Sui LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662989; Sun XY, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0101-6; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; Tao XR, 2013, J VIROL, V87, P9953, DOI 10.1128/JVI.01562-13; Tsoi H, 2014, BIOCHEM J, V464, P439, DOI 10.1042/BJ20131461; Verma R, 2020, MOL CELL, V77, P446, DOI 10.1016/j.molcel.2020.01.010; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; Wong HH, 2018, VIROLOGY, V515, P165, DOI 10.1016/j.virol.2017.12.028; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Yamamoto SP, 2011, MICROBES INFECT, V13, P339, DOI 10.1016/j.micinf.2010.12.002; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17554; Yang Y, 2013, PROTEIN CELL, V4, P951, DOI 10.1007/s13238-013-3096-8; Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]; Yu X, 2015, BIOCHEM BIOPH RES CO, V459, P270, DOI 10.1016/j.bbrc.2015.02.097; Yu Y., 2020, LANCET RESP MED, V8, P481; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17796-z; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	84	2	2	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101584	10.1016/j.jbc.2022.101584	http://dx.doi.org/10.1016/j.jbc.2022.101584			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1JE	35032548	gold, Green Published			2022-12-28	WOS:000761380200001
J	Schor, S; Pu, SY; Nicolaescu, V; Azari, S; Koivomagi, M; Karim, M; Cassonnet, P; Saul, S; Neveu, G; Yueh, AD; Demeret, C; Skotheim, JM; Jacob, Y; Randall, G; Einav, S				Schor, Stanford; Pu, Szuyuan; Nicolaescu, Vlad; Azari, Siavash; Koivomagi, Mardo; Karim, Marwah; Cassonnet, Patricia; Saul, Sirle; Neveu, Gregory; Yueh, Andrew; Demeret, Caroline; Skotheim, Jan M.; Jacob, Yves; Randall, Glenn; Einav, Shirit			The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; CLATHRIN; GENOME; EPSINR; IDENTIFICATION; REPLICATION; TRAFFICKING; REGULATOR; SECRETION; COMPLEXES	The signaling pathways and cellular functions regulated by the four Numb-associated kinases are largely unknown. We reported that AAK1 and GAK control intracellular trafficking of RNA viruses and revealed a requirement for BIKE in early and late stages of dengue virus (DENV) infection. However, the downstream targets phosphorylated by BIKE have not yet been identified. Here, to identify BIKE substrates, we conducted a barcode fusion genetics-yeast two-hybrid screen and retrieved publicly available data generated via affinity-purification mass spectrometry. We subsequently validated 19 of 47 putative BIKE interactors using mammalian cell-based protein-protein interaction assays. We found that CLINT1, a cargo-specific adapter implicated in bidirectional Golgi-to-endosome trafficking, emerged as a predominant hit in both screens. Our experiments indicated that BIKE catalyzes phosphorylation of a threonine 294 CLINT1 residue both in vitro and in cell culture. Our findings revealed that CLINT1 phosphorylation mediates its binding to the DENV nonstructural 3 protein and subsequently promotes DENV assembly and egress. Additionally, using live-cell imaging we revealed that CLINT1 cotraffics with DENV particles and is involved in mediating BIKE's role in DENV infection. Finally, our data suggest that additional cellular BIKE interactors implicated in the host immune and stress responses and the ubiquitin proteasome system might also be candidate phosphorylation substrates of BIKE. In conclusion, these findings reveal cellular substrates and pathways regulated by the understudied Numb-associated kinase enzyme BIKE, a mechanism for CLINT1 regulation, and control of DENV infection via BIKE signaling, with potential implications for cell biology, virology, and host-targeted antiviral design.	[Schor, Stanford; Pu, Szuyuan; Azari, Siavash; Karim, Marwah; Saul, Sirle; Neveu, Gregory; Einav, Shirit] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Nicolaescu, Vlad; Randall, Glenn] Univ Chicago, Dept Microbiol, Chicago, IL USA; [Koivomagi, Mardo; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA USA; [Cassonnet, Patricia; Demeret, Caroline; Jacob, Yves] Pasteur Inst, Natl Ctr Sci Res, Dept Virol, Mol Genet RNA Virus Genet GMVR, Paris, France; [Yueh, Andrew] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Einav, Shirit] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Schor, Stanford; Pu, Szuyuan; Azari, Siavash; Karim, Marwah; Saul, Sirle; Neveu, Gregory; Einav, Shirit] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Cassonnet, Patricia; Demeret, Caroline; Jacob, Yves] Paris Diderot Univ, Paris, France	Stanford University; University of Chicago; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Health Research Institutes - Taiwan; Stanford University; UDICE-French Research Universities; Universite Paris Cite	Einav, S (corresponding author), Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.; Einav, S (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Einav, S (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	seinav@stanford.edu	Azari, Siavash/AHE-4003-2022; Skotheim, Jan/C-3238-2015	Azari, Siavash/0000-0002-6787-279X; Neveu, Gregory/0000-0002-2363-6031; Karim, Marwah/0000-0003-0990-3962; Koivomagi, Mardo/0000-0003-4691-6930; Skotheim, Jan/0000-0001-8420-6820	Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States [W81XWH2110456]; National Institute of Allergy and Infectious Diseases (NIAID), United States [R01AI137514]; Stanford SPARK program; Child Health Research Institute, United States; Lucile Packard Foundation for Children's Health; Stanford CTSA, United States [UL1 TR000093]; PhRMA Foundation Postdoctoral Fellowship in Translational Medicine; NIH, United States [P30 CA124435]	Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States; National Institute of Allergy and Infectious Diseases (NIAID), United States; Stanford SPARK program; Child Health Research Institute, United States; Lucile Packard Foundation for Children's Health; Stanford CTSA, United States; PhRMA Foundation Postdoctoral Fellowship in Translational Medicine; NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by award number W81XWH2110456 and W81XWH2110456 from the Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States, award number R01AI137514 from the National Institute of Allergy and Infectious Diseases (NIAID), United States, and grants from the Stanford SPARK program to S. E. or G. R. S. P. was supported by the Child Health Research Institute, United States, Lucile Packard Foundation for Children's Health, as well as the Stanford CTSA, United States (grant number UL1 TR000093). M.K was supported by a PhRMA Foundation Postdoctoral Fellowship in Translational Medicine. This work was also supported in part by NIH, United States P30 CA124435 utilizing the Stanford Cancer Institute, United States Proteomics/Mass Spectrometry Shared Resource. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, National Institutes of Health, or the other funders. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Ayala-Nunez NV, 2011, METHODS, V55, P137, DOI 10.1016/j.ymeth.2011.07.009; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BOUT A, 1989, CYTOGENET CELL GENET, V52, P147, DOI 10.1159/000132865; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Choudhury R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4078; Clague MJ, 2017, FEBS J, V284, P1753, DOI 10.1111/febs.14007; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Escamilla M, 2008, SCHIZOPHR RES, V106, P253, DOI 10.1016/j.schres.2008.09.005; Eyre NS, 2017, J VIROL, V91, DOI 10.1128/JVI.01455-17; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Fognani C, 2002, NUCLEIC ACIDS RES, V30, P2043, DOI 10.1093/nar/30.9.2043; Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16; Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; In JG, 2014, BIOCHEM J, V463, P201, DOI 10.1042/BJ20140468; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kearns AE, 2001, J BIOL CHEM, V276, P42213, DOI 10.1074/jbc.M106163200; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Krieger JR, 2013, MOL CELL PROTEOMICS, V12, P499, DOI 10.1074/mcp.M112.020768; Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579; Lee MH, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.4; Lin Z, 2014, J VIROL, V88, P11872, DOI 10.1128/JVI.01867-14; Liu HP, 2009, J CLIN LAB ANAL, V23, P362, DOI 10.1002/jcla.20344; Lopez-Coral A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31426-1; Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mercado-Matos J, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00590-17; Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8; Cuartas-Lopez AM, 2018, VIRUS RES, V256, P153, DOI 10.1016/j.virusres.2018.08.013; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Nagy Zoltan, 2018, Curr Protoc Protein Sci, V93, pe64, DOI 10.1002/cpps.64; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Neveu G, 2015, J VIROL, V89, P4387, DOI 10.1128/JVI.02705-14; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; Progida C, 2016, J CELL SCI, V129, P3971, DOI 10.1242/jcs.185702; Pu SY, 2018, J MED CHEM, V61, P6178, DOI 10.1021/acs.jmedchem.8b00613; Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10; Pu SY, 2020, ANTIVIR RES, V184, DOI 10.1016/j.antiviral.2020.104966; Ramamurthy Narayan, 2016, Wellcome Open Res, V1, P17, DOI 10.12688/wellcomeopenres.9917.1; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson M, 2018, CELL MOL LIFE SCI, V75, P3693, DOI 10.1007/s00018-018-2882-0; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Sordillo JE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-158; Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x; Sorrell FJ, 2016, STRUCTURE, V24, P401, DOI 10.1016/j.str.2015.12.015; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Verdonck S, 2019, J MED CHEM, V62, P5810, DOI 10.1021/acs.jmedchem.9b00136; Vincentelli R, 2015, NAT METHODS, V12, P787, DOI [10.1038/nmeth.3438, 10.1038/NMETH.3438]; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Xiao F, 2018, MBIO, V9, DOI 10.1128/mBio.02233-17; Yachie N, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156660; Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001; Yang CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060873; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001	84	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101956	10.1016/j.jbc.2022.101956	http://dx.doi.org/10.1016/j.jbc.2022.101956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452674	Green Published, gold			2022-12-28	WOS:000807750700008
J	Yan, KZ; Stanley, M; Kowalski, B; Raimi, OG; Ferenbach, AT; Wei, PZ; Fang, WX; van Aalten, DMF				Yan, Kaizhou; Stanley, Mathew; Kowalski, Bartosz; Raimi, Olawale G.; Ferenbach, Andrew T.; Wei, Pingzhen; Fang, Wenxia; van Aalten, Daan M. F.			Genetic validation of Aspergillus fumigatus phosphoglucomutase as a viable therapeutic target in invasive aspergillosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL CELL-WALL; RABBIT MUSCLE PHOSPHOGLUCOMUTASE; PSEUDOMONAS-AERUGINOSA; STRUCTURAL INSIGHTS; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; VIRULENCE FACTOR; SWISS-MODEL; CONGO RED; ENZYME	Aspergillus fumigatus is the causative agent of invasive aspergillosis, an infection with mortality rates of up to 50%. The glucan-rich cell wall of A. fumigatus is a protective structure that is absent from human cells and is a potential target for antifungal treatments. Glucan is synthesized from the donor uridine diphosphate glucose, with the conversion of glucose-6-phosphate to glucose-1-phosphate by the enzyme phosphoglucomutase (PGM) representing a key step in its biosynthesis. Here, we explore the possibility of selectively targeting A. fumigatus PGM (AfPGM) as an antifungal treatment strategy. Using a promoter replacement strategy, we constructed a conditional pgm mutant and revealed that pgm is required for A. fumigatus growth and cell wall integrity. In addition, using a fragment screen, we identified the thiolreactive compound isothiazolone fragment of PGM as targeting a cysteine residue not conserved in the human ortholog. Furthermore, through scaffold exploration, we synthesized a para-aryl derivative (ISFP10) and demonstrated that it inhibits AfPGM with an IC50 of 2 mu M and exhibits 50-fold selectivity over the human enzyme. Taken together, our data provide genetic validation of PGM as a therapeutic target and suggest new avenues for inhibiting AfPGM using covalent inhibitors that could serve as tools for chemical validation.	[Yan, Kaizhou; Stanley, Mathew; Kowalski, Bartosz; Raimi, Olawale G.; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland; [Wei, Pingzhen; Fang, Wenxia] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China	University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.	dmfvanaalten@dundee.ac.uk		Fang, Wenxia/0000-0001-8055-2072; Raimi, Olawale G./0000-0003-2782-7318; van Aalten, Daan/0000-0002-1499-6908	MRC Programme Grant [V001094]; Wellcome Trust [200208]; China Scholarship Council; National Natural Science Foundation of China [31960032]	MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by an MRC Programme Grant (V001094) and a Wellcome Trust Collaborative Award (200208) to D. M. F. v. A. and K. Y. was funded by the China Scholarship Council. W. F. was supported by National Natural Science Foundation of China (31960032).	Abdul-Hay SO, 2015, ACS CHEM BIOL, V10, P2716, DOI 10.1021/acschembio.5b00334; Abranyi-Balogh P, 2018, EUR J MED CHEM, V160, P94, DOI 10.1016/j.ejmech.2018.10.010; Adibpour N, 2007, FOLIA MICROBIOL, V52, P573, DOI 10.1007/BF02932185; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; Alam MK, 2013, BOTANY, V91, P467, DOI 10.1139/cjb-2012-0270; Alanio A., 2020, SSRNELECTRON J, DOI [10.2139/ssrn.3575581, DOI 10.2139/SSRN.3575581]; Amano Y, 2015, ACTA CRYSTALLOGR D, V71, P1879, DOI 10.1107/S1399004715013048; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Antinori S, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101752; Aruanno M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00399-19; Ashu EE, 2018, INFECT DRUG RESIST, V11, P1549, DOI 10.2147/IDR.S170952; Awoonor-Williams E, 2016, J CHEM THEORY COMPUT, V12, P4662, DOI 10.1021/acs.jctc.6b00631; Backe PH., 2020, SCI REP-UK, V10, P1; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2015, ACS MED CHEM LETT, V6, P229, DOI 10.1021/acsmedchemlett.5b00032; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Beauvais A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003716; BEHRENS NH, 1970, P NATL ACAD SCI USA, V66, P153, DOI 10.1073/pnas.66.1.153; BELLAMY FD, 1984, TETRAHEDRON LETT, V25, P839, DOI 10.1016/S0040-4039(01)80041-1; BENZVI R, 1961, J BIOL CHEM, V236, P2186; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; BLACK CB, 1994, COORDIN CHEM REV, V135, P165, DOI 10.1016/0010-8545(94)80068-5; BOLES E, 1994, EUR J BIOCHEM, V220, P83, DOI 10.1111/j.1432-1033.1994.tb18601.x; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Bras NF, 2018, CHEM-EUR J, V24, P1978, DOI 10.1002/chem.201705090; Bravo Y, 2014, BIOORG MED CHEM LETT, V24, P4308, DOI 10.1016/j.bmcl.2014.07.013; BRITTON HG, 1968, BIOCHEM J, V110, P161, DOI 10.1042/bj1100161; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Burger M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69246-x; Cao W, 2009, J GEN APPL MICROBIOL, V55, P381, DOI 10.2323/jgam.55.381; CARDINI CE, 1949, ARCH BIOCHEM, V22, P87; CHAKRABARTI AC, 1992, BIOCHIM BIOPHYS ACTA, V1111, P171, DOI 10.1016/0005-2736(92)90308-9; Chen MY, 2019, J ORG CHEM, V84, P13194, DOI 10.1021/acs.joc.9b01872; Chen YH, 2016, J MED CHEM, V59, P9906, DOI 10.1021/acs.jmedchem.6b01280; Chihara Y, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00770-19; Chuang GY, 2010, PROTEIN SCI, V19, P1662, DOI 10.1002/pro.446; COLLIER PJ, 1990, J APPL BACTERIOL, V69, P578, DOI 10.1111/j.1365-2672.1990.tb01551.x; Cooper IR, 2016, BIOORG MED CHEM LETT, V26, P4179, DOI 10.1016/j.bmcl.2016.07.061; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; Davis MR, 2020, MED MYCOL, V58, P579, DOI 10.1093/mmy/myz083; Dekker FJ, 2009, BIOORGAN MED CHEM, V17, P460, DOI 10.1016/j.bmc.2008.12.008; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; DEVOS R, 1994, EUR J BIOCHEM, V225, P635, DOI 10.1111/j.1432-1033.1994.00635.x; Dhingra S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00092; Dichtl K, 2015, MOL MICROBIOL, V95, P458, DOI 10.1111/mmi.12877; du Pre S, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00231-18;e00231-18, 10.1128/AAC.00231-18]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG WK, 1994, GENE, V151, P61, DOI 10.1016/0378-1119(94)90633-5; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Furdas SD, 2014, MEDCHEMCOMM, V5, P1856, DOI 10.1039/c4md00245h; Gardiner RE, 2005, MED MYCOL, V43, pS299, DOI 10.1080/13693780400029023; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Georgopapadakou Nafsika H., 1995, Trends in Microbiology, V3, P98, DOI 10.1016/S0966-842X(00)88890-3; Ghizzoni M, 2009, EUR J MED CHEM, V44, P4855, DOI 10.1016/j.ejmech.2009.07.025; Gonzalez-Rosende ME, 2017, ORG BIOMOL CHEM, V15, P1484, DOI 10.1039/c6ob02618d; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Goto L. S., 2016, BBA-PROTEINS PROTEOM, V1864, pI1658; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Haritha CV, 2020, INT J SURG, V84, P53, DOI 10.1016/j.ijsu.2020.10.018; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Hayakawa N, 1999, BIOCHEMISTRY-US, V38, P11501, DOI 10.1021/bi982829k; Head MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004129; HEARN VM, 1994, MICROBIOL-UK, V140, P789, DOI 10.1099/00221287-140-4-789; Herman A, 2019, J EUR ACAD DERMATOL, V33, P267, DOI 10.1111/jdv.15267; HOFMANN M, 1994, EUR J BIOCHEM, V221, P741, DOI 10.1111/j.1432-1033.1994.tb18787.x; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Hu YR, 2018, APPL MICROBIOL BIOT, V102, P1911, DOI 10.1007/s00253-017-8730-6; Huang WK, 2013, BIOINFORMATICS, V29, P2357, DOI 10.1093/bioinformatics/btt399; HUNZIKER N, 1992, DERMATOLOGY, V184, P85, DOI 10.1159/000247509; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Janout V, 2015, BIOCONJUGATE CHEM, V26, P2021, DOI 10.1021/acs.bioconjchem.5b00463; Jimenez-Ortigosa C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01277-17, 10.1128/aac.01277-17]; Jin Cheng, 2012, Int J Microbiol, V2012, P654251, DOI 10.1155/2012/654251; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jolly L, 2000, J BACTERIOL, V182, P1280, DOI 10.1128/JB.182.5.1280-1285.2000; Joseph-McCarthy D, 2014, J CHEM INF MODEL, V54, P693, DOI 10.1021/ci400731w; Kaji Y, 2009, GRAEF ARCH CLIN EXP, V247, P549, DOI 10.1007/s00417-008-1003-4; KANG MS, 1986, P NATL ACAD SCI USA, V83, P5808, DOI 10.1073/pnas.83.16.5808; Khalaj A, 2004, EUR J MED CHEM, V39, P699, DOI 10.1016/j.ejmech.2004.04.004; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; King AR, 2009, BRIT J PHARMACOL, V157, P974, DOI 10.1111/j.1476-5381.2009.00276.x; Koehler P, 2020, MYCOSES, V63, P528, DOI 10.1111/myc.13096; Komachi Y, 2013, MOL MICROBIOL, V90, P1054, DOI 10.1111/mmi.12416; Konigsberg W, 1972, Methods Enzymol, V25, P185, DOI 10.1016/S0076-6879(72)25015-7; KOPECKA M, 1992, ARCH MICROBIOL, V158, P115, DOI 10.1007/BF00245214; L'Enfant M, 2015, INT J BIOL MACROMOL, V81, P681, DOI 10.1016/j.ijbiomac.2015.08.066; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Langfelder K, 2002, CURR GENET, V41, P268, DOI 10.1007/s00294-002-0313-z; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Lee Y, 2017, DATA BRIEF, V10, P398, DOI 10.1016/j.dib.2016.12.017; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Letscher-Bru V, 2003, J ANTIMICROB CHEMOTH, V51, P513, DOI 10.1093/jac/dkg117; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu YW, 1997, ACTA CRYSTALLOGR D, V53, P392, DOI 10.1107/S0907444997000875; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Luebbering EK, 2012, J MOL BIOL, V423, P831, DOI 10.1016/j.jmb.2012.08.013; Lynch Eric, 2009, Seminars in Hearing, V30, P47, DOI 10.1055/s-0028-1111106; Magdaleno-Tapial J, 2020, CONTACT DERMATITIS, V82, P83, DOI 10.1111/cod.13396; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; Menichetti R, 2019, ACS CENTRAL SCI, V5, P290, DOI 10.1021/acscentsci.8b00718; MOL PC, 1994, J BIOL CHEM, V269, P31267; Morley JO, 2007, INT J CHEM KINET, V39, P254, DOI 10.1002/kin.20235; Mouyna I, 2004, FEMS MICROBIOL LETT, V237, P317, DOI 10.1016/j.femsle.2004.06.048; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; NAJJAR VA, 1954, SCIENCE, V119, P631, DOI 10.1126/science.119.3097.631; Naught LE, 2005, BIOCHEMISTRY-US, V44, P6831, DOI 10.1021/bi0501380; Naught LE, 2003, BIOCHEMISTRY-US, V42, P9946, DOI 10.1021/bi034673g; Naught LE, 2001, ARCH BIOCHEM BIOPHYS, V396, P111, DOI 10.1006/abbi.2001.2618; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nivoix Y, 2009, CURR DRUG METAB, V10, P395, DOI 10.2174/138920009788499012; Pasupneti S, 2017, MED MYCOL, V55, P96, DOI 10.1093/mmy/myw121; PERCIVAL MD, 1992, BIOCHEMISTRY-US, V31, P505, DOI 10.1021/bi00117a029; Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46; Prakash O, 2019, MOLECULES, V24, DOI 10.3390/molecules24050996; Raimi OG, 2018, BIOCHEM J, V475, P2547, DOI 10.1042/BCJ20180172; RAMADAS K, 1992, SYNTHETIC COMMUN, V22, P3189, DOI 10.1080/00397919208021132; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Regni C, 2002, STRUCTURE, V10, P269, DOI 10.1016/S0969-2126(02)00705-0; Regni C, 2006, ACTA CRYSTALLOGR F, V62, P722, DOI 10.1107/S1744309106025887; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Renson M., 1982, Patent No. [281,876, 281876]; Resnick E, 2019, J AM CHEM SOC, V141, P8951, DOI 10.1021/jacs.9b02822; Robinet P, 2014, J IMMUNOL, V192, P5332, DOI 10.4049/jimmunol.1303180; Rocha EMF, 2007, ANTIMICROB AGENTS CH, V51, P4174, DOI 10.1128/AAC.00917-07; Romero B, 2003, FUNGAL GENET BIOL, V40, P103, DOI 10.1016/S1087-1845(03)00090-2; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Rutkowska-Zbik D, 2013, J MOL MODEL, V19, P4661, DOI 10.1007/s00894-012-1459-3; Sakita KM, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.684525; Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1; Schramm AM, 2008, BIOCHEMISTRY-US, V47, P9154, DOI 10.1021/bi8005219; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; SHEMATEK EM, 1980, J BIOL CHEM, V255, P895; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sies H, 2020, FREE RADICAL BIO MED, V156, P107, DOI 10.1016/j.freeradbiomed.2020.06.032; Silva V, 2020, MOLECULES, V25, DOI 10.3390/molecules25040991; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Smaoui S, 2012, BIOCONTROL SCI, V17, P135, DOI 10.4265/bio.17.135; Song K, 2017, J CHEM INF MODEL, V57, P2358, DOI 10.1021/acs.jcim.7b00014; Steinbach WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003642; Stiers KM, 2018, STRUCTURE, V26, P1337, DOI 10.1016/j.str.2018.07.005; Stiers KM, 2016, J MOL BIOL, V428, P1493, DOI 10.1016/j.jmb.2016.02.032; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; SUTHERLAND EW, 1949, J BIOL CHEM, V180, P1285; Trevillyan JM, 1999, ARCH BIOCHEM BIOPHYS, V364, P19, DOI 10.1006/abbi.1999.1099; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van de Veerdonk FL, 2017, NAT REV MICROBIOL, V15, P661, DOI 10.1038/nrmicro.2017.90; Vasan M, 2010, CHEMMEDCHEM, V5, P2079, DOI 10.1002/cmdc.201000275; Verweij PE, 2020, LANCET MICROBE, V1, pE53, DOI 10.1016/S2666-5247(20)30027-6; Vicini P, 2002, EUR J MED CHEM, V37, P553, DOI 10.1016/S0223-5234(02)01378-8; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wang SQ, 2019, ADV SYNTH CATAL, V361, P1459, DOI 10.1002/adsc.201801579; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Wartchow CA, 2011, J COMPUT AID MOL DES, V25, P669, DOI 10.1007/s10822-011-9439-8; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Waugh B, 2016, BIOCHIMIE, V121, P102, DOI 10.1016/j.biochi.2015.11.015; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Williams T. M., 2004, NACE INTER, P1; Wisastra R, 2011, ORG BIOMOL CHEM, V9, P1817, DOI 10.1039/c0ob00464b; Wyatt PG, 2011, CURR TOP MED CHEM, V11, P1275; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yang Nicole J, 2015, Methods Mol Biol, V1266, P29, DOI 10.1007/978-1-4939-2272-7_3; Zhu JS, 2019, J ORG CHEM, V84, P9627, DOI 10.1021/acs.joc.9b01305; Zhu JS, 2019, ACS OMEGA, V4, P7029, DOI 10.1021/acsomega.9b00008; Zmeili OS, 2007, QJM-INT J MED, V100, P317, DOI 10.1093/qjmed/hcm035	188	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102003	10.1016/j.jbc.2022.102003	http://dx.doi.org/10.1016/j.jbc.2022.102003			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35504355	gold, Green Published			2022-12-28	WOS:000811813400014
J	Cerqueira, FM; Photenhauer, AL; Doden, HL; Brown, AN; Abdel-Hamid, AM; Morais, S; Bayer, EA; Wawrzak, Z; Cann, I; Ridlon, JM; Hopkins, JB; Koropatkin, NM				Cerqueira, Filipe M.; Photenhauer, Amanda L.; Doden, Heidi L.; Brown, Aric N.; Abdel-Hamid, Ahmed M.; Morais, Sarah; Bayer, Edward A.; Wawrzak, Zdzislaw; Cann, Isaac; Ridlon, Jason M.; Hopkins, Jesse B.; Koropatkin, Nicole M.			Sas20 is a highly flexible starch-binding protein in the Ruminococcus bromii cell-surface amylosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT SYMBIONT; X-RAY-DIFFRACTION; CLOSTRIDIUM-THERMOCELLUM; AFFINITY ELECTROPHORESIS; SECONDARY STRUCTURE; RESISTANT STARCH; STRUCTURAL BASIS; PREDICTION; MODULES; AMYLASE	Ruminococcus bromii is a keystone species in the human gut that has the rare ability to degrade dietary resistant starch (RS). This bacterium secretes a suite of starch-active proteins that work together within larger complexes called amylosomes that allow R. bromii to bind and degrade RS. Starch adherence system protein 20 (Sas20) is one of the more abundant proteins assembled within amylosomes, but little could be predicted about its molecular features based on amino acid sequence. Here, we performed a structure-function analysis of Sas20 and determined that it features two discrete starch-binding domains separated by a flexible linker. We show that Sas20 domain 1 contains an N-terminal beta-sandwich followed by a cluster of alpha-helices, and the nonreducing end of maltooligosaccharides can be captured between these structural features. Furthermore, the crystal structure of a close homolog of Sas20 domain 2 revealed a unique bilobed starch-binding groove that targets the helical alpha 1,4-linked glycan chains found in amorphous regions of amylopectin and crystalline regions of amylose. Affinity PAGE and isothermal titration calorimetry demonstrated that both domains bind maltoheptaose and soluble starch with relatively high affinity (K-d <= 20 mu M) but exhibit limited or no binding to cyclodextrins. Finally, small-angle Xray scattering analysis of the individual and combined domains support that these structures are highly flexible, which may allow the protein to adopt conformations that enhance its starch-targeting efficiency. Taken together, we conclude that Sas20 binds distinct features within the starch granule, facilitating the ability of R. bromii to hydrolyze dietary RS.	[Cerqueira, Filipe M.; Photenhauer, Amanda L.; Brown, Aric N.; Koropatkin, Nicole M.] Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Doden, Heidi L.; Abdel-Hamid, Ahmed M.; Cann, Isaac; Ridlon, Jason M.] Univ Illinois, Dept Anim Sci, Champaign, IL USA; [Doden, Heidi L.; Abdel-Hamid, Ahmed M.; Cann, Isaac; Ridlon, Jason M.] Univ Illinois, Carl R Woese Inst Genom Biol Microbiome Metab Engn, Champaign, IL USA; [Morais, Sarah; Bayer, Edward A.] Bengur Univ Negev, Fac Nat Sci, Life Sci, Beer Sheva, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Lemont, IL USA; [Hopkins, Jesse B.] IIT, Argonne Natl Lab, Biophys Collaborat Access Team, Adv Photon Source, Lemont, IL USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ben Gurion University; Weizmann Institute of Science; Northwestern University; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory	Koropatkin, NM (corresponding author), Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	nkoropat@umich.edu	Abdel-Hamid, Ahmed M/GRE-9409-2022	Photenhauer, Amanda/0000-0002-1553-4772; Brown, Aric/0000-0003-1455-4736; Cerqueira, Filipe/0000-0003-4438-7959; Doden, Heidi/0000-0002-9282-5645	National Institutes of Health Training Program in Translational Research [T32-GM113900]; Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research National Research [F31-GM137488]; Microbiome Metabolic Engineering Theme of the Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana Champaign; Research Program Project Grant [P01-HL149633]	National Institutes of Health Training Program in Translational Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research National Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microbiome Metabolic Engineering Theme of the Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana Champaign; Research Program Project Grant	This work is supported by the National Institutes of Health Training Program in Translational Research (grant no.: T32-GM113900 [to F. M. C.] ) , Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research National Research (grant no.: F31-GM137488 [to F. M. C.] ) , and a Research Program Project Grant (grant no.: P01-HL149633 [to N. M. K.] ) . This work was also funded in part from the Microbiome Metabolic Engineering Theme of the Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana Champaign (to I. C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; Atwood J. L., 1984, INCLUSION COMPOUNDS, V3; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Ben David Y, 2015, ENVIRON MICROBIOL, V17, P3407, DOI 10.1111/1462-2920.12868; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bule P, 2018, J BIOL CHEM, V293, P4201, DOI 10.1074/jbc.RA117.001241; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Cameron EA, 2012, J BIOL CHEM, V287, P34614, DOI 10.1074/jbc.M112.397380; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]; Cerqueira FM, 2020, TRENDS MICROBIOL, V28, P95, DOI 10.1016/j.tim.2019.09.004; Chen C, 2014, J STRUCT BIOL, V188, P188, DOI 10.1016/j.jsb.2014.09.006; Cockburn D, 2017, METHODS MOL BIOL, V1588, P119, DOI 10.1007/978-1-4939-6899-2_9; Cockburn DW, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107765; Cockburn DW, 2018, MOL MICROBIOL, V107, P249, DOI 10.1111/mmi.13881; Cockburn DW, 2015, MOL MICROBIOL, V95, P209, DOI 10.1111/mmi.12859; Copeland L, 2009, FOOD HYDROCOLLOID, V23, P1527, DOI 10.1016/j.foodhyd.2008.09.016; Crost EH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02558; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; DeMartino P, 2020, CURR OPIN BIOTECH, V61, P66, DOI 10.1016/j.copbio.2019.10.008; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foley MH, 2016, CELL MOL LIFE SCI, V73, P2603, DOI 10.1007/s00018-016-2242-x; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Giraud E, 1997, GENE, V198, P149, DOI 10.1016/S0378-1119(97)00309-0; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1; Jane J., 2006, J APPL GLYCOSCI, V53, P205, DOI DOI 10.5458/JAG.53.205; Jane JL, 2009, FOOD SCI TECHNOL-INT, P193, DOI 10.1016/B978-0-12-746275-2.00006-9; Janecek S, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.107451; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lam YY, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0573-y; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; Moller MS, 2016, CURR OPIN STRUC BIOL, V40, P33, DOI 10.1016/j.sbi.2016.07.006; Moller MS, 2016, CELL MOL LIFE SCI, V73, P2619, DOI 10.1007/s00018-016-2241-y; Morlon-Guyot J, 2001, DNA SEQUENCE, V12, P27, DOI 10.3109/10425170109042048; Mukhopadhya I, 2018, ENVIRON MICROBIOL, V20, P324, DOI 10.1111/1462-2920.14000; NCBI Resource Coordinators, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osiro KO, 2017, ENZYME MICROB TECH, V97, P43, DOI 10.1016/j.enzmictec.2016.11.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Perez S, 2009, FOOD SCI TECHNOL-INT, P149, DOI 10.1016/B978-0-12-746275-2.00005-7; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ravachol J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0301-4; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Stecher G, 2020, MOL BIOL EVOL, V37, P1237, DOI 10.1093/molbev/msz312; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TAKEO K, 1984, ELECTROPHORESIS, V5, P187, DOI 10.1002/elps.1150050402; Tamura K, 2019, CELL MOL LIFE SCI, V76, P4319, DOI 10.1007/s00018-019-03115-3; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Turkenburg JP, 2009, PROTEINS, V76, P516, DOI 10.1002/prot.22416; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Venkataraman A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0178-x; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; von Ossowski I, 2005, BIOPHYS J, V88, P2823, DOI 10.1529/biophysj.104.050146; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YARON S, 1995, FEBS LETT, V360, P121, DOI 10.1016/0014-5793(95)00074-J; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoav S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0909-7; Zaman SA, 2016, CRIT REV BIOTECHNOL, V36, P578, DOI 10.3109/07388551.2014.993590; Ze XL, 2015, MBIO, V6, DOI 10.1128/mBio.01058-15; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	91	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101896	10.1016/j.jbc.2022.101896	http://dx.doi.org/10.1016/j.jbc.2022.101896			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35378131	gold, Green Published			2022-12-28	WOS:000804923000002
J	Ko, MS; Cohen, SN; Polley, S; Mahata, SK; Biswas, T; Huxford, T; Ghosh, G				Ko, Myung Soo; Cohen, Samantha N.; Polley, Smarajit; Mahata, Sushil K.; Biswas, Tapan; Huxford, Tom; Ghosh, Gourisankar			Regulatory subunit NEMO promotes polyubiquitin-dependent induction of NF-kappa B through a targetable second interaction with upstream activator IKK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; UBIQUITIN CHAINS; STRUCTURAL BASIS; KINASE-ACTIVITY; BETA; PHOSPHORYLATION; BINDING; GAMMA; RECOGNITION; SPECIFICITY	Canonical NF-kappa B signaling through the inhibitor of kappa B kinase (IKK) complex requires induction of IKK2/IKK beta subunit catalytic activity via specific phosphorylation within its activation loop. This process is known to be dependent upon the accessory ubiquitin (Ub)-binding subunit NF-kappa B essential modulator (NEMO)/IKK gamma as well as poly-Ub chains. However, the mechanism through which poly-Ub binding serves to promote IKK catalytic activity is unclear. Here, we show that binding of NEMO/IKK gamma to linear poly-Ub promotes a second interaction between NEMO/IKK gamma and IKK2/IKK beta, distinct from the well-characterized interaction of the NEMO/IKK gamma N terminus to the "NEMO-binding domain" at the C terminus of IKK2/IKK beta. We mapped the location of this second interaction to a stretch of roughly six amino acids immediately N-terminal to the zinc finger domain in human NEMO/IKK gamma. We also showed that amino acid residues within this region of NEMO/IKK gamma are necessary for binding to IKK2/IKK beta through this secondary interaction in vitro and for full activation of IKK2/IKK beta in cultured cells. Furthermore, we identified a docking site for this segment of NEMO/IKK gamma on IKK2/IKK beta within its scaffold-dimerization domain proximal to the kinase domain-Ub-like domain. Finally, we showed that a peptide derived from this region of NEMO/IKK gamma is capable of interfering specifically with canonical NF-kappa B signaling in transfected cells. These in vitro biochemical and cell culture-based experiments suggest that, as a consequence of its association with linear poly-Ub, NEMO/IKK gamma plays a direct role in priming IKK2/IKK beta for phosphorylation and that this process can be inhibited to specifically disrupt canonical NF-kappa B signaling.	[Ko, Myung Soo; Polley, Smarajit; Biswas, Tapan; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ko, Myung Soo; Cohen, Samantha N.; Huxford, Tom] San Diego State Univ, Struct Biochem Lab, Dept Chem & Biochem, San Diego, CA 92182 USA; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.] VA San Diego Hlth Care Syst, Med, San Diego, CA USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	gghosh@ucsd.edu		Polley, Smarajit/0000-0003-3494-5267; Huxford, Tom/0000-0002-1939-7373	National Institutes of Health [CA197999, MD012397]; University of California Tobacco-Related Disease Research Program; American Association for Cancer Research; California Metabolic Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Tobacco-Related Disease Research Program(University of California System); American Association for Cancer Research; California Metabolic Research Foundation	This research was supported by grants from the National Institutes of Health (grant nos.: CA141722 and AI163327), the University of California Tobacco-Related Disease Research Program, and American Association for Cancer Research (to G. G.) and National Institutes of Health (grant nos.: CA197999 and MD012397; to T. H.). S. N. C. is a recipient of the Arne N. Wick predoctoral fellowship and is a Phillips Gausewitz, MD scholar of the Rees-Stealy Research Foundation. Biochemistry research at San Diego State University is supported in part by the California Metabolic Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bollrath J., 2007, NF; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hauenstein AV, 2017, J MOL BIOL, V429, P3793, DOI 10.1016/j.jmb.2017.10.026; Hauenstein AV, 2014, BIOCHEMISTRY-US, V53, P2064, DOI 10.1021/bi401551r; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Huxford T, 2011, CURR TOP MICROBIOL, V349, P1, DOI 10.1007/82_2010_99; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Kirisako T., 2009, NAT; Ko MS, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140526; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Mahlitin E, 2007, ANAL BIOCHEM, V365, P215, DOI 10.1016/j.ab.2007.03.020; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mulero MC, 2019, ADV EXP MED BIOL, V1172, P207, DOI 10.1007/978-981-13-9367-9_10; Mulero MC, 2018, BIOCHEMISTRY-US, V57, P2943, DOI 10.1021/acs.biochem.8b00158; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Napoleon JV, 2021, CHEM COMMUN, V57, P4678, DOI 10.1039/d1cc01245b; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sarkar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028881; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shaffer R, 2019, BIOCHEMISTRY-US, V58, P2906, DOI 10.1021/acs.biochem.8b01316; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tu D., 2013, CELL REP; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	47	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101864	10.1016/j.jbc.2022.101864	http://dx.doi.org/10.1016/j.jbc.2022.101864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35339487	gold, Green Published			2022-12-28	WOS:000794890400002
J	Zhou, YY; Sotcheff, SL; Routh, AL				Zhou, Yiyang; Sotcheff, Stephanea L.; Routh, Andrew L.			Next-generation sequencing: A new avenue to understand viral RNA-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTOME-WIDE IDENTIFICATION; CORONAVIRUS NUCLEOCAPSID PROTEIN; SINGLE-NUCLEOTIDE-RESOLUTION; CROSS-LINKING; HITS-CLIP; SECONDARY STRUCTURE; HIV-1 INTEGRASE; BINDING-SITES; MESSENGER-RNA; VIRUS-RNA	The genomes of RNA viruses present an astonishing source of both sequence and structural diversity. From intracellular viral RNA-host interfaces to interactions between the RNA genome and structural proteins in virus particles themselves, almost the entire viral lifecycle is accompanied by a myriad of RNA-protein interactions that are required to fulfill their replicative potential. It is therefore important to characterize such rich and dynamic collections of viral RNA-protein interactions to understand virus evolution and their adaptation to their hosts and environment. Recent advances in nextgeneration sequencing technologies have allowed the characterization of viral RNA-protein interactions, including both transient and conserved interactions, where molecular and structural approaches have fallen short. In this review, we will provide a methodological overview of the high-throughput techniques used to study viral RNA-protein interactions, their biochemical mechanisms, and how they evolved from classical methods as well as one another. We will discuss how different techniques have fueled virus research to characterize how viral RNA and proteins interact, both locally and on a global scale. Finally, we will present examples on how these techniques influence the studies of clinically important pathogens such as HIV-1 and SARS-CoV-2.	[Zhou, Yiyang; Sotcheff, Stephanea L.; Routh, Andrew L.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Routh, Andrew L.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [Routh, Andrew L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Zhou, YY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	yizhou@utmb.edu			National Institute of Allergy and Infectious Diseases, NIH [U54AI150472]; NIH [P01AI150585]; Institute for Human Infections & Immunity, Sealy & Smith Foundation [CON29094]	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Human Infections & Immunity, Sealy & Smith Foundation	This work was funded by the National Institute of Allergy and Infectious Diseases, NIH, U54AI150472 subcontract to A. L. R., National Institute of Allergy and Infectious Diseases, NIH, R21AI151725 to A. L. R., National Institute of Allergy and Infectious Diseases, NIH, P01AI150585 to A. L. R. Y. Z. is supported by the Institute for Human Infections & Immunity, Sealy & Smith Foundation, UTMB (CON29094) .	Alfadhli A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00253; Anderson Stephen J, 2016, Curr Protoc Plant Biol, V1, P163, DOI 10.1002/cppb.20001; Antzin-Anduetza I, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0374-1; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Ariza-Mateos A, 2012, NUCLEIC ACIDS RES, V40, P1748, DOI 10.1093/nar/gkr822; Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Atasoy U, 1998, J CELL SCI, V111, P3145; Au PCK, 2014, MOL BIOL REP, V41, P2971, DOI 10.1007/s11033-014-3154-1; Ayoubian H, 2019, J VIROL, V93, DOI 10.1128/JVI.01297-18; BALTIMORE D, 1970, Journal of Molecular Biology, V47, P263, DOI 10.1016/0022-2836(70)90301-3; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Barrows NJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45910-9; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Benhalevy D, 2018, NAT METHODS, V15, P1074, DOI 10.1038/s41592-018-0220-y; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; Bieniasz PD, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0417-2; Bohn JA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01309-6; Bosch JA, 2021, WIRES DEV BIOL, V10, DOI 10.1002/wdev.392; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Bottini S, 2018, BRIEF BIOINFORM, V19, P1290, DOI 10.1093/bib/bbx063; Boudreault S, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1137-5; BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; Brown RS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18447-z; Bullard WL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007843; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen CL, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.272; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Cordero P, 2012, BIOCHEMISTRY-US, V51, P7037, DOI 10.1021/bi3008802; Craigie R, 2012, FUTURE VIROL, V7, P679, DOI 10.2217/FVL.12.56; Dahm GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3851; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; De S, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1404; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Fais F, 1999, LEUKEMIA, V13, P1093, DOI 10.1038/sj.leu.2401436; Favre A, 1998, J PHOTOCH PHOTOBIO B, V42, P109, DOI 10.1016/S1011-1344(97)00116-4; FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9; Favre A, 1990, BIOORG PHOTOCHEM, V1, P379; Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027; Fillebeen C, 2014, JOVE-J VIS EXP, DOI 10.3791/52230; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Foley Shawn W, 2016, Curr Protoc Mol Biol, V116, DOI 10.1002/cpmb.21; Foley SW, 2015, CURR OPIN PLANT BIOL, V27, P36, DOI 10.1016/j.pbi.2015.05.021; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Gilbert C., 2006, CURR PROTOC MOL BIOL; Gillen AE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2675-5; Gogakos T, 2017, CELL REP, V20, P1463, DOI 10.1016/j.celrep.2017.07.029; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; GORNER H, 1994, J PHOTOCH PHOTOBIO B, V26, P117, DOI 10.1016/1011-1344(94)07068-7; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Guo YE, 2015, J VIROL, V89, P10901, DOI 10.1128/JVI.01884-15; Guo YE, 2014, MOL CELL, V54, P67, DOI 10.1016/j.molcel.2014.03.025; Haecker I, 2014, CRIT REV EUKAR GENE, V24, P101, DOI 10.1615/CritRevEukaryotGeneExpr.2014006367; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HAHNENSTEIN I, 1995, IND ENG CHEM RES, V34, P440, DOI 10.1021/ie00041a003; Harold C, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0602-7; Harris ME, 2009, METHOD ENZYMOL, V468, P127, DOI 10.1016/S0076-6879(09)68007-1; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Houldcroft CJ, 2015, REV MED VIROL, V25, P71, DOI 10.1002/rmv.1816; Hsin WC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0449-x; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Itri F, 2016, CELL MOL LIFE SCI, V73, P637, DOI 10.1007/s00018-015-2015-y; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Jain R., RIP CHIP ANAL RNA BI; Jaworski E, 2021, ELIFE, V10, DOI [10.7554/eLife.68479, 10.7554/eLife.68479.sa1, 10.7554/eLife.68479.sa2, 10.1101/2021.03.10.434828]; Jaworski E, 2018, METHODS MOL BIOL, V1712, P71, DOI 10.1007/978-1-4939-7514-3_6; Jaworski E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006365; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaewsapsak P, 2017, ELIFE, V6, DOI [10.7554/elife.29224, 10.7554/eLife.29224]; Kargapolova Y, 2017, NUCLEIC ACIDS RES, V45, P6074, DOI 10.1093/nar/gkx152; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; KATO T, 1980, MOL GEN GENET, V180, P283, DOI 10.1007/BF00425840; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kenyon JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep14369; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kim B, 2021, NAT PROTOC, V16, P516, DOI 10.1038/s41596-020-00429-6; Kim B, 2020, MOL CELL, V78, P624, DOI 10.1016/j.molcel.2020.04.013; Kint S, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00829-1; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kutluay SB, 2016, METHODS MOL BIOL, V1354, P119, DOI 10.1007/978-1-4939-3046-3_8; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Kvaratskhelia Mamuka, 2008, V488, P213, DOI 10.1007/978-1-60327-475-3_15; LaCava John, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top077545; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lambert NJ, 2015, METHOD ENZYMOL, V558, P465, DOI 10.1016/bs.mie.2015.02.007; Lawrence C W, 1982, Basic Life Sci, V20, P109; Le Sage V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107823; Le Sage V, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100522; Lee FCY, 2018, MOL CELL, V69, P354, DOI 10.1016/j.molcel.2018.01.005; Lee N, 2017, NUCLEIC ACIDS RES, V45, P8968, DOI 10.1093/nar/gkx584; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lin CY, 2019, NUCLEIC ACIDS RES, V47, P5490, DOI 10.1093/nar/gkz295; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JE, 2021, CELL RES, V31, P404, DOI 10.1038/s41422-020-00465-7; Liu ZR, 1999, METH MOL B, V118, P35; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; LOZZIO CB, 1971, J CELL PHYSIOL, V78, P25, DOI 10.1002/jcp.1040780105; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Madison MK, 2017, J VIROL, V91, DOI 10.1128/JVI.00821-17; Mailler E, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1518; Matolcsy A, 1998, AM J PATHOL, V153, P1609, DOI 10.1016/S0002-9440(10)65749-5; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Meisenheimer KM, 2000, METHOD ENZYMOL, V318, P88; MELVIN WT, 1978, EUR J BIOCHEM, V92, P373, DOI 10.1111/j.1432-1033.1978.tb12756.x; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Nie ZM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-661; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2; Padron A, 2019, MOL CELL, V75, P875, DOI 10.1016/j.molcel.2019.07.030; Pan DL, 2014, CELL HOST MICROBE, V15, P446, DOI 10.1016/j.chom.2014.03.004; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Poria DK, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2193; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Rice AP, 2017, CURR PHARM DESIGN, V23, P4098, DOI 10.2174/1381612823666170704130635; Riley KJ, 2013, MOL CELL, V49, P601, DOI 10.1016/j.molcel.2013.01.030; Riley KJ, 2012, RNA, V18, P1581, DOI 10.1261/rna.034934.112; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Riquelme-Barrios S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2018.00576; Rivera-Santiago RF, 2015, METHODS, V89, P99, DOI 10.1016/j.ymeth.2015.04.031; Rolfsson O, 2016, J MOL BIOL, V428, P431, DOI 10.1016/j.jmb.2015.11.014; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Routh A, 2015, J MOL BIOL, V427, P2610, DOI 10.1016/j.jmb.2015.06.011; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Schmidt N, 2021, NAT MICROBIOL, V6, P339, DOI 10.1038/s41564-020-00846-z; SCHOEMAKER HJ, 1974, J MOL BIOL, V84, P503, DOI 10.1016/0022-2836(74)90112-0; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shetlar M.D., 1980, PHOTOCHEMICAL AND PHOTOBIOLOGICAL REVIEWS, V5, P105; Shi SR, 2013, PROTEOM CLIN APPL, V7, P264, DOI 10.1002/prca.201200031; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Sievers C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks697; Silverman IM, 2015, METHODS, V72, P76, DOI 10.1016/j.ymeth.2014.10.021; Silverman IM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r3; Singh G, 2014, METHODS, V65, P320, DOI 10.1016/j.ymeth.2013.09.013; Skalsky RL, 2017, METHODS MOL BIOL, V1532, P133, DOI 10.1007/978-1-4939-6655-4_9; Skalsky RL, 2014, J VIROL, V88, P1617, DOI 10.1128/JVI.02071-13; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; SMITH KC, 1966, BIOCHEMISTRY-US, V5, P2125, DOI 10.1021/bi00870a046; Smola MJ, 2018, NAT PROTOC, V13, P1181, DOI 10.1038/nprot.2018.010; Smola MJ, 2015, NAT PROTOC, V10, P1643, DOI 10.1038/nprot.2015.103; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Sotcheff S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010042; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Strobel EJ, 2018, NAT REV GENET, V19, P615, DOI 10.1038/s41576-018-0034-x; Sukosd Z, 2013, NUCLEIC ACIDS RES, V41, P2807, DOI 10.1093/nar/gks1283; Sun BQ, 2021, NAT MICROBIOL, V6, P682, DOI 10.1038/s41564-020-00860-1; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; TANNER NK, 1988, BIOCHEMISTRY-US, V27, P8852, DOI 10.1021/bi00424a025; Testa SM, 1999, BIOCHEMISTRY-US, V38, P16655, DOI 10.1021/bi991187d; Tihova M, 2004, J VIROL, V78, P2897, DOI 10.1128/JVI.78.6.2897-2905.2004; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Urdaneta EC, 2020, METHODS, V178, P72, DOI 10.1016/j.ymeth.2019.09.013; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang T, 2015, NUCLEIC ACIDS RES, V43, P5263, DOI 10.1093/nar/gkv439; Wang Z., 2020, EPIGENETICS METHODS, V18, P495; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Wessels HH, 2016, METHODS MOL BIOL, V1358, P141, DOI 10.1007/978-1-4939-3067-8_9; WETZ K, 1982, J GEN VIROL, V59, P397, DOI 10.1099/0022-1317-59-2-397; Williams GD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02886-w; Wisniewski JR, 2013, PROTEOM CLIN APPL, V7, P225, DOI 10.1002/prca.201200046; Wu KE, 2020, CELL SYST, V11, P102, DOI 10.1016/j.cels.2020.06.008; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Yamada T, 2021, NAT IMMUNOL, V22, P820, DOI 10.1038/s41590-021-00942-0; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; York A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005833; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zambelli F, 2015, METHODS MOL BIOL, V1269, P293, DOI 10.1007/978-1-4939-2291-8_18; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141; Zhou YY, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkz1124; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108; Zubradt M, 2017, NAT METHODS, V14, P75, DOI [10.1038/nmeth.4057, 10.1038/NMETH.4057]; ZWIEB C, 1978, NUCLEIC ACIDS RES, V5, P2705, DOI 10.1093/nar/5.8.2705	218	2	2	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101924	10.1016/j.jbc.2022.101924	http://dx.doi.org/10.1016/j.jbc.2022.101924			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35413291	gold, Green Published			2022-12-28	WOS:000817175700013
J	Cai, H; Wang, X; Zhang, ZX; Chen, J; Wang, FB; Wang, L; Liu, J				Cai, Hao; Wang, Xin; Zhang, Zhixin; Chen, Juan; Wang, Fangbin; Wang, Lu; Liu, Jian			Moderate L-lactate administration suppresses adipose tissue macrophage M1 polarization to alleviate obesity-associated insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID; INFLAMMATION; AMPK; ACTIVATION; METABOLISM; MICE; KINASE; TARGET; MUSCLE	As a crucial metabolic intermediate, L-lactate is involved in redox balance, energy balance, and acid-base balance in organisms. Moderate exercise training transiently elevates plasma L-lactate levels and ameliorates obesity-associated type 2 diabetes. However, whether moderate L-lactate administration improves obesity-associated insulin resistance remains unclear. In this study, we defined 800 mg/kg/day as the dose of moderate L-lactate administration. In mice fed with a high-fat diet (HFD), moderate L-lactate administration for 12 weeks was shown to alleviate weight gain, fat accumulation, and insulin resistance. Along with the phenotype alterations, white adipose tissue thermogenesis was also found to be elevated in HFD-fed mice. Meanwhile, moderate L-lactate administration suppressed the infiltration and proinflammatory M1 polarization of adipose tissue macrophages (ATMs) in HFD-fed mice. Furthermore, L-lactate treatment suppressed the lipopolysaccharide-induced M1 polarization of bone marrowderived macrophages (BMDMs). L-lactate can bind to the surface receptor GPR132, which typically drives the downstream cAMP-PKA signaling. As a nutrient sensor, AMP-activated protein kinase (AMPK) critically controls macrophage inflammatory signaling and phenotype. Thus, utilizing inhibitors of the kinases PKA and AMPK as well as siRNA against GPR132, we demonstrated that GPR132-PKA-AMPKa1 signaling mediated the suppression caused by L-lactate treatment on BMDM M1 polarization. Finally, L-lactate addition remarkably resisted the impairment of lipopolysaccharide-treated BMDM conditional media on adipocyte insulin sensitivity. In summary, moderate L-lactate administration suppresses ATM proinflammatory M1 polarization through activation of the GPR132-PKA-AMPKa1 signaling pathway to improve insulin resistance in HFD-fed mice, suggesting a new therapeutic and interventional approach to obesity-associated type 2 diabetes.	[Cai, Hao; Wang, Xin; Zhang, Zhixin; Chen, Juan; Wang, Fangbin; Wang, Lu; Liu, Jian] Hefei Univ Technol, Sch Food & Biol Engn, Hefei, Anhui, Peoples R China; [Liu, Jian] Hefei Univ Technol, Engn Res Ctr Bioproc, Minist Educ, Hefei, Anhui, Peoples R China	Hefei University of Technology; Hefei University of Technology	Liu, J (corresponding author), Hefei Univ Technol, Sch Food & Biol Engn, Hefei, Anhui, Peoples R China.; Liu, J (corresponding author), Hefei Univ Technol, Engn Res Ctr Bioproc, Minist Educ, Hefei, Anhui, Peoples R China.	liujian509@hfut.edu.cn		Wang, Xin/0000-0002-8694-1172; Cai, Hao/0000-0002-3316-2271	National Natural Science Foundation of China [32070757, 31671485, 31801114]; Fundamental Research Funds for the Central Universities [JZ2018QTXM0553]; University Synergy Innovation Program of Anhui Province [GXXT-2019-026]; Natural Science Foundation of Anhui Province [1908085QC98]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); University Synergy Innovation Program of Anhui Province; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by the National Natural Science Foundation of China (grant nos.: 32070757 and 31671485 [to J. L.] and 31801114 [to J. C.]), the Fundamental Research Funds for the Central Universities (grant no.: JZ2018QTXM0553 [to J. L.]), the University Synergy Innovation Program of Anhui Province (grant no.: GXXT-2019-026; to J. L.), and the Natural Science Foundation of Anhui Province (grant no.: 1908085QC98; to J. C.).	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Bao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084075; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bolick DT, 2009, CIRC RES, V104, P318, DOI 10.1161/CIRCRESAHA.108.181131; Brooks GA, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101454; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Carbone S, 2019, PROG CARDIOVASC DIS, V62, P327, DOI 10.1016/j.pcad.2019.08.004; Carneiro L, 2017, MOL METAB, V6, P1625, DOI 10.1016/j.molmet.2017.10.005; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Ceppo F, 2014, ENDOCRINOLOGY, V155, P951, DOI 10.1210/en.2013-1815; Chaurasia B, 2016, CELL METAB, V24, P820, DOI 10.1016/j.cmet.2016.10.002; Chen PW, 2017, P NATL ACAD SCI USA, V114, P580, DOI 10.1073/pnas.1614035114; Chiang CF, 2017, ONCOTARGET, V8, P20706, DOI 10.18632/oncotarget.14982; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Gellen B, 2018, LANCET HAEMATOL, V5, pE554, DOI 10.1016/S2352-3026(18)30163-7; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heden TD, 2017, APPL PHYSIOL NUTR ME, V42, P732, DOI 10.1139/apnm-2016-0382; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang YJ, 2019, AGING-US, V11, P2217, DOI 10.18632/aging.101910; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Ippolito L, 2019, TRENDS BIOCHEM SCI, V44, P153, DOI 10.1016/j.tibs.2018.10.011; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kari S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00769; Keiran N, 2019, NAT IMMUNOL, V20, P581, DOI 10.1038/s41590-019-0372-7; Kim N, 2017, SCI REP-UK, V7, DOI 10.1038/srep41066; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Petridou A, 2019, METABOLISM, V92, P163, DOI 10.1016/j.metabol.2018.10.009; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ren WK, 2019, ADV NUTR, V10, P321, DOI 10.1093/advances/nmy084; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Tao SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26835; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Wu LM, 2018, FREE RADICAL BIO MED, V121, P215, DOI 10.1016/j.freeradbiomed.2018.05.004; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561; Zhang J, 2020, CELL METAB, V31, P1136, DOI 10.1016/j.cmet.2020.05.004; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhou HF, 2014, ACS NANO, V8, P7305, DOI 10.1021/nn502372n	57	1	1	16	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101768	10.1016/j.jbc.2022.101768	http://dx.doi.org/10.1016/j.jbc.2022.101768			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35218776	gold, Green Published			2022-12-28	WOS:000823106100007
J	Cale, EM; Driscoll, JI; Lee, M; Gorman, J; Zhou, TQ; Lu, ML; Geng, H; Lai, YT; Chuang, GY; Doria-Rose, NA; Mothes, W; Kwong, PD; Mascola, JR				Cale, Evan M.; Driscoll, Jefferson, I; Lee, Myungjin; Gorman, Jason; Zhou, Tongqing; Lu, Maolin; Geng, Hui; Lai, Yen-Ting; Chuang, Gwo-Yu; Doria-Rose, Nicole A.; Mothes, Walther; Kwong, Peter D.; Mascola, John R.			<p>Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2 & nbsp;</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; GP120; VIRUS; GLYCOPROTEIN; REGION; ARCHITECTURE; EPITOPES; COMPLEX	The conformationally dynamic HIV-1 envelope trimer (Env) is the target of broadly neutralizing antibodies (bnAbs) that block viral entry. Single-molecule Forster resonance energy transfer (smFRET) has revealed that HIV-1 Env exists in at least three conformational states on the virion. Prior to complete host-receptor engagement (State 3), Env resides most prevalently in the smFRET-defined State 1, which is preferentially recognized by most bnAbs that are elicited by natural infection. smFRET has also revealed that soluble trimers containing prefusion-stabilizing disulfide and isoleucine-to-proline substitutions reside primarily in State 2, which is a required intermediate between States 1 and 3. While high-resolution Env structures have been determined for States 2 and 3, the structure of these trimers in State 1 is unknown. To provide insight into the State 1 structure, here we characterized antigenic differences between smFRET-defined states and then correlated these differences with known structural differences between States 2 and 3. We found that cell surface-expressed Env was enriched in each state using state-enriching antibody fragments or small-molecule virus entry inhibitors and then different states. We observed small but consistent differences in binding between Env enriched in States 1 and 2, and a more than 10-fold difference in binding to Env enriched in these states versus Env enriched in State 3. We conclude that structural differences between HIV-1 Env States 1 and 3 are likely providing important insight into State 1.	[Cale, Evan M.; Driscoll, Jefferson, I; Lee, Myungjin; Gorman, Jason; Zhou, Tongqing; Geng, Hui; Lai, Yen-Ting; Chuang, Gwo-Yu; Doria-Rose, Nicole A.; Kwong, Peter D.; Mascola, John R.] NIAID, NIH, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lu, Maolin; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT USA; [Lu, Maolin] Univ Texas Tyler, Dept Cellular & Mol Biol, Hlth Sci Ctr, Tyler, TX 75799 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Kwong, PD; Mascola, JR (corresponding author), NIAID, NIH, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@mail.nih.gov	; Zhou, Tongqing/A-6880-2010	Lee, Myungjin/0000-0002-4972-3811; Zhou, Tongqing/0000-0002-3935-4637	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Foundation for AIDS Research (amfAR) [110214-70RKVA];  [R01 AI150560-01];  [P01 AI150471]	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Foundation for AIDS Research (amfAR); ; 	Funding and additional information-Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health. This work was also supported by federal grants R01 AI150560-01 and P01 AI150471 to W. M. and The Foundation for AIDS Research (amfAR) grant 110214-70RKVA to M. Lu. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; de la Pena AT, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007920; de Los Rios M, 2015, CURR OPIN STRUC BIOL, V33, P27, DOI 10.1016/j.sbi.2015.06.002; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Herschhorn A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01119-w; Herschhorn A, 2016, MBIO, V7, DOI 10.1128/mBio.01598-16; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Johnson S., 1997, DEVEL OPMENT HUMANIZ; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kozal M., 2020, N ENGL; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lai YT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07851-1; Landais E, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0443-0; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li Z., 2020, NAT STRUCT; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lu ML, 2020, J VIROL, V94, DOI 10.1128/JVI.00597-20; Lu ML, 2019, NATURE, V568, P415, DOI 10.1038/s41586-019-1101-y; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma XC, 2018, ELIFE, V7, DOI 10.7554/eLife.34271; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mitternacht Simon, 2016, F1000Res, V5, P189, DOI 10.12688/f1000research.7931.1; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pan JH, 2020, J MOL BIOL, V432, P1158, DOI 10.1016/j.jmb.2019.11.028; Pancera M., 2017, BMS 378806; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Salimi H, 2020, J BIOL CHEM, V295, P348, DOI 10.1074/jbc.RA119.009481; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Stadtmueller BM, 2018, IMMUNITY, V49, P235, DOI 10.1016/j.immuni.2018.06.017; Stanfield R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0468; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei X., 2003, ANTIBODY NEUTRALIZAT; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013; Zou ST, 2020, J VIROL, V94, DOI 10.1128/JVI.00148-20	59	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101819	10.1016/j.jbc.2022.101819	http://dx.doi.org/10.1016/j.jbc.2022.101819			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35283191	Green Published, gold			2022-12-28	WOS:000793502000013
J	Raja, R; Wang, CY; Mishra, R; Das, A; Ali, A; Banerjea, AC				Raja, Rameez; Wang, Chenyao; Mishra, Ritu; Das, Arundhoti; Ali, Amjad; Banerjea, Akhil C.			Host AKT-mediated phosphorylation of HIV-1 accessory protein Vif potentiates infectivity via enhanced degradation of the restriction factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBF-BETA; UBIQUITINATION; VIRIONS; PATHWAY	HIV-1 encodes accessory proteins that neutralize antiviral restriction factors to ensure its successful replication. One accessory protein, the HIV-1 viral infectivity factor (Vif), is known to promote ubiquitination and proteasomal degradation of the antiviral restriction factor apolipoprotein B mRNAediting enzyme-catalytic polypeptide-like 3G (APOBEC3G), a cytosine deaminase that leads to hypermutations in the viral DNA and subsequent aberrant viral replication. We have previously demonstrated that the HIV-1 viral transcription mediator Tat activates the host progrowth PI-3-AKT pathway, which in turn promotes HIV-1 replication. Because the HIV-1 Vif protein contains the putative AKT phosphorylation motif RMRINT, here we investigated whether AKT directly phosphorylates HIV-1 Vif to regulate its function. Coimmunoprecipitation experiments showed that AKT and Vif interact with each other, supporting this hypothesis. Using in vitro kinase assays, we further showed that AKT phosphorylates Vif at threonine 20, which promotes its stability, as Vif becomes destabilized after this residue is mutated to alanine. Moreover, expression of dominant-negative kinase-deficient AKT as well as treatment with a chemical inhibitor of AKT increased K48ubiquitination and proteasomal degradation of HIV-1 Vif. In contrast, constitutively active AKT (Myr-AKT) reduced K48ubiquitination of Vif to promote its stability. Finally, inhibition of AKT function restored APOBEC3G levels, which subsequently reduced HIV-1 infectivity. Thus, our results establish a novel mechanism of HIV-1 Vif stabilization through AKTmediated phosphorylation at threonine 20, which reduces APOBEC3G levels and potentiates HIV-1 infectivity.	[Raja, Rameez; Wang, Chenyao] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Raja, Rameez; Banerjea, Akhil C.] Natl Inst Immunol, Virol 2, New Delhi, India; [Mishra, Ritu] Amity Univ, Amity Inst Virol & Immunol, Noida, Uttar Pradesh, India; [Das, Arundhoti] NCI, Lab Genome Integr, Bethesda, MD 20892 USA; [Ali, Amjad] UMass Chan Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA USA	Cleveland Clinic Foundation; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Amity University Noida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Raja, R (corresponding author), Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44106 USA.; Raja, R; Banerjea, AC (corresponding author), Natl Inst Immunol, Virol 2, New Delhi, India.	rajar@ccf.org; akhil@nii.ac.in		Raja, Rameez/0000-0001-6940-5880	Department of Science and Technology of Government of India; Department of Biotechnology of Government of India	Department of Science and Technology of Government of India(Department of Science & Technology (India)); Department of Biotechnology of Government of India(Department of Biotechnology (DBT) India)	Several reagents were obtained from AIDS Reference & Reagent Program of NIH, MD, USA. This work was supported by the Department of Biotechnology and Department of Science and Technology of Government of India. We thank Smriti Parashar and Sneh Lata for their technical help and sharing reagents.	Ali A, 2021, BIOCHEM BIOPH RES CO, V574, P27, DOI 10.1016/j.bbrc.2021.08.031; Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; Antonucci JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01541; Baldauf H. M., 2012, SAMHD1 RESTRICTS HIV; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Bres V., 2003, NAT; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ganser-Pornillos BK, 2019, NAT REV MICROBIOL, V17, P546, DOI 10.1038/s41579-019-0225-2; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Lata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8244; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyakawa K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7945; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Okada A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02027; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Raja R, 2022, CELL DEATH DIFFER, V29, P504, DOI 10.1038/s41418-021-00870-4; Raja R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32316-2; Raja R, 2017, BIOCHEM J, V474, P2449, DOI 10.1042/BCJ20160825; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	27	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101805	10.1016/j.jbc.2022.101805	http://dx.doi.org/10.1016/j.jbc.2022.101805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35259395	gold, Green Published			2022-12-28	WOS:000793692600007
J	Eh, M; Kaczmarek, AT; Schwarz, G; Bender, D				Eh, Malin; Kaczmarek, Alexander Tobias; Schwarz, Guenter; Bender, Daniel			Molecular mechanism of intramolecular electron transfer in dimeric sulfite oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM; NITRITE; MITOCHONDRIA; DEFICIENCY; CATALYSIS; COFACTOR; IMPORT; G473D	Sulfite oxidase (SOX) is a homodimeric molybdoheme enzyme that oxidizes sulfite to sulfate at the molybdenum center. Following substrate oxidation, molybdenum is reduced and subsequently regenerated by two sequential electron transfers (ETs) via heme to cytochrome c. SOX harbors both metals in spatially separated domains within each subunit, suggesting that domain movement is necessary to allow intramolecular ET. To address whether one subunit in a SOX dimer is sufficient for catalysis, we produced heterodimeric SOX variants with abolished sulfite oxidation by replacing the molybdenum-coordinating and essential cysteine in the active site. To further elucidate whether electrons can bifurcate between subunits, we truncated one or both subunits by deleting the heme domain. We generated three SOX heterodimers: (i) SOX/Mo with two active molybdenum centers but one deleted heme domain, (ii) SOX/Mo_C264S with one unmodified and one inactive subunit, and (iii) SOX_C264S/Mo harboring a functional molybdenum center on one subunit and a heme domain on the other subunit. Steady-state kinetics showed 50% SOX activity for the SOX/Mo and SOX/Mo_C264S heterodimers, whereas SOX_C264S/Mo activity was reduced by two orders of magnitude. Rapid reaction kinetics monitoring revealed comparable ET rates in SOX/Mo, SOX/Mo_C264S, and SOX/SOX, whereas in SOX_C264S/Mo, ET was strongly compromised. We also combined a functional SOX Mo domain with an inactive full-length SOX R217W variant and demonstrated interdimer ET that resembled SOX_C264S/Mo activity. Collectively, our results indicate that one functional subunit in SOX is sufficient for catalysis and that electrons derived from either Mo(IV)or Mo(V) follow this path.	[Eh, Malin; Kaczmarek, Alexander Tobias; Schwarz, Guenter; Bender, Daniel] Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany; [Bender, Daniel] Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland	University of Cologne; University Children's Hospital Zurich	Schwarz, G; Bender, D (corresponding author), Univ Cologne, Inst Biochem, Dept Chem, Cologne, Germany.; Bender, D (corresponding author), Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland.	gschwarz@uni-koeln.de; daniel.bender@kispi.uzh.ch		Schwarz, Guenter/0000-0002-2118-9338; Kaczmarek, Alexander/0000-0001-5425-0425; Bender, Daniel/0000-0002-2975-4186	Center for Molecular Medicine Cologne, Germany [CMMC2017-C13]	Center for Molecular Medicine Cologne, Germany	Acknowledgments-We thank Monika Laurien, Simona Jansen, Joana Stegemann, and Julia Reich for excellent technical assistance. We thank Laura Vierbaum for initiating the project. This research was funded by grant CMMC2017-C13 from the Center for Molecular Medicine Cologne, Germany.	Bender D, 2020, J INHERIT METAB DIS, V43, P748, DOI 10.1002/jimd.12216; Bender D, 2019, BIOCHEM J, V476, P1805, DOI 10.1042/BCJ20190143; Bender D, 2019, HUM MOL GENET, V28, P2885, DOI 10.1093/hmg/ddz109; Claerhout H, 2018, J INHERIT METAB DIS, V41, P101, DOI 10.1007/s10545-017-0089-4; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Edwards MC, 1999, OPHTHALMOLOGY, V106, P1957, DOI 10.1016/S0161-6420(99)90408-6; Enemark JH, 2008, BIOCHEM SOC T, V36, P1129, DOI 10.1042/BST0361129; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Feng CJ, 2005, BIOCHEMISTRY-US, V44, P13734, DOI 10.1021/bi050907f; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; ITO A, 1971, J BIOCHEM-TOKYO, V70, P1061, DOI 10.1093/oxfordjournals.jbchem.a129716; JOHNSON JL, 1977, J BIOL CHEM, V252, P2017; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Johnson-Winters K, 2010, BIOCHEMISTRY-US, V49, P1290, DOI 10.1021/bi9020296; Kaczmarek AT, 2019, NITRIC OXIDE-BIOL CH, V89, P22, DOI 10.1016/j.niox.2019.04.004; Kaczmarek AT, 2021, MOL GENET METAB, V134, P188, DOI 10.1016/j.ymgme.2021.07.011; Kaczmarek AT, 2022, J INHERIT METAB DIS, V45, P169, DOI 10.1002/jimd.12454; Kappler U, 2015, J BIOL INORG CHEM, V20, P253, DOI 10.1007/s00775-014-1197-3; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Klein JM, 2012, J CELL SCI, V125, P4876, DOI 10.1242/jcs.110114; Kumar A., 2017, S SULFOCYSTEINENMDA; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; ONO H, 1984, J BIOCHEM-TOKYO, V95, P345, DOI 10.1093/oxfordjournals.jbchem.a134614; Pacheco A, 1999, J BIOL INORG CHEM, V4, P390, DOI 10.1007/s007750050325; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Peariso K, 2002, J AM CHEM SOC, V124, P9006, DOI 10.1021/ja017217t; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Tejada-Jimenez M, 2018, MOLECULES, V23, DOI 10.3390/molecules23123287; Wang J, 2015, ANTIOXID REDOX SIGN, V23, P283, DOI 10.1089/ars.2013.5397; Wilson HL, 2006, BIOCHEMISTRY-US, V45, P2149, DOI 10.1021/bi051609l; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	35	0	0	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101668	10.1016/j.jbc.2022.101668	http://dx.doi.org/10.1016/j.jbc.2022.101668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120924	gold, Green Published, Green Accepted			2022-12-28	WOS:000791230900011
J	Guan, GY; Xie, JJ; Dai, YM; Han, H				Guan, Guoying; Xie, Jinjiao; Dai, Yamei; Han, Hui			TFPI2 suppresses the interaction of TGF-beta 2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR PATHWAY; GROWTH-FACTOR-BETA; SMURF2 UBIQUITIN LIGASE; KIDNEY FIBROSIS; RENAL FIBROSIS; CROSS-TALK; CELLS; INHIBITOR-2; APOPTOSIS; EXPRESSION	Endothelial-mesenchymal transition (EndMT) is an important source of myofibroblasts, but also contributes to the progression of diabetic nephropathy (DN). By several differential gene expression analyses from the Gene Expression Omnibus (GEO) database, the tissue factor pathway inhibitor 2 (TFPI2) gene, known as a tumor suppressor, was shown to be dysregulated in DN; however, the potential role and regulatory mechanism of TFPI2 in DN are unclear. Here, we found abnormal upregulation of TFPI2 in the renal cortex of diabetic mice, accompanied by impaired renal function. We also injected a single dose of adeno-associated virus (AAV)2 carrying shRNA targeting TFPI2 intravenously into these mice and found that knockdown of TFPI2 improved renal function and reduced renal fibrosis and cell apoptosis in experimental DN. Furthermore, hyperglycemia-induced EndMT was inhibited in the absence of TFPI2, as evidenced by increased expression of endothelial markers (VE-cadherin and CD31) and decreased expression of mesenchymal markers (alpha-SMA, des-min, and FSP-1). To further explore the mechanism in vitro, human renal glomerular endothelial cells (hRGECs) were incubated in the presence of high glucose or transforming growth factor beta (TGF-beta)2. TFPI2 deficiency inhibited high glucose-induced cell apoptosis and TGF-beta 2-induced EndMT in hRGECs, while overexpression of TFPI2 had the opposite effects. Importantly, TGF-beta 2 is a crucial driver of EndMT, and we found that TFPI2 promoted TGF-beta 2/Smad signaling activation by interferring the interaction of TGF-beta pathway regulators (SMURF2 with SMAD7). Our results show that TFPI2 regulates EndMT and the TGF-beta 2 signaling pathway and is a potential promoter of DN pathogenesis.	[Guan, Guoying; Xie, Jinjiao; Han, Hui] Harbin Med Univ, Dept Geriatr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Dai, Yamei] Harbin Med Univ, Hlth Management Ctr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Han, H (corresponding author), Harbin Med Univ, Dept Geriatr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China.	hydyyqkgp@163.com	han, han/HDL-7807-2022		Youth Project of National Natural Science Foundation of China [81600629]; Surface Project of National Natural Science Foundation of China [81671383]	Youth Project of National Natural Science Foundation of China; Surface Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Youth Project of National Natural Science Foundation of China (No. 81600629) and the Surface Project of National Natural Science Foundation of China (No. 81671383) .	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Azushima K, 2018, NAT REV NEPHROL, V14, P48, DOI 10.1038/nrneph.2017.142; Bai YJM, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00128; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eleftheriadis T, 2018, INT UROL NEPHROL, V50, P179, DOI 10.1007/s11255-017-1733-5; Ferreira FU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030458; Fu J, 2015, AM J PHYSIOL-RENAL, V308, pF287, DOI 10.1152/ajprenal.00533.2014; Giordo R, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.683594; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Iino M, 1998, ARTERIOSCL THROM VAS, V18, P40, DOI 10.1161/01.ATV.18.1.40; Ivanciu L, 2007, ARTERIOSCL THROM VAS, V27, P310, DOI 10.1161/01.ATV.0000254147.89321.cf; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kawanami D, 2016, HISTOL HISTOPATHOL, V31, P1059, DOI 10.14670/HH-11-777; Kempaiah P, 2008, APOPTOSIS, V13, P702, DOI 10.1007/s10495-008-0207-8; Kushioka J, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00115-z; Lam BQ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113077; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Liang W, 2009, PEPTIDES, V30, P2330, DOI 10.1016/j.peptides.2009.08.016; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin YF, 2007, APOPTOSIS, V12, P2163, DOI 10.1007/s10495-007-0136-y; Liu X, 2018, J CELL MOL MED, V22, P808, DOI 10.1111/jcmm.13360; Loeffler I, 2018, CELL TISSUE RES, V372, P115, DOI 10.1007/s00441-017-2754-1; Mallat RK, 2017, CRIT REV CL LAB SCI, V54, P458, DOI 10.1080/10408363.2017.1394267; Massague J, 2000, GENE DEV, V14, P627; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; MIYAGI Y, 1994, J BIOCHEM-TOKYO, V116, P939, DOI 10.1093/oxfordjournals.jbchem.a124648; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Okazaki Yuko, 2007, Clin Exp Nephrol, V11, P77, DOI 10.1007/s10157-006-0456-1; Pardali E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102157; Pedone E, 2020, EXPLORE MED, V1, P314, DOI [10.37349/emed.2020.00021, DOI 10.37349/EMED.2020.00021]; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sabbineni H, 2018, J CELL PHYSIOL, V233, P8418, DOI 10.1002/jcp.26801; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Sniegon I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112290; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Thomas B, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1133-6; Tsai YC, 2020, MOL THER, V28, P963, DOI 10.1016/j.ymthe.2020.01.014; Tuleta I, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.166044; Vigili de Kreutzenberg S.., 2021, EXPLOR MED, V2, P1; Wang ZJ, 2017, J CELL MOL MED, V21, P2359, DOI 10.1111/jcmm.13157; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yu CH, 2017, EXP MOL PATHOL, V102, P377, DOI 10.1016/j.yexmp.2017.03.007; Yuan Q, 2019, ADV EXP MED BIOL, V1165, P253, DOI 10.1007/978-981-13-8871-2_12; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeng LF, 2019, ADV EXP MED BIOL, V1165, P49, DOI 10.1007/978-981-13-8871-2_4; Zeng LF, 2013, J BIOL CHEM, V288, P31853, DOI 10.1074/jbc.M113.463745; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	69	2	2	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101725	10.1016/j.jbc.2022.101725	http://dx.doi.org/10.1016/j.jbc.2022.101725			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35157852	Green Published, gold			2022-12-28	WOS:000789394500011
J	Kumar, A; Yang, TH; Chakravorty, S; Majumdar, A; Nairn, BL; Six, DA; dos Santos, NM; Price, SL; Lawrenz, MB; Actis, LA; Marques, M; Russo, TA; Newton, SM; Klebba, PE				Kumar, Ashish; Yang, Taihao; Chakravorty, Somnath; Majumdar, Aritri; Nairn, Brittany L.; Six, David A.; dos Santos, Naara Marcondes; Price, Sarah L.; Lawrenz, Matthew B.; Actis, Luis A.; Marques, Marilis; Russo, Thomas A.; Newton, Salete M.; Klebba, Phillip E.			Fluorescent sensors of siderophores produced by bacterial pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SITE-DIRECTED ALKYLATION; UROPATHOGENIC ESCHERICHIA-COLI; FERRIC ENTEROBACTIN RECEPTOR; FLANKING HYDROPHILIC DOMAINS; IRON ACQUISITION-SYSTEMS; LOW-COPY-NUMBER; LACTOSE PERMEASE; OUTER-MEMBRANE; SALMONELLA-ENTERICA	Siderophores are iron-chelating molecules that solubilize Fe3+ for microbial utilization and facilitate colonization or infection of eukaryotes by liberating host iron for bacterial uptake. By fluorescently labeling membrane receptors and binding proteins, we created 20 sensors that detect, discriminate, and quantify apo-and ferric siderophores. The sensor proteins originated from TonB-dependent ligand-gated porins (LGPs) of Escherichia coli (Fiu, FepA, Cir, FhuA, IutA, BtuB), Klebsiella pneumoniae (IroN, FepA, FyuA), Acinetobacter baumannii (PiuA, FepA, PirA, BauA), Pseudomonas aeruginosa (FepA, FpvA), and Caulobacter crescentus (HutA) from a periplasmic E. coli binding protein (FepB) and from a human serum binding protein (siderocalin). They detected ferric catecholates (enterobactin, degraded enterobactin, glucosylated enterobactin, dihydroxybenzoate, dihydroxybenzoyl serine, cefidericol, MB 1), ferric hydroxamates (ferrichromes, aerobactin), mixed iron complexes (yersiniabactin, acinetobactin, pyoverdine), and porphyrins (hemin, vitamin B12). The sensors defined the specificities and corresponding affinities of the LGPs and binding proteins and monitored ferric siderophore and porphyrin transport by microbial pathogens. We also quantified, for the first time, broad recognition of diverse ferric complexes by some LGPs, as well as monospecificity for a single metal chelate by others. In addition to their primary ferric siderophore ligands, most LGPs bound the corresponding aposiderophore with ~& nbsp;100-fold lower affinity. These sensors provide insights into ferric siderophore biosynthesis and uptake pathways in freeliving, commensal, and pathogenic Gram-negative bacteria.	[Kumar, Ashish; Yang, Taihao; Chakravorty, Somnath; Majumdar, Aritri; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Chakravorty, Somnath; Russo, Thomas A.] Univ Buffalo, Sch Med, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA; [Nairn, Brittany L.] Bethel Univ, Dept Biol Sci, St Paul, MN USA; [Six, David A.] Venatorx Pharmaceut Inc, Dept Biol, Malvern, PA USA; [dos Santos, Naara Marcondes; Marques, Marilis] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, Brazil; [Price, Sarah L.; Lawrenz, Matthew B.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Kansas State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade de Sao Paulo; University of Louisville; University System of Ohio; Miami University	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	peklebba@ksu.edu	Marques, Marilis V/C-3085-2013; Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711; Marques, Marilis/0000-0003-1542-8221; Santos, Naara Marcondes/0000-0001-7487-952X	Veterans Administration Western New York Healthcare System, Buffalo, New York, USA; Department of Veterans Affairs VA Merit Review [1I01BX004677-01A1]; NIH [1R21AI141826-01A1, R21AI135225, R01AI148241, F31AI147404]; Defense Threat Reduction Agency (DTRA) [HDTRA117C0070]; NIAID, National Institutes of Health [75N93020C00016]; Sao Paulo Research Foundation (FAPESP ) [2019/08514-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) [307974/2017-0]; FAPESP [2017/021279]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil [CAPES 88887.470428/2019-00]	Veterans Administration Western New York Healthcare System, Buffalo, New York, USA; Department of Veterans Affairs VA Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sao Paulo Research Foundation (FAPESP )(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	T. A. R. was supported by the Veterans Administration Western New York Healthcare System, Buffalo, New York, USA, the Department of Veterans Affairs VA Merit Review 1I01BX004677-01A1, and NIH 1R21AI141826-01A1. D. A. S. was supported by the Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA117C0070 and NIAID, National Institutes of Health under Contract No. 75N93020C00016. M. B. L. was supported by NIH grants R21AI135225 and R01AI148241 and S. L. P. by NIH F31AI147404. N. M. d. S. was supported by the Sao Paulo Research Foundation (FAPESP 2019/08514-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil 307974/2017-0), FAPESP (2017/021279), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES 88887.470428/2019-00). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelhamed H, 2016, MICROB PATHOGENESIS, V100, P195, DOI 10.1016/j.micpath.2016.09.018; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; ACTIS LA, 1986, J BACTERIOL, V167, P57, DOI 10.1128/jb.167.1.57-65.1986; Allred BE, 2013, ACS CHEM BIOL, V8, P1882, DOI 10.1021/cb4002552; AMES GFL, 1974, J BIOL CHEM, V249, P634; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Balhesteros H, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00723-16; Bister B, 2004, BIOMETALS, V17, P471, DOI 10.1023/B:BIOM.0000029432.69418.6a; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; BROCK JH, 1991, INFECT IMMUN, V59, P3185, DOI 10.1128/IAI.59.9.3185-3190.1991; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chakravorty S, 2019, J BIOL CHEM, V294, P4682, DOI 10.1074/jbc.RA118.006921; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; DERVARTANIAN M, 1992, INFECT IMMUN, V60, P2800, DOI 10.1128/IAI.60.7.2800-2807.1992; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; FAUNDEZ G, 1988, J CLIN MICROBIOL, V26, P928, DOI 10.1128/JCM.26.5.928-932.1988; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; Fischbach M. A., 2006, PROC NATL ACAD SCI S; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P3950, DOI 10.1021/bi952601m; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P5333, DOI 10.1021/bi953068d; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P269, DOI 10.1021/bi9618629; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grinter R, 2019, J BIOL CHEM, V294, P19523, DOI 10.1074/jbc.RA119.011018; GROMAN NB, 1965, J BACTERIOL, V90, P1563, DOI 10.1128/JB.90.6.1563-1568.1965; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HANCOCK REW, 1976, FEBS LETT, V65, P208, DOI 10.1016/0014-5793(76)80481-4; Hanson M, 2016, J BIOMOL SCREEN, V21, P316, DOI 10.1177/1087057115613788; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holden VI, 2016, MBIO, V7, DOI 10.1128/mBio.01397-16; Holden VI, 2015, METALLOMICS, V7, P986, DOI 10.1039/c4mt00333k; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Ito A, 2016, ANTIMICROB AGENTS CH, V60, P7396, DOI 10.1128/AAC.01405-16; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; JUNG K, 1994, BIOCHEMISTRY-US, V33, P3980, DOI 10.1021/bi00179a026; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2021, CHEM REV, V121, P5193, DOI 10.1021/acs.chemrev.0c01005; KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030; Kohira N., 2016, ANTIMICROB AGENTS CH; Kokesov A., 2006, FOLIA MICROBIOL, V51; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee I. R., 2016, SCI REP-UK; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Liu J., 1994, FEPA BIOCH, V33, P13274; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Lukacik P., 2012, P NATL ACAD SCI; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mabayoje DA, 2021, JAC-ANTIMICROB RESIS, V3, P21, DOI 10.1093/jacamr/dlab055; Majumdar A, 2020, J BIOL CHEM, V295, P4974, DOI 10.1074/jbc.RA119.011850; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; Massip C, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008029; MCLAUCHLIN J, 1990, EPIDEMIOL INFECT, V104, P181, DOI 10.1017/S0950268800059343; MONTGOMERIE JZ, 1984, INFECT IMMUN, V46, P835, DOI 10.1128/IAI.46.3.835-838.1984; Moynie L, 2018, ELIFE, V7, DOI 10.7554/eLife.42270; Moynie L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02531-16; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; Nazareth H, 2007, INFECT IMMUN, V75, P2776, DOI 10.1128/IAI.01095-06; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neilands J. B., 1974, MICROBIAL IRON METAB, P434; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Nie Y, 2007, J MOL BIOL, V374, P356, DOI 10.1016/j.jmb.2007.09.006; NIKAIDO H, 1990, J BACTERIOL, V172, P1361, DOI 10.1128/jb.172.3.1361-1367.1990; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; Pradhan S, 2020, MBIO, V11, DOI 10.1128/mBio.01470-20; Ramakrishnan G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00107; Roberts R. B., 1957, STUDIES BIOSYNTHESIS, V607, P5; ROSENBUSCH JP, 1990, EXPERIENTIA, V46, P167; Russo TA, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00001-19; Russo TA, 2015, INFECT IMMUN, V83, P3325, DOI 10.1128/IAI.00430-15; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; RUTZ JM, 1991, J BACTERIOL, V173, P5964, DOI 10.1128/jb.173.19.5964-5974.1991; Saha P, 2019, GUT MICROBES, V10, P412, DOI 10.1080/19490976.2018.1546519; SAHINTOTH M, 1993, PROTEIN SCI, V2, P1024, DOI 10.1002/pro.5560020615; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Schalk IJ, 1999, BIOCHEMISTRY-US, V38, P9357, DOI 10.1021/bi990421x; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schauer K., 2008, TRENDS BIOCHEM SCI, V6, P6; Scott D. C., 2000, THESIS U OKLAHOMA; Scott DC, 2002, J BACTERIOL, V184, P4906, DOI 10.1128/JB.184.17.4906-4911.2002; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Sheldon JR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008995; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Song WY, 2017, ORG LETT, V19, P500, DOI 10.1021/acs.orglett.6b03671; Sonnenborn U, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw212; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tomaras AP, 2015, ANTIMICROB AGENTS CH, V59, P2439, DOI 10.1128/AAC.04172-14; Tomaras AP, 2013, ANTIMICROB AGENTS CH, V57, P4197, DOI 10.1128/AAC.00629-13; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10641, DOI 10.1021/bi000438b; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10649, DOI 10.1021/bi0004394; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10656, DOI 10.1021/bi0004403; Voss J, 1997, BIOCHEMISTRY-US, V36, P15055, DOI 10.1021/bi971726j; Voss J, 1996, BIOCHEMISTRY-US, V35, P12915, DOI 10.1021/bi9608774; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEITZMAN C, 1995, BIOCHEMISTRY-US, V34, P9374, DOI 10.1021/bi00029a013; WILLIAMS P, 1989, J GEN MICROBIOL, V135, P3173; Williams PH, 2006, VACCINE, V24, P3840, DOI 10.1016/j.vaccine.2005.07.020; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506; Wright H, 2017, CLIN MICROBIOL INFEC, V23, P704, DOI 10.1016/j.cmi.2017.09.001; Wu JY, 2020, INFECT DIS THER, V9, P17, DOI 10.1007/s40121-020-00286-6; Wu JH, 1996, P NATL ACAD SCI USA, V93, P10123, DOI 10.1073/pnas.93.19.10123; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Zhang W, 2003, BIOCHEMISTRY-US, V42, P4904, DOI 10.1021/bi034078e	157	3	3	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101651	10.1016/j.jbc.2022.101651	http://dx.doi.org/10.1016/j.jbc.2022.101651			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101443	gold, Green Published			2022-12-28	WOS:000794865600014
J	Matsuoka, K; Imahashi, N; Ohno, M; Ode, H; Nakata, Y; Kubota, M; Sugimoto, A; Imahashi, M; Yokomaku, Y; Iwatani, Y				Matsuoka, Kazuhiro; Imahashi, Nobuhiko; Ohno, Miki; Ode, Hirotaka; Nakata, Yoshihiro; Kubota, Mai; Sugimoto, Atsuko; Imahashi, Mayumi; Yokomaku, Yoshiyuki; Iwatani, Yasumasa			SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; HORSESHOE BATS; CHAPERONES; EXPRESSION; INDUCTION; ALIGNMENT; SEVERITY; DELETION; ENCODES; GENOME	ORF8 is an accessory protein encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Consensus regarding the biological functions of ORF8 is lacking, largely because the fundamental characteristics of this protein in cells have not been determined. To clarify these features, we herein established an ORF8 expression system in 293T cells. Using this system, approximately 41% of the ORF8 expressed in 293T cells were secreted extracellularly as a glycoprotein homodimer with inter/intramolecular disulfide bonds. Intracellular ORF8 was sensitive to the glycosidase Endo H, whereas the secreted portion was Endo-H-resistant, suggesting that secretion occurs via a conventional pathway. Additionally, immunoblotting analysis showed that the total amounts of the major histocompatibility complex class I (MHC-I), angiotensin-converting enzyme 2 (ACE2), and SARS-CoV-2 spike (CoV-2 S) proteins coexpressed in cells were not changed by the increased ORF8 expression, although FACS analysis revealed that the expression of the cell surface MHC-I protein, but not that of ACE2 and CoV-2 S proteins, was reduced by ORF8 expression. Finally, we demonstrate by RNA-seq analysis that ORF8 had no significant stimulatory effects in human primary monocytederived macrophages (MDMs). Taken together, our results provide fundamental evidence that the ORF8 glycoprotein acts as a secreted homodimer, and its functions are likely associated with the intracellular transport and/or extracellular signaling in SARS-CoV-2 infection.	[Matsuoka, Kazuhiro; Ohno, Miki; Nakata, Yoshihiro; Kubota, Mai; Sugimoto, Atsuko; Imahashi, Mayumi; Yokomaku, Yoshiyuki; Iwatani, Yasumasa] Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi, Japan; [Imahashi, Nobuhiko] Nagoya Med Ctr, Natl Hosp Org, Dept Hematol, Nagoya, Aichi, Japan; [Nakata, Yoshihiro; Iwatani, Yasumasa] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi, Japan	Nagoya Medical Center; Nagoya University	Iwatani, Y (corresponding author), Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi, Japan.; Iwatani, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi, Japan.	iwatani.yasumasa.cp@mail.hosp.go.jp	; Iwatani, Yasumasa/A-8675-2016	Imahashi, Nobuhiko/0000-0002-1398-2002; Iwatani, Yasumasa/0000-0001-9269-4828; Ode, Hirotaka/0000-0001-8624-2382; Matsuoka, Kazuhiro/0000-0003-1217-3550	Japan Society for the Promotion of Science [JP20K07533, JP19H03482]; Japan Agency for Medical Research and Development (AMED) [20fk0108293h0001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Japan Society for the Promotion of Science (grant numbers JP20K07533 (K. M.) and JP19H03482 (Y. I.) ) and by the Research Programs on COVID-19 from Japan Agency for Medical Research and Development (AMED grant numbers 20fk0108293h0001 (Y. I.) ) .	Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Chen MF, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01948-2020; Chen SY, 2020, J INFECT DIS, V222, P223, DOI 10.1093/infdis/jiaa278; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Davies NG, 2021, NATURE, V593, P270, DOI [10.1038/s41586-021-03426-1, 10.1101/2021.02.01.21250959]; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Echavarria-Consuegra L, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009644; Flower TG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021785118; Gamage AM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009130; Geng H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.679482; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Halperin L, 2014, IUBMB LIFE, V66, P318, DOI 10.1002/iub.1272; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Jungreis I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22905-7; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lau SKP, 2015, J VIROL, V89, P10532, DOI 10.1128/JVI.01048-15; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Li WW, 1997, MOL CELL BIOL, V17, P54, DOI 10.1128/MCB.17.1.54; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin XY, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102293; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; MELNICK J, 1992, J BIOL CHEM, V267, P21303; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Mohammad S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090677; Muth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33487-8; Mwimanzi F, 2018, J VIROL, V92, DOI 10.1128/JVI.01409-17; Nakashima M, 2016, J VIROL, V90, P1034, DOI 10.1128/JVI.02369-15; Ninagawa S, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129812; Oostra M, 2007, J VIROL, V81, P13876, DOI 10.1128/JVI.01631-07; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Pereira F, 2021, GENE, V784, DOI 10.1016/j.gene.2021.145596; PETERSON PA, 1974, P NATL ACAD SCI USA, V71, P35, DOI 10.1073/pnas.71.1.35; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Rashid F, 2021, VIRUS RES, V296, DOI 10.1016/j.virusres.2021.198350; Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shuai HP, 2022, NATURE, V603, P693, DOI 10.1038/s41586-022-04442-5; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Vohringer HS, 2021, NATURE, V600, P506, DOI 10.1038/s41586-021-04069-y; Wang XH, 2020, MBIO, V11, DOI 10.1128/mBio.02431-20; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu ZG, 2016, J INFECT DIS, V213, P579, DOI 10.1093/infdis/jiv476; Xiong Y., 2021, UNCONVENTIONAL SECRE, DOI 10; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8; Zhang YW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024202118	64	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101724	10.1016/j.jbc.2022.101724	http://dx.doi.org/10.1016/j.jbc.2022.101724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35157849	Green Published, gold			2022-12-28	WOS:000789394500006
J	Siang, S; Underbakke, ES; Roche, J				Siang, Steven; Underbakke, Eric S.; Roche, Julien			Intricate coupling between the transactivation and basic-leucine zipper domains governs phosphorylation of transcription factor ATF4 by casein kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; FUNCTIONAL INTERACTION; BETA-TRCP; BINDING; STRESS; SYSTEM; NMR; PREDICTION; MECHANISM; PATHWAY	Most transcription factors possess at least one long intrinsically disordered transactivation domain that binds to a variety of coactivators and corepressors and plays a key role in modulating the transcriptional activity. Despite the crucial importance of these domains, the structural and functional basis of transactivation remains poorly understood. Here, we focused on activating transcription factor 4 (ATF4)/cAMP response element-binding protein-2, an essential transcription factor for cellular stress adaptation. Bioinformatic sequence analysis of the ATF4 transactivation domain sequence revealed that the first 125 amino acids have noticeably less propensity for structural disorder than the rest of the domain. Using solution nuclear magnetic resonance spectroscopy complemented by a range of biophysical methods, we found that the isolated transactivation domain is predominantly yet not fully disordered in solution. We also observed that a short motif at the N-terminus of the transactivation domain has a high helical propensity. Importantly, we found that the N -terminal region of the transactivation domain is involved in transient long-range interactions with the basic-leucine zipper domain involved in DNA binding. Finally, in vitro phosphorylation assays with the casein kinase 2 show that the presence of the basic-leucine zipper domain is required for phosphorylation of the transactivation domain. This study uncovers the intricate coupling existing between the transactivation and basic-leucine zipper domains of ATF4, highlighting its potential regulatory significance.	[Siang, Steven; Underbakke, Eric S.; Roche, Julien] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA	Iowa State University	Roche, J (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA.	jroche@iastate.edu		Siang, Steven/0000-0001-8765-8064; Roche, Julien/0000-0003-1254-1173	Roy J. Carver Charitable Trust of Muscatine, Iowa; NIGMS [R01 GM132561]	Roy J. Carver Charitable Trust of Muscatine, Iowa; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by funds from the Roy J. Carver Charitable Trust of Muscatine, Iowa, and from NIGMS R01 GM132561 (J. R.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Ampofo E, 2013, BBA-MOL CELL RES, V1833, P439, DOI 10.1016/j.bbamcr.2012.10.025; Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bagheri-Yarmand R, 2015, J BIOL CHEM, V290, P11749, DOI 10.1074/jbc.M114.619833; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Clark S, 2018, ELIFE, V7, DOI 10.7554/eLife.36258; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Conforti F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.27; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Goddard T. D., 2010, SPARKY 3; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim J, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166808; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Krois AS, 2018, P NATL ACAD SCI USA, V115, pE11302, DOI 10.1073/pnas.1814051115; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; Millard PS, 2020, PROTEIN SCI, V29, P169, DOI 10.1002/pro.3754; Mollica L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00052; Nygaard M, 2017, BIOPHYS J, V113, P550, DOI 10.1016/j.bpj.2017.06.042; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Piai A, 2016, BIOPHYS J, V110, P372, DOI 10.1016/j.bpj.2015.11.3516; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Pons J, 2007, PEPTIDES, V28, P2253, DOI 10.1016/j.peptides.2007.09.016; Pons J, 2008, BIOCHEMISTRY-US, V47, P14, DOI 10.1021/bi7014212; Raj N, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026047; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Schoch S, 2001, NEUROCHEM INT, V38, P601, DOI 10.1016/S0197-0186(00)00127-3; Shammas SL, 2017, CURR OPIN STRUC BIOL, V42, P155, DOI 10.1016/j.sbi.2017.02.003; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Soda T, 2013, MOL PSYCHIATR, V18, P898, DOI 10.1038/mp.2013.38; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	50	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101633	10.1016/j.jbc.2022.101633	http://dx.doi.org/10.1016/j.jbc.2022.101633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35077711	gold, Green Published			2022-12-28	WOS:000789261900009
J	Tominari, T; Akita, M; Matsumoto, C; Hirata, M; Yoshinouchi, S; Tanaka, Y; Karouji, K; Itoh, Y; Maruyama, T; Miyaura, C; Numabe, Y; Inada, M				Tominari, Tsukasa; Akita, Miyuki; Matsumoto, Chiho; Hirata, Michiko; Yoshinouchi, Shosei; Tanaka, Yuki; Karouji, Kento; Itoh, Yoshifumi; Maruyama, Takayuki; Miyaura, Chisato; Numabe, Yukihiro; Inada, Masaki			Endosomal TLR3 signaling in stromal osteoblasts induces prostaglandin E-2-mediated inflammatory periodontal bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; OSTEOCLAST DIFFERENTIATION; PORPHYROMONAS-GINGIVALIS; CYTOKINE PRODUCTION; EXPRESSION; RANKL; E-2; LIPOPOLYSACCHARIDE; STIMULATION	Toll-like receptors (TLRs) are pattern recognition receptors that play a critical role in innate immune diseases. TLR3, which is localized in the endosomal compartments of hematopoietic immune cells, is able to recognize double-stranded RNA (dsRNA) derived from viruses and bacteria and thereby induce innate immune responses. Inflammatory periodontal bone resorption is caused by bacterial infections, which initially is regulated by innate immunity; however, the roles of TLR3 signaling in bone resorption are still not known. We examined the roles of TLR3 signaling in bone resorption using poly(I:C), a synthetic dsRNA analog. In cocultures of mouse bone marrow cells and stromal osteoblasts, poly(I:C) clearly induced osteoclast differentiation. In osteoblasts, poly(I:C) increased PGE(2) production and upregulated the mRNA expression of PGE2- related genes, Ptgs2 and Ptges, as well as that of a gene related to osteoclast differentiation, Tnfsf11. In addition, we found that indomethacin (a COX-2 inhibitor) or an antagonist of the PGE(2)-receptor EP4 attenuated the poly(I:C)-induced PGE(2) production and subsequent Tnfsf11 expression. Poly(I:C) also prolonged the survival of the mature osteoclasts associated with the increased mRNA expression of osteoclast marker genes, Nfatc1 and Ctsk. In ex vivo organ cultures of periodontal alveolar bone, poly(I:C) induced bone-resorbing activity in a dose-dependent manner, which was attenuated by the simultaneous administration of either indomethacin or an EP4 antagonist. These data suggest that TLR3 signaling in osteoblasts controls PGE(2) production and induces the subsequent differentiation and survival of mature osteoclasts. Endogenous TLR3 in stromal osteoblasts and osteoclasts synergistically induces inflammatory alveolar bone resorption in periodontitis.	[Tominari, Tsukasa; Akita, Miyuki; Matsumoto, Chiho; Hirata, Michiko; Tanaka, Yuki; Karouji, Kento; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Yoshinouchi, Shosei; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Adv Hlth Sci, Koganei, Tokyo, Japan; [Itoh, Yoshifumi; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan; [Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Maruyama, Takayuki] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka, Japan; [Numabe, Yukihiro] Nippon Dent Univ Tokyo, Sch Dent, Dept Periodontol, Chiyoda Ku, Tokyo, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; University of Oxford; Ono Pharmaceutical Co Ltd; Nippon Dental University	Inada, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.; Inada, M (corresponding author), Tokyo Univ Agr & Technol, Adv Hlth Sci, Koganei, Tokyo, Japan.; Inada, M (corresponding author), Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan.	m-inada@cc.tuat.ac.jp	Tominari, Tsukasa/B-6054-2015	Tominari, Tsukasa/0000-0001-5683-8951	Japan Society for the Promotion of Science (Kakenhi) [JP18K19730]; Institute of Global Innovation Research in Tokyo University of Agriculture and Technology	Japan Society for the Promotion of Science (Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute of Global Innovation Research in Tokyo University of Agriculture and Technology	We thank Ms Wakana Kaizuka for expert assistance. This work was supported by the Grant-in-aid for Sci-entific Research by the Japan Society for the Promotion of Science (Kakenhi grants JP18K19730) and Institute of Global Innovation Research in Tokyo University of Agriculture and Technology.	Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Campos PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00028; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Gan TT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03174; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kassem A, 2015, FASEB J, V29, P4449, DOI 10.1096/fj.15-272559; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kim K.-W., 2009, IMMUNOL LETT; Kim KW, 2019, J BIOCHEM, V166, P259, DOI 10.1093/jb/mvz033; Kim PD, 2015, INFECT IMMUN, V83, P2992, DOI 10.1128/IAI.00424-15; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lacey D. L., 1998, CELL; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Miyaura C, 2000, J BIOL CHEM, V275, P19819, DOI 10.1074/jbc.M002079200; Mori K, 2015, J DENT RES, V94, P1149, DOI 10.1177/0022034515589289; Myneni SR, 2011, J IMMUNOL, V187, P501, DOI 10.4049/jimmunol.1100683; Noguchi K, 2007, PERIODONTOL 2000, V43, P85, DOI 10.1111/j.1600-0757.2006.00170.x; Park HJ, 2015, J CELL PHYSIOL, V230, P667, DOI 10.1002/jcp.24790; Park KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23103; Pilbeam C, 2019, HANDB EXP PHARM, V262, P157; Raisz LG, 2003, PROSTAG OTH LIPID M, V71, P287, DOI 10.1016/S1098-8823(03)00049-2; Sahingur SE, 2013, J PERIODONTOL, V84, pE48, DOI 10.1902/jop.2013.120739; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Suda K, 2004, J IMMUNOL, V172, P2504, DOI 10.4049/jimmunol.172.4.2504; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanabe N, 2005, LIFE SCI, V77, P615, DOI 10.1016/j.lfs.2004.10.079; Tanaka S, 2018, MOD RHEUMATOL, V28, P9, DOI 10.1080/14397595.2017.1369491; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yu BH, 2019, INT J MOL MED, V43, P2341, DOI 10.3892/ijmm.2019.4165; Zare F, 2004, J IMMUNOL, V172, P5656, DOI 10.4049/jimmunol.172.9.5656; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136; Zubery Y, 1998, INFECT IMMUN, V66, P4158	50	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101603	10.1016/j.jbc.2022.101603	http://dx.doi.org/10.1016/j.jbc.2022.101603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35101442	Green Published, gold			2022-12-28	WOS:000791267400017
J	Bagneris, C; Kumar, SLS; Baratchian, M; Britt, HM; Assafa, TE; Thalassinos, K; Collins, MK; Barrett, TE				Bagneris, Claire; Kumar, Swathi L. Senthil; Baratchian, Mehdi; Britt, Hannah M.; Assafa, Tufa E.; Thalassinos, Konstantinos; Collins, Mary K.; Barrett, Tracey E.			Mechanistic insights into the activation of the IKK kinase complex by the Kaposi's sarcoma herpes virus oncoprotein vFLIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KAPPA-B; CELL-DEATH; NEMO; PROTEIN; PATHWAY; GAMMA; TAK1; BETA; MASS	Constitutive activation of the canonical NF-KB signaling pathway is a major factor in Kaposi's sarcoma-associated herpes virus pathogenesis where it is essential for the survival of primary effusion lymphoma. Central to this process is persistent upregulation of the inhibitor of KB kinase (IKK) complex by the virally encoded oncoprotein vFLIP. Although the physical interaction between vFLIP and the IKK kinase regulatory component essential for persistent activation, IKK gamma, has been well characterized, it remains unclear how the kinase subunits are rendered active mechanistically. Using a combination of cell-based assays, biophysical techniques, and structural biology, we demonstrate here that vFLIP alone is sufficient to activate the IKK kinase complex. Furthermore, we identify weakly stabilized, high molecular weight vFLIP-IKK gamma assemblies that are key to the activation process. Taken together, our results are the first to reveal that vFLIP-induced NF-KB activation pivots on the formation of structurally specific vFLIP-IKK gamma multimers which have an important role in rendering the kinase subunits active through a process of autophosphorylation. This mechanism of NF-KB activation is in contrast to those utilized by endogenous cytokines and celluar FLIP homologues.	[Bagneris, Claire; Kumar, Swathi L. Senthil; Thalassinos, Konstantinos; Barrett, Tracey E.] Birkbeck Coll, Inst Struct Mol Biol, Dept Biol Sci, London, England; [Baratchian, Mehdi] Cleveland Clin, Genitourinary Malignancies Res Ctr, Lerner Res Inst, Cleveland, OH 44106 USA; [Britt, Hannah M.; Thalassinos, Konstantinos] UCL, Inst Struct & Mol Biol, Div Biosci, London, England; [Assafa, Tufa E.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Collins, Mary K.] Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan	University of London; Birkbeck University London; Cleveland Clinic Foundation; University of London; Birkbeck University London; University College London; University of California System; University of California Santa Cruz; Okinawa Institute of Science & Technology Graduate University	Barrett, TE (corresponding author), Birkbeck Coll, Inst Struct Mol Biol, Dept Biol Sci, London, England.	t.barrett@bbk.ac.uk		Britt, Hannah/0000-0001-8510-0331; Thalassinos, Konstantinos/0000-0001-5072-8428	Sarcoma UK [SUK203.2017]; BBSRC LIDo DTP award; Wellcome Trust collaborative grant [209250/Z/17/Z]; CRUK [C484/A12595]	Sarcoma UK; BBSRC LIDo DTP award; Wellcome Trust collaborative grant(Wellcome Trust); CRUK(Cancer Research UK)	This work was supported by a Sarcoma UK grant (SUK203.2017) to T. E. B., a BBSRC LIDo DTP award to S. L. S. K., a Wellcome Trust collaborative grant (209250/Z/17/Z) to K. T. and a CRUK grant to M. K. C. and T. E. B. (C484/A12595) .	Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bagneris C, 2015, J BIOL CHEM, V290, P23024, DOI 10.1074/jbc.A114.622928; Baratchian M, 2016, J BIOL CHEM, V291, P7608, DOI 10.1074/jbc.M116.718122; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Briggs LC, 2017, J VIROL, V91, DOI 10.1128/JVI.01170-17; Catici DAM, 2016, FEBS J, V283, P2272, DOI 10.1111/febs.13724; Catici DAM, 2015, J BIOL CHEM, V290, P14130, DOI 10.1074/jbc.M115.640417; Chang Y, 2014, VIRUSES-BASEL, V6, P4258, DOI 10.3390/v6114258; CHOWDHURY SK, 1990, J AM CHEM SOC, V112, P9012, DOI 10.1021/ja00180a074; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Hauenstein AV, 2017, J MOL BIOL, V429, P3793, DOI 10.1016/j.jmb.2017.10.026; Hauenstein AV, 2014, BIOCHEMISTRY-US, V53, P2064, DOI 10.1021/bi401551r; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kai X, 2014, J BIOL CHEM, V289, P26960, DOI 10.1074/jbc.M114.598763; Ko MS, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140526; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Matta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036601; Maubach G, 2017, TRENDS MOL MED, V23, P1138, DOI 10.1016/j.molmed.2017.10.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Randall CMH, 2012, J IMMUNOL, V188, P2371, DOI 10.4049/jimmunol.1100136; Ritthipichai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039438; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scholefield J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12629; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Schulz TF, 2015, CURR OPIN VIROL, V14, P116, DOI 10.1016/j.coviro.2015.08.016; Sivalingam GN, 2013, INT J MASS SPECTROM, V345, P54, DOI 10.1016/j.ijms.2012.09.005; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tolani B, 2014, J VIROL, V88, P6345, DOI 10.1128/JVI.00028-14; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005584; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	46	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102012	10.1016/j.jbc.2022.102012	http://dx.doi.org/10.1016/j.jbc.2022.102012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35525271	Green Published, gold, Green Accepted			2022-12-28	WOS:000807778400008
J	Ji, RP; Shi, QQ; Cao, YX; Zhang, JY; Zhao, CC; Zhao, HY; Sayyed, Y; Fu, L; Li, LY				Ji, Renpeng; Shi, Qianqian; Cao, Yixin; Zhang, Jingyue; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Fu, Li; Li, Lu-Yuan			Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; APOPTOSIS	The human rhomboid-5 homolog-1 (RHBDF1) is a multi-transmembrane protein present mainly on the endoplasmic reticulum. RHBDF1 has been implicated in the activation of epidermal growth factor receptor (EGFR)-derived cell growth signals and other activities critical to cellular responses to stressful conditions, but details of this activation mechanism are unclear. Here, we report a RHBDF1 mRNA transcript alternative splicing variant X6 (RHBDF1 X6 or RHX6) that antagonizes RHBDF1 activities. We found that while the RHBDF1 gene is marginally expressed in breast tumor-adjacent normal tissues, it is markedly elevated in the tumor tissues. In sharp contrast, the RHX6 mRNA represents the primary RHBDF1 variant in normal breast epithelial cells and tumor adjacent normal tissues but is diminished in breast cancer cells and tumors. We demonstrate that, functionally, RHX6 acts as an inhibitor of RHBDF1 activities. We show that artificially overexpressing RHX6 in breast cancer cells leads to retarded proliferation, migration, and decreased production of epithelial-mesenchymal transition-related adhesion molecules. Mechanically, RHX6 is able to inhibit the maturation of TACE, a protease that processes pro-TGF alpha, a pro-ligand of EGFR, and to prevent intracellular transportation of pro-TGF alpha to the cell surface. Additionally, we show that the production of RHX6 is under the control of the alternative splicing regulator RNA binding motif protein-4 (RBM4). Our findings suggest that differential splicing of the RHBDF1 gene transcript may have a regulatory role in the development of epithelial cell cancers.	[Ji, Renpeng; Cao, Yixin; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Li, Lu-Yuan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Shi, Qianqian; Zhang, Jingyue; Fu, Li] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Tianjin, Peoples R China; [Ji, Renpeng; Shi, Qianqian; Cao, Yixin; Zhang, Jingyue; Zhao, Cancan; Zhao, Huanyu; Sayyed, Yasra; Fu, Li; Li, Lu-Yuan] Nankai Univ, Coll Pharm, Haihe Lab Cell Ecosyst, Tianjin Key Lab Mol Drug Res, Tianjin, Peoples R China	Nankai University; Tianjin Medical University; Nankai University	Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	liluyuan@nankai.edu.cn			National Natural Science Foundation of China, China [81874167, 82073064]; Haihe Laboratory of Cell Ecosystem Innovation Fund	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Haihe Laboratory of Cell Ecosystem Innovation Fund	Funding and addition information-This study was funded in part by grants from the National Natural Science Foundation of China, China (Grants 81874167 and 82073064 to L. Y. L.) and the Haihe Laboratory of Cell Ecosystem Innovation Fund.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; [Anonymous], 2014, CANCER DISCOV, V4, P1253, DOI 10.1158/2159-8290.CD-RW2014-198; Dulloo I, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190003; Freeman M, 2016, BIOCHEM SOC T, V44, P945, DOI 10.1042/BST20160035; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gao S, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00597-1; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kim HK, 2018, PFLUG ARCH EUR J PHY, V470, P995, DOI 10.1007/s00424-018-2136-x; Ladomery Michael, 2013, Int J Cell Biol, V2013, P463786, DOI 10.1155/2013/463786; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep11559; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li J, 2018, EBIOMEDICINE, V36, P229, DOI 10.1016/j.ebiom.2018.09.038; Maney SK, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5356; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Peng XM, 2018, FASEB J, V32, P5577, DOI 10.1096/fj.201800016R; Powles Joshua, 2018, F1000Res, V7, P139, DOI 10.12688/f1000research.13383.2; Qi YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11840; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Su CH, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00466-16; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Wang WY, 2020, MOL GENET GENOMICS, V295, P95, DOI 10.1007/s00438-019-01606-3; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yong HM, 2019, MED SCI MONITOR, V25, P4025, DOI 10.12659/MSM.914513; Yong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28222; Yuan HP, 2018, EXP CELL RES, V368, P24, DOI 10.1016/j.yexcr.2018.04.009; Zhang Y, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/5555950; Zhou Z, 2014, CANCER RES, V74, P2719, DOI 10.1158/0008-5472.CAN-13-1027; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	36	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102033	10.1016/j.jbc.2022.102033	http://dx.doi.org/10.1016/j.jbc.2022.102033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35595096	Green Published, gold			2022-12-28	WOS:000829588600009
J	Li, Y; Huang, SJ; Wang, JS; Dai, JL; Cai, J; Yan, S; Huang, ZL; He, SQ; Wang, P; Liu, JM; Liu, Y				Li, Yang; Huang, Shijia; Wang, Jingsi; Dai, Jianli; Cai, Jie; Yan, Shuai; Huang, Zhiliang; He, Shengqi; Wang, Ping; Liu, Jianmiao; Liu, Yong			Phosphorylation at Ser(724) of the ER stress sensor IRE1 alpha governs its activation state and limits ER stress-induced hepatosteatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; IRE1; KINASE; PATHWAY; OLIGOMERIZATION; SUPPRESSION; REQUIRES	Inositol-requiring enzyme 1 (IRE1) is an evolutionarily conserved sensor of endoplasmic reticulum (ER) stress and mediates a key branch of the unfolded protein response in eukaryotic cells. It is an ER-resident transmembrane protein that possesses Ser/Thr protein kinase and endoribonuclease (RNase) activities in its cytoplasmic region. IRE1 is activated through dimerization/oligomerization and autophosphorylation at multiple sites, acting through its RNase activity to restore the functional capacity of the ER. However, it remains poorly defined in vivo how the autophosphorylation events of endogenous IRE1 govern its dynamic activation and functional output. Here, we generated a mouse model harboring a S724A knock-in mutation (Ern1(S724A/S724A)) and investigated the importance of phosphorylation at Ser(724) within the kinase activation loop of murine IRE1 alpha. We found that in mouse embryonic fibroblast cells and in primary hepatocytes, S724A mutation resulted in markedly reduced IRE1 alpha autophosphorylation in parallel with blunted activation of its RNase activity to catalyze X-box binding protein 1 (Xbp1) mRNA splicing. Furthermore, ablation of IRE1 alpha phosphorylation at Ser(724) exacerbated ER stress-induced hepatic steatosis in tunicamycin-treated Ern1(S724A/S724A) mice. This was accompanied by significantly decreased hepatic production of spliced XBP1 protein but increased CCAAT-enhancer-binding protein homologous protein (CHOP) level, along with suppressed expression of key metabolic regulators of fatty acid beta-oxidation and lipid secretion. These results demonstrate a critical role of phosphorylation at Ser(724) of IRE1 alpha in dynamically controlling its kinase activity, and thus its autophosphorylation state, which is coupled to activation of its RNase activity in counteracting hepatic steatosis under ER stress conditions.	[Li, Yang; Huang, Shijia; Wang, Jingsi; Cai, Jie; He, Shengqi; Liu, Yong] Wuhan Univ, Hubei Key Lab Cell Homeostasis, Frontier Sci Ctr Immunol & Metab, Coll Life Sci, Wuhan, Peoples R China; [Li, Yang; Huang, Shijia; Wang, Jingsi; Cai, Jie; He, Shengqi; Liu, Yong] Wuhan Univ, Inst Adv Studies, Wuhan, Peoples R China; [Dai, Jianli] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Yan, Shuai; Huang, Zhiliang; Wang, Ping] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China; [Liu, Jianmiao] Huazhong Univ Sci & Technol, Cellular Signaling Lab, Minist Educ, Key Lab Mol Biophys, Wuhan, Peoples R China; [Dai, Jianli] Abcam Biotech Co Ltd, Hangzhou 310015, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, Y (corresponding author), Wuhan Univ, Hubei Key Lab Cell Homeostasis, Frontier Sci Ctr Immunol & Metab, Coll Life Sci, Wuhan, Peoples R China.; Liu, Y (corresponding author), Wuhan Univ, Inst Adv Studies, Wuhan, Peoples R China.	liuyong31279@whu.edu.cn		Wang, Ping/0000-0002-5168-6829; Yan, Shuai/0000-0002-9083-7749; Huang, Shijia/0000-0003-1961-4312	National Natural Science Foundation of China [62075076, 91857204, 31690102, 32021003, 91739303]; Ministry of Science and Technology of China (National Key R&D Program of China) [2018YFA0800700]; Fundamental Research Funds for the Central Universities [2042020kf1056]; Science Fund for Creative Research Group of China [61421064]; Innovation Fund of the Wuhan National Laboratory for Optoelectronics	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (National Key R&D Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); Innovation Fund of the Wuhan National Laboratory for Optoelectronics	This work was supported by grants from the National Natural Science Foundation of China (grant nos.: 91857204, 31690102, 32021003, and 91739303; to Yong Liu and J. L.) and the Ministry of Science and Technology of China (National Key R&D Program of China; grant no.: 2018YFA0800700; to Yong Liu). Supported also by Fundamental Research Funds for the Central Universities (grant no.: 2042020kf1056; to Yong Liu). P. W. acknowledges the supports from the National Natural Science Foundation of China (grant no.: 62075076), Science Fund for Creative Research Group of China (grant no.: 61421064), and Innovation Fund of the Wuhan National Laboratory for Optoelectronics.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Bae D, 2019, J CELL BIOL, V218, P1118, DOI 10.1083/jcb.201809027; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang TK, 2018, MOL CELL, V71, P629, DOI 10.1016/j.molcel.2018.06.038; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Fu D, 2014, J AM CHEM SOC, V136, P8820, DOI 10.1021/ja504199s; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Han J, 2017, GENE DEV, V31, P1417, DOI 10.1101/gad.297374.117; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang B, 2018, SMALL, V14, DOI 10.1002/smll.201703246; Huang CX, 2015, J BIOL CHEM, V290, P5367, DOI 10.1074/jbc.M114.603738; Huang SJ, 2019, J BIOL CHEM, V294, P18726, DOI 10.1074/jbc.REV119.007036; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Le Thomas A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27597-7; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Liu Y, 2015, J HEPATOL, V62, P590, DOI 10.1016/j.jhep.2014.10.022; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; MORI K, 1993, CELL, V74, P743; Prischi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4554; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401; Tang CHA, 2018, J CELL BIOL, V217, P1739, DOI 10.1083/jcb.201709137; Tian SD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13784-0; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang JM, 2017, DIABETES, V66, P177, DOI 10.2337/db16-0052; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	63	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101997	10.1016/j.jbc.2022.101997	http://dx.doi.org/10.1016/j.jbc.2022.101997			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5E0QB	35500653	Green Published, gold			2022-12-28	WOS:000865334800001
J	Khan, N; Sasmal, A; Khedri, Z; Secrest, P; Verhagen, A; Srivastava, S; Varki, N; Chen, X; Yu, H; Beddoe, T; Paton, AW; Paton, JC; Varki, A				Khan, Naazneen; Sasmal, Aniruddha; Khedri, Zahra; Secrest, Patrick; Verhagen, Andrea; Srivastava, Saurabh; Varki, Nissi; Chen, Xi; Yu, Hai; Beddoe, Travis; Paton, Adrienne W.; Paton, James C.; Varki, Ajit			Sialoglycan-binding patterns of bacterial AB5 toxin B subunits correlate with host range and toxicity, indicating evolution independent of A subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-PESTIS; SUBTILASE CYTOTOXIN; PLAGUE; PATHOGEN; MUTATION; PROTEIN; SUSCEPTIBILITY; ENTEROTOXIN; ADAPTATION; MECHANISM	Many pathogenic bacteria secrete AB5 toxins that can be virulence factors. Cytotoxic A subunits are delivered to the cytosol following B subunit binding to specific host cell surface glycans. Some B subunits are not associated with A subunits, for example, YpeB of Yersinia pestis, the etiologic agent of plague. Plague cannot be eradicated because of Y. pestis' adaptability to numerous hosts. We previously showed selective binding of other B-5 pentamers to a sialoglycan microarray, with sialic acid (Sia) preferences corresponding to those prominently expressed by various hosts, for example, N-acetylneuraminic acid (Neu5Ac; prominent in humans) or N-glycolylneuraminic acid (Neu5Gc; prominent in ruminant mammals and rodents). Here, we report that A subunit phylogeny evolved independently of B subunits and suggest a future B subunit nomenclature based on bacterial species names. We also found via phylogenetic analysis of B subunits, which bind Sias, that homologous molecules show poor correlation with species phylogeny. These data indicate ongoing lateral gene transfers between species, including mixing of A and B subunits. Consistent with much broader host range of Y. pestis, we show that YpeB recognizes all mammalian Sia types, except for 4-O-acetylated ones. Notably, YpeB alone causes dose-dependent cytotoxicity, which is abolished by a mutation (Y77F) eliminating Sia recognition, suggesting that cell proliferation and death are promoted via lectin-like crosslinking of cell surface sialoglycoconjugates. These findings help explain the host range of Y. pestis and could be important for pathogenesis. Overall, our data indicate ongoing rapid evolution of both host Sias and pathogen toxin-binding properties.	[Khan, Naazneen; Sasmal, Aniruddha; Khedri, Zahra; Secrest, Patrick; Verhagen, Andrea; Srivastava, Saurabh; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, San Diego, CA 92093 USA; [Khan, Naazneen; Sasmal, Aniruddha; Khedri, Zahra; Secrest, Patrick; Verhagen, Andrea; Srivastava, Saurabh; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Chen, Xi; Yu, Hai] Univ Calif Davis, Dept Chem, Davis, CA USA; [Beddoe, Travis] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Beddoe, Travis] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Biomed Sci, Adelaide, SA, Australia; [Beddoe, Travis] La Trobe Univ, Ctr Agri Biosci Agri Bio, Bundoora, Vic, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; Monash University; La Trobe University; University of Adelaide; La Trobe University	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, San Diego, CA 92093 USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA.	a1varki@ucsd.edu		Varki, Nissi/0000-0001-9839-1254	National Institutes of Health [R01GM32373]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Ajit Varki was supported by the National Institutes of Health grant (grant no: R01GM32373). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bevins SN, 2012, INTEGR ZOOL, V7, P99, DOI [10.1111/j.1749-4877.2012.00280.x, 10.1111/j.1749-4877.2011.00277.x]; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chaudhuri D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01632; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Connell TD, 2007, EXPERT REV VACCINES, V6, P821, DOI 10.1586/14760584.6.5.821; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Deng LQ, 2014, CELL, V159, P1290, DOI 10.1016/j.cell.2014.10.057; Dziarski R, 2006, NAT IMMUNOL, V7, P1017, DOI 10.1038/ni1006-1017; Fowler CC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11592-0; Gage KL, 2000, CLIN INFECT DIS, V30, P893, DOI 10.1086/313804; Gao X, 2017, NAT MICROBIOL, V2, P1592, DOI 10.1038/s41564-017-0033-2; Herdman BP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00214-17; Heroven AK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00146; Hinnebusch BJ, 2011, INFECT IMMUN, V79, P4984, DOI 10.1128/IAI.05307-11; Ji SN, 2017, GLYCOCONJUGATE J, V34, P21, DOI 10.1007/s10719-016-9724-9; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Littler DR, 2017, J BIOL CHEM, V292, P15143, DOI 10.1074/jbc.M117.796094; LOCHT C, 1995, BIOCHIMIE, V77, P333, DOI 10.1016/0300-9084(96)88143-0; Lu N, 2019, J AM CHEM SOC, V141, P4547, DOI 10.1021/jacs.9b00044; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MENDELSOHN J, 1971, J CLIN INVEST, V50, P818, DOI 10.1172/JCI106553; Meng CC, 2018, ANGEW CHEM INT EDIT, V57, P9003, DOI 10.1002/anie.201804373; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Naha A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008128; Ng N, 2013, ACTA CRYSTALLOGR F, V69, P912, DOI 10.1107/S1744309113018927; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Oyston PCF, 2011, ANIMALS-BASEL, V1, P242, DOI 10.3390/ani1020242; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potvin B, 1995, J BIOL CHEM, V270, P30415, DOI 10.1074/jbc.270.51.30415; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Ryva B, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00100; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Singh RS, 2016, BIOTECHNOL ADV, V34, P1018, DOI 10.1016/j.biotechadv.2016.06.002; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; SPORECKE I, 1984, J BACTERIOL, V157, P253, DOI 10.1128/JB.157.1.253-261.1984; Steensma DP, 2020, MAYO CLIN PROC, V95, pE7, DOI 10.1016/j.mayocp.2019.11.006; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; Varki A, 2009, P NATL ACAD SCI USA, V106, P14739, DOI 10.1073/pnas.0908196106; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Wang H, 2013, INFECT IMMUN, V81, P673, DOI 10.1128/IAI.01043-12; Wasik BR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00379-16; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yang RF, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01519-17	54	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101900	10.1016/j.jbc.2022.101900	http://dx.doi.org/10.1016/j.jbc.2022.101900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35398357	Green Published, gold			2022-12-28	WOS:000817175700006
J	Rutledge, BS; Choy, WY; Duennwald, ML				Rutledge, Benjamin S.; Choy, Wing-Yiu; Duennwald, Martin L.			Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTRINSICALLY DISORDERED PROTEINS; SYNUCLEIN FIBRIL FORMATION; ALPHA-SYNUCLEIN; SUBSTRATE-BINDING; STEROID-RECEPTOR; ATP BINDING; TAU; HSP70; AGGREGATION; REVEALS	The toxic accumulation of misfolded proteins as inclusions, fibrils, or aggregates is a hallmark of many neurodegenerative diseases. However, how molecular chaperones, such as heat shock protein 70 kDa (Hsp70) and heat shock protein 90 kDa (Hsp90), defend cells against the accumulation of misfolded proteins remains unclear. The ATP-dependent foldase function of both Hsp70 and Hsp90 actively transitions misfolded proteins back to their native conformation. By contrast, the ATPindependent holdase function of Hsp70 and Hsp90 prevents the accumulation of misfolded proteins. Foldase and holdase functions can protect against the toxicity associated with protein misfolding, yet we are only beginning to understand the mechanisms through which they modulate neurodegeneration. This review compares recent structural findings regarding the binding of Hsp90 to misfolded and intrinsically disordered proteins, such as tau, alpha-synuclein, and Tar DNA-binding protein 43. We propose that Hsp90 and Hsp70 interact with these proteins through an extended and dynamic interface that spans the surface of multiple domains of the chaperone proteins. This contrasts with many other Hsp90-client protein interactions for which only a single bound conformation of Hsp90 is proposed. The dynamic nature of these multidomain interactions allows for polymorphic binding of multiple conformations to vast regions of Hsp90. The holdase functions of Hsp70 and Hsp90 may thus allow neuronal cells to modulate misfolded proteins more efficiently by reducing the long-term ATP running costs of the chaperone budget. However, it remains unclear whether holdase functions protect cells by preventing aggregate formation or can increase neurotoxicity by inadvertently stabilizing deleterious oligomers.	[Rutledge, Benjamin S.; Choy, Wing-Yiu] Western Univ, Dept Biochem, London, ON, Canada; [Duennwald, Martin L.] Western Univ, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Duennwald, ML (corresponding author), Western Univ, Dept Anat & Cell Biol, London, ON, Canada.	martin.duennwald@schulich.uwo.ca		Rutledge, Benjamin/0000-0001-8490-4493				Arosi A, 2020, AMYOTROPH LAT SCL FR, V21, P51, DOI 10.1080/21678421.2019.1672749; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Burmann BM, 2020, NATURE, V577, P127, DOI 10.1038/s41586-019-1808-9; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; Chaari A, 2016, INT J BIOL MACROMOL, V83, P433, DOI 10.1016/j.ijbiomac.2015.10.089; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Csizmok V, 2016, CHEM REV, V116, P6424, DOI 10.1021/acs.chemrev.5b00548; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; de Graff AMR, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008460; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240; Ferrari L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13745-7; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Francois-Moutal L, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00301; Gu JE, 2021, CELL RES, V31, P1024, DOI 10.1038/s41422-021-00526-5; Gupta A, 2020, NEUROSCI LETT, V716, DOI 10.1016/j.neulet.2019.134678; Hagemans D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00056; Hall D, 2020, FEBS LETT, V594, P43, DOI 10.1002/1873-3468.13580; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; Jinwal UK, 2012, J BIOL CHEM, V287, P24814, DOI 10.1074/jbc.M112.367268; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kitamura A, 2018, CELL STRESS CHAPERON, V23, P1177, DOI 10.1007/s12192-018-0930-1; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kovacs GG, 2018, HAND CLINIC, V145, P355, DOI 10.1016/B978-0-12-802395-2.00025-0; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kundel F, 2018, ACS CHEM BIOL, V13, P636, DOI 10.1021/acschembio.7b01039; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lin LTW, 2021, FASEB J, V35, DOI 10.1096/fj.202002645R; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meade RM, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0329-1; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oroz J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06880-0; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Radli M, 2018, J MOL BIOL, V430, P3029, DOI 10.1016/j.jmb.2018.05.026; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P352, DOI 10.1007/s13311-015-0338-x; Sharma D, 2009, PROTEIN PEPTIDE LETT, V16, P571, DOI 10.2174/092986609788490230; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tao JH, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100613; Taylor IR, 2018, J BIOL CHEM, V293, P10796, DOI 10.1074/jbc.RA118.002234; Do TN, 2014, J CHEM THEORY COMPUT, V10, P5081, DOI 10.1021/ct5004803; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010; Uversky VN, 2015, ADV EXP MED BIOL, V870, P215, DOI 10.1007/978-3-319-20164-1_7; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI [10.1586/epr.10.36, 10.1586/EPR.10.36]; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Weickert S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6999; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Witt SN, 2013, MOL NEUROBIOL, V47, P552, DOI 10.1007/s12035-012-8325-2; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu HY, 2021, SCIENCE, V371, P585, DOI 10.1126/science.abb4309; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518	77	3	3	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101905	10.1016/j.jbc.2022.101905	http://dx.doi.org/10.1016/j.jbc.2022.101905			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35398094	gold, Green Published			2022-12-28	WOS:000860390500014
J	Sato, O; Sakai, T; Choo, YY; Ikebe, R; Watanabe, TM; Ikebe, M				Sato, Osamu; Sakai, Tsuyoshi; Choo, Young-yeon; Ikebe, Reiko; Watanabe, Tomonobu M.; Ikebe, Mitsuo			Mitochondria-associated myosin 19 processively transports mitochondria on actin tracks in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBULAR TAIL DOMAIN; AXONAL-TRANSPORT; NECK LENGTH; MOTOR; MECHANISM; BINDING; VI; DIMERIZATION; COMPLEX; PROTEIN	Mitochondria are fundamentally important in cell function, and their malfunction can cause the development of cancer, cardiovascular disease, and neuronal disorders. Myosin 19 (Myo19) shows discrete localization with mitochondria and is thought to play an important role in mitochondrial dynamics and function; however, the function of Myo19 in mitochondrial dynamics at the cellular and molecular levels is poorly understood. Critical missing information is whether Myo19 is a processive motor that is suitable for transportation of mitochondria. Here, we show for the first time that single Myo19 molecules processively move on actin filaments and can transport mitochondria in cells. We demonstrate that Myo19 dimers having a leucine zipper processively moved on cellular actin tracks in demembraned cells with a velocity of 50 to 60 nm/s and a run length of X0.4 mu m, similar to the movement of isolated mitochondria from Myo19 dimer-transfected cells on actin tracks, suggesting that the Myo19 dimer can transport mitochondria. Furthermore, we show single molecules of Myo19 dimers processively moved on single actin filaments with a large step size of X34 nm. Importantly, WT Myo19 single molecules without the leucine zipper processively move in filopodia in living cells similar to Myo19 dimers, whereas deletion of the tail domain abolished such active movement. These results suggest that Myo19 can processively move on actin filaments when two Myo19 monomers form a dimer, presumably as a result of tail- tail association. In conclusion, Myo19 molecules can directly transport mitochondria on actin tracks within living cells.	[Sato, Osamu; Sakai, Tsuyoshi; Choo, Young-yeon; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Tyler, Dept Cellular & Mol Biol, Hlth Sci Ctr, Tyler, TX 75799 USA; [Watanabe, Tomonobu M.] RIKEN Ctr Biosyst Dynam Res, Lab Comprehens Bioimaging, Kobe, Hyogo, Japan	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); RIKEN	Ikebe, M (corresponding author), Univ Texas Tyler, Dept Cellular & Mol Biol, Hlth Sci Ctr, Tyler, TX 75799 USA.	Mitsuo.lkebe@uthct.edu		Sato, Osamu/0000-0001-9913-1745	TEXAS STARS PLUS award; National Institutes of Health [RO1 HL142853]	TEXAS STARS PLUS award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the TEXAS STARS PLUS award and National Institutes of Health Grant (RO1 HL142853) to M. I.	Adikes RC, 2013, CYTOSKELETON, V70, P281, DOI 10.1002/cm.21110; AMBROSE EJ, 1956, NATURE, V178, P1194, DOI 10.1038/1781194a0; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brenner B, 2006, J MUSCLE RES CELL M, V27, P173, DOI 10.1007/s10974-006-9056-7; Cao QJ, 2019, J BIOL CHEM, V294, P11333, DOI 10.1074/jbc.RA119.007384; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hawthorne JL, 2016, CYTOSKELETON, V73, P286, DOI 10.1002/cm.21305; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kincaid MM, 2006, CELL CYCLE, V5, P2733, DOI 10.4161/cc.5.23.3521; Kruppa AJ, 2021, J CELL SCI, V134, DOI 10.1242/jcs.226084; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lu ZK, 2014, J BIOL CHEM, V289, P18535, DOI 10.1074/jbc.M114.569087; Machiyama H, 2017, BIOPHYS PHYSICOBIOL, V14, P119, DOI 10.2142/biophysico.14.0_119; Melkov A, 2018, CELL MOL LIFE SCI, V75, P163, DOI 10.1007/s00018-017-2590-1; Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oeding SJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.219469; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Quintero OA, 2012, P NATL ACAD SCI USA, V109, P17313, DOI 10.1073/pnas.1216035109; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sato O, 2017, J BIOL CHEM, V292, P10950, DOI 10.1074/jbc.M116.765966; Sato O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44237; Shneyer BI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11002-9; Shneyer BI, 2016, J CELL SCI, V129, P543, DOI 10.1242/jcs.175349; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Usaj M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11984-6; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Watanabe TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012224; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	64	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101883	10.1016/j.jbc.2022.101883	http://dx.doi.org/10.1016/j.jbc.2022.101883			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35367209	Green Published, gold			2022-12-28	WOS:000798142000008
J	Zhang, BX; Munske, GR; Timokhin, VI; Ralph, J; Davydov, DR; Vermerris, W; Sattler, SE; Kang, C				Zhang, Bixia; Munske, Gerhard R.; Timokhin, Vitaliy, I; Ralph, John; Davydov, Dmitri R.; Vermerris, Wilfred; Sattler, Scott E.; Kang, ChulHee			Functional and structural insight into the flexibility of cytochrome P450 reductases from Sorghum bicolor and its for lignin composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450 OXIDOREDUCTASE; ARABIDOPSIS-THALIANA; BIOCHEMICAL-CHARACTERIZATION; CATALYTIC MECHANISM; ELECTRON-TRANSFER; KINETIC-ANALYSIS; C REDUCTASE; PLANT; BIOSYNTHESIS; PROTEIN	Plant NADPH-dependent cytochrome P450 reductase (CPR) is a multidomain enzyme that donates electrons for hydroxylation reactions catalyzed by class II cytochrome P450 monooxygenases involved in the synthesis of many primary and secondary metabolites. These P450 enzymes include trans-cinnamate-4-hydroxylase, p-coumarate-30-hydroxylase, and ferulate-5-hydroxylase involved in monolignol biosynthesis. Because of its role in monolignol biosynthesis, alterations in CPR activity could change the composition and overall output of lignin. Therefore, to understand the structure and function of three CPR subunits from sorghum, recombinant subunits SbCPR2a, SbCPR2b, and SbCPR2c were subjected to X-ray crystallography and kinetic assays. Steady-state kinetic analyses demonstrated that all three CPR subunits supported the oxidation reactions catalyzed by SbC4H1 (CYP73A33) and structure with the well-investigated CPRs from mammals enabled us to identify critical residues of functional importance and suggested that the plant flavin mononucleotide-binding domain might be more flexible than mammalian homologs. In addition, the elucidated structure of SbCPR2b included the first observation of NADP+ in a native CPR. Overall, we conclude that the connecting domain of SbCPR2, especially its hinge region, could serve as a target to alter biomass composition in bioenergy and forage sorghums through protein engineering.	[Zhang, Bixia; Davydov, Dmitri R.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Munske, Gerhard R.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Timokhin, Vitaliy, I; Ralph, John] Univ Wisconsin, Dept Biochem, Great Lakes Bioenergy Res Ctr, 420 Henry Mall, Madison, WI 53705 USA; [Timokhin, Vitaliy, I; Ralph, John] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Vermerris, Wilfred] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Vermerris, Wilfred] Univ Florida, UF Genet Inst, Gainesville, FL 32611 USA; [Sattler, Scott E.] USDA ARS, Sorghum & Forage Res Unit, Lincoln, NE USA	Washington State University; Washington State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Kang, C (corresponding author), Washington State Univ, Dept Chem, Pullman, WA 99164 USA.	chkang@wsu.edu		Sattler, Scott/0000-0002-6814-4073; Zhang, Bixia/0000-0002-4907-3062	National Science Foundation [CHE-1804699, MCB-2043248]; Murdock Charitable Trust; US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office; US DOE's International Affairs [DEPI0000031]; US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative [2011-1006-30358]; US Department of Agriculture-Agriculture Research Service project [3042-21220-033-000-D]; DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science [DE-SC0018409]	National Science Foundation(National Science Foundation (NSF)); Murdock Charitable Trust; US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office(United States Department of Energy (DOE)); US DOE's International Affairs(United States Department of Energy (DOE)); US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative; US Department of Agriculture-Agriculture Research Service project; DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science(United States Department of Energy (DOE))	Funding and additional information-Original research was supported by grant from the National Science Foundation (grant numbers: CHE-1804699 and MCB-2043248) and Murdock Charitable Trust (to C. H. K.). W. V. acknowledges financial support from the US Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office and sponsored by the US DOE's International Affairs (grant no.: DEPI0000031) and the US Department of Agriculture-National Institute of Food and Agriculture Biomass Research and Development Initiative (grant no.: 2011-1006-30358). S. E. S. acknowledges support from US Department of Agriculture-Agriculture Research Service project (grant no.: 3042-21220-033-000-D). V. I. T. and J. R. were funded by the DOE Great Lakes Bioenergy Research Center, DOE Biological and Environmental Research Office of Science (grant no.: DE-SC0018409). And we thank Sebastien SantiniCNRS/Aix-Marseille University IGS UMR7256 for releasing the Phylogeny.fr for phylogenetic tree building.	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballard CR, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, P185, DOI 10.1016/B978-0-12-814774-0.00010-4; BENVENISTE I, 1986, BIOCHEM J, V235, P365, DOI 10.1042/bj2350365; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Campelo D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00755; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dixon RA, 2001, PHYTOCHEMISTRY, V57, P1069, DOI 10.1016/S0031-9422(01)00092-9; Ebrecht AC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56516-6; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feltus FA, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-80; Frances O, 2015, BIOPHYS J, V108, P1527, DOI 10.1016/j.bpj.2015.01.032; Freeman SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09840-8; Gou MY, 2019, PLANT CELL, V31, P1344, DOI 10.1105/tpc.18.00778; Green AR, 2014, PLANT PHYSIOL, V165, P1440, DOI 10.1104/pp.114.241729; Grinkova YV, 2013, BIOCHEM BIOPH RES CO, V430, P1223, DOI 10.1016/j.bbrc.2012.12.072; Guillaumie S, 2007, PLANTA, V226, P235, DOI 10.1007/s00425-006-0468-9; HALAKA FG, 1985, BIOPHYS J, V48, P209, DOI 10.1016/S0006-3495(85)83774-7; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORECKER BL, 1949, J BIOL CHEM, V178, P683; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; IYANAGI T, 1973, BIOCHEMISTRY-US, V12, P2297, DOI 10.1021/bi00736a018; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jiao YP, 2016, PLANT CELL, V28, P1551, DOI 10.1105/tpc.16.00373; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jun SY, 2017, PLANT PHYSIOL, V174, P2128, DOI 10.1104/pp.17.00576; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Li YD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2968; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Linger J. G., 2014, P NATL ACAD SCI USA; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Mansfield SD, 2012, NEW PHYTOL, V194, P91, DOI 10.1111/j.1469-8137.2011.04031.x; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Mothersole RG, 2016, ARCH BIOCHEM BIOPHYS, V606, P111, DOI 10.1016/j.abb.2016.07.018; Moural TW, 2017, PLANT PHYSIOL, V173, P417, DOI 10.1104/pp.16.01426; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Niu GQ, 2017, FEBS J, V284, P754, DOI 10.1111/febs.14017; OMURA T, 1962, J BIOL CHEM, V237, P1375; Padmakshan D, 2022, HOLZFORSCHUNG, V76, P133, DOI 10.1515/hf-2021-0149; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rastogi S, 2008, PLANT SCI, V174, P264, DOI 10.1016/j.plantsci.2007.11.014; RAW I, 1959, J BIOL CHEM, V234, P1867; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Rwere F, 2016, J BIOL CHEM, V291, P14639, DOI 10.1074/jbc.M116.724625; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Sattler SE, 2014, G3-GENES GENOM GENET, V4, P2115, DOI 10.1534/g3.114.014001; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; Sattler SA, 2017, PLANT PHYSIOL, V173, P1031, DOI 10.1104/pp.16.01671; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Schreiner M, 2012, CRIT REV PLANT SCI, V31, P229, DOI 10.1080/07352689.2012.664979; Scully ED, 2018, NEW PHYTOL, V217, P82, DOI 10.1111/nph.14815; Scully ED, 2016, PLANT J, V85, P378, DOI 10.1111/tpj.13112; Sellner M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031023; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shuai L, 2016, SCIENCE, V354, P329, DOI 10.1126/science.aaf7810; Simtchouk S, 2013, FEBS J, V280, P6627, DOI 10.1111/febs.12567; STANIER RY, 1954, J BIOL CHEM, V210, P799; Stone ML, 2018, ACS SUSTAIN CHEM ENG, V6, P11211, DOI 10.1021/acssuschemeng.8b02741; Sundermann A, 2013, PROTEIN SCI, V22, P1183, DOI 10.1002/pro.2307; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Sundin L, 2014, PLANT PHYSIOL, V166, P1956, DOI 10.1104/pp.114.245548; Terrett OM, 2019, CURR OPIN BIOTECH, V56, P97, DOI 10.1016/j.copbio.2018.10.010; Tetreault HM, 2020, PLANT MOL BIOL, V103, P269, DOI 10.1007/s11103-020-00991-3; Tetreault HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204153; van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Walker AM, 2016, PLANT PHYSIOL, V172, P78, DOI 10.1104/pp.16.00845; Walker AM, 2013, PLANT PHYSIOL, V162, P640, DOI 10.1104/pp.113.217836; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Watson CJW, 2001, PLANT CELL PHYSIOL, V42, P873, DOI 10.1093/pcp/pce110; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Whitelaw DA, 2015, ARCH BIOCHEM BIOPHYS, V584, P107, DOI 10.1016/j.abb.2015.09.002; Xia CW, 2018, BIOCHEMISTRY-US, V57, P945, DOI 10.1021/acs.biochem.7b01102; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Zhang BX, 2020, PLANT PHYSIOL, V183, P957, DOI 10.1104/pp.20.00406	98	2	2	13	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101761	10.1016/j.jbc.2022.101761	http://dx.doi.org/10.1016/j.jbc.2022.101761			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35202651	Green Published, gold			2022-12-28	WOS:000793502000011
J	Kirley, TL; Norman, AB; Greis, KD				Kirley, Terence L.; Norman, Andrew B.; Greis, Kenneth D.			Oxidation of specific tryptophan residues inhibits high-affinity binding of cocaine and its metabolites to a humanized anticocaine mAb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; DYE	Cocaine addiction remains a serious problem lacking an effective pharmacological treatment. Thus, we have developed a high-affinity anti-cocaine monoclonal antibody (mAb), h2E2, for the treatment of cocaine use disorders. We show that selective tryptophan (Trp) oxidation by 2,20-azobis(2-amidino propane) dihydrochloride (AAPH) resulted in a loss of high affinity binding of cocaine to this mAb. The newly developed use of excess methionine (Met) to protect mAb met residues from AAPH oxidation did not substantially attenuate the effects of oxidation on cocaine binding but greatly decreased the modification of met residues in the mAb. Similar large decreases in ligand affinity (5000-10,000-fold) upon oxidation were observed using cocaine and two cocaine metabolites, cocaethylene and benzoylecgonine, which also bind with nanomolar affinity to this h2E2 mAb. The decrease in binding affinity was accompanied by a decrease of approximately 50% in Trp fluorescence, and increases in mAb 310 to 370 nm absorbance were consistent with the presence of oxidized forms of Trp. Finally, mass spectral analysis of peptides derived from control and AAPH-oxidized mAb indicated that excess free met did effectively protect mAb met residues from oxidation, and that AAPH-oxidized mAb heavy-chain Trp33 and light-chain Trp91 residues are important for cocaine binding, consistent with a recently derived h2E2 Fab fragment crystal structure containing bound benzoylecgonine. Thus, protection of the anti-cocaine h2E2 mAb from Trp oxidation prior to its clinical administration is critical for its proposed therapeutic use in the treatment of cocaine use disorders.	[Kirley, Terence L.; Norman, Andrew B.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA; [Greis, Kenneth D.] Univ Cincinnati, Coll Med, Dept Canc Biol, Prote Lab, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kirley, TL (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA.	terry.kirley@uc.edu			National Institutes of Health National Institute on Drug Abuse [U01DA050330]; National Institutes of Health high-end instrumentation grant [S10OD026717-01]	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health high-end instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health National Institute on Drug Abuse (grant no.: U01DA050330 [to A. B. N.] ) . Mass spectrometry data for this study were collected on an Orbitrap mass spectrometer that was obtained in part through a National Institutes of Health high-end instrumentation grant (grant no.: S10OD026717-01; to K. D. G.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck A, 2019, ANTIBODIES, V8, DOI 10.3390/antib8010018; Dion MZ, 2018, J PHARM SCI-US, V107, P550, DOI 10.1016/j.xphs.2017.09.022; Dwivedi P, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0015-8; Folzer E, 2015, J PHARM SCI-US, V104, P2824, DOI 10.1002/jps.24509; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Hageman T, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-018-2545-8; Kirley TL, 2021, J IMMUNOL METHODS, V496, DOI 10.1016/j.jim.2021.113103; Kirley TL, 2021, BIOCHEM BIOPH RES CO, V535, P93, DOI 10.1016/j.bbrc.2020.12.034; Kirley TL, 2020, J IMMUNOL METHODS, V476, DOI 10.1016/j.jim.2019.112676; Kirley TL, 2018, BIOCHEM BIOPHYS REP, V16, P138, DOI 10.1016/j.bbrep.2018.10.004; Kirley TL, 2018, BIOCHEM BIOPH RES CO, V503, P944, DOI 10.1016/j.bbrc.2018.06.100; Kirley TL, 2015, HUM VACC IMMUNOTHER, V11, P458, DOI 10.4161/21645515.2014.990856; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Norman AB, 2014, DRUG METAB DISPOS, V42, P1125, DOI 10.1124/dmd.114.057034; Tan KM, 2019, ACTA CRYSTALLOGR F, V75, P697, DOI 10.1107/S2053230X19013608; Vocci F, 2005, PHARMACOL THERAPEUT, V108, P94, DOI 10.1016/j.pharmthera.2005.06.010; Wetzel HN, 2017, BIOCHEM BIOPH RES CO, V487, P690, DOI 10.1016/j.bbrc.2017.04.117; Wetzel HN, 2014, INT IMMUNOPHARMACOL, V23, P387, DOI 10.1016/j.intimp.2014.10.025; Wong JJH, 2016, J BIOMOL SCREEN, V21, P842, DOI 10.1177/1087057116646553; Zheng K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083952	20	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101689	10.1016/j.jbc.2022.101689	http://dx.doi.org/10.1016/j.jbc.2022.101689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143837	Green Published, gold			2022-12-28	WOS:000789400700006
J	Medeiros, PJJ; Pascetta, SAA; Kirsh, SMM; Al-Khazraji, BKK; Uniacke, J				Medeiros, Philip J. J.; Pascetta, Sydney A. A.; Kirsh, Sarah M. M.; Al-Khazraji, Baraa K. K.; Uniacke, James			Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; BINDING SITES; TARGET GENES; GROWTH; HIF; ACTIVATION; PROMOTES; SIGNAL; IDENTIFICATION	Neuropeptide Y (NPY) is an abundant neurohormone in the central and peripheral nervous system involved in feeding behavior, energy balance, nociception, and anxiety. Several NPY receptor (NPYR) subtypes display elevated expression in many cancers including in breast tumors where it is exploited for imaging and diagnosis. Here, we address how hypoxia, a common feature of the tumor microenvironment, influences the expression of the NPYRs. We show that NPY1R and NPY5R mRNA abundance is induced by hypoxia in a hypoxia inducible factor (HIF)-dependent manner in breast cancer cell lines MCF7 and MDA-MB-231. We demonstrate that HIFs bind to several genomic regions upstream of the NPY1R and NPY5R transcription start sites. In addition, the MAPK/ERK pathway is activated more rapidly upon NPY5R stimulation in hypoxic cells compared with normoxic cells. This pathway requires insulin-like growth factor 1 receptor (IGF1R) activity in normoxia, but not in hypoxic cells, which display resistance to the radiosensitizer and IGF1R inhibitor AG1024. Furthermore, hypoxic cells proliferate and migrate more when stimulated with NPY relative to normoxic cells and exhibit a more robust response to a Y5-specific agonist. Our data suggest that hypoxia-induced NPYRs render hypoxic cells more sensitive to NPY stimulation. Considering that breast tissue receives a constant supply of NPY, hypoxic breast tumors are the perfect storm for hyperactive NPYR. This study not only highlights a new relationship between the HIFs and NPYR expression and activity but may inform the use of chemotherapeutics targeting NPYRs and hypoxic cells.	[Medeiros, Philip J. J.; Pascetta, Sydney A. A.; Kirsh, Sarah M. M.; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Al-Khazraji, Baraa K. K.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Medeiros, Philip J. J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON, Canada	University of Guelph; McMaster University; Wilfrid Laurier University	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	juniacke@uoguelph.ca		Kirsh, Sarah/0000-0002-5261-2100	Natural Sciences and Engineering Council of Canada [04807]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding and additional information-This work was funded by the Natural Sciences and Engineering Council of Canada grant number 04807 to J. U.	Ahrens VM, 2015, CHEMMEDCHEM, V10, P164, DOI 10.1002/cmdc.201402368; Al-Khazraji BK, 2011, BIOL PROCED ONLINE, V13, P1, DOI 10.1186/1480-9222-13-9; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Czarnecka M, 2019, NEUROPEPTIDES, V73, P11, DOI 10.1016/j.npep.2018.11.008; Daimiel I, 2019, J BREAST CANCER, V22, P155, DOI 10.4048/jbc.2019.22.e26; Dimitrijevic M, 2013, AMINO ACIDS, V45, P41, DOI 10.1007/s00726-011-1185-7; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; Hofmann S, 2015, MOL PHARMACEUT, V12, P1121, DOI 10.1021/mp500601z; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khan IU, 2010, ANGEW CHEM INT EDIT, V49, P1155, DOI 10.1002/anie.200905008; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korner M, 2008, J NEUROPATH EXP NEUR, V67, P741, DOI 10.1097/NEN.0b013e318180e618; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Korner M, 2004, CLIN CANCER RES, V10, P8426, DOI 10.1158/1078-0432.CCR-04-0821; Korner M, 2004, LAB INVEST, V84, P71, DOI 10.1038/labinvest.3700009; Lecat S, 2015, CELL SIGNAL, V27, P1297, DOI 10.1016/j.cellsig.2015.03.016; Li J, 2015, ACS APPL MATER INTER, V7, P5574, DOI 10.1021/acsami.5b00270; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Magni P, 2001, ANN ONCOL, V12, pS27, DOI 10.1093/annonc/12.suppl_2.S27; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Medeiros PJ, 2013, PEPTIDES, V48, P106, DOI 10.1016/j.peptides.2013.07.029; Medeiros PJ, 2012, INT J CANCER, V131, P276, DOI 10.1002/ijc.26350; Michel MC, 1998, PHARMACOL REV, V50, P143; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nie M, 1998, REGUL PEPTIDES, V75-6, P207, DOI 10.1016/S0167-0115(98)00070-6; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pressley M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85184-8; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reubi JC, 2001, CANCER RES, V61, P4636; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2007, CANCER METAST REV, V26, P223, DOI 10.1007/s10555-007-9058-y; Sheriff S, 2010, MOL CANCER RES, V8, P604, DOI 10.1158/1541-7786.MCR-09-0301; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Tilan JU, 2013, ONCOTARGET, V4, P2487, DOI 10.18632/oncotarget.1604; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zagorac I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05742-z; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhdanov AV, 2015, BBA-BIOENERGETICS, V1847, P1254, DOI 10.1016/j.bbabio.2015.06.016	52	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101645	10.1016/j.jbc.2022.101645	http://dx.doi.org/10.1016/j.jbc.2022.101645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093384	gold, Green Published			2022-12-28	WOS:000789261900008
J	Mohamed, T; Adolph, MB; Cortez, D				Mohamed, Taha; Adolph, Madison B.; Cortez, David			Oligomerization of DNA replication regulatory protein RADX is essential to maintain replication fork stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENOME STABILITY; REGRESSION; SMARCAL1; REVERSAL	Genome integrity requires complete and accurate DNA replication once per cell division cycle. Replication stress poses obstacles to this process that must be overcome to prevent replication fork collapse. An important regulator of replication fork stability is the RAD51 protein, which promotes replication fork reversal and protects nascent DNA strands from nuclease mediated degradation. Many regulatory proteins control these RAD51 activities, including RADX, which binds both ssDNA and RAD51 at replication forks to ensure that fork reversal is confined to stalled forks. Many ssDNA-binding proteins function as hetero-or homo-oligomers. In this study, we addressed whether this is also the case for RADX. Using biochemical and genetic approaches, we found that RADX acts as a homooligomer to control replication fork stability. RADX oligomerizes using at least two different interaction surfaces, including one mapped to a C-terminal region. We demonstrate that mutations in this region prevent oligomerization and prevent RADX function in cells, and that addition of a heterologous dimerization domain to the oligomerization mutants restored their ability to regulate replication. Taken together, our results demonstrate that like many ssDNA-binding proteins, oligomerization is essential for RADX-mediated regulation of genome stability.	[Mohamed, Taha; Adolph, Madison B.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA.	david.cortez@vanderbilt.edu	Mohamed, Taha M./GQH-0736-2022	Mohamed, Taha M./0000-0002-2752-9663	National Institutes of Health [R01GM116616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-Funding for this work was provided by National Institutes of Health grant R01GM116616 to D. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adolph MB, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.036; Bai GS, 2020, MOL CELL, V78, P1237, DOI 10.1016/j.molcel.2020.04.031; Berti M, 2020, NAT REV MOL CELL BIO, V21, P633, DOI 10.1038/s41580-020-0257-5; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2018, CELL REP, V24, P538, DOI 10.1016/j.celrep.2018.06.061; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cortez D, 2019, MOL CELL, V74, P866, DOI 10.1016/j.molcel.2019.04.027; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Dungrawala H, 2017, MOL CELL, V67, P374, DOI 10.1016/j.molcel.2017.06.023; Fugger K, 2015, CELL REP, V10, P1749, DOI 10.1016/j.celrep.2015.02.028; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Krishnamoorthy A, 2021, MOL CELL, V81, P3007, DOI 10.1016/j.molcel.2021.05.014; Liu W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc3598; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schubert L, 2017, EMBO REP, V18, P1991, DOI 10.15252/embr.201744877; Vujanovic M, 2017, MOL CELL, V67, P882, DOI 10.1016/j.molcel.2017.08.010; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang HS, 2020, NUCLEIC ACIDS RES, V48, P7834, DOI 10.1093/nar/gkaa559	22	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101672	10.1016/j.jbc.2022.101672	http://dx.doi.org/10.1016/j.jbc.2022.101672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120927	gold, Green Published			2022-12-28	WOS:000791230900008
J	Wall, CTJ; Lefebvre, G; Metairon, S; Descombes, P; Wiederkehr, A; Santo-Domingo, J				Wall, Christopher Tadhg James; Lefebvre, Gregory; Metairon, Sylviane; Descombes, Patrick; Wiederkehr, Andreas; Santo-Domingo, Jaime			Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-SYNTHESIS; GENE-EXPRESSION; CELL BIOLOGY; DEGRADATION; BINDING; PHOSPHORYLATION; INHIBITION; METABOLISM; ATF4	Mitochondrial dysfunction induces a strong adaptive retrograde signaling response; however, many of the downstream effectors of this response remain to be discovered. Here, we studied the shared transcriptional responses to three different mitochondrial respiratory chain inhibitors in human primary skin fibroblasts using QuantSeq 3 '-RNA-sequencing. We found that genes involved in the mevalonate pathway were concurrently downregulated, irrespective of the respiratory chain complex affected. Targeted metabolomics demonstrated that impaired mitochondrial respiration at any of the three affected complexes also had functional consequences on the mevalonate pathway, reducing levels of cholesterol precursor metabolites. A deeper study of complex I inhibition showed a reduced activity of endoplasmic reticulum-bound sterol-sensing enzymes through impaired processing of the transcription factor Sterol Regulatory Element-Binding Protein 2 and accelerated degradation of the endoplasmic reticulum cholesterol-sensors squalene epoxidase and HMG-CoA reductase. These adaptations of mevalonate pathway activity affected neither total intracellular cholesterol levels nor the cellular free (nonesterified) cholesterol pool. Finally, measurement of intracellular cholesterol using the fluorescent cholesterol binding dye filipin revealed that complex I inhibition elevated cholesterol on intracellular compartments. Taken together, our study shows that mitochondrial respiratory chain dysfunction elevates intracellular free cholesterol levels and therefore attenuates the expression of mevalonate pathway enzymes, which lowers endogenous cholesterol biosynthesis, disrupting the metabolic output of the mevalonate pathway. We conclude that intracellular disturbances in cholesterol homeostasis may alter systemic cholesterol management in diseases associated with declining mitochondrial function.	[Wall, Christopher Tadhg James; Wiederkehr, Andreas; Santo-Domingo, Jaime] Soc Produits Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland; [Wall, Christopher Tadhg James; Wiederkehr, Andreas] Ecole Polytech Fed Lausanne, Inst Bioengn, Life Sci Fac, Lausanne, Switzerland; [Lefebvre, Gregory; Metairon, Sylviane; Descombes, Patrick] Soc Prod Nestle SA, Nestle Inst Food Safety & Analyt Sci, Nestle Res, Lausanne, Switzerland; [Santo-Domingo, Jaime] Univ Valladolid, Fac Med, Unidad Excelencia Inst Biol & Genet Mol IBGM, Dept Biochem & Mol Biol, Valladolid, Spain; [Santo-Domingo, Jaime] CSIC, Valladolid, Spain	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nestle SA; Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Wiederkehr, A; Santo-Domingo, J (corresponding author), Soc Produits Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland.; Wiederkehr, A (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Life Sci Fac, Lausanne, Switzerland.; Santo-Domingo, J (corresponding author), Univ Valladolid, Fac Med, Unidad Excelencia Inst Biol & Genet Mol IBGM, Dept Biochem & Mol Biol, Valladolid, Spain.; Santo-Domingo, J (corresponding author), CSIC, Valladolid, Spain.	andreas.wiederkehr@epfl.ch; jaime.santo-domingo@uva.es		Lefebvre, Greg/0000-0001-7519-2316; Wall, Christopher/0000-0001-7807-4534; Santo Domingo, Jaime/0000-0001-5501-0482				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Distelmaier F, 2015, BBA-MOL BASIS DIS, V1852, P529, DOI 10.1016/j.bbadis.2014.12.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Bartolome A, 2017, HUM MOL GENET, V26, P2493, DOI 10.1093/hmg/ddx144; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kuhl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7; Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Ribatti D, 2017, EXP CELL RES, V359, P17, DOI 10.1016/j.yexcr.2017.06.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Sprouffske K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1016-7; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilhelm LP, 2019, METHODS MOL BIOL, V1949, P137, DOI 10.1007/978-1-4939-9136-5_11; Zheng B., 2011, AMPK PHOSPHORYLATES; Zorova L. D., 2018, ANAL BIOCHEM	50	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101652	10.1016/j.jbc.2022.101652	http://dx.doi.org/10.1016/j.jbc.2022.101652			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101444	Green Published, gold			2022-12-28	WOS:000794865600001
J	Wang, YQ; Zhang, X; Yao, HY; Chen, XC; Shang, L; Li, P; Cui, XJ; Zeng, J				Wang, Yaoqing; Zhang, Xiao; Yao, Haoya; Chen, Xiaocui; Shang, Lin; Li, Ping; Cui, Xiaojuan; Zeng, Jia			Peroxisome-generated succinate induces lipid accumulation and oxidative stress in the kidneys of diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ALBUMIN PERMEABILITY; ISOLATED RAT GLOMERULI; FATTY-ACID OXIDATION; BETA-OXIDATION; DICARBOXYLIC-ACIDS; OMEGA-OXIDATION; COA THIOESTERASE; RECEPTOR GPR91; ANGIOTENSIN-II; LIVER	Diabetes normally causes lipid accumulation and oxidative stress in the kidneys, which plays a critical role in the onset of diabetic nephropathy; however, the mechanism by which dysregulated fatty acid metabolism increases lipid and reactive oxygen species (ROS) formation in the diabetic kidney is not clear. As succinate is remarkably increased in the diabetic kidney, and accumulation of succinate suppresses mitochondrial fatty acid oxidation and increases ROS formation, we hypothesized that succinate might play a role in inducing lipid and ROS accumulation in the diabetic kidney. Here we demonstrate a novel mechanism by which diabetes induces lipid and ROS accumulation in the kidney of diabetic animals. We show that enhanced oxidation of dicarboxylic acids by peroxisomes leads to lipid and ROS accumulation in the kidney of diabetic mice via the metabolite succinate. Furthermore, specific suppression of peroxisomal beta-oxidation improved diabetes-induced nephropathy by reducing succinate generation and attenuating lipid and ROS accumulation in the kidneys of the diabetic mice. We suggest that peroxisome-generated succinate acts as a pathological molecule inducing lipid and ROS accumulation in kidney, and that specifically targeting peroxisomal beta-oxidation might be an effective strategy in treating diabetic nephropathy and related metabolic disorders.	[Wang, Yaoqing; Zhang, Xiao; Yao, Haoya; Chen, Xiaocui; Shang, Lin; Li, Ping; Cui, Xiaojuan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			Distinguished Professor Funds from Hunan University of Science and Technology	Distinguished Professor Funds from Hunan University of Science and Technology	Supported by Distinguished Professor Funds from Hunan University of Science and Technology.	Ackrell B A, 1978, Methods Enzymol, V53, P466; Antonenkov E. D., 2004, AM J PHYSIOL-CELL PH, V287, pC1623; BERGSETH S, 1988, BIOCHIM BIOPHYS ACTA, V961, P103, DOI 10.1016/0005-2760(88)90135-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnet F, 2000, DIABETES METAB, V26, P254; BREMER J, 1966, BIOCHIM BIOPHYS ACTA, V116, P1, DOI 10.1016/0005-2760(66)90087-7; BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Chen XC, 2020, J BIOL CHEM, V295, P10168, DOI 10.1074/jbc.RA120.013583; De Vries A. P. J., 2014, FATTY KIDNEY EMERGIN; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; EATON S, 1994, EUR J BIOCHEM, V220, P671, DOI 10.1111/j.1432-1033.1994.tb18668.x; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; He AY, 2020, MOL CELL, V79, P30, DOI 10.1016/j.molcel.2020.05.007; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; HORIE S, 1981, J BIOCHEM, V90, P1691, DOI 10.1093/oxfordjournals.jbchem.a133645; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Inouye M, 2000, ATHEROSCLEROSIS, V148, P197, DOI 10.1016/S0021-9150(99)00263-4; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Kakizawa H, 2004, HORM METAB RES, V36, P458, DOI 10.1055/s-2004-825725; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; KING MT, 1988, METHOD ENZYMOL, V166, P70; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; KREBS HA, 1961, BIOCHEM J, V79, P537, DOI 10.1042/bj0790537; LATIPAA PM, 1988, ANAL BIOCHEM, V171, P67, DOI 10.1016/0003-2697(88)90125-X; LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1987, J INHERIT METAB DIS, V10, P11, DOI 10.1007/BF01812843; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LIEBICH HM, 1986, J CHROMATOGR, V379, P347, DOI 10.1016/S0378-4347(00)80689-1; MARKWELL MA, 1973, J BIOL CHEM, V248, P3426; McCarthy ET, 1998, J AM SOC NEPHROL, V9, P433; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; MORTENSEN PB, 1980, BIOCHIM BIOPHYS ACTA, V620, P177, DOI 10.1016/0005-2760(80)90199-X; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; Okada M, 2002, KIDNEY INT, V61, P113, DOI 10.1046/j.1523-1755.2002.00107.x; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Peti-Peterdi J, 2013, PFLUG ARCH EUR J PHY, V465, P53, DOI 10.1007/s00424-012-1130-y; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; PREISS B, 1964, J BIOL CHEM, V239, P85; QUANT PA, 1989, BIOCHEM J, V262, P159, DOI 10.1042/bj2620159; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; SCHIFFERDECKER J, 1974, LIFE SCI, V14, P1487, DOI 10.1016/0024-3205(74)90159-3; Sharma R, 2000, KIDNEY INT, V58, P131, DOI 10.1046/j.1523-1755.2000.00148.x; SINGH B, 1982, H-S Z PHYSIOL CHEM, V363, P920; SMITH CM, 1974, J BIOL CHEM, V249, P1497; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; Veeger C., 1969, METHODS ENZYMOL, V13, P524; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; WADA F, 1977, BIOCHIM BIOPHYS ACTA, V487, P261, DOI 10.1016/0005-2760(77)90002-9; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532; Zhang X, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100622	66	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101660	10.1016/j.jbc.2022.101660	http://dx.doi.org/10.1016/j.jbc.2022.101660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35124006	gold, Green Published			2022-12-28	WOS:000794865600008
J	Xiao, MM; Zhang, SY; Liu, Z; Mo, YQ; Wang, H; Zhao, X; Yang, X; Boohaker, RJ; Chen, Y; Han, YM; Liu, H; Xu, B				Xiao, Mingming; Zhang, Siyue; Liu, Zhuang; Mo, Yaqi; Wang, Han; Zhao, Xu; Yang, Xue; Boohaker, Rebecca J.; Chen, Yang; Han, Yamei; Liu, Hong; Xu, Bo			Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BREAKS; INSTABILITY; INHIBITION; ACTIVATION; STABILITY; REVEALS; BIOLOGY; CANCER; CELLS	Both the DNA damage response (DDR) and the mitotic checkpoint are critical for the maintenance of genomic stability. Among proteins involved in these processes, the ataxia-telangiectasia mutated (ATM) kinase is required for both activation of the DDR and the spindle assembly checkpoint (SAC). In mitosis without DNA damage, the enzymatic activity of ATM is enhanced; however, substrates of ATM in mitosis are unknown. Using stable isotope labeling of amino acids in cell culture mass spectrometry analysis, we identified a number of proteins that can potentially be phosphorylated by ATM during mitosis. This list is highly enriched in proteins involved in cell cycle regulation and the DDR. Among them, we further validated that ATM phosphorylated budding uninhibited by benzimidazoles 3 (Bub3), a major component of the SAC, on serine 135 (Ser135) both in vitro and in vivo. During mitosis, this phosphorylation promoted activation of another SAC component, benzimidazoles 1. Mutation of Bub3 Ser135 to alanine led to a defect in SAC activation. Furthermore, we found that ATM-mediated phosphorylation of Bub3 on Ser135 was also induced by ionizing radiation-induced DNA damage. However, this event resulted in independent signaling involving interaction with the Ku70-Ku80-DNA-PKcs sensor/kinase complex, leading to efficient nonhomologous end-joining repair. Taken together, we highlight the functional significance of the crosstalk between the kinetochore-oriented signal and double-strand break repair pathways via ATM phosphorylation of Bub3 on Ser135.	[Xiao, Mingming; Xu, Bo] Chongqing Univ Canc Hosp, Chongqing Key Lab Intelligent Oncol Breast Canc, Chongqing, Peoples R China; [Xiao, Mingming; Xu, Bo] Chongqing Univ, Sch Med, Chongqing, Peoples R China; [Xiao, Mingming; Zhang, Siyue; Liu, Zhuang; Mo, Yaqi; Wang, Han; Zhao, Xu; Yang, Xue; Chen, Yang; Han, Yamei; Liu, Hong; Xu, Bo] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Tianjins Clin Res Ctr Ca, Dept Biochem & Mol Biol,Key Lab Canc Prevent &, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin, Peoples R China; [Xiao, Mingming] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China; [Boohaker, Rebecca J.; Xu, Bo] Southern Res Inst, Dept Oncol, Birmingham, AL 35205 USA	Chongqing University; Tianjin Medical University; Fudan University	Xu, B (corresponding author), Chongqing Univ Canc Hosp, Chongqing Key Lab Intelligent Oncol Breast Canc, Chongqing, Peoples R China.; Xu, B (corresponding author), Chongqing Univ, Sch Med, Chongqing, Peoples R China.; Xu, B (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Tianjins Clin Res Ctr Ca, Dept Biochem & Mol Biol,Key Lab Canc Prevent &, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin, Peoples R China.; Xu, B (corresponding author), Southern Res Inst, Dept Oncol, Birmingham, AL 35205 USA.	xubo731@cqu.edu.cn			National Natural Science Foundation of China [81974464, 81672743, 82003237]; Beijing Tianjin Hebei basic research cooperation project [19JCZDJC64500]; Shenzhen Basic Research Project [JCYJ20160331114230843]; US National Institutes of Health [R01CA133093]; Tianjin Medical University Cancer Institute and Hospital Innovation Fund [:1803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Tianjin Hebei basic research cooperation project; Shenzhen Basic Research Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Medical University Cancer Institute and Hospital Innovation Fund	This work was supported by the National Natural Science Foundation of China (grant nos.: 81974464 and 81672743; to B. X.), Beijing Tianjin Hebei basic research cooperation project (grant no.: 19JCZDJC64500(Z); to B. X.), the National Natural Science Foundation of China (grant no.: 82003237; to Y. H.), Shenzhen Basic Research Project (grant no.: JCYJ20160331114230843; to B. X.), the US National Institutes of Health grant (grant no.:R01CA133093; to B. X.), and the Tianjin Medical University Cancer Institute and Hospital Innovation Fund (grant no.:1803; to M. X.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Blackford AN, 2020, TRENDS BIOCHEM SCI, V45, P321, DOI 10.1016/j.tibs.2019.12.010; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; de Voer RM, 2013, GASTROENTEROLOGY, V145, P544, DOI 10.1053/j.gastro.2013.06.001; Derive N, 2015, J CELL BIOL, V211, P517, DOI 10.1083/jcb.201504059; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Landmann C, 2020, J CELL SCI, V133, DOI 10.1242/jcs.244442; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Levy A, 2018, MOVEMENT DISORD, V33, P1238, DOI 10.1002/mds.27319; Li YM, 2018, MOL CELL PROTEOMICS, V17, P607, DOI 10.1074/mcp.RA118.000586; Liu CL, 2019, CANCER RES, V79, P2392, DOI 10.1158/0008-5472.CAN-18-3024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morales AG, 2013, CHILD NERV SYST, V29, P2241, DOI 10.1007/s00381-013-2175-8; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; Rigbolt KTG, 2012, SEMIN CELL DEV BIOL, V23, P863, DOI 10.1016/j.semcdb.2012.05.006; Shindo K, 2017, J CLIN ONCOL, V35, P3382, DOI 10.1200/JCO.2017.72.3502; Siemeister G, 2019, CLIN CANCER RES, V25, P1404, DOI 10.1158/1078-0432.CCR-18-0628; Silva PMA, 2019, ORAL DIS, V25, P1291, DOI 10.1111/odi.13089; Subramanian C, 2019, SURGERY, V165, P202, DOI 10.1016/j.surg.2018.04.080; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; Terradas M, 2016, ARCH TOXICOL, V90, P2657, DOI 10.1007/s00204-016-1818-4; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Toulany M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010025; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yu HT, 2005, CELL CYCLE, V4, P262	38	0	0	7	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101632	10.1016/j.jbc.2022.101632	http://dx.doi.org/10.1016/j.jbc.2022.101632			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35085551	Green Published, gold			2022-12-28	WOS:000821051800014
J	Hashizume, M; Takashima, A; Iwasaki, M				Hashizume, Mei; Takashima, Ayako; Iwasaki, Masaharu			A small stem-loop-forming region within the 3 '-UTR of a nonpolyadenylated LCMV mRNA promotes translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; INTERGENIC REGION; LASSA FEVER; ARENAVIRUS; SEQUENCE; TRANSCRIPTION; NSP3; INHIBITOR	Mammalian arenavirus (mammarenavirus) mRNAs are characterized by 5'-capped and 3'-nonpolyadenylated untranslated regions (UTRs). We previously reported that the nonpolyadenylated 3'-UTR of viral mRNA (vmRNA), which is derived from the noncoding intergenic region (IGR), regulates viral protein levels at the posttranscriptional level. This finding provided the basis for the development of novel live-attenuated vaccines (LAVs) against human pathogenic mammarenaviruses. Detailed information about the roles of specific vmRNA 3'-UTR sequences in controlling translation efficiency will help in understanding the mechanism underlying attenuation by IGR manipulations. Here, we characterize the roles of cis-acting mRNA regulatory sequences of a prototypic mammarenavirus, lymphocytic choriomeningitis virus (LCMV), in modulating translational efficiency. Using in vitro transcribed RNA mimics encoding a reporter gene, we demonstrate that the 3'-UTR of nucleoprotein (NP) mRNA without a poly(A) tail promotes translation in a poly(A)-binding protein-independent manner. Comparison with the 3'-UTR of glycoprotein precursor mRNA, which is translated less efficiently, revealed that a 10-nucleotide sequence proximal to the NP open reading frame is essential for promoting translation. Modification of this 10-nucleotide sequence also impacted reporter gene expression in recombinant LCMV. Our findings will enable rational design of the 10-nucleotide sequence to further improve our mammarenavirus LAV candidates and to develop a novel LCMV vector capable of controlling foreign gene expression.	[Hashizume, Mei; Takashima, Ayako; Iwasaki, Masaharu] Osaka Univ, Int Res Ctr Infect Dis, Res Inst Microbial Dis, Lab Emerging Viral Dis, Suita, Osaka, Japan; [Iwasaki, Masaharu] Osaka Univ, Ctr Infect Dis Educ & Res CiDER, Suita, Osaka, Japan	Osaka University; Osaka University	Iwasaki, M (corresponding author), Osaka Univ, Int Res Ctr Infect Dis, Res Inst Microbial Dis, Lab Emerging Viral Dis, Suita, Osaka, Japan.; Iwasaki, M (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res CiDER, Suita, Osaka, Japan.	miwasaki@biken.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [18H06144, 19H03477]; Japan Agency for Medical Research and Development (AMED) [JP20fm0208101]; Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokyo Biochemical Research Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	This research was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 18H06144 and 19H03477, to M. I.) and the Japan Agency for Medical Research and Development (AMED) (grant number JP20fm0208101, to M. I.), the Tokyo Biochemical Research Foundation (to M. I.), and the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (to M. I.).	Aviner R, 2021, NATURE, V596, P558, DOI 10.1038/s41586-021-03851-2; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Barton LL, 2002, AM J OBSTET GYNECOL, V187, P1715, DOI 10.1067/mob.2002.126297; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bergeron E, 2012, J VIROL, V86, P10759, DOI 10.1128/JVI.01144-12; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Buchmeier M.J., 2013, FIELDS VIROLOGY, V6, P1283; Cai YY, 2020, MBIO, V11, DOI 10.1128/mBio.00186-20; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Eberhardt KA, 2019, INT J INFECT DIS, V87, P15, DOI 10.1016/j.ijid.2019.07.015; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; Golden JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04889-x; Haridhasapavalan KK, 2019, GENE, V686, P146, DOI 10.1016/j.gene.2018.11.069; IAPALUCCI S, 1991, VIROLOGY, V182, P269, DOI 10.1016/0042-6822(91)90670-7; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Iwasaki M, 2016, J VIROL, V90, P3187, DOI 10.1128/JVI.03145-15; Iwasaki M, 2015, J VIROL, V89, P12166, DOI 10.1128/JVI.02075-15; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Lee KJ, 2002, J VIROL, V76, P6393, DOI 10.1128/JVI.76.12.6393-6397.2002; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Martinez-Sobrido L, 2016, METHODS MOL BIOL, V1403, P313, DOI 10.1007/978-1-4939-3387-7_17; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Peters CJ, 2006, NEW ENGL J MED, V354, P2208, DOI 10.1056/NEJMp068021; Pinschewer DD, 2005, J VIROL, V79, P4519, DOI 10.1128/JVI.79.7.4519-4526.2005; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; SINGH MK, 1987, VIROLOGY, V161, P448, DOI 10.1016/0042-6822(87)90138-3; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101576	10.1016/j.jbc.2022.101576	http://dx.doi.org/10.1016/j.jbc.2022.101576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026225	gold, Green Published			2022-12-28	WOS:000761371500008
J	Aboheimed, GI; AlRasheed, MM; Almudimeegh, S; Pena-Guerra, KA; Cardona-Londono, KJ; Salih, MA; Seidahmed, MZ; Al-Mohanna, F; Colak, D; Harvey, RJ; Harvey, K; Arold, ST; Kaya, N; Ruiz, AJ				Aboheimed, Ghada, I; AlRasheed, Maha M.; Almudimeegh, Sultan; Pena-Guerra, Karla A.; Cardona-Londono, Kelly J.; Salih, Mustafa A.; Seidahmed, Mohammed Z.; Al-Mohanna, Futwan; Colak, Dilek; Harvey, Robert J.; Harvey, Kirsten; Arold, Stefan T.; Kaya, Namik; Ruiz, Arnaud J.			Clinical, genetic, and functional characterization of the glycine receptor beta-subunit A455P variant in a family affected by hyperekplexia syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; GLRB; DOMINANT; SLC6A5; SERVER	Hyperekplexia is a rare neurological disorder characterized by exaggerated startle responses affecting newborns with the hallmark characteristics of hypertonia, apnea, and noise or touch-induced nonepileptic seizures. The genetic causes of the disease can vary, and several associated genes and mutations have been reported to affect glycine receptors (GlyRs); however, the mechanistic links between GlyRs and hyperekplexia are not yet understood. Here, we describe a patientwith hyperekplexia froma consanguineous family. Extensive genetic screening using exome sequencing coupled with autozygome analysis and iterative filtering supplemented by in silico prediction identified that the patient carries the homozygous missense mutation A455P in GLRB, which encodes the GlyR beta-subunit. To unravel the physiological and molecular effects of A455PonGlyRs, weused electrophysiology inaheterologous system as well as immunocytochemistry, confocal microscopy, and cellular biochemistry. We found a reduction in glycine-evoked currents in N2A cells expressing the mutation compared toWT cells. Western blot analysis also revealed a reduced amount of GlyR beta protein both in cell lysates andisolatedmembranefractions. In line with the above observations, coimmunoprecipitation assays suggested that the GlyR alpha(1)-subunit retained coassembly with beta(A455P) to form membrane-bound heteromeric receptors. Finally, structural modeling showed that the A455P mutation affected the interaction between theGlyR beta-subunit transmembrane domain 4 and the other helices of the subunit. Taken together, our study identifies and validates a novel loss-of-function mutation in GlyRs whose pathogenicity is likely to cause hyperekplexia in the affected individual.	[Aboheimed, Ghada, I; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Ctr Genom Med, Dept Translat Genom, Riyadh, Saudi Arabia; [Aboheimed, Ghada, I; AlRasheed, Maha M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia; [Aboheimed, Ghada, I; Almudimeegh, Sultan; Harvey, Kirsten; Ruiz, Arnaud J.] UCL, Sch Pharm, Dept Pharmacol, London, England; [Almudimeegh, Sultan] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Pena-Guerra, Karla A.; Cardona-Londono, Kelly J.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Salih, Mustafa A.; Arold, Stefan T.] King Saud Univ, Coll Med, Dept Pediat, Riyadh, Saudi Arabia; [Seidahmed, Mohammed Z.] Secur Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Al-Mohanna, Futwan] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh, Saudi Arabia; [Harvey, Robert J.] Univ Sunshine Coast, Sch Hlth & Behav Sci, Maroochydore, Qld, Australia; [Harvey, Robert J.] Sunshine Coast Hlth Inst, Birtinya, Qld, Australia; [Arold, Stefan T.] Univ Montpellier, Ctr Biol Struct, INSERM, CNRS, Montpellier, France	King Faisal Specialist Hospital & Research Center; King Saud University; University of London; University College London; University of London School of Pharmacy; King Saud University; King Abdullah University of Science & Technology; King Saud University; Security Forces Hospital - Saudi Arabia; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; University of the Sunshine Coast; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Kaya, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Ctr Genom Med, Dept Translat Genom, Riyadh, Saudi Arabia.; Ruiz, AJ (corresponding author), UCL, Sch Pharm, Dept Pharmacol, London, England.	nkaya@kfshrc.edu.sa; a.ruiz@ucl.ac.uk	Aboheimed, Ghada I./GXV-3323-2022; Harvey, Robert/D-3994-2016	Aboheimed, Ghada I./0000-0002-4752-6363; Harvey, Robert/0000-0001-5956-6664; Colak, Dilek/0000-0001-6485-8768; Almudimeegh, Sultan/0000-0003-4215-0157; Pena Guerra, Karla Angelica/0000-0003-1445-994X	External Joint Supervision Program, King Saud University; King Abdullah University of Science and Technology, Saudi Arabia; Office of Sponsored Research [FCC/1/1976-25, REI/1/4446-01]; King Salman Center for Disability Research [RAC#2180-004]; King Saud University, Saudi Arabia [RSP 2020/38]	External Joint Supervision Program, King Saud University; King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology); Office of Sponsored Research; King Salman Center for Disability Research; King Saud University, Saudi Arabia(King Saud University)	G. I. A. was sponsored by a PhD studentship provided by the External Joint Supervision Program, King Saud University. S. T. A., K. A. P.-G., and K. J. C.-L. were supported by the King Abdullah University of Science and Technology, Saudi Arabia through the baseline fund and the Office of Sponsored Research, under awards numbers FCC/1/1976-25 and REI/1/4446-01. N. K. was supported by King Salman Center for Disability Research (Grant No: RAC#2180-004). M. A. S. was supported by the Researchers Supporting Project grant (RSP 2020/38), King Saud University, Saudi Arabia. The funders had no role in study design, data collection, and analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Owain M, 2012, CLIN GENET, V81, P479, DOI 10.1111/j.1399-0004.2011.01661.x; Alkuraya FS, 2013, CLIN GENET, V84, P203, DOI 10.1111/cge.12131; Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chelban V, 2020, EUR J NEUROL, V27, P334, DOI 10.1111/ene.14082; Chung SK, 2013, HUM MOL GENET, V22, P927, DOI 10.1093/hmg/dds498; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Elmslie FV, 1996, J MED GENET, V33, P435, DOI 10.1136/jmg.33.5.435; Estevez-Fraga C, 2020, PARKINSONISM RELAT D, V79, P97, DOI 10.1016/j.parkreldis.2020.08.016; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Kasaragod VB, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00317; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Lee CG, 2013, J CHILD NEUROL, V28, P90, DOI 10.1177/0883073812441058; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Pagel KA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007112; Piro I, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.745275; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Rea R, 2002, EUR J NEUROSCI, V16, P186, DOI 10.1046/j.1460-9568.2002.02054.x; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Sanderson Leslie E, 2021, Brain, V144, P769, DOI 10.1093/brain/awaa459; Schaefer N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00291; Schaefer N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00167; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sylantyev S, 2013, NAT PROTOC, V8, P1299, DOI 10.1038/nprot.2013.075; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306; Wu ZY, 2020, J PHYSIOL-LONDON, V598, P3417, DOI 10.1113/JP279803; Yu HL, 2021, NEURON, V109, P2707, DOI 10.1016/j.neuron.2021.08.019; Zhu HT, 2021, NATURE, V599, P513, DOI 10.1038/s41586-021-04022-z	47	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102018	10.1016/j.jbc.2022.102018	http://dx.doi.org/10.1016/j.jbc.2022.102018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4Y3JY	35526563	Green Published, gold			2022-12-28	WOS:000861425800001
J	Gomes, MT; Palasiewicz, K; Gadiyar, V; Lahey, K; Calianese, D; Birge, RB; Ucker, DS				Gomes, Marta T.; Palasiewicz, Karol; Gadiyar, Varsha; Lahey, Kevin; Calianese, David; Birge, Raymond B.; Ucker, David S.			Phosphatidylserine externalization by apoptotic cells is dispensable for specific recognition leading to innate apoptotic immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMPAIRED UPTAKE; NECROTIC CELLS; MICE LACKING; CLEARANCE; DEATH; MACROPHAGES; PHAGOCYTOSIS; CASPASES; INDUCTION	Surface determinants newly expressed by apoptotic cells that are involved in triggering potent immunosuppressive responses, referred to as "innate apoptotic immunity (IAI)" have not been characterized fully. It is widely assumed, often implicitly, that phosphatidylserine, a phospholipid normally cloistered in the inner leaflet of cells and externalized specifically during apoptosis, is involved in triggering IAI, just as it plays an essential role in the phagocytic recognition of apoptotic cells. It is notable, however, that the triggering of IAI in responder cells is not dependent on the engulfment of apoptotic cells by those responders. Contact between the responder and the apoptotic target, on the other hand, is necessary to elicit IAI. Previously, we demonstrated that exposure of protease-sensitive determinants on the apoptotic cell surface are essential for initiating IAI responses; exposed glycolytic enzyme molecules were implicated in particular. Here, we report our analysis of the involvement of externalized phosphatidylserine in triggering IAI. To analyze the role of phosphatidylserine, we employed a panel of target cells that either externalized phosphatidylserine constitutively, independently of apoptosis, or did not, as well as their WT parental cells that externalized the phospholipid in an apoptosis-dependent manner. We found that the externalization of phosphatidylserine, which can be fully uncoupled from apoptosis, is neither sufficient nor necessary to trigger the profound immunomodulatory effects of IAI. These results reinforce the view that apoptotic immunomodulation and phagocytosis are dissociable and further underscore the significance of protein determinants localized to the cell surface during apoptosis in triggering innate apoptotic immunity.	[Gomes, Marta T.; Palasiewicz, Karol; Ucker, David S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Gadiyar, Varsha; Lahey, Kevin; Calianese, David; Birge, Raymond B.] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Ucker, David S.] Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Indianapolis, IN 46202 USA; [Palasiewicz, Karol] Loyola Univ, Stritch Sch Med, Dept Surg, Maywood, IL 60153 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Loyola University Chicago	Ucker, DS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.; Ucker, DS (corresponding author), Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Indianapolis, IN 46202 USA.	duck@uic.edu		Lahey, Kevin/0000-0002-9105-4471	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program [201923/2014-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M. T. G. received support from a fellowship (No. 201923/2014-9) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Science without Borders program.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bozelli JC, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183241; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chang SH, 2002, EXP CELL RES, V277, P15, DOI 10.1006/excr.2002.5539; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Davies SP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00044; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferguson TA, 2003, IMMUNOL REV, V193, P111, DOI 10.1034/j.1600-065X.2003.00042.x; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Giampazolias E, 2017, NAT CELL BIOL, V19, P1116, DOI 10.1038/ncb3596; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Ke FFS, 2018, CELL, V173, P1217, DOI 10.1016/j.cell.2018.04.036; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Legrand AJ, 2019, MOL CELL, V76, P232, DOI 10.1016/j.molcel.2019.09.006; Lorent JH, 2020, NAT CHEM BIOL, V16, P644, DOI 10.1038/s41589-020-0529-6; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; McArthur K, 2018, TRENDS CELL BIOL, V28, P475, DOI 10.1016/j.tcb.2018.02.003; McDonald PP, 1999, J IMMUNOL, V163, P6164; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2021, CURR OPIN IMMUNOL, V68, P1, DOI 10.1016/j.coi.2020.07.007; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Pattabiraman G, 2017, AGING CELL, V16, P585, DOI 10.1111/acel.12589; Pattabiraman G, 2017, MICROB PATHOGENESIS, V105, P218, DOI 10.1016/j.micpath.2017.02.036; Pattabiraman G, 2016, MECH AGEING DEV, V157, P44, DOI 10.1016/j.mad.2016.07.008; Penberthy KK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15191-1; Powers MJ, 2019, P NATL ACAD SCI USA, V116, P17147, DOI 10.1073/pnas.1902026116; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; TUCKER KA, 1987, BLOOD, V70, P372; Ucker DS, 2016, CELL DEATH DIFFER, V23, P990, DOI 10.1038/cdd.2016.17; Ucker DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00241; Ucker DS, 2012, J BIOL CHEM, V287, P10325, DOI 10.1074/jbc.M111.314971; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	78	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102034	10.1016/j.jbc.2022.102034	http://dx.doi.org/10.1016/j.jbc.2022.102034			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35588784	gold, Green Published			2022-12-28	WOS:000818686700001
J	Kroning, A; van den Boom, J; Kracht, M; Kueck, AF; Meyer, H				Kroning, Alexander; van den Boom, Johannes; Kracht, Matthias; Kueck, Anja F.; Meyer, Hemmo			Ubiquitin-directed AAA+ ATPase p97/VCP unfolds stable proteins crosslinked to DNA for proteolysis by SPRTN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DVC1 C1ORF124; P97 ADAPTER; MECHANISM; REPAIR	The protease SPRTN degrades DNA-protein crosslinks (DPCs) that threaten genome stability. SPRTN has been connected to the ubiquitin-directed protein unfoldase p97 (also called VCP or Cdc48), but a functional cooperation has not been demonstrated directly. Here, we biochemically reconstituted p97-assisted proteolysis with purified proteins and showed that p97 targets ubiquitin-modified DPCs and unfolds them to prepare them for proteolysis by SPRTN. We demonstrate that purified SPRTN alone was unable to degrade a tightly-folded Eos fluorescent reporter protein even when Eos was crosslinked to DNA (Eos-DPC). However, when present, p97 unfolded poly-ubiquitinated Eos-DPC in a manner requiring its ubiquitin adapter, Ufd1-Npl4. Notably, we show that, in cooperation with p97 and Ufd1-Npl4, SPRTN proteolyzed unfolded Eos-DPC, which relied on recognition of the DNA-crosslink by SPRTN. In a simplified unfolding assay, we further demonstrate that p97, while unfolding a protein substrate, can surmount the obstacle of a DNA crosslink site in the substrate. Thus, our data demonstrate that p97, in conjunction with Ufd1-Npl4, assists SPRTN-mediated proteolysis of tightly-folded proteins crosslinked to DNA, even threading bulky protein-DNA adducts. These findings will be relevant for understanding how cells handle DPCs to ensure genome stability and for designing strategies that target p97 in combination cancer therapy.	[Kroning, Alexander; van den Boom, Johannes; Kracht, Matthias; Kueck, Anja F.; Meyer, Hemmo] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany	University of Duisburg Essen	Meyer, H (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany.	hemmo.meyer@uni-due.de	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Kueck, Anja F./0000-0003-2746-2793	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center [424228829, SFB 1430]; Collaborative Research Center [SFB 1093]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center(German Research Foundation (DFG)); Collaborative Research Center	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center SFB 1430 (Project-ID 424228829) and Collaborative Research Center SFB 1093 (project B2) to H. M.	Balakirev MY, 2015, ELIFE, V4, DOI [10.7554/eLife.06763.001, 10.7554/eLife.06763]; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Fielden J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15000-w; Huang JZ, 2020, MOL CELL, V79, P824, DOI 10.1016/j.molcel.2020.06.027; Ji ZJ, 2022, MOL CELL, V82, P570, DOI 10.1016/j.molcel.2021.11.033; Kracht M, 2020, J MOL BIOL, V432, P6061, DOI 10.1016/j.jmb.2020.10.001; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Li FX, 2019, CELL REP, V26, P3336, DOI 10.1016/j.celrep.2019.02.082; Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Olszewski MM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0283-z; Reinking HK, 2020, MOL CELL, V80, P102, DOI 10.1016/j.molcel.2020.08.003; Reinking HK, 2020, DNA REPAIR, V88, DOI 10.1016/j.dnarep.2020.102822; Ruggiano A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01539-3; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Twomey EC, 2019, SCIENCE, V365, P462, DOI 10.1126/science.aax1033; van den Boom J, 2021, NAT STRUCT MOL BIOL, V28, P964, DOI 10.1038/s41594-021-00684-5; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weith M, 2018, MOL CELL, V72, P766, DOI 10.1016/j.molcel.2018.09.020; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhao SB, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1224	31	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101976	10.1016/j.jbc.2022.101976	http://dx.doi.org/10.1016/j.jbc.2022.101976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35469923	Green Published, gold			2022-12-28	WOS:000807750700003
J	Leissing, TM; Hardy, AP; Chan, HK; Wang, YH; Tumber, A; Chowdhury, R; Feng, TS; Coleman, ML; Cockman, ME; Kramer, HB; Berridge, G; Fischer, R; Kessler, BM; Ratcliffe, PJ; Lu, X; Scho, CJ				Leissing, Thomas M.; Hardy, Adam P.; Chan, Hokfung; Wang, Yihua; Tumber, Anthony; Chowdhury, Rasheduzzaman; Feng, Tianshu; Coleman, Mathew L.; Cockman, Matthew E.; Kramer, Holger B.; Berridge, Georgina; Fischer, Roman; Kessler, Benedikt M.; Ratcliffe, Peter J.; Lu, Xin; Scho, Christopher J.			Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR FIH; REPEAT DOMAIN; BETA-HYDROXYLATION; BINDING; SELECTIVITY; SUBSTRATE; ALPHA; P53	The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain-containing proteins, including apoptosis stimulating of p53 protein (ASPP) family members. ASPP2 is reported to undergo a single FIH-catalyzed hydroxylation at Asn-986. We report biochemical and crystallographic evidence showing that FIH catalyzes the unprecedented posttranslational hydroxylation of both asparaginyl residues in "VNVN" and related motifs of ankyrin repeat domains in ASPPs (i.e., ASPP1, ASPP2, and iASPP) and the related ASB11 and p18-INK4C proteins. Our biochemical results extend the substrate scope of FIH catalysis and may have implications for its biological roles, including in the hypoxic response and ASPP family function.	[Leissing, Thomas M.; Hardy, Adam P.; Tumber, Anthony; Chowdhury, Rasheduzzaman; Scho, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Leissing, Thomas M.; Chan, Hokfung; Wang, Yihua; Feng, Tianshu; Ratcliffe, Peter J.; Lu, Xin] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford, England; [Feng, Tianshu; Fischer, Roman; Kessler, Benedikt M.] Univ Oxford, NDM Res Bldg, Oxford, England; [Coleman, Mathew L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, England; [Cockman, Matthew E.; Ratcliffe, Peter J.] Francis Crick Inst, Ratcliffe Lab, London, England; [Kramer, Holger B.] MRC London Inst Med Sci, London, England; [Kramer, Holger B.] Imperial Coll London, Inst Clin Sci, Hammersmith Hosp Campus, London, England; [Leissing, Thomas M.; Hardy, Adam P.; Tumber, Anthony; Chowdhury, Rasheduzzaman; Scho, Christopher J.] Univ Oxford, Ineos Oxford Inst Antimicrobial Res, Oxford, England	University of Oxford; Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; University of Birmingham; Francis Crick Institute; Imperial College London; University of Oxford	Scho, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England.; Ratcliffe, PJ; Lu, X (corresponding author), Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford, England.; Ratcliffe, PJ (corresponding author), Francis Crick Inst, Ratcliffe Lab, London, England.; Scho, CJ (corresponding author), Univ Oxford, Ineos Oxford Inst Antimicrobial Res, Oxford, England.	peter.ratcliffe@ndm.ox.ac.uk; xin.lu@ludwig.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Fischer, Roman/N-4408-2017; Coleman, Mathew/C-1676-2014	Fischer, Roman/0000-0002-9715-5951; Coleman, Mathew/0000-0001-6020-9023	Biotechnology and Biological Research Council; Cancer Research UK; Wellcome Trust; Wellcome Trust [106244/Z/14/Z)]	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust)	We thank the Biotechnology and Biological Research Council, Cancer Research UK, and the Wellcome Trust for funding. This research was funded in part by the Wellcome Trust (grant no.: 106244/Z/14/Z) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonnici J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0071; Brocato J, 2014, MOL PHARMACOL, V85, P651, DOI 10.1124/mol.113.089623; Canning P, 2012, J MOL BIOL, V423, P515, DOI 10.1016/j.jmb.2012.08.005; Choi H, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-0290-5; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Hakimi O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177656; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Perez-Riverol Y., 2019, ACTA CRYSTALLOGR D, V66, P213; Pickel C, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101265; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Ten T, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101304; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102020	10.1016/j.jbc.2022.102020	http://dx.doi.org/10.1016/j.jbc.2022.102020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35537551	gold, Green Published			2022-12-28	WOS:000829588600011
J	Tachida, Y; Miura, S; Muto, Y; Takuwa, H; Sahara, N; Shindo, A; Matsuba, Y; Saito, T; Taniguchi, N; Kawaguchi, Y; Tomimoto, H; Saido, T; Kitazume, S				Tachida, Yuriko; Miura, Saori; Muto, Yui; Takuwa, Hiroyuki; Sahara, Naruhiko; Shindo, Akihiro; Matsuba, Yukio; Saito, Takashi; Taniguchi, Naoyuki; Kawaguchi, Yasushi; Tomimoto, Hidekazu; Saido, Takaomi; Kitazume, Shinobu			Endothelial expression of human amyloid precursor protein leads to amyloid beta in the blood and induces cerebral amyloid angiopathy in knock-in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; MOUSE MODELS; HEMORRHAGE; PEPTIDE; ACTIVATION; CLEARANCE; AIOLOS; CELLS	The deposition of amyloid P (A beta) in blood vessels of the brain, known as cerebral amyloid angiopathy (CAA), is observed in most patients with Alzheimer's disease (AD). Compared with the pathology of CAA in humans, the pathology in most mouse models of AD is not as evident, making it difficult to examine the contribution of CAA to the pathogenesis of AD. On the basis of biochemical analyses that showed blood levels of soluble amyloid precursor protein (APP) in rats and mice were markedly lower than those measured in human samples, we hypothesized that endothelial APP expression would be markedly lower in rodents and subsequently generated mice that specifically express human WT APP (APP770) in endothelial cells (ECs). The resulting ECAPP770(+) mice exhibited increased levels of serum A beta and soluble APP, indicating that endothelial APP makes a critical contribution to blood AP levels. Even though aged EC-APP770(+) mice did not exhibit A beta deposition in the cortical blood vessels, crossing these animals with APP knock-in mice (App(NL-F/NL-F)) led to an expanded CAA pathology, as evidenced by increased amounts of amyloid accumulated in the cortical blood vessels. These results highlight an overlooked interplay between neuronal and endothelial APP in brain vascular A beta deposition. We propose that these EC-APP770(+):App(NL-F/NL-F) mice may be useful to study the basic molecular mechanisms behind the possible breakdown of the blood-brain barrier upon administration of anti-A beta antibodies.	[Tachida, Yuriko; Taniguchi, Naoyuki; Kitazume, Shinobu] Dis Glyc Team, Glycobiol Res Grp, Global Res Cluster, RIKEN, Saitama, Japan; [Miura, Saori; Kitazume, Shinobu] Fukushima Med Univ Sch Med, Sch Hlth Sci, Dept Clin Lab Sci, Fukushima, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control, Tokyo, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo, Japan; [Takuwa, Hiroyuki; Sahara, Naruhiko] Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan; [Shindo, Akihiro; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Mie, Japan; [Matsuba, Yukio; Saito, Takashi; Saido, Takaomi] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Saito, Takashi] Nagoya City Univ Grad Sch Med Sci, Inst Brain Sci, Dept Neurocognit Sci, Nagoya, Japan; [Kitazume, Shinobu] Osaka Int Canc Ctr, Dept Glyco Oncol & Med Biochem, Osaka, Japan	Fukushima Medical University; University of Tokyo; University of Tokyo; University of Tokyo; National Institutes for Quantum Science & Technology; Mie University; RIKEN; Nagoya City University	Kitazume, S (corresponding author), Dis Glyc Team, Glycobiol Res Grp, Global Res Cluster, RIKEN, Saitama, Japan.; Kitazume, S (corresponding author), Fukushima Med Univ Sch Med, Sch Hlth Sci, Dept Clin Lab Sci, Fukushima, Japan.; Kitazume, S (corresponding author), Osaka Int Canc Ctr, Dept Glyco Oncol & Med Biochem, Osaka, Japan.	shinobuk@fmu.ac.jp	Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968	Japan Agency for Medical Research and Development (AMED) [JP18am0101036]; Mitsubishi Foundation [16K08601, 25840043]; KAKENHI grant	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Mitsubishi Foundation; KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding and additional information-This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant no.: JP18am0101036 [to S. K.] ) , the Mitsubishi Foundation (to S. K.) , and KAKENHI grant (grant nos.: 16K08601 [to S. K.] and 25840043 to [Y. T.] ) .	Attems J, 2005, ACTA NEUROPATHOL, V110, P345, DOI 10.1007/s00401-005-1074-9; Auriel E, 2012, CURR ATHEROSCLER REP, V14, P343, DOI 10.1007/s11883-012-0254-z; Austin SA, 2009, J NEUROSCI, V29, P14451, DOI 10.1523/JNEUROSCI.3107-09.2009; Burgermeister P, 2000, ANN NY ACAD SCI, V903, P307, DOI 10.1111/j.1749-6632.2000.tb06381.x; BUSH AI, 1990, J BIOL CHEM, V265, P15977; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; d'Uscio LV, 2017, PHYSIOLOGY, V32, P20, DOI 10.1152/physiol.00021.2016; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fukuchi K, 1996, AM J PATHOL, V149, P219; Gallardo G, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024331; Greenberg SM, 2020, NAT REV NEUROL, V16, P30, DOI 10.1038/s41582-019-0281-2; Han BH, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-86; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kumpers P, 2009, ANN RHEUM DIS, V68, P1638, DOI 10.1136/ard.2008.094664; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miura S, 2020, J BIOL CHEM, V295, P13194, DOI 10.1074/jbc.RA120.012904; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Nakayama Y, 2017, J IMMUNOL, V199, P2388, DOI 10.4049/jimmunol.1601725; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sunshine S, 2016, J VIROL, V90, P4511, DOI 10.1128/JVI.01617-15; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wiseman SJ, 2016, STROKE, V47, P2722, DOI 10.1161/STROKEAHA.116.014330; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101880	10.1016/j.jbc.2022.101880	http://dx.doi.org/10.1016/j.jbc.2022.101880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35367207	Green Published, gold			2022-12-28	WOS:000807750700012
J	Valenciano-Bellido, S; Caaveiro, JMM; Morante, K; Sushko, T; Nakakido, M; Nagatoishi, S; Tsumoto, K				Valenciano-Bellido, Sandra; Caaveiro, Jose M. M.; Morante, Koldo; Sushko, Tatyana; Nakakido, Makoto; Nagatoishi, Satoru; Tsumoto, Kouhei			Structure and role of the linker domain of the iron surface-determinant protein IsdH in heme transportation in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOGLOBIN BINDING; MOLECULAR-BASIS; NEAT DOMAIN; SORTASE-B; RECEPTOR; SYSTEM; PORPHYRINS; ISDH-NEAT3; FEATURES; CAPTURE	Staphylococcus aureus is a major cause of deadly nosocomial infections, a severe problem fueled by the steady increase of resistant bacteria. The iron surface determinant (Isd) system is a family of proteins that acquire nutritional iron from the host organism, helping the bacterium to proliferate during infection, and therefore represents a promising antibacterial target. In particular, the surface protein IsdH captures hemoglobin (Hb) and acquires the heme moiety containing the iron atom. Structurally, IsdH comprises three distinctive NEAr-iron Transporter (NEAT) domains connected by linker domains. The objective of this study was to characterize the linker region between NEAT2 and NEAT3 from various biophysical viewpoints and thereby advance our understanding of its role in the molecular mechanism of heme extraction. We demonstrate the linker region contributes to the stability of the bound protein, likely influencing the flexibility and orientation of the NEAT3 domain in its interaction with Hb, but only exerts a modest contribution to the affinity of IsdH for heme. Based on these data, we suggest that the flexible nature of the linker facilitates the precise positioning of NEAT3 to acquire heme. In addition, we also found that residues His45 and His89 of Hb located in the heme transfer route toward IsdH do not play a critical role in the transfer rate-determining step. In conclusion, this study clarifies key elements of the mechanism of heme extraction of human Hb by IsdH, providing key insights into the Isd system and other protein systems containing NEAT domains.	[Valenciano-Bellido, Sandra; Caaveiro, Jose M. M.; Morante, Koldo; Sushko, Tatyana; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Global Healthcare, Fukuoka, Japan; [Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Tokyo, Japan	University of Tokyo; Kyushu University; University of Tokyo; University of Tokyo	Caaveiro, JMM; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan.; Caaveiro, JMM (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Global Healthcare, Fukuoka, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	jose@phar.kyushu-u.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp		Sushko, Tatyana/0000-0001-6132-5499; Nagatoishi, Satoru/0000-0002-0794-3963	Japan Society for the Promotion of Science [19H05766, 20H02531]; Japan Agency for Medical Research and Development [JP21am0101094, JP18fm0208030h, JP19fk0108073h]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This project was funded by grants from the Japan Society for the Promotion of Science (Grantin-Aid for Scientific Research on Innovative Areas "Bio-metal" 19H05766, and Grants-in-Aid for Scientific Research 20H02531 to K. T.), the Japan Agency for Medical Research and Development (JP19fk0108073h, and J-PRIDE JP18fm0208030h to K. T.), and the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (JP21am0101094).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; Brennan GI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149396; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dumas P, 2016, METHOD ENZYMOL, V567, P157, DOI 10.1016/bs.mie.2015.08.026; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Ellis-Guardiola K, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.607679; Ellis-Guardiola K, 2020, J MOL BIOL, V432, P1064, DOI 10.1016/j.jmb.2019.12.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; Macdonald R, 2018, J BIOL CHEM, V293, P18365, DOI 10.1074/jbc.RA118.005261; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Martins R, 2018, CURR OPIN IMMUNOL, V50, P14, DOI 10.1016/j.coi.2017.10.005; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikkelsen JH, 2020, J BIOL CHEM, V295, P1781, DOI 10.1074/jbc.RA119.011612; Moriwaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145125; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Munoz E, 2019, METHODS MOL BIOL, V1964, P225, DOI 10.1007/978-1-4939-9179-2_16; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pineiro A, 2019, ANAL BIOCHEM, V577, P117, DOI 10.1016/j.ab.2019.02.031; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Sjodt M, 2018, J BIOL CHEM, V293, P6942, DOI 10.1074/jbc.RA117.000803; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; Yuan Y, 2015, CHEM REV, V115, P1702, DOI 10.1021/cr500495x; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	54	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101995	10.1016/j.jbc.2022.101995	http://dx.doi.org/10.1016/j.jbc.2022.101995			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35500652	gold, Green Published			2022-12-28	WOS:000811813400007
J	Wang, JJ; Wang, X; Xian, YE; Chen, ZQ; Sun, YP; Fu, YW; Wu, ZK; Li, PX; Zhou, ES; Yang, ZT				Wang, Jing-Jing; Wang, Xia; Xian, Yin-Er; Chen, Zi-Qing; Sun, You-Peng; Fu, Yi-Wu; Wu, Zhi-Kai; Li, Pei-Xuan; Zhou, Er-Shun; Yang, Zheng-Tao			The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STAPHYLOCOCCUS-AUREUS; SIGNALING PATHWAYS; BOVINE MASTITIS; RESPONSES; TLR4; EXPRESSION; INNATE; RECEPTORS; ROLES	Jumonji domain-containing 3 (JMJD3/KDM6B) is a histone demethylase that plays an important role in regulating development, differentiation, immunity, and tumorigenesis. However, the mechanisms responsible for the epigenetic regulation of inflammation during mastitis remain incompletely understood. Here, we aimed to investigate the role of JMJD3 in the lipopolysaccharide (LPS)-induced mastitis model. GSK-J1, a small molecule inhibitor of JMJD3, was applied to treat LPSinduced mastitis in mice and in mouse mammary epithelial cells in vivo and in vitro. Breast tissues were then collected for histopathology and protein/gene expression examination, and mouse mammary epithelial cells were used to investigate the mechanism of regulation of the inflammatory response. We found that the JMJD3 gene and protein expression were upregulated in injured mammary glands during mastitis. Unexpectedly, we also found JMJD3 inhibition by GSK-J1 significantly alleviated the severity of inflammation in LPS-induced mastitis. These results are in agreement with the finding that GSK-J1 treatment led to the recruitment of histone 3 lysine 27 trimethylation (H3K27me3), an inhibitory chromatin mark, in vitro. Furthermore, mechanistic investigation suggested that GSK-J1 treatment directly interfered with the transcription of inflammatory-related genes by H3K27me3 modification of their promoters. Meanwhile, we also demonstrated that JMJD3 depletion or inhibition by GSK-J1 decreased the expression of toll-like receptor 4 and negated downstream NF-kappa B proinflammatory signaling and subsequently reduced LPSstimulated upregulation of Tnfa, Il1b, and Il6. Together, we propose that targeting JMJD3 has therapeutic potential for the treatment of inflammatory diseases.	[Wang, Jing-Jing; Wang, Xia; Xian, Yin-Er; Chen, Zi-Qing; Sun, You-Peng; Fu, Yi-Wu; Wu, Zhi-Kai; Li, Pei-Xuan; Zhou, Er-Shun; Yang, Zheng-Tao] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China; [Wang, Jing-Jing; Wang, Xia; Xian, Yin-Er; Chen, Zi-Qing; Sun, You-Peng; Fu, Yi-Wu; Wu, Zhi-Kai; Li, Pei-Xuan; Zhou, Er-Shun; Yang, Zheng-Tao] Foshan Univ, Guangdong Prov Key Lab Anim Mol Design & Precise, Foshan, Guangdong, Peoples R China	Foshan University; Foshan University	Yang, ZT (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.; Yang, ZT (corresponding author), Foshan Univ, Guangdong Prov Key Lab Anim Mol Design & Precise, Foshan, Guangdong, Peoples R China.	yangzhengtao01@sina.com	Fu, YiWu/HGB-5480-2022		National Natural Science Foundation of China [31772721]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 31772721).	Akhtar M, 2020, INFLAMMATION, V43, P579, DOI 10.1007/s10753-019-01139-2; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; Bhattarai D, 2018, MICROB PATHOGENESIS, V120, P64, DOI 10.1016/j.micpath.2018.04.010; Burgess SL, 2016, INFECT IMMUN, V84, P2824, DOI 10.1128/IAI.00316-16; Chen Y, 2018, INT IMMUNOPHARMACOL, V59, P40, DOI 10.1016/j.intimp.2018.03.027; Costa EO, 1996, MYCOPATHOLOGIA, V133, P85, DOI 10.1007/BF00439118; Daskalaki MG, 2018, J CELL PHYSIOL, V233, P6495, DOI 10.1002/jcp.26497; Davis FM, 2020, EUR J IMMUNOL, V50, P1929, DOI 10.1002/eji.202048651; Davis FM, 2019, J IMMUNOL, V202, P1777, DOI 10.4049/jimmunol.1801258; Francis M, 2019, STEM CELLS DEV, V28, P1015, DOI 10.1089/scd.2019.0125; Fu YH, 2014, INT IMMUNOPHARMACOL, V20, P54, DOI 10.1016/j.intimp.2014.01.024; Fu YH, 2013, VET IMMUNOL IMMUNOP, V155, P245, DOI 10.1016/j.vetimm.2013.08.003; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Ingman WV, 2014, J MAMMARY GLAND BIOL, V19, P161, DOI 10.1007/s10911-014-9325-9; Jia WW, 2018, FASEB J, V32, P4031, DOI 10.1096/fj.201701483R; Jia Y, 2019, J BIOL CHEM, V294, P12695, DOI 10.1074/jbc.RA119.007575; Jingjing W., 2021, INT IMMUNOPHARMACOL, V91; Katsafadou AI, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100726; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Li YN, 2017, ONCOL LETT, V13, P3529, DOI 10.3892/ol.2017.5949; Malinczak CA, 2020, J IMMUNOL, V204, P159, DOI 10.4049/jimmunol.1900741; Modak R, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-12; Modak R, 2012, EPIGENETICS-US, V7, P492, DOI 10.4161/epi.19742; Na J, 2016, J INVEST DERMATOL, V136, P847, DOI 10.1016/j.jid.2015.11.029; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nicholas RAJ, 2016, VET J, V216, P142, DOI 10.1016/j.tvjl.2016.08.001; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Salminen A, 2014, J MOL MED, V92, P1035, DOI 10.1007/s00109-014-1182-x; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Silva LG, 2018, J ANIM SCI, V96, P5244, DOI 10.1093/jas/sky373; Song XJ, 2014, INFLAMMATION, V37, P1588, DOI 10.1007/s10753-014-9885-2; Sun DH, 2019, PROTEIN CELL, V10, P285, DOI 10.1007/s13238-018-0581-0; Surace AEA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01525; Tamgue Ousman, 2017, Asian Pac J Cancer Prev, V18, P2519, DOI 10.22034/APJCP.2017.18.9.2519; Wang JJ, 2017, BRIT J PHARMACOL, V174, P3811, DOI 10.1111/bph.13976; Wang JJ, 2016, J DAIRY SCI, V99, P3016, DOI 10.3168/jds.2015-10330; Wellenberg GJ, 2002, VET MICROBIOL, V88, P27, DOI 10.1016/S0378-1135(02)00098-6; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Xiao ZG, 2016, CURR MED CHEM, V23, P3687, DOI 10.2174/0929867323666160725093522; Yapp C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1053-7; Yin XJ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109384; Yu SQ, 2017, BIOCHEM BIOPH RES CO, V485, P62, DOI 10.1016/j.bbrc.2017.02.020; Zhang L, 2020, ADV EXP MED BIOL, V1253, P3, DOI 10.1007/978-981-15-3449-2_1; Zhang Q, 2019, NAT REV IMMUNOL, V19, P417, DOI 10.1038/s41577-019-0151-6; Zhang XX, 2019, PROTEIN CELL, V10, P864, DOI 10.1007/s13238-019-0653-9; Zhou J, 2020, INFLAMM RES, V69, P657, DOI 10.1007/s00011-020-01356-8	47	0	0	10	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102017	10.1016/j.jbc.2022.102017	http://dx.doi.org/10.1016/j.jbc.2022.102017			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35526564	Green Published, gold			2022-12-28	WOS:000811813400013
J	Zhang, Q; Haak, AJ; Sjogren, B				Zhang, Qian; Haak, Andrew J.; Sjogren, Benita			Regulator of G protein signaling 2 inhibits Gaq-dependent uveal melanoma cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RGS PROTEINS; ACTIVATION; MUTATIONS; YAP/TAZ; YAP	Activating mutations in G alpha(q/11) are a major driver of uveal melanoma (UM), the most common intraocular cancer in adults. While progress has recently been made in targeting G alpha(q/11) for UM therapy, the crucial role for these proteins in normal physiology and their high structural similarity with many other important GTPase proteins renders this approach challenging. The aim of the current study was to validate whether a key regulator of Gq signaling, regulator of G protein signaling 2 (RGS2), can inhibit G alpha(q)-mediated UM cell growth. We used two UM cell lines, 92.1 and Mel-202, which both contain the most common activating mutation G alpha(Q209L)(q) and developed stable cell lines with doxycycline-inducible RGS2 protein expression. Using cell viability assays, we showed that RGS2 could inhibit cell growth in both of these UM cell lines. We also found that this effect was independent of the canonical GTPase-activating protein activity of RGS2 but was dependent on the association between RGS2 and G alpha(q). Furthermore, RGS2 induction resulted in only partial reduction in cell growth as compared to siRNA-mediated Gaq knockdown, perhaps because RGS2 was only able to reduce mitogen-activated protein kinase signaling downstream of phospholipase C beta, while leaving activation of the Hippo signaling mediators yes-associated protein 1/TAZ, the other major pathway downstream of Gaq, unaffected. Taken together, our data indicate that RGS2 can inhibit UM cancer cell growth by associating with G alpha(Q209L)(q) as a partial effector antagonist.	[Zhang, Qian; Sjogren, Benita] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Haak, Andrew J.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Mayo Clinic	Sjogren, B (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	jsjogren@purdue.edu						Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Aravamudhan A, 2020, AM J PHYSIOL-LUNG C, V318, pL852, DOI 10.1152/ajplung.00324.2019; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Choi KM, 2021, J CELL PHYSIOL, V236, P7759, DOI 10.1002/jcp.30459; Cunningham ML, 2001, J BIOL CHEM, V276, P5438, DOI 10.1074/jbc.M007699200; Daniels AB, 2012, INVEST OPHTH VIS SCI, V53, P6991, DOI 10.1167/iovs.12-10427; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Haak AJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6296; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Kaliki S, 2017, EYE, V31, P241, DOI 10.1038/eye.2016.275; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; Li HP, 2019, CELL REP, V29, P3200, DOI 10.1016/j.celrep.2019.03.021; Liu HL, 2015, ONCOL REP, V34, P295, DOI 10.3892/or.2015.3949; Ma JF, 2021, ONCOGENE, V40, P806, DOI 10.1038/s41388-020-01569-5; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Nguyen CH, 2009, J CELL BIOL, V186, P755, DOI 10.1083/jcb.200811058; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100403; Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x; Phan HTN, 2017, MOL PHARMACOL, V92, P451, DOI 10.1124/mol.117.109215; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Sjogren B, 2017, BRIT J PHARMACOL, V174, P427, DOI 10.1111/bph.13716; Sjogren B, 2016, J PHARMACOL EXP THER, V357, P311, DOI 10.1124/jpet.115.231571; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	41	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101955	10.1016/j.jbc.2022.101955	http://dx.doi.org/10.1016/j.jbc.2022.101955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452684	Green Published, gold			2022-12-28	WOS:000838892100010
J	Babaei-Abraki, S; Karamali, F; Nasr-Esfahani, MH				Babaei-Abraki, Shahnaz; Karamali, Fereshteh; Nasr-Esfahani, Mohammad Hossein			Monitoring the induction of ferroptosis following dissociation in human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; CANCER; INHIBITOR; REGULATOR; PATHWAY; DEATH; NRF2; P53; PROLIFERATION; EXPRESSION	Human embryonic stem cells (hESCs) are vulnerable to cell death upon dissociation. Thus, dissociation is an obstacle in culturing, maintaining, and differentiating of hESCs. To date, apoptosis has become the focus of research into the nature of cell death triggered by cellular detachment; it remains baffling whether another form of cell death can occur upon dissociation in hESCs. Here, we demonstrate that iron accumulation and subsequently lipid peroxidation are responsible for dissociation-mediated hESC death. Moreover, we found that a decrease of glutathione peroxidase 4 because of iron accumulation promotes ferroptosis. Inhibition of lipid peroxidation (ferrostatin-1) or chelating iron (deferoxamine) largely suppresses iron accumulation-induced ferroptosis in dissociated hESCs. The results show that P53 mediates the dissociation induced ferroptosis in hESCs, which is suppressed by pifi-thrin alpha. Multiple genes involved in ferroptosis are regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2). In this study, solute carrier family 7 member 11 and glutathione peroxidase 4 are involved in GSH synthesis decreased upon dissociation as a target of Nrf2. In conclusion, our study demonstrates that iron accumulation as a consequence of cytoskeleton disruption appears as a pivotal factor in the initiation of ferroptosis in dissociated hESCs. Nrf2 inhibits ferroptosis via its downstream targets. Our study suggests that the antiferroptotic target might be a good candidate for the maintenance of hESCs.	[Babaei-Abraki, Shahnaz] Univ Isfahan, Fac Biol Sci & Technol, Dept Plant & Anim Biol, Esfahan, Iran; [Karamali, Fereshteh; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran	University of Isfahan; Academic Center for Education, Culture & Research (ACECR)	Nasr-Esfahani, MH (corresponding author), ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran.	mh.nasresfahani@royaninstitute.org		Nasr-Esfahani, Mohammad-Hossein/0000-0003-1983-3435; babaei abraki, shahnaz/0000-0003-1425-0900				Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; BARRADAS MA, 1989, FEBS LETT, V245, P105, DOI 10.1016/0014-5793(89)80201-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CW, 2018, J BIOL CHEM, V293, P12741, DOI 10.1074/jbc.RA118.003017; Brown CW, 2017, J CELL BIOL, V216, P4287, DOI 10.1083/jcb.201701136; Chen MJ, 2017, BIOL REPROD, V97, P438, DOI 10.1093/biolre/iox099; Dai XZ, 2020, TRENDS MOL MED, V26, P185, DOI 10.1016/j.molmed.2019.09.007; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Doll S., 2017, NAT, VChem; El Hout M, 2018, SEMIN CANCER BIOL, V53, P125, DOI 10.1016/j.semcancer.2018.07.009; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Funauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16497; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gnanapradeepan K, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00124; Han ZB, 2020, FEBS OPEN BIO, V10, P726, DOI 10.1002/2211-5463.12811; Han ZB, 2019, STEM CELLS, V37, P489, DOI 10.1002/stem.2967; Ishii T, 2014, REDOX BIOL, V2, P786, DOI 10.1016/j.redox.2014.04.008; Jang JW, 2014, STEM CELLS, V32, P2616, DOI 10.1002/stem.1764; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jin LF, 2019, SCI TOTAL ENVIRON, V666, P713, DOI 10.1016/j.scitotenv.2019.02.307; La Rosa P, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101791; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Liu J, 2019, J MOL CELL BIOL, V11, P284, DOI 10.1093/jmcb/mjy070; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu ZX, 2020, TOXICOL APPL PHARM, V407, DOI 10.1016/j.taap.2020.115241; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Masuda S, 2016, NAT REV CARDIOL, V13, P574, DOI 10.1038/nrcardio.2016.129; Mbah NE, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101617; Musunuru K, 2010, ANNU REV CELL DEV BI, V26, P667, DOI 10.1146/annurev-cellbio-100109-103948; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; RAPOPORT TA, 1991, FASEB J, V5, P2792, DOI 10.1096/fasebj.5.13.1916103; Sart S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/105135; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setoguchi K, 2016, J MOL BIOL, V428, P1465, DOI 10.1016/j.jmb.2015.07.019; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Sun X, 2015, ONCOGENE, V34, P5617, DOI 10.1038/onc.2015.32; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang SJ, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1046581; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu YH, 2016, THERIOGENOLOGY, V85, P302, DOI 10.1016/j.theriogenology.2015.09.020; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xu X, 2010, BIOTECHNOL PROGR, V26, P827, DOI 10.1002/btpr.368; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Yu HT, 2017, J CELL MOL MED, V21, P648, DOI 10.1111/jcmm.13008; Zhang L, 2018, EXP CELL RES, V369, P226, DOI 10.1016/j.yexcr.2018.05.024; Zhang L, 2016, HUM REPROD, V31, P832, DOI 10.1093/humrep/dew011	62	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101855	10.1016/j.jbc.2022.101855	http://dx.doi.org/10.1016/j.jbc.2022.101855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35337799	gold, Green Published			2022-12-28	WOS:000793483000007
J	Feng, SZ; Peden, EK; Guo, QY; Lee, TH; Li, QT; Yuan, YH; Chen, CY; Huang, FZ; Cheng, JZ				Feng, Shaozhen; Peden, Eric K.; Guo, Qunying; Lee, Tae Hoon; Li, Qingtian; Yuan, Yuhui; Chen, Changyi; Huang, Fengzhang; Cheng, Jizhong			Downregulation of the endothelial histone demethylase JMJD3 is associated with neointimal hyperplasia of arteriovenous fistulas in failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; DNA METHYLATION; KIDNEY-DISEASE; HEMODIALYSIS; DIFFERENTIATION; DYSFUNCTION; MODEL; INFLAMMATION; TGF-BETA-1; MIGRATION	Jumonji domain-containing protein-3 (JMJD3), a histone H3 lysine 27 (H3K27) demethylase, promotes endothelial regeneration, but its function in neointimal hyperplasia (NIH) of arteriovenous fistulas (AVFs) has not been explored. In this study, we examined the contribution of endothelial JMJD3 to NIH of AVFs and the mechanisms underlying JMJD3 expression during kidney failure. We found that endothelial JMJD3 expression was negatively associated with NIH of AVFs in patients with kidney failure. JMJD3 expression in endothelial cells (ECs) was also downregulated in the vasculature of chronic kidney disease (CKD) mice. In addition, specific knockout of endothelial JMJD3 delayed EC regeneration, enhanced endothelial mesenchymal transition, impaired endothelial barrier function as determined by increased Evans blue staining and inflammatory cell infiltration, and accelerated neointima formation in AVFs created by venous end to arterial side anastomosis in CKD mice. Mechanistically, JMJD3 expression was downregulated via binding of transforming growth factor beta 1-mediated Hes family transcription factor Hes1 to its gene promoter. Knockdown of JMJD3 enhanced H3K27 methylation, thereby inhibiting transcriptional activity at promoters of EC markers and reducing migration and proliferation of ECs. Furthermore, knockdown of endothelial JMJD3 decreased endothelial nitric oxide synthase expression and nitric oxide production, leading to the proliferation of vascular smooth muscle cells. In conclusion, we demonstrate that decreased expression of endothelial JMJD3 impairs EC regeneration and function and accelerates neointima formation in AVFs. We propose increasing the expression of endothelial JMJD3 could represent a new strategy for preventing endothelial dysfunction, attenuating NIH, and improving AVF patency in patients with kidney disease.	[Feng, Shaozhen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China; [Feng, Shaozhen; Guo, Qunying; Lee, Tae Hoon; Li, Qingtian; Huang, Fengzhang; Cheng, Jizhong] Baylor Coll Med, Selzman Inst Kidney Hlth, Dept Med, Sect Nephrol, Houston, TX 77030 USA; [Peden, Eric K.] Houston Methodist Hosp, DeBakey Heart & Vasc Inst, Dept Vasc Surg, Houston, TX USA; [Yuan, Yuhui; Chen, Changyi] Baylor Coll Med, Dept Surg, Dept Med, Houston, TX USA; [Feng, Shaozhen] Guangdong Prov Key Lab Nephrol, Guangzhou, Peoples R China	Sun Yat Sen University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Baylor College of Medicine	Cheng, JZ (corresponding author), Baylor Coll Med, Selzman Inst Kidney Hlth, Dept Med, Sect Nephrol, Houston, TX 77030 USA.	jizhongc@bcm.edu		LEE, TAE HOON/0000-0001-6396-9378	National Institutes of Health [DK095867, R01-DK0124259]; American Heart Association [15GRNT25700209]; Natural Science Foundation ofGuangdong Province, China [2021A1515010427]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Natural Science Foundation ofGuangdong Province, China(National Natural Science Foundation of Guangdong Province)	This research was funded by the National Institutes of Health grants (grant nos.: R01-DK095867 and R01-DK0124259), American Heart Association grant (grant no.:15GRNT25700209), the Natural Science Foundation ofGuangdong Province, China (grant no.: 2021A1515010427), andgenerous support from Dr and Mrs Harold Selzman. We thankWilliam E. Mitch, Hunter Cheng, and Rajendra Sharma forediting the article.	Al Shakarchi J, 2016, ANN VASC SURG, V32, P1, DOI 10.1016/j.avsg.2015.09.027; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brahmbhatt A, 2016, KIDNEY INT, V89, P303, DOI 10.1016/j.kint.2015.12.019; Bylsma LC, 2017, EUR J VASC ENDOVASC, V54, P513, DOI 10.1016/j.ejvs.2017.06.024; Cheng JZ, 2012, CIRC RES, V110, P230, DOI 10.1161/CIRCRESAHA.111.246025; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Croatt AJ, 2010, AM J PATHOL, V176, P2530, DOI 10.2353/ajpath.2010.090649; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Cui X, 2009, NEUROSCIENCE, V159, P744, DOI 10.1016/j.neuroscience.2008.12.055; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Fu CH, 2012, ARTERIOSCL THROM VAS, V32, P2418, DOI 10.1161/ATVBAHA.112.255786; Fujisawa M, 2000, J AM SOC NEPHROL, V11, P1889, DOI 10.1681/ASN.V11101889; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huber TS, 2021, JAMA SURG, V156, P1111, DOI 10.1001/jamasurg.2021.4527; Irish AB, 2017, JAMA INTERN MED, V177, P184, DOI 10.1001/jamainternmed.2016.8029; Jeong Jisu, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0312-5; Jia WW, 2018, FASEB J, V32, P4031, DOI 10.1096/fj.201701483R; Junker U, 2000, CYTOKINE, V12, P1084, DOI 10.1006/cyto.1999.0645; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kennedy R, 2001, AM J MED, V110, P198, DOI 10.1016/S0002-9343(00)00695-1; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lee T, 2014, J VASC ACCESS, V15, P298, DOI 10.5301/jva.5000212; Lee T, 2011, NEPHROL DIAL TRANSPL, V26, P2264, DOI 10.1093/ndt/gfq733; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Liang AL, 2013, AM J PHYSIOL-RENAL, V304, pF1413, DOI 10.1152/ajprenal.00585.2012; Liang M, 2019, KIDNEY INT, V95, P1347, DOI 10.1016/j.kint.2018.11.027; Liang M, 2015, KIDNEY INT, V88, P490, DOI 10.1038/ki.2015.73; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Luo XL, 2018, CARDIOVASC RES, V114, P1894, DOI 10.1093/cvr/cvy176; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Ohtani K, 2013, CIRC RES, V113, P856, DOI 10.1161/CIRCRESAHA.113.302035; Ohtani K, 2011, CIRC RES, V109, P1219, DOI 10.1161/CIRCRESAHA.111.247304; Pearce CG, 2008, FREE RADICAL BIO MED, V44, P73, DOI 10.1016/j.freeradbiomed.2007.09.010; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Rao M, 2007, KIDNEY INT, V72, P549, DOI 10.1038/sj.ki.5002391; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Roy-Chaudhury P, 2007, AM J KIDNEY DIS, V50, P782, DOI 10.1053/j.ajkd.2007.07.019; Roy-Chaudhury P, 2009, NEPHROL DIAL TRANSPL, V24, P2786, DOI 10.1093/ndt/gfn708; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shihan MH, 2021, BIOCHEM BIOPHYS REP, V25, DOI 10.1016/j.bbrep.2021.100916; Song K, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137298; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Tokunaga R, 2016, ANN SURG ONCOL, V23, P678, DOI 10.1245/s10434-015-4879-3; Trerotola SO, 2020, J VASC INTERV RADIOL, V31, P1, DOI 10.1016/j.jvir.2019.08.035; Tsihlis ND, 2011, CELL BIOCHEM BIOPHYS, V60, P89, DOI 10.1007/s12013-011-9179-3; Tulis David A., 2007, V139, P3; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vazquez-Padron RI, 2021, KIDNEY360, V2, P1360, DOI [10.34067/kid.0002022021, 10.34067/KID.0002022021]; Wang Y, 2014, J AM SOC NEPHROL, V25, P773, DOI 10.1681/ASN.2013050490; Wong CY, 2015, EUR J VASC ENDOVASC, V49, P480, DOI 10.1016/j.ejvs.2014.12.035; Wong CY, 2016, JOVE-J VIS EXP, DOI 10.3791/53294; Yamamoto K, 2014, CARCINOGENESIS, V35, P2404, DOI 10.1093/carcin/bgu136; Yang B, 2014, KIDNEY INT, V85, P289, DOI 10.1038/ki.2013.290; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Yu SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05548-z	64	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101816					17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35278430	Green Published, gold			2022-12-28	WOS:000804436700002
J	Kostenko, A; Lien, Y; Mendauletova, A; Ngendahimana, T; Novitskiy, IM; Eaton, SS; Latham, JA				Kostenko, Anastasiia; Lien, Yi; Mendauletova, Aigera; Ngendahimana, Thacien; Novitskiy, Ivan M.; Eaton, Sandra S.; Latham, John A.			Identification of a poly-cyclopropylglycine-containing peptide via bioinformatic mapping of radical S-adenosylmethionine enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOETHER BOND FORMATION; PROTEIN; BIOSYNTHESIS; METHYLTRANSFERASE	Peptide-derived natural products are a large class of bioactive molecules that often contain chemically challenging modifications. In the biosynthesis of ribosomally synthesized and posttranslationally modified peptides (RiPPs), radical-SAM (rSAM) enzymes have been shown to catalyze the formation of ether, thioether, and carbon-carbon bonds on the precursor peptide. The installation of these bonds typically establishes the skeleton of the mature RiPP. To facilitate the search for unexplored rSAM-dependent RiPPs for the community, we employed a bioinformatic strategy to screen a subfamily of peptide-modifying rSAM enzymes which are known to bind up to three [4Fe-4S] clusters. A sequence similarity network was used to partition related families of rSAM enzymes into >250 clusters. Using representative sequences, genome neighborhood diagrams were generated using the Genome Neighborhood Tool. Manual inspection of bacterial pathways with unique features. From this analysis, we identified and experimentally characterized the rSAM enzyme, TvgB, from the tvg gene cluster from Halomonas anticariensis. In the tvg gene cluster, the precursor peptide, TvgA, is comprised of a repeating TVGG motif. Structural characterization of the TvgB product revealed the repeated formation of cyclopropylglycine, where a new bond is formed between the gamma-carbons on the precursor valine. This novel RiPP modification broadens the functional potential of rSAM enzymes and validates the proposed bioinformatic approach as a practical broad search tool for the discovery of new RiPP topologies.	[Kostenko, Anastasiia; Lien, Yi; Mendauletova, Aigera; Ngendahimana, Thacien; Novitskiy, Ivan M.; Eaton, Sandra S.; Latham, John A.] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Latham, JA (corresponding author), Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.	john.latham@du.edu		Latham, John/0000-0002-3034-1768; Mendauletova, Aigera/0000-0002-6443-0144; Novitskiy, Ivan/0000-0002-2675-3348	National Institutes of Health [GM 124002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by National Institutes of Health Grant GM 124002 to J. A. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Ayikpoe R, 2019, BIOCHEMISTRY-US, V58, P940, DOI 10.1021/acs.biochem.8b01082; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2017, J BIOL CHEM, V292, P10835, DOI 10.1074/jbc.M117.783464; Bhandari DM, 2016, J AM CHEM SOC, V138, P16184, DOI 10.1021/jacs.6b06139; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Bushin LB, 2020, J AM CHEM SOC, V142, P16265, DOI 10.1021/jacs.0c05546; Bushin LB, 2018, J AM CHEM SOC, V140, P17674, DOI 10.1021/jacs.8b10266; Caruso A, 2019, J AM CHEM SOC, V141, P16610, DOI 10.1021/jacs.9b09210; Caruso A, 2019, J AM CHEM SOC, V141, P990, DOI 10.1021/jacs.8b11060; Cheng J.D., 2022, ACS BIOMED CHEM, V2, P109, DOI [10.1021/acsbiomedchemau.1c00058, DOI 10.1021/ACSBIOMEDCHEMAU.1C00058]; Clark KA, 2019, J AM CHEM SOC, V141, P10610, DOI 10.1021/jacs.9b05151; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hiratsuka T, 2014, ANGEW CHEM INT EDIT, V53, P5423, DOI 10.1002/anie.201402623; Huang W, 2012, J AM CHEM SOC, V134, P8831, DOI 10.1021/ja211098r; Hudson GA, 2019, J AM CHEM SOC, V141, P8228, DOI 10.1021/jacs.9b01519; Hudson GA, 2018, CURR OPIN MICROBIOL, V45, P61, DOI 10.1016/j.mib.2018.02.010; Jin WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05217-1; Khaliullin B, 2017, J BIOL CHEM, V292, P13022, DOI 10.1074/jbc.M117.795682; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; Kutateladze AG, 2017, J ORG CHEM, V82, P3368, DOI 10.1021/acs.joc.7b00188; Mahanta N, 2017, J AM CHEM SOC, V139, P4310, DOI 10.1021/jacs.7b00693; Montalban-Lopez M, 2021, NAT PROD REP, V38, P130, DOI 10.1039/d0np00027b; Morinaka BI, 2014, ANGEW CHEM INT EDIT, V53, P8503, DOI 10.1002/anie.201400478; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Nguyen TQN, 2020, NAT CHEM, V12, P1042, DOI 10.1038/s41557-020-0519-z; Oberg N., 2022, ACS BIO MED CHEM, V2, P22; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Phelan RW, 2013, MAR DRUGS, V11, P1878, DOI 10.3390/md11061878; Qiu YP, 2019, ORG LETT, V21, P1502, DOI 10.1021/acs.orglett.9b00293; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Schramma KR, 2017, ACS CHEM BIOL, V12, P922, DOI 10.1021/acschembio.6b01069; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Shang Z, 2019, ACS CHEM BIOL, V14, P415, DOI 10.1021/acschembio.8b01058; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; Zallot R, 2019, BIOCHEMISTRY-US, V58, P4169, DOI 10.1021/acs.biochem.9b00735	46	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101881	10.1016/j.jbc.2022.101881	http://dx.doi.org/10.1016/j.jbc.2022.101881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35367210	Green Published, gold			2022-12-28	WOS:000798142000013
J	Shon, DJ; Fernandez, D; Riley, NM; Ferracane, MJ; Bertozzi, CR				Shon, D. Judy; Fernandez, Daniel; Riley, Nicholas M.; Ferracane, Michael J.; Bertozzi, Carolyn R.			Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MICROBIOTA; MASS-SPECTROMETRY; MODELS; RECOGNITION; IMPROVEMENT; DATABASE; COLON; ACIDS; ETD	Akkermansia muciniphila, a mucin-degrading microbe found in the human gut, is often associated with positive health outcomes. The abundance of A. muciniphila is modulated by the presence and accessibility of nutrients, which can be derived from diet or host glycoproteins. In particular, the ability to degrade host mucins, a class of proteins carrying densely O-glycosylated domains, provides a competitive advantage in the sustained colonization of niche mucosal environments. Although A. muciniphila is known to rely on mucins as a carbon and nitrogen source, the enzymatic machinery used by this microbe to process mucins in the gut is not yet fully characterized. Here, we focus on the mucin-selective metalloprotease, Amuc_0627 (AM0627), which is known to cleave between adjacent residues carrying truncated core 1 O-glycans. We showed that this enzyme is capable of degrading purified mucin 2 (MUC2), the major protein component of mucus in the gut. An X-ray crystal structure of AM0627 (1.9 angstrom resolution) revealed O-glycan-binding residues that are conserved between structurally characterized enzymes from the same family. We further rationalized the substrate cleavage motif using molecular modeling to identify nonconserved glycan-interacting residues. We conclude that mutagenesis of these residues resulted in altered substrate preferences down to the glycan level, providing insight into the structural determinants of O-glycan recognition.	[Shon, D. Judy; Riley, Nicholas M.; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem & Stanford ChEM H, Stanford, CA 94305 USA; [Fernandez, Daniel] Stanford Univ, Stanford ChEM H Macromol Struct Knowledge Ctr, Stanford, CA USA; [Ferracane, Michael J.] Univ Redlands, Dept Chem, Redlands, CA USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Bertozzi, CR (corresponding author), Stanford Univ, Dept Chem & Stanford ChEM H, Stanford, CA 94305 USA.; Bertozzi, CR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	bertozzi@stanford.edu	; Fernandez Fleischhauer, Daniel/F-5017-2013	Riley, Nicholas/0000-0002-1536-2966; Shon, Judy/0000-0001-8379-6195; Fernandez Fleischhauer, Daniel/0000-0002-6221-152X; Ferracane, Michael/0000-0002-3007-3126	National Science Foundation Graduate Research Fellowship; Stanford Graduate Fellowship; National Cancer Institute Grant [R01CA200423]; NIH Predoctoral to Postdoctoral Transition Award [K00 CA212454]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Predoctoral to Postdoctoral Transition Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Science Foundation Graduate Research Fellowship (to D. J. S.) , Stanford Graduate Fellowship (to D. J. S.) , NIH Predoctoral to Postdoctoral Transition Award (Grant K00 CA212454) (to N. M. R.) , and National Cancer Institute Grant R01CA200423 (to C. R. B.) . The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	[Anonymous], 2022, 202009 MOL OP ENV MO; Bardoel BW, 2012, CELL MICROBIOL, V14, P902, DOI 10.1111/j.1462-5822.2012.01765.x; Bian XY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02259; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delano W.L., 2002, CCP4 NEWSLETTER PROC, V40, P82; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Earley H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51878-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Fernandez D, 2013, ACTA CRYSTALLOGR D, V69, P1946, DOI 10.1107/S0907444913017642; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Guillot A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35666; Hansson GC, 2020, ANNU REV BIOCHEM, V89, P769, DOI [10.1146/annurev-biochem-011520-105053, 10.1146/annurev-biochem-011520105053]; Haurat MF, 2020, MBIO, V11, DOI 10.1128/mBio.02033-20; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu D, 2015, MOLECULES, V20, P7637, DOI 10.3390/molecules20057637; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2018, ACTA CRYSTALLOGR D, V74, P167, DOI 10.1107/S2059798318003455; Konstantinidi A, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101784; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Lu L, 2020, NAT METHODS, V17, P1133, DOI 10.1038/s41592-020-00985-5; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Noach I, 2021, GLYCOBIOLOGY, V31, P385, DOI 10.1093/glycob/cwaa095; Noach I, 2017, P NATL ACAD SCI USA, V114, pE679, DOI 10.1073/pnas.1615141114; Ottman N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01014-17; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Pluvinage Benjamin, 2021, Proc Natl Acad Sci U S A, V118, DOI 10.1073/pnas.2019220118; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Pruss KM, 2021, ISME J, V15, P577, DOI 10.1038/s41396-020-00798-6; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Riley NM, 2020, J PROTEOME RES, V19, P3286, DOI 10.1021/acs.jproteome.0c00218; Rose CM, 2015, J AM SOC MASS SPECTR, V26, P1848, DOI 10.1007/s13361-015-1183-1; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Russi S, 2016, J APPL CRYSTALLOGR, V49, P622, DOI 10.1107/S1600576716000649; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shon DJ, 2021, BIOCHEM J, V478, P1585, DOI 10.1042/BCJ20200607; Shon DJ, 2020, P NATL ACAD SCI USA, V117, P21299, DOI 10.1073/pnas.2012196117; Singh C, 2012, J PROTEOME RES, V11, P4517, DOI 10.1021/pr300257c; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18696-y; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Windwarder M, 2014, J PROTEOMICS, V108, P258, DOI 10.1016/j.jprot.2014.05.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Yamada T, 2019, EBIOMEDICINE, V48, P513, DOI 10.1016/j.ebiom.2019.09.008; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	67	2	2	8	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101917	10.1016/j.jbc.2022.101917	http://dx.doi.org/10.1016/j.jbc.2022.101917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35405095	Green Published, gold			2022-12-28	WOS:000804923000015
J	Yang, CF; Liu, WW; Wang, HQ; Zhang, JL; Li, K; Diao, ZY; Yue, QL; Yan, GJ; Li, CJ; Sun, HX				Yang, Chao-Fan; Liu, Wen-Wen; Wang, Hai-Quan; Zhang, Jia-Le; Li, Kang; Diao, Zhen-Yu; Yue, Qiu-Ling; Yan, Gui-Jun; Li, Chao-Jun; Sun, Hai-Xiang			Gonadal white adipose tissue is important for gametogenesis in mice through maintenance of local metabolic and immune niches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDIDYMAL FAT; OBESITY; PREGNANCY; LEPTIN; WOMEN; AXIS; CELL; SPERMATOGENESIS; TESTOSTERONE; DISORDERS	Gonadal white adipose tissue (gWAT) can regulate gametogenesis via modulation of neuroendocrine signaling. However, the effect of gWAT on the local microenvironment of the gonad was largely unknown. Herein, we ruled out that gWAT had a neuroendocrine effect on gonad function through a unilateral lipectomy strategy, in which cutting off epididymal white adipose tissue could reduce seminiferous tubule thickness and decrease sperm counts only in the adjacent testis and epididymis of the affected gonad. Consistent with the results in males, in females, ovary mass was similarly decreased by lipectomy. We determined that the defects in spermatogenesis were mainly caused by augmented apoptosis and decreased proliferation of germ cells. Transcriptome analysis suggested that lipectomy could disrupt immune privilege and activate immune responses in both the testis and ovary on the side of the lipectomy. In addition, lipidomics analysis in the testis showed that the levels of lipid metabolites such as free carnitine were elevated, whereas the levels of glycerophospholipids such as phosphatidylcholines and phosphatidylethanolamines were decreased, which indicated that the metabolic niche was also altered. Finally, we show that supplementation of phosphatidylcholine and phosphatidylethanolamine could partially rescue the observed phenotype. Collectively, our findings suggest that gWAT is important for gonad function by not only affecting whole-body homeostasis but also via maintaining local metabolic and immune niches.	[Yang, Chao-Fan; Liu, Wen-Wen; Wang, Hai-Quan; Li, Kang; Diao, Zhen-Yu; Yue, Qiu-Ling; Yan, Gui-Jun; Sun, Hai-Xiang] Nanjing Univ, Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol,Minist Educ Key Lab Model An, Nanjing, Peoples R China; [Zhang, Jia-Le; Li, Chao-Jun] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Peoples R China; [Yang, Chao-Fan; Liu, Wen-Wen; Wang, Hai-Quan; Li, Kang; Diao, Zhen-Yu; Yue, Qiu-Ling; Yan, Gui-Jun; Sun, Hai-Xiang] Nanjing Univ, Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Ctr Reprod Med,Med Sch,Dept Obstet & Gynecol, Nanjing, Peoples R China; [Zhang, Jia-Le; Li, Chao-Jun] Nanjing Med Univ, China Int Joint Res Ctr Environm & Human Hlth, Ctr Global Hlth, Sch Publ Hlth, Nanjing, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing University; Nanjing Medical University	Yan, GJ; Sun, HX (corresponding author), Nanjing Univ, Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol,Minist Educ Key Lab Model An, Nanjing, Peoples R China.; Li, CJ (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Peoples R China.; Yan, GJ; Sun, HX (corresponding author), Nanjing Univ, Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Ctr Reprod Med,Med Sch,Dept Obstet & Gynecol, Nanjing, Peoples R China.; Li, CJ (corresponding author), Nanjing Med Univ, China Int Joint Res Ctr Environm & Human Hlth, Ctr Global Hlth, Sch Publ Hlth, Nanjing, Peoples R China.	yanguijun55@163.com; lichaojun@njmu.edu.cn; stevensunz@163.com	Li, Chao-Jun/G-3522-2019	Li, Chao-Jun/0000-0002-3859-8824; Li, Chaojun/0000-0001-9474-7321	National Key Research and Development Program of China [2018YFC1004703]	National Key Research and Development Program of China	Acknowledgments-This work was supported by the National Key Research and Development Program of China (grant no.: 2018YFC1004703) .	BARKER CF, 1977, ADV IMMUNOL, V25, P1; Britt KL, 2003, MOL CELL ENDOCRINOL, V202, P11, DOI 10.1016/S0303-7207(03)00055-8; CHIEFFI G, 1975, CELL TISSUE RES, V161, P157; Chu Y, 2010, ENDOCRINOLOGY, V151, P5669, DOI 10.1210/en.2010-0772; Cunningham MJ, 1999, BIOL REPROD, V60, P216, DOI 10.1095/biolreprod60.2.216; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Endo M, 2013, REPRODUCTION, V145, P85, DOI 10.1530/REP-12-0319; Fan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120775; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Fijak M, 2011, J IMMUNOL, V186, P5162, DOI 10.4049/jimmunol.1001958; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Hohos NM, 2017, ENDOCRINOLOGY, V158, P2407, DOI 10.1210/en.2017-00371; Jiang M, 2014, P NATL ACAD SCI USA, V111, P7054, DOI 10.1073/pnas.1324025111; Katib A, 2015, CENT EUR J UROL, V68, P79, DOI 10.5173/ceju.2015.01.435; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koroglu BK, 2011, ENDOKRYNOL POL, V62, P429; Kubota K, 2016, P NATL ACAD SCI USA, V113, P4212, DOI 10.1073/pnas.1601825113; Li YL, 2021, APPL PHYSIOL NUTR ME, V46, P229, DOI 10.1139/apnm-2020-0477; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; Liu XY, 2020, BIOCHEM BIOPH RES CO, V529, P104, DOI 10.1016/j.bbrc.2020.05.194; Maguire M, 2012, OBSTET GYNECOL, V119, P452, DOI 10.1097/AOG.0b013e31822cecf7; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Mauer MM, 2001, NEUROSCI BIOBEHAV R, V25, P15, DOI 10.1016/S0149-7634(00)00047-6; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Miyazaki S, 2002, AM J REPROD IMMUNOL, V47, P222, DOI 10.1034/j.1600-0897.2002.01074.x; Nehus E, 2012, J PEDIATR-US, V161, P276, DOI 10.1016/j.jpeds.2012.01.055; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Safarinejad MR, 2010, CLIN NUTR, V29, P100, DOI 10.1016/j.clnu.2009.07.008; Samavat J, 2018, OBES SURG, V28, P69, DOI 10.1007/s11695-017-2802-7; SRINIVASAN V, 1986, INDIAN J EXP BIOL, V24, P487; STARKEY TA, 1969, AM J OBSTET GYNECOL, V105, P374, DOI 10.1016/0002-9378(69)90266-X; Tokmak A, 2017, J REPROD MED, V62, P300; Vantyghem MC, 2008, J CLIN ENDOCR METAB, V93, P2223, DOI 10.1210/jc.2007-2521; Wang HH, 2017, J ENDOCRINOL, V232, P155, DOI 10.1530/JOE-16-0174; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Whittaker J, 2021, J STEROID BIOCHEM, V210, DOI 10.1016/j.jsbmb.2021.105878; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; YEN SSC, 1993, ENDOCRIN METAB CLIN, V22, P29, DOI 10.1016/S0889-8529(18)30179-8	42	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101818	10.1016/j.jbc.2022.101818	http://dx.doi.org/10.1016/j.jbc.2022.101818			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35278432	Green Published, gold			2022-12-28	WOS:000804436700011
J	Aisenberg, WH; McCray, BA; Sullivan, JM; Diehl, E; DeVine, LR; Alevy, J; Bagnell, AM; Carr, P; Donohue, JK; Goretzki, B; Cole, RN; Hellmich, UA; Sumner, CJ				Aisenberg, William H.; McCray, Brett A.; Sullivan, Jeremy M.; Diehl, Erika; DeVine, Lauren R.; Alevy, Jonathan; Bagnell, Anna M.; Carr, Patrice; Donohue, Jack K.; Goretzki, Benedikt; Cole, Robert N.; Hellmich, Ute A.; Sumner, Charlotte J.			Multiubiquitination of TRPV4 reduces channel activity independent of surface localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL VANILLOID 4; CATION CHANNEL; UBIQUITIN LIGASES; ANKYRIN DOMAIN; MODULATION; TRAFFICKING; EXPRESSION; MUTATIONS; NEDD4; ENDOCYTOSIS	Ubiquitin (Ub)-mediated regulation of plasmalemmal ion channel activity canonically occurs via stimulation of endocytosis. Whether ubiquitination can modulate channel activity by alternative mechanisms remains unknown. Here, we show that the transient receptor potential vanilloid 4 (TRPV4) cation channel is multiubiquitinated within its cytosolic N-terminal and C-terminal intrinsically disordered regions (IDRs). Muta-genizing select lysine residues to block ubiquitination of the N- terminal but not C-terminal IDR resulted in a marked elevation of TRPV4-mediated intracellular calcium influx, without increasing cell surface expression levels. Conversely, enhancing TRPV4 ubiquitination via expression of an E3 Ub ligase reduced TRPV4 channel activity but did not decrease plasma membrane abundance. These results demonstrate Ub-dependent regulation of TRPV4 channel function independent of effects on plasma membrane localization. Consistent with ubiquitination playing a key negative modulatory role of the channel, gain-of-function neuropathy-causing mutations in the TRPV4 gene led to reduced channel ubiquitination in both cellular and Drosophila models of TRPV4 neuropathy, whereas increasing mutant TRPV4 ubiquitination partially suppressed channel overactivity. Together, these data reveal a novel mechanism via which ubiquitination of an intracellular flexible IDR domain modulates ion channel function independently of endocytic trafficking and identify a contributory role for this pathway in the dysregulation of TRPV4 channel activity by neuropathy-causing mutations.	[Aisenberg, William H.; McCray, Brett A.; Sullivan, Jeremy M.; Alevy, Jonathan; Bagnell, Anna M.; Carr, Patrice; Donohue, Jack K.; Sumner, Charlotte J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Diehl, Erika] Johannes Gutenberg Univ Mainz, Dept Chem, Biochem Sect, Mainz, Germany; [DeVine, Lauren R.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Goretzki, Benedikt; Cole, Robert N.; Hellmich, Ute A.] Friedrich Schiller Univ, Cluster Excellence Balance Microverse, Inst Organ Chem & Macromol Chem, Jena, Germany; [Goretzki, Benedikt; Hellmich, Ute A.] Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany; [Sumner, Charlotte J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johannes Gutenberg University of Mainz; Johns Hopkins University; Friedrich Schiller University of Jena; Goethe University Frankfurt; Johns Hopkins University	Sumner, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Sumner, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	csummer1@jhmi.edu		Donohue, Jack/0000-0002-7975-570X; Aisenberg, William/0000-0002-8715-1439; Bagnell, Anna/0000-0002-8469-0154	TransMED PhD Fellowship; Sibylle Kalkhof-Rose Stiftung Fellowship; Max Planck Graduate Centre PhD Fellowship; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt - state of Hesse; Fulbright PhD Fellowship;  [F31 NS105404];  [R35 NS122306]	TransMED PhD Fellowship; Sibylle Kalkhof-Rose Stiftung Fellowship; Max Planck Graduate Centre PhD Fellowship; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt - state of Hesse; Fulbright PhD Fellowship; ; 	This work was supported by F31 NS105404 (to W. H. A.) and R35 NS122306 (to C. J. S.). E. D. acknowledges a Fulbright PhD Fellowship, a TransMED PhD Fellowship, and a Sibylle Kalkhof-Rose Stiftung Fellowship. B. G. acknowledges a Max Planck Graduate Centre PhD Fellowship. U. A. H. acknowledges support by the Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, funded by the state of Hesse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Appadurai R, 2019, J MEMBRANE BIOL, V252, P273, DOI 10.1007/s00232-019-00069-2; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Azimi I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249417; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Baratchi S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00006; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Bonvini S. J., 2016, TRANSIENT RECEPTOR P; Chen CK, 2018, MOL NEUROBIOL, V55, P4127, DOI 10.1007/s12035-017-0625-0; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Choi UB, 2013, J BIOL CHEM, V288, P22506, DOI 10.1074/jbc.M113.477810; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Dalton HE, 2011, CELL DEATH DIFFER, V18, P1150, DOI 10.1038/cdd.2010.130; Darby WG, 2016, INT J BIOCHEM CELL B, V78, P217, DOI 10.1016/j.biocel.2016.07.012; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Deng ZQ, 2018, NAT STRUCT MOL BIOL, V25, P252, DOI 10.1038/s41594-018-0037-5; Dupont C, 2020, ANN NEUROL, V88, P297, DOI 10.1002/ana.25780; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Everaerts W., 2010, INHIBITION CATION CH; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Garcia-Elias A., 2013, PROC NATL ACAD; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Goretzki B, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166931; Goretzki B, 2018, STRUCTURE, V26, P1583, DOI 10.1016/j.str.2018.08.002; Grove LM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau1533; Gualdani R, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abc6967; Harraz OF, 2018, ELIFE, V7, DOI 10.7554/eLife.38689; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Huang X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2142-8; Ilic N, 2021, FASEB J, V35, DOI 10.1096/fj.202001759R; Inada H, 2012, BIOCHEMISTRY-US, V51, P6195, DOI 10.1021/bi300279b; Jaudon F, 2020, CELL DEATH DIFFER, V27, P1505, DOI 10.1038/s41418-019-0431-5; Kanner SA, 2020, NAT METHODS, V17, P1245, DOI 10.1038/s41592-020-00992-6; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kullmann DM, 2002, LANCET NEUROL, V1, P157, DOI 10.1016/S1474-4422(02)00071-6; Laedermann C. J., 2013, THE J; Lamothe SM, 2016, PROG MOL BIOL TRANSL, V141, P161, DOI 10.1016/bs.pmbts.2016.02.005; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lee S, 2019, ELIFE, V8, DOI 10.7554/eLife.44502; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lim K. L., 2005, THE J; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Loukin SH, 2015, P NATL ACAD SCI USA, V112, P9400, DOI 10.1073/pnas.1510602112; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Magidovich E, 2006, BIOINFORMATICS, V22, P1546, DOI 10.1093/bioinformatics/btl137; Mannaa M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23165-0; Matsumoto H, 2018, J NEUROSCI, V38, P8745, DOI 10.1523/JNEUROSCI.0897-18.2018; McCray BA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21699-y; Mukaiyama M, 2019, FEBS LETT, V593, P2250, DOI 10.1002/1873-3468.13490; Nakagawa T, 2015, GENES CELLS, V20, P543, DOI 10.1111/gtc.12250; Narasumani M, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006349; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nirenberg VA, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01644; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Piper R. C., 2014, COLD SPRING HARB PER, V6, DOI [10.1101/cshperspect.a016808, DOI 10.1101/CSHPERSPECT.A016808]; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rakers C, 2017, GLIA, V65, P1550, DOI 10.1002/glia.23183; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Scheraga RG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00503; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shin D, 2017, ELIFE, V6, DOI 10.7554/eLife.29154; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; Springael JY, 1999, J CELL SCI, V112, P1375; Sullivan JM, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000029; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Takahashi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5994; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Voolstra O, 2014, CELLS-BASEL, V3, P258, DOI 10.3390/cells3020258; Warnet XL, 2021, EUR J NEUROSCI, V54, P6713, DOI 10.1111/ejn.14842; Weber J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134464; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015; Woolums BM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16411-5; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Ying LH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0376; Zaccor NW, 2020, J BIOL CHEM, V295, P9986, DOI 10.1074/jbc.RA120.014325; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272	105	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101826	10.1016/j.jbc.2022.101826	http://dx.doi.org/10.1016/j.jbc.2022.101826			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35300980	Green Published, gold			2022-12-28	WOS:000793692600006
J	Azuma, K; Koumura, T; Iwamoto, R; Matsuoka, M; Terauchi, R; Yasuda, S; Shiraya, T; Watanabe, S; Aihara, M; Imai, H; Ueta, T				Azuma, Kunihiro; Koumura, Tomoko; Iwamoto, Ryo; Matsuoka, Masaki; Terauchi, Ryo; Yasuda, Shu; Shiraya, Tomoyasu; Watanabe, Sumiko; Aihara, Makoto; Imai, Hirotaka; Ueta, Takashi			Mitochondrial glutathione peroxidase 4 is indispensable for photoreceptor development and survival in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; LIPID-PEROXIDATION; FERROPTOSIS; PHGPX; METABOLISM; EXPRESSION; PROTECTS; GPX4; DEGENERATION; APOPTOSIS	Glutathione peroxidase 4 (GPx4) is known for its unique function in the direct detoxification of lipid peroxides in the cell membrane and as a key regulator of ferroptosis, a form of lipid peroxidation-induced nonapoptotic cell death. However, the cytosolic isoform of GPx4 is considered to play a major role in inhibiting ferroptosis in somatic cells, whereas the roles of the mitochondrial isoform of GPx4 (mGPx4) in cell survival are not yet clear. In the present study, we found that mGPx4 KO mice exhibit a cone-rod dystrophy-like phenotype in which loss of cone photoreceptors precedes loss of rod photoreceptors. Specifically, in mGPx4 KO mice, cone photoreceptors disappeared prior to their maturation, whereas rod photoreceptors persisted through maturation but gradually degenerated afterward. Mechanistically, we demonstrated that vitamin E supplementation significantly ameliorated photoreceptor loss in these mice. Furthermore, LC-MS showed a significant increase in peroxidized phosphatidylethanolamine esterified with docosahexaenoic acid in the retina of mGPx4 KO mice. We also observed shrunken and uniformly condensed nuclei as well as caspase-3 activation in mGPx4 KO photoreceptors, suggesting that apoptosis was prevalent. Taken together, our findings indicate that mGPx4 is essential for the maturation of cone photoreceptors but not for the maturation of rod photoreceptors, although it is still critical for the survival of rod photoreceptors after maturation. In conclusion, we reveal novel functions of mGPx4 in supporting development and survival of photoreceptors in vivo.	[Azuma, Kunihiro; Shiraya, Tomoyasu; Aihara, Makoto; Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Koumura, Tomoko; Iwamoto, Ryo; Matsuoka, Masaki; Yasuda, Shu; Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Dept Hyg Chem, Tokyo, Japan; [Koumura, Tomoko; Iwamoto, Ryo; Matsuoka, Masaki; Yasuda, Shu; Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Med Res Labs, Tokyo, Japan; [Terauchi, Ryo] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Watanabe, Sumiko] Jikei Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan	University of Tokyo; Kitasato University; Kitasato University; University of Tokyo; Jikei University	Ueta, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.; Imai, H (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Dept Hyg Chem, Tokyo, Japan.; Imai, H (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Med Res Labs, Tokyo, Japan.	imaih@pharm.kitasato-u.ac.jp; ueta-tky@umin.ac.jp		Aihara, Makoto/0000-0001-6810-0583; Terauchi, Ryo/0000-0002-6714-2543	Kitasato University; Japan Agency for Medical Research and Development (AMED) [JP20gm0910013, JP21gm0910013]; Japan Society for the Promotion of Science KAKENHI [JP19K18901]	Kitasato University; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Tajima-Iwamoto and Matsubara (School of Pharmaceutical Sciences, Kitasato University) for generation of mGPx4KO mice, Ichinose (Instrumental Analysis Research Center, School of Medicine, Tokyo Medical and Dental University) for TEM analysis for spermatozoa, and Tsuhako (Institute of Medical Science, the University of Tokyo) for supporting ERG experiments. This work was supported by Kitasato University Research Grant for Young Researcher and Japan Agency for Medical Research and Development (AMED) (grant numbers: JP20gm0910013 and JP21gm0910013) and Japan Society for the Promotion of Science KAKENHI (grant number: JP19K18901).	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Ball WB, 2018, FEBS LETT, V592, P1273, DOI 10.1002/1873-3468.12887; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Brzezinski JA, 2015, DEVELOPMENT, V142, P3263, DOI 10.1242/dev.127043; Carlson BA, 2016, REDOX BIOL, V9, P22, DOI 10.1016/j.redox.2016.05.003; Castro-Sepulveda M, 2020, AM J PHYSIOL-ENDOC M, V318, pE848, DOI 10.1152/ajpendo.00025.2020; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; DeHart DN, 2018, SLAS DISCOV, V23, P23, DOI 10.1177/2472555217731556; Didenco S, 2011, AM J CLIN NUTR, V93, P368, DOI 10.3945/ajcn.110.008367; Dong H, 2020, AGING-US, V12, P12943, DOI 10.18632/aging.103378; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2006, J BIOCHEM, V140, P573, DOI 10.1093/jb/mvj186; Imai H, 2017, CURR TOP MICROBIOL, V403, P143, DOI 10.1007/82_2016_508; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Li CF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.698679; Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Meschede IP, 2020, P NATL ACAD SCI USA, V117, P15684, DOI 10.1073/pnas.2000304117; Nakamura T, 2003, BIOCHEM BIOPH RES CO, V311, P139, DOI 10.1016/j.bbrc.2003.09.183; Ni Y, 2012, CLIN CANCER RES, V18, P4954, DOI 10.1158/1078-0432.CCR-12-1055; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Sakamoto T, 2020, J CLIN BIOCHEM NUTR, V66, P116, DOI 10.3164/jcbn.19-51; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tsubouchi K, 2019, J IMMUNOL, V203, P2076, DOI 10.4049/jimmunol.1801232; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Wang H, 2020, EUR J CELL BIOL, V99, DOI 10.1016/j.ejcb.2019.151058; Wei S, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109824; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7	44	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101824	10.1016/j.jbc.2022.101824	http://dx.doi.org/10.1016/j.jbc.2022.101824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35288190	Green Published, gold			2022-12-28	WOS:000793617400004
J	Yang, RY; Sun, LL; Li, CF; Wang, YH; Xia, WY; Liu, BN; Chu, YY; Bover, L; Vien, L; Hung, MC				Yang, Riyao; Sun, Linlin; Li, Ching-Fei; Wang, Yu-Han; Xia, Weiya; Liu, Boning; Chu, Yu-Yi; Bover, Laura; Vien, Long; Hung, Mien-Chie			Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PROGNOSIS; GALECTINS; SURVIVAL; IMMUNITY; THERAPY; GLIOMA	Antibodies that target immune checkpoint proteins such as programmed cell death protein 1, programmed death ligand 1, and cytotoxic T-lymphocyte-associated antigen 4 in human cancers have achieved impressive clinical success; however, a significant proportion of patients fail to respond to these treatments. Galectin-9 (Gal-9), a beta-galactoside-binding protein, has been shown to induce T-cell death and facilitate immunosuppression in the tumor microenvironment by binding to immunomodulatory receptors such as T-cell immunoglobulin and mucin domain-containing molecule 3 and the innate immune receptor dectin-1, suggesting that it may have potential as a target for cancer immunotherapy. Here, we report the development of two novel Gal-9-neutralizing antibodies that specifically react with the N-carbohydrate-recognition domain of human Gal-9 with high affinity. We also show using cellbased functional assays that these antibodies efficiently protected human T cells from Gal-9-induced cell death. Notably, in a T-cell/tumor cell coculture assay of cytotoxicity, these antibodies significantly promoted T cell-mediated killing of tumor cells. Taken together, our findings demonstrate potent inhibition of human Gal-9 by neutralizing antibodies, which may open new avenues for cancer immunotherapy.	[Yang, Riyao; Sun, Linlin; Li, Ching-Fei; Wang, Yu-Han; Xia, Weiya; Chu, Yu-Yi; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX USA; [Yang, Riyao; Liu, Boning] Antibody Therapeut Inc, Hayward, CA USA; [Sun, Linlin] Tianjin Med Univ Gen Hosp, Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Wang, Yu-Han; Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Wang, Yu-Han; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Bover, Laura; Vien, Long] Univ Texas MD Anderson Canc Ctr, Monoclonal Antibody Core Facil, Houston, TX USA; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Asia University Taiwan	Yang, RY; Sun, LL; Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX USA.; Yang, RY (corresponding author), Antibody Therapeut Inc, Hayward, CA USA.; Sun, LL (corresponding author), Tianjin Med Univ Gen Hosp, Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	ryyangster@gmail.com; lsun1@tmu.edu.cn; mhung@cmu.edu.tw		Li, Ching-Fei/0000-0001-7844-7003; Hung, Mien-Chie/0000-0003-4317-4740	Ministry of Science and Technology in Taiwan [MOST110-2639-B-039-001-ASP]; National Natural Science Foundation of China [82172687, 81972186]; Natural Science Foundation of Tianjin [20JCYBJC00360]; Health Commission of Tianjin [TJWJ2021MS002]; China Scholarship Council; University of Texas MD Anderson Cancer Center; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Health Commission of Tianjin; China Scholarship Council(China Scholarship Council); University of Texas MD Anderson Cancer Center; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund	This work was funded in part by the following: Ministry of Science and Technology in Taiwan (grant no.: MOST110-2639-B-039-001-ASP; to M.-C. H.) ; National Natural Science Foundation of China (grant nos.: 82172687 and 81972186; to L. S.) ; Natural Science Foundation of Tianjin (grant no.: 20JCYBJC00360; to L. S.) ; Health Commission of Tianjin (grant no.: TJWJ2021MS002; to L. S.) ; China Scholarship Council (to L. S.) ; The Odyssey Fellowship from The University of Texas MD Anderson Cancer Center (to C.-F. L.) ; and The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (to M-C. H.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertino P, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1601482; Chen HY, 2020, J IMMUNOL, V204, P1158, DOI 10.4049/jimmunol.1901114; Chen L., 2019, ABSTR 1551 1 CLASS I, P1551; Chen PX, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001391; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; de Miguel M, 2020, CANCER CELL, V38, P326, DOI 10.1016/j.ccell.2020.07.004; Enninga EAL, 2016, MELANOMA RES, V26, P429, DOI 10.1097/CMR.0000000000000281; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Imaizumi T., INTERFERON GAMMA STI; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Kikushige Y, 2015, CELL STEM CELL, V17, P341, DOI 10.1016/j.stem.2015.07.011; Kroemer G, 2021, J EXP MED, V218, DOI 10.1084/jem.20201979; Lhuillier C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202512; Lhuillier C, 2015, J BIOL CHEM, V290, P16797, DOI 10.1074/jbc.M115.661272; Liang TY, 2019, WORLD NEUROSURG, V132, pE455, DOI 10.1016/j.wneu.2019.08.117; Liu ZJ, 2016, ONCOL LETT, V11, P1829, DOI 10.3892/ol.2016.4142; Lv K, 2013, MOL MED REP, V7, P205, DOI 10.3892/mmr.2012.1125; Madireddi S, 2017, J IMMUNOL, V199, P2721, DOI 10.4049/jimmunol.1700575; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Okoye I, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001849; Sabatos-Peyton CA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1385690; Seifert AM, 2020, ONCOGENE, V39, P3102, DOI 10.1038/s41388-020-1186-7; Sideras K, 2017, INT J CANCER, V141, P572, DOI 10.1002/ijc.30760; Silva IG, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1195535; Sun LL, 2020, CANCER RES, V80, P2298, DOI 10.1158/0008-5472.CAN-19-3133; Tavares LB, 2018, PANCREAS, V47, pE59, DOI 10.1097/MPA.0000000000001126; Thiemann S, 2016, ANNU REV IMMUNOL, V34, P243, DOI 10.1146/annurev-immunol-041015-055402; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Tu L, 2020, INT J CANCER, V147, P423, DOI 10.1002/ijc.32785; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Xu YL, 2018, TRANSL CANCER RES, V7, P571, DOI 10.21037/tcr.2018.05.18; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21099-2; Yuan F, 2020, J CELL PHYSIOL, V235, P4326, DOI 10.1002/jcp.29309; Zhang YP, 2021, J CANCER, V12, P4257, DOI 10.7150/jca.53686; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou XX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00452; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	42	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101821	10.1016/j.jbc.2022.101821	http://dx.doi.org/10.1016/j.jbc.2022.101821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35283189	Green Published, gold			2022-12-28	WOS:000797895000002
J	Chen, GX; Li, Q; Yan, JS				Chen, Guanxing; Li, Qin; Yan, Jiusheng			The leucine-rich repeat domains of BK channel auxiliary ? subunits regulate their expression, trafficking, and channel-modulation functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; BETA-SUBUNITS; POTASSIUM CHANNELS; MOLECULAR-BASIS; VOLTAGE; STOICHIOMETRY; CURRENTS; PROTEIN; ALPHA	As high-conductance calcium-and voltage-dependent potassium channels, BK channels consist of pore-forming, voltage-, and Ca2+-sensing alpha and auxiliary subunits. The leucine-rich repeat (LRR) domain-containing auxiliary gamma subunits potently modulate the voltage dependence of BK channel activation. Despite their dominant size in whole protein masses, the function of the LRR domain in BK channel gamma subunits is unknown. We here investigated the function of these LRR domains in BK channel modulation by the auxiliary gamma 1-3 (LRRC26, LRRC52, and LRRC55) subunits. Using cell surface protein immunoprecipitation, we validated the predicted extracellular localization of the LRR domains. We then refined the structural models of mature proteins on the membrane via molecular dynamic simulations. By replacement of the LRR domain with extracellular regions or domains of non-LRR proteins, we found that the LRR domain is nonessential for the maximal channel-gating modulatory effect but is necessary for the all-or-none phenomenon of BK channel modulation by the gamma 1 subunit. Mutational and enzymatic blockade of N-glycosylation in the gamma 1-3 subunits resulted in a reduction or loss of BK channel modulation by gamma subunits. Finally, by analyzing their expression in whole cells and on the plasma membrane, we found that blockade of N-glycosylation drastically reduced total expression of the gamma 2 subunit and the cell surface expression of the gamma 1 and gamma 3 subunits. We conclude that the LRR domains play key roles in the regulation of the expression, cell surface trafficking, and channel-modulation functions of the BK channel gamma subunits.	[Chen, Guanxing; Li, Qin; Yan, Jiusheng] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Yan, Jiusheng] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Grad Programs Neurosci & Biochem & Cell Biol, Houston, TX 77030 USA; [Li, Qin] Penn State Univ, Coll Med, Heart & Vasc Inst, Hershey, PA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yan, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA.; Yan, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Grad Programs Neurosci & Biochem & Cell Biol, Houston, TX 77030 USA.	jyan1@mdanderson.org			National Institutes of Health [NS078152]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by National Institutes of Health grants NS078152 (J. Y.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00035; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brody MJ, 2016, AM J PHYSIOL-HEART C, V310, pH269, DOI 10.1152/ajpheart.00717.2014; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Carrasquel-Ursulaez W, 2018, BIOPHYS J, V114, P2493, DOI 10.1016/j.bpj.2018.04.008; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Dudem S, 2020, P NATL ACAD SCI USA, V117, P2194, DOI 10.1073/pnas.1916715117; Gonzalez-Perez V., 2021, PROC NATL; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gonzalez-Perez V, 2018, P NATL ACAD SCI USA, V115, P9923, DOI 10.1073/pnas.1804560115; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Guan X, 2017, SCI REP-UK, V7, DOI 10.1038/srep42240; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC750, DOI 10.1152/ajpcell.00116.2006; Huang ZG, 2017, CHANNELS, V11, P156, DOI 10.1080/19336950.2016.1243631; Khan HM, 2019, J CHEM THEORY COMPUT, V15, P7, DOI 10.1021/acs.jctc.8b00839; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Lee J., 2016; Li Q, 2016, INT REV NEUROBIOL, V128, P51, DOI 10.1016/bs.irn.2016.03.015; Li Q, 2016, J GEN PHYSIOL, V147, P337, DOI 10.1085/jgp.201511551; Li Q, 2015, J GEN PHYSIOL, V145, P543, DOI 10.1085/jgp.201511356; Lingle CJ, 2019, P NATL ACAD SCI USA, V116, P18397, DOI 10.1073/pnas.1907065116; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Murray CI, 2016, ELIFE, V5, DOI 10.7554/eLife.11815; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Noda S, 2020, BIOL PHARM BULL, V43, P1118, DOI 10.1248/bpb.b20-00125; Peltola MA, 2011, EMBO REP, V12, P1293, DOI 10.1038/embor.2011.204; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; Sausbier M., 2004, CEREBELLAR ATAXIA PU; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014; Tao X, 2019, ELIFE, V8, DOI 10.7554/eLife.51409; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Typlt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081270; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang XL, 2021, J VENOM ANIM TOXINS, V27, DOI [10.1590/1678-9199-jvatitd-2020-0182, 10.1590/1678-9199-JVATITD-2020-0182]; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Xia XM, 2000, J NEUROSCI, V20, P4890; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang CT, 2017, P NATL ACAD SCI USA, V114, pE3739, DOI 10.1073/pnas.1703081114; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zhang JY, 2018, P NATL ACAD SCI USA, V115, pE9006, DOI 10.1073/pnas.1802567115	57	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101664	10.1016/j.jbc.2022.101664	http://dx.doi.org/10.1016/j.jbc.2022.101664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35104503	gold, Green Published			2022-12-28	WOS:000791230900002
J	Ciacchi, L; Farenc, C; Dahal-Koirala, S; Petersen, J; Sollid, LM; Reid, HH; Rossjohn, J				Ciacchi, Laura; Farenc, Carine; Dahal-Koirala, Shiva; Petersen, Jan; Sollid, Ludvig M.; Reid, Hugh H.; Rossjohn, Jamie			Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; GLIADIN PEPTIDES; BINDING; USAGE; CRYSTALLIZATION; DEAMIDATION; COMPLEXES; RESPONSES; SELECTION	Celiac disease is a T cell-mediated chronic inflammatory condition often characterized by human leukocyte antigen (HLA)-DQ2.5 molecules presenting gluten epitopes derived from wheat, barley, and rye. Although some T cells exhibit cross-reactivity toward distinct gluten epitopes, the structural basis underpinning such cross-reactivity is unclear. Here, we investigated the T-cell receptor specificity and cross-reactivity of two immunodominant wheat gluten epitopes, DQ2.5-gliaala (PFPQPELPY) and DQ2.5-glia-w 1 (PFPQPEQPF). We show by surface plasmon resonance that a T-cell receptor alpha variable (TRAY) 4(+)-T-cell receptor beta variable (TRBV) 29-1(+)TCR bound to HLA-DQ2.5-glia-alpha 1a and HLA-DQ2.5-glia-omega 1 with similar affinity, whereas a TRAV4(-) (TRAV9-2(+)) TCR recognized HLA-DQ2.5-glia-omega 1 only. We further determined the crystal structures of the TRAV4(+)-TRBV29-1(+) TCR bound to HLA-DQ2.5-glia-alpha 1a and HLA-DQ2.5-glia-omega 1, as well as the structure of an epitope-specific TRAV9-2(+)-TRBV7-3(+) TCR-HLA-DQ2.5-glia-omega 1 complex. We found that position 7 (p7) of the DQ2.5-glia-alpha 1a and DQ2.5-glia-omega 1 epitopes made very limited contacts with the TRAV4(+) TCR, thereby explaining the TCR cross-reactivity across these two epitopes. In contrast, within the TRAV9-2(+) TCR-HLA-DQ2.5-glia-omega 1 ternary complex, the p7-Gln was situated in an electrostatic pocket formed by the hypervariable CDR3 beta loop of the TCR and Arg70 beta from HLA-DQ2.5, a polar network which would not be supported by the p7-Leu residue of DQ2.5-glia-alpha 1a. In conclusion, we provide additional insights into the molecular determinants of TCR specificity and cross-reactivity to two closely-related epitopes in celiac disease.	[Ciacchi, Laura; Farenc, Carine; Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Ciacchi, Laura; Farenc, Carine; Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Dahal-Koirala, Shiva; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Dahal-Koirala, Shiva; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Dahal-Koirala, Shiva; Sollid, Ludvig M.] Univ Oslo, KG Jebsen Ctr Coeliac Dis Res, Inst Clin Med, Oslo, Norway; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales	Monash University; Monash University; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales.	Jamie.rossjohn@monash.edu		Dahal-Koirala, Shiva/0000-0002-0165-5098; Ciacchi, Laura/0000-0002-9708-1526	National Health and Medical Research Council of Australia; South-Eastern Norway Regional Health Authority [2011050, 2015009]; Research Council of Norway [179573/V40, 233885]; Stiftelsen Kristian Gerhard Jebsen [SKGJ-MED-017]; ARC Australian Laureate Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; ARC Australian Laureate Fellowship(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and by the South-Eastern Norway Regional Health Authority (projects 2011050 and 2015009), the Research Council of Norway (project 179573/V40 through the Centre of Excellence funding scheme and project 233885) and by Stiftelsen Kristian Gerhard Jebsen (project SKGJ-MED-017) to L. M. S.; J. R. is supported by an ARC Australian Laureate Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Christophersen A, 2016, J IMMUNOL, V196, P2819, DOI 10.4049/jimmunol.1501152; Christophersen A, 2014, UNITED EUR GASTROENT, V2, P268, DOI 10.1177/2050640614540154; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Cole DK, 2016, J CLIN INVEST, V126, P2191, DOI 10.1172/JCI85679; Dahal-Koirala S, 2016, MUCOSAL IMMUNOL, V9, P587, DOI 10.1038/mi.2015.147; Dahal-Koirala S, 2020, EUR J IMMUNOL, V50, P256, DOI 10.1002/eji.201948253; Dahal-Koirala S, 2019, J BIOL CHEM, V294, P941, DOI 10.1074/jbc.RA118.005736; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcigno L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239301; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Gunnarsen KS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95193; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hardy MY, 2020, GUT, V69, P830, DOI 10.1136/gutjnl-2019-319093; Hardy MY, 2015, GASTROENTEROLOGY, V149, P1541, DOI 10.1053/j.gastro.2015.07.013; Hardy MY, 2015, J AUTOIMMUN, V56, P56, DOI 10.1016/j.jaut.2014.10.003; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hoydahl LS, 2019, GASTROENTEROLOGY, V156, P1428, DOI 10.1053/j.gastro.2018.12.013; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koning F, 2005, GASTROENTEROLOGY, V129, P1294, DOI 10.1053/j.gastro.2005.07.030; La Gruta NL, 2018, NAT REV IMMUNOL, V18, P467, DOI 10.1038/s41577-018-0007-5; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lindeman I, 2021, J EXP MED, V218, DOI 10.1084/jem.20200852; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Petersen J, 2020, NAT STRUCT MOL BIOL, V27, P49, DOI 10.1038/s41594-019-0353-4; Petersen J, 2016, STRUCTURE, V24, P1643, DOI 10.1016/j.str.2016.07.010; Petersen J, 2015, J IMMUNOL, V194, P6112, DOI 10.4049/jimmunol.1500161; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Qiao SW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.646163; Qiao SW, 2014, INT IMMUNOL, V26, P13, DOI 10.1093/intimm/dxt037; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sethi DK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3623; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Shahine A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07898-0; Singh P, 2018, CLIN GASTROENTEROL H, V16, P823, DOI 10.1016/j.cgh.2017.06.037; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2020, IMMUNOGENETICS, V72, P85, DOI 10.1007/s00251-019-01141-w; Ting YT, 2020, P NATL ACAD SCI USA, V117, P3063, DOI 10.1073/pnas.1914308117; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao Y, 2021, CLIN IMMUNOL, V222, DOI 10.1016/j.clim.2020.108621	60	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101619	10.1016/j.jbc.2022.101619	http://dx.doi.org/10.1016/j.jbc.2022.101619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35065967	Green Accepted, gold, Green Published			2022-12-28	WOS:000821051800002
J	Malik, M; Fang, YY; Wakle-Prabagaran, M; Roh, M; Prifti, K; Frolova, AI; Imoukhuede, PI; England, SK				Malik, Manasi; Fang, Yingye; Wakle-Prabagaran, Monali; Roh, Michelle; Prifti, Kevin; Frolova, Antonina, I; Imoukhuede, Princess I.; England, Sarah K.			Pharmacological chaperones for the oxytocin receptor increase oxytocin responsiveness in myometrial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL-FETAL MEDICINE; MEMBRANE-PERMEABILITY; SURFACE EXPRESSION; FUNCTIONAL RESCUE; CESAREAN DELIVERY; IN-VITRO; VASOPRESSIN; PHARMACOCHAPERONES; SELECTIVITY; POTENT	Oxytocin is a potent uterotonic agent administered to nearly all patients during childbirth in the United States. Inadequate oxytocin response can necessitate Cesarean delivery or lead to uterine atony and postpartum hemorrhage. Thus, it may be clinically useful to identify patients at risk for poor oxytocin response and develop strategies to sensitize the uterus to oxytocin. Previously, we showed that the V281M variant in the oxytocin receptor (OXTR) gene impairs OXTR trafficking to the cell surface, leading to a decreased oxytocin response in cells. Here, we sought to identify pharmacological chaperones that increased oxytocin response in cells expressing WT or V281M OXTR. We screened nine small-molecule agonists and antagonists of the oxytocin/vasopressin receptor family and identified two, SR49059 and L371,257, that restored both OXTR trafficking and oxytocin response in HEK293T cells transfected with V281M OXTR. In hTERT-immortalized human myometrial cells, which endogenously express WT OXTR, treatment with SR49059 and L371,257 increased the amount of OXTR on the cell surface by two-to fourfold. Furthermore, SR49059 and L371,257 increased the endogenous oxytocin response in hTERT-immortalized human myometrial cells by 35% and induced robust oxytocin responses in primary myometrial cells obtained from patients at the time of Cesarean section. If future studies demonstrate that these pharmacological chaperones or related compounds function similarly in vivo, we propose that they could potentially be used to enhance clinical response to oxytocin.	[Malik, Manasi; Wakle-Prabagaran, Monali; Roh, Michelle; Prifti, Kevin; Frolova, Antonina, I; England, Sarah K.] Washington Univ, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Fang, Yingye; Imoukhuede, Princess I.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	England, SK (corresponding author), Washington Univ, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	englands@wustl.edu		Fang, Yingye/0000-0003-4137-866X; England, Sarah/0000-0003-4247-0281; Malik, Manasi/0000-0002-4203-962X	National Institute of Child Health and Human Development [R01 HD096737, F30 HD097925]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National Institute of Child Health and Human Development (R01 HD096737 to S. K. E. and P. I. I., and F30 HD097925 to M. M.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130; Bennion BJ, 2017, J PHYS CHEM B, V121, P5228, DOI 10.1021/acs.jpcb.7b02914; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen S, 2017, METHODS MOL BIOL, V1570, P117, DOI 10.1007/978-1-4939-6840-4_8; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Frantz MC, 2010, J MED CHEM, V53, P1546, DOI 10.1021/jm901084f; Frey HA, 2015, J MATERN-FETAL NEO M, V28, P1614, DOI 10.3109/14767058.2014.963046; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Griffante C, 2005, BRIT J PHARMACOL, V146, P744, DOI 10.1038/sj.bjp.0706383; Hall DA, 2010, BRIT J PHARMACOL, V161, P1276, DOI 10.1111/j.1476-5381.2010.00879.x; Hammad IA, 2014, J MATERN-FETAL NEO M, V27, P463, DOI 10.3109/14767058.2013.818970; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Iijima M, 2014, BRIT J PHARMACOL, V171, P3511, DOI 10.1111/bph.12699; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kondo K, 1999, BIOORGAN MED CHEM, V7, P1743, DOI 10.1016/S0968-0896(99)00101-7; Malik M, 2021, ACS PHARMACOL TRANSL, V4, P1543, DOI 10.1021/acsptsci.1c00095; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; MEDDINGS JB, 1989, AM J PHYSIOL, V257, pG982, DOI 10.1152/ajpgi.1989.257.6.G982; MILLER RR, 1975, NEW ENGL J MED, V293, P416, DOI 10.1056/NEJM197508282930902; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mouillac B, 2018, HANDB EXP PHARMACOL, V245, P63, DOI 10.1007/164_2017_50; Nasrollahi-Shirazi S, 2016, J PHARMACOL EXP THER, V359, P73, DOI 10.1124/jpet.116.232884; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Pergialiotis V, 2020, EUR J OBSTET GYN R B, V252, P62, DOI 10.1016/j.ejogrb.2020.06.018; Refsgaard HHF, 2005, J MED CHEM, V48, P805, DOI 10.1021/jm049661n; Ring RH, 2010, NEUROPHARMACOLOGY, V58, P69, DOI [10.1016/j.neuropharm.2009.07.016, 10.1016/j.neuropharm.2009.08.015]; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Spong CY, 2013, OBSTET GYNECOL, V121, P687, DOI 10.1097/AOG.0b013e3182854b36; Tahara A, 2000, BRIT J PHARMACOL, V129, P131, DOI 10.1038/sj.bjp.0702996; Tahara A, 1997, J PHARMACOL EXP THER, V282, P301; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; WILLIAMS PD, 1995, J MED CHEM, V38, P4634, DOI 10.1021/jm00023a002; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	38	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101646	10.1016/j.jbc.2022.101646	http://dx.doi.org/10.1016/j.jbc.2022.101646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093385	gold, Green Published			2022-12-28	WOS:000789261900014
J	Raeeszadeh-Sarmazdeh, M; Coban, M; Mahajan, S; Hockla, A; Sankaran, B; Downey, GP; Radisky, DC; Radisky, ES				Raeeszadeh-Sarmazdeh, Maryam; Coban, Mathew; Mahajan, Shivansh; Hockla, Alexandra; Sankaran, Banumathi; Downey, Gregory P.; Radisky, Derek C.; Radisky, Evette S.			Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; MODERATES INFLAMMATION; MOLECULAR REPLACEMENT; THERAPEUTIC TARGETS; PROTECTIVE ROLES; TERMINAL DOMAIN; GELATINASE-B; MATRIX-METALLOPROTEINASE-9; CANCER; DEFICIENCY	Matrix metalloproteinases (MMPs) have long been known as key drivers in the development and progression of diseases, including cancer and neurodegenerative, cardiovascular, and many other inflammatory and degenerative diseases, making them attractive potential drug targets. Engineering selective inhibitors based upon tissue inhibitors of metalloproteinases (TIMPs), endogenous human proteins that tightly yet nonspecifically bind to the family of MMPs, represents a promising new avenue for therapeutic development. Here, we used a counter-selective screening strategy for directed evolution of yeast-displayed human TIMP-1 to obtain TIMP-1 variants highly selective for the inhibition of MMP-3 in preference over MMP-10. As MMP-3 and MMP-10 are the most similar MMPs in sequence, structure, and function, our results thus clearly demonstrate the capability for engineering full-length TIMP proteins to be highly selective MMP inhibitors. We show using protein crystal structures and models of MMP-3-selective TIMP-1 variants bound to MMP-3 and counter-target MMP10 how structural alterations within the N-terminal and C-terminal TIMP-1 domains create new favorable and selective interactions with MMP-3 and disrupt unique interactions with MMP-10. While our MMP-3-selective inhibitors may be of interest for future investigation in diseases where this enzyme drives pathology, our platform and screening strategy can be employed for developing selective inhibitors of additional MMPs implicated as therapeutic targets in disease.	[Raeeszadeh-Sarmazdeh, Maryam; Coban, Mathew; Mahajan, Shivansh; Hockla, Alexandra; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Div Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Downey, Gregory P.] Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO USA; [Downey, Gregory P.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Downey, Gregory P.] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Raeeszadeh-Sarmazdeh, Maryam] Univ Nevada, Dept Chem & Mat Engn, Reno, NV 89557 USA; [Mahajan, Shivansh] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Nevada System of Higher Education (NSHE); University of Nevada Reno; California Institute of Technology	Radisky, ES (corresponding author), Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu		Radisky, Evette/0000-0003-3121-109X	US National Institutes of Health [R01 GM132100, R01 CA258274, R01 HL157424]; US Department of Defense [W81XWH-16-2-0030]; National Institutes of Health [P20 GM103650]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grants (R01 GM132100 and R01 CA258274 [to E. S. R.], R01 HL157424 [to G. P. D., D. C. R., and E. S. R.]) and US Department of Defense grant (grant no.: W81XWH-16-2-0030 [to G. P. D. and D. C. R.]). M. R.-S. is supported in part by National Institutes of Health grant (grant no.: P20 GM103650). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine P. V., 2005, CCP4 NEWSL, V42, P42; Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Arkadash Valeria, 2018, Oncotarget, V9, P32036, DOI 10.18632/oncotarget.25885; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; Artham S, 2020, CYTOKINE, V131, DOI 10.1016/j.cyto.2020.155086; Artham S, 2019, PHARMACOL RES, V141, P249, DOI 10.1016/j.phrs.2019.01.006; Batra J., 2014, ENCY INORGANIC BIOIN, P1; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Cabrera S, 2019, AM J PHYSIOL-LUNG C, V316, pL961, DOI 10.1152/ajplung.00455.2017; Coban M. A., 2021, BIOMOLECULES, V11, P787; Cohen I, 2019, J BIOL CHEM, V294, P5105, DOI 10.1074/jbc.RA118.007292; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Craig VJ, 2015, AM J RESP CELL MOL, V53, P585, DOI 10.1165/rcmb.2015-0020TR; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Fingleton B, 2017, BBA-MOL CELL RES, V1864, P2036, DOI 10.1016/j.bbamcr.2017.05.010; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Kassim SY, 2007, INFECT IMMUN, V75, P5640, DOI 10.1128/IAI.00799-07; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Konning D, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0881-3; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuhlman B, 2019, NAT REV MOL CELL BIO, V20, P681, DOI 10.1038/s41580-019-0163-x; Manicone AM, 2009, J IMMUNOL, V182, P3866, DOI 10.4049/jimmunol.0713949; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMahan RS, 2016, J IMMUNOL, V197, P899, DOI 10.4049/jimmunol.1600502; McPherson A, 2014, ACTA CRYSTALLOGR F, V70, P1445, DOI 10.1107/S2053230X14019670; Mehner C, 2014, MOL CANCER RES, V12, P1430, DOI 10.1158/1541-7786.MCR-13-0557-T; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nerusu KC, 2007, EXP MOL PATHOL, V83, P169, DOI 10.1016/j.yexmp.2007.04.003; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Puntorieri V, 2016, EXP LUNG RES, V42, P365, DOI 10.1080/01902148.2016.1231243; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Radisky ES, 2017, J CELL BIOCHEM, V118, P3531, DOI 10.1002/jcb.26185; Radisky ES, 2015, FRONT BIOSCI-LANDMRK, V20, P1144, DOI 10.2741/4364; Raeeszadeh-Sarmazdeh M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051313; Raeeszadeh-Sarmazdeh M, 2019, J BIOL CHEM, V294, P9476, DOI 10.1074/jbc.RA119.008321; Razai AS, 2020, J BIOL CHEM, V295, P2464, DOI 10.1074/jbc.RA119.011712; Sen AI, 2010, EXP LUNG RES, V36, P615, DOI 10.3109/01902148.2010.497201; Shirian J, 2018, FEBS LETT, V592, P1122, DOI 10.1002/1873-3468.13016; Stallings-Mann ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004062; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandivort TC, 2017, INT J NANOMED, V12, P1019, DOI 10.2147/IJN.S123484; Wang YJ, 2021, CHEM REV, V121, P12384, DOI 10.1021/acs.chemrev.1c00260; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Yamashita CM, 2016, CAN J PHYSIOL PHARM, V94, P682, DOI 10.1139/cjpp-2015-0377; Yamashita CM, 2014, EXPERT REV RESP MED, V8, P411, DOI 10.1586/17476348.2014.909288; Yamashita CM, 2011, AM J PATHOL, V179, P1733, DOI 10.1016/j.ajpath.2011.06.041; Yoon HK, 2007, ENVIRON HEALTH PERSP, V115, P1557, DOI 10.1289/ehp.10289; Yosef G, 2018, J BIOL CHEM, V293, P13310, DOI 10.1074/jbc.RA118.004406; Yu GY, 2012, AM J RESP CRIT CARE, V186, P752, DOI 10.1164/rccm.201202-0302OC	80	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101654	10.1016/j.jbc.2022.101654	http://dx.doi.org/10.1016/j.jbc.2022.101654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101440	gold, Green Accepted, Green Published			2022-12-28	WOS:000794865600006
J	Uppala, JK; Sathe, L; Chakraborty, A; Bhattacharjee, S; Pulvino, AT; Dey, M				Uppala, Jagadeesh Kumar; Sathe, Leena; Chakraborty, Abhijit; Bhattacharjee, Sankhajit; Pulvino, Anthony Thomas; Dey, Madhusudan			The cap-proximal RNA secondary structure inhibits preinitiation complex formation on HAC1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; GENOME-WIDE ANALYSIS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; TRANSLATION INITIATION; MECHANISM; HAC1; REVEALS	Translation of HAC1 mRNA in the budding yeast Saccharomyces cerevisiae is derepressed when RNase Ire1 removes its intron via nonconventional cytosolic splicing in response to accumulation of unfolded proteins inside the endoplasmic reticulum. The spliced HAC1 mRNA is translated into a transcription factor that changes the cellular gene expression patterns to increase the protein folding capacity of cells. Previously, we showed that a segment of the intronic sequence interacts with the 5'-UTR of the unspliced mRNA, resulting in repression of HAC1 translation at the initiation stage. However, the exact mechanism of translational derepression is not clear. Here, we show that at least 11-base-pairing interactions between the 5'-UTR and intron (UI) are sufficient to repress HAC1 translation. We also show that overexpression of the helicase eukaryotic initiation factor 4A derepressed translation of an unspliced HAC1 mRNA containing only 11-bp interactions between the 5'-UTR and intronic sequences. In addition, our genetic screen identifies that single mutations in the UI interaction site could derepress translation of the unspliced HAC1 mRNA. Furthermore, we show that the addition of 24 RNA bases between the mRNA 5'-cap and the UI interaction site derepressed translation of the unspliced HAC1 mRNA. Together, our data provide a mechanistic explanation for why the cap-proximal UI-RNA duplex inhibits the recruitment of translating ribosomes to HAC1 mRNA, thus keeping mRNA translationally repressed.	[Uppala, Jagadeesh Kumar; Sathe, Leena; Bhattacharjee, Sankhajit; Pulvino, Anthony Thomas; Dey, Madhusudan] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA; [Chakraborty, Abhijit] La Jolla Inst Immunol, Ctr Autoimmun & Inflammat, Ctr Canc Immunotherapy, La Jolla, CA USA	University of Wisconsin System; University of Wisconsin Milwaukee; La Jolla Institute for Immunology	Dey, M (corresponding author), Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA.	deym@uwm.edu	Uppala, Jagadeesh/AAY-7265-2021	Uppala, Jagadeesh/0000-0002-3653-0316	National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA [1R01GM124183]	National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA	This work was supported partly by grant from the National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA (grant no.: 1R01GM124183; to M. D.) . The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2018, ELIFE, V7, DOI 10.7554/eLife.43036; Amin-ul Mannan M, 2013, J MOL BIOL, V425, P2083, DOI 10.1016/j.jmb.2013.02.036; Andreev DE, 2017, NUCLEIC ACIDS RES, V45, P513, DOI 10.1093/nar/gkw1190; Bevilacqua PC, 2016, ANNU REV GENET, V50, P235, DOI 10.1146/annurev-genet-120215-035034; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dever TE, 2016, GENETICS, V203, P65, DOI 10.1534/genetics.115.186221; Di Santo R, 2016, ELIFE, V5, DOI 10.7554/eLife.20069; Elfakess R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003094; Gao ZF, 2016, ELIFE, V5, DOI 10.7554/eLife.16408; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haimov O, 2015, BBA-GENE REGUL MECH, V1849, P1313, DOI 10.1016/j.bbagrm.2015.09.006; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iracane E, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00532-18; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sathe L, 2015, J BIOL CHEM, V290, P21821, DOI 10.1074/jbc.M115.649335; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Uppala JK, 2021, MOL CELL BIOL, V41, DOI 10.1128/MCB.00662-20; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Weenink T, 2018, SYN BIOL, V3, DOI 10.1093/synbio/ysy019; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001	45	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101648	10.1016/j.jbc.2022.101648	http://dx.doi.org/10.1016/j.jbc.2022.101648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35101452	Green Published, gold			2022-12-28	WOS:000789261900016
J	Beauvais, DM; Nelson, SE; Adams, KM; Stueven, NA; Jung, OS; Rapraeger, AC				Beauvais, DeannaLee M.; Nelson, Scott E.; Adams, Kristin M.; Stueven, Noah A.; Jung, Oisun; Rapraeger, Alan C.			Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; TYROSINE KINASE; TETRASPANIN CD151; INTEGRIN ALPHA-3-BETA-1; DNA-REPLICATION; MAP KINASE; CROSS-TALK; C-ABL; HEAD	Epidermal growth factor receptor (EGFR) is a causal factor in carcinoma, yet many carcinoma patients are resistant to EGFR inhibitors. Potential insight into this resistance stems from prior work that showed EGFR in normal epithelial cells docks to the extracellular domain of the plasma membrane proteoglycan syndecan-4 (Sdc4) engaged with alpha 3 beta 1 and alpha 6 beta 4 integrins. We now report that this receptor complex is modified by the recruitment of syndecan-2 (Sdc2), the Recepteur d'Origine Nantais (RON) tyrosine kinase, and the cellular signaling mediator Abelson murine leukemia viral oncogene homolog 1 (ABL1) in triple-negative breast carcinoma and head and neck squamous cell carcinoma, where it contributes to EGFR kinase-independent proliferation. Treatment with a peptide mimetic of the EGFR docking site in the extracellular domain of Sdc4 (called SSTNEGFR) disrupts the entire complex and causes a rapid, global arrest of the cell cycle. Normal epithelial cells do not recruit these additional receptors to the adhesion mechanism and are not arrested by SSTNEGFR. Although EGFR docking with Sdc4 in the tumor cells is required, cell cycle progression does not depend on EGFR kinase. Instead, progression depends on RON kinase, activated by its incorporation into the complex. RON activates ABL1, which suppresses p38 mitogen-activated protein kinase and prevents a p38-mediated signal that would otherwise arrest the cell cycle. These findings add to the growing list of receptor tyrosine kinases that support tumorigenesis when activated by their association with syndecans at sites of matrix adhesion and identify new potential targets for cancer therapy.	[Beauvais, DeannaLee M.; Nelson, Scott E.; Adams, Kristin M.; Stueven, Noah A.; Jung, Oisun; Rapraeger, Alan C.] Univ Wisconsin Madison, Univ Wisconsin Carbone Canc Ctr, Dept Human Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Univ Wisconsin Madison, Univ Wisconsin Carbone Canc Ctr, Dept Human Oncol, Madison, WI 53706 USA.	rapraeger@humonc.wisc.edu			National Institutes of Health [R01-CA163662, R01-DE028341]; UW School of Medicine and Public Health; UW Carbone Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW School of Medicine and Public Health; UW Carbone Cancer Center	This work was supported by funds from the National Institutes of Health to A. C. R. (R01-CA163662, R01-DE028341) and funds in support of head and neck cancer research to A. C. R. from the UW School of Medicine and Public Health and the UW Carbone Cancer Center. The con-tent is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beauvais DM, 2016, CANCER RES, V76, P4981, DOI 10.1158/0008-5472.CAN-16-0232; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Carvalho FM, 2010, CLINICS, V65, P1033, DOI 10.1590/S1807-59322010001000019; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chang SS, 2008, J SURG ONCOL, V97, P640, DOI 10.1002/jso.21023; Choi Y, 2015, J BIOL CHEM, V290, P16943, DOI 10.1074/jbc.M114.611798; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dent P, 1999, MOL BIOL CELL, V10, P2493, DOI 10.1091/mbc.10.8.2493; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Grandis JR, 1997, ONCOGENE, V15, P409, DOI 10.1038/sj.onc.1201188; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gryp JL, 2012, CELL CYCLE, V11, P3917, DOI 10.4161/cc.22394; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Harlow E., 1988, ANTIBODIES LAB MANUA; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jung O, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.5; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Keller J, 2013, BRIT J CANCER, V109, P482, DOI 10.1038/bjc.2013.321; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Oh ES, 2004, MOL CELLS, V17, P181; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Park JW, 2014, RADIOTHER ONCOL, V113, P337, DOI 10.1016/j.radonc.2014.08.026; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; RONSIN C, 1993, ONCOGENE, V8, P1195; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Saxena M, 2017, NAT MATER, V16, P775, DOI [10.1038/NMAT4893, 10.1038/nmat4893]; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; SCHMIDTULLRICH RK, 1994, INT J RADIAT ONCOL, V29, P813, DOI 10.1016/0360-3016(94)90570-3; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2002, J CELL SCI, V115, P1161; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang HY, 2015, J BIOL CHEM, V290, P26103, DOI 10.1074/jbc.M115.679084; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yu PT, 2012, INT J CANCER, V131, P1744, DOI 10.1002/ijc.27447; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zhao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029416; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	65	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102029	10.1016/j.jbc.2022.102029	http://dx.doi.org/10.1016/j.jbc.2022.102029			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35569509	Green Published, gold			2022-12-28	WOS:000829588600013
J	Buel, GR; Dang, HQ; Asara, JM; Blenis, J; Mutvei, AP				Buel, Gwen R.; Dang, Huy Q.; Asara, John M.; Blenis, John; Mutvei, Anders P.			Prolonged deprivation of arginine or leucine induces PI3K/ Akt-dependent reactivation of mTORC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAG GTPASES; GROWTH-FACTOR; INSULIN; PROTEIN; MECHANISM; AUTOPHAGY; COMPLEX; PHOSPHORYLATION; SUFFICIENCY; ACTIVATION	The mechanistic target of rapamycin complex 1 (mTORC1) is a serine/threonine kinase complex that promotes anabolic processes including protein, lipid, and nucleotide synthesis, while suppressing catabolic processes such as macroautophagy. mTORC1 activity is regulated by growth factors and amino acids, which signal through distinct but integrated molecular pathways: growth factors largely signal through the PI3K/Aktdependent pathway, whereas the availabilities of amino acids leucine and arginine are communicated to mTORC1 by the Rag-GTPase pathway. While it is relatively well described how acute changes in leucine and arginine levels affect mTORC1 signaling, the effects of prolonged amino acid deprivation remain less well understood. Here, we demonstrate that prolonged deprivation of arginine and/or leucine leads to reactivation of mTORC1 activity, which reaches activation levels similar to those observed in nutrient-rich conditions. Surprisingly, we find that this reactivation is independent of the regeneration of amino acids by canonical autophagy or proteasomal degradation but is dependent on PI3K/Akt signaling. Together, our data identify a novel crosstalk between the amino acid and PI3K/Akt signaling pathways upstream of mTORC1. These observations extend our understanding of the role of mTORC1 in growth-related diseases and indicate that dietary intervention by removal of leucine and/or arginine may be an ineffective therapeutic approach.	[Buel, Gwen R.] Harvard Med Sch, Programs Biol & Biomed Sci, Boston, MA USA; [Buel, Gwen R.; Blenis, John] Weill Cornell Med Coll, Meyer Canc Ctr, Dept Pharmacol, New York, NY 10021 USA; [Buel, Gwen R.; Blenis, John] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Dang, Huy Q.; Mutvei, Anders P.] Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden; [Asara, John M.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Cornell University; Harvard University; Harvard Medical School; Uppsala University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Blenis, J (corresponding author), Weill Cornell Med Coll, Meyer Canc Ctr, Dept Pharmacol, New York, NY 10021 USA.; Blenis, J (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Mutvei, AP (corresponding author), Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden.	jblenis@med.cornell.edu; anders.mutvei@igp.uu.se		Buel, Gwen/0000-0003-2917-3055	Swedish Research Council [2020-01126]; Swedish Cancer Society [21 0437 JIA, 20 1188 Pj]; Magnus Bergvall foundation; National Institutes of Health [F31 CA173942, R01 GM051405]; Ake Wibergs foundation; Lars Hierta's Memory Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvall foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ake Wibergs foundation; Lars Hierta's Memory Foundation	This work was supported by grants from The Swedish Research Council (2020-01126), The Swedish Cancer Society (21 0437 JIA, 20 1188 Pj), Ake Wibergs foundation, Lars Hierta's Memory Foundation and Magnus Bergvall foundation to A. P. M., National Institutes of Health F31 CA173942 to G. R. B., and National Institutes of Health R01 GM051405 to J. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang CC, 2012, ORAL ONCOL, V48, P1227, DOI 10.1016/j.oraloncology.2012.06.004; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kang JS, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00439-x; KAWASE T, 1995, ARCH ORAL BIOL, V40, P921, DOI 10.1016/0003-9969(95)00061-S; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kelly MP, 2012, BRIT J CANCER, V106, P324, DOI 10.1038/bjc.2011.524; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Melick CH, 2020, GENES-BASEL, V11, DOI 10.3390/genes11090989; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Mutvei AP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15156-5; Nakashima N, 1999, GENETICS, V152, P853; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Yao Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030051; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	41	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102030	10.1016/j.jbc.2022.102030	http://dx.doi.org/10.1016/j.jbc.2022.102030			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35577075	Green Published, gold			2022-12-28	WOS:000816927100001
J	Chen, HH; Lin, CJ; Anand, A; Lin, HJ; Lin, HY; Mao, JY; Wang, PH; Tseng, YJ; Tzou, WS; Huang, CC; Wang, RYL				Chen, Han-Hsiang; Lin, Chin-Jung; Anand, Anisha; Lin, Han-Jia; Lin, Hung-Yun; Mao, Ju-Yi; Wang, Pei-Hua; Tseng, Yufeng Jane; Tzou, Wen-Shyong; Huang, Chih-Ching; Wang, Robert Y. L.			Development of antiviral carbon quantum dots that target the Japanese encephalitis virus envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENGUE VIRUS; GRAPHENE OXIDE; FULLERENE DERIVATIVES; CRYSTAL-STRUCTURE; CURCUMIN; INHIBITION; ENTRY; NS3; NANOMATERIALS; MUTATION	Japanese encephalitis is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV) that is prevalent in Asia and the Western Pacific. Currently, there is no effective treatment for Japanese encephalitis. Curcumin (Cur) is a compound extracted from the roots of Curcuma longa, and many studies have reported its antiviral and anti-inflammatory activities. However, the high cytotoxicity and very low solubility of Cur limit its biomedical applications. In this study, Cur carbon quantum dots (Cur-CQDs) were synthesized by mild pyrolysis-induced polymerization and carbonization, leading to higher water solubility and lower cytotoxicity, as well as superior antiviral activity against JEV infection. We found that CurCQDs effectively bound to the E protein of JEV, preventing viral entry into the host cells. In addition, after continued treatment of JEV with Cur-CQDs, a mutant strain of JEV was evolved that did not support binding of Cur-CQDs to the JEV envelope. Using transmission electron microscopy, biolayer interferometry, and molecular docking analysis, we revealed that the S123R and K312R mutations in the E protein play a key role in binding Cur-CQDs. The S123 and K312 residues are located in structural domains II and III of the E protein, respectively, and are responsible for binding to receptors on and fusing with the cell membrane. Taken together, our results suggest that the E protein of flaviviruses represents a potential target for the development of CQD-based inhibitors to prevent or treat viral infections.	[Chen, Han-Hsiang; Wang, Robert Y. L.] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Div Microbiol & Immunol, Taoyuan, Taiwan; [Lin, Chin-Jung; Anand, Anisha; Lin, Han-Jia; Lin, Hung-Yun; Mao, Ju-Yi; Tzou, Wen-Shyong; Huang, Chih-Ching] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Lin, Han-Jia; Huang, Chih-Ching] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Wang, Pei-Hua; Tseng, Yufeng Jane] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Tseng, Yufeng Jane] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan; [Huang, Chih-Ching] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Wang, Robert Y. L.] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem & Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan	Chang Gung University; National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan University; National Taiwan University; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wang, RYL (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Div Microbiol & Immunol, Taoyuan, Taiwan.; Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.; Huang, CC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.; Wang, RYL (corresponding author), Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem & Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	huanging@ntou.edu.tw; yuwang@mail.cgu.edu.tw	Huang, Chih-Ching/D-3103-2012; Tzou, Wen-Shyong/H-4517-2014	Huang, Chih-Ching/0000-0002-0363-1129; Tzou, Wen-Shyong/0000-0002-6726-1390	Ministry of Science and Technology of Taiwan [110 to 2221-E-019 to 001, 110 to 2320-B-182 to 029, 110 to 2811-M-019 to 501]; Chang Gung memorial hospital research fund [CMRPD1H0321-3, CMRPD1K0251-2, CMRPD1L0061]; Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung memorial hospital research fund(Chang Gung Memorial Hospital); Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within Ministry of Education (MOE) in Taiwan	This study was supported by the Ministry of Science and Technology of Taiwan under Contract Nos. 110 to 2221-E-019 to 001, 110 to 2320-B-182 to 029 and 110 to 2811-M-019 to 501, by Chang Gung memorial hospital research fund (CMRPD1H0321-3, CMRPD1K0251-2 and CMRPD1L0061) and by the Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.	Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Baikerikar S, 2017, PHARMACOGN RES, V9, pS15, DOI 10.4103/pr.pr_30_17; Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002; Barras A, 2016, ACS APPL MATER INTER, V8, P9004, DOI 10.1021/acsami.6b01681; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Carro SD, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010013; Chakravarty M, 2021, DRUG DELIV TRANSL RE, V11, P748, DOI 10.1007/s13346-020-00818-0; Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010; Aparicio JAC, 2020, MRS ADV, V5, P3345, DOI 10.1557/adv.2020.410; Das C, 2020, INT J NANOMED, V15, P9301, DOI 10.2147/IJN.S280976; Mendes LAD, 2020, CHEM-BIOL INTERACT, V331, DOI 10.1016/j.cbi.2020.109218; de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011; Du T, 2018, ACS APPL BIO MATER, V1, P1286, DOI 10.1021/acsabm.8b00154; Du T, 2016, CARBON, V110, P278, DOI 10.1016/j.carbon.2016.09.032; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; EDWARD Z, 1993, MICROBIOL IMMUNOL, V37, P239, DOI 10.1111/j.1348-0421.1993.tb03206.x; Fahmi MZ, 2016, RSC ADV, V6, P92996, DOI 10.1039/c6ra21062g; Falynskova IN, 2014, PHARM CHEM J+, V48, P85, DOI 10.1007/s11094-014-1053-3; Fan WC, 2016, VIRUS RES, V220, P112, DOI 10.1016/j.virusres.2016.04.021; Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Fujisawa S, 2004, ANTICANCER RES, V24, P563; Garg P, 2020, NANO TODAY, V35, DOI 10.1016/j.nantod.2020.101001; Hansen V, 2016, JAMA-J AM MED ASSOC, V316, P2149, DOI 10.1001/jama.2016.12423; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Hiraga K, 2021, ACS SYNTH BIOL, V10, P357, DOI 10.1021/acssynbio.0c00542; Hu T, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01611-2; Iannazzo D, 2018, BIOCONJUGATE CHEM, V29, P3084, DOI 10.1021/acs.bioconjchem.8b00448; Innocenzi P, 2020, CHEM SCI, V11, P6606, DOI 10.1039/d0sc02658a; Iro MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011367.pub2; Jackman JA, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202008352; Jelinek T, 2008, EXPERT REV VACCINES, V7, P689, DOI 10.1586/14760584.7.5.689; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Kataoka H, 2016, BIOORG MED CHEM LETT, V26, P4565, DOI 10.1016/j.bmcl.2016.08.086; Kim M, 2021, EUR J PHARMACOL, V904, DOI 10.1016/j.ejphar.2021.174144; Klimova R, 2020, FULLER NANOTUB CAR N, V28, P487, DOI 10.1080/1536383X.2019.1706495; Kurane I, 2000, VACCINE, V18, P33, DOI 10.1016/S0264-410X(00)00041-4; Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6; Li PC, 2019, ACS INFECT DIS, V5, P460, DOI 10.1021/acsinfecdis.8b00322; Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127; Lin CJ, 2019, SMALL, V15, DOI 10.1002/smll.201902641; Liu HB, 2015, J VIROL, V89, P5668, DOI 10.1128/JVI.00293-15; Liu JJ, 2020, ACS CENTRAL SCI, V6, P2179, DOI 10.1021/acscentsci.0c01306; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014; Martinez ZS, 2016, ANTIMICROB AGENTS CH, V60, P5731, DOI 10.1128/AAC.00341-16; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002; Mostafavi ST, 2009, DESALINATION, V238, P271, DOI 10.1016/j.desal.2008.02.018; Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014; Pacho MN, 2021, J PHARM PHARMACOL, V73, P357, DOI 10.1093/jpp/rgaa045; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Nelson KM, 2017, ACS MED CHEM LETT, V8, P467, DOI 10.1021/acsmedchemlett.7b00139; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585; Osminkina LA, 2022, BIOACT MATER, V7, P39, DOI 10.1016/j.bioactmat.2021.06.001; Padilla L, 2014, ARCH VIROL, V159, P573, DOI 10.1007/s00705-013-1849-6; Peng MH, 2017, ANTIVIR RES, V143, P176, DOI 10.1016/j.antiviral.2017.03.026; Pilaquinga F, 2021, WIRES NANOMED NANOBI, V13, DOI 10.1002/wnan.1707; Ramos-Soriano J, 2019, J AM CHEM SOC, V141, P15403, DOI 10.1021/jacs.9b08003; Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627; Serrano-Aroca A, 2021, ACS NANO, V15, P8069, DOI 10.1021/acsnano.1c00629; Skalny AV, 2020, INT J MOL MED, V46, P17, DOI 10.3892/ijmm.2020.4575; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653; Tollas S, 2014, BIOORG MED CHEM LETT, V24, P2420, DOI 10.1016/j.bmcl.2014.04.032; Tong T, 2020, SMALL, V16, DOI 10.1002/smll.201906206; Tortella G, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10070783; Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30; Unal MA, 2021, SMALL, V17, DOI 10.1002/smll.202101483; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; Wang XX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00024-6; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128; Yamaguchi Y, 2013, J GEN VIROL, V94, P90, DOI 10.1099/vir.0.044925-0; Yang J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010020; Yang XX, 2017, NANOSCALE, V9, P16086, DOI 10.1039/c7nr06520e; Yang XX, 2016, NANOSCALE, V8, P3040, DOI 10.1039/c5nr07918g; Ye SY, 2015, ACS APPL MATER INTER, V7, P21571, DOI 10.1021/acsami.5b06876; Yoon BK, 2021, ACS NANO, V15, P125, DOI 10.1021/acsnano.0c07489; Yun SI, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030068; Zandi K, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-91; Zeng QS, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00579-6; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou JR, 2021, NANO TODAY, V36, DOI 10.1016/j.nantod.2020.101031; Zhou YY, 2018, ARCH VIROL, V163, P1351, DOI 10.1007/s00705-018-3765-2; Ziem B, 2017, NANOSCALE, V9, P3774, DOI 10.1039/c7nr00611j	89	3	3	6	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101957	10.1016/j.jbc.2022.101957	http://dx.doi.org/10.1016/j.jbc.2022.101957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452675	Green Published, gold			2022-12-28	WOS:000838892100011
J	Chhakchhuak, PIR; Sen, R				Chhakchhuak, Passong Immanual R.; Sen, Ranjan			In vivo regulation of bacterial Rho-dependent transcription termination by the nascent RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE-MUTANTS; NUSG; ELONGATION; MECHANISM; RECOGNITION	Bacterial Rho is a RNA-dependent ATPase that functions in the termination of transcription. The in vivo nature of the bacterial Rho-dependent terminators, as well as the mechanism of the Rho-dependent termination process, are not fully understood. Here, we measured the in vivo termination efficiencies of 72 Rho-dependent terminators in Escherichia coli by systematically performing qRT-PCR analyses of cDNA prepared from mid-log phase bacterial cultures. We found that these terminators exhibited a wide range of efficiencies, and many behaved differently in vivo compared to the predicted or experimentally determined efficiencies in vitro. Rho-utilization sites (rut sites) present in the RNA terminator sequences are characterized by the presence of C-rich/G-poor sequences or C > G bubbles. We found that weaker terminators exhibited a robust correlation with the properties (size, length, density, etc.) of these C > G bubbles of their respective rut sites, while stronger terminators lack this correlation, suggesting a limited role of rut sequences in controlling in vivo termination efficiencies. We also found that in vivo termination efficiencies are dependent on the rates of ATP hydrolysis as well as Rhotranslocation on the nascent RNA. We demonstrate that weaker terminators, in addition to having rut sites with diminished C > G bubble sizes, are dependent on the Rhoauxiliary factor, NusG, in vivo. From these results, we concluded that in vivo Rho-dependent termination follows a nascent RNA-dependent pathway, where Rho-translocation along the RNA is essential and rut sequences may recruit Rho in vivo, but Rho-rut binding strengths do not regulate termination efficiencies.	[Chhakchhuak, Passong Immanual R.; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India; [Chhakchhuak, Passong Immanual R.] Reg Ctr Biotechnol, Grad Studies, Faridabad, Haryana, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India.	rsen@cdfd.org.in			Department of Biotechnology (DBT) Centre for Excellence project on Microbial Physiology [BT/01/COE/07/02-II]	Department of Biotechnology (DBT) Centre for Excellence project on Microbial Physiology(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT) Centre for Excellence project on Microbial Physiology (BT/01/COE/07/02-II) to R. S.	ALIFANO P, 1991, CELL, V64, P553; Banerjee S, 2006, J MICROBIOL, V44, P11; Bartolini M, 2013, J PHARMACEUT BIOMED, V73, P77, DOI 10.1016/j.jpba.2012.03.021; Bastet L, 2017, NUCLEIC ACIDS RES, V45, P7474, DOI 10.1093/nar/gkx434; Bendak K, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks285; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Dar D, 2018, NUCLEIC ACIDS RES, V46, P6797, DOI 10.1093/nar/gky274; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Ghosh G, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100653; Hafeezunnisa M, 2021, FEBS LETT, V595, P2057, DOI 10.1002/1873-3468.14150; Hao ZT, 2021, TRANSCR-AUSTIN, V12, P171, DOI 10.1080/21541264.2021.1991773; Hao ZT, 2021, MOL CELL, V81, P281, DOI 10.1016/j.molcel.2020.11.013; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KUPPER H, 1978, NATURE, V272, P423, DOI 10.1038/272423a0; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Lawson MR, 2018, MOL CELL, V71, P911, DOI 10.1016/j.molcel.2018.07.014; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Menouni R, 2013, P NATL ACAD SCI USA, V110, P14414, DOI 10.1073/pnas.1303400110; Mitra P, 2017, ANNU REV MICROBIOL, V71, P687, DOI 10.1146/annurev-micro-030117-020432; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Nadiras C, 2018, NUCLEIC ACIDS RES, V46, P8245, DOI 10.1093/nar/gky563; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Ray-Soni A, 2016, ANNU REV BIOCHEM, V85, P319, DOI 10.1146/annurev-biochem-060815-014844; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Said N, 2021, SCIENCE, V371, P44, DOI 10.1126/science.abd1673; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Shashni R, 2012, MICROBIOL-SGM, V158, P1468, DOI 10.1099/mic.0.056804-0; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sozhamannan S, 1997, J MOL BIOL, V268, P689, DOI 10.1006/jmbi.1997.1004; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Valabhoju V, 2016, J BIOL CHEM, V291, P22386, DOI 10.1074/jbc.M116.745364	44	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102001	10.1016/j.jbc.2022.102001	http://dx.doi.org/10.1016/j.jbc.2022.102001			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35500654	gold, Green Published			2022-12-28	WOS:000807755100002
J	Kondo, K; Harada, Y; Nakano, M; Suzuki, T; Fukushige, T; Hanzawa, K; Yagi, H; Takagi, K; Mizuno, K; Miyamoto, Y; Taniguchi, N; Kato, K; Kanekura, T; Dohmae, N; Machida, K; Maruyama, I; Inoue, H				Kondo, Kiyotaka; Harada, Yoichiro; Nakano, Miyako; Suzuki, Takehiro; Fukushige, Tomoko; Hanzawa, Ken; Yagi, Hirokazu; Takagi, Koichi; Mizuno, Keiko; Miyamoto, Yasuhide; Taniguchi, Naoyuki; Kato, Koichi; Kanekura, Takuro; Dohmae, Naoshi; Machida, Kentaro; Maruyama, Ikuro; Inoue, Hiromasa			Identification of distinct N-glycosylation patterns on extracellular vesicles from small-cell and non-small-cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FUCOSYL-TRANSFERASE 8; LINKED OLIGOSACCHARIDES; CORE FUCOSYLATION; EXPRESSION; INTEGRIN; EXOSOMES; PURIFICATION; GLYCANS; ALPHA	Asparagine-linked glycosylation (N-glycosylation) of proteins in the cancer secretome has been gaining increasing attention as a potential biomarker for cancer detection and diagnosis. Small extracellular vesicles (sEVs) constitute a large part of the cancer secretome, yet little is known about whether their N-glycosylation status reflects known cancer characteristics. Here, we investigated the N-glycosylation of sEVs released from small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) cells. We found that the N-glycans of SCLC-sEVs were characterized by the presence of structural units also found in the brain N-glycome, while NSCLC-sEVs were dominated by typical lung-type N-glycans with NSCLC-associated core fucosylation. In addition, lectin-assisted N-glycoproteomics of SCLC-sEVs and NSCLC-sEVs revealed that integrin alpha V was commonly expressed in sEVs of both cancer cell types, while the epithelium-specific integrin alpha 6 beta 4 heterodimer was selectively expressed in NSCLC-sEVs. Importantly, N-glycomics of the immunopurified integrin alpha 6 from NSCLC-sEVs identified NSCLC-type N-glycans on this integrin subunit. Thus, we conclude that protein N-glycosylation in lung cancer sEVs may potentially reflect the histology of lung cancers.	[Kondo, Kiyotaka; Takagi, Koichi; Mizuno, Keiko; Machida, Kentaro; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan; [Harada, Yoichiro; Taniguchi, Naoyuki] Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama, Japan; [Fukushige, Tomoko; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima, Japan; [Hanzawa, Ken; Miyamoto, Yasuhide] Osaka Int Canc Inst, Dept Mol Biol, Chuo Ku, Osaka, Japan; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Kato, Koichi] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci IMS, Okazaki, Aichi, Japan; [Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima, Japan	Kagoshima University; Hiroshima University; RIKEN; Kagoshima University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Kagoshima University	Inoue, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan.; Harada, Y (corresponding author), Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan.	yoharada3@mc.pref.osaka.jp; inoue@m2.kufm.kagoshima-u.ac.jp	; Taniguchi, Naoyuki/I-4182-2014	Mizuno, Keiko/0000-0001-6738-7906; Kato, Koichi/0000-0001-7187-9612; Taniguchi, Naoyuki/0000-0001-5889-5968	SENSHIN Medical Research Foundation; Kodama Memorial Fund for Medical Research; JSPS KAKENHI [JP19K06546, JP17K09661, JP21K08160]; Japan Agency of Medical Research and Development (AMED) [JP20ek0410052]; Takeda Science Foundation	SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Kodama Memorial Fund for Medical Research; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency of Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was partly supported by grants from the SENSHIN Medical Research Foundation (Y. H.), the Kodama Memorial Fund for Medical Research (Y. H.), JSPS KAKENHI (Grant Number JP19K06546 to Y. H. and JP17K09661 and JP21K08160 to H. I.), the Japan Agency of Medical Research and Development (AMED) (JP20ek0410052 to H. I.), and the Takeda Science Foundation (Y. H.).	AOYAGI Y, 1991, CANCER-AM CANCER SOC, V67, P2390, DOI 10.1002/1097-0142(19910501)67:9<2390::AID-CNCR2820670928>3.0.CO;2-V; Asano N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09143-8; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; CARNEY DN, 1985, CANCER RES, V45, P2913; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Granovsky M, 2000, NAT MED, V6, P306; GREEN ED, 1988, J BIOL CHEM, V263, P18253; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Haga Y, 2019, ANAL CHEM, V91, P2247, DOI 10.1021/acs.analchem.8b04829; Hang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33507; Harada Y, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108261; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Harada Y, 2019, FEBS LETT, V593, P942, DOI 10.1002/1873-3468.13377; Honma R, 2015, ONCOLOGY-BASEL, V88, P298, DOI 10.1159/000369495; Hoshino A, 2020, CELL, V182, P1044, DOI 10.1016/j.cell.2020.07.009; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Itakura Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061160; Jia LY, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00565; Jia N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62074-z; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kosaka N, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0219-1; Kosaka N, 2016, J CLIN INVEST, V126, P1163, DOI 10.1172/JCI81130; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Lee J, 2020, P NATL ACAD SCI USA, V117, P28743, DOI 10.1073/pnas.2014207117; Liu HO, 2015, JPN J CLIN ONCOL, V45, P844, DOI 10.1093/jjco/hyv080; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239; MIYAMOTO H, 1986, ACTA MED OKAYAMA, V40, P65; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pozo K, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102953; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robinson JL, 2019, CELL REP, V26, P2622, DOI 10.1016/j.celrep.2019.02.025; Rusch V, 1997, CLIN CANCER RES, V3, P515; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; SHIBUYA N, 1989, J BIOCHEM-TOKYO, V106, P1098, DOI 10.1093/oxfordjournals.jbchem.a122972; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stewart RL, 2015, LAB INVEST, V95, P976, DOI 10.1038/labinvest.2015.82; Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; TOWNSEND RR, 1989, ANAL BIOCHEM, V182, P1; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wilson NL, 2002, J PROTEOME RES, V1, P521, DOI 10.1021/pr025538d; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yamamoto M, 2019, ANAL BIOCHEM, V580, P21, DOI 10.1016/j.ab.2019.06.001; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	68	0	0	11	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101950	10.1016/j.jbc.2022.101950	http://dx.doi.org/10.1016/j.jbc.2022.101950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447118	gold, Green Published			2022-12-28	WOS:000838892100008
J	Mojumdar, A; Adam, N; Cobb, JA				Mojumdar, Aditya; Adam, Nancy; Cobb, Jennifer A.			Nej1 interacts with Sae2 at DNA double-stranded breaks to inhibit DNA resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RESECTION; ENDONUCLEASE ACTIVITY; FUNCTIONAL MRX; RAD50 HOOK; COMPLEX; REPAIR; MRE11; REPLICATION; HELICASE; PROTEIN	The two major pathways of DNA double-strand break repair, nonhomologous end-joining and homologous recombination, are highly conserved from yeast to mammals. The regulation of 5'-DNA resection controls repair pathway choice and influences repair outcomes. Nej1 was first identified as a canonical NHEJ factor involved in stimulating the ligation of broken DNA ends, and more recently, it was shown to participate in DNA end-bridging and in the inhibition of 5'-resection mediated by the nuclease/helicase complex Dna2-Sgs1. Here, we show that Nej1 interacts with Sae2 to impact DSB repair in three ways. First, we show that Nej1 inhibits interaction of Sae2 with the Mre11-Rad50-Xrs2 complex and Sae2 localization to DSBs. Second, we found that Nej1 inhibits Sae2-dependent recruitment of Dna2 independently of Sgs1. Third, we determined that NEJ1 and SAE2 showed an epistatic relationship for end-bridging, an event that restrains broken DNA ends and reduces the frequency of genomic deletions from developing at the break site. Finally, we demonstrate that deletion of NEJ1 suppressed the synthetic lethality of sae2 Delta sgs1 Delta mutants, and that triple mutant viability was dependent on Dna2 nuclease activity. Taken together, these findings provide mechanistic insight to how Nej1 functionality inhibits the initiation of DNA resection, a role that is distinct from its involvement in endjoining repair at DSBs.	[Cobb, Jennifer A.] Univ Calgary, Dept Biochem & Mol Biol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Oncol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Cobb, JA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada.	jcobb@ucalgary.ca		Mojumdar, Aditya/0000-0003-0254-6958	CIHR [MOP-82736, MOP-137062]; NSERC [418122]	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Our work was supported by operating grants from CIHR MOP-82736; MOP-137062 and NSERC 418122 awarded to J. A. C.	Andres SN, 2019, J BIOL CHEM, V294, P3312, DOI 10.1074/jbc.RA118.006759; Arora S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00156-17; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bonetti D, 2015, EMBO REP, V16, P351, DOI 10.15252/embr.201439764; Bressan DA, 1998, GENETICS, V150, P591; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Cannavo E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06417-5; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Ceppi I, 2020, P NATL ACAD SCI USA, V117, P8859, DOI 10.1073/pnas.2001165117; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Daley JM, 2017, CELL REP, V21, P324, DOI 10.1016/j.celrep.2017.09.048; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Ferrari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004928; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Fu Q, 2014, MOL CELL BIOL, V34, P778, DOI 10.1128/MCB.00963-13; Gilles JF, 2017, METHODS, V115, P55, DOI 10.1016/j.ymeth.2016.11.016; Gobbini E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005685; Hoa NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124495; Hohl M, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008422; Hohl M, 2015, MOL CELL, V57, P479, DOI 10.1016/j.molcel.2014.12.018; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jia PP, 2017, DNA REPAIR, V59, P9, DOI 10.1016/j.dnarep.2017.09.001; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kumar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.15; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mahaney BL, 2014, DNA REPAIR, V14, P9, DOI 10.1016/j.dnarep.2013.12.002; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mojumdar A, 2019, CELL REP, V28, P1564, DOI 10.1016/j.celrep.2019.07.018; Oz R, 2020, P NATL ACAD SCI USA, V117, P21403, DOI 10.1073/pnas.2008645117; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sorenson KS, 2017, J BIOL CHEM, V292, P14576, DOI 10.1074/jbc.M117.796011; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yu TY, 2018, P NATL ACAD SCI USA, V115, pE11961, DOI 10.1073/pnas.1816539115; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	50	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101937	10.1016/j.jbc.2022.101937	http://dx.doi.org/10.1016/j.jbc.2022.101937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35429499	gold, Green Published			2022-12-28	WOS:000838892100001
J	Yokoo, T; Tanabe, A; Yoshida, Y; Caaveiro, JMM; Nakakido, M; Ikeda, Y; Fujimura, Y; Matsumoto, M; Entzminger, K; Maruyama, T; Okumura, CJ; Nangaku, M; Tsumoto, K				Yokoo, Takanori; Tanabe, Aki; Yoshida, Yoko; Caaveiro, Jose M. M.; Nakakido, Makoto; Ikeda, Yoichiro; Fujimura, Yoshihiro; Matsumoto, Masaneori; Entzminger, Kevin; Maruyama, Toshiaki; Okumura, C. J.; Nangaku, Masaomi; Tsumoto, Kouhei			Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FACTOR-I; AUTOANTIBODIES; PROTEIN; C3B; DISCRIMINATION; MUTATIONS; CFHR1; SITE	Atypical hemolytic uremic syndrome (aHUS) is a disease associated with dysregulation of the immune complement system, especially of the alternative pathway (AP). Complement factor H (CFH), consisting of 20 domains called complement control protein (CCP1-20), downregulates the AP as a cofactor for mediating C3 inactivation by complement factor I. However, anomalies related to CFH are known to cause excessive complement activation and cytotoxicity. In aHUS, mutations and the presence of anti-CFH autoantibodies (AAbs) have been reported as plausible causes of CFH dysfunction, and it is known that CFH-related aHUS carries a high probability of end-stage renal disease. Elucidating the detailed functions of CFH at the molecular level will help to understand aHUS pathogenesis. Herein, we used biophysical data to reveal that a heavy-chain antibody fragment, termed VHH4, recognized CFH with high affinity. Hemolytic assays also indicated that VHH4 disrupted the protective function of CFH on sheep erythrocytes. Furthermore, Xray crystallography revealed that VHH4 recognized the Leu1181-Leu1189(CCP20) loop, a known anti-CFH AAbs epitope. We next analyzed the dynamics of the C-terminal region of CFH and showed that the epitopes recognized by anti-CFH AAbs and VHH4 were the most flexible regions in CCP18-20. Finally, we conducted mutation analyses to elucidate the mechanism of VHH4 recognition of CFH and revealed that VHH4 inserts the Trp1183(CCP20) residue of CFH into the pocket formed by the complementary determining region 3 loop. These results suggested that anti-CFH AAbs may adopt a similar molecular mechanism to recognize the flexible loop of Leu1181Leu1189(CCP20), leading to aHUS pathogenesis.	[Yokoo, Takanori; Nakakido, Makoto; Tsumoto, Kouhei] Sch Engn Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan; [Tanabe, Aki; Nakakido, Makoto; Tsumoto, Kouhei] Sch Engn Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Yoshida, Yoko; Ikeda, Yoichiro; Nangaku, Masaomi] Univ Tokyo, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Global Healthcare, Higashi Ku, Fukuoka, Japan; [Fujimura, Yoshihiro; Matsumoto, Masaneori] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara, Japan; [Entzminger, Kevin; Maruyama, Toshiaki; Okumura, C. J.] Abwiz Bio Inc, San Diego, CA USA; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	University of Tokyo; Kyushu University; Nara Medical University; University of Tokyo	Nakakido, M; Tsumoto, K (corresponding author), Sch Engn Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan.; Nakakido, M; Tsumoto, K (corresponding author), Sch Engn Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan.	nakakido@g.ecc.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp		Matsumoto, Masanori/0000-0002-7243-3126; Tanabe, Aki/0000-0002-1018-9586; Fujimura, Yoshihiro/0000-0002-4887-5741	Japan Society for the Promotion of Science [20K16377, 16H02420, 20H02531]; Japan Agency for Medical Research and Development [JP20 AM0101094j]; University of Tokyo, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); University of Tokyo, Japan	This work was funded in part by Japan Society for the Promotion of Science (grant no. 20K16377 to A. T. 16H02420 and 20H02531 to K. T.) and by Japan Agency for Medical Research and Development (grant no. JP20 AM0101094j to K. T.) . The super-computing resources used in this study were provided by the Human Genome Center at the Institute of Medical Science, the University of Tokyo, Japan.	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Akiba H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50722-y; Al Qaraghuli MM, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2592; Barbas C.F., 2001, PHAGE DISPLAY LAB MA; Bhattacharjee A, 2015, J BIOL CHEM, V290, P9500, DOI 10.1074/jbc.M114.630871; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Goh GKM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9050178; Henry KA, 2018, MABS-AUSTIN, V10, P815, DOI 10.1080/19420862.2018.1489633; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hofer J, 2014, SEMIN THROMB HEMOST, V40, P431, DOI 10.1055/s-0034-1375297; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ishii M, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015996; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerr H, 2017, J BIOL CHEM, V292, P13345, DOI 10.1074/jbc.M117.795088; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kromann-Hansen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03457-7; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Makabe K, 2005, BIOCHEM BIOPH RES CO, V328, P98, DOI 10.1016/j.bbrc.2004.12.141; Makou E, 2015, BIOCHEM SOC T, V43, P812, DOI 10.1042/BST20150074; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Meri S, 2016, FEBS LETT, V590, P2418, DOI 10.1002/1873-3468.12284; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Pechtl IC, 2011, J BIOL CHEM, V286, P11082, DOI 10.1074/jbc.M110.211839; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Raina R, 2019, THER APHER DIAL, V23, P4, DOI 10.1111/1744-9987.12763; de Cordoba SR, 2014, SEMIN THROMB HEMOST, V40, P422, DOI 10.1055/s-0034-1375296; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Strobel S, 2011, KIDNEY INT, V80, P397, DOI 10.1038/ki.2011.152; Strobel S, 2010, NEPHROL DIAL TRANSPL, V25, P136, DOI 10.1093/ndt/gfp388; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Trojnar E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00302; Uversky VN, 2021, CRIT REV BIOCHEM MOL, V56, P149, DOI 10.1080/10409238.2020.1869683; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xue XG, 2017, NAT STRUCT MOL BIOL, V24, P643, DOI 10.1038/nsmb.3427; Yang B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102568; Yoshida Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124655; Zadura AF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4016; Zavrtanik U, 2018, J MOL BIOL, V430, P4369, DOI 10.1016/j.jmb.2018.09.002	63	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101962	10.1016/j.jbc.2022.101962	http://dx.doi.org/10.1016/j.jbc.2022.101962			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452676	gold, Green Published			2022-12-28	WOS:000807750700015
J	Zhou, Q; Hu, HQ; Li, ZY				Zhou, Qing; Hu, Huiqing; Li, Ziyin			KLIF-associated cytoskeletal proteins in Trypanosoma brucei regulate cytokinesis by promoting cleavage furrow positioning and ingression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MORPHOGENESIS; BLOOD-STREAM; INITIATION; FLAGELLUM; KINASE; DUPLICATION; EXPRESSION; ROLES	Cytokinesis in the early divergent protozoan Trypanosoma brucei occurs from the anterior cell tip of the new-flagellum daughter toward the nascent posterior end of the oldflagellum daughter of a dividing biflagellated cell. The cleavage furrow ingresses unidirectionally along the preformed cell division fold and is regulated by an orphan kinesin named kinesin localized to the ingressing furrow (KLIF) that localizes to the leading edge of the ingressing furrow. Little is known about how furrow ingression is controlled by KLIF and whether KLIF interacts with and cooperates with other cytokinesis regulatory proteins to promote furrow ingression. Here, we investigated the roles of KLIF in cleavage furrow ingression and identified a cohort of KLIF-associated cytoskeletal proteins as essential cytokinesis regulators. By genetic complementation, we demonstrated the requirement of the kinesin motor activity, but not the putative tropomyosin domain, of KLIF in promoting furrow ingression. We further showed that depletion of KLIF impaired the resolution of the nascent posterior of the old-flagellar daughter cell, thereby stalking cleavage furrow ingression at late stages of cytokinesis. Through proximity biotinylation, we identified a subset of cytoskeleton-associated proteins (CAPs) as KLIF-proximal proteins, and functional characterization of these cytoskeletal proteins revealed the essential roles of CAP46 and CAP52 in positioning the cleavage furrow and the crucial roles of CAP42 and CAP50 in promoting cleavage furrow ingression. Together, these results identified multiple cytoskeletal proteins as cytokinesis regulators and uncovered their essential and distinct roles in cytokinesis.	[Zhou, Qing; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960	National Institutes of Health, United States [AI101437, AI118736]; Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States	This work was supported by the National Institutes of Health, United States R01 grants AI101437 and AI118736 to Z. L. and in part by the Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Brasseur A, 2013, EUKARYOT CELL, V12, P168, DOI 10.1128/EC.00077-12; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hilton NA, 2018, MOL MICROBIOL, V109, P306, DOI 10.1111/mmi.13986; Hu HQ, 2019, J BIOL CHEM, V294, P16672, DOI 10.1074/jbc.RA119.010538; Hu HQ, 2012, J CELL SCI, V125, P4126, DOI 10.1242/jcs.106534; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kurasawa Y, 2018, J BIOL CHEM, V293, P10275, DOI 10.1074/jbc.RA118.003113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Pham KTM, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230581; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Schock M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9112234; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Sinclair AN, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009588; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang X, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00199-19; Zhou Q, 2018, J BIOL CHEM, V293, P16177, DOI 10.1074/jbc.RA118.004888; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	36	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101943	10.1016/j.jbc.2022.101943	http://dx.doi.org/10.1016/j.jbc.2022.101943			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447115	gold, Green Published			2022-12-28	WOS:000838892100004
J	Du, QD; Huang, YH; Wang, CK; Kaas, Q; Craik, DJ				Du, Qingdan; Huang, Yen-Hua; Wang, Conan K.; Kaas, Quentin; Craik, David J.			Mutagenesis of bracelet cyclotide hyen D reveals functionally and structurally critical residues for membrane binding and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALATA B1; INSECTICIDAL ACTIVITY; SCANNING MUTAGENESIS; STABILITY; MECHANISM; PROTEINS	Cyclotides have a wide range of bioactivities relevant for agricultural and pharmaceutical applications. This large family of naturally occurring macrocyclic peptides is divided into three subfamilies, with the bracelet subfamily being the largest and comprising the most potent cyclotides reported to date. However, attempts to harness the natural bioactivities of bracelet cyclotides and engineer-optimized analogs have been hindered by a lack of understanding of the structural and functional role of their constituent residues, which has been challenging because bracelet cyclotides are difficult to produce synthetically. We recently established a facile strategy to make the I11L mutant of cyclotide hyen D that is as active as the parent peptide, enabling the subsequent production of a series of variants. In the current study, we report an alanine mutagenesis structure-activity study of [I11L] hyen D to probe the role of individual residues on peptide folding using analytical chromatography, on molecular function using surface plasmon resonance, and on therapeutic potential using cytotoxicity assays. We found that Glu-6 and Thr-15 are critical for maintaining the structure of bracelet cyclotides and that hydrophobic residues in loops 2 and 3 are essential for membrane binding and cytotoxic activity, findings that are distinct from the structural and functional characteristics determined for other cyclotide subfamilies. In conclusion, this is the first report of a mutagenesis scan conducted on a bracelet cyclotide, offering insights into their function and supporting future efforts to engineer bracelet cyclotides for biotechnological applications.	[Du, Qingdan; Huang, Yen-Hua; Wang, Conan K.; Kaas, Quentin; Craik, David J.] Univ Queensland, Australian Res Council Ctr Excellence Innovat Pep, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Huang, YH; Craik, DJ (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Innovat Pep, Inst Mol Biosci, Brisbane, Qld, Australia.	y.huang@imb.uq.edu.au; d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Huang, Yen-Hua/J-9056-2014	Craik, David/0000-0003-0007-6796; Huang, Yen-Hua/0000-0001-6937-2660	Australian Research Council (ARC) Australian Laureate Fellowship [FL150100146]; Chinese Scholarship Council	Australian Research Council (ARC) Australian Laureate Fellowship(Australian Research Council); Chinese Scholarship Council(China Scholarship Council)	Funding and additional information-D. J. C. is supported by an Australian Research Council (ARC) Australian Laureate Fellowship (FL150100146). Q. D. is supported by the Chinese Scholarship Council.	Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Cheneval O, 2014, J ORG CHEM, V79, P5538, DOI 10.1021/jo500699m; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2003, LETT PEPT SCI, V10, P523, DOI 10.1007/BF02442584; de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402; Du QD, 2020, J NAT PROD, V83, P3736, DOI 10.1021/acs.jnatprod.0c01045; Du QD, 2020, J BIOL CHEM, V295, P10911, DOI 10.1074/jbc.RA120.012627; Gerlach Samantha L, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6010033; Goransson U, 2009, CHEMBIOCHEM, V10, P2354, DOI 10.1002/cbic.200900342; Grundemann C, 2012, J NAT PROD, V75, P167, DOI 10.1021/np200722w; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Henriques ST, 2015, CHEM BIOL, V22, P1087, DOI 10.1016/j.chembiol.2015.07.012; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Huang YH, 2021, MOLECULES, V26, DOI 10.3390/molecules26185554; Huang YH, 2019, TOXICON, V172, P33, DOI 10.1016/j.toxicon.2019.10.244; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lei XT, 2021, J PHYS CHEM B, V125, P3476, DOI 10.1021/acs.jpcb.0c10513; Lindholm P, 2002, MOL CANCER THER, V1, P365; Plan MR, 2010, BIOPOLYMERS, V94, P647, DOI 10.1002/bip.21409; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Slazak B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01296; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tan LTH, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00012; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wang CKL, 2011, BIOCHEMISTRY-US, V50, P4077, DOI 10.1021/bi2004153; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	43	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101822	10.1016/j.jbc.2022.101822	http://dx.doi.org/10.1016/j.jbc.2022.101822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35283188	Green Published, gold			2022-12-28	WOS:000793502000002
J	Dutta, S; Selvam, B; Das, A; Shukla, D				Dutta, Soumajit; Selvam, Balaji; Das, Aditi; Shukla, Diwakar			Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC COMMUNICATION PIPELINES; RESOLUTION CRYSTAL-STRUCTURE; TRANSITION PATH THEORY; MOLECULAR-DYNAMICS; STRUCTURAL INSIGHTS; INVERSE AGONISM; CB1; DISTANCE; PHARMACOLOGY; ACTIVATION	Cannabinoid receptor 1 (CB1) is a therapeutically relevant drug target for controlling pain, obesity, and other central nervous system disorders. However, full agonists and antagonists of CB1 have been reported to cause serious side effects in patients. Therefore, partial agonists have emerged as a viable alternative as they can mitigate overstimulation and side effects. One of the key bottlenecks in the design of partial agonists, however, is the lack of understanding of the molecular mechanism of partial agonism itself. In this study, we examine two mechanistic hypotheses for the origin of partial agonism in cannabinoid receptors and predict the mechanistic basis of partial agonism particular, we inspect whether partial agonism emerges from the ability of THC to bind in both agonist and antagonist-binding poses or from its ability to only partially activate the receptor. We used extensive molecular dynamics simulations and Markov state modeling to capture the THC binding in both antagonist and agonist-binding poses in the CB1 receptor. Furthermore, we predict that binding of THC in the agonist-binding pose leads to rotation of toggle switch residues and causes partial outward movement of intracellular transmembrane helix 6 (TM6). Our simulations also suggest that the alkyl side chain of THC plays a crucial role in determining partial agonism by stabilizing the ligand in the agonist and antagonist-like poses within the pocket. Taken together, this study provides important insights into the mechanistic origin of the partial agonism of THC.	[Dutta, Soumajit; Selvam, Balaji; Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Das, Aditi] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA; [Das, Aditi] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Das, Aditi] Univ Illinois, Dept Biochem, Urbana, IL USA; [Das, Aditi; Shukla, Diwakar] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Das, Aditi; Shukla, Diwakar] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shukla, D (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA.	diwakar@illinois.edu	Shukla, Diwakar/GRY-2518-2022	Shukla, Diwakar/0000-0003-4079-5381; Dutta, Soumajit/0000-0003-3951-8088	NSF Early CAREER Award [MCB-1845606]	NSF Early CAREER Award(National Science Foundation (NSF))	Funding and additional information-D. S. acknowledges support from NSF Early CAREER Award (MCB-1845606) .	A.White, 2020, bioRxiv, DOI 10.1101/2020.07.28.225722; Adams AJ, 2017, NEW ENGL J MED, V376, P235, DOI 10.1056/NEJMoa1610300; Aldukhi F, 2020, J PHYS CHEM B, V124, P355, DOI 10.1021/acs.jpcb.9b09377; Badowski ME, 2018, THER CLIN RISK MANAG, V14, P643, DOI 10.2147/TCRM.S126849; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhattacharya S, 2014, BIOPHYS J, V107, P422, DOI 10.1016/j.bpj.2014.06.015; Bow EW, 2016, PERSPECT MED CHEM, V8, DOI 10.4137/PMC.S32171; Bowman GR, 2014, ADV EXP MED BIOL, V797, P1, DOI 10.1007/978-94-007-7606-7; Case D. A., 2018, AMBER 2019; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dohm S, 2020, J CHEM THEORY COMPUT, V16, P2002, DOI 10.1021/acs.jctc.9b01266; Dutta S, 2022, ACS CHEM NEUROSCI, V13, P379, DOI 10.1021/acschemneuro.1c00760; E W, 2006, J STAT PHYS, V123, P503, DOI 10.1007/s10955-005-9003-9; Eddy MT, 2021, STRUCTURE, V29, P170, DOI 10.1016/j.str.2020.11.005; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fay JF, 2013, BIOCHEMISTRY-US, V52, P8286, DOI 10.1021/bi400842k; Fleetwood O, 2021, ELIFE, V10, DOI 10.7554/eLife.60715; Hagberg A. A., 2008, P 7 PYTHON SCI C, P11, DOI DOI 10.25080/ISSN.2575-9752; Hernandez C. X., 2017, J OPEN SOURCE SOFTW, V2, P427, DOI [DOI 10.21105/JOSS.00427, 10.21105/joss.00427]; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hua T, 2020, CELL, V180, P655, DOI 10.1016/j.cell.2020.01.008; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibsen MS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00350; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kapoor A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11483-8; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Lawrenz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07918; Li XT, 2020, TRENDS PHARMACOL SCI, V41, P665, DOI 10.1016/j.tips.2020.06.010; Li XT, 2019, CELL, V176, P459, DOI 10.1016/j.cell.2018.12.011; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Meng Y, 2016, P NATL ACAD SCI USA, V113, P9193, DOI 10.1073/pnas.1602790113; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Mey Antonia S J S, 2020, Living J Comput Mol Sci, V2, DOI 10.33011/livecoms.2.1.18378; Mittal S, 2018, J PHYS CHEM B, V122, P10793, DOI 10.1021/acs.jpcb.8b07076; Mittal S, 2018, MOL SIMULAT, V44, P891, DOI 10.1080/08927022.2018.1448976; Nivedha AK, 2018, MOL PHARMACOL, V93, P288, DOI 10.1124/mol.117.110395; Noe F, 2015, J CHEM THEORY COMPUT, V11, P5002, DOI 10.1021/acs.jctc.5b00553; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saleh N, 2018, ANGEW CHEM INT EDIT, V57, P2580, DOI 10.1002/anie.201708764; Sam AH, 2011, J OBES, V2011, DOI 10.1155/2011/432607; Selvam B, 2018, ACS CENTRAL SCI, V4, P1146, DOI 10.1021/acscentsci.8b00330; Selvam B, 2018, ANGEW CHEM INT EDIT, V57, P3048, DOI 10.1002/anie.201708889; Selvana B, 2019, ACS CENTRAL SCI, V5, P1085, DOI 10.1021/acscentsci.9b00252; Shao ZH, 2019, NAT CHEM BIOL, V15, P1199, DOI 10.1038/s41589-019-0387-2; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shukla D, 2015, ACCOUNTS CHEM RES, V48, P414, DOI 10.1021/ar5002999; Shukla S, 2019, STRUCTURE, V27, P692, DOI 10.1016/j.str.2018.12.005; Song LF, 2019, J CHEM INF MODEL, V59, P3128, DOI 10.1021/acs.jcim.9b00105; Sultan MM, 2018, NAT CHEM, V10, P903, DOI 10.1038/s41557-018-0077-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vaidehi N, 2016, CURR OPIN PHARMACOL, V30, P76, DOI 10.1016/j.coph.2016.07.010; Walther S, 2010, PHARMACEUTICALS-BASE, V3, P2689, DOI 10.3390/ph3082689; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wehmeyer C., 2018, LIVECOMS, V1, P1; Zou SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030833	78	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101764	10.1016/j.jbc.2022.101764	http://dx.doi.org/10.1016/j.jbc.2022.101764			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35227761	gold, Green Published			2022-12-28	WOS:000797895000009
J	Chen, Y; Yang, WH; Chen, HF; Huang, LM; Gao, JY; Lin, CW; Wang, YC; Yang, CS; Liu, YL; Hou, MH; Tsai, CL; Chou, YZ; Huang, BY; Hung, CF; Hung, YL; Wang, WJ; Su, WC; Kumar, V; Wu, YC; Chao, SW; Chang, CS; Chen, JS; Chiang, YP; Cho, DY; Jeng, LB; Tsai, CH; Hung, MC				Chen, Yeh; Yang, Wen-Hao; Chen, Hsiao-Fan; Huang, Li-Min; Gao, Jing-Yan; Lin, Cheng-Wen; Wang, Yu-Chuan; Yang, Chia-Shin; Liu, Yi-Liang; Hou, Mei-Hui; Tsai, Chia-Ling; Chou, Yi-Zhen; Huang, Bao-Yue; Hung, Chian-Fang; Hung, Yu-Lin; Wang, Wei-Jan; Su, Wen-Chi; Kumar, Vathan; Wu, Yu-Chieh; Chao, Shih-Wei; Chang, Chih-Shiang; Chen, Jin-Shing; Chiang, Yu-Ping; Cho, Der-Yang; Jeng, Long-Bin; Tsai, Chang-Hai; Hung, Mien-Chie			Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-VIVAX MALARIA; THERMAL SHIFT ASSAYS; MAIN PROTEINASE; PREVENTION; RELAPSE; COVID-19; ENTRY	The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has severely affected human lives around the world as well as the global economy. Therefore, effective treatments against COVID-19 are urgently needed. Here, we screened a library containing Food and Drug Administration (FDA)-approved compounds to identify drugs that could target the SARS-CoV-2 main protease (M-pro), which is indispensable for viral protein maturation and regard as an important therapeutic target. We identified antimalarial drug tafenoquine (TFQ), which is approved for radical cure of Plasmodium vivax and malaria prophylaxis, as a top candidate to inhibit Mpro protease activity. The crystal structure of SARS-CoV-2 M-pro in complex with TFQ revealed that TFQ non-covalently bound to and reshaped the substrate-binding pocket of Mpro by altering the loop region (residues 139-144) near the catalytic Cys145, which could block the catalysis of its peptide substrates. We also found that TFQ inhibited human trans-membrane protease serine 2 (TMPRSS2). Furthermore, one TFQ derivative, compound 7, showed a better therapeutic in-dex than TFQ on TMPRSS2 and may therefore inhibit the infectibility of SARS-CoV-2, including that of several mutant variants. These results suggest new potential strategies to block infection of SARS-CoV-2 and rising variants.	[Chen, Yeh; Wang, Yu-Chuan; Yang, Chia-Shin; Hou, Mei-Hui; Tsai, Chia-Ling; Chou, Yi-Zhen] China Med Univ, Inst New Drug Dev, Taichung, Taiwan; [Chen, Yeh; Yang, Wen-Hao; Gao, Jing-Yan; Kumar, Vathan; Chao, Shih-Wei; Chang, Chih-Shiang; Hung, Mien-Chie] China Med Univ, Drug Dev Ctr, Taichung, Taiwan; [Chen, Yeh; Yang, Wen-Hao; Wang, Wei-Jan; Hung, Mien-Chie] China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan; [Yang, Wen-Hao; Chen, Hsiao-Fan; Huang, Bao-Yue; Hung, Chian-Fang; Su, Wen-Chi; Cho, Der-Yang; Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Yang, Wen-Hao; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Huang, Li-Min; Chiang, Yu-Ping] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Gao, Jing-Yan; Wu, Yu-Chieh; Chang, Chih-Shiang] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Lin, Cheng-Wen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lin, Cheng-Wen] Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Liu, Yi-Liang] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Hung, Yu-Lin] China Med Univ, Program Digital Hlth Innovat, Taichung, Taiwan; [Wang, Wei-Jan] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Chen, Jin-Shing] Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei, Taiwan; [Chen, Jin-Shing] Natl Taiwan Univ, Taipei, Taiwan; [Cho, Der-Yang] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan; [Jeng, Long-Bin; Tsai, Chang-Hai] China Med Univ, China Med Univ Hosp, Sch Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, China Med Univ Childrens Hosp, Taichung, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Chen, Y (corresponding author), China Med Univ, Inst New Drug Dev, Taichung, Taiwan.; Chen, Y; Hung, MC (corresponding author), China Med Univ, Drug Dev Ctr, Taichung, Taiwan.; Chen, Y; Hung, MC (corresponding author), China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	bluecrystalprotein@gmail.com; mhung@cmu.edu.tw	Yang, wenhao/GXG-5965-2022	Yang, Wen-Hao/0000-0002-6292-9048; Wang, Wei-Jan/0000-0002-0811-8199; Hung, Mien-Chie/0000-0003-4317-4740; Hung, Yu-Lin/0000-0002-6394-9753; CHEN, JIN-SHING/0000-0001-5077-4483; Jeng, Long-Bin/0000-0002-2928-4698	Ministry of Science and Technology, Taiwan [MOST108-2311-B-241-001, MOST109-2327-B039-003, MOST110-2923-B-039-001-MY3]; Yingtsai Young Scholar Award [CMU108-YTY-04]; "Drug Development Center, China Medical University" from the Featured Areas Research Center Program by the Ministry of Education (MOE), Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Yingtsai Young Scholar Award; "Drug Development Center, China Medical University" from the Featured Areas Research Center Program by the Ministry of Education (MOE), Taiwan	This research was supported in part by the following: The Ministry of Science and Technology, Taiwan (MOST108-2311-B-241-001; to Y. C., MOST109-2327-B039-003; to M.-C. H. and MOST110-2923-B-039-001-MY3; to C.-W. L.); Yingtsai Young Scholar Award (CMU108-YTY-04; to W.-H. Y.); the "Drug Development Center, China Medical University" from the Featured Areas Research Center Program within the Framework of the Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan.	Aljoundi A, 2020, PROTEIN J, V39, P97, DOI 10.1007/s10930-020-09884-2; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Ayerbe L, 2021, LANCET RHEUMATOL, V3, pE172, DOI [10.1016/S2665-9913(21)00030-8, 10.1016/S2665-9913(21)00031-X]; Bansal P., 2021, ANN MED; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Campo B, 2015, PATHOG GLOB HEALTH, V109, P107, DOI 10.1179/2047773215Y.0000000013; Cherian S., 2021, BIORXIV, DOI [10.1101/2021. 04.22.440932, DOI 10.1101/2021.04.22.440932, 10.1101/2021.04.22.440932]; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ebstie YA, 2016, DRUG DES DEV THER, V10, P2387, DOI 10.2147/DDDT.S61443; Fornasier E., 2021, BIORXIV, DOI [10.1101/2021.03.04.433882, DOI 10.1101/2021.03.04.433882]; Frampton JE, 2018, DRUGS, V78, P1517, DOI 10.1007/s40265-018-0979-2; Gordon D. E., 2020, SARS; Gunther S, 2021, SCIENCE, V372, P642, DOI 10.1126/science.abf7945; Harcourt J., 2020, EMERG INFECT DIS, DOI 10.3201/; Haston JC, 2019, MMWR-MORBID MORTAL W, V68, P1062, DOI 10.15585/mmwr.mm6846a4; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hoffmann M., 2021, SARS COV 2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hossain MK, 2021, EXPERT REV VACCINES, V20, P635, DOI 10.1080/14760584.2021.1915140; Hounkpatin AB, 2019, INFECT DRUG RESIST, V12, P553, DOI 10.2147/IDR.S151031; Zahradník J, 2021, bioRxiv, DOI 10.1101/2021.01.06.425392; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jirjees F, 2021, INFECT DIS REP, V13, P259, DOI 10.3390/idr13020029; Katz IT, 2021, NEW ENGL J MED, V384, P1281, DOI 10.1056/NEJMp2103614; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179131; Lee TC, 2021, INT J INFECT DIS, V104, P671, DOI 10.1016/j.ijid.2021.01.065; Levine-Tiefenbrun M., 2021, INITIAL REPORT DECRE; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lockbaum GJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020174; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Mahmoud IS, 2020, BIOCHIMIE, V175, P93, DOI 10.1016/j.biochi.2020.05.012; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Mibulo T., RESEARCHSQUARE, P2022, DOI [10.21203/rs.3.rs-1708394/v1, DOI 10.21203/RS.3.RS-1708394/V1, 11.17.516888, 10.1101/2021.05.19.21257469v2, DOI 10.1101/2021.05.19.21257469V2]; Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Naqvi A. A. T., 2020, BIOCH BIOPHYS ACTA M; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park WB, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e84; Pawlowski C, 2021, MED-CAMBRIDGE, V2, P979, DOI 10.1016/j.medj.2021.06.007; Pillaiyar T, 2016, J MED CHEM, V59, P6595, DOI 10.1021/acs.jmedchem.5b01461; Ragia G, 2020, EUR J CLIN PHARMACOL, V76, P1623, DOI 10.1007/s00228-020-02963-4; Reynolds C. J., UK COVIDSOR TIUM IMM, P2021; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Seetoh WG, 2016, J AM CHEM SOC, V138, P14303, DOI 10.1021/jacs.6b07440; Singh J, 2021, NAT MED, V27, P1131, DOI 10.1038/s41591-021-01397-4; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Su H, 2020, BIORXIV, DOI [10.1101/2020.04.13.038687v1, DOI 10.1101/2020.04.13.038687, 10.1101/2020.04.13.038687]; Tada T., 2021, BIORXIV2021051444407, DOI [10.1101/2021.05.14.444076, DOI 10.1101/2021.05.14.444076]; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Vaidyanathan G, 2021, NATURE, V593, P321, DOI 10.1038/d41586-021-01274-7; Verschueren KHG, 2008, CHEM BIOL, V15, P597, DOI 10.1016/j.chembiol.2008.04.011; Vicenzi E, 2004, EMERG INFECT DIS, V10, P413, DOI 10.3201/eid1003.030683; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wang YC, 2020, AM J CANCER RES, V10, P2535; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Woolger N, 2017, J BIOL CHEM, V292, P18577, DOI 10.1074/jbc.M117.790014; World Health Organization, 2020, WHO; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiu SY, 2020, J MED CHEM, V63, P12256, DOI 10.1021/acs.jmedchem.0c00502; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; Yang H., 2003, P NATL ACAD SCI USA; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	70	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101658	10.1016/j.jbc.2022.101658	http://dx.doi.org/10.1016/j.jbc.2022.101658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101449	gold, Green Published			2022-12-28	WOS:000794865600003
J	Chernyavsky, A; Khylynskyi, MM; Patel, KG; Grando, SA				Chernyavsky, Alex; Khylynskyi, Mykhailo M.; Patel, Krupa G.; Grando, Sergei A.			Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINERGIC-RECEPTORS; NICOTINIC RECEPTOR; CELLS; DESMOGLEIN; M-3; DIFFERENTIATION; IDENTIFICATION; ACANTHOLYSIS; MECHANISMS; ANTIBODIES	Pemphigus vulgaris (PV) is a potentially lethal autoimmune mucocutaneous blistering disease characterized by binding of IgG autoantibodies (AuAbs) to keratinocytes (KCs). In addition to AuAbs against adhesion molecules desmogleins 1 and 3, PV patients also produce an AuAb against the M3 muscarinic acetylcholine (ACh) receptor (M3AR) that plays an important role in regulation of vital functions of KCs upon binding endogenous ACh. This anti-M3AR AuAb is pathogenic because its adsorption eliminates the acantholytic activity of PV IgG; however, the molecular mechanism of its action is unclear. In the present study, we sought to elucidate the mode of immunopharmacologic action of the anti-M3AR AuAb in PV. Shortterm exposures of cultured KCs to PV IgG or the muscarinic agonist muscarine both induced changes in the expression of keratins 5 and 10, consistent with the inhibition of proliferation and upregulated differentiation and in keeping with the biological function of M3AR. In contrast, long-term incubations induced a keratin expression pattern consistent with upregulated proliferation and decreased differentiation, in keeping with the hyperproliferative state of KCs in PV. This change could result from desensitization of the M3AR, representing the net antagonist-like effect of the AuAb. Therefore, chronic exposure of KCs to the anti-M3AR AuAb interrupts the physiological regulation of KCs by endogenous ACh, contributing to the onset of acantholysis. Since cholinergic agents have already demonstrated antiacantholytic activity in a mouse model of PV and in PV patients, our results have translational significance and can guide future development of therapies for PV patients employing cholinergic drugs.	[Chernyavsky, Alex; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA USA; [Khylynskyi, Mykhailo M.] Municipal Dept Hlth, Unit Dermato venereol, Kiev, Ukraine; [Patel, Krupa G.] Oakland Univ, Dept Neurol, William Beaumont Sch Med, Rochester, MI USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; Oakland University; University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA USA.; Grando, SA (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA USA.; Grando, SA (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA USA.	sgrando@uci.edu			Dysimmune Diseases Foundation	Dysimmune Diseases Foundation	This work was supported in part by a research grant from Dysimmune Diseases Foundation (to S. A. G.) .	Ahmed AR, 2016, EXP DERMATOL, V25, P839, DOI 10.1111/exd.13106; AHMED AR, 1982, J AM ACAD DERMATOL, V7, P221; Alexandroff AB, 2009, BRIT J DERMATOL, V160, P502, DOI 10.1111/j.1365-2133.2008.08857.x; Amber KT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01190; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2003, LIFE SCI, V72, P2063, DOI 10.1016/S0024-3205(03)00084-5; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Bhatia SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233957; Buchli R, 2001, MOL CELL BIOCHEM, V228, P57, DOI 10.1023/A:1013368509855; Bystryn JC, 2009, GIORN ITAL DERMAT V, V144, P351; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chernyavsky AI, 2009, INT J IMMUNOPATH PH, V22, P461, DOI 10.1177/039463200902200223; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Chernyavsky A, 2019, J BIOL CHEM, V294, P4520, DOI 10.1074/jbc.RA118.006743; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Chernyaysky A, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.106149; Daoud YJ, 2006, INT IMMUNOPHARMACOL, V6, P600, DOI 10.1016/j.intimp.2005.11.002; ESAKI C, 1995, J INVEST DERMATOL, V105, P329, DOI 10.1111/1523-1747.ep12319948; FISHER SK, 1988, MOL PHARMACOL, V33, P414; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando S. A., 2009, EXP; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Grando SA, 2004, J INVEST DERM SYMP P, V9, P84, DOI 10.1111/j.1087-0024.2004.00826.x; Grando SA, 2003, J AM ACAD DERMATOL, V48, P86, DOI 10.1067/mjd.2003.39; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grando SA, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106385; Grando SA, 2019, INT J DERMATOL, V58, P114, DOI 10.1111/ijd.14143; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Gualtieri B, 2021, ITAL J DERMATOL VENE, V156, P134, DOI 10.23736/S2784-8671.20.06619-5; Hannh R, 2022, ORAL DIS, V28, P1760, DOI 10.1111/odi.13937; Herbst A, 2000, J AM ACAD DERMATOL, V42, P422, DOI 10.1016/S0190-9622(00)90213-5; Kalantari-Dehaghi M., 2013, PEMPHIGUS; Kalantari-Dehaghi M, 2013, J BIOL CHEM, V288, P16916, DOI 10.1074/jbc.M113.472100; Kalantari-Dehaghi M, 2011, EXP DERMATOL, V20, P154, DOI 10.1111/j.1600-0625.2010.01193.x; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lin MS, 1997, CLIN EXP IMMUNOL, V107, P9; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Ndoye A, 1998, J INVEST DERMATOL, V111, P410, DOI 10.1046/j.1523-1747.1998.00299.x; Nguyen V. T., 2004, EXP CELL RES; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; ROSENBERG FR, 1976, ARCH DERMATOL, V112, P962, DOI 10.1001/archderm.112.7.962; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Schmitt T, 2021, BRIT J DERMATOL, V185, P595, DOI 10.1111/bjd.20091; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sell S., 1996, IMMUNOLOGY IMMUNOPAT, V5th, P299; Shafer SH, 2004, MOL PHARMACOL, V65, P1080, DOI 10.1124/mol.65.5.1080; Shafer SH, 1999, EXP CELL RES, V248, P148, DOI 10.1006/excr.1998.4385; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Toosi R, 2021, CLIN EXP DERMATOL, V46, P1230, DOI 10.1111/ced.14645; Wan XL, 2001, ANTICANCER RES, V21, P2657; Wei B, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/2471518; WILLIAMS CL, 1993, J CELL BIOL, V121, P643, DOI 10.1083/jcb.121.3.643; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; YAMAMURA HI, 1974, P NATL ACAD SCI USA, V71, P1725, DOI 10.1073/pnas.71.5.1725	61	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101687	10.1016/j.jbc.2022.101687	http://dx.doi.org/10.1016/j.jbc.2022.101687			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143842	gold, Green Published			2022-12-28	WOS:000789400700003
J	Dangerfield, TL; Kirmizialtin, S; Johnson, KA				Dangerfield, Tyler L.; Kirmizialtin, Serdal; Johnson, Kenneth A.			Substrate specificity and proposed structure of the proofreading complex of T7 DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-5' EXONUCLEASE ACTIVITY; STATE KINETIC-ANALYSIS; ESCHERICHIA-COLI; AMINO-ACID; KLENOW FRAGMENT; HIGH-FIDELITY; ACTIVE-SITE; BACTERIOPHAGE-T4; SEPARATION; MECHANISM	Faithful replication of genomic DNA by high-fidelity DNA polymerases is crucial for the survival of most living organisms. While high-fidelity DNA polymerases favor canonical base pairs over mismatches by a factor of similar to 1 x 10(5), fidelity is further enhanced several orders of magnitude by a 3'-5' proofreading exonuclease that selectively removes mispaired bases in the primer strand. Despite the importance of proofreading to maintaining genome stability, it remains much less studied than the fidelity mechanisms employed at the polymerase active site. Here we characterize the substrate specificity for the proofreading exonuclease of a high-fidelity DNA polymerase by investigating the proofreading kinetics on various DNA substrates. The contribution of the exonuclease to net fidelity is a function of the kinetic partitioning between extension and excision. We show that while proofreading of a terminal mismatch is efficient, proofreading a mismatch buried by one or two correct bases is even more efficient. Because the polymerase stalls after incorporation of a mismatch and after incorporation of one or two correct bases on top of a mismatch, the net contribution of the exonuclease is a function of multiple opportunities to correct mistakes. We also characterize the exonuclease stereospecificity using phosphorothioate-modified DNA, provide a homology model for the DNA primer strand in the exonuclease active site, and propose a dynamic structural model for the transfer of DNA from the polymerase to the exonuclease active site based on MD simulations.	[Dangerfield, Tyler L.; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Kirmizialtin, Serdal] New York Univ Abu Dhabi, Sci Div, Chem Program, Abu Dhabi, U Arab Emirates	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Kirmizialtin, S (corresponding author), New York Univ Abu Dhabi, Sci Div, Chem Program, Abu Dhabi, U Arab Emirates.	serdal@nyu.edu; kajohnson@mail.utexas.edu			National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [R01AI110577]; National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R01114223]; Faculty Research grant [AD181]	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Faculty Research grant	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) R01AI110577 (to K. A. J) and National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) R01114223 (to K. A. J.). Computational research was carried out on the HighPerformance Computing resources at New York University Abu Dhabi. S. K. is supported by AD181 Faculty Research grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; Beechem JM, 1998, BIOCHEMISTRY-US, V37, P10144, DOI 10.1021/bi980074b; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Black CB, 1998, J BIOL INORG CHEM, V3, P292, DOI 10.1007/s007750050234; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Dangerfield T. L., 2021, J BIOL CHEM, V298; Dangerfield TL, 2021, ANAL BIOCHEM, V629, DOI 10.1016/j.ab.2021.114239; Dangerfield TL, 2020, J BIOL CHEM, V295, P17265, DOI 10.1074/jbc.RA120.015557; Dangerfield TL, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016617; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; Dodd T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19165-2; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Elisseeva E, 1999, J BIOL CHEM, V274, P25151, DOI 10.1074/jbc.274.35.25151; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enmark M, 2019, ANAL BIOANAL CHEM, V411, P3383, DOI 10.1007/s00216-019-01813-2; Fiala KA, 2008, NUCLEIC ACIDS RES, V36, P1990, DOI 10.1093/nar/gkn004; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gammon DB, 2009, J VIROL, V83, P4236, DOI 10.1128/JVI.02255-08; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Jacewicz A, 2007, J MOL BIOL, V368, P18, DOI 10.1016/j.jmb.2007.01.067; Jahns H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7317; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Li A, 2017, J BIOL CHEM, V292, P6695, DOI 10.1074/jbc.M116.760827; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marquez LA, 1996, J BIOL CHEM, V271, P28903, DOI 10.1074/jbc.271.46.28903; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Otto MR, 1998, BIOCHEMISTRY-US, V37, P10156, DOI 10.1021/bi9800754; Parkash V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08114-9; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Reha-Krantz LJ, 1998, GENETICS, V148, P1551; Reha-Krantz LJ, 1998, J BIOL CHEM, V273, P22969, DOI 10.1074/jbc.273.36.22969; Ren Z, 2016, NUCLEIC ACIDS RES, V44, P7457, DOI 10.1093/nar/gkw555; SLIM G, 1991, NUCLEIC ACIDS RES, V19, P1183, DOI 10.1093/nar/19.6.1183; SPITZER S, 1988, NUCLEIC ACIDS RES, V16, P11691, DOI 10.1093/nar/16.24.11691; STEC WJ, 1985, J CHROMATOGR, V326, P263, DOI 10.1016/S0021-9673(01)87452-5; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Thorogood H, 1996, J BIOL CHEM, V271, P8855, DOI 10.1074/jbc.271.15.8855; Trzemecka A, 2009, J MOL BIOL, V389, P797, DOI 10.1016/j.jmb.2009.04.055; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang CX, 2004, BIOCHEMISTRY-US, V43, P3853, DOI 10.1021/bi0302292; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Zahurancik WJ, 2014, NUCLEIC ACIDS RES, V42, P13853, DOI 10.1093/nar/gku1184	60	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101627	10.1016/j.jbc.2022.101627	http://dx.doi.org/10.1016/j.jbc.2022.101627			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35074426	gold, Green Published			2022-12-28	WOS:000821051800010
J	Morrison, JJ; Conti, J; Camberg, JL				Morrison, Josiah J.; Conti, Joseph; Camberg, Jodi L.			Assembly and architecture of Escherichia coli divisome proteins FtsA and FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION GENE; Z-RING; SELF-INTERACTION; ATP HYDROLYSIS; SWISS-MODEL; COLI FTSA; ACTIN; ZIPA; RECRUITMENT; ACTIVATION	During Escherichia coli cell division, an intracellular complex of cell division proteins known as the Z-ring assembles at midcell during early division and serves as the site of constriction. While the predominant protein in the Z-ring is the widely conserved tubulin homolog FtsZ, the actin homolog FtsA tethers the Z-ring scaffold to the cytoplasmic membrane by binding to FtsZ. While FtsZ is known to function as a dynamic, polymerized GTPase, the assembly state of its partner, FtsA, and the role of ATP are still unclear. We report that a substitution mutation in the FtsA ATP-binding site impairs ATP hydrolysis, phospholipid vesicle remodeling in vitro, and Z-ring assembly in vivo. We demonstrate by transmission electron microscopy and Forster Resonance Energy Transfer that a truncated FtsA variant, FtsA(& UDelta;MTS) lacking a C -terminal membrane targeting sequence, self assembles into ATP dependent filaments. These filaments coassemble with FtsZ polymers but are destabilized by unassembled FtsZ. These findings suggest a model wherein ATP binding drives FtsA polymerization and membrane remodeling at the lipid surface, and FtsA polymerization is coregulated with FtsZ polymerization. We conclude that the coordinated assembly of FtsZ and FtsA polymers may serve as a key checkpoint in division that triggers cell wall synthesis and division progression.	[Morrison, Josiah J.; Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Camberg, JL (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	cambergj@uri.edu			National Institute of General Medical Sciences of the National Institutes of Health [R01GM118927]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM118927 to J. L. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the authors' respective institutions.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Caldas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13702-4; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chou SZ, 2019, P NATL ACAD SCI USA, V116, P4265, DOI 10.1073/pnas.1807028115; Conti J, 2018, MOL MICROBIOL, V107, P558, DOI 10.1111/mmi.13902; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Du SS, 2020, MBIO, V11, DOI 10.1128/mBio.01247-20; Du SS, 2019, TRENDS MICROBIOL, V27, P781, DOI 10.1016/j.tim.2019.04.011; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; FOWLER WE, 1983, J CELL BIOL, V97, P264, DOI 10.1083/jcb.97.1.264; GAYDA RC, 1992, J BACTERIOL, V174, P5362, DOI 10.1128/JB.174.16.5362-5370.1992; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Gurung R, 2016, BIOCHEM J, V473, P383, DOI 10.1042/BJ20151050; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; HANSON J, 1965, BRIT MED BULL, V21, P264, DOI 10.1093/oxfordjournals.bmb.a070407; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Krupka M, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15957; Krupka M, 2014, MBIO, V5, DOI 10.1128/mBio.02221-14; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; McCullagh M, 2014, J AM CHEM SOC, V136, P13053, DOI 10.1021/ja507169f; Merino F, 2018, NAT STRUCT MOL BIOL, V25, P531, DOI 10.1038/s41594-018-0074-0; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Nag D, 2020, INT J BIOL MACROMOL, V142, P18, DOI 10.1016/j.ijbiomac.2019.11.217; Ostrowska Z, 2017, POSTEP HIG MED DOSW, V71, P339; Park KT, 2020, MBIO, V11, DOI 10.1128/mBio.03012-20; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Pichoff S, 2018, P NATL ACAD SCI USA, V115, pE6855, DOI 10.1073/pnas.1806450115; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Shaevitz JW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000364; Soderstrom B, 2016, MOL MICROBIOL, V101, P425, DOI 10.1111/mmi.13400; Stoddard PR, 2017, MOL BIOL CELL, V28, P2461, DOI 10.1091/mbc.E15-11-0778; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vega DE, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00579-18; Viola MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170505; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	65	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101663	10.1016/j.jbc.2022.101663	http://dx.doi.org/10.1016/j.jbc.2022.101663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35104502	gold, Green Published			2022-12-28	WOS:000794865600009
J	Tavasoli, M; Feridooni, T; Feridooni, H; Sokolenko, S; Mishra, A; Lefsay, A; Srinivassane, S; Reid, SA; Rowell, J; Praest, M; MacKinnon, A; Mammoliti, M; Maloney, AA; Moraca, M; Uaesoontrachoon, KP; Nagaraju, KR; Hoffman, E; Pasumarthi, KBS; McMaster, C				Tavasoli, Mahtab; Feridooni, Tiam; Feridooni, Hirad; Sokolenko, Stanislav; Mishra, Abhishek; Lefsay, Abir; Srinivassane, Sadish; Reid, Sarah Anne; Rowell, Joyce; Praest, Molly; MacKinnon, Alexandra; Mammoliti, Melissa; Maloney, Ashley Alyssa; Moraca, Marina; Uaesoontrachoon, Kitipong P.; Nagaraju, Kanneboyina R.; Hoffman, Eric; Pasumarthi, Kishore B. S.; McMaster, Christopher			A mouse model of inherited choline kinase beta-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CONGENITAL MUSCULAR-DYSTROPHY; HEART-FAILURE; SURVIVAL; LIPIDS; ACYLCARNITINES; CONTRACTION; PLASMA; GROWTH; DEFECT	The CHKB gene encodes choline kinase beta, which catalyzes the first step in the biosynthetic pathway for the major phospholipid phosphatidylcholine. Homozygous loss-of-function variants in human CHKB are associated with a congenital muscular dystrophy. Dilated cardiomyopathy is present in some CHKB patients and can cause heart failure and death. Mechanisms underlying a cardiac phenotype due to decreased CHKB levels are not well characterized. We determined that there is cardiac hypertrophy in Chkb(-/-) mice along with a decrease in left ventricle size, internal diameter, and stroke volume compared with wildtype and Chkb(+/-) mice. Unlike wildtype mice, 60% of the Chkb(+/-) and all Chkb(-/-) mice tested displayed arrhythmic events when challenged with isoproterenol. Lipidomic analysis revealed that the major change in lipid level in Chkb(+/-) and Chkb(-/-) hearts was an increase in the arrhythmogenic lipid acylcarnitine. An increase in acylcarnitine level is also associated with a defect in the ability of mitochondria to use fatty acids for energy and we observed that mitochondria from Chkb(-/-) hearts had abnormal cristae and inefficient electron transport chain activity. Atrial natriuretic peptide (ANP) is a hormone produced by the heart that protects against the development of heart failure including ventricular conduction defects. We determined that there was a decrease in expression of ANP, its receptor NPRA, as well as ventricular conduction system markers in Chkb(+/-) and Chkb(-/-) mice.	[Tavasoli, Mahtab; Feridooni, Tiam; Mishra, Abhishek; Reid, Sarah Anne; Nagaraju, Kanneboyina R.; Pasumarthi, Kishore B. S.; McMaster, Christopher] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Sokolenko, Stanislav] Dalhousie Univ, Dept Proc Engn & Appl Sci, Halifax, NS, Canada; [Lefsay, Abir] Dalhousie Univ, Mass Spectrometry Core Facil, Halifax, NS, Canada; [Srinivassane, Sadish; Rowell, Joyce; Praest, Molly; MacKinnon, Alexandra; Mammoliti, Melissa; Maloney, Ashley Alyssa; Moraca, Marina; Uaesoontrachoon, Kitipong P.; Hoffman, Eric] Agada Biosci Inc, Halifax, NS, Canada; [Nagaraju, Kanneboyina R.; Hoffman, Eric] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA	Dalhousie University; Dalhousie University; Dalhousie University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	McMaster, C (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada.	christopher.mcmaster@dal.ca		Feridooni, Tiam/0000-0002-9480-9737; Mishra, Abhishek kumar/0000-0002-8903-2644	Canadian Institutes of Health Research grant [SOP-159230]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research grant SOP-159230 to C. R. M.	Ahmad T, 2016, J AM COLL CARDIOL, V67, P291, DOI 10.1016/j.jacc.2015.10.079; Aitken-Buck HM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.577856; Boutagy NE, 2015, JOVE-J VIS EXP, DOI 10.3791/53216; Chan SHS, 2020, NEUROMUSCULAR DISORD, V30, P47, DOI 10.1016/j.nmd.2019.10.009; Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Bold AJ, 2011, CAN J PHYSIOL PHARM, V89, P527, DOI [10.1139/Y11-019, 10.1139/y11-019]; Desai AJ, 2018, BRIT J PHARMACOL, V175, P4009, DOI 10.1111/bph.13943; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Elmariah S, 2018, JAMA CARDIOL, V3, P242, DOI 10.1001/jamacardio.2017.4873; Escriba PV, 1997, P NATL ACAD SCI USA, V94, P11375, DOI 10.1073/pnas.94.21.11375; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gallo S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092164; Govindapillai A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25292-0; Haliloglu G, 2015, J INHERIT METAB DIS, V38, P1099, DOI 10.1007/s10545-015-9856-2; Hotchkiss A, 2015, AM J PHYSIOL-CELL PH, V308, pC557, DOI 10.1152/ajpcell.00323.2014; Hunter WG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003190; Verdonschot JAJ, 2020, J CARD FAIL, V26, P212, DOI 10.1016/j.cardfail.2019.09.004; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Lai L, 2014, CIRC-HEART FAIL, V7, P1022, DOI 10.1161/CIRCHEARTFAILURE.114.001469; Lanfear DE, 2017, JACC-HEART FAIL, V5, P823, DOI 10.1016/j.jchf.2017.07.009; Mahmaljy H., 2021, DILATED CARDIOMYOPAT; Milani-Nejad N, 2014, PHARMACOL THERAPEUT, V141, P235, DOI 10.1016/j.pharmthera.2013.10.007; Miquerol L, 2010, CIRC RES, V107, P153, DOI 10.1161/CIRCRESAHA.110.218156; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Molnar P, 2014, METHODS MOL BIOL, V1183, P253, DOI 10.1007/978-1-4939-1096-0_16; Muallem S, 2017, EMBO REP, V18, P1893, DOI 10.15252/embr.201744331; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; Preble JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51682; Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002; Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029; Ruiz M, 2017, AM J PHYSIOL-HEART C, V313, pH768, DOI 10.1152/ajpheart.00820.2016; Sayed-Zahid AA, 2019, HUM MOL GENET, V28, P2635, DOI 10.1093/hmg/ddz068; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; STEVENS TL, 1995, J CLIN INVEST, V95, P1101, DOI 10.1172/JCI117757; Sunshine H, 2017, CURR OPIN LIPIDOL, V28, P408, DOI 10.1097/MOL.0000000000000443; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Torres M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072322; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vanlander AV, 2016, MITOCHONDRION, V27, P32, DOI 10.1016/j.mito.2016.02.001; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; WEIBEL ER, 1981, RESP PHYSIOL, V44, P39, DOI 10.1016/0034-5687(81)90076-1; WEIBEL ER, 1981, J HISTOCHEM CYTOCHEM, V29, P1043, DOI 10.1177/29.9.7026667; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yasuno S, 2009, AM J PHYSIOL-HEART C, V296, pH1804, DOI 10.1152/ajpheart.01033.2008; Zordoky BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124844	53	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101716	10.1016/j.jbc.2022.101716	http://dx.doi.org/10.1016/j.jbc.2022.101716			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151687	Green Published, gold			2022-12-28	WOS:000789394500002
J	Xin, Y; Shen, C; Tang, MW; Guo, ZT; Shi, Y; Gu, ZH; Shao, J; Zhang, L				Xin, Yu; Shen, Chen; Tang, Mengwei; Guo, Zitao; Shi, Yi; Gu, Zhenghua; Shao, Jun; Zhang, Liang			Recreating the natural evolutionary trend in key microdomains provides an effective strategy for engineering of a thermomicrobial N-demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOSINE OXIDASE; METHYLATION; AMINES; EXPRESSION; MECHANISM; PEPTIDES; REVEALS; IMPACT; BASES; SITE	N-demethylases have been reported to remove the methyl groups on primary or secondary amines, which could further affect the properties and functions of biomacromolecules or chemical compounds; however, the substrate scope and the robustness of N-demethylases have not been systematically investigated. Here we report the recreation of natural evolution in key microdomains of the Thermomicrobium roseum sarcosine oxidase (TrSOX), an N-demethylase with marked stability (melting temperature over 100(degrees)C) and enantioselectivity, for enhanced substrate scope and catalytic efficiency on -C-Nbonds. We obtained the structure of TrSOX by crystallization and X-ray diffraction (XRD) for the initial framework. The natural evolution in the nonconserved residues of key microdomains-including the catalytic loop, coenzyme pocket, substrate pocket, and entrance site-was then identified using ancestral sequence reconstruction (ASR), and the substitutions that accrued during natural evolution were recreated by site directed mutagenesis. The single and double substitution variants catalyzed the N-demethylation of N-methyl-L-amino acids up to 1800- and 6000-fold faster than the wild type, respectively. Additionally, these single substitution variants catalyzed the terminal N-demethylation of non-amino-acid compounds and the oxidation of the main chain -C-N- bond to a -C=N- bond in the nitrogen-containing heterocycle. Notably, these variants retained the enantioselectivity and stability of the initial framework. We conclude that the variants of TrSOX are of great potential use in N-methyl enantiomer resolution, main-chain Schiff base synthesis, and alkaloid modification or degradation.	[Xin, Yu; Shen, Chen; Tang, Mengwei; Guo, Zitao; Shi, Yi; Gu, Zhenghua; Zhang, Liang] Jiangnan Univ, Key Lab Ind Biotechnol, Natl Engn Lab Cereal Fermentat Technol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Shao, Jun] Nanjing Med Univ, Dept Ophthalmol, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Nanjing Medical University	Xin, Y; Zhang, L (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Natl Engn Lab Cereal Fermentat Technol, Minist Educ, Wuxi, Jiangsu, Peoples R China.; Shao, J (corresponding author), Nanjing Med Univ, Dept Ophthalmol, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China.	yuxin@jiangnan.edu.cn; shaojun@njmu.edu.cn; zhangl@jiangnan.edu.cn	Shao, Jun/AAX-5904-2021; Xin, Yu/AAG-8968-2021	Shao, Jun/0000-0003-3477-4568; Xin, Yu/0000-0002-5396-4319	National Key Research and Development Program of China [2021YFC2100303]; National Natural Science Foundation of China [81970819]; Natural Science Foundation of Jiangsu Province [BK20160053, BE2018055]; Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee [2020012]; Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project [111-2-06]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee; Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project	This work was supported by National Key Research and Development Program of China (2021YFC2100303); National Natural Science Foundation of China (Grant No. 81970819); Natural Science Foundation of Jiangsu Province (BK20160053 and BE2018055); Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (2020012); Priority Academic Program Development of Jiangsu Higher Education Institutions, 111 Project (No. 111-2-06). The authors are grateful to Shanghai Medicilon Inc for technological support. We thank the staff at the Beamline 17U, Shanghai Synchrotron Radiation Facility (SSRF).	Abe Y, 2017, PHYS CHEM CHEM PHYS, V19, P9811, DOI 10.1039/c6cp08172j; Augustin MM, 2019, NAT SUSTAIN, V2, P465, DOI 10.1038/s41893-019-0302-6; Ayuso-Fernandez I, 2019, P NATL ACAD SCI USA, V116, P17900, DOI 10.1073/pnas.1905040116; Bobbink FD, 2017, NAT PROTOC, V12, P417, DOI 10.1038/nprot.2016.175; Cappelletti P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196283; Chatterjee J, 2013, ANGEW CHEM INT EDIT, V52, P254, DOI 10.1002/anie.201205674; Chen YS, 2020, CHEM-EUR J, V26, P2973, DOI 10.1002/chem.201905505; Clifton BE, 2018, NAT CHEM BIOL, V14, P542, DOI 10.1038/s41589-018-0043-2; Farber Nuri B, 2019, Handb Exp Pharmacol, V250, P287, DOI 10.1007/164_2018_165; Gao QY, 2021, INT J BIOL MACROMOL, V178, P434, DOI 10.1016/j.ijbiomac.2021.02.176; Ghislandi AB, 2020, J MOL NEUROSCI, V70, P590, DOI 10.1007/s12031-019-01463-0; Glotz G, 2020, ORG LETT, V22, P6891, DOI 10.1021/acs.orglett.0c02424; Hameed A, 2017, EXPERT OPIN THER PAT, V27, P63, DOI 10.1080/13543776.2017.1252752; Han HaoLei, 2021, Shipin Kexue / Food Science, V42, P255, DOI 10.7506/spkx1002-6630-20200708-106; Hassan-Abdalla A, 2008, BIOCHEMISTRY-US, V47, P2913, DOI 10.1021/bi702351v; Hsu A, 2018, METHODS, V138, P76, DOI 10.1016/j.ymeth.2017.12.020; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Janik E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051181; Johnson RC, 2009, J ANAL TOXICOL, V33, P77, DOI 10.1093/jat/33.2.77; Jorns MS, 2010, BIOCHEMISTRY-US, V49, P3631, DOI 10.1021/bi100160j; Kazlauskas R, 2018, CHEM SOC REV, V47, P9026, DOI 10.1039/c8cs00014j; KEDDERIS GL, 1983, J BIOL CHEM, V258, P8129; Kok GB, 2010, J ORG CHEM, V75, P4806, DOI 10.1021/jo1008492; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lauterbach E. H, 2009, Deme-thylation of 14-hydroxy substituted alkaloid derivatives, Patent No. [US2009/0163717A1, 20090163717]; Li WJ, 2018, CHEM COMMUN, V54, P1865, DOI 10.1039/c7cc09201f; Liu Q, 2019, BIOTECHNOL ADV, V37, P530, DOI 10.1016/j.biotechadv.2018.10.011; Mathis D, 2020, J INHERIT METAB DIS, V43, P1102, DOI 10.1002/jimd.12244; McBrayer DN, 2019, ACS INFECT DIS, V5, P1035, DOI 10.1021/acsinfecdis.9b00097; Mori S, 2018, NAT CHEM BIOL, V14, P428, DOI 10.1038/s41589-018-0014-7; Nagata K, 2005, P JPN ACAD B-PHYS, V81, P220, DOI 10.2183/pjab.81.220; Negreira N, 2014, SCI TOTAL ENVIRON, V497, P68, DOI 10.1016/j.scitotenv.2014.07.101; Ongpipattanakul C, 2018, ACS CHEM BIOL, V13, P2989, DOI 10.1021/acschembio.8b00668; Peat AJ, 1996, J AM CHEM SOC, V118, P1028, DOI 10.1021/ja953080t; Qin J, 2021, NAT PROD RES, V35, P3254, DOI 10.1080/14786419.2019.1696334; Rader AFB, 2018, BIOORGAN MED CHEM, V26, P2766, DOI 10.1016/j.bmc.2017.08.031; Rosenau T, 2004, ORG LETT, V6, P541, DOI 10.1021/ol036319g; Schriever K, 2021, J AM CHEM SOC, V143, P3794, DOI 10.1021/jacs.0c10214; Sciabola S, 2016, BIOORGAN MED CHEM, V24, P3513, DOI 10.1016/j.bmc.2016.05.062; Selfridge BR, 2015, J MED CHEM, V58, P5038, DOI 10.1021/acs.jmedchem.5b00426; Sun ZT, 2019, CHEM REV, V119, P1626, DOI 10.1021/acs.chemrev.8b00290; Dang TT, 2015, ACS CATAL, V5, P4082, DOI 10.1021/acscatal.5b00606; Vallejo-Lopez M, 2017, CHEM-EUR J, V23, P16491, DOI 10.1002/chem.201702232; van der Velden NS, 2017, NAT CHEM BIOL, V13, P833, DOI 10.1038/nchembio.2393; von Braun J, 1909, BER DTSCH CHEM GES, V42, P2035; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Wicks Christopher, 2021, Alkaloids Chem Biol, V86, P145, DOI 10.1016/bs.alkal.2021.04.001; Xin Y, 2021, FRONT CHEM SCI ENG, V15, P615, DOI 10.1007/s11705-020-1989-7; Xin Y, 2019, MOL CATAL, V464, P48, DOI 10.1016/j.mcat.2018.12.021; Yi XW, 2020, ORG LETT, V22, P4583, DOI 10.1021/acs.orglett.0c00863; Yu HR, 2015, BBA-PROTEINS PROTEOM, V1854, P65, DOI 10.1016/j.bbapap.2014.10.017; Zamanian G, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107343; Zhao Senzhi, 2021, Alkaloids Chem Biol, V86, P1, DOI 10.1016/bs.alkal.2021.05.001	53	1	1	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101656	10.1016/j.jbc.2022.101656	http://dx.doi.org/10.1016/j.jbc.2022.101656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35124004	gold, Green Published			2022-12-28	WOS:000794865600010
J	Akasu, R; Miyazaki, T; Elhussiny, MZ; Sugiura, Y; Tomitsuka, Y; Haraguchi, S; Otsu, K; Chowdhury, VS; Miyazaki, A				Akasu, Risako; Miyazaki, Takuro; Elhussiny, Mohamed Z.; Sugiura, Yuki; Tomitsuka, Yuki; Haraguchi, Shogo; Otsu, Kinya; Chowdhury, Vishwajit S.; Miyazaki, Akira			Calpain-mediated proteolytic production of free amino acids in vascular endothelial cells augments obesity-induced hepatic steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM-L; MOUSE; DEGRADATION; METABOLISM; DISEASES	Free amino acids that accumulate in the plasma of patients with diabetes and obesity influence lipid metabolism and protein synthesis in the liver. The stress-inducible intracellular protease calpain proteolyzes various substrates in vascular endothelial cells (ECs), although its contribution to the supply of free amino acids in the liver microenvironment remains enigmatic. In the present study, we showed that calpains are associated with free amino acid production in cultured ECs. Furthermore, conditioned media derived from calpain-activated ECs facilitated the phosphorylation of ribosomal protein S6 kinase (S6K) and de novo lipogenesis in hepatocytes, which were abolished by the amino acid transporter inhibitor, JPH203, and the mammalian target of rapamycin complex 1 inhibitor, rapamycin. Meanwhile, calpain-overexpressing capillary-like ECs were observed in the livers of high-fat diet-fed mice. Conditional KO of EC/hematopoietic Capns1, which encodes a calpain regulatory subunit, diminished levels of branched-chain amino acids in the hepatic microenvironment without altering plasma amino acid levels. Concomitantly, conditional KO of Capns1 mitigated hepatic steatosis without normalizing body weight and the plasma lipoprotein profile in an amino acid transporter-dependent manner. Mice with targeted Capns1 KO exhibited reduced phosphorylation of S6K and maturation of lipogenic factor sterol regulatory elementbinding protein 1 in hepatocytes. Finally, we show that bone marrow transplantation negated the contribution of hematopoietic calpain systems. We conclude that overactivation of calpain systems may be responsible for the production of free amino acids in ECs, which may be sufficient to potentiate S6K/sterol regulatory element-binding protein 1-induced lipogenesis in surrounding hepatocytes.	[Akasu, Risako; Miyazaki, Takuro; Tomitsuka, Yuki; Haraguchi, Shogo; Miyazaki, Akira] Showa Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Elhussiny, Mohamed Z.; Chowdhury, Vishwajit S.] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka, Japan; [Elhussiny, Mohamed Z.] Aswan Univ, Fac Vet Med, Dept Anim & Poultry Behav & Management, Aswan, Egypt; [Sugiura, Yuki] Keio Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Otsu, Kinya] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr Excellence, London, England; [Chowdhury, Vishwajit S.] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan	Showa University; Kyushu University; Egyptian Knowledge Bank (EKB); Aswan University; Keio University; University of London; King's College London; Kyushu University	Miyazaki, T (corresponding author), Showa Univ, Dept Biochem, Sch Med, Tokyo, Japan.	taku@pharm.showa-u.ac.jp	Elhussiny, Mohamed Z./AAM-9418-2021	Elhussiny, Mohamed Z./0000-0003-1177-9315; Miyazaki, Takuro/0000-0003-3354-0292	Japan Society for the Promotion of Science KAKENHI grant [JP21K08585, JP19K08590, JP22H03520, JP19H03110]; Bristol-Myers Squibb; British Heart Foundation [CH/11/3/29051, RG/16/15/32294]; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Memorial Foundation	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bristol-Myers Squibb(Bristol-Myers Squibb); British Heart Foundation(British Heart Foundation); Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Memorial Foundation(Naito Memorial Foundation)	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI grant (grant nos.: JP21K08585 [to A. M.], JP19K08590 [to T. M.], JP22H03520 [to T. M.], and JP19H03110 [to V. S. C.]), research grant from Bristol-Myers Squibb (to T. M.), personal chair grant from the British Heart Foundation (grant nos.: CH/11/3/29051 and RG/16/15/32294 [to K. O.]), research grant from the Suzuken Memorial Foundation (to T. M.), and research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. M.), and a research grant from the Naito Memorial Foundation (to T. M.).	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Cheng Q, 2016, J MOL ENDOCRINOL, V56, P175, DOI 10.1530/JME-15-0212; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Han G, 2020, ANIMAL, V14, P1701, DOI 10.1017/S1751731120000464; Ito K, 2015, COMP BIOCHEM PHYS A, V187, P13, DOI 10.1016/j.cbpa.2015.04.010; Javed K, 2019, BIOCHEM SOC T, V47, P571, DOI 10.1042/BST20180250; Kigawa Y, 2014, ARTERIOSCL THROM VAS, V34, P2413, DOI 10.1161/ATVBAHA.114.303086; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Le Couteur DG, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101198; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Marcu R, 2018, ISCIENCE, V4, P20, DOI 10.1016/j.isci.2018.05.003; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Miyazaki T., 2016, J CLIN INVEST; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Miyazaki T, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00114-x; Miyazaki T, 2019, FASEB J, V33, P2037, DOI 10.1096/fj.201800588RR; Miyazaki T, 2018, J ATHEROSCLER THROMB, V25, P1, DOI 10.5551/jat.RV17008; Miyazaki T, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00079; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Oka M, 2017, J CELL SCI, V130, P3568, DOI 10.1242/jcs.200519; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Shinkai-Ouchi F, 2016, MOL CELL PROTEOMICS, V15, P1262, DOI 10.1074/mcp.M115.053413; Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Taki M, 2021, ACS MATER LETT, V3, P42, DOI 10.1021/acsmaterialslett.0c00451; Taneike M., 2011, J BIOL UDAYANA; Tomita T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16003-3; Uno K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8940; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wempe MF, 2012, DRUG METAB PHARMACOK, V27, P155, DOI 10.2133/dmpk.DMPK-11-RG-091; White PJ, 2019, SCIENCE, V363, P582, DOI 10.1126/science.aav0558; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yothaisong S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694545; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	47	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101953	10.1016/j.jbc.2022.101953	http://dx.doi.org/10.1016/j.jbc.2022.101953			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447117	Green Published, gold			2022-12-28	WOS:000838892100009
J	Mostofa, G; Tran, M; Gilling, S; Lee, GC; Fraher, O; Jin, L; Kang, HYJ; Park, YK; Lee, JY; Wang, L; Shin, DJ				Mostofa, Golam; Tran, Melanie; Gilling, Shaynian; Lee, Grace; Fraher, Ondine; Jin, Lei; Kang, Hyunju; Park, Young-Ki; Lee, Ji-Young; Wang, Li; Shin, Dong-Ju			MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HIGH-DENSITY; ETHANOL; METABOLISM; EXPRESSION; MICE; PHOSPHATIDYLCHOLINE; ALPHA; TRANSCRIPTION; PATHOGENESIS; INHIBITION	Hepatic steatosis is an initial manifestation of alcoholic liver disease. An imbalance of hepatic lipid processes including fatty acid uptake, esterification, oxidation, and triglyceride secretion leads to alcoholic fatty liver (AFL). However, the precise molecular mechanisms underlying the pathogenesis of AFL remain elusive. Here, we show that mice deficient in microRNAs (miRs)-141 and -200c display resistance to the development of AFL. We found that miR-200c directly targets HNF1 homeobox B (Hnf1b), a transcriptional activator for microsomal triglyceride transfer protein (Mttp), as well as apolipoprotein O (ApoO), an integral component of the mitochondrial contact site and cristae organizing system complex. We show that expression of these miRs is significantly induced by chronic ethanol exposure, which is accompanied by reduced HNF1B and APOO levels. Furthermore, miR-141/200c deficiency normalizes ethanol-mediated impairment of triglyceride secretion, which can be attributed to the restored levels of HNF1B and MTTP, as well as phosphatidylcholine abundance. Moreover, we demonstrate that miR-141/200c deficiency restores ethanol-mediated inhibition of APOO expression and mitochondrial dysfunction, improving mitochondrial antioxidant defense capacity and fatty acid oxidation. Taken together, these results suggest that miR-200c contributes to the modulation of lipid homeostasis in AFL disease by cooperatively regulating Hnf1b and ApoO functions.	[Kang, Hyunju; Park, Young-Ki; Lee, Ji-Young] Yale Univ, Dept Physiol & Neurobiol, Sect Digest Dis, New Haven, CT 06520 USA; [Wang, Li] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA; [Tran, Melanie] Yale Univ, Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT USA; [Shin, Dong-Ju] Univ Connecticut Hlth Ctr, Dept ofMedicine, Div Nephrol, Farmington, CT 06030 USA	Yale University; University of Connecticut; Yale University; University of Connecticut	Shin, DJ (corresponding author), Univ Connecticut Hlth Ctr, Dept ofMedicine, Div Nephrol, Farmington, CT 06030 USA.	dong-ju-shin@uconn.edu		Mostofa, Md./0000-0002-0488-9121	National Institutes of Health [R01AA026322]; American Heart Association postdoctoral fellowship [18POST33960183]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association)	This study was supported by the National Institutes of Health (R01AA026322 to D.-J. S.) . M. T. was supported by an American Heart Association postdoctoral fellowship (18POST33960183) .	Attal N, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100975; BARAONA E, 1979, J LIPID RES, V20, P289; BARAONA E, 1970, J CLIN INVEST, V49, P769, DOI 10.1172/JCI106290; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Chen L, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa7efa; Clugston RD, 2014, J LIPID RES, V55, P239, DOI 10.1194/jlr.M041863; Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Feng YY, 2014, CELL PHYSIOL BIOCHEM, V34, P1983, DOI 10.1159/000366394; Fischer M, 2003, J BIOL CHEM, V278, P27997, DOI 10.1074/jbc.M302140200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GORDON ER, 1972, BIOCHEM PHARMACOL, V21, P2991, DOI 10.1016/0006-2952(72)90192-X; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jandacek RJ, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020025; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Koob S, 2015, BBA-MOL CELL RES, V1853, P1551, DOI 10.1016/j.bbamcr.2015.03.004; Koob S, 2014, BIOL CHEM, V395, P285, DOI 10.1515/hsz-2013-0274; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIEBER CS, 1994, ALCOHOL CLIN EXP RES, V18, P592, DOI 10.1111/j.1530-0277.1994.tb00915.x; Lin MCM, 1997, FASEB J, V11, P1145, DOI 10.1096/fasebj.11.13.9367349; Long Z, 2017, FREE RADICAL BIO MED, V113, P71, DOI 10.1016/j.freeradbiomed.2017.09.016; LOSOWSKY MS, 1963, AM J MED, V35, P794, DOI 10.1016/0002-9343(63)90241-9; MAVRELIS PG, 1983, HEPATOLOGY, V3, P226; MORLAND J, 1974, BIOCHEM PHARMACOL, V23, P21, DOI 10.1016/0006-2952(74)90310-4; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ONTKO JA, 1973, J LIPID RES, V14, P78; Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z; SCHAPIRO RH, 1964, J CLIN INVEST, V43, P1338, DOI 10.1172/JCI105009; SCHAPIRO RH, 1965, NEW ENGL J MED, V272, P610, DOI 10.1056/NEJM196503252721203; Smathers RL, 2013, J LIPID RES, V54, P1335, DOI 10.1194/jlr.M034892; Sugimoto T, 2002, J HEPATOL, V36, P157, DOI 10.1016/S0168-8278(01)00263-X; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; Tian F, 2017, BIOCHEM BIOPH RES CO, V491, P8, DOI 10.1016/j.bbrc.2017.06.128; Tran M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96094; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; VENKATESAN S, 1988, BIOCHIM BIOPHYS ACTA, V960, P61, DOI 10.1016/0005-2760(88)90009-4; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; YAO ZM, 1988, J BIOL CHEM, V263, P2998; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29352; Zaqout S, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.582218; Zhang GX, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0858-x	65	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101966	10.1016/j.jbc.2022.101966	http://dx.doi.org/10.1016/j.jbc.2022.101966			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35460694	Green Published, gold			2022-12-28	WOS:000807750700002
J	Mukundan, A; Byeon, CH; Hinck, CS; Cunningham, K; Campion, T; Smyth, DJ; Maizels, RM; Hinck, AP				Mukundan, Ananya; Byeon, Chang-Hyeock; Hinck, Cynthia S.; Cunningham, Kyle; Campion, Tiffany; Smyth, Danielle J.; Maizels, Rick M.; Hinck, Andrew P.			Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-beta to its receptors, T beta RI and T beta RII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RESONANCE ASSIGNMENTS; NMR-SPECTROSCOPY; TERNARY COMPLEX; II RECEPTOR; IN-VITRO; CELLS; IMMUNITY; QUALITY; DOMAIN; MICE	The mouse intestinal helminth Heligmosomoides polygyrus modulates host immune responses by secreting a transforming growth factor (TGF)-beta mimic (TGM), to expand the population of Foxp3(+) T-regs. TGM comprises five complement control protein (CCP)-like domains, designated D1-D5. Though lacking homology to TGF-beta, TGM binds directly to the TGF-beta receptors T beta RI and T beta RII and stimulates the differentiation of naive T-cells into Tregs. However, the molecular determinants of binding are unclear. Here, we used surface plasmon resonance, isothermal calorimetry, NMR spectroscopy, and mutagenesis to investigate how TGM binds the TGF-beta receptors. We demonstrate that binding is modular, with D1-D2 binding to T beta RI and D3 binding to T beta RII. D1-D2 and D3 were further shown to compete with TGF-beta(T beta RII) 2 and TGF-beta for binding to T beta RI and T beta RII, respectively. The solution structure of TGM-D3 revealed that TGM adopts a CCP-like fold but is also modified to allow the C-terminal strand to diverge, leading to an expansion of the domain and opening potential interaction surfaces. TGM-D3 also incorporates a long structurally ordered hypervariable loop, adding further potential interaction sites. Through NMR shift perturbations and binding studies of TGM-D3 and T beta RII variants, TGM-D3 was shown to occupy the same site of T beta RII as bound by TGF-beta using both a novel interaction surface and the hypervariable loop. These results, together with the identification of other secreted CCP-like proteins with immunomodulatory activity in H. polygyrus, suggest that TGM is part of a larger family of evolutionarily plastic parasite effector molecules that mediate novel interactions with their host.	[Mukundan, Ananya; Byeon, Chang-Hyeock; Hinck, Cynthia S.; Hinck, Andrew P.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15213 USA; [Cunningham, Kyle; Campion, Tiffany; Smyth, Danielle J.; Maizels, Rick M.] Univ Glasgow, Wellcome Ctr Integrat Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Smyth, Danielle J.] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Glasgow; University of Dundee	Hinck, AP (corresponding author), Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15213 USA.	ahinck@pitt.edu		Mukundan, Ananya/0000-0003-1161-4158	NIH [AI157069, GM58670, AI53915]; Wellcome Trust [104111, 219530]; NIGMS [P41GM103311]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH (GM58670 and AI53915 awarded to A. H.), the Wellcome Trust through an Investigator Award to RMM (Ref 219530), and the Wellcome Trust core-funded Wellcome Centre for Integrative Parasitology (Ref: 104111). Training support for A. M. was provided by the NIH (AI157069). Molecular graphics and analyses were performed with UCSF Chimera, which is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco supported by NIGMS P41GM103311. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhurst RJ, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022301; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chauche C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01363; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cook L, 2021, IMMUNOL CELL BIOL, V99, P833, DOI 10.1111/imcb.12475; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derynck R, 2021, NAT REV CLIN ONCOL, V18, P9, DOI 10.1038/s41571-020-0403-1; EBERHARDT ES, 1992, J AM CHEM SOC, V114, P5437, DOI 10.1021/ja00039a072; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Gerhard Wider D. N., 1991, J BIOMOL NMR, V1, P5; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hansen MR, 2000, J BIOMOL STRUCT DYN, P365, DOI 10.1080/07391102.2000.10506642; Hewitson JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003492; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Hinck AP, 2000, J BIOMOL NMR, V18, P369, DOI 10.1023/A:1026775321886; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hu HH, 2018, CHEM-BIOL INTERACT, V292, P76, DOI 10.1016/j.cbi.2018.07.008; Huang T, 2016, METHODS MOL BIOL, V1344, P63, DOI 10.1007/978-1-4939-2966-5_4; Huang T, 2011, EMBO J, V30, P1263, DOI 10.1038/emboj.2011.54; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Ihara S, 2017, J GASTROENTEROL, V52, P777, DOI 10.1007/s00535-017-1350-1; Ilangovan U, 2004, J BIOMOL NMR, V29, P103, DOI 10.1023/B:JNMR.0000019468.50957.42; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johnston CJC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01886-6; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kim SK, 2017, J BIOL CHEM, V292, P7173, DOI 10.1074/jbc.M116.768754; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Logan J, 2018, CURR OPIN IMMUNOL, V54, P1, DOI 10.1016/j.coi.2018.05.007; Maizels RM, 2018, IMMUNITY, V49, P801, DOI 10.1016/j.immuni.2018.10.016; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mitra MS, 2020, TOXICOL SCI, V175, P24, DOI 10.1093/toxsci/kfaa024; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Osbourn M, 2017, IMMUNITY, V47, P739, DOI 10.1016/j.immuni.2017.09.015; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ryan SM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008508; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Skinner SP, 2015, ACTA CRYSTALLOGR D, V71, P154, DOI 10.1107/S1399004714026662; Smith KA, 2016, MUCOSAL IMMUNOL, V9, P428, DOI 10.1038/mi.2015.73; Smyth DJ, 2021, J BIOTECHNOL, V340, P1, DOI 10.1016/j.jbiotec.2021.08.006; Smyth DJ, 2018, INT J PARASITOL, V48, P379, DOI 10.1016/j.ijpara.2017.12.004; Tauriello DVF, 2022, NAT REV CANCER, V22, P25, DOI 10.1038/s41568-021-00413-6; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Vacca F, 2020, ELIFE, V9, DOI 10.7554/eLife.54017; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1; White MPJ, 2021, IMMUNOL CELL BIOL, V99, P848, DOI 10.1111/imcb.12479; White MPJ, 2020, IMMUNOLOGY, V160, P248, DOI 10.1111/imm.13190; Wiedemann M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.572865; Willems E, 2012, CELL STEM CELL, V11, P242, DOI 10.1016/j.stem.2012.04.025; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014; Zuniga JE, 2011, J MOL BIOL, V412, P601, DOI 10.1016/j.jmb.2011.07.046	84	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101994	10.1016/j.jbc.2022.101994	http://dx.doi.org/10.1016/j.jbc.2022.101994			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35500648	gold, Green Published, Green Accepted			2022-12-28	WOS:000811813400004
J	Ponce, JRJ; Kapps, D; Paulus, C; Chicher, J; Frugier, M				Ponce, Jose R. Jaramillo; Kapps, Delphine; Paulus, Caroline; Chicher, Johana; Frugier, Magali			Discovery of two distinct aminoacyl-tRNA synthetase complexes anchored to the Plasmodium surface tRNA import protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CAPPING BOX; CRYSTAL-STRUCTURES; CONSERVED DOMAIN; BINDING DOMAIN; ARC1P; EXTENSION; ROLES; P43; IDENTIFICATION; ARCHITECTURE	Aminoacyl-tRNA synthetases (aaRSs) attach amino acids to their cognate transfer RNAs. In eukaryotes, a subset of cytosolic aaRSs is organized into a multisynthetase complex (MSC), along with specialized scaffolding proteins referred to as aaRSinteracting multifunctional proteins (AIMPs). In Plasmodium, the causative agent of malaria, the tRNA import protein (tRip), is a membrane protein that participates in tRNA trafficking; we show that tRip also functions as an AIMP. We identified three aaRSs, the glutamyl-tRNA synthetase (ERS), glutaminyl-tRNA synthetase (QRS), and methionyl-tRNA synthetase (MRS), which were specifically coimmunoprecipitated with tRip in Plasmodium berghei blood stage parasites. All four proteins contain an N-terminal glutathione-S-transferase (GST)-like domain that was demonstrated to be involved in MSC assembly. In contrast to previous studies, further dissection of GST-like interactions identified two exclusive heterotrimeric complexes: the Q-complex (tRip-ERS-QRS) and the M-complex (tRip-ERS-MRS). Gel filtration and light scattering suggest a 2:2:2 stoichiometry for both complexes but with distinct biophysical properties and mutational analysis further revealed that the GST-like domains of QRS and MRS use different strategies to bind ERS. Taken together, our results demonstrate that neither the singular homodimerization of tRip nor its localization in the parasite plasma membrane prevents the formation of MSCs in Plasmodium. Besides, the extracellular localization of the tRNA-binding module of tRip is compensated by the presence of additional tRNA-binding modules fused to MRS and QRS, providing each MSC with two spatially distinct functions: aminoacylation of intraparasitic tRNAs and binding of extracellular tRNAs. This unique host-pathogen interaction is discussed.	[Ponce, Jose R. Jaramillo; Kapps, Delphine; Paulus, Caroline; Frugier, Magali] Univ Strasbourg, CNRS, Architecture & React ARN, UPR 9002, Strasbourg, France; [Chicher, Johana] Univ Strasbourg, Strasbourg Esplanade Prote Facil, Esplanade Prote Facil, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frugier, M (corresponding author), Univ Strasbourg, CNRS, Architecture & React ARN, UPR 9002, Strasbourg, France.	m.frugier@ibmc-cnrs.unistra.fr		Jaramillo Ponce, Jose Refugio/0000-0002-9273-5922; Paulus, Caroline/0000-0002-4621-1757	Interdisciplinary Thematic Institute IMCBio, as part of the ITI 2021-2028 program of the University of Strasbourg; CNRS; Inserm; IdEx Unistra [ANR-10-IDEX-0002]; SFRI-STRAT'US project [ANR 20-SFRI-0012]; EUR IMCBio [IMCBio ANR-17-EURE-0023]; Labex NetRNA [ANR-10-LABX-0036]; Universite de Strasbourg, IdEx "Equipement mi-lourd" (2015); CONACYT-Mexico [439648]	Interdisciplinary Thematic Institute IMCBio, as part of the ITI 2021-2028 program of the University of Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); IdEx Unistra; SFRI-STRAT'US project; EUR IMCBio; Labex NetRNA; Universite de Strasbourg, IdEx "Equipement mi-lourd" (2015); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was performed under the framework of the Interdisciplinary Thematic Institute IMCBio, as part of the ITI 2021-2028 program of the University of Strasbourg, CNRS and Inserm. It was supported by IdEx Unistra (ANR-10-IDEX-0002), by SFRI-STRAT'US project (ANR 20-SFRI-0012), and EUR IMCBio (IMCBio ANR-17-EURE-0023) under the framework of the French Investments for the Future Program", by previous Labex NetRNA (ANR-10-LABX-0036), by the CNRS and the Universite de Strasbourg, IdEx "Equipement mi-lourd" (2015), and CONACYT-Mexico (grant number 439648) to JRJP.	ABADIA J, 1992, J PLANT NUTR, V15, P1699, DOI 10.1080/01904169209364432; Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; Achilonu I, 2018, J MOL RECOGNIT, V31, DOI 10.1002/jmr.2708; Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Argenzio E, 2016, J CELL SCI, V129, P4165, DOI 10.1242/jcs.189795; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BEC G, 1994, J BIOL CHEM, V269, P2086; Bour T, 2016, P NATL ACAD SCI USA, V113, P4717, DOI 10.1073/pnas.1600476113; Bouyssie D, 2020, BIOINFORMATICS, V36, P3148, DOI 10.1093/bioinformatics/btaa118; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cela M, 2021, NUCLEIC ACIDS RES, V49, P10618, DOI 10.1093/nar/gkab769; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Cha SJ, 2016, J EXP MED, V213, P2099, DOI 10.1084/jem.20160059; Chaudhry SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18695-y; Cho HY, 2019, J MOL BIOL, V431, P4475, DOI 10.1016/j.jmb.2019.08.013; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Crepin T, 2011, J MOL BIOL, V405, P1056, DOI 10.1016/j.jmb.2010.11.049; Cui HS, 2021, NUCLEIC ACIDS RES, V49, P3603, DOI 10.1093/nar/gkaa1183; Davies HM, 2017, FEMS MICROBIOL REV, V41, P923, DOI 10.1093/femsre/fux046; Deinert K, 2001, J BIOL CHEM, V276, P6000, DOI 10.1074/jbc.M008682200; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Frechin M, 2014, MOL CELL, V56, P763, DOI 10.1016/j.molcel.2014.10.015; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Frugier M, 2010, FEBS LETT, V584, P448, DOI 10.1016/j.febslet.2009.11.004; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Golinelli-Cohen MP, 2007, MOL CELL BIOCHEM, V300, P47, DOI 10.1007/s11010-006-9367-4; Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gupta S, 2020, ACTA CRYSTALLOGR D, V76, P135, DOI 10.1107/S2059798319016413; Hahn H, 2019, IUCRJ, V6, P958, DOI 10.1107/S2052252519010790; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Hare JE, 2016, BIOCHEMISTRY-US, V55, P3825, DOI 10.1021/acs.biochem.6b00080; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; Havrylenko S, 2011, J BIOL CHEM, V286, P28476, DOI 10.1074/jbc.M111.254037; Hussain T, 2015, ANTIMICROB AGENTS CH, V59, P1856, DOI 10.1128/AAC.02220-13; Hyeon DY, 2019, J BIOL CHEM, V294, P5340, DOI 10.1074/jbc.REV118.002958; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kapps D, 2016, FEBS LETT, V590, P4180, DOI 10.1002/1873-3468.12441; Karanasios E, 2007, J MOL BIOL, V374, P1077, DOI 10.1016/j.jmb.2007.10.010; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; Khan K, 2020, NUCLEIC ACIDS RES, V48, P8740, DOI 10.1093/nar/gkaa569; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Koehler C, 2013, NUCLEIC ACIDS RES, V41, P667, DOI 10.1093/nar/gks1072; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lange H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11807-4; Laporte D, 2014, FEBS LETT, V588, P4268, DOI 10.1016/j.febslet.2014.10.007; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Magis C, 2014, METHODS MOL BIOL, V1079, P117, DOI 10.1007/978-1-62703-646-7_7; Mailu BM, 2015, J BIOL CHEM, V290, P29629, DOI 10.1074/jbc.M115.655100; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Minns AM, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00435-17, 10.1128/msphere.00435-17]; Mirande M, 2017, SUBCELL BIOCHEM, V83, P505, DOI 10.1007/978-3-319-46503-6_18; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; van Rooyen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089487; White MR, 2016, WIRES RNA, V7, P53, DOI 10.1002/wrna.1315; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	84	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101987	10.1016/j.jbc.2022.101987	http://dx.doi.org/10.1016/j.jbc.2022.101987			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35487244	Green Submitted, gold, Green Published			2022-12-28	WOS:000807750700001
J	Goldsmith, M; Barad, S; Knafo, M; Savidor, A; Ben-Dor, S; Brandis, A; Mehlman, T; Peleg, Y; Albeck, S; Dym, O; Ben-Zeev, E; Barbole, RS; Aharoni, A; Reich, Z				Goldsmith, Moshe; Barad, Shiri; Knafo, Maor; Savidor, Alon; Ben-Dor, Shifra; Brandis, Alexander; Mehlman, Tevie; Peleg, Yoav; Albeck, Shira; Dym, Orly; Ben-Zeev, Efrat; Barbole, Ranjit S.; Aharoni, Asaph; Reich, Ziv			Identification and characterization of the key enzyme in the biosynthesis of the neurotoxin beta-ODAP in grass pea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATHYRUS-SATIVUS L.; BETA-N-OXALYL-L-ALPHA,BETA-DIAMINOPROPIONIC ACID; 6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATE; ACCURATE DOCKING; PROTEIN; ACCUMULATION; PERFORMANCE; EFFICIENT; SYNTHASE; ISOMER	Grass pea (Lathyrus sativus L.) is a grain legume commonly grown in Asia and Africa for food and forage. It is a highly nutritious and robust crop, capable of surviving both droughts and floods. However, it produces a neurotoxic compound, beta-N- oxalyl-L-alpha,beta-diaminopropionic acid (beta-ODAP), which can cause a severe neurological disorder when consumed as a primary diet component. While the catalytic activity associated with beta-ODAP formation was demonstrated more than 50 years ago, the enzyme responsible for this activity has not been identified. Here, we report on the identity, activity, 3D structure, and phylogenesis of this enzyme-beta-ODAP synthase (BOS). We show that BOS belongs to the benzylalcohol O-acetyltransfer-ase, anthocyanin O-hydroxycinnamoyltransferase, anthranilate N-hydroxycinnamoyl/benzoyltransferase, deacetylvindoline 4-O-acetyltransferase superfamily of acyltransferases and is structurally similar to hydroxycinnamoyl transferase. Using molecular docking, we propose a mechanism for its catalytic activity, and using heterologous expression in tobacco leaves (Nicotiana benthamiana), we demonstrate that expression of BOS in the presence of its substrates is sufficient for beta-ODAP production in vivo. The identification of BOS may pave the way toward engineering beta-ODAP-free grass pea cultivars, which are safe for human and animal consumption.	[Goldsmith, Moshe; Barad, Shiri; Knafo, Maor; Reich, Ziv] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Savidor, Alon] Nancy & Stephen Grand Israel Natl Ctr Personalized, Botton Inst Prot Profiling, Rehovot, Israel; [Ben-Dor, Shifra; Brandis, Alexander; Mehlman, Tevie; Peleg, Yoav; Albeck, Shira; Dym, Orly] Weizmann Inst Sci, Dept Life Sci Core Facil, Rehovot, Israel; [Ben-Zeev, Efrat] Nancy & Stephen Grand Israel Natl Ctr Personalized, Med Chem Unit, Rehovot, Israel; [Barbole, Ranjit S.; Aharoni, Asaph] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Barbole, Ranjit S.] Council Sci, Div Biochem Sci, Plant Mol Biol Unit, Ind Res Natl Chem Lab, Pune, Maharashtra, India	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Goldsmith, M; Reich, Z (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.	moshe.goldsmith@weizmann.ac.il; ziv.reich@weizmann.ac.il		Knafo, Maor/0000-0002-3800-4555; Peleg, Yoav/0000-0002-0756-8788	Israeli Ministry of Agriculture and Rural Development [15-37-0003]; Prof. David Casson Research Fellowship; Planning and Budgeting Committee (VATAT) fellowship	Israeli Ministry of Agriculture and Rural Development; Prof. David Casson Research Fellowship; Planning and Budgeting Committee (VATAT) fellowship	This work was supported by a grant from the Israeli Ministry of Agriculture and Rural Development (#15-37-0003). S. A. is the incumbent of Prof. David Casson Research Fellowship. R. S. B was supported by a Planning and Budgeting Committee (VATAT) fellowship to the Weizmann Institute of Science.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Almeida NF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00178; Amiola RO, 2018, TURK J BIOCHEM, V43, P638, DOI 10.1515/tjb-2017-0214; Arslan M, 2017, LEGUME RES, V40, P803, DOI [10.18805/lr-369, 10.18805/LR-369]; Asadieh B, 2017, HYDROL EARTH SYST SC, V21, P5863, DOI 10.5194/hess-21-5863-2017; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Belay A, 1997, ANAL CHEM, V69, P3471, DOI 10.1021/ac961098w; BELL EA, 1964, NATURE, V203, P378, DOI 10.1038/203378a0; Bontpart T, 2015, NEW PHYTOL, V208, P695, DOI 10.1111/nph.13498; Boukecha D, 2018, LEGUME RES, V41, P12, DOI 10.18805/LR-346; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAMPBELL CG, 1994, EUPHYTICA, V73, P167, DOI 10.1007/BF00027192; Chakrabarti P, 1997, PROTEIN SCI, V6, P851; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2000, J AGR FOOD CHEM, V48, P3383, DOI 10.1021/jf000033y; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cullis C, 2017, J EXP BOT, V68, P1895, DOI 10.1093/jxb/erw437; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Elinger D, 2019, J PROTEOME RES, V18, P1441, DOI 10.1021/acs.jproteome.8b00891; Emmrich P.M.F., 2017, GENETIC IMPROVEMENT; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eudes A, 2016, PLANT CELL PHYSIOL, V57, P568, DOI 10.1093/pcp/pcw016; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fearon C., 2016, BRADLEYS NEUROLOGY C, V7th, P1484; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gengsheng X, 2001, J AGR FOOD CHEM, V49, P216, DOI 10.1021/jf000912k; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Goldsmith M, 2022, RSC CHEM BIOL, V3, P320, DOI 10.1039/d1cb00202c; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; IKEGAMI F, 1993, PHYTOCHEMISTRY, V33, P93, DOI 10.1016/0031-9422(93)85402-D; Jiang JL, 2013, BIOLOGIA, V68, P231, DOI 10.2478/s11756-013-0003-y; Jiao CJ, 2011, FOOD CHEM TOXICOL, V49, P556, DOI 10.1016/j.fct.2010.05.054; Jiao CJ, 2011, FOOD CHEM TOXICOL, V49, P543, DOI 10.1016/j.fct.2010.04.050; Jiao CJ, 2006, J AGR SCI-CAMBRIDGE, V144, P369, DOI 10.1017/S0021859606006265; JOHNSTON GA, 1967, AUST J BIOL SCI, V20, P1241; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kumar S, 2013, ELSEV INSIGHT, P269, DOI 10.1016/B978-0-12-397935-3.00011-6; Kumar S, 2011, FOOD CHEM TOXICOL, V49, P589, DOI 10.1016/j.fct.2010.06.051; Kumar V, 2016, PLANT BIOTECHNOL J, V14, P1394, DOI 10.1111/pbi.12503; KUO YH, 1991, PHYTOCHEMISTRY, V30, P3241, DOI 10.1016/0031-9422(91)83184-M; LAMBEIN F, 1994, TOXICON, V32, P461, DOI 10.1016/0041-0101(94)90298-4; Lambein F, 2007, ARKIVOC, P45, DOI 10.3998/ark.5550190.0008.906; Lambein F, 2019, PLANTA, V250, P821, DOI 10.1007/s00425-018-03084-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Long YC, 1996, INT J PEPT PROT RES, V47, P42; Lubkowski J, 2019, PROTEIN SCI, V28, P1850, DOI 10.1002/pro.3709; Mahdavi B, 2007, Pak J Biol Sci, V10, P273, DOI 10.3923/pjbs.2007.273.279; MALATHI K, 1967, BIOCHIM BIOPHYS ACTA, V141, P71, DOI 10.1016/0304-4165(67)90246-2; MALATHI K, 1970, PHYTOCHEMISTRY, V9, P1603, DOI 10.1016/S0031-9422(00)85283-8; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mikic A, 2015, ADV AGRON, V130, P337, DOI 10.1016/bs.agron.2014.10.004; Molina I, 2015, PLANT CELL REP, V34, P587, DOI 10.1007/s00299-014-1721-5; Mondal MMA, 2014, LEGUME RES, V37, P479, DOI 10.5958/0976-0571.2014.00663.8; Ngudi DD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001759; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Patto MCV, 2006, EUPHYTICA, V147, P133, DOI 10.1007/s10681-006-3607-2; Peleg Yoav, 2008, V426, P197, DOI 10.1007/978-1-60327-058-8_12; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; QUERESHI MY, 1977, PHYTOCHEMISTRY, V16, P477, DOI 10.1016/S0031-9422(00)94332-2; RAO SLN, 1978, ANAL BIOCHEM, V86, P386, DOI 10.1016/0003-2697(78)90762-5; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shimizu Kana, 2006, Journal of Bioinformatics and Computational Biology, V4, P649, DOI 10.1142/S0219720006002260; Tan RY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40677; Tiwari KR, 1996, EUPHYTICA, V91, P195; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Ulloa P, 2010, CHIL J AGR RES, V70, P357, DOI 10.4067/S0718-58392010000300002; WU G, 1976, PHYTOCHEMISTRY, V15, P1257, DOI 10.1016/0031-9422(76)85088-1; Xiong JL, 2015, J AGR FOOD CHEM, V63, P6133, DOI 10.1021/acs.jafc.5b01729; Xiong YC, 2006, PLANT PHYSIOL BIOCH, V44, P161, DOI 10.1016/j.plaphy.2006.03.002; Xu QL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030526; Yan ZY, 2006, PHYTOCHEMISTRY, V67, P107, DOI 10.1016/j.phytochem.2005.10.022; Zewdu A. D., 2008, AGR ENG INT, VX, P1; Zhang J, 2003, RUSS J PLANT PHYSL+, V50, P618, DOI 10.1023/A:1025631906115; Zhang YL, 2017, PROG MOL BIOL TRANSL, V149, P133, DOI 10.1016/bs.pmbts.2017.03.008; Zhou LN, 2016, J PLANT GROWTH REGUL, V35, P690, DOI 10.1007/s00344-016-9572-7	90	1	1	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101806	10.1016/j.jbc.2022.101806	http://dx.doi.org/10.1016/j.jbc.2022.101806			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35271851	Green Published, gold			2022-12-28	WOS:000798082100009
J	Dewar, CE; Oeljeklaus, S; Wenger, C; Warscheid, B; Schneider, A				Dewar, Caroline E.; Oeljeklaus, Silke; Wenger, Christoph; Warscheid, Bettina; Schneider, Andre			Characterization of a highly diverged mitochondrial ATP synthase F-o subunit in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-ENCODED PROTEIN; BLOOD-STREAM; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; DIMER REVEALS; OSCP SUBUNIT; COMPLEX I; CARDIOLIPIN; IDENTIFICATION; ORGANIZATION	The mitochondrial F1Fo ATP synthase of the parasite Try-panosoma brucei has been previously studied in detail. This unusual enzyme switches direction in functionality during the life cycle of the parasite, acting as an ATP synthase in the insect stages, and as an ATPase to generate mitochondrial membrane potential in the mammalian bloodstream stages. Whereas the trypanosome F-1 moiety is relatively highly conserved in structure and composition, the F-o subcomplex and the peripheral stalk have been shown to be more variable. Interestingly, a core subunit of the latter, the normally conserved subunit b, has been resistant to identification by sequence alignment or biochemical methods. Here, we identified a 17 kDa mitochondrial protein of the inner membrane, Tb927.8.3070, that is essential for normal growth, efficient oxidative phosphorylation, and membrane potential maintenance. Pull-down experiments and native PAGE analysis indicated that the protein is both associated with the F1Fo ATP synthase and integral to its assembly. In addition, its knockdown reduced the levels of F-o subunits, but not those of F-1, and disturbed the cell cycle. Finally, analysis of structural homology using the HHpred algorithm showed that this protein has structural similarities to F-o subunit b of other species, indicating that this subunit may be a highly diverged form of the elusive subunit b.	[Dewar, Caroline E.; Wenger, Christoph; Schneider, Andre] Univ Bern, Dept Chem Biochem & Pharmaceut Sci, Bern, Switzerland; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Wurzburg, Theodor Boveri Inst, Dept Biochem, Wurzburg, Germany; [Warscheid, Bettina] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany	University of Bern; University of Wurzburg; University of Freiburg	Schneider, A (corresponding author), Univ Bern, Dept Chem Biochem & Pharmaceut Sci, Bern, Switzerland.; Warscheid, B (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dept Biochem, Wurzburg, Germany.; Warscheid, B (corresponding author), Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany.	bettina.warscheid@uni-wuerzburg.de; andre.schneider@unibe.ch		Dewar, Caroline/0000-0002-0107-6985; Oeljeklaus, Silke/0000-0001-8908-4295	Deutsche Forschungsgemeinschaft (German Research Foundation) [403222702/SFB 1381]; Germany's Excellence Strategy [CIBSS-EXC-2189, 390939984]; National Center of Competence in Research (NCCR) "RNA & Disease" - Swiss National Science Foundation; Swiss National Science Foundation [175563]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Germany's Excellence Strategy; National Center of Competence in Research (NCCR) "RNA & Disease" - Swiss National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Bettina Knapp and Wignand W.D. Muhlhauser for assistance in LC-MS and computational analyses, respectively, and Elke Horn for technical assistance. In the laboratory of Bettina Warscheid, the study was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) (project ID: 403222702/SFB 1381) as well as Germany's Excellence Strategy (CIBSS--EXC-2189--project ID: 390939984). In the laboratory of Andre Schneider, the study was supported by the National Center of Competence in Research (NCCR) "RNA & Disease" and in part by grant 175563, both funded by the Swiss National Science Foundation.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Anderson CM, 2001, PLANT MOL BIOL, V47, P197, DOI 10.1023/A:1010691701578; Gahura O, 2022, bioRxiv, DOI 10.1101/2021.10.10.463820; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRINGAUD F, 1995, MOL BIOCHEM PARASIT, V71, P65, DOI 10.1016/0166-6851(95)00023-T; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRUN R, 1979, ACTA TROP, V36, P289; Cadena LR, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00327-21; Carbajo RJ, 2007, J MOL BIOL, V368, P310, DOI 10.1016/j.jmb.2007.02.059; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chi TB, 1998, MOL BIOCHEM PARASIT, V92, P29, DOI 10.1016/S0166-6851(97)00222-3; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; DIVO AA, 1993, J EUKARYOT MICROBIOL, V40, P329, DOI 10.1111/j.1550-7408.1993.tb04924.x; Dolezelova E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000741; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P16305, DOI 10.1074/jbc.M513805200; EBLE KS, 1990, J BIOL CHEM, V265, P19434; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Flygaard RK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18993-6; Gahura O, 2021, PARASITOLOGY, V148, P1151, DOI 10.1017/S0031182021000202; Gahura O, 2018, FEBS J, V285, P614, DOI 10.1111/febs.14364; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037; Hashimi H, 2010, INT J PARASITOL, V40, P45, DOI 10.1016/j.ijpara.2009.07.005; Hierro-Yap C, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100357; Huang GZ, 2020, MBIO, V11, DOI 10.1128/mBio.00268-20; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lapaille M, 2010, MOL BIOL EVOL, V27, P1630, DOI 10.1093/molbev/msq049; Lee J, 2015, J BIOL CHEM, V290, P13308, DOI 10.1074/jbc.M115.645283; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Mbang-Benet DE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1505-5; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Montgomery MG, 2018, P NATL ACAD SCI USA, V115, P2102, DOI 10.1073/pnas.1720940115; Muhleip AW, 2017, P NATL ACAD SCI USA, V114, P992, DOI 10.1073/pnas.1612386114; Muhleip A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20381-z; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Murphy BJ, 2019, SCIENCE, V364, P1155, DOI 10.1126/science.aaw9128; Nebohacova M, 2004, J BIOL CHEM, V279, P7819, DOI 10.1074/jbc.M311360200; Nelson RE, 2004, MOL BIOCHEM PARASIT, V135, P219, DOI 10.1016/j.molbiopara.2004.02.003; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2002, J MOL BIOL, V321, P613, DOI 10.1016/S0022-2836(02)00671-X; SANTIAGO E, 1973, BIOCHEM BIOPH RES CO, V53, P439, DOI 10.1016/0006-291X(73)90681-5; Schadeli D, 2019, FASEB J, V33, P13161, DOI 10.1096/fj.201901184RR; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Serricchio M, 2021, FASEB J, V35, DOI 10.1096/fj.202001579RR; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skodova-Sverakova I, 2015, MOL BIOCHEM PARASIT, V201, P135, DOI 10.1016/j.molbiopara.2015.08.002; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; VELOURS J, 1987, EUR J BIOCHEM, V164, P579, DOI 10.1111/j.1432-1033.1987.tb11166.x; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; von Kanel C, 2020, ELIFE, V9, DOI [10.7554/elife.52560, 10.7554/eLife.52560]; Weber J, 2004, J BIOL CHEM, V279, P11253, DOI 10.1074/jbc.M312576200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yadav KNS, 2017, BBA-BIOENERGETICS, V1858, P267, DOI 10.1016/j.bbabio.2017.01.007; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	89	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101829	10.1016/j.jbc.2022.101829	http://dx.doi.org/10.1016/j.jbc.2022.101829			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35293314	gold, Green Published			2022-12-28	WOS:000823106100016
J	Legare, S; Heide, F; Bailey-Elkin, B; Stetefeld, J				Legare, Scott; Heide, Fabian; Bailey-Elkin, Ben A.; Stetefeld, Jorg			Improved SARS-CoV-2 main protease high-throughput screening assay using a 5-carboxyfluorescein substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONAVIRUS; INHIBITORS	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a global threat to human health has highlighted the need for the development of novel therapies targeting current and emerging coronaviruses with pandemic potential. The coronavirus main protease (M-pro, also called 3CL(pro)) is a validated drug target against coronaviruses and has been heavily studied since the emergence of SARS-CoV-2 in late 2019. Here, we report the biophysical and enzymatic characterization of native M-pro, then characterize the steadystate kinetics of several commonly used FRET substrates, fluorogenic substrates, and six of the 11 reported SARS-CoV-2 polyprotein cleavage sequences. We then assessed the suitability of these substrates for high-throughput screening. Guided by our assessment of these substrates, we developed an improved 5-carboxyfluorescein-based FRET substrate, which is better suited for high-throughput screening and is less susceptible to interference and false positives than existing substrates. This study provides a useful framework for the design of coronavirus M-pro enzyme assays to facilitate the discovery and development of therapies targeting M-pro.	[Legare, Scott; Heide, Fabian; Bailey-Elkin, Ben A.; Stetefeld, Jorg] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada	University of Manitoba	Legare, S; Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB, Canada.	legares@myumanitoba.ca; jorg.stetefeld@umanitoba.ca		Heide, Fabian/0000-0002-6849-3177	Canadian Institutes of Health Research [201610PJT-152935]; Natural Sciences and Engineering Research Council of Canada [RGPIN-004954-2017]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is funded by the Canadian Institutes of Health Research (grant number: 201610PJT-152935) and the Natural Sciences and Engineering Research Council of Canada (grant number: RGPIN-004954-2017).	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Abian O, 2020, INT J BIOL MACROMOL, V164, P1693, DOI 10.1016/j.ijbiomac.2020.07.235; [Anonymous], MMWR MORB MORTAL WKL, V70, P792; Breidenbach J, 2021, ANGEW CHEM INT EDIT, V60, P10423, DOI 10.1002/anie.202016961; Coelho C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240079; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Drazic T, 2021, SLAS DISCOV, V26, P1189, DOI 10.1177/24725552211020681; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ferreira JC, 2021, FASEB J, V35, DOI 10.1096/fj.202100994; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hattori S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20900-6; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jo S, 2020, J ENZYM INHIB MED CH, V35, P1539, DOI 10.1080/14756366.2020.1801672; Koudelka T, 2021, PROTEOMICS, V21, DOI 10.1002/pmic.202000246; Kuzikov M, 2021, ACS PHARMACOL TRANSL, V4, P1096, DOI 10.1021/acsptsci.0c00216; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Li Z, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024937118; Li Z, 2020, P NATL ACAD SCI USA, V117, P27381, DOI 10.1073/pnas.2010470117; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Ma CL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024420118; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Pablos I, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109892; Rut W, 2021, NAT CHEM BIOL, V17, P222, DOI 10.1038/s41589-020-00689-z; Simeonov A., 2004, ASSAY GUIDANCE MANUA; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Solowiej J, 2008, BIOCHEMISTRY-US, V47, P2617, DOI 10.1021/bi702107v; Su HX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23751-3; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vuong W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18096-2; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhang LL, 2020, J MED CHEM, V63, P4562, DOI 10.1021/acs.jmedchem.9b01828; Zhu W, 2020, ACS PHARMACOL TRANSL, V3, P1008, DOI 10.1021/acsptsci.0c00108	41	0	0	6	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101739	10.1016/j.jbc.2022.101739	http://dx.doi.org/10.1016/j.jbc.2022.101739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35182525	Green Published, gold			2022-12-28	WOS:000823106100003
J	Rosendahl, AH; Monnius, M; Laitala, A; Railo, A; Miinalainen, I; Heljasvaara, R; Maki, JM; Myllyharju, J				Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Miinalainen, Ilkka; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna			Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE; INTRACELLULAR DOMAIN; EPITHELIAL-CELLS; BNIP3 PLAYS; STEM-CELLS; HIF-ALPHA; NOTCH; SKIN; DIFFERENTIATION; BIOLOGY	Hypoxia-inducible factors (HIFs) induce numerous genes regulating oxygen homeostasis. As oxygen sensors of the cells, the HIF prolyl 4-hydroxylases (HIF-P4Hs) regulate the stability of HIFs in an oxygen-dependent manner. During hair follicle (HF) morphogenesis and cycling, the location of dermal papilla (DP) alternates between the dermis and hypodermis and results in varying oxygen levels for the DP cells. These cells are known to express hypoxia-inducible genes, but the role of the hypoxia response pathway in HF development and homeostasis has not been studied. Using conditional gene targeting and analysis of hair morphogenesis, we show here that lack of Hif-p4h-2 in Forkhead box D1 (FoxD1)-lineage mesodermal cells interferes with the normal HF development in mice. FoxD1-lineage cells were found to be mainly mesenchymal cells located in the dermis of truncal skin, including those cells composing the DP of HFs. We found that upon Hif-p4h-2 inactivation, HF development was disturbed during the first catagen leading to formation of epithelial-lined HF cysts filled by unorganized keratins, which eventually manifested as truncal alopecia. Furthermore, the depletion of Hif-p4h-2 led to HIF stabilization and dysregulation of multiple genes involved in keratin formation, HF differentiation, and HIF, transforming growth factor beta (TGF-beta), and Notch signaling. We hypothesize that the failure of HF cycling is likely to be mechanistically caused by disruption of the interplay of the HIF, TGF-beta, and Notch pathways. In summary, we show here for the first time that HIF-P4H-2 function in FoxD1-lineage cells is essential for the normal development and homeostasis of HFs.	[Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, Electron Microscope Core Facil, Oulu, Finland; [Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Miinalainen, Ilkka; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Electron Microscope Core Facil, Oulu, Finland; [Rosendahl, Ann-Helen; Monnius, Mia; Laitala, Anu; Railo, Antti; Heljasvaara, Ritva; Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, Electron Microscope Core Facil, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Electron Microscope Core Facil, Oulu, Finland.; Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Electron Microscope Core Facil, Oulu, Finland.; Maki, JM; Myllyharju, J (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Electron Microscope Core Facil, Oulu, Finland.	joni.maki@oulu.fi; johanna.myllyharju@oulu.fi		Miinalainen, Ilkka/0000-0002-3922-3442; Laitala, Anu/0000-0002-9587-2025; Rosendahl, Ann-Helen Sigrid/0000-0001-7968-0990	Academy of Finland Center of Excellence 2012 to 2017 grant [251314]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; Finnish Cultural Foundation; Instrumentarium Science Foundation;  [296498]	Academy of Finland Center of Excellence 2012 to 2017 grant(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instrumentarium Science Foundation; 	This study was supported by the Academy of Finland Center of Excellence 2012 to 2017 grant (grant no.: 251314) (to J. M.) and Academy Project Grant (grant no.: 296498) (to J. M.), S. Juselius Foundation (to J. M.), Jane and Aatos Erkko Foundation (to J. M.), FibroGen, Inc (to J. M.), The Finnish Cultural Foundation (to A.-H. R.), and the Instrumentarium Science Foundation (to A.-H. R.).	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alibardi L, 2013, ACTA HISTOCHEM, V115, P519, DOI 10.1016/j.acthis.2012.11.011; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bose A, 2013, INT J MOL SCI, V14, P19385, DOI 10.3390/ijms141019385; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Cockman M. E., 2019, LACK ACTIVITY RECOMB; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COULY G, 1988, DEVELOPMENT, V103, P101; Cowburn AS, 2014, J INVEST DERMATOL, V134, P801, DOI 10.1038/jid.2013.395; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erber L, 2019, MOL CELL PROTEOMICS, V18, P1772, DOI 10.1074/mcp.RA119.001535; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hashimoto T, 2001, J INVEST DERM SYMP P, V6, P38, DOI 10.1046/j.0022-202x.2001.00003.x; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hu YY, 2014, CANCER LETT, V349, P67, DOI 10.1016/j.canlet.2014.03.035; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Imamura Y, 2014, FASEB J, V28, P2517, DOI 10.1096/fj.13-244079; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M., 2002, PROC NATL; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Joshi Rajiv S, 2011, Int J Trichology, V3, P57, DOI 10.4103/0974-7753.82119; Kobayashi H, 2016, J CLIN INVEST, V126, P1926, DOI 10.1172/JCI83551; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Kothari S, 2003, ONCOGENE, V22, P4734, DOI 10.1038/sj.onc.1206666; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Kutchuk L, 2015, DEVELOPMENT, V142, P983, DOI 10.1242/dev.113449; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Moriyama M, 2014, J INVEST DERMATOL, V134, P1627, DOI 10.1038/jid.2014.11; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Nowell C, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a017772; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Rathman-Josserand M, 2013, J INVEST DERMATOL, V133, P2094, DOI 10.1038/jid.2013.113; Rezvani HR, 2011, J INVEST DERMATOL, V131, P1793, DOI 10.1038/jid.2011.141; Rezza A, 2016, CELL REP, V14, P3001, DOI 10.1016/j.celrep.2016.02.078; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Roth KJ, 2015, CELL MOL GASTROENTER, V1, P589, DOI 10.1016/j.jcmgh.2015.09.005; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Rundle CW, 2017, CLIN DERMATOL, V35, P367, DOI 10.1016/j.clindermatol.2017.03.009; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Soma T, 2002, J INVEST DERMATOL, V118, P993, DOI 10.1046/j.1523-1747.2002.01746.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Ueno M., 2011, AM J PHYSIOL-LUNG C; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang S, 2016, ONCOTARGET, V7, P58848, DOI 10.18632/oncotarget.11585; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Zhao B, 2017, INT J MOL MED, V39, P153, DOI 10.3892/ijmm.2016.2816; Zheng XF, 2017, EXP CELL RES, V358, P129, DOI 10.1016/j.yexcr.2017.06.006	76	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101787	10.1016/j.jbc.2022.101787	http://dx.doi.org/10.1016/j.jbc.2022.101787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35247391	Green Submitted, gold, Green Published			2022-12-28	WOS:000793617400006
J	Wagner, K; Pierce, R; Gordon, E; Hay, A; Lessard, A; Telling, GC; Ballard, JR; Moreno, JA; Zabel, MD				Wagner, Kaitlyn; Pierce, Robyn; Gordon, Elizabeth; Hay, Arielle; Lessard, Avery; Telling, Glenn C.; Ballard, Jennifer R.; Moreno, Julie A.; Zabel, Mark D.			Tissue-specific biochemical differences between chronic wasting disease prions isolated from free-ranging white-tailed deer (Odocoileus virginianus)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULE DEER; MOLECULAR-BASIS; PROTEIN PRPC; MOUSE MODEL; TRANSMISSION; SCRAPIE; ELK; EXPRESSION; INFECTION; SUSCEPTIBILITY	Chronic wasting disease (CWD) is an invariably fatal prion disease affecting cervid species worldwide. Prions can manifest as distinct strains that can influence disease pathology and transmission. CWD is profoundly lymphotropic, and most infected cervids likely shed peripheral prions replicated in lymphoid organs. However, CWD is a neurodegenerative disease, and most research on prion strains has focused on neurogenic prions. Thus, a knowledge gap exists comparing neurogenic prions to lymphogenic prions. In this study, we compared prions from the obex and lymph nodes of naturally exposed white-tailed deer to identify potential biochemical strain differences. Here, we report biochemical evidence of strain differences between the brain and lymph node from these animals. Conformational stability assays, glycoform ratio analyses, and immunoreactivity scanning across the structured domain of the prion protein that refolds into the amyloid aggregate of the infectious prion reveal significantly more structural and glycoform variation in lymphogenic prions than neurogenic prions. Surprisingly, we observed greater biochemical differences among neurogenic prions than lymphogenic prions across individuals. We propose that the lymphoreticular system propagates a diverse array of prions from which the brain selects a more restricted pool of prions that may be quite different than those from another individual of the same species. Future work should examine the biological and zoonotic impact of these biochemical differences and examine more cervids from multiple locations to determine if these differences are conserved across species and locations.	[Wagner, Kaitlyn; Pierce, Robyn; Gordon, Elizabeth; Hay, Arielle; Lessard, Avery; Telling, Glenn C.; Moreno, Julie A.; Zabel, Mark D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Ft Collins, CO 80523 USA; [Wagner, Kaitlyn; Pierce, Robyn; Gordon, Elizabeth; Hay, Arielle; Lessard, Avery; Telling, Glenn C.; Zabel, Mark D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ballard, Jennifer R.] Arkansas Game & Fish Commiss, Res Div, Little Rock, AR USA; [Moreno, Julie A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Zabel, MD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Ft Collins, CO 80523 USA.; Zabel, MD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mark.Zabel@colostate.edu			United States Fish and Wildlife Service Grant [008732-00002]; CSU CVMBS	United States Fish and Wildlife Service Grant; CSU CVMBS	The United States Fish and Wildlife Service Grant 008732-00002 and the CSU CVMBS funded this research.	Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Bartz JC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024349; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bradford BM, 2014, IMMUNOLOGY, V143, P120, DOI 10.1111/imm.12294; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Chafin TK, 2020, PRION, V14, P238, DOI 10.1080/19336896.2020.1832947; Crowell J, 2015, J VIROL, V89, P10427, DOI 10.1128/JVI.01586-15; Davenport KA, 2018, J GEN VIROL, V99, P753, DOI 10.1099/jgv.0.001053; Davenport KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183927; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; DeVivo MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186512; Edmunds DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161127; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P1087, DOI 10.1177/1040638712461249; Hamir AN, 2006, J VET DIAGN INVEST, V18, P558, DOI 10.1177/104063870601800606; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Herbst A, 2017, EMERG INFECT DIS, V23, P1598, DOI [10.3201/eid2309.161474, 10.3201/eid2309.161747]; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hoover CE, 2017, J VIROL, V91, DOI 10.1128/JVI.00077-17; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Kane SJ, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00493-17; Kane SJ, 2017, J IMMUNOL, V199, P3821, DOI 10.4049/jimmunol.1701100; Kang HE, 2020, J BIOL CHEM, V295, P10420, DOI 10.1074/jbc.RA120.012796; Le Dur A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14170; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Lin T, 2001, J IMMUNOL, V166, P3733; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Mabbott NA, 2004, IMMUNOBIOLOGY, V209, P545, DOI 10.1016/j.imbio.2004.06.003; Manjerovic MB, 2014, PREV VET MED, V113, P139, DOI 10.1016/j.prevetmed.2013.09.011; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005249; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Meyerett-Reid C, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00372-16; Michel B, 2013, INT IMMUNOL, V25, P697, DOI 10.1093/intimm/dxt034; Michel B, 2012, J IMMUNOL, V189, P4520, DOI 10.4049/jimmunol.1201579; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2004, J WILDLIFE DIS, V40, P320, DOI 10.7589/0090-3558-40.2.320; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Monello RJ, 2017, P NATL ACAD SCI USA, V114, P12208, DOI 10.1073/pnas.1707807114; Moore SJ, 2017, J VIROL, V91, DOI [10.1128/JVI.00926-17, 10.1128/jvi.00926-17]; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Morales R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006323; Nalls AV, 2017, J VIROL, V91, DOI 10.1128/JVI.00501-17; Nalls AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071844; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Prusiner S. B., 1998, PRION PROTEIN BIOL, V93, P337; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Selariu A, 2015, J GEN VIROL, V96, P3444, DOI 10.1099/jgv.0.000281; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Uehlinger FD, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0804-7; Velasquez CD, 2020, J BIOL CHEM, V295, P4985, DOI 10.1074/jbc.RA120.012546; Xie Z., 2006, J BIOL CHEM; Zabel M. D., 2007, J IMMUNOL	75	0	0	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101834	10.1016/j.jbc.2022.101834	http://dx.doi.org/10.1016/j.jbc.2022.101834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35304100	Green Submitted, gold, Green Published			2022-12-28	WOS:000793560400002
J	Wang, Z; Lou, JZ; Zhang, H				Wang, Zheng; Lou, Jizhong; Zhang, Hong			Essence determines phenomenon: Assaying the material properties of biological condensates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHASE-SEPARATION; LIQUID-PHASE; STRESS GRANULES; TRANSITIONS; NOISE; FUS; COMPARTMENTS; MECHANISMS; COMPLEXITY; AUTOPHAGY	Intracellular spaces are partitioned into separate compartments to ensure that numerous biochemical reactions and cellular functions take place in a spatiotemporally controlled manner. Biomacromolecules including proteins and RNAs undergo liquid-liquid phase separation and subsequent phase transition to form biological condensates with diverse material states. The material/physical properties of biological condensates are crucial for fulfilling their distinct physiological functions, and abnormal material properties can cause deleterious effects under pathological conditions. Here, we review recent studies showing the role of the material properties of biological condensates in their physiological functions. We also summarize several classic methods as well as newly emerging techniques for characterization and/or measurement of the material properties of biological condensates.	[Wang, Zheng; Zhang, Hong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, CAS Ctr Excellence Biomacromol, Beijing, Peoples R China; [Lou, Jizhong; Zhang, Hong] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Z; Zhang, H (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Lou, JZ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, CAS Ctr Excellence Biomacromol, Beijing, Peoples R China.; Lou, JZ; Zhang, H (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China.	wz1103@ibp.ac.cn; jlou@ibp.ac.cn; hongzhang@ibp.ac.cn			National Natural Science Foundation of China [82188101, 92054301, 31790403, 31871426]; Chinese Ministry of Science and Technology [2017YFA0503401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by the following grants: National Natural Science Foundation of China (82188101, 92054301, and 31790403 to H. Z. and 31871426 to Z. W.) and Chinese Ministry of Science and Technology (2017YFA0503401 to H. Z.).	Agudo-Canalejo J, 2021, NATURE, V591, P142, DOI 10.1038/s41586-020-2992-3; Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Alberti S, 2016, BIOESSAYS, V38, P959, DOI 10.1002/bies.201600042; Alshareedah I, 2019, J AM CHEM SOC, V141, P14593, DOI 10.1021/jacs.9b03689; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Boyko S, 2020, P NATL ACAD SCI USA, V117, P31882, DOI 10.1073/pnas.2012460117; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Bremer A, 2020, LAB CHIP, V20, P4225, DOI 10.1039/d0lc00613k; Bressloff PC, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.042804; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chen D, 2020, DEV CELL, V55, P588, DOI 10.1016/j.devcel.2020.10.010; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Drelich J., 2002, ENCY SURFACE COLLOID, P3152, DOI DOI 10.1081/E-ESCS-120000636; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Feng Z, 2019, J BIOL CHEM, V294, P14823, DOI 10.1074/jbc.REV119.007895; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Folkmann AW, 2021, SCIENCE, V373, P1218, DOI 10.1126/science.abg7071; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2018, CELL, V174, P202, DOI 10.1016/j.cell.2018.05.045; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Gui XR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09902-7; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Gwon Y, 2021, SCIENCE, V372, P1410, DOI 10.1126/science.abf6548; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Holehouse AS, 2018, BIOCHEMISTRY-US, V57, P2415, DOI 10.1021/acs.biochem.7b01136; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P3, DOI 10.1016/B978-0-12-375182-9.10001-6; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jawerth LM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.258101; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Jung JH, 2020, NATURE, V585, P256, DOI 10.1038/s41586-020-2644-7; Kaganovich D, 2017, TRENDS BIOCHEM SCI, V42, P765, DOI 10.1016/j.tibs.2017.08.002; Kaur T, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020071; Kihara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082382; Klosin A, 2020, SCIENCE, V367, P464, DOI 10.1126/science.aav6691; Kroschwald S, 2017, CELL, V168, P947, DOI 10.1016/j.cell.2017.02.029; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kuznetsova IM, 2015, MOLECULES, V20, P1377, DOI 10.3390/molecules20011377; Lee DSW, 2021, NAT PHYS, V17, P531, DOI 10.1038/s41567-020-01125-8; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Linsenmeier M, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118823; Liu ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16135-6; Lyu XC, 2021, DEV CELL, V56, P2592, DOI 10.1016/j.devcel.2021.08.015; Ma WR, 2018, CELL, V175, P1492, DOI 10.1016/j.cell.2018.10.007; Mathieu C, 2020, SCIENCE, V370, P56, DOI 10.1126/science.abb8032; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nava MM, 2020, CELL, V181, P800, DOI 10.1016/j.cell.2020.03.052; Nedelsky NB, 2019, NAT REV NEUROL, V15, P272, DOI 10.1038/s41582-019-0157-5; Nil Z, 2019, CELL, V178, P1403, DOI 10.1016/j.cell.2019.08.019; Nong JX, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012112; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pan Q, 2021, ACS NANO, V15, P539, DOI 10.1021/acsnano.0c05486; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peng SJ, 2020, P NATL ACAD SCI USA, V117, P27124, DOI 10.1073/pnas.2008447117; Prinz WA, 2020, NAT REV MOL CELL BIO, V21, P7, DOI 10.1038/s41580-019-0180-9; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Riback JA, 2020, NATURE, V581, P209, DOI 10.1038/s41586-020-2256-2; Riback JA, 2020, SCIENCE, V367, P364, DOI 10.1126/science.aba0446; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Saunders TE, 2012, DEV CELL, V22, P558, DOI 10.1016/j.devcel.2012.01.001; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Shen Y, 2020, NAT NANOTECHNOL, V15, P841, DOI 10.1038/s41565-020-0731-4; Shin Y, 2018, CELL, V175, P1481, DOI 10.1016/j.cell.2018.10.057; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Singatulina AS, 2019, CELL REP, V27, P1809, DOI 10.1016/j.celrep.2019.04.031; Stoeger T, 2016, CELL, V164, P1151, DOI 10.1016/j.cell.2016.02.005; Strickfaden H, 2020, CELL, V183, P1772, DOI 10.1016/j.cell.2020.11.027; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Sun DX, 2018, CELL RES, V28, P405, DOI 10.1038/s41422-018-0017-7; Taylor N, 2016, SOFT MATTER, V12, P9142, DOI 10.1039/c6sm01087c; Taylor NO, 2019, BIOPHYS J, V117, P1285, DOI 10.1016/j.bpj.2019.08.030; VOORHEES PW, 1992, ANNU REV MATER SCI, V22, P197, DOI 10.1146/annurev.ms.22.080192.001213; Wan G, 2018, NATURE, V557, P679, DOI 10.1038/s41586-018-0132-0; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang Z, 2019, TRENDS CELL BIOL, V29, P417, DOI 10.1016/j.tcb.2019.01.008; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Weirich KL, 2017, P NATL ACAD SCI USA, V114, P2131, DOI 10.1073/pnas.1616133114; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923; Wu M, 2021, SCIENCE, V373, P547, DOI 10.1126/science.abf6582; Wu XD, 2021, MOL CELL, V81, P13, DOI 10.1016/j.molcel.2020.10.029; Yamasaki A, 2020, MOL CELL, V77, P1163, DOI 10.1016/j.molcel.2019.12.026; Yamazaki T, 2018, MOL CELL, V70, P1038, DOI 10.1016/j.molcel.2018.05.019; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Zeng ML, 2018, CELL, V174, P1172, DOI 10.1016/j.cell.2018.06.047; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang GM, 2018, CELL, V174, P1492, DOI 10.1016/j.cell.2018.08.006; Zhang H, 2020, SCI CHINA LIFE SCI, V63, P953, DOI 10.1007/s11427-020-1702-x; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang Y, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.08.009; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao YG, 2020, DEV CELL, V55, P30, DOI 10.1016/j.devcel.2020.06.033; Zheng Wang, 2019, Biophysics Reports, V5, P1, DOI 10.1007/s41048-018-0078-7; Zhu L, 2019, P NATL ACAD SCI USA, V116, P17330, DOI 10.1073/pnas.1903870116; Zwicker D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012317	116	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101782	10.1016/j.jbc.2022.101782	http://dx.doi.org/10.1016/j.jbc.2022.101782			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35245500	Green Published, gold			2022-12-28	WOS:000823106100008
J	Yu, D; Dai, N; Wolf, EJ; Correa, IR; Zhou, JJ; Wu, T; Blumenthal, RM; Zhang, X; Cheng, XD				Yu, Dan; Dai, Nan; Wolf, Eric J.; Correa, Ivan R., Jr.; Zhou, Jujun; Wu, Tao; Blumenthal, Robert M.; Zhang, Xing; Cheng, Xiaodong			Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; CIS-ACTING SIGNALS; NUCLEAR-ENVELOPE; PROTEIN; METHYLATION; CELL; N6-METHYLADENOSINE; DEMETHYLATION; RECOGNITION; TERMINATION	The phosphorylated RNA polymerase II CTD interacting factor 1 (PCIF1) is a methyltransferase that adds a methyl group to the N6-position of 20O-methyladenosine (Am), generating N6, 20O-dimethyladenosine (m6Am) when Am is the cap-proximal nucleotide. In addition, PCIF1 has ancillary methylation activities on internal adenosines (both A and Am), although with much lower catalytic efficiency relative to that of its preferred cap substrate. The PCIF1 preference for 20Omethylated Am over unmodified A nucleosides is due mainly to increased binding affinity for Am. Importantly, it was recently reported that PCIF1 can methylate viral RNA. Although some viral RNA can be translated in the absence of a cap, it is unclear what roles PCIF1 modifications may play in the functionality of viral RNAs. Here we show, using in vitro assays of binding and methyltransfer, that PCIF1 binds an uncapped 50-Am oligonucleotide with approximately the same affinity as that of a cap analog (KM = 0.4 versus 0.3 mu M). In addition, PCIF1 methylates the uncapped 50-Am with activity decreased by only fivefold to sixfold compared with its preferred capped substrate. We finally discuss the relationship between PCIF1-catalyzed RNA methylation, shown here to have broader substrate specificity than previously appreciated, and that of the RNA demethylase fat mass and obesity-associated protein (FTO), which demonstrates PCIF1-opposing activities on capped RNAs.	[Yu, Dan; Zhou, Jujun; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Dai, Nan; Wolf, Eric J.; Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA USA; [Wu, Tao] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Blumenthal, Robert M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Blumenthal, Robert M.] Univ Toledo, Program Bioinformat, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Texas System; UTMD Anderson Cancer Center; New England Biolabs; Baylor College of Medicine; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	XZhang21@mdanderson.org; XCheng5@mdanderson.org	; Wu, Tao/A-1063-2013	Cheng, Xiaodong/0000-0002-6967-6362; Zhou, Jujun/0000-0003-4104-7158; Correa, Ivan/0000-0002-3169-6878; Wu, Tao/0000-0002-9859-4534	US National Institutes of Health [R35GM134744]; Cancer Prevention and Research Institute of Texas [RR160029]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas	This work was supported by US National Institutes of Health (grant no.: R35GM134744; to X. C.); Cancer Prevention and Research Institute of Texas (grant no.: RR160029; to X. C., who is a Cancer Prevention and Research Institute of Texas Scholar in Cancer Research). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; An YY, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01500-4; Barr JN, 1997, J VIROL, V71, P8718, DOI 10.1128/JVI.71.11.8718-8725.1997; Berger MR, 2019, FEBS LETT, V593, P670, DOI 10.1002/1873-3468.13349; Boulias K., 2019, IDENTIFICATION M 6 A; Cohen S, 2012, INT REV CEL MOL BIO, V299, P117, DOI 10.1016/B978-0-12-394310-1.00003-5; Covelo-Molares H, 2021, NUCLEIC ACIDS RES, V49, P10895, DOI 10.1093/nar/gkab900; Cowling VH, 2019, TRENDS BIOCHEM SCI, V44, P183, DOI 10.1016/j.tibs.2019.01.002; Fan H, 2003, BIOCHEM BIOPH RES CO, V301, P378, DOI 10.1016/S0006-291X(02)03015-2; Fernandez-Alvarez A, 2017, TRENDS CELL BIOL, V27, P255, DOI 10.1016/j.tcb.2016.11.005; Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Li ZC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009055; Liu L, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01508-w; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Lu JN, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00741-y; Lu ZL, 2021, GENOME RES, V31, P51, DOI 10.1101/gr.264325.120; Malka Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02099-7; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Mettenleiter TC, 2016, J MOL BIOL, V428, P1949, DOI 10.1016/j.jmb.2015.10.001; Morales DD, 2020, NUCLEIC ACIDS RES, V48, P3806, DOI 10.1093/nar/gkaa046; MOYER SA, 1976, VIROLOGY, V70, P339, DOI 10.1016/0042-6822(76)90276-2; Niedzwiecka A., 2002, BIOPHYSICAL STUDIES; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038; Peng LM, 2022, CELL BIOL INT, V46, P711, DOI 10.1002/cbin.11773; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Relier S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21758-4; Ringeard M, 2019, NATURE, V565, P500, DOI 10.1038/s41586-018-0841-4; Sendinc E, 2019, MOL CELL, V75, P620, DOI 10.1016/j.molcel.2019.05.030; Stillman EA, 1997, J VIROL, V71, P2127, DOI 10.1128/JVI.71.3.2127-2137.1997; Sugita A., 2021, J BIOCHEM, V170, P203; Tamarkin-Ben-Harush A, 2017, ELIFE, V6, DOI 10.7554/eLife.21907; Tartell MA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025769118; Wang DX, 2018, NUCLEIC ACIDS RES, V46, P3864, DOI 10.1093/nar/gkx1274; Wang JT, 2007, J VIROL, V81, P11499, DOI 10.1128/JVI.01057-07; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14665-7; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0136-4; Worpenberg L, 2022, BIOESSAYS, V44, DOI 10.1002/bies.202100174; Yu Dan, 2021, Nucleic Acids Res, V49, P11629, DOI 10.1093/nar/gkab460; Yu D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100270; Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	54	1	1	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101751	10.1016/j.jbc.2022.101751	http://dx.doi.org/10.1016/j.jbc.2022.101751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35189146	Green Published, gold			2022-12-28	WOS:000793617400011
J	Conroy, JN; Coulson, EJ				Conroy, Jacinta N.; Coulson, Elizabeth J.			High-affinity TrkA and p75 neurotrophin receptor complexes: A twisted affair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; TYROSINE KINASE; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; LIGAND-BINDING; DEATH DOMAIN; NGF RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; EXTRACELLULAR DOMAIN	Neurotrophin signaling is essential for normal nervous system development and adult function. Neurotrophins are secreted proteins that signal via interacting with two neuro-trophin receptor types: the multifaceted p75 neurotrophin re-ceptor and the tropomyosin receptor kinase receptors. In vivo, neurons compete for the limited quantities of neurotrophins, a process that underpins neural plasticity, axonal targeting, and ultimately survival of the neuron. Thirty years ago, it was discovered that p75 neurotrophin receptor and tropomyosin receptor kinase A form a complex and mediate high-affinity ligand binding and survival signaling; however, despite de-cades of functional and structural research, the mechanism of modulation that yields this high-affinity complex remains unclear. Understanding the structure and mechanism of high-affinity receptor generation will allow development of phar-maceuticals to modulate this function for treatment of the many nervous system disorders in which altered neurotrophin expression or signaling plays a causative or contributory role. Here we re-examine the key older literature and integrate it with more recent studies on the topic of how these two re-ceptors interact. We also identify key outstanding questions and propose a model of inside-out allosteric modulation to assist in resolving the elusive high-affinity mechanism and complex.	[Conroy, Jacinta N.; Coulson, Elizabeth J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Coulson, Elizabeth J.] Univ Queensland, Clem Jones Ctr Ageing & Dis Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Coulson, EJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.; Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Coulson, EJ (corresponding author), Univ Queensland, Clem Jones Ctr Ageing & Dis Res, Brisbane, Qld, Australia.	e.coulson@uq.edu.au	; Coulson, Elizabeth/C-8766-2009	Conroy, Jacinta/0000-0001-9451-3322; Coulson, Elizabeth/0000-0003-3783-6197	Australian Federal Government Research Training Program Scholarships, Australia; National Health and Medical Research Council, Australia [GRP1162505]	Australian Federal Government Research Training Program Scholarships, Australia; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Federal Government Research Training Program Scholarships, Australia to J. N. C. and National Health and Medical Research Council, Australia funding (GRP1162505) to E. J. C.	Ahmed F, 2018, BIOCHEM J, V475, P3669, DOI 10.1042/BCJ20180637; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Auernhammer C. J., 2004, NEUROIMMUNOMODULAT; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Bagal SK, 2018, J MED CHEM, V61, P6779, DOI 10.1021/acs.jmedchem.8b00633; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; BARKER PA, 1994, J BIOL CHEM, V269, P30645; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Barker PA, 2007, NEURON, V53, P1, DOI 10.1016/j.neuron.2006.12.018; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; Bertrand T, 2012, J MOL BIOL, V423, P439, DOI 10.1016/j.jmb.2012.08.002; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casarotto PC, 2021, CELL, V184, P1299, DOI 10.1016/j.cell.2021.01.034; Cellerino A, 1996, EUR J NEUROSCI, V8, P1190, DOI 10.1111/j.1460-9568.1996.tb01287.x; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Cheema SS, 1996, J NEUROSCI RES, V46, P239, DOI 10.1002/(SICI)1097-4547(19961015)46:2<239::AID-JNR12>3.0.CO;2-Y; Chen Y, 2009, J INT MED RES, V37, P281, DOI 10.1177/147323000903700201; Choi HS, 2015, ACS MED CHEM LETT, V6, P562, DOI 10.1021/acsmedchemlett.5b00050; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; DISTEFANO PS, 1988, P NATL ACAD SCI USA, V85, P270, DOI 10.1073/pnas.85.1.270; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Franco ML, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100926; Franco ML, 2020, J BIOL CHEM, V295, P275, DOI 10.1074/jbc.RA119.011312; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gargano N, 1997, J NEUROSCI RES, V50, P1; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Goncharuk SA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70721-8; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HERRUP K, 1973, P NATL ACAD SCI USA, V70, P3884, DOI 10.1073/pnas.70.12.3884; Horton A, 1997, MOL CELL NEUROSCI, V10, P162, DOI 10.1006/mcne.1997.0650; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2001, MOL CELL, V8, P481, DOI 10.1016/S1097-2765(01)00350-1; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Koenderman L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00544; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Lamballe F, 1991, Princess Takamatsu Symp, V22, P153; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; LEE KF, 1994, DEVELOPMENT, V120, P1027; LeSauteur L, 1996, J NEUROSCI, V16, P1308; Li Z., 2021, BIORXIV, DOI [10.1101/2021.05.02.442373, DOI 10.1101/2021.05.02.442373]; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; LOEB DM, 1994, J BIOL CHEM, V269, P8901; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Matusica D, 2016, J CELL SCI, V129, P517, DOI 10.1242/jcs.173864; Matusica D, 2014, SEMIN CELL DEV BIOL, V31, P57, DOI 10.1016/j.semcdb.2014.03.032; Matusica D, 2013, J BIOL CHEM, V288, P11144, DOI 10.1074/jbc.M112.436469; Millar RP, 2004, ENDOCRINOLOGY, V145, P3590, DOI 10.1210/en.2004-0461; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Obianyo O, 2013, BBA-PROTEINS PROTEOM, V1834, P2213, DOI 10.1016/j.bbapap.2012.08.021; Qu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057839; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Sankorrakul K, 2021, J NEUROCHEM, V158, P1292, DOI 10.1111/jnc.15451; Saragovi HU, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00231; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Shen JY, 2011, FEBS LETT, V585, P295, DOI 10.1016/j.febslet.2010.12.031; Skeldal S., 2016, ENCY CELL BIOL, V3, P67; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SUTTER A, 1979, J BIOL CHEM, V254, P5972; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Szobota S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224022; Tanaka H, 2018, MOL CANCER THER, V17, P2519, DOI 10.1158/1535-7163.MCT-17-1180; Tanaka K, 2016, J NEUROSCI, V36, P5587, DOI 10.1523/JNEUROSCI.4536-15.2016; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Vesa J, 2000, J BIOL CHEM, V275, P24414, DOI 10.1074/jbc.M001641200; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	139	4	4	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101568	10.1016/j.jbc.2022.101568	http://dx.doi.org/10.1016/j.jbc.2022.101568			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35051416	gold, Green Published			2022-12-28	WOS:000791267400008
J	Gasparrini, M; Mazzola, F; Cuccioloni, M; Sorci, L; Audrito, V; Zamporlini, F; Fortunato, C; Amici, A; Cianci, M; Deaglio, S; Angeletti, M; Raffaelli, N				Gasparrini, Massimiliano; Mazzola, Francesca; Cuccioloni, Massimiliano; Sorci, Leonardo; Audrito, Valentina; Zamporlini, Federica; Fortunato, Carlo; Amici, Adolfo; Cianci, Michele; Deaglio, Silvia; Angeletti, Mauro; Raffaelli, Nadia			Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; EQUILIBRIUM; RECOGNITION; EXPRESSION; INHIBITOR; MECHANISM; SEQUENCE; COMPLEX; ENZYMES; MODEL	The secreted form of the enzyme nicotinamide phosphoribosyltransferase (NAMPT), which catalyzes a key reaction in intracellular NAD biosynthesis, acts as a damage-associated molecular pattern triggering Toll-like receptor 4 (TLR4)mediated inflammatory responses. However, the precise mechanism of interaction is unclear. Using an integrated approach combining bioinformatics and functional and structural analyses, we investigated the interaction between NAMPT and TLR4 at the molecular level. Starting from previous evidence that the bacterial ortholog of NAMPT cannot elicit the inflammatory response, despite a high degree of structural conservation, two positively charged areas unique to the human enzyme (the alpha 1-alpha 2 and beta 1-beta 2 loops) were identified as likely candidates for TLR4 binding. However, alanine substitution of the positively charged residues within these loops did not affect either the oligomeric state or the catalytic efficiency of the enzyme. The kinetics of the binding of wildtype and mutated NAMPT to biosensor-tethered TLR4 was analyzed. We found that mutations in the alpha 1-alpha 2 loop strongly decreased the association rate, increasing the KD value from 18 nM, as determined for the wildtype, to 1.3 mu M. In addition, mutations in the beta 1-beta 2 loop or its deletion increased the dissociation rate, yielding KD values of 0.63 and 0.22 mu M, respectively. Mutations also impaired the ability of NAMPT to trigger the NF -KB inflammatory signaling pathway in human cultured macrophages. Finally, the involvement of the two loops in receptor binding was supported by NAMPT-TLR4 docking simulations. This study paves the way for future development of compounds that selectively target eNAMPT/TLR4 signaling in inflamma-tory disorders.	[Gasparrini, Massimiliano; Zamporlini, Federica; Fortunato, Carlo; Cianci, Michele; Raffaelli, Nadia] Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Mazzola, Francesca; Amici, Adolfo] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Cuccioloni, Massimiliano; Angeletti, Mauro] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy; [Sorci, Leonardo] Polytech Univ Marche, Dept Mat Environm Sci & Urban Planning, Div Bioinformat & Biochem, Ancona, Italy; [Audrito, Valentina; Deaglio, Silvia] Univ Turin, Dept Med Sci, Turin, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Camerino; Marche Polytechnic University; University of Turin	Raffaelli, N (corresponding author), Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	n.raffaelli@staff.univpm.it	Amici, Adolfo/C-5342-2012; SORCI, LEONARDO/AAD-7395-2019; Mazzola, Francesca/ADC-1197-2022; Cianci, Michele/I-5577-2012	Amici, Adolfo/0000-0002-1081-7749; SORCI, LEONARDO/0000-0002-4356-8873; Cianci, Michele/0000-0001-5607-6061	Ministero dell'Universita e della Ricerca, PRIN Project [2017CBNCYT]; Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018 [NADBES 2018.0773]	Ministero dell'Universita e della Ricerca, PRIN Project; Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018	This work was supported by Ministero dell'Universita e della Ricerca, PRIN Project 2017CBNCYT to N. R. and by Fondazione Cariverona, Bando Ricerca Scientifica di Eccellenza 2018, Project NADBES 2018.0773, to N. R.	Akashi S., 2003, J EXP MED; Audrito V, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00358; Audrito V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01720; Berglund NA, 2015, PROG BIOPHYS MOL BIO, V119, P72, DOI 10.1016/j.pbiomolbio.2015.06.021; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bockwoldt M, 2019, P NATL ACAD SCI USA, V116, P15957, DOI 10.1073/pnas.1902346116; Buonvicino D., 2018, IDENTIFICATION NICOT; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Camp SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13135; Carbone F, 2017, COMPR PHYSIOL, V7, P603, DOI 10.1002/cphy.c160029; Chandana T, 2016, CURR PROTEIN PEPT SC, V17, P507, DOI 10.2174/1389203717666151201192348; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Colombo G, 2020, J MOL MED, V98, P595, DOI 10.1007/s00109-020-01892-0; Cuccioloni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13709-1; Cuccioloni M, 2016, FOOD CHEM, V213, P571, DOI 10.1016/j.foodchem.2016.07.020; Garten A., 2010, BIOCHEM BIOPH RES CO; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grolla A. A., 2015, NICOTINAMIDE PHOSPHO; Grolla AA, 2020, J BIOL CHEM, V295, P3635, DOI 10.1074/jbc.RA119.010571; Grolla AA, 2016, BRIT J PHARMACOL, V173, P2182, DOI 10.1111/bph.13505; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; He MZ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0023-8; Jaffe EK, 2012, METHODS MOL BIOL, V796, P217, DOI 10.1007/978-1-61779-334-9_12; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kishko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043902; Knoops B, 2018, CELL CHEM BIOL, V25, P550, DOI 10.1016/j.chembiol.2018.02.006; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Lu YB, 2019, J NEUROCHEM, V150, P723, DOI 10.1111/jnc.14811; Manago A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12055-2; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Quijada H, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02536-2020; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ratnayake D., 2021, MACROPHAGES PROVIDE; Romacho T., 2020; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Shazman S, 2007, NUCLEIC ACIDS RES, V35, pW526, DOI 10.1093/nar/gkm401; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Torretta S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020496; Van den Bergh R., 2012, PLOS; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yoshida M, 2019, CELL METAB, V30, P329, DOI 10.1016/j.cmet.2019.05.015; Zamporlini F, 2014, FEBS J, V281, P5104, DOI 10.1111/febs.13050; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75	51	2	2	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101669	10.1016/j.jbc.2022.101669	http://dx.doi.org/10.1016/j.jbc.2022.101669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120922	Green Published, gold			2022-12-28	WOS:000791230900013
J	Mathews, II; Horikoshi, N; Matsui, T; Kaur, M; Wakatsuki, S; Mochly-Rosen, D; Garcia, AA				Mathews, Irimpan I.; Horikoshi, Naoki; Matsui, Tsutomu; Kaur, Manat; Wakatsuki, Soichi; Mochly-Rosen, Daria; Garcia, Adriana Ann			Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DEFICIENCY; MUTATIONS; NADPH; INTERCONVERSION; SCATTERING; DIMERS	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic trait that can cause hemolytic anemia. To date, over 150 nonsynonymous mutations have been identified in G6PD, with pathogenic mutations clustering near the dimer and/or tetramer interface and the allosteric NADP+-binding site. Recently, our lab identified a small molecule that activates G6PD variants by stabilizing the allosteric NADP(+) and dimer complex, suggesting therapeutics that target these regions may improve structural defects. Here, we elucidated the connection between allosteric NADP+ binding, oligomerization, and pathogenicity to determine whether oligomer stabilization can be used as a therapeutic strategy for G6PD deficiency (G6PD(def)). We first solved the crystal structure for G6PD(K403Q), a mutant that mimics the physiological acetylation of wild-type G6PD in erythrocytes and demonstrated that loss of allosteric NADP+ binding induces conformational changes in the dimer. These structural changes prevent tetramerization, are unique to Class I variants (the most severe form of G6PD(def)), and cause the deactivation and destabilization of G6PD. We also introduced nonnative cysteines at the oligomer interfaces and found that the tetramer complex is more catalytically active and stable than the dimer. Furthermore, stabilizing the dimer and tetramer improved protein stability in clinical variants, regardless of clinical classification, with tetramerization also improving the activity of G6PD(K403Q) and Class I variants. These findings were validated using enzyme activity and thermostability assays, analytical size-exclusion chromatography (SEC), and SEC coupled with small-angle X-ray scattering (SEC-SAXS). Taken together, our findings suggest a potential therapeutic strategy for G6PDdef and provide a foundation for future drug discovery efforts.	[Mochly-Rosen, Daria; Garcia, Adriana Ann] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Mathews, Irimpan I.; Matsui, Tsutomu] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Horikoshi, Naoki] Univ Tsukuba, Life Sci Ctr Survival Dynam, Tsukuba, Ibaraki, Japan; [Horikoshi, Naoki; Wakatsuki, Soichi] SLAC Natl Accelerator Lab, Biol Sci Div, Menlo Pk, CA 94025 USA; [Horikoshi, Naoki; Kaur, Manat; Wakatsuki, Soichi] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Tsukuba; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Wakatsuki, S (corresponding author), SLAC Natl Accelerator Lab, Biol Sci Div, Menlo Pk, CA 94025 USA.; Wakatsuki, S (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.	soichi.wakatsuki@stanford.edu; mochly@stanford.edu		Wakatsuki, Soichi/0000-0001-5896-7968; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institutes of Health (NIH) [HD084422]; National Science Foundation Graduate Research Fellowship (NSF-GRFP) [DGE - 1656518]; NIH [5T32GM113854]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P30GM133894]; National Institutes of Health [S10OD021512]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship (NSF-GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health (NIH) R01, grant HD084422 (to D. M.-R.) . A. A. G. was supported by National Science Foundation Graduate Research Fellowship (NSF-GRFP) , grant DGE - 1656518 and NIH training grant, grant 5T32GM113854. Use of the Stanford Synchrotron Radiation Lightsource (SSRL) , SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894) . The Pilatus detector at beamline 4-2 at SSRL was funded under National Institutes of Health Grant, grant S10OD021512. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Ali AK, 2002, ACTA HAEMATOL-BASEL, V108, P19, DOI 10.1159/000063062; [Anonymous], 1967, World Health Organ Tech Rep Ser, V366, P1; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BONSIGNORE A, 1971, ARCH BIOCHEM BIOPHYS, V147, P493, DOI 10.1016/0003-9861(71)90406-1; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; CANCEDDA R, 1973, EUR J BIOCHEM, V34, P199, DOI 10.1111/j.1432-1033.1973.tb02746.x; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; COHEN P, 1969, EUR J BIOCHEM, V8, P8, DOI 10.1111/j.1432-1033.1969.tb00488.x; Cotrina EY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197166; Cunningham A. D., 2017, MATTERS, V3; Cunningham AD, 2017, CELL REP, V18, P2592, DOI 10.1016/j.celrep.2017.02.048; Devendra R, 2020, INFECT GENET EVOL, V86, DOI 10.1016/j.meegid.2020.104597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia AA, 2021, TRENDS PHARMACOL SCI, V42, P829, DOI 10.1016/j.tips.2021.07.002; Horikoshi N, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022790118; Hwang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06447-z; Iakovleva I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153529; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIRKMAN HN, 1975, J CLIN INVEST, V55, P875, DOI 10.1172/JCI107998; LAKOMEK M, 1992, EUR J HAEMATOL, V49, P82; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Malashkevich VN, 2010, P NATL ACAD SCI USA, V107, P8605, DOI 10.1073/pnas.0913660107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller M, 2018, J MED CHEM, V61, P7862, DOI 10.1021/acs.jmedchem.8b00817; Mizukawa B, 2011, PEDIATR BLOOD CANCER, V56, P840, DOI 10.1002/pbc.22744; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Park J, 2020, ANN PHARMACOTHER, V54, P470, DOI 10.1177/1060028019888489; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Doss CGP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37284; Ranzani AT, 2017, FEBS LETT, V591, P1278, DOI 10.1002/1873-3468.12638; Raub AG, 2019, CHEMMEDCHEM, V14, P1321, DOI 10.1002/cmdc.201900341; SCIONTI L, 1982, HORM METAB RES, V14, P233, DOI 10.1055/s-2007-1018980; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wang XT, 2008, PROTEIN SCI, V17, P1403, DOI 10.1110/ps.035352.108; Wang X, 2019, BIOORG CHEM, V85, P413, DOI 10.1016/j.bioorg.2019.01.007; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; WRIGLEY NG, 1972, J MOL BIOL, V68, P483, DOI 10.1016/0022-2836(72)90101-5	45	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101610	10.1016/j.jbc.2022.101610	http://dx.doi.org/10.1016/j.jbc.2022.101610			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065072	Green Published, gold			2022-12-28	WOS:000789396300005
J	Schweininger, J; Kriegel, M; Hage, S; Conrad, M; Alkhashrom, S; Losing, J; Weiler, S; Tillmanns, J; Egerer-Sieber, C; Decker, A; Rovis, TL; Eichler, J; Sticht, H; Marschall, M; Muller, YA				Schweininger, Johannes; Kriegel, Mark; Hage, Sigrun; Conrad, Marcus; Alkhashrom, Sewar; Losing, Josephine; Weiler, Sigrid; Tillmanns, Julia; Egerer-Sieber, Claudia; Decker, Andrea; Rovis, Tihana Lenac; Eichler, Jutta; Sticht, Heinrich; Marschall, Manfred; Muller, Yves A.			The crystal structure of the varicella-zoster Orf24-Orf27 nuclear egress complex spotlights multiple determinants of herpesvirus subfamily specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYTOMEGALOVIRUS; KINASE PUL97; VIRUS; MEMBRANE; PROTEINS; INFECTION; FEATURES; PUL50; NEC	Varicella-zoster virus (VZV) is a human pathogen from the alpha-subfamily of herpesviruses. The VZV Orf24-Orf27 complex represents the essential viral core nuclear egress complex (NEC) that orchestrates the egress of the preassembled virus capsids from the nucleus. While previous studies have primarily emphasized that the architecture of core NEC complexes is highly conserved among herpesviruses, the present report focuses on subfamily-specific structural and functional features that help explain the differences in the autologous versus nonautologous interaction patterns observed for NEC formation across herpesviruses. Here, we describe the crystal structure of the Orf24-Orf27 complex at 2.1 angstrom resolution. Coimmunoprecipitation and confocal imaging data show that Orf24-Orf27 complex formation displays some promiscuity in a herpesvirus subfamily-restricted manner. At the same time, analysis of thermodynamic parameters of NEC formation of three prototypical alpha-, beta-, and gamma herpesviruses, i.e., VZV, human cytomegalovirus (HCMV), and Epstein-Barr virus (EBV), revealed highly similar binding affinities for the autologous interaction with specific differences in enthalpy and entropy. Computational alanine scanning, structural comparisons, and mutational data highlight intermolecular interactions shared among alpha-herpesviruses that are clearly distinct from those seen in beta- and gamma-herpesviruses, including a salt bridge formed between Orf24-Arg167 and Orf27-Asp126. This interaction is located outside of the hook-into-groove interface and contributes significantly to the free energy of complex formation. Combined, these data explain distinct properties of specificity and permissivity so far observed in herpesviral NEC interactions. These findings will prove valuable in attempting to target multiple herpesvirus core NECs with selective or broad-acting drug candidates.	[Schweininger, Johannes; Kriegel, Mark; Weiler, Sigrid; Egerer-Sieber, Claudia; Decker, Andrea; Muller, Yves A.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Biol, Div Biotechnol, Erlangen, Germany; [Hage, Sigrun; Losing, Josephine; Tillmanns, Julia; Marschall, Manfred] Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr Erlangen, Inst Clin & Mol Virol, Erlangen, Germany; [Conrad, Marcus; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Biochem, Div Bioinformat, Erlangen, Germany; [Alkhashrom, Sewar; Eichler, Jutta] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Chem & Pharm, Erlangen, Germany; [Rovis, Tihana Lenac] Univ Rijeka, Fac Med, Ctr Prote, Rijeka, Croatia	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Rijeka	Muller, YA (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Biol, Div Biotechnol, Erlangen, Germany.; Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr Erlangen, Inst Clin & Mol Virol, Erlangen, Germany.	manfred.marschall@fau.de; yves.muller@fau.de	; Eichler, Jutta/H-7847-2018	Lenac Rovis, Tihana/0000-0002-3299-1334; Schweininger, Johannes/0000-0002-5490-1950; Eichler, Jutta/0000-0001-6683-9456	Deutsche Forschungsgemeinschaft [MA 1289/8-1, EI 423/4-1, MU 1477/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The synchrotron MX data were collected at beamline P14 operated by EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg, Germany). We would like to thank Gleb Bourenkov for the assistance in using the beamline. M. M. greatly appreciates the excellent technical assistance by Christina Wangen (Virology, FAU). We are very grateful for our long-term cooperation partners providing very valuable materials and detection tools, i.e., Benedikt Kaufer for the supply with VZV-GFP (Virology, FU Berlin; Ref.), Rona Scott and Lindsey Hutt-Fletcher for providing Akata-BX1/EBV-GFP (Dept. Microbiology and Immunology, Louisiana State Univ. LSUHSC, Shreveport, LA, USA). This research was supported by Deutsche Forschungsgemeinschaft (MA 1289/8-1, EI 423/4-1, and MU 1477/10-1).	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bailer SM, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040046; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bigalke JM, 2017, ADV VIRUS RES, V97, P107, DOI 10.1016/bs.aivir.2016.07.002; Bigalke JM, 2016, ANNU REV VIROL, V3, P387, DOI 10.1146/annurev-virology-110615-042215; Bigalke JM, 2015, EMBO J, V34, P2921, DOI 10.15252/embj.201592359; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Bollaerts K, 2017, EPIDEMIOL INFECT, V145, P2666, DOI 10.1017/S0950268817001546; Britt WJ, 2018, ANTIVIR RES, V159, P153, DOI 10.1016/j.antiviral.2018.09.003; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farina A, 2000, J VIROL, V74, P3235, DOI 10.1128/JVI.74.7.3235-3244.2000; Hage S, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020165; Hage S, 2020, J VIROL METHODS, V283, DOI 10.1016/j.jviromet.2020.113909; Hage S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030303; Hagen C, 2015, CELL, V163, P1692, DOI 10.1016/j.cell.2015.11.029; Heldwein E. E., 2020, ALPHAHERPESVIRUSES M; Hellberg T, 2016, ADV VIRUS RES, V94, P81, DOI 10.1016/bs.aivir.2015.10.002; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Hutterer C, 2015, ANTIMICROB AGENTS CH, V59, P2062, DOI 10.1128/AAC.04534-14; Jha HC, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010018; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kicuntod J, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030462; Kriegel M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89785-1; Lemnitzer F, 2013, CELL MICROBIOL, V15, P335, DOI 10.1111/cmi.12080; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin R, 2017, J VIROL METHODS, V247, P15, DOI 10.1016/j.jviromet.2017.04.012; Liu ZM, 2015, J VIROL, V89, P8982, DOI 10.1128/JVI.01220-15; Lye MF, 2017, CURR OPIN CELL BIOL, V46, P9, DOI 10.1016/j.ceb.2016.12.007; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Marschall M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060683; Marschall M, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1934; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Milbradt J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010035; Milbradt J, 2014, MOL CELL PROTEOMICS, V13, P2132, DOI 10.1074/mcp.M113.035782; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; Muller YA, 2020, J BIOL CHEM, V295, P3189, DOI 10.1074/jbc.RA119.011546; Oladunni FS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02668; Ouwendijk WJD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01179; Perera MR, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050817; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Raaperi K, 2014, VET J, V201, P249, DOI 10.1016/j.tvjl.2014.05.040; Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3; ROIZMAN B, 1991, COMP IMMUNOL MICROB, V14, P63, DOI 10.1016/0147-9571(91)90122-T; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Rovis TL, 2013, J VIROL, V87, P6943, DOI 10.1128/JVI.00407-13; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schmeiser C, 2013, J GEN VIROL, V94, P2056, DOI 10.1099/vir.0.052571-0; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Sonntag E, 2017, J GEN VIROL, V98, P2569, DOI 10.1099/jgv.0.000931; Sonntag E, 2016, J GEN VIROL, V97, P1676, DOI 10.1099/jgv.0.000495; Steingruber M, 2015, VIRUSES-BASEL, V7, P4582, DOI 10.3390/v7082834; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Webel R, 2012, J GEN VIROL, V93, P1756, DOI 10.1099/vir.0.040592-0; Wild Peter, 2017, F1000Res, V6, P1804, DOI 10.12688/f1000research.12252.2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008; Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215	67	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101625	10.1016/j.jbc.2022.101625	http://dx.doi.org/10.1016/j.jbc.2022.101625			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35074430	gold, Green Published, Green Submitted			2022-12-28	WOS:000821051800008
J	Zhang, C; Zhao, HL; Song, XY; Wang, J; Zhao, SS; Deng, H; He, L; Zhou, XY; Yin, XM; Zhang, KW; Zhang, Y; Wu, ZY; Chen, QY; Du, JN; Yu, D; Zhang, SH; Deng, WS				Zhang, Cheng; Zhao, Houliang; Song, Xiaoye; Wang, Juan; Zhao, Shasha; Deng, Huan; He, Liu; Zhou, Xiangyu; Yin, Xiaomei; Zhang, Kewei; Zhang, Yue; Wu, Zhongyu; Chen, Qiyue; Du, Jiannan; Yu, Deen; Zhang, Shihua; Deng, Wensheng			Transcription factor GATA4 drives RNA polymerase III-directed transcription and transformed cell proliferation through a filamin A/GATA4/SP1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-TRANSCRIPTION; BREAST-CANCER; EXPRESSION; BRF1; OVEREXPRESSION; HYPERTROPHY; MECHANISM; INSIGHTS; GROWTH; SP1	RNA polymerase III (pol III) products play fundamental roles in a variety of cellular processes, including protein synthesis and cancer cell proliferation. In addition, dysregulation of pol III-directed transcription closely correlates with tumorigenesis. It is therefore of interest to identify novel pathways or factors governing pol III-directed transcription. Here, we show that transcription factor (TF) GATA binding protein 4 (GATA4) expression in SaOS2 cells was stimulated by the silencing of filamin A (FLNA), a repressor of pol IIIdirected transcription, suggesting that GATA4 is potentially associated with the regulation of pol III-directed transcription. Indeed, we show that GATA4 expression positively correlates with pol III-mediated transcription and tumor cell proliferation. Mechanistically, we found that GATA4 depletion inhibits the occupancies of the pol III transcription machinery factors at the loci of pol III target genes by reducing expression of both TFIIIB subunit TFIIB-related factor 1 and TFIIIC subunit general transcription factor 3C subunit 2 (GTF3C2). GATA4 has been shown to activate specificity factor 1 (Sp1) gene transcription by binding to the Sp1 gene promoter, and Sp1 has been confirmed to activate pol III gene transcription by directly binding to both Bif1 and Gtf3c2 gene promoters. Thus, the findings from this study suggest that GATA4 links FLNA and pol III-directed transcription and transformed cell proliferation. Taken together, these results provide novel insights into the regulatory mechanism of pol III-directed transcription.	[Zhang, Cheng; Zhao, Houliang; Song, Xiaoye; Zhao, Shasha; Deng, Huan; He, Liu; Zhou, Xiangyu; Yin, Xiaomei; Zhang, Kewei; Zhang, Yue; Wu, Zhongyu; Chen, Qiyue; Du, Jiannan; Yu, Deen; Zhang, Shihua; Deng, Wensheng] Wuhan Univ Sci & Technol, Sch Life Sci & Hlth, Wuhan, Peoples R China; [Wang, Juan] Wuhan Univ Sci & Technol, Sch Mat & Met, Wuhan, Peoples R China	Wuhan University of Science & Technology; Wuhan University of Science & Technology	Zhang, SH; Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Sch Life Sci & Hlth, Wuhan, Peoples R China.	zhangshihua@wust.edu.cn; dengwensheng@wust.edu.cn			Natural Science Foundation of China, China [31671357, 62172312]	Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	Funding and additional information-This work was funded by the project (grant no.: 31671357 to W. D. grant no.: 62172312 to S. Zhang) from the Natural Science Foundation of China, China.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Acosta AJ, 2020, BASIC CLIN PHARMACOL, V127, P178, DOI 10.1111/bcpt.13398; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bergeron F, 2019, ANDROLOGY-US, V7, P357, DOI 10.1111/andr.12601; Bisping E., 2006, PROC NATL; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Choquet K., 2019, J BIOL UDAYANA, VChem; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Enane FO, 2017, J CLIN INVEST, V127, P3527, DOI 10.1172/JCI93488; Fang Z, 2017, MOL ONCOL, V11, P1752, DOI 10.1002/1878-0261.12141; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gao L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09295-7; Girbig M, 2021, NAT STRUCT MOL BIOL, V28, P210, DOI 10.1038/s41594-020-00555-5; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Han XF, 2019, J CELL BIOCHEM, V120, P917, DOI 10.1002/jcb.27455; Hasegawa K, 1997, CIRCULATION, V96, P3943; Hashmi Satwat, 2019, Cell Regen, V8, P12, DOI 10.1016/j.cr.2018.11.002; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Hong ZF, 2020, CHEM-BIOL INTERACT, V325, DOI 10.1016/j.cbi.2020.109129; Hu XQ, 2011, J CELL MOL MED, V15, P1865, DOI 10.1111/j.1582-4934.2010.01182.x; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; KELLEY C, 1993, DEVELOPMENT, V118, P817; Kohinhofer BM, 2016, CELL MOL GASTROENTER, V2, P189, DOI 10.1016/j.jcmgh.2015.11.010; Lesniewska E, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170001; Li JH, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0384-1; Liang JL, 2019, ELIFE, V8, DOI 10.7554/eLife.48767; Liang X, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1232-x; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Nikitina TV, 2011, BIOL CHEM, V392, P395, DOI 10.1515/BC.2011.049; Park JL, 2017, EPIGENOMICS-UK, V9, P171, DOI 10.2217/epi-2016-0108; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Pei YH, 2016, ONCOTARGET, V7, P77890, DOI 10.18632/oncotarget.12839; Peng FX, 2020, J BIOL CHEM, V295, P4617, DOI 10.1074/jbc.RA119.011555; Petrie JL, 2019, NUCLEIC ACIDS RES, V47, P3937, DOI 10.1093/nar/gkz128; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Santos M, 2019, TRENDS MOL MED, V25, P853, DOI 10.1016/j.molmed.2019.05.011; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Shah AA, 2015, CURR OPIN RHEUMATOL, V27, P563, DOI 10.1097/BOR.0000000000000222; Soini Tea, 2018, Tumour Biol, V40, p1010428318785498, DOI 10.1177/1010428318785498; Suzuki YJ, 2011, CELL SIGNAL, V23, P1094, DOI 10.1016/j.cellsig.2011.02.007; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2016, J BIOL CHEM, V291, P25239, DOI 10.1074/jbc.M116.735886; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yeganeh Meghdad, 2020, Genes Dev, V34, P865, DOI 10.1101/gad.333989.119; Yu W, 2016, DEVELOPMENT, V143, P936, DOI 10.1242/dev.130971; Zaytouni T, 2011, ADV GENET, V76, P93, DOI 10.1016/B978-0-12-386481-9.00004-3; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223; Zhong Q, 2016, ONCOTARGET, V7, P6243, DOI 10.18632/oncotarget.6668; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	57	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101581	10.1016/j.jbc.2022.101581	http://dx.doi.org/10.1016/j.jbc.2022.101581			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35038452	gold, Green Published			2022-12-28	WOS:000791267400002
J	Nakano, S; Nishikawa, M; Kobayashi, T; Harlin, EW; Ito, T; Sato, K; Sugiyama, T; Yamakawa, H; Nagase, T; Ueda, H				Nakano, Shun; Nishikawa, Masashi; Kobayashi, Tomoyo; Harlin, Eka Wahyuni; Ito, Takuya; Sato, Katsuya; Sugiyama, Tsuyoshi; Yamakawa, Hisashi; Nagase, Takahiro; Ueda, Hiroshi			The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; PROTEIN; GTPASES; RAC1; MECHANOTRANSDUCTION; PALMITOYLATION; REORIENTATION; ASSOCIATION; EXPRESSION; MIGRATION	Rho family small GTPases (Rho) regulate various cell motility processes by spatiotemporally controlling the actin cytoskeleton. Some Rho-specific guanine nucleotide exchange factors (RhoGEFs) are regulated via tyrosine phosphorylation by Src family tyrosine kinase (SFK). We also previously re-ported that PLEKHG2, a RhoGEF for the GTPases Rac1 and Cdc42, is tyrosine-phosphorylated by SRC. However, the de-tails of the mechanisms by which SFK regulates RhoGEFs are not well understood. In this study, we found for the first time that PLEKHG1, which has very high homology to the Dbl and pleckstrin homology domains of PLEKHG2, activates Cdc42 following activation by FYN, a member of the SFK family. We also show that this activation of PLEKHG1 by FYN requires interaction between these two proteins and FYN-induced tyrosine phosphorylation of PLEKHG1. We also found that the region containing the Src homology 3 and Src homology 2 domains of FYN is required for this interaction. Finally, we demonstrated that tyrosine phosphorylation of Tyr-720 and Tyr-801 in PLEKHG1 is important for the activation of PLEKHG1. These results suggest that FYN is a regulator of PLEKHG1 and may regulate cell morphology through Rho signaling via the interaction with and tyrosine phosphorylation of PLEKHG1.	[Nakano, Shun; Nishikawa, Masashi; Ueda, Hiroshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kobayashi, Tomoyo] Gifu Univ, Fac Engn, Gifu, Japan; [Harlin, Eka Wahyuni; Ito, Takuya; Ueda, Hiroshi] Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan; [Sato, Katsuya] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan; [Sugiyama, Tsuyoshi] Gifu Univ Med Sci, Fac Pharm, Kani, Gifu, Japan; [Yamakawa, Hisashi; Nagase, Takahiro] Kazusa DNA Res Inst, Chiba, Japan	Gifu University; Gifu University; Gifu University; Gifu University; Kazusa DNA Research Institute	Ueda, H (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan.; Ueda, H (corresponding author), Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan.	hueda@gifu-u.ac.jp		Sugiyama, Tsuyoshi/0000-0002-8517-9067	JSPS KAKENHI [23590073, 15K07927]; Division of Genomic Research of the Life Science Research Center at Gifu University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division of Genomic Research of the Life Science Research Center at Gifu University	This study was supported by JSPS KAKENHI Grants Number 23590073 and 15K07927. The DNA sequence analysis was supported by the Division of Genomic Research of the Life Science Research Center at Gifu University.	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chiu YJ, 2008, J CELL BIOL, V182, P753, DOI 10.1083/jcb.200801062; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Fujiwara S, 2019, GENES CELLS, V24, P390, DOI 10.1111/gtc.12682; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gray KJ, 2018, HYPERTENSION, V72, P408, DOI 10.1161/HYPERTENSIONAHA.117.10688; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hansen K, 1997, BIOCHEM BIOPH RES CO, V241, P355, DOI 10.1006/bbrc.1997.7743; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Liang XQ, 2004, J BIOL CHEM, V279, P8133, DOI 10.1074/jbc.M311180200; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakano S, 2019, MOL CELL BIOCHEM, V459, P83, DOI 10.1007/s11010-019-03552-5; Niediek V, 2012, EUR J CELL BIOL, V91, P118, DOI 10.1016/j.ejcb.2011.10.003; Nishikawa M, 2019, CELL SIGNAL, V61, P93, DOI 10.1016/j.cellsig.2019.04.016; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Reebye V, 2012, CELL SIGNAL, V24, P388, DOI 10.1016/j.cellsig.2011.10.003; Reinhard Nathalie R, 2021, Small GTPases, V12, P226, DOI 10.1080/21541248.2019.1658509; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SABE H, 1992, P NATL ACAD SCI USA, V89, P2190, DOI 10.1073/pnas.89.6.2190; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Sato K, 2014, CELL SIGNAL, V26, P691, DOI 10.1016/j.cellsig.2013.12.006; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Traylor M, 2019, NEUROLOGY, V92, pE749, DOI 10.1212/WNL.0000000000006952; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yu B., 2020, CELL DEATH DIS, V11, P1	45	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101579	10.1016/j.jbc.2022.101579	http://dx.doi.org/10.1016/j.jbc.2022.101579			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031323	Green Published, gold			2022-12-28	WOS:000761371500013
J	Qifti, A; Balaji, S; Scarlata, S				Qifti, Androniqi; Balaji, Shravani; Scarlata, Suzanne			Deformation of caveolae impacts global transcription and translation processes through relocalization of cavin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I; P-BODIES; PROTEINS; STRESS; PROMOTER; FAMILY; PTRF	Caveolae are invaginated membrane domains that provide mechanical strength to cells in addition to being focal points for the localization of signaling molecules. Caveolae are formed through the aggregation of caveolin-1 or -3 (Cav1/3), mem-brane proteins that assemble into multifunctional complexes with the help of caveola-associated protein cavin-1. In addition to its role in the formation of caveolae, cavin-1, also called polymerase I and transcript release factor, is further known to promote ribosomal RNA transcription in the nucleus. However, the mechanistic link between these functions is not clear. Here, we found that deforming caveolae by subjecting cells to mild osmotic stress (150-300 mOsm) changes levels of GAPDH, Hsp90, and Ras only when Cav1/cavin-1 levels are reduced, suggesting a link between caveola deformation and global protein expression. We show that this link may be due to relocalization of cavin-1 to the nucleus upon caveola deformation. Cavin-1 relocalization is also seen when Cav1-G alpha qcontacts change upon stimulation. Furthermore, Cav1 andcavin-1 levels have been shown to have profound effects on cytosolic RNA levels, which in turn impact the ability of cells to form stress granules and RNA-processing bodies (p-bodies)which sequester and degrade mRNAs, respectively. Our studies here using a cavin-1-knockout cell line indicate adaptive changes in cytosolic RNA levels but a reduced ability to form stress granules. Taken together, our findings suggest that caveolae, through release of cavin-1, communicate extracellular cues to the cell interior to impact transcriptional and translational.	[Qifti, Androniqi; Balaji, Shravani; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			NIH [GM116178]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH GM116178. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	A. Qifti, 2021, bioRxiv, DOI 10.1101/521369; Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56; Bernatchez P, 2011, J CLIN INVEST, V121, P3747, DOI 10.1172/JCI44778; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Buwa N, 2020, J MEMBRANE BIOL, V253, P509, DOI 10.1007/s00232-020-00143-0; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Echarri A, 2015, J CELL SCI, V128, P2747, DOI 10.1242/jcs.153940; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Faggi F, 2015, LAB INVEST, V95, P585, DOI 10.1038/labinvest.2015.45; Guo YJ, 2015, J BIOL CHEM, V290, P16698, DOI 10.1074/jbc.M115.655126; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Kultz D, 2007, FEBS J, V274, P5781, DOI 10.1111/j.1742-2007-06097-x; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu LB, 2020, BIOCHEM SOC T, V48, P147, DOI 10.1042/BST20190380; Liu LB, 2016, ELIFE, V5, DOI 10.7554/eLife.17508; Luo Y, 2018, BIOCHEMISTRY-US, V57, P2424, DOI 10.1021/acs.biochem.7b01162; McMahon KA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11111-1; Mohan J, 2015, J CELL SCI, V128, P979, DOI 10.1242/jcs.161463; Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Parton RG, 2018, CURR BIOL, V28, pR402, DOI 10.1016/j.cub.2017.11.075; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Qifti A, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.aav1012; Qifti A, 2019, J MEMBRANE BIOL, V252, P307, DOI 10.1007/s00232-019-00063-8; Sahu S, 2017, PROTEIN SCI, V26, P1807, DOI 10.1002/pro.3219; Sahu S, 2014, J BIOL CHEM, V289, P5134, DOI 10.1074/jbc.M113.531467; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Williams JJL, 2014, BIOCHEM SOC T, V42, P284, DOI 10.1042/BST20130270; Yang L, 2017, J BIOL CHEM, V292, P3779, DOI 10.1074/jbc.M116.768499	46	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102005	10.1016/j.jbc.2022.102005	http://dx.doi.org/10.1016/j.jbc.2022.102005			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D0JU	35513070	gold, Green Published			2022-12-28	WOS:000811243600002
J	Tao, Y; Chaudhari, S; Shotorbani, PY; Ding, YF; Chen, ZL; Kasetti, R; Zode, G; Ma, R				Tao, Yu; Chaudhari, Sarika; Shotorbani, Parisa Yazdizadeh; Ding, Yanfeng; Chen, Zhenglan; Kasetti, Ramesh; Zode, Gulab; Ma, Rong			Enhanced Orai1-mediated store-operated Ca2+ channel/calpain signaling contributes to high glucose-induced podocyte injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-II; TRPC6 CHANNELS; CRAC CHANNELS; ENTRY; ORAI1; EXPRESSION; PATHWAY; PROTEIN; INFLUX; STIM1	Podocyte injury induced by hyperglycemia is the main cause of kidney dysfunction in diabetic nephropathy. However, the underlying mechanism is unclear. Store-operated Ca2+ entry (SOCE) regulates a diversity of cellular processes in a variety of cell types. Calpain, a Ca2+-dependent cysteine protease, was recently shown to be involved in podocyte injury. In the present study, we sought to determine whether increased SOCE contributed to high glucose (HG)-induced podocyte injury through activation of the calpain pathway. In cultured human podocytes, whole-cell patch clamp indicated the presence of functional store-operated Ca2+ channels, which are composed of Orai1 proteins and mediate SOCE. Western blots showed that HG treatment increased the protein abundance of Orai1 in a dose-dependent manner. Consistently, calcium imaging experiments revealed that SOCE was significantly enhanced in podocytes following HG treatment. Furthermore, HG treatment caused overt podocyte F-actin disorganization as well as a significant decrease in nephrin protein abundance, both of which are indications of podocyte injury. These podocyte injury responses were significantly blunted by both pharmacological inhibition of Orai1 using the small molecule inhibitor BTP2 or by genetic deletion of Orai1 using CRISPR-Cas9 lentivirus. Moreover, activation of SOCE by thapsigargin, an inhibitor of Ca2+ pump on the endoplasmic/sarcoplasmic reticulum membrane, significantly increased the activity of cal pain, which was inhibited by BTP2. Finally, the calpain-1/calpain-2 inhibitor calpeptin significantly blunted the nephrin protein reduction induced by HG treatment. Taken together, our results suggest that enhanced signaling via an Orai1/SOCE/Calpain axis contributes to HG-induced podocyte injury.	[Tao, Yu; Chaudhari, Sarika; Shotorbani, Parisa Yazdizadeh; Ding, Yanfeng; Chen, Zhenglan; Ma, Rong] Univ North Texas, Hlth Sci Ctr, Dept Physiol & Anat, Ft Worth, TX 76107 USA; [Kasetti, Ramesh; Zode, Gulab] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX 76107 USA; [Kasetti, Ramesh; Zode, Gulab] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Ma, R (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Physiol & Anat, Ft Worth, TX 76107 USA.	Rong.Ma@unthsc.edu	ma, rong/GVU-3096-2022	Tao, Yu/0000-0003-1128-3176	National Institutes of Health (NIH/NIDDK) [R01 (DK115424-01)]; Translational Project Award from American Heart Association [20TPA35500045]; Sigma Xi [G20211001-457]	National Institutes of Health (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Translational Project Award from American Heart Association; Sigma Xi	We thank Dr Jochen Reiser at Department of Internal Medicine, Rush University for providing us immortalized human podocytes. The work was supported by National Institutes of Health (NIH/NIDDK) Grant R01 (DK11542401, to R. Ma), the Translational Project Award from American Heart Association(20TPA35500045, to R. Ma), and the Grants in Aid from Sigma Xi(G20211001-457, to Y. Tao).	Anderson M, 2014, J CELL PHYSIOL, V229, P434, DOI 10.1002/jcp.24461; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bensaada I, 2021, KIDNEY INT, V100, P90, DOI 10.1016/j.kint.2021.02.024; Blaine J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071700; Chaudhari S, 2017, AM J PHYSIOL-RENAL, V313, pF729, DOI 10.1152/ajprenal.00483.2016; Chaudhari S, 2014, AM J PHYSIOL-RENAL, V306, pF1069, DOI 10.1152/ajprenal.00463.2013; Chaudhuri P, 2021, AM J PHYSIOL-CELL PH, V320, pC731, DOI 10.1152/ajpcell.00425.2020; Chen Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01477; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Farmer LK, 2019, J AM SOC NEPHROL, V30, P1910, DOI 10.1681/ASN.2018070729; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gigante M, 2011, CLIN J AM SOC NEPHRO, V6, P1626, DOI 10.2215/CJN.07830910; Greka A, 2011, J AM SOC NEPHROL, V22, P1969, DOI 10.1681/ASN.2011040370; He X, 2020, DIABET METAB SYND OB, V13, P3551, DOI 10.2147/DMSO.S271290; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Ilatovskaya DV, 2015, AM J PHYSIOL-RENAL, V309, pF393, DOI 10.1152/ajprenal.00186.2015; Jiang H, 2018, AM J PHYSIOL-RENAL, V314, pF855, DOI 10.1152/ajprenal.00513.2017; Jin J, 2018, INT J CLIN EXP PATHO, V11, P2450; Kim JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26900-w; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liu WJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/3945469; Lu XY, 2019, AM J PHYSIOL-RENAL, V317, pF1605, DOI 10.1152/ajprenal.00215.2019; Lv ZM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5671803; Ma R, 2000, AM J PHYSIOL-RENAL, V278, pF954, DOI 10.1152/ajprenal.2000.278.6.F954; Ma YQ, 2019, ENDOCR CONNECT, V8, P1206, DOI 10.1530/EC-19-0234; Mai XY, 2016, J AM SOC NEPHROL, V27, P3063, DOI 10.1681/ASN.2015080889; Mehrotra P, 2019, J CLIN INVEST, V129, P4951, DOI 10.1172/JCI126108; Metwally E, 2021, CELL RES, V31, P433, DOI 10.1038/s41422-020-0388-4; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nomura A, 2020, J BIOL CHEM, V295, P17071, DOI 10.1074/jbc.RA120.014271; Nwokonko RM, 2017, ADV EXP MED BIOL, V993, P83, DOI 10.1007/978-3-319-57732-6_5; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Rapti K, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.67; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Shotorbani PY, 2020, AM J PHYSIOL-RENAL, V318, pF673, DOI 10.1152/ajprenal.00508.2019; Sours-Brorhers S, 2009, EXP BIOL MED, V234, P673, DOI 10.3181/0809-RM-279; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Tian XF, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142740; Verheijden KAT, 2018, J AM SOC NEPHROL, V29, P2099, DOI 10.1681/ASN.2016111248; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wu PW, 2017, AM J PHYSIOL-RENAL, V312, pF1090, DOI 10.1152/ajprenal.00642.2016; Wu PW, 2015, J AM SOC NEPHROL, V26, P2691, DOI 10.1681/ASN.2014090853; Zhang LH, 2019, AM J PHYSIOL-RENAL, V317, pF12, DOI 10.1152/ajprenal.00399.2018; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang T, 2019, J CELL PHYSIOL, V234, P5033, DOI 10.1002/jcp.27306	57	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101990	10.1016/j.jbc.2022.101990	http://dx.doi.org/10.1016/j.jbc.2022.101990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35490782	Green Published, gold			2022-12-28	WOS:000807778400005
J	Zechner, C; Henne, WM; Sathe, AA; Xing, C; Hernandez, G; Sun, SY; Cheong, MC				Zechner, Christoph; Henne, W. Mike; Sathe, Adwait A.; Xing, Chao; Hernandez, Genaro; Sun, Shengyi; Cheong, Mi Cheong			Cellular abundance of sodium phosphate cotransporter SLC20A1/PiT1 and phosphate uptake are controlled post-transcriptionally by ESCRT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; COMPLEX; PROTEIN; UBIQUITIN; EXPRESSION; TRANSPORT; RECRUITMENT; RETROVIRUS; MACHINERY; RECEPTORS	Inorganic phosphate is essential for human life. The widely expressed mammalian sodium/phosphate cotransporter SLC20A1/PiT1 mediates phosphate uptake into most cell types; however, while SLC20A1 is required for development, and elevated SLC20A1 expression is associated with vascular calcification and aggressive tumor growth, the mechanisms regulating SLC20A1 protein abundance are unknown. Here, we found that SLC20A1 protein expression is low in phosphate-replete cultured cells but is strikingly induced following phosphate starvation, whereas mRNA expression is high in phosphate-replete cells and only mildly increased by phosphate starvation. To identify regulators of SLC20A1 protein levels, we performed a genome-wide CRISPR-based loss-of-function genetic screen in phosphate-replete cells using SLC20A1 protein induction as readout. Our screen revealed that endosomal sorting complexes required for transport (ESCRT) machinery was essential for proper SLC20A1 protein downregulation in phosphate-replete cells. We show that SLC20A1 colocalizes with ESCRT and that ESCRT deficiency increases SLC20A1 protein and phosphate uptake into cells. We also found numerous additional candidate regulators of mammalian phosphate homeostasis, including genes modifying protein ubiquitination and the Krebs cycle and oxidative phosphorylation pathways. Many of these targets have not been previously implicated in this process. We present here a model in which SLC20A1 protein abundance and phosphate uptake are tonically negatively regulated post-transcriptionally in phosphate-replete cells through direct ESCRT-mediated SLC20A1 degradation. Moreover, our screening results provide a comprehensive resource for future studies to elucidate the mechanisms governing cellular phosphate homeostasis. We conclude that genome-wide CRISPR-based genetic screening is a powerful tool to discover proteins and pathways relevant to physiological processes.	[Zechner, Christoph] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Zechner, Christoph] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Zechner, Christoph; Hernandez, Genaro; Sun, Shengyi; Cheong, Mi Cheong] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Henne, W. Mike] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sathe, Adwait A.; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Hernandez, Genaro] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Shengyi] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University	Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA.; Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA.; Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	christoph.zechner@utsouthwestern.edu	Zechner, Christoph/AAW-7249-2021	Zechner, Christoph/0000-0002-2829-9935; Sun, Shengyi/0000-0002-1734-3902; Xing, Chao/0000-0002-1838-0502	National Institutes of Health, United States [K08DK106569]; O'Brien Kidney Research Center [P30DK079328, R01DK081423, R01DK115703, R01DK091392, R01DK126887]; Welch Foundation, United States [I-1873]; Ford Foundation Fellowship, United States; UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research); Howard Hughes Medical Institute, United States; Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Brien Kidney Research Center; Welch Foundation, United States(The Welch Foundation); Ford Foundation Fellowship, United States; UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research); Howard Hughes Medical Institute, United States(Howard Hughes Medical Institute); Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States	This project was supported by the National Institutes of Health, United States (grant no.: K08DK106569 [to C. Z.]); O'Brien Kidney Research Center (grant nos.: P30DK079328, R01DK081423, R01DK115703, and R01DK091392 [to O. W. M.] and R01DK126887 [to W. M. H.]), The Welch Foundation, United States (grant no.: I-1873 [to W. M. H.]), a Ford Foundation Fellowship, United States (to G. H.), the UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research [to C. Z.]), the Howard Hughes Medical Institute, United States (to D. J. M.), and the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States. None of these funding sources influenced design and execution of this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056753; Bon N, 2018, J BIOL CHEM, V293, P2102, DOI 10.1074/jbc.M117.807339; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Chande S, 2018, NAT REV ENDOCRINOL, V14, P637, DOI 10.1038/s41574-018-0076-3; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Florenzano P, 2020, LANCET DIABETES ENDO, V8, P163, DOI 10.1016/S2213-8587(19)30426-7; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Green J, 2001, KIDNEY INT, V60, P1182, DOI 10.1046/j.1523-1755.2001.0600031182.x; Hasegawa J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.229179; Helbig I, 2019, AM J HUM GENET, V104, P1060, DOI 10.1016/j.ajhg.2019.04.001; Hernando N, 2021, PHYSIOL REV, V101, P1, DOI 10.1152/physrev.00008.2019; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kolmus K, 2021, J CELL SCI, V134, DOI 10.1242/jcs.250951; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Krebs EG, 2000, ADV ENZYME REGUL, V40, P441, DOI 10.1016/S0065-2571(99)00030-8; Kumari D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081185; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Masuda M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88646; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Onaga C, 2021, ANTICANCER RES, V41, P43, DOI 10.21873/anticanres.14750; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Ritter CS, 2016, CLIN J AM SOC NEPHRO, V11, P1088, DOI 10.2215/CJN.11901115; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Keiko, 2017, Clin Breast Cancer, V17, pe135, DOI 10.1016/j.clbc.2016.11.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoneberg J, 2018, SCIENCE, V362, P1423, DOI 10.1126/science.aat1839; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tenenhouse HS, 1998, AM J PHYSIOL-RENAL, V275, pF527, DOI 10.1152/ajprenal.1998.275.4.F527; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Wood KM, 2021, BIOCHEM J, V478, P3099, DOI 10.1042/BCJ20200740; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227	53	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101945	10.1016/j.jbc.2022.101945	http://dx.doi.org/10.1016/j.jbc.2022.101945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447110	gold, Green Published			2022-12-28	WOS:000838892100005
J	Chen, LP; Guo, P; Li, WX; Jiang, XH; Zhao, Q; Li, DC; Wang, Q; Xiao, YM; Xing, XM; Pang, YQ; Aschner, M; Zhang, LH; Chen, W				Chen, Liping; Guo, Ping; Li, Wenxue; Jiang, Xinhang; Zhao, Qun; Li, Daochuan; Wang, Qing; Xiao, Yongmei; Xing, Xiumei; Pang, Yaqin; Aschner, Michael; Zhang, Lihua; Chen, Wen			Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating AHR and MDR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC ENZYMES; CYTOCHROMES P450; EXPRESSION; INDUCTION; PP2A; GENE	Protein phosphatase 2A (PP2A) is a serine/threonine dephosphorylating enzyme complex that plays numerous roles in biological processes, including cell growth and metabolism. However, its specific actions in many of these critical pathways are unclear. To explore mechanisms underlying metabolic enzyme regulation in the liver, we investigated the key pathways involved in regulation of xenobiotic-metabolizing enzymes in a mouse model with hepatocyte-specific deletion of Ppp2r1a, encoding the A alpha subunit of PP2A. We performed transcriptome and phosphoproteome analysis in mouse livers at the age of 3 months and identified 2695 differentially expressed genes and 549 upregulated phosphoproteins in homozygous knockout mouse livers compared with WT littermates. In particular, the expression of metabolic enzymes Cyp2e1, Cyp1a1, Cyp1a2, Mdr1a, and Abcg2 was dramatically altered in homozygous knockout mouse livers. We also demonstrated that activation of PP2A reversed the decline of metabolic enzyme expression in primary mouse hepatocytes. We found that specific PP2A holoenzymes were involved in metabolic enzyme induction through dephosphorylation of transcription factors, nuclear receptors, or the target enzymes themselves, leading to dysregulation of xenobiotic metabolism or drug-induced hepatotoxicity. Notably, we confirmed that a regulatory axis, PP2A B56 alpha-aryl hydrocarbon receptor-Cyp1a1, was involved in benzo(a)pyrene-induced cytotoxicity through dephosphorylation of the metabolic nuclear receptor, aryl hydrocarbon receptor, at serine 36. In addition, we showed that PP2A B56 delta complexes directly dephosphorylated the multidrug efflux pump MDR1 (encoded by multi-drug resistance gene 1), contributing to drug resistance against the chemotherapeutic 5-fluorouracil. Taken together, these novel findings demonstrate the involvement of PP2A in the regulation of liver metabolism.	[Chen, Liping; Guo, Ping; Jiang, Xinhang; Li, Daochuan; Wang, Qing; Xiao, Yongmei; Xing, Xiumei; Chen, Wen] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China; [Li, Wenxue] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Peoples R China; [Zhang, Lihua] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog Res & Anal Ctr, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Pang, Yaqin] Youjiang Med Coll Nationalities, Fac Toxicol, Sch Publ Hlth, Baise, Guangxi, Peoples R China; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY USA	Sun Yat Sen University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Youjiang Medical University for Nationalities; Yeshiva University; Albert Einstein College of Medicine	Chen, W (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China.; Zhang, LH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog Res & Anal Ctr, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	lihuazhang@dicp.ac.cn; chenwen@mail.sysu.edu.cn		Zhang, Lihua/0000-0003-2543-1547; Zhao, Qun/0000-0003-3798-2047	National Nature Science Foundation of China [82073580, 81960595, 31401213]; Natural Science Foundation of Guangdong Province [2019A1515012069]; Distinguished Young Scholar of National Nature Science Foundation of China [21725506]; National Institute of Environmental Health Sci-ences, National Institutes of Health [R01 ES10563, R01 ES07331]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Distinguished Young Scholar of National Nature Science Foundation of China; National Institute of Environmental Health Sci-ences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Nature Science Foundation of China (grant nos.: 82073580, 81960595, and 31401213) , Natural Science Foundation of Guangdong Province (grant no.: 2019A1515012069) , a Distinguished Young Scholar of National Nature Science Foundation of China (grant no.: 21725506) , and National Institute of Environmental Health Sciences, National Institutes of Health (grant nos.: R01 ES10563 and R01 ES07331) .	Almazroo OA, 2017, CLIN LIVER DIS, V21, P1, DOI 10.1016/j.cld.2016.08.001; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738; Chen LM, 2020, MOL PHARMACOL, V97, P278, DOI 10.1124/mol.119.118778; Chen LP, 2021, HEPATOLOGY, V73, P1551, DOI 10.1002/hep.31457; Chen LP, 2019, J BIOL CHEM, V294, P2486, DOI 10.1074/jbc.RA118.006319; Chen ML, 2021, NATURE, V593, P147, DOI 10.1038/s41586-021-03421-6; Chen S, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105703; Choi DW, 2002, FREE RADICAL RES, V36, P893, DOI 10.1080/1071576021000005339; Czuba LC, 2018, PHARMACOL THERAPEUT, V192, P88, DOI 10.1016/j.pharmthera.2018.06.013; Ding XS, 2005, BIOCHEM PHARMACOL, V69, P867, DOI 10.1016/j.bcp.2004.11.025; Fang F, 2016, ANAL CHIM ACTA, V945, P39, DOI 10.1016/j.aca.2016.09.032; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; Hakkola J, 2018, BASIC CLIN PHARMACOL, V123, P42, DOI 10.1111/bcpt.13004; Han S, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700079; Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001; Henkens T, 2007, TOXICOL APPL PHARM, V218, P64, DOI 10.1016/j.taap.2006.10.012; Hitosugi T, 2014, ONCOGENE, V33, P4279, DOI 10.1038/onc.2013.406; Hu Z, 2000, J BIOL CHEM, V275, P2979, DOI 10.1074/jbc.275.4.2979; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kim SM, 2016, DRUG METAB REV, V48, P405, DOI 10.1080/03602532.2016.1195403; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Lazar MA, 2017, J CLIN INVEST, V127, P1123, DOI 10.1172/JCI92949; Losman JA, 2003, J BIOL CHEM, V278, P4800, DOI 10.1074/jbc.M208246200; Manikandan P, 2018, CURR DRUG TARGETS, V19, P38, DOI 10.2174/1389450118666170125144557; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Nakatsukasa K, 2015, CRIT REV BIOCHEM MOL, V50, P489, DOI 10.3109/10409238.2015.1081869; O'Connor CM, 2018, INT J BIOCHEM CELL B, V96, P182, DOI 10.1016/j.biocel.2017.10.008; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Sausville LN, 2019, PHARMACOL THERAPEUT, V196, P183, DOI 10.1016/j.pharmthera.2018.11.009; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Taneja G, 2018, DRUG METAB DISPOS, V46, P397, DOI 10.1124/dmd.117.079160; Tang J, 2015, ONCOTARGET, V6, P34831, DOI 10.18632/oncotarget.5225; Wang S, 2019, TOXICOLOGY, V412, P19, DOI 10.1016/j.tox.2018.11.011; Xie YQ, 2010, MOL PHARMACOL, V78, P310, DOI 10.1124/mol.109.061713; Yang YT, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040348; Yende AS, 2019, MOL CELL BIOCHEM, V461, P127, DOI 10.1007/s11010-019-03596-7; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang C, 2019, ENVIRON POLLUT, V253, P889, DOI 10.1016/j.envpol.2019.07.058	46	1	1	9	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101918	10.1016/j.jbc.2022.101918	http://dx.doi.org/10.1016/j.jbc.2022.101918			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35405096	gold, Green Published			2022-12-28	WOS:000817175700001
J	Mercier, R; LaPointe, P				Mercier, Rebecca; LaPointe, Paul			The role of cellular proteostasis in antitumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MHC CLASS-I; UNFOLDED PROTEIN RESPONSE; HEAT-SHOCK PROTEINS; HLA CLASS-I; TRANSCRIPTION FACTOR; MOLECULAR CHAPERONES; ANTIGEN PRESENTATION; ADVANCED MELANOMA; CLINICAL ACTIVITY; TUMOR-DEVELOPMENT	Immune checkpoint blockade therapy is perhaps the most important development in cancer treatment in recent memory. It is based on decades of investigation into the biology of immune cells and the role of the immune system in controlling cancer growth. While the molecular circuitry that governs the immune system in general-and antitumor immunity in particular-is intensely studied, far less attention has been paid to the role of cellular stress in this process. Proteostasis, intimately linked to cell stress responses, refers to the dynamic regulation of the cellular proteome and is maintained through a complex network of systems that govern the synthesis, folding, and degradation of proteins in the cell. Disruption of these systems can result in the loss of protein function, altered protein function, the formation of toxic aggregates, or pathologies associated with cell stress. However, the importance of proteostasis extends beyond its role in maintaining proper protein function; proteostasis governs how tolerant cells may be to mutations in protein-coding genes and the overall halflife of proteins. Such gene expression changes may be associated with human diseases including neurodegenerative diseases, metabolic disease, and cancer and manifest at the protein level against the backdrop of the proteostasis network in any given cellular environment. In this review, we focus on the role of proteostasis in regulating immune responses against cancer as well the role of proteostasis in determining immunogenicity of cancer cells.	[Mercier, Rebecca; LaPointe, Paul] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta	LaPointe, P (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB, Canada.				Alberta Cancer Foundation [27364]; Natural Sciences and Engineering Research Council [RGPIN-2019-04967]; Canadian Institutes of Health Research [178282]	Alberta Cancer Foundation; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding and additional information-The authors are supported by funding from the Alberta Cancer Foundation (27364) , the Natural Sciences and Engineering Research Council (RGPIN-2019-04967) , and the Canadian Institutes of Health Research (178282) .	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adams CJ, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00011; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Alam A, 2019, NEOPLASIA, V21, P945, DOI 10.1016/j.neo.2019.07.002; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Arshad N, 2018, J BIOL CHEM, V293, P9555, DOI 10.1074/jbc.RA118.002836; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Basler M, 2020, GENES IMMUN, V21, P273, DOI 10.1038/s41435-020-00109-1; Basler M, 2009, J IMMUNOL, V183, P6145, DOI 10.4049/jimmunol.0901596; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Bonaventura P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00168; Borst L, 2020, CLIN CANCER RES, V26, P5549, DOI 10.1158/1078-0432.CCR-19-2095; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Calderwood SK, 2016, TRENDS BIOCHEM SCI, V41, P311, DOI 10.1016/j.tibs.2016.01.003; Callahan MK, 2008, P NATL ACAD SCI USA, V105, P1662, DOI 10.1073/pnas.0711365105; Chambers JE, 2008, J BIOL CHEM, V283, P1862, DOI 10.1074/jbc.M708196200; Chang LC, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/5068701; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen YC, 2019, CANCER IMMUNOL RES, V7, P123, DOI 10.1158/2326-6066.CIR-18-0124; Chou CW, 2020, AM J CANCER RES, V10, P2621; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dasgupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103604; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Noblejas-Lopez MD, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1629780; Dhatchinamoorthy K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.636568; Dierssen JWF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-33; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Finn JD, 2010, MOL THER, V18, P135, DOI 10.1038/mt.2009.257; Firat E, 2009, CANCER RES, V69, P3325, DOI 10.1158/0008-5472.CAN-08-3269; Fisette O, 2020, P NATL ACAD SCI USA, V117, P20597, DOI 10.1073/pnas.2004445117; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2007, CURR OPIN IMMUNOL, V19, P99, DOI 10.1016/j.coi.2006.11.013; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gaudino SJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00360; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Gettinger SN, 2018, J THORAC ONCOL, V13, P831, DOI 10.1016/j.jtho.2018.03.008; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gooden MJM, 2012, ONCOIMMUNOLOGY, V1, P92, DOI 10.4161/onci.1.1.17961; GORELIK E, 1983, ADV CANCER RES, V39, P71, DOI 10.1016/S0065-230X(08)61033-7; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Harada A, 2015, PATHOL INT, V65, P569, DOI 10.1111/pin.12343; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harshbarger W, 2015, STRUCTURE, V23, P418, DOI 10.1016/j.str.2014.11.017; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslam A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2535; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He SN, 2021, J CELL MOL MED, V25, P1415, DOI 10.1111/jcmm.16227; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Heink S, 2006, CANCER RES, V66, P649, DOI 10.1158/0008-5472.CAN-05-2872; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hillary RF, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0453-1; Hirano F, 2005, CANCER RES, V65, P1089; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Hsu FF, 2019, ONCOGENE, V38, P1688, DOI 10.1038/s41388-018-0539-y; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Ishigami S, 2015, ANTICANCER RES, V35, P2279; Ito S, 2020, CANCERS, V12, DOI 10.3390/cancers12020265; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jaeger AM, 2019, CLIN CANCER RES, V25, P6392, DOI 10.1158/1078-0432.CCR-19-0596; Javed A, 2017, ACTA CRYSTALLOGR D, V73, P509, DOI 10.1107/S2059798317007446; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Kastle M, 2012, PROG MOL BIOL TRANSL, V109, P113, DOI 10.1016/B978-0-12-397863-9.00004-3; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kobayashi M, 2015, LUNG CANCER, V90, P342, DOI 10.1016/j.lungcan.2015.08.015; Kochan G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26491; Kopp MC, 2019, NAT STRUCT MOL BIOL, V26, P1053, DOI 10.1038/s41594-019-0324-9; Koren J, 2020, ADV EXP MED BIOL, V1243, P135, DOI 10.1007/978-3-030-40204-4_9; Krijgsman D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124528; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazard S, 2015, MOL IMMUNOL, V68, P72, DOI 10.1016/j.molimm.2015.04.014; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lemin AJ, 2007, FEBS LETT, V581, P1819, DOI 10.1016/j.febslet.2007.03.069; Liang YH, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-021-00769-9; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Ling A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1356143; Liu YT, 2021, THERANOSTICS, V11, P5365, DOI 10.7150/thno.58390; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Marchingo JM, 2022, CELL MOL IMMUNOL, V19, P303, DOI 10.1038/s41423-021-00792-8; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; Marrero MC, 2021, ACS OMEGA, V6, P5091, DOI 10.1021/acsomega.0c05318; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; Newell F, 2022, CANCER CELL, V40, P88, DOI 10.1016/j.ccell.2021.11.012; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Oliveira CC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00298; Pallmann N, 2019, ONCOGENE, V38, P6301, DOI 10.1038/s41388-019-0879-2; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Powers ET, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167197; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reeves E, 2017, IMMUNOLOGY, V150, P16, DOI 10.1111/imm.12675; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; RUGGIERO RA, 1989, MEDICINA-BUENOS AIRE, V49, P277; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schwartz AL, 1999, ANNU REV MED, V50, P57; Seliger B, 1997, SCAND J IMMUNOL, V46, P625, DOI 10.1046/j.1365-3083.1997.d01-176.x; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Shaikh SR, 2008, SCAND J IMMUNOL, V68, P30, DOI 10.1111/j.1365-3083.2008.02113.x; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shionoya Y, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1274476; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Sokol L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0647-1; STARNES CO, 1992, NATURE, V357, P11, DOI 10.1038/357011a0; Strome SE, 2003, CANCER RES, V63, P6501; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Thuring C, 2015, BRIT J CANCER, V113, P952, DOI 10.1038/bjc.2015.297; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tripathi SC, 2016, P NATL ACAD SCI USA, V113, pE1555, DOI 10.1073/pnas.1521812113; Ulianich L, 2011, BBA-MOL BASIS DIS, V1812, P431, DOI 10.1016/j.bbadis.2010.12.013; van Deutekom HWM, 2015, IMMUNOGENETICS, V67, P425, DOI 10.1007/s00251-015-0849-y; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zavareh RB, 2021, CELL CHEM BIOL, V28, P158, DOI 10.1016/j.chembiol.2020.10.005; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	175	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101930	10.1016/j.jbc.2022.101930	http://dx.doi.org/10.1016/j.jbc.2022.101930			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35421375	gold, Green Published			2022-12-28	WOS:000817175700003
J	Ward, AS; Hsiung, CH; Kesterson, DG; Kamath, VG; McKee, EE				Ward, Avery S.; Hsiung, Chia-Heng; Kesterson, Daniel G.; Kamath, Vasudeva G.; McKee, Edward E.			Entecavir competitively inhibits deoxyguanosine and deoxyadenosine phosphorylation in isolated mitochondria and the perfused rat heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDINE KINASE 2; IN-VITRO SUPPLEMENTATION; DNA DEPLETION; HEPATITIS-B; SUBSTRATE-SPECIFICITY; DEOXYRIBONUCLEOTIDE POOLS; LACTIC-ACIDOSIS; METABOLISM; DEOXYNUCLEOSIDE; TOXICITY	Deoxyguanosine kinase (dGK) is reported responsible for the phosphorylation of deoxyadenosine (dA) and deoxyguanosine (dG) in the mitochondrial purine salvage pathway. Antiviral nucleoside analogs known as nucleoside reverse transcriptase inhibitors (NRTIs) must be phosphorylated by host enzymes for the analog to become active. We address the possibility that NRTI purine analogs may be competitive inhibitors of dGK. From a group of such analogs, we demonstrate that entecavir (ETV) competitively inhibited the phosphorylation of dG and dA in rat mitochondria. Mitochondria from the brain, heart, kidney, and liver showed a marked preference for phosphorylation of dG over dA (10-30-fold) and ETV over dA (2.5-4fold). We found that ETV inhibited the phosphorylation of dG with an IC50 of 15.3 +/- 2.2 mu M and that ETV and dG were both potent inhibitors of dA phosphorylation with IC50s of 0.034 +/- 0.007 and 0.028 +/- 0.006 mu M, respectively. In addition, the phosphorylation of dG and ETV followed Michaelis- Menten kinetics and each competitively inhibited the phosphorylation of the other. We observed that the kinetics of dA phosphorylation were strikingly different from those of dG phosphorylation, with an exponentially lower affinity for dGK and no effect of dA on dG or ETV phosphorylation. Finally, in an isolated heart perfusion model, we demonstrated that dG, dA, and ETV were phosphorylated and dG phosphorylation was inhibited by ETV. Taken together, these data demonstrate that dGK is inhibited by ETV and that the primary role of dGK is in the phosphorylation of dG rather than dA.	[Ward, Avery S.; Hsiung, Chia-Heng; Kesterson, Daniel G.; Kamath, Vasudeva G.; McKee, Edward E.] Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA; [Hsiung, Chia-Heng] Westlake Univ, Westlake Inst Adv Study, Sch Sci, Hangzhou, Zhejiang, Peoples R China; [Kesterson, Daniel G.] Univ Michigan Ann Arbor, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI USA; [Kamath, Vasudeva G.] Touro Coll Osteopath Med, Dept Basic Med Sci, Middletown, NY USA	Central Michigan University; Westlake University; University of Michigan System; University of Michigan	McKee, EE (corresponding author), Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA.	mckee1ee@cmich.edu		Hsiung, Chia-Heng/0000-0003-3542-587X	National Institute of Health Grant [R01/HL096480]	National Institute of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institute of Health Grant R01/HL096480. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Arya VB, 2019, CLIN ENDOCRINOL, V91, P900, DOI 10.1111/cen.14084; Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022; Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074; Camara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Cohen SM, 2009, J CLIN GASTROENTEROL, V43, P1008, DOI 10.1097/MCG.0b013e31819c3945; de Fuenmayor-Fernndez de la Hoz C. P., 2021, MOL GENET METAB REP, V26; Dominguez-Gonzalez C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z; El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003; Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Kamath VG, 2015, J BIOL CHEM, V290, P2034, DOI 10.1074/jbc.M114.624213; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; LAMPERTH L, 1991, LAB INVEST, V65, P742; Lange CM, 2009, HEPATOLOGY, V50, P2001, DOI 10.1002/hep.23346; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lin SC, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910849; Lynx MD, 2006, BIOCHEM PHARMACOL, V71, P1342, DOI 10.1016/j.bcp.2006.01.003; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07; McCann KA, 2012, J NEUROCHEM, V122, P126, DOI 10.1111/j.1471-4159.2012.07765.x; MCKEE EE, 1990, AM J PHYSIOL, V258, pE503, DOI 10.1152/ajpendo.1990.258.3.E503; MCKEE EE, 1990, AM J PHYSIOL, V258, pE492, DOI 10.1152/ajpendo.1990.258.3.E492; Morris GW, 2010, ANTIVIR THER, V15, P587, DOI 10.3851/IMP1567; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Osborn Melissa, 2011, Infect Drug Resist, V4, P55, DOI 10.2147/IDR.S4188; PODZUWEIT T, 1995, CELL SIGNAL, V7, P733, DOI 10.1016/0898-6568(95)00042-N; Robinson DM, 2006, DRUGS, V66, P1605, DOI 10.2165/00003495-200666120-00009; Saada A, 2004, DNA CELL BIOL, V23, P797; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; Sang L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.570656; Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000; Sjoberg AH, 1998, MOL PHARMACOL, V53, P270, DOI 10.1124/mol.53.2.270; Snowdin JW, 2015, ANTIMICROB AGENTS CH, V59, P6328, DOI 10.1128/AAC.01180-15; SNYDER FF, 1982, BIOCHIM BIOPHYS ACTA, V696, P299, DOI 10.1016/0167-4781(82)90061-6; Sun R, 2014, BIOCHEM BIOPH RES CO, V450, P1021, DOI 10.1016/j.bbrc.2014.06.098; Susan-Resiga D, 2007, ANTIMICROB AGENTS CH, V51, P1142, DOI 10.1128/AAC.01227-06; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001; Vanden Avond MA, 2021, J INHERIT METAB DIS, V44, P492, DOI 10.1002/jimd.12354; Waich S, 2019, J PEDIATR GASTR NUTR, V68, pE1, DOI 10.1097/MPG.0000000000002149; WANG LY, 1993, J BIOL CHEM, V268, P22847; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yamanaka G, 1999, ANTIMICROB AGENTS CH, V43, P190, DOI 10.1128/AAC.43.1.190; Zhou Li, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P751, DOI 10.3760/cma.j.issn.1007-3418.2012.10.009	51	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101876	10.1016/j.jbc.2022.101876	http://dx.doi.org/10.1016/j.jbc.2022.101876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35358513	Green Published, gold			2022-12-28	WOS:000804923000006
J	Molinar-Inglis, O; Wozniak, JM; Grimsey, NJ; Orduna-Castillo, LB; Cheng, N; Lin, Y; Ramirez, MLG; Birch, CA; Lapek, JD; Gonzalez, DJ; Trejo, J				Molinar-Inglis, Olivia; Wozniak, Jacob M.; Grimsey, Neil J.; Orduna-Castillo, Lennis B.; Cheng, Norton; Lin, Ying; Ramirez, Monica L. Gonzalez; Birch, Cierra A.; Lapek, John D.; Gonzalez, David J.; Trejo, JoAnn			Phosphoproteomic analysis of thrombin- and p38 MAPK-regulated signaling networks in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK ACTIVATION; ALPHA-CATENIN; BETA-CATENIN; KINASE-II; PROTEIN; PHOSPHORYLATION; TRANSACTIVATION; JUNCTIONS; STRATEGY; SWITCH	Endothelial dysfunction is a hallmark of inflammation and is mediated by inflammatory factors that signal through G protein-coupled receptors including protease-activated receptor-1 (PAR1). PAR1, a receptor for thrombin, signals via the small GTPase RhoA and myosin light chain intermediates to facilitate endothelial barrier permeability. PAR1 also induces endothelial barrier disruption through a p38 mitogen-activated protein kinase-dependent pathway, which does not integrate into the RhoA/MLC pathway; however, the PAR1-p38 signaling pathways that promote endothelial dysfunction remain poorly defined. To identify effectors of this pathway, we performed a global phosphoproteome analysis of thrombin signaling regulated by p38 in human cultured endothelial cells using multiplexed quantitative mass spectrometry. We identified 5491 unique phosphopeptides and 2317 phosphoproteins, four distinct dynamic phosphoproteome profiles of thrombin-p38 signaling, and an enrichment of biological functions associated with endothelial dysfunction, including modulators of endothelial barrier disruption and a subset of kinases predicted to regulate p38-dependent thrombin signaling. Using available antibodies to detect identified phosphosites of key p38 regulated proteins, we discovered that inhibition of p38 activity and siRNA-targeted depletion of the p38 alpha isoform increased basal phosphorylation of extracellular signal-regulated protein kinase 1/2, resulting in amplified thrombin-stimulated extra cellular signal-regulated protein kinase 1/2 phosphorylation that was dependent on PAR1. We also discovered a role for p38 in the phosphorylation of alpha-catenin, a component of adherens junctions, suggesting that this phosphorylation may function as an important regulatory process. Taken together, these studies define a rich array of thrombin-and p38-regulated candidate proteins that may serve important roles in endothelial dysfunction.	[Molinar-Inglis, Olivia; Wozniak, Jacob M.; Orduna-Castillo, Lennis B.; Cheng, Norton; Lin, Ying; Ramirez, Monica L. Gonzalez; Birch, Cierra A.; Lapek, John D.; Gonzalez, David J.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Wozniak, Jacob M.; Cheng, Norton] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Grimsey, Neil J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Gonzalez, David J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Cheng, Norton/0000-0002-0591-3963; Molinar-Inglis, Olivia/0000-0002-4974-9608	NIH/National Institute of General Medical Sciences (NIGMS) [R35 GM127121]; NIH/NIGMS [T32 GM007752, K12 GM068524]; UC President's Postdoctoral Fellowship Program; NIH/NIAMS [T32 AR064194]; NIH/NHLBI [T32 HL007444]	NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UC President's Postdoctoral Fellowship Program; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding and additional information-This work was supported by NIH/National Institute of General Medical Sciences (NIGMS) Grant R35 GM127121 (to J. T.), NIH/NIGMS Grant K12 GM068524 (O. M. I., J. D. L., M. R. G.), UC President's Postdoctoral Fellowship Program (O. M. I.), NIH/NIAMS T32 AR064194 (J. M. W.), NIH/NHLBI T32 HL007444 (C. A. B.), and NIH/NIGMS T32 GM007752 (N. C.). The content is solely the responsibility of the authors and does not necessarily represents the official views of the National institutes of health.	Aslam M, 2010, CARDIOVASC RES, V87, P375, DOI 10.1093/cvr/cvq065; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Chen L, 2010, J PROTEOME RES, V9, P174, DOI 10.1021/pr900338q; Chen X, 2013, BLOOD, V121, P3718, DOI 10.1182/blood-2012-10-461897; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1315s35, 10.1002/0471250953.bi1316s36]; De Nicola GF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121144; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2019, J BIOL CHEM, V294, P5867, DOI 10.1074/jbc.RA119.007495; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Indraccolo S., 2007, J IMMUNOL; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kaur J, 2003, AM J PHYSIOL-HEART C, V284, pH1095, DOI 10.1152/ajpheart.00016.2002; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lapek JD, 2017, MOL CELL PROTEOMICS, V16, P1447, DOI 10.1074/mcp.M116.066019; Lapek JD, 2017, NAT BIOTECHNOL, V35, P983, DOI 10.1038/nbt.3955; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Lin Y., 2020, PROC NATL ACAD; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; McGough IJ, 2014, J CELL SCI, V127, P4940, DOI 10.1242/jcs.156299; Needham EJ, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau8645; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rada CC, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abc1044; Rao HV, 2009, NEUROSCI LETT, V450, P347, DOI 10.1016/j.neulet.2008.12.018; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Tanno M., 2003, DIVERSE MECH MYOCARD; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Tolonen AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51416; Wang CW, 2020, GENOM PROTEOM BIOINF, V18, P72, DOI 10.1016/j.gpb.2020.01.001; Wozniak JM, 2019, PEERJ, V7, DOI 10.7717/peerj.7046; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Xie LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161397; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	57	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101801	10.1016/j.jbc.2022.101801	http://dx.doi.org/10.1016/j.jbc.2022.101801			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35257745	Green Published, gold			2022-12-28	WOS:000793502000008
J	Zhang, C; Zhao, W; Duvall, SW; Kowallis, KA; Childers, WS				Zhang, Chao; Zhao, Wei; Duvall, Samuel W.; Kowallis, Kimberly A.; Childers, W. Seth			Regulation of the activity of the bacterial histidine kinase PleC by the scaffolding protein PodJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCALIZATION FACTOR; PHASE-SEPARATION; CELL; DOMAINS; LIGHT; ATP; ATTACHMENT; EXPRESSION; SENSOR	Scaffolding proteins can customize the response of signaling networks to support cell development and behaviors. PleC is a bifunctional histidine kinase whose signaling activity coordinates asymmetric cell division to yield a motile swarmer cell and a stalked cell in the gram-negative bacterium Caulobacter crescentus. Past studies have shown that PleC's switch in activity from kinase to phosphatase correlates with a change in its subcellular localization pattern from diffuse to localized at the new cell pole. Here we investigated how the bacterial scaffolding protein PodJ regulates the subcellular positioning and activity of PleC. We reconstituted the PleC-PodJ signaling complex through both heterologous expressions in Escherichia coli and in vitro studies. In vitro, PodJ phase separates as a biomolecular condensate that recruits PleC and inhibits its kinase activity. We also constructed an in vivo PleC-CcaS chimeric histidine kinase reporter assay and demonstrated using this method that PodJ leverages its intrinsically disordered region to bind to PleC's PAS sensory domain and regulate PleC-CcaS signaling. Regulation of the PleC-CcaS was most robust when PodJ was concentrated at the cell poles and was dependent on the allosteric coupling between PleC-CcaS's PAS sensory domain and its downstream histidine kinase domain. In conclusion, our in vitro biochemical studies suggest that PodJ phase separation may be coupled to changes in PleC enzymatic function. We propose that this coupling of phase separation and allosteric regulation may be a generalizable phenomenon among enzymes associated with biomolecular condensates.& nbsp;	[Zhang, Chao; Zhao, Wei; Duvall, Samuel W.; Kowallis, Kimberly A.; Childers, W. Seth] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Childers, WS (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	wschild@pitt.edu	Zhang, Chao/AHC-8871-2022; Childers, Seth/I-6063-2017	Zhang, Chao/0000-0002-3836-151X; Duvall, Samuel/0000-0002-3133-7592; Kowallis, Kimberly/0000-0003-3038-0596; Childers, Seth/0000-0003-1160-7767	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This research was funded through the University of Pittsburgh Start-up funds to W. S. C.	Al-Husini N, 2020, MOL CELL, V78, P670, DOI 10.1016/j.molcel.2020.04.001; Al-Husini N, 2018, MOL CELL, V71, P1027, DOI 10.1016/j.molcel.2018.08.003; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Aretakis James R., 2019, MSYSTEMS, V4; Azaldegui CA, 2021, BIOPHYS J, V120, P1123, DOI 10.1016/j.bpj.2020.09.023; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Blair JA, 2013, STRUCTURE, V21, P1590, DOI 10.1016/j.str.2013.06.024; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Chen JC, 2006, EMBO J, V25, P377, DOI 10.1038/sj.emboj.7600935; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Cohan MC, 2020, TRENDS BIOCHEM SCI, V45, P668, DOI 10.1016/j.tibs.2020.04.011; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Curtis PD, 2012, MOL MICROBIOL, V84, P712, DOI 10.1111/j.1365-2958.2012.08055.x; Del Medico L, 2020, P NATL ACAD SCI USA, V117, P9546, DOI 10.1073/pnas.1920143117; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; ELY B, 1991, METHOD ENZYMOL, V204, P372; Emenecker R. J., 2021, METAPREDICT FAST ACC, V2021; Fare CM, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.210137; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guilhas B, 2020, MOL CELL, V79, P293, DOI 10.1016/j.molcel.2020.06.034; Harami GM, 2020, P NATL ACAD SCI USA, V117, P26206, DOI 10.1073/pnas.2000761117; Heinkel F., 2019, PROC NATL; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hinz AJ, 2003, MOL MICROBIOL, V47, P929, DOI 10.1046/j.1365-2958.2003.03349.x; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmes JA, 2016, P NATL ACAD SCI USA, V113, P12490, DOI 10.1073/pnas.1602380113; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Ladouceur AM, 2020, P NATL ACAD SCI USA, V117, P18540, DOI 10.1073/pnas.2005019117; Lasker K, 2020, NAT MICROBIOL, V5, P418, DOI 10.1038/s41564-019-0647-7; Lawler ML, 2006, MOL MICROBIOL, V59, P301, DOI 10.1111/j.1365-2958.2005.04935.x; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lyon AS, 2021, NAT REV MOL CELL BIO, V22, P215, DOI 10.1038/s41580-020-00303-z; MacCready JS, 2020, MOL BIOL EVOL, V37, P1434, DOI 10.1093/molbev/msz308; Mann TH, 2018, P NATL ACAD SCI USA, V115, pE7166, DOI 10.1073/pnas.1808543115; Mann TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11454; Mehringer J, 2021, CELL REP PHYS SCI, V2, DOI 10.1016/j.xcrp.2021.100343; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monterroso B, 2019, EMBO REP, V20, DOI 10.15252/embr.201845946; Nakajima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37595; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Pattanayak GK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108032; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Peeples W, 2021, NAT CHEM BIOL, V17, P693, DOI 10.1038/s41589-021-00801-x; Perez AM, 2017, MBIO, V8, DOI 10.1128/mBio.02238-16; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robles-Ramos M.A., 1868, BBA-MOL CELL RES; Saurabh S, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm6570; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tibble RW, 2021, NAT CHEM BIOL, V17, P615, DOI 10.1038/s41589-021-00774-x; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; Wang JF, 2021, ACS SYNTH BIOL, V10, P1605, DOI 10.1021/acssynbio.1c00090; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wunder T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07624-w; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	67	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101683	10.1016/j.jbc.2022.101683	http://dx.doi.org/10.1016/j.jbc.2022.101683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35124010	Green Published, gold			2022-12-28	WOS:000793560400012
J	Taylor, JL; Brown, BL				Taylor, Jessica L.; Brown, Breann L.			Structural basis for dysregulation of aminolevulinic acid synthase in human disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LINKED SIDEROBLASTIC ANEMIA; ERYTHROID 5-AMINOLEVULINATE SYNTHASE; SUCCINYL-COA SYNTHETASE; ALAS2 MUTATION; DOMINANT PROTOPORPHYRIA; HEME-BIOSYNTHESIS; TERMINAL REGION; INITIAL-STAGES; GENE; IDENTIFICATION	Heme is a critical biomolecule that is synthesized in vivo by several organisms such as plants, animals, and bacteria. Reflecting the importance of this molecule, defects in heme biosynthesis underlie several blood disorders in humans. Aminolevulinic acid synthase (ALAS) initiates heme biosynthesis in alpha-proteobacteria and nonplant eukaryotes. Debilitating and painful diseases such as X-linked sideroblastic anemia and X-linked protoporphyria can result from one of more than 91 genetic mutations in the human erythroidspecific enzyme ALAS2. This review will focus on recent structure-based insights into human ALAS2 function in health and how it dysfunctions in disease. We will also discuss how certain genetic mutations potentially result in disease-causing structural perturbations. Furthermore, we use thermodynamic and structural information to hypothesize how the mutations affect the human ALAS2 structure and categorize some of the unique human ALAS2 mutations that do not respond to typical treatments, that have paradoxical in vitro activity, or that are highly intolerable to changes. Finally, we will examine where future structure-based insights into the family of ALA synthases are needed to develop additional enzyme therapeutics.	[Taylor, Jessica L.; Brown, Breann L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN USA; [Brown, Breann L.] Vanderbilt Univ, Sch Med, Ctr Struct Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Brown, BL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN USA.; Brown, BL (corresponding author), Vanderbilt Univ, Sch Med, Ctr Struct Biol, Nashville, TN USA.	breann.brown@vanderbilt.edu		Taylor, Jessica/0000-0003-4083-7545	Molecular Biophysics Training Grant [T32GM008320]; United Mitochondrial Disease Foundation [ESPI-2020-0003]; National Institute of General Medical Sci-ences of the National Institutes of Health [DP2GM146255]	Molecular Biophysics Training Grant; United Mitochondrial Disease Foundation; National Institute of General Medical Sci-ences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J. L. T. was supported by the Molecular Biophysics Training Grant (T32GM008320) . B. L. B. issupported by the United Mitochondrial Disease Foundation (ESPI-2020-0003) and by the National Institute of General Medical Sci-ences of the National Institutes of Health (DP2GM146255) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aivado M, 2006, BLOOD CELL MOL DIS, V37, P40, DOI 10.1016/j.bcmd.2006.04.003; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bailey HJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16586-x; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Balwani M, 2012, BLOOD, V120, P4496, DOI 10.1182/blood-2012-05-423186; Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244; Besur S, 2014, METABOLITES, V4, P977, DOI 10.3390/metabo4040977; Bishop DF, 2013, MOL MED, V19, P18, DOI 10.2119/molmed.2013.00003; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; BISHOP DF, 1990, NUCLEIC ACIDS RES, V18, P7187, DOI 10.1093/nar/18.23.7187; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008; Brown BL, 2018, STRUCTURE, V26, P580, DOI 10.1016/j.str.2018.02.012; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Burch JS, 2018, BLOOD, V132, P987, DOI 10.1182/blood-2018-01-829036; Cao HL, 2019, J CHEM INF MODEL, V59, P1508, DOI 10.1021/acs.jcim.8b00697; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; COTTER PD, 1995, J CLIN INVEST, V96, P2090, DOI 10.1172/JCI118258; COTTER PD, 1995, CYTOGENET CELL GENET, V69, P207, DOI 10.1159/000133964; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; Creasey T, 2018, BRIT J HAEMATOL, V180, P10, DOI 10.1111/bjh.14909; Creixell P, 2012, PHILOS T R SOC B, V367, P2584, DOI 10.1098/rstb.2012.0076; Dailey HA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011676; de Gennes C, 2022, BRIT J HAEMATOL, V196, pE17, DOI 10.1111/bjh.17810; Donker AE, 2014, NETH J MED, V72, P210; Doshi BS, 2014, AM J BLOOD RES, V4, P41; Ducamp S, 2013, HUM MOL GENET, V22, P1280, DOI 10.1093/hmg/dds531; Ducamp S, 2011, HUM MUTAT, V32, P590, DOI 10.1002/humu.21455; Edgar AJ, 1998, BRIT J HAEMATOL, V100, P389; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fang RG, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00622-3; Fratz-Berilla EJ, 2017, BBA-MOL BASIS DIS, V1863, P428, DOI 10.1016/j.bbadis.2016.11.011; Fujiwara T, 2017, ANN HEMATOL, V96, P1955, DOI 10.1007/s00277-017-3106-7; Furuyama K, 1997, BLOOD, V90, P822, DOI 10.1182/blood.V90.2.822.822_822_830; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; GIBSON KD, 1958, BIOCHEM J, V70, P71, DOI 10.1042/bj0700071; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Gotoh S, 2011, GENE, V472, P28, DOI 10.1016/j.gene.2010.10.008; Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4; Hoffman M, 2003, BIOCHEM BIOPH RES CO, V310, P1247, DOI 10.1016/j.bbrc.2003.09.151; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; Kardon JR, 2020, ELIFE, V9, DOI 10.7554/eLife.54387; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Katsurada T, 2016, INT J HEMATOL, V103, P713, DOI 10.1007/s12185-016-1949-7; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; Koike M, 1976, Adv Biophys, P187; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Kucerova J, 2011, ACTA HAEMATOL-BASEL, V125, P193, DOI 10.1159/000322870; LAVER WG, 1958, BIOCHEM J, V70, P4, DOI 10.1042/bj0700004; Le Rouzic MA, 2017, BLOOD CELL MOL DIS, V66, P11, DOI 10.1016/j.bcmd.2017.07.003; Lee JS, 2017, ANN CLIN LAB SCI, V47, P319; Li J, 2020, INT J LAB HEMATOL, V42, pE160, DOI 10.1111/ijlh.13214; Zidanes AL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.581386; Liu G, 2013, HAEMATOLOGICA, V98, pE158, DOI 10.3324/haematol.2013.095513; Liu JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06883-x; May A, 1998, HAEMATOLOGICA, V83, P56; May A. K., 2006, 11 C EUR HEM ASS PAV; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Mendez M, 2016, MOL GENET GENOM MED, V4, P273, DOI 10.1002/mgg3.202; MERRILL AH, 1990, ANN NY ACAD SCI, V585, P110, DOI 10.1111/j.1749-6632.1990.tb28047.x; Moon SY, 2014, ANN LAB MED, V34, P159, DOI 10.3343/alm.2014.34.2.159; Moreno-Carralero MI, 2019, INT J LAB HEMATOL, V41, pE5, DOI 10.1111/ijlh.12902; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parker CJ, 2019, MOL GENET METAB, V128, P309, DOI 10.1016/j.ymgme.2019.07.017; Percy MJ, 2006, J CLIN PATHOL, V59, P1002, DOI 10.1136/jcp.2005.030932; Pereira J. C., 2004, HUM GENET, V115, P533; Pereira Janet Carvalho, 2009, Hum Genet, V126, P333; Ponka P, 1997, BLOOD, V89, P1; Qiu Y, 2020, ANN HEMATOL, V99, P371, DOI 10.1007/s00277-019-03894-6; RADIN NS, 1950, J BIOL CHEM, V184, P755; Rondelli CM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100972; Rose C, 2017, BRIT J HAEMATOL, V178, P648, DOI 10.1111/bjh.14164; SANADI DR, 1952, J BIOL CHEM, V197, P851; Sankaran VG, 2015, J CLIN INVEST, V125, P1665, DOI 10.1172/JCI78619; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; SHEMIN D, 1946, J BIOL CHEM, V166, P621; SHEMIN D, 1952, J BIOL CHEM, V198, P827; Stenson PD, 2020, HUM GENET, V139, P1197, DOI 10.1007/s00439-020-02199-3; Stojanovski BM, 2019, MOL GENET METAB, V128, P178, DOI 10.1016/j.ymgme.2019.06.003; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; Tchaikovskii V, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0070-9; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; To-Figueras J, 2011, BLOOD, V118, P1443, DOI 10.1182/blood-2011-03-342873; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yien YY, 2017, P NATL ACAD SCI USA, V114, pE8045, DOI 10.1073/pnas.1700632114; Zhang YC, 2017, NUCLEIC ACIDS RES, V45, P657, DOI 10.1093/nar/gkw901; Zhu P, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P478	99	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101643	10.1016/j.jbc.2022.101643	http://dx.doi.org/10.1016/j.jbc.2022.101643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35093382	gold, Green Published			2022-12-28	WOS:000789261900007
J	Vanselow, S; Neumann-Arnold, L; Wojciech-Moock, F; Seufert, W				Vanselow, Sven; Neumann-Arnold, Lea; Wojciech-Moock, Franziska; Seufert, Wolfgang			Stepwise assembly of the eukaryotic translation initiation factor 2 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INTELLECTUAL DISABILITY; BETA-SUBUNIT; TRANSFER-RNA; CELL-CYCLE; PROTEIN; EIF2-GAMMA; MECHANISM; GENES; IDENTIFICATION	The eukaryotic translation initiation factor 2 (eIF2) has key functions in the initiation step of protein synthesis. eIF2 guides the initiator tRNA to the ribosome, participates in scanning of the mRNA molecule, supports selection of the start codon, and modulates the translation of mRNAs in response to stress. eIF2 comprises a heterotrimeric complex whose assembly depends on the ATP-grasp protein Cdc123. Mutations of the eIF2 gamma subunit that compromise eIF2 complex formation cause severe neurological disease in humans. To this date, however, details about the assembly mechanism, step order, and the individual functions of eIF2 subunits remain unclear. Here, we quantified assembly intermediates and studied the behavior of various binding site mutants in budding yeast. Based on these data, we present a model in which a Cdc123-mediated conformational change in eIF2 gamma exposes binding sites for eIF2 alpha and eIF2 beta subunits. Contrary to an earlier hypothesis, we found that the associations of eIF2 alpha and eIF2 beta with the gamma-subunit are independent of each other, but the resulting heterodimers are nonfunctional and fail to bind the guanosine exchange factor eIF2B. In addition, levels of eIF2 alpha influence the rate of eIF2 assembly. By binding to eIF2 gamma, eIF2 alpha displaces Cdc123 and thereby completes the assembly process. Experiments in human cell culture indicate that the mechanism of eIF2 assembly is conserved between yeast and humans. This study sheds light on an essential step in eukaryotic translation initiation, the dysfunction of which is linked to human disease.	[Vanselow, Sven; Neumann-Arnold, Lea; Wojciech-Moock, Franziska; Seufert, Wolfgang] Univ Regensburg, Regensburg Ctr Biochem, Dept Genet, Regensburg, Germany	University of Regensburg	Seufert, W (corresponding author), Univ Regensburg, Regensburg Ctr Biochem, Dept Genet, Regensburg, Germany.	wolfgang.seufert@ur.de			Deutsche Forschungsgemeinschaft (DFG) [SFB960]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through a project grant to W. S. (SFB960, B10)	Adomavicius T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10167-3; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Das S, 1997, J BIOL CHEM, V272, P31712, DOI 10.1074/jbc.272.50.31712; Dever T. E., 2016, GENETICS, V203, P65; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gordiyenko Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10606-1; Hashem Y, 2018, ANNU REV BIOPHYS, V47, P125, DOI 10.1146/annurev-biophys-070816-034034; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoja MR, 2000, EXP CELL RES, V259, P239, DOI 10.1006/excr.2000.4948; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marintchev A, 2020, BIOCHEMISTRY-US, V59, P1299, DOI 10.1021/acs.biochem.0c00132; Moortgat S, 2016, AM J MED GENET A, V170, P2927, DOI 10.1002/ajmg.a.37792; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naveau M, 2010, BIOCHEMISTRY-US, V49, P8680, DOI 10.1021/bi1009166; OHNO K, 1984, SOMAT CELL MOLEC GEN, V10, P17, DOI 10.1007/BF01534469; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Panvert M, 2015, STRUCTURE, V23, P1596, DOI 10.1016/j.str.2015.06.014; Perzlmaier AF, 2013, J BIOL CHEM, V288, P21537, DOI 10.1074/jbc.M113.472290; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Roll-Mecak A, 2004, J BIOL CHEM, V279, P10634, DOI 10.1074/jbc.M310418200; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; SIKORSKI RS, 1989, GENETICS, V122, P19; Sokabe M, 2006, P NATL ACAD SCI USA, V103, P13016, DOI 10.1073/pnas.0604165103; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2005, BIOCHEMISTRY-US, V44, P8749, DOI 10.1021/bi050373i; Young-Baird SK, 2020, MOL CELL, V77, P875, DOI 10.1016/j.molcel.2019.11.008	43	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101583	10.1016/j.jbc.2022.101583	http://dx.doi.org/10.1016/j.jbc.2022.101583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031321	Green Published, gold			2022-12-28	WOS:000761371500004
J	da Silva, EA; Corcini, CD; Camelo, FDA; Martins, D; Gheller, SMM; Haedrich, G; Dora, CL; Junior, ASV				da Silva, Edenara Anastacio; Corcini, Carine Dahl; Araujo Camelo Junior, Francisco de Assis; Martins, Diego; Gheller, Stela Mari Meneghello; Haedrich, Gabriela; Dora, Cristiana Lima; Junior, Antonio Sergio Varela			Probe ultrasonification of egg yolk plasma forms low-density lipoprotein nanoparticles that efficiently protect canine semen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-CHARGE NONUNIFORMITY; BOVINE SEMINAL PLASMA; SPERM; PRESERVATION	Around the world, many couples have turned to in vitro fertilization as a viable solution to fertility issues. Low-density lipoprotein (LDL) is a protein best known for transporting fat molecules throughout the body, but it has also been shown to protect sperm cells during cryopreservation due to its micellar structure. In the present study, we aimed to evaluate different protocols for the preparation of nanoparticles from egg yolk plasma (EYP) containing LDL to improve the viability of cry-opreserved canine semen. EYP was subjected to three distinct treatments: ultrasonification in an ultrasound bath at 40 kHz for 30 min (LDL-B); ultrasonification via an ultrasound probe at 50% amplitude for 30 min (LDL-P); and high-pressure homogenization at 10,000 PSI for six cycles (LDL-H). Sperm quality was assessed after thawing using computer-assisted sperm analysis and flow cytometry. The results revealed that compared to the EYP control, the LDL-P formulation pre-sented significantly higher efficiency (p < 0.05) in maintaining total and progressive sperm motility, sperm membrane integ-rity and fluidity, and levels of intracellular reactive oxygen species. The LDL-P nanoparticles had an average size of approximately 250 nm, a PDI value of 0.3, and -1.15 mV of zeta potential, which are very important because it is an indicator of the stability of a colloidal dispersion. Therefore, we conclude that ultrasonication of EYP using a probe is an efficient method for the preparation of LDL nanoparticles that would enhance the cryoprotection of semen during freezing.	[da Silva, Edenara Anastacio; Corcini, Carine Dahl; Araujo Camelo Junior, Francisco de Assis; Martins, Diego; Gheller, Stela Mari Meneghello] Univ Fed Pelotas, Fac Vet, Capao De Leao, Brazil; [Haedrich, Gabriela] Univ Vienna, Dept Pharmaceut Technol & Biopharm, Vienna, Austria; [Corcini, Carine Dahl] Univ Fed Rio Grande, Lab Nanotecnol Aplicada Saude, Rio Grande, Brazil; [Junior, Antonio Sergio Varela] Univ Fed Rio Grande, Reprod Anim Comparada, Inst Ciencias Biol, Rio Grande, Brazil	Universidade Federal de Pelotas; University of Vienna; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	Junior, ASV (corresponding author), Univ Fed Rio Grande, Reprod Anim Comparada, Inst Ciencias Biol, Rio Grande, Brazil.	varelajras@gmail.com	Varela, Antonio Sergio/AAW-3798-2020; Dora, Cristiana Lima/AAF-9520-2021	Varela, Antonio Sergio/0000-0003-4901-5118; Dora, Cristiana Lima/0000-0002-9198-437X	National Institutes of Health, United States [GM019629]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, United States Grant GM019629 (to S. A. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2017, EUR J BIOPHYS, DOI DOI 10.1002/chem.201301060; Belala R, 2016, ANIM REPROD SCI, V168, P100, DOI 10.1016/j.anireprosci.2016.02.032; Bergeron A, 2004, BIOL REPROD, V70, P708, DOI 10.1095/biolreprod.103.022996; Christiansen I. J., 1986, REPROD DOG CAT, P363; Corcini CD, 2016, ANDROLOGIA, V48, P114, DOI 10.1111/and.12411; Dagastine RR, 2006, SCIENCE, V313, P210, DOI 10.1126/science.1125527; Feick JD, 2004, LANGMUIR, V20, P3090, DOI 10.1021/la0355545; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Gadella BM, 2001, ANIM REPROD SCI, V68, P249, DOI 10.1016/S0378-4320(01)00161-0; Gao D, 2000, ILAR J, V41, P187; GAVELLA M, 1992, ARCH ANDROLOGY, V28, P135, DOI 10.3109/01485019208987691; GRAHAM JK, 1987, CRYOBIOLOGY, V24, P42, DOI 10.1016/0011-2240(87)90005-8; Iguer-ouada M, 2001, THERIOGENOLOGY, V55, P671, DOI 10.1016/S0093-691X(01)00435-6; Le Guillou J, 2016, COLLOID SURFACE B, V140, P523, DOI 10.1016/j.colsurfb.2015.11.034; Len JS, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191601; Martinez-Pastor F, 2010, REPROD DOMEST ANIM, V45, P67, DOI 10.1111/j.1439-0531.2010.01622.x; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Patist A, 2005, COLLOID SURFACE B, V40, P107, DOI 10.1016/j.colsurfb.2004.05.003; Perry CT, 2019, AQUACULTURE, V508, P90, DOI 10.1016/j.aquaculture.2019.03.015; Silva EF, 2016, TOXICOL IN VITRO, V35, P31, DOI 10.1016/j.tiv.2016.05.002; Velegol D, 2001, LANGMUIR, V17, P7687, DOI 10.1021/la010634z	21	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7								10.1016/j.jbc.2022.101975	http://dx.doi.org/10.1016/j.jbc.2022.101975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3F8ED	35489470	Green Published, gold			2022-12-28	WOS:000830894600009
J	Michell, DL; Allen, RM; Cavnar, AB; Contreras, DM; Yu, MZ; Semler, EM; Massick, C; Raby, CA; Castleberry, M; Ramirez, MA; Zhu, WY; May-Zhang, LD; Ifrim, A; Carr, JJ; Terry, JG; Schwendeman, A; Davies, SS; Sheng, QH; Linton, MF; Vickers, KC				Michell, Danielle L.; Allen, Ryan M.; Cavnar, Ashley B.; Contreras, Danielle M.; Yu, Minzhi; Semler, Elizabeth M.; Massick, Clark; Raby, Chase A.; Castleberry, Mark; Ramirez, Marisol A.; Zhu, Wanying; May-Zhang, Linda; Ifrim, Anca; Carr, John Jeffrey; Terry, James G.; Schwendeman, Anna; Davies, Sean S.; Sheng, Quanhu; Linton, MacRae F.; Vickers, Kasey C.			Elucidation of physico-chemical principles of high-density lipoprotein-small RNA binding interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY CALCIUM; DIETARY TRANS FAT; HDL; STRESS; DNA; IDENTIFICATION; TRANSLATION; METHYLATION; CONSUMPTION; MICRORNAS	Extracellular small RNAs (sRNAs) are abundant in many biofluids, but little is known about their mechanisms of transport and stability in RNase-rich environments. We previously reported that high-density lipoproteins (HDLs) in mice were enriched with multiple classes of sRNAs derived from the endogenous transcriptome, but also from exogenous organisms. Here, we show that human HDL transports tRNA-derived sRNAs (tDRs) from host and nonhost species, the profiles of which were found to be altered in human atherosclerosis. We hypothesized that HDL binds to tDRs through apolipoprotein A-I (apoA-I) and that these interactions are conferred by RNAspecific features. We tested this using microscale thermophoresis and electrophoretic mobility shift assays and found that HDL binds to tDRs and other single-stranded sRNAs with strong affinity but did not bind to double-stranded RNA or DNA. Furthermore, we show that natural and synthetic RNA modifications influenced tDR binding to HDL. We demonstrate that reconstituted HDL bound to tDRs only in the presence of apoA-I, and purified apoA-I alone were able to bind sRNA. Conversely, phosphatidylcholine vesicles did not bind tDRs. In summary, we conclude that HDL binds to singlestranded sRNAs likely through nonionic interactions with enable extracellular RNA communication and provide a foundation for future studies to manipulate HDL-sRNA interactions for therapeutic approaches to prevent or treat disease.	[Michell, Danielle L.; Allen, Ryan M.; Cavnar, Ashley B.; Contreras, Danielle M.; Massick, Clark; Raby, Chase A.; Castleberry, Mark; Zhu, Wanying; Ifrim, Anca; Linton, MacRae F.; Vickers, Kasey C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Yu, Minzhi; Schwendeman, Anna] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Semler, Elizabeth M.; Vickers, Kasey C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ramirez, Marisol A.; Sheng, Quanhu] Vanderbilt Univ, Dept Biostat, Med Ctr, Nashville, TN USA; [May-Zhang, Linda; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Carr, John Jeffrey; Terry, James G.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Michell, DL; Vickers, KC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.; Vickers, KC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	danielle.michell@vumc.org; kasey.c.vickers@vumc.org	; Carr, John/A-1938-2012	Michell, Danielle/0000-0002-2048-4191; Yu, Minzhi/0000-0002-3141-7285; Terry, James/0000-0001-6659-3441; allen, ryan/0000-0002-8057-3436; Carr, John/0000-0002-4398-8237	American Heart Association, United States [16POST26630003]; Keck Foundation Medical Research Program; National Institutes of Health, United States [P01HL116263, P01CA229123, UH3CA241685, R01HL128996, R01CA260958]	American Heart Association, United States(American Heart Association); Keck Foundation Medical Research Program; National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the American Heart Association, United States 16POST26630003 (D. L.M.); W. M. Keck Foundation Medical Research Program (K. C. V.);and the National Institutes of Health, United States: P01HL116263(M. F. L, K. C. V.), P01CA229123 (K. C. V.), UH3CA241685 (K. C.V.), R01HL128996 (K. C. V.), and R01CA260958 (K. C. V.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aggarwal G, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101019; Akat KM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127317; Akiyama Y, 2020, RNA BIOL, V17, P1116, DOI 10.1080/15476286.2020.1732702; Allen RM, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1506198; Asztalos BF, 2011, CURR OPIN LIPIDOL, V22, P176, DOI 10.1097/MOL.0b013e3283468061; Axmann M, 2019, JOVE-J VIS EXP, DOI 10.3791/59573; Axmann M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110533; Ben-Aicha S, 2020, CARDIOVASC RES, V116, P1288, DOI 10.1093/cvr/cvz239; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2017, JAMA CARDIOL, V2, P391, DOI 10.1001/jamacardio.2016.5493; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; Desgagne V, 2017, EPIGENOMICS-UK, V9, P669, DOI 10.2217/epi-2016-0177; Desgagne V, 2017, CLIN CHEM LAB MED, V55, P667, DOI 10.1515/cclm-2016-0575; Desgagne V, 2016, EPIGENETICS-US, V11, P438, DOI 10.1080/15592294.2016.1176816; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Dhahbi JM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00074; Di Bartolo BA, 2011, ATHEROSCLEROSIS, V217, P395, DOI 10.1016/j.atherosclerosis.2011.04.001; Drino A, 2020, RNA BIOL, V17, P1104, DOI 10.1080/15476286.2020.1733798; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Florijn BW, 2019, DIABETES, V68, P2287, DOI 10.2337/db18-1360; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680 , 10.1517/17425250902877680]; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796; Guo LL, 2015, ANTIOXID REDOX SIGN, V22, P1633, DOI 10.1089/ars.2014.6078; Guzzi N, 2018, CELL, V173, P1204, DOI 10.1016/j.cell.2018.03.008; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kang M, 2016, CURR OPIN COLLOID IN, V26, P58, DOI 10.1016/j.cocis.2016.09.006; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li HM, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101642; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu DM, 2002, BBA-BIOMEMBRANES, V1563, P45, DOI 10.1016/S0005-2736(02)00384-X; May-Zhang LS, 2019, J BIOL CHEM, V294, P19022, DOI 10.1074/jbc.RA119.009424; May-Zhang LS, 2018, J BIOL CHEM, V293, P9176, DOI 10.1074/jbc.RA117.001099; Megel C, 2015, INT J MOL SCI, V16, P1873, DOI 10.3390/ijms16011873; Mengistu DH, 2009, J PHYS CHEM B, V113, P12277, DOI 10.1021/jp904986j; Michanek A, 2010, BBA-BIOMEMBRANES, V1798, P829, DOI 10.1016/j.bbamem.2009.12.009; Michell DL, 2016, JOVE-J VIS EXP, DOI 10.3791/54488; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Tosar JP, 2020, NUCLEIC ACIDS RES, V48, P12874, DOI 10.1093/nar/gkaa674; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Scicali R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56857-2; Sedgeman LR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40338-7; Seo Minguk, 2019, Curr Protoc Nucleic Acid Chem, V76, pe70, DOI 10.1002/cpnc.70; Shi JC, 2021, NAT CELL BIOL, V23, P424, DOI 10.1038/s41556-021-00652-7; Shigematsu M, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00562; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Suleymanoglu Erhan, 2006, PDA J Pharm Sci Technol, V60, P218; Tabet F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151061; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Talbot CPJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800027; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Torres LFC, 2019, ATHEROSCLEROSIS, V286, P20, DOI 10.1016/j.atherosclerosis.2019.04.227; Tosar JP, 2018, NUCLEIC ACIDS RES, V46, P9081, DOI 10.1093/nar/gky495; Tsujita M, 2021, FEBS LETT, V595, P773, DOI 10.1002/1873-3468.13950; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang YF, 2018, NAT CELL BIOL, V20, P535, DOI 10.1038/s41556-018-0087-2; Zhang YF, 2014, J MOL CELL BIOL, V6, P172, DOI 10.1093/jmcb/mjt052	72	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101952	10.1016/j.jbc.2022.101952	http://dx.doi.org/10.1016/j.jbc.2022.101952			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35447119	Green Submitted, Green Published, gold			2022-12-28	WOS:000807778400003
J	Theisen, FF; Salladini, E; Davidsen, R; Rasmussen, CJ; Staby, L; Kragelund, BB; Skriver, K				Theisen, Frederik Friis; Salladini, Edoardo; Davidsen, Rikke; Rasmussen, Christina Jo; Staby, Lasse; Kragelund, Birthe B.; Skriver, Karen			alpha alpha-hub coregulator structure and flexibility determine transcription factor binding and selection in regulatory interactomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-CAPACITY; DISORDER; TAF4; COACTIVATOR; ACTIVATION; MOTIF; SPECTROSCOPY; SPECIFICITY; PROTEINS; ANAC013	Formation of transcription factor (TF)-coregulator complexes is a key step in transcriptional regulation, with coregulators having essential functions as hub nodes in molecular networks. How specificity and selectivity are maintained in these nodes remain open questions. In this work, we addressed specificity in transcriptional networks using complexes formed between TFs and alpha alpha-hubs, which are defined by a common alpha alpha hairpin secondary structure motif, as a model. Using NMR spectroscopy and binding thermodynamics, we analyzed the structure, dynamics, stability, and ligand-binding properties of the Arabidopsis thaliana RST domains from TAF4 and known binding partner RCD1, and the TAFH domain from human TAF4, allowing comparison across species, functions, and architectural contexts. While these alpha alpha-hubs shared the alpha alpha hairpin motif, they differed in length and orientation of accessory helices as well as in their thermodynamic profiles of ligand binding. Whereas biologically relevant RCD1-ligand pairs displayed high affinity driven by enthalpy, TAF4-ligand interactions were entropy driven and exhibited less binding induced structuring. We in addition identified a thermal unfolding state with a structured core for all three domains, although the temperature sensitivity differed. Thermal stability studies suggested that initial unfolding of the RCD1-RST domain localized around helix 1, lending this region structural malleability, while effects in TAF4-RST were more stochastic, suggesting variability in structural adaptability upon binding. Collectively, our results support a model in which hub structure, flexibility, and binding thermodynamics contribute to alpha alpha hub-TF binding specificity, a finding of general relevance to the understanding of coregulator-ligand interactions and interactome sizes.	[Theisen, Frederik Friis; Salladini, Edoardo; Davidsen, Rikke; Rasmussen, Christina Jo; Staby, Lasse; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, REPIN & Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark; [Staby, Lasse; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Kragelund, BB; Skriver, K (corresponding author), Univ Copenhagen, REPIN & Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark.; Kragelund, BB (corresponding author), Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark.	bbk@bio.ku.dk; kskriver@bio.ku.dk	; Skriver, Karen/K-9860-2014	Theisen, Frederik Friis/0000-0002-3412-4242; Skriver, Karen/0000-0003-2225-4012	Novo Nordisk Foundation challenge grant REPIN [NNF18OC0033926]; Novo Nordisk Founda-tion, Denmark grant [NNF18OC0052177]	Novo Nordisk Foundation challenge grant REPIN; Novo Nordisk Founda-tion, Denmark grant	This work was supported by the Novo Nordisk Foundation challenge grant REPIN, rethinking protein interactions (grant no.: NNF18OC0033926; to B. B. K. and K. S.) . Support was also achieved from the Novo Nordisk Founda-tion, Denmark grant (grant no.: NNF18OC0052177; to K. S.) .	A.Shapiguzov, 2020, bioRxiv, DOI 10.1101/2020.07.02.184937; Adams GE, 2018, BIOCHEM J, V475, P3921, DOI 10.1042/BCJ20170314; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Alhindi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44948; Berlow RB, 2019, BIOCHEMISTRY-US, V58, P1354, DOI 10.1021/acs.biochem.8b01290; Berlow RB, 2017, NATURE, V543, P447, DOI 10.1038/nature21705; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Bugge K, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.REV120.012928; Bugge K, 2018, STRUCTURE, V26, P734, DOI 10.1016/j.str.2018.03.013; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; Christensen LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55385-3; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; EFIMOV AV, 1991, PROTEIN ENG, V4, P245, DOI 10.1093/protein/4.3.245; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Erkina TY, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0092-2; Ferreira RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056579; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gianni S, 2019, PROTEIN ENG DES SEL, V32, P355, DOI 10.1093/protein/gzz020; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Had Zi, 2021, P NATL ACAD SCI USA, V118; Hamborg L, 2020, ANAL BIOCHEM, V605, DOI 10.1016/j.ab.2020.113863; Henley MJ, 2020, P NATL ACAD SCI USA, V117, P27346, DOI 10.1073/pnas.2013244117; Jaspers P, 2010, PLANT SIGNAL BEHAV, V5, P78, DOI 10.4161/psb.5.1.10293; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jemth P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4130; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Kragelund BB, 2012, TRENDS PLANT SCI, V17, P625, DOI 10.1016/j.tplants.2012.06.010; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lawit SJ, 2007, PLANT MOL BIOL, V64, P73, DOI 10.1007/s11103-007-9135-1; Lawrence CW, 2014, J PHYS CHEM LETT, V5, P833, DOI 10.1021/jz402729x; Lawrence EJ, 2019, CURR BIOL, V29, P2676, DOI 10.1016/j.cub.2019.06.084; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Narayan A, 2019, BIOCHEMISTRY-US, V58, P2519, DOI 10.1021/acs.biochem.9b00089; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; O'Shea C, 2017, J BIOL CHEM, V292, P512, DOI 10.1074/jbc.M116.753426; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ravarani CNJ, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188190; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Sanborn AL, 2021, ELIFE, V10, DOI 10.7554/eLife.68068; Shapiguzov A, 2019, ELIFE, V8, DOI 10.7554/eLife.43284; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shirdel SA, 2019, EUR BIOPHYS J BIOPHY, V48, P305, DOI 10.1007/s00249-019-01362-7; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Staby L, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167320; Staby L, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-020-00686-8; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Theisen FF, 2021, J AM CHEM SOC, V143, P14540, DOI 10.1021/jacs.1c04214; Tian Y, 2014, J MAGN RESON, V243, P54, DOI 10.1016/j.jmr.2014.03.011; Tuttle LM, 2018, CELL REP, V22, P3251, DOI 10.1016/j.celrep.2018.02.097; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Wirthmueller L, 2018, NEW PHYTOL, V220, P232, DOI 10.1111/nph.15277; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	74	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101963	10.1016/j.jbc.2022.101963	http://dx.doi.org/10.1016/j.jbc.2022.101963			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452682	gold, Green Published			2022-12-28	WOS:000807750700004
J	Dennis, EA				Dennis, Edward A.			Allosteric regulation by membranes and hydrophobic subsites in phospholipase A(2) enzymes determine their substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; MIXED MICELLES; INHIBITORS; SUPERFAMILY; VESICLES	Lipids play critical roles in several major chronic diseases of our times, including those that involve inflammatory sequelae such as metabolic syndrome including obesity, insulin sensitivity, and cardiovascular diseases. However, defining the substrate specificity of enzymes of lipid metabolism is a challenging task. For example, phospholipase A(2) (PLA(2)) enzymes constitute a superfamily of degradative, biosynthetic, and signaling enzymes that all act stereospecifically to hydrolyze and release the fatty acids of membrane phospholipids. This review focuses on how membranes interact allosterically with enzymes to regulate cell signaling and metabolic pathways leading to inflammation and other diseases. Our group has developed "substrate lipidomics" to quantify the substrate phospholipid specificity of each PLA(2) and coupled this with molecular dynamics simulations to reveal that enzyme specificity is linked to specific hydrophobic binding subsites for membrane phospholipid substrates. We have also defined unexpected headgroup and acyl chain specificity for each of the major human PLA(2) enzymes, which explains the observed specificity at a structural level. Finally, we discovered that a unique hydrophobic binding site-and not each enzyme's catalytic residues or polar headgroup binding site-predominantly determines enzyme specificity. We also discuss how PLA(2)s release specific fatty acids after allosteric enzyme association with membranes and extraction of the phospholipid substrate, which can be blocked by stereospecific inhibitors. After decades of work, we can now correlate PLA(2) specificity and inhibition potency with molecular structure and physiological function.	[Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	edennis@ucsd.edu		Dennis, Edward A/0000-0003-3738-3140	NIH's National Institute of General Medical Sciences [R35 GM13964101, RO1GM20501-44]	NIH's National Institute of General Medical Sciences	Our laboratory's work on phospholipase A2 was supported by NIH's National Institute of General Medical Sciences over these past 45 years via RO1GM20501-44 and its recent renewal as a MIRA R35 GM13964101. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	BasuRay S, 2019, P NATL ACAD SCI USA, V116, P9521, DOI 10.1073/pnas.1901974116; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Cao J, 2013, J LIPID RES, V54, P127, DOI 10.1194/jlr.M030221; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dennis EA, 2016, J BIOL CHEM, V291, P24431, DOI 10.1074/jbc.X116.723791; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Hsu YH, 2013, J AM CHEM SOC, V135, P1330, DOI 10.1021/ja306490g; Kokotou MG, 2017, EXPERT OPIN THER PAT, V27, P217, DOI 10.1080/13543776.2017.1246540; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mouchlis VD, 2019, BBA-MOL CELL BIOL L, V1864, P766, DOI 10.1016/j.bbalip.2018.08.010; Mouchlis VD, 2019, J MED CHEM, V62, P1999, DOI 10.1021/acs.jmedchem.8b01568; Mouchlis VD, 2018, J AM CHEM SOC, V140, P3285, DOI 10.1021/jacs.7b12045; Mouchlis VD, 2016, BIOORGAN MED CHEM, V24, P4801, DOI 10.1016/j.bmc.2016.05.009; Mouchlis VD, 2016, J MED CHEM, V59, P4403, DOI 10.1021/acs.jmedchem.6b00377; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nikolaou A, 2019, BBA-MOL CELL BIOL L, V1864, P941, DOI 10.1016/j.bbalip.2018.08.009; Shirai Y, 2005, BBA-MOL CELL BIOL L, V1735, P119, DOI 10.1016/j.bbalip.2005.05.005	28	3	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101873	10.1016/j.jbc.2022.101873	http://dx.doi.org/10.1016/j.jbc.2022.101873			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35358512	Green Published, gold			2022-12-28	WOS:000860390500010
J	Harold, LK; Jinich, A; Hards, K; Cordeiro, A; Keighley, LM; Cross, A; McNeil, MB; Rhee, K; Cook, GM				Harold, Liam K.; Jinich, Adrian; Hards, Kiel; Cordeiro, Alexandra; Keighley, Laura M.; Cross, Alec; McNeil, Matthew B.; Rhee, Kyu; Cook, Gregory M.			Deciphering functional redundancy and energetics of malate oxidation in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; TUBERCULOSIS; DEHYDROGENASE; PROTEIN; METABOLISM; SMEGMATIS; HYPOXIA; GENE; MICE	Oxidation of malate to oxaloacetate, catalyzed by either malate dehydrogenase (Mdh) or malate quinone oxidoreduc-tase (Mqo), is a critical step of the tricarboxylic acid cycle. Both Mqo and Mdh are found in most bacterial genomes, but the level of functional redundancy between these enzymes remains unclear. A bioinformatic survey revealed that Mqo was not as widespread as Mdh in bacteria but that it was highly conserved in mycobacteria. We therefore used mycobacteria as a model genera to study the functional role(s) of Mqo and its redun-dancy with Mdh. We deleted mqo from the environmental saprophyte Mycobacterium smegmatis, which lacks Mdh, and found that Mqo was essential for growth on nonfermentable carbon sources. On fermentable carbon sources, the Delta mqo mutant exhibited delayed growth and lowered oxygen con-sumption and secreted malate and fumarate as terminal end products. Furthermore, heterologous expression of Mdh from the pathogenic species Mycobacterium tuberculosis shortened the delayed growth on fermentable carbon sources and restored growth on nonfermentable carbon sources at a reduced growth rate. In M. tuberculosis, CRISPR interference of either mdh or mqo expression resulted in a slower growth rate compared to controls, which was further inhibited when both genes were knocked down simultaneously. These data reveal that exergonic Mqo activity powers mycobacterial growth under nonenergy limiting conditions and that ender-gonic Mdh activity complements Mqo activity, but at an energetic cost for mycobacterial growth. We propose Mdh is maintained in slow-growing mycobacterial pathogens for use under conditions such as hypoxia that require reductive tricarboxylic acid cycle activity.	[Harold, Liam K.; Hards, Kiel; Keighley, Laura M.; Cross, Alec; McNeil, Matthew B.; Cook, Gregory M.] Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Harold, Liam K.; Hards, Kiel; McNeil, Matthew B.; Cook, Gregory M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Jinich, Adrian; Rhee, Kyu] Weill Cornell Med Coll, Weill Dept Med, Div Infect Dis, New York, NY USA	University of Otago; University of Auckland; Cornell University	Harold, LK; Cook, GM (corresponding author), Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.; Harold, LK; Cook, GM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.	liamharold@gmail.com; greg.cook@otago.ac.nz		Jinich, Adrian/0000-0001-8616-9250	Maurice Wilkins Centre; Marsden Fund; Royal Society; Hanna Gray Fellowship; Howard Hughes Medical Institute	Maurice Wilkins Centre; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society(Royal Society of London); Hanna Gray Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was financially supported by the Maurice Wilkins Centre for Molecular Bio-discovery and the Marsden Fund, Royal Society of New Zealand. A. J. was supported by a Hanna Gray Fellowship, Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Aung HL, 2015, MICROBIOL-SGM, V161, P648, DOI 10.1099/mic.0.000015; Aung HL, 2014, J BACTERIOL, V196, P3091, DOI 10.1128/JB.01771-14; Basu P, 2018, J BIOL CHEM, V293, P5695, DOI 10.1074/jbc.RA118.001839; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Berney M, 2014, P NATL ACAD SCI USA, V111, P11479, DOI 10.1073/pnas.1407034111; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fedrizzi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45258; Gourdon P, 2000, APPL ENVIRON MICROB, V66, P2981, DOI 10.1128/AEM.66.7.2981-2987.2000; Greening C, 2014, P NATL ACAD SCI USA, V111, P4257, DOI 10.1073/pnas.1320586111; Hards K, 2020, PROG BIOPHYS MOL BIO, V152, P35, DOI 10.1016/j.pbiomolbio.2019.11.003; Hards K, 2015, J ANTIMICROB CHEMOTH, V70, P2028, DOI 10.1093/jac/dkv054; Harold LK, 2019, J BIOL CHEM, V294, P2903, DOI 10.1074/jbc.RA118.006237; Hartuti ED, 2018, BBA-BIOENERGETICS, V1859, P191, DOI 10.1016/j.bbabio.2017.12.004; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Lamprecht DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12393; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; McNeil MB, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00492-20; McNeil MB, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00629-19; Mogi T, 2009, J BIOCHEM, V146, P491, DOI 10.1093/jb/mvp096; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Molenaar D, 1998, EUR J BIOCHEM, V254, P395, DOI 10.1046/j.1432-1327.1998.2540395.x; Nandakumar Madhumitha, 2015, Methods Mol Biol, V1285, P105, DOI 10.1007/978-1-4939-2450-9_6; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Puckett S, 2017, P NATL ACAD SCI USA, V114, pE2225, DOI 10.1073/pnas.1617655114; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rittershaus ESC, 2018, CELL CHEM BIOL, V25, P1495, DOI 10.1016/j.chembiol.2018.09.009; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; van der Rest ME, 2000, J BACTERIOL, V182, P6892, DOI 10.1128/JB.182.24.6892-6899.2000; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wu F, 2015, ANGEW CHEM INT EDIT, V54, P1851, DOI 10.1002/anie.201409336	45	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101859	10.1016/j.jbc.2022.101859	http://dx.doi.org/10.1016/j.jbc.2022.101859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35337802	gold, Green Published			2022-12-28	WOS:000804436700004
J	Komatsu, A; Iida, I; Nasu, Y; Ito, G; Harada, F; Kishikawa, S; Moss, SJ; Maeda, T; Terunuma, M				Komatsu, Ayaka; Iida, Izumi; Nasu, Yusuke; Ito, Genki; Harada, Fumiko; Kishikawa, Sari; Moss, Stephen J.; Maeda, Takeyasu; Terunuma, Miho			Ammonia induces amyloidogenesis in astrocytes by promoting amyloid precursor protein translocation into the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; GLUTAMINE-SYNTHETASE; CELL-SURFACE; SECRETASE CLEAVAGE; HUMAN MICROGLIA; TRAFFICKING; HYPERAMMONEMIA; DEGRADATION; ENDOCYTOSIS	Hyperammonemia is known to cause various neurological dysfunctions such as seizures and cognitive impairment. Several studies have suggested that hyperammonemia may also be linked to the development of Alzheimer's disease (AD). However, the direct evidence for a role of ammonia in the pathophysiology of AD remains to be discovered. Herein, we report that hyperammonemia increases the amount of mature amyloid precursor protein (mAPP) in astrocytes, the largest and most prevalent type of glial cells in the central nervous system that are capable of metabolizing glutamate and ammonia, and promotes amyloid beta (A beta) production. We demonstrate the accumulation of mAPP in astrocytes was primarily due to enhanced endocytosis of mAPP from the plasma membrane. A large proportion of internalized mAPP was targeted not to the lysosome, but to the endoplasmic resite APP cleaving enzyme 1) and gamma-secretase presenilin-1 are expressed, and mAPP is cleaved to produce A beta. Finally, we show the ammonia-induced production of A beta in astrocytic endoplasmic reticulum was specific to A beta 42, a principal component of senile plaques in AD patients. Our studies uncover a novel mechanism of A beta 42 production in astrocytes and also provide the first evidence that ammonia induces the pathogenesis of AD by regulating astrocyte function.	[Komatsu, Ayaka; Iida, Izumi; Nasu, Yusuke; Ito, Genki; Harada, Fumiko; Kishikawa, Sari; Terunuma, Miho] Niigata Univ, Fac Dent, Div Oral Biochem, Niigata, Japan; [Harada, Fumiko; Maeda, Takeyasu] Niigata Univ, Fac Dent, Ctr Adv Oral Sci, Niigata, Japan; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA USA; [Harada, Fumiko; Maeda, Takeyasu] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan	Niigata University; Niigata University; Tufts University; Niigata University	Terunuma, M (corresponding author), Niigata Univ, Fac Dent, Div Oral Biochem, Niigata, Japan.	mterunuma@dent.niigata-u.ac.jp		Terunuma, Miho/0000-0003-1876-9726; Maeda, Takeyasu/0000-0001-5317-7510				Adlimoghaddam A, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00057; Assentoft M, 2016, J BIOL CHEM, V291, P19184, DOI 10.1074/jbc.M116.740217; ATANASSOV CL, 1995, NEUROCHEM INT, V27, P417, DOI 10.1016/0197-0186(95)00023-2; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; BRANCONNIER RJ, 1986, AM J PSYCHIAT, V143, P1313, DOI 10.1176/ajp.143.10.1313; Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Dai HL, 2013, NEUROCHEM INT, V63, P610, DOI 10.1016/j.neuint.2013.09.005; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; FISMAN M, 1985, AM J PSYCHIAT, V142, P71; FISMAN M, 1989, J AM GERIATR SOC, V37, P1102, DOI 10.1111/j.1532-5415.1989.tb06935.x; Gouras GK, 2015, NEUROTHERAPEUTICS, V12, P3, DOI 10.1007/s13311-014-0313-y; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; HOYER S, 1990, NEUROSCI LETT, V117, P358, DOI 10.1016/0304-3940(90)90691-2; JAMES JH, 1979, LANCET, V2, P772, DOI 10.1016/S0140-6736(79)92119-6; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Jin YY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050564; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Koo EH, 1996, J CELL SCI, V109, P991; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Li ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153526; Lie PPY, 2019, NEUROBIOL DIS, V122, P94, DOI 10.1016/j.nbd.2018.05.015; Linde CI, 2011, AM J PHYSIOL-CELL PH, V300, pC1502, DOI 10.1152/ajpcell.00379.2010; Mader S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020090; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Seiler N, 2002, NEUROCHEM INT, V41, P189, DOI 10.1016/S0197-0186(02)00041-4; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Sosa LJ, 2017, J NEUROCHEM, V143, P11, DOI 10.1111/jnc.14122; TANAKA RD, 1986, J LIPID RES, V27, P261; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Terunuma M, 2015, NEUROPHARMACOLOGY, V88, P74, DOI 10.1016/j.neuropharm.2014.09.015; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Vasquez KO, 2017, J PHARMACOL EXP THER, V361, P87, DOI 10.1124/jpet.116.238378; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verkman AS, 2017, EXPERT OPIN THER TAR, V21, P1161, DOI 10.1080/14728222.2017.1398236; Wu HT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7239; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	62	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101933	10.1016/j.jbc.2022.101933	http://dx.doi.org/10.1016/j.jbc.2022.101933			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35427648	gold, Green Published			2022-12-28	WOS:000817175700009
J	Liu, YX; Wang, TV; Cui, YF; Gao, SX; Rao, Y				Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Gao, Shengxian; Rao, Yi			Biochemical purification uncovers mammalian sterile 3 (MST3) as a new protein kinase for multifunctional protein kinases AMPK and SIK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; COENZYME-A REDUCTASE; RAT-LIVER; YEAST SNF1; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; SUBSTRATE-SPECIFICITY; NONCATALYTIC BETA; ACTIVATED KINASE; UPSTREAM KINASE; FATTY-ACID	The AMP-activated protein kinase (AMPK) and AMPKrelated kinase salt-inducible kinase 3 (SIK3) regulate many important biological processes ranging from metabolism to sleep. Liver kinase B1 is known to phosphorylate and activate both AMPK and SIK3, but the existence of other upstream kinases was unclear. In this study, we detected liver kinase ities in human embryonic kidney cells as well as in mouse brains. Biochemical purification of this phosphorylation activity uncovered mammalian sterile 20-like kinase 3 (MST3). We demonstrate that MST3 from human embryonic kidney cells could phosphorylate AMPK and SIK3 in vivo. In addition, recombinant MST3 expressed in and purified from Escherichia coli could directly phosphorylate AMPK and SIK3 in vitro. Moreover, four other members of the MST kinase family could also phosphorylate AMPK or SIK3. Our results have revealed new kinases able to phosphorylate and activate AMPK and SIK3.	[Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Gao, Shengxian; Rao, Yi] Peking Univ, Coll Chem & Chem Engn, Peking Tsinghua Ctr Life Sci,Sch Life Sci,Sch Pha, Hlth Sci Ctr,Lab Neurochem Biol,Dept Chem Biol,PK, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Gao, Shengxian; Rao, Yi] Chinese Inst Brain Res, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Gao, Shengxian; Rao, Yi] Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Liu, Yuxiang; Wang, Tao, V; Cui, Yunfeng; Gao, Shengxian; Rao, Yi] Changping Lab, Beijing, Peoples R China	Peking University; Capital Medical University	Rao, Y (corresponding author), Peking Univ, Coll Chem & Chem Engn, Peking Tsinghua Ctr Life Sci,Sch Life Sci,Sch Pha, Hlth Sci Ctr,Lab Neurochem Biol,Dept Chem Biol,PK, Beijing, Peoples R China.; Rao, Y (corresponding author), Chinese Inst Brain Res, Beijing, Peoples R China.; Rao, Y (corresponding author), Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China.; Rao, Y (corresponding author), Changping Lab, Beijing, Peoples R China.	yrao@pku.edu.cn						Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; CARLING D, 1994, J BIOL CHEM, V269, P11442; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Fujii S, 2017, P NATL ACAD SCI USA, V114, pE6669, DOI 10.1073/pnas.1620483114; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; GAO G, 1995, BBA-MOL CELL RES, V1266, P73, DOI 10.1016/0167-4889(94)00222-Z; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hsu CC, 2021, MOL CELL, V81, P3803, DOI 10.1016/j.molcel.2021.08.025; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; INGEBRITSEN TS, 1978, BIOCHEM BIOPH RES CO, V81, P1268, DOI 10.1016/0006-291X(78)91273-1; Li Y., 2021, BIORXIV, DOI [10.1101/2021.11.06. 467421, DOI 10.1101/2021.11.06.467421]; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lopez M, 2016, NAT REV ENDOCRINOL, V12, P421, DOI 10.1038/nrendo.2016.67; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Neumann D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082412; Park M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65647-0; Pombo CM, 2019, ENDOCRINOLOGY, V160, P1111, DOI 10.1210/en.2018-00898; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Russell FM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010186; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	59	1	1	11	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101929	10.1016/j.jbc.2022.101929	http://dx.doi.org/10.1016/j.jbc.2022.101929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35413286	Green Published, gold			2022-12-28	WOS:000817175700007
J	Cha, JH; Chan, LC; Wang, YN; Chu, YY; Wang, CH; Lee, HH; Xia, WY; Shyu, WC; Liu, SP; Yao, J; Chang, CW; Cheng, FR; Liu, JL; Lim, SO; Hsu, JL; Yang, WH; Hortobagyi, GN; Lin, CR; Yang, LQ; Yu, DH; Jeng, LB; Hung, MC				Cha, Jong-Ho; Chan, Li-Chuan; Wang, Ying-Nai; Chu, Yu-Yi; Wang, Chie-Hong; Lee, Heng-Huan; Xia, Weiya; Shyu, Woei-Cherng; Liu, Shih-Ping; Yao, Jun; Chang, Chiung-Wen; Cheng, Fan-Ru; Liu, Jielin; Lim, Seung-Oe; Hsu, Jennifer L.; Yang, Wen-Hao; Hortobagyi, Gabriel N.; Lin, Chunru; Yang, Liuqing; Yu, Dihua; Jeng, Long-Bin; Hung, Mien-Chie			Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES MIGRATION; TYROSINE KINASES; PREDICTION; IMMUNITY; EPHA10; DRUG; IMMUNOTHERAPY; PROGRESSION; EXPRESSION; LIGANDS	Expression of the receptor tyrosine kinase ephrin receptor A10 (EphA10), which is undetectable in most normal tissues except for the male testis, has been shown to correlate with tumor progression and poor prognosis in several malignancies, including triple-negative breast cancer (TNBC). Therefore, EphA10 could be a potential therapeutic target, likely with minimal adverse effects. However, no effective clinical drugs against EphA10 are currently available. Here, we report high expression levels of EphA10 in tumor regions of breast, lung, and ovarian cancers as well as in immunosuppressive myeloid cells in the tumor microenvironment. Furthermore, we developed anti-EphA10 monoclonal antibodies (mAbs) that specifically recognize cell surface EphA10, but not other EphA family isoforms, and target tumor regions precisely in vivo with no apparent accumulation in other organs. In syngeneic TNBC mouse models, we found that anti-EphA10 mAb clone #4 enhanced tumor regression, therapeutic response rate, and T cell-mediated antitumor immunity. Notably, the chimeric antigen receptor T cells derived from clone #4 significantly inhibited TNBC cell viability in vitro and tumor growth in vivo. Together, our findings suggest that targeting EphA10 via EphA10 mAbs and EphA10-specific chimeric antigen receptor-T cell therapy may represent a promising strategy for patients with EphA10-positive tumors.	[Cha, Jong-Ho; Chan, Li-Chuan; Wang, Ying-Nai; Chu, Yu-Yi; Lee, Heng-Huan; Xia, Weiya; Yao, Jun; Chang, Chiung-Wen; Cheng, Fan-Ru; Liu, Jielin; Lim, Seung-Oe; Hsu, Jennifer L.; Yang, Wen-Hao; Lin, Chunru; Yang, Liuqing; Yu, Dihua; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Cha, Jong-Ho] Inha Univ, Grad Sch, Dept Biomed Sci, Coll Med, Incheon, South Korea; [Cha, Jong-Ho] Inha Univ, Grad Sch, Dept Biomed Sci & Engn, Incheon, South Korea; [Wang, Chie-Hong; Jeng, Long-Bin] China Med Univ, Coll Med, Cell Therapy Ctr, Taichung, Taiwan; [Wang, Chie-Hong; Liu, Shih-Ping] China Med Univ, Coll Med, Neurosci & Brain Dis Ctr, Taichung, Taiwan; [Wang, Chie-Hong; Shyu, Woei-Cherng; Liu, Shih-Ping] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Xia, Weiya; Shyu, Woei-Cherng; Cheng, Fan-Ru; Yang, Wen-Hao; Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Xia, Weiya; Cheng, Fan-Ru; Yang, Wen-Hao; Hung, Mien-Chie] China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan; [Xia, Weiya; Cheng, Fan-Ru; Yang, Wen-Hao; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Drug Dev Ctr, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ, Drug Dev Ctr, Taichung, Taiwan; [Shyu, Woei-Cherng] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ, Coll Med, PhD Program Aging, Taichung, Taiwan; [Liu, Shih-Ping] China Med Univ Hosp, Ctr Translat Med, Taichung, Taiwan; [Liu, Shih-Ping] Asia Univ, Dept Social Work, Taichung, Taiwan; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Lin, Chunru; Yang, Liuqing; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Jeng, Long-Bin] China Med Univ, Organ Transplantat Ctr, Taichung, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; Inha University; Inha University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Jeng, LB (corresponding author), China Med Univ, Coll Med, Cell Therapy Ctr, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ, Organ Transplantat Ctr, Taichung, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	longbin.cmuh@gmail.com; mhung77030@gmail.com	Yang, wenhao/GXG-5965-2022	Hung, Mien-Chie/0000-0003-4317-4740; Liu, Shih-Ping/0000-0002-5803-4460; Liu, Jielin/0000-0001-9596-8943; Wang, Chie-Hong/0000-0003-0774-5323; Yang, Wen-Hao/0000-0002-6292-9048; Jeng, Long-Bin/0000-0002-2928-4698; Wang, Ying-Nai/0000-0002-5275-6729	MDA Startup Fund; NIH/NCI Cancer Center Support Grant; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Breast Cancer Research Foundation; Drug Development Center, China Medical University by the Ministry of Education (MOE) in Taiwan [P30CA016672]; Ministry of Science and Technology, Taiwan, R. O. C.; China Medical University Hospital [BCRF-21-070]; National Research Foundation of Korea - Korea government Ministry of Science and ICT (MSIT); National Breast Cancer Foundation, Inc [MOST 110-2639-B-039-001-ASP, MOST 110-2314-B-039-043-MY3, MOST 109-2314-B-039-025-MY2]; T32 Training Grant in Cancer Biology [C1090615012]; Ying Tsai Young Scholar Award [2020R1C1C1005631, 2021R1A4A1031856]; Ministry of Science and Technology; Innovative Research Grant from the National Health Research Institutes, Taiwan [5T32CA186892];  [CMU108-YTY-04];  [MOST 110-2320-B-039-065];  [NHRI-EX110-11010BI]	MDA Startup Fund; NIH/NCI Cancer Center Support Grant; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Breast Cancer Research Foundation; Drug Development Center, China Medical University by the Ministry of Education (MOE) in Taiwan; Ministry of Science and Technology, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); China Medical University Hospital; National Research Foundation of Korea - Korea government Ministry of Science and ICT (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); National Breast Cancer Foundation, Inc; T32 Training Grant in Cancer Biology; Ying Tsai Young Scholar Award; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Innovative Research Grant from the National Health Research Institutes, Taiwan; ; ; 	This study was supported in part by the following: an MDA Startup Fund; NIH/NCI Cancer Center Support Grant under award number P30CA016672; The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (to M.-C. H.) ; Breast Cancer Research Foundation (Grant No. BCRF-21-070 to Y.-N. W., G. N. H., M.-C. H.) ; Drug Development Center, China Medical University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (to M.-C. H.) ; Ministry of Science and Technology, Taiwan, R. O. C. (Grant Nos. MOST 110-2639-B-039-001-ASP, MOST 110-2314-B-039-043-MY3, and MOST 109-2314-B-039-025-MY2) ; China Medical University Hospital (Grant No. C1090615012) ; The National Research Foundation of Korea grant funded by the Korea government Ministry of Science and ICT (MSIT) (Grant Nos. 2020R1C1C1005631 and 2021R1A4A1031856 to J.-H.C.) ; National Breast Cancer Foundation, Inc; and T32 Training Grant in Cancer Biology (5T32CA186892 to H.-H. L. and L.-C. C.) ; Ying Tsai Young Scholar Award (CMU108-YTY-04 to W.-H. Y) ; Ministry of Science and Technology (MOST 110-2320-B-039-065 to W.-H. Y.) ; an Innovative Research Grant from the National Health Research Institutes, Taiwan (NHRI-EX110-11010BI to W.-H. Y.) .	Aasheim HC, 2005, BBA-GEN SUBJECTS, V1723, P1, DOI 10.1016/j.bbagen.2005.01.011; Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Anfray C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010046; Bloemberg D, 2020, MOL THER-METH CLIN D, V16, P238, DOI 10.1016/j.omtm.2020.01.012; Carey LA, 2021, NAT CANCER, V2, P476, DOI 10.1038/s43018-021-00211-x; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cortes J, 2011, NAT REV CLIN ONCOL, V8, P307, DOI 10.1038/nrclinonc.2010.185; Darling TK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01473; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Donaghy H, 2016, MABS-AUSTIN, V8, P659, DOI 10.1080/19420862.2016.1156829; Dunn J, 2017, MOL IMMUNOL, V87, P227, DOI 10.1016/j.molimm.2017.04.012; Durgeau A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00014; Emens LA, 2021, CANCER J, V27, P59, DOI 10.1097/PPO.0000000000000497; Gasser M, 2016, ADV EXP MED BIOL, V917, P95, DOI 10.1007/978-3-319-32805-8_6; Ghetie V, 2004, CANC DRUG DISC DEV, P475; Gillespie Theresa W, 2012, J Adv Pract Oncol, V3, P106; Gruosso T, 2019, J CLIN INVEST, V129, P1785, DOI 10.1172/JCI96313; Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0111-2, 10.1038/s41572-019-0122-z]; Hjorthaug HS, 2007, EUR J IMMUNOL, V37, P2326, DOI 10.1002/eji.200737111; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Hsu JL, 2016, CANCER METAST REV, V35, P575, DOI 10.1007/s10555-016-9649-6; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep26240; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P394, DOI 10.1038/nrclinonc.2016.65; Khongorzul P, 2020, MOL CANCER RES, V18, P3, DOI 10.1158/1541-7786.MCR-19-0582; Kim DW, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020263; Klymenko Y, 2018, CANCERS, V10, DOI 10.3390/cancers10090295; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krawczyk K, 2014, BIOINFORMATICS, V30, P2288, DOI 10.1093/bioinformatics/btu190; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee HH, 2019, CANCER CELL, V36, P168, DOI 10.1016/j.ccell.2019.06.008; Leem J, 2016, MABS-AUSTIN, V8, P1259, DOI 10.1080/19420862.2016.1205773; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Li M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3916-y; Li Y, 2017, ONCOTARGET, V8, P30344, DOI 10.18632/oncotarget.15910; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Lu RM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0592-z; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Mei J, 2021, MOL CANCER, V20, DOI 10.1186/s12943-020-01304-4; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Nagano K, 2014, BIOCHEM BIOPH RES CO, V450, P545, DOI 10.1016/j.bbrc.2014.06.007; Nagano K, 2013, CANCER MED-US, V2, P972, DOI 10.1002/cam4.156; Nakamura K, 2020, CELL MOL IMMUNOL, V17, P1, DOI 10.1038/s41423-019-0306-1; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Shin WS, 2020, CANCER SCI, V111, P3292, DOI 10.1111/cas.14568; Tatari N., 2020, STAR PROTOC, V1; Wang Y, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440169; Wang YN, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00670-x; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xia L, 2021, CANCER IMMUNOL RES, V9, P707, DOI 10.1158/2326-6066.CIR-20-0405; Yan HX, 2018, INT J CLIN EXP PATHO, V11, P512; Yang WH, 2018, CANCER RES, V78, P3761, DOI 10.1158/0008-5472.CAN-18-0040; Yu SN, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1057-4	59	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101817	10.1016/j.jbc.2022.101817	http://dx.doi.org/10.1016/j.jbc.2022.101817			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35278434	gold, Green Published			2022-12-28	WOS:000797895000013
J	Tei, R; Baskin, JM				Tei, Reika; Baskin, Jeremy M.			Click chemistry and optogenetic approaches to visualize and manipulate phosphatidic acid signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D; CRYSTAL-STRUCTURE; OPTICAL CONTROL; MEMBRANE; PATHWAY; ACTIVATION; CHOLINE; MTOR; D1	The simple structure of phosphatidic acid (PA) belies its complex biological functions as both a key phospholipid biosynthetic intermediate and a potent signaling molecule. In the latter role, PA controls processes including vesicle trafficking, actin dynamics, cell growth, and migration. However, experimental methods to decode the pleiotropy of PA are sorely lacking. Because PA metabolism and trafficking are rapid, approaches to accurately visualize and manipulate its levels require high spatiotemporal precision. Here, we describe recent efforts to create a suite of chemical tools that enable imaging and perturbation of PA signaling. First, we describe techniques to visualize PA production by phospholipase D (PLD) enzymes, which are major producers of PA, called Imaging Phospholipase D Activity with Clickable Alcohols via Transphosphatidylation (IMPACT). IMPACT harnesses the ability of endogenous PLD enzymes to accept bioorthogonally tagged alcohols in transphosphatidylation reactions to generate functionalized reporter lipids that are subsequently fluorescently tagged via click chemistry. Second, we describe two light-controlled approaches for precisely manipulating PA signaling. Optogenetic PLDs use light-mediated heterodimerization to recruit a bacterial PLD to desired organelle membranes, and photoswitchable PA analogs contain azobenzene photoswitches in their acyl tails, enabling molecular shape and bioactivity to be controlled by light. We highlight select applications of these tools for studying GPCR-Gq signaling, discovering regulators of PLD signaling, tracking intracellular lipid transport pathways, and elucidating new oncogenic signaling roles for PA. We envision that these chemical tools hold promise for revealing many new insights into lipid signaling pathways.	[Baskin, Jeremy M.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Baskin, JM (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jeremy.baskin@cornell.edu		Tei, Reika/0000-0002-9492-9309	Honjo International Fellowship; Funai Overseas Fellowship; Cornell Fellowship	Honjo International Fellowship; Funai Overseas Fellowship; Cornell Fellowship	R. T. acknowledges support from by Honjo International, Funai Overseas, and Cornell Fellowships.	Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Bowling Forrest Z., 2021, Advances in Biological Regulation, V79, P100783, DOI 10.1016/j.jbior.2020.100783; Bowling FZ, 2020, NAT CHEM BIOL, V16, P400, DOI 10.1038/s41589-020-0499-8; Brailoiu E, 2019, CELL REP, V26, P330, DOI 10.1016/j.celrep.2018.12.051; Bumpus TW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025265118; Bumpus TW, 2020, METHOD ENZYMOL, V641, P75, DOI 10.1016/bs.mie.2020.04.037; Bumpus TW, 2018, BIOCHEMISTRY-US, V57, P226, DOI 10.1021/acs.biochem.7b01021; Bumpus TW, 2017, ACS CENTRAL SCI, V3, P1070, DOI 10.1021/acscentsci.7b00222; Bumpus TW, 2016, ANGEW CHEM INT EDIT, V55, P13155, DOI 10.1002/anie.201607443; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Coreta-Gomes FM, 2018, J MEMBRANE BIOL, V251, P431, DOI 10.1007/s00232-017-0009-4; Corradi V, 2019, CHEM REV, V119, P5775, DOI 10.1021/acs.chemrev.8b00451; Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Everett PB, 2010, J NEUROCHEM, V112, P963, DOI 10.1111/j.1471-4159.2009.06508.x; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Frank JA, 2016, NAT CHEM BIOL, V12, P755, DOI 10.1038/nchembio.2141; Frias MA, 2020, J BIOL CHEM, V295, P263, DOI 10.1074/jbc.RA119.010892; Gomez-Cambronero J, 2020, HANDB EXP PHARMACOL, V259, P89, DOI 10.1007/164_2019_216; Ha EEJ, 2014, BIOFACTORS, V40, P419, DOI 10.1002/biof.1169; Han H, 2018, MOL CELL, V72, P328, DOI 10.1016/j.molcel.2018.08.038; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Kassas N, 2017, J BIOL CHEM, V292, P4266, DOI 10.1074/jbc.M116.742346; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khayyo VI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15124-z; Kol M, 2019, ELIFE, V8, DOI 10.7554/eLife.43230; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Leiros I, 2004, J MOL BIOL, V339, P805, DOI 10.1016/j.jmb.2004.04.003; Liang DJ, 2022, CELL CHEM BIOL, V29, P67, DOI 10.1016/j.chembiol.2021.05.020; Liang DJ, 2019, P NATL ACAD SCI USA, V116, P15453, DOI 10.1073/pnas.1903949116; Lutkewitte AJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101386; Massart J, 2019, TRENDS ENDOCRIN MET, V30, P603, DOI 10.1016/j.tem.2019.06.003; Metrick CM, 2020, NAT CHEM BIOL, V16, P391, DOI 10.1038/s41589-019-0458-4; Morstein J, 2021, CHEMBIOCHEM, V22, P73, DOI 10.1002/cbic.202000449; Morstein J, 2020, J AM CHEM SOC, V142, P10612, DOI 10.1021/jacs.0c02154; Morstein J, 2019, NAT CHEM BIOL, V15, P623, DOI 10.1038/s41589-019-0269-7; Mozzicato S, 2003, FASEB J, V17, P406, DOI 10.1096/fj.03-0592fje; Powner DJ, 2002, FEBS LETT, V531, P62, DOI 10.1016/S0014-5793(02)03410-5; Salazar C, 2020, HANDB EXP PHARMACOL, V259, P79, DOI 10.1007/164_2019_244; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Schuhmacher M, 2020, P NATL ACAD SCI USA, V117, P7729, DOI 10.1073/pnas.1912684117; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Tanguy E, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00002; Tanguy E, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020020; Tei R, 2021, ACS CENTRAL SCI, V7, P1205, DOI 10.1021/acscentsci.1c00444; Tei R, 2021, CURR OPIN CHEM BIOL, V65, P93, DOI 10.1016/j.cbpa.2021.06.005; Tei R, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907013; Thakur R, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00083; Thaller DJ, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202004222; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wang MZ, 2019, CHEM COMMUN, V55, P2485, DOI 10.1039/c8cc09747j; Weng ZF, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166989; YANG SF, 1967, J BIOL CHEM, V242, P477; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu WZ, 2021, ACS CHEM BIOL, DOI 10.1021/acschembio.1c00584; Zegarlinska J, 2018, ACTA BIOCHIM POL, V65, P163, DOI 10.18388/abp.2018_2592; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhukovsky MA, 2019, FEBS LETT, V593, P2428, DOI 10.1002/1873-3468.13563	67	2	2	5	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101810	10.1016/j.jbc.2022.101810	http://dx.doi.org/10.1016/j.jbc.2022.101810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35276134	gold, Green Published			2022-12-28	WOS:000823106100014
J	Gasilina, A; Yoon, HY; Jian, XY; Luo, RB; Randazzo, PA				Gasilina, Anjelika; Yoon, Hye-Young; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.			A lysine-rich cluster in the N-BAR domain of ARF GTPase-activating protein ASAP1 is necessary for binding and bundling actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; STRUCTURAL BASIS; TARGET PROTEIN; CELL MOTILITY; GAP; FAMILY; REGULATOR; IRSP53	Actin filament maintenance is critical for both normal cell homeostasis and events associated with malignant transformation. The ADP-ribosylation factor GTPase-activating protein ASAP1 regulates the dynamics of filamentous actin-based structures, including stress fibers, focal adhesions, and circular dorsal ruffles. Here, we have examined the molecular basis for ASAP1 association with actin. Using a combination of structural modeling, mutagenesis, and in vitro and cell-based assays, we identify a putative-binding interface between the N-Bin-Amphiphysin-Rvs (BAR) domain of ASAP1 and actin filaments. We found that neutralization of charges and charge reversal at positions 75, 76, and 79 of ASAP1 reduced the binding of ASAP1 BAR-pleckstrin homology tandem to actin filaments and abrogated actin bundle formation in vitro. In addition, overexpression of actin-binding defective ASAP1 BAR-pleckstrin homology [K75, K76, K79] mutants prevented cellular actin remodeling in U2OS cells. Exogenous expression of [K75E, K76E, K79E] mutant of full-length ASAP1 did not rescue the reduction of cellular actin fibers consequent to knockdown of endogenous ASAP1. Taken together, our results support the hypothesis that the lysine-rich cluster in the N-BAR domain of ASAP1 is important for regulating actin filament organization.	[Gasilina, Anjelika; Yoon, Hye-Young; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gasilina, Anjelika] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Gasilina, Anjelika] NHLBI, Cell & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov		Yoon, Hye-Young/0000-0002-0526-0958	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [BC007365]	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services (project number BC007365 to P. A. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreev J, 1999, MOL CELL BIOL, V19, P2338; Beck MR, 2013, J MOL BIOL, V425, P3325, DOI 10.1016/j.jmb.2013.06.016; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Boraas LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195588; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Carman Peter J, 2018, Biophys Rev, V10, P1587, DOI 10.1007/s12551-018-0467-7; Chen PW, 2020, J BIOL CHEM, V295, P11303, DOI 10.1074/jbc.RA119.009903; Chen PW, 2016, J BIOL CHEM, V291, P7517, DOI 10.1074/jbc.M115.701292; Cui J, 2021, TUBERCULOSIS, V129, DOI 10.1016/j.tube.2021.102090; Tien DN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05094; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Drager NM, 2017, EMBO REP, V18, P2051, DOI 10.15252/embr.201744137; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gasilina A, 2019, ISCIENCE, V22, P166, DOI 10.1016/j.isci.2019.11.015; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Haque A, 2011, CANCER IMMUNOL IMMUN, V60, P1439, DOI 10.1007/s00262-011-1048-9; He JC, 2020, ONCOGENE, V39, P4118, DOI 10.1038/s41388-020-1279-3; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; King FJ, 1999, MOL CELL BIOL, V19, P2330; Kostan J, 2014, EMBO REP, V15, P1154, DOI 10.15252/embr.201439267; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Misra A, 2012, INT J BIOCHEM CELL B, V44, P928, DOI 10.1016/j.biocel.2012.02.020; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Schevzov G, 2015, MOL BIOL CELL, V26, P2475, DOI 10.1091/mbc.E14-10-1453; Schreiber C, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008216; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Stanishneva-Konovalova TB, 2016, ACTA NATURAE, V8, P60, DOI 10.32607/20758251-2016-8-4-60-69; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9; Zhang T, 2018, ONCOL LETT, V15, P4432, DOI 10.3892/ol.2018.7834	52	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101700	10.1016/j.jbc.2022.101700	http://dx.doi.org/10.1016/j.jbc.2022.101700			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35143843	Green Published, gold			2022-12-28	WOS:000821054100001
J	Jeon, M; Chauhan, KM; Szeto, GL; Kyoung, M; An, SG				Jeon, Miji; Chauhan, Krishna M.; Szeto, Gregory L.; Kyoung, Minjoung; An, Songon			Subcellular regulation of glucose metabolism through multienzyme glucosome assemblies by EGF-ERK1/2 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYSIS; IDENTIFICATION; ACTIVATION; COMPLEXES; KINASE; GROWTH; CELLS; MODEL	A multienzyme metabolic assembly for human glucose metabolism, namely the glucosome, has been previously demonstrated to partition glucose flux between glycolysis and building block biosynthesis in an assembly size-dependent manner. Among three different sizes of glucosome assem-blies, we have shown that large-sized glucosomes are func-tionally associated with the promotion of serine biosynthesis in the presence of epidermal growth factor (EGF). However, due to multifunctional roles of EGF in signaling pathways, it is unclear which EGF-mediated signaling pathways promote these large glucosome assemblies in cancer cells. In this study, we used Luminex multiplexing assays and high-content single-cell imaging to demonstrate that EGF triggers temporal acti-vation of extracellular signal-regulated kinases 1/2 (ERK1/2) in Hs578T cells. Subsequently, we found that treatments with a pharmacological inhibitor of ERK1/2, SCH772984, or short-hairpin RNAs targeting ERK1/2 promote the dissociation of large-sized assemblies to medium-sized assemblies in Hs578T cells. In addition, our Western blot analyses revealed that EGF treatment does not increase the expression levels of enzymes that are involved in both glucose metabolism and serine biosynthesis. The observed spatial transition of glucosome as-semblies between large and medium sizes appears to be mediated by the degree of dynamic partitioning of glucosome enzymes without changing their expression levels. Collectively, our study demonstrates that EGF-ERK1/2 signaling pathways play an important role in the upregulation of large-sized glu-cosomes in cancer cells, thus functionally governing the pro-motion of glycolysis-derived serine biosynthesis.	[Jeon, Miji; Chauhan, Krishna M.; Kyoung, Minjoung; An, Songon] Univ Maryland Baltimore Cty UMBC, Dept Chem & Biochem, Baltimore, MD USA; [Szeto, Gregory L.] Univ Maryland Baltimore Cty UMBC, Dept Chem Biochem & Environm Engn, Baltimore, MD USA; [Szeto, Gregory L.; Kyoung, Minjoung; An, Songon] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD USA; [Szeto, Gregory L.] Allen Inst Immunol, Seattle, WA 98109 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	An, SG (corresponding author), Univ Maryland Baltimore Cty UMBC, Dept Chem & Biochem, Baltimore, MD USA.; An, SG (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Program Oncol, Baltimore, MD USA.	san@umbc.edu		Szeto, Gregory/0000-0001-7604-1333; An, Songon/0000-0003-2189-7374	National Institutes of Health [R01GM125981, R03CA219609, R01GM134086, T32GM066706]; UMBC	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMBC	This work is supported by the National Institutes of Health: R01GM125981 (S. A.) , R03CA219609 (S. A.) , R01GM134086 (M. K.) , and T32GM066706 (M. J.) , as well as UMBC: Start-Up (G. L. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2019, METHOD ENZYMOL, V628, P1, DOI 10.1016/bs.mie.2019.06.013; Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Jeon M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20348-7; Kohnhorst CL, 2017, J BIOL CHEM, V292, P9191, DOI 10.1074/jbc.M117.783050; Lee JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00906-9; Li K, 2020, CELL RES, V30, P163, DOI 10.1038/s41422-019-0257-1; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Locasale J. W., 2011, PHOSPHOGLYCERATE; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Morris E. J., 2013, CANCER DISCOV; Moschos SJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.92352; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Pacold M. E., 2016, PHGDH; Pegram LM, 2019, P NATL ACAD SCI USA, V116, P15463, DOI 10.1073/pnas.1906824116; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Waters KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034515; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Zhang J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13732; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	29	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101675	10.1016/j.jbc.2022.101675	http://dx.doi.org/10.1016/j.jbc.2022.101675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35122791	gold, Green Published			2022-12-28	WOS:000791230900004
J	Kaur, S; Sang, Y; Aballay, A				Kaur, Supender; Sang, Yu; Aballay, Alejandro			Myotubularin-related protein protects against neuronal degeneration mediated by oxidative stress or infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; PHOSPHATASES; FAMILY; NEUROPATHY; MYOPATHY; DISTINCT; DEFECTS	Microbial infections have been linked to the onset and severity of neurodegenerative diseases such as amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's disease, but the underlying mechanisms remain largely unknown. Here, we used a genetic screen for genes involved in protection from infection-associated neurodegeneration and identified the gene mtm-10. We then validated the role of the encoded myotubularin-related protein, MTM-10, in protecting the dendrites of Caenorhabditis elegans from degeneration mediated by oxidative stress or Pseudomonas aeruginosa infection. Further experiments indicated that mtm-10 is expressed in the AWC neurons of C. elegans, where it functions in a cell autonomous manner to protect the dendrite degeneration caused by pathogen infection. We also confirm that the changes observed in the dendrites of the animals were not because of premature death or overall sickness. Finally, our studies indicated that mtm-10 functions in AWC neurons to preserve chemosensation after pathogen infection. These results reveal an essential role for myotubularin-related protein 10 in the protection of dendrite morphology and function against the deleterious effects of oxidative stress or infection.	[Kaur, Supender; Sang, Yu; Aballay, Alejandro] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA	Oregon Health & Science University	Aballay, A (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA.	aballay@ohsu.edu			National Institute of Health (NIH) [GM070977, AI156900]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health (NIH) grants GM070977 and AI156900 to A. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arendt T, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0187-1; Asti A, 2014, J ALZHEIMERS DIS, V39, P169, DOI 10.3233/JAD-131394; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baskoylu SN, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007682; Beilina A, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13266; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Caldwell KA, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.046110; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Cao X, 2017, CELL REP, V21, P1442, DOI 10.1016/j.celrep.2017.10.050; Chen L, 2011, NEURON, V70, P51, DOI 10.1016/j.neuron.2011.02.039; Cook SJ, 2019, NATURE, V571, P63, DOI 10.1038/s41586-019-1352-7; Dehhaghi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00466; DeVault L, 2018, GENE DEV, V32, P402, DOI 10.1101/gad.308270.117; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Kaur S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107662; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee SB, 2011, P NATL ACAD SCI USA, V108, P16795, DOI 10.1073/pnas.1113573108; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Lezi E, 2018, NEURON, V97, P125, DOI 10.1016/j.neuron.2017.12.001; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Pareyson D, 2019, ANN NEUROL, V86, P55, DOI 10.1002/ana.25500; Rasakham K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102524; Robinson FL, 2008, P NATL ACAD SCI USA, V105, P4916, DOI 10.1073/pnas.0800742105; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scherer SS, 2006, ARCH NEUROL-CHICAGO, V63, P812, DOI 10.1001/archneur.63.6.812; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Swinehart BD, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00707-0; Tao JA, 2011, J NEUROSCI, V31, P5398, DOI 10.1523/JNEUROSCI.3826-10.2011; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wang CY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106504118; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wu QL, 2015, J BIOL CHEM, V290, P29231, DOI 10.1074/jbc.M115.674259; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200	47	0	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101614	10.1016/j.jbc.2022.101614	http://dx.doi.org/10.1016/j.jbc.2022.101614			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35101447	gold, Green Published			2022-12-28	WOS:000789396300012
J	Silva, RP; DiVenere, AM; Amengor, D; Maynard, JA				Silva, Rui P.; DiVenere, Andrea M.; Amengor, Dzifa; Maynard, Jennifer A.			Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P.69 PERTACTIN; IMMUNOLOGICAL-PROPERTIES; REGIONS; PARAPERTUSSIS; POLYMORPHISM; ADHERENCE; VACCINES; STRAINS; ADHESIN	Infection by the bacterium Bordetella pertussis continues to cause considerable morbidity and mortality worldwide. Many current acellular pertussis vaccines include the antigen pertactin, which has presumptive adhesive and immunomodulatory activities, but is rapidly lost from clinical isolates after the introduction of these vaccines. To better understand the contributions of pertactin antibodies to protection and pertactin's role in pathogenesis, we isolated and characterized recombinant antibodies binding four distinct epitopes on pertactin. We demonstrate that four of these antibodies bind epitopes that are conserved across all three classical Bordetella strains, and competition assays further showed that antibodies binding these epitopes are also elicited by B. pertussis infection of baboons. Surprisingly, we found that representative antibodies binding each epitope protected mice against experimental B. pertussis infection. A cocktail of antibodies from each epitope group protected mice against a subsequent lethal dose of B. pertussis and greatly reduced lung colonization levels after sublethal challenge. Each antibody reduced B. pertussis lung colonization levels up to 100-fold when administered individually, which was significantly reduced when antibody effector functions were impaired, with no antibody mediating antibody-dependent complement-induced lysis. These data suggest that antibodies binding multiple pertactin epitopes protect primarily by the same bactericidal mechanism, which overshadows contributions from blockade of other pertactin functions. These antibodies expand the available tools to further dissect pertactin's role in infection and understand the impact of antipertactin antibodies on bacterial fitness.	[Silva, Rui P.; Amengor, Dzifa; Maynard, Jennifer A.] Univ Texas, Dept Mol Biosci, Austin, TX USA; [DiVenere, Andrea M.] Univ Texas, Dept Chem Engn, Austin, TX USA; [Maynard, Jennifer A.] Univ Texas, LaMontagne Ctr Infect Dis, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas, Dept Mol Biosci, Austin, TX USA.; Maynard, JA (corresponding author), Univ Texas, LaMontagne Ctr Infect Dis, Austin, TX USA.	maynard@che.utexas.edu		DiVenere, Andrea/0000-0001-9254-5347; Amengor, Dzifa/0000-0001-5705-3259	National Institutes of Health [AI122753, AI155453]; Welch Foundation [F-1767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by the National Institutes of Health (grant nos.: AI122753 and AI155453; to J. A. M.) and the Welch Foundation (grant no.: F-1767;to J. A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NationalInstitutes of Health	Aase A, 2011, CLIN VACCINE IMMUNOL, V18, P1269, DOI 10.1128/CVI.05067-11; Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Barkoff AM, 2019, EUROSURVEILLANCE, V24, P39, DOI 10.2807/1560-7917.ES.2019.24.7.1700832; Barnes MG, 2003, FEMS MICROBIOL LETT, V220, P271, DOI 10.1016/S0378-1097(03)00132-0; Barnes MG, 2002, INFECT IMMUN, V70, P403, DOI 10.1128/IAI.70.1.403-406.2002; Boehm DT, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00857-17; Boursaux-Eude C, 2000, INFECT IMMUN, V68, P4815, DOI 10.1128/IAI.68.8.4815-4817.2000; Brookes C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0084-3; Carriquiriborde F, 2019, EMERG INFECT DIS, V25, P2048, DOI 10.3201/eid2511.190329; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Georgieva M, 2018, MBIO, V9, DOI 10.1128/mBio.00264-18; Goldsmith JA, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009920; GOTTO JW, 1993, INFECT IMMUN, V61, P2211, DOI 10.1128/IAI.61.5.2211-2215.1993; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Harvill ET, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01075-13; Hellwig SMM, 2003, J INFECT DIS, V188, P738, DOI 10.1086/377283; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hijnen M, 2004, INFECT IMMUN, V72, P3716, DOI 10.1128/IAI.72.7.3716-3723.2004; Hijnen M, 2007, VACCINE, V25, P5902, DOI 10.1016/j.vaccine.2007.05.039; Hovingh ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170027; Hovingh ES, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0039-8; Huang J., 2021, INFECT IMMUN, V89, P1; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kubler-Kielb J, 2011, P NATL ACAD SCI USA, V108, P4087, DOI 10.1073/pnas.1100782108; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Lesne E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02108; Ma LH, 2021, EMERG INFECT DIS, V27, P1561, DOI 10.3201/eid2706.203850; Martin SW, 2015, CLIN INFECT DIS, V60, P223, DOI 10.1093/cid/ciu788; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Nguyen AW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9258; Nguyen AW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0966; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Olin P, 2001, CLIN INFECT DIS, V33, pS288, DOI 10.1086/322564; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Shin EK, 2007, J VET MED SCI, V69, P771, DOI 10.1292/jvms.69.771; Skopova K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00937-16; Thiriard A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00777; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6; Weingart CL, 2000, INFECT IMMUN, V68, P7175, DOI 10.1128/IAI.68.12.7175-7179.2000; Weiss AA, 2004, INFECT IMMUN, V72, P7346, DOI 10.1128/IAI.72.12.7346-7351.2004; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101715	10.1016/j.jbc.2022.101715	http://dx.doi.org/10.1016/j.jbc.2022.101715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151691	gold, Green Published			2022-12-28	WOS:000789394500003
J	Wang, XY; Xiong, J; Zhou, DW; Zhang, SF; Wang, L; Tian, QQ; Li, CM; Liu, J; Wu, YP; Li, JY; Wang, J				Wang, Xiaoyan; Xiong, Jing; Zhou, Diwei; Zhang, Shanfeng; Wang, Li; Tian, Qingqing; Li, Changming; Liu, Jie; Wu, Yaping; Li, Junying; Wang, Jun			TRIM34 modulates influenza virus-activated programmed cell death by targeting Z-DNA-binding protein 1 for K63-linked polyubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; INFECTION; APOPTOSIS; NECROSIS; DEFENSE; RIP3	Z-DNA-binding protein 1 (ZBP1) is an innate sensor of influenza A virus (IAV) that participates in IAV-induced programmed cell death. Nevertheless, little is known about the upstream signaling pathways regulating ZBP1. We found that a member of the tripartite motif (TRIM) family, TRIM34, interacted with ZBP1 to promote its K63-linked polyubiquitination. Using a series of genetic approaches, we provide in vitro and in vivo evidence indicating that IAV triggered cell death and inflammatory responses via dependent on TRIM34/ZBP1 interaction. TRIM34 and ZBP1 expression and interaction protected mice from death during IAV infection owing to reduced inflammatory responses and epithelial damage. Additionally, analysis of clinical samples revealed that TRIM34 associates with ZBP1 and mediates ZBP1 polyubiquitination in vivo. Higher levels of proinflammatory cytokines correlated with higher levels of ZBP1 in IAV-infected patients. Taken together, we conclude that TRIM34 serves as a critical regulator of IAV-induced programmed cell death by mediating the K63-linked polyubiquitination of ZBP1.	[Wang, Xiaoyan; Li, Changming; Liu, Jie; Wang, Jun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China; [Zhou, Diwei] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China; [Zhang, Shanfeng] Huazhong Univ Sci & Technol, Wuhan Hosp 4, Puai Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Wang, Li] Tianyou Hosp af fi liated Wuhan Univ Sci & Technol, Dept Stomatol, Wuhan, Peoples R China; [Tian, Qingqing] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China; [Wu, Yaping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China; [Li, Junying] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China.	wangjun2028@whu.edu.cn			National Natural Science Foundation of China [81700013, 81300099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81700013 to J. W., 81300099 to X. W.) .	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Coates BM, 2015, JAMA PEDIATR, V169, P956, DOI 10.1001/jamapediatrics.2015.1387; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530; Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kuriakose T, 2017, MOL IMMUNOL, V86, P56, DOI 10.1016/j.molimm.2017.01.023; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Liu GQ, 2019, J VIROL, V93, DOI 10.1128/JVI.02299-18; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Si LL, 2016, SCIENCE, V354, P1170, DOI 10.1126/science.aah5869; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050	28	5	5	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101611	10.1016/j.jbc.2022.101611	http://dx.doi.org/10.1016/j.jbc.2022.101611			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065966	Green Published, gold			2022-12-28	WOS:000789396300006
J	de Hoog, E; Spencer, GE				de Hoog, Eric; Spencer, Gaynor E.			Activity-dependent modulation of neuronal K-V channels by retinoic acid enhances Ca-V channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; U-TYPE INACTIVATION; CALCIUM-CHANNELS; PLASTICITY; GAMMA; LTP	The metabolite of vitamin A, retinoic acid (RA), is known to affect synaptic plasticity in the nervous system and to play an important role in learning and memory. A ubiquitous mechanism by which neuronal plasticity develops in the nervous system is through modulation of voltage-gated Ca2+ (CaV) and voltage-gated K+ channels. However, how retinoids might regulate the activity of these channels has not been determined. Here, we show that RA modulates neuronal firing by inducing spike broadening and complex spiking in a dose-dependent manner in peptidergic and dopaminergic cell types. Using patch-clamp electrophysiology, we show that RA-induced complex spiking is activity dependent and involves enhanced inactivation of delayed rectifier voltage-gated K+ channels. The prolonged depolarizations observed during RA-modulated spiking lead to an increase in Ca2+ influx through CaV channels, though we also show an opposing effect of RA on the same neurons to inhibit Ca2+ influx. At physiological levels of Ca2+, this inhibition is specific to CaV2 (not CaV1) channels. Examining the interaction between the spike-modulating effects of RA and its inhibition of CaV channels, we found that inhibition of CaV2 channels limits the Ca2+ influx resulting from spike modulation. Our data thus provide novel evidence to suggest that retinoid signaling affects both delayed rectifier K+ channels and CaV channels to fine-tune Ca2+ influx through CaV2 channels. As these channels play important roles in synaptic function, we propose that these modulatory effects of retinoids likely contribute to synaptic plasticity in the nervous system.	[de Hoog, Eric; Spencer, Gaynor E.] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada	Brock University	Spencer, GE (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON, Canada.	gspencer@brocku.ca			Natural Sciences and Engineering Research Council of Canada [02825]; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding and additional information-This work was supported by a Discovery Grant from The Natural Sciences and Engineering Research Council of Canada (02825; to G. E. S.) . E. d. H. was sup-ported by an Ontario Graduate Scholarship.	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Arendt KL, 2015, P NATL ACAD SCI USA, V112, pE5744, DOI 10.1073/pnas.1510239112; Arendt KL, 2015, NEURON, V86, P442, DOI 10.1016/j.neuron.2015.03.009; Balind SR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09767-w; Bett GCL, 2011, BIOPHYS J, V100, P11, DOI 10.1016/j.bpj.2010.11.011; Byrne JH, 1996, J NEUROSCI, V16, P425; Carrillo E, 2013, CHANNELS, V7, P97, DOI 10.4161/chan.23569; Chang CW, 2017, ELIFE, V6, DOI 10.7554/eLife.26278; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cho IH, 2020, P NATL ACAD SCI USA, V117, P29937, DOI 10.1073/pnas.2000790117; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; de Hoog E, 2019, J BIOL CHEM, V294, P10076, DOI 10.1074/jbc.RA118.006444; de Hoog E, 2018, CELL CALCIUM, V72, P51, DOI 10.1016/j.ceca.2018.02.001; Dmetrichuk JM, 2008, J NEUROSCI, V28, P13014, DOI 10.1523/JNEUROSCI.3192-08.2008; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hsu IU, 2020, P NATL ACAD SCI USA, V117, P29914, DOI 10.1073/pnas.2009224117; Hsu YT, 2019, P NATL ACAD SCI USA, V116, P7113, DOI 10.1073/pnas.1820690116; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Klemic KG, 2001, BIOPHYS J, V81, P814, DOI 10.1016/S0006-3495(01)75743-8; Liou JC, 2005, J CELL SCI, V118, P4721, DOI 10.1242/jcs.02603; Nanou E, 2018, NEURON, V98, P466, DOI 10.1016/j.neuron.2018.03.017; Nomoto M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-8; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Rothwell CM, 2017, J NEUROPHYSIOL, V117, P692, DOI 10.1152/jn.00737.2016; Rothwell CM, 2014, NEUROBIOL LEARN MEM, V114, P251, DOI 10.1016/j.nlm.2014.07.007; Rothwell CM, 2014, NEUROBIOL LEARN MEM, V114, P127, DOI 10.1016/j.nlm.2014.05.010; Sakakibara M, 2005, J NEUROPHYSIOL, V94, P3884, DOI 10.1152/jn.01163.2004; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; SIDELL N, 1986, BIOCHEM BIOPH RES CO, V138, P560, DOI 10.1016/S0006-291X(86)80533-2; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Upreti C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84943-x; Vesprini ND, 2015, J NEUROPHYSIOL, V113, P172, DOI 10.1152/jn.00458.2014; Vesprini ND, 2014, J NEUROPHYSIOL, V111, P1318, DOI 10.1152/jn.00434.2013; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Yee AX, 2016, SYNAPSE, V70, P445, DOI 10.1002/syn.21921; Zhong LR, 2018, J NEUROSCI, V38, P10454, DOI 10.1523/JNEUROSCI.1133-18.2018; Zhou YD, 2005, P NATL ACAD SCI USA, V102, P19121, DOI 10.1073/pnas.0509856103	46	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101959	10.1016/j.jbc.2022.101959	http://dx.doi.org/10.1016/j.jbc.2022.101959			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35452677	gold, Green Published			2022-12-28	WOS:000804798000001
J	Kolay, S; Vega, AR; Dodd, DA; Perez, VA; Kashmer, OM; White, CL; Diamond, MI				Kolay, Sourav; Vega, Anthony R.; Dodd, Dana A.; Perez, Valerie A.; Kashmer, Omar M.; White, Charles L.; Diamond, Marc I.			The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPAGATION; AUTOPHAGY	Tau assembly movement from the extracellular to intracellular space may underlie transcellular propagation of neurodegenerative tauopathies. This begins with tau binding to cell surface heparan sulfate proteoglycans, which triggers macropinocytosis. Pathological tau assemblies are proposed then to exit the vesicular compartment as "seeds" for replication in the cytoplasm. Tau uptake is highly efficient, but only t o 10% of cells that endocytose aggregates exhibit seeding. Consequently, we studied fluorescently tagged full-length (FL) tau fibrils added to native U2OS cells or "biosensor" cells expressing FL tau or repeat domain. FL tau fibrils bound tubulin. Seeds triggered its aggregation in multiple locations simultaneously in the cytoplasm, generally independent of visible exogenous aggregates. Most exogenous tau trafficked to the lysosome, but fluorescence imaging revealed a small percentage that steadily accumulated in the cytosol. Intracellular expression of Gal3-mRuby, which binds intravesicular galactosides and forms puncta upon vesicle rupture, revealed no evidence of vesicle damage following tau exposure, and most seeded cells had no evidence of endolysosome rupture. However, live-cell imaging indicated that cells with pre-existing Gal3positive puncta were seeded at a slightly higher rate than the general population, suggesting a potential predisposing role for vesicle instability. Clearance of tau seeds occurred rapidly in both vesicular and cytosolic fractions. The lysosome/autophagy inhibitor bafilomycin inhibited vesicular clearance, whereas the proteasome inhibitor MG132 inhibited cytosolic clearance. Tau seeds that enter the cell thus have at least two fates: lysosomal clearance that degrades most tau, and entry into the cytosol, where seeds amplify, and are cleared by the proteasome.	[Kolay, Sourav; Vega, Anthony R.; Dodd, Dana A.; Perez, Valerie A.; Kashmer, Omar M.; White, Charles L.; Diamond, Marc I.] Univ Texas Dallas, Southwestern Med Ctr, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Diamond, MI (corresponding author), Univ Texas Dallas, Southwestern Med Ctr, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75080 USA.	marc.diamond@utsouthwestern.edu	White, Charles L/AAJ-1858-2021; Kolay, Sourav/GPX-3876-2022	White, Charles L/0000-0002-3870-2804; Kolay, Sourav/0000-0002-3325-2189	Crowley Foundation; Cure Alzheimer's Foundation; Rainwater Charitable Foundation; Hamon Foundation; National Institutes of Health [WU-16-376-MOD-5]	Crowley Foundation; Cure Alzheimer's Foundation; Rainwater Charitable Foundation; Hamon Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Crowley Foundation, the Cure Alzheimer's Foundation, the Rainwater Charitable Foundation, the Hamon Foundation, and the National Institutes of Health (grant no.: WU-16-376-MOD-5) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also thank the Moody Foundation Flow Cytometry Core Facility and the Sequencing Core Facility at UT Southwestern.	B. J. Tuck, 2021, bioRxiv, DOI 10.1101/2021.06.21.449238; Baghirova S, 2015, METHODSX, V2, P440, DOI 10.1016/j.mex.2015.11.001; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Chen JJ, 2019, J BIOL CHEM, V294, P18952, DOI 10.1074/jbc.RA119.009432; Darwich NF, 2020, SCIENCE, V370, P932, DOI 10.1126/science.aay8826; Falcon B, 2018, J BIOL CHEM, V293, P2438, DOI 10.1074/jbc.M117.809293; Festa BP, 2021, CURR OPIN PHARMACOL, V60, P149, DOI 10.1016/j.coph.2021.07.011; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gao S, 2018, BRAIN, V141, P2711, DOI 10.1093/brain/awy197; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hitt BD, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01185-8; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Kolay S, 2020, FEBS OPEN BIO, V10, P1912, DOI 10.1002/2211-5463.12928; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; McCaig WD, 2019, JOVE-J VIS EXP, DOI 10.3791/59022; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Polanco JC, 2021, ACTA NEUROPATHOL, V141, P235, DOI 10.1007/s00401-020-02254-3; Siew JJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00158; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Vaquer-Alicea J, 2019, ANNU REV BIOCHEM, V88, P785, DOI 10.1146/annurev-biochem-061516-045049	23	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102014	10.1016/j.jbc.2022.102014	http://dx.doi.org/10.1016/j.jbc.2022.102014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35525272	Green Submitted, Green Published, gold			2022-12-28	WOS:000829588600006
J	Yuan, YW; Li, KL; Teng, F; Wang, WW; Zhou, B; Zhou, X; Lin, JY; Ye, XR; Deng, YJ; Liu, WH; Luo, SJ; Zhang, PZ; Liu, DY; Zheng, MH; Li, J; Lu, Y; Zhang, HJ				Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Bing; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zheng, Minghua; Li, Jin; Lu, Yan; Zhang, Huijie			Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; SELF-RENEWAL; LIF; THERAPY; CANCER	Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. However, the molecular mechanisms that promote dysregulation of hepatic triglyceride metabolism and lead to NAFLD are poorly understood, and effective treatments are limited. Leukemia inhibitory factor (LIF) is a member of the interleukin-6 cytokine family and has been shown to regulate a variety of physiological processes, although its role in hepatic triglyceride metabolism remains unknown. In the present study, we measured circulating LIF levels by ELISA in 214 patients with biopsy-diagnosed NAFLD as well as 314 normal control patients. We further investigated the potential role and mechanism of LIF on hepatic lipid metabolism in obese mice. We found that circulating LIF levels correlated with the severity of liver steatosis. Patients with ballooning, fibrosis, lobular inflammation, and abnormally elevated liver injury markers alanine transaminase and aspartate aminotransferase also had higher levels of serum LIF than control patients. Furthermore, animal studies showed that white adipose tissue-derived LIF could ameliorate liver steatosis through activation of hepatic LIF receptor signaling pathways. Together, our results suggested that targeting LIF-LIF receptor signaling might be a promising strategy for treating NAFLD.	[Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zhang, Huijie] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China; [Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zhang, Huijie] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China; [Zhou, Bing; Lu, Yan] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China; [Zheng, Minghua] Wenzhou Med Univ, Affiliated Hosp 1, MAFLD Res Ctr, Dept Hepatol, Wenzhou, Zhejiang, Peoples R China; [Zheng, Minghua] Key Lab Diag & Treatment Dev Chron Liver Dis, Wenzhou, Zhejiang, Peoples R China; [Li, Jin] Shanxi Med Univ, Affiliated Hosp 2, Dept Med, Div Endocrinol, Taiyuan, Peoples R China	Southern Medical University - China; Southern Medical University - China; Fudan University; Wenzhou Medical University; Shanxi Medical University	Zhang, HJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China.; Zhang, HJ (corresponding author), Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China.; Lu, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China.	lu.yan2@zs-hospital.sh.cn; huijiezhang2005@126.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Zheng, Ming-Hua/0000-0003-4984-2631	National Key Research and Development Project [2018YFA0800404]; Natural Science Foundation [2018B030311031]; Key-Area Research and Development Program of Guangdong Province [2018B030311031]; National Natural Science Foundation of China [81970736, 81974119, 82070588]; Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee [21XD1423400]; Distinguished Young Scholars Training Program of Nanfang Hospital	National Key Research and Development Project; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key-Area Research and Development Program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee; Distinguished Young Scholars Training Program of Nanfang Hospital	This study was supported by the National Key Research and Development Project (No.2018YFA0800404), Natural Science Foundation and Key-Area Research and Development Program of Guangdong Province (No.2018B030311031), National Natural Science Foundation of China (Nos.81970736, 81974119 and 82070588), and the Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee (No. 21XD1423400). Dr Huijie Zhang was partially supported by Distinguished Young Scholars Training Program of Nanfang Hospital.	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Arora GK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121221; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; Beretta E, 2002, PEPTIDES, V23, P975, DOI 10.1016/S0196-9781(02)00021-9; Brandt N, 2015, AM J PHYSIOL-ENDOC M, V309, pE142, DOI 10.1152/ajpendo.00313.2014; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cai JJ, 2020, CIRC RES, V126, P679, DOI 10.1161/CIRCRESAHA.119.316337; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Chen Z, 2019, TRENDS ENDOCRIN MET, V30, P903, DOI 10.1016/j.tem.2019.08.006; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Fioravante M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0956-9; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Florholmen G, 2006, DIABETOLOGIA, V49, P724, DOI 10.1007/s00125-006-0150-6; Francque S, 2021, NAT REV GASTRO HEPAT, V18, P24, DOI 10.1038/s41575-020-00366-5; Gallego-Escuredo JM, 2015, INT J OBESITY, V39, P121, DOI 10.1038/ijo.2014.76; Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Jansson JO, 2006, EUR J ENDOCRINOL, V154, P349, DOI 10.1530/eje.1.02082; Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006; Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Liu SC, 2013, J CLIN INVEST, V123, P5269, DOI 10.1172/JCI63428; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Rosado-Olivieri EA, 2020, CELL METAB, V31, P327, DOI 10.1016/j.cmet.2019.12.009; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Shi Y, 2019, NATURE, V569, P131, DOI 10.1038/s41586-019-1130-6; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wu T, 2021, J EXP MED, V218, DOI 10.1084/jem.20201203; Yki-Jarvinen H, 2021, NAT REV GASTRO HEPAT, V18, P770, DOI 10.1038/s41575-021-00472-y; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zarei M, 2020, TRENDS PHARMACOL SCI, V41, P199, DOI 10.1016/j.tips.2019.12.005; Zhang C, 2021, PHARMACOL THERAPEUT, V221, DOI 10.1016/j.pharmthera.2020.107754	36	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101946	10.1016/j.jbc.2022.101946	http://dx.doi.org/10.1016/j.jbc.2022.101946			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447114	Green Published, gold			2022-12-28	WOS:000838892100006
J	Blackler, RJ; Mueller-Loennies, S; Pokorny-Lehrer, B; Legg, MSG; Brade, L; Brade, H; Kosma, P; Evans, SV				Blackler, Ryan J.; Mueller-Loennies, Sven; Pokorny-Lehrer, Barbara; Legg, Max S. G.; Brade, Lore; Brade, Helmut; Kosma, Paul; V. Evans, Stephen			Antigen binding by conformational selection in near-germline antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL PLASTICITY; STRUCTURE PREDICTION; AFFINITY MATURATION; MONOCLONAL-ANTIBODY; INDUCED FIT; RECOGNITION; SPECIFICITY; POLYSPECIFICITY; DIVERSITY; MECHANISM	Conformational flexibility in antibody-combining sites has been hypothesized to facilitate polyspecificity toward multiple unique epitopes and enable the limited germline repertoire to match an overwhelming diversity of potential antigens; however, elucidating the mechanisms of antigen recognition by flexible antibodies has been understandably challenging. Here, multiple liganded and unliganded crystal structures of the near-germline anticarbohydrate antibodies S25-2 and S25-39 are reported, which reveal an unprecedented diversity of complementarity-determining region H3 conformations in apparent equilibrium. These structures demonstrate that at least some germline or near-germline antibodies are flexible entities sensitive to their chemical environments, with conformational selection available as an evolved mechanism that preserves the inherited ability to recognize common pathogens while remaining adaptable to new threats.	[Blackler, Ryan J.; Legg, Max S. G.; V. Evans, Stephen] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Mueller-Loennies, Sven; Brade, Lore; Brade, Helmut] Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany; [Pokorny-Lehrer, Barbara; Kosma, Paul] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria; [Pokorny-Lehrer, Barbara] Tyrenium GmbH, A-1230 Vienna, Austria	University of Victoria; Forschungszentrum Borstel; University of Natural Resources & Life Sciences, Vienna	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	svevans@uvic.ca		Kosma, Paul/0000-0001-5342-7161; Evans, Stephen/0000-0002-0366-4027; Blackler, Ryan/0000-0002-2795-8337; Legg, Max/0000-0002-9065-7019	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN-2020-0621]; Austrian Science Fund FWF [P 24021, P 26919]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund FWF(Austrian Science Fund (FWF))	Funding for this work was provided by the Natural Sciences and Engineering Research Council (NSERC) of Canada (CGSD to R. J. B.; CGSD to M. S. G. L.; and RGPIN-2020-0621 to S. V. E.) and the Austrian Science Fund FWF (P 24021, P 26919 to P. K.).	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adhikary R, 2015, BIOCHEMISTRY-US, V54, P2085, DOI 10.1021/bi501417q; Almagro JC, 2014, PROTEINS, V82, P1553, DOI 10.1002/prot.24567; Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Dimitrov JD, 2006, J BIOL CHEM, V281, P439, DOI 10.1074/jbc.M509190200; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2012, ADV EXP MED BIOL, V750, P213, DOI 10.1007/978-1-4614-3461-0_16; Dunbar J, 2016, NUCLEIC ACIDS RES, V44, pW474, DOI 10.1093/nar/gkw361; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fernandez-Quintero ML, 2019, MABS-AUSTIN, V11, P1077, DOI 10.1080/19420862.2019.1618676; Fernandez-Quintero ML, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03065; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Golinelli-Pimpaneau B, 2006, J BIOL CHEM, V281, P23969, DOI 10.1074/jbc.M602184200; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; Kanyavuz A, 2019, NAT REV IMMUNOL, V19, P355, DOI 10.1038/s41577-019-0126-7; Kaur H, 2018, BMC STRUCT BIOL, V18, DOI 10.1186/s12900-018-0096-1; Khan T, 2014, J IMMUNOL, V192, P5398, DOI 10.4049/jimmunol.1302143; Kuroda D, 2008, PROTEINS, V73, P608, DOI 10.1002/prot.22087; Lang KS, 2007, J AUTOIMMUN, V29, P206, DOI 10.1016/j.jaut.2007.07.018; Lecerf M, 2015, J BIOL CHEM, V290, P5203, DOI 10.1074/jbc.M114.618124; Leem J, 2016, MABS-AUSTIN, V8, P1259, DOI 10.1080/19420862.2016.1205773; Lepore R, 2017, NUCLEIC ACIDS RES, V45, pW17, DOI 10.1093/nar/gkx334; Li T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004327; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Manivel V, 2002, J IMMUNOL, V169, P888, DOI 10.4049/jimmunol.169.2.888; Marks C, 2017, COMPUT STRUCT BIOTEC, V15, P222, DOI 10.1016/j.csbj.2017.01.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntyre JA, 2009, CLIN REV ALLERG IMMU, V37, P49, DOI 10.1007/s12016-008-8093-y; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2021, R LANG ENV STAT COMP; RICHARDS FF, 1975, SCIENCE, V187, P130, DOI 10.1126/science.46122; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Schuermann JP, 2005, J MOL BIOL, V347, P965, DOI 10.1016/j.jmb.2005.02.008; Schuermann JP, 2004, PROTEINS, V57, P269, DOI 10.1002/prot.20200; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; Shehata L, 2019, CELL REP, V28, P3300, DOI 10.1016/j.celrep.2019.08.056; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; Van Regenmortel MHV, 2014, J MOL RECOGNIT, V27, P627, DOI 10.1002/jmr.2394; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Wang W, 2013, J PHYS CHEM B, V117, P4912, DOI 10.1021/jp4010967; Weikl TR, 2014, PROTEIN SCI, V23, P1508, DOI 10.1002/pro.2539; Weitzner BD, 2017, NAT PROTOC, V12, P401, DOI 10.1038/nprot.2016.180; Weitzner BD, 2017, J IMMUNOL, V198, P505, DOI 10.4049/jimmunol.1601137; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojciak JM, 2009, P NATL ACAD SCI USA, V106, P17717, DOI 10.1073/pnas.0906153106; Xu HF, 2015, PROTEINS, V83, P771, DOI 10.1002/prot.24745; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102	61	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101901	10.1016/j.jbc.2022.101901	http://dx.doi.org/10.1016/j.jbc.2022.101901			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35395245	gold, Green Published			2022-12-28	WOS:000804923000009
J	Legg, MSG; Hager-Mair, FF; Krauter, S; Gagnon, SML; Lopez-Guzman, A; Lim, C; Blaukopf, M; Kosma, P; Schaeffer, C; Evans, SV				Legg, Max S. G.; Hager-Mair, Fiona F.; Krauter, Simon; Gagnon, Susannah M. L.; Lopez-Guzman, Arturo; Lim, Charlie; Blaukopf, Markus; Kosma, Paul; Schaeffer, Christina; Evans, Stephen, V			The S-layer homology domains of Paenibacillus alvei surface protein SpaA bind to cell wall polysaccharide through the terminal monosaccharide residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLH DOMAINS; BACTERIAL; GLYCOSYLATION; MECHANISM; DISPLAY	Self-assembling (glyco)protein surface layers (S-layers) are ubiquitous prokaryotic cell-surface structures involved in structural maintenance, nutrient diffusion, host adhesion, virulence, and other processes, which makes them appealing targets for therapeutics and biotechnological applications as biosensors or drug delivery systems. However, unlocking this potential requires expanding our understanding of S-layer properties, especially the details of surface-attachment. S-layers of Gram-positive bacteria often are attached through the interaction of S-layer homology (SLH) domain trimers with peptidoglycan-linked secondary cell wall polymers (SCWPs). Cocrystal structures of the SLH domain trimer from the Paenibacillus alvei S-layer protein SpaA (SpaASLH) with synthetic, terminal SCWP disaccharide and trisaccharide analogs, together with isothermal titration calorimetry binding analyses, reveal that while SpaA(SLH) accommodates longer biologically relevant SCWP ligands within both its primary (G2) and secondary (G1) binding sites, the terminal pyruvylated ManNAc moiety serves as the nearly exclusive SCWP anchoring point. Binding is accompanied by displacement of a flexible loop adjacent to the receptor site that enhances the complementarity between protein and ligand, including electrostatic complementarity with the terminal pyruvate moiety. Remarkably, binding of the pyruvylated monosaccharide SCWP fragment alone is sufficient to cause rearrangement of the receptor-binding sites in a manner necessary to accommodate longer SCWP fragments. The observation of multiple conformations in longer oligosaccharides bound to the protein, together with the demonstrated functionality of two of the three SCWP receptor-binding sites, reveals how the SpaA(SLH-) SCWP interaction has evolved to accommodate longer SCWP ligands and alleviate the strain inherent to bacterial S-layer adhesion during growth and division.	[Legg, Max S. G.; Gagnon, Susannah M. L.; Evans, Stephen, V] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Hager-Mair, Fiona F.; Lopez-Guzman, Arturo; Schaeffer, Christina] Univ Bodenkultur Wien, Dept NanoBiotechnol, NanoGlycobiol Unit, Vienna, Austria; [Krauter, Simon; Lim, Charlie; Blaukopf, Markus; Kosma, Paul] Univ Bodenkultur Wien, Inst Organ Chem, Dept Chem, Vienna, Austria	University of Victoria; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	svevans@uvic.ca		Blaukopf, Markus/0000-0002-9649-1064; Kosma, Paul/0000-0001-5342-7161; Legg, Max/0000-0002-9065-7019; Hager-Mair, Fiona/0000-0001-9586-5127	Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund FWF [P27374-B22, P32521-B22]; Hochschuljubilaumsstiftung der Stadt Wien [H 318348/2018]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Hochschuljubilaumsstiftung der Stadt Wien	This work was supported by the Natural Sciences and Engineering Research Council of Canada (to M. S. G. L. and S. V. E.), the Austrian Science Fund FWF, projects P27374-B22 and P32521-B22 (to C. S.), and the Hochschuljubilaumsstiftung der Stadt Wien, project H 318348/2018 (to F. F. H.-M.).	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Awram P, 2001, MICROBIOL-SGM, V147, P1451, DOI 10.1099/00221287-147-6-1451; Bharat TAM, 2021, TRENDS MICROBIOL, V29, P405, DOI 10.1016/j.tim.2020.09.009; Blackler RJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05471-3; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Gerbino E, 2015, WORLD J MICROB BIOT, V31, P1877, DOI 10.1007/s11274-015-1952-9; Huber C, 2006, SMALL, V2, P142, DOI 10.1002/smll.200500147; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Janesch B, 2013, J BACTERIOL, V195, P565, DOI 10.1128/JB.01487-12; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Krauter S, 2021, ARKIVOC, P137, DOI 10.24820/ark.5550190.p011.358; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MESSNER P, 1992, ADV MICROB PHYSIOL, V33, P213, DOI 10.1016/S0065-2911(08)60218-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues-Oliveira T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02597; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schaffer C, 2007, SMALL, V3, P1549, DOI 10.1002/smll.200700200; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schaffer C, 2000, GLYCOCONJUGATE J, V17, P681, DOI 10.1023/A:1011062302889; Schuster B, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8020040; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEYTR UB, 1993, MOL MICROBIOL, V10, P911, DOI 10.1111/j.1365-2958.1993.tb00962.x; Sleytr UB, 1997, TRENDS BIOTECHNOL, V15, P20, DOI 10.1016/S0167-7799(96)10063-9; Sleytr UB, 2007, FEMS MICROBIOL LETT, V267, P131, DOI 10.1111/j.1574-6968.2006.00573.x; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063; Sychantha D, 2018, BIOCHEMISTRY-US, V57, P1949, DOI 10.1021/acs.biochem.8b00060; Usenik A, 2017, STRUCTURE, V25, P514, DOI 10.1016/j.str.2016.12.018; Vollenkle C, 2004, APPL ENVIRON MICROB, V70, P1514, DOI 10.1128/AEM.70.3.1514-1521.2004; Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Zarschler K, 2010, CARBOHYD RES, V345, P1422, DOI 10.1016/j.carres.2010.04.010; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	41	5	4	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101745	10.1016/j.jbc.2022.101745	http://dx.doi.org/10.1016/j.jbc.2022.101745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35189140	gold, Green Published			2022-12-28	WOS:000793694800003
J	Miyamoto, D; Takeuchi, K; Chihara, K; Fujieda, S; Sada, K				Miyamoto, Daisuke; Takeuchi, Kenji; Chihara, Kazuyasu; Fujieda, Shigeharu; Sada, Kiyonao			Protein tyrosine kinase Abl promotes hepatitis C virus particle assembly via interaction with viral substrate activator NS5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; RNA REPLICATION; FAMILY KINASES; PHOSPHORYLATION; DOMAIN; LEUKEMIA; ENTRY; BCR	Previously, we reported that knockdown of Abl protein tyrosine kinase by shRNA or pharmacological inhibition suppresses particle assembly of J6/JFH1 strain-derived hepatitis C virus (HCV) in Huh-7.5 cells. However, the detailed mechanism by which Abl regulates HCV replication remained unclear. In this study, we established Abl-deficient (Abl(-)) cells through genome editing and compared HCV production between Abl(-) cells expressing WT or kinase-dead Abl and parental Huh-7.5 cells. Our findings revealed that Abl expression was not required from the stages of virus attachment and entry to viral gene expression; however, the kinase activity of Abl was necessary for the assembly of HCV particles. Reconstitution experiments using human embryonic kidney 293T cells revealed that phosphorylation of Tyr(412) in the activation loop of Abl was enhanced by coexpression with the viral nonstructural protein 5A (NS5A) and was abrogated by the substitution of NS5A Tyr(330) with Phe (Y330F), suggesting that NS5A functions as a substrate activator of Abl. Abl-NS5A association was also attenuated by the Y330F mutation of NS5A or the kinase-dead Abl, and Abl Tyr(412) phosphorylation was not enhanced by NS5A bearing a mutation disabling homodime-rization, although the association of Abl with NS5A was still observed. Taken together, these results demonstrate that Abl forms a phosphorylation-dependent complex with dimeric NS5A necessary for viral particle assembly, but that Abl is capable of complex formation with monomeric NS5A regard-less of tyrosine phosphorylation. Our findings provide the foundation of a molecular basis for a new hepatitis C treatment strategy using Abl inhibitors.	[Miyamoto, Daisuke; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fac Med Sci, Fukui, Japan; [Miyamoto, Daisuke; Takeuchi, Kenji; Chihara, Kazuyasu; Sada, Kiyonao] Univ Fukui, Dept Genome Sci & Microbiol, Fac Med Sci, Fukui, Japan; [Takeuchi, Kenji; Chihara, Kazuyasu; Fujieda, Shigeharu; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui, Japan	University of Fukui; University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Dept Genome Sci & Microbiol, Fac Med Sci, Fukui, Japan.; Sada, K (corresponding author), Univ Fukui, Org Life Sci Adv Programs, Fukui, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	Japan Society for the Promotion of Science KAKENHI grant [21H03086, 17H04344, 18K19734, 17K08656, 20K07354]; Life Science Innovation Center at the University of Fukui; Yakult Honsha Co, Ltd	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Life Science Innovation Center at the University of Fukui; Yakult Honsha Co, Ltd	This work was supported by the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 17K08656 and 20K07354 [to K. S.]), the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 21H03086, 17H04344, and 18K19734 [to S. F.]), a grant from the Life Science Innovation Center at the University of Fukui (to K. T.), and a grant from Yakult Honsha Co, Ltd (to K. S.).	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chihara K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11915-5; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Fan PD, 2003, CANCER RES, V63, P873; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Gomperts BD, 2009, SIGNAL TRANSDUCTION, 2ND EDITION, P1; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; Klinker S, 2019, J BIOL CHEM, V294, P7388, DOI 10.1074/jbc.RA119.007656; Kumar S, 2019, CELL REP, V26, P1800, DOI 10.1016/j.celrep.2019.01.075; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Min S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01129; MULLER AJ, 1992, MOL CELL BIOL, V12, P5087, DOI 10.1128/MCB.12.11.5087; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Noda T., 2006, PLOS PATHOG, V2, P99; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Shanmugam S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007177; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Yamauchi S, 2015, J BIOL CHEM, V290, P21857, DOI 10.1074/jbc.M115.666859; Yin CH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006834; Zayas M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005376	48	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101804	10.1016/j.jbc.2022.101804	http://dx.doi.org/10.1016/j.jbc.2022.101804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35257746	Green Published, gold			2022-12-28	WOS:000793560400008
J	Berti, F				Berti, Francesco			Expanding polysaccharide-protein coupling of glycoconjugate vaccines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								For the preparation of glycoconjugate vaccines, polysaccharide antigens can usually be chemically modified to generate reactive functional groups (e.g., the formation of aldehyde groups by periodate oxidation of adjacent diols) for covalent coupling with proteins. In a recent issue of JBC, Duke et al. showed that an alternative agent, galactose oxidase (GOase) isolated from the fungus Fusarium sp. can generate aldehyde groups in a unique chemoenzymatic approach to prepare a conjugate vaccine against Streptococcus pneumoniae. These findings introduce a new strategy for the design and development of glycoconjugate vaccines.	[Berti, Francesco] GSK Vaccines Srl, Tech R&D, Siena, Italy	GlaxoSmithKline	Berti, F (corresponding author), GSK Vaccines Srl, Tech R&D, Siena, Italy.	francesco.x.berti@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was sponsored by GlaxoSmithKline Biologicals SA.	ANDERSON PW, 1986, J IMMUNOL, V137, P1181; Berti F, 2020, CURR OPIN IMMUNOL, V65, P42, DOI 10.1016/j.coi.2020.03.015; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Duke JA, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101453; Javed, 2021, CARBOHYD RES, V502, DOI 10.1016/j.carres.2021.108277; Kim JS, 2006, ANAL BIOCHEM, V358, P136, DOI 10.1016/j.ab.2006.08.016; Lees Andrew, 2008, P163; Pizza M, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abm3249; Ravenscroft N., 2020, RECENT TRENDS CARBOH, V2, P239, DOI [10.1016/B978-0-12-820954-7.00007-4, DOI 10.1016/B978-0-12-820954-7.00007-4]; Zou W., 2009, CARBOHYDRATE BASED V, P55	10	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101755	10.1016/j.jbc.2022.101755	http://dx.doi.org/10.1016/j.jbc.2022.101755			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35202656	gold, Green Published			2022-12-28	WOS:000789398100006
J	Lee, B; Oh, Y; Cho, E; DiAntonio, A; Cavalli, V; Shin, JE; Choi, HW; Cho, Y				Lee, Bohm; Oh, Yeonsoo; Cho, Eunhye; DiAntonio, Aaron; Cavalli, Valeria; Shin, Jung Eun; Choi, Hae Woong; Cho, Yongcheol			FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGENERATION; PATHWAY; LOCALIZATION; REGENERATION; ISOMERASES; DISTINCT; PROGRAM; STRESS; HDAC5	The dual leucine zipper kinase (DLK) is a key regulator of axon regeneration and degeneration in response to neuronal injury; however, regulatory mechanisms of the DLK function via its interacting proteins are largely unknown. To better understand the molecular mechanism of DLK function, we performed yeast two-hybrid screening analysis and identified FK506-binding protein-like (FKBPL, also known as WAF-1/ CIP1 stabilizing protein 39) as a DLK-binding protein. FKBPL binds to the kinase domain of DLK and inhibits its kinase activity. In addition, FKBPL induces DLK protein degradation through ubiquitin-dependent pathways. We further assessed other members in the FKBP protein family and found that FK506-binding protein 8 (FKBP8) also induced DLK degradation. We identified the lysine 271 residue in the kinase domain as a major site of DLK ubiquitination and SUMO3 conjugation and was thus responsible for regulating FKBP8-mediated proteasomal degradation that was inhibited by the substitution of the lysine 271 to arginine. FKBP8-mediated degradation of DLK is mediated by autophagy pathway because knockdown of Atg5 inhibited DLK destabilization. We show that in vivo overexpression of FKBP8 delayed the pro-gression of axon degeneration and suppressed neuronal death after axotomy in sciatic and optic nerves. Taken together, this study identified FKBPL and FKBP8 as novel DLK-interacting proteins that regulate DLK stability via the ubiquitin-proteasome and lysosomal protein degradation pathways.	[Lee, Bohm; Oh, Yeonsoo; Cho, Eunhye; Choi, Hae Woong; Cho, Yongcheol] Korea Univ, Dept Life Sci, Seoul, South Korea; [DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St. Louis, MO USA; [DiAntonio, Aaron] Washington Univ, Needleman Ctr Neurometab & Axonal Therapeut, Sch Med, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Sch Med, Dept Neurosci, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Ctr Regenerat Med, Sch Med, St. Louis, MO USA; [Cavalli, Valeria] Washington Univ, Hope Ctr Neurol Disorders, Sch Med, St. Louis, MO USA; [Choi, Hae Woong] Dong A Univ Coll Med, Dept Mol Neurosci, Busan, South Korea; [Choi, Hae Woong] Grad Sch Dong A Univ, Dept Translat Biomed Sci, Busan, South Korea	Korea University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Dong A University	Choi, HW; Cho, Y (corresponding author), Korea Univ, Dept Life Sci, Seoul, South Korea.	haewoongchoi@korea.ac.kr; ycho77@korea.ac.kr		Choi, Hae Woong/0000-0001-9372-1875; Shin, Jung Eun/0000-0002-8502-7979; Lee, Bohm/0000-0003-0887-2703	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2019R1A2C1005380, 2016R1A5A2007009, 2020R1C1C1011074]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2019R1A2C1005380 to Y. C., 2016R1A5A2007009 and 2020R1C1C1011074 to J. E. S.) .	Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Cho Y, 2014, J BIOL CHEM, V289, P15820, DOI 10.1074/jbc.M113.536607; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; DiAntonio A, 2019, PAIN, V160, pS17, DOI 10.1097/j.pain.0000000000001528; Fernandes KA, 2014, NEUROBIOL DIS, V69, P108, DOI 10.1016/j.nbd.2014.05.015; Geden MJ, 2016, CURR OPIN NEUROBIOL, V39, P108, DOI 10.1016/j.conb.2016.05.002; Ghartey-Kwansah G, 2018, BMC DEV BIOL, V18, DOI 10.1186/s12861-018-0167-3; HEITMAN J, 1992, NEW BIOL, V4, P448; Holland SM, 2016, P NATL ACAD SCI USA, V113, P763, DOI 10.1073/pnas.1514123113; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Jeon Y, 2021, MOL NEUROBIOL, V58, P750, DOI 10.1007/s12035-020-02155-2; Jin YS, 2019, ANNU REV CELL DEV BI, V35, P501, DOI 10.1146/annurev-cellbio-100617-062644; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Larhammar M, 2017, ELIFE, V6, DOI 10.7554/eLife.20725; Lee B., 2021, PROMOTING AXON REGEN, DOI [10.1101/2021.02.19.431965, DOI 10.1101/2021.02.19.431965]; Lee J, 2020, P NATL ACAD SCI USA, V117, P15955, DOI 10.1073/pnas.1920829117; Lim GGY, 2017, EMBO REP, V18, P864, DOI 10.15252/embr.201744313; Martin DDO, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39968-8; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Misaka T, 2018, J MOL CELL CARDIOL, V114, P93, DOI 10.1016/j.yjmcc.2017.11.004; Montersino A, 2015, MOL MEMBR BIOL, V32, P179, DOI 10.1080/09687688.2016.1182652; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Niu JW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108365; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Shin JE, 2019, NEUROBIOL DIS, V127, P178, DOI 10.1016/j.nbd.2019.02.001; Shin JE, 2018, J COMP NEUROL, V526, P1195, DOI 10.1002/cne.24404; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Summers DW, 2020, MOL NEUROBIOL, V57, P1146, DOI 10.1007/s12035-019-01796-2; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2018, INVEST OPHTH VIS SCI, V59; Yoo SM, 2020, FASEB J, V34, P2944, DOI 10.1096/fj.201901735R	38	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101647	10.1016/j.jbc.2022.101647	http://dx.doi.org/10.1016/j.jbc.2022.101647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35101451	Green Published, gold			2022-12-28	WOS:000789261900004
J	Peng, JH; Ramatchandirin, B; Wang, Y; Pearah, A; Namachivayam, K; Wolf, RM; Steele, K; MohanKumar, K; Yu, LQ; Guo, SD; White, MF; Maheshwari, A; He, L				Peng, Jinghua; Ramatchandirin, Balamurugan; Wang, Yu; Pearah, Alexia; Namachivayam, Kopperuncholan; Wolf, Risa M.; Steele, Kimberley; MohanKumar, Krishnan; Yu, Liqing; Guo, Shaodong; White, Morris F.; Maheshwari, Akhil; He, Ling			The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; CRYSTAL-STRUCTURE; ADIPOSE-TISSUE; GUT MICROBIOTA; HIGH-FAT; BINDING; OBESITY; KINASE; PHOSPHORYLATION; GLUCONEOGENESIS	Inhibition of P300 acetyltransferase activity by specific inhibitor C646 has been shown to improve insulin signaling. However, the underlying molecular mechanism of this improvement remains unclear. In this study, we analyzed P300 levels of obese patients and found that they were significantly increased in liver hepatocytes. In addition, large amounts of P300 appeared in the cytoplasm. Inhibition of P300 acetyltransferase activity by C646 drastically increased tyrosine phosphorylation of the insulin receptor protein substrates (IRS1/2) without affecting the tyrosine phosphorylation of the beta subunit of the insulin receptor (TR beta) in hepatocytes in the absence of insulin. Since IRS1/2 requires membrane translocation and binding to inositol compounds for normal functions, we also examined the role of acetylation on binding to phosphatidylinositol(4,5)P2 and found that IRS1/2 acetylation by P300 reduced this binding. In contrast, we show that inhibition of IRS1/2 acetylation by C646 facilitates IRS1/2 membrane translocation. Intriguingly, we demonstrate that C646 activates IR beta's tyrosine kinase activity and directly promotes IR beta interaction with IRS1/2, leading to the tyrosine phosphorylation of IRS1/2 and subsequent activation of insulin signaling even in the absence of insulin. In conclusion, these data reveal the unique effects of C646 in activating insulin signaling in patients with obesity and diabetes.	[Peng, Jinghua; Ramatchandirin, Balamurugan; Wang, Yu; Pearah, Alexia; Namachivayam, Kopperuncholan; Wolf, Risa M.; MohanKumar, Krishnan; Maheshwari, Akhil; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Steele, Kimberley] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Yu, Liqing] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Guo, Shaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [White, Morris F.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [He, Ling] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Maheshwari, Akhil] Global Newborn Soc, Clarksville, MD 21029 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station; Harvard University; Boston Children's Hospital; Johns Hopkins University	He, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.; He, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	heling@jhmi.edu	Ramatchandirin, Balamurugan/AAB-7958-2020	Ramatchandirin, Balamurugan/0000-0003-0390-1878	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK120309, R01DK107641]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Dr Philip Cole for providing C37 and initial C646 and A-485 compounds to us. This work was supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases: R01DK120309 and R01DK107641.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An HY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67030-5; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cao J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00163-w; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Farooq A, 1999, J BIOL CHEM, V274, P6114, DOI 10.1074/jbc.274.10.6114; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; He L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042121; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008946; Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; PETRUZZELLI LM, 1982, P NATL ACAD SCI-BIOL, V79, P6792, DOI 10.1073/pnas.79.22.6792; Razzini G, 2000, MOL ENDOCRINOL, V14, P823, DOI 10.1210/me.14.6.823; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Tai NW, 2015, REV ENDOCR METAB DIS, V16, P55, DOI 10.1007/s11154-015-9309-0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wondisford AR, 2014, J BIOL CHEM, V289, P4326, DOI 10.1074/jbc.M113.540500; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200	45	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101621	10.1016/j.jbc.2022.101621	http://dx.doi.org/10.1016/j.jbc.2022.101621			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35074429	Green Published, gold			2022-12-28	WOS:000821051800004
J	Wang, H; Gao, T; Zhou, Y; Ren, JH; Guo, JH; Zeng, JW; Xiao, Y; Zhang, Y; Feng, Y				Wang, Hao; Gao, Teng; Zhou, Yu; Ren, Junhui; Guo, Junhua; Zeng, Jianwei; Xiao, Yu; Zhang, Yi; Feng, Yue			Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE REVEALS; STRUCTURAL BASIS; RESOURCE	Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide prokaryotes with nucleic acid-based adaptive immunity against infections of mobile genetic elements, including phages. To counteract this immune process, phages have evolved various anti-CRISPR (Acr) proteins which deactivate CRISPR-Cas-based immunity. However, the mechanisms of many of these Acr-mediated inhibitions are not clear. Here, we report the crystal structure of AcrIF13 and explore its inhibi-tion mechanism. The structure of AcrIF13 is unique and dis-plays a negatively charged surface. Additionally, biochemical studies identified that AcrIF13 interacts with the type I-F CRISPR-Cas surveillance complex (Csy complex) to block target DNA recognition and that the Cas5f-8f tail and Cas7.6f subunit of the Csy complex are specific binding targets of AcrIF13. Further mutational studies demonstrated that several negatively charged residues of AcrIF13 and positively charged residues of Cas8f and Cas7f of the Csy complex are involved in AcrIF13-Csy binding. Together, our findings provide mecha-nistic insights into the inhibition mechanism of AcrIF13 and further suggest the prevalence of the function of Acr proteins as DNA mimics.	[Wang, Hao; Gao, Teng; Ren, Junhui; Guo, Junhua; Zhang, Yi; Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing Key Lab Bioproc, Beijing, Peoples R China; [Zhou, Yu] Natl Inst Biol Sci, Beijing, Peoples R China; [Zeng, Jianwei; Xiao, Yu] Tsinghua Univ, Minist Educ Key Lab Prot Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol,Tsinghua Pekin, Beijing, Peoples R China	Beijing University of Chemical Technology; National Institute of Biological Sciences, Beijing; Tsinghua University	Feng, Y (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing Key Lab Bioproc, Beijing, Peoples R China.	fengyue@mail.buct.edu.cn	Feng, Yue/HGE-4589-2022	Feng, Yue/0000-0002-1576-1385; Gao, Teng/0000-0002-2305-5800; Zeng, Jianwei/0000-0002-6880-3366	National Natural Science Foundation of China [32171274, 31822012, 32000901]; National Key Research and Development Program of China [2017YFA0506500, 2019YFC1200500, 2019YFC1200502]; Beijing Natural Science Foundation [5204038]; Beijing Nova Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	We would like to thank the staff at beamlines BL17U1 and BL19U1 of the Shanghai Synchrotron Radiation Facility for their assistance with data collection. We would like to thank the Tsinghua University Branch of China National Center for Protein Sciences Beijing and Shilong Fan for providing facility support for X-ray diffraction of the crystal samples. The authors would like to thank Mrs Wu Yao (State Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences) for assistance in the microscale thermophoresis experiment. This work was supported by National Natural Science Foundation of China (32171274, 31822012, and 32000901) , the National Key Research and Development Program of China (2017YFA0506500, 2019YFC1200500, and 2019YFC1200502) , the Beijing Natural Science Foundation (5204038) , and the Beijing Nova Program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2018, CRISPR J, V1, P304, DOI 10.1089/crispr.2018.0043; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Davidson AR, 2020, ANNU REV BIOCHEM, V89, P309, DOI 10.1146/annurev-biochem-011420-111224; Dong C, 2018, NUCLEIC ACIDS RES, V46, pD393, DOI 10.1093/nar/gkx835; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabel C, 2021, NUCLEIC ACIDS RES, V49, P584, DOI 10.1093/nar/gkaa1199; Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hirschi M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16512-1; Kim I, 2020, NUCLEIC ACIDS RES, V48, P9959, DOI 10.1093/nar/gkaa690; Koonin EV, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0087; Liu X., 2021, NUCLEIC ACIDS RES, V49, P10178; Lu WT, 2021, NUCLEIC ACIDS RES, V49, P3381, DOI 10.1093/nar/gkab092; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Niu YY, 2020, MOL CELL, V80, P512, DOI 10.1016/j.molcel.2020.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinilla-Redondo R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19415-3; Rollins MF, 2019, MOL CELL, V74, P132, DOI 10.1016/j.molcel.2019.02.001; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang KM, 2020, P NATL ACAD SCI USA, V117, P7176, DOI 10.1073/pnas.1922638117; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2	28	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101636	10.1016/j.jbc.2022.101636	http://dx.doi.org/10.1016/j.jbc.2022.101636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085557	Green Published, gold			2022-12-28	WOS:000789261900003
J	Wang, WA; Demaurex, N				Wang, Wen-An; Demaurex, Nicolas			The mammalian trafficking chaperone protein UNC93B1 maintains the ER calcium sensor STIM1 in a dimeric state primed for translocation to the ER cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ CHANNELS; INITIATION MECHANISM; EF-HAND; STORE; MUTATION; ACTIVATION; CELLS; ORAI1; OLIGOMERIZATION; IDENTIFICATION	The stromal interaction molecule 1 (STIM1) is an endoplasmic reticulum (ER) Ca2+ sensor that regulates the activity of Orai plasma membrane Ca2+ channels to mediate the store operated Ca2+ entry pathway essential for immunity. Uncoordinated 93 homolog B1 (UNC93B1) is a multiple membrane spanning ER protein that acts as a trafficking chaperone by guiding nucleic-acid sensing toll-like receptors to their respective endosomal signaling compartments. We previously showed that UNC93B1 interacts with STIM1 to promote antigen cross-presentation in dendritic cells, but the STIM1 binding site(s) and activation step(s) impacted by this interaction remained unknown. In this study, we show that UNC93B1 interacts with STIM1 in the ER lumen by binding to residues in close proximity to the transmembrane domain. Cysteine crosslinking in vivo showed that UNC93B1 binding promotes the zipping of transmembrane and proximal cytosolic helices within resting STIM1 dimers, priming STIM1 for trans location. In addition, we show that UNC93B1 deficiency reduces store-operated Ca2+ entry and STIM1-Orai1 interactions and targets STIM1 to lighter ER domains, whereas UNC93B1 expression accelerates the recruitment of STIM1 to cortical ER domains. We conclude that UNC93B1 therefore acts as a trafficking chaperone by maintaining the pool of resting STIM1 proteins in a state primed for activation, enabling their rapid translocation in an extended conformation to cortical ER signaling compartments.	[Wang, Wen-An; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Geneva	Wang, WA (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland.	wen-an.wang@unige.ch		Wang, Wen-An/0000-0003-3871-0174; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [310030_189042]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was funded bythe Swiss National Foundation (grant number: 310030_189042; toN. D.)	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Butorac C, 2019, CELL CALCIUM, V79, P57, DOI 10.1016/j.ceca.2019.02.009; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Dadsetan S, 2008, J BIOL CHEM, V283, P12512, DOI 10.1074/jbc.M709330200; de la Cruz IP, 2003, J NEUROSCI, V23, P9133; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Gudlur A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06816-8; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; He ZL, 2021, EUR J IMMUNOL, V51, P1672, DOI 10.1002/eji.202048901; Hirve N, 2018, CELL REP, V22, P72, DOI 10.1016/j.celrep.2017.12.030; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Ishida H, 2021, NAT STRUCT MOL BIOL, V28, P173, DOI 10.1038/s41594-020-00542-w; Itoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028500; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kashuba VI, 2002, GENE, V283, P209, DOI 10.1016/S0378-1119(01)00856-3; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; LEVIN JZ, 1992, J CELL BIOL, V117, P143, DOI 10.1083/jcb.117.1.143; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Manjarres IM, 2011, CELL CALCIUM, V49, P153, DOI 10.1016/j.ceca.2011.01.007; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Maschalidi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01601-5; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mohan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36654; Nunes P, 2012, CURR BIOL, V22, P1990, DOI 10.1016/j.cub.2012.08.049; Nunes-Hasler P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01600-6; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Peckys DB, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020799; Peinelt C, 2009, CELL CALCIUM, V45, P326, DOI 10.1016/j.ceca.2008.12.001; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1999, CYTOGENET CELL GENET, V86, P214, DOI 10.1159/000015341; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Schober R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax3194; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2010, BIOCHEM CELL BIOL, V88, P175, DOI [10.1139/o09-125, 10.1139/O09-125]; Steiner OG, 2008, BLOOD, V111, P2073, DOI 10.1182/blood-2007-06-097576; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Alonso MT, 2012, MOL CELL ENDOCRINOL, V353, P37, DOI 10.1016/j.mce.2011.08.021; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	53	1	1	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101607	10.1016/j.jbc.2022.101607	http://dx.doi.org/10.1016/j.jbc.2022.101607			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065962	Green Published, gold			2022-12-28	WOS:000789396300003
J	Yilmaz, DE; Kirschner, K; Demirci, H; Himmerkus, N; Bachmann, S; Mutig, K				Yilmaz, Duygu Elif; Kirschner, Karin; Demirci, Hasan; Himmerkus, Nina; Bachmann, Sebastian; Mutig, Kerim			Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; CYCLOPHILIN; TACROLIMUS; TRANSPLANTATION; TOXICITY; NEPHROTOXICITY; AUTOPHAGY; FIBROSIS; GROWTH	Current immunosuppressive strategies in organ trans-plantation rely on calcineurin inhibitors cyclosporine A (CsA) or tacrolimus (Tac). Both drugs are nephrotoxic, but CsA has been associated with greater renal damage than Tac. CsA in-hibits calcineurin by forming complexes with cyclophilins, whose chaperone function is essential for proteostasis. We hypothesized that stronger toxicity of CsA may be related to suppression of cyclophilins with ensuing endoplasmic reticu-lum (ER) stress and unfolded protein response (UPR) in kid-ney epithelia. Effects of CsA and Tac (10 mu M for 6 h each) were compared in cultured human embryonic kidney 293 (HEK 293) cells, primary human renal proximal tubule (PT) cells, freshly isolated rat PTs, and knockout HEK 293 cell lines lacking the critical ER stress sensors, protein kinase RNA-like ER kinase or activating transcription factor 6 (ATF6). UPR was evaluated by detection of its key components. Compared with Tac treatment, CsA induced significantly stronger UPR in native cultured cells and isolated PTs. Evaluation of pro-apoptotic and antiapoptotic markers suggested an enhanced apoptotic rate in CsA-treated cells compared with Tac-treated cells as well. Similar to CsA treatment, knockdown of cyclo-philin A or B by siRNA caused proapoptotic UPR, whereas application of the chemical chaperones tauroursodeoxycholic acid or 4-phenylbutyric acid alleviated CsA-induced UPR. Deletion of protein kinase RNA-like ER kinase or ATF6 blunted CsA-induced UPR as well. In summary, inhibition of cyclophilin chaperone function with ensuing ER stress and proapoptotic UPR aggravates CsA toxicity, whereas pharmacological modulation of UPR bears potential to alleviate renal side effects of CsA.	[Yilmaz, Duygu Elif; Demirci, Hasan; Bachmann, Sebastian] Charite Univ Med Berlin, Inst Funct Anat, Berlin, Germany; [Kirschner, Karin; Mutig, Kerim] Charite Univ Med Berlin, Inst Vegetat Physiol, Berlin, Germany; [Himmerkus, Nina] Christian Albrecht Univ Kiel, Inst Physiol, Kiel, Germany; [Mutig, Kerim] IM Sechenov First Moscow State Med Univ, Minist Healthcare Russian Federat Sechenov Univ, Dept Pharmacol, Moscow, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Sechenov First Moscow State Medical University	Mutig, K (corresponding author), Charite Univ Med Berlin, Inst Vegetat Physiol, Berlin, Germany.; Mutig, K (corresponding author), IM Sechenov First Moscow State Med Univ, Minist Healthcare Russian Federat Sechenov Univ, Dept Pharmacol, Moscow, Russia.	kerim.mutig@charite.de		Kirschner, Karin/0000-0003-0226-8636; Yilmaz, Duygu Elif/0000-0002-1110-8389; Himmerkus, Nina/0000-0002-2910-6728	Deutsche For-schungsgemeinschaft [MU2924/2-2, BA700/22-2, SFB 1365-C04/-S01]	Deutsche For-schungsgemeinschaft(German Research Foundation (DFG))	Acknowledgments-We thank Anette Drobbe for secretarial help and Katja Dorfel for excellent technical assistance. This work received financial support from the Deutsche For-schungsgemeinschaft (grants MU2924/2-2, BA700/22-2, and SFB 1365-C04/-S01) .	Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; Blankenstein KI, 2017, AM J PHYSIOL-RENAL, V312, pF489, DOI 10.1152/ajprenal.00575.2016; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Borschewski A, 2016, J AM SOC NEPHROL, V27, P107, DOI 10.1681/ASN.2014070728; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Casey MJ, 2011, CURR OPIN NEPHROL HY, V20, P610, DOI 10.1097/MNH.0b013e32834b4343; Chiasson VL, 2011, HYPERTENSION, V57, P1167, DOI 10.1161/HYPERTENSIONAHA.110.162917; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; Ekberg H., 2009, AM J TRANSPLANT; Ekberg H., 2007, REDUCED EXPOSURE CAL; Fedele AO, 2020, J BIOL CHEM, V295, P15134, DOI 10.1074/jbc.RA120.014531; Fougeray S, 2011, Cell Death Dis, V2, pe143, DOI 10.1038/cddis.2011.26; Gooch JL, 2007, TRANSPLANTATION, V83, P439, DOI 10.1097/01.tp.0000251423.78124.51; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hong F, 2004, BIOCHEM BIOPH RES CO, V316, P1073, DOI 10.1016/j.bbrc.2004.02.160; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Hou WP, 2018, CLIN EXP PHARMACOL P, V45, P250, DOI 10.1111/1440-1681.12881; Hu JD, 2021, ACTA PHYSIOL, V232, DOI 10.1111/apha.13612; Jelinek M, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0155-7; Jiang HS, 1999, TRANSPLANT INT, V12, P92, DOI 10.1007/s001470050192; Jurewicz WA, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI 10.1093/ndt/gfg1028; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Kitamura M, 2010, NEPHROL DIAL TRANSPL, V25, P6, DOI 10.1093/ndt/gfp516; Klawitter J, 2019, AM J PHYSIOL-RENAL, V317, pE683, DOI 10.1152/ajprenal.00417.2018; Kramer BK, 2005, NEPHROL DIAL TRANSPL, V20, P968, DOI 10.1093/ndt/gfh739; Lamoureux F, 2011, J PROTEOMICS, V75, P677, DOI 10.1016/j.jprot.2011.09.005; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LAU DCW, 1989, KIDNEY INT, V35, P604, DOI 10.1038/ki.1989.29; Lazelle R. A., 2016, J AM SOC NEPHROL; Leong KG, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010271; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Liu SH, 2016, ONCOTARGET, V7, P22116, DOI 10.18632/oncotarget.7904; Lucey MR, 2005, AM J TRANSPLANT, V5, P1111, DOI 10.1111/j.1600-6143.2005.00808.x; LYSON T, 1993, CIRC RES, V73, P596, DOI 10.1161/01.RES.73.3.596; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Navarro-Betancourt JR, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00361-4; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pohl M, 2010, J BIOL CHEM, V285, P41935, DOI 10.1074/jbc.M110.150284; Ram BM, 2014, BBA-MOL CELL RES, V1843, P2497, DOI 10.1016/j.bbamcr.2014.06.020; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rathi M, 2015, TRANSPL P, V47, P1158, DOI 10.1016/j.transproceed.2014.12.050; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SCHONBRUNNER ER, 1991, J BIOL CHEM, V266, P3630; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vanrenterghem YFC, 1999, CURR OPIN NEPHROL HY, V8, P669, DOI 10.1097/00041552-199911000-00003; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang B, 2016, ONCOTARGET, V7, P69309, DOI 10.18632/oncotarget.12503; Williams CR, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.8; Wissing KM, 2018, AM J TRANSPLANT, V18, P1726, DOI 10.1111/ajt.14665; Yang H, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100860; Zivanovic V, 2019, ACS NANO, V13, P9363, DOI 10.1021/acsnano.9b04001	57	4	4	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101589	10.1016/j.jbc.2022.101589	http://dx.doi.org/10.1016/j.jbc.2022.101589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35033536	gold, Green Published			2022-12-28	WOS:000791267400018
J	Zhang, X; Abel, T; Su, S; Herrmann, A; Ludwig, K; Veit, M				Zhang, Xu; Abel, Tim; Su, Shuo; Herrmann, Andreas; Ludwig, Kai; Veit, Michael			Structural and functional analysis of the roles of influenza C virus membrane proteins in assembly and budding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORD-LIKE STRUCTURES; ESTERASE-FUSION GLYCOPROTEIN; MATRIX PROTEIN; A VIRUS; M1 PROTEIN; M2 PROTEIN; CYTOPLASMIC TAILS; CM2 PROTEIN; HEMAGGLUTININ; DOMAIN	Assembly and budding of the influenza C virus is mediated by three membrane proteins: the hemagglutinin-esterase-fusion glycoprotein (HEF), the matrix protein (CM1), and the ion channel (CM2). Here we investigated whether the forma-tion of the hexagonal HEF arrangement, a distinctive feature of influenza C virions is important for virus budding. We used super resolution microscopy and found 250-nm sized HEF clusters at the plasma membrane of transfected cells, which were insensitive to cholesterol extraction and cytochalasin treatment. Overexpression of either CM1, CM2, or HEF caused the release of membrane-enveloped particles. Cryo-electron microscopy of the latter revealed spherical vesicles exhibiting the hexagonal HEF clusters. We subsequently used reverse genetics to identify elements in HEF required for this clus-tering. We found that deletion of the short cytoplasmic tail of HEF reduced virus titer and hexagonal HEF arrays, suggesting that an interaction with CM1 stabilizes the HEF clusters. In addition, we substituted amino acids at the surface of the closed HEF conformation and identified specific mutations that prevented virus rescue, others reduced virus titers and the number of HEF clusters in virions. Finally, mutation of two regions that mediate contacts between trimers in the in-situ structure of HEF was shown to prevent rescue of infectious virus particles. Mutations at residues thought to mediate lateral interactions were revealed to promote intracellular trafficking defects. Taken together, we propose that lateral interactions between the ectodomains of HEF trimers are a driving force for virus budding, although CM2 and CM1 also play important roles in this process.	[Zhang, Xu; Su, Shuo] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Engn Lab Anim Immun Jiangsu Prov, Nanjing, Peoples R China; [Zhang, Xu; Veit, Michael] Free Univ Berlin, Inst Virol, Berlin, Germany; [Abel, Tim; Herrmann, Andreas] Humboldt Univ, Inst Biol Molekulare Biophys, Berlin, Germany; [Herrmann, Andreas] Free Univ Berlin, Inst Chem & Biochem, Biophys Chem, Berlin, Germany; [Ludwig, Kai] Free Univ Berlin, Dept Chem & Biochem & Core Facil BioSupraMol, Res Ctr Electron Microscopy, Berlin, Germany	Nanjing Agricultural University; Free University of Berlin; Humboldt University of Berlin; Free University of Berlin; Free University of Berlin	Su, S (corresponding author), Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Engn Lab Anim Immun Jiangsu Prov, Nanjing, Peoples R China.; Veit, M (corresponding author), Free Univ Berlin, Inst Virol, Berlin, Germany.	shuosu@njau.edu.cn; mveit@zedat.fu-berlin.de		Ludwig, Kai/0000-0001-6808-8107; Herrmann, Andreas/0000-0002-6716-2026	German Research Foundation (DFG) [Ve 141/18-1, SFB 1449]; Fundamental Research Funds for the Central Universities [Y0201900459]; Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China [NY-045]; China Scholarship Council fellowship; Bioinformatics Center of Nanjing Agricultural University	German Research Foundation (DFG)(German Research Foundation (DFG)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China; China Scholarship Council fellowship(China Scholarship Council); Bioinformatics Center of Nanjing Agricultural University	This work was supported by the German Research Foundation (DFG) , grant Ve 141/18-1 and SFB 1449 (Dynamic hydrogels at biointerfaces) , by the Fundamental Research Funds for the Central Universities (grant No. Y0201900459) , The Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China (grant No. NY-045) , the China Scholarship Council fellowship, and the Bioinformatics Center of Nanjing Agricultural University.	Andronov L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24084; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Barnard TR, 2021, TRENDS BIOCHEM SCI, V46, P378, DOI 10.1016/j.tibs.2020.12.007; Bethune J, 2018, ANNU REV BIOPHYS, V47, P63, DOI 10.1146/annurev-biophys-070317-033259; Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Cao S, 2014, J VIROL, V88, P7464, DOI 10.1128/JVI.00794-14; Cao S, 2012, J VIROL, V86, P4883, DOI 10.1128/JVI.06586-11; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chlanda P, 2016, FEBS LETT, V590, P1940, DOI 10.1002/1873-3468.12118; Chlanda P, 2015, J VIROL, V89, P8957, DOI 10.1128/JVI.00592-15; Crescenzo-Chaigne B, 2007, J VIROL, V81, P11282, DOI 10.1128/JVI.00910-07; Dahmani I, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191024; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Flewett T H, 1967, J Gen Virol, V1, P297; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Halldorsson S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21818-9; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; HERRLER G, 1985, EMBO J, V4, P1503, DOI 10.1002/j.1460-2075.1985.tb03809.x; HERRLER G, 1991, ADV VIRUS RES, V40, P213; HERRLER G, 1981, VIROLOGY, V113, P439, DOI 10.1016/0042-6822(81)90173-2; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hofer CT, 2019, BBA-BIOMEMBRANES, V1861, P1123, DOI 10.1016/j.bbamem.2019.03.013; HONGO S, 1994, J GEN VIROL, V75, P3503, DOI 10.1099/0022-1317-75-12-3503; Hongo S, 1997, J VIROL, V71, P2786, DOI 10.1128/JVI.71.4.2786-2792.1997; Hu B, 2020, J VIROL, V94, DOI 10.1128/JVI.01605-19; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Muraki Y, 2004, J GEN VIROL, V85, P1885, DOI 10.1099/vir.0.79937-0; Muraki Y, 2007, J VIROL, V81, P8766, DOI 10.1128/JVI.00075-07; Muraki Y, 2010, JPN J INFECT DIS, V63, P157; Nakatsu S, 2018, J VIROL, V92, DOI 10.1128/JVI.02084-17; NISHIMURA H, 1994, VIROLOGY, V200, P140, DOI 10.1006/viro.1994.1172; NISHIMURA H, 1990, VIROLOGY, V179, P179, DOI 10.1016/0042-6822(90)90287-2; OCALLAGHAN RJ, 1977, J VIROL, V24, P875, DOI 10.1128/JVI.24.3.875-882.1977; Pachler Karin, 2010, J Mol Genet Med, V4, P239; Pekosz A, 1997, VIROLOGY, V237, P439, DOI 10.1006/viro.1997.8788; Peukes J, 2020, NATURE, V587, P495, DOI 10.1038/s41586-020-2696-8; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Saletti D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40801; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Sederdahl BK, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010089; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Snead WT, 2017, P NATL ACAD SCI USA, V114, pE3258, DOI 10.1073/pnas.1616199114; Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411; Stewart SM, 2012, J VIROL, V86, P1277, DOI 10.1128/JVI.05681-11; Stewart SM, 2011, J VIROL, V85, P12179, DOI 10.1128/JVI.05970-11; Su S, 2017, VIRULENCE, V8, P1580, DOI 10.1080/21505594.2017.1365216; SUGAWARA K, 1991, J GEN VIROL, V72, P103, DOI 10.1099/0022-1317-72-1-103; Takashita E, 2012, J VIROL, V86, P13108, DOI 10.1128/JVI.01925-12; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Veit M, 2013, CELL MICROBIOL, V15, P179, DOI 10.1111/cmi.12045; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang MY, 2016, CELL MICROBIOL, V18, P692, DOI 10.1111/cmi.12541; Wang MY, 2016, PROTEIN CELL, V7, P28, DOI 10.1007/s13238-015-0193-x; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wolff T., 2021, ENCY VIROLOGY, V2021, P561, DOI DOI 10.1016/B978-0-12-809633-8.21505-7; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	70	1	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101727	10.1016/j.jbc.2022.101727	http://dx.doi.org/10.1016/j.jbc.2022.101727			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35157850	Green Published, gold			2022-12-28	WOS:000789398100008
J	Hao, BH; Zhou, WJ; Theg, SM				Hao, Binhan; Zhou, Wenjie; Theg, Steven M.			Hydrophobic mismatch is a key factor in protein transport across lipid bilayer membranes via the Tat pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; TRANSMEMBRANE HELICES; SIGNAL PEPTIDE; ARGININE; COMPONENT; TRANSLOCATION; COMPLEXES; SYSTEM; EXPORT	The twin-arginine translocation (Tat) pathway transports folded proteins across membranes in bacteria, thylakoids, plant mitochondria, and archaea. In most species, the active Tat machinery consists of three independent subunits: TatA, TatB, and TatC. TatA and TatB possess short transmembrane alpha helices (TMHs), both of which are only 15 residues long in Escherichia coli. Such short TMHs cause a hydrophobic mismatch between Tat subunits and the membrane bilayer, although the functional significance of this mismatch is unclear. Here, we sought to address the functional importance of the hydrophobic mismatch in the Tat transport mechanism in E. coli. We conducted three different assays to evaluate the effect of TMH length mutants on Tat activity and observed that the TMHs of TatA and TatB appear to be evolutionarily tuned to 15 amino acids, with activity dropping off following any modification of this length. Surprisingly, TatA and TatB with as few as 11 residues in their TMHs can still insert into the membrane bilayer, albeit with a decline in membrane integrity. These findings support a model of Tat transport utilizing localized toroidal pores that form when the membrane bilayer is thinned to a critical threshold. In this context, we conclude that the 15-residue length of the TatA and TatB TMHs can be seen as a compromise between the need for some hydrophobic mismatch to allow the membrane to reversibly reach the threshold thinness required for toroidal pore formation and the permanently destabilizing effect of placing even shorter helices into these energy-transducing membranes.	[Hao, Binhan; Zhou, Wenjie; Theg, Steven M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	smtheg@ucdavis.edu		Hao, Binhan/0000-0002-4907-0849; Zhou, Wenjie/0000-0001-8055-1520	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-SC0020304]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	Funding and additional information-The work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-SC0020304 to S.M.T.	Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Asher AH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018122118; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Celler K, 2013, BIOCHEM BIOPH RES CO, V438, P38, DOI 10.1016/j.bbrc.2013.07.016; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frain KM, 2019, PROTEIN J, V38, P377, DOI 10.1007/s10930-019-09859-y; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Habersetzer J, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170091; Hauer RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08818-w; Hauer RS, 2013, BBA-MOL CELL RES, V1833, P957, DOI 10.1016/j.bbamcr.2013.01.030; He YL, 2020, PROTEIN CELL, V11, P458, DOI 10.1007/s13238-020-00712-y; Hou B, 2018, J BIOL CHEM, V293, P7592, DOI 10.1074/jbc.RA118.002205; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huan YC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.582779; Huang Q, 2017, MBIO, V8, DOI 10.1128/mBio.00909-17; Iadanza MG, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01419-w; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Kim HY, 2015, PROTEIN SCI, V24, P2063, DOI 10.1002/pro.2817; Kirchhoff H, 2011, P NATL ACAD SCI USA, V108, P20248, DOI 10.1073/pnas.1104141109; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Kreutzberger AJB, 2019, SCIENCE, V363, P497, DOI 10.1126/science.aao0076; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee MT, 2013, P NATL ACAD SCI USA, V110, P14243, DOI 10.1073/pnas.1307010110; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mol A. R., 2018, BIORXIV, DOI [10.1101/416347, DOI 10.1101/416347]; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MURAKAMI S, 1970, PLANT PHYSIOL, V45, P289, DOI 10.1104/pp.45.3.289; New CP, 2018, PHOTOSYNTH RES, V138, P289, DOI 10.1007/s11120-018-0567-z; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Petiti M, 2017, METHODS MOL BIOL, V1615, P59, DOI 10.1007/978-1-4939-7033-9_3; Pettersson P, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2020.183529; Pettersson P, 2018, FEBS J, V285, P1886, DOI 10.1111/febs.14452; Pleiner T, 2020, SCIENCE, V369, P433, DOI 10.1126/science.abb5008; Pribil M, 2014, J EXP BOT, V65, P1955, DOI 10.1093/jxb/eru090; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Saidijam M, 2018, J BIOMOL STRUCT DYN, V36, P443, DOI 10.1080/07391102.2017.1285725; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; Teter SA, 1998, P NATL ACAD SCI USA, V95, P1590, DOI 10.1073/pnas.95.4.1590; Tsirigotaki A, 2017, NAT REV MICROBIOL, V15, P21, DOI 10.1038/nrmicro.2016.161; Ulmschneider JP, 2018, ACCOUNTS CHEM RES, V51, P1106, DOI 10.1021/acs.accounts.7b00613; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu XD, 2020, SCIENCE, V368, P385, DOI 10.1126/science.aaz2449; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103157; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015	83	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	298	7							101991	10.1016/j.jbc.2022.101991	http://dx.doi.org/10.1016/j.jbc.2022.101991			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D8KE	35490783	gold, Green Published			2022-12-28	WOS:000829544300002
J	Bibo-Verdugo, B; Joglekar, I; Giridhar, MNK; Ramirez, ML; Snipas, SJ; Clark, AC; Poreba, M; Salvesen, GS				Bibo-Verdugo, Betsaida; Joglekar, Isha; Giridhar, Mithun N. Karadi; Ramirez, Monica L.; Snipas, Scott J.; Clark, A. Clay; Poreba, Marcin; Salvesen, Guy S.			Resurrection of an ancient inflammatory locus reveals switch to caspase-1 specificity on a caspase-4 scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASDERMIN-D; MAMMALIAN CASPASES; IL-1 FAMILY; ACTIVATION; PYROPTOSIS; INFLAMMASOMES; MECHANISMS; REGULATORS; SECRETION; EVOLUTION	Pyroptosis is a mechanism of inflammatory cell death mediated by the activation of the prolytic protein gasdermin D by caspase-1, caspase-4, and caspase-5 in human, and caspase-1 and caspase-11 in mouse. In addition, caspase-1 amplifies inflammation by proteolytic activation of cytokine interleukin-1 beta (IL-1 beta). Modern mammals of the order Carnivora lack the caspase-1 catalytic domain but express an unusual version of caspase-4 that can activate both gasdermin D and IL-1 beta. Seeking to understand the evolutionary origin of this caspase, we utilized the large amount of data available in public databases to perform ancestral sequence reconstruction of an inflammatory caspase of a Carnivora ancestor. We expressed the catalytic domain of this putative ancestor in Escherichia coli, purified it, and compared its substrate specificity on synthetic and protein substrates to extant caspases. We demonstrated that it activates gasdermin D but has reduced ability to activate IL-1 beta. Our reconstruction suggests that caspase-1 was lost in a Carnivora ancestor, perhaps upon a selective pressure for which the generation of biologically active IL-1 beta by caspase-1 was detrimental. We speculate that later, a Carnivora encountered selective pressures that required the production of IL-1 beta, and caspase-4 subsequently gained this activity. This hypothesis would explain why extant Carnivora possess an inflammatory caspase with caspase-1 catalytic function placed on a caspase-4 scaffold.	[Bibo-Verdugo, Betsaida; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Joglekar, Isha; Giridhar, Mithun N. Karadi; Clark, A. Clay] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Ramirez, Monica L.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Poreba, Marcin] Wroclaw Univ Sci & Technol, Dept Bioorgan Chem, Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; University of Texas Arlington; University of California System; University of California San Diego; Wroclaw University of Science & Technology	Salvesen, GS (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	gsalvesen@sbpdiscovery.org		Karadi Giridhar, Mithun Nag/0000-0003-0520-5921; Joglekar, Isha/0000-0001-7930-5533; Clark, Allan/0000-0003-4371-4102	National Institutes of Health [R01 GM99040, P30 CA30199, RO1 GM127654]; National Science Centre in Poland [UMO-2018/29/B/NZ1/02249]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the National Institutes of Health grants R01 GM99040 and P30 CA30199 (to G. S. S.) and RO1 GM127654 (to A. C. C.). M. P. laboratory is supported by the National Science Centre in Poland (grant OPUS, UMO-2018/29/B/NZ1/02249). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bibo-Verdugo B, 2022, MOL ASPECTS MED, V88, DOI 10.1016/j.mam.2022.101085; Bibo-Verdugo B, 2020, J BIOL CHEM, V295, P11292, DOI 10.1074/jbc.RA120.014259; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cui HR, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.592622; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Devant P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh3567; Digby Z, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109614; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Eick GN, 2017, MOL BIOL EVOL, V34, P247, DOI 10.1093/molbev/msw223; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fischer H, 2020, APOPTOSIS, V25, P474, DOI 10.1007/s10495-020-01614-4; Fischer H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00939; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Goh G, 2020, P NATL ACAD SCI USA, V117, P28939, DOI 10.1073/pnas.2003352117; Grinshpon RD, 2019, BIOCHEM J, V476, P3475, DOI 10.1042/BCJ20190625; Grinshpon RD, 2018, PROTEIN SCI, V27, P1857, DOI 10.1002/pro.3494; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Martin L.D., 1989, P536; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Ramirez MLG, 2018, SEMIN CELL DEV BIOL, V82, P79, DOI 10.1016/j.semcdb.2018.01.002; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wong JP, 2017, FUTURE MED CHEM, V9, P169, DOI 10.4155/fmc-2016-0181; Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3; Xie JZ, 2018, CELL HOST MICROBE, V23, P297, DOI 10.1016/j.chom.2018.01.006	56	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101931	10.1016/j.jbc.2022.101931	http://dx.doi.org/10.1016/j.jbc.2022.101931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35427646	gold, Green Published			2022-12-28	WOS:000807755100009
J	Mano, S; Hayashi, Y; Hikino, K; Otomo, M; Kanai, M; Nishimura, M				Mano, Shoji; Hayashi, Yasuko; Hikino, Kazumi; Otomo, Masayoshi; Kanai, Masatake; Nishimura, Mikio			Ubiquitin-conjugating activity by PEX4 is required for efficient protein transport to peroxisomes in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATEWAY BINARY VECTORS; IMPORT RECEPTOR PEX5P; HIGHER MOLECULAR-MASS; TARGETING SIGNAL; FUNCTIONAL-CHARACTERIZATION; CARBOXY-TERMINUS; PTS1 RECEPTOR; IDENTIFICATION; GENE; BIOGENESIS	Protein transport to peroxisomes requires various proteins, such as receptors in the cytosol and components of the transport machinery on peroxisomal membranes. The Arabidopsis apem (aberrant peroxisome morphology) mutant apem7 shows decreased efficiency of peroxisome targeting signal 1-dependent protein transport to peroxisomes. In apem7 mutants, peroxisome targeting signal 2-dependent protein transport is also disturbed, and plant growth is repressed. The APEM7 gene encodes a protein homologous to peroxin 4 (PEX4), which belongs to the ubiquitin-conjugating (UBC) protein family; however, the UBC activity of Arabidopsis PEX4 remains to be investigated. Here, we show using electron microscopy and immunoblot analysis using specific PEX4 antibodies and in vitro transcription/translation assay that PEX4 localizes to peroxisomal membranes and possesses UBC activity. We found that the substitution of proline with leucine by apem7 mutation alters ubiquitination of PEX4. Furthermore, substitution of the active-site cysteine residue at position 90 in PEX4, which was predicted to be a ubiquitin-conjugation site, with alanine did not restore the apem7 phenotype. Taken together, these findings indicate that abnormal ubiquitination in the apem7 mutant alters ubiquitin signaling during the process of protein transport, suggesting that the UBC activity of PEX4 is indispensable for efficient protein transport to peroxisomes.	[Mano, Shoji; Hikino, Kazumi; Kanai, Masatake; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Hayashi, Yasuko; Otomo, Masayoshi] Niigata Univ, Grad Sch Sci & Technol, Ikarashi, Niigata, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Niigata University	Mano, S (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.; Mano, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	mano@nibb.ac.jp		Nishimura, Mikio/0000-0001-7960-9721	Japan Society for the Promotion of Science KAKENHI grant [20059035, 22112523, 17K07457, 20K06711, 17K07467]	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI grant (grant numbers: 20059035, 22112523, 17K07457, and 20K06711; to S. M.; and 17K07467; to Y. H.).	Asano T, 2004, PLANT J, V38, P448, DOI 10.1111/j.1365-313X.2004.02057.x; Baker A, 2016, BIOCHEM SOC T, V44, P783, DOI 10.1042/BST20160036; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CRANE DI, 1994, J BIOL CHEM, V269, P21835; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Fan JL, 2005, PLANT PHYSIOL, V139, P231, DOI 10.1104/pp.105.066811; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Gonzalez KL, 2018, P NATL ACAD SCI USA, V115, pE3163, DOI 10.1073/pnas.1721279115; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Goto-Yamada S, 2015, PLANT CELL PHYSIOL, V56, P1264, DOI 10.1093/pcp/pcv081; Goto-Yamada S, 2014, PLANT CELL PHYSIOL, V55, P482, DOI 10.1093/pcp/pcu017; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; Gurvitz A, 2001, MOL GENET GENOMICS, V265, P276, DOI 10.1007/s004380000412; Hasan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00261; Hayashi H, 1998, J BIOL CHEM, V273, P8301, DOI 10.1074/jbc.273.14.8301; Hayashi M, 1999, PLANT CELL PHYSIOL, V40, P263, DOI 10.1093/oxfordjournals.pcp.a029537; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hayashi M, 1997, PLANT CELL PHYSIOL, V38, P759, DOI 10.1093/oxfordjournals.pcp.a029233; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hayashi Y, 2001, PROTOPLASMA, V218, P83, DOI 10.1007/BF01288364; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kao YT, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0605-3; Kaplan CP, 2001, BBA-MOL CELL RES, V1539, P173, DOI 10.1016/S0167-4889(01)00091-X; KATO A, 1995, PLANT MOL BIOL, V27, P377, DOI 10.1007/BF00020191; Kato A, 1998, PLANT CELL PHYSIOL, V39, P186, DOI 10.1093/oxfordjournals.pcp.a029356; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Mano S, 2005, VITAM HORM, V72, P111, DOI 10.1016/S0083-6729(05)72004-5; Mano S, 2004, PLANT J, V38, P487, DOI 10.1111/j.1365-313X.2004.02063.x; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Mural RV, 2013, PLANT CELL, V25, P3615, DOI 10.1105/tpc.113.117093; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Philip N, 2007, P NATL ACAD SCI USA, V104, P7845, DOI 10.1073/pnas.0611601104; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Prestele J, 2010, P NATL ACAD SCI USA, V107, P14915, DOI 10.1073/pnas.1009174107; Rinaldi MA, 2017, PLANT PHYSIOL, V174, P2231, DOI 10.1104/pp.17.00548; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schumann U., 1999, Plant Physiology, V120, P339, DOI 10.1104/pp.120.1.339; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Tanaka Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1795, DOI 10.1271/bbb.130405; van der Klei IJ, 1998, EMBO J, V17, P3608, DOI 10.1093/emboj/17.13.3608; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; Wimmer C, 1998, PLANT J, V16, P453, DOI 10.1046/j.1365-313x.1998.00320.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Zhou BJ, 2017, PLANT PHYSIOL, V173, P1371, DOI 10.1104/pp.16.01190; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101	75	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102038	10.1016/j.jbc.2022.102038	http://dx.doi.org/10.1016/j.jbc.2022.102038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35595097	gold, Green Published			2022-12-28	WOS:000811813400006
J	Sarr, M; Kitoka, K; Walsh-White, KA; Kaldmaee, M; Metlans, R; Tars, K; Mantese, A; Shan, DP; Landreh, M; Rising, A; Johansson, J; Jaudzems, K; Kronqvist, N				Sarr, Medoune; Kitoka, Kristine; Walsh-White, Kellie-Ann; Kaldmaee, Margit; Metlans, Rimants; Tars, Kaspar; Mantese, Alessandro; Shan, Dipen; Landreh, Michael; Rising, Anna; Johansson, Jan; Jaudzems, Kristaps; Kronqvist, Nina			The dimerization mechanism of the N-terminal domain of spider silk proteins is conserved despite extensive sequence divergence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NMR STRUCTURE DETERMINATION; PH-DEPENDENT DIMERIZATION; TORSION ANGLE DYNAMICS; BACKBONE DYNAMICS; STRUCTURAL BASIS; AMPULLATE GLAND; SOFTWARE; MODEL; SPECTROSCOPY; RECOGNITION	The N-terminal (NT) domain of spider silk proteins (spi-droins) is crucial for their storage at high concentrations and also regulates silk assembly. NTs from the major ampullate spidroin (MaSp) and the minor ampullate spidroin are mono-meric at neutral pH and confer solubility to spidroins, whereas at lower pH, they dimerize to interconnect spidroins in a fiber. This dimerization is known to result from modulation of electrostatic interactions by protonation of well-conserved glutamates, although it is undetermined if this mechanism applies to other spidroin types as well. Here, we determine the solution and crystal structures of the flagelliform spidroin NT, which shares only 35% identity with MaSp NT, and investigate the mechanisms of its dimerization. We show that flagelliform spidroin NT is structurally similar to MaSp NT and that the electrostatic intermolecular interaction between Asp 40 and Lys 65 residues is conserved. However, the protonation events involve a different set of residues than in MaSp, indicating that an overall mechanism of pH-dependent dimerization is conserved but can be mediated by different pathways in different silk types.	[Sarr, Medoune; Walsh-White, Kellie-Ann; Johansson, Jan; Kronqvist, Nina] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden; [Kitoka, Kristine; Metlans, Rimants; Jaudzems, Kristaps] Latvian Inst Organ Synth, Dept Phys Organ Chem, Riga, Latvia; [Kaldmaee, Margit; Landreh, Michael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Tars, Kaspar] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Mantese, Alessandro; Shan, Dipen] ZoBio BV, Leiden, Netherlands; [Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Johansson, Jan; Kronqvist, Nina] Karolinska Inst, Dept Biosci & Nutr, Neo, Huddinge, Sweden	Karolinska Institutet; Latvian Institute of Organic Synthesis; Karolinska Institutet; Latvian Biomedical Research & Study Centre; Swedish University of Agricultural Sciences; Karolinska Institutet	Kronqvist, N (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden.; Jaudzems, K (corresponding author), Latvian Inst Organ Synth, Dept Phys Organ Chem, Riga, Latvia.; Kronqvist, N (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Neo, Huddinge, Sweden.	kristaps.jaudzems@osi.lv; nina.kronqvist@ki.se	Jaudzems, Kristaps/P-4403-2017	Jaudzems, Kristaps/0000-0003-3922-2447; Rising, Anna/0000-0002-1872-1207	Swedish Research Council; VINNOVA; European Regional Development Fund [1.1.1.1/18/A/004]; CIMED	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); European Regional Development Fund(European Commission); CIMED	The authors would like to thank the Swedish Research Council, CIMED, VINNOVA and the European Regional Development Fund (agreement no 1.1.1.1/18/A/004) for funding this work.	Abdelkader EH, 2021, J BIOTECHNOL, V325, P145, DOI 10.1016/j.jbiotec.2020.11.005; Abelein A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57143-x; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Aramini JM, 2010, J BIOL CHEM, V285, P13736, DOI 10.1074/jbc.M109.093591; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Atkison JH, 2016, J BIOL CHEM, V291, P19006, DOI 10.1074/jbc.M116.736710; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34442; BELL AL, 1969, J CELL BIOL, V42, P284, DOI 10.1083/jcb.42.1.284; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Casem ML, 2002, TISSUE CELL, V34, P427, DOI 10.1016/S0040816602000836; Chaw RC, 2018, J ARACHNOL, V46, P159, DOI 10.1636/JoA-16-S-063.1; Chen GF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02056-4; Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Giesa T, 2016, BIOMACROMOLECULES, V17, P427, DOI 10.1021/acs.biomac.5b01246; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hagn F, 2011, ANGEW CHEM INT EDIT, V50, P310, DOI 10.1002/anie.201003795; Heiby JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12365-5; Heiby JC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16881-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004; Jiang WS, 2019, ACTA CRYSTALLOGR D, V75, P618, DOI 10.1107/S2059798319007253; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, COMPUTER AIDED RESON, V1; Kronqvist Nina, 2022, Methods Mol Biol, V2406, P113, DOI 10.1007/978-1-0716-1859-2_6; Kronqvist N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15504; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otikovs M, 2015, CHEMBIOCHEM, V16, P1720, DOI 10.1002/cbic.201500263; PEAKALL DB, 1969, AM ZOOL, V9, P71; Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sarr M, 2018, FEBS J, V285, P1873, DOI 10.1111/febs.14451; Schmuck B, 2021, MICROB CELL FACT, V20, DOI 10.1186/s12934-021-01638-8; Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Wallace JA, 2012, J PHYS CHEM LETT, V3, P658, DOI 10.1021/jz2016846; Wang ZN, 2022, PROTEIN EXPRES PURIF, V189, DOI 10.1016/j.pep.2021.105992; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	56	3	3	16	17	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101913	10.1016/j.jbc.2022.101913	http://dx.doi.org/10.1016/j.jbc.2022.101913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35398358	Green Published, gold			2022-12-28	WOS:000798082100005
J	Skopal, A; Keki, T; Toth, PA; Csoka, B; Koscso, B; Nemeth, ZH; Antonioli, L; Ivessa, A; Ciruela, F; Virag, L; Hasko, G; Kokai, E				Skopal, Adrienn; Keki, Tamas; Toth, Peter A.; Csoka, Balazs; Koscso, Balazs; Nemeth, Zoltan H.; Antonioli, Luca; Ivessa, Andreas; Ciruela, Francisco; Virag, Laszlo; Hasko, Gyorgy; Kokai, Endre			Cathepsin D interacts with adenosine A(2A) receptors in mouse macrophages to modulate cell surface localization and inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL PROTEASES; PROTEIN; BINDING; ALPHA; DESENSITIZATION; UBIQUITINATION; DEGRADATION; ACTIVATION; CALMODULIN; EXPRESSION	Adenosine A(2A) receptor (A(2A)R)-dependent signaling in macrophages plays a key role in the regulation of inflammation. However, the processes regulating A(2A)R targeting to the cell surface and degradation in macrophages are incompletely understood. For example, the C-terminal domain of the A(2A)R and proteins interacting with it are known to regulate receptor recycling, although it is unclear what role potential A(2A)R-interacting partners have in macrophages. Here, we aimed to identify A(2A)R-interacting partners in macrophages that may effect receptor trafficking and activity. To this end, we performed a yeast two-hybrid screen using the C-terminal tail of A(2A)R as the "bait" and a macrophage expression library as the "prey." We found that the lysosomal protease cathepsin D (CtsD) was a robust hit. The A(2A)R-CtsD interaction was validated in vitro and in cellular models, including RAW 264.7 and mouse peritoneal macrophage (IPM) cells. We also demonstrated that the A(2A)R is a substrate of CtsD and that the blockade of CtsD activity increases the density and cell surface targeting of A(2A)R in macrophages. Conversely, we demonstrate that A(2A)R activation prompts the maturation and enzymatic activity of CtsD in macrophages. In summary, we conclude that CtsD is a novel A(2A)R-interacting partner and thus describe molecular and functional interplay that may be crucial for adenosine-mediated macrophage regulation in inflammatory processes.	[Skopal, Adrienn; Keki, Tamas; Toth, Peter A.; Virag, Laszlo; Kokai, Endre] Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary; [Skopal, Adrienn; Keki, Tamas] Univ Debrecen, Doctoral Sch Mol Med, Debrecen, Hungary; [Csoka, Balazs; Nemeth, Zoltan H.; Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA; [Koscso, Balazs] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Antonioli, Luca] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Ivessa, Andreas] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA; [Ciruela, Francisco] Univ Barcelona, Sch Med & Hlth Sci, Inst Neurosci, Dept Pathol & Expt Therapeut,Pharmacol Unit, Barcelona, Spain; [Ciruela, Francisco] Bellvitge Inst Biomed Res, Neurosci Program, Neuropharmacol & Pain Grp, Barcelona, Spain; [Virag, Laszlo] Univ Debrecen, MTA Cell Biol & Signaling Res Grp, Debrecen, Hungary	University of Debrecen; University of Debrecen; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Atlantic Health System; University of Pisa; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Debrecen	Kokai, E (corresponding author), Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary.; Hasko, G (corresponding author), Columbia Univ, Dept Anesthesiol, New York, NY 10027 USA.	gh2503@cumc.columbia.edu; ekokai@med.unideb.hu		Koscso, Balazs/0000-0001-9676-2066; Ivessa, Andreas/0000-0002-7578-1337	OTKA [MB08A 84685]; National Research, Development and Innovation Office [GINOP-2.3.2-15-2016-00020-TUMORDNS, GINOP-2.3.2-152016-00048-STAYALIVE, OTKA-K132193]; National Institutes of Health [R01GM066189, R01DK113790, R01HL158519, 1 R35 GM145245]; MCIN/AEI "ERDF. A way of making Europe" [PID2020-118511RB-I00]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCIN/AEI "ERDF. A way of making Europe"	E. K. received funding from OTKA (grant no.: MB08A 84685). L. V. received funding from the National Research, Development and Innovation Office grants (GINOP-2.3.2-15-2016-00020-TUMORDNS, GINOP-2.3.2-152016-00048-STAYALIVE, and OTKA-K132193). G. H. received funding from the National Institutes of Health grants R01GM066189, R01DK113790, R01HL158519, and 1 R35 GM145245. Also supported by project PID2020-118511RB-I00 founded by MCIN/AEI/10.13039/501100011033 "ERDF. A way of making Europe" to F. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonioli L, 2022, TRENDS PHARMACOL SCI, V43, P43, DOI 10.1016/j.tips.2021.10.010; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Cancla L, 2007, MOL CELL NEUROSCI, V36, P1, DOI 10.1016/j.mcn.2007.05.007; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Ciruela F, 2010, BBA-BIOMEMBRANES, V1798, P9, DOI 10.1016/j.bbamem.2009.10.016; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Csoka B, 2007, PURINERG SIGNAL, V3, P447, DOI 10.1007/s11302-007-9075-x; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Dores MR, 2019, TRAFFIC, V20, P101, DOI 10.1111/tra.12619; Dubey V, 2017, CURR CANCER DRUG TAR, V17, P404, DOI 10.2174/1568009616666161229145115; Eddy MT, 2018, CELL, V172, P68, DOI 10.1016/j.cell.2017.12.004; Eguchi A, 2013, ADIPOCYTE, V2, P170, DOI 10.4161/adip.24144; Fernandez-Duenas V, 2015, DIS MODEL MECH, V8, P57, DOI 10.1242/dmm.018143; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hasko G, 2000, BRIT J PHARMACOL, V129, P909, DOI 10.1038/sj.bjp.0703134; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jain AR, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8120603; Jespers W, 2018, TRENDS PHARMACOL SCI, V39, P75, DOI 10.1016/j.tips.2017.11.001; Kara FM, 2010, FASEB J, V24, P2325, DOI 10.1096/fj.09-147447; Keuerleber S, 2012, J BIOL CHEM, V287, P42104, DOI 10.1074/jbc.M112.393579; Keuerleber S, 2011, BBA-BIOMEMBRANES, V1808, P1350, DOI 10.1016/j.bbamem.2010.05.009; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Koroskenyi K, 2016, BBA-MOL CELL RES, V1863, P1461, DOI 10.1016/j.bbamcr.2016.04.003; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moore RH, 1999, J CELL SCI, V112, P329; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Mundell S, 2011, BBA-BIOMEMBRANES, V1808, P1319, DOI 10.1016/j.bbamem.2010.06.007; Navarro G, 2020, COMPUT STRUCT BIOTEC, V18, P2723, DOI 10.1016/j.csbj.2020.09.028; Navarro G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00053; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Palmer TM, 1997, BIOCHEMISTRY-US, V36, P832, DOI 10.1021/bi962290v; PIERSEN CE, 1994, MOL PHARMACOL, V45, P861; Piirainen H, 2015, BIOPHYS J, V108, P903, DOI 10.1016/j.bpj.2014.12.036; Radisky ES, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12855; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Reece TB, 2005, J THORAC CARDIOV SUR, V129, P1137, DOI 10.1016/j.jtcvs.2004.11.042; Singh S, 2010, PROTEIN EXPRES PURIF, V74, P80, DOI 10.1016/j.pep.2010.04.018; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Thurner P, 2014, J BIOL CHEM, V289, P9263, DOI 10.1074/jbc.M113.505685; Truong LD, 2016, AM J PATHOL, V186, P2601, DOI 10.1016/j.ajpath.2016.06.017; Tsukuba T, 2000, MOL CELLS, V10, P601, DOI 10.1007/s100590000019; Woods AS, 2008, J PROTEOME RES, V7, P3428, DOI 10.1021/pr8001782; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zaidi N, 2007, BIOCHEM BIOPH RES CO, V364, P243, DOI 10.1016/j.bbrc.2007.09.114	62	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101888	10.1016/j.jbc.2022.101888	http://dx.doi.org/10.1016/j.jbc.2022.101888			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35367412	Green Published, gold			2022-12-28	WOS:000860390500011
J	Whitman, BT; Murray, CRA; Whitford, DS; Paul, SS; Fahlman, RP; Glover, MJN; Owttrim, GW				Whitman, Brendan T.; Murray, Cameron R. A.; Whitford, Denise S.; Paul, Simanta S.; Fahlman, Richard P.; Glover, Mark J. N.; Owttrim, George W.			Degron-mediated proteolysis of CrhR-like DEAD-box RNA helicases in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PROTEOLYSIS; INITIATION FACTOR-4A; ADAPTER PROTEIN; LON PROTEASE; AMINO-ACID; DEGRADATION; TRANSLATION; MODULATION; INSIGHTS; PATHWAY	Conditional proteolytic degradation is an irreversible and highly regulated process that fulfills crucial regulatory functions in all organisms. As proteolytic targets tend to be critical metabolic or regulatory proteins, substrates are targeted for degradation only under appropriate conditions through the recognition of an amino acid sequence referred to as a "degron". DEAD-box RNA helicases mediate all aspects of RNA metabolism, contributing to cellular fitness. However, the mechanism by which abiotic-stress modulation of protein stability regulates bacterial helicase abundance has not been extensively characterized. Here, we provide in vivo evidence that proteolytic degradation of the cyanobacterial DEAD-box RNA helicase CrhR is conditional, being initiated by a temperature upshift from 20 to 30 degrees C in the model cyanobacterium, Synechocystis sp. PCC 6803. We show degradation requires a unique, highly conserved, inherently bipartite degron located in the C-terminal extension found only in CrhR-related RNA helicases in the phylum Cyanobacteria. However, although necessary, the degron is not sufficient for proteolysis, as disruption of RNA helicase activity and/or translation inhibits degradation. These results suggest a positive feedback mechanism involving a role for CrhR in expression of a crucial factor required for degradation. Furthermore, AlphaFold structural prediction indicated the C-terminal extension is a homodimerization domain with homology to other bacterial RNA helicases, and mass photometry data confirmed that CrhR exists as a dimer in solution at 22 degrees C. These structural data suggest a model wherein the CrhR degron is occluded at the dimerization interface but could be exposed if dimerization was disrupted by nonpermissive conditions.	[Whitman, Brendan T.; Whitford, Denise S.; Owttrim, George W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Murray, Cameron R. A.; Fahlman, Richard P.; Glover, Mark J. N.] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB, Canada; [Paul, Simanta S.] Univ Alberta, Dept Phys, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Owttrim, GW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	gowttrim@ualberta.ca		Owttrim, George/0000-0002-4709-2091	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05448, 1705792, 2016-05163]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding and additional information-This work was supported by the Natural Sciences and Engineering Research Council of Canada grant RGPIN-2016-05448 to G. W. O., 1705792 to R. P. F. and 2016-05163 to M. J. N. G.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bittner LM, 2015, J BIOL CHEM, V290, P19367, DOI 10.1074/jbc.M115.648550; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Cohen SE, 2018, P NATL ACAD SCI USA, V115, pE7805, DOI 10.1073/pnas.1800828115; Dougan D. A., 2013, REGULATED PROTEOLYSI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Engman J, 2012, J BACTERIOL, V194, P1186, DOI 10.1128/JB.06414-11; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Georg J, 2019, RNA BIOL, V16, P1205, DOI 10.1080/15476286.2019.1621622; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Huen J, 2017, STRUCTURE, V25, P469, DOI 10.1016/j.str.2017.01.012; Hughes AC, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00659-17; Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105; Iost I, 2013, BBA-GENE REGUL MECH, V1829, P866, DOI 10.1016/j.bbagrm.2013.01.012; Ishii Y, 2001, BIOCHEM J, V358, P473, DOI 10.1042/0264-6021:3580473; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Jin HJ, 2021, ENVIRON MICROBIOL, V23, P559, DOI 10.1111/1462-2920.14911; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947; Knipfer N, 1999, GENE, V231, P95, DOI 10.1016/S0378-1119(99)00087-6; Kujat SL, 2000, PLANT PHYSIOL, V124, P703, DOI 10.1104/pp.124.2.703; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langklotz S, 2011, J BACTERIOL, V193, P1090, DOI 10.1128/JB.01043-10; Liao JYR, 2019, TRENDS BIOCHEM SCI, V44, P528, DOI 10.1016/j.tibs.2018.12.006; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu J, 2019, MOL MICROBIOL, V111, P176, DOI 10.1111/mmi.14146; Liu YL, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01753-5; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Mahmoud SA, 2018, ANNU REV BIOCHEM, V87, P677, DOI 10.1146/annurev-biochem-062917-012848; Marcaida MJ, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101811; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Marr AK, 2007, MICROBIOL-SGM, V153, P474, DOI 10.1099/mic.0.2006/002519-0; Migur A, 2021, J EXP BOT, V72, P7564, DOI 10.1093/jxb/erab416; Mloszewska AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05520-x; Nguyen AY, 2017, PHOTOSYNTH RES, V132, P95, DOI 10.1007/s11120-016-0334-y; Owttrim GW, 2012, METHOD ENZYMOL, V511, P385, DOI 10.1016/B978-0-12-396546-2.00018-8; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Puri N, 2017, MOL CELL, V66, P672, DOI 10.1016/j.molcel.2017.05.016; Qi QG, 2005, APPL ENVIRON MICROB, V71, P5678, DOI 10.1128/AEM.71.10.5678-5684.2005; Redder P, 2015, FEMS MICROBIOL REV, V39, P392, DOI 10.1093/femsre/fuv011; Ritter SPA, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129462; Rosana ARR, 2020, J BIOL CHEM, V295, P6372, DOI 10.1074/jbc.RA120.013148; Rosana ARR, 2016, J BACTERIOL, V198, P2089, DOI 10.1128/JB.00267-16; Rosana ARR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048683; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; Rowland JG, 2011, J PROTEOME RES, V10, P3674, DOI 10.1021/pr200299t; ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061; Savakis P, 2015, CURR OPIN BIOTECH, V33, P8, DOI 10.1016/j.copbio.2014.09.007; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Sloan KE, 2018, TRENDS BIOCHEM SCI, V43, P237, DOI 10.1016/j.tibs.2018.02.001; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Sonn-Segev A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15642-w; Soo RM, 2017, SCIENCE, V355, P1436, DOI 10.1126/science.aal3794; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Tarassova OS, 2014, J BACTERIOL, V196, P1560, DOI 10.1128/JB.01362-13; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Tryggvesson A, 2015, FEBS LETT, V589, P4039, DOI 10.1016/j.febslet.2015.11.026; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Whitford DS, 2021, MICROB GENOMICS, V7, DOI 10.1099/mgen.0.000517; Xu L, 2017, STRUCTURE, V25, P1795, DOI 10.1016/j.str.2017.09.013; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839	74	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101925	10.1016/j.jbc.2022.101925	http://dx.doi.org/10.1016/j.jbc.2022.101925			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35413287	Green Published, gold			2022-12-28	WOS:000804923000003
J	Wang, X; Bernstein, HD				Wang, Xu; Bernstein, Harris D.			The Escherichia coli outer membrane protein OmpA acquires secondary structure prior to its integration into the membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL ASSEMBLY MACHINE; PERIPLASMIC PROTEIN; CHAPERONE; SKP; BIOGENESIS; COMPLEX; BAM; VARIANTS; ACCURACY; PEPTIDE	Almost all proteins that reside in the outer membrane (OM) of Gram-negative bacteria contain a membrane-spanning segment that folds into a unique beta barrel structure and inserts into the membrane by an unknown mechanism. To obtain further insight into outer membrane protein (OMP) biogenesis, we revisited the surprising observation reported over 20 years ago that the Escherichia coli OmpA beta barrel can be assembled into a native structure in vivo when it is expressed as two noncovalently linked fragments. Here, we show that disulfide bonds between beta strand 4 in the N-terminal fragment and beta strand 5 in the C-terminal fragment can form in the periplasmic space and greatly increase the efficiency of assembly of "split" OmpA, but only if the cysteine residues are engineered in perfect register (i.e., they are aligned in the fully folded beta barrel). In contrast, we observed only weak disulfide bonding between beta strand 1 in the N-terminal fragment and beta strand 8 in the C-terminal fragment that would form a closed or circularly permutated beta barrel. Our results not only demonstrate that beta barrels begin to fold into a beta-sheet-like structure before they are integrated into the OM but also help to discriminate among the different models of OMP biogenesis that have been proposed.	[Wang, Xu; Bernstein, Harris D.] NIDDKD, NIH, Genet & Biochem Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDKD, NIH, Genet & Biochem Branch, Bethesda, MD USA.	harris_bernstein@nih.gov	Wang, Xu/GLU-4713-2022	Wang, Xu/0000-0003-1309-1848	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Matt Doyle and Thushani Nilaweerafor providing insightful comments on the article. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NationalInstitutes of Health	Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Cierpicki T, 2006, J AM CHEM SOC, V128, P6947, DOI 10.1021/ja0608343; Combs AN, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2114997119; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Doerner PA, 2017, BIOCHEMISTRY-US, V56, P3142, DOI 10.1021/acs.biochem.7b00281; Doyle MT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11230-9; Doyle MT, 2022, CELL, V185, P1143, DOI 10.1016/j.cell.2022.02.016; Doyle MT, 2021, MOL CELL, V81, P2000, DOI 10.1016/j.molcel.2021.02.023; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; FREUDL R, 1986, J BIOL CHEM, V261, P1355; Gao X, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67230-z; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2015, P NATL ACAD SCI USA, V112, P2011, DOI 10.1073/pnas.1415955112; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Horne JE, 2020, J BIOL CHEM, V295, P10340, DOI 10.1074/jbc.REV120.011473; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Imai Y, 2019, NATURE, V576, P459, DOI 10.1038/s41586-019-1791-1; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kaur H, 2021, NATURE, V593, P125, DOI 10.1038/s41586-021-03455-w; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Koebnik R, 1996, EMBO J, V15, P3529, DOI 10.1002/j.1460-2075.1996.tb00722.x; KOEBNIK R, 1995, J MOL BIOL, V250, P617, DOI 10.1006/jmbi.1995.0403; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lauber F, 2018, NATURE, V564, P77, DOI 10.1038/s41586-018-0693-y; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lundquist K, 2018, P NATL ACAD SCI USA, V115, pE7942, DOI 10.1073/pnas.1722530115; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Malinverni Juliana C, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.4.3.8; MORONA R, 1985, J BACTERIOL, V164, P539, DOI 10.1128/JB.164.2.539-543.1985; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110; Reynolds CR, 2018, J MOL BIOL, V430, P2244, DOI 10.1016/j.jmb.2018.01.013; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schiffrin B, 2017, J MOL BIOL, V429, P3776, DOI 10.1016/j.jmb.2017.09.008; Sikdar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01246-4; Slusky JSG, 2017, CURR OPIN STRUC BIOL, V45, P45, DOI 10.1016/j.sbi.2016.11.003; Stapleton JA, 2015, P NATL ACAD SCI USA, V112, P9632, DOI 10.1073/pnas.1501836112; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Wang X, 2021, MBIO, V12, DOI 10.1128/mBio.00597-21; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yan Z, 2019, MOL MICROBIOL, V112, P1373, DOI 10.1111/mmi.14358	53	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101802	10.1016/j.jbc.2022.101802	http://dx.doi.org/10.1016/j.jbc.2022.101802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35257747	Green Published, gold			2022-12-28	WOS:000797895000005
J	Cascarina, SM; Ross, ED				Cascarina, Sean M.; Ross, Eric D.			Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PRION-LIKE DOMAINS; N-PROTEIN; RNA; INTERFERONS; DISEASE; FORMS	In response to the recent SARS-CoV-2 pandemic, a number of labs across the world have reallocated their time and resources to better our understanding of the virus. For some viruses, including SARS-CoV-2, viral proteins can undergo phase separation: a biophysical process often related to the partitioning of protein and RNA into membraneless organelles in vivo. In this review, we discuss emerging observations of phase separation by the SARS-CoV-2 nucleocapsid (N) protein -an essential viral protein required for viral replication-and the possible in vivo functions that have been proposed for N protein phase separation, including viral replication, viral genomic RNA packaging, and modulation of host-cell response to infection. Additionally, since a relatively large number of studies examining SARS-CoV-2 N-protein phase separation have been published in a short span of time, we take advantage of this situation to compare results from similar experiments across studies. Our evaluation highlights potential strengths and pitfalls of drawing conclusions from a single set of experiments, as well as the value of publishing overlapping scientific observations performed simultaneously by multiple labs.	[Cascarina, Sean M.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Ross, ED (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Eric.Ross@colostate.edu			National Institute of General Medical Sciences [R35GM130352]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and additional information-This work was supported by the National Institute of General Medical Sciences, grant number R35GM130352 to E. D. R.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alberti S, 2018, J MOL BIOL, V430, P4806, DOI 10.1016/j.jmb.2018.06.038; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boson B, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016175; Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034; Burke JM, 2021, RNA, V27, P1318, DOI 10.1261/rna.078923.121; Cai T, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100821; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cao CC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22785-x; Carlson CR, 2020, MOL CELL, V80, P1092, DOI 10.1016/j.molcel.2020.11.025; Cascarina SM, 2020, FASEB J, V34, P9832, DOI 10.1096/fj.202001351; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chang CK, 2009, J VIROL, V83, P2255, DOI 10.1128/JVI.02001-08; Chen H, 2020, CELL RES, V30, P1143, DOI 10.1038/s41422-020-00408-2; Cubuk J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21953-3; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; Dang M, 2021, BIOCHEM BIOPH RES CO, V541, P50, DOI 10.1016/j.bbrc.2021.01.018; Davidson AD, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00763-0; Dignon GL, 2020, ANNU REV PHYS CHEM, V71, P53, DOI 10.1146/annurev-physchem-071819-113553; Ditlev JA, 2018, J MOL BIOL, V430, P4666, DOI 10.1016/j.jmb.2018.08.003; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Espinosa-Cantu A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00451; Etibor TA, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030366; Filho H. V. R., 2021, BIORXIV, DOI [10.1101/2021.08.27.457964, DOI 10.1101/2021.08.27.457964]; Fomicheva A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031251; Gaete-Argel A, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00336; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang WJ, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00306-w; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iserman C, 2020, MOL CELL, V80, P1078, DOI 10.1016/j.molcel.2020.11.041; Jack A, 2021, PLOS BIOL, V19, DOI [10.1371/journal.pbio.3001425, 10.1101/2020.09.14.295824]; Jiang HW, 2020, CELL MOL IMMUNOL, V17, P998, DOI 10.1038/s41423-020-0514-8; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Kasuga Y, 2021, EXP MOL MED, V53, P723, DOI 10.1038/s12276-021-00602-1; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kim YM, 2021, EXP MOL MED, V53, P750, DOI 10.1038/s12276-021-00592-0; Klann K, 2020, MOL CELL, V80, P164, DOI 10.1016/j.molcel.2020.08.006; Klein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19619-7; Kruse T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26498-z; Lee B. T., 2021, NUCLEIC ACIDS RES, V50, pD1115; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Li J., 2020, MED NY, DOI [10.1101/2020.03.31.019216, 10.1016/j.medj.2020.07.002]; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu XL, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2113401118, 10.1101/2021.02.17.21251933]; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; Luo LL, 2021, SCI BULL, V66, P1194, DOI 10.1016/j.scib.2021.01.013; Lutomski CA, 2021, JACS AU, V1, P1147, DOI 10.1021/jacsau.1c00139; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meyer B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25796-w; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nabeel-Shah S, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103562; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peng Y, 2020, EMBO J, V39, DOI 10.15252/embj.2020105938; Perdikari TM, 2020, EMBO J, V39, DOI 10.15252/embj.2020106478; Ribero MS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008737; Roden C, 2021, NAT REV MOL CELL BIO, V22, P183, DOI 10.1038/s41580-020-0264-6; Ruff Kiersten M, 2021, Biophys Rev, V2, P021302, DOI 10.1063/5.0050059; Savastano A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19843-1; Seim I, 2021, BIOPHYS J, V120, P2771, DOI 10.1016/j.bpj.2021.06.018; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Somasekharan SP, 2021, FEBS LETT, V595, P2872, DOI 10.1002/1873-3468.14229; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; Tarczewska A, 2021, INT J BIOL MACROMOL, V188, P391, DOI 10.1016/j.ijbiomac.2021.08.026; Tayeb-Fligelman Einav, 2021, bioRxiv, DOI 10.1101/2021.03.05.434000; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tian WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19706-9; Tseng YT, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-34; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Wang J, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-020-00240-3; Wang S, 2021, NAT CELL BIOL, V23, P718, DOI 10.1038/s41556-021-00710-0; Wu C, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102681; Wu HB, 2021, CELL HOST MICROBE, V29, P1788, DOI 10.1016/j.chom.2021.11.005; Wu YX, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00575-7; Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234; Yang M, 2021, FRONT CHEM, V8, DOI 10.3389/fchem.2020.624765; Yao H., 2020, CELL, V183, pe13; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yaron Tomer M, 2020, bioRxiv, DOI 10.1101/2020.08.14.251207; Ye QZ, 2020, PROTEIN SCI, V29, P1890, DOI [10.1002/pro.3909, 10.1101/2020.05.17.100685]; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; ZHAO D, 2021, CELL, V12, P734, DOI DOI 10.1007/S13238-021-00832-Z; Zhao HY, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102523; Zhao M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22297-8; Zhao YH, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00742-w; Zheng Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0146-6; Zheng Zhou-Qin, 2021, Cell Discov, V7, P38, DOI 10.1038/s41421-021-00275-0; Zhou R., 2020, MOL BIOMED, V1, P2, DOI [10.1186/s43556-020-00001-4, DOI 10.1186/S43556-020-00001-4]	95	4	4	7	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101677	10.1016/j.jbc.2022.101677	http://dx.doi.org/10.1016/j.jbc.2022.101677			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35131265	Green Published, gold			2022-12-28	WOS:000791230900003
J	Friso, G; Forsythe, ES; Williams, AM; Boguraev, SS; Ponnala, L; Sloan, DB; Liao, JYR; Michel, EJS; van Wijk, KJ				Friso, Giulia; Forsythe, Evan S.; Williams, Alissa M.; Boguraev, Sasha S.; Ponnala, Lalit; Sloan, Daniel B.; Liao, Jui-Yun Re; Michel, Elena J. S.; van Wijk, Klaas J.			Proteomics, phylogenetics, and coexpression analyses indicate novel interactions in the plastid CLP chaperone-protease system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED RNA-POLYMERASE; DEAD-BOX PROTEIN; CHLOROPLAST DEVELOPMENT; DNA GYRASE; ARABIDOPSIS; DISCOVERY; COMPLEX; MAIZE; BIOSYNTHESIS; MACHINERIES	The chloroplast chaperone CLPC1 unfolds and delivers substrates to the stromal CLPPRT protease complex for degradation. We previously used an in vivo trapping approach to identify interactors with CLPC1 in Arabidopsis thaliana by expressing a STREPII-tagged copy of CLPC1 mutated in its Walker B domains (CLPC1-TRAP) followed by affinity purification and mass spectrometry. To create a larger pool of candidate substrates, adaptors, or regulators, we carried out a far more sensitive and comprehensive in vivo protein trapping analysis. We identified 59 highly enriched CLPC1 protein interactors, in particular proteins belonging to families of unknown functions (DUF760, DUF179, DUF3143, UVR-DUF151, HugZ/DUF2470), as well as the UVR domain proteins EXE1 and EXE2 implicated in singlet oxygen damage and signaling. Phylogenetic and functional domain analyses identified other members of these families that appear to localize (nearly) exclusively to plastids. In addition, several of these DUF proteins are of very low abundance as determined through the Arabidopsis PeptideAtlas http://www. peptideatlas.org/builds/arabidopsis/ showing that enrichment in the CLPC1-TRAP was extremely selective. Evolutionary rate covariation indicated that the HugZ/DUF2470 family coevolved with the plastid CLP machinery suggesting functional and/or physical interactions. Finally, mRNA-based coexpression networks showed that all 12 CLP protease subunits tightly coexpressed as a single cluster with deep connections to DUF760-3. Coexpression modules for other trapped proteins suggested specific functions in biological processes, e.g., UVR2 and UVR3 were associated with extraplastidic degradation, whereas DUF760-6 is likely involved in senescence. This study provides a strong foundation for discovery of substrate selection by the chloroplast CLP protease system.	[Friso, Giulia; Boguraev, Sasha S.; Liao, Jui-Yun Re; van Wijk, Klaas J.] Cornell Univ, Sch Integrat Plant Sci SIPS, Sect Plant Biol, Ithaca, NY USA; [Forsythe, Evan S.; Williams, Alissa M.; Sloan, Daniel B.] Colorado State Univ, Dept Biol, Grad Program Cell & Mol Biol, Ft Collins, CO USA; [Ponnala, Lalit] Viqstra Inc, Staten Isl, NY USA; [van Wijk, Klaas J.] Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Michel, Elena J. S.] Boyce Thompson Inst Plant Res, Ithaca, NY USA	Cornell University; Colorado State University; National Institutes of Health (NIH) - USA; Cornell University; Boyce Thompson Institute for Plant Research	van Wijk, KJ (corresponding author), Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	kv35@cornell.edu			National Science Foundation [DGE-1321845]; National Institutes of Health [T32-GM132057]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Science Foundation (MCB 1940961 to K. J. v. W., MCB-1733227 to D. B. S., and IOS-2114641 to D. B. S and E. S. F.) . A. M. W. was supported by graduate fellowships from the National Science Foundation (DGE-1321845) and the National Institutes of Health (T32-GM132057) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Lucero DA, 2021, FEBS LETT, V595, P1525, DOI 10.1002/1873-3468.14081; Apitz J, 2016, PLANT PHYSIOL, V170, P2040, DOI 10.1104/pp.15.01945; Asakura Y, 2012, PLANT PHYSIOL, V159, P961, DOI 10.1104/pp.112.197525; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhuiyan NH, 2020, PLANT PHYSIOL, V184, P110, DOI 10.1104/pp.20.00752; Bhuiyan NH, 2016, PLANT CELL, V28, P3020, DOI 10.1105/tpc.16.00745; Bocobza SE, 2013, PLANT CELL, V25, P288, DOI 10.1105/tpc.112.106385; Bouchnak I, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100338; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang SH, 2017, PLANT PHYSIOL, V174, P435, DOI 10.1104/pp.17.00248; Clark NL, 2012, GENOME RES, V22, P714, DOI 10.1101/gr.132647.111; Coquille S, 2013, J STRUCT BIOL, V184, P438, DOI 10.1016/j.jsb.2013.10.005; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Diray-Arce J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-36; Dogra V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10760-6; Dogra V, 2018, PLANT CELL ENVIRON, V41, P1727, DOI 10.1111/pce.13332; Dogra V, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01145; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Evans-Roberts KM, 2016, J BIOL CHEM, V291, P3136, DOI 10.1074/jbc.M115.689554; Forsythe ES, 2021, PLANT CELL, V33, P980, DOI 10.1093/plcell/koab021; Friso G, 2011, METHODS MOL BIOL, V775, P265, DOI 10.1007/978-1-61779-237-3_14; Gruber AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113835; Hayer-Hartl M, 2020, TRENDS BIOCHEM SCI, V45, P748, DOI 10.1016/j.tibs.2020.05.001; Huang MS, 2013, J PROTEOME RES, V12, P491, DOI 10.1021/pr300952g; Huang YS, 2009, PLANT PHYSIOL, V150, P636, DOI 10.1104/pp.109.135368; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Izumi M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030828; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim J, 2015, PLANT CELL, V27, P1477, DOI 10.1105/tpc.15.00106; Kim J, 2013, PLANT PHYSIOL, V162, P157, DOI 10.1104/pp.113.215699; Kuhlmann NJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2010523118; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Liao JYR, 2019, TRENDS BIOCHEM SCI, V44, P528, DOI 10.1016/j.tibs.2018.12.006; Liao JYR, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.86; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Michel EJS, 2021, J EXP BOT, V72, P4663, DOI 10.1093/jxb/erab175; Montandon C, 2019, J PROTEOME RES, V18, P2585, DOI 10.1021/acs.jproteome.9b00112; Moody LA, 2016, NEW PHYTOL, V211, P940, DOI 10.1111/nph.13938; Moody LA, 2012, PLANTA, V236, P1927, DOI 10.1007/s00425-012-1742-7; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Morley SA, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1854-3; Nibau C, 2011, PLANT MOL BIOL, V75, P77, DOI 10.1007/s11103-010-9709-1; Nishimura K, 2017, MOL PLANT, V10, P4, DOI 10.1016/j.molp.2016.08.005; Nishimura K, 2015, PLANT CELL, V27, P2677, DOI 10.1105/tpc.15.00574; Nishimura K, 2015, BBA-BIOENERGETICS, V1847, P915, DOI 10.1016/j.bbabio.2014.11.012; Nishimura K, 2013, PLANT CELL, V25, P2276, DOI 10.1105/tpc.113.112557; Nishimura K, 2010, PLANT J, V63, P766, DOI 10.1111/j.1365-313X.2010.04276.x; Obayashi T, 2018, PLANT CELL PHYSIOL, V59, P440, DOI 10.1093/pcp/pcx209; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Richter AS, 2019, ELIFE, V8, DOI 10.7554/eLife.46300; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Rockenbach K, 2016, GENETICS, V204, P1507, DOI 10.1534/genetics.116.188268; Rodriguez-Concepcion M, 2019, J EXP BOT, V70, P2049, DOI 10.1093/jxb/ery441; Sa N, 2016, PLANT J, V88, P705, DOI 10.1111/tpj.13291; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seraphim TV, 2020, CURR BIOL, V30, pR251, DOI 10.1016/j.cub.2020.01.044; Sharma M, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01218; Shin JS, 2020, FEBS LETT, V594, P986, DOI 10.1002/1873-3468.13664; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Trosch R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023039; Tsitsekian D, 2019, J EXP BOT, V70, P2185, DOI 10.1093/jxb/ery440; van Wijk KJ, 2021, PLANT CELL, V33, P3421, DOI 10.1093/plcell/koab211; van Wijk KJ, 2017, ANNU REV PLANT BIOL, V68, P253, DOI 10.1146/annurev-arplant-043015-111737; van Wijk KJ, 2015, ANNU REV PLANT BIOL, V66, P75, DOI 10.1146/annurev-arplant-043014-115547; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; Williams AM, 2019, PLANT J, V98, P243, DOI 10.1111/tpj.14208; Williams-Carrier R, 2014, PLANT PHYSIOL, V164, P239, DOI 10.1104/pp.113.228726; Woodson JD, 2015, SCIENCE, V350, P450, DOI 10.1126/science.aac7444; Wu WJ, 2016, PLANT J, V85, P607, DOI 10.1111/tpj.13126; Yagi Y, 2012, P NATL ACAD SCI USA, V109, P7541, DOI 10.1073/pnas.1119403109; Yeom J, 2019, GENE DEV, V33, P1280, DOI 10.1101/gad.325241.119; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhao Y., 2021, CRYO EM STRUCTURE CH, DOI [10.1101/2021.07.26.453741, DOI 10.1101/2021.07.26.453741]; Zhou W, 2017, P NATL ACAD SCI USA, V114, pE1554, DOI 10.1073/pnas.1612460114; Zoschke R, 2016, PLANT J, V85, P594, DOI 10.1111/tpj.13093	85	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101609	10.1016/j.jbc.2022.101609	http://dx.doi.org/10.1016/j.jbc.2022.101609			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065075	gold, Green Published			2022-12-28	WOS:000789396300009
J	He, XY; Hua, Y; Li, Q; Zhu, W; Pan, Y; Yang, YL; Li, XY; Wu, MX; Wang, JY; Gan, XQ				He, Xinyu; Hua, Yue; Li, Qian; Zhu, Wei; Pan, Yu; Yang, Yilin; Li, Xinyang; Wu, Mengxiao; Wang, Jiyong; Gan, Xiaoqing			FNDC5/irisin facilitates muscle-adipose-bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING IRISIN; WHITE ADIPOCYTES; TISSUE; FAT; WWP2; PALATOGENESIS; METABOLISM; OBESITY; PRDM16; FGF21	In the past decade, the cleavage protein irisin derived from fibronectin type III domain-containing protein 5 (FNDC5) in exercise-stimulated skeletal muscle has increasingly become a biomarker associated with metabolic syndrome and osteoporosis in humans. However, it is unclear how this protein facilitates muscle-adipose-bone connectivity in metabolic and skeletal homeostasis. In this study, we unexpectedly observed that the FNDC5 gene can be markedly activated during the differentiation of brown adipocytes but not white adipocytes, and that FNDC5 is specifically expressed in mouse brown adipose tissues (BATs). But unlike it in the skeletal muscles, the expression of FNDC5/irisin in BAT is promoted by cold exposure rather than exercise in mice. Analysis of promoter activity and chromatin immunoprecipitation further showed that peroxisome proliferator-activated receptor gamma coactivator1 alpha and thyroid hormone receptors cooperate on the FNDC5 gene promoter to induce its transcription. We found that FNDC5/irisin stimulates the runt-related transcriptional factors RUNX1/2 via a focal adhesion kinase-dependent pathway in both bone and subcutaneous white adipose tissues. Mechanistically, focal adhesion kinase is stimulated by FNDC5/irisin and then facilitates E3 ubiquitin-protein ligase WW domain- containing protein 2 to ubiquitinate and subsequently activate RUNX1/2, culminating in the activation of osteoblast-related or thermogenesis-related genes. Interestingly, the PR domain containing protein 16 that is crucial for subcutaneous white adipose "browning " and skeletal development was found to form a complex with RUNX1/2 in a WW domain-containing protein 2-dependent manner. These findings elucidate a signaling mechanism by which FNDC5/irisin supports the muscle-adipose-bone connectivity, especially BAT-bone connectivity.	[He, Xinyu; Hua, Yue; Li, Qian; Zhu, Wei; Pan, Yu; Yang, Yilin; Li, Xinyang; Wu, Mengxiao; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China.	jiyongwang@fudan.edu.cn; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China [31872829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding and additional information-This work was sponsored by the National Natural Science Foundation of China (grant no.: 31872829 [to G. X. Q.] ) .	Al-Daghri NM, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0224-5; Allah AMA, 2018, PROTEIN PEPTIDE LETT, V25, P560, DOI 10.2174/0929866525666180508120653; Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; Backstrom S, 2002, J MOL BIOL, V322, P259, DOI 10.1016/S0022-2836(02)00702-7; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bousmpoula A, 2019, GYNECOL ENDOCRINOL, V35, P803, DOI 10.1080/09513590.2019.1594761; Bredella MA, 2014, BONE, V58, P55, DOI 10.1016/j.bone.2013.10.007; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Colaianni G., 2015, PROC; Colaianni G, 2021, J BONE MINER RES, V36, P305, DOI 10.1002/jbmr.4192; Colaianni G, 2019, PEDIATR RES, V85, P484, DOI 10.1038/s41390-019-0278-y; Colaianni G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02557-8; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Ellefsen S., 2014, EUR J APPL MICROBIOL; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Faienza MF, 2018, DIABETES RES CLIN PR, V141, P10, DOI 10.1016/j.diabres.2018.03.046; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Greaves M, 2018, NAT REV CANCER, V18, P471, DOI 10.1038/s41568-018-0015-6; Grygiel-Gorniak B, 2017, EUR REV MED PHARMACO, V21, P4687; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jia J, 2019, WORLD J CLIN CASES, V7, P1444, DOI 10.12998/wjcc.v7.i12.1444; Karampatsou SI, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041274; Karsenty G, 2017, ENDOCR PRACT, V23, P1270, DOI 10.4158/EP171966.RA; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lee P, 2013, OSTEOPOROSIS INT, V24, P1513, DOI 10.1007/s00198-012-2110-y; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li Q, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00562-17; Liu T. Y., 2016, FATTY ACID; Luo YY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74588-7; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Munoz IYM, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/7816806; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Oguri Y, 2020, CELL, V182, P563, DOI 10.1016/j.cell.2020.06.021; Ott C. E., 2010, DELETIONS; Bonfante ILP, 2017, EUR J SPORT SCI, V17, P629, DOI 10.1080/17461391.2017.1296025; Palermo A., 2015, IRISIN IS ASS OSTEOP; Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rabiee F, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00413-3; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Staiger H., 2013, PLOS; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Vadala G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061478; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang FS, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090810; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiong Y, 2019, FASEB J, V33, P5876, DOI 10.1096/fj.201801754RR; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhu W, 2017, J BIOL CHEM, V292, P11178, DOI 10.1074/jbc.M116.772277; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	55	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101679	10.1016/j.jbc.2022.101679	http://dx.doi.org/10.1016/j.jbc.2022.101679			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35124008	gold, Green Published			2022-12-28	WOS:000791230900005
J	Lowary, TL; Achkar, JM				Lowary, Todd L.; Achkar, Jacqueline M.			Tailor made: New insights into lipoarabinomannan structure may improve TB diagnosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Detecting the mycobacterial glycolipid lipoarabinomannan (LAM) in urine by anti-LAM antibodies fills a gap in the diagnostic armamentarium of much needed simple rapid tests for tuberculosis, but lacks high sensitivity in all patient groups. A better understanding of LAM structure from clinically relevant strains may allow improvements in diagnostic performance. De et al. have recently determined the structures of LAM from three epidemiologically important lineages of Mycobacterium tuberculosis and probed their interaction with an anti-LAM monoclonal antibody. Their results not only identify a series of tailoring modifications that impact antibody binding but also provide a roadmap for improving U-LAM based diagnostics.	[Lowary, Todd L.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lowary, Todd L.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Achkar, Jacqueline M.] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Achkar, Jacqueline M.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA	Academia Sinica - Taiwan; National Taiwan University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lowary, TL (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.; Lowary, TL (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.; Achkar, JM (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY USA.; Achkar, JM (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA.	tlowary@gate.sinica.edu.tw; jacqueline.achkar@einsteinmed.edu	Lowary, Todd/F-9608-2019	Lowary, Todd/0000-0002-8331-8211; Achkar, Jacqueline M./0000-0002-5227-7293	Academia Sinica (T. L. L.); NIH/NIAID [AI146329, AI 117927 toJ]; NIH/NIAID;  [AI 117927]	Academia Sinica (T. L. L.); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); 	The authors thank Academia Sinica (T. L. L.) and NIH/NIAID (AI146329 & AI 117927 to J. M. A.) for support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angala SK, 2018, NAT CHEM BIOL, V14, P193, DOI 10.1038/nchembio.2571; Boom WH, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136222; Choudhary A., 2018, CHARACTERIZATION ANT; Correia-Neves M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01968; De P, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101265; Flores J, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.638047; Ishida E, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02714-w; Magee GM, 2012, BERGEYS MANUAL SYSTE, V5, P312; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Sigal GB, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01338-18	10	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101678	10.1016/j.jbc.2022.101678	http://dx.doi.org/10.1016/j.jbc.2022.101678			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35122792	gold, Green Published			2022-12-28	WOS:000791230900012
J	Lu, CJ; Meng, Y; Wang, YL; Zhang, T; Yang, GF; Mo, MH; Ji, KF; Liang, LM; Zou, CG; Zhang, KQ				Lu, Chao-Jun; Meng, Yang; Wang, Yan-Li; Zhang, Tao; Yang, Gui-Fang; Mo, Ming-He; Ji, Kai-Fang; Liang, Lian-Ming; Zou, Cheng-Gang; Zhang, Ke-Qin			Survival and infectivity of second-stage root-knot nematode Meloidogyne incognita juveniles depend on lysosome-mediated lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RESERVES; REPRODUCTION; BIOGENESIS; STARVATION; EXPANSION; SEQUENCE; FIELD; SPP.	Adaptation to nutrient deprivation depends on the activation of metabolic programs to use reserves of energy. When outside a host plant, second-stage juveniles (J2) of the root knot nematode (Meloidogyne spp.), an important group of pests responsible for severe losses in the production of crops (e.g., rice, wheat, and tomato), are unable to acquire food. Although lipid hydrolysis has been observed in J2 nematodes, its role in fitness and the underlying mechanisms remain unknown. Using RNA-seq analysis, here, we demonstrated that in the absence of host plants, the pathway for the biosynthesis of polyunsaturated fatty acids was upregulated, thereby increasing the production of arachidonic acid in middle-stage J2 Meloidogyne incognita worms. We also found that arachidonic acid upregulated the expression of the transcription factor hlh-30b, which in turn induced lysosomal biogenesis. Lysosomes promoted lipid hydrolysis via a lysosomal lipase, LIPL-1. Furthermore, our data demonstrated that blockage of lysosomal lipolysis reduced both lifespan and locomotion of J2 worms. Strikingly, disturbance of lysosomal lipolysis resulted in a decline in infectivity of these juveniles on tomato roots. Our findings not only reveal the molecular mechanism of lipolysis in J2 worms but also suggest potential novel strategies for the management of root-knot nematode pests.	[Lu, Chao-Jun; Meng, Yang; Zhang, Tao; Yang, Gui-Fang; Mo, Ming-He; Ji, Kai-Fang; Liang, Lian-Ming; Zou, Cheng-Gang; Zhang, Ke-Qin] Yunnan Univ, State Key Lab Conservat & Utilizat BioResources, Kunming, Yunnan, Peoples R China; [Wang, Yan-Li] Yunnan Univ, Ctr Life Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Zou, CG; Zhang, KQ (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat BioResources, Kunming, Yunnan, Peoples R China.	chgzou@ynu.edu.cn; kqzhang@ynu.edu.cn		Zou, Cheng-Gang/0000-0001-5519-4402	National Natural Science Foundation of China [U1802233]; Ministry of Education of PR China & Yunnan University [C176280101]; Department of Science and Technology of Yunnan Province [202102AE090042-02-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of PR China & Yunnan University; Department of Science and Technology of Yunnan Province	We thank Dr Heng Jian (China Agricultural University) for M. incognita strain. We are grateful to Dr Jianping Xu (McMaster University, Canada) for his critical reading of this article and Dr Bin Liang (Yunnan University) for his technical assistance for GC-MS. This work was supported by a grant from the National Natural Science Foundation of China (U1802233) , a Joint project from the Ministry of Education of PR China & Yunnan University (C176280101) , and a grant from the Department of Science and Technology of Yunnan Province (202102AE090042-02-08) .	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; Bakhetia M, 2005, MOL PLANT MICROBE IN, V18, P1099, DOI 10.1094/MPMI-18-1099; Barker K.R, 1989, ADV TREATISE MELOIDO, V1, P47; BARRETT J, 1968, NATURE, V218, P1267, DOI 10.1038/2181267a0; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; Chen J, 2017, ELIFE, V6, DOI 10.7554/eLife.31268; Chen SY, 2000, J NEMATOL, V32, P117; Chen YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10475-8; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Christophers AEP, 1997, NEMATOLOGICA, V43, P117, DOI 10.1163/004725997X00089; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Das S., 2011, AGR SCI RES J, V1, P102; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dutta TK, 2011, NEMATOLOGY, V13, P509, DOI 10.1163/138855410X528262; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Ghosh A, 2015, J BIOL CHEM, V290, P10309, DOI 10.1074/jbc.M114.610659; GOODELL PB, 1989, J NEMATOL, V21, P328; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Ijani ASM, 2000, EUR J PLANT PATHOL, V106, P1, DOI 10.1023/A:1008788805581; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Oka Y, 2002, NEMATOLOGY, V4, P65, DOI 10.1163/156854102760082212; OTEIFA BAKIR A., 1955, PLANT DIS REPORTER, V39, P902; Patel MN, 1997, PARASITOLOGY, V114, P489, DOI 10.1017/S0031182096008748; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Perry RN, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P1, DOI 10.1079/9781845936877.0000; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Rocha FD, 2015, NEMATOLOGY, V17, P345, DOI 10.1163/15685411-00002871; Rocha FD, 2010, NEMATOLOGY, V12, P365, DOI 10.1163/138855409X12548945788367; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Schulze RJ, 2020, P NATL ACAD SCI USA, V117, P32443, DOI 10.1073/pnas.2011442117; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shivakumara TN, 2019, NEMATOLOGY, V21, P267, DOI 10.1163/15685411-00003212; STOREY RMJ, 1984, ANN APPL BIOL, V104, P511, DOI 10.1111/j.1744-7348.1984.tb03034.x; Su L., 2015, SCI REP-UK, V5, P1; Tao J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501372; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torto B, 2018, J AGR FOOD CHEM, V66, P8672, DOI 10.1021/acs.jafc.8b01940; VANGUNDY SD, 1967, PHYTOPATHOLOGY, V57, P559; Wang Z., 2019, CELL SCI, V132; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	54	0	0	8	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101637	10.1016/j.jbc.2022.101637	http://dx.doi.org/10.1016/j.jbc.2022.101637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085555	gold, Green Published			2022-12-28	WOS:000789261900010
J	Rai, A; Shrivastava, R; Vang, D; Ritt, M; Sadler, F; Bhaban, S; Salapaka, M; Sivaramakrishnan, S				Rai, Ashim; Shrivastava, Rachit; Vang, Duha; Ritt, Michael; Sadler, Fredrik; Bhaban, Shreyas; Salapaka, Murti; Sivaramakrishnan, Sivaraj			Multimodal regulation of myosin VI ensemble transport by cargo adaptor protein GIPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL MYOSIN; PDZ DOMAIN; MOTOR; BINDING; DIMERIZATION; PROCESSIVITY; MELANOPHILIN; COMPLEXES; MECHANISM; FILAMENTS	A range of cargo adaptor proteins are known to recruit cytoskeletal motors to distinct subcellular compartments. However, the structural impact of cargo recruitment on motor function is poorly understood. Here, we dissect the multimodal regulation of myosin VI activity through the cargo adaptor GAIP-interacting protein, C terminus (GIPC), whose over-expression with this motor in cancer enhances cell migration. Using a range of biophysical techniques, including motility assays, FRET-based conformational sensors, optical trapping, and DNA origami-based cargo scaffolds to probe the individ-ual and ensemble properties of GIPC-myosin VI motility, we report that the GIPC myosin-interacting region (MIR) releases an autoinhibitory interaction within myosin VI. We show that the resulting conformational changes in the myosin lever arm, including the proximal tail domain, increase the flexibility of the adaptor-motor linkage, and that increased flexibility cor-relates with faster actomyosin association and dissociation rates. Taken together, the GIPC MIR-myosin VI interaction stimulates a twofold to threefold increase in ensemble cargo speed. Furthermore, the GIPC MIR-myosin VI ensembles yield similar cargo run lengths as forced processive myosin VI di-mers. We conclude that the emergent behavior from these individual aspects of myosin regulation is the fast, processive, and smooth cargo transport on cellular actin networks. Our study delineates the multimodal regulation of myosin VI by the cargo adaptor GIPC, while highlighting linkage flexibility as a novel biophysical mechanism for modulating cellular cargo motility.	[Rai, Ashim; Ritt, Michael; Sadler, Fredrik; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Shrivastava, Rachit; Bhaban, Shreyas; Salapaka, Murti] Univ Minnesota Twin Cities, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	sivaraj@umn.edu		Bhaban, Shreyas/0000-0001-9265-1617; Vang, Duha/0000-0002-8990-8968; Sivaramakrishnan, Sivaraj/0000-0002-9541-6994	National Institutes of Health [R35GM126940]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grant no.: R35GM126940; to S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Batters C, 2016, P NATL ACAD SCI USA, V113, pE1162, DOI 10.1073/pnas.1519435113; Bhaban S, 2018, IEEE-ASME T MECH, V23, P1532, DOI 10.1109/TMECH.2018.2852367; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; de Jonge JJ, 2019, FEBS LETT, V593, P1494, DOI 10.1002/1873-3468.13486; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Fili N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02050-w; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hariadi RF, 2015, NAT NANOTECHNOL, V10, P696, DOI [10.1038/NNANO.2015.132, 10.1038/nnano.2015.132]; Hariadi RF, 2015, ELIFE, V4, DOI 10.7554/eLife.05472; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Rai A, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.012703; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sarshar M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.115001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shang GJ, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27322; Shrivastava R, 2019, BIOCHEMISTRY-US, V58, P4721, DOI 10.1021/acs.biochem.9b00422; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sommese RF, 2016, PROTEIN SCI, V25, P2089, DOI 10.1002/pro.3020; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025	48	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101688	10.1016/j.jbc.2022.101688	http://dx.doi.org/10.1016/j.jbc.2022.101688			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143838	Green Published, gold			2022-12-28	WOS:000789400700014
J	Fan, S; Lv, GX; Feng, X; Wu, GT; Jin, YY; Yan, MC; Yang, ZY				Fan, Shuai; Lv, Guangxin; Feng, Xiao; Wu, Guangteng; Jin, Yuanyuan; Yan, Maocai; Yang, Zhaoyong			Structural insights into the specific interaction between Geobacillus stearothermophilus tryptophanyl-tRNA synthetase and antimicrobial Chuangxinmycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTIFUNGAL AGENT; ACTIVATION; MECHANISM; BINDING; RECOGNITION; RESOLUTION; REVEALS; POTENT; ENERGY	The potential antimicrobial compound Chuangxinmycin (CXM) targets the tryptophanyl-tRNA synthetase (TrpRS) of both Gram-negative and Gram-positive bacteria. However, the specific steric recognition mode and interaction mechanism between CXM and TrpRS is unclear. Here, we studied this interaction using recombinant GsTrpRS from Geobacillus stearothermophilus by X-ray crystallography and molecular dynamics (MD) simulations. The crystal structure of the recombinant GsTrpRS in complex with CXM was experimentally determined to a resolution at 2.06 angstrom. After analysis using a complex-structure probe, MD simulations, and site-directed mutation verification through isothermal titration calorimetry, the interaction between CXM and GsTrpRS was determined to involve the key residues M129, D132, I133, and V141 of GsTrpRS. We further evaluated binding affinities between GsTrpRS WT/mutants and CXM; GsTrpRS was found to bind CXM through hydrogen bonds with D132 and hydrophobic interactions between the lipophilic tricyclic ring of CXM and M129, I133, and V141 in the substrate-binding pockets. This study elucidates the precise interaction mechanism between CXM and its target GsTrpRS at the molecular level and provides a theoretical foundation and guidance for the screening and rational design of more effective CXM analogs against both Gram-negative and Gram-positive bacteria.	[Fan, Shuai; Lv, Guangxin; Feng, Xiao; Jin, Yuanyuan; Yang, Zhaoyong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China; [Wu, Guangteng] ArNuXon Pharm Sci Co Ltd, Res & Dev Dept, Beijing, Peoples R China; [Yan, Maocai] Jining Med Univ, Sch Pharm, Rizhao, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jining Medical University	Yang, ZY (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China.; Yan, MC (corresponding author), Jining Med Univ, Sch Pharm, Rizhao, Shandong, Peoples R China.	yanmaocai@126.com; zhaoyongy@imb.pumc.edu.cn			National Key Research and Development Program of China [2018YFA0901800]; National Natural Science Foundation of China [81761128016, 8187131584]; CAMS Innovation Fund for Medical Sciences [2019-I2M-1-005]; NSFC cultivation project of Jining Medical University [JYP2018KJ18]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; NSFC cultivation project of Jining Medical University	This work was funded by the National Key Research and Development Program of China (No. 2018YFA0901800) , National Natural Science Foundation of China (Grants 81761128016 and 8187131584) , CAMS Innovation Fund for Medical Sciences (2019-I2M-1-005) , and NSFC cultivation project of Jining Medical University (JYP2018KJ18) . We thank Prof. Zhuorong Li (Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, China) for providing the Chuangxinmycin. We thank BL18U1 in Shanghai Synchrotron Radiation Facility (SSRF) for providing technical support and assistance in data collection and process. We also thank Mr Yi Han at the Institute of Biophysics Core-Facility for the support during in-house data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1977, SCI SINICA, V20, P106; Brown MJ, 2002, BIOORG MED CHEM LETT, V12, P3171, DOI 10.1016/S0960-894X(02)00604-2; Carter CW, 2021, ANNU REV BIOCHEM, V90, P349, DOI 10.1146/annurev-biochem-071620-021218; Carter CW, 2017, ANNU REV BIOPHYS, V46, P433, DOI 10.1146/annurev-biophys-070816-033811; Carter CW, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4974218; Carter CW, 2020, PROTEINS, V88, P710, DOI 10.1002/prot.25856; Case D. A., AMBER 2018; Chandrasekaran SN, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4976142; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Elewski BE, 2015, J AM ACAD DERMATOL, V73, P62, DOI 10.1016/j.jaad.2015.04.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Ilyin VA, 2000, PROTEIN SCI, V9, P218; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Retailleau P, 2001, ACTA CRYSTALLOGR D, V57, P1595, DOI 10.1107/S090744490101215X; Retailleau P, 2007, J MOL BIOL, V369, P108, DOI 10.1016/j.jmb.2007.01.091; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Shen N, 2006, NUCLEIC ACIDS RES, V34, P3246, DOI 10.1093/nar/gkl441; Shi YY, 2018, ACTA PHARM SIN B, V8, P283, DOI 10.1016/j.apsb.2017.07.005; Sun LQ, 2019, FUTURE MED CHEM, V11, P2877, DOI 10.4155/fmc-2019-0209; Williams TL, 2016, J BIOL CHEM, V291, P255, DOI 10.1074/jbc.M115.690321; Xu XK, 2018, J NAT PROD, V81, P1060, DOI 10.1021/acs.jnatprod.7b00835; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	32	0	0	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101580	10.1016/j.jbc.2022.101580	http://dx.doi.org/10.1016/j.jbc.2022.101580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35031320	gold, Green Published			2022-12-28	WOS:000761371500003
J	Gada, KD; Logothetis, DE				Gada, Kirin D.; Logothetis, Diomedes E.			PKC regulation of ion channels: The involvement of PIP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; CA2+-ACTIVATED K+ CHANNELS; CALCIUM-CHANNELS; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TRANSIENT RECEPTOR; POTASSIUM CHANNELS; SODIUM-CHANNELS; FUNCTIONAL-CHARACTERIZATION; DEPENDENT PHOSPHORYLATION	Ion channels are integral membrane proteins whose gating has been increasingly shown to depend on the presence of the low-abundance membrane phospholipid, phosphatidylinositol (4,5) bisphosphate. The expression and function of ion chan-nels is tightly regulated via protein phosphorylation by specific kinases, including various PKC isoforms. Several channels have further been shown to be regulated by PKC through altered surface expression, probability of channel opening, shifts in voltage dependence of their activation, or changes in inacti-vation or desensitization. In this review, we survey the impact of phosphorylation of various ion channels by PKC isoforms and examine the dependence of phosphorylated ion channels on phosphatidylinositol (4,5) bisphosphate as a mechanistic endpoint to control channel gating.	[Gada, Kirin D.; Logothetis, Diomedes E.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Bouve Coll Hlth Sci, Ctr Drug Discovery, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Coll Sci, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; Northeastern University	Logothetis, DE (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Coll Sci, Boston, MA 02115 USA.	d.logothetis@northeastern.edu			National Heart, Lung and Blood institute [R01-HL59949-19]	National Heart, Lung and Blood institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding and additional information-This work was supported by National Heart, Lung and Blood institute, R01-HL59949-19 awar-ded to D. E. L.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Adney SK, 2015, J NEUROSCI, V35, P14397, DOI 10.1523/JNEUROSCI.1415-15.2015; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI [10.1111/bph.14752, 10.1111/bph.14749]; Andersen MN, 2018, CHANNELS, V12, P34, DOI 10.1080/19336950.2017.1405196; Andersen MN, 2015, CHANNELS, V9, P121, DOI 10.1080/19336950.2015.1036205; Archer CR, 2020, J BIOL CHEM, V295, P7958, DOI 10.1074/jbc.RA120.012606; Attali B., 2019, IUPHAR BPS GUIDE PHA, V2019, P1, DOI [10.2218.gtopdb/F81.2019.4, DOI 10.2218/GTOPDB/F81/2019.4]; Aziz Q, 2012, J BIOL CHEM, V287, P6196, DOI 10.1074/jbc.M111.243923; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bao XY, 2004, AM J PHYSIOL-CELL PH, V286, pC647, DOI 10.1152/ajpcell.00295.2003; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Baudel MASMA, 2020, J PHYSIOL-LONDON, V598, P3911, DOI 10.1113/JP279947; Bayliss DA., 2019, OXFORD HDB NEURONAL; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Blair NT., 2019, IUPHARBPS GUIDE PHAR, V2019, DOI [10.2218/gtopdb/F78/2019.4, DOI 10.2218/GTOPDB/F78/2019.4]; BOURINET E, 1992, PFLUG ARCH EUR J PHY, V421, P247, DOI 10.1007/BF00374834; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Bowling N, 2001, J MOL CELL CARDIOL, V33, P789, DOI 10.1006/jmcc.2000.1349; Braun C, 2020, J MOL CELL CARDIOL, V138, P283, DOI 10.1016/j.yjmcc.2019.10.010; Cang CL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-33; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; CHANG CF, 1991, J BIOL CHEM, V266, P16395; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y; Chou CY, 1998, J PHYSIOL-LONDON, V512, P435, DOI 10.1111/j.1469-7793.1998.435be.x; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Cogolludo A, 2003, CIRC RES, V93, P656, DOI 10.1161/01.RES.0000095245.97945.FE; COLLIER ML, 1995, CIRC RES, V76, P317, DOI 10.1161/01.RES.76.2.317; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; Cui Meng, 2021, Handb Exp Pharmacol, V267, P277, DOI 10.1007/164_2021_501; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652; Delgado-Ramirez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20280-w; Derst C, 2001, KIDNEY INT, V59, P2197; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Ding D, 2019, CELL REP, V27, P1848, DOI 10.1016/j.celrep.2019.04.050; Doble BW, 2000, CIRC RES, V86, P293, DOI 10.1161/01.RES.86.3.293; DOSEMECI A, 1988, CIRC RES, V62, P347, DOI 10.1161/01.RES.62.2.347; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duong-Ly Krisna C, 2013, Curr Protoc Pharmacol, VChapter 2, DOI 10.1002/0471141755.ph0209s60; Dutta AK, 2013, AM J PHYSIOL-GASTR L, V304, pG87, DOI 10.1152/ajpgi.00154.2012; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gada K, 2019, BRIT J PHARMACOL, V176, P256, DOI 10.1111/bph.14518; Gada KD, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101893; Gao S, 2021, NATURE, V596, P143, DOI 10.1038/s41586-021-03699-6; Gold MS, 1998, J NEUROSCI, V18, P10345; HALL KE, 1995, J NEUROSCI, V15, P6069; Hallaq H, 2012, AM J PHYSIOL-HEART C, V302, pH782, DOI 10.1152/ajpheart.00817.2010; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Himmel B, 2004, EMBO REP, V5, P85, DOI 10.1038/sj.embor.7400034; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Huang PT, 2012, J MOL MODEL, V18, P2929, DOI 10.1007/s00894-011-1266-2; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Iftinca M, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00599-0; ISMAILOV II, 1995, KIDNEY INT, V48, P1167, DOI 10.1038/ki.1995.400; Joseph J, 2019, J NEUROSCI, V39, P9954, DOI 10.1523/JNEUROSCI.1064-19.2019; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Keselman I, 2007, CHANNELS, V1, P113, DOI 10.4161/chan.4321; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kidd JF, 2006, J NEUROBIOL, V66, P476, DOI 10.1002/neu.20227; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Kweon HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122014; Large WA, 2009, CELL CALCIUM, V45, P574, DOI 10.1016/j.ceca.2009.02.007; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; Liedtke CM, 1998, AM J PHYSIOL-CELL PH, V275, pC1357, DOI 10.1152/ajpcell.1998.275.5.C1357; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; Liu XL, 2017, BRIT J PHARMACOL, V174, P4464, DOI 10.1111/bph.14049; Logothetis DE, 2015, INT REV NEUROBIOL, V123, P1, DOI 10.1016/bs.irn.2015.05.013; Logothetis DE, 2015, ANNU REV PHYSIOL, V77, P81, DOI 10.1146/annurev-physiol-021113-170358; Lu Ming, 1996, American Journal of Physiology, V271, pF1045; Ma DR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0027-z; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Manis AD, 2020, AM J PHYSIOL-RENAL, V318, pF332, DOI 10.1152/ajprenal.00523.2019; Mao JZ, 2004, P NATL ACAD SCI USA, V101, P1087, DOI 10.1073/pnas.0304827101; Marionneau C, 2012, J PROTEOME RES, V11, P5994, DOI 10.1021/pr300702c; Martens JR, 1999, TRENDS CARDIOVAS MED, V9, P253, DOI 10.1016/S1050-1738(00)00037-2; Martin K, 2003, COMB CHEM HIGH T SCR, V6, P331; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; McHugh D, 2000, P NATL ACAD SCI USA, V97, P12334, DOI 10.1073/pnas.210384297; Mo G, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-14; Mounsey JP, 1999, BRIT J PHARMACOL, V128, P989, DOI 10.1038/sj.bjp.0702877; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Newton AC, 2018, SEMIN CANCER BIOL, V48, P18, DOI 10.1016/j.semcancer.2017.04.017; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Ningoo M, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100726; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NUMANN R, 1994, J NEUROSCI, V14, P4226; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Rampino MAF, 2011, J NEUROSCI, V31, P13596, DOI 10.1523/JNEUROSCI.2655-11.2011; Rivas-Ramirez P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020389; Rodriguez-Menchaca AA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00170; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Rosenbohm A, 1999, J PHYSIOL-LONDON, V514, P677, DOI 10.1111/j.1469-7793.1999.677ad.x; RYVES WJ, 1991, FEBS LETT, V288, P5, DOI 10.1016/0014-5793(91)80989-G; Samanta A, 2018, SUBCELL BIOCHEM, V87, P141, DOI 10.1007/978-981-10-7757-9_6; Scherer D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156181; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Scholz EP, 2011, J MOL CELL CARDIOL, V51, P722, DOI 10.1016/j.yjmcc.2011.07.012; Schrader LA, 2009, BIOCHEM J, V417, P705, DOI 10.1042/BJ20081213; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL1115, DOI 10.1152/ajplung.2001.281.5.L1115; Singh RM, 2017, HEART FAIL REV, V22, P843, DOI 10.1007/s10741-017-9634-3; Son YK, 2011, BMB REP, V44, P559, DOI 10.5483/BMBRep.2011.44.9.559; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; Storch U, 2017, P NATL ACAD SCI USA, V114, pE37, DOI 10.1073/pnas.1612263114; Strauss O, 1997, FASEB J, V11, P859, DOI 10.1096/fasebj.11.11.9285484; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sutherland-Deveen ME, 2019, MOL PHARMACOL, V96, P1, DOI 10.1124/mol.118.115188; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Taguchi K, 2000, BIOL PHARM BULL, V23, P1450; Talon S, 2005, J PHYSIOL-LONDON, V565, P827, DOI 10.1113/jphysiol.2005.084681; Talwar S, 2014, INT J BIOCHEM CELL B, V53, P218, DOI 10.1016/j.biocel.2014.05.028; Tan ZY, 2014, FEBS LETT, V588, P3964, DOI 10.1016/j.febslet.2014.09.011; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Tembo M, 2019, J BIOL CHEM, V294, P12556, DOI 10.1074/jbc.RA118.007128; Tian YT, 2015, J GEN PHYSIOL, V145, P331, DOI 10.1085/jgp.201511363; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Weiss S, 2004, J BIOL CHEM, V279, P12503, DOI 10.1074/jbc.M310196200; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Williams CP, 2002, J PHARMACOL EXP THER, V302, P545, DOI 10.1124/jpet.102.033357; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Wolschin F, 2005, RAPID COMMUN MASS SP, V19, P3626, DOI 10.1002/rcm.2236; Xiao GQ, 2003, BIOCHEM BIOPH RES CO, V306, P1019, DOI 10.1016/S0006-291X(03)01095-7; Xu J, 2019, BIOSCI BIOTECH BIOCH, V83, P1676, DOI 10.1080/09168451.2019.1617106; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Yarotskyy V, 2019, AM J PHYSIOL-CELL PH, V317, pC1268, DOI 10.1152/ajpcell.00189.2019; Yokoyama CT, 1997, J NEUROSCI, V17, P6929; Yu K, 2019, P NATL ACAD SCI USA, V116, P19952, DOI 10.1073/pnas.1904012116; Zang K, 2018, CNS NEUROL DISORD-DR, V17, P248, DOI 10.2174/1871527317666180404104055; Zeng WZ, 2003, J BIOL CHEM, V278, P16852, DOI 10.1074/jbc.M300619200; Zhang H, 2011, CIRC-CARDIOVASC GENE, V4, P711, DOI 10.1161/CIRCGENETICS.110.957829; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007; Zhang L, 2020, MOL NEUROBIOL, V57, P4754, DOI 10.1007/s12035-020-02056-4; Zhang Liyan, 2002, Environmental Medicine (Nagoya), V46, P81; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhang W, 2008, BIOCHEM BIOPH RES CO, V377, P981, DOI 10.1016/j.bbrc.2008.10.110; Zhang XD, 2015, HEART RHYTHM, V12, P1845, DOI 10.1016/j.hrthm.2015.04.046; Zheng W, 2018, CELL REP, V22, P1560, DOI 10.1016/j.celrep.2018.01.042; Zhu GY, 1999, J BIOL CHEM, V274, P11643, DOI 10.1074/jbc.274.17.11643	173	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							102035	10.1016/j.jbc.2022.102035	http://dx.doi.org/10.1016/j.jbc.2022.102035			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L3OF	35588786	Green Published, gold			2022-12-28	WOS:000816927100004
J	Ghosh, K; Zhang, GF; Chen, H; Chen, SR; Pan, HL				Ghosh, Krishna; Zhang, Guang-Fen; Chen, Hong; Chen, Shao-Rui; Pan, Hui-Lin			Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-HORN NEURONS; METABOTROPIC GLUTAMATE RECEPTORS; MU-OPIOID RECEPTORS; PROTEIN-KINASE-C; NERVE INJURY; SENSORY NEURONS; EXPRESSION; ALLODYNIA; HYPERSENSITIVITY; ACTIVATION	Type-2 cannabinoid receptors (CB2, encoded by the Cnr2 gene) are mainly expressed in immune cells, and CB2 agonists normally have no analgesic effect. However, nerve injury upregulates CB2 in the dorsal root ganglion (DRG), following which CB2 stimulation reduces neuropathic pain. It is unclear how nerve injury increases CB2 expression or how CB2 activity is transformed in neuropathic pain. In this study, immunoblotting showed that spinal nerve ligation (SNL) induced a delayed and sustained increase in CB2 expression in the DRG and dorsal spinal cord synaptosomes. RNAscope in situ hybridization also showed that SNL substantially increased CB2 mRNA levels, mostly in medium and large DRG neurons. Furthermore, we found that the specific CB2 agonist JWH-133 significantly inhibits the amplitude of dorsal root-evoked glutamatergic excitatory postsynaptic currents in spinal dorsal horn neurons in SNL rats, but not in sham control rats; intrathecal injection of JWH-133 reversed pain hypersensitivity in SNL rats, but had no effect in sham control rats. In addition, chromatin immunoprecipitation-qPCR analysis showed that SNL increased enrichment of two activating histone marks (H3K4me3 and H3K9ac) and diminished occupancy of two repressive histone marks (H3K9me2 and H3K27me3) at the Cnr2 promoter in the DRG. In contrast, SNL had no effect on DNA methylation levels around the Cnr2 promoter. Our findings suggest that peripheral nerve injury promotes CB2 expression in primary sensory neurons via epigenetic bivalent histone modifications and that CB2 activation reduces neuropathic pain by attenuating nociceptive transmission from primary afferent nerves to the spinal cord.	[Ghosh, Krishna; Zhang, Guang-Fen; Chen, Hong; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Zhang, Guang-Fen] Shandong First Med Univ, Shandong Prov Hosp, Dept Anesthesiol, Jinan 250014, Shandong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Shandong First Medical University & Shandong Academy of Medical Sciences	Chen, SR; Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA.	schen@mdanderson.org; huilinpan@mdanderson.org			National Institutes of Health [NS101880, DA041711]; N. G. and Helen T. Hawkins Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment	This study was supported by grants (NS101880 and DA041711) from the National Institutes of Health and by the N. G. and Helen T. Hawkins Endowment.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borodinova AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40823-z; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Chen SR, 2005, J PHARMACOL EXP THER, V312, P120, DOI 10.1124/jpet.104.073817; Chen YF, 2019, J NEUROCHEM, V148, P252, DOI 10.1111/jnc.14627; Deng MC, 2019, CELL MOL LIFE SCI, V76, P1889, DOI 10.1007/s00018-019-03047-y; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Donvito G, 2018, NEUROPSYCHOPHARMACOL, V43, P52, DOI 10.1038/npp.2017.204; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garriga J, 2018, J NEUROSCI, V38, P6090, DOI 10.1523/JNEUROSCI.2616-17.2018; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; Huang YY, 2022, J NEUROSCI, V42, P513, DOI 10.1523/JNEUROSCI.1968-21.2021; Huang YY, 2019, J NEUROCHEM, V149, P381, DOI 10.1111/jnc.14677; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li AL, 2019, MOL PHARMACOL, V95, P155, DOI 10.1124/mol.118.113233; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li FF, 2018, CURR STEM CELL RES T, V13, P83, DOI 10.2174/1574888X12666170123144743; Liu QR, 2009, GENES BRAIN BEHAV, V8, P519, DOI 10.1111/j.1601-183X.2009.00498.x; Luo Y, 2020, J BIOL CHEM, V295, P3553, DOI 10.1074/jbc.RA119.011053; McGaraughty S, 2009, NEUROSCIENCE, V158, P1652, DOI 10.1016/j.neuroscience.2008.11.015; Nicolay-Kritter K, 2021, NEUROBIOL LEARN MEM, V179, DOI 10.1016/j.nlm.2021.107406; Oliveira LH, 2015, CANCER SCI, V106, P1264, DOI 10.1111/cas.12766; Pan HL, 1999, J PHARMACOL EXP THER, V288, P1026; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Petrov RR, 2013, EUR J MED CHEM, V69, P881, DOI 10.1016/j.ejmech.2013.09.038; Qian WJ, 2017, NEUROPHARMACOLOGY, V124, P143, DOI 10.1016/j.neuropharm.2017.04.027; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Roche M, 2010, PHARMACEUTICALS, V3, P2517, DOI 10.3390/ph3082517; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Sheng WS, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/1260353; Stern E, 2006, J MED CHEM, V49, P70, DOI 10.1021/jm050467q; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun J, 2019, J PHYSIOL-LONDON, V597, P1661, DOI 10.1113/JP277428; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Veress G, 2013, BRAIN STRUCT FUNCT, V218, P733, DOI 10.1007/s00429-012-0425-2; Wotherspoon G, 2005, NEUROSCIENCE, V135, P235, DOI 10.1016/j.neuroscience.2005.06.009; Xie JD, 2016, J BIOL CHEM, V291, P19364, DOI 10.1074/jbc.M116.732347; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Zhang GF, 2021, J NEUROSCI, V41, P5963, DOI 10.1523/JNEUROSCI.0303-21.2021; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang YH, 2016, J BIOL CHEM, V291, P8475, DOI 10.1074/jbc.M115.711812; Zhang YH, 2015, J BIOL CHEM, V290, P14647, DOI 10.1074/jbc.M115.650218; Zhao Z, 2000, NEUROSCIENCE, V97, P743, DOI 10.1016/S0306-4522(00)00052-X; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou MH, 2021, J NEUROSCI, V41, P6415, DOI 10.1523/JNEUROSCI.0757-21.2021	65	3	3	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101999	10.1016/j.jbc.2022.101999	http://dx.doi.org/10.1016/j.jbc.2022.101999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2D8TZ	35500651	gold, Green Published			2022-12-28	WOS:000811813400003
J	Takagi, H; Tamura, I; Fujimura, T; Doi-Tanaka, Y; Shirafuta, Y; Mihara, Y; Maekawa, R; Taketani, T; Sato, S; Tamura, H; Sugino, N				Takagi, Haruka; Tamura, Isao; Fujimura, Taishi; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro			Transcriptional coactivator PGC-1 alpha contributes to decidualization by forming a histone-modifying complex with C/EBP beta and p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-1; ENDOMETRIAL STROMAL CELLS; GAMMA COACTIVATOR-1-ALPHA; ACETYLATION STATUS; PROMOTER REGION; GRANULOSA-CELLS; PROGESTERONE-RECEPTOR; PGC-1 COACTIVATORS; ENERGY-METABOLISM; DNA METHYLATION	We previously reported that CCAAT/enhancer-binding protein beta (C/EBP beta) is the pioneer factor inducing tran-scription enhancer mark H3K27 acetylation (H3K27ac) in the promoter and enhancer regions of genes encoding insulin-like growth factor-binding protein-1 (IGFBP-1) and prolactin (PRL) and that this contributes to decidualization of human endometrial stromal cells (ESCs). Peroxisome proliferator- activated receptor gamma coactivator 1-alpha (PGC-1 alpha; PPARGC1A) is a transcriptional coactivator known to regulate H3K27ac. However, although PGC-1 alpha is expressed in ESCs, the potential role of PGC-1 alpha in mediating decidualization is un-clear. Here, we investigated the involvement of PGC-1 alpha in the regulation of decidualization. We incubated ESCs with cAMP to induce decidualization and knocked down PPARGC1A to inhibit cAMP-induced expression of IGFBP-1 and PRL. We found cAMP increased the recruitment of PGC-1 alpha and p300 to C/EBP beta-binding sites in the promoter and enhancer regions of IGFBP-1 and PRL, corresponding with increases in H3K27ac. Moreover, PGC-1 alpha knockdown inhibited these increases, suggesting PGC-1 alpha forms a histone-modifying complex with C/EBP beta and p300 at these regions. To further investigate the regulation of PGC-1 alpha, we focused on C/EBP beta upstream of PGC-1 alpha. We found cAMP increased C/EBP beta recruitment to the novel enhancer regions of PPARGC1A. Deletion of these enhancers decreased PGC-1 alpha expression, indicating that C/EBP beta upregulates PGC-1 alpha expression by binding to novel enhancer regions. In conclusion, PGC-1 alpha is upregulated by C/EBP beta recruitment to novel enhancers and contributes to decidualization by forming a histone-modifying complex with C/EBP beta and p300, thereby inducing epigenomic changes in the promoters and enhancers of IGFBP-1 and PRL.	[Takagi, Haruka; Tamura, Isao; Fujimura, Taishi; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Tamura, I (corresponding author), Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan.	isao@yamaguchi-u.ac.jp			JSPS KAKENHI [16K20191, 17K11239, 18K09230, 20K09645, 20K18191, 20H03825]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding and additional information-This work was supported in part by JSPS KAKENHI (Grant Number 16K20191, 17K11239, 18K09230, 20K09645, 20K18191, and 20H03825) .	Agostinis C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02387; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bombail V, 2008, HUM REPROD, V23, P2782, DOI 10.1093/humrep/den298; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Charos AE, 2012, GENOME RES, V22, P1668, DOI 10.1101/gr.127761.111; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Dankel SN, 2010, BBA-MOL CELL RES, V1803, P1013, DOI 10.1016/j.bbamcr.2010.05.008; Du QQ, 2019, CANCER SCI, V110, P2050, DOI 10.1111/cas.14011; Eisele PS, 2015, BIOCHEM BIOPH RES CO, V464, P692, DOI 10.1016/j.bbrc.2015.06.166; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fuglerud BM, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0208-y; Fukui Y, 2019, REPROD MED BIOL, V18, P234, DOI 10.1002/rmb2.12280; Gao JG, 1999, MOL CELL ENDOCRINOL, V153, P11, DOI 10.1016/S0303-7207(99)00096-9; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gerlach JM, 2017, P NATL ACAD SCI USA, V114, pE9224, DOI 10.1073/pnas.1705816114; Hu WB, 2019, J CELL BIOCHEM, V120, P14908, DOI 10.1002/jcb.28753; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jozaki K, 2019, REPRODUCTION, V157, P457, DOI 10.1530/REP-18-0393; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kohlmeier A, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa070; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lee HJ, 2008, FEBS LETT, V582, P627, DOI 10.1016/j.febslet.2008.01.033; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liu X, 2017, BIOL TRACE ELEM RES, V175, P440, DOI 10.1007/s12011-016-0799-8; Maekawa R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5695-0; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mihara Y, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa618; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Misra J, 2013, NUCLEIC ACIDS RES, V41, P6960, DOI 10.1093/nar/gkt429; Nishigaki A, 2020, REPROD MED BIOL, V19, P189, DOI 10.1002/rmb2.12323; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shinagawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36566-y; Spruce C, 2020, GENE DEV, V34, P398, DOI 10.1101/gad.333542.119; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Tamura I, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101150; Tamura I, 2021, MOL CELL ENDOCRINOL, V520, DOI 10.1016/j.mce.2020.111085; Tamura I, 2020, J BIOL CHEM, V295, P4673, DOI 10.1074/jbc.RA120.012841; Tamura I, 2018, J BIOL CHEM, V293, P5270, DOI 10.1074/jbc.RA117.000234; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Teles A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00158; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Ticconi C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215332; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Watanabe K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34290-1; Wu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2426-z; Wu Tao, 2016, Biochem Biophys Rep, V5, P374, DOI 10.1016/j.bbrep.2016.01.014; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Zhang Qian, 2016, Reproductive Medicine and Biology, V15, P95, DOI 10.1007/s12522-015-0226-4; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhu H, 2014, GENE, V551, P1, DOI 10.1016/j.gene.2014.08.047	84	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101874	10.1016/j.jbc.2022.101874	http://dx.doi.org/10.1016/j.jbc.2022.101874			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35358514	gold, Green Submitted, Green Published			2022-12-28	WOS:000798142000002
J	Wu, SZ; Huang, YC; Selby, CP; Gao, M; Sancar, A; Hu, JC				Wu, Sizhong; Huang, Yanchao; Selby, Christopher P.; Gao, Meng; Sancar, Aziz; Hu, Jinchuan			A new technique for genome-wide mapping of nucleotide excision repair without immunopurification of damaged DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; ESCHERICHIA-COLI; UV DAMAGE; DIMERIC LESIONS; CHROMATIN STATE; MECHANISMS; INDUCTION; LANDSCAPE; INCREASES; ALIGNMENT	Nucleotide excision repair functions to protect genome integrity, and ongoing studies using excision repair sequencing (XR-seq) have contributed to our understanding of how cells prioritize repair across the genome. In this method, the products of excision repair bearing damaged DNA are captured, sequenced, and then mapped genome-wide at single-nucleotide resolution. However, reagent requirements and complex procedures have limited widespread usage of this technique. In addition to the expense of these reagents, it has been hypothesized that the immunoprecipitation step using antibodies directed against damaged DNA may introduce bias in different sequence contexts. Here, we describe a newly developed adaptation called dA-tailing and adaptor ligation (ATL)-XR-seq, a relatively simple XR-seq method that avoids the use of immunoprecipitation targeting damaged DNA. ATL-XR-seq captures repair products by 3'-dA-tailing and 5'-adapter ligation instead of the original 5'- and 3'-dual adapter ligation. This new approach avoids adapter dimer formation during subsequent PCR, omits inefficient and time-consuming purification steps, and is very sensitive. In addition, poly(dA) tail length heterogeneity can serve as a molecular identifier, allowing more repair hotspots to be mapped. Importantly, a comparison of both repair mapping methods showed that no major bias is introduced by the anti-UV damage antibodies used in the original XR-seq procedure. Finally, we also coupled the described dA-tailing approach with quantitative PCR in a new method to quantify repair products. These new methods provide powerful and user-friendly tools to qualitatively and quantitatively measure excision repair.	[Wu, Sizhong; Huang, Yanchao; Gao, Meng; Hu, Jinchuan] Fudan Univ, Shanghai Peoples Hosp 5, Shanghai, Peoples R China; [Wu, Sizhong; Huang, Yanchao; Gao, Meng; Hu, Jinchuan] Fudan Univ, Inst Biomed Sci, Minist Sci & Technol, Shanghai Key Lab Med Epigenet,Int Colab Med Epige, Shanghai, Peoples R China; [Selby, Christopher P.; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA	Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hu, JC (corresponding author), Fudan Univ, Shanghai Peoples Hosp 5, Shanghai, Peoples R China.; Hu, JC (corresponding author), Fudan Univ, Inst Biomed Sci, Minist Sci & Technol, Shanghai Key Lab Med Epigenet,Int Colab Med Epige, Shanghai, Peoples R China.; Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.	aziz_sancar@med.unc.edu; hujinchuan@fudan.edu.cn		Hu, Jinchuan/0000-0001-7096-0195	National Natural Science Foundation of China (NSFC) [31870804]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program; National Institutes of Health [GM118102, ES033414]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019); innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019); innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program	This work was supported by National Natural Science Foundation of China (NSFC, 31870804) , Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019) , innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program (2019, to J. H.) , and National Institutes of Health (GM118102, ES033414 to A. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Akkose U, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07898-3; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Canturk F, 2016, P NATL ACAD SCI USA, V113, P4706, DOI 10.1073/pnas.1604097113; Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Crowley DJ, 1998, J BACTERIOL, V180, P3345, DOI 10.1128/JB.180.13.3345-3352.1998; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Douki T, 2000, J BIOL CHEM, V275, P11678, DOI 10.1074/jbc.275.16.11678; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2017, PHOTOCHEM PHOTOBIOL, V93, P199, DOI 10.1111/php.12668; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang YC, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100581; Jin SG, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi6508; Karbaschi Mahsa, 2012, Methods Mol Biol, V920, P163, DOI 10.1007/978-1-61779-998-3_12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Liakos A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14566-9; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Mao P, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102645; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Premi S, 2019, P NATL ACAD SCI USA, V116, P24196, DOI 10.1073/pnas.1907860116; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Seplyarskiy VB, 2019, NAT GENET, V51, P36, DOI 10.1038/s41588-018-0285-7; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; van den Heuvel D, 2021, TRENDS CELL BIOL, V31, P359, DOI 10.1016/j.tcb.2021.02.007; van der Weegen Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15903-8; Wu DN, 2018, J CHROMATOGR B, V1096, P135, DOI 10.1016/j.jchromb.2018.08.015; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115	55	0	0	15	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101863	10.1016/j.jbc.2022.101863	http://dx.doi.org/10.1016/j.jbc.2022.101863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35339490	Green Published, gold			2022-12-28	WOS:000793483000005
J	Bruguera, ES; Mahoney, JP; Weis, WI				Bruguera, Elise S.; Mahoney, Jacob P.; Weis, William, I			Reconstitution of purified membrane protein dimers in lipid nanodiscs with defined stoichiometry and orientation using a split GFP tether	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEIN; BILAYER NANODISCS; WNT; RECEPTOR; BINDING; NANOPARTICLES; LRP6	Many membrane proteins function as dimers or larger oligomers, including transporters, channels, certain signaling receptors, and adhesion molecules. In some cases, the interactions between individual proteins may be weak and/or dependent on specific lipids, such that detergent solubilization used for biochemical and structural studies disrupts functional oligomerization. Solubilized membrane protein oligomers can be captured in lipid nanodiscs, but this is an inefficient process that can produce stoichiometrically and topologically heterogeneous preparations. Here, we describe a technique to obtain purified homogeneous membrane protein dimers in nanodiscs using a split GFP (sGFP) tether. Complementary sGFP tags associate to tether the coexpressed dimers and control both stoichiometry and orientation within the nanodiscs, as assessed by quantitative Western blotting and negative-stain EM. The sGFP tether confers several advantages over other methods: it is highly stable in solution and in SDS-PAGE, which facilitates screening of dimer expression and purification by fluorescence, and also provides a dimer-specific purification handle for use with GFP nanobody-conjugated resin. We used this method to purify a Frizzled-4 homodimer and a Frizzled-4/low-density lipoprotein receptor-related protein 6 heterodimer in nanodiscs. These examples demonstrate the utility and flexibility of this method, which enables subsequent mechanistic molecular and structural studies of membrane protein pairs.	[Weis, William, I] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	bill.weis@stanford.edu	; Weis, William/G-1437-2011	Mahoney, Jacob/0000-0002-7174-9161; Weis, William/0000-0002-5583-6150; Bruguera, Elise/0000-0003-1983-3013	Stanford Graduate Fellowship; National Institutes of Health (NIH) predoctoral fellowship [F31 EY031947]; NIH postdoctoral fellowship [F32 GM126642]; NIH [R35 GM131747]	Stanford Graduate Fellowship(Stanford University); National Institutes of Health (NIH) predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E. S. B. was supported by a Stanford Graduate Fellowship and the National Institutes of Health (NIH) predoctoral fellowship (grant no.: F31 EY031947). J. P. M. was supported by an NIH postdoctoral fellowship (grant no.: F32 GM126642). This project was funded by an NIH grant R35 GM131747 (to W. I. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Alvarez-Sieiro P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115912; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Deng A, 2018, J AM CHEM SOC, V140, P375, DOI 10.1021/jacs.7b10680; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Du J, 2021, NATURE, V594, P589, DOI 10.1038/s41586-021-03641-w; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Fairweather Stephen J, 2021, Adv Exp Med Biol, V21, P13, DOI 10.1007/5584_2020_584; Forrest LR, 2015, ANNU REV BIOPHYS, V44, P311, DOI 10.1146/annurev-biophys-051013-023008; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; Jiang WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20568; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; Koker T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23625-7; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Lee SC, 2016, NAT PROTOC, V11, P1149, DOI 10.1038/nprot.2016.070; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; Nguyen HB, 2013, ACTA CRYSTALLOGR D, V69, P2513, DOI 10.1107/S0907444913024608; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Raschle T, 2015, ACS CHEM BIOL, V10, P2448, DOI 10.1021/acschembio.5b00627; Riederer EA, 2018, ELIFE, V7, DOI 10.7554/eLife.36478; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Staus DP, 2019, J BIOL CHEM, V294, P13218, DOI 10.1074/jbc.AC119.009848; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Ward AE, 2021, BIOCHEM SOC T, V49, P1685, DOI 10.1042/BST20201074; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xie WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170118; Yang SF, 2018, NATURE, V560, P666, DOI 10.1038/s41586-018-0447-x; Yang YH, 2020, EMBO J, V39, DOI 10.15252/embj.2020105246	42	1	1	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101628	10.1016/j.jbc.2022.101628	http://dx.doi.org/10.1016/j.jbc.2022.101628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35074428	Green Published, gold			2022-12-28	WOS:000823106100001
J	Yadav, PK; Haruehanroengra, P; Irani, S; Wang, T; Ansari, A; Sheng, J; Hussain, MM				Yadav, Pradeep Kumar; Haruehanroengra, Phensinee; Irani, Sara; Wang, Ting; Ansari, Abulaish; Sheng, Jia; Hussain, M. Mahmood			Novel efficacious microRNA-30c analogs reduce apolipoprotein B secretion in human hepatoma and primary hepatocyte cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA; INHIBITION; RNAI; ATHEROSCLEROSIS; THERAPEUTICS; PSEUDOURIDINE; DELIVERY; STATINS	High plasma lipid levels have been demonstrated to increase cardiovascular disease risk. Despite advances in treatments to decrease plasma lipids, additional therapeutics are still needed because many people are intolerant or nonresponsive to these therapies. We previously showed that increasing cellular levels of microRNA-30c (miR-30c) using viral vectors or liposomes reduces plasma lipids and atherosclerosis. In this study, we aimed to synthesize potent miR-30c analogs that can be delivered to hepatoma cells without the aid of viral vectors and lipid emulsions. We hypothesized that modification of the passenger strand of miR-30c would increase the stability of miR-30c and augment its delivery to liver cells. Here, we report the successful synthesis of a series of miR-30c analogs by using different chemically modified nucleosides. In these analogs, we left the active sense strand untouched so that its biological activity remained unaltered, and we modified the passenger strand of miR-30c to enhance the stability and uptake of miR30c by hepatoma cells through phosphorothiorate linkages and the addition of GalNAc. We show that these analogs significantly reduced apolipoprotein B secretion in Huh-7 human hepatoma cells and human primary hepatocytes without affecting apolipoprotein A1 secretion and cellular lipid levels. Our results provide a proof of concept that the passenger strand of miR-30c can be modified to increase its stability and delivery to cells while retaining the potency of the sense strand. We anticipate these miR-30c analogs will be useful in the development of more efficacious analogs for the treatment of hyperlipidemias and cardiovascular diseases.	[Yadav, Pradeep Kumar; Ansari, Abulaish; Hussain, M. Mahmood] NYU Long Isl Sch Med, Dept Fdn Med, Mineola, NY 10016 USA; [Haruehanroengra, Phensinee; Wang, Ting; Sheng, Jia] SUNY Albany, Univ Albany, RNA Inst, Dept Chem, Albany, NY USA; [Irani, Sara; Hussain, M. Mahmood] SUNY Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hussain, M. Mahmood] VA New York Harbor Healthcare Syst, Res Dept, Brooklyn, NY 10010 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hussain, MM (corresponding author), NYU Long Isl Sch Med, Dept Fdn Med, Mineola, NY 10016 USA.; Sheng, J (corresponding author), SUNY Albany, Univ Albany, RNA Inst, Dept Chem, Albany, NY USA.; Hussain, MM (corresponding author), SUNY Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.; Hussain, MM (corresponding author), VA New York Harbor Healthcare Syst, Res Dept, Brooklyn, NY 10010 USA.	jsheng@albany.edu; Mahmood.hussain@nyulangone.org	Ansari, Abulaish/GLQ-8370-2022; Yadav, Pradeep Kumar/GZA-4317-2022	Sheng, Jia/0000-0001-6198-390X; Yadav, Pradeep/0000-0002-4777-4914	US National Institutes of Health [DK121490, HL137202, HL158054, HD094778]; VA Merit Award [BX004113]; Research Foundation of State University of New York Technology Accelerator Fund [CHE1845486, CHE1726724]; National Science Foundation [19POST34400044]; American Heart Association Award	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Research Foundation of State University of New York Technology Accelerator Fund; National Science Foundation(National Science Foundation (NSF)); American Heart Association Award(American Heart Association)	This work was supported in part by the US National Institutes of Health grants (grant nos.: DK121490, HL137202, HL158054, and HD094778) ; VA Merit Award (grant no.: BX004113) ; and Research Foundation of State University of New York Technology Accelerator Fund (to M. M. H.) ; by the National Science Foundation grant (grant no.: CHE1845486 [to J. S.] and CHE1726724 [MRI grant] ) ; and the American Heart Association Award (grant no.: 19POST34400044; to P. K. Y.) . The contents of this article do not represent the views of the Department of Veterans Affairs or the US Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad Z, 2014, AM J CARDIOL, V113, P1765, DOI 10.1016/j.amjcard.2014.02.033; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blumenthal RS, 2000, AM HEART J, V139, P577, DOI 10.1016/S0002-8703(00)90033-4; Burnett JR, 2007, EXPERT OPIN THER TAR, V11, P181, DOI 10.1517/14728222.11.2.181; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; Cuchel M, 2013, CURR OPIN LIPIDOL, V24, P246, DOI 10.1097/MOL.0b013e32836139df; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Irani S, 2018, J LIPID RES, V59, P144, DOI 10.1194/jlr.M081299; Irani S, 2016, J BIOL CHEM, V291, P18397, DOI 10.1074/jbc.M116.728451; Irani S, 2015, CURR OPIN LIPIDOL, V26, P139, DOI 10.1097/MOL.0000000000000162; Janas MM, 2019, NUCLEIC ACIDS RES, V47, P3306, DOI 10.1093/nar/gkz140; Joy TR, 2008, NAT CLIN PRACT CARD, V5, P506, DOI 10.1038/ncpcardio1251; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Liebow A, 2017, J AM SOC NEPHROL, V28, P494, DOI 10.1681/ASN.2016030338; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Rizzo M, 2011, CURR PHARM DESIGN, V17, P943, DOI 10.2174/138161211795428768; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Saxon DR, 2016, PROG CARDIOVASC DIS, V59, P153, DOI 10.1016/j.pcad.2016.07.009; Sirwi A, 2018, J LIPID RES, V59, P1094, DOI 10.1194/jlr.R083451; Soh J, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-56; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Stoekenbroek RM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0503-4; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Voora D, 2008, CIRC-CARDIOVASC GENE, V1, P100, DOI 10.1161/CIRCGENETICS.108.795013; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Zhou LY, 2017, ARTERIOSCL THROM VAS, V37, P786, DOI 10.1161/ATVBAHA.117.309247; Zhou L, 2016, BBA-MOL CELL BIOL L, V1861, P2062, DOI 10.1016/j.bbalip.2016.02.020; Zimmermann TS, 2017, MOL THER, V25, P71, DOI 10.1016/j.ymthe.2016.10.019	47	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101813	10.1016/j.jbc.2022.101813	http://dx.doi.org/10.1016/j.jbc.2022.101813			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35278429	Green Published, gold			2022-12-28	WOS:000797895000001
J	Chen, YY; Sotomayor, M; Capponi, S; Hariharan, B; Sahu, ID; Haase, M; Lorigan, GA; Kuhn, A; White, SH; Dalbey, RE				Chen, Yuanyuan; Sotomayor, Marcos; Capponi, Sara; Hariharan, Balasubramani; Sahu, Indra D.; Haase, Maximilian; Lorigan, Gary A.; Kuhn, Andreas; White, Stephen H.; Dalbey, Ross E.			A hydrophilic microenvironment in the substrate-translocating groove of the YidC membrane insertase is essential for enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; PROTEIN FORCE-FIELD; SYNTHASE SUBUNIT-C; PF3 COAT PROTEIN; TRANSMEMBRANE PROTEIN; SECYEG; BIOGENESIS; RECONSTITUTION; VALIDATION; BACTERIAL	The YidC family of proteins are membrane insertases that catalyze the translocation of the periplasmic domain of membrane proteins via a hydrophilic groove located within the inner leaflet of the membrane. All homologs have a strictly conserved, positively charged residue in the center of this groove. In Bacillus subtilis, the positively charged residue has been proposed to be essential for interacting with negatively charged residues of the substrate, supporting a hypothesis that YidC catalyzes insertion via an early-step electrostatic attraction mechanism. Here, we provide data suggesting that the positively charged residue is important not for its charge but for increasing the hydrophilicity of the groove. We found that the positively charged residue is dispensable for Escherichia coli YidC function when an adjacent residue at position 517 was hydrophilic or aromatic, but was essential when the adjacent residue was apolar. Additionally, solvent accessibility studies support the idea that the conserved positively charged residue functions to keep the top and middle of the groove sufficiently hydrated. Moreover, we demonstrate that both the E. coli and Streptococcus mutans YidC homologs are functional when the strictly conserved arginine is replaced with a negatively charged residue, provided proper stabilization from neighboring residues. These combined results show that the positively charged residue functions to maintain a hydrophilic microenvironment in the groove necessary for the insertase activity, rather than to form electrostatic interactions with the substrates.	[Chen, Yuanyuan; Sotomayor, Marcos; Hariharan, Balasubramani; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH USA; [Capponi, Sara] IBM Almaden Res Ctr, IBM & Cognit Software Org, Dept Ind & Appl Genom, San Jose, CA USA; [Capponi, Sara] Univ Calif San Francisco, NSF Ctr Cellular Construct, San Francisco, CA USA; [Sahu, Indra D.; Lorigan, Gary A.] Miami Univ, Dept Chem & Biochem, Oxford, OH USA; [Sahu, Indra D.] Campbellsville Univ, Nat Sci Div, Campbellsville, KY USA; [Haase, Maximilian; Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, Stuttgart, Germany; [White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA	University System of Ohio; Ohio State University; International Business Machines (IBM); University of California System; University of California San Francisco; University System of Ohio; Miami University; University Hohenheim; University of California System; University of California Irvine	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH USA.	dalbey@chemistry.ohio-state.edu	Sotomayor, Marcos/J-4898-2012; Chen, Yuanyuan/GXG-2130-2022; White, Stephen/B-1053-2009; Capponi, Sara/R-6145-2016	Sotomayor, Marcos/0000-0002-3333-1805; White, Stephen/0000-0001-8540-7907; Capponi, Sara/0000-0001-8117-7526	National Science Foundation [MCB-1052033]; Deutsche Forschungsgemeinschaft [Ku 749/6]; NSF [MRI-1725502, MCB2040917]; NIGMS/NIH Maximizing Investigator's Research Award (MIRA) [R35 GM126935]; Miami University; NIH [RO1 GM-74637, R35 GM-139652]; John W. Steube Professorship	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NIGMS/NIH Maximizing Investigator's Research Award (MIRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John W. Steube Professorship	This work was supported by grants from National Science Foundation Grant MCB-1052033 to R. E. D. and from the Deutsche Forschungsgemeinschaft Ku 749/6 to A. K. Simulations were performed at the Ohio Supercomputer Center (PAS1037 to M. S.). G. A. L. would like to acknowledge NSF (MRI-1725502) grant, NIGMS/NIH Maximizing Investigator's Research Award (MIRA) R35 GM126935 award the Ohio Board of Regents, and Miami University. G. A. L. would also like to acknowledge support from the John W. Steube Professorship. I. D. S. would also like to acknowledge support from the NSF MCB2040917 award. S. W. is pleased to acknowledge the support of NIH grants RO1 GM-74637 and R35 GM-139652. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chen YY, 2018, TRENDS BIOCHEM SCI, V43, P151, DOI 10.1016/j.tibs.2017.12.005; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Chen YY, 2014, J BIOL CHEM, V289, P35656, DOI 10.1074/jbc.M114.595082; Coey AT, 2011, BIOCHEMISTRY-US, V50, P10851, DOI 10.1021/bi2009294; Dalbey RE, 2015, STRUCTURE, V23, P1559, DOI 10.1016/j.str.2015.08.002; Dalbey RE, 2014, NAT STRUCT MOL BIOL, V21, P435, DOI 10.1038/nsmb.2823; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; He HZ, 2020, J MOL BIOL, V432, P484, DOI 10.1016/j.jmb.2019.10.010; Hennon SW, 2015, J BIOL CHEM, V290, P14866, DOI 10.1074/jbc.R115.638171; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Laskowski PR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27315-3; Lundquist K, 2018, P NATL ACAD SCI USA, V115, pE7942, DOI 10.1073/pnas.1722530115; McDowell MA, 2021, NAT STRUCT MOL BIOL, V28, P234, DOI 10.1038/s41594-021-00567-9; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Petriman NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19019-w; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sachelaru I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00109-8; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Shimokawa-Chiba N, 2015, P NATL ACAD SCI USA, V112, P5063, DOI 10.1073/pnas.1423817112; Soman R, 2014, J BIOL CHEM, V289, P1023, DOI 10.1074/jbc.M113.522250; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wu XD, 2021, TRENDS CELL BIOL, V31, P473, DOI 10.1016/j.tcb.2021.01.002; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	42	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101690	10.1016/j.jbc.2022.101690	http://dx.doi.org/10.1016/j.jbc.2022.101690			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148995	Green Published, gold			2022-12-28	WOS:000789400700016
J	Gonias, SL; Banki, MA; Azmoon, P; Romero, HK; Sigurdson, CJ; Mantuano, E; Campana, WM				Gonias, Steven L.; Banki, Michael A.; Azmoon, Pardis; Romero, Haylie K.; Sigurdson, Christina J.; Mantuano, Elisabetta; Campana, Wendy M.			Cellular prion protein in human plasma-derived extracellular vesicles promotes neurite outgrowth via the NMDA receptor-LRP1 receptor system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOME-MEDIATED TRANSFER; MECHANISM; LRP1; CELLS; CALRETICULIN; ENDOCYTOSIS; TRAFFICKING; PHYSIOLOGY; CORECEPTOR; ASTROCYTES	Exosomes and other extracellular vesicles (EVs) participate in cell-cell communication. Herein, we isolated EVs from human plasma and demonstrated that these EVs activate cell signaling and promote neurite outgrowth in PC-12 cells. Analysis of human plasma EVs purified by sequential ultra centrifugation using tandem mass spectrometry indicated the presence of multiple plasma proteins, including alpha(2)-macro-globulin, which is reported to regulate PC-12 cell physiology. We therefore further purified EVs by molecular exclusion or phosphatidylserine affinity chromatography, which reduced plasma protein contamination. EVs subjected to these additional purification methods exhibited unchanged activity in PC-12 cells, even though alpha(2)-macroglobulin was reduced to undetectable levels. Nonpathogenic cellular prion protein (PrPC) was carried by human plasma EVs and essential for the effects of EVs on PC-12 cells, as EV-induced cell signaling and neurite outgrowth were blocked by the PrPC-specific antibody, POM2. In addition, inhibitors of the N-methyl-D-aspartate (NMDA) receptor (NMDA-R) and low-density lipoprotein receptor-related protein-1 (LRP1) blocked the effects of plasma EVs on PC-12 cells, as did silencing of Lrp1 or the gene encoding the GluN1 NMDA-R subunit (Grin1). These results implicate the NMDA-R-LRP1 complex as the receptor system responsible for mediating the effects of EV-associated PrPC. Finally, EVs harvested from rat astrocytes carried PrPC and replicated the effects of human plasma EVs on PC-12 cell signaling. We conclude that interaction of EV-associated PrPC with the NMDA-R-LRP1 complex in target cells represents a novel mechanism by which EVs may participate in intercellular communication in the nervous system.	[Gonias, Steven L.; Banki, Michael A.; Azmoon, Pardis; Sigurdson, Christina J.; Mantuano, Elisabetta] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92103 USA; [Romero, Haylie K.; Campana, Wendy M.] Univ Calif San Diego, Dept Anesthesiol, Program Neurosci, La Jolla, CA USA; [Campana, Wendy M.] San Diego Vet Adm Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92103 USA.	sgonias@health.ucsd.edu		Azmoon, Pardis/0000-0002-1512-5581; Banki, Michael/0000-0002-8910-4695	National Institutes of Health [R01 HL136395, R01 NS097590]; Veterans Administration [I01 RX003363]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs)	This work was supported by grants R01 HL136395 (to S. L. G.) and R01 NS097590 (to S. L. G. and W. M. C.) from the National Institutes of Health and grant I01 RX003363 from the Veterans Administration (to W. M. C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin L, 2016, J CELL SCI, V129, P3878, DOI 10.1242/jcs.183137; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Brifault C, 2017, J BIOL CHEM, V292, P18699, DOI 10.1074/jbc.M117.798413; Bucan V, 2019, MOL NEUROBIOL, V56, P1812, DOI 10.1007/s12035-018-1172-z; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cheng L, 2018, MOL ASPECTS MED, V60, P62, DOI 10.1016/j.mam.2017.11.011; Ching RC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1017-8; D'Arrigo G, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12114; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; GANROT PO, 1966, CLIN CHIM ACTA, V14, P493, DOI 10.1016/0009-8981(66)90037-4; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; HALL PK, 1978, BIOCHEM J, V173, P27, DOI 10.1042/bj1730027; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hooper NM, 2008, BIOCHEM SOC T, V36, P1272, DOI 10.1042/BST0361272; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kang YT, 2019, SMALL, V15, DOI 10.1002/smll.201903600; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; LAZARINI F, 1994, MOL BRAIN RES, V22, P268, DOI 10.1016/0169-328X(94)90055-8; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopez-Verrilli MA, 2016, NEUROSCIENCE, V320, P129, DOI 10.1016/j.neuroscience.2016.01.061; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2022, J IMMUNOL, V208, P85, DOI 10.4049/jimmunol.2100412; Mantuano E, 2020, J BIOL CHEM, V295, P14178, DOI 10.1074/jbc.RA120.013779; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsumoto A, 2017, J PHARM SCI-US, V106, P168, DOI 10.1016/j.xphs.2016.07.022; Mattei V, 2020, J NEUROCHEM, V152, P468, DOI 10.1111/jnc.14891; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Pontecorvi P, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1657-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Romeo R, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.642521; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sadri M, 2022, GLIA, V70, P256, DOI 10.1002/glia.24098; Sharma R, 2017, BRIT J CANCER, V117, P545, DOI 10.1038/bjc.2017.183; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0	67	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101642	10.1016/j.jbc.2022.101642	http://dx.doi.org/10.1016/j.jbc.2022.101642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090893	Green Published, gold			2022-12-28	WOS:000789261900002
J	Kwiatkowski, S; Bozko, M; Zarod, M; Witecka, A; Kocdemir, K; Jagielski, AK; Drozak, J				Kwiatkowski, Sebastian; Bozko, Maria; Zarod, Michal; Witecka, Apolonia; Kocdemir, Kubra; Jagielski, Adam K.; Drozak, Jakub			Recharacterization of the mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase as 4-oxo-L-proline reductase (EC 1.1.1.104)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; CIS-HYDROXYPROLINE; PROLINE; PROLIFERATION; METABOLISM; SURVIVAL; COLLAGEN; ENZYME	Early studies revealed that chicken embryos incubated with a rare analog of L-proline, 4-oxo-L-proline, showed increased levels of the metabolite 4-hydroxy-L-proline. In 1962, 4-oxo-L-proline reductase, an enzyme responsible for the reduction of 4-oxo-L-proline, was partially purified from rabbit kidneys and characterized biochemically. However, only recently was the molecular identity of this enzyme solved. Here, we report the purification from rat kidneys, identification, and biochemical characterization of 4-oxo-L-proline reductase. Following mass spectrometry analysis of the purified protein preparation, the previously annotated mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase (BDH2) emerged as the only candidate for the reductase. We subsequently expressed rat and human BDH2 in Escherichia coli, then purified it, and showed that it catalyzed the reversible reduction of 4-oxo-L-proline to cis-4-hydroxy-L-proline via chromatographic and tandem mass spectrometry analysis. Specificity studies with an array of compounds carried out on both enzymes showed that 4-oxo-L-proline was the best substrate, and the human enzyme acted with 12,500-fold higher catalytic efficiency on 4-oxo-L-proline than on (R)-beta-hydroxybutyrate. In addition, human embryonic kidney 293T (HEK293T) cells efficiently metabolized 4-oxo-L-proline to cis-4-hydroxy-L-proline, whereas HEK293T BDH2 KO cells were incapable of producing cis-4-hydroxy-L-proline. Both WT and KO HEK293T cells also produced trans-4-hydroxy-L-proline in the presence of 4-oxo-L-proline, suggesting that the latter compound might interfere with the trans-4-hydroxy-L-proline breakdown in human cells. We conclude that BDH2 is a mammalian 4-oxo-L-proline reductase that converts 4-oxo-L-proline to cis-4-hydroxy-L-proline and not to trans-4-hydroxy-L-proline, as originally thought. We also hypothesize that this enzyme may be a potential source of cis-4-hydroxy-L-proline in mammalian tissues.	[Kwiatkowski, Sebastian; Bozko, Maria; Zarod, Michal; Witecka, Apolonia; Kocdemir, Kubra; Jagielski, Adam K.; Drozak, Jakub] Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Warsaw, Poland	University of Warsaw	Drozak, J (corresponding author), Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Warsaw, Poland.	jdrozak@biol.uw.edu.pl		Witecka, Apolonia/0000-0002-7171-3222; Jagielski, Adam/0000-0002-4331-1816; Drozak, Jakub/0000-0002-3601-3845; Kwiatkowski, Sebastian/0000-0003-4908-1633	Foundation for Polish Science; Erasmus+ traineeship from the European Commission	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Erasmus+ traineeship from the European Commission	S. K. was supported by the Foundation for Polish Science, and K. K. was awarded the Erasmus+ traineeship from the European Commission.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Collard F, 2016, NAT CHEM BIOL, V12, P601, DOI [10.1038/NCHEMBIO.2104, 10.1038/nchembio.2104]; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; den Ouden H, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0930-4; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dickens H, 2008, MOL MED REP, V1, P459; Drozak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064805; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hara R, 2009, BIOCHEM BIOPH RES CO, V379, P882, DOI 10.1016/j.bbrc.2008.12.158; Hu SD, 2022, AMINO ACIDS, V54, P513, DOI 10.1007/s00726-021-03056-x; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kuttan R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1303-1; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; Langrock T, 2007, J CHROMATOGR B, V847, P282, DOI 10.1016/j.jchromb.2006.10.015; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Liu ZM, 2014, MOL CELL BIOL, V34, P2533, DOI 10.1128/MCB.00231-14; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pan L, 2018, MOLECULES, V23, DOI 10.3390/molecules23040735; PATCHETT AA, 1957, J AM CHEM SOC, V79, P185, DOI 10.1021/ja01558a050; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Rausch T, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6635-8; ROSENBLOOM J, 1971, J BIOL CHEM, V246, P1549; Semsary S, 2018, CHEMBIOCHEM, V19, P706, DOI 10.1002/cbic.201700666; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SMITH TE, 1959, SCIENCE, V129, P95, DOI 10.1126/science.129.3341.95; SMITH TE, 1962, J BIOL CHEM, V237, P1177; Sturm D, 2010, INT J COLORECTAL DIS, V25, P921, DOI 10.1007/s00384-010-0946-1; Summitt CB, 2015, BIOCHEM J, V466, P273, DOI 10.1042/BJ20141159; Bach TMH, 2013, APPL MICROBIOL BIOT, V97, P6623, DOI 10.1007/s00253-013-5022-7; Walejko JM, 2018, INT J CARDIOL, V271, P336, DOI 10.1016/j.ijcard.2018.04.074; Yoo JS, 1997, INVEST OPHTH VIS SCI, V38, P520	38	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101708	10.1016/j.jbc.2022.101708	http://dx.doi.org/10.1016/j.jbc.2022.101708			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150746	gold, Green Published			2022-12-28	WOS:000821054100008
J	Wang, YL; Liu, H; Zhang, RX; Xiang, YY; Lu, JF; Xia, B; Peng, L; Wu, JW				Wang, Yongliang; Liu, Huan; Zhang, Ruixin; Xiang, Yuyao; Lu, Junfeng; Xia, Bo; Peng, Liang; Wu, Jiangwei			AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21-mediated time-dependent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; SHORT LIFE; ADIPONECTIN; PROTEIN; OXIDATION; AGONIST	Increasing evidence has shown that AdipoRon, a synthetic adiponectin receptor agonist, is involved in the regulation of whole-body insulin sensitivity and energy homeostasis. How-ever, the mechanisms underlying these alterations remain un-clear. Here, using hyperinsulinemic-euglycemic clamp and isotopic tracing techniques, we show that short-term (10 days) AdipoRon administration indirectly inhibits lipolysis in white adipose tissue via increasing circulating levels of fibroblast growth factor 21 in mice fed a high-fat diet. This led to reduced plasma-free fatty acid concentrations and improved lipid-induced whole-body insulin resistance. In contrast, we found that long-term (20 days) AdipoRon administration directly exacerbated white adipose tissue lipolysis, increased hepatic gluconeogenesis, and impaired the tricarboxylic acid cycle in the skeletal muscle, resulting in aggravated whole-body insulin resistance. Together, these data provide new insights into the comprehensive understanding of multifaceted functional complexity of AdipoRon.	[Wang, Yongliang; Liu, Huan; Zhang, Ruixin; Xiang, Yuyao; Lu, Junfeng; Xia, Bo; Wu, Jiangwei] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Shaanxi, Peoples R China; [Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China	Northwest A&F University - China; China-Japan Friendship Hospital	Xia, B; Wu, JW (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Shaanxi, Peoples R China.; Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.	imed23@nwafu.edu.cn; pengliang8028@163.com; wujiangwei@nwafu.edu.cn	Liu, Huan/HIK-2282-2022; Lu, Junfeng/AFN-9843-2022	Lu, Junfeng/0000-0002-2640-8595; Wang, Yongliang/0000-0002-1494-0496; Peng, Liang/0000-0001-8377-0833	National Key Research and Development Program of China [2021YFF1000602]; National Natural Science Foundation of China [31902137, 81970713, 82170817]; Beijing Municipal Natural Science Foundation of China [7222160]; Chinese Universities Scientific Fund from Northwest AF University [2452018049]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation of China; Chinese Universities Scientific Fund from Northwest AF University	We thank all members of our laboratory for their help. This work was supported by the National Key Research and Development Program of China (grant no.: 2021YFF1000602), National Natural Science Foundation of China (grant nos.: 31902137, 81970713, and 82170817), Beijing Municipal Natural Science Foundation of China (grant no.: 7222160), and Chinese Universities Scientific Fund (grant no.: 2452018049) from Northwest A&F University. We also thank the Life Science Research Core Services NWAFU (Xiaorui Liu) for assistance with immunofluorescence.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Camporez JP, 2017, P NATL ACAD SCI USA, V114, pE11285, DOI 10.1073/pnas.1716990115; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Choi SR, 2018, METABOLISM, V85, P348, DOI 10.1016/j.metabol.2018.02.004; Holland WL, 2013, SCIENCE, V342, P1460, DOI 10.1126/science.1249077; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu XL, 2019, ACTA BIOCH BIOPH SIN, V51, P20, DOI 10.1093/abbs/gmy152; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iwabu M, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00116; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Liu XY, 2017, J CELL PHYSIOL, V232, P1893, DOI 10.1002/jcp.25735; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Okada-Iwabu M, 2015, DIABETES METAB J, V39, P363, DOI 10.4093/dmj.2015.39.5.363; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Perry RJ, 2019, P NATL ACAD SCI USA, V116, P13670, DOI 10.1073/pnas.1901795116; Perry RJ, 2018, CELL, V172, P234, DOI 10.1016/j.cell.2017.12.001; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; Xiang YY, 2020, BIOCHEM BIOPH RES CO, V532, P605, DOI 10.1016/j.bbrc.2020.08.099; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yu J, 2019, NEUROCHEM RES, V44, P1678, DOI 10.1007/s11064-019-02794-5; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014	27	2	2	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101641	10.1016/j.jbc.2022.101641	http://dx.doi.org/10.1016/j.jbc.2022.101641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35090894	gold, Green Published			2022-12-28	WOS:000789261900001
J	Wu, DC; Gowathaman, R; Pierce, BG; Mariuzza, RA				Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.			T cell receptors employ diverse strategies to target a p53 cancer neoantigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOTHERAPY; THERAPY; LANDSCAPE; AFFINITY; DESIGN	Adoptive cell therapy with tumor-specific T cells can mediate durable cancer regression. The prime target of tumor specific T cells are neoantigens arising from mutations in self proteins during malignant transformation. To understand T cell recognition of cancer neoantigens at the atomic level, we studied oligoclonal T cell receptors (TCRs) that recognize a neoepitope arising from a driver mutation in the p53 oncogene (p53R175H) presented by the major histocompatibility complex class I molecule HLA-A2. We previously reported the structures of three p53R175H-specific TCRs (38-10, 12-6, and 1a2) bound to p53R175H and HLA-A2. The structures showed that these TCRs discriminate between WT and mutant p53 by forming extensive interactions with the R175H mutation. Here, we report the structure of a fourth p53R175H-specific TCR (611) in complex with p53R175H and HLA-A2. In contrast to 3810, 12-6, and 1a2, TCR 6-11 makes no direct contacts with the R175H mutation, yet is still able to distinguish mutant from WT p53. Structure-based in silico mutagenesis revealed that the 60-fold loss in 6-11 binding affinity for WT p53 compared to p53R175H is mainly due to the higher energetic cost of desolvating R175 in the WT p53 peptide during complex formation than H175 in the mutant. This indirect strategy for preferential neoantigen recognition by 6-11 is fundamentally different from the direct strategies employed by other TCRs and highlights the multiplicity of solutions to recognizing p53R175H with sufficient selectivity to mediate T cell killing of tumor but not normal cells.	[Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, WM Keck Lab Struct Biol, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Wu, Daichao] Univ South China, Hengyang Med Sch, Dept Histol & Embryol, Hengyang, Hunan, Peoples R China; [Wu, Daichao; Gowathaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD USA	University of South China; University System of Maryland; University of Maryland College Park	Mariuzza, RA (corresponding author), Univ Maryland, WM Keck Lab Struct Biol, Inst Biosci & Biotechnol Res, Rockville, MD USA.; Mariuzza, RA (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD USA.	rmariuzz@umd.edu		Pierce, Brian/0000-0003-4821-0368; Wu, Daichao/0000-0003-2086-0190	National Institutes of Health [GM126299, AI129893]; Natural Science Foundation of China [32100985]; Natural Science Foundation of Hunan Province [2021JJ40456]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This work was supported by National Institutes of Health Grants GM126299 (to B. G. P.) and AI129893 (to R. A. M.), by Natural Science Foundation of China Grant 32100985 (to D. W.), and by Natural Science Foundation of Hunan Province Grant 2021JJ40456 (to D. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentzen A. K., 2019, IMMUNOONCOL TECHNOL, V2, P1; Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gowthaman R, 2019, BIOINFORMATICS, V35, P5323, DOI 10.1093/bioinformatics/btz517; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Hsiue EHC, 2021, SCIENCE, V371, P1009, DOI 10.1126/science.abc8697; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Lo W, 2019, CANCER IMMUNOL RES, V7, P534, DOI 10.1158/2326-6066.CIR-18-0686; Malekzadeh P, 2019, J CLIN INVEST, V129, P1109, DOI 10.1172/JCI123791; McGranahan N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax7918; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierce BG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003478; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; Reinink P, 2019, J IMMUNOL, V203, P3395, DOI 10.4049/jimmunol.1900872; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Sim MJW, 2020, P NATL ACAD SCI USA, V117, P12826, DOI 10.1073/pnas.1921964117; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Wu DC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16755-y; Yang XB, 2017, J BIOL CHEM, V292, P18618, DOI 10.1074/jbc.M117.810382; Yin R, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009380; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	38	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101684	10.1016/j.jbc.2022.101684	http://dx.doi.org/10.1016/j.jbc.2022.101684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35124005	gold, Green Published			2022-12-28	WOS:000789400700002
J	Xu, Y; Miller, PC; Ren, MD; Nargis, T; Rajan, S; Schlame, M; Phoon, CKL; Hussain, MM				Xu, Yang; Miller, Paighton C.; Ren, Mindong; Nargis, Titli; Rajan, Sujith; Schlame, Michael; Phoon, Colin K. L.; Hussain, M. Mahmood			LPGAT1 controls the stearate/palmitate ratio of phosphatidylethanolamine and phosphatidylcholine in sn-1 specific remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-COMPOSITION; N-METHYLTRANSFERASE; LIVER MICROSOMES; DENSITY; PHOSPHATIDYLINOSITOL; ACYLTRANSFERASE; IDENTIFICATION; METHYLATION; EXPRESSION; SECRETION	Most mammalian phospholipids contain a saturated fatty acid at the sn-1 carbon atom and an unsaturated fatty acid at the sn-2 carbon atom of the glycerol backbone group. While the sn-2 linked chains undergo extensive remodeling by deacylation and reacylation (Lands cycle), it is not known how the composition of saturated fatty acids is controlled at the sn1 position. Here, we demonstrate that lysophosphatidylglycerol acyltransferase 1 (LPGAT1) is an sn-1 specific acyltransferase that controls the stearate/palmitate ratio of phosphatidylethanolamine (PE) and phosphatidylcholine. Bacterially expressed murine LPGAT1 transferred saturated acyl-CoAs specifically into the sn-1 position of lysophosphatidylethanolamine (LPE) rather than lysophosphatidylglycerol and preferred stearoylCoA over palmitoyl-CoA as the substrate. In addition, genetic ablation of LPGAT1 in mice abolished 1-LPE:stearoyl-CoA acyltransferase activity and caused a shift from stearate to palmitate species in PE, dimethyl-PE, and phosphatidylcholine. Lysophosphatidylglycerol acyltransferase 1 KO mice were leaner and had a shorter life span than their littermate controls. Finally, we show that total lipid synthesis was reduced in isolated hepatocytes of LPGAT1 knockout mice. Thus, we conclude that LPGAT1 is an sn-1 specific LPE acyltransferase that controls the stearate/palmitate homeostasis of PE and the metabolites of the PE methylation pathway and that LPGAT1 plays a central role in the regulation of lipid biosynthesis with implications for body fat content and longevity.	[Xu, Yang; Ren, Mindong; Schlame, Michael] New York Univ, Dept Anesthesiol, Grossman Sch Med, New York, NY USA; [Miller, Paighton C.; Phoon, Colin K. L.] New York Univ, Dept Pediat, Grossman Sch Med, New York, NY USA; [Ren, Mindong; Schlame, Michael] New York Univ, Dept Cell Biol, Grossman Sch Med, New York, NY USA; [Nargis, Titli; Rajan, Sujith; Hussain, M. Mahmood] New York Univ, Dept Fdn Med, Long Isl Sch Med, Mineola, NY USA	New York University; New York University; New York University	Schlame, M (corresponding author), New York Univ, Dept Anesthesiol, Grossman Sch Med, New York, NY USA.; Schlame, M (corresponding author), New York Univ, Dept Cell Biol, Grossman Sch Med, New York, NY USA.	michael.schlame@med.nyu.edu	rajan, sujith/AFW-0548-2022; Rajan, Sujith/GLR-8662-2022	rajan, sujith/0000-0002-8376-0587; 	U.S. National Institutes of Health (NIH) [GM115593, DK121490, HL137202, HL158054]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by U.S. National Institutes of Health (NIH) grant GM115593 (to M. S.) and grants DK121490, HL137202, and HL158054 (to M. M. H.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Hiramine Y, 2010, J LIPID RES, V51, P1424, DOI 10.1194/jlr.M002584; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P380, DOI 10.1016/0005-2760(72)90052-5; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; Kawana H, 2019, BBA-MOL CELL BIOL L, V1864, P1053, DOI 10.1016/j.bbalip.2019.02.008; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Le Guedard M, 2009, FEBS J, V276, P6412, DOI 10.1111/j.1742-4658.2009.07355.x; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Liu GY, 2019, J BIOL CHEM, V294, P10146, DOI 10.1074/jbc.RA119.008766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; RUSTOW B, 1988, BIOCHIM BIOPHYS ACTA, V961, P364, DOI 10.1016/0005-2760(88)90083-5; Schlame M, 2020, J LIPID RES, V61, P95, DOI 10.1194/jlr.D119000318; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; THOMPSON W, 1986, BIOCHIM BIOPHYS ACTA, V876, P379, DOI 10.1016/0005-2760(86)90023-8; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P184, DOI 10.1016/0005-2760(91)90093-W; Traurig MT, 2013, OBESITY, V21, P193, DOI 10.1002/oby.20243; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Wang LQ, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01346-z; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Zhang XY, 2019, CELL MOL GASTROENTER, V7, P763, DOI 10.1016/j.jcmgh.2019.02.002	33	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101685	10.1016/j.jbc.2022.101685	http://dx.doi.org/10.1016/j.jbc.2022.101685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35131264	Green Published, gold			2022-12-28	WOS:000789400700005
J	Zhao, YH; Liang, YY; Xu, ZX; Liu, JN; Liu, XY; Ma, JY; Sun, C; Yang, YM				Zhao, Yahong; Liang, Yunyun; Xu, Zhixin; Liu, Jina; Liu, Xiaoyu; Ma, Jinyu; Sun, Cheng; Yang, Yumin			Exosomal miR-673-5p from fibroblasts promotes Schwann cell-mediated peripheral neuron myelination by targeting the TSC2/mTORC1/SREBP2 axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; OLIGODENDROCYTE DIFFERENTIATION; NERVE REGENERATION; MTORC1 ACTIVITY; GROWTH; GALACTOCEREBROSIDE; METABOLISM; ACTIVATION; MIGRATION; MEMBRANE	Peripheral myelination is a complicated process, wherein Schwann cells (SCs) promote the formation of the myelin sheath around the axons of peripheral neurons. Fibroblasts are the second resident cells in the peripheral nerves; however, the precise function of fibroblasts in SC-mediated myelination has rarely been examined. Here, we show that exosomes derived from fibroblasts boost myelination-related gene expression in SCs. We used exosome sequencing, together with bioinformatic analysis, to demonstrate that exosomal microRNA miR-673-5p is capable of stimulating myelin gene expression in SCs. Subsequent functional studies revealed that miR-6735p targets the regulator of mechanistic target of the rapamy2 in SCs, leading to the activation of downstream signaling pathways including mTORC1 and sterol-regulatory element binding protein 2. In vivo experiments further confirmed that miR-673-5p activates the tuberous sclerosis complex 2/ mTORC1/sterol-regulatory element binding protein 2 axis, thus promoting the synthesis of cholesterol and related lipids and subsequently accelerating myelin sheath maturation in mediated cross talk between fibroblasts and SCs that plays a pivotal role in peripheral myelination. We propose that exosomes derived from fibroblasts and miR-673-5p might be useful for promoting peripheral myelination in translational medicine.	[Zhao, Yahong; Liang, Yunyun; Xu, Zhixin; Liu, Jina; Liu, Xiaoyu; Ma, Jinyu; Sun, Cheng; Yang, Yumin] Nantong Univ, Key Lab Neuroregenerat Jiangsu & Minist Educ, Coinnovat Ctr Neurogenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong, Peoples R China	Nantong University	Zhao, YH; Sun, C; Yang, YM (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu & Minist Educ, Coinnovat Ctr Neurogenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong, Peoples R China.	zhaoyh108@ntu.edu.cn; suncheng1975@ntu.edu.cn; yangym@ntu.edu.cn			National Natural Science Foundation of China [81970747, 81701835]; National Key Research and Development Program of China [2017YFA0701304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was provided by the National Natural Science Foundation of China (Nos. 81970747, 81701835) and the National Key Research and Development Program of China (Grant No. 2017YFA0701304).	Beirowski B, 2017, P NATL ACAD SCI USA, V114, pE4261, DOI 10.1073/pnas.1620761114; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Cai S, 2017, STEM CELL REP, V9, P1097, DOI 10.1016/j.stemcr.2017.08.004; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Clarke BA, 2019, ELIFE, V8, DOI 10.7554/eLife.51067; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Deng CL, 2021, CELL DEATH DIFFER, V28, P1041, DOI 10.1038/s41418-020-00636-4; Dimas P, 2019, ELIFE, V8, DOI 10.7554/eLife.44702; Dreesmann L, 2009, EUR J CELL BIOL, V88, P285, DOI 10.1016/j.ejcb.2009.01.001; Figlia G, 2017, ELIFE, V6, DOI 10.7554/eLife.29241; Furusho M, 2017, J NEUROSCI, V37, P2931, DOI 10.1523/JNEUROSCI.3316-16.2017; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; Hackett AR, 2020, GLIA, V68, P963, DOI 10.1002/glia.23755; Henriques-Antunes H, 2019, ACS NANO, V13, P8694, DOI 10.1021/acsnano.9b00376; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsieh CCJ, 2021, BRAIN PATHOL, V31, P4, DOI 10.1111/bpa.12870; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jiang MQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12185; Jiang N, 2017, ACS NANO, V11, P7736, DOI 10.1021/acsnano.7b01087; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Keller MD, 2020, NATURE, V579, P260, DOI 10.1038/s41586-020-2066-6; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; LeBleu VS, 2020, FASEB J, V34, P3519, DOI 10.1096/fj.201903188R; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Liu XY, 2017, MOL NEUROBIOL, V54, P3554, DOI 10.1007/s12035-016-9913-3; Lu XY, 2020, NATURE, V588, P479, DOI 10.1038/s41586-020-2928-y; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; McLane LE, 2017, J NEUROSCI, V37, P7534, DOI 10.1523/JNEUROSCI.3454-16.2017; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Monnerie H, 2017, J NEUROCHEM, V140, P53, DOI 10.1111/jnc.13721; Montani L, 2018, J CELL BIOL, V217, P1352, DOI 10.1083/jcb.201706010; Morad G, 2019, ACS NANO, V13, P13853, DOI 10.1021/acsnano.9b04397; Norrmen C, 2018, J NEUROSCI, V38, P4811, DOI 10.1523/JNEUROSCI.3619-17.2018; Norrmen C, 2014, CELL REP, V9, P646, DOI 10.1016/j.celrep.2014.09.001; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Plikus MV, 2021, CELL, V184, P3852, DOI 10.1016/j.cell.2021.06.024; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Salzer JL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020529; Sawade L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16696-6; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Sharpe LJ, 2020, J BIOL CHEM, V295, P17549, DOI 10.1074/jbc.REV120.010723; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; Song H, 2019, NANO LETT, V19, P3040, DOI 10.1021/acs.nanolett.9b00287; Su T, 2019, ACS NANO, V13, P2450, DOI 10.1021/acsnano.8b09375; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; THOMAS PK, 1963, J ANAT, V97, P35; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Neerven SGA, 2013, NEUROSCIENCE, V252, P144, DOI 10.1016/j.neuroscience.2013.08.009; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; WOOD JG, 1976, J NEUROCYTOL, V5, P605, DOI 10.1007/BF01175573; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yi JM, 2020, P NATL ACAD SCI USA, V117, P31189, DOI 10.1073/pnas.2017152117; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang RR, 2021, GLIA, V69, P765, DOI 10.1002/glia.23928; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282; Zhang YZ, 2021, J CELL PHYSIOL, V236, P1345, DOI 10.1002/jcp.29942; Zhang ZH, 2016, GLIA, V64, P374, DOI 10.1002/glia.22934; Zhao YH, 2017, BIOMATERIALS, V134, P64, DOI 10.1016/j.biomaterials.2017.02.026; Zhou XJ, 2020, ACS NANO, V14, P12732, DOI 10.1021/acsnano.0c03064; Zhou X, 2021, ELIFE, V10, DOI 10.7554/eLife.60467	78	1	1	7	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101718	10.1016/j.jbc.2022.101718	http://dx.doi.org/10.1016/j.jbc.2022.101718			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151688	Green Published, gold			2022-12-28	WOS:000789394500009
J	Zheng, DJ; Nakabayashi, M; Asano, Y				Zheng, Daijun; Nakabayashi, Makoto; Asano, Yasuhisa			Structural characterization of Linum usitatissimum hydroxynitrile lyase: A new cyanohydrin decomposition mechanism involving a cyano-zinc complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ALCOHOL-DEHYDROGENASE; ALPHA-HYDROXYNITRILE LYASE; CRYSTAL-STRUCTURE; MANIHOT-ESCULENTA; MOLECULAR-CLONING; CATALYTIC MECHANISM; SORGHUM-BICOLOR; ACTIVE-SITE; FORMALDEHYDE DEHYDROGENASE; COLORIMETRIC DETERMINATION	Hydroxynitrile lyase from Linum usitatissimum (LuHNL) is an enzyme involved in the catabolism of cyanogenic glycosides to release hydrogen cyanide upon tissue damage. This enzyme strictly conserves the substrate-and NAD(H)-binding domains of Zn2(+)-containing alcohol dehydrogenase (ADH); however, there is no evidence suggesting that LuHNL possesses ADH activity. Herein, we determined the ligand-free 3D structure of LuHNL and its complex with acetone cyanohydrin and (R)-2-butanone cyanohydrin using X-ray crystallography. These structures reveal that an A-form NAD(+)& nbsp;is tightly but not covalently bound to each subunit of LuHNL. The restricted movement of the NAD(+)& nbsp;molecule is due to the "sandwich structure " on the adenine moiety of NAD(+). Moreover, the structures and mutagenesis analysis reveal a novel reaction mechanism for cyanohydrin decomposition involving the cyano-zinc complex and hydrogen-bonded interaction of the hydroxyl group of cyanohydrin with Glu323/Thr65 and H2O/ Lys162 of LuHNL. The deprotonated Lys162 and protonated Glu323 residues are presumably stabilized by a partially desolvated microenvironment. In summary, the substrate binding geometry of LuHNL provides insights into the differences in activities of LuHNL and ADH, and identifying this novel reaction mechanism is an important contribution to the study of hydroxynitrile lyases.	[Zheng, Daijun; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan; [Zheng, Daijun; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama, Japan; [Nakabayashi, Makoto] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan	Toyama Prefectural University; Toyama Prefectural University	Asano, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan.; Asano, Y (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama, Japan.	asano@pu-toyama.ac.jp	Asano, Yasuhisa/K-5898-2016	Asano, Yasuhisa/0000-0003-3645-3952	Japan Society for Promotion of Science [17H06169]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful for the funding support from the Grant-in-Aid for Scientific Research (S) from the Japan Society for Promotion of Science (Grant No. 17H06169) awarded to Y. A.	Andexer J, 2007, ANGEW CHEM INT EDIT, V46, P8679, DOI 10.1002/anie.200701455; Andexer JN, 2012, CHEMBIOCHEM, V13, P1932, DOI 10.1002/cbic.201200239; Asano Y, 2005, BIOSCI BIOTECH BIOCH, V69, P2349, DOI 10.1271/bbb.69.2349; Asano Y, 2011, PROTEIN ENG DES SEL, V24, P607, DOI 10.1093/protein/gzr030; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; Breithaupt H, 1999, J MOL CATAL B-ENZYM, V6, P315, DOI 10.1016/S1381-1177(98)00109-X; Chen FF, 2015, BIOCHIMIE, V108, P33, DOI 10.1016/j.biochi.2014.10.023; CUTLER AJ, 1981, ARCH BIOCHEM BIOPHYS, V212, P468, DOI 10.1016/0003-9861(81)90389-1; Dadashipour M, 2015, P NATL ACAD SCI USA, V112, P10605, DOI 10.1073/pnas.1508311112; Dadashipour M, 2011, ACS CATAL, V1, P1121, DOI 10.1021/cs200325q; Dadashipour M, 2011, J BIOTECHNOL, V153, P100, DOI 10.1016/j.jbiotec.2011.02.004; Dadashipour M, 2011, PROTEIN EXPRES PURIF, V77, P92, DOI 10.1016/j.pep.2010.12.010; Diaz-Sanchez AG, 2011, BIOCHEM J, V439, P443, DOI 10.1042/BJ20110376; Dreveny I, 2002, PROTEIN SCI, V11, P292, DOI 10.1110/ps.38102; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Dreveny I, 2009, BIOCHEMISTRY-US, V48, P3370, DOI 10.1021/bi802162s; DRUM DE, 1970, BIOCHEMISTRY-US, V9, P4078, DOI 10.1021/bi00823a008; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukuta Y, 2011, BIOSCI BIOTECH BIOCH, V75, P214, DOI 10.1271/bbb.100187; Gartler G, 2007, J BIOTECHNOL, V129, P87, DOI 10.1016/j.jbiotec.2006.12.009; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Gruber K, 2004, J POLYM SCI POL CHEM, V42, P479, DOI 10.1002/pola.10845; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Hajnal I, 2013, FEBS J, V280, P5815, DOI 10.1111/febs.12501; Hasslacher M, 1996, J BIOL CHEM, V271, P5884, DOI 10.1074/jbc.271.10.5884; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUGHES J, 1994, ARCH BIOCHEM BIOPHYS, V311, P496, DOI 10.1006/abbi.1994.1267; Hughes J, 1997, BIOTECHNOL BIOENG, V53, P332, DOI 10.1002/(SICI)1097-0290(19970205)53:3&lt;332::AID-BIT12&gt;3.0.CO;2-M; Hussain Z, 2012, APPL ENVIRON MICROB, V78, P2053, DOI 10.1128/AEM.06899-11; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; KOLTHOFF IM, 1951, J AM CHEM SOC, V73, P390, DOI 10.1021/ja01145a129; Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010; LAMBERT JL, 1975, ANAL CHEM, V47, P916, DOI 10.1021/ac60356a036; Lanfranchi E, 2017, SCI REP-UK, V7, DOI 10.1038/srep46738; Lauble H, 2002, BIOCHEMISTRY-US, V41, P12043, DOI 10.1021/bi020300o; Lauble H, 2002, PROTEIN SCI, V11, P65, DOI 10.1110/ps.ps.33702; Lauble H, 2001, ACTA CRYSTALLOGR D, V57, P194, DOI 10.1107/S0907444900015766; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Motojima F, 2021, FEBS J, V288, P1679, DOI 10.1111/febs.15490; Motojima F, 2018, FEBS J, V285, P313, DOI 10.1111/febs.14339; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakano S, 2014, BBA-PROTEINS PROTEOM, V1844, P2059, DOI 10.1016/j.bbapap.2014.09.004; Nuylert A, 2020, ACS OMEGA, V5, P27896, DOI 10.1021/acsomega.0c03070; Nuylert A, 2017, CHEMBIOCHEM, V18, P257, DOI 10.1002/cbic.201600447; Pasternak K, 2010, J ELEMENTOL, V15, P601; Pavkov-Keller T, 2016, J BIOTECHNOL, V235, P24, DOI 10.1016/j.jbiotec.2016.04.013; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rubach JK, 2002, BIOCHEMISTRY-US, V41, P15770, DOI 10.1021/bi026581h; Rudyk O, 2014, REDOX BIOL, V2, P803, DOI 10.1016/j.redox.2014.06.005; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P10778, DOI 10.1021/bi0257639; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Sharma M, 2005, ENZYME MICROB TECH, V37, P279, DOI 10.1016/j.enzmictec.2005.04.013; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Tanaka N, 2002, J MOL BIOL, V324, P519, DOI 10.1016/S0022-2836(02)01066-5; Trummler K, 1997, J BIOL CHEM, V272, P4770, DOI 10.1074/jbc.272.8.4770; Trummler K, 1998, PLANT SCI, V139, P19, DOI 10.1016/S0168-9452(98)00173-3; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Ueatrongchit T, 2008, BIOSCI BIOTECH BIOCH, V72, P1513, DOI 10.1271/bbb.80023; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; WAJANT H, 1993, PLANT SCI, V89, P127, DOI 10.1016/0168-9452(93)90120-O; WAJANT H, 1994, PLANT MOL BIOL, V26, P735, DOI 10.1007/BF00013758; WAJANT H, 1995, PLANT SCI, V108, P1, DOI 10.1016/0168-9452(95)04118-E; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; Weston J, 2009, PATAIS CHEM FUNCTION, P315; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Wiedner R, 2014, COMPUT STRUCT BIOTEC, V10, P58, DOI 10.1016/j.csbj.2014.07.002; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wymore T, 2007, BIOCHEMISTRY-US, V46, P9495, DOI 10.1021/bi700555g; Xie PGT, 1999, PROTEIN SCI, V8, P2639; XU LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P256, DOI 10.1016/0003-9861(88)90634-0; Yahashiri A, 2014, BIOCHEMISTRY-US, V53, P881, DOI 10.1021/bi401583f; Yamaguchi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20190-x; YEMM RS, 1986, ARCH BIOCHEM BIOPHYS, V247, P440, DOI 10.1016/0003-9861(86)90604-1; Zhai ZY, 2019, J IND MICROBIOL BIOT, V46, P887, DOI 10.1007/s10295-019-02162-w; Zhao GJ, 2011, J BIOSCI BIOENG, V112, P321, DOI 10.1016/j.jbiosc.2011.06.015	83	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101650	10.1016/j.jbc.2022.101650	http://dx.doi.org/10.1016/j.jbc.2022.101650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35101448	Green Published, gold			2022-12-28	WOS:000794865600007
J	Liu, X; Pappas, EJ; Husby, ML; Motsa, BB; Stahelin, RV; Pienaar, E				Liu, Xiao; Pappas, Ethan J.; Husby, Monica L.; Motsa, Balindile B.; Stahelin, Robert, V; Pienaar, Elsje			Mechanisms of phosphatidylserine influence on viral production: A computational model of Ebola virus matrix protein assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CONVALESCENT PLASMA; VP40; DISEASE; INFECTION; OLIGOMERIZATION; TRAFFICKING; FAVIPIRAVIR; KINETICS; DOMAIN	Ebola virus (EBOV) infections continue to pose a global public health threat, with high mortality rates and sporadic outbreaks in Central and Western Africa. A quantitative understanding of the key processes driving EBOV assembly and budding could provide valuable insights to inform drug development. Here, we use a computational model to evaluate EBOV matrix assembly. Our model focuses on the assembly kinetics of VP40, the matrix protein in EBOV, and its interaction with phosphatidylserine (PS) in the host cell membrane. It has been shown that mammalian cells transfected with VP40-expressing plasmids are capable of producing virus-like particles (VLPs) that closely resemble EBOV virions. Previous studies have also shown that PS levels in the host cell membrane affects VP40 association with the plasma membrane inner leaflet and that lower membrane PS levels result in lower VLP production. Our computational findings indicate that PS may also have a direct influence on VP40 VLP assembly and budding, where a higher PS level will result in a higher VLP budding rate and filament dissociation rate. Our results further suggest that the assembly of VP40 filaments follow the nucleation-elongation theory, where initialization and oligomerization of VP40 are two distinct steps in the assembly process. Our findings advance the current understanding of VP40 VLP formation by identifying new possible mechanisms of PS influence on VP40 assembly. We propose that these mechanisms could inform treatment strategies targeting PS alone or in combination with other VP40 assembly steps.	[Liu, Xiao; Pappas, Ethan J.; Pienaar, Elsje] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Husby, Monica L.; Motsa, Balindile B.; Stahelin, Robert, V] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Pappas, Ethan J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Pienaar, E (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	epienaar@purdue.edu		Pappas, Ethan/0000-0001-6139-8532; Stahelin, Robert/0000-0001-5443-7863	NIH/NIAID [AI081077]; NIH/NIGMS [T32GM075762]; Frederick N. Andrews Fellowship; Purdue Pharmacy Live Cell Imaging Facility [NIH OD027034]; Indiana CTSI [UL1TR001108]	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Frederick N. Andrews Fellowship; Purdue Pharmacy Live Cell Imaging Facility; Indiana CTSI	These studies were supported by the NIH/NIAID (AI081077) to R. V. S., the NIH/NIGMS to M. L. H. (T32GM075762), the Indiana CTSI (UL1TR001108) to R. V. S and E. P., and the Frederick N. Andrews Fellowship to X. L. We would like to thank the Purdue Pharmacy Live Cell Imaging Facility for confocal imaging (NIH OD027034 to R. V. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2014, VIRUSES-BASEL, V6, P3837, DOI 10.3390/v6103837; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Aruna A, 2019, MMWR-MORBID MORTAL W, V68, P1162, DOI 10.15585/mmwr.mm6850a3; Aschenbrenner DS, 2021, AM J NURS, V121, P22, DOI 10.1097/01.NAJ.0000742484.81331.b2; Bai CQ, 2016, CLIN INFECT DIS, V63, P1288, DOI 10.1093/cid/ciw571; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Chatani Eri, 2018, Biophys Rev, V10, P527, DOI 10.1007/s12551-017-0353-8; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Dayeh MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196402; Del Vecchio K, 2018, J BIOL CHEM, V293, P3335, DOI 10.1074/jbc.M117.816280; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Dunning J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162199; Dunning J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001997; Fan JN, 2020, BIOCHEM BIOPH RES CO, V527, P387, DOI 10.1016/j.bbrc.2020.04.041; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Gc JB, 2017, BIOCHEM BIOPH RES CO, V493, P176, DOI 10.1016/j.bbrc.2017.09.052; Gc JB, 2016, PHYS CHEM CHEM PHYS, V18, P28409, DOI 10.1039/c6cp03776c; Gc JB, 2016, PROTEIN SCI, V25, P1648, DOI 10.1002/pro.2969; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Husby M. L., 2021, BIORXIV, DOI [10.1101/2021.06.08.447555, DOI 10.1101/2021.06.08.447555]; Husby ML, 2018, FASEB J, V32; Jeevan BGC, 2017, BBA-BIOMEMBRANES, V1859, P2012, DOI 10.1016/j.bbamem.2017.07.007; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Johnson K. A, 2016, SCI REP-UK, V6, P1; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kalenga OI, 2019, NEW ENGL J MED, V381, P373, DOI 10.1056/NEJMsr1904253; Kende M, 2019, ANTIVIR RES, V163, P179, DOI 10.1016/j.antiviral.2018.12.020; Khan A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0043-3; Konde MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169255; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; Krebs E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217559; LANGE G, 1988, EUR J BIOCHEM, V178, P61, DOI 10.1111/j.1432-1033.1988.tb14429.x; Lawson B. A. J., 2017, ARXIV, DOI [10.48550/arXiv.1706.06763, DOI 10.48550/ARXIV.1706.06763]; Li HY, 2020, J AM CHEM SOC, V142, P1367, DOI 10.1021/jacs.9b10869; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Madelain V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06215-z; Maekawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35762; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Markham A, 2021, DRUGS, V81, P175, DOI 10.1007/s40265-020-01452-3; Martyushev A, 2016, ANTIVIR RES, V135, P62, DOI 10.1016/j.antiviral.2016.10.004; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Nanbo A, 2019, DNA CELL BIOL, V38, P115, DOI 10.1089/dna.2018.4485; Nickbakhsh S, 2019, P NATL ACAD SCI USA, V116, P27142, DOI 10.1073/pnas.1911083116; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pasin C, 2019, J VIROL, V93, DOI 10.1128/JVI.00579-19; Piorkowski G, 2017, ANTIVIR RES, V140, P95, DOI 10.1016/j.antiviral.2017.01.017; Sahr F, 2017, J INFECTION, V74, P302, DOI 10.1016/j.jinf.2016.11.009; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Spouge JL, 1996, MATH BIOSCI, V138, P1, DOI 10.1016/S0025-5564(96)00064-8; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stahelin RV, 2014, EXPERT OPIN THER TAR, V18, P115, DOI 10.1517/14728222.2014.863877; Sueblinvong V, 2015, CRIT CARE MED, V43, P2066, DOI 10.1097/CCM.0000000000001197; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Nguyen VK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08884-0; Nguyen VK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00257; Wan W, 2020, ELIFE, V9, DOI 10.7554/eLife.59225; Wang PY, 2021, EUR J MED CHEM, V217, DOI 10.1016/j.ejmech.2021.113381; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zhang JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050295; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zitzmann C, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00725	81	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							102025	10.1016/j.jbc.2022.102025	http://dx.doi.org/10.1016/j.jbc.2022.102025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2N9JG	35568195	Green Published, Green Submitted, gold			2022-12-28	WOS:000818686700004
J	Ruis, K; Huynh, O; Montales, K; Barr, NA; Michael, WM				Ruis, Kenna; Huynh, Oanh; Montales, Katrina; Barr, Nina A.; Michael, W. Matthew			Delineation of a minimal topoisomerase II binding protein 1 for regulated activation of ATR at DNA double-strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION CHECKPOINT; MRN COMPLEX; TOPBP1; PHOSPHORYLATION; RAD9-HUS1-RAD1; RECONSTITUTION; RECRUITMENT; INTERACTS; DOMAINS; CLASPIN	Topoisomerase II Binding Protein 1 (TOPBP1) is an important activator of the DNA damage response kinase Ataxia Telangiectasia and Rad3-related (ATR), although the mecha-nism by which this activation occurs is not yet known. TOPBP1 contains nine copies of the BRCA1 C-terminal repeat (BRCT) motif, which allows protein-protein and protein-DNA in-teractions. TOPBP1 also contains an ATR activation domain (AAD), which physically interacts with ATR and its partner ATR-interacting protein (ATRIP) in a manner that stimulates ATR kinase activity. It is unclear which of TOPBP1's nine BRCT domains participate in the reaction, as well as the in-dividual roles played by these relevant BRCT domains. To address this knowledge gap, here, we delineated a minimal TOPBP1 that can activate ATR at DNA double-strand breaks in a regulated manner. We named this minimal TOPBP1 "Ju-nior " and we show that Junior is composed of just three re-gions: BRCT0-2, the AAD, and BRCT7 & 8. We further defined the individual functions of these three regions by showing that BRCT0-2 is required for recruitment to DNA double-strand breaks and is dispensable thereafter, and that BRCT7 & 8 is dispensable for recruitment but essential to allow the AAD to multimerize and activate ATR. The delineation of TOPBP1 Junior creates a leaner, simplified, and better understood TOPBP1 and provides insight into the mechanism of ATR activation.	[Ruis, Kenna; Huynh, Oanh; Montales, Katrina; Barr, Nina A.; Michael, W. Matthew] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California	Michael, WM (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mattm@usc.edu	McDermott, Michael Francis/GZM-5330-2022		National Institutes of Health [R01GM122887]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported entirely by grant #R01GM122887 from the National Institutes of Health to W. M. M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagge J, 2021, SEMIN CELL DEV BIOL, V113, P57, DOI 10.1016/j.semcdb.2020.08.009; Bigot N, 2019, ELIFE, V8, DOI 10.7554/eLife.44353; Blackford AN, 2015, MOL CELL, V57, P1133, DOI 10.1016/j.molcel.2015.02.012; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Choi SH, 2016, BIOCHEM BIOPH RES CO, V479, P5, DOI 10.1016/j.bbrc.2016.08.158; Day M, 2018, ELIFE, V7, DOI 10.7554/eLife.39979; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Frattini C, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.049; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Kim A, 2020, DNA REPAIR, V96, DOI 10.1016/j.dnarep.2020.102973; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Leimbacher PA, 2019, MOL CELL, V74, P571, DOI 10.1016/j.molcel.2019.02.014; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Montales K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80626-1; Mooser C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13981-x; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Niedzwiedz W, 2016, NAT CELL BIOL, V18, P1120, DOI 10.1038/ncb3431; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; Ramirez-Lugo JS, 2011, CELL CYCLE, V10, P469, DOI 10.4161/cc.10.3.14711; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Thada V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100455; Thada V, 2019, J BIOL CHEM, V294, P8395, DOI 10.1074/jbc.RA119.008154; Van C, 2010, J CELL BIOL, V189, P233, DOI 10.1083/jcb.200909105; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Wan BB, 2016, CELL CYCLE, V15, P2561, DOI 10.1080/15384101.2016.1218102; Wang XJ, 2017, SCIENCE, V358, P1206, DOI 10.1126/science.aan8414; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Waterman DP, 2020, ANNU REV BIOCHEM, V89, P103, DOI 10.1146/annurev-biochem-011520-104722; Williams RM, 2021, PROG BIOPHYS MOL BIO, V161, P27, DOI 10.1016/j.pbiomolbio.2020.11.005; Williams RM, 2020, CURR OPIN STRUC BIOL, V61, P98, DOI 10.1016/j.sbi.2019.12.010; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yan S, 2009, J CELL BIOL, V184, P793, DOI 10.1083/jcb.200810185; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190	48	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2022	298	7							101992	10.1016/j.jbc.2022.101992	http://dx.doi.org/10.1016/j.jbc.2022.101992			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3E7NR	35490781	Green Published, gold			2022-12-28	WOS:000830168100007
J	Fort, PE; Losiewicz, MK; Elghazi, L; Kong, DJ; Cras-Meneur, C; Fingar, DC; Kimball, SR; Rajala, RVS; Smith, AJ; Ali, RR; Abcouwer, SF; Gardner, TW				Fort, Patrice E.; Losiewicz, Mandy K.; Elghazi, Lynda; Kong, Dejuan; Cras-Meneur, Corentin; Fingar, Diane C.; Kimball, Scot R.; Rajala, Raju V. S.; Smith, Alexander J.; Ali, Robin R.; Abcouwer, Steven F.; Gardner, Thomas W.			mTORC1 regulates high levels of protein synthesis in retinal ganglion cells of adult mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; SECONDARY REDUCTION; SKELETAL-MUSCLE; MECHANISMS; METABOLISM; MODEL; PHOSPHORYLATION; EXPRESSION; MIGRATION; DEFECTS	Mechanistic target of rapamycin (mTOR) and mTOR complex 1 (mTORC1), linchpins of the nutrient sensing and protein synthesis pathways, are present at relatively high levels in the ganglion cell layer (GCL) and retinal ganglion cells (RGCs) of rodent and human retinas. However, the role of mTORCs in the control of protein synthesis in RGC is unknown. Here, we applied the SUrface SEnsing of Translation (SUnSET) method of nascent protein labeling to localize and quantify protein synthesis in the retinas of adult mice. We also used intravitreal injection of an adeno-associated virus 2 vector encoding Cre recombinase in the eyes of mtor-or rptor-floxed mice to conditionally knockout either both mTORCs or only mTORC1, respectively, in cells within the GCL. A novel vector encoding an inactive Cre mutant (Cre & UDelta;C) served as control. We found that retinal protein synthesis was highest in the GCL, particularly in RGC. Negation of both complexes or only mTORC1 significantly reduced protein synthesis in RGC. In addition, loss of mTORC1 function caused a significant reduction in the panRGC marker, RNA-binding protein with multiple splicing, with little decrease of the total number of cells in the RGC layer, even at 25 weeks after adeno-associated virus-Cre injection. These findings reveal that mTORC1 signaling is necessary for maintaining the high rate of protein synthesis in RGCs of adult rodents, but it may not be essential to maintain RGC viability. These findings may also be relevant to understanding the pathophysiology of RGC disorders, including glaucoma, diabetic retinopathy, and optic neuropathies.	[Fort, Patrice E.; Losiewicz, Mandy K.; Elghazi, Lynda; Kong, Dejuan; Abcouwer, Steven F.; Gardner, Thomas W.] Univ Michigan, Ophthalmol & Visual Sci, Med Sch, Ann Arbor, MI 48109 USA; [Fort, Patrice E.; Gardner, Thomas W.] Univ Michigan, Mol & Integrat Physiol, Med Sch, Ann Arbor, MI USA; [Gardner, Thomas W.] Univ Michigan, MEND Div, Internal Med, Med Sch, Ann Arbor, MI USA; [Fingar, Diane C.] Univ Michigan, Cell & Dev Biol, Med Sch, Ann Arbor, MI USA; [Kimball, Scot R.] Penn State Coll Med, Cellular & Mol Physiol, Hershey, PA USA; [Rajala, Raju V. S.] Univ Oklahoma, Dept Ophthalmol, Hlth Sci Ctr, Oklahoma City, OK USA; [Rajala, Raju V. S.] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Abcouwer, SF (corresponding author), Univ Michigan, Ophthalmol & Visual Sci, Med Sch, Ann Arbor, MI 48109 USA.	sabcouwe@umich.edu		Elghazi, Lynda/0000-0003-1755-9217	National Institutes of Health (NIH) [R01EY031961, R01EY020582, R01EY020823, R01EY029349, R24-DK-082841, R01DK100722, DK15658]; Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan; Research to Prevent Blindness; Core Grant for Vision Research at the University of Michigan [NIH P30EY007003]; Michigan Diabetes Research Center [NIH P30DK020572]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Core Grant for Vision Research at the University of Michigan; Michigan Diabetes Research Center	This work was supported by the National Institutes of Health (NIH) grants R01EY031961 (to S. F. A. and P. E. F.) , R01EY020582 (to S. F. A. and T. W. G.) , R01EY020823 (to S. F. A.) , R01EY029349 (to S. F. A.) , R24-DK-082841 (to S. F. A., P. E. F., and T. W. G.) , R01DK100722 (to D. C. F.) , DK15658 (to S. R. K.) ; the Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan (to T. W. G. and P. E. F.) ; and Research to Prevent Blindness (to T. W. G.) , NIH P30EY007003 (Core Grant for Vision Research at the University of Michigan) , and NIH P30DK020572 (Michigan Diabetes Research Center) .	Assouvie A, 2018, METHODS MOL BIOL, V1784, P29, DOI 10.1007/978-1-4939-7837-3_3; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Boutouja F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010018; CHIHARA E, 1981, J NEUROCHEM, V37, P247, DOI 10.1111/j.1471-4159.1981.tb05316.x; CHIHARA E, 1982, BRAIN RES, V250, P363, DOI 10.1016/0006-8993(82)90432-2; Choi JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04774-9; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Elghazi L, 2017, MOL METAB, V6, P560, DOI 10.1016/j.molmet.2017.03.010; Farazi TA, 2014, RNA, V20, P1090, DOI 10.1261/rna.045005.114; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Fu ZJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041503; Gardner TW, 2015, AM J PHYSIOL-ENDOC M, V309, pE546, DOI 10.1152/ajpendo.00180.2015; Garza-Lombo C, 2016, FRONT CELL NEUROSCI, V10, DOI [10.1101/GAD.1212704, 10.3389/fncel.2016.00157]; Georgiadis A, 2016, GENE THER, V23, P857, DOI 10.1038/gt.2016.66; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Ha YJ, 2018, INVEST OPHTH VIS SCI, V59, P4670, DOI 10.1167/iovs.18-24427; Hartung M, 1998, J BIOL CHEM, V273, P22884, DOI 10.1074/jbc.273.36.22884; HODSON S, 1967, J CELL BIOL, V35, P722, DOI 10.1083/jcb.35.3.722; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hornberg H, 2016, J NEUROSCI, V36, P12697, DOI 10.1523/JNEUROSCI.2400-16.2016; Jhanwar-Uniyal Meena, 2017, Advances in Biological Regulation, V64, P39, DOI 10.1016/j.jbior.2016.12.001; Jones I, 2019, BIOL OPEN, V8, DOI 10.1242/bio.044370; Jones I, 2015, DIS MODEL MECH, V8, P1517, DOI 10.1242/dmm.021972; KARLSSON JO, 1971, J NEUROCHEM, V18, P749, DOI 10.1111/j.1471-4159.1971.tb12005.x; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kimball SR, 2002, J APPL PHYSIOL, V93, P1168, DOI 10.1152/japplphysiol.00221.2002; Koley S, 2019, NEUROSCI RES, V139, P26, DOI 10.1016/j.neures.2018.10.003; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lam C, 2019, MOL MED REP, V20, P2734, DOI 10.3892/mmr.2019.10525; LEON JA, 1990, INVEST OPHTH VIS SCI, V31, P1709; Leveillard T, 2017, CELL MOL LIFE SCI, V74, P3649, DOI 10.1007/s00018-016-2318-7; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Losiewicz MK, 2020, EXP EYE RES, V197, DOI 10.1016/j.exer.2020.108131; Ma S, 2015, EXP EYE RES, V135, P1, DOI 10.1016/j.exer.2015.04.006; MARAINI G., 1962, OPHTHALMOLOGICA, V144, P141; MARAINL G., 1962, OPHTHALMOLOGICA, V144, P13; Masin L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80308-y; Maus M, 2006, J NEUROCHEM, V96, P815, DOI 10.1111/j.1471-4159.2005.03601.x; Metea MR, 2007, EXP PHYSIOL, V92, P635, DOI 10.1113/expphysiol.2006.036376; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nishiguchi KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7006; NOVER A, 1960, Albrecht Von Graefes Arch Ophthalmol, V161, P554, DOI 10.1007/BF00686431; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pereiro X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239330; Petit L, 2015, ONCOTARGET, V6, P16786, DOI 10.18632/oncotarget.4466; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rajala RVS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00266; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Romano GL, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114199; Saha S, 2016, NEUROSCIENCE, V329, P1, DOI 10.1016/j.neuroscience.2016.04.032; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schiapparelli LM, 2019, CELL REP, V28, P1935, DOI 10.1016/j.celrep.2019.07.037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCHULTZE B, 1959, Beitr Pathol Anat, V120, P58; Seigel GM, 2014, MOL VIS, V20, P301; Shah SH, 2018, DEV NEUROBIOL, V78, P998, DOI 10.1002/dneu.22630; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Shigeoka T, 2013, J CELL BIOL, V202, P991, DOI 10.1083/jcb.201305139; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sindelar DK, 2004, ENDOCRINOLOGY, V145, P3363, DOI 10.1210/en.2003-1727; Starr CR, 2019, INVEST OPHTH VIS SCI, V60, P4849, DOI 10.1167/iovs.19-27512; Starr CR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0513-1; STEINMAN L, 1974, TISSUE CELL, V6, P137, DOI 10.1016/0040-8166(74)90028-7; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Switon K, 2017, NEUROSCIENCE, V341, P112, DOI 10.1016/j.neuroscience.2016.11.017; Tailler M, 2019, CELL DEATH DIFFER, V26, P1766, DOI 10.1038/s41418-018-0244-y; Tee AR, 2016, SEMIN CELL DEV BIOL, V52, P12, DOI 10.1016/j.semcdb.2016.01.040; Thoreen CC, 2017, BIOCHEM SOC T, V45, P213, DOI 10.1042/BST20160072; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Umegaki Y, 2018, J NEUROSCI, V38, P4985, DOI 10.1523/JNEUROSCI.2370-17.2018; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Xie J, 2014, TRANSLATION, V2, DOI 10.4161/trla.28174; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00558; Zieger M, 2016, ONCOTARGET, V7, P9620, DOI 10.18632/oncotarget.7330; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	85	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101944	10.1016/j.jbc.2022.101944	http://dx.doi.org/10.1016/j.jbc.2022.101944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35447116	Green Published, gold			2022-12-28	WOS:000804798000004
J	Shen, WC; Borchert, AJ; Downs, DM				Shen, Wangchen; Borchert, Andrew J.; Downs, Diana M.			2-Aminoacrylate stress damages diverse PLP-dependent enzymes in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; THREONINE DEAMINASE; TRANSAMINASE-B; SERINE; MECHANISM; FAMILY; YJGF; PHOSPHORIBOSYLAMINE; AMINOTRANSFERASE; INACTIVATION	Pyridoxal 50-phosphate (PLP) is an essential cofactor for a class of enzymes that catalyze diverse reactions in central metabolism. The catalytic mechanism of some PLP-dependent enzymes involves the generation of reactive enamine intermediates like 2-aminoacrylate (2AA). 2AA can covalently modify PLP in the active site of some PLP-dependent enzymes and subsequently inactivate the enzyme through the formation of a PLP-pyruvate adduct. In the absence of the enamine/imine deaminase RidA, Salmonella enterica experiences 2AA-mediated metabolic stress. Sur-prisingly, PLP-dependent enzymes that generate endogenous 2AA appear to be immune to its attack, while other PLP-dependent enzymes accumulate damage in the presence of 2AA stress; however, structural determinants of 2AA sensi-tivity are unclear. In this study, we refined a molecular method to query proteins from diverse systems for their sensitivity to 2AA in vivo. This method was then used to examine active site residues of Alr, a 2AA-sensitive PLP-dependent enzyme, that affect its sensitivity to 2AA in vivo. Unexpectedly, our data also showed that a low level of 2AA stress can persist even in the presence of a functional RidA. In summary, this study expands our understanding of 2AA metabolism and takes an initial step toward characterizing the structural determinants influencing enzyme susceptibility to damage by free 2AA.	[Shen, Wangchen; Borchert, Andrew J.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Downs, Diana M.] Renewable Resources & Enabling Sci Ctr, Natl Renewable Energy Lab, Golden, CO USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu		Borchert, Andrew/0000-0003-1435-3643; Shen, Wangchen/0000-0002-8296-2822	NIH [GM095837]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an award from the competitive grants program at the NIH (GM095837) to D. M. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARFIN SM, 1971, J BACTERIOL, V105, P519, DOI 10.1128/JB.105.2.519-522.1971; BADET B, 1984, BIOCHEMISTRY-US, V23, P5188, DOI 10.1021/bi00317a016; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Bazurto JV, 2016, MBIO, V7, DOI 10.1128/mBio.01840-15; Borchert AJ, 2019, TRENDS BIOCHEM SCI, V44, P849, DOI 10.1016/j.tibs.2019.04.011; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; BURNS RO, 1979, J BIOL CHEM, V254, P1074; Casasnovas R, 2012, J PHYS CHEM B, V116, P10665, DOI 10.1021/jp303678n; Chargaff E, 1943, J BIOL CHEM, V151, P273; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; CROUT DHG, 1980, EUR J BIOCHEM, V106, P97; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; FLAVIN M, 1964, BIOCHEMISTRY-US, V3, P885, DOI 10.1021/bi00895a004; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hunter GA, 2009, CELL MOL BIOL, V55, P102, DOI 10.1170/T844; Irons J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02058; Irons J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00434-18; Irons JL, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00024-20; Islam MM, 2010, J BIOL CHEM, V285, P265, DOI 10.1074/jbc.M109.048777; Jhee KH, 1998, BIOCHEMISTRY-US, V37, P14591, DOI 10.1021/bi981325j; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2013, ACS CHEM BIOL, V8, P242, DOI 10.1021/cb300364k; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064; Singh R, 2013, J ENZYM INHIB MED CH, V28, P183, DOI 10.3109/14756366.2011.643305; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Whitaker GH, 2021, YEAST, V38, P615, DOI 10.1002/yea.3670; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c	46	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101970	10.1016/j.jbc.2022.101970	http://dx.doi.org/10.1016/j.jbc.2022.101970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35460692	Green Published, gold			2022-12-28	WOS:000807750700010
J	Detry, S; Andries, J; Bloch, Y; Gabay, C; Clancy, DM; Savvides, SN				Detry, Sam; Andries, Julie; Bloch, Yehudi; Gabay, Cem; Clancy, Danielle M.; Savvides, Savvas N.			Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-INDUCING FACTOR; HIGH-LEVEL EXPRESSION; IFN-GAMMA; HUMAN INTERLEUKIN-18; RHEUMATOID-ARTHRITIS; BIOLOGICAL-ACTIVITY; MATURE FORM; INTERFERON; ACTIVATION; CYTOKINE	Human Interleukin-18 (IL-18) is an omnipresent proinflammatory cytokine of the IL-1 family with central roles in autoimmune and inflammatory diseases and serves as a staple biomarker in the evaluation of inflammation in physiology and disease, including the inflammatory phase of COVID-19. The sequestration of IL-18 by its soluble decoy receptor IL-18Binding Protein (IL-18BP) is critical to the regulation of IL-18 activity. Since an imbalance in expression and circulating levels of IL-18 is associated with disease, structural insights into how IL-18BP outcompetes binding of IL-18 by its cognate cell-surface receptors are highly desirable; however, the structure of human IL-18BP in complex with IL-18 has been elusive. Here, we elucidate the sequestration mechanism of human IL18 mediated by IL-18BP based on the crystal structure of the IL-18:IL-18BP complex. These detailed structural snapshots reveal the interaction landscape leading to the ultra-high affinity of IL-18BP toward IL-18 and identify substantial differences with respect to previously characterized complexes of IL-18 with IL-18BP of viral origin. Furthermore, our structure captured a fortuitous higher-order assembly between IL-18 and IL-18BP coordinated by a disulfide-bond distal to the binding surface connecting IL-18 and IL-18BP molecules from different complexes, resulting in a novel tetramer with 2:2 stoichiometry. This tetrapartite assembly was found to restrain IL-18 activity more effectively than the canonical 1:1 complex. Collectively, our findings provide a framework for innovative, structuredriven therapeutic strategies and further functional interrogation of IL-18 in physiology and disease.	[Detry, Sam; Andries, Julie; Bloch, Yehudi; Clancy, Danielle M.; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, Unit Struct Biol, Ghent, Belgium; [Detry, Sam; Andries, Julie; Bloch, Yehudi; Clancy, Danielle M.; Savvides, Savvas N.] VIB Ctr Inflammat Res, Unit Struct Biol, Ghent, Belgium; [Gabay, Cem] Geneva Univ Hosp, Dept Med, Div Rheumatol, CH-14 Geneva, Switzerland; [Gabay, Cem] Univ Geneva, Fac Med, CH-14 Geneva, Switzerland	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; University of Geneva	Savvides, SN (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Unit Struct Biol, Ghent, Belgium.; Savvides, SN (corresponding author), VIB Ctr Inflammat Res, Unit Struct Biol, Ghent, Belgium.	savvas.savvides@ugent.be	Savvides, Savvas/E-1938-2011	Savvides, Savvas/0000-0003-3420-5947; Bloch, Yehudi/0000-0001-7924-3539	Research Foundation Flanders (FWO) , Belgium	Research Foundation Flanders (FWO) , Belgium(FWO)	J. A., Y. B., and D. M. C. are research fellows of Research Foundation Flanders (FWO) , Belgium.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Au L, 2021, NAT MED, V27, P1362, DOI 10.1038/s41591-021-01387-6; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Calderara S, 2001, VIROLOGY, V279, P22, DOI 10.1006/viro.2000.0689; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Clark DN, 2013, CLIN IMMUNOL, V148, P335, DOI 10.1016/j.clim.2012.11.001; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Elegheert J, 2012, NAT STRUCT MOL BIOL, V19, P938, DOI 10.1038/nsmb.2367; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteban DJ, 2004, VIROLOGY, V323, P197, DOI 10.1016/j.virol.2004.02.027; Felix J, 2017, NAT REV IMMUNOL, V17, P112, DOI 10.1038/nri.2016.134; Felix J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13228; Felix J, 2015, STRUCTURE, V23, P1621, DOI 10.1016/j.str.2015.06.019; Flament H, 2021, NAT IMMUNOL, V22, P322, DOI 10.1038/s41590-021-00870-z; Fukushima K, 2005, J BIOL CHEM, V280, P18056, DOI 10.1074/jbc.M413297200; Gabay C, 2018, ANN RHEUM DIS, V77, P840, DOI 10.1136/annrheumdis-2017-212608; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Girard C, 2016, RHEUMATOLOGY, V55, P2237, DOI 10.1093/rheumatology/kew300; Gisby J, 2021, ELIFE, V10, DOI 10.7554/eLife.64827; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta A, 2021, BLOOD, V137, P1208, DOI 10.1182/blood.2020005944; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Harel M, 2020, J IMMUNOL, V205, P1167, DOI 10.4049/jimmunol.2000168; Huang W, 2021, J IMMUNOL, V206, P1597, DOI 10.4049/jimmunol.2001327; Jamilloux Y, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102567; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karki Rajendra, 2020, bioRxiv, DOI [10.1016/j.cell.2020.11.025, 10.1101/2020.10.29.361048]; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krumm B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002876; Krumm B, 2008, P NATL ACAD SCI USA, V105, P20711, DOI 10.1073/pnas.0809086106; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Ma ZF, 2016, CLIN CANCER RES, V22, P2969, DOI 10.1158/1078-0432.CCR-15-1655; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Monteleone G, 1999, J IMMUNOL, V163, P143; Muhl H, 2000, BIOCHEM BIOPH RES CO, V267, P960, DOI 10.1006/bbrc.1999.2064; NAKAMURA K, 1989, INFECT IMMUN, V57, P590, DOI 10.1128/IAI.57.2.590-595.1989; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Novick D, 2010, J AUTOIMMUN, V34, P121, DOI 10.1016/j.jaut.2009.08.002; OKAMURA H, 1982, INFECT IMMUN, V38, P440, DOI 10.1128/IAI.38.2.440-443.1982; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Rodriguez-Smith JJ, 2021, LANCET RHEUMATOL, V3, pE574, DOI 10.1016/S2665-9913(21)00139-9; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tak PP, 2006, EUR J DRUG METAB PH, V31, P109; Tanaka M, 2001, J RHEUMATOL, V28, P1779; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tone M, 1997, J IMMUNOL, V159, P6156; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Ushio S, 1996, J IMMUNOL, V156, P4274; Vecchie A, 2021, J CELL PHYSIOL, V236, P1638, DOI 10.1002/jcp.30008; Vonrhein C, 2018, ACTA CRYSTALLOGR A, V74, pA360, DOI 10.1107/S010876731809640X; WADA M, 1985, J INTERFERON RES, V5, P431, DOI 10.1089/jir.1985.5.431; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wong CK, 2000, RHEUMATOLOGY, V39, P1078, DOI 10.1093/rheumatology/39.10.1078; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Xiang Y, 2001, J BIOL CHEM, V276, P17380, DOI 10.1074/jbc.M009581200; Yamamura M, 2001, ARTHRITIS RHEUM, V44, P275, DOI 10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.3.CO;2-2; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhou T, 2020, NATURE, V583, P609, DOI 10.1038/s41586-020-2422-6	85	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101908	10.1016/j.jbc.2022.101908	http://dx.doi.org/10.1016/j.jbc.2022.101908			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35398099	Green Published, gold			2022-12-28	WOS:000817175700002
J	Grass, M; McDougal, AD; Blazeski, A; Kamm, RD; Garcia-Cardena, G; Dewey, CF				Grass, Matthias; McDougal, Anthony D.; Blazeski, Adriana; Kamm, Roger D.; Garcia-Cardena, Guillermo; Dewey, C. Forbes, Jr.			A computational model of cardiomyocyte metabolism predicts unique reperfusion protocols capable of reducing cell damage during ischemia/reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; OXYGEN SPECIES PRODUCTION; CYTOCHROME BC(1) COMPLEX; ISCHEMIA-REPERFUSION; MYOCARDIAL-ISCHEMIA; OXIDATIVE-PHOSPHORYLATION; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; INDUCED CARDIOPROTECTION; SUPEROXIDE GENERATION	If a coronary blood vessel is occluded and the neighboring cardiomyocytes deprived of oxygen, subsequent reperfusion of the ischemic tissue can lead to oxidative damage due to excessive generation of reactive oxygen species. Cardiomyocytes and their mitochondria are the main energy producers and consumers of the heart, and their metabolic changes during ischemia seem to be a key driver of reperfusion injury. Here, we hypothesized that tracking changes in cardiomyocyte metabolism, such as oxygen and ATP concentrations, would help in identifying points of metabolic failure during ischemia and reperfusion. To track some of these changes continuously from the onset of ischemia through reperfusion, we developed a system of differential equations representing the chemical reactions involved in the production and consumption of 67 molecular species. This model was validated and used to identify conditions present during periods of critical transition in ischemia and reperfusion that could lead to oxidative damage. These simulations identified a range of oxygen concentrations that lead to reverse mitochondrial electron transport at complex I of the respiratory chain and a spike in mitochondrial membrane potential, which are key suspects in the generation of reactive oxygen species at the onset of reperfusion. Our model predicts that a short initial reperfusion treatment with reduced oxygen content (5% of physiological levels) could reduce the cellular damage from both of these mechanisms. This model should serve as an open-source platform to test ideas for treatment of the ischemia reperfusion process by following the temporal evolution of molecular concentrations in the cardiomyocyte.	[Grass, Matthias] Swiss Fed Inst Technol, Dept Mech Engn, Zurich, Switzerland; [Grass, Matthias; Blazeski, Adriana; Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Grass, Matthias; Blazeski, Adriana; Garcia-Cardena, Guillermo] Harvard Med Sch, Program Human Biol & Translat Med, Boston, MA 02115 USA; [McDougal, Anthony D.; Blazeski, Adriana; Kamm, Roger D.; Dewey, C. Forbes, Jr.] MIT, Dept Mech Eng, Cambridge, MA 02139 USA; [Kamm, Roger D.; Dewey, C. Forbes, Jr.] MIT, Dept Biol Eng, Cambridge, MA 02139 USA; [Garcia-Cardena, Guillermo] Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garcia-Cardena, G (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Garcia-Cardena, G (corresponding author), Harvard Med Sch, Program Human Biol & Translat Med, Boston, MA 02115 USA.; Dewey, CF (corresponding author), MIT, Dept Mech Eng, Cambridge, MA 02139 USA.; Dewey, CF (corresponding author), MIT, Dept Biol Eng, Cambridge, MA 02139 USA.; Garcia-Cardena, G (corresponding author), Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA.	guillermo_garcia-cardena@hms.harvard.edu; cfdewey@mit.edu		McDougal, Anthony/0000-0002-9980-4193	Zeno Karl Schindler Foundation; National Institutes of Health [T32 HL007627]	Zeno Karl Schindler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by a grant from the Zeno Karl Schindler Foundation to M. G. and a Post-Doctoral Research Fellowship to A. B. from the National Institutes of Health (T32 HL007627). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Rahman U, 2009, J THORAC CARDIOV SUR, V137, P978, DOI 10.1016/j.jtcvs.2008.09.025; Abdel-Rahman Ulf, 2003, Med Sci Monit, V9, pCR389; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Angelova PR, 2016, FREE RADICAL BIO MED, V100, P81, DOI 10.1016/j.freeradbiomed.2016.06.005; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Atkinson C, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI DOI 10.1001/JAMA.2013.13805; Babiker FA, 2017, J PHYSIOL BIOCHEM, V73, P175, DOI 10.1007/s13105-016-0535-z; Bazil JN, 2016, BIOPHYS J, V110, P962, DOI 10.1016/j.bpj.2015.09.036; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Beretta M, 2020, EMBO J, V39, DOI 10.15252/embj.2019103530; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Borutaite V, 1995, BBA-MOL BASIS DIS, V1272, P154, DOI 10.1016/0925-4439(95)00080-1; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; CLARKE K, 1987, AM J PHYSIOL, V253, pH412, DOI 10.1152/ajpheart.1987.253.2.H412; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Cortassa S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00201; Del Re DP, 2019, PHYSIOL REV, V99, P1763, DOI 10.1152/physrev.00022.2018; del Rio CL, 2005, J APPL PHYSIOL, V99, P1576, DOI 10.1152/japplphysiol.00830.2004; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Douzinas EE, 2003, CRIT CARE MED, V31, P2183, DOI 10.1097/01.CCM.0000080488.30157.D8; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Endeward V, 2012, J APPL PHYSIOL, V112, P1466, DOI 10.1152/japplphysiol.00835.2011; Gateau-Roesch O, 2006, CARDIOVASC RES, V70, P264, DOI 10.1016/j.cardiores.2006.02.024; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063; Guillaud F, 2014, BBA-BIOENERGETICS, V1837, P1643, DOI 10.1016/j.bbabio.2014.05.358; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Henry Timothy D., 1993, American Journal of Physiology, V264, pH1478; Heusch G, 2010, BASIC RES CARDIOL, V105, P151, DOI 10.1007/s00395-009-0080-9; Hirschhauser C, 2015, ANTIOXID REDOX SIGN, V23, P1106, DOI 10.1089/ars.2014.6238; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; JENNINGS RB, 1969, AM J CARDIOL, V24, P753, DOI 10.1016/0002-9149(69)90464-0; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; Korge P, 2017, J BIOL CHEM, V292, P9882, DOI 10.1074/jbc.M116.768317; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korzeniewski B, 2001, BBA-BIOENERGETICS, V1504, P31, DOI 10.1016/S0005-2728(00)00237-1; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Luo X, 2015, ANESTHESIOLOGY, V123, P1122, DOI 10.1097/ALN.0000000000000859; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Malyala S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006719; McDougal AD, 2017, J BIOL CHEM, V292, P11760, DOI 10.1074/jbc.M116.751826; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Muntean DM, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8254942; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nowbar AN, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005375; Orlowski P, 2011, INTERFACE FOCUS, V1, P408, DOI 10.1098/rsfs.2010.0025; Padmaraj D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101793; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; SCHAPER J, 1988, Cardiovascular Drugs and Therapy, V2, P17, DOI 10.1007/BF00054248; SCHAPER J, 1979, J MOL CELL CARDIOL, V11, P521, DOI 10.1016/0022-2828(79)90428-0; SCHWARTZ GG, 1990, CIRC RES, V67, P490, DOI 10.1161/01.RES.67.2.490; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Starkov AA, 2013, MOL CELL NEUROSCI, V55, P13, DOI 10.1016/j.mcn.2012.07.005; Sun HY, 2005, AM J PHYSIOL-HEART C, V288, pH1900, DOI 10.1152/ajpheart.01244.2003; Suski J, 2018, METHODS MOL BIOL, V1782, P357, DOI 10.1007/978-1-4939-7831-1_22; Tasoulis MK, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0220-0; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; VANERP HE, 1988, EUR J CELL BIOL, V47, P388; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; Winslow RL, 2011, WIRES SYST BIOL MED, V3, P392, DOI 10.1002/wsbm.122; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497; Xu AJ, 2013, BIOCHEM BIOPH RES CO, V435, P627, DOI 10.1016/j.bbrc.2013.05.033; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Yaniv Y, 2010, ANN NY ACAD SCI, V1188, P133, DOI 10.1111/j.1749-6632.2009.05093.x; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	88	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101693	10.1016/j.jbc.2022.101693	http://dx.doi.org/10.1016/j.jbc.2022.101693			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35157851	Green Published, gold			2022-12-28	WOS:000860390500001
J	Jurkowitz, MS; Azad, A; Monsma, PC; Keiser, TL; Kanyo, J; Lam, TT; Bell, CE; Schlesinger, LS				Jurkowitz, Marianne S.; Azad, Abul K.; Monsma, Paula C.; Keiser, Tracy L.; Kanyo, Jean; Lam, TuKiet T.; Bell, Charles E.; Schlesinger, Larry S.			Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; PHOSPHOLIPASE A(2); LEGIONELLA-PNEUMOPHILA; L-FORMS; PLASMALOGEN; MACROPHAGES; BACTERIA; BIOSYNTHESIS; PURIFICATION; METABOLISM	The pathogen Mycobacterium tuberculosis (M.tb) resides in human macrophages, wherein it exploits host lipids for sur-vival. However, little is known about the interaction between M.tb and macrophage plasmalogens, a subclass of glycer-ophospholipids with a vinyl ether bond at the sn-1 position of the glycerol backbone. Lysoplasmalogens, produced from plasmalogens by hydrolysis at the sn-2 carbon by phospholi-pase A(2), are potentially toxic but can be broken down by host lysoplasmalogenase, an integral membrane protein of the YhhN family that hydrolyzes the vinyl ether bond to release a fatty aldehyde and glycerophospho-ethanolamine or glycerophospho-choline. Curiously, M.tb encodes its own YhhN protein (MtbYhhN), despite having no endogenous plasmalogens. To understand the purpose of this protein, the gene for MtbYhhN (Rv1401) was cloned and expressed in Mycobacterium smegmatis (M.smeg). We found the partially purified protein exhibited abundant lysoplasmalogenase activ-ity specific for lysoplasmenylethanolamine or lysoplasme- nylcholine (pLPC) (V-max similar to 15.5 mu mol/min/mg; km similar to 83 mu M). Based on cell density, we determined that lysoplasmenyletha-nolamine, pLPC, lysophosphatidylcholine, and lysophosphati-dylethanolamine were not toxic to M.smeg cells, but pLPC and LPC were highly toxic to M.smeg spheroplasts, which are cell wall-deficient mycobacterial forms. Importantly, spheroplasts prepared from M.smeg cells overexpressing MtbYhhN were protected from membrane disruption/lysis by pLPC, which was rapidly depleted from the media. Finally, we found that over-expression of full-length MtbYhhN in M.smeg increased its survival within human macrophages by 2.6-fold compared to vector controls. These data support the hypothesis that MtbYhhN protein confers a growth advantage for mycobacteria in macrophages by cleaving toxic host pLPC into potentially energy-producing products.	[Jurkowitz, Marianne S.; Bell, Charles E.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Azad, Abul K.; Schlesinger, Larry S.] Texas Biomed Res Inst, Host Pathogen Interact Program, San Antonio, TX 78227 USA; [Monsma, Paula C.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Keiser, Tracy L.] Vrije Univ, Dept Mol Microbiol, Amsterdam, Netherlands; [Kanyo, Jean; Lam, TuKiet T.] Yale Univ, Keck MS & Prote Resource, New Haven, CT USA; [Lam, TuKiet T.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Bell, Charles E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Texas Biomedical Research Institute; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam; Yale University; Yale University; University System of Ohio; Ohio State University	Jurkowitz, MS (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.; Schlesinger, LS (corresponding author), Texas Biomed Res Inst, Host Pathogen Interact Program, San Antonio, TX 78227 USA.	jurkowitz.1@osu.edu; lschlesinger@txbiomed.org			Ohio State University Development fund Grant [306500]; NIH [SIG RR031795];  [AI059639];  [P30NS104177];  [S10 OD010383]	Ohio State University Development fund Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; 	This work was supported in part by AI059639 (L. S. S.) and by the Ohio State University Development fund Grant 306500 (from Daniel S. and Amy E. F. Jurkowitz) (to M. S. J.) and grants P30NS104177 (Anthony Brown, PI) and S10 OD010383 (Anthony Brown, PI) that supported the confocal microscopy. The LTQ-Orbitrap Elite located at the Keck Mass Spectrometry (MS) & Proteomics Resource at Yale University School of Medicine was funded by NIH SIG RR031795. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astudillo AM, 2012, BBA-MOL CELL BIOL L, V1821, P249, DOI 10.1016/j.bbalip.2011.11.006; Barisch C, 2017, BIOCHIMIE, V141, P54, DOI 10.1016/j.biochi.2017.06.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cook Gregory M, 2014, Microbiol Spectr, V2, DOI 10.1128/microbiolspec.MGM2-0015-2013; CORR PB, 1984, CIRC RES, V55, P135, DOI 10.1161/01.RES.55.2.135; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Domingue GJ, 2010, DISCOV MED, V10, P234; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; Fozo EM, 2016, ADV MICROB PHYSIOL, V69, P51, DOI [10.4161/GMIC.25721, 10.1016/bs.ampbs.2016.07.001]; FREEMAN BA, 1980, BIOCHIM BIOPHYS ACTA, V620, P528, DOI 10.1016/0005-2760(80)90145-9; Gaposchkin DP, 2008, BBA-MOL CELL BIOL L, V1781, P213, DOI 10.1016/j.bbalip.2008.01.007; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Gil-de-Gomez L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01251; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; GOTTFRIED EL, 1963, J LIPID RES, V4, P57; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; GUNAWAN J, 1981, H-S Z PHYSIOL CHEM, V362, P445, DOI 10.1515/bchm2.1981.362.1.445; HARWICK HJ, 1972, INFECT IMMUN, V5, P976, DOI 10.1128/IAI.5.6.976-981.1972; HARWICK HJ, 1977, AUST J EXP BIOL MED, V55, P431, DOI 10.1038/icb.1977.41; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; Jurkowitz MS, 2015, BBA-BIOMEMBRANES, V1848, P742, DOI 10.1016/j.bbamem.2014.11.011; Jurkowitz MS, 1999, BBA-MOL CELL BIOL L, V1437, P142, DOI 10.1016/S1388-1981(99)00013-X; JURKOWITZALEXANDER M, 1989, BIOCHIM BIOPHYS ACTA, V1002, P203, DOI 10.1016/0005-2760(89)90288-9; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P79; KANETSUNA F, 1985, MICROBIOL IMMUNOL, V29, P127, DOI 10.1111/j.1348-0421.1985.tb00811.x; Keiser TL, 2011, INFECT IMMUN, V79, P4668, DOI 10.1128/IAI.05635-11; KONDO E, 1982, JPN J MED SCI BIOL, V35, P197, DOI 10.7883/yoken1952.35.197; KRAMER RM, 1983, J BIOL CHEM, V258, P3806; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YB, 2018, J BIOL CHEM, V293, P3386, DOI 10.1074/jbc.RA117.001231; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Maitra A, 2019, FEMS MICROBIOL REV, V43, P548, DOI 10.1093/femsre/fuz016; MARDH PA, 1974, ACTA PATH MICRO IM B, VB 82, P748; Markova N, 2015, HUM VACC IMMUNOTHER, V11, P1192, DOI 10.1080/21645515.2015.1016682; Mattman L., 2001, CELL WALL DEFICIENT; Michailova L, 2005, INT J TUBERC LUNG D, V9, P907; Onwuamaegbu M, 2005, J INT MED RES, V33, P1, DOI 10.1177/147323000503300101; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Rajararna MVS, 2014, SEMIN IMMUNOL, V26, P471, DOI 10.1016/j.smim.2014.09.010; RAPPORT MM, 1957, J BIOL CHEM, V225, P859; RASTOGI N, 1981, J GEN MICROBIOL, V124, P71; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rosu V, 2013, MICROBIOL RES, V168, P153, DOI 10.1016/j.micres.2012.10.002; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Rubio JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01723; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Slavchev G, 2016, INT J MYCOBACT, V5, P454, DOI 10.1016/j.ijmyco.2016.06.011; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; UDOU T, 1982, J BACTERIOL, V151, P1035, DOI 10.1128/JB.151.2.1035-1039.1982; UDOU T, 1983, CAN J MICROBIOL, V29, P60, DOI 10.1139/m83-010; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Wallner S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205706; WARNER HR, 1961, J BIOL CHEM, V236, P2404; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Wu LC, 2011, J BIOL CHEM, V286, P24916, DOI 10.1074/jbc.M111.247163; ZHANG Y, 1988, J BIOL CHEM, V263, P9965; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	78	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101849	10.1016/j.jbc.2022.101849	http://dx.doi.org/10.1016/j.jbc.2022.101849			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35314194	gold, Green Published			2022-12-28	WOS:000860390500005
J	Aihara, A; Iwawaki, T; Abe-Fukasawa, N; Otsuka, K; Saruhashi, K; Mikashima, T; Nishino, T; Dohlman, H				Aihara, Ayako; Iwawaki, Takumi; Abe-Fukasawa, Natsuki; Otsuka, Keiichiro; Saruhashi, Koichiro; Mikashima, Takumi; Nishino, Taito; Dohlman, Henrik			Small molecule LATS kinase inhibitors block the Hippo signaling pathway and promote cell growth under 3D culture conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SELF-ORGANIZATION; DRUG DISCOVERY; YAP; TAZ; DOWNSTREAM; DIFFERENTIATION; SUPPRESSES; MECHANISMS; POTENT	Although 3D cell culture models are considered to reflect the physiological microenvironment and exhibit high concordance with in vivo conditions, one disadvantage has been that cell proliferation is slower in 3D culture as compared to 2D culture. However, the signaling differences that lead to this slower proliferation are unclear. Here, we conducted a cell-based high-throughput screening study and identified novel small molecules that promote cell proliferation, particularly under 3D conditions. We found that one of these molecules, designated GA-017, increases the number and size of spheroids of various cell-types in both scaffold-based and scaffoldindependent cultures. In addition, GA-017 also enhances the ex vivo formation of mouse intestinal organoids. Importantly, we demonstrate that GA-017 inhibits the serine/threonine protein kinases large tumor suppressor kinase 1/2, which phosphorylate Yes-associated protein and transcriptional coactivator with PDZ-binding motif , key effectors of the growth- and proliferation-regulating Hippo signaling pathway. We showed that GA-017 facilitates the growth of spheroids and organoids by stabilizing and translocating Yes-associated protein and transcriptional coactivator with PDZ-binding motif into the cell nucleus. Another chemical analog of GA-017 obtained in this screening also exhibited similar activities and functions. We conclude that experiments with these small molecule large tumor suppressor kinase inhibitors will contribute to further development of efficient 3D culture systems for the ex vivo expansion of spheroids and organoids.	[Aihara, Ayako; Iwawaki, Takumi; Abe-Fukasawa, Natsuki; Nishino, Taito] Nissan Chem Corp, Biol Res Labs, Saitama, Japan; [Otsuka, Keiichiro; Saruhashi, Koichiro; Mikashima, Takumi] Nissan Chem Corp, Head Off, Tokyo, Japan	Nissan Chemical Corporation; Nissan Chemical Corporation	Nishino, T (corresponding author), Nissan Chem Corp, Biol Res Labs, Saitama, Japan.	nishino@nissanchem.co.jp		/0000-0001-7531-4061; Nishino, Taito/0000-0001-5298-4353	Nissan Chemical Corporation	Nissan Chemical Corporation	We thank H. Hoshino and H. Konari for technical assistance and Dr A. Iwama and Dr N. Itasaki for reading the article. This work was supported by Nissan Chemical Corporation.	Aihara A, 2016, CANCER SCI, V107, P1858, DOI 10.1111/cas.13095; Ardestani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12880-5; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Booij TH, 2019, SLAS DISCOV, V24, P615, DOI 10.1177/2472555219830087; Brassard JA, 2019, CELL STEM CELL, V24, P860, DOI 10.1016/j.stem.2019.05.005; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cheng XY, 2018, EXP THER MED, V15, P2812, DOI 10.3892/etm.2018.5761; Dasgupta I, 2019, J BIOL CHEM, V294, P17693, DOI 10.1074/jbc.REV119.007963; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Fang Y, 2017, SLAS DISCOV, V22, P456, DOI 10.1177/1087057117696795; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Gan WJ, 2020, NAT CELL BIOL, V22, P246, DOI 10.1038/s41556-020-0463-6; Gantner F, 1998, BRIT J PHARMACOL, V123, P1031, DOI 10.1038/sj.bjp.0701688; Grimshaw KM, 2010, MOL CANCER THER, V9, P1100, DOI 10.1158/1535-7163.MCT-09-0986; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kapalczynska M, 2018, ARCH MED SCI, V14, P910, DOI 10.5114/aoms.2016.63743; Kondo J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050470; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Leroux AE, 2018, SEMIN CANCER BIOL, V48, P1, DOI 10.1016/j.semcancer.2017.05.011; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lopes A. P., 2019, MICRORNA 130A; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Mana-Capelli S, 2018, J BIOL CHEM, V293, P18230, DOI 10.1074/jbc.RA118.004187; McKee C, 2017, COLLOID SURFACE B, V159, P62, DOI 10.1016/j.colsurfb.2017.07.051; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Naito K, 2019, BIOL PHARM BULL, V42, P631, DOI 10.1248/bpb.b18-00831; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pan WW, 2019, ONCOGENE, V38, P2595, DOI 10.1038/s41388-018-0610-8; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Pawitan J. A., 2018, J BIOS MED, V6, P128; Prior N, 2019, GUT, V68, P2228, DOI 10.1136/gutjnl-2019-319256; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; Samal RP, 2013, CHEM BIOL DRUG DES, V81, P715, DOI 10.1111/cbdd.12118; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Sherk A. B., 2008, CANCER RES; Sum TH, 2015, TETRAHEDRON, V71, P4557, DOI 10.1016/j.tet.2015.02.017; Tanaka H., 2020, YAP DEPENDENT NECROS; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Xin M., 2013, P NATL ACAD SCI; Xu HX, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0122-9; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Zhang Y, 2015, MOL CANCER THER, V14, P799, DOI 10.1158/1535-7163.MCT-14-0648	61	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101779	10.1016/j.jbc.2022.101779	http://dx.doi.org/10.1016/j.jbc.2022.101779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35231442	Green Published, gold			2022-12-28	WOS:000793692600001
J	Battle, S; Gogonea, V; Willard, B; Wang, ZN; Fu, XM; Huang, Y; Graham, LM; Cameron, SJ; DiDonato, JA; Crabb, JW; Hazen, SL				Battle, Shawna; Gogonea, Valentin; Willard, Belinda; Wang, Zeneng; Fu, Xiaoming; Huang, Ying; Graham, Linda M.; Cameron, Scott J.; DiDonato, Joseph A.; Crabb, John W.; Hazen, Stanley L.			The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; MYELOPEROXIDASE-CATALYZED OXIDATION; REVERSE CHOLESTEROL TRANSPORT; PROTEIN CARBAMYLATION; POSTTRANSLATIONAL MODIFICATIONS; EOSINOPHIL PEROXIDASE; NITRIC-OXIDE; HDL; SITE; NITRATION	Protein lysine carbamylation is an irreversible post translational modification resulting in generation of homocitrulline (N-epsilon-carbamyllysine), which no longer possesses a charged epsilon-amino moiety. Two distinct pathways can promote protein carbamylation. One results from urea decomposition, forming an equilibrium mixture of cyanate (CNO-) and the reactive electrophile isocyanate. The second pathway involves myeloperoxidase (MPO)-catalyzed oxidation of thiocyanate (SCN-), yielding CNO- and isocyanate. Apolipoprotein A-I (apoA-I), the major protein constituent of high-density lipoprotein (HDL), is a known target for MPO-catalyzed modifi- cation in vivo, converting the cardioprotective lipoprotein into a proatherogenic and proapoptotic one. We hypothesized that monitoring site-specific carbamylation patterns of apoA-I recovered from human atherosclerotic aorta could provide insights into the chemical environment within the artery wall. To test this, we first mapped carbamyllysine obtained from in vitro carbamylation of apoA-I by both the urea-driven (nonenzymatic) and inflammatory-driven (enzymatic) pathways in lipid-poor and lipidated apoA-I (reconstituted HDL). Our results suggest that lysine residues within proximity of the known MPO-binding sites on HDL are preferentially targeted by the enzymatic (MPO) carbamylation pathway, whereas the nonenzymatic pathway leads to nearly uniform distribution of carbamylated lysine residues along the apoA-I polypeptide chain. Quantitative proteomic analyses of apoA-I from human aortic atheroma identified 16 of the 21 lysine residues as carbamylated and suggested that the majority of apoA-I carbamylation in vivo occurs on "lipid-poor " apoA-I forms via the nonenzymatic CNO- pathway. Monitoring patterns of apoA-I carbamylation recovered from arterial tissues can provide insights into both apoA-I structure and the chemical environment within human atheroma.	[Battle, Shawna; Gogonea, Valentin; Wang, Zeneng; Fu, Xiaoming; Huang, Ying; Cameron, Scott J.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Battle, Shawna; Wang, Zeneng; Graham, Linda M.; Cameron, Scott J.; DiDonato, Joseph A.; Crabb, John W.; Hazen, Stanley L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Gogonea, Valentin; Hazen, Stanley L.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Willard, Belinda] Cleveland Clin, Prote Shared Lab Resource, Cleveland, OH 44106 USA; [Graham, Linda M.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Graham, Linda M.; Cameron, Scott J.; Hazen, Stanley L.] Cleveland Clin, Heart Vasc & Thorac Inst, Cleveland, OH 44106 USA; [Cameron, Scott J.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Crabb, John W.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.; Hazen, SL (corresponding author), Cleveland Clin, Heart Vasc & Thorac Inst, Cleveland, OH 44106 USA.	hazens@ccf.org		Wang, Zeneng/0000-0002-6455-8228	Howard Hughes Medical Institute Gilliam Fellowship	Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute)	S. B. was supported by a Howard Hughes Medical Institute Gilliam Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Agner K., 1972, STRUCTURE FUNCTION O, P329; Al Shweiki MHDR, 2017, J PROTEOME RES, V16, P1410, DOI 10.1021/acs.jproteome.6b00645; Berlyne GM, 1998, NEPHRON, V79, P125, DOI 10.1159/000045013; Brennan M. L., 2001, J CLIN INVEST; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cameron SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144372; Chantepie S, 2009, ARCH BIOCHEM BIOPHYS, V487, P28, DOI 10.1016/j.abb.2009.05.005; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chen ZL, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02623-2; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DiDonato J. A., 2013, CIRCULATION; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; ERILL S, 1980, CLIN PHARMACOL THER, V27, P612, DOI 10.1038/clpt.1980.87; Fazio S, 2016, CIRC RES, V119, P704, DOI 10.1161/CIRCRESAHA.116.309506; Gogonea V, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00318; GONEN B, 1985, METABOLISM, V34, P10, DOI 10.1016/0026-0495(85)90052-6; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Gu XD, 2016, J BIOL CHEM, V291, P6386, DOI 10.1074/jbc.M115.696088; Hadfield K. A., 2013, MYELOPEROXIDASE DERI; Hazen SL, 1999, CIRC RES, V85, P950; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 2000, BIOCHEM J, V352, P693, DOI 10.1042/0264-6021:3520693; Hogrebe A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03309-6; Holzer M, 2012, ANTIOXID REDOX SIGN, V17, P1043, DOI 10.1089/ars.2011.4403; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; HORKKO S, 1992, KIDNEY INT, V41, P1175, DOI 10.1038/ki.1992.179; Huang Y., 2014, ABUNDANT DYSFUNCTION; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Inker L. A., 2012, N ENGL; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kosmas Constantine E, 2018, Drugs Context, V7, P212525, DOI 10.7573/dic.212525; Kothapalli D, 2004, J CLIN INVEST, V113, P609, DOI 10.1172/JCI200419097; Lee AJ, 1997, EUR HEART J, V18, P671; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Lin H, 2017, FREE RADICAL BIO MED, V104, P20, DOI 10.1016/j.freeradbiomed.2017.01.006; Liu D, 2018, J MOL CELL CARDIOL, V122, P47, DOI 10.1016/j.yjmcc.2018.08.001; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nemet I, 2020, CELL, V180, P862, DOI 10.1016/j.cell.2020.02.016; OLEA F, 1992, J ANAL TOXICOL, V16, P258, DOI 10.1093/jat/16.4.258; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; PENNEY CL, 1976, ANAL BIOCHEM, V75, P201, DOI 10.1016/0003-2697(76)90071-3; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Pollard RD, 2013, BIOCHEMISTRY-US, V52, P9470, DOI 10.1021/bi401080k; Rached FH, 2015, BIOFACTORS, V41, P67, DOI 10.1002/biof.1202; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Riwanto M, 2015, HANDB EXP PHARMACOL, V224, P337, DOI 10.1007/978-3-319-09665-0_10; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Siasos G., 2014, CURR; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; STARK GR, 1965, BIOCHEMISTRY-US, V4, P588, DOI 10.1021/bi00879a032; Sun JT, 2016, AM J PHYSIOL-RENAL, V310, pF511, DOI 10.1152/ajprenal.00508.2015; Tang WHW, 2011, CLIN CHEM, V57, P33, DOI 10.1373/clinchem.2010.152827; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tikhonov D, 2020, MOLECULES, V25, DOI 10.3390/molecules25143144; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; WEVER R, 1981, FEBS LETT, V123, P327, DOI 10.1016/0014-5793(81)80320-1; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; Zamanian-Daryoush M, 2020, J BIOL CHEM, V295, P4836, DOI 10.1074/jbc.RA119.012092; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	78	2	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101832	10.1016/j.jbc.2022.101832	http://dx.doi.org/10.1016/j.jbc.2022.101832			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35304099	gold, Green Published			2022-12-28	WOS:000793560400005
J	Konstantinidi, A; Nason, R; Caval, T; Sun, LB; Sorensen, DM; Furukawa, S; Ye, ZL; Vincentelli, R; Narimatsu, Y; Vakhrushev, SY; Clausen, H				Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Vincentelli, Renaud; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik			Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; TANDEM REPEAT; SUBMAXILLARY MUCIN; MOLECULAR-CLONING; GALNAC; GLYCOPEPTIDE; PEPTIDE; GLYCAN; GLYCOPROTEOME; PORCINE	Mucins and glycoproteins with mucin-like regions contain densely O-glycosylated domains often found in tandem repeat (TR) sequences. These O-glycodomains have traditionally been difficult to characterize because of their resistance to proteolytic digestion, and knowledge of the precise positions of Oglycans is particularly limited for these regions. Here, we took advantage of a recently developed glycoengineered cell-based platform for the display and production of mucin TR reporters with custom-designed O-glycosylation to characterize O-glycodomains derived from mucins and mucin-like glycoproteins. We combined intact mass and bottom-up site specific analysis for mapping O-glycosites in the mucins, MUC2, MUC20, MUC21, protein P-selectin-glycoprotein ligand 1, and proteoglycan syndecan-3. We found that all the potential Ser/Thr positions in these O-glycodomains were O-glycosylated when expressed in human embryonic kidney 293 SimpleCells (Tn-glycoform). Interestingly, we found that all potential Ser/Thr O-glycosites in TRs derived from secreted mucins and most glycosites from transmembrane mucins were almost fully occupied, whereas TRs from a subset of trans membrane mucins were less efficiently processed. We further used the mucin TR reporters to characterize cleavage sites of glycoproteases StcE (secreted protease of C1 esterase inhibitor from EHEC) and BT4244, revealing more restricted substrate specificities than previously reported. Finally, we conducted a bottom-up analysis of isolated ovine submaxillary mucin, which supported our findings that mucin TRs in general are efficiently O-glycosylated at all potential glycosites. This study provides insight into O-glycosylation of mucins and mucin-like domains, and the strategies developed open the field for wider analysis of native mucins.	[Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark; [Konstantinidi, Andriana; Nason, Rebecca; Caval, Tomislav; Sun, Lingbo; Sorensen, Daniel M.; Furukawa, Sanae; Ye, Zilu; Narimatsu, Yoshiki; Vakhrushev, Sergey Y.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark; [Vincentelli, Renaud] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Narimatsu, Yoshiki] GlycoDisplay ApS, Copenhagen, Denmark; [Sun, Lingbo] Yanan Univ, Med Coll, Yanan 716000, Shaanxi, Peoples R China; [Ye, Zilu] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3B, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Yanan University; University of Copenhagen	Vakhrushev, SY; Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark.; Vakhrushev, SY; Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark.	seva@sund.ku.dk; hclau@sund.ku.dk	Narimatsu, Yoshiki/G-8388-2019	Narimatsu, Yoshiki/0000-0003-1428-5695; Sorensen, Daniel Madriz/0000-0001-8811-2506; Ye, Zilu/0000-0001-8829-6579	Neye Foundation; Lundbeck Foundation; Novo Nordisk Foundation; European Commission [H2020-MSCA-ITN-721297, H2020-MSCA-ITN-722171]; Mizutani Foundation; Danish National Research Foundation [DNRF107]	Neye Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); Mizutani Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Neye Foundation, Lundbeck Foundation, the Novo Nordisk Foundation, the European Commission (GlycoImaging H2020-MSCA-ITN-721297, BioCapture H2020-MSCA-ITN-722171), the Mizutani Foundation (to Y. N.), and the Danish National Research Foundation (grant no.: DNRF107).	Ali L, 2014, MOL CELL PROTEOMICS, V13, P3396, DOI 10.1074/mcp.M114.040865; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Bagdonaite I, 2020, EMBO REP, V21, DOI 10.15252/embr.201948885; Bennett E. P., 1998, CLONING HUMAN UDP N; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BHARGAVA AS, 1966, BIOCHIM BIOPHYS ACTA, V127, P223, DOI 10.1016/0304-4165(66)90492-2; Bll C., 2021, P NATL ACAD SCI USA, V118, P1; Bull Christian, 2020, STAR Protoc, V1, P100017, DOI 10.1016/j.xpro.2020.100017; Caval T, 2021, J AM SOC MASS SPECTR, V32, P2099, DOI 10.1021/jasms.1c00060; Caval T, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.R120.002093; Caval T, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608466; Caval T, 2021, CURR OPIN STRUC BIOL, V68, P135, DOI 10.1016/j.sbi.2020.12.010; Caval T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05536-3; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Daniel EJP, 2020, GLYCOBIOLOGY, V30, P910, DOI 10.1093/glycob/cwaa036; Darula Z, 2018, MOL CELL PROTEOMICS, V17, P2, DOI 10.1074/mcp.MR117.000126; De Las Rivas M., 2018, STRUCTURAL MECHANIST; de las Rivas M, 2020, NAT CHEM BIOL, V16, P351, DOI 10.1038/s41589-019-0444-x; de las Rivas M, 2019, CURR OPIN STRUC BIOL, V56, P87, DOI 10.1016/j.sbi.2018.12.007; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; Gerken T. A., 2002, J BIOL CHEM 277; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hanisch FG, 1998, J MASS SPECTROM, V33, P358, DOI 10.1002/(SICI)1096-9888(199804)33:4<358::AID-JMS642>3.0.CO;2-3; Hansson GC, 2019, J INTERN MED, V285, P479, DOI 10.1111/joim.12910; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HILL HD, 1977, J BIOL CHEM, V252, P3799; HILL HD, 1977, J BIOL CHEM, V252, P3791; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; HOUNSELL EF, 1985, EUR J BIOCHEM, V148, P367, DOI 10.1111/j.1432-1033.1985.tb08848.x; Irimura T, 1999, J BIOCHEM, V126, P975, DOI 10.1093/oxfordjournals.jbchem.a022565; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P131, DOI 10.1093/glycob/cwx104; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Khoo KH, 2019, CURR OPIN STRUC BIOL, V56, P146, DOI 10.1016/j.sbi.2019.02.007; KJELDSEN T, 1988, CANCER RES, V48, P2214; Kong Y., 2015, PROBING POLYPEPTIDE; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Lin YH, 2019, MOL CELL PROTEOMICS, V18, P1479, DOI 10.1074/mcp.RA119.001411; Malaker S. A., 2019, PROC NATL ACAD; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos-Silva L, 2014, J PROTEOME RES, V13, P3349, DOI 10.1021/pr500215g; Mohl JE, 2021, GLYCOBIOLOGY, V31, P168, DOI 10.1093/glycob/cwaa067; Narimatsu Y., 2019, MOL; Narimatsu Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100448; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Nason R., NAT COMMUN, V12, P1; Noach I., 2017, P NATL ACAD SCI USA; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; OBoyle K. P, 2006, CANC IMMUN, V6, P1; OBoyle K. P., 1992, IMMUNIZATION COLOREC; Olson FJ, 2005, GLYCOBIOLOGY, V15, P177, DOI 10.1093/glycob/cwh158; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Riley N.M, BIORXIV, DOI [10.1101/2021.01.27.428510, DOI 10.1101/2021.01.27.428510]; Riley NM, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.R120.002277; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shon DJ, 2021, BIOCHEM J, V478, P1585, DOI 10.1042/BCJ20200607; Shon DJ, 2020, P NATL ACAD SCI USA, V117, P21299, DOI 10.1073/pnas.2012196117; SPRINGER GF, 1985, MOL IMMUNOL, V22, P1303, DOI 10.1016/0161-5890(85)90050-1; Steentoft C, 2019, GLYCOBIOLOGY, V29, P307, DOI 10.1093/glycob/cwz004; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18696-y; Vakhrushev SY, 2009, ANAL CHEM, V81, P3252, DOI 10.1021/ac802408f; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wohlschlager T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04061-7; Wu D, 2019, CHEM SCI, V10, P5146, DOI 10.1039/c9sc00360f; Wu D, 2018, P NATL ACAD SCI USA, V115, P8763, DOI 10.1073/pnas.1807439115; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12613; Ye ZL, 2019, NAT METHODS, V16, P902, DOI 10.1038/s41592-019-0504-x; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	94	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101784	10.1016/j.jbc.2022.101784	http://dx.doi.org/10.1016/j.jbc.2022.101784			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35247390	gold, Green Published			2022-12-28	WOS:000793694800007
J	Lu, JC; Chu, RL; Yin, Y; Yu, HJ; Xu, QW; Yang, B; Sun, YF; Song, J; Wang, QB; Xu, JH; Lu, F; Cheng, Y				Lu, Jiachen; Chu, Ruilin; Yin, Yi; Yu, Huijie; Xu, Qinwen; Yang, Bo; Sun, Yifan; Song, Jing; Wang, Qiubo; Xu, Jiahui; Lu, Feng; Cheng, Yang			Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) interacts with the band 3 receptor to promote erythrocyte invasion by malaria parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM INVASION; BINDING ANTIGEN; ANION-EXCHANGER; HOST RECEPTOR; ANKYRIN; MEMBRANE; DOMAIN; VIVAX; PROTEIN; ANTIBODIES	Glycosylphosphatidylinositol-anchored micronemal antigen (GAMA) is an erythrocyte binding protein known to be involved in malarial parasite invasion. Although anti-GAMA antibodies have been shown to block GAMA attachment to the erythrocyte surface and subsequently inhibit parasite invasion, little is known about the molecular mechanisms by which GAMA promotes the invasion process. In this study, LC-MS analysis was performed on the erythrocyte membrane to identify the specific receptor that interacts with GAMA. We found that ankyrin 1 and the band 3 membrane protein showed affinity for GAMA, and characterization of their binding specificity indicated that both Plasmodium falciparum and Plasmodium vivax GAMA bound to the same extracellular loop of band 3 (loop 5). In addition, we show the interaction between GAMA and band 3 was sensitive to chymotrypsin. Furthermore, antibodies against band 3 loop 5 were able to reduce the binding activity of GAMA to erythrocytes and inhibit the invasion of P. falciparum merozoites into human erythrocytes, whereas antibodies against P. falciparum GAMA (PfGAMA)-Tr3 only slightly reduced P. falciparum invasion. The identification and characterization of the erythrocyte GAMA receptor is a novel finding that identifies an essential mechanism of parasite invasion of host erythrocytes.	[Lu, Jiachen; Chu, Ruilin; Yu, Huijie; Xu, Qinwen; Yang, Bo; Sun, Yifan; Cheng, Yang] Jiangnan Univ, Wuxi Sch Med, Dept Publ Hlth & Prevent Med, Lab Pathogen Infect & Immun, Wuxi, Jiangsu, Peoples R China; [Chu, Ruilin] Shanghai Municipal Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Shanghai, Peoples R China; [Yin, Yi; Xu, Jiahui; Lu, Feng] Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China; [Song, Jing] Jiangnan Univ, Dept Gynecol, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China; [Wang, Qiubo] Soochow Univ, Dept Clin Lab, Wuxi Affiliated Hosp 9, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Shanghai Center for Disease Control & Prevention; Yangzhou University; Jiangnan University; Soochow University - China	Cheng, Y (corresponding author), Jiangnan Univ, Wuxi Sch Med, Dept Publ Hlth & Prevent Med, Lab Pathogen Infect & Immun, Wuxi, Jiangsu, Peoples R China.	woerseng@126.com	xu, jia/GSD-6347-2022		National Natural Science Foundation of China [81871681, 81601787]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all study participants for their participation and support. This work was supported by the National Natural Science Foundation of China [81871681, 81601787].	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alam MS, 2015, J BIOL CHEM, V290, P20257, DOI 10.1074/jbc.M115.644906; Almukadi H, 2019, BLOOD, V133, P470, DOI 10.1182/blood-2018-07-865451; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Arumugam T. U., 2011, DISCOVERY GAMA; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Asimakopoulou A., 2013, BR; Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; BENNETT V, 1992, J BIOL CHEM, V267, P8703; Burns AL, 2019, FEMS MICROBIOL REV, V43, P223, DOI 10.1093/femsre/fuz005; Changrob S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1967-9; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35581; CLOUGH B, 1995, MOL BIOCHEM PARASIT, V69, P19, DOI 10.1016/0166-6851(94)00185-P; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; Haldar Kasturi, 2007, Annu Rev Pathol, V2, P217; Hinds L, 2009, EUKARYOT CELL, V8, P1869, DOI 10.1128/EC.00218-09; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Lamarque M., 2011, RON2; Laurens MB, 2018, ANNU REV MICROBIOL, V72, P273, DOI 10.1146/annurev-micro-090817-062427; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; Longley R. J., 2017, ASYMPTOMATIC; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Huynh MH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-16; Nagaoka H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02669; Ndegwa DN, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008864; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Perez-Mazliah D, 2020, IMMUNOL REV, V293, P57, DOI 10.1111/imr.12822; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Shakya B, 2017, MOL BIOCHEM PARASIT, V216, P5, DOI 10.1016/j.molbiopara.2017.06.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Skwarczynski M, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030373; Srinivasan P., 2011, PROC NATL ACAD; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Uwase J, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03207-7; Volz JC, 2016, CELL HOST MICROBE, V20, P60, DOI 10.1016/j.chom.2016.06.004; Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zenonos ZA, 2015, J EXP MED, V212, P1145, DOI 10.1084/jem.20150032; Zhang DC, 2000, BLOOD, V96, P2925	64	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101765	10.1016/j.jbc.2022.101765	http://dx.doi.org/10.1016/j.jbc.2022.101765			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35202655	gold, Green Published			2022-12-28	WOS:000793560400013
J	Sestok, AE; Brown, JB; Obi, JO; O'Sullivan, SM; Garcin, ED; Deredge, DJ; Smith, AT				Sestok, Alex E.; Brown, Janae B.; Obi, Juliet O.; O'Sullivan, Sean M.; Garcin, Elsa D.; Deredge, Daniel J.; Smith, Aaron T.			A fusion of the Bacteroides fragilis ferrous iron import proteins reveals a role for FeoA in stabilizing GTP-bound FeoB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER FEOB; HIGH-RESOLUTION; UPTAKE SYSTEM; HEME UPTAKE; G-DOMAIN; X-RAY; ACQUISITION; PURIFICATION; EXPRESSION; BACTERIA	Iron is an essential element for nearly all organisms, and under anoxic and/or reducing conditions, Fe2+ is the dominant form of iron available to bacteria. The ferrous iron transport (Feo) system is the primary prokaryotic Fe2+ import machinery, and two constituent proteins (FeoA and FeoB) are conserved across most bacterial species. However, how FeoA and FeoB function relative to one another remains enigmatic. In this work, we explored the distribution of feoAB operons encoding a fusion of FeoA tethered to the N-terminal, G-protein domain of FeoB via a connecting linker region. We hypothesized that this fusion poises FeoA to interact with FeoB to affect function. To test this hypothesis, we characterized the soluble NFeoAB fusion protein from Bacteroides fragilis, a commensal organism implicated in drug-resistant infections. Using X-ray crystallography, we determined the 1.50-angstrom resolution structure of BfFeoA, which adopts an SH3-like fold implicated in protein- protein interactions. Using a combination of structural modeling, small-angle X-ray scattering, and hydrogen- deuterium exchange mass spectrometry, we show that FeoA and NFeoB interact in a nucleotide-dependent manner, and we mapped the protein-protein interaction interface. Finally, using guanosine triphosphate (GTP) hydrolysis assays, we demonstrate that BfNFeoAB exhibits one of the slowest known rates of Feo-mediated GTP hydrolysis that is not potassium stimulated. Importantly, truncation of FeoA from this fusion demonstrates that FeoA-NFeoB interactions function to stabilize the GTP-bound form of FeoB. Taken together, our work reveals a role for FeoA function in the fused FeoAB system and suggests a function for FeoA among prokaryotes.	[Sestok, Alex E.; Brown, Janae B.; O'Sullivan, Sean M.; Garcin, Elsa D.; Smith, Aaron T.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Obi, Juliet O.; Deredge, Daniel J.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Garcin, Elsa D.] Aix Marseille Univ, UMR7256, Lab Informat Genom & Struct, Campus Luminy, Marseille, France	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Smith, AT (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	smitha@umbc.edu		Obi, Juliet/0000-0002-6851-0096; Smith, Aaron/0000-0002-9332-8683; Garcin, Elsa/0000-0003-0501-8421	NIH-NIDCR [R21 DE027803]; NIH-NIGMS [T32 GM066706, R35 GM133497]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; DOE Office of Science [DE-AC02CH11357, DE-AC03CH11357, DE-AC04CH11357, DE-AC05CH11357, DE-AC06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; DOE Office of Biological and Environmental Research; National Institute of Health [P30 GM124169, S10OD018483]	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by NIH-NIDCR grant R21 DE027803, NIH-NIGMS grant R35 GM133497, in part by NIH-NIGMS grant T32 GM066706 (A. E. S. and J. O. O), and by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02 to 06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). SAXS experiments were conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by the DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project ALS-ENABLE (P30 GM124169) and a High-End Instrumentation Grant S10OD018483. Sequence searches utilized both database and analysis functions of the Universal Protein Resource (UniProt) Knowledgebase and Reference Clusters (http://www.uniprot.org) and the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).NMR experiments were carried out at the University of Maryland Baltimore County Molecular Characterization and Analysis Complex.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aranda J, 2009, INT MICROBIOL, V12, P137, DOI 10.2436/20.1501.01.91; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Brzoska K, 2006, ACTA BIOCHIM POL, V53, P685; Cain TJ, 2021, J INORG BIOCHEM, V218, DOI 10.1016/j.jinorgbio.2021.111407; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Deshpande CN, 2013, ACTA CRYSTALLOGR F, V69, P399, DOI 10.1107/S1744309113005939; Ellermann M, 2017, FREE RADICAL BIO MED, V105, P68, DOI 10.1016/j.freeradbiomed.2016.10.489; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Forster S, 2005, J PHYS CHEM B, V109, P1347, DOI 10.1021/jp0467494; Hagelueken G, 2016, BIOPHYS J, V110, P2642, DOI 10.1016/j.bpj.2016.05.018; Hagelueken G, 2015, PROTEIN EXPRES PURIF, V114, P30, DOI 10.1016/j.pep.2015.05.014; HANTKE K, 1987, FEMS MICROBIOL LETT, V44, P53, DOI 10.1111/j.1574-6968.1987.tb02241.x; Hantke K, 2003, TRENDS MICROBIOL, V11, P192, DOI 10.1016/S0966-842X(03)00100-8; Hu YL, 2015, J BIOL INORG CHEM, V20, P435, DOI 10.1007/s00775-014-1225-3; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hung KW, 2012, J BACTERIOL, V194, P6518, DOI 10.1128/JB.01228-12; Hung KW, 2010, J STRUCT BIOL, V170, P501, DOI 10.1016/j.jsb.2010.01.017; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; Koster S, 2009, ACTA CRYSTALLOGR F, V65, P684, DOI 10.1107/S1744309109019216; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lau CKY, 2013, J BACTERIOL, V195, P46, DOI 10.1128/JB.01121-12; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Linkous RO, 2019, PROTEINS, V87, P897, DOI 10.1002/prot.25755; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Norris M, 2016, J BIOMOL NMR, V65, P205, DOI 10.1007/s10858-016-0049-6; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Richard KL, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00081; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Rocha ER, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.669; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Sestok AE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00097b; Seyedmohammad S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160046; Seyedmohammad S, 2014, PROTEIN EXPRES PURIF, V101, P138, DOI 10.1016/j.pep.2014.06.012; Shin M, 2020, ARCH BIOCHEM BIOPHYS, V685, DOI 10.1016/j.abb.2020.108350; Shin M, 2019, P NATL ACAD SCI USA, V116, P4599, DOI 10.1073/pnas.1817964116; Smith AT, 2018, PROTEIN EXPRES PURIF, V142, P1, DOI 10.1016/j.pep.2017.09.007; Smith SM, 2011, METHOD ENZYMOL, P195, DOI 10.1016/B978-0-12-386905-0.00013-9; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stevenson B, 2016, J BACTERIOL, V198, P1160, DOI 10.1128/JB.00930-15; Su YC, 2010, ACTA CRYSTALLOGR F, V66, P636, DOI 10.1107/S1744309110013941; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Veeranagouda Y, 2014, J ANTIMICROB CHEMOTH, V69, P2634, DOI 10.1093/jac/dku219; Veloria J, 2019, SLAS DISCOV, V24, P597, DOI 10.1177/2472555219844572; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weaver EA, 2013, J BACTERIOL, V195, P4826, DOI 10.1128/JB.00738-13; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200	73	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101808	10.1016/j.jbc.2022.101808	http://dx.doi.org/10.1016/j.jbc.2022.101808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35271852	gold, Green Published			2022-12-28	WOS:000793502000016
J	Arakawa, M; Tabata, K; Ishida, K; Kobayashi, M; Arai, A; Ishikawa, T; Suzuki, R; Takeuchi, H; Tripathi, LP; Mizuguchi, K; Morita, E				Arakawa, Masashi; Tabata, Keisuke; Ishida, Kotaro; Kobayashi, Makiko; Arai, Arisa; Ishikawa, Tomohiro; Suzuki, Ryosuke; Takeuchi, Hiroaki; Tripathi, Lokesh P.; Mizuguchi, Kenji; Morita, Eiji			Flavivirus recruits the valosin-containing protein-NPL4 complex to induce stress granule disassembly for efficient viral genome replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENGUE VIRUS; PKR ACTIVATION; AAA-ATPASE; VCP/P97; KINASE; TRANSLATION; AUTOPHAGY; IMPAIRS; NS4B; P97	Flaviviruses are human pathogens that can cause severe diseases, such as dengue fever and Japanese encephalitis, which can lead to death. Valosin-containing protein (VCP)/p97, a cellular ATPase associated with diverse cellular activities (AAA-ATPase), is reported to have multiple roles in flavivirus replication. Nevertheless, the importance of each role still has not been addressed. In this study, the functions of 17 VCP mutants that are reportedly unable to interact with the VCP cofactors were validated using the short-interfering RNA rescue experiments. Our findings of this study suggested that VCP exerts its functions in replication of the Japanese encephalitis virus by interacting with the VCP cofactor nuclear protein localization 4 (NPL4). We show that the depletion of NPL4 impaired the early stage of viral genome replication. In addition, we demonstrate that the direct interaction between NPL4 and viral nonstructural protein (NS4B) is critical for the translocation of NS4B to the sites of viral replication. Finally, we found that Japanese encephalitis virus and dengue virus promoted stress granule formation only in VCP inhibitor treated cells and the expression of NS4B or VCP attenuated stress granule formation mediated by protein kinase R, which is generally known to be activated by type I interferon and viral genome RNA. These results suggest that the NS4B-mediated recruitment of VCP to the virus replication site inhibits cellular stress responses and consequently facilitates viral protein synthesis in the flavivirus-infected cells.	[Arakawa, Masashi; Ishida, Kotaro; Arai, Arisa; Morita, Eiji] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Arakawa, Masashi; Ishida, Kotaro; Morita, Eiji] Iwate Univ, United Grad Sch Agr Sci, Div Biomol Funct, Bioresources Sci, Morioka, Iwate, Japan; [Tabata, Keisuke] Osaka Univ, Lab Intracellular Membrane Dynam, Grad Sch Frontier Biosci, Osaka, Japan; [Tabata, Keisuke] Osaka Univ, Dept Genet, Grad Sch Med, Osaka, Japan; [Tabata, Keisuke; Kobayashi, Makiko; Morita, Eiji] Osaka Univ, Res Inst Microbial Dis, Lab Viral Infect, Osaka, Japan; [Ishikawa, Tomohiro] Dokkyo Med Univ, Dept Microbiol, Sch Med, Mibu, Tochigi, Japan; [Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Takeuchi, Hiroaki] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Tripathi, Lokesh P.; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr, Artificial Intelligence Ctr Hlth & Biomed Res, Osaka, Japan; [Tripathi, Lokesh P.] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Mizuguchi, Kenji] Osaka Univ, Inst Prot Res, Osaka, Japan	Hirosaki University; Iwate University; Osaka University; Osaka University; Osaka University; Dokkyo Medical University; National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); RIKEN; Osaka University	Morita, E (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan.; Morita, E (corresponding author), Iwate Univ, United Grad Sch Agr Sci, Div Biomol Funct, Bioresources Sci, Morioka, Iwate, Japan.; Morita, E (corresponding author), Osaka Univ, Res Inst Microbial Dis, Lab Viral Infect, Osaka, Japan.	moritae@hirosaki-u.ac.jp	Mizuguchi, Kenji/GVS-5857-2022	Mizuguchi, Kenji/0000-0003-3021-7078; Suzuki, Ryosuke/0000-0003-0296-8843; Tripathi, Lokesh Pati/0000-0001-5812-2252; Tabata, Keisuke/0000-0001-6776-1689	JSPS KAKENHI [23790503, 26460555, 16H01188, 17H06413]; Health Labour Sciences Research Grant [12103320]; JST CREST, Japan [JPMJCR17H4]; Uehara Memorial Foundation; Cell Science Research Foundation; Naito Foundation; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr Shigeru Tajima for gifting the plasmid rJEV (Mie/41/2002) /pMW119 and Dr Alessia Ruggieri for reviewing this manuscript. This research was supported by JSPS KAKENHI (grant numbers 23790503, 26460555, 16H01188, and 17H06413) , a Health Labour Sciences Research Grant for Research on Emerging and Re-emerging Infectious Diseases (grant number 12103320) , JST CREST, Japan (grant number JPMJCR17H4) , the Uehara Memorial Foundation, the Cell Science Research Foundation, the Naito Foundation, and the Takeda Science Foundation.	Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775; Arita M, 2012, J VIROL, V86, P5541, DOI 10.1128/JVI.00114-12; Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Elbahesh H, 2011, VIROLOGY, V421, P51, DOI 10.1016/j.virol.2011.08.008; Emara M. M., 2007, PROC NATL ACAD; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gwon Y, 2021, SCIENCE, V372, P1410, DOI 10.1126/science.abf6548; Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Matsuda M., 2018, SCI REP-UK, V8; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Miller CL, 2011, FUTURE VIROL, V6, P1329, DOI 10.2217/FVL.11.108; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Perkins DJ, 2004, MOL CELL BIOL, V24, P2025, DOI 10.1128/MCB.24.5.2025-2040.2004; Phongphaew W, 2017, VIRUS RES, V228, P114, DOI 10.1016/j.virusres.2016.11.029; Ramanathan HN, 2020, MBIO, V11, DOI 10.1128/mBio.00467-20; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Roth H, 2017, MBIO, V8, DOI [10.1128/mBio.02150-16, 10.1128/mbio.02150-16]; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103; Sehrawat S, 2021, J VIROL, V95, DOI 10.1128/JVI.02336-20; Tabata K, 2021, J VIROL, V95, DOI 10.1128/JVI.02234-20; Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12; Wang B, 2019, MOL CELL, V74, P742, DOI 10.1016/j.molcel.2019.03.027; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; Yi ZG, 2016, J VIROL, V90, P9953, DOI 10.1128/JVI.01140-16; Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835	47	4	4	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101597	10.1016/j.jbc.2022.101597	http://dx.doi.org/10.1016/j.jbc.2022.101597			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7QD	35063505	gold, Green Published			2022-12-28	WOS:000791267400010
J	Geleta, BR; Tout, F; Lim, SC; Sahni, S; Jansson, PJ; Apte, MV; Richardson, D; Kovacevic, Z				Geleta, Bekesho R.; Tout, Faten; Lim, Syer Choon; Sahni, Sumit; Jansson, Patric J.; Apte, Minoti V.; Richardson, Des R.; Kovacevic, Zaklina			Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWNSTREAM-REGULATED GENE-1; EPITHELIAL-MESENCHYMAL TRANSITION; TENASCIN-C; IRON CHELATORS; BETA-CATENIN; UP-REGULATION; IN-VITRO; WNT/BETA-CATENIN; STROMAL CELLS; TGF-BETA	A major barrier to successful pancreatic cancer (PC) treatment is the surrounding stroma, which secretes growth factors/cytokines that promote PC progression. Wnt and tenascin C (TnC) are key ligands secreted by stromal pancreatic stellate cells (PSCs) that then act on PC cells in a paracrine manner to activate the oncogenic beta-catenin and YAP/TAZ signaling pathways. Therefore, therapies targeting oncogenic Wnt/TnC cross talk between PC cells and PSCs constitute a promising new therapeutic approach for PC treatment. The metastasis suppressor N-myc downstream regulated gene-1 (NDRG1) inhibits tumor progression and metastasis in numerous cancers, including PC. We demonstrate herein that targeting NDRG1 using the clinically trialed anticancer agent di-2-pyridylketone-4-cyclohexyl-4-methyl-3thiosemicarbazone (DpC) inhibited Wnt/TnC-mediated interactions between PC cells and the surrounding PSCs. Mechanistically, NDRG1 and DpC markedly inhibit secretion of Wnt3a and TnC by PSCs, while also attenuating Wnt/beta- catenin and YAP/TAZ activation and downstream signaling in PC cells. This antioncogenic activity was mediated by direct inhibition of beta-catenin and YAP/TAZ nuclear localization and by increasing the Wnt inhibitor, DKK1. Expression of NDRG1 also inhibited transforming growth factor (TGF)-beta secretion by PC cells, a key mechanism by which PC cells activate PSCs. Using an in vivo orthotopic PC mouse model, we show DpC downregulated beta-catenin, TnC, and YAP/TAZ, while potently increasing NDRG1 expression in PC tumors. We conclude that NDRG1 and DpC inhibit Wnt/TnC-mediated interactions between PC cells and PSCs. These results further illuminate the antioncogenic mechanism of NDRG1 and the potential of targeting this metastasis suppressor to overcome the oncogenic effects of the PC-PSC interaction.	[Geleta, Bekesho R.; Tout, Faten; Lim, Syer Choon; Kovacevic, Zaklina] Univ Sydney, Canc Metastasis & Tumor Microenvironm Program, Sydney, NSW, Australia; [Geleta, Bekesho R.; Tout, Faten; Lim, Syer Choon; Jansson, Patric J.; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia; [Tout, Faten] Hashemite Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Zarqa, Jordan; [Sahni, Sumit; Jansson, Patric J.] Univ Sydney, Kolling Inst Med Res, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia; [Jansson, Patric J.] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Canc Drug Resistance & Stem Cell Program, Sydney, NSW, Australia; [Apte, Minoti V.] UNSW Sydney, Pancreat Res Grp, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Apte, Minoti V.] Ingham Inst Appl Med Res, Pancreat Res Grp, Sydney, NSW, Australia; [Richardson, Des R.] Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol & Drug Discovery, Brisbane, Qld, Australia; [Richardson, Des R.] Nagoya Univ, Dept Pathol & Biol Responses, Grad Sch Med, Nagoya, Japan	University of Sydney; University of Sydney; Hashemite University; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Griffith University; Nagoya University	Kovacevic, Z (corresponding author), Univ Sydney, Canc Metastasis & Tumor Microenvironm Program, Sydney, NSW, Australia.; Kovacevic, Z (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia.	zaklina.kovacevic@sydney.edu.au	Lim, Syer Choon/AAN-7043-2021	Lim, Syer Choon/0000-0002-5648-9453; S. Tout, Faten/0000-0001-8259-7047; Richardson, Des/0000-0002-5506-3274; Apte, Minoti/0000-0003-0194-8939	Avner Pancreatic Cancer Foundation 2018 Innovation grant; National Health and Medical Research Council (NHMRC) [APP1160968]; Cancer Institute of NSW (CINSW) [2016/0RFlOl]; University of Sydney; National Health and Medical Research Council RD Wright Fellowship [APP1140447]; CINSW Career Development Fellowship [CDF171126]; University of Sydney Equity Fellowship; University of Sydney International Scholarship (USydIS); Cancer Institute NSW Career Development Fellowship [CDF171147]; Pankind Foundation; NHMRC [1062607, 1159596, APP1144829, APP1128152, APP1144456]; Avner Pancreatic Cancer Foundation	Avner Pancreatic Cancer Foundation 2018 Innovation grant; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of NSW (CINSW); University of Sydney(University of Sydney); National Health and Medical Research Council RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); CINSW Career Development Fellowship; University of Sydney Equity Fellowship; University of Sydney International Scholarship (USydIS); Cancer Institute NSW Career Development Fellowship; Pankind Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Avner Pancreatic Cancer Foundation	This work was supported by the Avner Pancreatic Cancer Foundation 2018 Innovation grant, the National Health and Medical Research Council (NHMRC; grant#APP1160968), Cancer Institute of NSW (CINSW; grant #2016/0RFlOl), and University of Sydney grants to Z. K. Z. K. is grateful for a University of Sydney Bridging Fellowship, a National Health and Medical Research Council RD Wright Fellowship [APP1140447], a CINSW Career Development Fellowship [CDF171126], and a University of Sydney Equity Fellowship. B. G. is grateful for his University of Sydney International Scholarship (USydIS). P. J. J. is grateful for Cancer Institute NSW Career Development Fellowship[CDF171147] support. S. S. would like to acknowledge Pankind Foundation for a Collaboration Grant. D. R. R. thanks the NHMRC for Senior Principal Research Fellowships [1062607 and 1159596]; NHMRC Project Grants [APP1144829; APP1128152; APP1144456];and the Avner Pancreatic Cancer Foundation for a 2017 Innovation Grant.	Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Adams DJ, 2012, TRENDS PHARMACOL SCI, V33, P173, DOI 10.1016/j.tips.2012.02.001; Aguilera KY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.671022; Alsolami M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52830-1; Ambe CM, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729076; Ansari D, 2019, ANTICANCER RES, V39, P3317, DOI 10.21873/anticanres.13474; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Awaji M, 2019, CANCERS, V11, DOI 10.3390/cancers11030290; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bai YY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002996; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bazzichetto C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020309; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Boghaert ER, 2017, NEOPLASIA, V19, P695, DOI 10.1016/j.neo.2017.06.004; Bosada FM, 2016, DEVELOPMENT, V143, P1041, DOI 10.1242/dev.130575; Brack SS, 2006, CLIN CANCER RES, V12, P3200, DOI 10.1158/1078-0432.CCR-05-2804; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cannon Andrew, 2018, Genes Cancer, V9, P78, DOI 10.18632/genesandcancer.171; Chekmarev J, 2021, CELLS-BASEL, V10, DOI [10.1158/0008-5472.CAN-20-2017, 10.3390/cells10092382]; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chen ZZ, 2018, INT J BIOL SCI, V14, P799, DOI 10.7150/ijbs.25928; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Donfrancesco A, 1996, ACTA HAEMATOL-BASEL, V95, P66; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Ferrari N., 2019, Nat, VCommun; Foley K, 2017, CELL ADHES MIGR, V11, P514, DOI 10.1080/19336918.2016.1259057; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Garcia de Herreros A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101148; Geleta B, 2021, FASEB J, V35, DOI 10.1096/fj.202002279R; Goehrig D, 2019, GUT, V68, P693, DOI 10.1136/gutjnl-2018-317570; Gong XG, 2010, BIOL PHARM BULL, V33, P1261, DOI 10.1248/bpb.33.1261; Gruber R, 2016, GASTROENTEROLOGY, V151, P526, DOI 10.1053/j.gastro.2016.05.006; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hagen T, 2002, BIOCHEM BIOPH RES CO, V294, P324, DOI 10.1016/S0006-291X(02)00485-0; He SH, 2019, BRIT J CANCER, V121, P922, DOI 10.1038/s41416-019-0608-1; Hendaoui S, 2014, MATRIX BIOL, V40, P46, DOI 10.1016/j.matbio.2014.08.017; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Hoarau-Vechot J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010181; Hosein A. N., 2020, Nat. Rev. Gas-troenterol. Hepatol., V17; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Igbinigie E, 2019, CLIN CHIM ACTA, V488, P226, DOI 10.1016/j.cca.2018.11.023; Jansson P. J., 2015, Pharmacol; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jiang ZD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0740-4; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Jung YS, 2020, EXP MOL MED, V52, P183, DOI 10.1038/s12276-020-0380-6; Kagawa S, 2012, J SURG RES, V178, P758, DOI 10.1016/j.jss.2012.05.065; Kagey MH, 2017, BRIT J PHARMACOL, V174, P4637, DOI 10.1111/bph.13894; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kobayashi H, 2019, NAT REV GASTRO HEPAT, V16, P282, DOI 10.1038/s41575-019-0115-0; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee JE, 2015, GENET MOL BIOL, V38, P527, DOI 10.1590/S1415-475738420150028; Li PC, 2016, AM J TRANSL RES, V8, P5370; Li XQ, 2014, CLIN CANCER RES, V20, P4326, DOI 10.1158/1078-0432.CCR-13-3426; Lim SC, 2020, FASEB J, V34, P11511, DOI 10.1096/fj.201903167R; Liu W., 2012, N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signalling and pleiotropically suppresses metastasis; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lowy CM, 2015, CELL ADHES MIGR, V9, P112, DOI 10.1080/19336918.2015.1008331; Makena MR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174242; Mao B., 2002, Nature, V417; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Mizrahi JD, 2020, LANCET, V395, P2008, DOI 10.1016/S0140-6736(20)30974-0; Mortensen M. B., 2016, World J. Gastroenterol., V22; Morvaridi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16759; Mullor JL, 2001, CURR BIOL, V11, P769, DOI 10.1016/S0960-9822(01)00229-9; Murakami T, 2017, BRIT J CANCER, V117, P1360, DOI 10.1038/bjc.2017.291; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Noda N, 2000, BIOL REPROD, V63, P1713, DOI 10.1095/biolreprod63.6.1713; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Ogilvie LA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00219; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Paron I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021684; Pedersen EA, 2016, CANCER RES, V76, P5040, DOI 10.1158/0008-5472.CAN-15-3422; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Pothula SP, 2017, ONCOTARGET, V8, P76722, DOI 10.18632/oncotarget.20822; Pothula SP, 2016, BRIT J CANCER, V114, P269, DOI 10.1038/bjc.2015.478; Principe DR, 2016, CANCER RES, V76, P2525, DOI 10.1158/0008-5472.CAN-15-1293; Qian SY, 2019, ONCOTARGETS THER, V12, P3197, DOI 10.2147/OTT.S192218; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson D. R., 1997, Blood, V89; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2002, CRIT REV ONCOL HEMAT, V42, P267, DOI 10.1016/S1040-8428(01)00218-9; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Rozengurt E, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-017-0005-2; Safavi M, 2016, EXPERT OPIN DRUG DIS, V11, P939, DOI 10.1080/17460441.2016.1217196; Sano M, 2016, NEOPLASIA, V18, P785, DOI 10.1016/j.neo.2016.11.004; Santoro R, 2020, MOL CANCER THER, V19, P247, DOI 10.1158/1535-7163.MCT-19-0270; Sarper M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27639; Saukkonen K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2497-5; Saupe F, 2013, CELL REP, V5, P482, DOI 10.1016/j.celrep.2013.09.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnittert J, 2019, FASEB J, V33, P6609, DOI 10.1096/fj.201802336R; Shi MY, 2015, APOPTOSIS, V20, P843, DOI 10.1007/s10495-015-1106-4; Spenle C, 2015, CELL ADHES MIGR, V9, P141, DOI 10.1080/19336918.2014.1000074; Sperb N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155486; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Stacy AE, 2016, J MED CHEM, V59, P4965, DOI 10.1021/acs.jmedchem.6b00238; Stylianou A, 2018, BBA-GEN SUBJECTS, V1862, P1537, DOI 10.1016/j.bbagen.2018.02.009; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Sun Q., 2018, Theranostics, V8; Sundquist E, 2017, BRIT J CANCER, V116, P640, DOI 10.1038/bjc.2016.455; Tu B, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130811; Veenstra VL, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0096-9; Vogelmann R, 2001, AM J PHYSIOL-GASTR L, V280, pG164, DOI 10.1152/ajpgi.2001.280.1.G164; Vonlaufen A, 2010, PANCREATOLOGY, V10, P434, DOI 10.1159/000260900; Wang Z, 2013, ANTICANCER RES, V33, P4103; Wang ZY, 2018, J CELL MOL MED, V22, P429, DOI 10.1111/jcmm.13332; Wangpu XZ, 2016, MOL PHARMACOL, V89, P521, DOI 10.1124/mol.115.103044; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yoneura N, 2018, INT J MOL MED, V42, P821, DOI 10.3892/ijmm.2018.3652; Yoon H, 2021, ONCOGENESIS, V10, DOI 10.1038/s41389-021-00302-5; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang Rong, 2019, Gene Expression, V19, P121, DOI 10.3727/105221618X15373858350141; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	139	8	7	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101608	10.1016/j.jbc.2022.101608	http://dx.doi.org/10.1016/j.jbc.2022.101608			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065073	Green Published, gold			2022-12-28	WOS:000789396300007
J	Lopez, C; Delmonti, J; Bonomo, RA; Vila, AJ				Lopez, Carolina; Delmonti, Juliana; Bonomo, Robert A.; Vila, Alejandro J.			Deciphering the evolution of metallo-beta-lactamases: A journey from the test tube to the bacterial periplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OUTER-MEMBRANE VESICLES; GRAM-NEGATIVE BACTERIA; FAVOR ENZYME-ACTIVITY; ANTIBIOTIC-RESISTANCE; MOLECULAR EVOLUTION; SIGNAL PEPTIDASE; PSEUDOMONAS-AERUGINOSA; CARBAPENEM RESISTANCE; FITNESS LANDSCAPE; QUINARY STRUCTURE	Understanding the evolution of metallo-beta-lactamases (MBLs) is fundamental to deciphering the mechanistic basis of resistance to carbapenems in pathogenic and opportunistic bacteria. Presently, these MBL-producing pathogens are linked to high rates of morbidity and mortality worldwide. However, the study of the biochemical and biophysical features of MBLs in vitro provides an incomplete picture of their evolutionary potential, since this limited and artificial environment disregards the physiological context where evolution and selection take place. Herein, we describe recent efforts aimed to address the evolutionary traits acquired by different clinical variants of MBLs in conditions mimicking their native environment (the bacterial periplasm) and considering whether they are soluble or membrane-bound proteins. This includes addressing the metal content of MBLs within the cell under zinc starvation conditions and the context provided by different bacterial hosts that result in particular resistance phenotypes. Our analysis highlights recent progress bridging the gap between in vitro and in-cell studies.	[Lopez, Carolina; Delmonti, Juliana; Vila, Alejandro J.] CONICET UNR, Lab Metaloproteinas, Inst Biol Mol & Celular Rosario IBR, Rosario, Argentina; [Bonomo, Robert A.] Vet Affairs Northeast Ohio Healthcare Syst, Res Serv, Cleveland Hts, OH USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med Pharmacol Mol Biol & Microbiol, Sch Med, Cleveland Hts, OH USA; [Bonomo, Robert A.] GRECC, Med Serv, Vet Affairs Northeast Ohio Healthcare Syst, Cleveland Hts, OH USA; [Bonomo, Robert A.; Vila, Alejandro J.] CWRU, US Dept Vet Affairs, Cleveland VAMC Ctr Antimicrobial Resistance & Epid, Cleveland Hts, OH USA; [Vila, Alejandro J.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Biofis, Rosario, Argentina; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland Hts, OH USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Case Western Reserve University; Geriatric Research Education & Clinical Center; Case Western Reserve University; US Department of Veterans Affairs; National University of Rosario; Case Western Reserve University	Vila, AJ (corresponding author), CONICET UNR, Lab Metaloproteinas, Inst Biol Mol & Celular Rosario IBR, Rosario, Argentina.; Vila, AJ (corresponding author), CWRU, US Dept Vet Affairs, Cleveland VAMC Ctr Antimicrobial Resistance & Epid, Cleveland Hts, OH USA.; Vila, AJ (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Biofis, Rosario, Argentina.	vila@ibr-conicet.gov.ar		, Carolina/0000-0002-9357-3486; Vila, Alejandro/0000-0002-7978-3233	ANPCyT [PICT-2016-1657]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [2R01AI100560-06A1]; CONICET; National Institute of Allergy and Infectious Diseases [R01AI100560]; Cleveland Department of Veterans Affairs from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [1I01BX001974]; Geriatric Research Education and Clinical Center	ANPCyT(ANPCyT); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland Department of Veterans Affairs from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; Geriatric Research Education and Clinical Center	This work was supported by a grant from ANPCyT (grant no.: PICT-2016-1657; to A. J. V.) and a National Institute of Allergy and Infectious Diseases, National In-stitutes of Health, grant (grant no.: 2R01AI100560-06A1; to A. J. V. and R. A. B) . C. L. and J. D. are recipients of a postdoctoral and doctoral fellowships from CONICET, respectively. A. J. V. is a staff member from CONICET. Research reported in this publication was supported by the National Institute of Allergy and Infectious Dis-eases (to R. A. B.) under Award number R01AI100560. This study was also supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs (Award number: 1I01BX001974; to R. A. B.) from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development and the Geriatric Research Education and Clinical Center (Veterans Integrated Service Networks 10) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs.	AMBLER RP, 1985, FEBS LETT, V189, P207, DOI 10.1016/0014-5793(85)81024-3; Andersson DI, 2020, FEMS MICROBIOL REV, V44, P171, DOI 10.1093/femsre/fuaa001; Antelo GT, 2021, TRENDS MICROBIOL, V29, P441, DOI 10.1016/j.tim.2020.08.001; Aron AT, 2022, NAT CHEM, V14, P100, DOI 10.1038/s41557-021-00803-1; Asempa TE, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02271-20; Bahr G, 2022, CURR OPIN CHEM BIOL, V66, DOI 10.1016/j.cbpa.2021.102103; Bahr G, 2021, CHEM REV, V121, P7957, DOI 10.1021/acs.chemrev.1c00138; Bahr G, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01849-17; Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Belanger CR, 2021, NAT PROTOC, V16, P3761, DOI 10.1038/s41596-021-00572-8; Berglund F, 2021, J ANTIMICROB CHEMOTH, V76, P117, DOI 10.1093/jac/dkaa392; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bicknell R., 2002, BIOCHEMISTRY-US, V25, P7208; Bielaszewska M, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11110806; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Bonomo RA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025239; Borgianni L, 2010, ANTIMICROB AGENTS CH, V54, P3197, DOI 10.1128/AAC.01336-09; Brawley HN, 2021, J AM CHEM SOC, V143, P18571, DOI 10.1021/jacs.1c08213; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; Bush K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00047-19; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Chatterjee S, 2017, J ANTIMICROB CHEMOTH, V72, P2201, DOI 10.1093/jac/dkx131; Chen JZ, 2020, ELIFE, V9, DOI 10.7554/eLife.56707; Cheng Z., 2018, EVOLUTION NEW DELHI; Cheng Z., 2021, ANTIMICROB AGENTS CH, V65, P1; Cheng ZS, 2019, MBIO, V10, DOI 10.1128/mBio.02412-19; Cheung CHP, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02412-20; CHUNG L, 1971, BIOPHYS J, V11, P469, DOI 10.1016/S0006-3495(71)86229-X; Ciofu O, 2000, J ANTIMICROB CHEMOTH, V45, P9, DOI 10.1093/jac/45.1.9; Cohen RD, 2017, PROTEIN SCI, V26, P403, DOI 10.1002/pro.3092; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DEV IK, 1985, J BIOL CHEM, V260, P5891; Devos S, 2016, ANTIMICROB AGENTS CH, V60, P2516, DOI 10.1128/AAC.02171-15; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Domingues S, 2017, CURR OPIN MICROBIOL, V38, P16, DOI 10.1016/j.mib.2017.03.012; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Easton J Allen, 2006, J Biomol Tech, V17, P303; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Foster AW, 2022, CURR OPIN CHEM BIOL, V66, DOI 10.1016/j.cbpa.2021.102095; Tran F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07447-7; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Giannini E, 2019, PROTEIN SCI, V28, P2004, DOI 10.1002/pro.3728; Gong LI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004328; Gonzalez JM, 2012, NAT CHEM BIOL, V8, P698, DOI [10.1038/NCHEMBIO.1005, 10.1038/nchembio.1005]; Gonzalez LJ, 2016, NAT CHEM BIOL, V12, P516, DOI [10.1038/nchembio.2083, 10.1038/NCHEMBIO.2083]; Gonzalez LJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003817; Guerrero-Mandujano A, 2017, TRAFFIC, V18, P425, DOI 10.1111/tra.12488; Guin D, 2019, CHEM REV, V119, P10691, DOI 10.1021/acs.chemrev.8b00753; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horton LB, 2012, ANTIMICROB AGENTS CH, V56, P5667, DOI 10.1128/AAC.01276-12; Hughes D, 2017, FEMS MICROBIOL REV, V41, P374, DOI 10.1093/femsre/fux004; HUSSAIN M, 1985, J BACTERIOL, V164, P223, DOI 10.1128/JB.164.1.223-229.1985; Iyobe S, 2000, ANTIMICROB AGENTS CH, V44, P2023, DOI 10.1128/AAC.44.8.2023-2027.2000; Iyobe S, 2002, ANTIMICROB AGENTS CH, V46, P2014, DOI 10.1128/AAC.46.6.2014-2016.2002; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Jan AT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01053; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Kubota H, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00736-19; Kulanthaivel P, 2004, J BIOL CHEM, V279, P36250, DOI 10.1074/jbc.M405884200; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kuzmanic A, 2020, ACCOUNTS CHEM RES, V53, P654, DOI 10.1021/acs.accounts.9b00613; LaCuran AE, 2015, ANTIMICROB AGENTS CH, V59, P7299, DOI 10.1128/AAC.01651-15; Laraki N., 1999, ANTIMICROB AGENTS CH, V43; Lasko MJ, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01902-8; Lassaux P., 2011, ANTIMICROB AGENTS CH; Liao YT, 2015, ANTIMICROB AGENTS CH, V59, P7346, DOI 10.1128/AAC.01343-15; Liu EM, 2012, ANTIMICROB AGENTS CH, V56, P6403, DOI 10.1128/AAC.01440-12; Lonergan ZR, 2019, TRENDS BIOCHEM SCI, V44, P1041, DOI 10.1016/j.tibs.2019.06.010; Lopez C, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.00507-21; Lopez C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11615-w; Makena A., 2016, ANTIMICROB AGENTS CH; Makena A, 2015, J ANTIMICROB CHEMOTH, V70, P463, DOI 10.1093/jac/dku403; Marshall S., 2017, CAN CEFTAZIDIME; Martinez MMB, 2021, MBIO, V12, DOI 10.1128/mBio.01836-21; Martinez-Garcia L, 2018, MBIO, V9, DOI 10.1128/mBio.02109-17; Materon IC, 2004, J MOL BIOL, V344, P653, DOI 10.1016/j.jmb.2004.09.074; Materon IC, 2001, PROTEIN SCI, V10, P2556, DOI 10.1110/ps.ps.40884; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Mehlhoff JD, 2020, P NATL ACAD SCI USA, V117, P11597, DOI 10.1073/pnas.1918680117; Mehta R, 2021, J AM CHEM SOC, V143, P8314, DOI 10.1021/jacs.1c00290; Meini MR, 2015, FEBS LETT, V589, P3419, DOI 10.1016/j.febslet.2015.08.015; Meini MR, 2015, MOL BIOL EVOL, V32, P1774, DOI 10.1093/molbev/msv059; Meini MR, 2013, FUTURE MICROBIOL, V8, P947, DOI [10.2217/FMB.13.34, 10.2217/fmb.13.34]; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Mojica M. F., 2015, EXPLORING; Mojica MF, 2022, LANCET INFECT DIS, V22, pE28, DOI 10.1016/S1473-3099(20)30868-9; Mojica MF, 2019, MBIO, V10, DOI 10.1128/mBio.00405-19; Mojica MF, 2016, CURR DRUG TARGETS, V17, P1029, DOI 10.2174/1389450116666151001105622; Monteith WB, 2015, P NATL ACAD SCI USA, V112, P1739, DOI 10.1073/pnas.1417415112; Moran-Barrio J, 2009, ANTIMICROB AGENTS CH, V53, P2908, DOI 10.1128/AAC.01637-08; Naas T, 2017, J ENZYM INHIB MED CH, V32, P917, DOI 10.1080/14756366.2017.1344235; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2019, CLIN INFECT DIS, V69, P521, DOI 10.1093/cid/ciz824; Oelschlaeger P, 2005, J MOL BIOL, V350, P395, DOI 10.1016/j.jmb.2005.04.044; Oelschlaeger P, 2007, J MOL BIOL, V366, P316, DOI 10.1016/j.jmb.2006.11.027; Oelschlaeger P, 2008, J INORG BIOCHEM, V102, P2043, DOI 10.1016/j.jinorgbio.2008.05.007; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pal A, 2013, INFECT GENET EVOL, V20, P39, DOI 10.1016/j.meegid.2013.07.028; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Pathirana RD, 2016, CELL MICROBIOL, V18, P1518, DOI 10.1111/cmi.12658; Pegg KM, 2014, PROTEIN SCI, V23, P1451, DOI 10.1002/pro.2530; Pereira C, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02052-x; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Philippon A, 1998, CELL MOL LIFE SCI, V54, P341, DOI 10.1007/s000180050161; Porse A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02944-3; Pradel N, 2009, ANTIMICROB AGENTS CH, V53, P242, DOI 10.1128/AAC.00642-08; Prunotto A, 2020, ACS INFECT DIS, V6, P2719, DOI 10.1021/acsinfecdis.0c00341; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; Rumbo C., 2011, ANTIMICROB AGENTS CH; SABATH LD, 1966, BIOCHEM J, V98, pC11, DOI 10.1042/bj0980011C; SAINO Y, 1982, ANTIMICROB AGENTS CH, V22, P564, DOI 10.1128/AAC.22.4.564; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Segawa T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208976; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Siemann S, 2006, CHEM COMMUN, P532, DOI 10.1039/b514227j; Sigdel TK, 2006, BIOMETALS, V19, P461, DOI 10.1007/s10534-005-4962-5; Sjostrom AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15329; Smith PA, 2012, ANTIMICROB AGENTS CH, V56, P5054, DOI 10.1128/AAC.00785-12; Socha RD, 2019, J MOL BIOL, V431, P1172, DOI 10.1016/j.jmb.2019.01.041; Softley CA, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00123-20; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Stentz R, 2015, J ANTIMICROB CHEMOTH, V70, P701, DOI 10.1093/jac/dku466; Stewart AC, 2017, ACS INFECT DIS, V3, P927, DOI 10.1021/acsinfecdis.7b00128; Sugden R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.187, 10.1038/nmicrobiol.2016.187]; Sun ZZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06839-1; Tada T, 2015, ANTIMICROB AGENTS CH, V59, P7090, DOI 10.1128/AAC.01611-15; Toleman MA, 2002, J ANTIMICROB CHEMOTH, V50, P673, DOI 10.1093/jac/dkf210; Tooke CL, 2019, J MOL BIOL, V431, P3472, DOI 10.1016/j.jmb.2019.04.002; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Valladares MH, 2000, FEBS LETT, V467, P221, DOI 10.1016/S0014-5793(00)01102-9; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Weber BS, 2017, TRENDS MICROBIOL, V25, P533, DOI 10.1016/j.tim.2017.01.005; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yamaguchi Y., 2005, J BIOL UDAYANA, VChem; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Zlatkov N, 2021, FEMS MICROBIOL REV, V45, DOI 10.1093/femsre/fuaa047	159	3	3	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101665	10.1016/j.jbc.2022.101665	http://dx.doi.org/10.1016/j.jbc.2022.101665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0Z7CD	35120928	Green Published, gold			2022-12-28	WOS:000791230900010
J	Prins, S; Corradi, V; Sheppard, DNN; Tieleman, DP; Vergani, P				Prins, Stella; Corradi, Valentina; Sheppard, David N. N.; Tieleman, D. Peter; Vergani, Paola			Can two wrongs make a right? F508del-CFTR ion channel rescue by second-site mutations in its transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; PARTICLE MESH EWALD; CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; ABC TRANSPORTER; PLASMA-MEMBRANE; MOLECULAR-BASIS; WILD-TYPE; CFTR	Deletion of phenylalanine 508 (F508del) in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel is the most common cause of cystic fibrosis. The F508 residue is located on nucleotide-binding domain 1 (NBD1) in contact with the cytosolic extensions of the transmembrane helices, in particular intracellular loop 4 (ICL4). To investigate how absence of F508 at this interface impacts the CFTR protein, we carried out a mutagenesis scan of ICL4 by introducing second site mutations at 11 positions in cis with F508del. Using an image-based fluorescence assay, we measured how each mutation affected membrane proximity and ion-channel function. The scan strongly validated the effectiveness of R1070W at rescuing F508del defects. Molecular dynamics simulations highlighted two features characterizing the ICL4/NBD1 interface of F508del/R1070W-CFTR: flexibility, with frequent transient formation of interdomain hydrogen bonds, and loosely stacked aromatic sidechains (F1068, R1070W, and F1074, mimicking F1068, F508, and F1074 in WT CFTR). F508del-CFTR displayed a distorted aromatic stack, with F1068 displaced toward the space vacated by F508, while in F508del/R1070F-CFTR, which largely retained F508del defects, R1070F could not form hydrogen bonds and the interface was less flexible. Other ICL4 second-site mutations which partially rescued F508del-CFTR included F1068M and F1074M. Methionine side chains allow hydrophobic interactions without the steric rigidity of aromatic rings, possibly conferring flexi-bility to accommodate the absence of F508 and retain a dynamic interface. These studies highlight how both hydrophobic interactions and conformational flexibility might be important at the ICL4/NBD1 interface, suggesting possible structural underpinnings of F508del-induced dysfunction.	[Prins, Stella; Tieleman, D. Peter; Vergani, Paola] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB, Canada; [Sheppard, David N. N.] Univ Bristol, Sch Physiol, Pharmacol & Neurosci, Bristol, Gloucestershire, England	University of London; University College London; University of Bristol	Vergani, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	p.vergani@ucl.ac.uk	Vergani, Paola/C-2019-2008	Vergani, Paola/0000-0002-5422-4662	Cystic Fibrosis Trust [SRC 005]; Natural Sciences and Engineering Research Council (Canada); Canadian Institutes of Health Research; Canada Research Chairs program	Cystic Fibrosis Trust; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	S. P., D. N. S., and P. V. gratefully acknowledge funding by the Cystic Fibrosis Trust [SRC 005]. Work in D. P. T.'s group is supported by the Natural Sciences and Engineering Research Council (Canada) and the Canadian Institutes of Health Research. Further support came from the Canada Research Chairs program. Calculations were carried out on Compute Canada facilities supported by the Canada Foundation for Innovation and partners.	Abreu B, 2020, PROTEINS, V88, P113, DOI 10.1002/prot.25776; Aledo JC, 2019, PROTEIN SCI, V28, P1785, DOI 10.1002/pro.3698; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alvarez O, 2017, J GEN PHYSIOL, V149, P911, DOI 10.1085/jgp.201711839; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Cai ZW, 2015, J PHYSIOL-LONDON, V593, P2427, DOI 10.1113/JP270227; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Corradi V, 2018, BIOPHYS J, V114, P1751, DOI 10.1016/j.bpj.2018.03.003; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ford RC, 2020, FEBS LETT, V594, P3857, DOI 10.1002/1873-3468.13921; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Haws C. M., 1996, American Journal of Physiology, V270, pC1544; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann B, 2018, CELL MOL LIFE SCI, V75, P3829, DOI 10.1007/s00018-018-2835-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Hwang TC, 2018, J GEN PHYSIOL, V150, P539, DOI 10.1085/jgp.201711946; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Langron E, 2018, BRIT J PHARMACOL, V175, P3990, DOI 10.1111/bph.14475; Langron E, 2017, BRIT J PHARMACOL, V174, P525, DOI 10.1111/bph.13715; Last NB, 2017, ELIFE, V6, DOI 10.7554/eLife.31259; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Linsdell P, 2001, J PHYSIOL-LONDON, V531, P51, DOI 10.1111/j.1469-7793.2001.0051j.x; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu J, 2018, BRIT J PHARMACOL, V175, P1017, DOI 10.1111/bph.14141; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mall MA, 2020, AM J RESP CRIT CARE, V201, P1193, DOI 10.1164/rccm.201910-1943SO; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Merski M, 2020, MOLECULES, V25, DOI 10.3390/molecules25225326; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Mundlapati VR, 2015, J PHYS CHEM LETT, V6, P1385, DOI 10.1021/acs.jpclett.5b00491; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Okiyoneda T, 2018, DEV CELL, V44, P694, DOI 10.1016/j.devcel.2018.02.001; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Pagant S, 2010, J BIOL CHEM, V285, P36304, DOI 10.1074/jbc.M110.142760; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PIND S, 1994, J BIOL CHEM, V269, P12784; Prins S, 2020, J BIOL CHEM, V295, P16529, DOI 10.1074/jbc.RA120.014061; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rapedius M, 2005, J BIOL CHEM, V280, P30760, DOI 10.1074/jbc.M503503200; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Saint-Criq V, 2017, CELL MOL LIFE SCI, V74, P93, DOI 10.1007/s00018-016-2391-y; Sanz DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184009; Scholl D, 2021, NAT CHEM BIOL, V17, P989, DOI 10.1038/s41589-021-00844-0; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sigoillot M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10714-y; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thomas C, 2020, FEBS LETT, V594, P3767, DOI 10.1002/1873-3468.13935; Thomas C, 2020, ANNU REV BIOCHEM, V89, P605, DOI 10.1146/annurev-biochem-011520-105201; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Veit G, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139983; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yu Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15887-5; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	109	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101615	10.1016/j.jbc.2022.101615	http://dx.doi.org/10.1016/j.jbc.2022.101615			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065958	Green Published, Green Submitted, gold			2022-12-28	WOS:000789396300013
J	Mattice, JR; Shisler, KA; DuBois, JL; Peters, JW; Bothner, B				Mattice, Jenna R.; Shisler, Krista A.; DuBois, Jennifer L.; Peters, John W.; Bothner, Brian			A catalytic dyad modulates conformational change in the CO2-fixing flavoenzyme 2-ketopropyl coenzyme M oxidoreductase/carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; DISULFIDE OXIDOREDUCTASE; STABILITY; MECHANISM; BINDING	2-Ketopropyl-coenzyme M oxidoreductase/carboxylase (2-KPCC) is a member of the flavin and cysteine disulfide containing oxidoreductase family (DSOR) that catalyzes the unique reaction between atmospheric CO2 and a ketone/eno-late nucleophile to generate acetoacetate. However, the mechanism of this reaction is not well understood. Here, we present evidence that 2-KPCC, in contrast to the well -characterized DSOR enzyme glutathione reductase, un-dergoes conformational changes during catalysis. Using a suite of biophysical techniques including limited proteolysis, differ-ential scanning fluorimetry, and native mass spectrometry in the presence of substrates and inhibitors, we observed conformational differences between different ligand-bound 2-KPCC species within the catalytic cycle. Analysis of site -specific amino acid variants indicated that 2-KPCC-defining residues, Phe501-His506, within the active site are important for transducing these ligand induced conformational changes. We propose that these conformational changes promote sub-strate discrimination between H+ and CO2 to favor the meta-bolically preferred carboxylation product, acetoacetate.	[Mattice, Jenna R.; DuBois, Jennifer L.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Shisler, Krista A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Montana State University System; Montana State University Bozeman; Washington State University	Bothner, B (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	bbothner@montana.edu			U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02x04ER15563]; USDA National Institute of Food and Agriculture [1015621]; MJ Murdock Charitable Trust; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103474, S10OD28650]; MSU Office of Research, Economic Development and Graduate Education	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); MJ Murdock Charitable Trust; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MSU Office of Research, Economic Development and Graduate Education	This work was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-FG02x04ER15563 to J. L. D., J. W. P., and B. B. Partial salary support for J. W. P. was supported by the USDA National Institute of Food and Agriculture, Hatch umbrella project #1015621. Funding for the Mass Spectrometry Facility used in this publication was made possible in part by the MJ Murdock Charitable Trust, the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers P20GM103474 and S10OD28650, and the MSU Office of Research, Economic Development and Graduate Education. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; Erb TJ, 2011, APPL ENVIRON MICROB, V77, P8466, DOI 10.1128/AEM.05702-11; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Frey P., 2007, ENZYMATIC REACTION M, P418; Guarnera E, 2017, BIOINFORMATICS, V33, P3996, DOI 10.1093/bioinformatics/btx430; Guarnera E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004678; JANES W, 1990, J BIOL CHEM, V265, P10443; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; Kopec J, 2011, J STRUCT BIOL, V175, P216, DOI 10.1016/j.jsb.2011.04.006; Kurochkin IV, 2017, BIOCHEMISTRY-US, V56, P228, DOI 10.1021/acs.biochem.6b00783; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nocek B, 2002, BIOCHEMISTRY-US, V41, P12907, DOI 10.1021/bi026580p; PAI EF, 1983, J BIOL CHEM, V258, P1752; Pandey AS, 2011, FEBS LETT, V585, P459, DOI 10.1016/j.febslet.2010.12.035; Pandey AS, 2006, BIOCHEMISTRY-US, V45, P113, DOI 10.1021/bi051518o; Prussia GA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100961; Prussia GA, 2016, FEBS LETT, V590, P2991, DOI 10.1002/1873-3468.12325; Rayaprolu V., 2014, BIOPROTOC, V4, P1199; Rayaprolu V, 2013, J VIROL, V87, P13150, DOI 10.1128/JVI.01415-13; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; Streit BR, 2019, J BIOL CHEM, V294, P5137, DOI 10.1074/jbc.RA118.005554; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tan ZW, 2020, NUCLEIC ACIDS RES, V48, pW116, DOI 10.1093/nar/gkaa338; Tee WV, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006228; Tokmina-Lukaszewska M., 2018, FRONT MICROBIOL, V9, P1; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wright TA, 2017, J PHYS CHEM LETT, V8, P553, DOI 10.1021/acs.jpclett.6b02894; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421	34	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101884	10.1016/j.jbc.2022.101884	http://dx.doi.org/10.1016/j.jbc.2022.101884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35367206	gold, Green Published			2022-12-28	WOS:000798142000006
J	Sanders, MJ; Ratinaud, Y; Neopane, K; Bonhoure, N; Day, EA; Ciclet, O; Lassueur, S; Pinta, MN; Deak, M; Brinon, B; Christen, S; Steinberg, GR; Barron, D; Sakamoto, K				Sanders, Matthew J.; Ratinaud, Yann; Neopane, Katyayanee; Bonhoure, Nicolas; Day, Emily A.; Ciclet, Olivier; Lassueur, Steve; Pinta, Martine Naranjo; Deak, Maria; Brinon, Benjamin; Christen, Stefan; Steinberg, Gregory R.; Barron, Denis; Sakamoto, Kei			Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-HOMEOSTASIS; PROTEIN-KINASE; HETEROTRIMERIC COMPLEXES; LIVER; IDENTIFICATION; METFORMIN; SALSALATE; MECHANISM; A-769662; UPSTREAM	AMP-activated protein kinase (AMPK) is a central energy sensor that coordinates the response to energy challenges to maintain cellular ATP levels. AMPK is a potential therapeutic target for treating metabolic disorders, and several direct synthetic activators of AMPK have been developed that show promise in preclinical models of type 2 diabetes. These compounds have been shown to regulate AMPK through binding to a novel allosteric drug and metabolite (ADaM)-binding site on AMPK, and it is possible that other molecules might similarly bind this site. Here, we performed a high-throughput screen with natural plant compounds to identify such direct allosteric activators of AMPK. We identified a natural plant dihydrophenathrene, Lusianthridin, which allosterically activates and protects AMPK from dephos-phorylation by binding to the ADaM site. Similar to other ADaM site activators, Lusianthridin showed preferential activation of AMPK beta 1-containing complexes in intact cells and was unable to activate an AMPK beta 1 S108A mutant. Lusianthridin dose-dependently increased phosphorylation of acetyl-CoA carboxylase in mouse primary hepatocytes, which led to a corresponding decrease in de novo lipogenesis. This ability of Lusianthridin to inhibit lipogenesis was impaired in hepatocytes from beta 1 S108A knock-in mice and mice bearing a mutation at the AMPK phosphorylation site of acetyl-CoA carboxylase 1/2. Finally, we show that activation of AMPK by natural compounds extends to several analogs of Lusian-thridin and the related chemical series, phenanthrenes. The emergence of natural plant compounds that regulate AMPK through the ADaM site raises the distinct possibility that other natural compounds share a common mechanism of regulation.	[Sanders, Matthew J.; Ratinaud, Yann; Neopane, Katyayanee; Bonhoure, Nicolas; Ciclet, Olivier; Lassueur, Steve; Pinta, Martine Naranjo; Deak, Maria; Brinon, Benjamin; Barron, Denis; Sakamoto, Kei] Soc Prod Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland; [Neopane, Katyayanee] Ecole Polytech Fed Lausanne EPFL, Sch Life Sci, Lausanne, Switzerland; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Christen, Stefan] Soc Prod Nestle SA, Nestle Inst Food Safety & Analyt Sci, Nestle Res, Lausanne, Switzerland; [Sakamoto, Kei] Univ Copenhagen, Novo Nord Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; McMaster University; McMaster University; McMaster University; Nestle SA; University of Copenhagen	Sanders, MJ; Sakamoto, K (corresponding author), Soc Prod Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland.; Sakamoto, K (corresponding author), Univ Copenhagen, Novo Nord Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.	matthew.sanders@rd.nestle.com; kei.sakamoto@sund.ku.dk	; Sakamoto, Kei/C-8806-2019	Ciclet, Olivier/0000-0002-0463-8189; Sakamoto, Kei/0000-0001-8839-5980; Sanders, Matthew James/0000-0001-6185-6337; Neopane, Katyayanee/0000-0002-6281-6588	Diabetes Canada Investigator Award [DI-5-17-5302-GS]; Canadian Institutes of Health Research Foundation [201709FDN-CEBA-116200]; Tier 1 Canada Research Chair; J. Bruce Duncan Endowed Chair in Metabolic Diseases; Novo Nordisk Foundation [NNF21OC0070257]	Diabetes Canada Investigator Award; Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); J. Bruce Duncan Endowed Chair in Metabolic Diseases; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	-G. R. S. is supported by a Diabetes Canada Investigator Award (grant no.: DI-5-17-5302-GS) , a Canadian Institutes of Health Research Foundation Grant (grant no.: 201709FDN-CEBA-116200) , a Tier 1 Canada Research Chair and a J. Bruce Duncan Endowed Chair in Metabolic Diseases. K. S. is supported by a project grant from the Novo Nordisk Foundation (grant no.: NNF21OC0070257) . The authors acknowledge the provision of ACC DKI mice to G.R.S. from Prof. Bruce Kemp, St. Vincents Institute of Medical Research, Australia.	Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhummaphan N, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152932; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Cakova V, 2017, AGING DIS, V8, P827, DOI 10.14336/AD.2017.0214; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Cameron KO, 2016, BIOORG MED CHEM LETT, V26, P5139, DOI 10.1016/j.bmcl.2016.09.065; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Coulerie P, 2016, J NAT PROD, V79, P2856, DOI 10.1021/acs.jnatprod.6b00628; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Esquejo RM, 2018, EBIOMEDICINE, V31, P122, DOI 10.1016/j.ebiom.2018.04.009; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; FRITZEMEIER KH, 1983, EUR J BIOCHEM, V133, P545, DOI 10.1111/j.1432-1033.1983.tb07498.x; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gluais-Dagorn P, 2022, HEPATOL COMMUN, V6, P101, DOI 10.1002/hep4.1799; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2016, ACTA PHARM SIN B, V6, P1, DOI 10.1016/j.apsb.2015.06.002; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2016, DIABETES, V65, P2784, DOI 10.2337/db16-0058; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Klongkumnuankarn P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/350410; Kopietz F, 2021, BIOCHEM J, V478, P633, DOI 10.1042/BCJ20200659; LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023; Leri M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041250; Marcinko K, 2015, MOL METAB, V4, P643, DOI 10.1016/j.molmet.2015.06.002; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Ou-yang SH, 2018, CHEM CENT J, V12, DOI 10.1186/s13065-018-0423-4; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Pinkosky SL, 2020, NAT METAB, V2, P873, DOI 10.1038/s42255-020-0245-2; Pollastro F, 2018, CURR MED CHEM, V25, P1160, DOI 10.2174/0929867324666170810164636; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Rena G, 2014, DIABETOL INT, V5, P212, DOI 10.1007/s13340-014-0177-8; Rhein P, 2021, MOL METAB, V51, DOI 10.1016/j.molmet.2021.101228; Salastekar N, 2017, DIABETES OBES METAB, V19, P1458, DOI 10.1111/dom.12940; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Toth B, 2018, J NAT PROD, V81, P661, DOI [10.1021/acs.jnatprod.7b00619, 10.10]; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	61	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101852	10.1016/j.jbc.2022.101852	http://dx.doi.org/10.1016/j.jbc.2022.101852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35331736	gold, Green Published			2022-12-28	WOS:000817175700012
J	Fang, Y; Liu, DY; Jiang, JJ; He, AX; Zhu, R; Tian, LJ				Fang, Yuan; Liu, Dongyang; Jiang, Jingjing; He, Axin; Zhu, Rui; Tian, Lijin			Photoprotective energy quenching in the red alga Porphyridium purpureum occurs at the core antenna of the photosystem II but not at its reaction center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEXES; CHLOROPHYLL FLUORESCENCE; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; EXCESS LIGHT; PROTEIN; DISSIPATION; CYANOBACTERIAL; MECHANISMS; MEMBRANES	Photosynthetic organisms have evolved light-harvesting antennae over time. In cyanobacteria, external phycobilisomes (PBSs) are the dominant antennae, whereas in green algae and higher plants, PBSs have been replaced by proteins of the Lhc family that are integrated in the membrane. Red algae represent an evolutionary intermediate between these two systems, as they employ both PBSs and membrane LHCR proteins as light-harvesting units. Understanding how red algae cope with light is not only interesting for biotechnological applications, but is also of evolutionary interest. For example, energy-dependent quenching (qE) is an essential photoprotective mechanism widely used by species from cyanobacteria to higher plants to avoid light damage; however, the quenching mechanism in red algae remains largely unexplored. Here, we used both pulse amplitude-modulated (PAM) and time-resolved chlorophyll fluorescence to characterize qE kinetics in the red alga Porphyridium purpureum. PAM traces confirmed that qE in P. purpureum is activated by a decrease in the thylakoid lumen pH, whereas time-resolved fluorescence results further revealed the quenching site and ultrafast quenching kinetics. We found that quenching exclusively takes place in the photosystem II (PSII) complexes and preferentially occurs at PSII's core antenna rather than at its reaction center, with an overall quenching rate of 17.6 +/- 3.0 ns(-1). In conclusion, we propose that qE in red algae is not a reaction center type of quenching, and that there might be a membrane-bound protein that resembles PsbS of higher plants or LHCSR of green algae that senses low luminal pH and triggers qE in red algae.	[Fang, Yuan; Liu, Dongyang; Jiang, Jingjing; Tian, Lijin] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China; [Fang, Yuan; Liu, Dongyang] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Axin] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China; [Zhu, Rui] Peking Univ, Sch Phys, Electron Microscopy Lab, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Tian, LJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Beijing, Peoples R China.	ltian@ibcas.ac.cn			National Key Research and Development Program of China [2019YFA0904604]; National Natural Science Foundation of China [11804172, 31970381, 11605001, 91850104]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Gert Schansker for useful discussions. This work is supported by grants from the National Key Research and Development Program of China (Grant No. 2019YFA0904604), the National Natural Science Foundation of China (Grant Nos.11804172, 31970381, 11605001, 91850104).	Ago H, 2016, J BIOL CHEM, V291, P5676, DOI 10.1074/jbc.M115.711689; Allorent G, 2016, P NATL ACAD SCI USA, V113, P14864, DOI 10.1073/pnas.1607695114; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bruce D, 1997, BIOCHEMISTRY-US, V36, P749, DOI 10.1021/bi962216c; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Calzadilla PI, 2020, PHOTOCH PHOTOBIO SCI, V19, P585, DOI 10.1039/c9pp00451c; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Cian RE, 2015, MAR DRUGS, V13, P5358, DOI 10.3390/md13085358; Croce R, 2020, SCIENCE, V369, P933, DOI 10.1126/science.aay2058; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Dall'Osto L, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.33; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Endo T, 1996, PLANT CELL PHYSIOL, V37, P551, DOI 10.1093/oxfordjournals.pcp.a028979; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Farooq S, 2018, NAT PLANTS, V4, P225, DOI 10.1038/s41477-018-0127-8; Fattore N, 2021, PHYSIOL PLANTARUM, V173, P805, DOI 10.1111/ppl.13489; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Gabilly ST, 2019, P NATL ACAD SCI USA, V116, P17556, DOI 10.1073/pnas.1821689116; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; Giovagnetti V, 2018, BIOCHEM SOC T, V46, P1263, DOI 10.1042/BST20170304; Girolomoni L, 2019, P NATL ACAD SCI USA, V116, P4212, DOI 10.1073/pnas.1809812116; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Ho MY, 2017, CURR OPIN PLANT BIOL, V37, P24, DOI 10.1016/j.pbi.2017.03.006; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Krishnan-Schmieden M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22530-4; Krupnik T, 2013, J BIOL CHEM, V288, P23529, DOI 10.1074/jbc.M113.484659; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2019, J PHYS CHEM LETT, V10, P1737, DOI 10.1021/acs.jpclett.9b00437; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Luimstra VM, 2019, PHOTOSYNTH RES, V141, P291, DOI 10.1007/s11120-019-00630-z; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murata N, 2009, PHOTOSYNTH RES, V99, P155, DOI 10.1007/s11120-008-9389-8; Murchie EH, 2020, PLANT J, V101, P885, DOI 10.1111/tpj.14601; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nicol L, 2019, NAT PLANTS, V5, P1177, DOI 10.1038/s41477-019-0526-5; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pi X, 2018, P NATL ACAD SCI USA, V115, P4423, DOI 10.1073/pnas.1722482115; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Sacharz J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.225; Snellenburg JJ, 2017, BBA-BIOENERGETICS, V1858, P64, DOI 10.1016/j.bbabio.2016.10.001; Snellenburg JJ, 2013, J PHYS CHEM B, V117, P11363, DOI 10.1021/jp4031283; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Su HN, 2010, PHOTOSYNTH RES, V106, P73, DOI 10.1007/s11120-010-9560-x; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Tian LJ, 2019, P NATL ACAD SCI USA, V116, P8320, DOI 10.1073/pnas.1817796116; Tian LJ, 2013, PHYS CHEM CHEM PHYS, V15, P3146, DOI 10.1039/c3cp43813a; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Ueno Y, 2015, PHOTOSYNTH RES, V125, P211, DOI 10.1007/s11120-015-0078-0; Usov AI, 2011, ADV CARBOHYD CHEM BI, V65, P115, DOI 10.1016/B978-0-12-385520-6.00004-2; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Wang HMD, 2015, BIORESOURCE TECHNOL, V184, P355, DOI 10.1016/j.biortech.2014.12.001; Wesselhoeft RA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05096-6; Wientjes E, 2012, PHOTOSYNTH RES, V111, P185, DOI 10.1007/s11120-011-9671-z; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Xu PQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13679; Yu P, 2017, CRIT REV FOOD SCI, V57, P3840, DOI 10.1080/10408398.2016.1167668; Zhan J, 2021, PLANT CELL, V33, P358, DOI 10.1093/plcell/koaa030	68	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101783	10.1016/j.jbc.2022.101783	http://dx.doi.org/10.1016/j.jbc.2022.101783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35245502	gold, Green Published			2022-12-28	WOS:000823106100009
J	Ueda, C; Langton, M; Chen, JH; Pandelia, ME				Ueda, Chie; Langton, Michelle; Chen, Jiahua; Pandelia, Maria-Eirini			The HBx protein from hepatitis B virus coordinates a redox-active Fe-S cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; X-PROTEIN; 4FE-4S CLUSTERS; ESCHERICHIA-COLI; 2FE-2S; GENE; CARCINOGENESIS; CHEMISTRY; SCAFFOLD; BINDING	The viral protein HBx is the key regulatory factor of the hepatitis B virus (HBV) and the main etiology for HBVassociated liver diseases, such as cirrhosis and hepatocellular carcinoma. Historically, HBx has defied biochemical and structural characterization, deterring efforts to understand its molecular mechanisms. Here we show that soluble HBx fused to solubility tags copurifies with either a [2Fe-2S] or a [4Fe-4S] cluster, a feature that is shared among five HBV genotypes. We show that the O-2-stable [2Fe-2S] cluster form converts to an O-2-sensitive [4Fe-4S] state when reacted with chemical reductants, a transformation that is best described by a reductive coupling mechanism reminiscent of Fe-S cluster scaffold proteins. In addition, the Fe-S cluster conversions are partially reversible in successive reduction-oxidation cycles, with cluster loss mainly occurring during (re)oxidation. The considerably negative reduction potential of the [4Fe-4S](2+/1+) couple (-520 mV) suggests that electron transfer may not be likely in the cell. Collectively, our findings identify HBx as an Fe-S protein with striking similarities to Fe-S scaffold proteins both in cluster type and reductive transformation. An Fe-S cluster in HBx offers new insights into its previously unknown molecular properties and sets the stage for deciphering the roles of HBx-associated iron (mis)regulation and reactive oxygen species in the context of liver tumorigenesis.	[Ueda, Chie; Langton, Michelle; Chen, Jiahua; Pandelia, Maria-Eirini] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University	Pandelia, ME (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA.	mepandelia@brandeis.edu		Pandelia, Maria-Eirini/0000-0002-6750-1948; Ueda, Chie/0000-0001-7604-7065	National Institutes of Health [GM111978, GM126303]; Brandeis University Innovation SPROUT Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brandeis University Innovation SPROUT Program	This work was supported by the National Institutes of Health (Grant Nos. GM111978 and GM126303 to M.-E. P.) and the Brandeis University Innovation SPROUT Program (to C. U., M. L., and M.-E. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Bak DW, 2014, CURR OPIN CHEM BIOL, V19, P50, DOI 10.1016/j.cbpa.2013.12.015; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; DEMEDINA T, 1994, VIROLOGY, V202, P401, DOI 10.1006/viro.1994.1356; Funauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16497; Geng M, 2015, WORLD J GASTROENTERO, V21, P10732, DOI 10.3748/wjg.v21.i38.10732; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gtlich P., 2011, MSSBAUER SPECTROSCOP; Gu JM, 2008, VIRUS RES, V133, P167, DOI 10.1016/j.virusres.2007.12.014; Gupta V., 2009, J AM CHEM SOC; Ha HL, 2010, WORLD J GASTROENTERO, V16, P4932, DOI 10.3748/wjg.v16.i39.4932; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Jiang TY, 2016, P NATL ACAD SCI USA, V113, P2074, DOI 10.1073/pnas.1525616113; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Langton M, 2020, ACS OMEGA, V5, P16772, DOI 10.1021/acsomega.0c01762; Lee SH, 2012, MOL CELLS, V34, P165, DOI 10.1007/s10059-012-0060-z; Li D, 2015, INT J MOL MED, V35, P319, DOI 10.3892/ijmm.2014.2018; Li JH, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01967-18; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540; Lim W, 2010, J MOL MED, V88, P359, DOI 10.1007/s00109-009-0563-z; Ling LR, 2020, ONCOL LETT, V19, P2861, DOI 10.3892/ol.2020.11404; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Maio N, 2021, SCIENCE, V373, P236, DOI 10.1126/science.abi5224; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Martin D, 2013, FASEB J, V27, P1074, DOI 10.1096/fj.12-217182; Nasta V, 2020, FEBS J, V287, P2312, DOI 10.1111/febs.15140; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7; Ramakrishnan D, 2019, J VIROL, V93, DOI 10.1128/JVI.00250-19; Rouault T. A., 2014, IRON SULFUR CLUSTERS; Saeed U, 2019, J VIROL, V93, DOI 10.1128/JVI.01840-18; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shimberg GD, 2018, METHOD ENZYMOL, V599, P101, DOI 10.1016/bs.mie.2017.09.005; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Tsang SH, 2016, J VIROL, V90, P1544, DOI 10.1128/JVI.02121-15; Ueda C, 2021, METHODS MOL BIOL, V2353, P281, DOI 10.1007/978-1-0716-1605-5_15; Urban S, 1997, HEPATOLOGY, V26, P1045, DOI 10.1002/hep.510260437; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Velkov S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100495; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Weiler BD, 2020, P NATL ACAD SCI USA, V117, P20555, DOI 10.1073/pnas.2003982117; Zamor PJ, 2017, J GASTROINTEST ONCOL, V8, P229, DOI 10.21037/jgo.2017.03.14; Zhang Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0366-3; Zheng BY, 2014, INT J ONCOL, V45, P1143, DOI 10.3892/ijo.2014.2499	59	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101698	10.1016/j.jbc.2022.101698	http://dx.doi.org/10.1016/j.jbc.2022.101698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35148994	gold, Green Published			2022-12-28	WOS:000793560400006
J	Fakhraldeen, SA; Berry, SM; Beebe, DJ; Roopra, A; Bisbach, CM; Spiegelman, VS; Niemi, NM; Alexander, CM				Fakhraldeen, Saja A.; Berry, Scott M.; Beebe, David J.; Roopra, Avtar; Bisbach, Celia M.; Spiegelman, Vladimir S.; Niemi, Natalie M.; Alexander, Caroline M.			Enhanced immunoprecipitation techniques for the identification of RNA-binding protein partners: IGF2BP1 interactions in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTOME-WIDE IDENTIFICATION; MESSENGER-RNA; CRD-BP; CODING REGION; BREAST-CANCER; PAR-CLIP; EXPRESSION; TARGETS; GROWTH; TRANSLATION	RNA-binding proteins (RBPs) regulate the expression of large cohorts of RNA species to produce programmatic changes in cellular phenotypes. To describe the function of RBPs within a cell, it is key to identify their mRNA-binding partners. This is often done by crosslinking nucleic acids to RBPs, followed by chemical release of the nucleic acid fragments for analysis. However, this methodology is lengthy, which involves complex processing with attendant sample losses, thus large amounts of starting materials and prone to artifacts. To evaluate potential alternative technologies, we tested "exclusion-based " purification of immunoprecipitates (IFAST or SLIDE) and report here that these methods can efficiently, rapidly, and specifically isolate RBP-RNA complexes. The analysis requires less than 1% of the starting material required for techniques that include crosslinking. Depending on the antibody used, 50% to 100% starting protein can be retrieved, facilitating the assay of endogenous levels of RBPs; the isolated ribonucleoproteins are subsequently analyzed using standard techniques, to provide a comprehensive portrait of RBP complexes. Using exclusion-based techniques, we show that the mRNA-binding partners for RBP IGF2BP1 in cultured mammary epithelial cells are enriched in mRNAs important for detoxifying superoxides (specifically glutathione peroxidase [GPX]-1 and GPX-2) and mRNAs encoding mitochondrial proteins. We show that these interactions are functionally significant, as loss of function of IGF2BP1 leads to destabilization of GPX mRNAs and reduces mitochondrial membrane potential and oxygen consumption. We speculate that this underlies a consistent requirement for IGF2BP1 for the expression of clonogenic activity in vitro.	[Fakhraldeen, Saja A.; Bisbach, Celia M.; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA; [Berry, Scott M.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA; [Spiegelman, Vladimir S.] Penn State Univ, Dept Pediat, Div Pediat Hematol Oncol, Coll Med, Hershey, PA USA; [Niemi, Natalie M.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO USA; [Fakhraldeen, Saja A.] Kuwait Inst Sci Res, Kuwait, Kuwait; [Berry, Scott M.] Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA; [Bisbach, Celia M.] Promega Corp, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Washington University (WUSTL); Kuwait Institute for Scientific Research; University of Kentucky; Promega Corporation	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	cmalexander@wisc.edu		alexander, caroline/0000-0002-7830-8043; Fakhraldeen, Saja/0000-0003-3919-0270; Bisbach, Celia/0000-0001-6161-1401	Kuwait Foundation for the Advancement of Sciences [2013-6302-03]; Department of Defense Scholar Award [W81XWH-06-1-0491]; National Institute of Neurological Disorders and Stroke [R21NS095187]; National Cancer Institute [RO1CA121851]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1AR063361]	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Department of Defense Scholar Award(United States Department of Defense); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	S. A. F. was supported by the Kuwait Foundation for the Advancement of Sciences under project no.: 2013-6302-03. This project was also supported by a Department of Defense Scholar Award (grant no.: W81XWH-06-1-0491; to C. M. A.), National Institute of Neurological Disorders and Stroke (grant no.: R21NS095187 [to A. R.], National Cancer Institute (grant no.: RO1CA186134 [to D. J. B.]), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant nos.: RO1AR063361 and National Cancer Institute RO1CA121851 [to V. S. S.]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ascano M, 2013, CURR OPIN GENET DEV, V23, P20, DOI 10.1016/j.gde.2013.01.003; Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Berry SM, 2014, J MOL DIAGN, V16, P297, DOI 10.1016/j.jmoldx.2014.01.004; Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g; Berry SM, 2014, ANAL BIOCHEM, V447, P133, DOI 10.1016/j.ab.2013.10.038; Berry SM, 2013, JALA-J LAB AUTOM, V18, P206, DOI 10.1177/2211068212462023; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Biegel JM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.608816; Brigelius-Flohe R, 2020, ANTIOXID REDOX SIGN, V33, P498, DOI 10.1089/ars.2019.7905; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Buszczak M, 2014, CELL, V159, P242, DOI 10.1016/j.cell.2014.09.016; Casavant BP, 2014, ANAL CHEM, V86, P6355, DOI 10.1021/ac500574t; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chen E, 2014, MOL CELL, V54, P407, DOI 10.1016/j.molcel.2014.03.023; Chin EN, 2016, MOL CELL BIOL, V36, P871, DOI 10.1128/MCB.00800-15; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Cruz-Zaragoza LD, 2021, CELL, V184, P5824, DOI 10.1016/j.cell.2021.09.033; Dannenmann B., 2015, HIGH GLUTATHIONE GLU; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Doyle GA, 2000, CANCER RES, V60, P2756; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Elcheva IA, 2020, LEUKEMIA, V34, P1354, DOI 10.1038/s41375-019-0656-9; Eom T, 2003, J NEUROSCI, V23, P10433; Fakhraldeen SA, 2015, J BIOL CHEM, V290, P13386, DOI 10.1074/jbc.M115.655175; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Faye MD, 2015, ONCOGENE, V34, P1532, DOI 10.1038/onc.2014.90; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; Goel S., 2012, J BIOL CHEM, V287; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim T, 2018, MOL CARCINOGEN, V57, P678, DOI 10.1002/mc.22786; Kipp AP, 2017, ADV CANCER RES, V136, P109, DOI 10.1016/bs.acr.2017.07.004; Kloetgen A, 2015, BRIEF FUNCT GENOMICS, V14, P102, DOI 10.1093/bfgp/elu020; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moussavi-Harami SF, 2013, J PROTEOME RES, V12, P3393, DOI 10.1021/pr400225p; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Pla-Martin D, 2020, EMBO J, V39, DOI 10.15252/embj.2019102731; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Schaefer J., 2021, CELL, V82, P1; Scheibe M, 2012, NUCLEIC ACIDS RES, V40, P9897, DOI 10.1093/nar/gks746; Son MJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.74; Sperger Jamie M, 2017, Clin Cancer Res, V23, P746, DOI 10.1158/1078-0432.CCR-16-1021; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Van Nostrand EL, 2016, ADV EXP MED BIOL, V907, P1, DOI 10.1007/978-3-319-29073-7_1; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vellky JE, 2020, P NATL ACAD SCI USA, V117, P28092, DOI 10.1073/pnas.2008479117; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Woellhaf MW, 2014, BIOCHEM CELL BIOL, V92, P489, DOI 10.1139/bcb-2014-0029; Wu WT, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-00930-1; Yang F, 2014, FEBS J, V281, P802, DOI 10.1111/febs.12625; Yin R, 2022, CELL STEM CELL, V29, P149, DOI 10.1016/j.stem.2021.09.014; Zeliadt N., 2014, SCIENTIST	82	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101649	10.1016/j.jbc.2022.101649	http://dx.doi.org/10.1016/j.jbc.2022.101649			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0KH	35104504	gold, Green Published			2022-12-28	WOS:000794865600013
J	Gradisch, R; Szoelloesi, D; Niello, M; Lazzarin, E; Sitte, HH; Stockner, T				Gradisch, Ralph; Szoelloesi, Daniel; Niello, Marco; Lazzarin, Erika; Sitte, Harald H.; Stockner, Thomas			Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; OUTWARD-OPEN; FORCE-FIELD; MECHANISM; DYNAMICS; PROTEIN; EXTENSION; EFFICACY	The human serotonin transporter (hSERT) terminates neurotransmission by removing serotonin (5HT) from the synaptic cleft, an essential process for proper functioning of serotonergic neurons. Structures of the hSERT have revealed its molecular architecture in four conformations, including the outward-open and occluded states, and show the transporter's engagement with co-transported ions and the binding mode of inhibitors. In this study, we investigated the molecular mechanism by which the hSERT occludes and sequesters the substrate 5HT. This first step of substrate uptake into cells is a structural change consisting of the transition from the outward-open to the occluded state. Inhibitors such as the antidepressants citalopram, fluoxetine, and sertraline inhibit this step of the transport cycle. Using molecular dynamics simulations, we reached a fully occluded state, in which the transporter-bound 5HT becomes fully shielded from both sides of the membrane by two closed hydrophobic gates. Analysis of 5HT-triggered occlusion showed that bound 5HT serves as an essential trigger for transporter occlusion. Moreover, simulations revealed a complex sequence of steps and showed that movements of bundle domain helices are only partially correlated. 5HT-triggered occlusion is initially dominated by movements of transmembrane helix 1b, while in the final step, only transmembrane helix 6a moves and relaxes an intermediate change in its secondary structure.	[Gradisch, Ralph; Szoelloesi, Daniel; Niello, Marco; Lazzarin, Erika; Sitte, Harald H.; Stockner, Thomas] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Stockner, T (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria.	thomas.stockner@meduniwien.ac.at	; Stockner, Thomas/A-9509-2014	Gradisch, Ralph/0000-0002-3312-2472; Szollosi, Daniel/0000-0003-4641-3065; Stockner, Thomas/0000-0002-7071-8283	Austrian Science Fund (FWF) [P32017]; European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [860954]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	The research underlying the current publication has been supported by the Austrian Science Fund (FWF) stand-alone grant P32017 to T. S. and H. H. S. This project has received funding from the European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860954. The results presented have been achieved using the Vienna Scientific Cluster.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Barker EL, 1999, J NEUROSCI, V19, P4705; Bhat S, 2021, PHARMACOL THERAPEUT, V222, DOI 10.1016/j.pharmthera.2020.107785; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cheng MH, 2015, STRUCTURE, V23, P2171, DOI 10.1016/j.str.2015.09.001; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Duart-Castells L, 2021, NEUROPHARMACOLOGY, V186, DOI 10.1016/j.neuropharm.2021.108475; Focke PJ, 2013, STRUCTURE, V21, P694, DOI 10.1016/j.str.2013.03.002; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; FULLER RW, 1990, ANN NY ACAD SCI, V600, P68, DOI 10.1111/j.1749-6632.1990.tb16873.x; Gobbi M, 2008, J NEUROCHEM, V105, P1770, DOI 10.1111/j.1471-4159.2008.05272.x; Gotfryd K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14735-w; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; Hasenhuetl PS, 2019, MOL PHARMACOL, V95, P303, DOI 10.1124/mol.118.114793; Hellsberg E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217377; Jambeck JPM, 2013, J CHEM THEORY COMPUT, V9, P774, DOI 10.1021/ct300777p; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Niello M, 2020, TRENDS PHARMACOL SCI, V41, P446, DOI 10.1016/j.tips.2020.04.006; Niello M, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.04.021; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Rothman RB, 2012, J PHARMACOL EXP THER, V341, P251, DOI 10.1124/jpet.111.188946; Saha K, 2015, NEUROPSYCHOPHARMACOL, V40, P1321, DOI 10.1038/npp.2014.325; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; Szollosi D, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11020255; Szollosi D, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.673782; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Thomas JR, 2012, BIOPHYS J, V103, pL01, DOI 10.1016/j.bpj.2012.05.002; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Webb B, 2021, METHODS MOL BIOL, V2199, P239, DOI 10.1007/978-1-0716-0892-0_14; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang DX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abl3857; Zeppelin T, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.02.030	58	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101613	10.1016/j.jbc.2022.101613	http://dx.doi.org/10.1016/j.jbc.2022.101613			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HA	35065961	Green Published, gold			2022-12-28	WOS:000789396300011
J	Heo, K; Lee, JW; Jang, Y; Kwon, S; Lee, J; Seok, C; Ha, NC; Seok, YJ				Heo, Kyoo; Lee, Jae-Woo; Jang, Yongdae; Kwon, Sohee; Lee, Jaehun; Seok, Chaok; Ha, Nam-Chul; Seok, Yeong-Jae			A pGpG-specific phosphodiesterase regulates cyclic di-GMP signaling in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OXIDATIVE STRESS; OLIGORIBONUCLEASE; PROTEIN; DIGUANYLATE; ENZYME; IDENTIFICATION; DETERMINANTS; VIRULENCE	The bacterial second messenger bis-(3'-5')-cyclic diguanylate monophosphate (c-di-GMP) controls various cellular processes, including motility, toxin production, and biofilm formation. c-di-GMP is enzymatically synthesized by GGDEF domain-containing diguanylate cyclases and degraded by HD-GYP domain-containing phosphodiesterases (PDEs) to 2 GMP or by EAL domain-containing PDE-As to 5'-phosphoguanylyl-(3',5')-guanosine (pGpG). Since excess pGpG feedback inhibits PDE-A activity and thereby can lead to the uncontrolled accumulation of c-di-GMP, a PDE that degrades pGpG to 2 GMP (PDE-B) has been presumed to exist. To date, the only enzyme known to hydrolyze pGpG is oligoribonuclease Orn, which degrades all kinds of oligoribonucleotides. Here, we identified a pGpG-specific PDE, which we named PggH, using biochemical approaches in the gram-negative bacteria Vibrio cholerae. Biochemical experiments revealed that PggH exhibited specific PDE activity only toward pGpG, thus differing from the previously reported Orn. Furthermore, the high-resolution structure of PggH revealed the basis for its PDE activity and narrow substrate specificity. Finally, we propose that PggH could modulate the activities of PDE-As and the intracellular concentration of c-di-GMP, resulting in phenotypic changes including in biofilm formation.	[Heo, Kyoo; Lee, Jae-Woo; Lee, Jaehun; Seok, Yeong-Jae] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Heo, Kyoo; Lee, Jae-Woo; Lee, Jaehun; Seok, Yeong-Jae] Seoul Natl Univ, Inst Microbiol, Seoul, South Korea; [Jang, Yongdae; Ha, Nam-Chul] Seoul Natl Univ, Ctr Food & Bioconvergence, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Kwon, Sohee; Seok, Chaok] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Seok, YJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Seok, YJ (corresponding author), Seoul Natl Univ, Inst Microbiol, Seoul, South Korea.; Ha, NC (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea.	hanc210@snu.ac.kr; yjseok@snu.ac.kr		Heo, Kyoo/0000-0001-6570-5683; Kwon, Sohee/0000-0003-3447-4610	National Research Foundation - Ministry of Science and ICT [NRF-2018R1A5A1025077, NRF-2019R1A2C2004143]; Brain Korea 21 program	National Research Foundation - Ministry of Science and ICT(National Research Foundation of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation Grants NRF-2018R1A5A1025077 and NRF-2019R1A2C2004143 funded by the Ministry of Science and ICT and by the Brain Korea 21 program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; Choe M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50249-2; Choe M, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43431; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Conner JG, 2017, CURR OPIN MICROBIOL, V36, P20, DOI 10.1016/j.mib.2017.01.002; Drexler DJ, 2017, STRUCTURE, V25, P1887, DOI 10.1016/j.str.2017.10.001; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher CR, 2016, J BACTERIOL, V198, P2810, DOI 10.1128/JB.00215-16; Gao J, 2015, CELL RES, V25, P539, DOI 10.1038/cr.2015.40; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Hallberg ZF, 2016, P NATL ACAD SCI USA, V113, P1790, DOI 10.1073/pnas.1515287113; He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Heo K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13353-5; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Kim HM, 2015, MOL MICROBIOL, V96, P293, DOI 10.1111/mmi.12936; Kim SK, 2019, ELIFE, V8, DOI 10.7554/eLife.46313; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Lacey MM, 2010, MICROBIOL-SGM, V156, P2873, DOI 10.1099/mic.0.037887-0; Lee JW, 2018, P NATL ACAD SCI USA, V115, pE6845, DOI 10.1073/pnas.1722514115; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; NIYOGI SK, 1975, J BIOL CHEM, V250, P7307; Orr MW, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00300-18; Orr MW, 2015, P NATL ACAD SCI USA, V112, pE5048, DOI 10.1073/pnas.1507245112; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113811; Park S, 2019, MOL MICROBIOL, V112, P266, DOI 10.1111/mmi.14268; Park S, 2016, MOL MICROBIOL, V101, P795, DOI 10.1111/mmi.13424; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Srivastav R, 2019, INT J BIOL MACROMOL, V127, P66, DOI 10.1016/j.ijbiomac.2018.12.123; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Uemura Y, 2013, FEBS LETT, V587, P2669, DOI 10.1016/j.febslet.2013.06.053; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; 장용대, 2017, Biodesign, V5, P70; Wright TA, 2020, MOL MICROBIOL, V113, P222, DOI 10.1111/mmi.14412; Yadav M, 2019, BIOCHEM J, V476, P3333, DOI 10.1042/BCJ20190399; Yang J, 2019, J COMPUT CHEM, V40, P2739, DOI 10.1002/jcc.26050; Yoon CK, 2021, NUCLEIC ACIDS RES, V49, P1397, DOI 10.1093/nar/gkab013; Zhang XL, 1998, J BACTERIOL, V180, P2779, DOI 10.1128/JB.180.10.2779-2781.1998	54	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101626	10.1016/j.jbc.2022.101626	http://dx.doi.org/10.1016/j.jbc.2022.101626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R3ZO	35074425	gold, Green Published			2022-12-28	WOS:000821051800009
J	Lee, J; Pandey, AK; Venkatesh, S; Thilagavathi, J; Honda, T; Singh, K; Suzuki, CK				Lee, Jae; Pandey, Ashutosh K.; Venkatesh, Sundararajan; Thilagavathi, Jayapalraja; Honda, Tadashi; Singh, Kamal; Suzuki, Carolyn K.			Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BARDOXOLONE METHYL; TRITERPENOID CDDO; 2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OIC ACID; SEMIEMPIRICAL METHODS; SYNTHETIC OLEANANE; STAGE 4; CANCER; MECHANISM; PATHWAY	The mitochondrial protein LonP1 is an ATP-dependent protease that mitigates cell stress and calibrates mitochon-drial metabolism and energetics. Biallelic mutations in the LONP1 gene are known to cause a broad spectrum of diseases, and LonP1 dysregulation is also implicated in cancer and age-related disorders. Despite the importance of LonP1 in health and disease, specific inhibitors of this protease are unknown. Here, we demonstrate that 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its -methyl and-imidazole de-rivatives reversibly inhibit LonP1 by a noncompetitive mech-anism, blocking ATP-hydrolysis and thus proteolysis. By contrast, we found that CDDO-anhydride inhibits the LonP1 ATPase competitively. Docking of CDDO derivatives in the cryo-EM structure of LonP1 shows these compounds bind a hydrophobic pocket adjacent to the ATP-binding site. The binding site of CDDO derivatives was validated by amino acid substitutions that increased LonP1 inhibition and also by a pathogenic mutation that causes cerebral, ocular, dental, auricular and skeletal (CODAS) syndrome, which ablated in-hibition. CDDO failed to inhibit the ATPase activity of the purified 26S proteasome, which like LonP1 belongs to the AAA+ superfamily of ATPases Associated with diverse cellular Activities, suggesting that CDDO shows selectivity within this family of ATPases. Furthermore, we show that noncytotoxic concentrations of CDDO derivatives in cultured cells inhibited LonP1, but not the 26S proteasome. Taken together, these findings provide insights for future development of LonP1-specific inhibitors with chemotherapeutic potential.	[Lee, Jae; Pandey, Ashutosh K.; Venkatesh, Sundararajan; Thilagavathi, Jayapalraja; Suzuki, Carolyn K.] Rutgers New Jersey Med Sch, Dept Microbiol, Biochem & Mol Genet, Newark, NJ 07101 USA; [Honda, Tadashi] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11794 USA; [Singh, Kamal] Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Singh, Kamal] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Singh, Kamal] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Pandey, Ashutosh K.] Rutgers New Jersey Med Sch, Dept Pharmacol, Physiol & Neurosci, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Karolinska Institutet; Rutgers State University New Brunswick; Rutgers State University Medical Center	Suzuki, CK (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol, Biochem & Mol Genet, Newark, NJ 07101 USA.; Singh, K (corresponding author), Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA.; Singh, K (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Singh, K (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	singhka@missouri.edu; suzukick@njms.rutgers.edu	; Sundararajan, Venkatesh/H-3837-2014	Honda, Tadashi/0000-0003-0746-9453; Sundararajan, Venkatesh/0000-0003-4195-7776	National Institutes of Healths (NIH) [-1R21 NS067668-01, 1R01 GM084039-01A1]; NJ Health Foundation Research Award	National Institutes of Healths (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJ Health Foundation Research Award	This work was supported in part by grants from the National Institutes of Healths (NIH) -1R21 NS067668-01 and 1R01 GM084039-01A1 and a NJ Health Foun-dation Research Award to C. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Baigent C, 2018, J AM SOC NEPHROL, V29, P357, DOI 10.1681/ASN.2017101062; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Besse A, 2020, MITOCHONDRION, V51, P68, DOI 10.1016/j.mito.2020.01.004; Bonner ER, 2021, NEURO-ONCOLOGY, V23, P542, DOI 10.1093/neuonc/noaa283; Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Celentano S., 2019, G ITAL NEFROL, V36, P2019; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cheng AN, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001372; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; Chin MP, 2018, AM J NEPHROL, V47, P40, DOI 10.1159/000486398; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Deng P, 2017, SEMIN CANCER BIOL, V47, P43, DOI 10.1016/j.semcancer.2017.05.002; Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Feng Y, 2021, CANCERS, V13, DOI 10.3390/cancers13092020; Gibellini L, 2020, INT REV CEL MOL BIO, V354, P1, DOI 10.1016/bs.ircmb.2020.02.005; Gibellini L, 2015, ONCOTARGET, V6, P25466, DOI 10.18632/oncotarget.4510; Graves PR, 2019, ACS CHEM BIOL, V14, P1020, DOI 10.1021/acschembio.9b00222; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Honda T, 2010, BIOORG MED CHEM LETT, V20, P2275, DOI 10.1016/j.bmcl.2010.02.007; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hsu SK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102518; Ishizawa J, 2019, CANCER CELL, V35, P721, DOI 10.1016/j.ccell.2019.03.014; Kabe Y, 2020, NPJ SCI FOOD, V4, DOI 10.1038/s41538-020-0064-6; Khan YA, 2022, CRIT REV BIOCHEM MOL, V57, P156, DOI 10.1080/10409238.2021.1979460; Kim W, 2013, MOL PHARMACOL, V83, P367, DOI 10.1124/mol.112.082578; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Liao JH, 2013, ACTA CRYSTALLOGR D, V69, P1395, DOI 10.1107/S0907444913008214; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Maneix L, 2021, CANCERS, V13, DOI 10.3390/cancers13040843; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Mohammed I., 2021, BIORXIV, DOI [10.1101/2021.1107.1128.454137, DOI 10.1101/2021.1107.1128.454137]; Nimmo GAM, 2019, HUM MOL GENET, V28, P290, DOI 10.1093/hmg/ddy351; Nunes AT, 2017, SEMIN ONCOL, V44, P377, DOI 10.1053/j.seminoncol.2018.01.004; Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080; Place AE, 2003, CLIN CANCER RES, V9, P2798; Pujols L, 2012, J PHARMACOL EXP THER, V343, P184, DOI 10.1124/jpet.111.190710; Quiros PM, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.968505; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Samudio I, 2006, MOL PHARMACOL, V69, P1182, DOI 10.1124/mol.105.018051; Shin CS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20597-z; Shin M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23495-0; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003; Su SC, 2016, STRUCTURE, V24, P676, DOI 10.1016/j.str.2016.03.003; Tai TS, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/9401648; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Toto RD, 2018, J AM SOC NEPHROL, V29, P360, DOI 10.1681/ASN.2017121317; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Venkatesh S, 2020, MITOCHONDRION, V51, P46, DOI 10.1016/j.mito.2019.10.004; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Voos W, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020253; Wang HM, 2010, CANCER SCI, V101, P2612, DOI 10.1111/j.1349-7006.2010.01701.x; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Wong KS, 2019, ADV EXP MED BIOL, V1158, P119, DOI [10.1007/978-981-113-8367-0_8, 10.1007/978-981-13-8367-0_8]; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Yu L, 2015, HUM MOL GENET, V24, P4764, DOI 10.1093/hmg/ddv196	74	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101719	10.1016/j.jbc.2022.101719	http://dx.doi.org/10.1016/j.jbc.2022.101719			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151690	gold, Green Published			2022-12-28	WOS:000789394500004
J	Oo, A; Zandi, K; Shepard, C; Bassit, LC; Musall, K; Cho, YJ; Kim, DH; Schinazi, RF; Kim, B; Goh, SL				Oo, Adrian; Zandi, Keivan; Shepard, Caitlin; Bassit, Leda C.; Musall, Katie; Cho, Young-Jae; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek; Goh, Shu Ling			Elimination of Aicardi-Goutieres syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; I INTERFERON; INFECTED MACROPHAGES; C VIRUS; MUTATIONS; DNA; CELLS; HIV-1; RESPONSES; DEGRADATION	The lack of antiviral innate immune responses during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is characterized by limited production of interferons (IFNs). One protein associated with Aicardi-Goutieres syndrome, SAMHD1, has been shown to negatively regulate the IFN-1 signaling pathway. However, it is unclear whether elevated IFN signaling associated with genetic loss of SAMHD1 would affect SARS-CoV-2 replication. In this study, we established in vitro tissue culture model systems for SARS-CoV-2 and human coronavirus OC43 infections in which SAMHD1 protein expression was absent as a result of CRISPR-Cas9 gene KO or lentiviral viral protein X-mediated proteosomal degradation. We show that both SARS-CoV-2 and human coronavirus OC43 replications were suppressed in SAMHD1 KO 293T and differentiated THP-1 macrophage cell lines. Similarly, when SAMHD1 was degraded by virus-like particles in primary monocyte-derived macrophages, we observed lower levels of SARS-CoV-2 RNA. The loss of SAMHD1 in 293T and differentiated THP-1 cells resulted in upregulated gene expression of IFNs and innate immunity signaling proteins from several pathways, with STAT1 mRNA being the most prominently elevated ones. Furthermore, SARS-CoV-2 replication was significantly increased in both SAMHD1 WT and KO cells when expression and phosphorylation of STAT1 were downregulated by JAK inhibitor baricitinib, which over-rode the activated antiviral innate immunity in the KO cells. This further validates baricitinib as a treatment of SARS-CoV-2-infected patients primarily at the postviral clearance stage. Overall, our tissue culture model systems demonstrated that the elevated innate immune response and IFN activation upon genetic loss of SAMHD1 effectively suppresses SARS-CoV-2 replication.	[Oo, Adrian; Zandi, Keivan; Shepard, Caitlin; Bassit, Leda C.; Musall, Katie; Cho, Young-Jae; Schinazi, Raymond F.; Kim, Baek; Goh, Shu Ling] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Pharm, Seoul, South Korea; [Kim, Baek] Ctr Drug Discovery, Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.; Kim, B (corresponding author), Ctr Drug Discovery, Childrens Healthcare Atlanta, Atlanta, GA USA.	baek.kim@emory.edu	Oo, Adrian/ABB-6800-2021	Oo, Adrian/0000-0002-2469-5391; Kim, Baek/0000-0001-7986-4335; Goh, Shu Ling/0000-0001-8575-6103	National Institutes of Health [AI136581, AI162633, AI141327, MH116695]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (grant nos.: AI136581 [to B. K.] , AI162633 [to B. K.] , AI141327 [to B. K.] , and MH116695 [to R. F. S.] ) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; AlBurtamani N, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13061161; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan RWY, 2013, J VIROL, V87, P6604, DOI 10.1128/JVI.00009-13; Cheemarla NR, 2021, J EXP MED, V218, DOI 10.1084/jem.20210583; Chen DY, 2021, J VIROL, V95, DOI 10.1128/JVI.00862-21; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Clementi N, 2020, J INFECT DIS, V222, P722, DOI 10.1093/infdis/jiaa350; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dang C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.650708; Desforges M, 2007, VIRUS RES, V130, P228, DOI 10.1016/j.virusres.2007.06.016; DHAWAN S, 1995, PATHOBIOLOGY, V63, P93, DOI 10.1159/000163939; Dorner T, 2020, LUPUS SCI MED, V7, DOI 10.1136/lupus-2020-000424; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Fu WH, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100478; Goraya MU, 2020, MICROB PATHOGENESIS, V139, DOI 10.1016/j.micpath.2019.103919; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hosmillo M, 2020, MBIO, V11, DOI 10.1128/mBio.00215-20; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; La Rosee F, 2020, LEUKEMIA, V34, P1805, DOI 10.1038/s41375-020-0891-0; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Lenzi GM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0111-y; Li N, 2019, GENES IMMUN, V20, P234, DOI 10.1038/s41435-018-0028-x; Li Y, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104743; Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211211; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Mantlo E, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104811; Marconi VC, 2021, LANCET RESP MED, V9, P1407, DOI 10.1016/S2213-2600(21)00331-3; Matthews K, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0209-9; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Park BK, 2021, BIOMOL THER, V29, P273, DOI 10.4062/biomolther.2020.226; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Rebendenne A, 2021, J VIROL, V95, DOI 10.1128/JVI.02415-20; Ribero MS, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008737; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rincon-Arevalo H, 2022, EUR J IMMUNOL, V52, P138, DOI 10.1002/eji.202149575; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun LN, 2010, ACTA BIOCH BIOPH SIN, V42, P230, DOI 10.1093/abbs/gmq009; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Tanaka Y, 2016, J RHEUMATOL, V43, P504, DOI 10.3899/jrheum.150613; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Titanji BK, 2021, CLIN INFECT DIS, V72, P1247, DOI 10.1093/cid/ciaa879; Trottier C, 2009, FASEB J, V23, P3203, DOI 10.1096/fj.09-129288; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Wei X, 2009, J INTERF CYTOK RES, V29, P171, DOI 10.1089/jir.2008.0040; White TE, 2017, HUM MUTAT, V38, P658, DOI 10.1002/humu.23201; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wichit S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071695; Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010; Zheng J, 2021, J INFECT DIS, V223, P785, DOI 10.1093/infdis/jiaa753; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	79	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101635	10.1016/j.jbc.2022.101635	http://dx.doi.org/10.1016/j.jbc.2022.101635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0W8HP	35085552	gold, Green Published			2022-12-28	WOS:000789261900011
J	Wong, BH; Mei, D; Chua, GL; Galam, DL; Wenk, MR; Torta, F; Silver, DL				Wong, Bernice H.; Mei, Ding; Chua, Geok Lin; Galam, Dwight L.; Wenk, Markus R.; Torta, Federico; Silver, David L.			The lipid transporter Mfsd2a maintains pulmonary surfactant homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; PHOSPHOLIPASE A(2); LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; CLEARANCE; PROTEIN; INFLAMMATION; MECHANISMS; MEMBRANES; FIBROSIS	Pulmonary surfactant is a lipoprotein complex essential for lung function, and insufficiency or altered surfactant composition is associated with major lung diseases, such as acute respiratory distress syndromes, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease. Pulmonary surfactant is primarily composed of phosphatidylcholine (PC) in complex with specialized surfactant proteins and secreted by alveolar type 2 (AT2) cells. Surfactant homeostasis on the alveolar surface is balanced by the rates of synthesis and secretion with reuptake and recycling by AT2 cells, with some degradation by pulmonary macrophages and loss up the bronchial tree. However, whether phospholipid (PL) transporters exist in AT2 cells to mediate reuptake of surfactant PL remains to be identified. Here, we demonstrate that major facilitator superfamily domain containing 2a (Mfsd2a), a sodium-dependent lysophosphatidylcholine (LPC) transporter, is expressed at the apical surface of AT2 cells. A mouse model with inducible AT2 cell-specific deficiency of Mfsd2a exhibited AT2 cell hypertrophy with reduced total surfactant PL levels because of reductions in the most abundant surfactants, PC containing dipalmitic acid, and PC species containing the omega-3 fatty acid docosahexaenoic acid. These changes in surfactant levels and composition were mirrored by similar changes in the AT2 cell lipidome. Mechanistically, direct tracheal instillation of fluorescent LPC and PC probes indicated that Mfsd2a mediates the uptake of LPC generated by pulmonary phospholipase activity in the alveolar space. These studies reveal that Mfsd2a-mediated LPC uptake is quantitatively important in maintaining surfactant homeostasis and identify this lipid transporter as a physiological component of surfactant recycling.	[Wong, Bernice H.; Chua, Geok Lin; Galam, Dwight L.; Silver, David L.] Duke NUS Med Sch, Signat Res Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Mei, Ding; Wenk, Markus R.; Torta, Federico] Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore; [Mei, Ding; Wenk, Markus R.; Torta, Federico] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Silver, DL (corresponding author), Duke NUS Med Sch, Signat Res Program Cardiovasc & Metab Disorders, Singapore, Singapore.	david.silver@duke-nus.edu.sg		Chua, Geok Lin/0000-0002-9763-0652; Galam, Dwight Lark/0000-0002-1158-1969; Silver, David/0000-0002-7289-9890; Wong, Bernice/0000-0001-8981-1376	National Research Foundation (NRF), Singapore [NRF-NRFI2017-05]; Khoo Postdoctoral Research Fellowship Awards; National University of Singapore via the Life Sciences Institute; National Research Foundation [NRFSBP-P4]; NRF; A*STAR Industry Alignment Fund-Industry Collaboration Project [I1901E0040];  [NRF2017_SISFP08]	National Research Foundation (NRF), Singapore(National Research Foundation, Singapore); Khoo Postdoctoral Research Fellowship Awards; National University of Singapore via the Life Sciences Institute(National University of Singapore); National Research Foundation; NRF; A*STAR Industry Alignment Fund-Industry Collaboration Project(Agency for Science Technology & Research (A*STAR)); 	This study was supported by a grant from the National Research Foundation (NRF), Singapore (grant no.: NRF-NRFI2017-05; to D. L. S.) and by Khoo Postdoctoral Research Fellowship Awards (to B. H. W.). Work in SLING (M. R. W., F. T., and D. M.) is supported by grants from the National University of Singapore via the Life Sciences Institute, the National Research Foundation (grant no.: NRFSBP-P4), the NRF, and A*STAR Industry Alignment Fund-Industry Collaboration Project (grant no.: I1901E0040), and the NRF2017_SISFP08.	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Agudelo CW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228279; Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; BAISTED DJ, 1988, BIOCHEM J, V253, P693, DOI 10.1042/bj2530693; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Bernhard W, 2004, AM J RESP CRIT CARE, V170, P54, DOI 10.1164/rccm.200401-089OC; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; BURDGE GC, 1993, BIOCHIM BIOPHYS ACTA, V1166, P251, DOI 10.1016/0005-2760(93)90105-I; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cater RJ, 2021, NATURE, V595, P315, DOI 10.1038/s41586-021-03650-9; Chan JP, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006443; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; GRABNER R, 1991, AM J PHYSIOL, V261, pL472, DOI 10.1152/ajplung.1991.261.6.L472; Griese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117985; GROSS NJ, 1988, J APPL PHYSIOL, V64, P2017, DOI 10.1152/jappl.1988.64.5.2017; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; HALLMAN M, 1981, J CLIN INVEST, V68, P742, DOI 10.1172/JCI110310; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Harel T, 2018, NEUROGENETICS, V19, P227, DOI 10.1007/s10048-018-0556-6; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; JACOBS H, 1983, J BIOL CHEM, V258, P4156; Kandasamy P, 2016, J LIPID RES, V57, P993, DOI 10.1194/jlr.M065201; Karnati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203464; Koenitzer JR, 2020, AM J RESP CELL MOL, V63, P739, DOI 10.1165/rcmb.2020-0095MA; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lobanova ES, 2019, J NEUROSCI, V39, P9689, DOI 10.1523/JNEUROSCI.1142-19.2019; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madsen J, 2018, J LIPID RES, V59, P1880, DOI 10.1194/jlr.M085431; Mae MA, 2021, CIRC RES, V128, pE46, DOI 10.1161/CIRCRESAHA.120.317473; Martini WZ, 1999, AM J PHYSIOL-ENDOC M, V277, pE187, DOI 10.1152/ajpendo.1999.277.1.E187; McDonough JE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131597; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Numata M, 2015, J LIPID RES, V56, P578, DOI 10.1194/jlr.M055723; Numata M, 2013, INT J NANOMED, V8, P1417, DOI 10.2147/IJN.S39888; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OYARZUN MJ, 1980, AM REV RESPIR DIS, V121, P709; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Piccirillo AR, 2019, J IMMUNOL, V203, P117, DOI 10.4049/jimmunol.1801585; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Richmond BL, 2000, GENE, V244, P65, DOI 10.1016/S0378-1119(00)00006-8; Rindler TN, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97381; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Scala M, 2020, EUR J HUM GENET, V28, P1509, DOI 10.1038/s41431-020-0669-x; SCARPELLI EM, 1975, PEDIATR RES, V9, P195, DOI 10.1203/00006450-197504000-00011; Schmidt R, 2001, AM J RESP CRIT CARE, V163, P95, DOI 10.1164/ajrccm.163.1.9903029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinha Meenal, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2013; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wong BH, 2016, J BIOL CHEM, V291, P10501, DOI 10.1074/jbc.M116.721340; WRIGHT JR, 1990, AM J PHYSIOL, V259, pL1, DOI 10.1152/ajplung.1990.259.2.L1; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Yang R, 2019, METABOLITES, V9, DOI 10.3390/metabo9040080; Yoshida M, 2004, CELL MOL BIOL, V50, P639; Zepp JA, 2019, NAT REV MOL CELL BIO, V20, P551, DOI 10.1038/s41580-019-0141-3	67	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101709	10.1016/j.jbc.2022.101709	http://dx.doi.org/10.1016/j.jbc.2022.101709			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150739	Green Published, gold			2022-12-28	WOS:000821054100009
J	Park, Y; Stukey, GJ; Jog, R; Kwiatek, JM; Han, GS; Carman, GM				Park, Yeonhee; Stukey, Geordan J.; Jog, Ruta; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.			Mutant phosphatidate phosphatase Pah1-W637A exhibits altered phosphorylation, membrane association, and enzyme function in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-SYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; MEDIATED REGULATION; ORTHOLOGUE PAH1P; ACID PHOSPHATASE; GLOBAL ANALYSIS; CROSS-TALK	The Saccharomyces cerevisiae PAH1-encoded phosphatidate (PA) phosphatase, which catalyzes the dephosphorylation of PA to produce diacylglycerol, controls the bifurcation of PA into triacylglycerol synthesis and phospholipid synthesis. Pah1 is inactive in the cytosol as a phosphorylated form and becomes active on the membrane as a dephosphorylated form by the Nem1-Spo7 protein phosphatase. We show that the conserved Trp-637 residue of Pah1, located in the intrinsically disordered region, is required for normal synthesis of membrane phospholipids, sterols, triacylglycerol, and the formation of lipid droplets. Analysis of mutant Pah1-W637A showed that the tryptophan residue is involved in the phosphorylation-mediated/dephosphorylation-mediated membrane association of the enzyme and its catalytic activity. The endogenous phosphorylation of Pah1-W637A was increased at the sites of the N-terminal region but was decreased at the sites of the C-terminal region. The altered phosphorylation correlated with an increase in its membrane association. In addition, membrane-associated PA phosphatase activity in vitro was elevated in cells expressing Pah1-W637A as a result of the increased membrane association of the mutant enzyme. How-ever, the inherent catalytic function of Pah1 was not affected by the W637A mutation. Prediction of Pah1 structure by Alpha-Fold shows that Trp-637 and the catalytic residues Asp-398 and Asp-400 in the haloacid dehalogenase-like domain almost lie in the same plane, suggesting that these residues are important to properly position the enzyme for substrate recognition at the membrane surface. These findings underscore the importance of Trp-637 in Pah1 regulation by phosphorylation, membrane association of the enzyme, and its function in lipid synthesis.	[Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08854 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08854 USA.	gcarman@rutgers.edu		Stukey, Geordan/0000-0003-2562-5130; Kwiatek, Joanna/0000-0001-8934-0922	National Institutes of Health [GM136128]; United States Public Health Service	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported, in whole or in part, by the National Institutes of Health Grant GM136128 from the United States Public Health Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carey J, 2000, METHOD ENZYMOL, V328, P499, DOI 10.1016/S0076-6879(00)28415-2; Carman GM, 2019, J LIPID RES, V60, P2, DOI 10.1194/jlr.S087452; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Corcoles-Saez I, 2016, BBA-MOL CELL BIOL L, V1861, P213, DOI 10.1016/j.bbalip.2015.12.014; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Dey P, 2020, J LIPID RES, V61, P1556, DOI 10.1194/jlr.R120001092; Dey P, 2019, J BIOL CHEM, V294, P15997, DOI 10.1074/jbc.RA119.010592; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Gu WJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24929-5; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hassaninasab A, 2019, J BIOL CHEM, V294, P18256, DOI 10.1074/jbc.RA119.011314; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Khayyo VI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15124-z; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kwiatek JM, 2020, J LIPID RES, V61, P1232, DOI 10.1194/jlr.RA120000937; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanz MC, 2021, EMBO REP, V22, DOI 10.15252/embr.202051121; Li TY, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04363, 10.1038/s41467-018-04363-w]; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1990, J BIOL CHEM, V265, P166; Liu N, 2019, NEW PHYTOL, V223, P412, DOI 10.1111/nph.15748; Lussier M, 1997, GENETICS, V147, P435; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MacGilvray ME, 2020, J PROTEOME RES, V19, P3405, DOI 10.1021/acs.jproteome.0c00253; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Mirheydari M, 2020, J BIOL CHEM, V295, P11473, DOI 10.1074/jbc.RA120.014129; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Papagiannidis D, 2021, EMBO J, V40, DOI 10.15252/embj.2021107958; Park Y, 2017, J BIOL CHEM, V292, P19580, DOI 10.1074/jbc.M117.819375; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Romanauska A, 2018, CELL, V174, P700, DOI 10.1016/j.cell.2018.05.047; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Su WM, 2018, J BIOL CHEM, V293, P15801, DOI 10.1074/jbc.RA118.005348; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	117	2	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101578	10.1016/j.jbc.2022.101578	http://dx.doi.org/10.1016/j.jbc.2022.101578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1FV	35026226	Green Published, gold			2022-12-28	WOS:000761371500010
